<?xml version="1.0" encoding="ISO-8859-1"?><COCHRANE_REVIEW DESCRIPTION="For publication" DOI="10.1002/14651858.CD004476.pub3" GROUP_ID="ANAESTH" ID="523703020618503246" MERGED_FROM="" MODIFIED="2018-03-06 09:49:00 +0000" MODIFIED_BY="Jane Cracknell" REVIEW_NO="072" REVMAN_SUB_VERSION="5.3.5 " REVMAN_VERSION="5" SPLIT_FROM="" STAGE="R" STATUS="A" TYPE="INTERVENTION" VERSION_NO="5.0"><COVER_SHEET MODIFIED="2018-03-06 09:48:54 +0000" MODIFIED_BY="Jane Cracknell"><TITLE MODIFIED="2014-01-06 19:32:13 +0000" MODIFIED_BY="Hermann Blessberger">Perioperative beta-blockers for preventing surgery-related mortality and morbidity</TITLE><CONTACT MODIFIED="2018-03-06 09:48:54 +0000" MODIFIED_BY="Jane Cracknell"><PERSON ID="15DB2D0182E26AA200C069EC61219D96" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>Hermann</FIRST_NAME><LAST_NAME>Blessberger</LAST_NAME><POSITION>Resident</POSITION><EMAIL_1>hermann.blessberger@kepleruniklinikum.at</EMAIL_1><EMAIL_2>hermann.blessberger@me.com</EMAIL_2><ADDRESS><DEPARTMENT>Department of Cardiology, Med Campus III</DEPARTMENT><ORGANISATION>Kepler University Hospital, Medical Faculty of the Johannes Kepler University Linz</ORGANISATION><ADDRESS_1>Krankenhausstraße 9</ADDRESS_1><CITY>Linz</CITY><ZIP>4020</ZIP><COUNTRY CODE="AT">Austria</COUNTRY><PHONE_1>+43-732-7806 ext: 6220</PHONE_1><PHONE_2>+43/650/2646148</PHONE_2><FAX_1>+43-732- 7806 6205</FAX_1></ADDRESS></PERSON></CONTACT><CREATORS MODIFIED="2018-03-06 09:48:54 +0000" MODIFIED_BY="Jane Cracknell"><PERSON ID="15DB2D0182E26AA200C069EC61219D96" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>Hermann</FIRST_NAME><LAST_NAME>Blessberger</LAST_NAME><POSITION>Resident</POSITION><EMAIL_1>hermann.blessberger@kepleruniklinikum.at</EMAIL_1><EMAIL_2>hermann.blessberger@me.com</EMAIL_2><ADDRESS><DEPARTMENT>Department of Cardiology, Med Campus III</DEPARTMENT><ORGANISATION>Kepler University Hospital, Medical Faculty of the Johannes Kepler University Linz</ORGANISATION><ADDRESS_1>Krankenhausstraße 9</ADDRESS_1><CITY>Linz</CITY><ZIP>4020</ZIP><COUNTRY CODE="AT">Austria</COUNTRY><PHONE_1>+43-732-7806 ext: 6220</PHONE_1><PHONE_2>+43/650/2646148</PHONE_2><FAX_1>+43-732- 7806 6205</FAX_1></ADDRESS></PERSON><PERSON ID="z1303130952084090184797929316063" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>Juergen</FIRST_NAME><LAST_NAME>Kammler</LAST_NAME><POSITION>Specialist for cardiology</POSITION><EMAIL_1>juergen.kammler@kepleruniklinikum.at</EMAIL_1><MOBILE_PHONE>0043-664-2570596</MOBILE_PHONE><ADDRESS><DEPARTMENT>Department of Cardiology, Med Campus III</DEPARTMENT><ORGANISATION>Kepler University Hospital, Medical Faculty of the Johannes Kepler University Linz</ORGANISATION><ADDRESS_1>Krankenhausstrasse 9</ADDRESS_1><CITY>Linz</CITY><ZIP>4021</ZIP><COUNTRY CODE="AT">Austria</COUNTRY><PHONE_1>0043-732-7806-73213</PHONE_1><FAX_1>0043-732-7806-6205</FAX_1></ADDRESS></PERSON><PERSON ID="12568" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>Hans</FIRST_NAME><LAST_NAME>Domanovits</LAST_NAME><EMAIL_1>hans.domanovits@meduniwien.ac.at</EMAIL_1><ADDRESS><DEPARTMENT>Department of Emergency Medicine</DEPARTMENT><ORGANISATION>Vienna General Hospital, Medical University of Vienna</ORGANISATION><ADDRESS_1>Währinger Gürtel 18-20</ADDRESS_1><CITY>Vienna</CITY><ZIP>1090</ZIP><COUNTRY CODE="AT">Austria</COUNTRY><PHONE_1>+43-1-40400 ext: 3951</PHONE_1><FAX_1>+43-1-40400-2512</FAX_1></ADDRESS></PERSON><PERSON ID="12646" ROLE="AUTHOR"><FIRST_NAME>Oliver</FIRST_NAME><LAST_NAME>Schlager</LAST_NAME><EMAIL_1>oliver.schlager@meduniwien.ac.at</EMAIL_1><ADDRESS><DEPARTMENT>Department of Internal Medicine II, Division of Angiology</DEPARTMENT><ORGANISATION>Vienna General Hospital, Medical University of Vienna</ORGANISATION><ADDRESS_1>Währinger Gürtel 18-20</ADDRESS_1><CITY>Vienna</CITY><ZIP>1090</ZIP><COUNTRY CODE="AT">Austria</COUNTRY><PHONE_1>+43-1-40400 ext 4670</PHONE_1><FAX_1>+43-1- 40400 4216</FAX_1></ADDRESS></PERSON><PERSON ID="12666" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>Brigitte</FIRST_NAME><LAST_NAME>Wildner</LAST_NAME><SUFFIX>MSc</SUFFIX><EMAIL_1>brigitte.wildner@meduniwien.ac.at</EMAIL_1><EMAIL_2>brigitte.wildner@univie.ac.at</EMAIL_2><ADDRESS><DEPARTMENT>Information Retrieval Office</DEPARTMENT><ORGANISATION>University Library of the Medical University of Vienna</ORGANISATION><ADDRESS_1>Währinger Gürtel 18-20</ADDRESS_1><CITY>Vienna</CITY><ZIP>1090</ZIP><COUNTRY CODE="AT">Austria</COUNTRY><PHONE_1>+43-1-4040160 ext: 26125</PHONE_1><FAX_1>+43-1-40160 926 001</FAX_1></ADDRESS></PERSON><PERSON ID="28453367249125738568100913150343" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>Danyel</FIRST_NAME><LAST_NAME>Azar</LAST_NAME><EMAIL_1>Danyel.Azar@baden.lknoe.at</EMAIL_1><ADDRESS><DEPARTMENT>Department of General Surgery</DEPARTMENT><ORGANISATION>Landesklinikum Thermenregion Baden</ORGANISATION><ADDRESS_1>Wimmergasse 19</ADDRESS_1><CITY>Baden</CITY><ZIP>2500</ZIP><COUNTRY CODE="AT">Austria</COUNTRY></ADDRESS></PERSON><PERSON ID="12645" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>Martin</FIRST_NAME><LAST_NAME>Schillinger</LAST_NAME><POSITION>Associate Professor</POSITION><EMAIL_1>martin.schillinger@meduniwien.ac.at</EMAIL_1><EMAIL_2>m.schillinger@imed19.at</EMAIL_2><ADDRESS><DEPARTMENT>Department of Internal Medicine II, Division of Angiology</DEPARTMENT><ORGANISATION>Vienna General Hospital, Medical University of Vienna</ORGANISATION><ADDRESS_1>Währinger Gürtel 18-20</ADDRESS_1><CITY>Vienna</CITY><ZIP>1090</ZIP><COUNTRY CODE="AT">Austria</COUNTRY><PHONE_1>+43-1-40400 ext: 4671</PHONE_1><FAX_1>+43-1- 40400 4216</FAX_1></ADDRESS></PERSON><PERSON ID="12664" ROLE="AUTHOR"><PREFIX>Dr.</PREFIX><FIRST_NAME>Franz</FIRST_NAME><LAST_NAME>Wiesbauer</LAST_NAME><SUFFIX>MPH</SUFFIX><POSITION>Resident</POSITION><EMAIL_1>franz.wiesbauer@gmail.com</EMAIL_1><ADDRESS><DEPARTMENT>Department of Internal Medicine II</DEPARTMENT><ORGANISATION>Division of Cardiology, Vienna General Hospital, Medical University of Vienna</ORGANISATION><ADDRESS_1>Währingerstrasse 18-20</ADDRESS_1><CITY>Vienna</CITY><ZIP>1090</ZIP><COUNTRY CODE="AT">Austria</COUNTRY><PHONE_1>+43 -1- 40400 ext 4670</PHONE_1><FAX_1>+ 43-1 40400 4216</FAX_1></ADDRESS></PERSON><PERSON ID="z1307231311140781579851132978136" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>Clemens</FIRST_NAME><LAST_NAME>Steinwender</LAST_NAME><EMAIL_1>clemens.steinwender@kepleruniklinikum.at</EMAIL_1><ADDRESS><DEPARTMENT>Department of Cardiology, Med Campus III</DEPARTMENT><ORGANISATION>Kepler University Hospital, Medical Faculty of the Johannes Kepler University Linz</ORGANISATION><ADDRESS_1>Krankenhausstr. 9</ADDRESS_1><CITY>Linz</CITY><ZIP>4020</ZIP><COUNTRY CODE="AT">Austria</COUNTRY></ADDRESS></PERSON></CREATORS><DATES MODIFIED="2017-12-11 12:06:18 +0000" MODIFIED_BY="[Empty name]"><UP_TO_DATE><DATE DAY="30" MONTH="6" YEAR="2013"/></UP_TO_DATE><LAST_SEARCH><DATE DAY="30" MONTH="6" YEAR="2013"/></LAST_SEARCH><NEXT_STAGE><DATE DAY="31" MONTH="12" YEAR="2018"/></NEXT_STAGE><PROTOCOL_PUBLISHED ISSUE="4" YEAR="2003"/><REVIEW_PUBLISHED ISSUE="9" YEAR="2014"/><LAST_CITATION_ISSUE ISSUE="3" YEAR="2018"/></DATES><WHATS_NEW MODIFIED="2018-03-06 09:40:59 +0000" MODIFIED_BY="[Empty name]"><WHATS_NEW_ENTRY EVENT="NEW_CITATION_NEW_CONCLUSIONS" MODIFIED="2018-03-06 09:40:59 +0000" MODIFIED_BY="[Empty name]"><DATE DAY="22" MONTH="2" YEAR="2018"/><DESCRIPTION><P>Removal of retracted study (<LINK REF="STD-Suttner-2009" TYPE="STUDY">Suttner 2009</LINK>)</P></DESCRIPTION></WHATS_NEW_ENTRY><WHATS_NEW_ENTRY EVENT="AMENDMENT" MODIFIED="2018-02-23 18:15:04 +0000" MODIFIED_BY="[Empty name]"><DATE DAY="22" MONTH="2" YEAR="2018"/><DESCRIPTION><P>Following publication of the first version of this systematic review, a previously included study was retracted (<LINK REF="STD-Suttner-2009" TYPE="STUDY">Suttner 2009</LINK>). This trial has now been excluded and all relevant analyses and results have been amended accordingly. All NNTB/Hs were recalculated according to the formula in the <I>Cochrane Handbook for Systematic Reviews of Interventions</I> (<LINK REF="REF-Higgins-2011" TYPE="REFERENCE">Higgins 2011</LINK>) . Guideline recommendations were updated in the <I>Discussion</I> section.</P></DESCRIPTION></WHATS_NEW_ENTRY></WHATS_NEW><HISTORY/><SOURCES_OF_SUPPORT MODIFIED="2010-09-03 15:08:18 +0100" MODIFIED_BY="Hermann Blessberger"><INTERNAL_SOURCES MODIFIED="2010-09-03 15:08:18 +0100" MODIFIED_BY="Hermann Blessberger"><SOURCE MODIFIED="2010-09-03 15:08:18 +0100" MODIFIED_BY="Hermann Blessberger"><NAME>None</NAME><COUNTRY CODE="NONE">Other</COUNTRY><DESCRIPTION/></SOURCE></INTERNAL_SOURCES><EXTERNAL_SOURCES MODIFIED="2010-09-03 15:07:12 +0100" MODIFIED_BY="Hermann Blessberger"><SOURCE MODIFIED="2010-09-03 15:07:12 +0100" MODIFIED_BY="Hermann Blessberger"><NAME>None</NAME><COUNTRY CODE="NONE">Other</COUNTRY><DESCRIPTION/></SOURCE></EXTERNAL_SOURCES></SOURCES_OF_SUPPORT><MESH_TERMS VERIFIED="NO"/><KEYWORDS/></COVER_SHEET><MAIN_TEXT MODIFIED="2018-02-23 18:20:45 +0000" MODIFIED_BY="[Empty name]"><SUMMARY MODIFIED="2017-12-08 15:07:38 +0000" MODIFIED_BY="Hermann Blessberger"><TITLE MODIFIED="2014-01-06 19:35:11 +0000" MODIFIED_BY="Hermann Blessberger">Influence of beta-blockers on perioperative adverse events</TITLE><SUMMARY_BODY MODIFIED="2017-12-08 15:07:38 +0000" MODIFIED_BY="Hermann Blessberger"><P>Any type of surgery is associated with an increased stress response, which can make the body vulnerable to untoward outcomes. These outcomes may range from death to a heart attack and rhythm disturbances to heart failure, stroke and the like. Beta-blockers are drugs that attenuate this stress response, which results in slowing down of heart rate and a fall in blood pressure. Whereas on the one hand, these effects are desirable to fight the stress response, the same effects&#8212;if pronounced&#8212;may cause very low blood pressure, a very low pulse and ultimately stroke or death.</P><P>In our analysis of current evidence (88 randomized controlled trials with 19,161 participants: heart surgery&#8212;53 trials, other types of surgery&#8212;35 trials), we showed that beta-blockers had a protective effect against rhythm disturbances after heart surgery. We found no evidence of an effect of beta-blockers on death; on the occurrence of heart attacks, strokes or heart failure; or on development of disproportionately low blood pressure or slow pulse during this type of surgery. Length of hospital stay after heart surgery was reduced by about 0.5 days in patients taking beta-blockers.</P><P>In non-cardiac surgery, beta-blockers increased the risk of death and stroke, the latter only when a representative group of high-quality trials was analysed. The protective effect against heart attacks and rhythm disturbances was counterbalanced by this increased risk of death and stroke. We could not identify evidence of an effect of beta-blockers on heart failure or length of stay in this group of patients.</P><P>In conclusion, perioperative use of beta-blockers seems beneficial overall in <I><B>cardiac surgery</B></I>, as they can substantially reduce the high burden of rhythm disturbances after cardiac surgery. Their influence on death, heart attacks, stroke, heart failure or development of disproportionately low blood pressure or slow pulse in this setting remains unclear.</P><P>In <I><B>non-cardiac surgery, </B></I>evidence shows an increase in death and a potential increase in stroke rate with the use of beta-blockers. The substantial reduction in rhythm disturbances and heart attacks in this setting seems to be offset by this potential increase in mortality and stroke. As the quality of evidence is still low to moderate, more evidence is needed before a definitive conclusion can be drawn.</P></SUMMARY_BODY></SUMMARY><ABSTRACT MODIFIED="2018-02-23 18:18:53 +0000" MODIFIED_BY="[Empty name]"><ABS_BACKGROUND MODIFIED="2014-08-26 13:00:49 +0100" MODIFIED_BY="Jane Cracknell"><P>Randomized controlled trials have yielded conflicting results regarding the ability of beta-blockers to influence perioperative cardiovascular morbidity and mortality. Thus routine prescription of these drugs in unselected patients remains a controversial issue.</P></ABS_BACKGROUND><ABS_OBJECTIVES MODIFIED="2014-08-26 13:00:49 +0100" MODIFIED_BY="Jane Cracknell"><P>The objective of this review was to systematically analyse the effects of perioperatively administered beta-blockers for prevention of surgery-related mortality and morbidity in patients undergoing any type of surgery while under general anaesthesia.</P></ABS_OBJECTIVES><ABS_SEARCH_STRATEGY MODIFIED="2018-02-23 18:15:04 +0000" MODIFIED_BY="[Empty name]"><P>We identified trials by searching the following databases from the date of their inception until June 2013: MEDLINE, Embase , the Cochrane Central Register of Controlled Trials (CENTRAL), Biosis Previews, CAB Abstracts, Cumulative Index to Nursing and Allied Health Literature (CINAHL), Derwent Drug File, Science Citation Index Expanded, Life Sciences Collection, Global Health and PASCAL. In addition, we searched online resources to identify grey literature.</P></ABS_SEARCH_STRATEGY><ABS_SELECTION_CRITERIA MODIFIED="2014-08-26 13:00:49 +0100" MODIFIED_BY="Jane Cracknell"><P>We included randomized controlled trials if participants were randomly assigned to a beta-blocker group or a control group (standard care or placebo). Surgery (any type) had to be performed with all or at least a significant proportion of participants under general anaesthesia.</P></ABS_SELECTION_CRITERIA><ABS_DATA_COLLECTION MODIFIED="2014-08-26 13:00:56 +0100" MODIFIED_BY="Jane Cracknell"><P>Two review authors independently extracted data from all studies. In cases of disagreement, we reassessed the respective studies to reach consensus. We computed summary estimates in the absence of significant clinical heterogeneity. Risk ratios (RRs) were used for dichotomous outcomes, and mean differences (MDs) were used for continuous outcomes. We performed subgroup analyses for various potential effect modifiers.</P></ABS_DATA_COLLECTION><ABS_RESULTS MODIFIED="2018-02-23 18:18:53 +0000" MODIFIED_BY="[Empty name]"><P>We included 88 randomized controlled trials with 19,161 participants. Six studies (7%) met the highest methodological quality criteria (studies with overall low risk of bias: adequate sequence generation, adequate allocation concealment, double/triple-blinded design with a placebo group, intention-to-treat analysis), whereas in the remaining trials, some form of bias was present or could not be definitively excluded (studies with overall unclear or high risk of bias). Outcomes were evaluated separately for cardiac and non-cardiac surgery.</P><P><B>CARDIAC SURGERY (53 trials)</B></P><P>We found <B><U>no clear evidence of an effect</U></B> of beta-blockers on the following outcomes.</P><P>&#8226; <I><B>All-cause mortality:</B></I> RR 0.73, 95% CI 0.35 to 1.52, 3783 participants, moderate quality evidence.</P><P>&#8226; <I><B>Acute myocardial infarction (AMI):</B></I> RR 1.04, 95% CI 0.71 to 1.51, 3553 participants, moderate quality evidence.</P><P>&#8226; <I><B>Myocardial ischaemia:</B></I> RR 0.51, 95% CI 0.25 to 1.05, 166 participants, low quality evidence.</P><P>&#8226; <I><B>Cerebrovascular events:</B></I> RR 1.52, 95% CI 0.58 to 4.02, 1400 participants, low quality evidence.</P><P>&#8226; <I><B>Hypotension:</B></I> RR 1.54, 95% CI 0.67 to 3.51, 558 participants, low quality evidence.</P><P>&#8226; <I><B>Bradycardia:</B></I> RR 1.61, 95% CI 0.97 to 2.66, 660 participants, low quality evidence.</P><P>&#8226; <I><B>Congestive heart failure:</B></I> RR 0.22, 95% CI 0.04 to 1.34, 311 participants, low quality evidence.</P><P>Beta-blockers significantly <B><U>reduced</U></B> the occurrence of the following endpoints.</P><P>&#8226; <I><B>Ventricular arrhythmias:</B></I> RR 0.37, 95% CI 0.24 to 0.58, number needed to treat for an additional beneficial outcome (NNTB) 29, 2292 participants, moderate quality evidence.</P><P>&#8226; <I><B>Supraventricular arrhythmias:</B></I> RR 0.44, 95% CI 0.36 to 0.53, NNTB five, 6420 participants, high quality evidence.</P><P>&#8226; On average, beta-blockers reduced <I><B>length of hospital stay</B></I> by 0.54 days (95% CI -0.90 to -0.19, 2450 participants, low quality evidence).</P><P><B>NON-CARDIAC SURGERY (35 trials)</B></P><P>Beta-blockers significantly <B><U>increased</U></B> the occurrence of the following adverse events.</P><P>&#8226; <I><B>All-cause mortality:</B></I> RR 1.25, 95% CI 1.00 to 1.57, 11,413 participants, low quality of evidence, number needed to treat for an additional harmful outcome (NNTH) 167.</P><P>&#8226; <I><B>Hypotension:</B></I> RR 1.50, 95% CI 1.38 to 1.64, NNTH 16, 10,947 participants, high quality evidence.</P><P>&#8226; <I><B>Bradycardia:</B></I> RR 2.23, 95% CI 1.48 to 3.36, NNTH 21, 11,033 participants, moderate quality evidence.</P><P>We found a <B><U>potential increase</U></B> in the occurrence of the following outcomes with the use of beta-blockers.</P><P>&#8226; <I><B>Cerebrovascular events:</B></I> RR 1.59, 95% CI 0.93 to 2.71, 9150 participants, low quality evidence.</P><P>Whereas no clear evidence of an effect was found when all studies were analysed, restricting the meta-analysis to low risk of bias studies revealed a significant increase in cerebrovascular events with the use of beta-blockers: RR 2.09, 95% CI 1.14 to 3.82, NNTH 265, 8648 participants.</P><P>Beta-blockers significantly <B><U>reduced</U></B> the occurrence of the following endpoints.</P><P>&#8226; <I><B>AMI:</B></I> RR 0.73, 95% CI 0.61 to 0.87, NNTB 76, 10,958 participants, high quality evidence.</P><P>&#8226; <I><B>Myocardial ischaemia:</B></I> RR 0.51, 95% CI 0.34 to 0.77, NNTB nine, 978 participants, moderate quality evidence.</P><P>&#8226; <I><B>Supraventricular arrhythmias:</B></I> RR 0.73, 95% CI 0.57 to 0.94, NNTB 112, 8744 participants, high quality evidence.</P><P>We found <B><U>no clear evidence of an effect</U></B> of beta-blockers on the following outcomes.</P><P>&#8226; <I><B>Ventricular arrhythmias:</B></I> RR 0.68, 95% CI 0.31 to 1.49, 476 participants, moderate quality evidence.</P><P>&#8226; <I><B>Congestive heart failure:</B></I> RR 1.18, 95% CI 0.94 to 1.48, 9173 participants, moderate quality evidence.</P><P>&#8226; <I><B>Length of hospital stay:</B></I> mean difference -0.45 days, 95% CI -1.75 to 0.84, 551 participants, low quality evidence.</P></ABS_RESULTS><ABS_CONCLUSIONS MODIFIED="2017-12-08 15:02:16 +0000" MODIFIED_BY="Hermann Blessberger"><P>According to our findings, perioperative application of beta-blockers still plays a pivotal role in <I><B>cardiac surgery</B></I>, as they can substantially reduce the high burden of supraventricular and ventricular arrhythmias in the aftermath of surgery. Their influence on mortality, AMI, stroke, congestive heart failure, hypotension and bradycardia in this setting remains unclear.</P><P>In <I><B>non-cardiac surgery, </B></I>evidence shows an association of beta-blockers with increased all-cause mortality. Data from low risk of bias trials further suggests an increase in stroke rate with the use of beta-blockers. As the quality of evidence is still low to moderate, more evidence is needed before a definitive conclusion can be drawn. The substantial reduction in supraventricular arrhythmias and AMI in this setting seems to be offset by the potential increase in mortality and stroke.</P></ABS_CONCLUSIONS></ABSTRACT><BODY MODIFIED="2018-02-23 18:20:45 +0000" MODIFIED_BY="[Empty name]"><BACKGROUND MODIFIED="2018-02-23 18:15:04 +0000" MODIFIED_BY="[Empty name]"><P>Cardiovascular mortality and morbidity are prevalent and costly in patients undergoing cardiac and non-cardiac surgery. Prevention of early postoperative complications remains a major issue in these interventions (<LINK REF="REF-Mangano-1990a" TYPE="REFERENCE">Mangano 1990a</LINK>; <LINK REF="REF-Mangano-1995" TYPE="REFERENCE">Mangano 1995</LINK>). Surgery for acquired cardiac disease has a mortality rate of up to 3% (<LINK REF="REF-Kaplan-1993" TYPE="REFERENCE">Kaplan 1993</LINK>), a perioperative myocardial infarction rate up to 6% and overall complication rates of 15% to 24%, depending on the type of operation and patient co-morbidities (<LINK REF="REF-Hammermeister-1990" TYPE="REFERENCE">Hammermeister 1990</LINK>). Even in non-cardiac surgery, an estimated 4% of patients will have a perioperative cardiac complication, and 0.5% will suffer a myocardial infarction (<LINK REF="REF-Fleisher-2001" TYPE="REFERENCE">Fleisher 2001</LINK>). Cardiac adverse events appear to be related to the persistently exaggerated sympathetic response that is associated with substantial increases in heart rate and myocardial oxygen consumption. Drugs that block beta-adrenergic receptors,and thus the sympathetic response are capable of preventing cardiac complications in patients with acute myocardial infarction (AMI), silent ischaemia and heart failure (<LINK REF="REF-Lancet-1986" TYPE="REFERENCE">Lancet 1986</LINK>; <LINK REF="REF-Lancet-1999" TYPE="REFERENCE">Lancet 1999</LINK>; <LINK REF="REF-Kjekshus-1987" TYPE="REFERENCE">Kjekshus 1987</LINK>; <LINK REF="REF-Kjekshus-1991" TYPE="REFERENCE">Kjekshus 1991</LINK>; <LINK REF="REF-Pepine-1994" TYPE="REFERENCE">Pepine 1994</LINK>). Perioperative blockade of beta-adrenergic receptors therefore has been proposed to reduce the risk of perioperative complications in patients after cardiac and non-cardiac surgery (<LINK REF="REF-Mangano-1990b" TYPE="REFERENCE">Mangano 1990b</LINK>; <LINK REF="STD-Mangano-1996" TYPE="STUDY">Mangano 1996</LINK>; <LINK REF="STD-Wallace-1998" TYPE="STUDY">Wallace 1998</LINK>). Although several trials have provided encouraging findings demonstrating a reduced perioperative incidence of death from cardiac causes and non-fatal cardiovascular complications (<LINK REF="REF-Mangano-1990b" TYPE="REFERENCE">Mangano 1990b</LINK>; <LINK REF="STD-Mangano-1996" TYPE="STUDY">Mangano 1996</LINK>; <LINK REF="STD-Wallace-1998" TYPE="STUDY">Wallace 1998</LINK>), the routine administration of beta-blocking agents in unselected patients before major surgery is still discussed as a controversial topic, especially after the results of the POISE trial were published (<LINK REF="STD-POISE-2008" TYPE="STUDY">POISE 2008</LINK>). which demonstrated an increase of all-cause mortality and stroke with the use of beta-blockers. Until recently, recommendations were largely based on the results of four randomized trials (<LINK REF="STD-DECREASE_x002d_IV-2009" TYPE="STUDY">DECREASE-IV 2009</LINK>; <LINK REF="STD-Mangano-1996" TYPE="STUDY">Mangano 1996</LINK>; <LINK REF="STD-POISE-2008" TYPE="STUDY">POISE 2008</LINK>; <LINK REF="STD-Poldermans-1999" TYPE="STUDY">Poldermans 1999</LINK>). After the DECREASE (Dutch Echocardiographic Cardiac Risk Evaluation Applying Stress Echo) trial family&#8212;showing beneficial effects of beta-blockers on mortality and on prevention of myocardial infarction in the perioperative setting&#8212;was discredited in 2011 ( <LINK REF="REF-Bouri-2013" TYPE="REFERENCE">Bouri 2013</LINK>; <LINK REF="REF-Chopra-2012" TYPE="REFERENCE">Chopra 2012</LINK>,), perioperative use of beta-blockers became once again a matter of controversy. Therefore, it was our aim to summarize in a systematic way current knowledge on the issue of perioperative beta-blockade for prevention of the most relevant surgery-related adverse events.</P></BACKGROUND><OBJECTIVES MODIFIED="2014-08-26 13:09:55 +0100" MODIFIED_BY="Jane Cracknell"><P>The objective of this review was to systematically analyse the effects of perioperatively administered beta-blockers for prevention of surgery-related mortality and morbidity in patients undergoing any type of surgery while under general anaesthesia.</P></OBJECTIVES><METHODS MODIFIED="2018-02-23 18:19:03 +0000" MODIFIED_BY="[Empty name]"><SELECTION_CRITERIA MODIFIED="2018-02-23 18:15:04 +0000" MODIFIED_BY="[Empty name]"><CRIT_STUDIES MODIFIED="2011-05-26 23:20:03 +0100" MODIFIED_BY="Hermann Blessberger"><P>We included randomized controlled trials (RCTs).</P></CRIT_STUDIES><CRIT_PARTICIPANTS MODIFIED="2018-02-23 18:15:04 +0000" MODIFIED_BY="[Empty name]"><P>We included studies that looked at the effects of beta-blockers on adults 18 years of age or older undergoing any type of surgery while under general anaesthesia.</P><P>As opposed to these eligibility criteria as defined in the protocol (<LINK REF="REF-Wiesbauer-2007" TYPE="REFERENCE">Wiesbauer 2007</LINK>), we decided to consider trials in our meta-analysis that partially included patients not receiving general anaesthesia. Trials had to fulfil the following criteria to be eligible for inclusion: more than 100 randomly assigned participants operated on under general anaesthesia, or more than 70% of participants receiving general anaesthesia. We came to this conclusion, as we believed that a meta-analysis without data from the POISE (Perioperative Ischemia Evaluation Study), DIPOM (Diabetic Postoperative Mortality and Morbidity) or MaVS (Metoprolol After Vascular Surgery) trial would not find enough credibility within the clinical community.</P><P>We excluded trials investigating procedures that required local or regional anaesthesia only.</P></CRIT_PARTICIPANTS><CRIT_INTERVENTIONS MODIFIED="2014-08-26 13:10:12 +0100" MODIFIED_BY="Jane Cracknell"><P>Perioperative administration of beta-adrenoceptor-blockers via any route versus control (placebo or standard care). We defined the perioperative period as 30 days before to 30 days after surgery. Beta-blockers could be started before surgery, during surgery or at the latest by the end of the first day after surgery.</P></CRIT_INTERVENTIONS><CRIT_OUTCOMES MODIFIED="2014-08-26 13:10:21 +0100" MODIFIED_BY="Jane Cracknell"><P>We classified events as 'perioperative' if they occurred during or after surgery (from the time of induction of anaesthesia until 30 days after surgery).</P><CRIT_OUTCOMES_PRIMARY MODIFIED="2014-08-26 13:10:16 +0100" MODIFIED_BY="Jane Cracknell"><UL><LI>All-cause mortality, defined as death due to any cause occurring 30 days postoperatively or before hospital discharge (whichever occurs later).</LI></UL></CRIT_OUTCOMES_PRIMARY><CRIT_OUTCOMES_SECONDARY MODIFIED="2014-08-26 13:10:21 +0100" MODIFIED_BY="Jane Cracknell"><UL><LI>Long-term all-cause mortality, defined as death due to any cause not qualifying as a primary endpoint.</LI><LI>Death due to cardiac causes.</LI><LI>Incidence of acute myocardial infarction (AMI) as defined by study authors (non-fatal if distinction was possible).</LI><LI>Myocardial ischaemia as defined by study authors (minimal electrocardiographic (ECG) criteria: horizontal or descending ST depression of at least 1 mm).</LI><LI>Cerebrovascular complications (transient ischaemic attack (TIA), prolonged reversible ischaemic neurological deficit (PRIND), stroke) as defined by study authors (non-fatal if distinction was possible).</LI><LI>Ventricular arrhythmias (ventricular tachycardias and ventricular fibrillation).</LI><LI>Supraventricular arrhythmias (atrial fibrillation, atrial flutter, other supraventricular arrhythmias, symptomatic supraventricular extrasystoles except sinus tachycardia).</LI><LI>Bradycardia as defined by study authors (minimal criteria: below 60 beats per minute or requiring medical intervention).</LI><LI>Hypotension as defined by study authors (minimal criteria: below 90 mmHg systolic blood pressure or requiring medical intervention).</LI><LI>Ventricular extrasystoles.</LI><LI>Congestive heart failure as defined by study authors.</LI><LI>Bronchospasm.</LI><LI>Length of hospital stay (LOS).</LI><LI>Quality of life as defined by study authors.</LI><LI>Cost of care.</LI></UL></CRIT_OUTCOMES_SECONDARY></CRIT_OUTCOMES></SELECTION_CRITERIA><SEARCH_METHODS MODIFIED="2018-02-23 18:15:04 +0000" MODIFIED_BY="[Empty name]"><ELECTRONIC_SEARCHES MODIFIED="2018-02-23 18:15:04 +0000" MODIFIED_BY="[Empty name]"><P>We searched the Cochrane Central Register of Controlled Trials (CENTRAL) (2013 Issue 6), MEDLINE (Ovid SP, 1946 to June 2013), Embase (Ovid SP, 1974 to June 2013), Biosis Previews (1970 to June 2013), CAB Abstracts (1972 to June 2013), Global Health (1972 to June 2013), Life Sciences Collection (1982 to October 2010), Cumulative Index to Nursing and Allied Health Literature (CINAHL, EBSCOhost, 1982 to June 2013), Derwent Drug File (1964 to June 2013), Science Citation Index Expanded (1900 to June 2013), International Pharmaceutical Abstracts (1970 to June 2013) and PASCAL (1977 to June 2013).</P><P>We used a highly sensitive search strategy (<LINK REF="REF-Higgins-2011" TYPE="REFERENCE">Higgins 2011</LINK>) provided by The Cochrane Collaboration for identification of RCTs published in MEDLINE. We used Science Citation Index and its electronic counterpart Science Citation Index Expanded to identify studies referencing "key articles" in the field. In addition to applying these computer-enhanced search strategies, we surveyed the reference lists of relevant articles.</P><P>We designed our search strategy by defining an initial list of search terms. Using these terms, we performed a query of the latest publications in the field. We used the retrieved articles to modify the initial list of search terms. This was done to maximize sensitivity while trying not to decrease specificity. The final lists of terms and search strategies are provided in <LINK REF="APP-01" TYPE="APPENDIX">Appendix 1</LINK> (MEDLINE), <LINK REF="APP-02" TYPE="APPENDIX">Appendix 2</LINK> (EMBASE), <LINK REF="APP-03" TYPE="APPENDIX">Appendix 3</LINK> (CENTRAL), <LINK REF="APP-04" TYPE="APPENDIX">Appendix 4</LINK> (CINAHL) and <LINK REF="APP-05" TYPE="APPENDIX">Appendix 5</LINK> (Biosis Previews, CAB Abstracts, Global Health, Life Sciences Collection, Derwent Drug File, Science Citation Index Expanded, International Pharmaceutical Abstracts, PASCAL, Conference Proceedings Citation Index&#8211;Science, System for Information on Grey Literature in Europe, British Library Inside Conferences, Conference Papers Index, Index to Scientific and Technical Proceedings and Books).</P><P>When multiple publications of a given data set were identified, we included the first published article in our analysis. We made an exception to this rule if a more recent publication corroborated the results of a larger cohort, longer follow-up, or both.</P><P>The first retrospective literature search was performed in July 2003. This literature search was updated in October 2010 and June 2013. Some databases could be searched only for a limited time interval (e.g. until 2003, until 2010).</P><P>Abstracts (and full-text articles, when information provided in the abstract was inconclusive) of retrieved publications were reviewed by two review authors independently to identify trials that met the preset inclusion criteria (FW and OS for trials published until 2003, HB and DA for trials published between 2003 and October 2010, HB and JK for trials published after October 2010). We resolved differences of opinion by consultation with a third review author (CS or MS).</P><P>We imposed no language restrictions.</P></ELECTRONIC_SEARCHES><OTHER_SEARCHES MODIFIED="2014-08-26 13:10:48 +0100" MODIFIED_BY="Jane Cracknell"><P>For identification of so-called 'grey literature,' we surveyed databases that included conference proceedings, such as:</P><UL><LI>Conference Proceedings Citation Index&#8211;Science (CPCI-Science) (1995 to June 2013);</LI><LI>British Library Inside Conferences (1993 to 2003);</LI><LI>System for Information on Grey Literature in Europe (SIGLE; 1976 to June 2013);</LI><LI>Conference Papers Index (CONFSCI) (1973 to October 2010);</LI><LI>Index to Scientific and Technical Proceedings and Books (ISTPB) (1978 to June 2013);</LI><LI>Biosis Previews (1970 to June 2013); and</LI><LI>CAB Abstracts (1972 to June 2013).</LI></UL><P>Furthermore, to identify studies that were not published because of negative results or for other reasons, we searched online trial registers.</P><UL><LI>A registry of federally and privately supported clinical trials conducted in the United States and around the world: <A HREF="http://clinicaltrials.gov">http://clinicaltrials.gov</A>.</LI><LI>The National Research Register, a public database of research projects funded by, or of interest to, the UK National Health Service (NHS): <A HREF="http://www.nihr.ac.uk/Pages/NRRArchiveSearch.aspx">http://www.nihr.ac.uk/Pages/NRRArchiveSearch.aspx</A>.</LI><LI>Meta-register of controlled trials (International Standard Randomized Controlled Trial Number (ISRCTN) Register (international), Action Medical Research (UK), Medical Research Council (UK), The Wellcome Trust (UK), UK Trials (UK), National Institutes of Health (NIH) Clinical Trials Register (international), National Institute for Health Research (NIHR) Health Technology Assessment Programme (UK)): <A HREF="http://www.controlled-trials.com/mrct">http://www.controlled-trials.com/mrct</A>.</LI></UL></OTHER_SEARCHES></SEARCH_METHODS><DATA_COLLECTION MODIFIED="2018-02-23 18:19:03 +0000" MODIFIED_BY="[Empty name]"><STUDY_SELECTION MODIFIED="2018-02-23 18:15:04 +0000" MODIFIED_BY="[Empty name]"><P>We included trials in which participants were randomly assigned to a beta-blocker group or a control group. Participants in the control group had to receive standard care or placebo. Trials had to investigate at least one of the outcomes listed above (<LINK TAG="CRIT_OUTCOMES_PRIMARY" TYPE="SECTION">Primary outcomes</LINK>; <LINK TAG="CRIT_OUTCOMES_SECONDARY" TYPE="SECTION">Secondary outcomes</LINK>). Surgery had to be performed on study participants 18 years of age or older who were under general anaesthesia. We applied no restriction as to type of surgery .</P><P>As opposed to these eligibility criteria as defined in the protocol (<LINK REF="REF-Wiesbauer-2007" TYPE="REFERENCE">Wiesbauer 2007</LINK>), we decided to consider trials in our meta-analysis that partially included patients not receiving general anaesthesia. Trials had to fulfil the following criteria to be eligible for inclusion: more than 100 randomly assigned participants operated on while under general anaesthesia or more than 70% of participants receiving general anaesthesia. We came to this conclusion. as we believed that a meta-analysis without the POISE, DIPOM or MaVS trial would not find enough credibility within the clinical community.</P><P>We excluded all procedures that required local or regional anaesthesia only.</P></STUDY_SELECTION><DATA_EXTRACTION MODIFIED="2014-08-26 13:11:02 +0100" MODIFIED_BY="Jane Cracknell"><P>Two review authors (HB and JK) independently extracted data from all studies. In cases of disagreement, we reassessed the respective studies to reach consensus. We used standardized forms for this purpose (see <LINK REF="APP-06" TYPE="APPENDIX">Appendix 6</LINK>). We contacted the corresponding author (first author) if information was lacking that was deemed crucial for the decision whether to include the article in our meta-analysis. We considered study design (RCT, placebo or standard care group), type of intervention (beta-blocker vs control) and trial setting (hospital, type of surgery, general or regional/local anaesthesia) to be crucial information.</P></DATA_EXTRACTION><QUALITY_ASSESSMENT MODIFIED="2014-08-26 13:11:50 +0100" MODIFIED_BY="Jane Cracknell"><P>To assess the quality of studies, we used type of control group (placebo or standard care, as assessed by the respective <LINK TAG="CHARACTERISTICS_OF_INCLUDED_STUDIES" TYPE="SECTION">Characteristics of included studies</LINK> tables), method and adequacy of randomization, allocation concealment, level of masking (blinding of study participants/personnel/outcome assessors), description of withdrawals, use of the intention-to-treat principle for data analysis (participants analysed as randomly assigned) and completeness of reported outcomes. We entered information on risk of bias of included trials into the respective risk of bias tables (<LINK TAG="CHARACTERISTICS_OF_INCLUDED_STUDIES" TYPE="SECTION">Characteristics of included studies</LINK>). We evaluated the following methodological qualities (low risk of bias, high risk of bias, unclear risk of bias).</P><SUBSECTION><HEADING LEVEL="4">Random sequence generation (selection bias)</HEADING><UL><LI>Low risk: adequate sequence generation reported using random number tables, computer random number generators, coin tossing or shuffling.</LI><LI>High risk: randomization method that made allocation of participants predictable (quasi-randomization by date of birth or case record number, alteration).</LI><LI>Unclear risk: Method of sequence generation not reported.</LI></UL></SUBSECTION><SUBSECTION><HEADING LEVEL="4">Allocation concealment (selection bias)</HEADING><UL><LI>Low risk: adequate measures to conceal allocations such as central randomization; serially numbered, opaque, sealed envelopes; or other convincing elements of concealment.</LI><LI>High risk: inadequately concealed trials, using alteration methods, case record numbers or date of birth.</LI><LI>Unclear risk: unclearly concealed trials, in which study authors did not report an allocation concealment approach at all, or reported an approach that did not fall into one of the categories mentioned above.</LI></UL></SUBSECTION><SUBSECTION><HEADING LEVEL="4">Blinding of participants, personnel and outcome assessors (detection bias)</HEADING><UL><LI>Low risk: single- (participant or doctor only), double- (participant and doctor) or triple (participant, doctor and outcome assessor)-blinded trials.</LI><LI>High risk: open-label trials.</LI><LI>Unclear risk: level of blinding not reported.</LI></UL></SUBSECTION><SUBSECTION><HEADING LEVEL="4">Incomplete outcome data (attrition bias)</HEADING><UL><LI>Low risk: trials that correctly used an intention-to-treat principle for data analysis (participants were analysed as randomly assigned) and with few losses to follow-up.</LI><LI>High risk: trials that reported on excluded participants (participants were not analysed as randomly assigned) or major differences in dropouts between groups.</LI><LI>Unclear risk: no reporting on exclusions.</LI></UL><P>Use of the intention-to-treat principle was assessed separately.</P></SUBSECTION><SUBSECTION><HEADING LEVEL="4">Selective reporting (reporting bias)</HEADING><UL><LI>Low risk: complete reporting of all outcomes previously defined in the methods section.</LI><LI>High risk: selective underreporting of data (e.g. 'P &lt; 0.05,' 'n.s.'), including only statistically significant results or only a subset of data.</LI><LI>Unclear risk: no definitive judgement possible (e.g. abstract only).</LI></UL></SUBSECTION><SUBSECTION><HEADING LEVEL="4">Other bias</HEADING><UL><LI>Low risk: no other detectable sources of bias.</LI><LI>High risk: certain study designs (e.g. cross-over RCT, cluster-RCT, more than two intervention groups, blocked randomization in an unblinded trial), deviation from the study protocol, fraud, early termination of a trial, different care programmes in different treatment arms.</LI><LI>Unclear risk: no definitive judgement possible (e.g. abstract only).</LI></UL><P>We performed a sensitivity analysis using the first four quality criteria mentioned above. This was accomplished by performing meta-regression. Quality criteria were used as independent variables, and the point estimate was defined as the dependent variable. If one factor was associated with the point estimate in a statistically significant manner, results stratified according to the quality criteria were presented in the <LINK TAG="RESULTS" TYPE="SECTION">Results</LINK> section. Among those stratified results, we attributed greater credibility to estimates coming from studies using higher quality standards. We avoided the use of so-called composite scales, as they were found to have low interscale reliability, and some failed to measure internal validity appropriately (<LINK REF="REF-Juni-1999" TYPE="REFERENCE">Juni 1999</LINK>).</P></SUBSECTION></QUALITY_ASSESSMENT><EFFECT_MEASURES MODIFIED="2014-08-26 13:11:59 +0100" MODIFIED_BY="Jane Cracknell"><UL><LI>Dichotomous data: risk ratio (RR) with corresponding 95% confidence interval (CI).</LI><LI>Continuous data: mean difference (MD) with corresponding 95% CI.</LI></UL></EFFECT_MEASURES><UNIT_OF_ANALYSIS MODIFIED="2014-08-26 13:11:59 +0100" MODIFIED_BY="Jane Cracknell"><UL><LI>Trials with multiple beta-blocker treatment groups: We included dichotomous outcomes of studies with one control group and added up the different beta-blocker arms to create a single beta-blocker group for generation of a single comparison. This was done to prevent a unit of analysis error. For continuous variables (i.e. length of stay and cost of care), we calculated combined mean and standard deviation values according to the formula provided in Chapter 7.7.3.8 of the <I>Cochrane Handbook for Systematic Reviews of Interventions</I> (<LINK REF="REF-Higgins-2011" TYPE="REFERENCE">Higgins 2011</LINK>).</LI></UL></UNIT_OF_ANALYSIS><MISSING_DATA MODIFIED="2014-08-26 13:12:05 +0100" MODIFIED_BY="Jane Cracknell"><UL><LI>If information on both study group allocation and respective outcomes was available, we reincluded withdrawn participants in keeping with the intention-to-treat principle. If information was not available, we performed an available case analysis. We did not perform imputation techniques.</LI><LI>We excluded continuous data assessing length of stay or cost of care if a range of dispersion (standard deviation or standard error) was not provided along with mean values. When both measures of spread (standard deviation and standard error) were presented, we used the standard deviation as the measure of choice. We did not apply imputation techniques.</LI></UL></MISSING_DATA><HETEROGENEITY_ASSESSMENT MODIFIED="2018-02-23 18:19:03 +0000" MODIFIED_BY="[Empty name]"><P>We tested and evaluated heterogeneity using the so-called 'test of heterogeneity' at a significance level of P value &lt; 0.1, as well as the I<SUP>2 </SUP>statistic, which describes the proportion of variability due to heterogeneity (<LINK REF="REF-Higgins-2002" TYPE="REFERENCE">Higgins 2002</LINK>; <LINK REF="REF-Higgins-2003" TYPE="REFERENCE">Higgins 2003</LINK>). As suggested by Higgins and colleagues, an I<SUP>2</SUP> value below 40% might not be important, whereas a value above 40% might represent moderate to severe heterogeneity. We explored heterogeneity using meta-regression, which assessed the influence that different study characteristics and participant characteristics had on the effect measure.</P></HETEROGENEITY_ASSESSMENT><BIAS_ASSESSMENT MODIFIED="2014-08-26 13:12:37 +0100" MODIFIED_BY="Jane Cracknell"><P>We appraised reporting bias through visual assessment of funnel plots and Egger's regression model (regressing the magnitude of the point estimate vs precision) (<LINK REF="REF-Egger-1997" TYPE="REFERENCE">Egger 1997</LINK>).</P><P>In case of a suspected reporting bias, we used the 'trim-and-fill' method as a type of sensitivity analysis to correct for funnel asymmetry and to assess the impact of the potential bias on the robustness of the effect estimate (<LINK REF="REF-Duval-2000" TYPE="REFERENCE">Duval 2000</LINK>).</P></BIAS_ASSESSMENT><DATA_SYNTHESIS MODIFIED="2018-02-23 18:15:04 +0000" MODIFIED_BY="[Empty name]"><P>We presented a statistical summary of treatment effects (RR) in the absence of significant clinical heterogeneity. We expressed dichotomous data as the risk ratio. We calculated the mean difference for length of stay. We calculated overall estimates using both fixed-effect and random-effects models for all outcomes. We presented results of the fixed-effect analysis if heterogeneity was judged to be low. If the results of fixed-effect and random-effects models differed substantially, or if the I<SUP>2</SUP> statistic was above 25% (both are signs of heterogeneity), we chose a random-effects model for presentation (<LINK REF="REF-DerSimonian-1986" TYPE="REFERENCE">DerSimonian 1986</LINK>).</P><P>We used the software programmes <LINK REF="REF-RevMan-5.3" TYPE="REFERENCE">RevMan 5.3</LINK> and STATA 12.0 to perform data analysis.</P></DATA_SYNTHESIS><SUBGROUP_ANALYSIS MODIFIED="2018-02-23 18:15:04 +0000" MODIFIED_BY="[Empty name]"><P>It is possible that treatment effects differed not because of statistical heterogeneity, but rather because of clinical heterogeneity (e.g. beta-blockers could be more useful in participants with good ventricular function as opposed to those with reduced ventricular function. The negative inotropic effect of these drugs might be desirable in the first group but harmful in the second). To evaluate this possibility, we assessed the most important clinical parameters (effect modifiers) that could have influenced the effects of beta-blockers on selected clinical outcomes.</P><P><BR/>We used meta-regression for subgroup analysis. If one of the factors influenced the effects of beta-blockers in a statistically significant way, we stratified for this factor in the Results section. We stratified for some factors a priori. They did not need to be associated with the point estimate in a regression analysis. This was done so that readers could get a feel for the data themselves. These stratifications include the following.</P><UL><LI>Placebo versus standard care.</LI><LI>Risk of surgery (non-cardiac surgery only: low- and medium-risk vs high-risk procedures).</LI><LI>Start of beta-blocker therapy (before vs during vs after surgery).</LI><LI>Type of beta-blocker.</LI></UL><P>Furthermore, we used meta-regression techniques to assess the following clinical factors for effect modification.<BR/></P><UL><LI>Effect of age of study participants on overall effect.</LI><LI>Effect of gender on overall effect.</LI><LI>Types of surgery (high-risk vs low-risk operations).</LI><LI>Factors that have the potential to increase perioperative risk (prevalence of coronary heart disease (CHD), previous myocardial infarction, prevalence of hypertension, reduced ejection fraction).</LI><LI>Number of participants taking beta-blockers preoperatively.</LI><LI>Whether invasive haemodynamic monitoring was used.</LI><LI>Duration of beta-blocker treatment (up to 24 hours, two to seven days, eight to 14 days, nine to 21 days, exceeding 21 days).</LI><LI>Whether beta-blockers were administered titrated by heart rate or in a fixed-dose regimen.</LI></UL></SUBGROUP_ANALYSIS><SENSITIVITY_ANALYSIS MODIFIED="2018-02-23 18:15:04 +0000" MODIFIED_BY="[Empty name]"><P>We used both fixed-effect and random-effects models for all outcomes and compared results. (If studies are homogeneous, results should be fairly similar. If outliers are present, results from fixed-effect and random-effects analyses should differ.) We used this measure to assess the robustness of estimates. Additionally, we explored interaction of methodological quality parameters and the effect estimate using meta-regression (type of hospital; type of control group; blinding status of participants, doctors and outcome assessors; use of intention-to-treat principle; specification of baseline characteristics; inclusion criteria; outcome variables and co-morbidities). If one of these factors was statistically significantly associated with the effect estimate, we carried out stratification for this parameter in the Results section and compared subgroup results of stratification with the overall effect estimate to assess its robustness.</P><SUBSECTION><HEADING LEVEL="3">Assessing the quality of evidence</HEADING><P>We assessed quality of data by using the GRADE approach (<LINK REF="REF-Guyatt-2008" TYPE="REFERENCE">Guyatt 2008</LINK>). GRADE evaluates the body of evidence for an outcome according to different parameters.</P><UL><LI>Risk of bias.</LI><LI>Presence of a reporting bias.</LI><LI>Inconsistency of data (heterogeneity): Is unexplained heterogeneity present in the data?</LI><LI>Indirectness of data: Was the outcome of interest tested in a population of interest for the intervention of interest?</LI><LI>Imprecision of data: Is the sample size smaller than the optimal size of information? Is the confidence interval wide, covering zones of no effect (RR 1.0), potential harm (RR 1.25) and potential benefit (RR 0.75)?</LI></UL><P>GRADE allows classification of the level of confidence regarding an estimate as very low, low, moderate or high.</P><P>Confidence levels can be interpreted as outlined below.</P><UL><LI><B>Very low: </B>We are very uncertain about the estimate.</LI><LI><B>Low: </B>Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.</LI><LI><B>Moderate: </B>Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.</LI><LI><B>High: </B>Further research is very unlikely to change our confidence in the estimate of effect.</LI></UL></SUBSECTION><SUBSECTION><HEADING LEVEL="3">Trial sequential analysis</HEADING><P>Trial sequential analysis (TSA) is a type of statistical power analysis that can be used to further investigate the relevance of results ('strength of evidence') yielded by a meta-analysis (<LINK REF="REF-Wetterslev-2008" TYPE="REFERENCE">Wetterslev 2008</LINK>). It is the counterpart of a sample size calculation as part of a conventional study design. TSA allows researchers to differentiate between 'spurious' significant findings caused by random error in a dataset with only small numbers of participants and trials and a 'truly' significant result with sufficient statistical power. Thereby, TSA also accounts for repeated significance testing.</P><P>Further details can be found in the 'User Manual for Trial Sequential Analysis (TSA),' provided by the Centre for Clinical Intervention Research of the Copenhagen Trial Unit (<LINK REF="REF-Thorlund-2011" TYPE="REFERENCE">Thorlund 2011</LINK>).</P><P>Basically, optimal information size and O'Brien-Fleming alpha-spending boundaries indicating the 'real' significance threshold are constructed by providing the numbers for alpha level, power, control group risk and interstudy heterogeneity. Furthermore, an 'inner wedge' marks the 'futility zone'&#8212;a non-superiority/inferiority area. Meta-analysis data are imported in a plot in which the <I>x</I>-axis represents the number of randomly assigned participants and the <I>y</I>-axis represents the Z-score of the test statistics (Z = 1.96 with P value 0.05). The so-called Z-curve depicts the Z-score for any given number of randomly assigned participants. As more trials enter the meta-analysis, this curve extends farther to the right, indicating a larger cohort of randomly assigned participants. As the number of participants increases with every included trial, the Z-curve can now cross the upper or lower O'Brien-Fleming alpha-spending boundary, indicating a 'truly' significant effect, or can travel between the alpha-spending boundaries and the 'inner wedge,' which indicates an inconclusive result. If the Z-curve enters the 'inner wedge,' completion of further trials and randomization of participants are futile, as enough statistical power was accrued to show that there is no relevant difference between intervention and control groups.</P><P>TSA can be performed only if information size (number of participants) is large enough compared with optimal information size, and only if the outcome is dichotomous. We calculated TSA for every dichotomous outcome, if possible.</P><P>We downloaded the user manual and the software from <A HREF="http://www.ctu.dk/tsa">www.ctu.dk/tsa</A>.</P></SUBSECTION></SENSITIVITY_ANALYSIS></DATA_COLLECTION></METHODS><RESULTS MODIFIED="2018-02-23 18:20:45 +0000" MODIFIED_BY="[Empty name]"><STUDY_DESCRIPTION MODIFIED="2018-02-23 18:15:04 +0000" MODIFIED_BY="[Empty name]"><SEARCH_RESULTS MODIFIED="2018-02-23 18:15:04 +0000" MODIFIED_BY="[Empty name]"><P>Through the initial database search in July 2003 and updates in October 2010 and June 2013, we retrieved 10,175 titles and their respective abstracts (<LINK REF="APP-07" TYPE="APPENDIX">Appendix 7</LINK>). All titles initially were independently screened by two review authors (FW and OS for trials published until December 2003, HB and DA for trials published until October 2010, HB and JK for trials after October 2010). Of all retrieved titles, we judged 9968 to be irrelevant for our review. We obtained and reviewed the full-text versions of the remaining 207 studies and excluded another 119 trials that did not match our inclusion criteria. Finally, we identified 88 trials relevant for our review (cardiac surgery: 53 trials; non-cardiac surgery: 35 trials; <LINK REF="FIG-01" TYPE="FIGURE">Figure 1</LINK>). Data extraction for all included trials and assessment of risk of bias were independently performed by HB and JK from July until September 2013.</P></SEARCH_RESULTS><INCLUDED_STUDIES_DESCR MODIFIED="2018-02-23 18:15:04 +0000" MODIFIED_BY="[Empty name]"><P>We included 88 trials. We assessed the following types of surgery. </P><UL><LI>Cardiac surgery (coronary artery bypass grafting and/or valve replacement): 53 trials.</LI><LI>Other thoracic operations (lung resection, oesophagectomy, rigid bronchoscopy): four trials (<LINK REF="STD-Bayliff-1999" TYPE="STUDY">Bayliff 1999</LINK>; <LINK REF="STD-Jakobsen-1997" TYPE="STUDY">Jakobsen 1997</LINK>; <LINK REF="STD-Lai-2006" TYPE="STUDY">Lai 2006</LINK>; <LINK REF="STD-Sandler-1990" TYPE="STUDY">Sandler 1990</LINK>).</LI><LI>Vascular surgery: five trials (<LINK REF="STD-Cucchiara-1986" TYPE="STUDY">Cucchiara 1986</LINK>; <LINK REF="STD-Miller-1990" TYPE="STUDY">Miller 1990</LINK>; <LINK REF="STD-POBBLE-2005" TYPE="STUDY">POBBLE 2005</LINK>; <LINK REF="STD-Raby-1999" TYPE="STUDY">Raby 1999</LINK>; <LINK REF="STD-Yang-2006" TYPE="STUDY">Yang 2006</LINK>).</LI><LI>General (mostly abdominal) surgery: seven trials (<LINK REF="STD-Coleman-1980" TYPE="STUDY">Coleman 1980</LINK>; <LINK REF="STD-Inada-1989" TYPE="STUDY">Inada 1989</LINK>; <LINK REF="STD-Magnusson-1986" TYPE="STUDY">Magnusson 1986</LINK>; <LINK REF="STD-Lee-2010" TYPE="STUDY">Lee 2010</LINK>; <LINK REF="STD-Moon-2011" TYPE="STUDY">Moon 2011</LINK>; <LINK REF="STD-Shukla-2010" TYPE="STUDY">Shukla 2010</LINK>; <LINK REF="STD-Stone-1988" TYPE="STUDY">Stone 1988</LINK>).</LI><LI>Maxillofacial surgery: two trials (<LINK REF="STD-Apipan-2010" TYPE="STUDY">Apipan 2010</LINK>; <LINK REF="STD-Whitehead-1980" TYPE="STUDY">Whitehead 1980</LINK>).</LI><LI>Gynaecological surgery: four trials (<LINK REF="STD-Burns-1988" TYPE="STUDY">Burns 1988</LINK>; <LINK REF="STD-Jakobsen-1992" TYPE="STUDY">Jakobsen 1992</LINK>; <LINK REF="STD-Liu-1986" TYPE="STUDY">Liu 1986</LINK>; <LINK REF="STD-Oxorn-1990" TYPE="STUDY">Oxorn 1990</LINK>).</LI><LI>Neurosurgery: three trials (<LINK REF="STD-Gibson-1988" TYPE="STUDY">Gibson 1988</LINK>; <LINK REF="STD-Gupta-2011" TYPE="STUDY">Gupta 2011</LINK>; <LINK REF="STD-Kawaguchi-2010" TYPE="STUDY">Kawaguchi 2010</LINK>).</LI><LI>"Non-cardiac surgery" (not otherwise specified or different kinds of non-cardiac surgery): 10 trials (<LINK REF="STD-DIPOM-_x002d_-Juul-2006" TYPE="STUDY">DIPOM - Juul 2006</LINK>; <LINK REF="STD-Liu-2006" TYPE="STUDY">Liu 2006</LINK>; <LINK REF="STD-Mangano-1996" TYPE="STUDY">Mangano 1996</LINK>; <LINK REF="STD-Marwick-2009" TYPE="STUDY">Marwick 2009</LINK>; <LINK REF="STD-Miller-1991" TYPE="STUDY">Miller 1991</LINK>; <LINK REF="STD-Neary-2006" TYPE="STUDY">Neary 2006</LINK>; <LINK REF="STD-POISE-2008" TYPE="STUDY">POISE 2008</LINK>; <LINK REF="STD-Wallace-1998" TYPE="STUDY">Wallace 1998</LINK>; <LINK REF="STD-Yang-2008" TYPE="STUDY">Yang 2008</LINK>; <LINK REF="STD-Zaugg-1999" TYPE="STUDY">Zaugg 1999</LINK>).</LI></UL><P>All trials were published in English, except six (English abstracts were available for all trials).</P><UL><LI>One German article (<LINK REF="STD-Wenke-1999" TYPE="STUDY">Wenke 1999</LINK>).</LI><LI>One Turkish article (<LINK REF="STD-But-2006" TYPE="STUDY">But 2006</LINK>).</LI><LI>One Portuguese article (full-text English translation available) (<LINK REF="STD-De-Azevedo-L_x00fa_cio-2003" TYPE="STUDY">De Azevedo Lúcio 2003</LINK>).</LI><LI>Three Chinese articles (<LINK REF="STD-Lai-2006" TYPE="STUDY">Lai 2006</LINK>; <LINK REF="STD-Liu-2006" TYPE="STUDY">Liu 2006</LINK>; <LINK REF="STD-Yang-2008" TYPE="STUDY">Yang 2008</LINK>).</LI></UL><P>We were all capable of reading English and German (as German is our native language). The Portuguese article was available in English (full translation), the Turkish article was translated by DA, who is bilingual (German and Turkish), and the Chinese articles were translated with the help of Dr. Y. Wang.</P><P>All trials included participants under general anaesthesia only, except the following four trials.</P><UL><LI><LINK REF="STD-DIPOM-_x002d_-Juul-2006" TYPE="STUDY">DIPOM - Juul 2006</LINK>: 20% of participants received epidural anaesthesia only.</LI><LI><LINK REF="STD-POISE-2008" TYPE="STUDY">POISE 2008</LINK>: 2482 participants (59.5%) in the metoprolol group and 2491 participants (59.6%) in the placebo group received general anaesthesia.</LI><LI><LINK REF="STD-Raby-1999" TYPE="STUDY">Raby 1999</LINK>: General anaesthesia was provided in 73% of participants in the esmolol group and in 91% of participants in the placebo group.</LI><LI><LINK REF="STD-Yang-2006" TYPE="STUDY">Yang 2006</LINK> (MaVS): 12.7% of participants in the metoprolol group and 14.8% of those in the placebo group received regional anaesthesia only.</LI></UL><P>Individual data for the subgroup of participants who received general anaesthesia were not available for these trials.</P><P>We tried to establish contact with the following study authors to obtain additional information about trial design and outcomes under investigation.</P><UL><LI>Prof Dr G Hamilton (University College London Medical School) was contacted by e-mail and kindly provided information about a trial listed on <A HREF="http://www.controlled-trials.com/mrct">www.controlled-trials.com/mrct</A> (ISRCTN13072628); this was the POBBLE (Perioperative Beta-Clockade) trial, which we had already included (<LINK REF="STD-POBBLE-2005" TYPE="STUDY">POBBLE 2005</LINK>).</LI><LI>The corresponding authors of two trials were contacted by e-mail for more information about trial design (Chinese articles: <LINK REF="STD-Lai-2006" TYPE="STUDY">Lai 2006</LINK>; <LINK REF="STD-Liu-2006" TYPE="STUDY">Liu 2006</LINK>), but no contact could be established.</LI><LI>Dr P Rahimzadeh (Iran University of Medical Sciences) kindly provided information regarding the study 'Evaluation of the Metoprolol Effects in Controlled Hypotension and Reduction of Bleeding During Head and Neck Surgery' (<LINK REF="REF-Rahimzadeh-2008" TYPE="REFERENCE">Rahimzadeh 2008</LINK>). Ultimately, this trial was not included because it assessed no outcome under investigation by this meta-analysis.</LI><LI>Authors of identified abstracts were contacted for more information or for full-text publications (<LINK REF="STD-Dy-1998" TYPE="STUDY">Dy 1998</LINK>; <LINK REF="STD-Graham-1996" TYPE="STUDY">Graham 1996</LINK>; <LINK REF="STD-Ogawa-2013" TYPE="STUDY">Ogawa 2013</LINK>); contact was established only with Dr S. Ogawa, who kindly provided a full-text publication of his abstract, which was included in our meta-analysis (<LINK REF="STD-Ogawa-2013" TYPE="STUDY">Ogawa 2013</LINK>).</LI><LI>The corresponding author of the POISE trial was contacted to provide data on measures of spread for the parameter length of stay and for the subset of participants receiving general anaesthesia (<LINK REF="STD-POISE-2008" TYPE="STUDY">POISE 2008</LINK>). Only a subgroup of participants were operated on while under general anaesthesia in POISE, and only median and interquartile range (IQR) values were provided for length of stay; this precluded inclusion in our meta-analysis, as these measures of spread were incompatible with our analysis. No contact could be established.</LI></UL><P>For further specification of trial characteristics, please refer to the <LINK TAG="CHARACTERISTICS_OF_INCLUDED_STUDIES" TYPE="SECTION">Characteristics of included studies</LINK> table and the flow chart of included and excluded studies (<LINK REF="FIG-01" TYPE="FIGURE">Figure 1</LINK>).</P></INCLUDED_STUDIES_DESCR><EXCLUDED_STUDIES_DESCR MODIFIED="2018-02-23 18:15:04 +0000" MODIFIED_BY="[Empty name]"><P>We excluded three studies during the review process: one because the study included a subset of participants from another trial published by the same group of authors (<LINK REF="STD-Kl_x00f6_ter_x002d_Weber-1998" TYPE="STUDY">Klöter-Weber 1998</LINK>; see <LINK TAG="CHARACTERISTICS_OF_EXCLUDED_STUDIES" TYPE="SECTION">Characteristics of excluded studies</LINK> table). This study provided the same participant data-set as was provided by <LINK REF="STD-Pfisterer-1997" TYPE="STUDY">Pfisterer 1997</LINK>. One trial was excluded because of allegations of fictitious data (<LINK REF="STD-DECREASE_x002d_IV-2009" TYPE="STUDY">DECREASE-IV 2009</LINK>), and another trial by the same group of authors was excluded because credibility of data was uncertain (<LINK REF="STD-Poldermans-1999" TYPE="STUDY">Poldermans 1999</LINK>). </P><P>Following publication of the first version of this systematic review (<LINK REF="REF-Blessberger-2014" TYPE="REFERENCE">Blessberger 2014</LINK>), a previously included study was retracted (<LINK REF="STD-Suttner-2009" TYPE="STUDY">Suttner 2009</LINK>). This trial has now been excluded and all relevant analyses and results have been amended accordingly.</P></EXCLUDED_STUDIES_DESCR></STUDY_DESCRIPTION><STUDY_QUALITY MODIFIED="2018-02-23 18:20:35 +0000" MODIFIED_BY="[Empty name]"><P>We found most studies to be of adequate methodological quality for inclusion in our analysis. Nevertheless, it should be mentioned that adherence to certain quality prerequisites, such as those published in the Consolidated Standards of Reporting Trials (CONSORT) statement on reporting of randomized controlled trials, was low, even for studies published after the year 2001 (the year the statement was published) (<LINK REF="REF-Moher-2001" TYPE="REFERENCE">Moher 2001</LINK>). For additional details, see the <LINK TAG="CHARACTERISTICS_OF_INCLUDED_STUDIES" TYPE="SECTION">Characteristics of included studies</LINK> table, as well as respective 'Risk of bias' tables, graph (<LINK REF="FIG-02" TYPE="FIGURE">Figure 2</LINK>) and summary (<LINK REF="FIG-03" TYPE="FIGURE">Figure 3</LINK>).</P><ALLOCATION MODIFIED="2017-12-03 01:37:03 +0000" MODIFIED_BY="Hermann Blessberger"><P>Only 24 of 88 studies (27%) reported that investigators applied a valid method of allocation sequence generation, such as coin tossing, centralized randomization via telephone or computer or use of a random number table. Eight trials (9%) used invalid methods of sequence generation (quasi-randomization by hospital record numbers, date of birth or alternate randomization) (<LINK REF="STD-Abel-1983" TYPE="STUDY">Abel 1983</LINK>; <LINK REF="STD-Evrard-2000" TYPE="STUDY">Evrard 2000</LINK>; <LINK REF="STD-Matsuura-2001" TYPE="STUDY">Matsuura 2001</LINK>; <LINK REF="STD-Mohr-1981" TYPE="STUDY">Mohr 1981</LINK>; <LINK REF="STD-Sakaguchi-2012" TYPE="STUDY">Sakaguchi 2012</LINK>; <LINK REF="STD-Silverman-1982" TYPE="STUDY">Silverman 1982</LINK>; <LINK REF="STD-Stephenson-1980" TYPE="STUDY">Stephenson 1980</LINK>; <LINK REF="STD-Williams-1982" TYPE="STUDY">Williams 1982</LINK>). Most study authors did not specify the method of randomization used (56 trials; 64%). Thirty study authors (34%) reported that they used an appropriate method to maintain allocation concealment (preparation of the study drug by the hospital's pharmacy in identical outer packing, central randomization via telephone or computer or use of sealed, opaque, sequentially numbered envelopes), whereas 50 trials (57%) did not address this topic. In the eight trials (9%) mentioned above using quasi-randomization methods, allocation could be foreseen by date of birth, hospital record number or allocation of the participant recruited previously.</P></ALLOCATION><BLINDING MODIFIED="2018-02-23 18:20:35 +0000" MODIFIED_BY="[Empty name]"><P>We included 36 (41%) open-label studies, four (5%) single-blind studies, 32 (36%) double-blind trials and 11 (12.5%) triple-blind studies. We could not assess blinding status in five (5.5%) trials. Thus in about half of the included trials, doctors were not blinded to the study drug. However, we want to stress the fact that patients taking beta-blocker therapy are likely to be recognized by a skilled clinician because of the pharmacological properties of these drugs (which lead to lowering of blood pressure and slowing down of heart rate).</P></BLINDING><EXCLUSIONS MODIFIED="2017-12-03 01:45:40 +0000" MODIFIED_BY="Hermann Blessberger"><P>Handling of attrition remained unclear in most studies. Among all included studies, 20 (23%) reported incomplete outcome data and only 14 (16%) stated that investigators used an intention-to-treat analysis and actually analysed participants as randomly assigned (<LINK REF="STD-Bayliff-1999" TYPE="STUDY">Bayliff 1999</LINK>; <LINK REF="STD-Booth-2004" TYPE="STUDY">Booth 2004</LINK>; <LINK REF="STD-De-Azevedo-L_x00fa_cio-2003" TYPE="STUDY">De Azevedo Lúcio 2003</LINK>; <LINK REF="STD-DIPOM-_x002d_-Juul-2006" TYPE="STUDY">DIPOM - Juul 2006</LINK>; <LINK REF="STD-Marwick-2009" TYPE="STUDY">Marwick 2009</LINK>; <LINK REF="STD-Matangi-1985" TYPE="STUDY">Matangi 1985</LINK>; <LINK REF="STD-Matangi-1989" TYPE="STUDY">Matangi 1989</LINK>; <LINK REF="STD-Neary-2006" TYPE="STUDY">Neary 2006</LINK>; <LINK REF="STD-Paull-1997" TYPE="STUDY">Paull 1997</LINK>; <LINK REF="STD-Pfisterer-1997" TYPE="STUDY">Pfisterer 1997</LINK>; <LINK REF="STD-POBBLE-2005" TYPE="STUDY">POBBLE 2005</LINK>; <LINK REF="STD-POISE-2008" TYPE="STUDY">POISE 2008</LINK>; <LINK REF="STD-Wallace-1998" TYPE="STUDY">Wallace 1998</LINK>; <LINK REF="STD-Yang-2006" TYPE="STUDY">Yang 2006</LINK>). In 29 trials (33%), data were analysed according to the per-protocol principle, whereas for 45 (51%) included studies, we could not make a final decision because incomplete outcome data were not reported.</P></EXCLUSIONS><SELECTIVE_REPORTING MODIFIED="2014-08-26 13:15:08 +0100" MODIFIED_BY="Jane Cracknell"><P>We judged selective reporting to be present in three trials. Two trials reported statistically significant results only (<LINK REF="STD-Graham-1996" TYPE="STUDY">Graham 1996</LINK>&#8212;conference abstract; <LINK REF="STD-Janssen-1986" TYPE="STUDY">Janssen 1986</LINK>). In another trial (<LINK REF="STD-De-Azevedo-L_x00fa_cio-2003" TYPE="STUDY">De Azevedo Lúcio 2003</LINK>), study group allocation of participants with certain adverse events (AMI, stroke) remained unclear (selective underreporting).</P></SELECTIVE_REPORTING><OTHER_BIAS_SOURCES MODIFIED="2018-02-23 18:15:04 +0000" MODIFIED_BY="[Empty name]"><P>Five (6%) of the included trials encompassed more than two intervention arms (<LINK REF="STD-Auer-2004" TYPE="STUDY">Auer 2004</LINK>; <LINK REF="STD-Bert-2001" TYPE="STUDY">Bert 2001</LINK>; <LINK REF="STD-Forlani-2002" TYPE="STUDY">Forlani 2002</LINK>; <LINK REF="STD-Inada-1989" TYPE="STUDY">Inada 1989</LINK>; <LINK REF="STD-Stone-1988" TYPE="STUDY">Stone 1988</LINK>); four trials (4.5%) were terminated early (<LINK REF="STD-Jacquet-1994" TYPE="STUDY">Jacquet 1994</LINK>&#8212;high number of dropouts, <LINK REF="STD-Kurian-2001" TYPE="STUDY">Kurian 2001</LINK>&#8212;high number of adverse events in beta-blocker group and recruiting problems, <LINK REF="STD-Neary-2006" TYPE="STUDY">Neary 2006</LINK>&#8212;recruiting problems, <LINK REF="STD-Sezai-2012" TYPE="STUDY">Sezai 2012</LINK>&#8212;beta-blockers proved highly efficient in preventing atrial fibrillation in an interim analysis, and it was judged unethical to continue the trial); one trial used blocked randomization in an open-label setting, which might have made study group allocation predictable in some cases (<LINK REF="STD-Evrard-2000" TYPE="STUDY">Evrard 2000</LINK>); one trial provided different care programmes for beta-blocker and control groups (<LINK REF="STD-Marwick-2009" TYPE="STUDY">Marwick 2009</LINK>: heart rate&#8211;directed administration of beta-blocker exclusively in beta-blocker group (fixed-dose administration was used in the standard of care group), dobutamine stress echo for cardiovascular risk stratification exclusively in the standard of care group); and in one trial the number of patients taking beta-blockers before entry into the trial significantly differed between intervention and control groups (<LINK REF="STD-Gomes-1999" TYPE="STUDY">Gomes 1999</LINK>).</P></OTHER_BIAS_SOURCES></STUDY_QUALITY><INTERVENTION_EFFECTS MODIFIED="2018-02-23 18:20:45 +0000" MODIFIED_BY="[Empty name]"><P>In the following paragraphs, we present the results for cardiac and non-cardiac surgery derived from our analysis. Each outcome section is subdivided into five main subheadings: 'Overall effect,' 'Heterogeneity,' 'Reporting bias,' 'Sensitivity analysis' and 'Summary of confidence in estimates of effects using GRADE and TSA.'</P><SUBSECTION><HEADING LEVEL="4"><I>Cardiac surgery </I></HEADING><P>For a concise summary of the most important outcome variables see <LINK REF="SOF-01" TYPE="SOF">Summary of findings table 1</LINK>.</P></SUBSECTION><SUBSECTION><HEADING LEVEL="4"><I>All-cause mortality</I></HEADING><SUBSECTION><HEADING LEVEL="5">Overall effect</HEADING><P>We evaluated all-cause mortality win 24 trials that included 3783 participants. In 11 studies no deaths occurred in the beta-blocker group nor in the control group (<LINK REF="STD-Bert-2001" TYPE="STUDY">Bert 2001</LINK>; <LINK REF="STD-Connolly-2003" TYPE="STUDY">Connolly 2003</LINK>; <LINK REF="STD-Forlani-2002" TYPE="STUDY">Forlani 2002</LINK>; <LINK REF="STD-Hammon-1984" TYPE="STUDY">Hammon 1984</LINK>; <LINK REF="STD-Ivey-1983" TYPE="STUDY">Ivey 1983</LINK>; <LINK REF="STD-Janssen-1986" TYPE="STUDY">Janssen 1986</LINK>; <LINK REF="STD-Martinussen-1988" TYPE="STUDY">Martinussen 1988</LINK>; <LINK REF="STD-Matsuura-2001" TYPE="STUDY">Matsuura 2001</LINK>; <LINK REF="STD-Nystr_x00f6_m-1993" TYPE="STUDY">Nyström 1993</LINK>; <LINK REF="STD-Paull-1997" TYPE="STUDY">Paull 1997</LINK>; <LINK REF="STD-Suttorp-1991" TYPE="STUDY">Suttorp 1991</LINK>). None of the remaining 13 trials found a statistically significant difference between beta-blocker and control groups at an alpha level of 0.05. Overall, we found no clear evidence of an effect of beta-blockers on perioperative mortality, as evidenced by a fixed-effect risk ratio (RR) of 0.73 (95% confidence interval (CI) 0.35 to 1.52, P value 0.40; <LINK REF="CMP-001.01" TYPE="ANALYSIS">Analysis 1.1</LINK>). Four studies allowed classification of cause of death as cardiac or non-cardiac (<LINK REF="STD-Gomes-1999" TYPE="STUDY">Gomes 1999</LINK>; <LINK REF="STD-Oka-1980" TYPE="STUDY">Oka 1980</LINK>; <LINK REF="STD-Sezai-2011" TYPE="STUDY">Sezai 2011</LINK>; <LINK REF="STD-White-1984" TYPE="STUDY">White 1984</LINK>). With respect to these trials, we found no clear evidence of an effect of beta-blockers on death from cardiac causes in the setting of cardiac surgery (RR 0.85, 95% CI 0.16 to 4.40, P value 0.84; <LINK REF="CMP-001.04" TYPE="ANALYSIS">Analysis 1.4</LINK>). No studies investigated long-term mortality after the 30th postoperative day.</P></SUBSECTION><SUBSECTION><HEADING LEVEL="5">Heterogeneity</HEADING><P>The amount of variance explained by between-study variation was low (I<SUP>2</SUP> = 0%, P value 0.98). Thus we chose a fixed-effect model for presentation. Prespecified subgroup analyses for start of beta-blocker (<LINK REF="CMP-003.01" TYPE="ANALYSIS">Analysis 3.1</LINK>) and type of beta-blocker (<LINK REF="CMP-005.01" TYPE="ANALYSIS">Analysis 5.1</LINK>) did not detect sources of heterogeneity, and the effect estimate was consistently non-significant throughout all subgroups. When we applied meta-regression analysis, no clinical effect modifiers were detected.</P></SUBSECTION><SUBSECTION><HEADING LEVEL="5">Reporting bias</HEADING><P>Upon visual assessment of the funnel plot and formal assessment of funnel plot asymmetry while applying Egger's test (P value 0.94), we found no evidence of a reporting bias.</P></SUBSECTION><SUBSECTION><HEADING LEVEL="5">Sensitivity analysis</HEADING><P>The effect estimate remained virtually unchanged when we used a random-effects model (RR 0.75, 95% CI 0.34 to 1.66, P value 0.48) instead of a fixed-effect model (RR 0.73, 95% CI 0.35 to 1.52, P value 0.40). Restricting the meta-analysis to low risk of bias studies did not change estimates much (all studies: RR 0.73, 95% CI 0.35 to 1.52, P value 0.40; low risk of bias studies: RR 0.81, 95% CI 0.27 to 2.43, P value 0.70; <LINK REF="CMP-002.01" TYPE="ANALYSIS">Analysis 2.1</LINK>). Meta-regression analysis of study parameters representing methodological quality identified no relevant interaction.</P></SUBSECTION><SUBSECTION><HEADING LEVEL="5">Summary of confidence in estimates of effects using GRADE and TSA</HEADING><P>Whereas heterogeneity of the data was low and no evidence was found of a bias caused by studies of poorer methodological quality, overall information size was small (3783 participants; 5.1%) compared with the optimal information size of 74,577 participants calculated to detect a 20% relative change in mortality, assuming a control group event rate of 0.96% (mean control group event rate) with a power of 80% at an alpha level of 0.05. It was not possible for us to perform TSA analysis with such a small information size. The effect estimate of the meta-analysis was imprecise, as the 95% CI overlapped the zone of no effect (RR 1.0) and the zone of potential harm or benefit (RR 1.25 and RR 0.75, respectively). We therefore classified the quality of evidence as moderate (severe imprecision due to wide CI and small sample size: -1). Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.</P></SUBSECTION></SUBSECTION><SUBSECTION><HEADING LEVEL="4"><I>Acute myocardial infarction </I></HEADING><SUBSECTION><HEADING LEVEL="5">Overall effect</HEADING><P>We evaluated the occurrence of AMI in 22 trials that included 3553 participants. In two studies no AMI occurred in the beta-blocker group nor in the control group (<LINK REF="STD-Evrard-2000" TYPE="STUDY">Evrard 2000</LINK>; <LINK REF="STD-Forlani-2002" TYPE="STUDY">Forlani 2002</LINK>). None of the remaining 20 trials found a statistically significant difference between beta-blocker and control groups at an alpha level of 0.05. Overall, we found no clear evidence of an effect of beta-blockers on perioperative AMI in cardiac surgery, as evidenced by a fixed-effect RR of 1.04 (95% CI 0.71 to 1.51, P value 0.85; <LINK REF="CMP-001.06" TYPE="ANALYSIS">Analysis 1.6</LINK>).</P></SUBSECTION><SUBSECTION><HEADING LEVEL="5">Heterogeneity</HEADING><P>The amount of variance explained by between-study variation was low (I<SUP>2</SUP> = 0%, P value 0.96). Thus we chose a fixed-effect model for presentation. We performed pre-specified subgroup analyses for start of beta-blocker and type of beta-blocker (<LINK REF="CMP-003.06" TYPE="ANALYSIS">Analysis 3.6</LINK>; <LINK REF="CMP-005.06" TYPE="ANALYSIS">Analysis 5.6</LINK>). Results of all subgroups were consistently statistically non-significant. When we applied meta-regression analysis, no clinical effect modifiers were detected.</P></SUBSECTION><SUBSECTION><HEADING LEVEL="5">Reporting bias</HEADING><P>Upon visual assessment of the funnel plot and formal assessment of funnel plot asymmetry while applying Egger's test (P value 0.015), we found evidence of a reporting bias. Small studies tended to over-report a beneficial effect of beta-blockers in preventing perioperative AMI. Using the trim-and-fill method to correct for this bias did not change the point estimate nor the 95% CI (no study was simulated and added by this method to correct for the reporting bias).</P></SUBSECTION><SUBSECTION><HEADING LEVEL="5">Sensitivity analysis</HEADING><P>The effect estimate remained virtually unchanged when we used a random-effects model (RR 1.08, 95% CI 0.73 to 1.61, P value 0.69) instead of a fixed-effect model (RR 1.04, 95% CI 0.71 to 1.51, P value 0.85). Restricting the meta-analysis to the seven placebo-controlled studies with an assumed lower risk of bias did not change estimates much (all studies: RR 1.04, 95% CI 0.71 to 1.51; low risk of bias studies: RR 1.38, 95% CI 0.71 to 2.69, P value 0.35; <LINK REF="CMP-002.05" TYPE="ANALYSIS">Analysis 2.5</LINK>). Meta-regression analysis of methodological quality parameters did not detect relevant interactions.</P></SUBSECTION><SUBSECTION><HEADING LEVEL="5">Summary of confidence in estimates of effects using GRADE and TSA</HEADING><P>Whereas heterogeneity of the data was low and we found no evidence of a bias caused by studies of poorer methodological quality, we detected a reporting bias (small-studies effect). The method that we used to correct for this bias did not change the effect estimate and 95% CI. Overall information size was small (3553 participants; 19.8% of optimal information size) compared with the optimal information size of 17,954 participants calculated to detect a 20% relative change in occurrence of AMI, assuming a control group event rate of 3.8% (median control group event rate of included studies) with a power of 80% at an alpha level of 0.05. With the use of TSA, the O'Brien-Fleming alpha-spending boundaries were not crossed in either direction (<LINK REF="FIG-04" TYPE="FIGURE">Figure 4</LINK>). The effect estimate of the meta-analysis was imprecise, as the 95% CI overlapped the zone of no effect (RR 1.0) and the zone of potential harm or benefit (RR 1.25 and RR 0.75, respectively). We therefore classified the quality of evidence as moderate (serious imprecision due to wide CI and small sample size: -1). Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.</P></SUBSECTION></SUBSECTION><SUBSECTION><HEADING LEVEL="4"><I>Myocardial ischaemia </I></HEADING><SUBSECTION><HEADING LEVEL="5">Overall effect</HEADING><P>Four studies investigated myocardial ischaemia in cardiac surgery as defined by study authors (166 participants: <LINK REF="STD-Harrison-1987" TYPE="STUDY">Harrison 1987</LINK>; <LINK REF="STD-Kurian-2001" TYPE="STUDY">Kurian 2001</LINK>; <LINK REF="STD-Neustein-1994" TYPE="STUDY">Neustein 1994</LINK>; <LINK REF="STD-Reves-1990" TYPE="STUDY">Reves 1990</LINK>). Most of the weight (58.1%) came from the trial conducted by Kurian and colleagues in 2001 (<LINK REF="STD-Kurian-2001" TYPE="STUDY">Kurian 2001</LINK>), which was the only study to report a significant protective effect of beta-blockers (RR 0.30, 95% CI 0.09 to 0.96). None of the remaining three trials found a significant difference between beta-blocker and control groups at an alpha level of 0.05. Overall, we found no clear evidence of an effect of beta-blockers on perioperative myocardial ischaemia in cardiac surgery, as evidenced by a fixed-effect RR of 0.51 with a 95% CI of 0.25 to 1.05 (P value 0.07) (<LINK REF="CMP-001.08" TYPE="ANALYSIS">Analysis 1.8</LINK>).</P></SUBSECTION><SUBSECTION><HEADING LEVEL="5">Heterogeneity</HEADING><P>We found the amount of variance explained by between-study variation to be low (I<SUP>2</SUP> = 18%, P value 0.30). Thus we chose a fixed-effect model for presentation. Prespecified subgroup analysis for start of beta-blocker treatment (<LINK REF="CMP-003.08" TYPE="ANALYSIS">Analysis 3.8</LINK>) led to isolation of the Kurian trial in the subgroup 'start after surgery,' which as a matter of fact yielded a statistically significant result, as the only trial included was one that detected a significant protective effect of beta-blocker treatment (for RR, see above 'Overall effect'). Stratification for type of beta-blocker was not possible, as all studies used esmolol. Meta-regression analysis could not identify a clinical effect modifier.</P></SUBSECTION><SUBSECTION><HEADING LEVEL="5">Reporting bias</HEADING><P>We found no evidence of a reporting bias upon visual assessment of the funnel plot. We did not perform formal assessment of funnel plot asymmetry because fewer than 10 studies were combined. Formal tests cannot distinguish between study variance of estimates and a potential reporting bias in this case.</P></SUBSECTION><SUBSECTION><HEADING LEVEL="5">Sensitivity analysis</HEADING><P>The effect estimate was virtually unchanged when we used a random-effects model (RR 0.55, 95% CI 0.23 to 1.32, P value 0.18) instead of a fixed-effect model (RR 0.51, 95% CI 0.25 to 1.05, P value 0.07). Restricting the meta-analysis to the three placebo-controlled studies with an assumed lower risk of bias did not change estimates much (all studies: RR 0.51, 95% CI 0.25 to 1.05, P value 0.07; low risk of bias studies: RR 0.80, 95% CI 0.31 to 2.10, P value 0.66; <LINK REF="CMP-002.07" TYPE="ANALYSIS">Analysis 2.7</LINK>). Meta-regression analysis of methodological quality parameters did not detect relevant interactions.</P></SUBSECTION><SUBSECTION><HEADING LEVEL="5">Summary of confidence in estimates of effects using GRADE and TSA</HEADING><P>Whereas heterogeneity of the data was low and we found no evidence was found of a bias caused by studies of poorer methodological quality, overall information size was very small (166 participants; 4.7% of optimal information size) compared with the optimal information size of 3538 participants calculated to detect a 20% relative change in incidence of myocardial ischaemia, assuming a control group event rate of 20.7% (median control group event rate of included trials) with a power of 80% at an alpha level of 0.05. It was not possible for us to perform TSA with such a small information size. The effect estimate of the meta-analysis was imprecise, as the 95% CI overlapped the zone of no effect (RR 1.0) and the zone of potential benefit (RR 0.75). We therefore classified the quality of evidence as low (very serious imprecision due to wide CI and very small sample size below 5% of optimal information size: -2). Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.</P></SUBSECTION></SUBSECTION><SUBSECTION><HEADING LEVEL="4"><I>Cerebrovascular events </I></HEADING><SUBSECTION><HEADING LEVEL="5">Overall effect</HEADING><P>Four studies evaluated cerebrovascular events in cardiac surgery (1400 participants). None of the four trials found a significant difference between beta-blocker and control groups at an alpha level of 0.05. Overall, we found no clear evidence of an effect of beta-blockers on cerebrovascular events in cardiac surgery, as evidenced by a fixed-effect RR of 1.52 with a 95% CI of 0.58 to 4.02 (P value 0.40) (<LINK REF="CMP-001.10" TYPE="ANALYSIS">Analysis 1.10</LINK>).</P></SUBSECTION><SUBSECTION><HEADING LEVEL="5">Heterogeneity</HEADING><P>The amount of variance explained by between-study variation was low (I<SUP>2</SUP> = 0%, P value 0.49). Thus we chose a fixed-effect model for presentation. We performed prespecified subgroup analyses for start of beta-blocker (<LINK REF="CMP-003.10" TYPE="ANALYSIS">Analysis 3.10</LINK>) and type of beta-blocker (<LINK REF="CMP-005.09" TYPE="ANALYSIS">Analysis 5.9</LINK>). Results of all subgroups were consistently statistically non-significant. When meta-regression analysis was applied, we detected no clinical effect modifiers .</P></SUBSECTION><SUBSECTION><HEADING LEVEL="5">Reporting bias</HEADING><P>We found no evidence of a reporting bias upon visual assessment of the funnel plot. We did not perform formal assessment of funnel plot asymmetry because fewer than 10 studies were combined. Formal tests cannot distinguish between study variance of estimates a potential reporting bias in this case.</P></SUBSECTION><SUBSECTION><HEADING LEVEL="5">Sensitivity analysis</HEADING><P>The effect estimate was virtually unchanged when we used a random-effects model (RR 1.58, 95% CI 0.55 to 4.59, P value 0.40) instead of a fixed-effect model (RR 1.52, 95% CI 0.58 to 4.02, P value 0.40). All trials were placebo-controlled trials with blinding of participants and attending doctors. Meta-regression analysis of methodological quality parameters detected no relevant interactions.</P></SUBSECTION><SUBSECTION><HEADING LEVEL="5">Summary of confidence in estimates of effects using GRADE and TSA</HEADING><P>Whereas heterogeneity of the data was low and we found no evidence of a bias caused by studies of poorer methodological quality, overall information size was very small (1400 participants; 2.0% of optimal information size) compared with the optimal information size of 70,005 participants calculated to detect a 20% relative change in the incidence of cerebrovascular events, assuming a control group event rate of 1.0% (median control group event rate of included trials) with a power of 80% at an alpha level of 0.05. It was not possible for us to perform TSA with such a small information size. The effect estimate of the meta-analysis was imprecise, as the 95% CI overlapped the zone of no effect (RR 1.0), and the zones of potential benefit and harm (RR 0.75 and RR 1.25, respectively). We therefore classified the quality of evidence as low (serious imprecision due to wide CI and very small sample size below 5% of optimal information size: -2). Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.</P></SUBSECTION></SUBSECTION><SUBSECTION><HEADING LEVEL="4"><I>Ventricular arrhythmias </I></HEADING><SUBSECTION><HEADING LEVEL="5">Overall effect</HEADING><P>Twelve studies evaluated the occurrence of ventricular arrhythmias in cardiac surgery (2292 participants). Two trials found a significant protective effect of beta-blockers compared with control at an alpha level of 0.05 (<LINK REF="STD-Harrison-1987" TYPE="STUDY">Harrison 1987</LINK>: RR 0.36, 95% CI 0.15 to 0.89; <LINK REF="STD-Sun-2011" TYPE="STUDY">Sun 2011</LINK>: RR 0.10, 95% CI 0.01 to 0.77). In two trials (<LINK REF="STD-Matangi-1989" TYPE="STUDY">Matangi 1989</LINK>; <LINK REF="STD-Nystr_x00f6_m-1993" TYPE="STUDY">Nyström 1993</LINK>), no ventricular arrhythmias occurred in the beta-blocker group nor in the control group. Overall, beta-blockers statistically significantly reduced the incidence of ventricular arrhythmias in cardiac surgery by 63%, as evidenced by a fixed-effect RR of 0.37 with a 95% CI of 0.24 to 0.58 (P value &lt; 0.0001) (absolute risk reduction 3.47%; number needed to treat for an additional beneficial outcome (NNTB) 29, 95% CI: 24 to 44; <LINK REF="CMP-001.12" TYPE="ANALYSIS">Analysis 1.12</LINK>).</P></SUBSECTION><SUBSECTION><HEADING LEVEL="5">Heterogeneity</HEADING><P>The amount of variance explained by between-study variation was low (I<SUP>2</SUP> = 0%, P value 0.60). Thus we chose a fixed-effect model for presentation. We performed prespecified subgroup analyses for start of beta-blocker (<LINK REF="CMP-003.11" TYPE="ANALYSIS">Analysis 3.11</LINK>), and type of beta-blocker (<LINK REF="CMP-005.11" TYPE="ANALYSIS">Analysis 5.11</LINK>). Whereas a protective beta-blocker effect was evident when the drug was started during and after surgery (RR 0.26, 95% CI 0.08 to 0.84, and RR 0.27, 95% CI 0.11 to 0.67, respectively), this effect was blunted when the drug was started before surgery (RR 0.62, 95% CI 0.31 to 1.26; <LINK REF="CMP-003.11" TYPE="ANALYSIS">Analysis 3.11</LINK>). Indeed, meta-regression analysis identified start of beta-blocker treatment as an effect modifier (P value 0.03 before vs during surgery).</P></SUBSECTION><SUBSECTION><HEADING LEVEL="5">Reporting bias</HEADING><P>Upon visual assessment of the funnel plot and formal assessment of funnel plot asymmetry while applying Egger's test (P value 0.89), we found no evidence of a reporting bias.</P></SUBSECTION><SUBSECTION><HEADING LEVEL="5">Sensitivity analysis</HEADING><P>The effect estimate was virtually unchanged when we used a random-effects model (RR 0.40, 95% CI 0.25 to 0.63, P value &lt; 0.0001) instead of a fixed-effect model (RR 0.37, 95% CI 0.24 to 0.58, P value &lt; 0.0001), or when analysis was restricted to the seven placebo-controlled trials with an assumed low risk of bias (RR 0.41, 95% CI 0.25 to 0.68, P value 0.0006; <LINK REF="CMP-002.10" TYPE="ANALYSIS">Analysis 2.10</LINK>). Meta-regression analysis of methodological quality parameters did not detect relevant interactions.</P></SUBSECTION><SUBSECTION><HEADING LEVEL="5">Summary of confidence in estimates of effects using GRADE and TSA</HEADING><P>Heterogeneity of the data was low and no evidence was found of a bias caused by studies of poorer methodological quality. Overall information size was small (2292 participants; 22.8% of optimal information size) compared with the optimal information size of 10,068 participants calculated to detect a 20% relative change in the incidence of ventricular arrhythmias, assuming a control group event rate of 6.6% (median control group event rate of included trials) with a power of 80% at an alpha level of 0.05. TSA was inconclusive, as the Z-curve did not cross either O'Brien-Fleming alpha-spending boundary (<LINK REF="FIG-05" TYPE="FIGURE">Figure 5</LINK>). The effect estimate of the meta-analysis was precise, as the 95% CI did not overlap the zone of no effect (RR 1.0) nor the zone of potential harm (RR 1.25). We therefore classified the quality of evidence as moderate (serious imprecision due to small sample size compared with optimal information size: -1). Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.</P></SUBSECTION></SUBSECTION><SUBSECTION><HEADING LEVEL="4"><I>Supraventricular arrhythmias </I></HEADING><SUBSECTION><HEADING LEVEL="5">Overall effect</HEADING><P>A total of 48 studies evaluated the occurrence of supraventricular arrhythmias in cardiac surgery (6420 participants). Thirty-two trials found a significant protective effect of beta-blockers compared with control at an alpha level of 0.05, whereas 16 trials did not show a significant effect compared with control. Overall, beta-blockers statistically significantly reduced the incidence of supraventricular arrhythmias in cardiac surgery by 56%, as evidenced by a random-effects RR of 0.44 with a 95% CI of 0.36 to 0.53 (P value &lt; 0.00001) (absolute risk reduction 16.92%; NNTB 5, 95% CI: 5 to 6; <LINK REF="CMP-001.16" TYPE="ANALYSIS">Analysis 1.16</LINK>).</P></SUBSECTION><SUBSECTION><HEADING LEVEL="5">Heterogeneity</HEADING><P>We found the amount of variance explained by between-study variation was high (I<SUP>2</SUP> = 77%, P value &lt; 0.00001). Thus we chose a random-effects model for presentation. Stratification according to prespecified subgroup analyses (start of beta-blocker, type of beta-blocker) could not reduce statistical heterogeneity (<LINK REF="CMP-003.15" TYPE="ANALYSIS">Analysis 3.15</LINK>; <LINK REF="CMP-005.15" TYPE="ANALYSIS">Analysis 5.15</LINK>). Beta-blockers showed a consistently significant protective effect in preventing supraventricular arrhythmias, irrespective of the start of the drug (<LINK REF="CMP-003.15" TYPE="ANALYSIS">Analysis 3.15</LINK>). However, meta-regression found that duration of beta-blocker treatment was an effect modifier (P value 0.03 to 0.99, depending on exact duration of treatment). Stratification for this parameter could not explain statistical heterogeneity but revealed blunting of the protective effect when beta-blockers were administered only up to 24 hours (<LINK REF="CMP-006.09" TYPE="ANALYSIS">Analysis 6.9</LINK>).</P></SUBSECTION><SUBSECTION><HEADING LEVEL="5">Reporting bias</HEADING><P>Upon visual assessment of the funnel plot and formal assessment of funnel plot asymmetry while applying Egger's test (P value 0.003), we found evidence of a reporting bias (small studies were likely to report pronounced protection of participants taking beta-blockers against supraventricular arrhythmias). Using the trim-and-fill method to adjust for this bias did not change the point estimate and the 95% CI (no study was imputed when this method was applied).</P></SUBSECTION><SUBSECTION><HEADING LEVEL="5">Sensitivity analysis</HEADING><P>The effect estimate was not changed much when we used a fixed-effect model (RR 0.50, 95% CI 0.46 to 0.54, P value &lt; 0.00001) instead of a random-effects model (RR 0.44, 95% CI 0.36 to 0.53, P value &lt; 0.00001). Restricting the meta-analysis to the 20 placebo-controlled studies with an assumed lower risk of bias did not change the effect estimate much (all studies: RR 0.44, 95% CI 0.36 to 0.53, P value &lt; 0.00001; low risk of bias studies: RR 0.60, 95% CI 0.48 to 0.76, P value &lt; 0.0001; <LINK REF="CMP-002.13" TYPE="ANALYSIS">Analysis 2.13</LINK>). Restricting supraventricular arrhythmias to atrial fibrillation or flutter did not change the effect estimate much (all supraventricular arrhythmias: RR 0.44, 95% CI 0.36 to 0.53, P value &lt; 0.00001; atrial fibrillation and flutter only: RR 0.48, 95% CI 0.40 to 0.57, P value &lt; 0.00001; <LINK REF="CMP-001.14" TYPE="ANALYSIS">Analysis 1.14</LINK>). Meta-regression identified control group status (P value 0.01) as a methodological parameter influencing the effect estimate. Stratification for control group status was routinely performed (<LINK REF="CMP-002.13" TYPE="ANALYSIS">Analysis 2.13</LINK>). Standard care controlled trials systematically overestimated the effect of beta-blocker in preventing supraventricular arrhythmias (RR 0.36, 95% CI 0.31 to 0.43, P value &lt; 0.00001) but did not alter the effect estimate much.</P></SUBSECTION><SUBSECTION><HEADING LEVEL="5">Summary of confidence in estimates of effects using GRADE and TSA</HEADING><P>Heterogeneity of the data was high and could not be sufficiently explained. We identified two sources of bias as caused by studies of poorer methodological quality (did not significantly change the effect estimate) and a reporting bias. In both cases, the protective effect of beta-blockers was overestimated. However, restricting the analysis to placebo-controlled trials and adjusting for reporting bias did not alter the effect estimate nor the 95% CI significantly. The overall information size was sufficient (6420 participants; 156.7% of optimal information size)compared with the optimal information size of 4097 participants calculated to detect a 20% relative change in the incidence of supraventricular arrhythmias when a control group event rate of 36.5% was assumed (median control group event rate of included trials) with a power of 80% at an alpha level of 0.05. TSA showed a significant protective effect of beta-blockers as the Z-curve crossed the upper O'Brien-Fleming alpha-spending boundary (<LINK REF="FIG-06" TYPE="FIGURE">Figure 6</LINK>). The effect estimate of the meta-analysis was precise, as the 95% CI did not overlap the zone of no effect (RR 1.0) nor the zone of potential harm (RR 1.25). We therefore classified the quality of evidence as high (no downgrading). Further research is very unlikely to change our confidence in the estimate of effect.</P></SUBSECTION></SUBSECTION><SUBSECTION><HEADING LEVEL="4"><I>Bradycardia </I></HEADING><SUBSECTION><HEADING LEVEL="5">Overall effect</HEADING><P>Eight studies evaluated the occurrence of bradycardia in cardiac surgery (660 participants). One trial found a significant effect of beta-blockers causing bradycardia compared with control at an alpha level of 0.05 (<LINK REF="STD-Auer-2004" TYPE="STUDY">Auer 2004</LINK>: RR 4.68, 95% CI 1.12 to 19.55). In another trial (<LINK REF="STD-Cork-1995" TYPE="STUDY">Cork 1995</LINK>), no episodes of bradycardia occurred in the beta-blocker group nor in the control group. Six trials yielded non-significant results. Overall, we found no clear evidence of an effect of beta-blockers on the occurrence of episodes of bradycardia in cardiac surgery, as evidenced by a fixed-effect RR of 1.61 with a 95% CI of 0.97 to 2.66 (P value 0.06) (<LINK REF="CMP-001.20" TYPE="ANALYSIS">Analysis 1.20</LINK>).</P><P><I><B>Heterogeneity</B></I></P><P>The amount of variance explained by between-study variation was low (I<SUP>2</SUP> = 0%, P value 0.50). Thus we chose a fixed-effect model for presentation. We performed prespecified subgroup analyses for start of beta-blocker (<LINK REF="CMP-003.19" TYPE="ANALYSIS">Analysis 3.19</LINK>) and type of beta-blocker (<LINK REF="CMP-005.19" TYPE="ANALYSIS">Analysis 5.19</LINK>) were performed. Except for one trial mentioned above that yielded a significant result using metoprolol and sotalol (<LINK REF="STD-Auer-2004" TYPE="STUDY">Auer 2004</LINK>), subgroup stratification consistently provided non-significant results. When we applied meta-regression analysis , no clinical effect modifiers were detected.</P></SUBSECTION><SUBSECTION><HEADING LEVEL="5">Reporting bias</HEADING><P>We found no evidence of a reporting bias upon visual assessment of the funnel plot. We did not perform formal assessment of funnel plot asymmetry because fewer than 10 studies were combined. Formal tests cannot distinguish between study variance of estimates and a potential reporting bias in this case.</P></SUBSECTION><SUBSECTION><HEADING LEVEL="5">Sensitivity analysis</HEADING><P>The effect estimate was not changed much when we used a random-effects model (RR 1.39, 95% CI 0.84 to 2.31, P value 0.20) instead of a fixed-effect model (RR 1.61, 95% CI 0.97 to 2.66, P value 0.06). Restricting the meta-analysis to the six placebo-controlled studies with an assumed lower risk of bias led to a trend&#8212;albeit non-significant&#8212;towards a higher incidence of bradycardia with the use of beta-blockers (all studies: RR 1.61, 95% CI 0.97 to 2.66, P value 0.06; low risk of bias studies: RR 1.89, 95% CI 0.99 to 3.63, P value 0.05; <LINK REF="CMP-002.16" TYPE="ANALYSIS">Analysis 2.16</LINK>). Meta-regression analysis of methodological quality parameters did not detect relevant interactions.</P></SUBSECTION><SUBSECTION><HEADING LEVEL="5">Summary of confidence in estimates of effects using GRADE and TSA</HEADING><P>Whereas heterogeneity of the data was low, and we found no evidence of a bias caused by studies of poorer methodological quality or with a reporting bias, overall sample size was very small (660 participants; 1.4% of optimal information size) compared with the optimal information size of 47,355 participants calculated to detect a 20% relative change in the incidence of bradycardia, assuming a control group event rate of 1.43% (median control group event rate of included trials) with a power of 80% at an alpha level of 0.05. It was not possible for us to perform TSA with such a small information size. The effect estimate of the meta-analysis was imprecise, as the 95% CI overlapped the zone of no effect (RR 1.0) and the zone of potential harm (RR 1.25). We therefore classified the quality of evidence as low (very serious imprecision due to wide CI and very small sample size: -2). Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.</P></SUBSECTION></SUBSECTION><SUBSECTION><HEADING LEVEL="4"><I>Hypotension </I></HEADING><SUBSECTION><HEADING LEVEL="5">Overall effect</HEADING><P>Six studies evaluated the occurrence of hypotensive episodes in cardiac surgery (558 participants). None of the trials found a significant effect of beta-blockers causing hypotension compared with control at an alpha level of 0.05. All trials recorded episodes of hypotension in the beta-blocker group or in the control group. Overall, we found no clear evidence that beta-blockers induce hypotensive episodes in cardiac surgery, as evidenced by a fixed-effect RR of 1.54 with a 95% CI of 0.67 to 3.51 (P value 0.31) (<LINK REF="CMP-001.22" TYPE="ANALYSIS">Analysis 1.22</LINK>).</P></SUBSECTION><SUBSECTION><HEADING LEVEL="5">Heterogeneity</HEADING><P>The amount of variance explained by between-study variation was low (I<SUP>2</SUP> = 0%, P value 0.60). Thus we chose a fixed-effect model for presentation. Prespecified subgroup analyses for start of beta-blocker (<LINK REF="CMP-003.21" TYPE="ANALYSIS">Analysis 3.21</LINK>) and type of beta-blocker (<LINK REF="CMP-005.21" TYPE="ANALYSIS">Analysis 5.21</LINK>), provided non-significant results throughout all subgroups. When we applied meta-regression analysis , no clinical effect modifiers were detected.</P></SUBSECTION><SUBSECTION><HEADING LEVEL="5">Reporting bias</HEADING><P>We found no evidence of a reporting bias upon visual assessment of the funnel plot. We did not perform formal assessment of funnel plot asymmetry because fewer than 10 studies were combined. In this case, formal tests cannot distinguish between study variance of estimates and a potential reporting bias.</P></SUBSECTION><SUBSECTION><HEADING LEVEL="5">Sensitivity analysis</HEADING><P>The effect estimate remained virtually unchanged when we used a random-effects model (RR 1.48, 95% CI 0.60 to 3.69, P value 0.39) instead of a fixed-effect model (RR 1.54, 95% CI 0.67 to 3.51, P value 0.31). Restricting the meta-analysis to the five placebo-controlled studies with an assumed lower risk of bias also left the effect estimate unchanged (all studies: RR 1.54, 95% CI 0.67 to 3.51, P value 0.31; low risk of bias studies: RR 1.30, 95% CI 0.54 to 3.14, P value 0.56; <LINK REF="CMP-002.18" TYPE="ANALYSIS">Analysis 2.18</LINK>). Meta-regression analysis of methodological quality parameters did not detect relevant interactions.</P></SUBSECTION><SUBSECTION><HEADING LEVEL="5">Summary of confidence in estimates of effects using GRADE and TSA</HEADING><P>Whereas heterogeneity of the data was low, and we found no evidence of a bias caused by studies of poorer methodological quality nor a reporting bias, overall information size was very small (558 participants; 2.2% of optimal information size) compared with the optimal information size of 25,528 participants calculated to detect a 20% relative change in the incidence of hypotensive episodes, assuming a control group event rate of 2.7% (median control group event rate of included trials) with a power of 80% at an alpha level of 0.05. It was not possible for us to perform TSA with such a small information size. The effect estimate of the meta-analysis was imprecise, as the 95% CI overlapped the zone of no effect (RR 1.0) and the zones of potential benefit and harm (RR 0.75 and RR 1.25, respectively). We therefore classified the quality of evidence as low (serious imprecision due to wide CI and very small sample size: -2). Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.</P></SUBSECTION></SUBSECTION><SUBSECTION><HEADING LEVEL="4"><I>Ventricular extrasystoles </I></HEADING><SUBSECTION><HEADING LEVEL="5">Overall effect</HEADING><P>Five studies evaluated the incidence of ventricular extrasystoles in cardiac surgery (462 participants). None of the trials found a significant effect of beta-blockers preventing ventricular extrasystoles compared with control at an alpha level of 0.05. All trials recorded episodes of ventricular extrasystoles in the beta-blocker group or in the control group. Overall, we found no clear evidence of an effect of beta-blockers on the occurrence of ventricular extrasystoles in cardiac surgery, as evidenced by a fixed-effect RR of 0.58 with a 95% CI of 0.31 to 1.08 (P value 0.09) (<LINK REF="CMP-001.18" TYPE="ANALYSIS">Analysis 1.18</LINK>).</P></SUBSECTION><SUBSECTION><HEADING LEVEL="5">Heterogeneity</HEADING><P>The amount of variance explained by between-study variation was low (I<SUP>2</SUP> = 0%, P value 0.40). Thus we chose a fixed-effect model for presentation. Prespecified subgroup analyses for start of beta-blocker (<LINK REF="CMP-003.17" TYPE="ANALYSIS">Analysis 3.17</LINK>), and type of beta-blocker (<LINK REF="CMP-005.17" TYPE="ANALYSIS">Analysis 5.17</LINK>), provided non-significant results throughout all subgroups. When we applied meta-regression analysis, no clinical effect modifiers were detected.</P></SUBSECTION><SUBSECTION><HEADING LEVEL="5">Reporting bias</HEADING><P>We found no evidence of a reporting bias upon visual assessment of the funnel plot. We did not perform formal assessment of funnel plot asymmetry because fewer than 10 studies were combined. Formal tests cannot distinguish between study variance of estimates and a potential reporting bias in this case.</P></SUBSECTION><SUBSECTION><HEADING LEVEL="5">Sensitivity analysis</HEADING><P>The effect estimate remained virtually unchanged when we used a random-effects model (RR 0.57, 95% CI 0.29 to 1.11, P value 0.10) instead of a fixed-effect model (RR 0.58, 95% CI 0.31 to 1.08, P value 0.09). Sensitivity analysis for type of control group was not possible, as all studies included a standard care control group. Meta-regression analysis of methodological quality parameters did not detect relevant interactions.</P></SUBSECTION><SUBSECTION><HEADING LEVEL="5">Summary of confidence in estimates of effects using GRADE and TSA</HEADING><P>Heterogeneity of the data was low, and we found no evidence of a bias caused by studies of poorer methodological quality nor a reporting bias. Overall information size was small (462 participants; 58.9% of optimal information size) compared with the optimal information size of 784 participants calculated to detect a 20% relative change in the incidence of ventricular extrasystoles, assuming a control group event rate of 5.0% (median control group event rate of included trials) with a power of 80% at an alpha level of 0.05. We performed TSA and it yielded an inconclusive result, with the Z-curve between the upper O'Brien-Fleming alpha-spending boundary and the zone of futility (inner wedge) (<LINK REF="FIG-07" TYPE="FIGURE">Figure 7</LINK>). The effect estimate of the meta-analysis was imprecise, as the 95% CI overlapped the zone of no effect (RR 1.0) and the zone of potential benefit (RR 0.75). We therefore classified the quality of evidence as moderate (serious imprecision due to wide CI and small sample size: -1). Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.</P></SUBSECTION></SUBSECTION><SUBSECTION><HEADING LEVEL="4"><I>Congestive heart failure </I></HEADING><SUBSECTION><HEADING LEVEL="5">Overall effect</HEADING><P>Three studies evaluated the incidence of congestive heart failure in cardiac surgery (311 participants). None of the trials found a significant effect of beta-blockers preventing or causing congestive heart failure compared with control at an alpha level of 0.05. All trials recorded occurrence of congestive heart failure in the beta-blocker group or in the control group. Overall, we found no clear evidence of an effect of beta-blockers on the occurrence of congestive heart failure in cardiac surgery, as evidenced by a fixed-effect RR of 0.22 with a 95% CI of 0.04 to 1.34 (P value 0.10) (<LINK REF="CMP-001.24" TYPE="ANALYSIS">Analysis 1.24</LINK>).</P></SUBSECTION><SUBSECTION><HEADING LEVEL="5">Heterogeneity</HEADING><P>The amount of variance explained by between-study variation was low (I<SUP>2</SUP> = 0%, P value 0.95). Thus we chose a fixed-effect model for presentation. Prespecified subgroup analyses for start of beta-blocker (<LINK REF="CMP-003.23" TYPE="ANALYSIS">Analysis 3.23</LINK>), and type of beta-blocker (<LINK REF="CMP-005.23" TYPE="ANALYSIS">Analysis 5.23</LINK>), provided non-significant results throughout all subgroups. When we applied meta-regression analysis no clinical effect modifiers were detected.</P></SUBSECTION><SUBSECTION><HEADING LEVEL="5">Reporting bias</HEADING><P>We found no evidence of a reporting bias upon visual assessment of the funnel plot. We did not perform formal assessment of funnel plot asymmetry because fewer than 10 studies were combined. Formal tests cannot distinguish between study variance of estimates and a potential reporting bias in this case.</P></SUBSECTION><SUBSECTION><HEADING LEVEL="5">Sensitivity analysis</HEADING><P>The effect estimate remained virtually unchanged when we used a random-effects model (RR 0.22, 95% CI 0.04 to 1.36, P value 0.10) instead of a fixed-effect model (RR 0.22, 95% CI 0.04 to 1.34, P value 0.10). Sensitivity analysis for type of control group was not possible, as all studies had a placebo control group. Meta-regression analysis of methodological quality parameters did not detect relevant interactions.</P></SUBSECTION><SUBSECTION><HEADING LEVEL="5">Summary of confidence in estimates of effects using GRADE and TSA</HEADING><P>Whereas heterogeneity of the data was low,and we found no evidence of a bias caused by studies of poorer methodological quality, overall information size was very small (311 participants; 1.28% of optimal information size) compared with the optimal information size of 24,242 participants calculated to detect a 20% relative change in the incidence of congestive heart failure, assuming a control group event rate of 2.86% (median control group event rate of included trials) with a power of 80% at an alpha level of 0.05. It was not possible to perform TSA with such a small information size. The effect estimate of the meta-analysis was imprecise, as the 95% CI overlapped the zone of no effect (RR 1.0) and the zones of potential benefit and harm (RR 0.75 and RR 1.25, respectively). We therefore classified the quality of evidence as low (very serious imprecision due to wide CI and very small sample size: -2). Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.</P></SUBSECTION></SUBSECTION><SUBSECTION><HEADING LEVEL="4"><I>Bronchospasm </I></HEADING><SUBSECTION><HEADING LEVEL="5">Overall effect</HEADING><P>Three studies evaluated the incidence of bronchospasm in cardiac surgery (196 participants). None of the trials found a significant effect of beta-blockers causing bronchospasm compared with control at an alpha level of 0.05. All trials recorded occurrence of bronchospasm in the beta-blocker group or in the control group. Overall, we found no clear evidence of an effect of beta-blockers on the occurrence of bronchospasm in cardiac surgery, as evidenced by a fixed-effect RR of 1.49 with a 95% CI of 0.31 to 7.14 (P value 0.62) (<LINK REF="CMP-001.26" TYPE="ANALYSIS">Analysis 1.26</LINK>).</P></SUBSECTION><SUBSECTION><HEADING LEVEL="5">Heterogeneity</HEADING><P>The amount of variance explained by between-study variation was low (I<SUP>2</SUP> = 0%, P value 0.48). Thus we chose a fixed-effect model for presentation. Prespecified subgroup analysis was performed for type of beta-blocker (<LINK REF="CMP-005.25" TYPE="ANALYSIS">Analysis 5.25</LINK>). The effect of the exact type of beta-blocker on the development of bronchospasm remained non-significant in all subgroups. Stratification for start of beta-blocker was not possible, as all trials started beta-blocker treatment after surgery. When we applied meta-regression analysis, no clinical effect modifiers were detected.</P></SUBSECTION><SUBSECTION><HEADING LEVEL="5">Reporting bias</HEADING><P>We found no evidence of a reporting bias upon visual assessment of the funnel plot. We did not perform formal assessment of funnel plot asymmetry because fewer than 10 studies were combined. Formal tests cannot distinguish between study variance of estimates and a potential reporting bias in this case.</P></SUBSECTION><SUBSECTION><HEADING LEVEL="5">Sensitivity analysis</HEADING><P>The effect estimate remained virtually unchanged when we used a random-effects model (RR 1.53, 95% CI 0.25 to 9.51, P value 0.65)instead of a fixed-effect model (RR 1.49, 95% CI 0.31 to 7.14, P value 0.62). Restricting the meta-analysis to the two placebo-controlled studies with an assumed lower risk of bias did not change the estimate much (all studies: RR 1.49, 95% CI 0.31 to 7.14; low risk of bias studies: RR 0.98, 95% CI 0.14 to 6.67, P value 0.98; <LINK REF="CMP-002.20" TYPE="ANALYSIS">Analysis 2.20</LINK>). Meta-regression analysis of methodological quality parameters did not detect relevant interactions.</P></SUBSECTION><SUBSECTION><HEADING LEVEL="5">Summary of confidence in estimates of effects using GRADE and TSA</HEADING><P>Whereas heterogeneity of the data was low, and we found no evidence of a bias caused by studies of poorer methodological quality or a reporting bias, overall information size was very small (196 participants; 0.7% of optimal information size) compared with the optimal information size of 27,621 participants calculated to detect a 20% relative change in the incidence of bronchospasm, assuming a control group event rate of 2.5% (median control group event rate of included trials) with a power of 80% at an alpha level of 0.05. It was not possible for us to perform TSA with such a small information size. The effect estimate of the meta-analysis was imprecise, as the 95% CI was wide and overlapped the zone of no effect (RR 1.0) and the zones of potential benefit and harm (RR 0.75 and RR 1.25, respectively). We therefore classified the quality of evidence as low (very serious imprecision: wide confidence interval, very small sample size: -2). Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.</P></SUBSECTION></SUBSECTION><SUBSECTION><HEADING LEVEL="4"><I>Length of stay </I></HEADING><SUBSECTION><HEADING LEVEL="5">Overall effect</HEADING><P>Fourteen studies evaluated length of stay in cardiac surgery (2450 participants). Three trials reported a significant reduction in hospital stay among participants taking beta-blockers compared with control at an alpha level of 0.05 (<LINK REF="STD-Booth-2004" TYPE="STUDY">Booth 2004</LINK>; <LINK REF="STD-Sezai-2011" TYPE="STUDY">Sezai 2011</LINK>; <LINK REF="STD-Wenke-1999" TYPE="STUDY">Wenke 1999</LINK>), whereas 11 trials did not show a significant difference. Overall, we found that beta-blockers statistically significantly reduced length of hospital stay in cardiac surgery by 0.54 days, as evidenced by a random-effects mean difference of -0.54 with a 95% CI of -0.90 to -0.19 (P value 0.003) (<LINK REF="CMP-001.28" TYPE="ANALYSIS">Analysis 1.28</LINK>).</P></SUBSECTION><SUBSECTION><HEADING LEVEL="5">Heterogeneity</HEADING><P>Between-study variance was large (I<SUP>2 </SUP>= 58%, P value 0.004). Thus we chose a random-effects model for presentation. Prespecified stratification for start of beta-blocker treatment led to a substantial reduction in statistical heterogeneity in the strata 'start before surgery' (I<SUP>2</SUP> = 0%, P value 0.50; <LINK REF="CMP-003.26" TYPE="ANALYSIS">Analysis 3.26</LINK>) and 'start during surgery' (I<SUP>2</SUP> = 0%, P value 0.44). Conversely, heterogeneity was still high in the group 'start after surgery' (I<SUP>2</SUP> = 62%, P value 0.02). The effect estimate was influenced only mildly by start of beta-blocker treatment (before: mean difference -0.69, 95% CI -1.39 to 0.02; during: mean difference -0.71, 95% CI -0.83 to -0.59; after: mean difference -0.33, 95% CI -0.87 to 0.22). Much of the statistical heterogeneity was caused by substantial differences in the reported effect of metoprolol on length of hospital stay in metoprolol trials (<LINK REF="STD-Booth-2004" TYPE="STUDY">Booth 2004</LINK>: mean difference -0.70, 95% CI -0.82 to -0.58; <LINK REF="STD-Connolly-2003" TYPE="STUDY">Connolly 2003</LINK>: mean difference 0.20, 95% CI -0.20 to 0.60; <LINK REF="STD-Wenke-1999" TYPE="STUDY">Wenke 1999</LINK>: mean difference -1.41, 95% CI -2.20 to -0.62; <LINK REF="CMP-005.27" TYPE="ANALYSIS">Analysis 5.27</LINK>).</P><P>Meta-regression found that the following clinical parameters were statistically significantly associated with the effect estimate: route of beta-blocker application (oral vs intravenous route: P value 0.004), percentage of included patients already taking beta-blockers before entry into the trial (P value 0.03) and gender (P value 0.003). Stratification for these three parameters did not reduce statistical heterogeneity (<LINK REF="CMP-006.13" TYPE="ANALYSIS">Analysis 6.13</LINK>; <LINK REF="CMP-006.14" TYPE="ANALYSIS">Analysis 6.14</LINK>; <LINK REF="CMP-006.15" TYPE="ANALYSIS">Analysis 6.15</LINK>). We found that eduction in length of stay was more pronounced for parenteral administration (mean difference -0.84, 95% CI -1.42 to -0.25, P value 0.005 for subgroup overall effect) than for oral application (mean difference -0.56, 95% CI -1.14 to 0.02, P value 0.06 for overall subgroup effect; <LINK REF="CMP-006.13" TYPE="ANALYSIS">Analysis 6.13</LINK>). Splitting the trials into two groups according to whether or not more than 43.3% (median of all studies) of included patients were taking beta-blockers before entry into the trial only mildly changed the effect estimate (below median: mean difference -0.69, 95% CI -1.21 to -0.16, P value 0.01 for overall subgroup effect; above median: mean difference -0.43, 95% CI -0.91 to 0.04, P value 0.08 for overall subgroup effect; <LINK REF="CMP-006.15" TYPE="ANALYSIS">Analysis 6.15</LINK>). However, statistical significance was lost in the subgroup comprising trials with a higher than median percentage of patients who were taking beta-blockers before entry into the trial. When the effect of gender on the effect estimate was analysed (<LINK REF="CMP-006.14" TYPE="ANALYSIS">Analysis 6.14</LINK>), a pronounced reduction in length of stay could be observed in trials with the percentage of female participants exceeding 20.8% (median of all trials, below median: mean difference -0.35, 95% CI -0.74 to 0.04, P value 0.08 for overall subgroup effect; above median: mean difference -0.67, 95% CI -1.21 to -0.13, P value 0.01).</P></SUBSECTION><SUBSECTION><HEADING LEVEL="5">Reporting bias</HEADING><P>Visual assessment of the funnel plot indicated a reporting bias (small trials tended to report a pronounced reduction in length of stay), whereas formal assessment of funnel plot asymmetry could not confirm this finding (P value 0.892). In keeping with a conservative approach, we judged that a reporting bias was present. Using the trim-and-fill method to adjust for this bias did not change the point estimate and the 95% CI (no study was simulated and added by this method to correct for the reporting bias).</P></SUBSECTION><SUBSECTION><HEADING LEVEL="5">Sensitivity analysis</HEADING><P>Prespecified stratification for type of control group could confirm a statistically significant reduction in length of stay in placebo-controlled trials, whereas this effect was blunted in standard care trials (placebo: mean difference -0.60, 95% CI -1.11 to -0.09, P value 0.02 for overall subgroup effect; standard care: mean difference -0.51, 95% CI -1.09 to 0.06, P value 0.08 for overall subgroup effect; <LINK REF="CMP-002.22" TYPE="ANALYSIS">Analysis 2.22</LINK>). Meta-regression analysis identified blinding of participants and doctors (P value 0.001 and P value 0.002, respectively), application of the intention-to-treat principle in data analysis (P value 0.005) and specification of co-morbidities (P value 0.002) as methodological factors statistically significantly influencing the effect estimate. Stratification of trials according to these parameters did not reduce statistical heterogeneity (<LINK REF="CMP-006.10" TYPE="ANALYSIS">Analysis 6.10</LINK>; <LINK REF="CMP-006.11" TYPE="ANALYSIS">Analysis 6.11</LINK>; <LINK REF="CMP-006.12" TYPE="ANALYSIS">Analysis 6.12</LINK>; <LINK REF="CMP-006.16" TYPE="ANALYSIS">Analysis 6.16</LINK>). Trials with blinding of participants and doctors, trials exactly specifying co-morbidities and trials applying the intention-to-treat principle in data analysis were thought to be of higher quality. Stratification, however, led to inconsistent results: Whereas reduction in length of stay was more pronounced in trials using the intention-to-treat principle (used: mean difference -0.57, 95% CI -0.85 to -0.30, P value &lt; 0.0001 for overall subgroup effect; not used: mean difference -0.66, 95% CI -1.57 to 0.24, P value 0.15 for overall subgroup effect; <LINK REF="CMP-006.10" TYPE="ANALYSIS">Analysis 6.10</LINK>) and specifying co-morbidities (specified: mean difference -0.69, 95% CI -0.80 to -0.57, P value &lt; 0.00001 for overall subgroup effect; not specified: mean difference -0.44, 95% CI -1.10 to 0.21, P value 0.18 for overall subgroup effect; <LINK REF="CMP-006.16" TYPE="ANALYSIS">Analysis 6.16</LINK>), reduction was blunted in trials using blinding of doctors and participants compared with unblinded trials (participants definitively blinded: mean difference -0.72, 95% CI -1.53 to 0.10, P value 0.09 for overall subgroup effect; participants not definitively blinded: mean difference -0.64, 95% CI -0.87 to -0.41, P value &lt; 0.00001 for overall subgroup effect; <LINK REF="CMP-006.11" TYPE="ANALYSIS">Analysis 6.11</LINK>; doctors definitively blinded: mean difference -0.69, 95% CI -1.45 to 0.07, P value 0.08 for overall subgroup effect; doctors not definitively blinded: mean difference -0.62, 95% CI -0.91 to -0.33, P value &lt; 0.0001 for overall subgroup effect; <LINK REF="CMP-006.12" TYPE="ANALYSIS">Analysis 6.12</LINK>).</P></SUBSECTION><SUBSECTION><HEADING LEVEL="5">Summary of confidence in estimates of effects using GRADE and TSA</HEADING><P>Heterogeneity of the data was high and could be explained only partially by stratification for start of beta-blocker treatment and type of beta-blocker (see above, 'Heterogeneity' and 'Sensitivity analysis'). We identified many sources of bias as caused by clinical parameters (route of beta-blocker application, percentage of participants pretreated with beta-blockers, gender) and by methodological quality criteria (blinding of participants and attending doctors, application of the intention-to-treat principle in data analysis, specification of co-morbidities in baseline characteristics). The impact of these factors on the effect estimate was only marginal, and we could not identify a clear pattern. Furthermore, we assumed the presence of a reporting bias upon visual inspection of the funnel plot. Adjusting for this bias did not change the effect estimate. Overall information size was sufficient (2450 participants; 213.97% of optimal information size) compared with the optimal information size of 1145 participants calculated to detect a mean difference of 0.5 days in length of stay, assuming a control group length of stay of 10.16 days with a standard deviation (SD) of 4.27 days (length of stay in control groups of included trials) with a power of 80% at an alpha level of 0.05. This estimate was calculated using a conventional sample size calculator (assuming between-study heterogeneity of 0%), as TSA currently is not available for continuous variables and therefore could not be performed. The effect estimate of the meta-analysis was precise, as the 95% CI did not overlap the zone of no effect (mean difference 0) or significant prolongation of hospital stay (mean difference +0.5). We therefore classified the quality of evidence as low (multiple sources of bias: -1, serious inconsistency: -1). Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.</P></SUBSECTION></SUBSECTION><SUBSECTION><HEADING LEVEL="4"><I>Cost of care </I></HEADING><P>Three trials reported on cost of care (<LINK REF="STD-Connolly-2003" TYPE="STUDY">Connolly 2003</LINK>; <LINK REF="STD-Cork-1995" TYPE="STUDY">Cork 1995</LINK>; <LINK REF="STD-Sezai-2011" TYPE="STUDY">Sezai 2011</LINK>). The respective numbers were too far apart (differed nearly 10-fold) to allow a meaningful analysis (<LINK REF="CMP-001.30" TYPE="ANALYSIS">Analysis 1.30</LINK>). Conolly and colleagues reported that the total cost of care was USD 4586 in the beta-blocker group and USD 4414 in the control group (no SDs were provided by study authors), whereas in the studies by Cork and colleagues and Sezai and colleagues, on average USD 34,351 and USD 39,981 was spent for a participant in the beta-blocker group, and USD 31,551 and USD 35,679 was spent for a control participant, respectively. Thus all authors report higher costs of care for the intervention groups. This difference reached statistical significance only in the trial by Sezai and colleagues.</P></SUBSECTION><SUBSECTION><HEADING LEVEL="4"><I>Quality of life </I></HEADING><P>No trial reported on quality of life.</P></SUBSECTION><SUBSECTION><HEADING LEVEL="4"><I>Non-cardiac surgery</I></HEADING><P>For a concise summary of the most important outcome variables see <LINK REF="SOF-02" TYPE="SOF">Summary of findings table 2</LINK>.</P></SUBSECTION><SUBSECTION><HEADING LEVEL="4"><I>All-cause mortality </I></HEADING><SUBSECTION><HEADING LEVEL="5">Overall effect</HEADING><P>Thirteen trials reported on all-cause mortality (11,413 participants). The following types of surgery were evaluated: thoracic surgery (two trials), vascular surgery (three trials), neurosurgery (one trial) and 'non-cardiac' surgery (seven trials). In three trials, no deaths occurred in the beta-blocker group nor in the control group (<LINK REF="STD-Lai-2006" TYPE="STUDY">Lai 2006</LINK>; <LINK REF="STD-Miller-1990" TYPE="STUDY">Miller 1990</LINK>; <LINK REF="STD-Miller-1991" TYPE="STUDY">Miller 1991</LINK>). In the POISE trial (<LINK REF="STD-POISE-2008" TYPE="STUDY">POISE 2008</LINK>), a significant increase in mortality was observed, whereas in the remaining 13 trials, no significant difference was found between the beta-blocker group and the control group at an alpha level of 0.05. Overall, we found that beta-blockers increased perioperative mortality, as evidenced by a fixed-effect RR of 1.25 (95% CI 1.00 to 1.57, P value 0.05; absolute increase in risk: 0.50%, NNTH: 167, 95% CI: 73 to infinite, <LINK REF="CMP-001.02" TYPE="ANALYSIS">Analysis 1.2</LINK>). Four studies allowed classification of cause of death as cardiac or non-cardiac (<LINK REF="STD-Mangano-1996" TYPE="STUDY">Mangano 1996</LINK>; <LINK REF="STD-Marwick-2009" TYPE="STUDY">Marwick 2009</LINK>; <LINK REF="STD-POISE-2008" TYPE="STUDY">POISE 2008</LINK>; <LINK REF="STD-Yang-2006" TYPE="STUDY">Yang 2006</LINK>). With respect to these trials, we found no clear evidence of an effect of beta-blockers on death from cardiac causes in the setting of non-cardiac surgery (RR 1.26, 95% CI 0.91 to 1.75, P value 0.17; <LINK REF="CMP-001.05" TYPE="ANALYSIS">Analysis 1.5</LINK>). Four studies investigated long-term mortality after the 30th postoperative day (<LINK REF="STD-DIPOM-_x002d_-Juul-2006" TYPE="STUDY">DIPOM - Juul 2006</LINK>; <LINK REF="STD-Marwick-2009" TYPE="STUDY">Marwick 2009</LINK>; <LINK REF="STD-Neary-2006" TYPE="STUDY">Neary 2006</LINK>; <LINK REF="STD-Wallace-1998" TYPE="STUDY">Wallace 1998</LINK>). The effect estimate changed only slightly in number but lost its statistical significance, if the results of these long-term follow-ups were included in the analysis (RR 0.99, 95% CI 0.74 to 1.31, P value 0.92; <LINK REF="CMP-001.03" TYPE="ANALYSIS">Analysis 1.3</LINK>). If adding long-term mortality data to surgical risk status, long-term all-cause mortality for participants who had undergone high risk surgery was statistically significantly decreased (RR 0.62, 95% CI 0.39 to 0.98, P value 0.04, <LINK REF="CMP-004.02" TYPE="ANALYSIS">Analysis 4.2</LINK>) .</P></SUBSECTION><SUBSECTION><HEADING LEVEL="5">Heterogeneity</HEADING><P>The amount of variance explained by between-study variation was low (I<SUP>2</SUP> = 0%, P value 0.67). Thus we chose a fixed-effect model for presentation. Prespecified subgroup analyses for start of beta-blocker, type of beta-blocker and risk of surgery did not alter the results much, but the increase in mortality reached statistical significance in the 'before surgery,' ''metoprolol' and 'low and medium risk surgery' subgroups (start of beta-blocker: before: RR 1.30, 95% CI 1.03 to 1.63, P value 0.02 for overall subgroup effect; during: RR 0.54, 95% CI 0.18 to 1.62, P value 0.27 for overall subgroup effect; <LINK REF="CMP-003.02" TYPE="ANALYSIS">Analysis 3.2</LINK>; risk of surgery: low and medium risk: RR 1.31, 95% CI 1.04 to 1.66, P value 0.02; high risk: RR 0.83, 95% CI 0.41 to 1.66, P value 0.59; <LINK REF="CMP-004.01" TYPE="ANALYSIS">Analysis 4.1</LINK>). All these results were driven exclusively by one large trial, the POISE trial (<LINK REF="STD-POISE-2008" TYPE="STUDY">POISE 2008</LINK>), which represented 72.0% of the weight of the meta-analysis. Omitting this trial led to non-significant results in all three subgroups just mentioned. Meta-regression detected a statistically significant association between the surgical risk status (P value 0.04, <LINK REF="CMP-004.01" TYPE="ANALYSIS">Analysis 4.1</LINK>, see before) and the effect estimate.</P></SUBSECTION><SUBSECTION><HEADING LEVEL="5">Reporting bias</HEADING><P>Upon visual assessment of the funnel plot and formal assessment of funnel plot asymmetry while applying Egger's test (P value 0.20), we found no evidence of a reporting bias.</P></SUBSECTION><SUBSECTION><HEADING LEVEL="5">Sensitivity analysis</HEADING><P>The effect estimate was virtually unchanged when we used a random-effects model (RR 1.27, 95% CI 1.02 to 1.60, P value 0.03) instead of a fixed-effect model (RR 1.25, 95% CI 1.00 to 1.57, P value 0.05). Restricting the meta-analysis to low risk of bias studies also indicated increased mortality with the use of beta-blockers (all studies: RR 1.25, 95% CI 1.00 to 1.57, P value 0.05; low risk of bias studies: RR 1.29, 95% CI 1.02 to 1.62, P value 0.03 (<LINK REF="CMP-002.02" TYPE="ANALYSIS">Analysis 2.2</LINK>). This finding was blunted and lost its statistical significance when we analysed only trials with a poorer methodology (non-placebo controlled trials). Meta-regression analysis of methodological quality parameters revealed an association between type of hospital and the effect estimate (P value 0.02). Stratification for type of hospital showed a trend towards lower mortality at university hospitals than at other hospitals. We included multi-centre trials with more non-university hospitals than university hospitals in the 'non-university hospitals' subgroup. When the forest plot in <LINK REF="CMP-006.01" TYPE="ANALYSIS">Analysis 6.1</LINK> was inspected, we could identify a trend toward higher mortality in the 'non-university hospitals' group ('university hospitals' group: RR 0.58, 95% CI 0.15 to 2.14, P value 0.41 for overall subgroup effect, 'non-university hospitals' group: RR 1.27, 95% CI 1.02 to 1.60, P value 0.02 for overall subgroup effect). Again, these results were exclusively influenced by the POISE trial, and skipping this trial led to a non-significant result for both these groups.</P></SUBSECTION><SUBSECTION><HEADING LEVEL="5">Summary of confidence in estimates of effects using GRADE and TSA</HEADING><P>Heterogeneity of the data was low. However, we found evidence of a bias caused by over-reporting of positive study results by studies of poorer methodological quality. Overall information size was small (11,413 participants; 3.7% of optimal information size) compared with the optimal information size of 307,300 participants calculated to detect a 20% relative change in mortality, assuming a control group event rate of 2.0% (median control group event rate) with a power of 80% at an alpha level of 0.05. TSA was not possible, as no O'Brien-Fleming alpha-spending boundaries could be generated due to the small sample size in comparison with the optimal information size. The effect estimate of the meta-analysis was rather imprecise, as the 95% CI overlapped the zone of no effect (RR 1.0) and the zone of potential harm (RR 1.25). We therefore classified the quality of evidence as low (serious imprecision due to small sample size and wide confidence interval: -1; bias caused by studies of poorer methodological quality: -1). Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.</P></SUBSECTION></SUBSECTION><SUBSECTION><HEADING LEVEL="4"><I>Acute myocardial infarction </I></HEADING><SUBSECTION><HEADING LEVEL="5">Overall effect</HEADING><P>We evaluated the occurrence of AMI in 14 trials that included 10,958 participants. The following types of surgery were evaluated: 'non-cardiac' surgery: seven trials; thoracic surgery: two trials; vascular surgery: four trials; and general abdominal surgery: one trial. In three studies, no AMI occurred in the beta-blocker group nor in the control group (<LINK REF="STD-Lai-2006" TYPE="STUDY">Lai 2006</LINK>; <LINK REF="STD-Miller-1990" TYPE="STUDY">Miller 1990</LINK>; <LINK REF="STD-Stone-1988" TYPE="STUDY">Stone 1988</LINK>). Ten of the 11 remaining trials found no statistically significant difference between the beta-blocker group and the control group at an alpha level of 0.05. Only the large POISE trial (<LINK REF="STD-POISE-2008" TYPE="STUDY">POISE 2008</LINK>) could identify a protective effect of beta-blockers. This single trial had a weight of 80% in the meta-analysis. Overall, beta-blockers statistically significantly reduced perioperative AMI by 27% in non-cardiac surgery, as evidenced by a fixed-effect RR of 0.73 (95% CI 0.61 to 0.87, P value 0.0005) (absolute risk reduction 1.38%; NNTB 76, 95% CI: 52 to 157; <LINK REF="CMP-001.07" TYPE="ANALYSIS">Analysis 1.7</LINK>).</P></SUBSECTION><SUBSECTION><HEADING LEVEL="5">Heterogeneity</HEADING><P>The amount of variance explained by between-study variation was low (I<SUP>2</SUP> = 0%, P value 0.79). Thus we chose a fixed-effect model for presentation. We performed prespecified subgroup analyses for start of beta-blocker, type of beta-blocker and risk of surgery (<LINK REF="CMP-003.07" TYPE="ANALYSIS">Analysis 3.7</LINK>; <LINK REF="CMP-004.04" TYPE="ANALYSIS">Analysis 4.4</LINK>; <LINK REF="CMP-005.07" TYPE="ANALYSIS">Analysis 5.7</LINK>). Subgroups comprising participants of the POISE trial ('before surgery,' 'metoprolol' and 'low and medium risk surgery') all indicated a significant protective beta-blocker effect that was lost when the POISE trial was excluded from the analysis. Meta-regression could not identify any clinical effect modifiers.</P></SUBSECTION><SUBSECTION><HEADING LEVEL="5">Reporting bias</HEADING><P>Upon visual assessment of the funnel plot and formal assessment of funnel plot asymmetry while applying the Egger's test (P value 0.30), we found no evidence of a reporting bias.</P></SUBSECTION><SUBSECTION><HEADING LEVEL="5">Sensitivity analysis</HEADING><P>The effect estimate remained virtually unchanged when we used a random-effects model (RR 0.73, 95% CI 0.61 to 0.88, P value 0.0007) instead of a fixed-effect model (RR 0.73, 95% CI 0.61 to 0.87, P value 0.0005). Skipping the largest trial, POISE (8351 participants), led to a non-significant result (RR 0.81, 95% CI 0.55 to 1.18, P value 0.27). Restricting the meta-analysis to the nine placebo-controlled studies with an assumed lower risk of bias again left the effect estimate virtually unchanged (all studies: RR 0.73, 95% CI 0.61 to 0.87, P value 0.0005; low risk of bias studies: RR 0.72, 95% CI 0.60 to 0.87, P value 0.0007; <LINK REF="CMP-002.06" TYPE="ANALYSIS">Analysis 2.6</LINK>). Meta-regression analysis of methodological quality parameters did not detect relevant interactions.</P></SUBSECTION><SUBSECTION><HEADING LEVEL="5">Summary of confidence in estimates of effects using GRADE and TSA</HEADING><P>Heterogeneity of the data was low, and we found no evidence of a bias caused by studies of poorer methodological quality or a reporting bias. Overall information size was small (10,958 participants; 57.7% of optimal information size) compared with the optimal information size of 18,987 participants calculated to detect a 20% relative change in occurrence of AMI, assuming a control group event rate of 3.6% (median control group event rate of included studies) with a power of 80% at an alpha level of 0.05. However, when TSA was applied, the upper O'Brien-Fleming alpha-spending boundary was crossed, indicating a significant protective effect of beta-blockers in prevention of AMI in non-cardiac surgery (<LINK REF="FIG-08" TYPE="FIGURE">Figure 8</LINK>). The effect estimate of the meta-analysis was precise, as the 95% CI did not overlap the zone of no effect (RR 1.0) nor the zone of potential harm (RR 1.25). We therefore classified the quality of evidence as high (no downgrading). Further research is very unlikely to change our confidence in the estimate of effect.</P></SUBSECTION></SUBSECTION><SUBSECTION><HEADING LEVEL="4"><I>Myocardial ischaemia </I></HEADING><SUBSECTION><HEADING LEVEL="5">Overall effect</HEADING><P>Fourteen studies investigated myocardial ischaemia in non-cardiac surgery as defined by study authors (978 participants). The following types of surgery were evaluated: 'non-cardiac' surgery: three trials; neurosurgery: one trial; gynaecological surgery: two trials; vascular surgery: four trials; thoracic surgery: two trials; and general abdominal surgery: two trials. In four trials, no episodes of myocardial ischaemia occurred in the beta-blocker group nor in the control group. Two of the remaining 10 trials found a significant protective effect of beta-blockers at an alpha level of 0.05 (<LINK REF="STD-Stone-1988" TYPE="STUDY">Stone 1988</LINK>; <LINK REF="STD-Wallace-1998" TYPE="STUDY">Wallace 1998</LINK>). Overall, beta-blockers statistically significantly reduced perioperative myocardial ischaemia in non-cardiac surgery by 49%, as evidenced by a random-effects RR of 0.51 with a 95% CI of 0.34 to 0.77 (P value 0.001; absolute risk reduction 11.90%; NNTB 9, 95% CI: 7 to 19; <LINK REF="CMP-001.09" TYPE="ANALYSIS">Analysis 1.9</LINK>).</P></SUBSECTION><SUBSECTION><HEADING LEVEL="5">Heterogeneity</HEADING><P>The amount of variance explained by between-study variation was moderate (I<SUP>2</SUP> = 28%, P value 0.19). Thus we chose a random-effects model for presentation. We performed prespecified subgroup analyses for start of beta-blocker treatment, type of beta-blocker and risk of surgery (<LINK REF="CMP-003.09" TYPE="ANALYSIS">Analysis 3.9</LINK>; <LINK REF="CMP-004.05" TYPE="ANALYSIS">Analysis 4.5</LINK>; <LINK REF="CMP-005.08" TYPE="ANALYSIS">Analysis 5.8</LINK>). We could not fully explain statistical heterogeneity between trials by any of these stratifications. However, we found less heterogeneity for trials starting beta-blocker treatment during surgery (<LINK REF="CMP-003.09" TYPE="ANALYSIS">Analysis 3.9</LINK>), and investigating high risk patients (<LINK REF="CMP-004.05" TYPE="ANALYSIS">Analysis 4.5</LINK>). Furthermore, we noted a trend towards higher protection of beta-blockers against myocardial ischaemia in high-risk surgery (low and medium risk: RR 0.39, 95% CI 0.13 to 1.19, P value 0.10; high risk: RR 0.60, 95% CI 0.39 to 0.93, P value 0.02; <LINK REF="CMP-004.05" TYPE="ANALYSIS">Analysis 4.5</LINK>). Meta-regression analysis of clinical quality parameters did not detect relevant interactions.</P></SUBSECTION><SUBSECTION><HEADING LEVEL="5">Reporting bias</HEADING><P>Upon visual assessment of the funnel plot and formal assessment of funnel plot asymmetry while applying Egger's test (P value 0.28), we found no evidence of a reporting bias.</P></SUBSECTION><SUBSECTION><HEADING LEVEL="5">Sensitivity analysis</HEADING><P>The effect estimate was virtually unchanged when we used a fixed-effect model (RR 0.55, 95% CI 0.42 to 0.71, P value &lt; 0.00001) instead of a random-effects model (RR 0.51, 95% CI 0.34 to 0.77, P value 0.001). Restricting the meta-analysis to the nine placebo-controlled studies with an assumed lower risk of bias did not change the estimate much (all studies: RR 0.51, 95% CI 0.34 to 0.77, P value 0.001; low risk of bias studies: RR 0.65, 95% CI 0.49 to 0.86, P value 0.002; <LINK REF="CMP-002.08" TYPE="ANALYSIS">Analysis 2.8</LINK>). Meta-regression analysis of methodological quality parameters detected control group status (P value 0.02), blinding status of participants (P value 0.02) and use of an intention-to-treat analysis (P value 0.02) as effect modifiers. When we performed stratification for these parameters was, it could be observed that higher study quality (presence of a placebo control group, blinding of participants and use of intention-to-treat analysis) resulted in attenuation of the protective beta-blocker effect versus the overall estimate (placebo: RR 0.65, 95% CI 0.49 to 0.86, P value 0.002; <LINK REF="CMP-002.08" TYPE="ANALYSIS">Analysis 2.8</LINK>; blinding of participants: RR 0.65, 95% CI 0.49 to 0.86, P value 0.002; <LINK REF="CMP-006.03" TYPE="ANALYSIS">Analysis 6.3</LINK>; use of intention-to-treat analysis: RR 0.68, 95% CI 0.50 to 0.91, P value 0.009; <LINK REF="CMP-006.02" TYPE="ANALYSIS">Analysis 6.2</LINK>; overall estimate: RR 0.51, 95% CI 0.34 to 0.77, P value 0.001; <LINK REF="CMP-001.09" TYPE="ANALYSIS">Analysis 1.9</LINK>). However, the protective properties of beta-blockers remained statistically significant in all evaluated strata.</P></SUBSECTION><SUBSECTION><HEADING LEVEL="5">Summary of confidence in estimates of effects using GRADE and TSA</HEADING><P>Heterogeneity of the data was moderate. We could not clearly identify the source of heterogeneity . We found evidence of a small bias caused by studies of poorer methodological quality that overestimated the protective effect of beta-blockers in prevention of myocardial ischaemia. This bias was shown not to significantly affect the effect estimate. We detected no reporting bias . Overall information size was small (978 participants; 3.9% of optimal information size) compared with the optimal information size of 24,924 participants calculated to detect a 20% relative change in incidence of myocardial ischaemia, assuming a control group event rate of 6.3% (median control group event rate of included trials) with a power of 80% at an alpha level of 0.05. TSA was inconclusive, as the Z-curve did not cross either O'Brien-Fleming alpha-spending boundary (figure not shown). The effect estimate of the meta-analysis was precise, as the 95% CI did not overlap the zone of no effect (RR 1.0) nor the zone of potential harm (RR 1.25). We therefore classified the quality of evidence as moderate (serious imprecision due to small sample size: -1). Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.</P></SUBSECTION></SUBSECTION><SUBSECTION><HEADING LEVEL="4"><I>Cerebrovascular events </I></HEADING><SUBSECTION><HEADING LEVEL="5">Overall effect</HEADING><P>Five studies evaluated cerebrovascular events in non-cardiac surgery (9150 participants). The following types of surgery were evaluated: vascular surgery: one trial; 'non-cardiac' surgery: four trials. Only the largest of the five trials found a significant increase in cerebrovascular events in the beta-blocker group compared with the control group at an alpha level of 0.05 (<LINK REF="STD-POISE-2008" TYPE="STUDY">POISE 2008</LINK>). In contrast, the other four trials yielded non-significant results. Overall, we found no clear evidence of an effect of beta-blockers on cerebrovascular events in non-cardiac surgery, as evidenced by a fixed-effect RR of 1.59 with a 95% CI of 0.93 to 2.71 (P value 0.09) (<LINK REF="CMP-001.11" TYPE="ANALYSIS">Analysis 1.11</LINK>).</P></SUBSECTION><SUBSECTION><HEADING LEVEL="5">Heterogeneity</HEADING><P>The amount of variance explained by between-study variation was low (I<SUP>2</SUP> = 15%, P value 0.32). Thus a fixed-effect model was chosen for presentation. We performed prespecified subgroup analyses (type of beta-blocker, risk of surgery; <LINK REF="CMP-004.06" TYPE="ANALYSIS">Analysis 4.6</LINK>; <LINK REF="CMP-005.10" TYPE="ANALYSIS">Analysis 5.10</LINK>). Results of all subgroups were consistently statistically non-significant. Stratification for start of beta-blocker treatment was not possible, as all trials started beta-blocker treatment before surgery. Meta-regression analysis did not indicate an influence of clinical parameters on the effect estimate.</P></SUBSECTION><SUBSECTION><HEADING LEVEL="5">Reporting bias</HEADING><P>No evidence was found of a reporting bias upon visual assessment of the funnel plot. Formal assessment of funnel plot asymmetry was not performed because fewer than 10 studies were combined. Formal tests cannot distinguish between-study variance of estimates and a potential reporting bias in this case.</P></SUBSECTION><SUBSECTION><HEADING LEVEL="5">Sensitivity analysis</HEADING><P>The overall effect estimate was driven mainly by the largest trial (<LINK REF="STD-POISE-2008" TYPE="STUDY">POISE 2008</LINK>), which was assigned 63.7% of the weight. Omitting this study shifted the point estimate towards no effect (RR 0.99, 95% CI 0.37 to 2.64, P value 0.99). The effect estimate was slightly changed when a random-effects model (RR 1.48, 95% CI 0.70 to 3.16, P value 0.31) was used instead of a fixed-effect model (RR 1.59, 95% CI 0.93 to 2.71, P value 0.09). Meta-regression analysis of methodological quality parameters detected a relevant influence of the control group (P value 0.05) and participants' blinding status (P value 0.05). Stratification for both of these parameters could completely eradicate statistical heterogeneity (<LINK REF="CMP-002.09" TYPE="ANALYSIS">Analysis 2.9</LINK>; <LINK REF="CMP-006.04" TYPE="ANALYSIS">Analysis 6.4</LINK>). The effect estimate in the subgroups with an assumed lower risk of bias was shifted towards an increase in cerebrovascular events in the beta-blocker groups (RR 2.09, 95% CI 1.14 to 3.82, P value 0.02 for overall subgroup effect; absolute risk increase 0.39%; NNTH 265, 95% CI: 102 to 2058; <LINK REF="CMP-002.09" TYPE="ANALYSIS">Analysis 2.9</LINK>; RR 2.09, 95% CI 1.14 to 3.82, P value 0.02 for overall subgroup effect; absolute risk increase 0.39%; NNTH 255; <LINK REF="CMP-006.04" TYPE="ANALYSIS">Analysis 6.4</LINK>). Again, these results were driven by the POISE trial. Omitting this trial from subgroup analyses blunted the negative effect of beta-blockers.</P></SUBSECTION><SUBSECTION><HEADING LEVEL="5">Summary of confidence in estimates of effects using GRADE and TSA</HEADING><P>Statistical heterogeneity of the data was low and could be entirely eliminated by splitting the trials according to control group and blinding status. Studies of poorer methodological quality include a much smaller sample and tended to report a non-significant effect of beta-blockers on cerebrovascular events. No reporting bias was detected. Overall information size was small (9150 participants; 5.9% of optimal information size) compared with the optimal information size of 155,511 participants calculated to detect a 20% relative change in the incidence of cerebrovascular events, assuming a control group event rate of 1.0% (median control group event rate of included trials) with a power of 80% at an alpha level of 0.05. It was not possible to perform TSA with such a small information size. The effect estimate of the meta-analysis was imprecise, as the 95% CI overlapped the zone of no effect (RR 1.0) and the zone of potential harm (RR 1.25). We therefore classified the quality of evidence as low (presence of a bias introduced by studies of poorer methodological quality: -1; serious imprecision due to wide confidence interval and small sample size: -1). Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.</P></SUBSECTION></SUBSECTION><SUBSECTION><HEADING LEVEL="4"><I>Ventricular arrhythmias </I></HEADING><SUBSECTION><HEADING LEVEL="5">Overall effect</HEADING><P>Five studies evaluated the occurrence of ventricular arrhythmias in non-cardiac surgery (476 participants). The following types of surgery were evaluated: 'non-cardiac' surgery: one trial; vascular surgery: one trial; and thoracic surgery: three trials. One trial found a significant protective effect of beta-blockers compared with control at an alpha level of 0.05 (<LINK REF="STD-Sandler-1990" TYPE="STUDY">Sandler 1990</LINK>), whereas the other four yielded non-significant results. Overall, we found no clear evidence of an effect of beta-blockers on the incidence of ventricular arrhythmias in non-cardiac surgery, as evidenced by a random-effects RR of 0.68 with a 95% CI of 0.31 to 1.49 (P value 0.33) (<LINK REF="CMP-001.13" TYPE="ANALYSIS">Analysis 1.13</LINK>).</P></SUBSECTION><SUBSECTION><HEADING LEVEL="5">Heterogeneity</HEADING><P>The amount of variance explained by between-study variation was moderate to large (I<SUP>2</SUP> = 45%, P value 0.12). Thus a random-effects model was chosen for presentation. Prespecified subgroup analyses (start of beta-blocker treatment, type of beta-blocker and risk of surgery) were able to eliminate statistical heterogeneity (<LINK REF="CMP-003.12" TYPE="ANALYSIS">Analysis 3.12</LINK>; <LINK REF="CMP-004.07" TYPE="ANALYSIS">Analysis 4.7</LINK>; <LINK REF="CMP-005.12" TYPE="ANALYSIS">Analysis 5.12</LINK>). Meta-regression analysis identified start of beta-blocker treatment (P value 0.01), risk status of surgery (P value 0.01) and route of beta-blocker application (P value 0.01 for oral vs intravenous) as effect modifiers. Stratification for these parameters (<LINK REF="CMP-003.12" TYPE="ANALYSIS">Analysis 3.12</LINK>; <LINK REF="CMP-004.07" TYPE="ANALYSIS">Analysis 4.7</LINK>; <LINK REF="CMP-006.05" TYPE="ANALYSIS">Analysis 6.5</LINK>) revealed a more pronounced, statistically significant protective effect of beta-blockers when given intravenously (only on trial <LINK REF="STD-Sandler-1990" TYPE="STUDY">Sandler 1990</LINK>) : RR 0.25, 95% CI 0.09 to 0.70, P value 0.008; <LINK REF="CMP-006.05" TYPE="ANALYSIS">Analysis 6.5</LINK>) during surgery (only on trial (<LINK REF="STD-Sandler-1990" TYPE="STUDY">Sandler 1990</LINK>): RR 0.25, 95% CI 0.09 to 0.70, P value 0.008; <LINK REF="CMP-003.12" TYPE="ANALYSIS">Analysis 3.12</LINK>) in low- and medium-risk procedures (RR 0.34, 95% CI 0.14 to 0.82, P value 0.02; <LINK REF="CMP-004.07" TYPE="ANALYSIS">Analysis 4.7</LINK>).</P></SUBSECTION><SUBSECTION><HEADING LEVEL="5">Reporting bias</HEADING><P>No evidence of a reporting bias was found upon visual assessment of the funnel plot. Formal assessment of funnel plot asymmetry was not performed because fewer than 10 studies were combined. Formal tests cannot distinguish between-study variance of estimates and a potential reporting bias in this case.</P></SUBSECTION><SUBSECTION><HEADING LEVEL="5">Sensitivity analysis</HEADING><P>The effect estimate was virtually unchanged when a fixed-effect model (RR 0.72, 95% CI 0.43 to 1.19, P value 0.20) was used instead of a random-effects model (RR 0.68, 95% CI 0.30 to 1.49, P value 0.33). Restriction of the analysis to low risk of bias trials was not possible, as all trials were placebo-controlled trials. Meta-regression analysis could not identify methodological parameters influencing the effect estimate.</P></SUBSECTION><SUBSECTION><HEADING LEVEL="5">Summary of confidence in estimates of effects using GRADE and TSA</HEADING><P>Statistical heterogeneity of the data was moderate to large and could be explained by stratification for clinical parameters (start of beta-blocker, route of application and risk of surgery). We did not detect a reporting bias. Overall information size was small (476 participants; 4.1% of optimal information size) compared with the optimal information size of 11,697 participants calculated to detect a 20% relative change in the incidence of ventricular arrhythmias, assuming a control group event rate of 15.9% (median control group event rate of included trials) with a power of 80% at an alpha level of 0.05. It was not possible to perform TSA analysis with such a small information size. The effect estimate of the meta-analysis was imprecise, as the 95% CI was large and overlapped the zone of no effect (RR 1.0) and the zones of potential benefit and harm (RR 0.75 and RR 1.25, respectively). We therefore classified the quality of evidence as moderate (serious imprecision due to wide confidence interval and small sample size: -1). Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.</P></SUBSECTION></SUBSECTION><SUBSECTION><HEADING LEVEL="4"><I>Supraventricular arrhythmias </I></HEADING><SUBSECTION><HEADING LEVEL="5">Overall effect</HEADING><P>Eight studies evaluated the occurrence of supraventricular arrhythmias in non-cardiac surgery (8744 participants). The following types of surgery were evaluated: 'non-cardiac' surgery: one trial; gynaecological surgery: two trials; thoracic surgery: four trials; and general abdominal surgery: one trial. Only the largest trials (<LINK REF="STD-POISE-2008" TYPE="STUDY">POISE 2008</LINK>) found a significant protective effect of beta-blockers compared with control at an alpha level of 0.05, whereas the other eight trials yielded non-significant results. Overall, beta-blockers statistically significantly reduced the incidence of supraventricular arrhythmias in non-cardiac surgery by 27%, as evidenced by a fixed-effect RR of 0.73 with a 95% CI of 0.57 to 0.94 (P value 0.01) (absolute risk reduction 0.84%; NNTB 112, 95% CI: 70 to 505; <LINK REF="CMP-001.17" TYPE="ANALYSIS">Analysis 1.17</LINK>).</P></SUBSECTION><SUBSECTION><HEADING LEVEL="5">Heterogeneity</HEADING><P>The amount of variance explained by between-study variation was low (I<SUP>2</SUP> = 0%, P value 0.53). Thus we chose a fixed-effect model for presentation. Prespecified subgroup analyses showed that the protective effect of beta-blockers was blunted if the drug was not started until induction of anaesthesia (<LINK REF="CMP-003.16" TYPE="ANALYSIS">Analysis 3.16</LINK>). The significant protective effect was only preserved in low- and medium-risk, but not in high risk surgery (<LINK REF="CMP-004.09" TYPE="ANALYSIS">Analysis 4.9</LINK>). Metoprolol was the beta-blocker used for the greatest number of randomly assigned participants by far and proved to significantly reduce the incidence of all supraventricular arrhythmias (<LINK REF="CMP-005.16" TYPE="ANALYSIS">Analysis 5.16</LINK>). The effect was blunted for other beta-blockers with only a very small number of randomly assigned participants. Looking only at studies investigating the incidence of atrial fibrillation and atrial flutter did not change the effect estimate (RR 0.73, 95% CI 0.56 to 0.95, P value 0.02; <LINK REF="CMP-001.15" TYPE="ANALYSIS">Analysis 1.15</LINK>). Meta-regression analysis did not identify clinical effect modifiers.</P></SUBSECTION><SUBSECTION><HEADING LEVEL="5">Reporting bias</HEADING><P>We found no evidence of a reporting bias upon visual assessment of the funnel plot. We did not per from formal assessment of funnel plot asymmetry because fewer than 10 studies were combined. Formal tests cannot distinguish between-study variance of estimates and a potential reporting bias in this case.</P></SUBSECTION><SUBSECTION><HEADING LEVEL="5">Sensitivity analysis</HEADING><P>Much of the weight of the meta-analysis came from the large POISE trial (82.5%). Omitting this study from the analysis changed the effect estimate (RR 0.61, 95% CI 0.33 to 1.11, P value 0.10), and the result lost statistical significance. The effect estimate was virtually unchanged when we used a random-effects model (RR 0.74, 95% CI 0.58 to 0.95, P value 0.02) instead of a fixed-effect model (RR 0.73, 95% CI 0.57 to 0.94, P value 0.01). Restriction of the analysis to placebo-controlled trials with an assumed low risk of bias again did not change the effect estimate (RR 0.75, 95% CI 0.59 to 0.96, P value 0.02; <LINK REF="CMP-002.14" TYPE="ANALYSIS">Analysis 2.14</LINK>). Meta-regression analysis of methodological parameters did not detect an association between methodological parameters and the effect estimate.</P></SUBSECTION><SUBSECTION><HEADING LEVEL="5">Summary of confidence in estimates of effects using GRADE and TSA</HEADING><P>We found heterogeneity of the data was low, and that no reporting bias nor bias introduced by studies of poor methodological quality could be detected. Overall information size was fair (8744 participants; 85.4% of optimal information size) compared with the optimal information size of 10,243 participants calculated to detect a 20% relative change in the incidence of supraventricular arrhythmias, assuming a control group event rate of 12.4% (median control group event rate of included trials) with a power of 80% at an alpha level of 0.05. TSA showed a significant protective effect of beta-blockers as the Z-curve crossed the upper O'Brien-Fleming alpha-spending boundary (<LINK REF="FIG-09" TYPE="FIGURE">Figure 9</LINK>). The effect estimate of the meta-analysis was precise, as the 95% CI did not overlap the zone of no effect (RR 1.0) nor the zone of potential harm (RR 1.25). We therefore classified the quality of evidence as high (no downgrading). Further research is very unlikely to change our confidence in the estimate of effect.</P></SUBSECTION></SUBSECTION><SUBSECTION><HEADING LEVEL="4"><I>Bradycardia </I></HEADING><SUBSECTION><HEADING LEVEL="5">Overall effect</HEADING><P>Twenty-three studies evaluated the occurrence of bradycardia in non-cardiac surgery (11,033 participants). The following types of surgery were evaluated: 'non-cardiac' surgery: five trials; gynaecological surgery: three trials; neurosurgery: three trials; thoracic surgery: two trials; vascular surgery: three trials; general abdominal surgery: five trials; and maxillofacial surgery: two trials. Three trials found no episodes of bradycardia in the beta-blocker group nor in the control group. Of the remaining 20 trials, six found beta-blockers to significantly induce bradycardia, whereas 14 trials yielded non-significant results. Overall, we found that beta-blockers statistically significantly increased episodes of bradycardia by 123% in non-cardiac surgery, as evidenced by a random-effects RR of 2.23 with a 95% CI of 1.48 to 3.36 (P value &lt; 0.0001) (absolute increase in risk 5.64%; NNTH 21, 95% CI: 11 to 53; <LINK REF="CMP-001.21" TYPE="ANALYSIS">Analysis 1.21</LINK>).</P></SUBSECTION><SUBSECTION><HEADING LEVEL="5">Heterogeneity</HEADING><P>The amount of variance explained by between-study variation was high (I<SUP>2</SUP> = 76%, P value &lt; 0.00001). Thus we chose a random-effects model for presentation. In the prespecified subgroup analyses for start of beta-blocker, type of beta-blocker and risk of surgery, only type of beta-blocker could reduce statistical heterogeneity (<LINK REF="CMP-003.20" TYPE="ANALYSIS">Analysis 3.20</LINK>; <LINK REF="CMP-004.10" TYPE="ANALYSIS">Analysis 4.10</LINK>; <LINK REF="CMP-005.20" TYPE="ANALYSIS">Analysis 5.20</LINK>). The heart rate&#8211;slowing effect of beta-blockers was more pronounced when given before surgery than when given during surgery (before: RR 2.60, 95% CI 2.23 to 3.04, P value &lt; 0.00001; during: RR 1.60, 95% CI 1.01 to 2.52, P value 0.04; <LINK REF="CMP-003.20" TYPE="ANALYSIS">Analysis 3.20</LINK>) and in high-risk surgical procedures (high risk: RR 3.16, 95% CI 2.33 to 4.26, P value &lt; 0.00001; low and medium risk: RR 1.88, 95% CI 1.04 to 3.40, P value 0.04; <LINK REF="CMP-004.10" TYPE="ANALYSIS">Analysis 4.10</LINK>). Bradycardia was statistically significantly induced by all types of beta-blockers except esmolol, atenolol and nadolol (<LINK REF="CMP-005.20" TYPE="ANALYSIS">Analysis 5.20</LINK>). However, the effects of nadolol were investigated by only a single trial with a small sample size. When we applied meta-regression analysis , prevalence of coronary heart disease (CHD) among study participants (P value 0.03) was associated with the effect estimate. Stratification for this clinical parameter found a stronger effect of beta-blockers causing bradycardia in trials with more participants diagnosed with CHD (CHD prevalence below median of 25%: RR 1.27, 95% CI 0.52 to 3.08, P value 0.60 for overall subgroup effect; CHD prevalence above median: RR 2.25, 95% CI 1.14 to 4.45, P value 0.02 for overall subgroup effect; <LINK REF="CMP-006.08" TYPE="ANALYSIS">Analysis 6.8</LINK>). This stratification could not reduce statistical heterogeneity.</P></SUBSECTION><SUBSECTION><HEADING LEVEL="5">Reporting bias</HEADING><P>Upon visual assessment of the funnel plot and formal assessment of funnel plot asymmetry while applying Egger's test (P value 0.93), we found no evidence of a reporting bias.</P></SUBSECTION><SUBSECTION><HEADING LEVEL="5">Sensitivity analysis</HEADING><P>The effect estimate remained virtually unchanged when we used a fixed-effect model (RR 2.49, 95% CI 2.15 to 2.88, P value &lt; 0.00001) instead of a random-effects model (RR 2.23, 95% CI 1.48 to 3.36, P value 0.0001), or when we restricted the meta-analysis to the 19 placebo-controlled studies with an assumed lower risk of bias (low risk of bias studies: RR 2.13, 95% CI 1.31 to 3.46, P value 0.002; <LINK REF="CMP-002.17" TYPE="ANALYSIS">Analysis 2.17</LINK>). Meta-regression identified the methodological parameters 'explicit specification of outcome parameters' and 'specification of baseline characteristics' to interact with the effect estimate. Studies of poorer methodological quality tended to significantly underestimate bradycardia (outcome variables explicitly specified: RR 2.65, 95% CI 2.11 to 3.32, P value &lt; 0.00001 for overall subgroup effect; outcome variables not or vaguely specified: RR 0.93, 95% CI 0.72 to 1.20, P value 0.58 for overall subgroup effect; <LINK REF="CMP-006.07" TYPE="ANALYSIS">Analysis 6.7</LINK>; baseline characteristics specified: RR 2.70, 95% CI 2.13 to 3.44, P value &lt;0.00001 for overall subgroup effect; not specified: RR 1.09, 95% CI 0.63 to 1.87, P value 0.76 for overall subgroup effect; <LINK REF="CMP-006.06" TYPE="ANALYSIS">Analysis 6.6</LINK>). Statistical heterogeneity could be reduced by stratification for these methodological parameters.</P></SUBSECTION><SUBSECTION><HEADING LEVEL="5">Summary of confidence in estimates of effects using GRADE and TSA</HEADING><P>We found that heterogeneity of data was high and could be explained only partially by type of beta-blocker and methodological study quality parameters. We found Eevidence of a bias caused by studies of poorer methodological quality. This bias, however, did not significantly influence the overall effect estimate. We did not judge reporting bias to be present. Overall information size was moderate (11,033 participants; 19.50% of optimal information size) compared with the optimal information size of 56,584 participants calculated to detect a 20% relative change in the incidence of bradycardia, assuming a control group event rate of 4.0% (median control group event rate of included trials) with a power of 80% at an alpha level of 0.05. TSA confirmed a significant effect of beta-blockers causing bradycardia, as the Z-curve crossed the lower O'Brien-Fleming alpha-spending boundary (<LINK REF="FIG-10" TYPE="FIGURE">Figure 10</LINK>). The effect estimate of the meta-analysis was precise, as the 95% CI did not overlap the zone of no effect (RR 1.0) nor the zone of potential benefit (RR 0.75). We therefore classified the quality of evidence as moderate (serious inconsistency due to high heterogeneity of data that could be explained only partially: -1). Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.</P></SUBSECTION></SUBSECTION><SUBSECTION><HEADING LEVEL="4"><I>Hypotension </I></HEADING><SUBSECTION><HEADING LEVEL="5">Overall effect</HEADING><P>Twenty-two studies evaluated the occurrence of hypotensive episodes in non-cardiac surgery (10,947 participants). The following types of surgery were evaluated: 'non-cardiac' surgery: five trials; gynaecological surgery; one trial; neurosurgery; three trials; general abdominal surgery; five trials; vascular surgery; four trials; thoracic surgery; three trials; and maxillofacial surgery: one trial. In three trials, no hypotensive episodes occurred in the beta-blocker group nor the control group. Six of the remaining 19 trials found that beta-blockers significantly increased hypotensive episodes at an alpha level of 0.05, whereas 13 trials yielded non-significant results. Overall, we found that hypotensive episodes were statistically significantly increased by 50% in non-cardiac surgery if beta-blockers were administered, as evidenced by a fixed-effect RR of 1.50 with a 95% CI of 1.38 to 1.64 (P value &lt; 0.00001) (absolute increase in risk 6.47%; NNTH 16, 95% CI: 13 to 21; <LINK REF="CMP-001.23" TYPE="ANALYSIS">Analysis 1.23</LINK>).</P></SUBSECTION><SUBSECTION><HEADING LEVEL="5">Heterogeneity</HEADING><P>The amount of variance explained by between-study variation was low (I<SUP>2</SUP> = 4%, P value 0.40). Thus we chose a fixed-effect model for presentation. Prespecified subgroup analyses for start of beta-blocker, type of beta-blocker and risk of surgery were performed (<LINK REF="CMP-003.22" TYPE="ANALYSIS">Analysis 3.22</LINK>; <LINK REF="CMP-004.11" TYPE="ANALYSIS">Analysis 4.11</LINK>; <LINK REF="CMP-005.22" TYPE="ANALYSIS">Analysis 5.22</LINK>). The blood pressure&#8211;lowering effect of beta-blockers remained significant in all subgroup analyses investigating start of beta-blocker treatment and risk of surgery, as well as for all subgroups of types of beta-blocker that comprised more than one randomized trial. Stratification for risk of surgery could further reduce statistical heterogeneity to 0% in each subgroup (<LINK REF="CMP-004.11" TYPE="ANALYSIS">Analysis 4.11</LINK>). Meta-regression analysis of clinical parameters did not detect any effect modifiers.</P></SUBSECTION><SUBSECTION><HEADING LEVEL="5">Reporting bias</HEADING><P>Upon visual assessment of the funnel plot and formal assessment of funnel plot asymmetry while applying Egger's test (P value 0.44), we found no evidence of a reporting bias.</P></SUBSECTION><SUBSECTION><HEADING LEVEL="5">Sensitivity analysis</HEADING><P>The effect estimate remained virtually unchanged when we used a random-effects model (RR 1.40, 95% CI 1.29 to 1.53, P value &lt; 0.00001) instead of a fixed-effect model (RR 1.50, 95% CI 1.38 to 1.64, P value &lt; 0.00001). Restricting the meta-analysis to the 18 placebo-controlled studies with an assumed lower risk of bias also left the effect estimate unchanged (all studies: RR 1.50, 95% CI 1.38 to 1.64, P value &lt; 0.00001; low risk of bias studies: RR 1.51, 95% CI 0.38 to 1.65, P value &lt; 0.00001; <LINK REF="CMP-002.19" TYPE="ANALYSIS">Analysis 2.19</LINK>). Meta-regression did not detect an interaction between methodological parameters and the effect estimate.</P></SUBSECTION><SUBSECTION><HEADING LEVEL="5">Summary of confidence in estimates of effects using GRADE and TSA</HEADING><P>Heterogeneity of the data was low, and we found no evidence of a bias introduced by studies of poorer methodological quality. We did not detect reporting bias . Overall information size was sufficient (10,947 participants; 107.0% of optimal information size) compared with the optimal information size of 10,232 participants calculated to detect a 20% relative change in the incidence of hypotensive episodes, assuming a control group event rate of 6.5% (median control group event rate of included trials) with a power of 80% at an alpha level of 0.05. TSA showed a significant effect of beta-blockers causing hypotensive episodes as the Z-curve crossed the lower O'Brien-Fleming alpha-spending boundary (<LINK REF="FIG-11" TYPE="FIGURE">Figure 11</LINK>). The effect estimate of the meta-analysis was precise, as the 95% CI did not overlap the zone of no effect (RR 1.0) nor the zone of potential benefit (RR 0.75). We therefore classified the quality of evidence as high (no downgrading). Further research is very unlikely to change our confidence in the estimate of effect.</P></SUBSECTION></SUBSECTION><SUBSECTION><HEADING LEVEL="4"><I>Ventricular extrasystoles </I></HEADING><SUBSECTION><HEADING LEVEL="5">Overall effect</HEADING><P>Nine studies evaluated the incidence of ventricular extrasystoles in non-cardiac surgery (492 participants). The following types of surgery were evaluated: general abdominal surgery: four trials; gynaecological surgery: three trials; vascular surgery: one trial; and maxillofacial surgery: one trial. Four trials found a significant effect of beta-blockers in preventing the occurrence of ventricular extrasystoles at an alpha level of 0.05, whereas five trials yielded non-significant results. Overall, beta-blockers statistically significantly reduced the incidence of ventricular extrasystoles by 78% in non-cardiac surgery, as evidenced by a fixed-effect RR of 0.22 with a 95% CI of 0.13 to 0.37 (P value &lt; 0.00001) (absolute risk reduction 24.51%; NNTB 4, 95% CI: 4 to 5; <LINK REF="CMP-001.19" TYPE="ANALYSIS">Analysis 1.19</LINK>).</P></SUBSECTION><SUBSECTION><HEADING LEVEL="5">Heterogeneity</HEADING><P>The amount of variance explained by between-study variation was low (I<SUP>2</SUP> = 0%, P value 0.80). Thus we chose a fixed-effect model for presentation. We performed prespecified subgroup analyses for start of beta-blocker and type of beta-blocker (<LINK REF="CMP-003.18" TYPE="ANALYSIS">Analysis 3.18</LINK>; <LINK REF="CMP-005.18" TYPE="ANALYSIS">Analysis 5.18</LINK>). Stratification for risk of surgery was not possible, as all studies were low- or medium-risk procedures. The protective effect of beta-blockers was consistent within all subgroups, reflecting different start points of beta-blocker treatment (<LINK REF="CMP-003.18" TYPE="ANALYSIS">Analysis 3.18</LINK>). Meta-regression analysis found no association between clinical parameters and the effect estimate.</P></SUBSECTION><SUBSECTION><HEADING LEVEL="5">Reporting bias</HEADING><P>We found no evidence of a reporting bias upon visual assessment of the funnel plot. We did not perform formal assessment of funnel plot asymmetry because fewer than 10 studies were combined. Formal tests cannot distinguish between study variance of estimates and a potential reporting bias in this case.</P></SUBSECTION><SUBSECTION><HEADING LEVEL="5">Sensitivity analysis</HEADING><P>The effect estimate remained virtually unchanged when we used a random-effects model (RR 0.27, 95% CI 0.16 to 0.44, P value &lt; 0.00001) instead of a fixed-effect model (RR 0.22, 95% CI 0.13 to 0.37, P value &lt; 0.00001). Restricting the meta-analysis to the eight placebo-controlled studies with an assumed lower risk of bias also left the effect estimate unchanged (all studies: RR 0.22, 95% CI 0.13 to 0.37, P value &lt; 0.00001; low risk of bias studies: RR 0.23, 95% CI 0.13 to 0.39, P value &lt; 0.00001; <LINK REF="CMP-002.15" TYPE="ANALYSIS">Analysis 2.15</LINK>). Meta-regression did not detect an interaction between methodological parameters and the effect estimate.</P></SUBSECTION><SUBSECTION><HEADING LEVEL="5">Summary of confidence in estimates of effects using GRADE and TSA</HEADING><P>Heterogeneity of the data was low, and we found no evidence of a bias introduced by trials of poorer methodological quality and no evidence of a reporting bias. Overall information size was small (492 participants; 26.8% of optimal information size) compared with the optimal information size of 1835 participants calculated to detect a 20% relative change in the incidence of ventricular extrasystoles, assuming a control group event rate of 28.6% (median control group event rate of included trials) with a power of 80% at an alpha level of 0.05. TSA showed a significant effect of beta-blockers protecting against ventricular extrasystoles, as the Z-curve crossed the upper O'Brien-Fleming alpha-spending boundary (<LINK REF="FIG-12" TYPE="FIGURE">Figure 12</LINK>). The effect estimate of the meta-analysis was precise, as the 95% CI did not overlap the zone of no effect (RR 1.0) nor the zone of potential harm (RR 1.25). We therefore classified the quality of evidence as high (no downgrading). Further research is very unlikely to change our confidence in the estimate of effect.</P></SUBSECTION></SUBSECTION><SUBSECTION><HEADING LEVEL="4"><I>Congestive heart failure </I></HEADING><SUBSECTION><HEADING LEVEL="5">Overall effect</HEADING><P>Five studies evaluated the incidence of congestive heart failure in non-cardiac surgery (9173 participants). The following types of surgery were evaluated: 'non-cardiac' surgery two trials; thoracic surgery: one trial; vascular surgery: one trial; and abdominal surgery: one trial. None of the trials found a significant effect of beta-blockers preventing or causing congestive heart failure compared with control at an alpha level of 0.05. Overall, we found no clear evidence of an effect of beta-blockers on congestive heart failure in non-cardiac surgery, as evidenced by a fixed-effect RR of 1.18 with a 95% CI of 0.94 to 1.48 (P value 0.16) (<LINK REF="CMP-001.25" TYPE="ANALYSIS">Analysis 1.25</LINK>).</P></SUBSECTION><SUBSECTION><HEADING LEVEL="5">Heterogeneity</HEADING><P>The amount of variance explained by between-study variation was low (I<SUP>2</SUP> = 0%, P value 0.77). Thus we chose a fixed-effect model for presentation. Prespecified subgroup analyses for start of beta-blocker, type of beta-blocker and risk of surgery consistently yielded non-significant results (<LINK REF="CMP-003.24" TYPE="ANALYSIS">Analysis 3.24</LINK>; <LINK REF="CMP-004.12" TYPE="ANALYSIS">Analysis 4.12</LINK>; <LINK REF="CMP-005.24" TYPE="ANALYSIS">Analysis 5.24</LINK>). Meta-regression analysis detected no association between clinical parameters and the effect estimate.</P></SUBSECTION><SUBSECTION><HEADING LEVEL="5">Reporting bias</HEADING><P>We found no evidence of a reporting bias upon visual assessment of the funnel plot. We did not perform formal assessment of funnel plot asymmetry because fewer than 10 studies were combined. Formal tests cannot distinguish between study variance of estimates and a potential reporting bias in this case.</P></SUBSECTION><SUBSECTION><HEADING LEVEL="5">Sensitivity analysis</HEADING><P>If the largest trial, POISE (POISE 2008; 88.3% of weight), was skipped, we found that the effect estimate changed only slightly (RR 1.48, 95% CI 0.80 to 2.77, P value 0.21). Furthermore, the effect estimate remained unchanged when we used a random-effects model (RR 1.18, 95% CI 0.94 to 1.48, P value 0.16) instead of a fixed-effect model (RR 1.18, 95% CI 0.94 to 1.48, P value 0.16). All trials were placebo controlled, which precluded stratification for control group status. Meta-regression did not detect an interaction between methodological parameters and the effect estimate.</P></SUBSECTION><SUBSECTION><HEADING LEVEL="5">Summary of confidence in estimates of effects using GRADE and TSA</HEADING><P>Heterogeneity of the data was low, and we found no evidence of a bias caused by studies of poorer methodological quality nor of a reporting bias. Overall information size was sufficient (9173 participants; 95.5% of optimal information size) compared with the optimal information size of 9,602 participants calculated to detect a 20% relative change in the incidence of congestive heart failure, assuming a control group event rate of 6.9% (median control group event rate of included trials) with a power of 80% at an alpha level of 0.05. TSA indicated futility, as the Z-curve crossed the lower boundary of the inner futility wedge (<LINK REF="FIG-13" TYPE="FIGURE">Figure 13</LINK>). The effect estimate of the meta-analysis was imprecise, as the 95% CI overlapped the zone of no effect (RR 1.0) and the zone of potential harm (RR 1.25). We therefore classified the quality of evidence as moderate (serious imprecision due to wide confidence interval overlapping zones of no effect and potential harm: -1). Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.</P></SUBSECTION></SUBSECTION><SUBSECTION><HEADING LEVEL="4"><I>Bronchospasm </I></HEADING><SUBSECTION><HEADING LEVEL="5">Overall effect</HEADING><P>Eight studies evaluated the incidence of bronchospasm in non-cardiac surgery (1080 participants). The following types of surgery were evaluated: 'non-cardiac' surgery: two trials; gynaecological surgery: one trial; neurosurgery: one trial; thoracic surgery: one trial; vascular surgery: two trials; and general abdominal surgery: one trial. In one trial, no events occurred in the beta-blocker group nor in the control group. The remaining seven trials did not detect a statistically significant difference between beta-blocker and control groups at an alpha level of 0.05. Overall, we found no clear evidence of an effect of beta-blockers on the occurrence of bronchospasm in non-cardiac surgery, as evidenced by a fixed-effect RR of 0.94 with a 95% CI of 0.55 to 1.59 (P value 0.81) (<LINK REF="CMP-001.27" TYPE="ANALYSIS">Analysis 1.27</LINK>).</P></SUBSECTION><SUBSECTION><HEADING LEVEL="5">Heterogeneity</HEADING><P>The amount of variance explained by between-study variation was low (I<SUP>2</SUP> = 0%, P value 0.77). Thus we chose a fixed-effect model for presentation. Prespecified subgroup analyses for start of beta-blocker, type of beta-blocker and risk of surgery were performed (<LINK REF="CMP-003.25" TYPE="ANALYSIS">Analysis 3.25</LINK>; <LINK REF="CMP-004.13" TYPE="ANALYSIS">Analysis 4.13</LINK>; <LINK REF="CMP-005.26" TYPE="ANALYSIS">Analysis 5.26</LINK>). The effect estimate was consistently non-significant in all subgroups. Meta-regression analysis detected no association between clinical parameters and the effect estimate.</P></SUBSECTION><SUBSECTION><HEADING LEVEL="5">Reporting bias</HEADING><P>We found no evidence of a reporting bias upon visual assessment of the funnel plot. We did not perform formal assessment of funnel plot asymmetry because fewer than 10 studies were combined. Formal tests cannot distinguish between study variance of estimates and a potential reporting bias in this case.</P></SUBSECTION><SUBSECTION><HEADING LEVEL="5">Sensitivity analysis</HEADING><P>The effect estimate remained virtually unchanged when we used a random-effects model (RR 0.85, 95% CI 0.50 to 1.46, P value 0.56) instead of a fixed-effect model (RR 0.94, 95% CI 0.55 to 1.59, P value 0.81). Restricting the meta-analysis to the seven placebo-controlled studies with an assumed lower risk of bias again left the effect estimate virtually unchanged (all studies: RR 0.94, 95% CI 0.55 to 1.59, P value 0.81; low risk of bias studies: RR 0.98, 95% CI 0.57 to 1.67, P value 0.94 for overall subgroup effect; <LINK REF="CMP-002.21" TYPE="ANALYSIS">Analysis 2.21</LINK>). Meta-regression did not detect an interaction between methodological parameters and the effect estimate.</P></SUBSECTION><SUBSECTION><HEADING LEVEL="5">Summary of confidence in estimates of effects using GRADE and TSA</HEADING><P>Whereas heterogeneity of the data was low, and we found no evidence of a bias caused by studies of poorer methodological quality nor of a reporting bias, overall information size was very small (1080 participants; 3.6% of optimal information size) compared with the optimal information size of 30,078 participants calculated to detect a 20% relative change in the incidence of bronchospasm, assuming a control group event rate of 2.3% (median control group event rate of included trials) with a power of 80% at an alpha level of 0.05. It was not possible for us to perform TSA with such a small information size. The effect estimate of the meta-analysis was imprecise, as the 95% CI was wide and overlapped the zone of no effect (RR 1.0) and the zones of potential benefit and harm (RR 0.75 and RR 1.25, respectively). We therefore classified the quality of evidence as low (very serious imprecision due to very small sample size and wide confidence interval: -2). Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.</P></SUBSECTION></SUBSECTION><SUBSECTION><HEADING LEVEL="4"><I>Length of stay </I></HEADING><SUBSECTION><HEADING LEVEL="5">Overall effect</HEADING><P>Three studies evaluated length of stay in non-cardiac surgery (551 participants). The following types of surgery were evaluated: vascular surgery: one trial; 'non-cardiac' surgery: one trial; and general abdominal surgery: one trial. One trial reported a significant reduction in hospital stay among participants taking beta-blockers compared with control at an alpha level of 0.05, whereas two trials did not show a significant difference. Overall, we found no clear evidence of an effect of beta-blockers on length of hospital stay in non-cardiac surgery, as evidenced by a random-effects mean difference of -0.45 with a 95% CI of -1.75 to 0.84 (P value 0.49) (<LINK REF="CMP-001.29" TYPE="ANALYSIS">Analysis 1.29</LINK>).</P></SUBSECTION><SUBSECTION><HEADING LEVEL="5">Heterogeneity</HEADING><P>The amount of variance explained by between-study variation was moderate (I<SUP>2</SUP> = 36%, P value 0.21). Thus we chose a random-effects model for presentation. Prespecified stratification for start of beta-blocker, type of beta-blocker and risk of surgery could not significantly reduce statistical heterogeneity (<LINK REF="CMP-003.27" TYPE="ANALYSIS">Analysis 3.27</LINK>; <LINK REF="CMP-004.14" TYPE="ANALYSIS">Analysis 4.14</LINK>; <LINK REF="CMP-005.28" TYPE="ANALYSIS">Analysis 5.28</LINK>). The reduction in length of stay reached statistical significance in the subgroups 'during surgery,' 'low and medium risk procedure' and 'esmolol' (only one trial <LINK REF="STD-Lee-2010" TYPE="STUDY">Lee 2010</LINK>: mean difference -0.40, 95% CI -0.58 to -0.22, P value &lt;0.0001 for subgroup effect; mean difference -0.40, 95% CI -0.58 to -0.22, P value &lt; 0.0001 for subgroup effect; [only one trial <LINK REF="STD-Lee-2010" TYPE="STUDY">Lee 2010</LINK>: mean difference -0.40, 95% CI -0.58 to -0.22, P value &lt; 0.0001 for subgroup effect, respectively). These results were driven mainly by the trial by Lee and colleagues (<LINK REF="STD-Lee-2010" TYPE="STUDY">Lee 2010</LINK>; 73.0% of the weight of the meta-analysis), which reported a significant reduction in hospital stay with the use of beta-blockers and was predominant in the above mentioned subgroups. Meta-regression analysis detected no association between clinical parameters and the effect estimate.</P></SUBSECTION><SUBSECTION><HEADING LEVEL="5">Reporting bias</HEADING><P>We found no evidence of a reporting bias upon visual assessment of the funnel plot. We did not perform formal assessment of funnel plot asymmetry because fewer than 10 studies were combined. Formal tests cannot distinguish between study variance of estimates and a potential reporting bias in this case.</P></SUBSECTION><SUBSECTION><HEADING LEVEL="5">Sensitivity analysis</HEADING><P>When we used a fixed-effect model instead of a random-effects model, the effect estimate changed only modestly in number but reached statistical significance (mean difference -0.40, 95% CI -0.58 to -0.22, P value &lt;0.0001). Prespecified stratification for type of control group modestly altered the effect estimate which remained statistically not significant (placebo: mean difference -4.58, 95% CI -16.07 to 6.91, P value 0.43 for overall subgroup effect; Analysis 2.23). Meta-regression did not detect an interaction between methodological parameters and the effect estimate.</P></SUBSECTION><SUBSECTION><HEADING LEVEL="5">Summary of confidence in estimates of effects using GRADE and TSA</HEADING><P>We noted a moderate amount of unexplained heterogeneity of the data . We could not identify a reporting bias or a bias introduced by studies of poorer methodological quality. Overall information size was very small (551 participants; 2.8% of optimal information size) compared with the optimal information size of 19,854 participants calculated to detect a mean difference of 0.5 days in length of stay, assuming a control group length of stay of 12.8 days with an SD of 17.8 days (mean length of stay in control groups of included trials) and a power of 80% at an alpha level of 0.05. We calculated this estimate using a conventional sample size calculator (assuming between-study heterogeneity of 0%), as the TSA software currently can be used only to calculate the optimal information size for dichotomous outcomes. The effect estimate of the meta-analysis was imprecise, as the 95% CI was wide and overlapped the zones of relevant prolongation and reduction of hospital stay (mean difference +0.5 and -0.5 days, respectively). We therefore classified the quality of evidence as low (very serious imprecision due to wide confidence interval and very small sample size: -2). Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate</P></SUBSECTION></SUBSECTION><SUBSECTION><HEADING LEVEL="4"><I>Cost of care </I></HEADING><P>No trial reported on cost of care.</P></SUBSECTION><SUBSECTION><HEADING LEVEL="4"><I>Quality of life </I></HEADING><P>No trial reported on quality of life.<BR/></P></SUBSECTION></INTERVENTION_EFFECTS></RESULTS><DISCUSSION MODIFIED="2018-02-23 18:19:54 +0000" MODIFIED_BY="[Empty name]"><P>We could identify 88 randomized controlled trials with a total of 19,161 randomly assigned study participants that met our inclusion criteria. Our study looked at 13 different outcomes, and overall effect estimates could be calculated for 11 of them. The most important outcomes are presented in the summary of findings tables, which are presented separately for cardiac and non-cardiac surgery (<LINK REF="SOF-01" TYPE="SOF">Summary of findings table 1</LINK>; <LINK REF="SOF-02" TYPE="SOF">Summary of findings table 2</LINK>).</P><SUMMARY_OF_RESULTS MODIFIED="2018-02-23 18:15:04 +0000" MODIFIED_BY="[Empty name]"><SUBSECTION><HEADING LEVEL="4"><I>All-cause mortality</I></HEADING><SUBSECTION><HEADING LEVEL="5">Cardiac surgery</HEADING><P>In our analysis of 24 trials comprising 3783 participants, we found no clear evidence of an effect of beta-blockers on all-cause mortality (RR 0.73, 95% CI 0.35 to 1.52, P value 0.40) nor death from cardiac causes (RR 0.85, 95% CI 0.16 to 4.40, P value 0.84) in heart surgery. As the number of randomly assigned participants was rather small and the confidence interval was wide, with overlapping zones of no effect and potential harm or benefit of therapy, no definitive conclusion can be drawn from our data.</P><P>Current guidelines on the use of beta-blockers in aortocoronary bypass surgery suggest that patients with an ejection fraction greater than 30% should receive beta-blockers preoperatively to reduce in-hospital mortality (<LINK REF="REF-Hillis-2011" TYPE="REFERENCE">Hillis 2011</LINK>). This class IIa recommendation was based on smaller RCTs and observational studies indicating reduced mortality with the use of beta-blockers in bypass surgery. Besides, all patients undergoing aortocoronary bypass surgery are diagnosed with coronary heart disease and therefore should receive beta-blockers if not contraindicated for other reasons (class Ia recommendation; <LINK REF="REF-Montalescot-2013" TYPE="REFERENCE">Montalescot 2013</LINK>).</P></SUBSECTION><SUBSECTION><HEADING LEVEL="5">Non-cardiac surgery</HEADING><P>In our analysis of 13 trials comprising 11,413 participants, we found beta-blockers to increase all-cause mortality (RR 1.25, 95% CI 1.00 to 1.57, P value 0.05). Statistical significance was lost, if only cardiac mortality (RR 1.26, 95% CI 0.91 to 1.75, P value 0.17) was analysed or data from long-term follow-ups were added (RR 0.99, 95% CI 0.74 to 1.31, P value 0.92). No publication bias was detected in our dataset. Restricting the meta-analysis to trials with an assumed lower risk of bias in our sensitivity analysis (i.e. placebo-controlled trials) revealed increased risk of death from any cause in the beta-blocker group too (RR 1.29, 95% CI 1.02 to 1.62, P value 0.03). Our results were driven mainly by the largest trial, POISE (<LINK REF="STD-POISE-2008" TYPE="STUDY">POISE 2008</LINK>), which dominated subgroup analyses. Mortality was increased if beta-blockers were administered before surgery or in low- and medium-risk procedures, and if the duration of treatment exceeded 21 days. All of these were features of the POISE trial, and if POISE was omitted from subgroup analyses, all of these parameters lost statistical significance. However, as POISE met the highest methodological standards and recruited more than 8000 participants, we feel confident about our pooled estimates. Interestingly, stratification of trials according to surgical risk revealed conflicting results, as long-term all-cause mortality for participants who had undergone high risk surgery (RR 0.62, 95% CI 0.39 to 0.98, P value 0.04) was statistically significantly decreased. As the number of randomly assigned participants was far lower than the optimal information size, further trials may change our confidence in the estimate of effect.</P><P>Previous European Society of Cardiology (ESC) guidelines for preoperative cardiac risk assessment and perioperative cardiac management in non-cardiac surgery recommended the use of beta-blockers if patients had been treated previously with beta-blockers (class Ic), were undergoing high-risk surgery (class Ib) or were diagnosed with ischaemic heart disease or exhibited myocardial ischaemia with stress testing (class Ib) (<LINK REF="REF-Poldermans-2009" TYPE="REFERENCE">Poldermans 2009</LINK>). In their recent 2014 guidelines on cardiovascular assessment and management in non-cardiac surgery (<LINK REF="REF-Kristensen-2014" TYPE="REFERENCE">Kristensen 2014</LINK>), the European Society of Cardiology (ESC) and European Society of Aneasthesiology (ESA) issued joint recommendations that took into account both the results of POISE (<LINK REF="STD-POISE-2008" TYPE="STUDY">POISE 2008</LINK>) and recent discussions concerning the credibility of the DECREASE trial family data (<LINK REF="STD-Poldermans-1999" TYPE="STUDY">Poldermans 1999</LINK>, <LINK REF="STD-DECREASE_x002d_IV-2009" TYPE="STUDY">DECREASE-IV 2009</LINK>). Beta-blockers should be continued if patients are on a beta-blocker long-term medication prior to planned surgery (class I, level of evidence A). Initiation of beta-blocker treatment may be considered in high risk individuals (more than two revised cardiac risk index clinical risk factors, proven ischaemic heart disease or myocardial ischaemia) undergoing intermediate or high risk surgery (class IIb, level of evidence B). If beta-blockers are started before surgery, atenolol or bisoprolol may be considered as first choice (class IIb, level of evidence B), as metoprolol serum levels vary to a greater extent due to a CYP2D6 dependent metabolism. Beta-blocker therapy should be commenced between 30 and 2 days prior to surgery, and titration of beta-blocker dose is mandatory (target resting heart rate 60-70 beats per minute, target systolic blood pressure &gt;100 mmHg).</P><P>As opposed to previous guidelines (<LINK REF="REF-Fleisher-2007" TYPE="REFERENCE">Fleisher 2007</LINK>), current American College of Cardiology (ACC)/American Heart Association (AHA) guidelines are more reluctant in recommending perioperative use of beta-blockers, too, for the reasons outlined above (<LINK REF="REF-Fleisher-2014" TYPE="REFERENCE">Fleisher 2014</LINK>). Beta-blocker treatment should be continued in the perioperative setting if it is part of the patient's long-term medication (class I, level of evidence B). Start of beta-blockers may be considered only in intermediate or high risk individuals with proven myocardial ischaemia or in patients with at least three revised cardiac risk index clinical risk factors (class IIb, level of evidence C and B, respectively). Thereby, beta-blockers should not be started on the day of surgery (class III, level of evidence B). Guidance of beta-blocker dosage by clinical circumstances (such as bradycardia or hypotension) is reasonable (class IIa, level of evidence B).</P><P>POISE and the DECREASE trial family:</P><P>The PeriOperative ISchemic Evaluation (POISE) trial (<LINK REF="STD-POISE-2008" TYPE="STUDY">POISE 2008</LINK>) was published in 2008 and showed increased mortality in the beta-blocker group (odds ratio (OR) 1.33, 95% CI 1.03 to 1.74, P value 0.03, 8351 participants). This effect was explained by a higher incidence of stroke caused by hypotension (risk factor with the highest population attributable risk). However, these findings were not confirmed by the 2009 DECREASE-IV trial (1066 participants at intermediate cardiac risk randomly assigned to a beta-blocker group, a fluvastatin group, a beta-blocker and fluvastatin group and a double control group). The combined outcome parameter 'cardiovascular death or myocardial infarction' was lower in the beta-blocker group than in the control group (HR 0.34, 95% CI 0.17 to 0.67, P value 0.002), whereas the incidence of stroke did not significantly differ between these groups (P value 0.68). The DECREASE family of studies was later discredited in 2011 because of allegations of fictitious data (<LINK REF="REF-Chopra-2012" TYPE="REFERENCE">Chopra 2012</LINK>, <LINK REF="REF-Bouri-2013" TYPE="REFERENCE">Bouri 2013</LINK>). We therefore decided against the inclusion in our meta-analysis of both DECREASE trials meeting our eligibility criteria (<LINK REF="STD-DECREASE_x002d_IV-2009" TYPE="STUDY">DECREASE-IV 2009</LINK>; <LINK REF="STD-Poldermans-1999" TYPE="STUDY">Poldermans 1999</LINK>). Whereas allegations of fictitious data were raised for DECREASE-IV, the DECREASE-I trial (<LINK REF="STD-Poldermans-1999" TYPE="STUDY">Poldermans 1999</LINK>) did not undergo thorough investigation as it was more than 10 years old. The DECREASE-I trial (<LINK REF="STD-Poldermans-1999" TYPE="STUDY">Poldermans 1999</LINK>) examined the effect of bisoprolol in 112 high-risk individuals identified by stress echocardiography undergoing vascular surgery. The study authors found that all-cause mortality could be reduced by as much as 83% (OR 0.17, 95% CI 0.04 to 0.83). This trial was not placebo controlled and therefore was unblinded. Furthermore, the study authors were criticized for reporting above average event rates in their control group, which could also account for the unusually strong protective effect. Third, another point of criticism was based on the fact that this trial was stopped early because interim analysis had shown reduced event rates in the intervention group. Previous experience mandates though that skepticism should apply when unusually large treatment effects are reported by trials that have to be stopped early (<LINK REF="REF-Devereaux-2004" TYPE="REFERENCE">Devereaux 2004</LINK>; <LINK REF="REF-Wheatley-2003" TYPE="REFERENCE">Wheatley 2003</LINK>). In the light of these facts, results of DECREASE-I have to be classified as insecure and therefore were not considered in our meta-analysis.</P><P>Researchers hypothesized that increased mortality and risk of stroke in the POISE trial may be caused by two factors: First, beta-blockers were started only two to four hours before surgery. Second, beta-blockers were not heart rate&#8211;titrated in the POISE trial. Participants in the POISE trial were confronted with the study drug immediately before surgery in a (rather high) fixed dose. This might have reduced the plaque-stabilizing effect, which requires prolonged drug action, and might have caused bradycardia or hypotension in participants just above the eligibility criterion for beta-blocker application of 50 beats per minute. Thus timing and mode of beta-blocker application (fixed goal vs heart rate&#8211;titrated) may play a role. We could identify the start time of beta-blocker treatment as effect modifier in our set of data (see above), whereas the mode of application was not shown to interact with the effect estimate.</P><P>In our meta-analysis, we found that data from the POISE trial seem to have counterbalanced neutral or positive results from other trials, ultimately leading to an increase in mortality. A recently published meta-analysis of 'secure' randomized controlled trials investigating the effect of perioperative beta-blockade in non-cardiac surgery (<LINK REF="REF-Bouri-2013" TYPE="REFERENCE">Bouri 2013</LINK>) also found an increase in all-cause mortality with the use of beta-blockers (RR 1.27, 95% CI 1.01 to 1.60, P value 0.04).</P></SUBSECTION></SUBSECTION><SUBSECTION><HEADING LEVEL="4"><I>Acute myocardial infarction</I></HEADING><P><B>Cardiac surgery</B></P><P>In our analysis of 22 trials (3553 participants) investigating perioperative AMI in patients undergoing heart surgery, we found no clear evidence of an effect of beta-blockers on the occurrence of this outcome (RR 1.04, 95% CI 0.71 to 1.51, P value 0.85). A reporting bias was judged to be present. Smaller studies tended to overestimate the protective effect of beta-blockers. However, using the trim-and-fill method to adjust for the reporting bias did not change the effect estimate. Restricting the meta-analysis to trials with an assumed lower risk of bias did not much change the effect estimate either (RR 1.38, 95% CI 0.71 to 2.69, P value 0.35). The trauma of the aortocoronary bypass operation itself (potential occlusion of coronary arteries caused by manipulation resulting in endothelial injury) may constitute a major determinant in developing AMI in these patients rather than the sympathetic stress response or increased oxygen demand, which can be influenced with the use of beta-blockers. As the number of randomly assigned participants was rather small and the confidence interval was wide, leading to overlapping zones of no effect and potential harm or benefit of therapy, no definitive conclusion can be drawn from our data (moderate quality of evidence).</P><P><B>Non-cardiac surgery</B></P><P>As was found previously by other investigators (<LINK REF="REF-Bangalore-2008" TYPE="REFERENCE">Bangalore 2008</LINK>; <LINK REF="REF-Bouri-2013" TYPE="REFERENCE">Bouri 2013</LINK>; <LINK REF="REF-Stevens-2003" TYPE="REFERENCE">Stevens 2003</LINK>), in our analysis of 14 trials with a total of 10,958 participants, current evidence supported a protective effect of beta-blockers against perioperative AMI. The overall RR from a fixed-effect model was 0.73 and reached statistical significance (95% CI 0.61 to 0.87, P value 0.0005). TSA could confirm the protective effect of beta-blockers. Additionally, the estimate was precise. We therefore classified the quality of evidence as high.</P><P>Results were again driven mainly by the POISE trial. In this trial, the decrease in AMI was not large enough to compensate for the increased cerebrovascular risk leading to elevated all-cause mortality in the beta-blocker group. Studies that found a reduction in mortality with the use of beta-blockers have attributed the decrease in perioperative mortality mainly to a reduction in (fatal) perioperative AMI (e.g. <LINK REF="STD-Mangano-1996" TYPE="STUDY">Mangano 1996</LINK>). A recent meta-analysis of 'secure' randomized controlled trials in non-cardiac surgery also found AMI to be significantly reduced in the beta-blocker group (RR 0.73, 95% CI 0.61 to 0.88, P value 0.001; <LINK REF="REF-Bouri-2013" TYPE="REFERENCE">Bouri 2013</LINK>).</P><P>In summary, we feel confident about our findings, as they are supported by both current literature and pathophysiology (see 'Myocardial ischaemia').</P></SUBSECTION><SUBSECTION><HEADING LEVEL="4"><I>Myocardial ischaemia</I></HEADING><P><B>Cardiac surgery</B></P><P>Only four trials (166 participants) investigated the occurrence of myocardial ischaemia in cardiac surgery. As outlined above, myocardial ischaemia may be a sequel of trauma of surgery more than of stress response and increased oxygen demand in this setting. When pooling the four trials (RR 0.51, 95% CI 0.25 to 1.05, P value 0.07), we found no clear evidence of an effect of beta-blockers on this outcome. Overall, the number of randomly assigned participants (information size) was very small, and thus the quality of evidence was rated low.</P><P><B>Non-cardiac surgery </B></P><P>Upon analysing 14 studies (978 participants), we found that beta-blockers could prevent perioperative myocardial ischaemia, as evidenced by an overall RR of 0.51 (95% CI 0.34 to 0.77, P value 0.001). We detected a bias introduced by studies of poorer methodological quality. Stratification for certain quality parameters attenuated the protective effect of beta-blockers versus the overall estimate, but it never lost statistical significance (see <LINK TAG="INTERVENTION_EFFECTS" TYPE="SECTION">Effects of interventions</LINK>). As the number of participants was quite small, quality of evidence was classified as moderate.</P><P>The reduction in myocardial ischaemia caused by perioperative beta-blockers is consistent with the findings of Stevens and colleagues and Bangalore and colleagues (<LINK REF="REF-Bangalore-2008" TYPE="REFERENCE">Bangalore 2008</LINK>; <LINK REF="REF-Stevens-2003" TYPE="REFERENCE">Stevens 2003</LINK>). Stevens and co-workers reported odds ratios of 0.32 and 0.47 for perioperative and postoperative ischaemia, respectively. The effect size was found to be within the same range by Bangalore (OR 0.36, 95% CI 0.26 to 0.50). One limitation of these findings is that in most trials, intraoperative ischaemia was studied, and therefore detection of ischaemia was based on ECG monitoring rather than on symptoms. The anti-ischaemic properties of beta-blockers are well known and can be explained by the negative inotropic and chronotropic effects that reduce myocardial oxygen consumption. As a consequence, the heart can cope with a decreased blood supply without experiencing ischaemia. Ischaemic episodes can trigger ventricular rhythm disturbances, and a reduction in ischaemia could account for the reduced rate of ventricular arrhythmias seen in patients taking perioperative beta-blockers (see below, 'Ventricular arrhythmias and extrasystoles').</P></SUBSECTION><SUBSECTION><HEADING LEVEL="4"><I>Cerebrovascular events</I></HEADING><P><B>Cardiac surgery</B></P><P>Only four trials (1400 participants) evaluated cerebrovascular events in the setting of cardiac surgery. Overall, we found no clear evidence of an effect of beta-blockers on stroke or TIA, according to our data (RR 1.52, 95% CI 0.58 to 4.02, P value 0.40). The information size was very low, and the 95% CI showed wide overlapping zones of no effect and potential harm or benefit. Thus quality of evidence was judged to be low, and no definitive conclusion can be drawn from our data.</P><P>Again, the technique of surgery causing macro-embolization and micro-embolization (use of extracorporal cardiopulmonary bypass during surgery and manipulation of the aorta during surgery) may heavily influence the incidence of cerebrovascular events after heart surgery (<LINK REF="REF-Hillis-2011" TYPE="REFERENCE">Hillis 2011</LINK>).</P><SUBSECTION><HEADING LEVEL="5">Non-cardiac surgery</HEADING><P>Five trials comprising 9150 participants reported on the occurrence of cerebrovascular events in the setting of non-cardiac surgery. Overall, we found no clear evidence of an effect of beta-blockers on the incidence of perioperative cerebrovascular events (RR 1.59, 95% CI 0.93 to 2.71, P value 0.09). Meta-regression analysis, however, identified methodological quality parameters that could interact with the effect estimate (control group status and blinding status; see <LINK TAG="INTERVENTION_EFFECTS" TYPE="SECTION">Effects of interventions</LINK>). Stratification for these effect modifiers revealed a statistically significant increase in cerebrovascular events if only trials with an assumed lower risk of bias were analysed (placebo-controlled trials: RR 2.09, 95% CI 1.14 to 3.82, P value 0.02). This result was influenced mainly by the POISE trial, which was of highest methodological quality and observed an increase in stroke with the use of beta-blockers. This effect was explained by a higher incidence of stroke caused by hypotension (risk factor with the highest population attributable risk). In our opinion, higher credibility shall be given to trials with higher methodological quality. Thus in conclusion, a harmful effect of beta-blockers must be assumed. As the information size of participants was small compared with the optimal information size, and given that evidence of bias was found, the quality of evidence was classified as low.</P><P>A higher incidence of stroke in participants taking beta-blockers who were undergoing non-cardiac surgery was confirmed by the findings of Bouri and colleagues in their recent meta-analysis of 'secure' trials (RR 1.73, 95% CI 1.00 to 2.99, P value 0.05; <LINK REF="REF-Bouri-2013" TYPE="REFERENCE">Bouri 2013</LINK>).</P></SUBSECTION></SUBSECTION><SUBSECTION><HEADING LEVEL="4"><I>Ventricular arrhythmias and extrasystoles</I></HEADING><P><B>Cardiac surgery</B></P><P>Twelve trials comprising 2292 participants confirmed a protective effect of beta-blockers on the occurrence of ventricular tachycardias and fibrillation (RR 0.37, 95% CI 0.24 to 0.58, P value &lt; 0.0001). Subgroup analysis found that start of beta-blocker therapy was an effect modifier. Thereby, beta-blockers lost their protective potential when started before surgery. This effect goes against all pathophysiological reasoning, as up-titration of beta-blockers well in advance of surgery should ensure their antiarrhythmic effect at the time of surgery. This phenomenon can be explained in two ways: As with all subgroup analyses, results may reflect a play of chance. Second, all three trials conducted with sotalol fell into the subgroup 'start before surgery.' Sotalol was the least potent beta-blocker to prevent ventricular arrhythmias, most likely because of its proarrhythmic properties (class III antiarrhythmic drug; see <LINK REF="CMP-005.11" TYPE="ANALYSIS">Analysis 5.11</LINK>). Clustering of all sotalol trials within a single subgroup therefore blunted the protective effects of beta-blocker treatment. In our opinion the type of beta-blocker rather than the start of treatment influenced the effect estimate. As the information size was small, quality of evidence was classified as moderate.</P><P>In contrast to these findings, the five trials (462 participants) investigating the effect of beta-blockers on premature ventricular beats yielded a non-significant result (RR 0.58, 95% CI 0.31 to 1.08, P value 0.09). As sample size was small and the effect estimate was imprecise, with overlapping zones of no effect and potential benefit, overall quality of evidence was rated as moderate.</P><P>In conclusion, beta-blockers were not able to reduce the occurrence of ventricular extrasystoles in the setting of cardiac surgery, probably mainly because of the trauma of surgery and the stress response. However, data suggest that beta-blockers effectively prevented deterioration in ventricular tachycardias and fibrillation, as ventricular extra beats are known to spark off these tachyarrhythmias.</P><P><B>Non-cardiac surgery</B></P><P>Five studies with 476 accrued participants investigated the occurrence of ventricular arrhythmias in non-cardiac surgery. Incidence of ventricular arrhythmias was found to be higher for non-cardiac surgery than for cardiac surgery. This was presumably caused by a broader definition of 'ventricular tachycardia (VT),' including non-sustained VTs, and tighter ECG monitoring (every two minutes during bronchoscopy, <LINK REF="STD-Sandler-1990" TYPE="STUDY">Sandler 1990</LINK>; Holter ECG monitoring for 72 hours, <LINK REF="STD-POBBLE-2005" TYPE="STUDY">POBBLE 2005</LINK>) in some non-cardiac surgery trials. When the data were pooled, we found no clear evidence of an effect of beta-blockers on the occurrence of VTs (RR 0.68, 95% CI 0.31 to 1.49, P value 0.33). Start of beta-blocker treatment, route of beta-blocker application and risk status of surgery were identified as effect modifiers. Stratification for these parameters revealed a protective, statistically significant effect of beta-blockers when administered intravenously during surgery in low- or medium-risk procedures. These findings were influenced mainly by two metoprolol trials (<LINK REF="STD-Jakobsen-1997" TYPE="STUDY">Jakobsen 1997</LINK>; <LINK REF="STD-POBBLE-2005" TYPE="STUDY">POBBLE 2005</LINK>). Both of these trials were high-risk surgery trials (lung resection and infrarenal aortic surgery, respectively). It is conceivable that in high-risk procedures, oral beta-blocker administration cannot be assured, and intravenous application is superior in this setting. This hypothesis is consistent with the fact that ventricular extra beats were significantly reduced in non-cardiac surgery with the use of beta-blockers (RR 0.22, 95% CI 0.13 to 0.37, P value &lt; 0.00001). Stratification for risk of surgery was not possible, as all 492 participants in the nine trials reporting on this outcome underwent low- or medium-risk surgery procedures. Quality of evidence was judged to be moderate for ventricular arrhythmias (small sample size and wide confidence interval) and high for ventricular extrasystoles (no downgrading).</P><P>To summarize the evidence, the protective effect of beta-blockers against ventricular arrhythmias in non-cardiac surgery is not uniform. Our data indicate that patients undergoing high-risk procedures may benefit from intravenous drug application during the surgery. We could show that beta-blockers have the potential to prevent perioperative ventricular arrhythmias such as ventricular tachycardias, ventricular fibrillation and ventricular premature beats in certain subgroups of patients. This is important, as ventricular rhythm disturbances are potentially debilitating and life-threatening.</P><P>Similar numbers can be found in the setting of prevention of ventricular arrhythmias after AMI. In their trial, Ryden and colleagues found that administration of the beta-blocker metoprolol reduced the odds of development of ventricular fibrillation by as much as 65% in the postinfarction period (<LINK REF="REF-Ryden-1983" TYPE="REFERENCE">Ryden 1983</LINK>). An elevated sympathetic stress response can be held accountable for many cases of ventricular arrhythmia in perioperative and postinfarction settings. Therefore it is not surprising that beta-blockers exert similar preventive effects in both circumstances. We could show that beta-blockers are capable of reducing ventricular arrhythmias, especially after cardiac surgery (see above, 'Cardiac surgery').</P></SUBSECTION><SUBSECTION><HEADING LEVEL="4"><I>Supraventricular arrhythmias</I></HEADING><P><B>Cardiac surgery</B></P><P>A large body of evidence investigating this outcome was available for meta-analysis. Forty-eight trials comprising 6420 participants found that beta-blockers significantly reduced the incidence of supraventricular arrhythmias in the aftermath of heart surgery (RR 0.44, 95% CI 0.36 to 0.53, P value &lt; 0.00001). When scrutinizing the data, we detected a reporting bias and bias introduced by studies of poorer methodological quality. In both cases, the protective effect of beta-blockers was overestimated. Restricting the meta-analysis to the 20 placebo-controlled trials with an assumed lower risk of bias (RR 0.60, 95% CI 0.48 to 0.76, P value &lt; 0.0001) and restricting the meta-analysis to atrial fibrillation and flutter only (RR 0.48, 95% CI 0.40 to 0.57, P value &lt; 0.00001) did not alter the effect estimate much. The large amount of statistical between study heterogeneity could not be explained sufficiently by stratification for clinical or methodological parameters. TSA indicated a significant protective effect of beta-blockers, and the overall information size was adequate. Thus the quality of evidence was classified as high.</P><P>As many as 30% of patients develop postoperative atrial fibrillation in the aftermath of cardiac surgery (<LINK REF="REF-Lauer-1989" TYPE="REFERENCE">Lauer 1989</LINK>). Therefore, in the past, much attention has been attributed to prevention of this disease entity. 2011 ACCF/AHA guidelines on coronary artery bypass surgery issued a class Ib recommendation to start beta-blocker treatment at least 24 hours before surgery to prevent postoperative atrial fibrillation and its sequelae (<LINK REF="REF-Hillis-2011" TYPE="REFERENCE">Hillis 2011</LINK>). In the meta-analysis of 27 trials and 3840 participants performed by Crystal and colleagues on prevention of postoperative atrial fibrillation (AF) in cardiac surgery, beta-blockers reduced the odds of developing postoperative atrial fibrillation by 61% (OR 0.39, 95% CI 0.28 to 0.52) (<LINK REF="REF-Crystal-2002" TYPE="REFERENCE">Crystal 2002</LINK>). The authors likewise detected a significant amount of between-trial heterogeneity in their data but could not identify its source. Our analysis of 48 trials including 6420 participants revealed similar overall findings (RR 0.44, 95% CI 0.36 to 0.53) in a likewise heterogenous set of data. We found that only a small amount of intertrial heterogeneity in our review depended on control group status (<LINK REF="CMP-002.13" TYPE="ANALYSIS">Analysis 2.13</LINK>). In our analysis of 20 placebo-controlled trials, beta-blockers reduced the risk of developing supraventricular arrhythmias by 40% (RR 0.60, 95% CI 0.48 to 0.76, P value &lt; 0.0001). In our opinion, this value appears to be physiologically more plausible than the 61% reduction reported in other reviews (<LINK REF="REF-Crystal-2002" TYPE="REFERENCE">Crystal 2002</LINK>).</P><P><B>Non-cardiac surgery</B></P><P>Eight trials comprising 8744 randomly assigned participants investigated the effect of beta-blockers on the incidence of supraventricular arrhythmias in non-cardiac surgery. Meta-analysis found that beta-blockers significantly reduce the occurrence of supraventricular arrhythmias (RR 0.73, 95% CI 0.57 to 0.94, P value 0.01). The beneficial effect was blunted in high risk patients if the drug was not started until anaesthesia was induced. Restriction of the meta-analysis to only atrial fibrillation and flutter left the effect estimate virtually unchanged (RR 0.73, 95% CI 0.56 to 0.95, P value 0.02). Much of the weight of the pooled estimate came from the POISE trial. Without inclusion of POISE in the analysis, the statistically significance of the protective effect was lost (RR 0.61, 95% CI 0.33 to 1.11 P value 0.10). TSA confirmed the protective effect of beta-blockers. As information size was adequate, the quality of evidence was rated high.</P><P>The reduction in arrhythmias was more pronounced in cardiac surgery trials than in non-cardiac surgery trials. We observed this finding for ventricular arrhythmias as well. The stronger effect of beta-blockers in the cardiac surgery subgroup may be due to the higher burden of supraventricular and ventricular arrhythmias in the setting of this type of surgery.</P></SUBSECTION><SUBSECTION><HEADING LEVEL="4"><I>Bradycardia</I></HEADING><P>When evaluating trials investigating bradycardia, we noticed that bradycardia was defined very differently by study authors. Some classified a heart rate below 60 beats per minute as bradycardia, whereas others detected an episode of bradycardia only if heart rate fell below 40 beats per minute, or if bradycardia required treatment. These different thresholds for bradycardia are likely to have caused clinical and statistical heterogeneity (see 'Non-cardiac surgery' below).</P><P><B>Cardiac surgery</B></P><P>In our analysis of eight trials (660 participants), we found no clear evidence of an effect of beta-blockers on episodes of bradycardia in the setting of heart surgery (RR 1.61, 95% CI 0.97 to 2.66, P value 0.06). No effect modification was detected. As overall information size was very small, the quality of evidence was classified as low. As the confidence interval overlapped both the zone of no effect and the zone of potential harm (RR 1.25), no definitive conclusion can be drawn at the moment from our data.</P><P>On the one hand, slowing down heart rate is an intrinsic effect of beta-blockers, and one may argue that without detection of any episodes of bradycardia, the drug may be underdosed, whereas on the other hand, patients undergoing cardiac surgery are under tight haemodynamic control, and doctors probably are more determined than in non-cardiac surgery to keep these haemodynamic variables stable within a small range and to take action well in advance of a pulse below 40 or 50 beats per minute. Finally, because of the very small sample size, the true effect of beta-blockers may have gone undetected (imprecision).</P><P><B>Non-cardiac surgery</B></P><P>In our analysis of 23 trials comprising 11,033 participants, beta-blockers significantly induced episodes of bradycardia (RR 2.23, 95% CI 1.48 to 3.36, P value &lt; 0.0001). All types of beta-blockers except esmolol (short half-life and thus good controllability), atenolol and nadolol (only very few randomly assigned participants in this subgroups) statistically significantly induced episodes of bradycardia (class effect). Statistical interstudy heterogeneity was high and could be explained in part by type of beta-blocker and methodological study quality parameters. Different definitions of bradycardia may have contributed to this effect. Subgroup analyses revealed that trials with a higher percentage of patients diagnosed with coronary heart disease and investigating a high-risk surgery setting were more prone to episodes of bradycardia. Furthermore, start of the beta-blocker before surgery was associated with a higher incidence of bradycardia. This effect may reflect a more pronounced impact of beta-blocker effect if up-titrated before surgery. Studies of poorer methodological quality systematically underestimated bradycardia induced by beta-blockers. Stratification for these parameters did not significantly change the effect estimate. As serious inconsistency of data was noted, the quality of evidence was rated moderate.</P><P>Bangalore and colleagues in their respective meta-analysis also found that beta-blockers significantly induce bradycardia (OR 2.74, 95% CI 2.29 to 3.29, P value &lt; 0.0001; <LINK REF="REF-Bangalore-2008" TYPE="REFERENCE">Bangalore 2008</LINK>). Cmpared with our results, in this meta-analysis, only 'bradycardia requiring treatment' was evaluated.</P></SUBSECTION><SUBSECTION><HEADING LEVEL="4"><I>Hypotension</I></HEADING><P><B>Cardiac surgery</B></P><P>When pooling the six trials (558 participants) exploring the influence of beta-blockers on hypotension in cardiac surgery, we found no clear evidence of an effect of beta-blockers on episodes of hypotension, as evidenced by an RR of 1.54 with a confidence interval of 0.67 to 3.51 (P value 0.31). No source of bias and no effect modifier could be identified. As the confidence interval was wide with overlapping zones of no effect, potential harm or benefit, and given that information size was very small, we classified the quality of evidence as low.</P><P>As outline above (section 'Bradycardia') a reduction in heart rate and thereby a reduction in blood pressure are inherent properties of beta-blockers. Again, in our opinion, control of heart rate and blood pressure is much tighter in patients undergoing heart surgery than in those undergoing non-cardiac surgery (see below, 'Non-cardiac surgery'). Furthermore, information size was much less than in non-cardiac surgery (558 vs 10,947 participants), which makes a potential effect of beta-blockers harder to detect.</P><P><B>Non-cardiac surgery</B></P><P>As opposed to cardiac surgery, meta-analysis of 22 trials (10,947 participants) in non-cardiac surgery indicated that beta-blockers significantly increased hypotensive episodes (RR 1.50, 95% CI 1.38 to 1.64, P value &lt; 0.00001). This effect remained unchanged and consistent throughout all subgroup analyses and was confirmed by TSA. As no source of bias was identified and information size was adequate, the quality of evidence was rated high.</P><P>Results from two other meta-analyses were within the same range compared with our estimate: Bangalore and colleagues found a 62% increase in hypotensive episodes (OR 1.62, 95% CI 1.44 to 1.82, P value &lt; 0.0001; <LINK REF="REF-Bangalore-2008" TYPE="REFERENCE">Bangalore 2008</LINK>), and meta-analysis of 'secure' RCTs by Bouri and colleagues revealed a 51% rise in hypotension in the beta-blocker group (RR 1.51, 95% CI 1.37 to 1.67, P value &lt; 0.00001; <LINK REF="REF-Bouri-2013" TYPE="REFERENCE">Bouri 2013</LINK>). In the POISE trial, hypotension was the risk factor with the highest population attributable risk that caused stroke and ultimately increased mortality in patients taking beta-blockers (<LINK REF="STD-POISE-2008" TYPE="STUDY">POISE 2008</LINK>).</P></SUBSECTION><SUBSECTION><HEADING LEVEL="4"><I>Congestive heart failure</I></HEADING><P><B>Cardiac surgery</B></P><P>Three trials comprising 311 randomly assigned participants evaluated the occurrence of congestive heart failure in cardiac surgery. We found no clear evidence of an effect of beta-blockers on the incidence of this outcome (RR 0.22, 95% CI 0.04 to 1.34, P value 0.10). No effect modification was detected, especially for ejection fraction. The very small information size and the wide confidence interval covering zones of no effect and potential harm or benefit indicated low quality of evidence. More data are needed before definitive conclusions can be drawn.</P><P><B>Non-cardiac surgery</B></P><P>The available body of evidence was much larger in non-cardiac surgery. Five studies (9173 participants) evaluated congestive heart failure in the perioperative setting. We found no evidence of an effect of beta-blockers on the occurrence of congestive heart failure (RR 1.18, 95% CI 0.94 to 1.48, P value 0.16). The effect of beta-blocker treatment remained non-significant throughout all subgroup analyses. As no sources of bias were detected and information size was sufficient but the confidence interval was wide, the quality of evidence was classified as moderate. TSA indicated futility, which means that further studies investigating this outcome are very unlikely to add significant information, as the information size is already large enough to allow review authors to conclude that beta-blockers do not significantly influence the occurrence of congestive heart failure after non-cardiac surgery.</P><P>Our findings are consistent with results of the meta-analysis by Bangalore and colleagues (<LINK REF="REF-Bangalore-2008" TYPE="REFERENCE">Bangalore 2008</LINK>). Likewise, the review authors could not find an interaction between beta-blocker intake and development of perioperative congestive heart failure (OR 1.20, 95% CI 0.95 to 1.52, P value 0.13).</P></SUBSECTION><SUBSECTION><HEADING LEVEL="4"><I>Bronchospasm</I></HEADING><P><B>Cardiac surgery</B></P><P>Three trials comprising only 196 participants evaluated bronchospasm in the setting of cardiac surgery. We found no clear evidence of an effect of beta-blockers on the occurrence of bronchospasm (RR 1.49, 95% CI 0.31 to 7.14, P value 0.62). Because of the very small information size and the wide confidence interval with overlapping zones of no effect, potential harm or benefit, we classified the quality of evidence as low. Evidence on this topic was very limited, and no definitive conclusion can be drawn from our data.</P><P><B>Non-cardiac surgery</B></P><P>Eight studies (1080 participants) reported on the occurrence of bronchospasm. We found no clear evidence of an effect of beta-blockers on this outcome (RR 0.94, 95% CI 0.55 to 1.59, P value 0.81). Because of the very small information size and the wide confidence interval with overlapping zones of no effect, potential harm or benefit, we classified the quality of evidence as low.</P><P>The incidence of bronchospasm was also investigated by the meta-analysis conducted by Bangalore and colleagues (<LINK REF="REF-Bangalore-2008" TYPE="REFERENCE">Bangalore 2008</LINK>). The authors of this meta-analysis likewise could not find a significant effect of beta-blockers on the development of bronchospasms (OR 0.98, 95% CI 0.56 to 1.72, P value 0.96).</P></SUBSECTION><SUBSECTION><HEADING LEVEL="4"><I>Length of stay (LOS)</I></HEADING><P><B>Cardiac surgery</B></P><P>Overall, beta-blockers reduced length of hospital stay by 0.54 days on average (95% CI -0.90 to - 0.19 days, P value 0.003) when 14 trials (2450 participants) assessing this outcome were pooled. When scrutinizing these data, we identified many sources of bias and effect modifiers: gender, route of beta-blocker administration and percentage of participants receiving beta-blocker therapy before entry into the trial, as clinical parameters and blinding of participants and doctors and use of the intention-to-treat principle as methodological parameters significantly interacted with the effect estimate. Furthermore, a reporting bias was detected that did not alter the effect estimate after adjustment. No clear pattern of parameters affecting the effect size could be determined, except for the reporting bias (small studies tended to overestimate the effect of beta-blockers in reducing hospital stay). For the exact numbers, see <LINK TAG="INTERVENTION_EFFECTS" TYPE="SECTION">Effects of interventions</LINK>. Although the information size was adequate, these multiple inconsistencies led to classification of the quality of evidence as low only.</P><P>Length of hospital stay is often seen as a proxy for economic burden. However, it has to be taken into account that length of hospital stay is probably heavily influenced by local policies and healthcare regulations, economic resources and current guidelines besides the patient's physical condition. Therefore, it is a very unreliable parameter, which in our opinion is reflected by the large unexplained intertrial heterogeneity of the data and the large number of significant interactions not following a clear pattern. Furthermore, as a reporting bias is present, the reduction in length of stay may be overestimated in our meta-analysis.</P><P>In their analysis of seven trials of 2008 participants, Crystal and colleagues found that sotalol could reduce LOS by as much as 0.4 days, and other beta-blockers reduced LOS by 0.66 days. Nevertheless, their findings did not reach statistical significance (<LINK REF="REF-Crystal-2002" TYPE="REFERENCE">Crystal 2002</LINK>). We think that our analysis is in agreement with their results. The statistical significance in our review can be explained by a larger participant collective, and by the fact that we did not differentiate between sotalol and other beta-blockers.</P><P><B>Non-cardiac surgery</B></P><P>Three trials with 551 accrued randomized participants reported on length of stay in non-cardiac surgery. The intertrial heterogeneity was moderate and could not be sufficiently explained by subgroup analyses. As mentioned above, this may reflect the fact that factors other than adverse events after surgery heavily influenced length of hospital stay. Overall, we found no clear evidence of an effect of beta-blockers on length of stay (mean difference -0.45 days, 95% CI -1.75 to 0.84 days, P value 0.49). As information size was very small and the confidence interval was wide, the quality of evidence was judged to be low. Data from the largest trial, POISE, could not be included, as no measure of spread was provided in the publication nor in supplements on the world wide web (median values were the same for beta-blocker and control groups in POISE: eight days (<LINK REF="STD-POISE-2008" TYPE="STUDY">POISE 2008</LINK>).</P></SUBSECTION><SUBSECTION><HEADING LEVEL="4"><I>Cost of care</I></HEADING><P><B>Cardiac surgery</B></P><P>Three trials reported on cost of care. The respective numbers were too far apart (nearly 10-fold) and thus precluded meaningful statistical analysis. All study authors reported higher costs in the beta-blocker intervention group. The relevance of this finding is unclear, as calculating hospital costs is a sophisticated endeavour with many potential pitfalls and heavily depends on the economic environment and the national healthcare system. Therefore, numbers are unlikely to be comparable. The higher costs for patients receiving beta-blockers leaves room for speculation. However, more evidence is needed before making further inferences</P><P><B>Non-cardiac surgery</B></P><P>No trial reported on cost of care.</P></SUBSECTION><SUBSECTION><HEADING LEVEL="4"><I>Quality of life</I></HEADING><P>No trial reported on quality of life.<BR/></P></SUBSECTION></SUMMARY_OF_RESULTS><APPLICABILITY_OF_FINDINGS MODIFIED="2014-08-26 13:39:26 +0100" MODIFIED_BY="Jane Cracknell"><P>Our meta-analysis is based on large numbers of RCTs and participants. The quality of evidence was classified using TSA and GRADE in the Results section (<LINK TAG="INTERVENTION_EFFECTS" TYPE="SECTION">Effects of interventions</LINK>, <LINK REF="SOF-01" TYPE="SOF">Summary of findings table 1</LINK>; <LINK REF="SOF-02" TYPE="SOF">Summary of findings table 2</LINK>). Our findings are consistent with pathophysiological concepts as outlined above. Conversely, data on cost of care were assessed by only three trials, which precluded meaningful analysis, and trials investigating quality of life were not available.</P></APPLICABILITY_OF_FINDINGS><QUALITY_OF_EVIDENCE MODIFIED="2017-12-08 03:01:04 +0000" MODIFIED_BY="Hermann Blessberger"><P>In general, trials that were not placebo-controlled reported larger effects than placebo-controlled trials. This was true for almost all outcomes. Reasons for a larger effect in standard care trials include lack of blinding and lack of the so-called placebo effect in control groups. One should thus be cautious when presented with large effects stemming from trials that were not placebo controlled. Intertrial heterogeneity was often to some extent attributable to the control group status (placebo vs standard care). Separate examination of placebo-controlled trials and trials with standard care groups often resulted in significantly reduced heterogeneity. Whenever a factor of study quality affected between-trial heterogeneity in a statistically significant way, results from trials with higher quality standards should be regarded as more valid. Placebo-controlled trials are generally regarded as the gold standard of clinical trials. Therefore, results from these trials should more accurately reflect the true effect of beta-blockers.</P><P>To enhance the quality of meta-analysis data, we included only randomized controlled trials in our analysis. However, only six (7%) of 88 trials met (and reported) the highest quality criteria (adequate sequence generation, adequate allocation concealment, double- or triple-blinded design, intention-to-treat analysis and absence of other sources of bias): <LINK REF="STD-DIPOM-_x002d_-Juul-2006" TYPE="STUDY">DIPOM - Juul 2006</LINK>; <LINK REF="STD-Mangano-1996" TYPE="STUDY">Mangano 1996</LINK>; <LINK REF="STD-POBBLE-2005" TYPE="STUDY">POBBLE 2005</LINK>; <LINK REF="STD-POISE-2008" TYPE="STUDY">POISE 2008</LINK>; <LINK REF="STD-Wallace-1998" TYPE="STUDY">Wallace 1998</LINK>; <LINK REF="STD-Yang-2006" TYPE="STUDY">Yang 2006</LINK>). We applied meta-regression analysis to evaluate the impact that study quality parameters exhibited on effect estimates. In cases of cerebrovascular events in non-cardiac surgery, we could show that control group status (placebo vs standard of care) statistically significantly influenced the effect estimate (see <LINK TAG="INTERVENTION_EFFECTS" TYPE="SECTION">Effects of interventions</LINK>).</P><P>When grading the quality of evidence using GRADE and TSA, we classified the following outcomes as very low, low, moderate or high quality.</P><P><B>Very low </B></P><P>We are very uncertain about the estimate.</P><P><B>Cardiac surgery:</B> cost of care.</P><P><B>Non-cardiac surgery:</B> none.</P><P><B>Low</B></P><P>Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.</P><P><B>Cardiac surgery:</B> myocardial ischaemia, cerebrovascular events, bradycardia, hypotension, congestive heart failure, bronchospasm, length of stay.</P><P><B>Non-cardiac surgery:</B> all-cause mortality, cerebrovascular events, bronchospasm, length of stay.</P><P><B>Moderate </B></P><P>Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.</P><P><B>Cardiac surgery:</B> all-cause mortality, AMI, ventricular arrhythmias, ventricular extrasystoles.</P><P><B>Non-cardiac surgery:</B> myocardial ischaemia, ventricular arrhythmias, bradycardia, congestive heart failure.</P><P><B>High</B></P><P>Further research is very unlikely to change our confidence in the estimate of effect.</P><P><B>Cardiac surgery:</B> supraventricular arrhythmias.</P><P><B>Non-cardiac surgery:</B> AMI, supraventricular arrhythmias, hypotension, ventricular extrasystoles.</P></QUALITY_OF_EVIDENCE><POTENTIAL_BIASES MODIFIED="2018-02-23 18:19:54 +0000" MODIFIED_BY="[Empty name]"><P>Despite efforts made by the review authors (FW, OS, HB, DA, JK) to identify as many RCTs as possible, we might have missed published trials not listed in the databases searched for this meta-analysis.</P><P>We included only trials that investigated at least one outcome specified in the Methods section. Because of the vast scope of the literature search and the large number of search results and included trials, this modus operandi seemed justified. This approach was used to focus on the main clinical outcomes and became inevitable for handling the vast quantity of data. However, it may have introduced a source of bias. We judged the impact of potentially missing studies as small only in number compared with the available set of data derived from a large number of trials.</P><P>Furthermore, we could not contact all study authors to gather further information about trial design or data analysis (e.g. performance of an intention-to-treat analysis) because of the large number of studies. However, it would be likely that study authors&#8212;if contacted&#8212;would over report trial design quality criteria. Further limitations inherent to this type of meta-analysis include different study designs of the included trials that are combined to calculate summary point estimates.</P><P>Results of outcomes calculated for non-cardiac surgery were heavily influenced by the POISE trial. We therefore performed sensitivity analyses in the Results section (Does omitting data from the POISE trial change the overall estimate?) if we believed that the effect estimate was driven mainly by this study. However, it has to be stated that the POISE trial met the highest quality standards and was very large. So we feel confident in including it in our overall estimates.</P><P>As opposed to the eligibility criteria defined in the protocol, we decided to consider trials in our meta-analysis that partially included participants not receiving general anaesthesia. Trials had to fulfil the following criteria to be eligible for inclusion: more than 100 randomly assigned participants operated on under general anaesthesia, or more than 70% of participants receiving general anaesthesia. We came to that conclusion, as we believed a meta-analysis without the POISE, DIPOM or MaVS trial would not find enough credibility within the clinical community. Excluding these trials would have meant losing hundreds of randomly assigned participants. However, we cannot exclude a potential bias introduced by participants who did not receive general anaesthesia in these trials (low-risk procedures). We tried without success to obtain information about the subsets of participants from these trials who were operated on while under general anaesthesia.</P></POTENTIAL_BIASES></DISCUSSION><CONCLUSIONS MODIFIED="2017-12-08 02:50:58 +0000" MODIFIED_BY="Hermann Blessberger"><IMPLICATIONS_PRACTICE MODIFIED="2017-12-08 02:50:58 +0000" MODIFIED_BY="Hermann Blessberger"><P>According to our findings, perioperative application of beta-blockers still plays a pivotal role in <I><B>cardiac surgery</B></I>, as they can substantially reduce the high burden of supraventricular and ventricular arrhythmias in the aftermath of surgery. Furthermore, beta-blockers are a mainstay of conservative coronary heart disease therapy (<LINK REF="REF-Fihn-2012" TYPE="REFERENCE">Fihn 2012</LINK>). More evidence is needed to definitively assess the role of beta-blockers in influencing mortality, preventing AMI and causing stroke, hypotension and bradycardia in this setting. However, it is highly likely that surgical trauma rather than beta-blockers is an important co-factor causing AMI and cerebrovascular events, as well as hypotension (blood loss), in heart surgery.</P><P>In <I><B>non-cardiac surgery, </B></I>evidence indicates an increase in all-cause mortality and the incidence of stroke with the use of beta-blockers. As the quality of evidence is still low to moderate and mainly based on one single trial (<LINK REF="STD-POISE-2008" TYPE="STUDY">POISE 2008</LINK>), more trials investigating these outcomes are needed to come to a definitive conclusion. Beta-blockers substantially reduced supraventricular arrhythmias and AMIs in this setting. According to our data, these benefits are potentially counterbalanced by increased risks of stroke and death. After assessment of cardiovascular risk factors, the individual risk of stroke, hypotension and bradycardia should be weighed against potential benefits (prevention of acute myocardial infarction and arrhythmias) for every patient.</P></IMPLICATIONS_PRACTICE><IMPLICATIONS_RESEARCH MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Further research is needed in the field of non-cardiac surgery so that firm conclusions can be drawn as to whether beta-blockers increase all-cause mortality and cerebrovascular events.</P><P>Furthermore, timing of beta-blocker application may have an important influence on their effect (plaque stabilization, haemodynamic adaptation). Larger trials investigating this topic are needed for a definitive conclusion.</P><P>Research is needed on the issue of quality of life, as virtually no data at all are available. From a patient perspective, this is probably one&#8212;if not the most important&#8212;outcome. It is fairly easy to evaluate quality of life through established questionnaires. We suggest that future trials should focus their attention on this endpoint as well.</P></IMPLICATIONS_RESEARCH></CONCLUSIONS></BODY><ACKNOWLEDGEMENTS MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>We would like to thank the individuals listed here.</P><P>M. Müllner for editorial assistance with the protocol for the review; L. Richard, K. Schroeder and M.J. Zeitler for reviewing the protocol for the review and for providing insightful comments.</P><P>J. Cracknell (managing editor, Cochrane Anaesthesia Review Group) for reviewing our work at several stages; H. Herkner (content editor) for his insightful comments and editorial assistance.</P><P>C . Walsh (statistical editor) and J. Wale (consumer editor) for reviewing the first draft of the review.</P><P>Y. Wang (Linz General Hospital, Austria) for providing assistance with translation of the Chinese articles.</P><P>G. Guyatt, F. Botto, G. Lurati, M. Mrkobrada, P. Foex and J. Wetterslev for their peer review, which helped to substantially improve the quality of this meta-analysis.</P><P>Furthermore, we would like to thank colleagues contacted by email who provided further information regarding trials: G. Hamilton (University College London Medical School), S. Ogawa (Toyohashi Heart Center, Japan) and P. Rahimzadeh (Iran University of Medical Sciences).</P></ACKNOWLEDGEMENTS><CONFLICT_OF_INTEREST MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>H. Blessberger: received consultancy honoraria from Ever Neuro Pharma in 2012.</P><P>J. Kammler: none known.</P><P>H. Domanovits: received honoraria from MSD, Sanofi-Aventis, Boehringer-Ingelheim and Amomed Pharma for giving lectures and consulting.</P><P>O. Schlager: none known.</P><P>B. Wildner: none known.</P><P>D. Azar: none known.</P><P>M. Schillinger: none known.</P><P>F. Wiesbauer: received payments from Medtronic for lectures on cardiac resynchronization therapy and received travel grants to attend the EuroEcho meeting from GE and Medtronic. Dr. Wiesbauer was part-time employee of Ever Neuro Pharma between September 2010 and September 2011 and is currently managing director of Medmastery - a company producing online training materials for doctors. All these activities were unrelated to this review.</P><P>C. Steinwender: received honoraria from MSD, Sanofi-Aventis, Boehringer-Ingelheim, Bayer Austria, Medtronic, Biotronik, Abbott Vascular, St.Jude Medical and Boston Scientific for giving lectures.</P><P>Ever Neuro Pharma, Medmastery, Sanofi-Aventis, Boehringer-Ingelheim Europe, Medtronic, Biotronik, GE, Bayer Austria, Abbott Vascular, St. Jude Medical and Boston Scientific do not produce, market or distribute any of the studied drug entities.</P><P>MSD (timolol) and Amomed Pharma (esmolol) both have a beta-blocker in their portfolio.</P></CONFLICT_OF_INTEREST><CONTRIBUTIONS MODIFIED="2018-02-22 17:58:00 +0000" MODIFIED_BY="[Empty name]"><P>Hermann Blessberger (HB), Juergen Kammler (JK), Hans Domanovits (HD), Oliver Schlager (OS), Brigitte Wildner (BW), Danyel Azar (DA), Martin Schillinger (MS)</P><P>Franz Wiesbauer (FW), Clemens Steinwender (CS).</P><P>Conceiving of the review: FW.</P><P>Co-ordinating the review: HB, JK, FW.</P><P>Undertaking manual searches: BW.</P><P>Screening search results: FW, OS, HB, DA, JK.</P><P>Organizing retrieval of papers: BW.</P><P>Screening retrieved papers against inclusion criteria: FW, OS, HB, DA, JK.</P><P>Appraising quality of papers: FW, OS, HB, DA, JK.</P><P>Abstracting data from papers: FW, OS, HB, DA, JK.</P><P>Writing to authors of papers for additional information: FW, HB.</P><P>Providing additional data about papers: not applicable.</P><P>Obtaining and screening data on unpublished studies: BW.</P><P>Managing data for the review: HB, JK, FW, BW.</P><P>Entering data into Review Manager (<LINK REF="REF-RevMan-5.3" TYPE="REFERENCE">RevMan 5.3</LINK>): HB, JK, FW.</P><P>Analysing RevMan statistical data: HB, FW.</P><P>Performing other statistical analysis not using RevMan: FW, HB.</P><P>Performing double entry of data: (data entered by person one: HB; data entered by person two: JK).</P><P>Interpreting data: HB, JK, CS, FW, HD, OS, BW, DA, MS.</P><P>Making statistical inferences: HB, FW.</P><P>Writing the review: HB, FW, BW, JK, CS.</P><P>Securing funding for the review: not applicable (no funding).</P><P>Performing previous work that was the foundation of the present study: E. Villanueva, R. Johnston and A. Rauli (preparation of first protocol draft).</P><P>Serving as guarantor for the review (one author): HB.</P><P>Taking responsibility for reading and checking the review before submission: HB.</P></CONTRIBUTIONS><PRO_REV_DIFF MODIFIED="2014-08-26 13:39:56 +0100" MODIFIED_BY="Jane Cracknell"><P>As opposed to the eligibility criteria defined in the protocol, we decided to consider trials in our meta-analysis that partially included participants not receiving general anaesthesia. Trials had to fulfil the following criteria to be eligible for inclusion: more than 100 randomly assigned participants operated on under general anaesthesia, or more than 70% of participants receiving general anaesthesia. We came to this conclusion, as we believed a meta-analysis without the POISE, DIPOM or MaVS trial would not find enough credibility within the clinical community.</P><P>The incidence of bronchospasm and the cost of care were added as secondary outcomes.</P><P>In addition to the subgroup analyses specified in the protocol, the following effect modifiers were analysed: gender, percentage of participants taking beta-blockers when entering the study, ejection fraction of participants, heart rate versus fixed-dose application of beta-blockers, type of hospital (university vs non-university), methodological parameters (control group status; blinding status of participants, doctors and outcome assessors; use of the intention-to-treat principle for data analysis; specification of baseline characteristics; inclusion and exclusion criteria).</P><P>Trial sequential meta-analysis (TSA) was introduced as a type of statistical power analysis that allows better appreciation of the validity of results yielded by the meta-analysis.</P><P>During the review process, we decided to use the risk ratio instead of the odds ratio, as recommended by the reviewers. The RR 'is a metric that is better comprehended and avoids over-estimation of the relative risk which is an inherent problem of the OR.'</P><P>Furthermore, outcomes were presented separately for cardiac and non-cardiac surgery, in accordance with the reviewers' recommendations. Pooling data from both of these types of surgery was considered to constitute a major source of clinical heterogeneity and thus would substantially limit validity. Therefore, pooled overall effect estimates were omitted.</P></PRO_REV_DIFF><PUBLIC_NOTES MODIFIED="2011-06-26 21:24:42 +0100" MODIFIED_BY="Hermann Blessberger"><P>None.</P></PUBLIC_NOTES></MAIN_TEXT><STUDIES_AND_REFERENCES MODIFIED="2018-03-06 09:49:00 +0000" MODIFIED_BY="Jane Cracknell">
<STUDIES MODIFIED="2018-02-23 18:15:04 +0000" MODIFIED_BY="[Empty name]">
<INCLUDED_STUDIES MODIFIED="2018-02-23 18:15:04 +0000" MODIFIED_BY="[Empty name]">
<STUDY DATA_SOURCE="PUB" ID="STD-Abel-1983" MODIFIED="2010-09-03 15:13:13 +0100" MODIFIED_BY="Hermann Blessberger" NAME="Abel 1983" YEAR="1983">
<REFERENCE MODIFIED="2010-09-03 07:21:53 +0100" MODIFIED_BY="Hermann Blessberger" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Abel RM, van Gelder HM, Pores IH, Liguori J</AU>
<TI>Continued propranolol administration following coronary bypass surgery</TI>
<SO>Archives of Surgery</SO>
<YR>1983</YR>
<VL>118</VL>
<PG>727-31</PG>
<IDENTIFIERS MODIFIED="2010-09-03 07:21:53 +0100" MODIFIED_BY="Hermann Blessberger"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3145470"/><IDENTIFIER MODIFIED="2010-09-03 07:21:53 +0100" MODIFIED_BY="Hermann Blessberger" TYPE="PUBMED" VALUE="6601941"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2010-09-03 15:13:13 +0100" MODIFIED_BY="Hermann Blessberger"><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3145469"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Ali-1997" MODIFIED="2010-09-03 07:22:59 +0100" MODIFIED_BY="Hermann Blessberger" NAME="Ali 1997" YEAR="1997">
<REFERENCE MODIFIED="2010-09-03 07:22:59 +0100" MODIFIED_BY="Hermann Blessberger" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Ali IM, Sanalla AA, Clark V</AU>
<TI>Beta-blocker effects on postoperative atrial fibrillation</TI>
<SO>European Journal of Cardio-Thoracic Surgery</SO>
<YR>1997</YR>
<VL>11</VL>
<PG>1154-7</PG>
<IDENTIFIERS MODIFIED="2010-09-03 07:22:59 +0100" MODIFIED_BY="Hermann Blessberger"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3145472"/><IDENTIFIER MODIFIED="2010-09-03 07:22:59 +0100" MODIFIED_BY="Hermann Blessberger" TYPE="PUBMED" VALUE="9237602"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3145471"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Apipan-2010" MODIFIED="2013-10-27 19:33:05 +0000" MODIFIED_BY="Hermann Blessberger" NAME="Apipan 2010" YEAR="2010">
<REFERENCE MODIFIED="2013-10-27 19:32:41 +0000" MODIFIED_BY="Hermann Blessberger" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Apipan B, Rummasak D</AU>
<TI>Efficacy and safety of oral propranolol premedication to reduce reflex tachycardia during hypotensive anesthesia with sodium nitroprusside in orthognathic surgery: a double-blind randomized clinical trial</TI>
<SO>American Association of Oral and Maxillofacial Surgeons</SO>
<YR>2010</YR>
<VL>68</VL>
<PG>120-4</PG>
<IDENTIFIERS MODIFIED="2013-10-27 19:32:41 +0000" MODIFIED_BY="Hermann Blessberger"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3145474"/><IDENTIFIER MODIFIED="2013-10-27 19:32:41 +0000" MODIFIED_BY="Hermann Blessberger" TYPE="PUBMED" VALUE=" 20006165"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2013-10-27 19:33:05 +0000" MODIFIED_BY="Hermann Blessberger"><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3145473"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Auer-2004" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" NAME="Auer 2004" YEAR="2004">
<REFERENCE MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Auer J, Weber T, Berent R, Puschmann R, Hartl P, Ng C, et al</AU>
<TI>A comparison between oral antiarrhythmic drugs in the prevention of atrial fibrillation after cardiac surgery: the pilot study of prevention of postoperative atrial fibrillation (SSPAF), a randomized, placebo-controlled trial</TI>
<SO>American Heart Journal</SO>
<YR>2004</YR>
<VL>147</VL>
<NO>4</NO>
<PG>636-43</PG>
<IDENTIFIERS MODIFIED="2013-11-10 20:07:46 +0000" MODIFIED_BY="Hermann Blessberger"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3145476"/><IDENTIFIER MODIFIED="2013-11-10 20:07:46 +0000" MODIFIED_BY="Hermann Blessberger" TYPE="PUBMED" VALUE="15077078"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3145475"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Babin_x002d_Ebell-1996" MODIFIED="2010-09-03 07:23:46 +0100" MODIFIED_BY="Hermann Blessberger" NAME="Babin-Ebell 1996" YEAR="1996">
<REFERENCE MODIFIED="2010-09-03 07:23:46 +0100" MODIFIED_BY="Hermann Blessberger" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Babin-Ebell J, Keith PR, Elert O</AU>
<TI>Efficacy and safety of low-dose propranolol versus diltiazem in the prophylaxis of supraventricular tachyarrhythmia after coronary artery bypass grafting</TI>
<SO>European Journal of Cardio-Thoracic Surgery</SO>
<YR>1996</YR>
<VL>10</VL>
<PG>412-6</PG>
<IDENTIFIERS MODIFIED="2010-09-03 07:23:46 +0100" MODIFIED_BY="Hermann Blessberger"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3145478"/><IDENTIFIER MODIFIED="2010-09-03 07:23:46 +0100" MODIFIED_BY="Hermann Blessberger" TYPE="PUBMED" VALUE="8817135"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3145477"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Bayliff-1999" MODIFIED="2011-07-31 19:54:53 +0100" MODIFIED_BY="Hermann Blessberger" NAME="Bayliff 1999" YEAR="1999">
<REFERENCE MODIFIED="2011-07-31 19:54:53 +0100" MODIFIED_BY="Hermann Blessberger" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Bayliff CD, Massel DR, Inculet RI, Malthaner RA, Quinton SD, Powell FS, et al</AU>
<TI>Propranolol for the prevention of postoperative arrhythmias in general thoracic surgery</TI>
<SO>Annals of Thoracic Surgery</SO>
<YR>1999</YR>
<VL>67</VL>
<PG>182-6</PG>
<IDENTIFIERS MODIFIED="2010-09-03 07:24:27 +0100" MODIFIED_BY="Hermann Blessberger"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3145480"/><IDENTIFIER MODIFIED="2010-09-03 07:24:27 +0100" MODIFIED_BY="Hermann Blessberger" TYPE="PUBMED" VALUE="10086546 "/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3145479"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Bert-2001" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" NAME="Bert 2001" YEAR="2001">
<REFERENCE MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Bert A, Reinert SE, Singh AK</AU>
<TI>A beta-blocker, not magnesium, is effective prophylaxis for atrial tachyarrhythmias after coronary artery bypass graft surgery</TI>
<SO>Journal of Cardiothoracic and Vascular Anesthesia</SO>
<YR>2001</YR>
<VL>15</VL>
<PG>204-9</PG>
<IDENTIFIERS MODIFIED="2010-09-03 07:31:59 +0100" MODIFIED_BY="Hermann Blessberger"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3145482"/><IDENTIFIER MODIFIED="2010-09-03 07:31:59 +0100" MODIFIED_BY="Hermann Blessberger" TYPE="PUBMED" VALUE="11312480"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3145481"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Booth-2004" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" NAME="Booth 2004" YEAR="2004">
<REFERENCE MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Booth JV, Ward EE, Colgan KC, Funk BL, El-Moalem H, Smith MP, et al</AU>
<TI>Metoprolol and coronary artery bypass grafting surgery: does intraoperative metoprolol attenuate acute &#946;-adrenergic receptor desensitization during cardiac surgery?</TI>
<SO>Anaesthesia and Analgesia</SO>
<YR>2004</YR>
<VL>98</VL>
<PG>1224-31</PG>
<IDENTIFIERS MODIFIED="2011-05-22 13:41:06 +0100" MODIFIED_BY="Hermann Blessberger"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3145484"/><IDENTIFIER MODIFIED="2011-05-22 13:41:06 +0100" MODIFIED_BY="Hermann Blessberger" TYPE="PUBMED" VALUE="15105192"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3145483"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Burns-1988" MODIFIED="2010-09-03 07:33:18 +0100" MODIFIED_BY="Hermann Blessberger" NAME="Burns 1988" YEAR="1988">
<REFERENCE MODIFIED="2010-09-03 07:33:18 +0100" MODIFIED_BY="Hermann Blessberger" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Burns JMA, Hart DM, Hughes RL, Kelman AW, Hillis WS</AU>
<TI>Effects of nadolol on arrhythmias during laparoscopy performed under general anaesthesia</TI>
<SO>British Journal of Anaesthesiology</SO>
<YR>1988</YR>
<VL>61</VL>
<PG>345-6</PG>
<IDENTIFIERS MODIFIED="2010-09-03 07:33:18 +0100" MODIFIED_BY="Hermann Blessberger"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3145486"/><IDENTIFIER MODIFIED="2010-09-03 07:33:18 +0100" MODIFIED_BY="Hermann Blessberger" TYPE="PUBMED" VALUE="2972306"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3145485"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-But-2006" MODIFIED="2011-05-22 14:22:30 +0100" MODIFIED_BY="Hermann Blessberger" NAME="But 2006" YEAR="2006">
<REFERENCE MODIFIED="2011-05-22 14:22:30 +0100" MODIFIED_BY="Hermann Blessberger" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>But AK, Yapici E, Erdil F, Öztürk E, Gedik E, Durmus M, et al</AU>
<TI>The effects of esmolol and magnesium on blood glucose regulation in the patients with type II diabetes mellitus undergoing CABG surgery</TI>
<TO>Koroner arter cerrahisi planlanan tip II diyabetes mellitus olgularinda esmolol ve magnezyumun kan sekeri regülasyonuna etkisi</TO>
<SO>Gogus-Kalp-Damar Anestezi ve Yogun Bakim Dernegi Dergesi</SO>
<YR>2006</YR>
<VL>124</VL>
<NO>4</NO>
<PG>143-8</PG>
<IDENTIFIERS MODIFIED="2011-05-22 14:22:30 +0100" MODIFIED_BY="Hermann Blessberger"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3145488"/><IDENTIFIER MODIFIED="2011-05-22 14:22:30 +0100" MODIFIED_BY="Hermann Blessberger" TYPE="PUBMED" VALUE="not available"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3145487"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Coleman-1980" MODIFIED="2010-09-03 07:35:43 +0100" MODIFIED_BY="Hermann Blessberger" NAME="Coleman 1980" YEAR="1980">
<REFERENCE MODIFIED="2010-09-03 07:35:43 +0100" MODIFIED_BY="Hermann Blessberger" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Coleman AJ, Jordan C</AU>
<TI>Cardiovascular response to anaesthesia. Influence of beta-adrenergic blockade with metoprolol</TI>
<SO>Anaesthesia</SO>
<YR>1980</YR>
<VL>35</VL>
<PG>972-8</PG>
<IDENTIFIERS MODIFIED="2010-09-03 07:35:29 +0100" MODIFIED_BY="Hermann Blessberger"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3145490"/><IDENTIFIER MODIFIED="2010-09-03 07:35:29 +0100" MODIFIED_BY="Hermann Blessberger" TYPE="PUBMED" VALUE="7004251"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3145489"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Connolly-2003" MODIFIED="2011-07-31 19:54:09 +0100" MODIFIED_BY="Hermann Blessberger" NAME="Connolly 2003" YEAR="2003">
<REFERENCE MODIFIED="2011-07-31 19:54:09 +0100" MODIFIED_BY="Hermann Blessberger" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Connolly SJ, Cybulsky I, Lamy A, Roberts RS, Tech M, O'Brien B, et al</AU>
<TI>Double-blind, placebo-controlled, randomized trial of prophylactic metoprolol for reduction of hospital length of stay after heart surgery: the beta-blocker length of stay (BLOS) study</TI>
<SO>American Heart Journal</SO>
<YR>2003</YR>
<VL>145</VL>
<PG>226-32</PG>
<IDENTIFIERS MODIFIED="2010-09-03 07:36:36 +0100" MODIFIED_BY="Hermann Blessberger"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3145492"/><IDENTIFIER MODIFIED="2010-09-03 07:36:36 +0100" MODIFIED_BY="Hermann Blessberger" TYPE="PUBMED" VALUE="12595838"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3145491"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Cork-1995" MODIFIED="2010-09-03 07:37:36 +0100" MODIFIED_BY="Hermann Blessberger" NAME="Cork 1995" YEAR="1995">
<REFERENCE MODIFIED="2010-09-03 07:37:36 +0100" MODIFIED_BY="Hermann Blessberger" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Cork RC, Kramer TH, Dreischmeier B, Behr S, Di Nardo JA</AU>
<TI>The effect of esmolol given during cardiopulmonary bypass</TI>
<SO>Cardiovascular Anesthesia</SO>
<YR>1995</YR>
<VL>80</VL>
<PG>28-40</PG>
<IDENTIFIERS MODIFIED="2010-09-03 07:37:36 +0100" MODIFIED_BY="Hermann Blessberger"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3145494"/><IDENTIFIER MODIFIED="2010-09-03 07:37:36 +0100" MODIFIED_BY="Hermann Blessberger" TYPE="PUBMED" VALUE="7802296"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3145493"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Cucchiara-1986" MODIFIED="2010-09-03 07:38:14 +0100" MODIFIED_BY="Hermann Blessberger" NAME="Cucchiara 1986" YEAR="1986">
<REFERENCE MODIFIED="2010-09-03 07:38:14 +0100" MODIFIED_BY="Hermann Blessberger" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Cicchiara RF, Benefiel DJ, Matteo RS, DeWood M, Albin MS</AU>
<TI>Evaluation of esmolol in controlling increases in heart rate and blood pressure during endotracheal intubation in patients undergoing carotid endarterectomy</TI>
<SO>Anesthesiology</SO>
<YR>1986</YR>
<VL>65</VL>
<PG>528-31</PG>
<IDENTIFIERS MODIFIED="2010-09-03 07:38:14 +0100" MODIFIED_BY="Hermann Blessberger"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3145496"/><IDENTIFIER MODIFIED="2010-09-03 07:38:14 +0100" MODIFIED_BY="Hermann Blessberger" TYPE="PUBMED" VALUE="2877599 "/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3145495"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Daudon-1986" MODIFIED="2011-04-25 19:37:42 +0100" MODIFIED_BY="Hermann Blessberger" NAME="Daudon 1986" YEAR="1986">
<REFERENCE MODIFIED="2011-04-25 19:37:42 +0100" MODIFIED_BY="Hermann Blessberger" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Daudon P, Corcos T, Gandjabakhch I, Levasseur JP, Cabrol A, Cabrol C</AU>
<TI>Prevention of atrial fibrillation or flutter by acebutolol after coronary bypass grafting</TI>
<SO>American Journal of Cardiology</SO>
<YR>1986</YR>
<VL>58</VL>
<PG>933-6</PG>
<IDENTIFIERS MODIFIED="2010-09-03 07:40:12 +0100" MODIFIED_BY="Hermann Blessberger"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3145498"/><IDENTIFIER MODIFIED="2010-09-03 07:40:12 +0100" MODIFIED_BY="Hermann Blessberger" TYPE="PUBMED" VALUE="3535474"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3145497"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-De-Azevedo-L_x00fa_cio-2003" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" NAME="De Azevedo Lúcio 2003" YEAR="2003">
<REFERENCE MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>De Azevedo Lúcio E, Flores A, Blacher C, Leaes PE, Lucchese FA, Pinto Ribeiro J</AU>
<TI>Effectiveness of metoprolol in preventing atrial fibrillation and flutter in the postoperative period of coronary artery bypass graft surgery</TI>
<TO>Efetividade do metoprolol na prevencao de fibrilacao e flutter atrial no pos-operatorio de cirurgia de revascularizacao miocardica</TO>
<SO>Arquivos Brasileiros de Cardiologia</SO>
<YR>2003</YR>
<VL>82</VL>
<NO>1</NO>
<PG>37-41</PG>
<IDENTIFIERS MODIFIED="2010-09-03 08:18:27 +0100" MODIFIED_BY="Hermann Blessberger"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3145500"/><IDENTIFIER MODIFIED="2010-09-03 08:18:27 +0100" MODIFIED_BY="Hermann Blessberger" TYPE="PUBMED" VALUE="14978593"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3145499"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-DIPOM-_x002d_-Juul-2006" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" NAME="DIPOM - Juul 2006" YEAR="2006">
<REFERENCE MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Juul AB, Wetterslev J, Gluud C, Kofoed-Enevoldsen A, Gorm J, Callesen T, et al</AU>
<TI>Effect of perioperative &#946; blockade in patients with diabetes undergoing major non-cardiac surgery: randomised placebo controlled, blinded multicentre trial</TI>
<SO>BMJ</SO>
<YR>2006</YR>
<VL>332</VL>
<NO>7556</NO>
<PG>1482</PG>
<IDENTIFIERS MODIFIED="2011-05-04 19:35:39 +0100" MODIFIED_BY="Hermann Blessberger"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3145502"/><IDENTIFIER MODIFIED="2011-05-04 19:35:39 +0100" MODIFIED_BY="Hermann Blessberger" TYPE="PUBMED" VALUE="16793810"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2011-05-04 19:30:08 +0100" MODIFIED_BY="Hermann Blessberger"><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3145501"/><IDENTIFIER MODIFIED="2011-05-04 19:30:06 +0100" MODIFIED_BY="Hermann Blessberger" TYPE="ISRCTN" VALUE="58485613"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Dy-1998" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" NAME="Dy 1998" YEAR="1998">
<REFERENCE MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Dy J, Jayasundera T, Kapadala D, Cuperman C, Whitman G, DiSesa V, et al</AU>
<TI>Post-operative atrial fibrillation&#8212;a randomized trial of metoprolol, flecainide, and placebo</TI>
<SO>Journal of the American College of Cardiology</SO>
<YR>1998</YR>
<VL>31</VL>
<NO>SuplA</NO>
<PG>324A</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3145504"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3145503"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Evrard-2000" MODIFIED="2011-07-31 19:53:00 +0100" MODIFIED_BY="Hermann Blessberger" NAME="Evrard 2000" YEAR="2000">
<REFERENCE MODIFIED="2011-07-31 19:53:00 +0100" MODIFIED_BY="Hermann Blessberger" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Evrard P, Gonzalez M, Jamart J, Malhomme B, Blommaert D, Eucher P, et al</AU>
<TI>Prophylaxis of supraventricular and ventricular arrhythmias after coronary artery bypass grafting with low-dose sotalol</TI>
<SO>Annals of Thoracic Surgery</SO>
<YR>2000</YR>
<VL>70</VL>
<PG>151-6</PG>
<IDENTIFIERS MODIFIED="2010-09-03 10:56:56 +0100" MODIFIED_BY="Hermann Blessberger"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3145506"/><IDENTIFIER MODIFIED="2010-09-03 10:56:56 +0100" MODIFIED_BY="Hermann Blessberger" TYPE="PUBMED" VALUE="10921700"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3145505"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Forlani-2002" MODIFIED="2018-02-23 18:15:04 +0000" MODIFIED_BY="[Empty name]" NAME="Forlani 2002" YEAR="2002">
<REFERENCE MODIFIED="2018-02-23 18:15:04 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Forlani S, De Paulis R, De Notaris S, Nardi P, Tomai F, Proietti I, et al</AU>
<TI>Combination of sotalol and magnesium prevents atrial fibrillation after coronary artery bypass grafting</TI>
<SO>Annals of Thoracic Surgery</SO>
<YR>2002</YR>
<VL>74</VL>
<PG>720-6</PG>
<IDENTIFIERS MODIFIED="2010-09-03 11:00:11 +0100" MODIFIED_BY="Hermann Blessberger"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3145508"/><IDENTIFIER MODIFIED="2010-09-03 11:00:11 +0100" MODIFIED_BY="Hermann Blessberger" TYPE="PUBMED" VALUE="12238830"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3145507"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Gibson-1988" MODIFIED="2010-09-03 11:00:59 +0100" MODIFIED_BY="Hermann Blessberger" NAME="Gibson 1988" YEAR="1988">
<REFERENCE MODIFIED="2010-09-03 11:00:59 +0100" MODIFIED_BY="Hermann Blessberger" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Gibson BE, Black S, Maass L, Cucchiara RF</AU>
<TI>Esmolol for the control of hypertension after neurologic surgery</TI>
<SO>Clinical Pharmacologic Therapy</SO>
<YR>1988</YR>
<VL>44</VL>
<PG>650-3</PG>
<IDENTIFIERS MODIFIED="2010-09-03 11:00:59 +0100" MODIFIED_BY="Hermann Blessberger"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3145510"/><IDENTIFIER MODIFIED="2010-09-03 11:00:59 +0100" MODIFIED_BY="Hermann Blessberger" TYPE="PUBMED" VALUE="2904310"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3145509"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Gomes-1999" MODIFIED="2014-08-11 16:55:08 +0100" MODIFIED_BY="[Empty name]" NAME="Gomes 1999" YEAR="1999">
<REFERENCE MODIFIED="2014-08-11 16:55:08 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Gomes JA, Ip J, Santoni-Rugiu F, Mehta D, Ergin A, Lansman S, et al</AU>
<TI>Oral d,l sotalol reduces the incidence of postoperative atrial fibrillation in coronary artery bypass surgery patient: a randomized, double-blind, placebo-controlled study</TI>
<SO>Journal of the American College of Cardiology</SO>
<YR>1999</YR>
<VL>34</VL>
<NO>2</NO>
<PG>334-9</PG>
<IDENTIFIERS MODIFIED="2010-09-03 11:02:22 +0100" MODIFIED_BY="Hermann Blessberger"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3145512"/><IDENTIFIER MODIFIED="2010-09-03 11:02:22 +0100" MODIFIED_BY="Hermann Blessberger" TYPE="PUBMED" VALUE="10440141"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3145511"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Graham-1996" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" NAME="Graham 1996" YEAR="1996">
<REFERENCE MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Graham SP, Hasnain S, Celano J</AU>
<TI>Low dose but not medium dose beta blockers reduce post-operative atrial fibrillation</TI>
<SO>Circulation</SO>
<YR>1996</YR>
<VL>94</VL>
<NO>8 Suppl 1</NO>
<PG>190-1</PG>
<IDENTIFIERS MODIFIED="2010-09-14 22:24:43 +0100" MODIFIED_BY="Jane Cracknell"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3145514"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3145513"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Gupta-2011" MODIFIED="2013-10-27 20:11:20 +0000" MODIFIED_BY="Hermann Blessberger" NAME="Gupta 2011" YEAR="2011">
<REFERENCE MODIFIED="2013-10-27 20:11:20 +0000" MODIFIED_BY="Hermann Blessberger" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Gupta D, Srivastava S, Dubey RK, Prakash PS, Singh PK, Singh U</AU>
<TI>Comparative evaluation of atenolol and clonidine premedication on cardiovascular response to nasal speculum insertion during trans-sphenoid surgery for resection of pituitary adenoma: a prospective, randomised, double-blind, controlled study</TI>
<SO>Indian Journal of Anaesthesia</SO>
<YR>2011</YR>
<VL>55</VL>
<NO>2</NO>
<PG>135-40</PG>
<IDENTIFIERS MODIFIED="2013-10-27 20:11:05 +0000" MODIFIED_BY="Hermann Blessberger"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3145516"/><IDENTIFIER MODIFIED="2013-10-27 20:11:05 +0000" MODIFIED_BY="Hermann Blessberger" TYPE="PUBMED" VALUE=" 21712869"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3145515"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hammon-1984" MODIFIED="2018-02-23 18:15:04 +0000" MODIFIED_BY="[Empty name]" NAME="Hammon 1984" YEAR="1984">
<REFERENCE MODIFIED="2018-02-23 18:15:04 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hammon JW, Wood AJJ, Prager RL, Wood M, Muirhead J, Bender HW Jr</AU>
<TI>Perioperative beta blockade with propranolol: reduction in myocardial oxygen demands and incidence of atrial and ventricular arrhythmias</TI>
<SO>Annals of Thoracic Surgery</SO>
<YR>1984</YR>
<VL>38</VL>
<PG>363-7</PG>
<IDENTIFIERS MODIFIED="2010-09-03 11:47:29 +0100" MODIFIED_BY="Hermann Blessberger"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3145518"/><IDENTIFIER MODIFIED="2010-09-03 11:47:29 +0100" MODIFIED_BY="Hermann Blessberger" TYPE="PUBMED" VALUE="6385890"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3145517"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Harrison-1987" MODIFIED="2011-07-31 19:52:23 +0100" MODIFIED_BY="Hermann Blessberger" NAME="Harrison 1987" YEAR="1987">
<REFERENCE MODIFIED="2011-07-31 19:52:23 +0100" MODIFIED_BY="Hermann Blessberger" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Harrison L, Ralley FE, Wynands E, Robbins GR, Sami M, Ripley R, et al</AU>
<TI>The role of an ultra short-acting adrenergic blocker (esmolol) in patients undergoing coronary artery bypass surgery</TI>
<SO>Anesthesiology</SO>
<YR>1987</YR>
<VL>66</VL>
<PG>413-8</PG>
<IDENTIFIERS MODIFIED="2010-09-03 11:48:24 +0100" MODIFIED_BY="Hermann Blessberger"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3145520"/><IDENTIFIER MODIFIED="2010-09-03 11:48:24 +0100" MODIFIED_BY="Hermann Blessberger" TYPE="PUBMED" VALUE="2881505"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3145519"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Inada-1989" MODIFIED="2013-09-26 21:02:38 +0100" MODIFIED_BY="Hermann Blessberger" NAME="Inada 1989" YEAR="1989">
<REFERENCE MODIFIED="2010-09-03 11:50:02 +0100" MODIFIED_BY="Hermann Blessberger" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Inada E, Cullen DJ, Nemeskal AR, Teplick R</AU>
<TI>Effect of labetalol or lidocaine on the hemodynamic response to intubation: a controlled randomized double-blind study</TI>
<SO>Journal of Clinical Anesthesiology</SO>
<YR>1998</YR>
<VL>1</VL>
<NO>3</NO>
<PG>207-13</PG>
<IDENTIFIERS MODIFIED="2010-09-03 11:50:02 +0100" MODIFIED_BY="Hermann Blessberger"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3145522"/><IDENTIFIER MODIFIED="2010-09-03 11:50:02 +0100" MODIFIED_BY="Hermann Blessberger" TYPE="PUBMED" VALUE="2697239"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3145521"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Ivey-1983" MODIFIED="2010-09-03 11:50:33 +0100" MODIFIED_BY="Hermann Blessberger" NAME="Ivey 1983" YEAR="1983">
<REFERENCE MODIFIED="2010-09-03 11:50:33 +0100" MODIFIED_BY="Hermann Blessberger" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Ivey MF, Ivey TD, Bailey WW, Williams DB, Hessel EA, Miller DW</AU>
<TI>Influence of propranolol on supraventricular tachycardia early after coronary artery revascularization</TI>
<SO>Journal of Cardiovascular Surgery</SO>
<YR>1983</YR>
<VL>85</VL>
<PG>214-8</PG>
<IDENTIFIERS MODIFIED="2010-09-03 11:50:33 +0100" MODIFIED_BY="Hermann Blessberger"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3145524"/><IDENTIFIER MODIFIED="2010-09-03 11:50:33 +0100" MODIFIED_BY="Hermann Blessberger" TYPE="PUBMED" VALUE="6337306"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3145523"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Jacquet-1994" MODIFIED="2018-02-23 18:15:04 +0000" MODIFIED_BY="[Empty name]" NAME="Jacquet 1994" YEAR="1994">
<REFERENCE MODIFIED="2018-02-23 18:15:04 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Jacquet L, Evenepoel M, Marenne F, Evrard P, Verhelst R, Dion R, et al</AU>
<TI>Hemodynamic effects and safety of sotalol in the prevention of supraventricular arrhythmias after coronary artery bypass surgery</TI>
<SO>Journal of Cardiothoracic and Vascular Anesthesia</SO>
<YR>1994</YR>
<VL>8</VL>
<PG>431-6</PG>
<IDENTIFIERS MODIFIED="2010-09-03 11:51:15 +0100" MODIFIED_BY="Hermann Blessberger"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3145526"/><IDENTIFIER MODIFIED="2010-09-03 11:51:15 +0100" MODIFIED_BY="Hermann Blessberger" TYPE="PUBMED" VALUE="7948800"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3145525"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Jakobsen-1992" MODIFIED="2011-05-15 16:50:47 +0100" MODIFIED_BY="Hermann Blessberger" NAME="Jakobsen 1992" YEAR="1992">
<REFERENCE MODIFIED="2011-05-15 16:50:47 +0100" MODIFIED_BY="Hermann Blessberger" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Jakobsen CJ, Blom L</AU>
<TI>Effect of pre-operative metoprolol on cardiovascular and catecholamine response and bleeding during hysterectomy</TI>
<SO>European Journal of Anaesthesiology</SO>
<YR>1992</YR>
<VL>9</VL>
<PG>209-15</PG>
<IDENTIFIERS MODIFIED="2010-09-03 11:51:48 +0100" MODIFIED_BY="Hermann Blessberger"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3145528"/><IDENTIFIER MODIFIED="2010-09-03 11:51:48 +0100" MODIFIED_BY="Hermann Blessberger" TYPE="PUBMED" VALUE="1600972"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3145527"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Jakobsen-1997" MODIFIED="2011-05-15 16:50:41 +0100" MODIFIED_BY="Hermann Blessberger" NAME="Jakobsen 1997" YEAR="1997">
<REFERENCE MODIFIED="2011-05-15 16:50:41 +0100" MODIFIED_BY="Hermann Blessberger" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Jakobsen CJ, Bille S, Ahlburg P, Rybro L, Pedersen KD, Rasmussen B</AU>
<TI>Preoperative metoprolol improves cardiovascular stability and reduces oxygen consumption after thoracotomy</TI>
<SO>Acta Anaesthesiologica Scandinavica</SO>
<YR>1997</YR>
<VL>41</VL>
<PG>1324-30</PG>
<IDENTIFIERS MODIFIED="2010-09-03 11:52:20 +0100" MODIFIED_BY="Hermann Blessberger"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3145530"/><IDENTIFIER MODIFIED="2010-09-03 11:52:20 +0100" MODIFIED_BY="Hermann Blessberger" TYPE="PUBMED" VALUE="9422300"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3145529"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Janssen-1986" MODIFIED="2013-11-10 20:14:38 +0000" MODIFIED_BY="Hermann Blessberger" NAME="Janssen 1986" YEAR="1986">
<REFERENCE MODIFIED="2013-11-10 20:14:38 +0000" MODIFIED_BY="Hermann Blessberger" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Janssen J, Loomans L, Harink J, Taams M, Brunninkhuis L, van der Starre P, et al</AU>
<TI>Prevention and treatment of supraventricular tachycardia shortly after coronary artery bypass grafting: a randomized open trial</TI>
<SO>Angiology</SO>
<YR>1986</YR>
<VL>60</VL>
<PG>601-9</PG>
<IDENTIFIERS MODIFIED="2013-11-10 20:14:38 +0000" MODIFIED_BY="Hermann Blessberger"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3145532"/><IDENTIFIER MODIFIED="2013-11-10 20:14:38 +0000" MODIFIED_BY="Hermann Blessberger" TYPE="PUBMED" VALUE="2874755"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3145531"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kawaguchi-2010" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" NAME="Kawaguchi 2010" YEAR="2010">
<REFERENCE MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kawaguchi M, Utada K, Yoshitani K, Uchino H, Takeda Y, Masui K, et al</AU>
<TI>Effects of a short-acting &#946;1 receptor antagonist landiolol on hemodynamics and tissue injury markers in patients with subarachnoid hemorrhage undergoing intracranial aneurysm surgery</TI>
<SO>Journal of Neurosurgical Anesthesiology</SO>
<YR>2010</YR>
<VL>22</VL>
<NO>3</NO>
<PG>230-9</PG>
<IDENTIFIERS MODIFIED="2011-05-16 20:58:41 +0100" MODIFIED_BY="Hermann Blessberger"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3145534"/><IDENTIFIER MODIFIED="2011-05-16 20:58:41 +0100" MODIFIED_BY="Hermann Blessberger" TYPE="PUBMED" VALUE=" 20118792"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3145533"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Khuri-1987" MODIFIED="2011-07-31 19:51:02 +0100" MODIFIED_BY="Hermann Blessberger" NAME="Khuri 1987" YEAR="1987">
<REFERENCE MODIFIED="2011-07-31 19:51:02 +0100" MODIFIED_BY="Hermann Blessberger" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Khuri SF, Okike N, Josa M, Salm TJV, Assoussa S, Leone L, et al</AU>
<TI>Efficacy of nadolol in preventing supraventricular tachycardia after coronary artery bypass grafting</TI>
<SO>American Journal of Cardiology</SO>
<YR>1987</YR>
<VL>60</VL>
<PG>51-8D</PG>
<IDENTIFIERS MODIFIED="2010-09-03 11:57:01 +0100" MODIFIED_BY="Hermann Blessberger"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3145536"/><IDENTIFIER MODIFIED="2010-09-03 11:57:01 +0100" MODIFIED_BY="Hermann Blessberger" TYPE="PUBMED" VALUE="3498356"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3145535"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kurian-2001" MODIFIED="2010-09-03 11:57:29 +0100" MODIFIED_BY="Hermann Blessberger" NAME="Kurian 2001" YEAR="2001">
<REFERENCE MODIFIED="2010-09-03 11:57:29 +0100" MODIFIED_BY="Hermann Blessberger" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kurian SM, Evans R, Fernandes NO, Sherry KM</AU>
<TI>The effect of an infusion of esmolol on the incidence of myocardial ischaemia during tracheal extubation following coronary artery surgery</TI>
<SO>Anaesthesia</SO>
<YR>2001</YR>
<VL>56</VL>
<PG>1163-8</PG>
<IDENTIFIERS MODIFIED="2010-09-03 11:57:29 +0100" MODIFIED_BY="Hermann Blessberger"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3145538"/><IDENTIFIER MODIFIED="2010-09-03 11:57:29 +0100" MODIFIED_BY="Hermann Blessberger" TYPE="PUBMED" VALUE="11736772"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3145537"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Lai-2006" MODIFIED="2011-05-22 19:02:41 +0100" MODIFIED_BY="Hermann Blessberger" NAME="Lai 2006" YEAR="2006">
<REFERENCE MODIFIED="2011-05-22 19:02:41 +0100" MODIFIED_BY="Hermann Blessberger" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Lai R, Xu M, Huang W, Wang X, Zeng W, Lin W</AU>
<TI>Beneficial effects of metoprolol on perioperative cardiac function of elderly esophageal cancer patients</TI>
<SO>Chinese Journal of Cancer</SO>
<YR>2006</YR>
<VL>25</VL>
<NO>5</NO>
<PG>609-13</PG>
<IDENTIFIERS MODIFIED="2011-05-22 19:02:41 +0100" MODIFIED_BY="Hermann Blessberger"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3145540"/><IDENTIFIER MODIFIED="2011-05-22 19:02:41 +0100" MODIFIED_BY="Hermann Blessberger" TYPE="PUBMED" VALUE="16687084"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3145539"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Lamb-1988" MODIFIED="2010-09-03 11:58:03 +0100" MODIFIED_BY="Hermann Blessberger" NAME="Lamb 1988" YEAR="1988">
<REFERENCE MODIFIED="2010-09-03 11:58:03 +0100" MODIFIED_BY="Hermann Blessberger" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Lamb RK, Prabhakar G, Thorpe JAC, Smith S, Norton R, Dyde JA</AU>
<TI>The use of atenolol in the prevention of supraventricular arrhythmias following coronary artery surgery</TI>
<SO>European Heart Journal</SO>
<YR>1988</YR>
<VL>9</VL>
<PG>32-6</PG>
<IDENTIFIERS MODIFIED="2010-09-03 11:58:03 +0100" MODIFIED_BY="Hermann Blessberger"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3145542"/><IDENTIFIER MODIFIED="2010-09-03 11:58:03 +0100" MODIFIED_BY="Hermann Blessberger" TYPE="PUBMED" VALUE=" 3257915"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3145541"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Lee-2010" MODIFIED="2018-02-22 17:07:03 +0000" MODIFIED_BY="[Empty name]" NAME="Lee 2010" YEAR="2010">
<REFERENCE MODIFIED="2013-10-27 20:35:06 +0000" MODIFIED_BY="Hermann Blessberger" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Lee SJ, Lee JN</AU>
<TI>The effect of perioperative esmolol infusion on the post-operative nausea, vomiting and pain after laparoscopic appendectomy</TI>
<SO>Korean Journal of Anesthesiology</SO>
<YR>2010</YR>
<VL>59</VL>
<NO>3</NO>
<PG>179-84</PG>
<IDENTIFIERS MODIFIED="2013-10-27 20:35:06 +0000" MODIFIED_BY="Hermann Blessberger"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3145544"/><IDENTIFIER MODIFIED="2013-10-27 20:35:06 +0000" MODIFIED_BY="Hermann Blessberger" TYPE="PUBMED" VALUE="20877702"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3145543"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Liu-1986" MODIFIED="2014-05-15 14:18:29 +0100" MODIFIED_BY="Jane Cracknell" NAME="Liu 1986" YEAR="1986">
<REFERENCE MODIFIED="2014-05-15 14:18:29 +0100" MODIFIED_BY="Jane Cracknell" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Liu PL, Gatt S, Gugino LD, Mallampati SR, Covino BG</AU>
<TI>Esmolol for control of increases in heart rate and blood pressure during tracheal intubation after thiopentone and succinylcholine</TI>
<SO>Canadian Anaesthetists' Society Journal</SO>
<YR>1986</YR>
<VL>33</VL>
<PG>556-62</PG>
<IDENTIFIERS MODIFIED="2010-09-03 11:59:34 +0100" MODIFIED_BY="Hermann Blessberger"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3145546"/><IDENTIFIER MODIFIED="2010-09-03 11:59:34 +0100" MODIFIED_BY="Hermann Blessberger" TYPE="PUBMED" VALUE="3768764"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3145545"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Liu-2006" MODIFIED="2011-05-22 18:31:08 +0100" MODIFIED_BY="Hermann Blessberger" NAME="Liu 2006" YEAR="2006">
<REFERENCE MODIFIED="2011-05-22 18:31:08 +0100" MODIFIED_BY="Hermann Blessberger" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Liu Y, Huang C, He M, Zhang L, Cai H, Guo Q</AU>
<TI>Influences of perioperative metoprolol on haemodynamics and myocardial ischaemia in elderly patients undergoing noncardiac surgery</TI>
<SO>Journal of Central South University - Medical Sciences (Zhong Nan Da Xue Xue Bao Yi Xue Ban)</SO>
<YR>2006</YR>
<VL>31</VL>
<NO>2</NO>
<PG>249-53</PG>
<IDENTIFIERS MODIFIED="2011-05-22 18:31:00 +0100" MODIFIED_BY="Hermann Blessberger"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3145548"/><IDENTIFIER MODIFIED="2011-05-22 18:31:00 +0100" MODIFIED_BY="Hermann Blessberger" TYPE="PUBMED" VALUE="16706126"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3145547"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Magnusson-1986" MODIFIED="2010-09-03 12:00:15 +0100" MODIFIED_BY="Hermann Blessberger" NAME="Magnusson 1986" YEAR="1986">
<REFERENCE MODIFIED="2010-09-03 12:00:15 +0100" MODIFIED_BY="Hermann Blessberger" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Magnusson J, Thulin T, Werner O, Järhult J, Thomson D</AU>
<TI>Haemodynamic effects of pretreatment with metoprolol in hypertensive patients undergoing surgery</TI>
<SO>British Journal of Anaesthesiology</SO>
<YR>1986</YR>
<VL>58</VL>
<PG>251-60</PG>
<IDENTIFIERS MODIFIED="2010-09-03 12:00:15 +0100" MODIFIED_BY="Hermann Blessberger"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3145550"/><IDENTIFIER MODIFIED="2010-09-03 12:00:15 +0100" MODIFIED_BY="Hermann Blessberger" TYPE="PUBMED" VALUE="3511930"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3145549"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Mangano-1996" MODIFIED="2010-09-03 12:02:27 +0100" MODIFIED_BY="Hermann Blessberger" NAME="Mangano 1996" YEAR="1996">
<REFERENCE MODIFIED="2010-09-03 12:02:27 +0100" MODIFIED_BY="Hermann Blessberger" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Mangano DT, Layug EL, Wallace A, Tateo I</AU>
<TI>Effect of atenolol on mortality and cardiovascular morbidity after noncardiac surgery</TI>
<SO>New England Journal of Medicine</SO>
<YR>1996</YR>
<VL>335</VL>
<NO>23</NO>
<PG>1713-20</PG>
<IDENTIFIERS MODIFIED="2010-09-03 12:02:27 +0100" MODIFIED_BY="Hermann Blessberger"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3145552"/><IDENTIFIER MODIFIED="2010-09-03 12:02:27 +0100" MODIFIED_BY="Hermann Blessberger" TYPE="PUBMED" VALUE="8929262"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3145551"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Martinussen-1988" MODIFIED="2014-05-15 14:18:29 +0100" MODIFIED_BY="Jane Cracknell" NAME="Martinussen 1988" YEAR="1988">
<REFERENCE MODIFIED="2014-05-15 14:18:29 +0100" MODIFIED_BY="Jane Cracknell" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Martinussen HJ, Lolk A, Szczepanski C, Alstrup P</AU>
<TI>Supraventricular tachyarrhythmias after coronary bypass surgery - a double blind randomized trial of prophylactic low dose propranolol</TI>
<SO>Thoracic Cardiovascular Surgeon</SO>
<YR>1988</YR>
<VL>36</VL>
<PG>206-7</PG>
<IDENTIFIERS MODIFIED="2010-09-03 12:03:00 +0100" MODIFIED_BY="Hermann Blessberger"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3145554"/><IDENTIFIER MODIFIED="2010-09-03 12:03:00 +0100" MODIFIED_BY="Hermann Blessberger" TYPE="PUBMED" VALUE="2903581"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3145553"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Marwick-2009" MODIFIED="2011-06-11 13:52:43 +0100" MODIFIED_BY="Hermann Blessberger" NAME="Marwick 2009" YEAR="2009">
<REFERENCE MODIFIED="2011-06-11 13:52:43 +0100" MODIFIED_BY="Hermann Blessberger" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Marwick TH, Branagan H, Venkatesh B, Stewart S</AU>
<TI>Use of a nurse-led intervention to optimize beta-blockade for reducing cardiac events after major noncardiac surgery</TI>
<SO>American Heart Journal</SO>
<YR>2009</YR>
<VL>157</VL>
<NO>4</NO>
<PG>784-90</PG>
<IDENTIFIERS MODIFIED="2010-09-03 12:03:31 +0100" MODIFIED_BY="Hermann Blessberger"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3145556"/><IDENTIFIER MODIFIED="2010-09-03 12:03:31 +0100" MODIFIED_BY="Hermann Blessberger" TYPE="PUBMED" VALUE="19332211"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3145555"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Matangi-1985" MODIFIED="2018-02-23 18:15:04 +0000" MODIFIED_BY="[Empty name]" NAME="Matangi 1985" YEAR="1985">
<REFERENCE MODIFIED="2018-02-23 18:15:04 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Matangi MF, Neutze JM, Graham KJ, Hill DG, Kerr AR, Barratt-Boyes BG</AU>
<TI>Arrhythmia prophylaxis after aorta-coronary bypass. The effect of minidose propranolol</TI>
<SO>Journal of Thoracic and Cardiovascular Surgery</SO>
<YR>1985</YR>
<VL>89</VL>
<PG>439-43</PG>
<IDENTIFIERS MODIFIED="2010-09-03 12:05:01 +0100" MODIFIED_BY="Hermann Blessberger"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3145558"/><IDENTIFIER MODIFIED="2010-09-03 12:05:01 +0100" MODIFIED_BY="Hermann Blessberger" TYPE="PUBMED" VALUE="3871883"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3145557"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Matangi-1989" MODIFIED="2011-07-05 18:53:00 +0100" MODIFIED_BY="Jane Cracknell" NAME="Matangi 1989" YEAR="1989">
<REFERENCE MODIFIED="2011-05-22 19:46:45 +0100" MODIFIED_BY="Hermann Blessberger" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Matangi MF, Strickland J, Garbe GJ, Habib N, Basu A, Burgess JJ, et al</AU>
<TI>Atenolol for the prevention of arrhythmias following coronary artery bypass grafting</TI>
<SO>Canadian Journal of Cardiology</SO>
<YR>1989</YR>
<VL>5</VL>
<NO>4</NO>
<PG>229-34</PG>
<IDENTIFIERS MODIFIED="2010-09-03 12:05:38 +0100" MODIFIED_BY="Hermann Blessberger"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3145560"/><IDENTIFIER MODIFIED="2010-09-03 12:05:38 +0100" MODIFIED_BY="Hermann Blessberger" TYPE="PUBMED" VALUE="2659151"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3145559"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Materne-1985" MODIFIED="2013-11-25 13:27:11 +0000" MODIFIED_BY="Hermann Blessberger" NAME="Materne 1985" YEAR="1985">
<REFERENCE MODIFIED="2010-09-03 12:06:20 +0100" MODIFIED_BY="Hermann Blessberger" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Materne P, Larbuisson R, Collignon P, Limet R, Kulbertus H</AU>
<TI>Prevention by acebutolol of rhythm disorders following coronary bypass surgery</TI>
<SO>International Journal of Cardiology</SO>
<YR>1985</YR>
<VL>8</VL>
<PG>275-83</PG>
<IDENTIFIERS MODIFIED="2010-09-03 12:06:20 +0100" MODIFIED_BY="Hermann Blessberger"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3145562"/><IDENTIFIER MODIFIED="2010-09-03 12:06:20 +0100" MODIFIED_BY="Hermann Blessberger" TYPE="PUBMED" VALUE="3894250"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3145561"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Matsuura-2001" MODIFIED="2018-02-23 18:15:04 +0000" MODIFIED_BY="[Empty name]" NAME="Matsuura 2001" YEAR="2001">
<REFERENCE MODIFIED="2018-02-23 18:15:04 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Matsuura K, Takahara Y, Sudo Y, Ishida K</AU>
<TI>Effect of sotalol in the prevention of atrial fibrillation following coronary artery bypass grafting</TI>
<SO>Japanese Journal of Thoracic and Cardiovascular Surgery</SO>
<YR>2001</YR>
<VL>49</VL>
<PG>614-7</PG>
<IDENTIFIERS MODIFIED="2010-09-03 12:07:20 +0100" MODIFIED_BY="Hermann Blessberger"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3145564"/><IDENTIFIER MODIFIED="2010-09-03 12:07:20 +0100" MODIFIED_BY="Hermann Blessberger" TYPE="PUBMED" VALUE="11692587"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3145563"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Miller-1990" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" NAME="Miller 1990" YEAR="1990">
<REFERENCE MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Miller DR, Martineau RJ, Hull KA, Hill J</AU>
<TI>Bolus administration of esmolol for controlling the hemodynamic response to laryngoscopy and intubation: efficacy and effects on myocardial performance</TI>
<SO>Journal of Cardiothoracic Anesthesia</SO>
<YR>1990</YR>
<VL>4</VL>
<NO>5 Suppl 2</NO>
<PG>31-6</PG>
<IDENTIFIERS MODIFIED="2010-09-03 13:07:16 +0100" MODIFIED_BY="Hermann Blessberger"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3145566"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3145565"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Miller-1991" MODIFIED="2011-05-15 16:49:31 +0100" MODIFIED_BY="Hermann Blessberger" NAME="Miller 1991" YEAR="1991">
<REFERENCE MODIFIED="2011-05-15 16:49:31 +0100" MODIFIED_BY="Hermann Blessberger" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Miller DR, Martineau RJ, Wynands JE, Hill J</AU>
<TI>Bolus administration of esmolol for controlling the haemodynamic response to tracheal intubation: the Canadian multicentre trial</TI>
<SO>Canadian Journal of Anesthesia</SO>
<YR>1991</YR>
<VL>38</VL>
<NO>7</NO>
<PG>849-58</PG>
<IDENTIFIERS MODIFIED="2010-09-03 13:00:15 +0100" MODIFIED_BY="Hermann Blessberger"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3145568"/><IDENTIFIER MODIFIED="2010-09-03 13:00:15 +0100" MODIFIED_BY="Hermann Blessberger" TYPE="PUBMED" VALUE="1683818 "/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3145567"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Mohr-1981" MODIFIED="2018-02-23 18:15:04 +0000" MODIFIED_BY="[Empty name]" NAME="Mohr 1981" YEAR="1981">
<REFERENCE MODIFIED="2018-02-23 18:15:04 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Mohr R, Smolinsky A, Goor DA</AU>
<TI>Prevention of supraventricular tachyarrhythmia with low-dose propranolol after coronary bypass</TI>
<SO>Journal of Thoracic and Cardiovascular Surgery</SO>
<YR>1981</YR>
<VL>81</VL>
<PG>840-5</PG>
<IDENTIFIERS MODIFIED="2010-09-03 13:09:24 +0100" MODIFIED_BY="Hermann Blessberger"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3145570"/><IDENTIFIER MODIFIED="2010-09-03 13:09:24 +0100" MODIFIED_BY="Hermann Blessberger" TYPE="PUBMED" VALUE="7015021"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3145569"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Moon-2011" MODIFIED="2018-02-23 18:15:04 +0000" MODIFIED_BY="[Empty name]" NAME="Moon 2011" YEAR="2011">
<REFERENCE MODIFIED="2018-02-23 18:15:04 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Moon YE, Hwang WJ, Koh HJ, Min JY, Lee J</AU>
<TI>The sparing effect of low-dose esmolol on sevoflurane during laparoscopic gynaecological surgery</TI>
<SO>Journal of International Medical Research</SO>
<YR>2011</YR>
<VL>39</VL>
<PG>1861-9</PG>
<IDENTIFIERS MODIFIED="2013-10-27 20:48:36 +0000" MODIFIED_BY="Hermann Blessberger"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3145572"/><IDENTIFIER MODIFIED="2013-10-27 20:48:36 +0000" MODIFIED_BY="Hermann Blessberger" TYPE="PUBMED" VALUE=" 22117987 "/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3145571"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Myhre-1984" MODIFIED="2010-09-03 13:10:19 +0100" MODIFIED_BY="Hermann Blessberger" NAME="Myhre 1984" YEAR="1984">
<REFERENCE MODIFIED="2010-09-03 13:10:19 +0100" MODIFIED_BY="Hermann Blessberger" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Myhre ESP, Sorlie D, AArbakke J, Hals PA, Straume B</AU>
<TI>Effects of low dose propranolol after coronary bypass surgery</TI>
<SO>Journal of Cardiovascular Surgery</SO>
<YR>1984</YR>
<VL>25</VL>
<PG>348-51</PG>
<IDENTIFIERS MODIFIED="2010-09-03 13:10:19 +0100" MODIFIED_BY="Hermann Blessberger"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3145574"/><IDENTIFIER MODIFIED="2010-09-03 13:10:19 +0100" MODIFIED_BY="Hermann Blessberger" TYPE="PUBMED" VALUE="6148345"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3145573"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Neary-2006" MODIFIED="2011-05-22 09:04:33 +0100" MODIFIED_BY="Hermann Blessberger" NAME="Neary 2006" YEAR="2006">
<REFERENCE MODIFIED="2011-05-22 09:04:33 +0100" MODIFIED_BY="Hermann Blessberger" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Neary WD, McCrirrick A, Foy C, Heather BP, Earnshaw JJ</AU>
<TI>Lessons learned from a randomised controlled study of perioperative beta blockade in high risk patients undergoing emergency surgery</TI>
<SO>Surgeon</SO>
<YR>2006</YR>
<VL>4</VL>
<NO>3</NO>
<PG>139-43</PG>
<IDENTIFIERS MODIFIED="2011-05-22 09:02:55 +0100" MODIFIED_BY="Hermann Blessberger"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3145576"/><IDENTIFIER MODIFIED="2011-05-22 09:02:55 +0100" MODIFIED_BY="Hermann Blessberger" TYPE="PUBMED" VALUE="16764198"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3145575"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Neustein-1994" MODIFIED="2010-09-03 13:10:57 +0100" MODIFIED_BY="Hermann Blessberger" NAME="Neustein 1994" YEAR="1994">
<REFERENCE MODIFIED="2010-09-03 13:10:57 +0100" MODIFIED_BY="Hermann Blessberger" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Neustein SM, Bronheim DS, Lasker S, Reich DL, Thys DM</AU>
<TI>Esmolol and intraoperative myocardial ischemia: a double-blind study</TI>
<SO>Journal of Cardiothoracic and Vascular Anesthesia</SO>
<YR>1994</YR>
<VL>8</VL>
<NO>3</NO>
<PG>273-7</PG>
<IDENTIFIERS MODIFIED="2010-09-03 13:10:57 +0100" MODIFIED_BY="Hermann Blessberger"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3145578"/><IDENTIFIER MODIFIED="2010-09-03 13:10:57 +0100" MODIFIED_BY="Hermann Blessberger" TYPE="PUBMED" VALUE="7914754"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3145577"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Nystr_x00f6_m-1993" MODIFIED="2018-02-23 18:15:04 +0000" MODIFIED_BY="[Empty name]" NAME="Nyström 1993" YEAR="1993">
<REFERENCE MODIFIED="2018-02-23 18:15:04 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Nyström U, Edvardsson N, Berggren H, Pizzarelli GP, Radergran K</AU>
<TI>Oral sotalol reduces the incidence of atrial fibrillation after coronary artery bypass surgery</TI>
<SO>Thoracic and Cardiovascular Surgeon</SO>
<YR>1993</YR>
<VL>41</VL>
<PG>34-7</PG>
<IDENTIFIERS MODIFIED="2010-09-03 13:11:33 +0100" MODIFIED_BY="Hermann Blessberger"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3145580"/><IDENTIFIER MODIFIED="2010-09-03 13:11:33 +0100" MODIFIED_BY="Hermann Blessberger" TYPE="PUBMED" VALUE="8103611"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3145579"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Ogawa-2013" MODIFIED="2013-10-29 20:59:54 +0000" MODIFIED_BY="Hermann Blessberger" NAME="Ogawa 2013" YEAR="2013">
<REFERENCE MODIFIED="2013-10-29 20:59:54 +0000" MODIFIED_BY="Hermann Blessberger" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Ogawa S, Okawa Y, Goto Y, Aoki M, Baba H</AU>
<TI>Perioperative use of beta blocker in coronary artery bypass grafting</TI>
<SO>Asian Cardiovascular and Thoracic Annals</SO>
<YR>2013</YR>
<VL>21</VL>
<NO>3</NO>
<PG>265-9</PG>
<IDENTIFIERS MODIFIED="2013-10-29 20:59:54 +0000" MODIFIED_BY="Hermann Blessberger"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3145582"/><IDENTIFIER MODIFIED="2013-10-29 20:59:54 +0000" MODIFIED_BY="Hermann Blessberger" TYPE="DOI" VALUE="10.1177/0218492312451166 "/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3145581"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Oka-1980" MODIFIED="2011-07-31 19:50:04 +0100" MODIFIED_BY="Hermann Blessberger" NAME="Oka 1980" YEAR="1980">
<REFERENCE MODIFIED="2011-07-31 19:50:04 +0100" MODIFIED_BY="Hermann Blessberger" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Oka Y, Frishman W, Becker RM, Kadish A, Strom J, Matsumoto M, et al</AU>
<TI>Clinical pharmacology of the new beta-adrenergic blocking drugs. Part 10. Beta-adrenoceptor blockade and coronary artery surgery</TI>
<SO>American Heart Journal</SO>
<YR>1980</YR>
<VL>99</VL>
<NO>2</NO>
<PG>255-69</PG>
<IDENTIFIERS MODIFIED="2010-09-03 13:12:12 +0100" MODIFIED_BY="Hermann Blessberger"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3145584"/><IDENTIFIER MODIFIED="2010-09-03 13:12:12 +0100" MODIFIED_BY="Hermann Blessberger" TYPE="PUBMED" VALUE="6101516"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3145583"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Ormerod-1984" MODIFIED="2010-09-03 13:12:54 +0100" MODIFIED_BY="Hermann Blessberger" NAME="Ormerod 1984" YEAR="1984">
<REFERENCE MODIFIED="2010-09-03 13:12:54 +0100" MODIFIED_BY="Hermann Blessberger" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Ormerod OJM, McGregor CGA, Stone DL, Wisbey C, Petch MC</AU>
<TI>Arrhythmias after coronary bypass surgery</TI>
<SO>British Heart Journal</SO>
<YR>1984</YR>
<VL>51</VL>
<PG>618-21</PG>
<IDENTIFIERS MODIFIED="2010-09-03 13:12:54 +0100" MODIFIED_BY="Hermann Blessberger"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3145586"/><IDENTIFIER MODIFIED="2010-09-03 13:12:54 +0100" MODIFIED_BY="Hermann Blessberger" TYPE="PUBMED" VALUE="6610435"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3145585"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Osada-2012" MODIFIED="2013-10-29 20:21:12 +0000" MODIFIED_BY="Hermann Blessberger" NAME="Osada 2012" YEAR="2012">
<REFERENCE MODIFIED="2013-10-29 20:21:12 +0000" MODIFIED_BY="Hermann Blessberger" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Osada H, Nakajima H, Masuyama S, Morishima M, Su T</AU>
<TI>Landiolol hydrochloride: prevention of atrial fibrillation after open-heart surgery</TI>
<SO>European Heart Journal</SO>
<YR>2012</YR>
<VL>33</VL>
<NO>Suppl 1</NO>
<PG>65</PG>
<IDENTIFIERS MODIFIED="2013-10-29 20:21:12 +0000" MODIFIED_BY="Hermann Blessberger"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3145588"/><IDENTIFIER MODIFIED="2013-10-29 20:21:12 +0000" MODIFIED_BY="Hermann Blessberger" TYPE="DOI" VALUE="10.1093/eurheartj/ehs281 "/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3145587"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Oxorn-1990" MODIFIED="2010-09-03 13:13:36 +0100" MODIFIED_BY="Hermann Blessberger" NAME="Oxorn 1990" YEAR="1990">
<REFERENCE MODIFIED="2010-09-03 13:13:36 +0100" MODIFIED_BY="Hermann Blessberger" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Oxorn D, Know JWD, Hill J</AU>
<TI>Bolus doses of esmolol for the prevention of perioperative hypertension and tachycardia</TI>
<SO>Canadian Journal of Anaesthesiology</SO>
<YR>1990</YR>
<VL>37</VL>
<NO>2</NO>
<PG>206-9</PG>
<IDENTIFIERS MODIFIED="2010-09-03 13:13:36 +0100" MODIFIED_BY="Hermann Blessberger"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3145590"/><IDENTIFIER MODIFIED="2010-09-03 13:13:36 +0100" MODIFIED_BY="Hermann Blessberger" TYPE="PUBMED" VALUE="1968784"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3145589"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Paull-1997" MODIFIED="2011-07-31 19:49:49 +0100" MODIFIED_BY="Hermann Blessberger" NAME="Paull 1997" YEAR="1997">
<REFERENCE MODIFIED="2011-07-31 19:49:49 +0100" MODIFIED_BY="Hermann Blessberger" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Paull DL, Tidwell SL, Guyton SW, Harvey E, Woolf RA, Holmes JR, et al</AU>
<TI>Beta-blockade to prevent atrial dysrhythmias following coronary bypass surgery</TI>
<SO>American Journal of Surgery</SO>
<YR>1997</YR>
<VL>173</VL>
<PG>419-21</PG>
<IDENTIFIERS MODIFIED="2010-09-03 13:14:35 +0100" MODIFIED_BY="Hermann Blessberger"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3145592"/><IDENTIFIER MODIFIED="2010-09-03 13:14:35 +0100" MODIFIED_BY="Hermann Blessberger" TYPE="PUBMED" VALUE="9168080"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3145591"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Pfisterer-1997" MODIFIED="2011-07-31 19:49:39 +0100" MODIFIED_BY="Hermann Blessberger" NAME="Pfisterer 1997" YEAR="1997">
<REFERENCE MODIFIED="2011-07-31 19:49:39 +0100" MODIFIED_BY="Hermann Blessberger" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Pfister ME, Klöter-Weber UC, Huber M, Osswald S, Buser PT, Skarvan K, et al</AU>
<TI>Prevention of supraventricular tachyarrhythmias after open heart operation by low-dose sotalol: a prospective, double-blind, randomized, placebo-controlled study</TI>
<SO>Annals of Thoracic Surgery</SO>
<YR>1997</YR>
<VL>64</VL>
<PG>1113-9</PG>
<IDENTIFIERS MODIFIED="2010-09-03 13:15:55 +0100" MODIFIED_BY="Hermann Blessberger"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3145594"/><IDENTIFIER MODIFIED="2010-09-03 13:15:55 +0100" MODIFIED_BY="Hermann Blessberger" TYPE="PUBMED" VALUE="9354537"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3145593"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-POBBLE-2005" MODIFIED="2010-09-03 13:18:41 +0100" MODIFIED_BY="Hermann Blessberger" NAME="POBBLE 2005" YEAR="2005">
<REFERENCE MODIFIED="2010-09-03 13:18:41 +0100" MODIFIED_BY="Hermann Blessberger" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Brady AR, Gibbs JS, Greenhalgh RM, Powell JT, Sydes MR; POBBLE trial investigators</AU>
<TI>Perioperative beta-blockade (POBBLE) for patients undergoing infrarenal vascular surgery: results of a randomized double-blind controlled trial</TI>
<SO>Journal of Vascular Surgery</SO>
<YR>2005</YR>
<VL>41</VL>
<NO>4</NO>
<PG>602-9</PG>
<IDENTIFIERS MODIFIED="2010-09-03 13:18:41 +0100" MODIFIED_BY="Hermann Blessberger"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3145596"/><IDENTIFIER MODIFIED="2010-09-03 13:18:41 +0100" MODIFIED_BY="Hermann Blessberger" TYPE="PUBMED" VALUE="15874923"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3145595"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-POISE-2008" MODIFIED="2011-07-31 19:45:25 +0100" MODIFIED_BY="Hermann Blessberger" NAME="POISE 2008" YEAR="2008">
<REFERENCE MODIFIED="2011-07-31 19:45:25 +0100" MODIFIED_BY="Hermann Blessberger" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Devereaux PJ, Yang H, Yusuf S, Guyatt G, Leslie K, Villar JC, et al</AU>
<TI>Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial): a randomised controlled trial</TI>
<SO>Lancet</SO>
<YR>2008</YR>
<VL>371</VL>
<PG>1839-47</PG>
<IDENTIFIERS MODIFIED="2010-09-03 13:19:19 +0100" MODIFIED_BY="Hermann Blessberger"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3145598"/><IDENTIFIER MODIFIED="2010-09-03 13:19:19 +0100" MODIFIED_BY="Hermann Blessberger" TYPE="PUBMED" VALUE="18479744"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2009-09-13 11:05:33 +0100" MODIFIED_BY="Hermann Blessberger"><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3145597"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Raby-1999" MODIFIED="2011-07-31 19:45:38 +0100" MODIFIED_BY="Hermann Blessberger" NAME="Raby 1999" YEAR="1999">
<REFERENCE MODIFIED="2011-07-31 19:45:38 +0100" MODIFIED_BY="Hermann Blessberger" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Raby KE, Brull SJ, Timimi F, Akhtar S, Rosenbaum S, Naimi C, et al</AU>
<TI>The effect of heart rate control on myocardial ischemia among high-risk patients after vascular surgery</TI>
<SO>Anesthesia and Analgesia</SO>
<YR>1999</YR>
<VL>88</VL>
<PG>477-82</PG>
<IDENTIFIERS MODIFIED="2010-09-03 13:21:56 +0100" MODIFIED_BY="Hermann Blessberger"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3145600"/><IDENTIFIER MODIFIED="2010-09-03 13:21:56 +0100" MODIFIED_BY="Hermann Blessberger" TYPE="PUBMED" VALUE="10071990"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3145599"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Reves-1990" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" NAME="Reves 1990" YEAR="1990">
<REFERENCE MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Reves JG, Croughwell ND, Hawkins E, Smith LR, Jacobs JR, Rankin S, et al</AU>
<TI>Esmolol for treatment of intraoperative tachycardia and/or hypertension in patients having cardiac operations. Bolus loading technique</TI>
<SO>Journal of Thoracic and Cardiovascular Surgery</SO>
<YR>1990</YR>
<VL>100</VL>
<PG>221-7</PG>
<IDENTIFIERS MODIFIED="2010-09-03 13:24:27 +0100" MODIFIED_BY="Hermann Blessberger"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3145602"/><IDENTIFIER MODIFIED="2010-09-03 13:24:27 +0100" MODIFIED_BY="Hermann Blessberger" TYPE="PUBMED" VALUE="1974664"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3145601"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Rubin-1987" MODIFIED="2010-09-03 13:24:57 +0100" MODIFIED_BY="Hermann Blessberger" NAME="Rubin 1987" YEAR="1987">
<REFERENCE MODIFIED="2010-09-03 13:24:57 +0100" MODIFIED_BY="Hermann Blessberger" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Rubin DA, Nieminski KE, Reed GE, Herman MV</AU>
<TI>Predictors, prevention, and long-term prognosis of atrial fibrillation after coronary artery bypass graft operation</TI>
<SO>Journal of Thoracic and Cardiovascular Surgery</SO>
<YR>1987</YR>
<VL>94</VL>
<PG>331-5</PG>
<IDENTIFIERS MODIFIED="2010-09-03 13:24:57 +0100" MODIFIED_BY="Hermann Blessberger"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3145604"/><IDENTIFIER MODIFIED="2010-09-03 13:24:57 +0100" MODIFIED_BY="Hermann Blessberger" TYPE="PUBMED" VALUE="3306163"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3145603"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Sakaguchi-2012" MODIFIED="2013-10-27 21:46:04 +0000" MODIFIED_BY="Hermann Blessberger" NAME="Sakaguchi 2012" YEAR="2012">
<REFERENCE MODIFIED="2013-10-27 21:45:58 +0000" MODIFIED_BY="Hermann Blessberger" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Sakaguchi M, Sasaki Y, Hidekazu H, Hosono M, Nakahira A, Seo H, et al</AU>
<TI>Efficacy of landiolol hydrochloride for prevention of atrial fibrillation after heart valve surgery</TI>
<SO>International Heart Journal</SO>
<YR>2012</YR>
<VL>53</VL>
<NO>6</NO>
<PG>359-63</PG>
<IDENTIFIERS MODIFIED="2013-10-27 21:44:41 +0000" MODIFIED_BY="Hermann Blessberger"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3145606"/><IDENTIFIER MODIFIED="2013-10-27 21:44:41 +0000" MODIFIED_BY="Hermann Blessberger" TYPE="PUBMED" VALUE=" 23258136"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3145605"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Salazar-1979" MODIFIED="2011-07-31 19:45:58 +0100" MODIFIED_BY="Hermann Blessberger" NAME="Salazar 1979" YEAR="1979">
<REFERENCE MODIFIED="2011-07-31 19:45:58 +0100" MODIFIED_BY="Hermann Blessberger" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Salazar C, Frishman W, Friedman S, Patel J, Lin YT, Oka Y, et al</AU>
<TI>Beta-blockade therapy for supraventricular tachyarrhythmias after coronary surgery: a propranolol withdrawal syndrome?</TI>
<SO>Angiology</SO>
<YR>1979</YR>
<VL>30</VL>
<NO>12</NO>
<PG>816-9</PG>
<IDENTIFIERS MODIFIED="2010-09-03 13:25:44 +0100" MODIFIED_BY="Hermann Blessberger"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3145608"/><IDENTIFIER MODIFIED="2010-09-03 13:25:44 +0100" MODIFIED_BY="Hermann Blessberger" TYPE="PUBMED" VALUE="316976"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3145607"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Sandler-1990" MODIFIED="2018-02-22 17:05:28 +0000" MODIFIED_BY="[Empty name]" NAME="Sandler 1990" YEAR="1990">
<REFERENCE MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Sandler AN, Leitch LF, Badner NH, Colmenares M, Kimball B</AU>
<TI>Esmolol compared with placebo in preventing increases in heart rate and blood pressure during rigid bronchoscopy</TI>
<SO>Journal of Cardiothoracic Anesthesia</SO>
<YR>1990</YR>
<VL>4</VL>
<NO>5 Suppl 2</NO>
<PG>44-50</PG>
<IDENTIFIERS MODIFIED="2010-09-03 13:27:31 +0100" MODIFIED_BY="Hermann Blessberger"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3145610"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3145609"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Sezai-2011" MODIFIED="2018-02-23 18:15:04 +0000" MODIFIED_BY="[Empty name]" NAME="Sezai 2011" YEAR="2011">
<REFERENCE MODIFIED="2018-02-23 18:15:04 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Sezai A, Minami K, Nakai T, Hata M, Yoshitake I, Wakui S, et al</AU>
<TI>Landiolol hydrochloride for prevention of atrial fibrillation after coronary artery bypass grafting: new evidence from the PASCAL trial</TI>
<SO>Journal of Thoracic and Cardiovascular Surgery</SO>
<YR>2011</YR>
<VL>141</VL>
<NO>6</NO>
<PG>1478-87</PG>
<IDENTIFIERS MODIFIED="2013-10-29 17:51:05 +0000" MODIFIED_BY="Hermann Blessberger"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3145612"/><IDENTIFIER MODIFIED="2013-10-29 17:51:05 +0000" MODIFIED_BY="Hermann Blessberger" TYPE="PUBMED" VALUE="21269646"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3145611"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Sezai-2012" MODIFIED="2018-02-23 18:15:04 +0000" MODIFIED_BY="[Empty name]" NAME="Sezai 2012" YEAR="2012">
<REFERENCE MODIFIED="2018-02-23 18:15:04 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Sezai A, Nakai T, Hata M, Yoshitake I, Shiono M, Kunimoto S, et al</AU>
<TI>Feasibility of landiolol and bisoprolol for prevention of atrial fibrillation after coronary artery bypass grafting: a pilot study</TI>
<SO>Journal of Thoracic and Cardiovascular Surgery</SO>
<YR>2012</YR>
<VL>144</VL>
<NO>5</NO>
<PG>1241-8</PG>
<IDENTIFIERS MODIFIED="2013-10-29 18:18:42 +0000" MODIFIED_BY="Hermann Blessberger"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3145614"/><IDENTIFIER MODIFIED="2013-10-29 18:18:42 +0000" MODIFIED_BY="Hermann Blessberger" TYPE="PUBMED" VALUE="22858430"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3145613"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Shukla-2010" MODIFIED="2018-02-23 18:15:04 +0000" MODIFIED_BY="[Empty name]" NAME="Shukla 2010" YEAR="2010">
<REFERENCE MODIFIED="2018-02-23 18:15:04 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Shukla S, Gupta K, Gurha P, Sharma M, Sanjay RR, Shukla R, et al</AU>
<TI>Role of &#946; blockade in anaesthesia and postoperative pain management after major lower abdominal surgery</TI>
<SO>Internet Journal of Anesthesiology</SO>
<YR>2010</YR>
<VL>25</VL>
<NO>1</NO>
<PG>pagination not available</PG>
<IDENTIFIERS MODIFIED="2013-10-29 19:32:13 +0000" MODIFIED_BY="Hermann Blessberger"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3145616"/><IDENTIFIER MODIFIED="2013-10-29 19:30:24 +0000" MODIFIED_BY="Hermann Blessberger" TYPE="DOI" VALUE="10.5580/170f"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3145615"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Silverman-1982" MODIFIED="2010-09-03 13:28:42 +0100" MODIFIED_BY="Hermann Blessberger" NAME="Silverman 1982" YEAR="1982">
<REFERENCE MODIFIED="2010-09-03 13:28:42 +0100" MODIFIED_BY="Hermann Blessberger" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Silverman NA, Wright R, Levitsky S</AU>
<TI>Efficacy of low-dose propranolol in preventing postoperative supraventricular tachyarrhythmias: a prospective, randomized study</TI>
<SO>Annals of Surgery</SO>
<YR>1982</YR>
<VL>196</VL>
<NO>2</NO>
<PG>194-7</PG>
<IDENTIFIERS MODIFIED="2010-09-03 13:28:42 +0100" MODIFIED_BY="Hermann Blessberger"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3145618"/><IDENTIFIER MODIFIED="2010-09-03 13:28:42 +0100" MODIFIED_BY="Hermann Blessberger" TYPE="PUBMED" VALUE="6979982"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3145617"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Stephenson-1980" MODIFIED="2018-02-23 18:15:04 +0000" MODIFIED_BY="[Empty name]" NAME="Stephenson 1980" YEAR="1980">
<REFERENCE MODIFIED="2018-02-23 18:15:04 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Stephenson LW, MacVaugh H, Tomasello DN, Josephson ME</AU>
<TI>Propranolol for prevention of postoperative cardiac arrhythmias: a randomized study</TI>
<SO>Annals of Thoracic Surgery</SO>
<YR>1980</YR>
<VL>29</VL>
<NO>2</NO>
<PG>113-6</PG>
<IDENTIFIERS MODIFIED="2010-09-03 13:29:31 +0100" MODIFIED_BY="Hermann Blessberger"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3145620"/><IDENTIFIER MODIFIED="2010-09-03 13:29:31 +0100" MODIFIED_BY="Hermann Blessberger" TYPE="PUBMED" VALUE="6965579"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3145619"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Stone-1988" MODIFIED="2010-09-03 13:30:30 +0100" MODIFIED_BY="Hermann Blessberger" NAME="Stone 1988" YEAR="1988">
<REFERENCE MODIFIED="2010-09-03 13:30:30 +0100" MODIFIED_BY="Hermann Blessberger" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Stone JG, Foex P, Sear JW, Johnson LL, Khambatta HJ, Triner L</AU>
<TI>Myocardial ischemia in untreated hypertensive patients: effect of a single small oral dose of a beta-adrenergic blocking agent</TI>
<SO>Anesthesiology</SO>
<YR>1988</YR>
<VL>68</VL>
<PG>495-500</PG>
<IDENTIFIERS MODIFIED="2010-09-03 13:30:30 +0100" MODIFIED_BY="Hermann Blessberger"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3145622"/><IDENTIFIER MODIFIED="2010-09-03 13:30:30 +0100" MODIFIED_BY="Hermann Blessberger" TYPE="PUBMED" VALUE="2895596"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3145621"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Sun-2011" MODIFIED="2013-11-17 15:32:09 +0000" MODIFIED_BY="Hermann Blessberger" NAME="Sun 2011" YEAR="2011">
<REFERENCE MODIFIED="2013-11-17 15:32:09 +0000" MODIFIED_BY="Hermann Blessberger" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Sun J, Ding Z, Qian Y</AU>
<TI>Effect of short-acting beta blocker on the cardiac recovery after cardiopulmonary bypass</TI>
<SO>Journal of Cardiothoracic Surgery</SO>
<YR>2011</YR>
<VL>6</VL>
<NO>99</NO>
<PG>pagination not available</PG>
<IDENTIFIERS MODIFIED="2013-11-17 15:31:33 +0000" MODIFIED_BY="Hermann Blessberger"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3145624"/><IDENTIFIER MODIFIED="2013-10-29 19:53:46 +0000" MODIFIED_BY="Hermann Blessberger" TYPE="DOI" VALUE="10.1186/1749-8090-6-99"/><IDENTIFIER MODIFIED="2013-11-17 15:31:33 +0000" MODIFIED_BY="Hermann Blessberger" TYPE="PUBMED" VALUE=" 21854625"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3145623"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Suttorp-1991" MODIFIED="2011-07-31 19:49:05 +0100" MODIFIED_BY="Hermann Blessberger" NAME="Suttorp 1991" YEAR="1991">
<REFERENCE MODIFIED="2011-07-31 19:49:05 +0100" MODIFIED_BY="Hermann Blessberger" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Suttorp MJ, Kingma JH, Peels HO, Koomen EM, Tijssen JG, van Hemel NM, et al</AU>
<TI>Effectiveness of sotalol in preventing supraventricular tachyarrhythmias shortly after coronary artery bypass grafting</TI>
<SO>American Journal of Cardiology</SO>
<YR>1991</YR>
<VL>68</VL>
<PG>1163-9</PG>
<IDENTIFIERS MODIFIED="2010-09-05 00:44:05 +0100" MODIFIED_BY="Hermann Blessberger"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3145628"/><IDENTIFIER MODIFIED="2010-09-05 00:44:05 +0100" MODIFIED_BY="Hermann Blessberger" TYPE="PUBMED" VALUE="1951075"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3145627"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Vecht-1986" MODIFIED="2010-09-03 13:33:16 +0100" MODIFIED_BY="Hermann Blessberger" NAME="Vecht 1986" YEAR="1986">
<REFERENCE MODIFIED="2010-09-03 13:33:16 +0100" MODIFIED_BY="Hermann Blessberger" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Vecht RJ, Nicolaides EP, Ikeuke JK, Liassides C, Cleary J, Cooper WB</AU>
<TI>Incidence and prevention of supraventricular tachyarrhythmias after coronary bypass surgery</TI>
<SO>International Journal of Cardiology</SO>
<YR>1986</YR>
<VL>13</VL>
<PG>125-34</PG>
<IDENTIFIERS MODIFIED="2010-09-03 13:33:16 +0100" MODIFIED_BY="Hermann Blessberger"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3145630"/><IDENTIFIER MODIFIED="2010-09-03 13:33:16 +0100" MODIFIED_BY="Hermann Blessberger" TYPE="PUBMED" VALUE="3539826"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3145629"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Wallace-1998" MODIFIED="2011-07-31 19:48:37 +0100" MODIFIED_BY="Hermann Blessberger" NAME="Wallace 1998" YEAR="1998">
<REFERENCE MODIFIED="2011-07-31 19:48:37 +0100" MODIFIED_BY="Hermann Blessberger" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Wallace A, Layug B, Tateo I, Li J, Hollenberg M, Browner W, et al</AU>
<TI>Prophylactic atenolol reduces postoperative myocardial ischemia. McSPI Research Group</TI>
<SO>Anesthesiology</SO>
<YR>1998</YR>
<VL>88</VL>
<NO>1</NO>
<PG>7-17</PG>
<IDENTIFIERS MODIFIED="2010-09-03 13:33:47 +0100" MODIFIED_BY="Hermann Blessberger"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3145632"/><IDENTIFIER MODIFIED="2010-09-03 13:33:47 +0100" MODIFIED_BY="Hermann Blessberger" TYPE="PUBMED" VALUE="9447850"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3145631"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Wenke-1999" MODIFIED="2010-09-03 13:34:54 +0100" MODIFIED_BY="Hermann Blessberger" NAME="Wenke 1999" YEAR="1999">
<REFERENCE MODIFIED="2010-09-03 13:34:54 +0100" MODIFIED_BY="Hermann Blessberger" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Wenke K, Parsa MHA, Imhof M, Kemkes BM</AU>
<TI>Efficacy of metoprolol in prevention of supraventricular arrhythmias after coronary artery bypass grafting</TI>
<TO>Wirksamkeit der Metoprolol-Therapie in der Prävention supraventrikulärer Arrhythmien nach koronarer Bypass-Operation</TO>
<SO>Zeitschrift für Kardiologie</SO>
<YR>1999</YR>
<VL>88</VL>
<PG>647-52</PG>
<IDENTIFIERS MODIFIED="2010-09-03 13:34:54 +0100" MODIFIED_BY="Hermann Blessberger"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3145634"/><IDENTIFIER MODIFIED="2010-09-03 13:34:54 +0100" MODIFIED_BY="Hermann Blessberger" TYPE="PUBMED" VALUE="10525926"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3145633"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-White-1984" MODIFIED="2011-07-31 19:46:15 +0100" MODIFIED_BY="Hermann Blessberger" NAME="White 1984" YEAR="1984">
<REFERENCE MODIFIED="2011-07-31 19:46:15 +0100" MODIFIED_BY="Hermann Blessberger" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>White HD, Antman EM, Glynn MA, Collins JJ, Cohn LH, Shemin RJ, et al</AU>
<TI>Efficacy and safety of timolol for prevention of supraventricular tachyarrhythmias after coronary artery bypass surgery</TI>
<SO>Circulation</SO>
<YR>1984</YR>
<VL>70</VL>
<PG>479-84</PG>
<IDENTIFIERS MODIFIED="2010-09-03 13:35:25 +0100" MODIFIED_BY="Hermann Blessberger"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3145636"/><IDENTIFIER MODIFIED="2010-09-03 13:35:25 +0100" MODIFIED_BY="Hermann Blessberger" TYPE="PUBMED" VALUE="6378423"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3145635"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Whitehead-1980" MODIFIED="2010-09-03 13:36:11 +0100" MODIFIED_BY="Hermann Blessberger" NAME="Whitehead 1980" YEAR="1980">
<REFERENCE MODIFIED="2010-09-03 13:36:11 +0100" MODIFIED_BY="Hermann Blessberger" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Whitehead MH, Whitmarsh VB, Horton JN</AU>
<TI>Metoprolol in anaesthesia for oral surgery</TI>
<SO>Anaesthesia</SO>
<YR>1980</YR>
<VL>35</VL>
<PG>779-82</PG>
<IDENTIFIERS MODIFIED="2010-09-03 13:36:11 +0100" MODIFIED_BY="Hermann Blessberger"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3145638"/><IDENTIFIER MODIFIED="2010-09-03 13:36:11 +0100" MODIFIED_BY="Hermann Blessberger" TYPE="PUBMED" VALUE="7004258"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3145637"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Williams-1982" MODIFIED="2018-02-23 18:15:04 +0000" MODIFIED_BY="[Empty name]" NAME="Williams 1982" YEAR="1982">
<REFERENCE MODIFIED="2018-02-23 18:15:04 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Williams JB, Stephenson LW, Holford FD, Langer T, Dunkman WB, Josephson ME</AU>
<TI>Arrhythmia prophylaxis using propranolol after coronary artery surgery</TI>
<SO>Annals of Throacic Surgery</SO>
<YR>1982</YR>
<VL>34</VL>
<NO>4</NO>
<PG>435-8</PG>
<IDENTIFIERS MODIFIED="2010-09-03 13:36:39 +0100" MODIFIED_BY="Hermann Blessberger"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3145640"/><IDENTIFIER MODIFIED="2010-09-03 13:36:39 +0100" MODIFIED_BY="Hermann Blessberger" TYPE="PUBMED" VALUE="6982689 "/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3145639"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Yang-2006" MODIFIED="2011-05-08 07:54:54 +0100" MODIFIED_BY="Hermann Blessberger" NAME="Yang 2006" YEAR="2006">
<REFERENCE MODIFIED="2011-05-08 07:54:54 +0100" MODIFIED_BY="Hermann Blessberger" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Yang H, Raymer K, Butler R, Parlow J, Roberts R, Tech M</AU>
<TI>The effects of perioperative beta-blockade: results of the metoprolol after vascular surgery (MaVS) study, a randomized controlled trial</TI>
<SO>American Heart Journal</SO>
<YR>2006</YR>
<VL>152</VL>
<PG>983-90</PG>
<IDENTIFIERS MODIFIED="2011-05-08 07:54:54 +0100" MODIFIED_BY="Hermann Blessberger"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3145642"/><IDENTIFIER MODIFIED="2011-05-08 07:54:52 +0100" MODIFIED_BY="Hermann Blessberger" TYPE="PUBMED" VALUE="17070177"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3145641"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Yang-2008" MODIFIED="2011-05-22 17:10:52 +0100" MODIFIED_BY="Hermann Blessberger" NAME="Yang 2008" YEAR="2008">
<REFERENCE MODIFIED="2011-05-22 17:10:52 +0100" MODIFIED_BY="Hermann Blessberger" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Yang X, Wu X, Wang S, Wang Q</AU>
<TI>Effects of metoprolol on perioperative cardiovascular events in patients with risk or at high risk for coronary artery disease undergoing non-cardiac surgery</TI>
<SO>Chinese Medical Journal (Zhonghua Yi Xue Za Zhi)</SO>
<YR>2008</YR>
<VL>88</VL>
<NO>21</NO>
<PG>1476-80</PG>
<IDENTIFIERS MODIFIED="2011-05-22 15:51:48 +0100" MODIFIED_BY="Hermann Blessberger"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3145644"/><IDENTIFIER MODIFIED="2011-05-22 15:51:48 +0100" MODIFIED_BY="Hermann Blessberger" TYPE="PUBMED" VALUE=" 18953854"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3145643"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Zaugg-1999" MODIFIED="2011-05-22 08:20:36 +0100" MODIFIED_BY="Hermann Blessberger" NAME="Zaugg 1999" YEAR="1999">
<REFERENCE MODIFIED="2011-05-22 08:20:36 +0100" MODIFIED_BY="Hermann Blessberger" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Zaugg M, Tagliente T, Lucchinetti E, Jacobs E, Drol M, Bodian C, et al</AU>
<TI>Beneficial effects from beta-adrenergic blockade in elderly patients undergoing noncardiac surgery</TI>
<SO>Anesthesiology</SO>
<YR>1999</YR>
<VL>91</VL>
<PG>1674-86</PG>
<IDENTIFIERS MODIFIED="2010-09-03 13:38:43 +0100" MODIFIED_BY="Hermann Blessberger"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3145646"/><IDENTIFIER MODIFIED="2010-09-03 13:38:43 +0100" MODIFIED_BY="Hermann Blessberger" TYPE="PUBMED" VALUE="10598610"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3145645"/></IDENTIFIERS>
</STUDY>
</INCLUDED_STUDIES>
<EXCLUDED_STUDIES MODIFIED="2017-10-28 00:46:08 +0100" MODIFIED_BY="Hermann Blessberger">
<STUDY DATA_SOURCE="PUB" ID="STD-DECREASE_x002d_IV-2009" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" NAME="DECREASE-IV 2009" YEAR="2009">
<REFERENCE MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Dunkelgrun M, Boersma E, Schouten O, Koopman-van Gemert AWMM, van Poorten F, Bax JJ, et al</AU>
<TI>Bisoprolol and fluvastatin for the reduction of perioperative cardiac mortality and myocardial infarction in intermediate-risk patients undergoing noncardiovascular surgery&#8212;A randomized controlled trial (DECREASE-IV)</TI>
<SO>Annals of Surgery</SO>
<YR>2009</YR>
<VL>249</VL>
<PG>921-6</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3145648"/><IDENTIFIER TYPE="PUBMED" VALUE="19474688"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3145647"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kl_x00f6_ter_x002d_Weber-1998" MODIFIED="2011-05-15 16:43:37 +0100" MODIFIED_BY="Hermann Blessberger" NAME="Klöter-Weber 1998" YEAR="1998">
<REFERENCE MODIFIED="2011-05-15 16:43:37 +0100" MODIFIED_BY="Hermann Blessberger" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Klöter-Weber U, Osswald S, Buser P, Huber M, Skarvan K, Stulz P, et al</AU>
<TI>Significance of supraventricular tachyarrhythmias after coronary artery bypass graft surgery and their prevention by low-dose sotalol: a prospective double-blind randomized placebo-controlled study</TI>
<SO>Journal of Cardiovascular Pharmacology and Therapeutics</SO>
<YR>1998</YR>
<VL>3</VL>
<NO>3</NO>
<PG>209-16</PG>
<IDENTIFIERS MODIFIED="2010-09-03 13:43:30 +0100" MODIFIED_BY="Hermann Blessberger"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3145650"/><IDENTIFIER MODIFIED="2010-09-03 13:43:30 +0100" MODIFIED_BY="Hermann Blessberger" TYPE="PUBMED" VALUE="10684499"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3145649"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Poldermans-1999" MODIFIED="2013-11-26 21:58:26 +0000" MODIFIED_BY="Hermann Blessberger" NAME="Poldermans 1999" YEAR="1999">
<REFERENCE MODIFIED="2013-11-26 21:58:26 +0000" MODIFIED_BY="Hermann Blessberger" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Poldermans D, Boersma E, Bax JJ, Thomson IR, van de Ven LL, Blankensteijn JD, et al</AU>
<TI>The effect of bisoprolol on perioperative mortality and myocardial infarction in high-risk patients undergoing vascular surgery</TI>
<SO>New England Journal of Medicine</SO>
<YR>1999</YR>
<VL>341</VL>
<NO>24</NO>
<PG>1789-94</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3145652"/><IDENTIFIER TYPE="PUBMED" VALUE="10588963"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3145651"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Suttner-2009" MODIFIED="2017-10-28 00:46:08 +0100" MODIFIED_BY="Hermann Blessberger" NAME="Suttner 2009" YEAR="2009">
<REFERENCE MODIFIED="2017-10-28 00:46:08 +0100" MODIFIED_BY="Hermann Blessberger" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Suttner S, Boldt J, Mengistu A, Lang K, Mayer J</AU>
<TI>Influence of continuous perioperative beta-blockade in combination with phosphodiesterase inhibition on haemodynamics and myocardial ischaemia in high-risk vascular surgery patients</TI>
<SO>British Journal of Anaesthesia</SO>
<YR>2009</YR>
<VL>102</VL>
<NO>5</NO>
<PG>597-607</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3145626"/><IDENTIFIER TYPE="PUBMED" VALUE="19336536"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3145625"/></IDENTIFIERS>
</STUDY>
</EXCLUDED_STUDIES>
<AWAITING_STUDIES/>
<ONGOING_STUDIES/>
</STUDIES>
<OTHER_REFERENCES MODIFIED="2018-02-23 18:15:04 +0000" MODIFIED_BY="[Empty name]">
<ADDITIONAL_REFERENCES MODIFIED="2018-02-23 18:15:04 +0000" MODIFIED_BY="[Empty name]">
<REFERENCE ID="REF-Bangalore-2008" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" NAME="Bangalore 2008" TYPE="JOURNAL_ARTICLE">
<AU>Bangalore S, Wetterslev J, Pranesh S, Sawhney S, Gluud C, Messerli FH</AU>
<TI>Perioperative &#946; blockers in patients having non-cardiac surgery: a meta-analysis</TI>
<SO>Lancet</SO>
<YR>2008</YR>
<VL>372</VL>
<PG>1962-76</PG>
<IDENTIFIERS MODIFIED="2011-06-26 22:06:42 +0100" MODIFIED_BY="Hermann Blessberger"><IDENTIFIER MODIFIED="2011-06-26 22:06:42 +0100" MODIFIED_BY="Hermann Blessberger" TYPE="PUBMED" VALUE="  19012955"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Bouri-2013" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" NAME="Bouri 2013" TYPE="JOURNAL_ARTICLE">
<AU>Bouri S, Shun-Shin MJ, Cole GD, Mayet J, Francis DP</AU>
<TI>Meta-analysis of secure randomised controlled trials of &#946;-blockade to prevent perioperative death in non-cardiac surgery</TI>
<SO>Heart</SO>
<YR>2014</YR>
<VL>100</VL>
<NO>6</NO>
<PG>456-64</PG>
<IDENTIFIERS MODIFIED="2013-12-09 08:39:10 +0000" MODIFIED_BY="Hermann Blessberger"><IDENTIFIER MODIFIED="2013-12-09 08:39:10 +0000" MODIFIED_BY="Hermann Blessberger" TYPE="DOI" VALUE="10.1136/heartjnl-2013-304262"/><IDENTIFIER MODIFIED="2013-12-09 08:37:00 +0000" MODIFIED_BY="Hermann Blessberger" TYPE="PUBMED" VALUE="23904357"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Chopra-2012" MODIFIED="2018-02-23 18:15:04 +0000" MODIFIED_BY="[Empty name]" NAME="Chopra 2012" TYPE="JOURNAL_ARTICLE">
<AU>Chopra V, Eagle KA</AU>
<TI>Perioperative mischief: the price of academic misconduct</TI>
<SO>American Journal of Medicine</SO>
<YR>2012</YR>
<VL>125</VL>
<NO>10</NO>
<PG>953-5</PG>
<IDENTIFIERS MODIFIED="2017-12-08 12:31:42 +0000" MODIFIED_BY="Hermann Blessberger"><IDENTIFIER MODIFIED="2017-12-08 12:31:42 +0000" MODIFIED_BY="Hermann Blessberger" TYPE="PUBMED" VALUE="22884175"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Crystal-2002" MODIFIED="2010-09-03 14:09:22 +0100" MODIFIED_BY="Hermann Blessberger" NAME="Crystal 2002" TYPE="JOURNAL_ARTICLE">
<AU>Crystal E, Connolly SJ, Sleik K, Ginger TJ, Yusuf S</AU>
<TI>Interventions on prevention of postoperative atrial fibrillation in patients undergoing heart surgery: a meta-analysis</TI>
<SO>Circulation</SO>
<YR>2002</YR>
<VL>106</VL>
<PG>75-80</PG>
<IDENTIFIERS MODIFIED="2010-09-03 14:09:22 +0100" MODIFIED_BY="Hermann Blessberger"><IDENTIFIER MODIFIED="2010-09-03 14:09:22 +0100" MODIFIED_BY="Hermann Blessberger" TYPE="PUBMED" VALUE="12093773"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-DerSimonian-1986" MODIFIED="2010-09-03 14:11:43 +0100" MODIFIED_BY="Hermann Blessberger" NAME="DerSimonian 1986" TYPE="JOURNAL_ARTICLE">
<AU>DerSimonian R, Laird N</AU>
<TI>Meta-analysis in clinical trials</TI>
<SO>Controlled Clinical Trials</SO>
<YR>1986</YR>
<VL>7</VL>
<NO>3</NO>
<PG>177-88</PG>
<IDENTIFIERS MODIFIED="2010-09-03 14:11:43 +0100" MODIFIED_BY="Hermann Blessberger"><IDENTIFIER MODIFIED="2010-09-03 14:11:43 +0100" MODIFIED_BY="Hermann Blessberger" TYPE="PUBMED" VALUE="3802833"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Devereaux-2004" MODIFIED="2010-09-03 14:12:26 +0100" MODIFIED_BY="Hermann Blessberger" NAME="Devereaux 2004" TYPE="JOURNAL_ARTICLE">
<AU>Devereaux PJ, Yusuf S, Yang H, Choi PTL, Guyatt GH</AU>
<TI>Are the recommendations to use perioperative beta-blocker therapy in patients undergoing noncardiac surgery based on reliable evidence?</TI>
<SO>Canadian Medical Association Journal</SO>
<YR>2004</YR>
<VL>171</VL>
<NO>3</NO>
<PG>245-7</PG>
<IDENTIFIERS MODIFIED="2010-09-03 14:12:26 +0100" MODIFIED_BY="Hermann Blessberger"><IDENTIFIER MODIFIED="2010-09-03 14:12:26 +0100" MODIFIED_BY="Hermann Blessberger" TYPE="PUBMED" VALUE="15289423"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Duval-2000" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" NAME="Duval 2000" TYPE="JOURNAL_ARTICLE">
<AU>Duval S, Tweedie R</AU>
<TI>Trim and fill: a simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis</TI>
<SO>Biometrics</SO>
<YR>2000</YR>
<VL>56</VL>
<NO>2</NO>
<PG>455-63</PG>
<IDENTIFIERS MODIFIED="2014-06-29 23:20:56 +0100" MODIFIED_BY="Hermann Blessberger"><IDENTIFIER MODIFIED="2014-06-29 23:20:56 +0100" MODIFIED_BY="Hermann Blessberger" TYPE="PUBMED" VALUE=" 10877304"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Egger-1997" MODIFIED="2011-05-15 16:40:38 +0100" MODIFIED_BY="Hermann Blessberger" NAME="Egger 1997" TYPE="JOURNAL_ARTICLE">
<AU>Egger M, Davey Smith G, Schneider M, Minder C</AU>
<TI>Bias in meta-analysis detected by a simple, graphical test</TI>
<SO>BMJ</SO>
<YR>1997</YR>
<VL>315</VL>
<NO>7109</NO>
<PG>629-34</PG>
<IDENTIFIERS MODIFIED="2010-09-03 14:14:44 +0100" MODIFIED_BY="Hermann Blessberger"><IDENTIFIER MODIFIED="2010-09-03 14:14:44 +0100" MODIFIED_BY="Hermann Blessberger" TYPE="PUBMED" VALUE="9310563"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Fihn-2012" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" NAME="Fihn 2012" TYPE="JOURNAL_ARTICLE">
<AU>Fihn SD, Gardin JM, Abrams J, Berra K, Blankenship JC, Dallas AP, et al</AU>
<TI>2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines, and the American College of Physicians, American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons</TI>
<SO>Circulation</SO>
<YR>2012</YR>
<VL>126</VL>
<NO>25</NO>
<PG>3097-137</PG>
<IDENTIFIERS MODIFIED="2014-04-10 00:20:47 +0100" MODIFIED_BY="Hermann Blessberger"><IDENTIFIER MODIFIED="2014-04-10 00:20:47 +0100" MODIFIED_BY="Hermann Blessberger" TYPE="PUBMED" VALUE=" 23166210"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Fleisher-2001" MODIFIED="2010-09-03 14:17:09 +0100" MODIFIED_BY="Hermann Blessberger" NAME="Fleisher 2001" TYPE="JOURNAL_ARTICLE">
<AU>Fleisher LA, Eagle KA</AU>
<TI>Lowering cardiac risk in noncardiac surgery</TI>
<SO>New England Journal of Medicine</SO>
<YR>2001</YR>
<VL>345</VL>
<PG>1677-82</PG>
<IDENTIFIERS MODIFIED="2010-09-03 14:17:03 +0100" MODIFIED_BY="Hermann Blessberger"><IDENTIFIER MODIFIED="2010-09-03 14:17:03 +0100" MODIFIED_BY="Hermann Blessberger" TYPE="PUBMED" VALUE="11759647"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Fleisher-2007" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" NAME="Fleisher 2007" TYPE="JOURNAL_ARTICLE">
<AU>Fleisher LA, Beckman JA, Brown KA, Calkins H, Chaikof EL, Fleischmann KE, et al</AU>
<TI>ACC/AHA 2007 guidelines on perioperative cardiovascular care and care for noncardiac surgery: a report of the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery)</TI>
<SO>Circulation</SO>
<YR>2007</YR>
<VL>116</VL>
<NO>17</NO>
<PG>1971-96</PG>
<IDENTIFIERS MODIFIED="2010-09-03 14:19:32 +0100" MODIFIED_BY="Hermann Blessberger"><IDENTIFIER MODIFIED="2010-09-03 14:19:32 +0100" MODIFIED_BY="Hermann Blessberger" TYPE="PUBMED" VALUE="17950159"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Fleisher-2014" MODIFIED="2018-02-23 18:15:04 +0000" MODIFIED_BY="[Empty name]" NAME="Fleisher 2014" TYPE="JOURNAL_ARTICLE">
<AU>Fleisher LA, Fleischmann KE, Auerbach AD, Barnason SA, Beckman JA, Bozkurt B et al</AU>
<TI>2014 ACC/AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines</TI>
<SO>Journal of the American College of Cardiology</SO>
<YR>2014</YR>
<VL>64</VL>
<NO>22</NO>
<PG>e77-137</PG>
<IDENTIFIERS MODIFIED="2017-12-08 10:56:31 +0000" MODIFIED_BY="Hermann Blessberger"><IDENTIFIER MODIFIED="2017-12-08 10:56:31 +0000" MODIFIED_BY="Hermann Blessberger" TYPE="PUBMED" VALUE="25091544"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Guyatt-2008" MODIFIED="2013-12-09 22:54:14 +0000" MODIFIED_BY="Hermann Blessberger" NAME="Guyatt 2008" TYPE="JOURNAL_ARTICLE">
<AU>Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P, et al</AU>
<TI>GRADE: an emerging consensus on rating quality of evidence and strength of recommendations</TI>
<SO>BMJ</SO>
<YR>2008</YR>
<VL>336</VL>
<NO>7650</NO>
<PG>924-6</PG>
<IDENTIFIERS MODIFIED="2013-12-09 22:54:14 +0000" MODIFIED_BY="Hermann Blessberger"><IDENTIFIER MODIFIED="2013-12-09 22:54:14 +0000" MODIFIED_BY="Hermann Blessberger" TYPE="PUBMED" VALUE="18436948"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Hammermeister-1990" MODIFIED="2010-09-03 17:09:11 +0100" MODIFIED_BY="Hermann Blessberger" NAME="Hammermeister 1990" TYPE="JOURNAL_ARTICLE">
<AU>Hammermeister KE, Burchfield C, Johnstin R</AU>
<TI>Identification of patients at greatest risk for developing major complications at cardiac surgery</TI>
<SO>Circulation</SO>
<YR>1990</YR>
<VL>82</VL>
<PG>IV-380-9</PG>
<IDENTIFIERS MODIFIED="2010-09-03 14:20:06 +0100" MODIFIED_BY="Hermann Blessberger"><IDENTIFIER MODIFIED="2010-09-03 14:20:06 +0100" MODIFIED_BY="Hermann Blessberger" TYPE="PUBMED" VALUE="2225429"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Higgins-2002" MODIFIED="2011-05-15 16:41:01 +0100" MODIFIED_BY="Hermann Blessberger" NAME="Higgins 2002" TYPE="JOURNAL_ARTICLE">
<AU>Higgins JP, Thompson SG</AU>
<TI>Quantifying heterogeneity in a meta-analysis</TI>
<SO>Statistics in Medicine</SO>
<YR>2002</YR>
<VL>21</VL>
<NO>11</NO>
<PG>1539-58</PG>
<IDENTIFIERS MODIFIED="2010-09-03 14:25:30 +0100" MODIFIED_BY="Hermann Blessberger"><IDENTIFIER MODIFIED="2010-09-03 14:25:30 +0100" MODIFIED_BY="Hermann Blessberger" TYPE="PUBMED" VALUE=" 12111919"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Higgins-2003" MODIFIED="2011-05-15 16:41:12 +0100" MODIFIED_BY="Hermann Blessberger" NAME="Higgins 2003" TYPE="JOURNAL_ARTICLE">
<AU>Higgins JPT, Thompson SG, Deeks JJ, Altman DG</AU>
<TI>Measuring inconsistency in meta-analyses</TI>
<SO>BMJ</SO>
<YR>2003</YR>
<VL>327</VL>
<PG>557-60</PG>
<IDENTIFIERS MODIFIED="2010-09-03 14:26:05 +0100" MODIFIED_BY="Hermann Blessberger"><IDENTIFIER MODIFIED="2010-09-03 14:26:05 +0100" MODIFIED_BY="Hermann Blessberger" TYPE="PUBMED" VALUE="12958120"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Higgins-2011" MODIFIED="2018-02-23 18:15:04 +0000" MODIFIED_BY="[Empty name]" NAME="Higgins 2011" TYPE="OTHER">
<AU>Higgins JP, Green S, editor(s)</AU>
<TI>Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011</TI>
<SO>Available from handbook.cochrane.org</SO>
<IDENTIFIERS MODIFIED="2018-02-22 17:18:03 +0000" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<REFERENCE ID="REF-Hillis-2011" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" NAME="Hillis 2011" TYPE="JOURNAL_ARTICLE">
<AU>Hillis LD, Smith PK, Anderson JL, Bittl JA, Bridges CR, Byrne JG, et al</AU>
<TI>2011 ACCF/AHA guidelines for coronary artery bypass graft surgery: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines</TI>
<SO>Circulation</SO>
<YR>2011</YR>
<VL>124</VL>
<NO>23</NO>
<PG>e652-e735</PG>
<IDENTIFIERS MODIFIED="2013-12-09 07:21:31 +0000" MODIFIED_BY="Hermann Blessberger"><IDENTIFIER MODIFIED="2013-12-09 07:21:31 +0000" MODIFIED_BY="Hermann Blessberger" TYPE="PUBMED" VALUE="22064599"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Juni-1999" MODIFIED="2011-05-15 16:41:27 +0100" MODIFIED_BY="Hermann Blessberger" NAME="Juni 1999" TYPE="JOURNAL_ARTICLE">
<AU>Juni P, Witschi A, Bloch R, Egger M</AU>
<TI>The hazards of scoring the quality of clinical trials for meta-analysis</TI>
<SO>JAMA</SO>
<YR>1999</YR>
<VL>282</VL>
<NO>11</NO>
<PG>1054-60</PG>
<IDENTIFIERS MODIFIED="2010-09-03 14:26:32 +0100" MODIFIED_BY="Hermann Blessberger"><IDENTIFIER MODIFIED="2010-09-03 14:26:32 +0100" MODIFIED_BY="Hermann Blessberger" TYPE="PUBMED" VALUE="10493204"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Kaplan-1993" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" NAME="Kaplan 1993" TYPE="BOOK">
<AU>Kaplan JA</AU>
<SO>Cardiac Anesthesia</SO>
<YR>1993</YR>
<PB>WB Saunders</PB>
<CY>Philadelphia</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Kjekshus-1987" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" NAME="Kjekshus 1987" TYPE="JOURNAL_ARTICLE">
<AU>Kjekshus J</AU>
<TI>Heart rate reduction&#8212;a mechanism of benefit?</TI>
<SO>European Heart Journal</SO>
<YR>1987</YR>
<VL>8</VL>
<NO>Suppl L</NO>
<PG>115-22</PG>
<IDENTIFIERS MODIFIED="2010-09-03 14:27:54 +0100" MODIFIED_BY="Hermann Blessberger"><IDENTIFIER MODIFIED="2010-09-03 14:27:54 +0100" MODIFIED_BY="Hermann Blessberger" TYPE="PUBMED" VALUE="2897914"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Kjekshus-1991" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" NAME="Kjekshus 1991" TYPE="JOURNAL_ARTICLE">
<AU>Kjekshus J, Gullestad L</AU>
<TI>Heart rate as a therapeutic target in heart failure</TI>
<SO>European Heart Journal</SO>
<YR>1991</YR>
<VL>1</VL>
<NO>Suppl H</NO>
<PG>H64-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Kristensen-2014" MODIFIED="2018-02-23 18:15:03 +0000" MODIFIED_BY="[Empty name]" NAME="Kristensen 2014" TYPE="JOURNAL_ARTICLE">
<AU>Kristensen SD, Knuuti J, Saraste A, Anker S, Botker HE, DeHert S, et al</AU>
<TI>2014 ESC/ESA Guidelines on non-cardiac surgery: cardiovascular assessment and management</TI>
<SO>European Heart Journal</SO>
<YR>2014</YR>
<VL>35</VL>
<PG>2383-431</PG>
<IDENTIFIERS MODIFIED="2017-12-08 10:47:57 +0000" MODIFIED_BY="Hermann Blessberger"><IDENTIFIER MODIFIED="2017-12-08 10:47:57 +0000" MODIFIED_BY="Hermann Blessberger" TYPE="PUBMED" VALUE="25086026"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Lancet-1986" MODIFIED="2010-09-03 14:42:25 +0100" MODIFIED_BY="Hermann Blessberger" NAME="Lancet 1986" TYPE="JOURNAL_ARTICLE">
<AU>No authors listed</AU>
<TI>Randomised trial of intravenous atenolol among 16 027 cases of suspected acute myocardial infarction: ISIS-1. First International Study of Infarct Survival Collaborative Group</TI>
<SO>Lancet</SO>
<YR>1986</YR>
<VL>2</VL>
<NO>8498</NO>
<PG>57-66</PG>
<IDENTIFIERS MODIFIED="2010-09-03 14:42:25 +0100" MODIFIED_BY="Hermann Blessberger"><IDENTIFIER MODIFIED="2010-09-03 14:42:25 +0100" MODIFIED_BY="Hermann Blessberger" TYPE="PUBMED" VALUE="2873379"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Lancet-1999" MODIFIED="2010-09-03 14:43:06 +0100" MODIFIED_BY="Hermann Blessberger" NAME="Lancet 1999" TYPE="JOURNAL_ARTICLE">
<AU>No authors listed</AU>
<TI>The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial</TI>
<SO>Lancet</SO>
<YR>1999</YR>
<VL>353</VL>
<NO>9146</NO>
<PG>9-13</PG>
<IDENTIFIERS MODIFIED="2010-09-03 14:43:06 +0100" MODIFIED_BY="Hermann Blessberger"><IDENTIFIER MODIFIED="2010-09-03 14:43:06 +0100" MODIFIED_BY="Hermann Blessberger" TYPE="PUBMED" VALUE="10023943"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Lauer-1989" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" NAME="Lauer 1989" TYPE="JOURNAL_ARTICLE">
<AU>Lauer MS, Eagle KA, Buckley MJ, DeSanctis RW</AU>
<TI>Atrial fibrillation following coronary artery bypass surgery</TI>
<SO>Progress in Cardiovascular Disease</SO>
<YR>1989</YR>
<VL>31</VL>
<PG>367-78</PG>
<IDENTIFIERS MODIFIED="2010-09-03 14:43:47 +0100" MODIFIED_BY="Hermann Blessberger"><IDENTIFIER MODIFIED="2010-09-03 14:43:47 +0100" MODIFIED_BY="Hermann Blessberger" TYPE="PUBMED" VALUE="2646657 "/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Mangano-1990a" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" NAME="Mangano 1990a" TYPE="JOURNAL_ARTICLE">
<AU>Mangano DT, Browner WS, Hollenberg M, London MJ, Tubau JF, Tateo IM</AU>
<TI>Association of perioperative myocardial ischemia with cardiac morbidity and mortality in men undergoing noncardiac surgery. The Study of Perioperative Ischemia Research Group</TI>
<SO>New England Journal of Medicine</SO>
<YR>1990</YR>
<VL>323</VL>
<NO>26</NO>
<PG>1781-8</PG>
<IDENTIFIERS MODIFIED="2010-09-03 14:44:49 +0100" MODIFIED_BY="Hermann Blessberger"><IDENTIFIER MODIFIED="2010-09-03 14:44:49 +0100" MODIFIED_BY="Hermann Blessberger" TYPE="PUBMED" VALUE="2247116"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Mangano-1990b" MODIFIED="2010-09-14 18:44:53 +0100" MODIFIED_BY="Jane Cracknell" NAME="Mangano 1990b" TYPE="JOURNAL_ARTICLE">
<AU>Mangano DT</AU>
<TI>Perioperative cardiac morbidity</TI>
<SO>Anesthesiology</SO>
<YR>1990</YR>
<VL>72</VL>
<NO>1</NO>
<PG>153-84</PG>
<IDENTIFIERS MODIFIED="2010-09-03 14:45:10 +0100" MODIFIED_BY="Hermann Blessberger"><IDENTIFIER MODIFIED="2010-09-03 14:45:10 +0100" MODIFIED_BY="Hermann Blessberger" TYPE="PUBMED" VALUE="2404426"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Mangano-1995" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" NAME="Mangano 1995" TYPE="JOURNAL_ARTICLE">
<AU>Mangano DT, Goldman L</AU>
<TI>Preoperative assessment of patients with known or suspected coronary disease</TI>
<SO>New England Journal of Medicine</SO>
<YR>1995</YR>
<VL>333</VL>
<NO>26</NO>
<PG>1750-6</PG>
<IDENTIFIERS MODIFIED="2010-09-03 14:45:29 +0100" MODIFIED_BY="Hermann Blessberger"><IDENTIFIER MODIFIED="2010-09-03 14:45:29 +0100" MODIFIED_BY="Hermann Blessberger" TYPE="PUBMED" VALUE="7491140"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Moher-2001" MODIFIED="2010-09-03 14:47:34 +0100" MODIFIED_BY="Hermann Blessberger" NAME="Moher 2001" TYPE="JOURNAL_ARTICLE">
<AU>Moher D, Schulz KF, Altman DG, for the CONSORT group</AU>
<TI>The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials</TI>
<SO>Lancet</SO>
<YR>2001</YR>
<VL>357</VL>
<NO>9263</NO>
<PG>1191-4</PG>
<IDENTIFIERS MODIFIED="2010-09-03 14:47:34 +0100" MODIFIED_BY="Hermann Blessberger"><IDENTIFIER MODIFIED="2010-09-03 14:47:34 +0100" MODIFIED_BY="Hermann Blessberger" TYPE="PUBMED" VALUE="11323066"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Montalescot-2013" MODIFIED="2013-12-09 07:48:18 +0000" MODIFIED_BY="Hermann Blessberger" NAME="Montalescot 2013" TYPE="JOURNAL_ARTICLE">
<AU>Montalescot G, Sechtem U, Achenbach S, Andreotti F, Arden C, Budaj A, et al</AU>
<TI>2013 ESC guidelines in the management of stable coronary artery disease</TI>
<SO>European Heart Journal</SO>
<YR>2013</YR>
<VL>34</VL>
<NO>38</NO>
<PG>2949-3003</PG>
<IDENTIFIERS MODIFIED="2013-12-09 07:48:15 +0000" MODIFIED_BY="Hermann Blessberger"><IDENTIFIER MODIFIED="2013-12-09 07:48:15 +0000" MODIFIED_BY="Hermann Blessberger" TYPE="PUBMED" VALUE=" 23996286"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Pepine-1994" MODIFIED="2010-09-03 14:48:01 +0100" MODIFIED_BY="Hermann Blessberger" NAME="Pepine 1994" TYPE="JOURNAL_ARTICLE">
<AU>Pepine CJ, Cohn PF, Deedwania PC, Gibson RS, Handberg E, Hill JA, et al</AU>
<TI>Effects of treatment on outcome in mildly symptomatic patients with ischemia during daily life. The Atenolol Silent Ischemia Study (ASIST)</TI>
<SO>Circulation</SO>
<YR>1994</YR>
<VL>90</VL>
<NO>2</NO>
<PG>762-68</PG>
<IDENTIFIERS MODIFIED="2010-09-03 14:48:01 +0100" MODIFIED_BY="Hermann Blessberger"><IDENTIFIER MODIFIED="2010-09-03 14:48:01 +0100" MODIFIED_BY="Hermann Blessberger" TYPE="PUBMED" VALUE="8044945"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Poldermans-2009" MODIFIED="2013-12-09 09:57:03 +0000" MODIFIED_BY="Hermann Blessberger" NAME="Poldermans 2009" TYPE="JOURNAL_ARTICLE">
<AU>Poldermans D, Bax JJ, Boersma E, De Hert S, Eeckhout E, Fowkes G, et al</AU>
<TI>Guidelines for pre-operative cardiac risk assessment and perioperative cardiac management in non-cardiac surgery</TI>
<SO>European Heart Journal</SO>
<YR>2009</YR>
<VL>30</VL>
<PG>2769-812</PG>
<IDENTIFIERS MODIFIED="2013-12-09 09:57:03 +0000" MODIFIED_BY="Hermann Blessberger"><IDENTIFIER MODIFIED="2013-12-09 09:57:03 +0000" MODIFIED_BY="Hermann Blessberger" TYPE="PUBMED" VALUE="19713421"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Rahimzadeh-2008" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" NAME="Rahimzadeh 2008" TYPE="JOURNAL_ARTICLE">
<AU>Rahimzadeh P, Faiz SHR, Etemadi SH</AU>
<TI>Evaluation of the metoprolol effects in controlled hypotension and reduction of bleeding during head and neck surgery</TI>
<SO>University of Medical Sciences Journal</SO>
<YR>2008</YR>
<VL>1</VL>
<NO>4</NO>
<PG>37-43</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-RevMan-5.3" MODIFIED="2018-02-23 18:15:04 +0000" MODIFIED_BY="[Empty name]" NAME="RevMan 5.3" TYPE="COMPUTER_PROGRAM">
<TI>Review Manager (RevMan)</TI>
<YR>2014</YR>
<EN>5.3</EN>
<PB>The Nordic Cochrane Centre, The Cochrane Collaboration</PB>
<CY>Copenhagen</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Ryden-1983" MODIFIED="2014-05-15 14:18:29 +0100" MODIFIED_BY="Jane Cracknell" NAME="Ryden 1983" TYPE="JOURNAL_ARTICLE">
<AU>Ryden L, Ariniego R, Arnman K, Herlitz J, Hjalmarson A, Holmberg S, et al</AU>
<TI>A double-blind trial of metoprolol in acute myocardial infarction. Effects on ventricular tachyarrhythmias</TI>
<SO>New England Journal of Medicine</SO>
<YR>1983</YR>
<VL>308</VL>
<NO>11</NO>
<PG>614-8</PG>
<IDENTIFIERS MODIFIED="2010-09-03 14:50:17 +0100" MODIFIED_BY="Hermann Blessberger"><IDENTIFIER MODIFIED="2010-09-03 14:50:17 +0100" MODIFIED_BY="Hermann Blessberger" TYPE="PUBMED" VALUE="6828092"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Stevens-2003" MODIFIED="2011-05-15 16:42:48 +0100" MODIFIED_BY="Hermann Blessberger" NAME="Stevens 2003" TYPE="JOURNAL_ARTICLE">
<AU>Stevens RD, Burri H, Tramer M</AU>
<TI>Pharmacologic myocardial protection in patients undergoing noncardiac surgery: a quantitative systematic review</TI>
<SO>Anesthesia and Analgesia</SO>
<YR>2003</YR>
<VL>97</VL>
<NO>3</NO>
<PG>623-33</PG>
<IDENTIFIERS MODIFIED="2010-09-03 14:50:49 +0100" MODIFIED_BY="Hermann Blessberger"><IDENTIFIER MODIFIED="2010-09-03 14:50:49 +0100" MODIFIED_BY="Hermann Blessberger" TYPE="PUBMED" VALUE="12933373"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Thorlund-2011" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" NAME="Thorlund 2011" TYPE="BOOK">
<AU>Thorlund K, Engström J, Wetterslev J, Brok J, Imberger G, Gluud C</AU>
<SO>User Manual for Trial Sequential Analysis (TSA)</SO>
<YR>2011</YR>
<PB>Copenhagen Trial Unit, Centre for Clincal Intervention Research</PB>
<CY>Copenhagen, Denmark</CY>
<IDENTIFIERS MODIFIED="2013-12-09 23:39:43 +0000" MODIFIED_BY="Hermann Blessberger"><IDENTIFIER MODIFIED="2013-12-09 23:39:43 +0000" MODIFIED_BY="Hermann Blessberger" TYPE="OTHER" VALUE="www.ctu.dk/tsa"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Wetterslev-2008" MODIFIED="2013-12-09 23:35:49 +0000" MODIFIED_BY="Hermann Blessberger" NAME="Wetterslev 2008" TYPE="JOURNAL_ARTICLE">
<AU>Wetterslev J, Thorlund K, Brok J, Gluud C</AU>
<TI>Trial sequential analysis may establish when firm evidence is reached in cumulative meta-analysis</TI>
<SO>Journal of Clinical Epidemiology</SO>
<YR>2008</YR>
<VL>61</VL>
<NO>1</NO>
<PG>64-75</PG>
<IDENTIFIERS MODIFIED="2013-12-09 23:35:49 +0000" MODIFIED_BY="Hermann Blessberger"><IDENTIFIER MODIFIED="2013-12-09 23:35:49 +0000" MODIFIED_BY="Hermann Blessberger" TYPE="PUBMED" VALUE=" 18083463"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Wheatley-2003" MODIFIED="2010-09-03 14:56:47 +0100" MODIFIED_BY="Hermann Blessberger" NAME="Wheatley 2003" TYPE="JOURNAL_ARTICLE">
<AU>Wheatley KW, Clayton D</AU>
<TI>Be skeptical about unexpected large apparent treatment effects: the case of an MRC AML 12 randomization</TI>
<SO>Controlled Clinical Trials</SO>
<YR>2003</YR>
<VL>24</VL>
<NO>1</NO>
<PG>66-70</PG>
<IDENTIFIERS MODIFIED="2010-09-03 14:56:47 +0100" MODIFIED_BY="Hermann Blessberger"><IDENTIFIER MODIFIED="2010-09-03 14:56:47 +0100" MODIFIED_BY="Hermann Blessberger" TYPE="DOI" VALUE="10.1016/S0197-2456(02)00273-8"/></IDENTIFIERS>
</REFERENCE>
</ADDITIONAL_REFERENCES>
<OTHER_VERSIONS_REFERENCES MODIFIED="2018-02-23 18:15:04 +0000" MODIFIED_BY="[Empty name]">
<REFERENCE ID="REF-Blessberger-2014" MODIFIED="2018-02-23 18:15:04 +0000" MODIFIED_BY="[Empty name]" NAME="Blessberger 2014" TYPE="COCHRANE_REVIEW">
<AU>Blessberger H, Kammler J, Domanovits H, Schlager O, Wildner B, Azar D, Schillinger M, Wiesbauer F, Steinwender C</AU>
<TI>Perioperative beta-blockers for preventing surgery-related mortality and morbidity</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2014</YR>
<NO>9</NO>
<IDENTIFIERS MODIFIED="2018-02-22 17:13:38 +0000" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2018-02-22 17:13:36 +0000" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1002/14651858.CD004476.pub2"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Wiesbauer-2007" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" NAME="Wiesbauer 2007" TYPE="JOURNAL_ARTICLE">
<AU>Wiesbauer F, Schlager O, Domanovits H, Wildner B, Maurer G, Muellner M, et al</AU>
<TI>Perioperative &#946;-blockers for preventing surgery-related mortality and morbidity: a systematic review and meta-analysis</TI>
<SO>Anesthesia and Analgesia</SO>
<YR>2007</YR>
<VL>104</VL>
<NO>1</NO>
<PG>27-41</PG>
<IDENTIFIERS MODIFIED="2010-09-03 13:47:28 +0100" MODIFIED_BY="Hermann Blessberger"><IDENTIFIER MODIFIED="2010-09-03 13:47:28 +0100" MODIFIED_BY="Hermann Blessberger" TYPE="PUBMED" VALUE="17179240"/></IDENTIFIERS>
</REFERENCE>
</OTHER_VERSIONS_REFERENCES>
<PENDING_REFERENCES/>
</OTHER_REFERENCES>
</STUDIES_AND_REFERENCES><CHARACTERISTICS_OF_STUDIES MODIFIED="2017-12-08 12:23:52 +0000" MODIFIED_BY="Hermann Blessberger"><CHARACTERISTICS_OF_INCLUDED_STUDIES MODIFIED="2017-10-28 00:46:08 +0100" MODIFIED_BY="Hermann Blessberger" SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO"><INCLUDED_CHAR MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" STUDY_ID="STD-Abel-1983"><CHAR_METHODS MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Quasi-randomized, open-label trial; beta-blocker versus standard care</P></CHAR_METHODS><CHAR_PARTICIPANTS MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Overall: 91 participants; beta-blocker: 41 participants; standard care: 50 participants (100% of participants were taking beta-blockers preoperatively)</P><P>Mean age: 56.6 years</P><P>Percentage of female participants: 17</P></CHAR_PARTICIPANTS><CHAR_INTERVENTIONS MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Participants received either propranolol or standard care; treatment was initiated during surgery and was continued until hospital discharge</P></CHAR_INTERVENTIONS><CHAR_OUTCOMES MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Primary outcomes: supraventricular arrhythmias; secondary outcomes: ventricular arrhythmias, myocardial infarction, hospital mortality</P></CHAR_OUTCOMES><CHAR_NOTES MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Type of surgery: elective coronary artery bypass grafting (CABG)</P></CHAR_NOTES></INCLUDED_CHAR><INCLUDED_CHAR MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" STUDY_ID="STD-Ali-1997"><CHAR_METHODS MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Randomized, open-label clinical trial; beta-blocker versus standard care</P></CHAR_METHODS><CHAR_PARTICIPANTS MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Overall: 210 participants; each group consisting of 105 participants (all were taking beta-blockers preoperatively)</P><P>Mean age: 64.2 years</P><P>Percentage of female participants: 31.9</P></CHAR_PARTICIPANTS><CHAR_INTERVENTIONS MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>All participants were taking beta-blockers before initiation of the study. The 105 participants who were randomly assigned to the 'standard-care group' did not receive beta-blockers perioperatively, whereas beta-blockers were continued in the intervention group. The following beta-blockers were used: atenolol, metoprolol and sotalol</P></CHAR_INTERVENTIONS><CHAR_OUTCOMES MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Primary outcomes: atrial fibrillation </P><P>Secondary outcomes: mortality, myocardial infarction; time of observation, induction of surgery until discharge</P></CHAR_OUTCOMES><CHAR_NOTES MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Type of surgery: elective CABG</P></CHAR_NOTES></INCLUDED_CHAR><INCLUDED_CHAR MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" STUDY_ID="STD-Apipan-2010"><CHAR_METHODS MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Randomized, placebo-controlled, triple-blind trial; beta-blocker versus placebo</P></CHAR_METHODS><CHAR_PARTICIPANTS MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Overall: 60 participants; propranolol: 30 participants; placebo: 30 participants</P><P>Mean age: 25.5 years</P><P>Percentage of female participants: 63.3</P></CHAR_PARTICIPANTS><CHAR_INTERVENTIONS MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Participants received 10 mg propranolol or placebo orally 30 minutes before induction of anaesthesia (single-drug application)</P></CHAR_INTERVENTIONS><CHAR_OUTCOMES MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Primary outcome: heart rate during surgery</P><P>Secondary outcomes: amount of sodium nitroprusside and blood loss during surgery</P></CHAR_OUTCOMES><CHAR_NOTES MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Type of surgery: orthognathic surgery</P></CHAR_NOTES></INCLUDED_CHAR><INCLUDED_CHAR MODIFIED="2014-09-10 08:11:50 +0100" MODIFIED_BY="Jane Cracknell" STUDY_ID="STD-Auer-2004"><CHAR_METHODS MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Randomized, placebo-controlled, double-blind trial; beta-blocker versus placebo</P></CHAR_METHODS><CHAR_PARTICIPANTS MODIFIED="2014-09-10 08:11:50 +0100" MODIFIED_BY="Jane Cracknell"><P>Overall: 253 participants; metoprolol: 62 participants; sotalol: 63 participants; metoprolol + amiodarone: 63 participants; placebo: 65 participants. </P><P>Mean age: 65.6 years</P><P>Percentage of female participants: 39.5</P></CHAR_PARTICIPANTS><CHAR_INTERVENTIONS MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Participants received treatment 24 to 48 hours before surgery until the eighth postoperative day. Participants were followed until hospital discharge</P></CHAR_INTERVENTIONS><CHAR_OUTCOMES MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Primary outcome: postoperative atrial fibrillation</P><P>Secondary outcomes: mortality, cerebrovascular events, hypotension, bradycardia, ventricular tachycardia, length of stay</P></CHAR_OUTCOMES><CHAR_NOTES MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Type of surgery: cardiac surgery (CABG and valvular surgery)</P></CHAR_NOTES></INCLUDED_CHAR><INCLUDED_CHAR MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" STUDY_ID="STD-Babin_x002d_Ebell-1996"><CHAR_METHODS MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Open-label, randomized clinical trial; calcium antagonists versus blockers versus standard care</P></CHAR_METHODS><CHAR_PARTICIPANTS MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Overall: 103 participants; beta-blocker: 33 participants; calcium antagonist: 33 participants; control: 37 participants</P><P>Mean age: 62.9 years</P><P>Percentage of female participants: 20</P></CHAR_PARTICIPANTS><CHAR_INTERVENTIONS MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Participants were assigned to receive propranolol, diltiazem or no antiarrhythmic agent. Treatment was administered intraoperatively and up to 72 hours postoperatively</P></CHAR_INTERVENTIONS><CHAR_OUTCOMES MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Primary outcomes: supraventricular tachyarrhythmias </P><P>Secondary outcomes: acute myocardial infarction, bradycardia; outcomes were assessed up to 7 days following surgery</P></CHAR_OUTCOMES><CHAR_NOTES MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Type of surgery: elective CABG</P></CHAR_NOTES></INCLUDED_CHAR><INCLUDED_CHAR MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" STUDY_ID="STD-Bayliff-1999"><CHAR_METHODS MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Randomized, placebo-controlled, double-blind trial; beta-blocker versus placebo</P></CHAR_METHODS><CHAR_PARTICIPANTS MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Overall: 99 participants; beta-blocker: 49 participants; placebo: 50 participants</P><P>Mean age: 62.4 years</P><P>Percentage of female participants: 38.4</P></CHAR_PARTICIPANTS><CHAR_INTERVENTIONS MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Participants received propranolol or placebo; treatment was started preoperatively and was administered orally every 6 hours for 5 days</P></CHAR_INTERVENTIONS><CHAR_OUTCOMES MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Primary outcomes: arrhythmias requiring treatment (until 3 days following surgery, detected by Holter ECG) </P><P>Secondary outcomes: overall arrhythmia rate, myocardial ischaemia, mortality, bradycardia, hypotension, length of stay (no data for standard deviation of LOS provided)</P></CHAR_OUTCOMES><CHAR_NOTES MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Type of surgery: major thoracic operations (pneumectomy, lobectomy, oesophagectomy)</P></CHAR_NOTES></INCLUDED_CHAR><INCLUDED_CHAR MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" STUDY_ID="STD-Bert-2001"><CHAR_METHODS MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Randomized, open-label, controlled trial comparing a beta-blocker (± magnesium), digitalis (± magnesium), magnesium and standard care</P></CHAR_METHODS><CHAR_PARTICIPANTS MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Overall: 387 participants<BR/>Magnesium: 63 participants<BR/>Digoxin: 62 participants<BR/>Magnesium and digoxin: 62 participants<BR/>Beta-blocker (propranolol): 71 participants<BR/>Magnesium and beta-blocker: 69 participants</P><P>Control: 60 participants</P><P>Mean age: 63.7 years (average of propranolol and control groups)</P><P>Percentage of female participants: 20.6 (average of propranolol and control groups)</P></CHAR_PARTICIPANTS><CHAR_INTERVENTIONS MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Participants were assigned to 1 of 6 groups (see Methods). The studied beta-blocker was propranolol. Treatment was started postoperatively, upon arrival at the ICU, and was continued for 4 days</P></CHAR_INTERVENTIONS><CHAR_OUTCOMES MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Primary outcomes: atrial tachyarrhythmias; secondary outcomes: mortality, acute myocardial infarction, premature ventricular beats, ventricular arrhythmias and length of stay</P></CHAR_OUTCOMES><CHAR_NOTES MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Type of surgery: elective CABG</P></CHAR_NOTES></INCLUDED_CHAR><INCLUDED_CHAR MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" STUDY_ID="STD-Booth-2004"><CHAR_METHODS MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Randomized, placebo-controlled trial; beta-blocker versus placebo</P></CHAR_METHODS><CHAR_PARTICIPANTS MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Overall: 72 participants; beta-blocker: 33 participants; placebo: 39 participants</P><P>Mean age: 61.3 years</P><P>Percentage of female participants: 36.1</P></CHAR_PARTICIPANTS><CHAR_INTERVENTIONS MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Participants received a single dose of metoprolol 10 mg or placebo intravenously during CABG surgery</P></CHAR_INTERVENTIONS><CHAR_OUTCOMES MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Primary outcomes: isoproterenol-stimulated adenylyl cyclase activity (beta-adrenoceptor signalling) and major clinical endpoints (supraventricular arrhythmias, inotropic support)</P><P>Seconary outcome: length of stay</P></CHAR_OUTCOMES><CHAR_NOTES MODIFIED="2011-05-22 13:49:14 +0100" MODIFIED_BY="Hermann Blessberger"><P>Type of surgery: CABG</P></CHAR_NOTES></INCLUDED_CHAR><INCLUDED_CHAR MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" STUDY_ID="STD-Burns-1988"><CHAR_METHODS MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Randomized, placebo-controlled, triple-blind trial; beta-blocker versus placebo</P></CHAR_METHODS><CHAR_PARTICIPANTS MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Overall: 86 female participants; beta-blocker: 39 participants; placebo: 47 participants</P><P>Mean age: 34.2 years</P><P>Percentage of female participants: 100</P></CHAR_PARTICIPANTS><CHAR_INTERVENTIONS MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Participants received nadolol or placebo; treatment was given preoperatively as an oral single dose 12 hours before laparoscopy, and no further dose of the study medication was administered</P></CHAR_INTERVENTIONS><CHAR_OUTCOMES MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Primary outcome: all types of arrhythmias (bradycardia, atrial and ventricular tachyarrhythmias, supraventricular premature beats, ventricular premature beats)</P></CHAR_OUTCOMES><CHAR_NOTES MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Type of surgery: laparoscopy (gynaecological surgery)</P></CHAR_NOTES></INCLUDED_CHAR><INCLUDED_CHAR MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" STUDY_ID="STD-But-2006"><CHAR_METHODS MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Randomized, placebo-controlled trial; beta-blocker versus placebo</P></CHAR_METHODS><CHAR_PARTICIPANTS MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Overall: 45 participants; beta-blocker: 15 participants; placebo: 15 participants; magnesium sulfate: 15 participants</P><P>Mean age: 57.5 years</P><P>Percentage of female participants: 46.7</P></CHAR_PARTICIPANTS><CHAR_INTERVENTIONS MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Participants with diabetes mellitus type II received placebo (saline) or esmolol intravenously from induction of anaesthesia until 12 hours after surgery</P></CHAR_INTERVENTIONS><CHAR_OUTCOMES MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Primary outcomes: amount of glucose-insulin-potassium infusion consumption, blood glucose levels</P><P>Secondary outcomes: bradycardia, hypotension, length of stay, dysrhythmias, inotropic support</P></CHAR_OUTCOMES><CHAR_NOTES MODIFIED="2011-05-22 15:21:06 +0100" MODIFIED_BY="Hermann Blessberger"><P>Type of surgery: CABG</P></CHAR_NOTES></INCLUDED_CHAR><INCLUDED_CHAR MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" STUDY_ID="STD-Coleman-1980"><CHAR_METHODS MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Randomized, placebo-controlled, double-blind trial; beta-blocker versus placebo</P></CHAR_METHODS><CHAR_PARTICIPANTS MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Overall: 38 participants; beta-blocker: 24 participants; control: 14 participants</P><P>Mean age: 40.8 years</P><P>Percentage of female participants: 57.1</P></CHAR_PARTICIPANTS><CHAR_INTERVENTIONS MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Participants were assigned to receive 2 mg metoprolol or 4 mg metoprolol or saline as placebo. Treatment was given before induction of anaesthesia</P></CHAR_INTERVENTIONS><CHAR_OUTCOMES MODIFIED="2013-09-24 21:14:58 +0100" MODIFIED_BY="Hermann Blessberger"><P>Primary outcomes: cardiovascular responses (haemodynamic responses, sinus arrhythmia, supraventricular ectopics, ventricular ectopics, ST-segment changes)</P></CHAR_OUTCOMES><CHAR_NOTES MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Type of surgery: elective general surgery</P></CHAR_NOTES></INCLUDED_CHAR><INCLUDED_CHAR MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" STUDY_ID="STD-Connolly-2003"><CHAR_METHODS MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Randomized, placebo-controlled, double-blind trial; beta-blocker versus placebo</P></CHAR_METHODS><CHAR_PARTICIPANTS MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Overall: 1000 participants; beta-blocker: 500 participants; placebo: 500 participants</P><P>Mean age: 62.5 years</P><P>Percentage of female participants: 21</P></CHAR_PARTICIPANTS><CHAR_INTERVENTIONS MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Participants received metoprolol or placebo; treatment was started postoperatively and was administered until hospital discharge or 14 days after surgery (whichever occurred sooner)</P></CHAR_INTERVENTIONS><CHAR_OUTCOMES MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Primary outcome: length of stay (LOS) </P><P>Secondary outcomes: arrhythmias (supraventricular and ventricular arrhythmias), myocardial infarction, cost of care, stroke, death, haemodynamic parameters</P></CHAR_OUTCOMES><CHAR_NOTES MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Type of surgery: elective heart surgery</P></CHAR_NOTES></INCLUDED_CHAR><INCLUDED_CHAR MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" STUDY_ID="STD-Cork-1995"><CHAR_METHODS MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Randomized, placebo-controlled, double-blind trial; beta-blocker versus placebo</P></CHAR_METHODS><CHAR_PARTICIPANTS MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Overall: 30 participants; beta-blocker: 16 participants; placebo: 14 participants</P><P>Mean age: 61.5 years</P><P>Percentage of female participants: 36.7</P></CHAR_PARTICIPANTS><CHAR_INTERVENTIONS MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Participants received esmolol or placebo; treatment was administered only intraoperatively</P></CHAR_INTERVENTIONS><CHAR_OUTCOMES MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>No clear primary outcome was specified; multiple haemodynamic and laboratory parameters were recorded in addition to death, dysrhythmias, LOS and cost of care</P></CHAR_OUTCOMES><CHAR_NOTES MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Type of surgery: elective heart surgery involving cardiopulmonary bypass and aortic cross-clamping</P></CHAR_NOTES></INCLUDED_CHAR><INCLUDED_CHAR MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" STUDY_ID="STD-Cucchiara-1986"><CHAR_METHODS MODIFIED="2011-04-25 08:20:39 +0100" MODIFIED_BY="Hermann Blessberger"><P>Randomized, placebo-controlled, double-blind trial; beta-blocker versus placebo</P></CHAR_METHODS><CHAR_PARTICIPANTS MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Overall: 62 participants; beta-blocker: 32 participants; placebo: 30 participants</P><P>Mean age: data not provided</P><P>Percentage of female participants: data not provided</P></CHAR_PARTICIPANTS><CHAR_INTERVENTIONS MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Participants received esmolol or placebo; treatment was administered intravenously during anaesthesia</P></CHAR_INTERVENTIONS><CHAR_OUTCOMES MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Primary outcome: haemodynamic variables </P><P>Secondary outcomes: myocardial ischaemia, bradycardia, hypotension, bronchospasm</P></CHAR_OUTCOMES><CHAR_NOTES MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Type of surgery: carotid endarterectomy</P></CHAR_NOTES></INCLUDED_CHAR><INCLUDED_CHAR MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" STUDY_ID="STD-Daudon-1986"><CHAR_METHODS MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Randomized, open-label trial; beta-blocker versus standard care</P></CHAR_METHODS><CHAR_PARTICIPANTS MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Overall: 100 participants; beta-blocker: 50 participants; standard care: 50 participants</P><P>Mean age: 53.5 years</P><P>Percentage of female participants: 5</P></CHAR_PARTICIPANTS><CHAR_INTERVENTIONS MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Participants received acebutolol or standard care; treatment was initiated 36 hours postoperatively and was continued until discharge</P></CHAR_INTERVENTIONS><CHAR_OUTCOMES MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Primary outcome: atrial fibrillation/flutter </P><P>Secondary outcome: perioperative myocardial infarction</P></CHAR_OUTCOMES><CHAR_NOTES MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Type of surgery: elective CABG</P></CHAR_NOTES></INCLUDED_CHAR><INCLUDED_CHAR MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" STUDY_ID="STD-De-Azevedo-L_x00fa_cio-2003"><CHAR_METHODS MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Randomized, open-label trial; beta-blocker versus standard care</P></CHAR_METHODS><CHAR_PARTICIPANTS MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Overall: 200 participants; beta-blocker: 100 participants; standard care: 100 participants</P><P>Mean age: 60.5 years</P><P>Percentage of female participants: 27</P></CHAR_PARTICIPANTS><CHAR_INTERVENTIONS MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Participants received metoprolol or standard care; treatment was started 12 hours postoperatively and was continued for 7 days or until hospital discharge, whichever occurred first</P></CHAR_INTERVENTIONS><CHAR_OUTCOMES MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Primary outcome: atrial fibrillation/flutter </P><P>Secondary outcomes: death, myocardial infarction (group affiliation not specified), stroke (group affiliation not specified)</P></CHAR_OUTCOMES><CHAR_NOTES MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Type of surgery: elective CABG</P></CHAR_NOTES></INCLUDED_CHAR><INCLUDED_CHAR MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" STUDY_ID="STD-DIPOM-_x002d_-Juul-2006"><CHAR_METHODS MODIFIED="2014-01-06 19:22:43 +0000" MODIFIED_BY="Hermann Blessberger"><P>Randomized, placebo-controlled, triple-blind trial; beta-blocker versus placebo</P></CHAR_METHODS><CHAR_PARTICIPANTS MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Overall: 921 diabetic participants naive to beta-blockers with diabetes mellitus older than 39 years; metoprolol: 462 participants; placebo: 459 participants</P><P>Mean age: 64.9 years</P><P>Percentage of female participants: 41.5</P></CHAR_PARTICIPANTS><CHAR_INTERVENTIONS MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Participants received metoprolol or placebo; treatment was started the evening before surgery and was continued until hospital discharge (maximum 8 postoperative days). Median follow-up was 18 months for primary outcome (6 to 30 months)</P></CHAR_INTERVENTIONS><CHAR_OUTCOMES MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Primary composite outcome: all-cause mortality, myocardial infarction, unstable angina or new congestive heart failure </P><P>Secondary outcomes: all-cause mortality, cardiac mortality, non-fatal cardiac morbidity</P></CHAR_OUTCOMES><CHAR_NOTES MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Type of surgery: orthopaedic, neurological, vascular, gynaecological, thoracic, intra-abdominal and other operations (major non-cardiac surgery)</P></CHAR_NOTES></INCLUDED_CHAR><INCLUDED_CHAR MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" STUDY_ID="STD-Dy-1998"><CHAR_METHODS MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Randomized, placebo-controlled, double-blind trial; beta-blocker versus flecainide versus placebo</P></CHAR_METHODS><CHAR_PARTICIPANTS MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Overall: 201 participants; beta-blocker: 67 participants; flecainide: 68 participants; placebo: 66 participants</P><P>Mean age: data not provided</P><P>Percentage of female participants: data not provided</P></CHAR_PARTICIPANTS><CHAR_INTERVENTIONS MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Participants received metoprolol, flecainide or placebo; treatment was started after extubation and was continued until 24 hours before discharge</P></CHAR_INTERVENTIONS><CHAR_OUTCOMES MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Primary outcome: atrial fibrillation, period of observation unclear</P></CHAR_OUTCOMES><CHAR_NOTES MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Type of surgery: elective CABG. Conference abstract</P></CHAR_NOTES></INCLUDED_CHAR><INCLUDED_CHAR MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" STUDY_ID="STD-Evrard-2000"><CHAR_METHODS MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Randomized, open-label clinical trial; beta-blocker versus standard care</P></CHAR_METHODS><CHAR_PARTICIPANTS MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Overall: 206 participants; beta-blocker: 103 participants; control: 103 participants</P><P>Mean age: 61 years</P><P>Percentage of female participants: 11</P></CHAR_PARTICIPANTS><CHAR_INTERVENTIONS MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Participants received sotalol or no antiarrhythmic agent. Treatment was started on the first postoperative day, no time of discontinuation was specified</P></CHAR_INTERVENTIONS><CHAR_OUTCOMES MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Primary outcomes: supraventricular and ventricular arrhythmias </P><P>Secondary outcomes: LOS, mortality</P></CHAR_OUTCOMES><CHAR_NOTES MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Type of surgery: elective CABG</P></CHAR_NOTES></INCLUDED_CHAR><INCLUDED_CHAR MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" STUDY_ID="STD-Forlani-2002"><CHAR_METHODS MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Randomized, open-label clinical trial; beta-blocker versus standard care</P></CHAR_METHODS><CHAR_PARTICIPANTS MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Overall: 207 participants; beta-blocker (sotalol): 51 participants; control: 50 participants, beta-blocker + magnesium: 52 participants, magnesium: 54 participants</P><P>Mean age: 64 years</P><P>Percentage of female participants: 14.9</P></CHAR_PARTICIPANTS><CHAR_INTERVENTIONS MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Participants received sotalol, magnesium, sotalol and magnesium or no antiarrhythmic agent. Sotalol was started orally on the morning of the first postoperative day and then was continued for 4 weeks (dose reduction after 5 days of initial treatment)</P></CHAR_INTERVENTIONS><CHAR_OUTCOMES MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Primary outcome: atrial fibrillation </P><P>Secondary outcomes: postoperative hospital length of stay, myocardial infarction, all-cause mortality</P></CHAR_OUTCOMES><CHAR_NOTES MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Type of surgery: elective CABG</P></CHAR_NOTES></INCLUDED_CHAR><INCLUDED_CHAR MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" STUDY_ID="STD-Gibson-1988"><CHAR_METHODS MODIFIED="2011-04-25 09:01:18 +0100" MODIFIED_BY="Hermann Blessberger"><P>Randomized, placebo-controlled, double-blind trial; beta-blocker versus placebo</P></CHAR_METHODS><CHAR_PARTICIPANTS MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Overall: 40 participants; beta-blocker: 21 participants; placebo: 19 participants</P><P>Mean age: 51.4 years</P><P>Percentage of female participants: 42.5</P></CHAR_PARTICIPANTS><CHAR_INTERVENTIONS MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Participants received esmolol or placebo; treatment was intravenously administered during anaesthesia</P></CHAR_INTERVENTIONS><CHAR_OUTCOMES MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Primary outcome: control of perioperative hypertension </P><P>Secondary outcomes: hypotension, bradycardia</P></CHAR_OUTCOMES><CHAR_NOTES MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Type of surgery: different neurosurgical interventions</P></CHAR_NOTES></INCLUDED_CHAR><INCLUDED_CHAR MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" STUDY_ID="STD-Gomes-1999"><CHAR_METHODS MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Randomized, placebo-controlled, double-blind trial; beta-blocker versus placebo</P></CHAR_METHODS><CHAR_PARTICIPANTS MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Overall: 85 participants; beta-blocker: 40 participants; placebo: 45 participants</P><P>Mean age: 65.2 years</P><P>Percentage of female participants: 35.3</P></CHAR_PARTICIPANTS><CHAR_INTERVENTIONS MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Participants received sotalol or placebo; treatment was started 24 to 48 hours preoperatively and was continued for 4 days postoperatively. Participants were followed until hospital discharge</P></CHAR_INTERVENTIONS><CHAR_OUTCOMES MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Primary outcome: atrial fibrillation </P><P>Secondary outcomes: mortality, adverse events</P></CHAR_OUTCOMES><CHAR_NOTES MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Type of surgery: elective CABG ± valve replacement</P></CHAR_NOTES></INCLUDED_CHAR><INCLUDED_CHAR MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" STUDY_ID="STD-Graham-1996"><CHAR_METHODS MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Randomized, placebo-controlled trial; beta-blocker versus placebo</P></CHAR_METHODS><CHAR_PARTICIPANTS MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Overall: 320 participants; beta-blocker: 213 participants (103 participants 25 mg metoprolol and 110 participants 50 mg metoprolol); placebo: 107 participants</P><P>Mean age: data not provided</P><P>Percentage of female participants: data not provided</P></CHAR_PARTICIPANTS><CHAR_INTERVENTIONS MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Participants received metoprolol (high or low dose) or placebo; treatment was started postoperatively; duration of administration was unclear</P></CHAR_INTERVENTIONS><CHAR_OUTCOMES MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Primary outcome: atrial fibrillation</P></CHAR_OUTCOMES><CHAR_NOTES MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Type of surgery: elective CABG. Conference abstract</P></CHAR_NOTES></INCLUDED_CHAR><INCLUDED_CHAR MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" STUDY_ID="STD-Gupta-2011"><CHAR_METHODS MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Randomized, placebo-controlled, triple-blind trial; beta-blocker versus placebo</P></CHAR_METHODS><CHAR_PARTICIPANTS MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Overall: 66 participants; atenolol: 22 participants; clonidine: 22 participants; placebo: 22 participants</P><P>Mean age: not specified</P><P>Percentage female participants: not specified</P></CHAR_PARTICIPANTS><CHAR_INTERVENTIONS MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Participants received a single oral dose of placebo, atenolol or clonidine 2 hours before surgery</P></CHAR_INTERVENTIONS><CHAR_OUTCOMES MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Primary outcome: haemodynamic response to nasal speculum insertion (heart rate and blood pressure) </P><P>Secondary outcomes: bradycardia, hypotension, consumption of fentanyl and propofol</P></CHAR_OUTCOMES><CHAR_NOTES MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Type of surgery: neurosurgery</P></CHAR_NOTES></INCLUDED_CHAR><INCLUDED_CHAR MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" STUDY_ID="STD-Hammon-1984"><CHAR_METHODS MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Randomized, placebo-controlled, double-blind trial; beta-blocker versus placebo</P></CHAR_METHODS><CHAR_PARTICIPANTS MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Overall: 50 participants; beta-blocker: 24 participants; placebo: 26 participants</P><P>Mean age: data not provided</P><P>Percentage of female participants: data not provided</P></CHAR_PARTICIPANTS><CHAR_INTERVENTIONS MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Participants received propranolol or placebo. Treatment was started orally 24 to 48 hours preoperatively and was continued for 1 month</P></CHAR_INTERVENTIONS><CHAR_OUTCOMES MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Primary outcomes: atrial and ventricular arrhythmias </P><P>Secondary outcomes: death, myocardial infarction, bradycardia</P></CHAR_OUTCOMES><CHAR_NOTES MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Type of surgery: elective CABG</P></CHAR_NOTES></INCLUDED_CHAR><INCLUDED_CHAR MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" STUDY_ID="STD-Harrison-1987"><CHAR_METHODS MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Randomized, placebo-controlled, triple-blind trial; beta-blocker versus placebo</P></CHAR_METHODS><CHAR_PARTICIPANTS MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Overall: 30 participants; beta-blocker: 15 participants; placebo: 15 participants</P><P>Mean age: 56.4 years</P><P>Percentage of female participants: 10</P></CHAR_PARTICIPANTS><CHAR_INTERVENTIONS MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Participants received esmolol or placebo; treatment was administered IV intraoperatively</P></CHAR_INTERVENTIONS><CHAR_OUTCOMES MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Primary outcome: intraoperative myocardial ischaemia, intraoperative arrhythmias</P></CHAR_OUTCOMES><CHAR_NOTES MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Type of surgery: elective CABG</P></CHAR_NOTES></INCLUDED_CHAR><INCLUDED_CHAR MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" STUDY_ID="STD-Inada-1989"><CHAR_METHODS MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Randomized, placebo-controlled, double-blind trial; beta-blocker versus lidocaine versus placebo</P></CHAR_METHODS><CHAR_PARTICIPANTS MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Overall: 40 participants; labetalol 5 mg: 10 participants; labetalol 10 mg: 10 participants; lidocaine: 10 participants, placebo: 10 participants</P><P>Mean age: 51.3 years</P><P>Percentage of female participants: 53.3</P></CHAR_PARTICIPANTS><CHAR_INTERVENTIONS MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Participants received labetalol (5 or 10 mg), lidocaine or placebo; treatment was administered before induction and 2 minutes before the stimulus of intubation</P></CHAR_INTERVENTIONS><CHAR_OUTCOMES MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Primary outcome: haemodynamic response </P><P>Secondary outcome: dysrhythmias</P></CHAR_OUTCOMES><CHAR_NOTES MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Type of surgery not specified</P></CHAR_NOTES></INCLUDED_CHAR><INCLUDED_CHAR MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" STUDY_ID="STD-Ivey-1983"><CHAR_METHODS MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Randomized, placebo-controlled, double-blind trial; beta-blocker versus placebo</P></CHAR_METHODS><CHAR_PARTICIPANTS MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Overall: 109 participants; beta-blocker: 53 participants; placebo: 56 participants. Only participants receiving 80 mg or more propranolol per day were eligible for this study</P><P>Mean age: 56.8 years</P><P>Percentage of female participants: data not provided</P></CHAR_PARTICIPANTS><CHAR_INTERVENTIONS MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Participants received propranolol or placebo beginning 24 hours postoperatively. The study was discontinued after the fifth postoperative day</P></CHAR_INTERVENTIONS><CHAR_OUTCOMES MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Primary outcome: supraventricular tachycardia </P><P>Secondary outcome: mortality</P></CHAR_OUTCOMES><CHAR_NOTES MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Type of surgery: CABG</P></CHAR_NOTES></INCLUDED_CHAR><INCLUDED_CHAR MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" STUDY_ID="STD-Jacquet-1994"><CHAR_METHODS MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Randomized, open-label trial; beta-blocker versus standard care</P></CHAR_METHODS><CHAR_PARTICIPANTS MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Overall: 42 participants; beta-blocker: 25 participants; standard care: 17 participants</P><P>Mean age: 60.3 years</P><P>Percentage of female participants: 11.9</P></CHAR_PARTICIPANTS><CHAR_INTERVENTIONS MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Participants received sotalol or standard care; treatment was started 6 hours postoperatively (IV) and was continued orally for 3 months</P></CHAR_INTERVENTIONS><CHAR_OUTCOMES MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Primary outcome: supraventricular arrhythmias</P></CHAR_OUTCOMES><CHAR_NOTES MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Type of surgery: elective CABG</P></CHAR_NOTES></INCLUDED_CHAR><INCLUDED_CHAR MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" STUDY_ID="STD-Jakobsen-1992"><CHAR_METHODS MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Randomized, double-blind, placebo-controlled trial; beta-blocker versus placebo</P></CHAR_METHODS><CHAR_PARTICIPANTS MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Overall: 40 participants; beta-blocker: 20 participants; placebo: 20 participants</P><P>Mean age: 41 years</P><P>Percentage of female participants: 100</P></CHAR_PARTICIPANTS><CHAR_INTERVENTIONS MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Participants received a single dose of metoprolol (100 mg orally) or matching placebo 1 to 2.5 hours before surgery</P></CHAR_INTERVENTIONS><CHAR_OUTCOMES MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Primary outcomes: changes in catecholamine levels, heart rate, arrhythmias, blood pressure and perioperative blood loss</P></CHAR_OUTCOMES><CHAR_NOTES MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Type of surgery: hysterectomy</P></CHAR_NOTES></INCLUDED_CHAR><INCLUDED_CHAR MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" STUDY_ID="STD-Jakobsen-1997"><CHAR_METHODS MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Randomized, placebo-controlled, double-blind trial, beta-blocker versus placebo</P></CHAR_METHODS><CHAR_PARTICIPANTS MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Overall: 35 participants; beta-blocker: 18 participants; placebo: 17 participants (1 of 18 participants withdrawn)</P><P>Mean age: 60.4 years</P><P>Percentage of female participants: 34.3</P></CHAR_PARTICIPANTS><CHAR_INTERVENTIONS MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Participants received metoprolol or placebo orally 1.5 hours before surgery</P></CHAR_INTERVENTIONS><CHAR_OUTCOMES MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Primary outcomes: perioperative haemodynamic effects, surgical stress response </P><P>Secondary outcomes: dysrhythmias, myocardial infarction, bradycardia, hypotension</P></CHAR_OUTCOMES><CHAR_NOTES MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Type of surgery: elective thoracotomy for lung resection (general anaesthesia with thoracic epidural blockade)</P></CHAR_NOTES></INCLUDED_CHAR><INCLUDED_CHAR MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" STUDY_ID="STD-Janssen-1986"><CHAR_METHODS MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Randomized, open-label trial; 2 beta-blockers versus standard care</P></CHAR_METHODS><CHAR_PARTICIPANTS MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Overall: 130 participants; sotalol: 41 participants; metoprolol: 39 participants; standard care: 50 participants; here, only the metoprolol and standard care groups are considered</P><P>Mean age: 58.5 years</P><P>Percentage of female participants: 19.2</P></CHAR_PARTICIPANTS><CHAR_INTERVENTIONS MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Participants received sotalol, metoprolol or standard of care; treatment was started parenterally postoperatively, then 50 mg metoprolol 3 times a day orally until hospital discharge</P></CHAR_INTERVENTIONS><CHAR_OUTCOMES MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Primary outcome: supraventricular tachycardias</P></CHAR_OUTCOMES><CHAR_NOTES MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Type of surgery: elective CABG</P></CHAR_NOTES></INCLUDED_CHAR><INCLUDED_CHAR MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" STUDY_ID="STD-Kawaguchi-2010"><CHAR_METHODS MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Randomized, open-label multi-centre trial; beta-blocker versus standard of care</P></CHAR_METHODS><CHAR_PARTICIPANTS MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Overall: 56 participants (patients with subarachnoid haemorrhage and a heart rate above 90/min undergoing intracranial aneurysm repair surgery); landiolol: 28 participants; standard care: 28 participants</P><P>Mean age: 57.2 years</P><P>Percentage of female participants: 67.9</P></CHAR_PARTICIPANTS><CHAR_INTERVENTIONS MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Participants received landiolol or standard of care during intracranial aneurysm repair surgery. Landiolol was administered intravenously during surgery. Participants were prospectively followed until hospital discharge</P></CHAR_INTERVENTIONS><CHAR_OUTCOMES MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Primary outcomes: haemodynamic parameters, tissue injury markers</P><P>Secondary outcomes: mortality, acute myocardial infarction, bradycardia, hypotension</P></CHAR_OUTCOMES><CHAR_NOTES MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Type of surgery: neurosurgery</P></CHAR_NOTES></INCLUDED_CHAR><INCLUDED_CHAR MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" STUDY_ID="STD-Khuri-1987"><CHAR_METHODS MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Randomized, placebo-controlled, triple-blind trial; nadolol versus placebo</P></CHAR_METHODS><CHAR_PARTICIPANTS MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Overall: 141 participants; beta-blocker: 67 participants; placebo: 74 participants</P><P>Mean age: 59.9 years</P><P>Percentage of female participants: data not provided</P></CHAR_PARTICIPANTS><CHAR_INTERVENTIONS MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Participants received nadolol or placebo; treatment was started on the first postoperative day and was continued for 6 weeks</P></CHAR_INTERVENTIONS><CHAR_OUTCOMES MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Primary outcome: postoperative arrhythmias </P><P>Secondary outcomes: hypotension, myocardial infarction, mortality</P></CHAR_OUTCOMES><CHAR_NOTES MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Type of surgery: elective CABG</P></CHAR_NOTES></INCLUDED_CHAR><INCLUDED_CHAR MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" STUDY_ID="STD-Kurian-2001"><CHAR_METHODS MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Randomized, open-label trial; beta-blocker versus standard care</P></CHAR_METHODS><CHAR_PARTICIPANTS MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Overall: 68 participants; beta-blocker: 31 participants; standard care: 37 participants</P><P>Mean age: 60.7 years</P><P>Percentage of female participants: 14.7</P></CHAR_PARTICIPANTS><CHAR_INTERVENTIONS MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Participants received esmolol or standard care; treatment was started 120 minutes before extubation and was continued until 180 minutes after extubation</P></CHAR_INTERVENTIONS><CHAR_OUTCOMES MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Primary outcome: perioperative myocardial ischaemia (120 minutes before until 180 minutes after tracheal extubation)</P></CHAR_OUTCOMES><CHAR_NOTES MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Type of surgery: elective CABG</P></CHAR_NOTES></INCLUDED_CHAR><INCLUDED_CHAR MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" STUDY_ID="STD-Lai-2006"><CHAR_METHODS MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Randomized, open-label trial; beta-blocker versus standard care</P></CHAR_METHODS><CHAR_PARTICIPANTS MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Overall: 60 participants; beta-blocker: 30 participants; standard of care: 30 participants</P><P>Median age: 66.5 years</P><P>Percentage of female participants: 18.3</P></CHAR_PARTICIPANTS><CHAR_INTERVENTIONS MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Participants 65 years of age or older diagnosed with oesophageal cancer received metoprolol or standard care. Treatment was started at the induction of anaesthesia and was continued until 72 hours postoperatively</P></CHAR_INTERVENTIONS><CHAR_OUTCOMES MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Primary outcomes: haemodynamic parameters</P><P>Secondary outcomes: serum levels of troponin T, myocardial infarction, atrial fibrillation, mortality, myocardial ischaemia</P></CHAR_OUTCOMES><CHAR_NOTES MODIFIED="2011-08-04 17:39:53 +0100" MODIFIED_BY="Hermann Blessberger"><P>Type of surgery: oesophagectomy</P></CHAR_NOTES></INCLUDED_CHAR><INCLUDED_CHAR MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" STUDY_ID="STD-Lamb-1988"><CHAR_METHODS MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Randomized, open-label trial; beta-blocker versus standard care</P></CHAR_METHODS><CHAR_PARTICIPANTS MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Overall: 60 participants; beta-blocker: 30 participants; standard care: 30 participants</P><P>Mean age: 54.9 years</P><P>Percentage of female participants: 13.3</P></CHAR_PARTICIPANTS><CHAR_INTERVENTIONS MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Participants received atenolol or standard care; treatment was started 72 hours before surgery and was continued for 7 days</P></CHAR_INTERVENTIONS><CHAR_OUTCOMES MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Primary outcome: supraventricular arrhythmias</P></CHAR_OUTCOMES><CHAR_NOTES MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Type of surgery: elective CABG</P></CHAR_NOTES></INCLUDED_CHAR><INCLUDED_CHAR MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" STUDY_ID="STD-Lee-2010"><CHAR_METHODS MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Randomized, placebo-controlled trial; beta-blocker versus placebo</P></CHAR_METHODS><CHAR_PARTICIPANTS MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Overall: 60 participants; esmolol: 30 participants; placebo: 30 participants</P><P>Mean age: 35.4 years</P><P>Percentage female participants: 56.7</P></CHAR_PARTICIPANTS><CHAR_INTERVENTIONS MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Participants received esmolol or saline placebo during surgery intravenously with a bolus before intubation or extubation, respectively</P></CHAR_INTERVENTIONS><CHAR_OUTCOMES MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Primary outcomes: postoperative nausea, vomiting and pain </P><P>Secondary outcomes: haemodynamic variables, length of stay (surgery until discharge)</P></CHAR_OUTCOMES><CHAR_NOTES MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Type of surgery: laparoscopic appendectomy</P></CHAR_NOTES></INCLUDED_CHAR><INCLUDED_CHAR MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" STUDY_ID="STD-Liu-1986"><CHAR_METHODS MODIFIED="2011-04-25 17:09:30 +0100" MODIFIED_BY="Hermann Blessberger"><P>Randomized, placebo-controlled, double-blind trial; beta-blocker versus placebo</P></CHAR_METHODS><CHAR_PARTICIPANTS MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Overall: 30 participants; beta-blocker: 16 participants; placebo: 14 participants</P><P>Mean age: 45.3 years</P><P>Percentage of female participants: 90</P></CHAR_PARTICIPANTS><CHAR_INTERVENTIONS MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Participants received esmolol or placebo; treatment was administered during anaesthesia intravenously</P></CHAR_INTERVENTIONS><CHAR_OUTCOMES MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Primary outcome: haemodynamic variables </P><P>Secondary outcomes: dysrhythmias (bradycardia, ventricular ectopic beats) during surgery</P></CHAR_OUTCOMES><CHAR_NOTES MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Type of surgery: mainly gynaecological procedures</P></CHAR_NOTES></INCLUDED_CHAR><INCLUDED_CHAR MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" STUDY_ID="STD-Liu-2006"><CHAR_METHODS MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Randomized, open-label trial; beta-blocker versus standard care</P></CHAR_METHODS><CHAR_PARTICIPANTS MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Overall: 30 participants; beta-blocker: 15 participants; standard of care: 15 participants</P><P>Mean age: 69.5 years</P><P>Percentage of female participants: 46.7</P></CHAR_PARTICIPANTS><CHAR_INTERVENTIONS MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Participants received metoprolol intravenously during surgery or standard care</P></CHAR_INTERVENTIONS><CHAR_OUTCOMES MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Primary outcomes: haemodynamic parameters</P><P>Secondary outcomes: myocardial ischaemia, troponin levels, hypotension, bradycardia</P></CHAR_OUTCOMES><CHAR_NOTES MODIFIED="2013-11-24 06:23:55 +0000" MODIFIED_BY="Hermann Blessberger"><P>Type of surgery: non-cardiac surgery (lung resection, oesophagectomy, gastrectomy)</P></CHAR_NOTES></INCLUDED_CHAR><INCLUDED_CHAR MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" STUDY_ID="STD-Magnusson-1986"><CHAR_METHODS MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Randomized, double-blind, placebo-controlled trial; beta-blocker versus placebo</P></CHAR_METHODS><CHAR_PARTICIPANTS MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Overall: 27 participants with arterial hypertension; beta-blocker: 13 participants; placebo: 14 participants</P><P>Mean age: 57.6 years</P><P>Percentage of female participants: 63.0</P></CHAR_PARTICIPANTS><CHAR_INTERVENTIONS MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Participants received metoprolol or placebo tablets and saline; treatment was started 2 weeks before surgery until postoperative day 1</P></CHAR_INTERVENTIONS><CHAR_OUTCOMES MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Outcomes: multiple haemodynamic parameters, heart failure, ventricular extrasystoles, bradycardia, hypotension</P></CHAR_OUTCOMES><CHAR_NOTES MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Type of surgery: cholecystectomy, herniorrhaphy</P></CHAR_NOTES></INCLUDED_CHAR><INCLUDED_CHAR MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" STUDY_ID="STD-Mangano-1996"><CHAR_METHODS MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Randomized, placebo-controlled, triple-blind trial; beta-blocker versus placebo</P></CHAR_METHODS><CHAR_PARTICIPANTS MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Overall: 200 participants; beta-blocker: 99 participants; placebo: 101 participants; participants were included if they had, or were at risk for, coronary artery disease; <B>same population as </B><LINK REF="STD-Wallace-1998" TYPE="STUDY">Wallace 1998</LINK></P><P>Mean age: 67.5 years</P><P>Percentage of female participants: data not provided</P></CHAR_PARTICIPANTS><CHAR_INTERVENTIONS MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Participants received atenolol or placebo; treatment was started preoperatively and was continued until hospital discharge</P></CHAR_INTERVENTIONS><CHAR_OUTCOMES MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Primary outcome: mortality from all causes during the 2 years after discharge </P><P>Secondary outcomes: myocardial infarction, unstable angina, congestive heart failure, myocardial revascularization, adverse events</P></CHAR_OUTCOMES><CHAR_NOTES MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Type of surgery: non-cardiac surgery</P></CHAR_NOTES></INCLUDED_CHAR><INCLUDED_CHAR MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" STUDY_ID="STD-Martinussen-1988"><CHAR_METHODS MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Randomized, placebo-controlled, double-blind trial; beta-blocker versus placebo</P></CHAR_METHODS><CHAR_PARTICIPANTS MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Overall: 75 participants; beta-blocker: 35 participants; placebo: 40 participants</P><P>Mean age: 55.4 years</P><P>Percentage of female participants: 17.6</P></CHAR_PARTICIPANTS><CHAR_INTERVENTIONS MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Participants received propranolol or placebo; treatment was started on the evening of the day of surgery and was continued until the end of the fourth day after surgery</P></CHAR_INTERVENTIONS><CHAR_OUTCOMES MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Primary outcome: supraventricular tachyarrhythmias </P><P>Secondary outcome: myocardial infarction</P></CHAR_OUTCOMES><CHAR_NOTES MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Type of surgery: elective CABG</P></CHAR_NOTES></INCLUDED_CHAR><INCLUDED_CHAR MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" STUDY_ID="STD-Marwick-2009"><CHAR_METHODS MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Randomized, multi-centre, open-label, controlled trial; universal beta-blocker therapy versus standard of care</P></CHAR_METHODS><CHAR_PARTICIPANTS MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Overall 400 participants; beta-blocker: 197 participants; standard care: 203 participants</P><P>Mean age: 72.5 years</P><P>Percentage of female participants: 36</P></CHAR_PARTICIPANTS><CHAR_INTERVENTIONS MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Participants at intermediate cardiovascular risk were randomly assigned to universal beta-blocker therapy or usual care (beta-blockers were continued in participants already taking them and were newly prescribed in participants identified as at high risk based on evidence of ischaemia during dobutamine stress echocardiography). Beta-blockers were started at least 1 week before surgery and were continued until 30 days after surgery</P></CHAR_INTERVENTIONS><CHAR_OUTCOMES MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Primary endpoint: major cardiovascular event (cardiac death or non-fatal myocardial infarction)</P><P>Secondary outcomes: all-cause mortality, hypotension, bradycardia, length of stay, cerebrovascular events</P></CHAR_OUTCOMES><CHAR_NOTES MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Type of surgery: major, non-cardiac surgery</P></CHAR_NOTES></INCLUDED_CHAR><INCLUDED_CHAR MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" STUDY_ID="STD-Matangi-1985"><CHAR_METHODS MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Randomized, open-label trial; beta-blocker versus standard care</P></CHAR_METHODS><CHAR_PARTICIPANTS MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Overall: 164 participants (all participants received beta-blockers preoperatively); beta-blocker: 82 participants; standard care: 82 participants</P><P>Mean age: 55.2 years</P><P>Percentage of female participants: 20.7</P></CHAR_PARTICIPANTS><CHAR_INTERVENTIONS MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Participants received propranolol or placebo; treatment was started postoperatively and was continued until the time of discharge</P></CHAR_INTERVENTIONS><CHAR_OUTCOMES MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Primary outcomes: supraventricular arrhythmias, ventricular arrhythmias, ventricular premature beats </P><P>Secondary outcome: acute myocardial infarction</P></CHAR_OUTCOMES><CHAR_NOTES MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Type of surgery: elective CABG</P></CHAR_NOTES></INCLUDED_CHAR><INCLUDED_CHAR MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" STUDY_ID="STD-Matangi-1989"><CHAR_METHODS MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Randomized, placebo-controlled, double-blind trial; beta-blocker versus placebo</P></CHAR_METHODS><CHAR_PARTICIPANTS MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Overall: 70 participants; beta-blocker: 35 participants; placebo: 35 participants</P><P>Mean age: 59.2 years</P><P>Percentage of female participants: 21.4</P></CHAR_PARTICIPANTS><CHAR_INTERVENTIONS MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Participants received atenolol or placebo (at first intravenously, then orally); treatment was started postoperatively and was continued for 6 days</P></CHAR_INTERVENTIONS><CHAR_OUTCOMES MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Primary outcome: supraventricular arrhythmias </P><P>Secondary outcomes: acute myocardial infarction, adverse events</P></CHAR_OUTCOMES><CHAR_NOTES MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Type of surgery: CABG</P></CHAR_NOTES></INCLUDED_CHAR><INCLUDED_CHAR MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" STUDY_ID="STD-Materne-1985"><CHAR_METHODS MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Randomized, open-label trial, beta-blocker versus standard care</P></CHAR_METHODS><CHAR_PARTICIPANTS MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Overall: 71 participants; beta-blocker: 32 participants; standard care: 39 participants</P><P>Mean age: 56.6 years</P><P>Percentage of female participants: 15.5</P></CHAR_PARTICIPANTS><CHAR_INTERVENTIONS MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Participants received acebutolol or standard care; treatment was started 24 hours after initiation of surgery; no end of the treatment period was specified</P></CHAR_INTERVENTIONS><CHAR_OUTCOMES MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Primary outcome: supraventricular and ventricular arrhythmias </P><P>Secondary outcome: haemodynamic parameters</P></CHAR_OUTCOMES><CHAR_NOTES MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Type of surgery: elective CABG</P></CHAR_NOTES></INCLUDED_CHAR><INCLUDED_CHAR MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" STUDY_ID="STD-Matsuura-2001"><CHAR_METHODS MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Randomized, open-label trial, beta-blocker versus standard care</P></CHAR_METHODS><CHAR_PARTICIPANTS MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Overall: 80 participants; beta-blocker: 40 participants; standard care: 40 participants</P><P>Mean age: 61 years</P><P>Percentage of female participants: 19</P></CHAR_PARTICIPANTS><CHAR_INTERVENTIONS MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Participants received sotalol or standard care; treatment was started on the first postoperative day and was continued for 2 weeks</P></CHAR_INTERVENTIONS><CHAR_OUTCOMES MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Primary outcome: atrial fibrillation </P><P>Secondary outcome: length of stay</P></CHAR_OUTCOMES><CHAR_NOTES MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Type of surgery: elective CABG</P></CHAR_NOTES></INCLUDED_CHAR><INCLUDED_CHAR MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" STUDY_ID="STD-Miller-1990"><CHAR_METHODS MODIFIED="2011-04-25 17:46:43 +0100" MODIFIED_BY="Hermann Blessberger"><P>Randomized, placebo-controlled, double-blind trial; beta-blocker versus placebo</P></CHAR_METHODS><CHAR_PARTICIPANTS MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Overall: 45 participants (those above 75 years of age with coronary artery disease or a minimum of 2 risk factors for coronary artery disease); beta-blocker: 30 participants; placebo: 15 participants</P><P>Mean age: 59 years</P><P>Percentage of female participants: 15.6</P></CHAR_PARTICIPANTS><CHAR_INTERVENTIONS MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Participants received a single IV bolus of esmolol or placebo at induction of anaesthesia</P></CHAR_INTERVENTIONS><CHAR_OUTCOMES MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Primary outcome: haemodynamic variables </P><P>Secondary outcomes: death, myocardial infarction, myocardial ischaemia, hypotension</P></CHAR_OUTCOMES><CHAR_NOTES><P>Type of surgery: elective peripheral vascular surgery</P></CHAR_NOTES></INCLUDED_CHAR><INCLUDED_CHAR MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" STUDY_ID="STD-Miller-1991"><CHAR_METHODS MODIFIED="2011-04-25 17:48:24 +0100" MODIFIED_BY="Hermann Blessberger"><P>Randomized, placebo-controlled, double-blind trial; beta-blocker versus placebo</P></CHAR_METHODS><CHAR_PARTICIPANTS MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Overall: 548 participants; beta-blocker: 368 participants; placebo: 180 participants</P><P>Mean age: 55.7 years</P><P>Percentage of female participants: 52.0</P></CHAR_PARTICIPANTS><CHAR_INTERVENTIONS MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Participants received a bolus of esmolol or placebo at induction of anaesthesia</P></CHAR_INTERVENTIONS><CHAR_OUTCOMES MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Primary outcome: haemodynamic variables </P><P>Secondary outcomes: bradycardia, hypotension, bronchospasm</P></CHAR_OUTCOMES><CHAR_NOTES><P>Type of surgery: elective non-cardiac surgery</P></CHAR_NOTES></INCLUDED_CHAR><INCLUDED_CHAR MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" STUDY_ID="STD-Mohr-1981"><CHAR_METHODS MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Randomized, open-label trial; beta-blocker versus standard care</P></CHAR_METHODS><CHAR_PARTICIPANTS MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Overall: 85 participants; beta-blocker: 37 participants; standard care: 48 participants</P><P>Mean age: 56.6 years</P><P>Percentage of female participants: 15.3</P></CHAR_PARTICIPANTS><CHAR_INTERVENTIONS MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>All participants were receiving preoperative propranolol; in the standard care group, beta-blockers were withdrawn preoperatively, and in the intervention group, treatment was continued</P></CHAR_INTERVENTIONS><CHAR_OUTCOMES MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Primary outcome: supraventricular arrhythmias </P><P>Secondary outcomes: myocardial infarction, perioperative death</P></CHAR_OUTCOMES><CHAR_NOTES MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Type of surgery: elective CABG</P></CHAR_NOTES></INCLUDED_CHAR><INCLUDED_CHAR MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" STUDY_ID="STD-Moon-2011"><CHAR_METHODS MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Randomized, triple-blind, placebo-controlled trial; beta-blocker versus placebo</P></CHAR_METHODS><CHAR_PARTICIPANTS MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Overall: 54 participants; esmolol: 27 participants; placebo: 27 participants</P><P>Mean age: 39.4 years</P><P>Percentage of female participants: 100</P></CHAR_PARTICIPANTS><CHAR_INTERVENTIONS MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Participants received esmolol or saline placebo intravenously (loading dose followed by maintenance dose). The exact duration of drug application was not explicitly specified, but it can be inferred unambiguously that treatment was given during general anaesthesia</P></CHAR_INTERVENTIONS><CHAR_OUTCOMES MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Primary outcome: consumption of sevoflurane and fentanyl </P><P>Secondary outcome: haemodynamic parameters (bradycardia, hypotension)</P></CHAR_OUTCOMES><CHAR_NOTES MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Type of surgery: laparoscopic gynaecological surgery</P></CHAR_NOTES></INCLUDED_CHAR><INCLUDED_CHAR MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" STUDY_ID="STD-Myhre-1984"><CHAR_METHODS MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Randomized, open-label trial, beta-blocker versus standard care</P></CHAR_METHODS><CHAR_PARTICIPANTS MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Overall: 36 participants (all had stabile angina pectoris and were taking beta-blockers preoperatively); beta-blocker: 16 participants; standard care: 20 participants</P><P>Mean age: 56.0 years</P><P>Percentage of female participants: 20.0</P></CHAR_PARTICIPANTS><CHAR_INTERVENTIONS MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Participants received propranolol or standard care; treatment was restarted 2 hours postoperatively and was continued for 7 days (as all participants in the propranolol group were taking beta-blockers preoperatively)</P></CHAR_INTERVENTIONS><CHAR_OUTCOMES MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Primary outcome: supraventricular tachyarrhythmias </P><P>Secondary outcome: acute myocardial infarction</P></CHAR_OUTCOMES><CHAR_NOTES MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Type of surgery: elective CABG</P></CHAR_NOTES></INCLUDED_CHAR><INCLUDED_CHAR MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" STUDY_ID="STD-Neary-2006"><CHAR_METHODS MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Randomized, triple-blind, placebo-controlled trial; beta-blocker versus placebo</P></CHAR_METHODS><CHAR_PARTICIPANTS MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Overall: 38 participants; beta-blocker: 18 participants; placebo: 20 participants</P><P>Mean age: data not provided</P><P>Percentage of female participants: data not provided</P></CHAR_PARTICIPANTS><CHAR_INTERVENTIONS MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Cardiac high-risk participants naive to beta-blockers who underwent non-elective emergency surgery were randomly assigned to receive atenolol or placebo (from induction of anaesthesia until seventh postoperative day)</P></CHAR_INTERVENTIONS><CHAR_OUTCOMES MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Primary outcome: mortality and non-fatal cardiac events until 30 days after surgery. A long-term follow-up was also performed (2 years)</P></CHAR_OUTCOMES><CHAR_NOTES MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Type of surgery: non-elective, non-cardiac emergency surgery (gastrointestinal resection surgery, major limb amputation, arterial reconstruction, orthopaedic procedures)</P></CHAR_NOTES></INCLUDED_CHAR><INCLUDED_CHAR MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" STUDY_ID="STD-Neustein-1994"><CHAR_METHODS MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Randomized, triple-blind, placebo-controlled trial; beta-blocker versus placebo</P></CHAR_METHODS><CHAR_PARTICIPANTS MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Overall: 38 participants; beta-blocker: 16 participants; placebo: 22 participants</P><P>Mean age: 64.0 years</P><P>Percentage of female participants: 35.0</P></CHAR_PARTICIPANTS><CHAR_INTERVENTIONS MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Participants received esmolol or placebo; treatment was administered intraoperatively</P></CHAR_INTERVENTIONS><CHAR_OUTCOMES MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Primary outcome: intraoperative myocardial ischaemia</P></CHAR_OUTCOMES><CHAR_NOTES MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Type of surgery: elective CABG</P></CHAR_NOTES></INCLUDED_CHAR><INCLUDED_CHAR MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" STUDY_ID="STD-Nystr_x00f6_m-1993"><CHAR_METHODS MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Randomized, open-label trial; beta-blocker versus standard care</P></CHAR_METHODS><CHAR_PARTICIPANTS MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Overall: 101 participants; beta-blocker: 50; standard care: 51</P><P>Mean age: 59.5 years</P><P>Percentage of female participants: 12.9</P></CHAR_PARTICIPANTS><CHAR_INTERVENTIONS MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Participants received sotalol or standard care; treatment was started on the morning of the day of surgery; study ended on the sixth postoperative day</P></CHAR_INTERVENTIONS><CHAR_OUTCOMES MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Primary outcome: atrial fibrillation </P><P>Secondary outcomes: mortality, ventricular arrhythmias</P></CHAR_OUTCOMES><CHAR_NOTES MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Type of surgery: elective CABG</P></CHAR_NOTES></INCLUDED_CHAR><INCLUDED_CHAR MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" STUDY_ID="STD-Ogawa-2013"><CHAR_METHODS MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Randomized, controlled, open-label trial; beta-blocker versus standard of care</P></CHAR_METHODS><CHAR_PARTICIPANTS MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Overall: 136 participants; landiolol: 68 participants; standard of care: 68 participants</P><P>Mean age: 70.5 years</P><P>Percentage of female participants: 22.8</P></CHAR_PARTICIPANTS><CHAR_INTERVENTIONS MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Participants received standard of care or landiolol. Landiolol was started after induction of anaesthesia and was continued for 48 hours (heart rate titrated)</P></CHAR_INTERVENTIONS><CHAR_OUTCOMES MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Primary outcome: incidence of postoperative atrial fibrillation </P><P>Secondary outcomes: laboratory markers of ischaemia and inflammation, heart rate</P></CHAR_OUTCOMES><CHAR_NOTES MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Type of surgery: off-pump CABG (16.9% emergency surgery)</P></CHAR_NOTES></INCLUDED_CHAR><INCLUDED_CHAR MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" STUDY_ID="STD-Oka-1980"><CHAR_METHODS MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Randomized, open-label trial; beta-blocker versus standard care</P></CHAR_METHODS><CHAR_PARTICIPANTS MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Overall: 54 participants; beta-blocker: 19 participants; standard care: 35 participants</P><P>Mean age: 54.7 years</P><P>Percentage of female participants: 37</P></CHAR_PARTICIPANTS><CHAR_INTERVENTIONS MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>All participants received preoperative beta-blockers; in the standard care group, beta-blockers were withdrawn preoperatively; in the beta-blocker group, they were continued, with observation until hospital discharge</P></CHAR_INTERVENTIONS><CHAR_OUTCOMES MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Primary outcome: haemodynamic variables </P><P>Secondary outcomes: supraventricular arrhythmias, mortality, acute myocardial infarction</P></CHAR_OUTCOMES><CHAR_NOTES MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Type of surgery: elective CABG</P></CHAR_NOTES></INCLUDED_CHAR><INCLUDED_CHAR MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" STUDY_ID="STD-Ormerod-1984"><CHAR_METHODS MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Randomized, open-label trial; beta-blocker versus digoxin versus standard care</P></CHAR_METHODS><CHAR_PARTICIPANTS MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Overall: 90 participants; beta-blocker: 27 participants; digoxin: 30 participants; standard-care: 33 participants</P><P>Mean age: 53.2 years</P><P>Percentage of female participants: 11.7</P></CHAR_PARTICIPANTS><CHAR_INTERVENTIONS MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Participants received propranolol, digoxin or standard care; treatment was started on the morning after operation; no end of drug administration was specified</P></CHAR_INTERVENTIONS><CHAR_OUTCOMES MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Primary outcome: atrial fibrillation </P><P>Secondary outcome: ventricular extrasystoles</P></CHAR_OUTCOMES><CHAR_NOTES MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Type of surgery: elective CABG</P></CHAR_NOTES></INCLUDED_CHAR><INCLUDED_CHAR MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" STUDY_ID="STD-Osada-2012"><CHAR_METHODS MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Conference abstract. Randomized, controlled, open-label trial; beta-blocker versus standard of care</P></CHAR_METHODS><CHAR_PARTICIPANTS MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Overall: 141 participants; landiolol: 73 participants; standard of care: 68 participants</P><P>Mean age: data not provided</P><P>Percentage of female participants: data not provided</P></CHAR_PARTICIPANTS><CHAR_INTERVENTIONS MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Participants received landiolol intravenously or standard of care. Landiolol was started upon arrival in the intensive care unit after surgery and was continued for 48 hours</P></CHAR_INTERVENTIONS><CHAR_OUTCOMES MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Primary outcome: occurrence of postoperative atrial fibrillation</P></CHAR_OUTCOMES><CHAR_NOTES MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Type of surgery: open-heart surgery (CABG, valve surgery, thoracic aorta surgery)</P></CHAR_NOTES></INCLUDED_CHAR><INCLUDED_CHAR MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" STUDY_ID="STD-Oxorn-1990"><CHAR_METHODS MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Randomized, triple-blind, placebo-controlled trial; beta-blocker versus placebo</P></CHAR_METHODS><CHAR_PARTICIPANTS MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Overall: 48 participants; 2 esmolol groups, each consisting of 16 participants; placebo: 16 participants</P><P>Mean age: 42.6 years</P><P>Percentage of female participants: 100</P></CHAR_PARTICIPANTS><CHAR_INTERVENTIONS MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Participants received esmolol or placebo as a single dose; treatment was administered intraoperatively</P></CHAR_INTERVENTIONS><CHAR_OUTCOMES MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Primary outcomes: perioperative hypertension and tachycardia </P><P>Secondary outcome: ventricular extrasystoles</P></CHAR_OUTCOMES><CHAR_NOTES MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Type of surgery: hysterectomy</P></CHAR_NOTES></INCLUDED_CHAR><INCLUDED_CHAR MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" STUDY_ID="STD-Paull-1997"><CHAR_METHODS MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Randomized, placebo-controlled, single-blind trial; beta-blocker versus placebo</P></CHAR_METHODS><CHAR_PARTICIPANTS MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Overall: 100 participants; beta-blocker: 50 participants; placebo: 50 participants</P><P>Mean age: 63.4 years</P><P>Percentage of female participants: 11</P></CHAR_PARTICIPANTS><CHAR_INTERVENTIONS MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Participants received metoprolol or placebo; treatment was started when postoperative oral feeding was possible (typically 24 hours after surgery); no end of drug administration was specified</P></CHAR_INTERVENTIONS><CHAR_OUTCOMES MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Primary outcome: atrial fibrillation </P><P>Secondary outcome: mortality</P></CHAR_OUTCOMES><CHAR_NOTES MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Type of surgery: elective CABG</P></CHAR_NOTES></INCLUDED_CHAR><INCLUDED_CHAR MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" STUDY_ID="STD-Pfisterer-1997"><CHAR_METHODS MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Randomized, placebo-controlled, double-blind trial; beta-blocker versus placebo</P></CHAR_METHODS><CHAR_PARTICIPANTS MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Overall: 255 participants; beta-blocker: 126 participants; placebo: 129 participants</P><P>Mean age: 60.6 years</P><P>Percentage of female participants: 13.3</P></CHAR_PARTICIPANTS><CHAR_INTERVENTIONS MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Participants received sotalol or placebo; treatment was started 2 hours before induction of anaesthesia; treatment was given for a total of 3 months</P></CHAR_INTERVENTIONS><CHAR_OUTCOMES MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Primary outcome: supraventricular tachyarrhythmias/atrial fibrillation </P><P>Secondary outcomes: ventricular arrhythmias, bradycardia, hypotension</P></CHAR_OUTCOMES><CHAR_NOTES MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Type of surgery: elective CABG or aortic valve surgery</P></CHAR_NOTES></INCLUDED_CHAR><INCLUDED_CHAR MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" STUDY_ID="STD-POBBLE-2005"><CHAR_METHODS MODIFIED="2011-04-25 18:41:02 +0100" MODIFIED_BY="Hermann Blessberger"><P>Randomized, placebo-controlled, double-blind trial; beta-blocker versus placebo</P></CHAR_METHODS><CHAR_PARTICIPANTS MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Overall: 97 participants; beta-blocker: 53 participants; placebo: 44 participants</P><P>Mean age: 73.5 years</P><P>Percentage of female participants: 22.7</P></CHAR_PARTICIPANTS><CHAR_INTERVENTIONS MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Participants received oral metoprolol or placebo; treatment was started on the day before surgery and was continued until the seventh postoperative day</P></CHAR_INTERVENTIONS><CHAR_OUTCOMES MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Primary outcomes: fatal and non-fatal cardiovascular events (myocardial infarction, unstable angina, ventricular tachycardia, or stroke) within 30 days of operation </P><P>Secondary outcomes: length of hospital stay</P></CHAR_OUTCOMES><CHAR_NOTES><P>Type of surgery: elective infrarenal vascular surgery</P></CHAR_NOTES></INCLUDED_CHAR><INCLUDED_CHAR MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" STUDY_ID="STD-POISE-2008"><CHAR_METHODS MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Randomized, placebo-controlled, triple-blind multi-centre trial; beta-blocker versus placebo</P></CHAR_METHODS><CHAR_PARTICIPANTS MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Overall: 8351 participants with or at risk of atherosclerotic disease; metoprolol: 4174 participants; placebo: 4177 participants</P><P>Mean age: 69 years</P><P>Percentage of female participants: 36.6</P></CHAR_PARTICIPANTS><CHAR_INTERVENTIONS MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Participants received metoprolol succinate or placebo; treatment was started 2 to 4 hours before surgery and was continued for 30 days</P></CHAR_INTERVENTIONS><CHAR_OUTCOMES MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Primary composite outcome: cardiovascular death, non-fatal myocardial infarction, non-fatal cardiac arrest </P><P>Secondary outcomes: all-cause mortality, hypotension, bradycardia, stroke, congestive heart failure, new-onset atrial fibrillation</P></CHAR_OUTCOMES><CHAR_NOTES MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Type of surgery: non-cardiac surgery (vascular, intraperitoneal, orthopaedic and other)</P></CHAR_NOTES></INCLUDED_CHAR><INCLUDED_CHAR MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" STUDY_ID="STD-Raby-1999"><CHAR_METHODS MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Randomized, placebo-controlled, triple-blinded trial; beta-blocker versus placebo.</P></CHAR_METHODS><CHAR_PARTICIPANTS MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Overall: 26 participants; beta-blocker: 15 participants; placebo: 11 participants</P><P>Mean age: 68.2 years</P><P>Percentage of female participants: 53.8</P></CHAR_PARTICIPANTS><CHAR_INTERVENTIONS MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Participants received esmolol or placebo; treatment was administered intraoperatively</P></CHAR_INTERVENTIONS><CHAR_OUTCOMES MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Primary outcome: perioperative myocardial ischaemia </P><P>Secondary outcomes: myocardial infarction, unstable angina</P></CHAR_OUTCOMES><CHAR_NOTES MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Type of surgery: aortic aneurysm repair, infrainguinal arterial bypass, carotid endarteriectomy</P></CHAR_NOTES></INCLUDED_CHAR><INCLUDED_CHAR MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" STUDY_ID="STD-Reves-1990"><CHAR_METHODS MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Randomized, double-blind, placebo-controlled trial; beta-blocker versus placebo</P></CHAR_METHODS><CHAR_PARTICIPANTS MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Overall: 30 participants; beta-blocker: 16 participants; placebo: 14 participants</P><P>Mean age: 56.1 years</P><P>Percentage of female participants: 10</P></CHAR_PARTICIPANTS><CHAR_INTERVENTIONS MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Participants received esmolol or placebo; treatment was administered intraoperatively</P></CHAR_INTERVENTIONS><CHAR_OUTCOMES MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Primary outcome: resolution of tachycardia and hypertension </P><P>Secondary outcome: myocardial ischaemia</P></CHAR_OUTCOMES><CHAR_NOTES MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Type of surgery: elective CABG</P></CHAR_NOTES></INCLUDED_CHAR><INCLUDED_CHAR MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" STUDY_ID="STD-Rubin-1987"><CHAR_METHODS MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Randomized, open-label trial; beta-blocker versus digoxin versus standard care</P></CHAR_METHODS><CHAR_PARTICIPANTS MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Overall: 123 participants; beta-blocker: 37 participants; digoxin: 46 participants; standard care: 40 participants</P><P>Mean age: 55.4 years</P><P>Percentage of female participants: data not provided</P></CHAR_PARTICIPANTS><CHAR_INTERVENTIONS MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Participants received propranolol, digoxin or standard care; treatment was started on the first postoperative day and continued for 6 weeks</P></CHAR_INTERVENTIONS><CHAR_OUTCOMES MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Primary outcome: atrial fibrillation</P></CHAR_OUTCOMES><CHAR_NOTES MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Type of surgery: elective CABG</P></CHAR_NOTES></INCLUDED_CHAR><INCLUDED_CHAR MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" STUDY_ID="STD-Sakaguchi-2012"><CHAR_METHODS MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Randomized, open-label trial; beta-blocker versus standard care</P></CHAR_METHODS><CHAR_PARTICIPANTS MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Overall: 60 participants; landiolol: 30 participants; standard care: 30 participants</P><P>Mean age: 69.0 years</P><P>Percentage of female participants: 46.7</P></CHAR_PARTICIPANTS><CHAR_INTERVENTIONS MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Participants received landiolol or standard of care. Landiolol was administered heart rate titrated; it was started upon admission to the intensive care unit after surgery and was continued until 72 hours after surgery</P></CHAR_INTERVENTIONS><CHAR_OUTCOMES MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Primary outcome: occurrence of atrial fibrillation after surgery</P></CHAR_OUTCOMES><CHAR_NOTES MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Type of surgery: heart valve surgery</P></CHAR_NOTES></INCLUDED_CHAR><INCLUDED_CHAR MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" STUDY_ID="STD-Salazar-1979"><CHAR_METHODS MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Randomized, open-label trial; beta-blocker versus standard care</P></CHAR_METHODS><CHAR_PARTICIPANTS MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Overall: 42 participants; beta-blocker: 20 participants; standard care 22 participants</P><P>Mean age: data not provided</P><P>Percentage of female participants: data not provided</P></CHAR_PARTICIPANTS><CHAR_INTERVENTIONS MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>All participants received propranolol before surgery. Participants received propranolol or standard care; treatment was restarted immediately after surgery in the propranolol group; no end of therapy was specified</P></CHAR_INTERVENTIONS><CHAR_OUTCOMES MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Primary outcomes: supraventricular arrhythmias, atrial fibrillation </P><P>Secondary outcomes: hypotension</P></CHAR_OUTCOMES><CHAR_NOTES MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Type of surgery: elective CABG</P></CHAR_NOTES></INCLUDED_CHAR><INCLUDED_CHAR MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" STUDY_ID="STD-Sandler-1990"><CHAR_METHODS MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Randomized, placebo-controlled, double-blind trial; beta-blocker versus placebo</P></CHAR_METHODS><CHAR_PARTICIPANTS MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Overall: 45 participants; beta-blocker: 30 participants; placebo: 15 participants</P><P>Mean age: 60 years</P><P>Percentage of female participants: 35.6</P></CHAR_PARTICIPANTS><CHAR_INTERVENTIONS MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Patients received esmolol (100 mg or 200 mg) or placebo; treatment was administered intraoperatively</P></CHAR_INTERVENTIONS><CHAR_OUTCOMES MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Primary outcomes: increased heart rate, increased blood pressure </P><P>Secondary outcome: ventricular arrhythmias</P></CHAR_OUTCOMES><CHAR_NOTES MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Type of intervention: rigid bronchoscopy</P></CHAR_NOTES></INCLUDED_CHAR><INCLUDED_CHAR MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" STUDY_ID="STD-Sezai-2011"><CHAR_METHODS MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Randomized, double-blind, placebo-controlled trial; beta-blocker versus saline placebo</P></CHAR_METHODS><CHAR_PARTICIPANTS MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Overall: 140 participants; landiolol: 70 participants; placebo: 70 participants</P><P>Mean age: 67.6 years</P><P>Percentage female participants: 8.6</P></CHAR_PARTICIPANTS><CHAR_INTERVENTIONS MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Intravenous landiolol or saline placebo was started during surgery and was continued for 48 hours</P></CHAR_INTERVENTIONS><CHAR_OUTCOMES MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Primary endpoint: occurrence of atrial fibrillation during 1 week after surgery </P><P>Secondary endpoints: mortality, haemodynamic parameters, total cost of hospital treatment, multiple laboratory parameters indicating myocardial ischaemia or inflammation, length of stay, congestive heart failure, stroke</P></CHAR_OUTCOMES><CHAR_NOTES MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Type of surgery: elective CABG</P></CHAR_NOTES></INCLUDED_CHAR><INCLUDED_CHAR MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" STUDY_ID="STD-Sezai-2012"><CHAR_METHODS MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Randomized, single-blind, placebo-controlled trial; beta-blocker versus placebo</P></CHAR_METHODS><CHAR_PARTICIPANTS MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Overall: 101 participants; landiolol: 34 participants; landiolol + oral bisoprolol: 33 participants; placebo: 34 participants</P><P>Mean age: 68.2 years</P><P>Percentage of female participants: 18.8</P></CHAR_PARTICIPANTS><CHAR_INTERVENTIONS MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Participants were randomly assigned to receive landiolol IV or saline placebo IV or to receive oral bisoprolol and IV landiolol. The trial was double-blinded for the application of IV drugs and was single-blinded for oral bisoprolol treatment. Both beta-blocker groups were combined as a single beta-blocker group versus saline placebo in our analysis. Study drugs were started during surgery and were continued for 3 days</P></CHAR_INTERVENTIONS><CHAR_OUTCOMES MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Primary outcome: atrial fibrillation within first week after surgery </P><P>Secondary outcomes: haemodynamic parameters, multiple lab parameters indicating myocardial ischaemia or inflammation, mortality, acute myocardial infarction, congestive heart failure, length of stay</P></CHAR_OUTCOMES><CHAR_NOTES MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Type of surgery: elective CABG</P></CHAR_NOTES></INCLUDED_CHAR><INCLUDED_CHAR MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" STUDY_ID="STD-Shukla-2010"><CHAR_METHODS MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Randomized, double-blind, placebo-controlled trial; beta-blocker versus placebo</P></CHAR_METHODS><CHAR_PARTICIPANTS MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Overall: 60 participants; esmolol: 30 participants; saline placebo: 30 participants</P><P>Mean age: 43.6 years</P><P>Percentage of female participants: 50</P></CHAR_PARTICIPANTS><CHAR_INTERVENTIONS MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Participants received esmolol or saline placebo intravenously 15 minutes before induction of anaesthesia until the end of surgery</P></CHAR_INTERVENTIONS><CHAR_OUTCOMES MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Outcome parameters: haemodynamic variables (heart rate, mean arterial pressure), intraoperative morphine consumption, sedation level, nausea, emesis, pruritus, respiratory depression, postoperative pain and morphine consumption</P></CHAR_OUTCOMES><CHAR_NOTES MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Type of surgery: major lower abdominal surgery</P></CHAR_NOTES></INCLUDED_CHAR><INCLUDED_CHAR MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" STUDY_ID="STD-Silverman-1982"><CHAR_METHODS MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Randomized, open-label trial; beta-blocker versus standard care</P></CHAR_METHODS><CHAR_PARTICIPANTS MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Overall: 100 participants; beta-blocker: 50 participants; standard care: 50 participants</P><P>Mean age: 56.7 years</P><P>Percentage of female participants: 7</P></CHAR_PARTICIPANTS><CHAR_INTERVENTIONS MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Participants received propranolol or standard care; treatment was initiated after surgery and was continued until discharge</P></CHAR_INTERVENTIONS><CHAR_OUTCOMES MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Primary outcome: supraventricular arrhythmias </P><P>Secondary outcome: perioperative myocardial infarction</P></CHAR_OUTCOMES><CHAR_NOTES MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Type of surgery: elective CABG</P></CHAR_NOTES></INCLUDED_CHAR><INCLUDED_CHAR MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" STUDY_ID="STD-Stephenson-1980"><CHAR_METHODS MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Quasi-randomized (according to date of birth), open-label trial; beta-blocker versus standard care</P></CHAR_METHODS><CHAR_PARTICIPANTS MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Overall: 223 participants; beta-blocker 87 participants; standard care: 136 participants</P><P>Mean age: 55.2 years</P><P>Percentage of female participants: 9.0%</P></CHAR_PARTICIPANTS><CHAR_INTERVENTIONS MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Participants received propranolol or standard care; treatment was started at the time of discharge from the intensive care unit after surgery; no end of drug administration was specified</P></CHAR_INTERVENTIONS><CHAR_OUTCOMES MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Primary outcome: postoperative cardiac arrhythmias (supraventricular and ventricular)</P></CHAR_OUTCOMES><CHAR_NOTES MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Type of surgery: elective CABG</P></CHAR_NOTES></INCLUDED_CHAR><INCLUDED_CHAR MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" STUDY_ID="STD-Stone-1988"><CHAR_METHODS MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Randomized, open-label trial; beta-blocker versus standard care</P></CHAR_METHODS><CHAR_PARTICIPANTS MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Overall: 128 participants; beta-blocker (3 different beta-blocker groups; see below 'Other bias'): 89 participants; standard care: 39 participants</P><P>Mean age: 65.4 years</P><P>Percentage of female participants: 29.7</P></CHAR_PARTICIPANTS><CHAR_INTERVENTIONS MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Participants (with untreated hypertension) received atenolol, labetalol, oxprenolol or standard care; treatment was administered as a single oral tablet before induction of anaesthesia</P></CHAR_INTERVENTIONS><CHAR_OUTCOMES MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Primary outcome: myocardial ischaemia </P><P>Secondary outcomes: acute myocardial infarction, bradycardia, hypotension, ventricular extrasystoles</P></CHAR_OUTCOMES><CHAR_NOTES MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Type of surgery: abdominal, peripheral, and vascular surgery (no further specification)</P></CHAR_NOTES></INCLUDED_CHAR><INCLUDED_CHAR MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" STUDY_ID="STD-Sun-2011"><CHAR_METHODS MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Randomized, placebo-controlled trial; beta-blocker versus placebo</P></CHAR_METHODS><CHAR_PARTICIPANTS MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Overall: 58 participants; esmolol: 30 participants; placebo: 28 participants</P><P>Mean age: data not provided</P><P>Percentage female participants: data not provided</P></CHAR_PARTICIPANTS><CHAR_INTERVENTIONS MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Participants received an IV single shot of esmolol or saline placebo during surgery before removal of the aortic clamp</P></CHAR_INTERVENTIONS><CHAR_OUTCOMES MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Primary outcome: cardiac recovery after cardiopulmonary bypass as assessed by occurrence of arrhythmias, haemodynamic parameters and vasoactive drug use</P></CHAR_OUTCOMES><CHAR_NOTES MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Type of surgery: elective single mitral valve replacement in participants with rheumatic heart disease</P></CHAR_NOTES></INCLUDED_CHAR><INCLUDED_CHAR MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" STUDY_ID="STD-Suttorp-1991"><CHAR_METHODS MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Randomized, double-blind, placebo-controlled trial; beta-blocker versus placebo</P></CHAR_METHODS><CHAR_PARTICIPANTS MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Overall: 300 participants; beta-blocker: 150 participants; placebo: 150 participants</P><P>Mean age: 62 years</P><P>Percentage of female participants: 22</P></CHAR_PARTICIPANTS><CHAR_INTERVENTIONS MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Participants received sotalol or placebo; treatment was started 4 to 6 hours postoperatively and was continued until the sixth day after surgery</P></CHAR_INTERVENTIONS><CHAR_OUTCOMES MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Primary outcome: supraventricular tachyarrhythmias</P></CHAR_OUTCOMES><CHAR_NOTES MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Type of surgery: elective CABG</P></CHAR_NOTES></INCLUDED_CHAR><INCLUDED_CHAR MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" STUDY_ID="STD-Vecht-1986"><CHAR_METHODS MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Randomized, double-blind, placebo-controlled trial; beta-blocker versus placebo</P></CHAR_METHODS><CHAR_PARTICIPANTS MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Overall: 132 participants; beta-blocker: 66 participants; placebo: 66 participants</P><P>Mean age: 54.1 years</P><P>Percentage of female participants: 8.3</P></CHAR_PARTICIPANTS><CHAR_INTERVENTIONS MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Participants received timolol or placebo; treatment was started postoperatively, and no end of administration was specified</P></CHAR_INTERVENTIONS><CHAR_OUTCOMES MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Primary outcome: supraventricular tachyarrhythmias</P></CHAR_OUTCOMES><CHAR_NOTES MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Type of surgery: elective CABG</P></CHAR_NOTES></INCLUDED_CHAR><INCLUDED_CHAR MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" STUDY_ID="STD-Wallace-1998"><CHAR_METHODS MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Randomized, placebo-controlled, triple-blind trial; beta-blocker versus placebo</P></CHAR_METHODS><CHAR_PARTICIPANTS MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Overall: 200 participants; beta-blocker: 99 participants; placebo: 101 participants; <B>same population as in </B><LINK REF="STD-Mangano-1996" TYPE="STUDY">Mangano 1996</LINK></P><P>Mean age: 67.5 years</P><P>Percentage of female participants: data not provided</P></CHAR_PARTICIPANTS><CHAR_INTERVENTIONS MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Participants received atenolol or placebo; treatment was started preoperatively and was continued until hospital discharge</P></CHAR_INTERVENTIONS><CHAR_OUTCOMES MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Primary outcome: mortality from all causes during the 2 years after discharge </P><P>Secondary outcomes: myocardial infarction, unstable angina, congestive heart failure, myocardial revascularization, adverse events</P></CHAR_OUTCOMES><CHAR_NOTES MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Type of surgery: non-cardiac surgery</P></CHAR_NOTES></INCLUDED_CHAR><INCLUDED_CHAR MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" STUDY_ID="STD-Wenke-1999"><CHAR_METHODS MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Randomized, open-label trial; beta-blocker versus standard care</P></CHAR_METHODS><CHAR_PARTICIPANTS MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Overall: 200 participants; beta-blocker: 100 participants; standard care: 100 participants</P><P>Mean age: 63.6 years</P><P>Percentage of female participants: 23</P></CHAR_PARTICIPANTS><CHAR_INTERVENTIONS MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Participants received metoprolol or standard care; treatment was initiated postoperatively, and the observation period ended on the tenth postoperative day</P></CHAR_INTERVENTIONS><CHAR_OUTCOMES MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Primary outcome: supraventricular arrhythmias </P><P>Secondary outcomes: acute myocardial infarction, length of stay</P></CHAR_OUTCOMES><CHAR_NOTES MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Type of surgery: elective CABG</P></CHAR_NOTES></INCLUDED_CHAR><INCLUDED_CHAR MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" STUDY_ID="STD-White-1984"><CHAR_METHODS MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Randomized, placebo-controlled, double-blind trial; beta-blocker versus placebo</P></CHAR_METHODS><CHAR_PARTICIPANTS MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Overall: 41 participants; beta-blocker: 21 participants; placebo: 20 participants</P><P>Mean age: 55.5 years</P><P>Percentage of female participants: 17.1</P></CHAR_PARTICIPANTS><CHAR_INTERVENTIONS MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Participants received timolol or placebo; treatment was started 3 to 7 hours postoperatively and was continued for 7 days</P></CHAR_INTERVENTIONS><CHAR_OUTCOMES MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Primary outcome: supraventricular tachyarrhythmias </P><P>Secondary outcomes: mortality, death due to cardiac causes, myocardial ischaemia</P></CHAR_OUTCOMES><CHAR_NOTES MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Type of surgery: elective CABG</P></CHAR_NOTES></INCLUDED_CHAR><INCLUDED_CHAR MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" STUDY_ID="STD-Whitehead-1980"><CHAR_METHODS MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Randomized, placebo-controlled, triple-blind trial; beta-blocker versus placebo</P></CHAR_METHODS><CHAR_PARTICIPANTS MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Overall: 60 participants; beta-blocker: 30 participants; placebo: 30 participants</P><P>Mean age: 24.5 years</P><P>Percentage of female participants: data not provided</P></CHAR_PARTICIPANTS><CHAR_INTERVENTIONS MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Participants received metoprolol or placebo; treatment was administered as an IV single shot before induction of anaesthesia</P></CHAR_INTERVENTIONS><CHAR_OUTCOMES MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Primary outcome: cardial arrhythmias (supraventricular and ventricular)</P></CHAR_OUTCOMES><CHAR_NOTES MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Type of surgery: removal of wisdom teeth</P></CHAR_NOTES></INCLUDED_CHAR><INCLUDED_CHAR MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" STUDY_ID="STD-Williams-1982"><CHAR_METHODS MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Quasi-randomized, open-label trial; beta-blocker versus standard care</P></CHAR_METHODS><CHAR_PARTICIPANTS MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Overall: 60 participants; beta-blocker: 28 participants; standard care: 32 participants</P><P>Mean age: 55.3 years</P><P>Percentage of female participants: 18.3</P></CHAR_PARTICIPANTS><CHAR_INTERVENTIONS MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Participants received propranolol or standard care; treatment was started at noon of the participant's first postoperative day; no clear end of drug administration was specified</P></CHAR_INTERVENTIONS><CHAR_OUTCOMES MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Primary outcome: postoperative arrhythmias (supraventricular and ventricular)</P></CHAR_OUTCOMES><CHAR_NOTES MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Type of surgery: elective CABG</P></CHAR_NOTES></INCLUDED_CHAR><INCLUDED_CHAR MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" STUDY_ID="STD-Yang-2006"><CHAR_METHODS MODIFIED="2011-04-25 19:22:59 +0100" MODIFIED_BY="Hermann Blessberger"><P>Randomized, placebo-controlled, double-blind trial; beta-blocker versus placebo</P></CHAR_METHODS><CHAR_PARTICIPANTS MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Overall: 496 participants; beta-blocker: 246 participants; placebo: 250 participants</P><P>Mean age: 66.1 years</P><P>Percentage of female participants: 28.0</P></CHAR_PARTICIPANTS><CHAR_INTERVENTIONS MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Participants received metoprolol or placebo; treatment was started 2 hours before surgery and was continued until hospital discharge or for a maximum duration of 5 days</P></CHAR_INTERVENTIONS><CHAR_OUTCOMES MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Primary composite outcome (30 days): myocardial infarction, unstable angina, new CHF, atrial and ventricular arrhythmias, all-cause mortality </P><P>Secondary outcomes: hypotension, bradycardia</P></CHAR_OUTCOMES><CHAR_NOTES MODIFIED="2010-09-14 07:40:31 +0100" MODIFIED_BY="Hermann Blessberger"><P>Type of surgery: abdominal aortic surgery, infrainguinal or extra-anatomical revascularization</P></CHAR_NOTES></INCLUDED_CHAR><INCLUDED_CHAR MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" STUDY_ID="STD-Yang-2008"><CHAR_METHODS MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Randomized, open-label trial; beta-blocker versus standard care</P></CHAR_METHODS><CHAR_PARTICIPANTS MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Overall: 102 participants; beta-blocker: 51 participants; standard of care: 51 participants</P><P>Mean age: 71.0 years</P><P>Percentage of female participants: 58.8</P></CHAR_PARTICIPANTS><CHAR_INTERVENTIONS MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Participants received standard care or metoprolol (orally or intravenously, blood pressure and heart rate titrated); treatment was started 2 hours before surgery and was continued until 30 days after surgery</P></CHAR_INTERVENTIONS><CHAR_OUTCOMES MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Primary outcomes: changes in heart rate, levels of creatine kinase (CK-MB), mortality, acute myocardial infarction, stroke</P></CHAR_OUTCOMES><CHAR_NOTES MODIFIED="2013-11-24 06:13:55 +0000" MODIFIED_BY="Hermann Blessberger"><P>Type of surgery: non-cardiac surgery (major abdominal)</P></CHAR_NOTES></INCLUDED_CHAR><INCLUDED_CHAR MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" STUDY_ID="STD-Zaugg-1999"><CHAR_METHODS MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Randomized, open-label trial; beta-blocker versus standard care</P></CHAR_METHODS><CHAR_PARTICIPANTS MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Overall: 59 participants; beta-blocker: 40 participants; standard care: 19 participants</P><P>Mean age: 74.7 years</P><P>Percentage of female participants: 58.7</P></CHAR_PARTICIPANTS><CHAR_INTERVENTIONS MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Participants (65 years of age or older) were divided into 3 groups:</P><UL><LI>Group 1: standard care</LI><LI>Group 2: Preoperative and postoperative administration of atenolol (up until 72 hours postoperatively)</LI><LI>Group 3: Intraoperative administration of atenolol</LI></UL></CHAR_INTERVENTIONS><CHAR_OUTCOMES MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P>Primary outcome: haemodynamic variables<BR/>Secondary outcomes: myocardial infarction and ischaemia, stress hormone levels</P></CHAR_OUTCOMES><CHAR_NOTES MODIFIED="2011-05-08 08:03:37 +0100" MODIFIED_BY="Hermann Blessberger"><P>Type of surgery: non-cardiac surgery (major abdominal surgery, hip replacement, intrathoracic surgery)</P></CHAR_NOTES></INCLUDED_CHAR><FOOTNOTES><P>Abbreviations:</P><P>CABG: Coronary artery bypass graft.</P><P>CHF: Congestive heart failure.</P><P>CK-MB: Creatine kinase (MB isoenzyme).</P><P>DIPOM: Diabetic Postoperative Mortality and Morbidity.</P><P>ECG: Electrocardiogram.</P><P>IABP: Intra-aortic balloon pump.</P><P>ICU: Intensive care unit.</P><P>LOS: Length of stay</P></FOOTNOTES></CHARACTERISTICS_OF_INCLUDED_STUDIES><CHARACTERISTICS_OF_EXCLUDED_STUDIES MODIFIED="2017-12-08 12:23:52 +0000" MODIFIED_BY="Hermann Blessberger" SORT_BY="STUDY"><EXCLUDED_CHAR MODIFIED="2017-12-08 12:22:26 +0000" MODIFIED_BY="Hermann Blessberger" STUDY_ID="STD-DECREASE_x002d_IV-2009"><CHAR_REASON_FOR_EXCLUSION MODIFIED="2017-12-08 12:22:26 +0000" MODIFIED_BY="Hermann Blessberger"><P>Allegations of fictitious data.</P></CHAR_REASON_FOR_EXCLUSION></EXCLUDED_CHAR><EXCLUDED_CHAR MODIFIED="2017-12-08 02:48:18 +0000" MODIFIED_BY="Hermann Blessberger" STUDY_ID="STD-Kl_x00f6_ter_x002d_Weber-1998"><CHAR_REASON_FOR_EXCLUSION MODIFIED="2017-12-08 02:48:18 +0000" MODIFIED_BY="Hermann Blessberger"><P>Subpopulation of <LINK REF="STD-Pfisterer-1997" TYPE="STUDY">Pfisterer 1997</LINK>.</P></CHAR_REASON_FOR_EXCLUSION></EXCLUDED_CHAR><EXCLUDED_CHAR MODIFIED="2017-12-08 12:23:52 +0000" MODIFIED_BY="Hermann Blessberger" STUDY_ID="STD-Poldermans-1999"><CHAR_REASON_FOR_EXCLUSION MODIFIED="2017-12-08 12:23:52 +0000" MODIFIED_BY="Hermann Blessberger"><P>Credibility of data is uncertain.</P></CHAR_REASON_FOR_EXCLUSION></EXCLUDED_CHAR><EXCLUDED_CHAR MODIFIED="2017-12-08 02:48:15 +0000" MODIFIED_BY="Hermann Blessberger" STUDY_ID="STD-Suttner-2009"><CHAR_REASON_FOR_EXCLUSION MODIFIED="2017-12-08 02:48:15 +0000" MODIFIED_BY="Hermann Blessberger"><P>Manuscript was retracted.</P></CHAR_REASON_FOR_EXCLUSION></EXCLUDED_CHAR><FOOTNOTES/></CHARACTERISTICS_OF_EXCLUDED_STUDIES><CHARACTERISTICS_OF_AWAITING_STUDIES SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO"><FOOTNOTES/></CHARACTERISTICS_OF_AWAITING_STUDIES><CHARACTERISTICS_OF_ONGOING_STUDIES SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO"><FOOTNOTES/></CHARACTERISTICS_OF_ONGOING_STUDIES></CHARACTERISTICS_OF_STUDIES><QUALITY_ITEMS MODIFIED="2017-10-28 00:46:08 +0100" MODIFIED_BY="Hermann Blessberger"><QUALITY_ITEM CORE_ITEM="YES" ID="QIT-01" LEVEL="STUDY" MODIFIED="2017-10-28 00:46:08 +0100" MODIFIED_BY="Hermann Blessberger" NO="1"><NAME>Random sequence generation (selection bias)</NAME><DESCRIPTION><P>Selection bias (biased allocation to interventions) due to inadequate generation of a randomised sequence</P></DESCRIPTION><QUALITY_ITEM_DATA><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-26 13:46:20 +0100" MODIFIED_BY="Jane Cracknell" RESULT="NO" STUDY_ID="STD-Abel-1983"><DESCRIPTION><P>Quasi-randomization (last digit of hospital record number)</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="UNKNOWN" STUDY_ID="STD-Ali-1997"><DESCRIPTION><P>Not specified</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="UNKNOWN" STUDY_ID="STD-Apipan-2010"><DESCRIPTION><P>Not specified</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Auer-2004"><DESCRIPTION><P>Randomization table was used for sequence generation</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="UNKNOWN" STUDY_ID="STD-Babin_x002d_Ebell-1996"><DESCRIPTION><P>Not specified</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="UNKNOWN" STUDY_ID="STD-Bayliff-1999"><DESCRIPTION><P>Randomization in blocks of four, exact method of sequence generation unclear</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Bert-2001"><DESCRIPTION><P>Table of random numbers</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="UNKNOWN" STUDY_ID="STD-Booth-2004"><DESCRIPTION><P>Not specified</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="UNKNOWN" STUDY_ID="STD-Burns-1988"><DESCRIPTION><P>Not specified</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="UNKNOWN" STUDY_ID="STD-But-2006"><DESCRIPTION><P>Not specified</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="UNKNOWN" STUDY_ID="STD-Coleman-1980"><DESCRIPTION><P>Not specified</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-07-31 21:03:05 +0100" MODIFIED_BY="Hermann Blessberger" RESULT="UNKNOWN" STUDY_ID="STD-Connolly-2003"><DESCRIPTION><P>Not specified</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="UNKNOWN" STUDY_ID="STD-Cork-1995"><DESCRIPTION><P>Not specified</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="UNKNOWN" STUDY_ID="STD-Cucchiara-1986"><DESCRIPTION><P>Not specified</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-DIPOM-_x002d_-Juul-2006"><DESCRIPTION><P>Computer-generated allocation sequence</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="UNKNOWN" STUDY_ID="STD-Daudon-1986"><DESCRIPTION><P>Not specified</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="UNKNOWN" STUDY_ID="STD-De-Azevedo-L_x00fa_cio-2003"><DESCRIPTION><P>Not specified</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="UNKNOWN" STUDY_ID="STD-Dy-1998"><DESCRIPTION><P>Not specified</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="NO" STUDY_ID="STD-Evrard-2000"><DESCRIPTION><P>'Blocked randomization in a prospective open manner'</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Forlani-2002"><DESCRIPTION><P>Computer-generated randomization</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="UNKNOWN" STUDY_ID="STD-Gibson-1988"><DESCRIPTION><P>Not specified</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="UNKNOWN" STUDY_ID="STD-Gomes-1999"><DESCRIPTION><P>Not specified</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="UNKNOWN" STUDY_ID="STD-Graham-1996"><DESCRIPTION><P>Not specified</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Gupta-2011"><DESCRIPTION><P>Participants were randomly assigned to 3 study groups according to a computer-generated randomization schedule</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Hammon-1984"><DESCRIPTION><P>Random number table</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="UNKNOWN" STUDY_ID="STD-Harrison-1987"><DESCRIPTION><P>Not specified</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="UNKNOWN" STUDY_ID="STD-Inada-1989"><DESCRIPTION><P>Not specified</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="UNKNOWN" STUDY_ID="STD-Ivey-1983"><DESCRIPTION><P>Not specified</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="UNKNOWN" STUDY_ID="STD-Jacquet-1994"><DESCRIPTION><P>Not specified</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="UNKNOWN" STUDY_ID="STD-Jakobsen-1992"><DESCRIPTION><P>Not specified</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="UNKNOWN" STUDY_ID="STD-Jakobsen-1997"><DESCRIPTION><P>Not specified</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="UNKNOWN" STUDY_ID="STD-Janssen-1986"><DESCRIPTION><P>Not specified</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Kawaguchi-2010"><DESCRIPTION><P>Computer-generated randomization list</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="UNKNOWN" STUDY_ID="STD-Khuri-1987"><DESCRIPTION><P>Not specified</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="UNKNOWN" STUDY_ID="STD-Kurian-2001"><DESCRIPTION><P>Not further specified</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="UNKNOWN" STUDY_ID="STD-Lai-2006"><DESCRIPTION><P>Not specified</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="UNKNOWN" STUDY_ID="STD-Lamb-1988"><DESCRIPTION><P>Not specified</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="UNKNOWN" STUDY_ID="STD-Lee-2010"><DESCRIPTION><P>Participants 'were randomly placed into 2 groups'</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="UNKNOWN" STUDY_ID="STD-Liu-1986"><DESCRIPTION><P>Not specified</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="UNKNOWN" STUDY_ID="STD-Liu-2006"><DESCRIPTION><P>Not specified</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="UNKNOWN" STUDY_ID="STD-Magnusson-1986"><DESCRIPTION><P>Not specified</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Mangano-1996"><DESCRIPTION><P>"Computer generated, randomized list"</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="UNKNOWN" STUDY_ID="STD-Martinussen-1988"><DESCRIPTION><P>Not specified</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Marwick-2009"><DESCRIPTION><P>Computer-based online data entry and treatment allocation</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="UNKNOWN" STUDY_ID="STD-Matangi-1985"><DESCRIPTION><P>Not specified</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="UNKNOWN" STUDY_ID="STD-Matangi-1989"><DESCRIPTION><P>Not specified</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="UNKNOWN" STUDY_ID="STD-Materne-1985"><DESCRIPTION><P>Not specified</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="NO" STUDY_ID="STD-Matsuura-2001"><DESCRIPTION><P>Quasi-randomization: "patients were randomized alternately"</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Miller-1990"><DESCRIPTION><P>Computer-generated randomization schedule</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Miller-1991"><DESCRIPTION><P>"Randomization in blocks of 45 for each centre," study author has stated that computer-generated randomization was used (<LINK REF="STD-Miller-1990" TYPE="STUDY">Miller 1990</LINK>)</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="NO" STUDY_ID="STD-Mohr-1981"><DESCRIPTION><P>Quasi-randomization: "odd or even last numbers on medical records"</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="UNKNOWN" STUDY_ID="STD-Moon-2011"><DESCRIPTION><P>Not specified</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="UNKNOWN" STUDY_ID="STD-Myhre-1984"><DESCRIPTION><P>Not specified</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Neary-2006"><DESCRIPTION><P>The study medication was provided in 1 box per participant containing placebo, as well the active drug, in similar looking batches. The anaesthesiologist randomly chose 1 pack at the induction of anaesthesia</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="UNKNOWN" STUDY_ID="STD-Neustein-1994"><DESCRIPTION><P>Not specified</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="UNKNOWN" STUDY_ID="STD-Nystr_x00f6_m-1993"><DESCRIPTION><P>Not specified</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Ogawa-2013"><DESCRIPTION><P>Treatment group allocation was performed using 'a random number program'</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="UNKNOWN" STUDY_ID="STD-Oka-1980"><DESCRIPTION><P>Not specified</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="UNKNOWN" STUDY_ID="STD-Ormerod-1984"><DESCRIPTION><P>Not specified</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="UNKNOWN" STUDY_ID="STD-Osada-2012"><DESCRIPTION><P>Not specified</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="UNKNOWN" STUDY_ID="STD-Oxorn-1990"><DESCRIPTION><P>Not specified</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-POBBLE-2005"><DESCRIPTION><P>Central randomization via Web page</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-POISE-2008"><DESCRIPTION><P>Computerized randomization phone service</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="UNKNOWN" STUDY_ID="STD-Paull-1997"><DESCRIPTION><P>Not specified</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="UNKNOWN" STUDY_ID="STD-Pfisterer-1997"><DESCRIPTION><P>Not specified</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Raby-1999"><DESCRIPTION><P>Coin flipping</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="UNKNOWN" STUDY_ID="STD-Reves-1990"><DESCRIPTION><P>Not specified</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Rubin-1987"><DESCRIPTION><P>"Patients were randomized by lot"</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="NO" STUDY_ID="STD-Sakaguchi-2012"><DESCRIPTION><P>'60 subjects were randomized into 2 groups by the coin toss method.' Coin tossing is a valid method used to generate a randomization sequence. In our opinion, however, it is highly unlikely that coin tossing would result in exactly 30 participants in each study group. With such a low number of participants, we would expect an unequal number of participants in each trial arm if the randomization sequence was generated with coin flipping</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="UNKNOWN" STUDY_ID="STD-Salazar-1979"><DESCRIPTION><P>Not specified</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Sandler-1990"><DESCRIPTION><P>Table of random numbers</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Sezai-2011"><DESCRIPTION><P>Participants 'were randomized into two groups by the lottery method'</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Sezai-2012"><DESCRIPTION><P>'Patients were randomized into three groups by the lottery method'</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="UNKNOWN" STUDY_ID="STD-Shukla-2010"><DESCRIPTION><P>Participants 'were randomly divided&#8212;Not specified</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="NO" STUDY_ID="STD-Silverman-1982"><DESCRIPTION><P>Quasi-randomization: "randomization was by birthdate"</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="NO" STUDY_ID="STD-Stephenson-1980"><DESCRIPTION><P>Randomization by date of birth</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="UNKNOWN" STUDY_ID="STD-Stone-1988"><DESCRIPTION><P>Not specified</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Sun-2011"><DESCRIPTION><P>'Patients were randomly assigned to two groups by a computer program'</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="UNKNOWN" STUDY_ID="STD-Suttorp-1991"><DESCRIPTION><P>Not specified</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="UNKNOWN" STUDY_ID="STD-Vecht-1986"><DESCRIPTION><P>Not specified</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Wallace-1998"><DESCRIPTION><P>"Computer-generated, randomized list retained by the hospital pharmacy"</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Wenke-1999"><DESCRIPTION><P>Table of random numbers</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="UNKNOWN" STUDY_ID="STD-White-1984"><DESCRIPTION><P>Not specified</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="UNKNOWN" STUDY_ID="STD-Whitehead-1980"><DESCRIPTION><P>Not specified</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="NO" STUDY_ID="STD-Williams-1982"><DESCRIPTION><P>Quasi-randomization: "patients were randomized by odd or even birthdate"</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Yang-2006"><DESCRIPTION><P>"Randomization was constructed in blocks of four by the study statistician and study medication preparations by the pharmacists"</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="UNKNOWN" STUDY_ID="STD-Yang-2008"><DESCRIPTION><P>Not specified</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="UNKNOWN" STUDY_ID="STD-Zaugg-1999"><DESCRIPTION><P>Not specified</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY></QUALITY_ITEM_DATA></QUALITY_ITEM><QUALITY_ITEM CORE_ITEM="YES" ID="QIT-02" LEVEL="STUDY" MODIFIED="2017-10-28 00:46:08 +0100" MODIFIED_BY="Hermann Blessberger" NO="2"><NAME>Allocation concealment (selection bias)</NAME><DESCRIPTION><P>Selection bias (biased allocation to interventions) due to inadequate concealment of allocations prior to assignment</P></DESCRIPTION><QUALITY_ITEM_DATA><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-26 13:46:20 +0100" MODIFIED_BY="Jane Cracknell" RESULT="NO" STUDY_ID="STD-Abel-1983"><DESCRIPTION><P>See above</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="UNKNOWN" STUDY_ID="STD-Ali-1997"><DESCRIPTION><P>Not specified</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="UNKNOWN" STUDY_ID="STD-Apipan-2010"><DESCRIPTION><P>Not specified</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Auer-2004"><DESCRIPTION><P>Randomization schedule was sealed</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="UNKNOWN" STUDY_ID="STD-Babin_x002d_Ebell-1996"><DESCRIPTION><P>Not specified</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Bayliff-1999"><DESCRIPTION><P>Sealed envelopes</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-07-31 21:02:16 +0100" MODIFIED_BY="Hermann Blessberger" RESULT="UNKNOWN" STUDY_ID="STD-Bert-2001"><DESCRIPTION><P>Not specified</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="UNKNOWN" STUDY_ID="STD-Booth-2004"><DESCRIPTION><P>Not specified</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="UNKNOWN" STUDY_ID="STD-Burns-1988"><DESCRIPTION><P>Not specified</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="UNKNOWN" STUDY_ID="STD-But-2006"><DESCRIPTION><P>Not specified</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="UNKNOWN" STUDY_ID="STD-Coleman-1980"><DESCRIPTION><P>Participants were given 4 mL of solution intravenously, which consisted of saline as placebo or metoprolol. The assignment code was unknown to investigators until completion of the study</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="UNKNOWN" STUDY_ID="STD-Connolly-2003"><DESCRIPTION><P>Not specified</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="UNKNOWN" STUDY_ID="STD-Cork-1995"><DESCRIPTION><P>Not specified</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="UNKNOWN" STUDY_ID="STD-Cucchiara-1986"><DESCRIPTION><P>Not specified</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-DIPOM-_x002d_-Juul-2006"><DESCRIPTION><P>Participants were centrally randomly assigned</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="UNKNOWN" STUDY_ID="STD-Daudon-1986"><DESCRIPTION><P>Not specified</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="UNKNOWN" STUDY_ID="STD-De-Azevedo-L_x00fa_cio-2003"><DESCRIPTION><P>Not specified</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="UNKNOWN" STUDY_ID="STD-Dy-1998"><DESCRIPTION><P>Not specified</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="NO" STUDY_ID="STD-Evrard-2000"><DESCRIPTION><P>Blocked randomization in an unblinded trial</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Forlani-2002"><DESCRIPTION><P>See above</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="UNKNOWN" STUDY_ID="STD-Gibson-1988"><DESCRIPTION><P>Not specified</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Gomes-1999"><DESCRIPTION><P>Pharmacy at each institution dispensed medication and placebo pills for all participants</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="UNKNOWN" STUDY_ID="STD-Graham-1996"><DESCRIPTION><P>Not specified</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Gupta-2011"><DESCRIPTION><P>See above</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="UNKNOWN" STUDY_ID="STD-Hammon-1984"><DESCRIPTION><P>Not specified</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="UNKNOWN" STUDY_ID="STD-Harrison-1987"><DESCRIPTION><P>Not specified</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Inada-1989"><DESCRIPTION><P>Participants received study drugs from "identical syringes" intravenously: content of syringes not predictable in advance</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Ivey-1983"><DESCRIPTION><P>'Randomization was performed by the hospital pharmacy in a double-blind manner.' Control group participants 'received an exact propranolol placebo on an identical schedule'</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="UNKNOWN" STUDY_ID="STD-Jacquet-1994"><DESCRIPTION><P>Not specified</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="UNKNOWN" STUDY_ID="STD-Jakobsen-1992"><DESCRIPTION><P>Not specified</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="UNKNOWN" STUDY_ID="STD-Jakobsen-1997"><DESCRIPTION><P>Not specified</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Janssen-1986"><DESCRIPTION><P>Sealed envelope</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Kawaguchi-2010"><DESCRIPTION><P>Envelope method</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="UNKNOWN" STUDY_ID="STD-Khuri-1987"><DESCRIPTION><P>Not specified</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Kurian-2001"><DESCRIPTION><P>Numbered, sealed envelopes</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="UNKNOWN" STUDY_ID="STD-Lai-2006"><DESCRIPTION><P>Not specified</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="UNKNOWN" STUDY_ID="STD-Lamb-1988"><DESCRIPTION><P>Not specified</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="UNKNOWN" STUDY_ID="STD-Lee-2010"><DESCRIPTION><P>See above</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="UNKNOWN" STUDY_ID="STD-Liu-1986"><DESCRIPTION><P>Not specified</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="UNKNOWN" STUDY_ID="STD-Liu-2006"><DESCRIPTION><P>Not specified</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="UNKNOWN" STUDY_ID="STD-Magnusson-1986"><DESCRIPTION><P>Not specified</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Mangano-1996"><DESCRIPTION><P>See above</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="UNKNOWN" STUDY_ID="STD-Martinussen-1988"><DESCRIPTION><P>Not specified</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Marwick-2009"><DESCRIPTION><P>See above</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Matangi-1985"><DESCRIPTION><P>Sealed envelope</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Matangi-1989"><DESCRIPTION><P>Sealed envelopes were used in 1985 (see <LINK REF="STD-Matangi-1985" TYPE="STUDY">Matangi 1985</LINK>)</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="UNKNOWN" STUDY_ID="STD-Materne-1985"><DESCRIPTION><P>Not specified</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="NO" STUDY_ID="STD-Matsuura-2001"><DESCRIPTION><P>See above</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Miller-1990"><DESCRIPTION><P>See above</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Miller-1991"><DESCRIPTION><P>See above</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="NO" STUDY_ID="STD-Mohr-1981"><DESCRIPTION><P>See above</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Moon-2011"><DESCRIPTION><P>'Anaesthesiologists not involved in the patients' anaesthetic management prepared the covered syringe pump for esmolol or placebo solutions and held the randomization codes until the end of the study'</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="UNKNOWN" STUDY_ID="STD-Myhre-1984"><DESCRIPTION><P>Not specified</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Neary-2006"><DESCRIPTION><P>"The box also contained a sealed envelope with details of which packs contained the active drug in case of an emergency."</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="UNKNOWN" STUDY_ID="STD-Neustein-1994"><DESCRIPTION><P>Not specified</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="UNKNOWN" STUDY_ID="STD-Nystr_x00f6_m-1993"><DESCRIPTION><P>Not specified</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Ogawa-2013"><DESCRIPTION><P>See above</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="UNKNOWN" STUDY_ID="STD-Oka-1980"><DESCRIPTION><P>Not specified</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="UNKNOWN" STUDY_ID="STD-Ormerod-1984"><DESCRIPTION><P>Not specified</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="UNKNOWN" STUDY_ID="STD-Osada-2012"><DESCRIPTION><P>Not specified</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="UNKNOWN" STUDY_ID="STD-Oxorn-1990"><DESCRIPTION><P>Not specified</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-POBBLE-2005"><DESCRIPTION><P>Randomized, placebo-controlled, double-blind trial</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-POISE-2008"><DESCRIPTION><P>Randomized, placebo-controlled, triple-blind multi-centre trial</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="UNKNOWN" STUDY_ID="STD-Paull-1997"><DESCRIPTION><P>Not specified</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="UNKNOWN" STUDY_ID="STD-Pfisterer-1997"><DESCRIPTION><P>Not specified</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Raby-1999"><DESCRIPTION><P>See above</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="UNKNOWN" STUDY_ID="STD-Reves-1990"><DESCRIPTION><P>Not specified</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Rubin-1987"><DESCRIPTION><P>See above</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="NO" STUDY_ID="STD-Sakaguchi-2012"><DESCRIPTION><P>See above</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="UNKNOWN" STUDY_ID="STD-Salazar-1979"><DESCRIPTION><P>Not specified</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="UNKNOWN" STUDY_ID="STD-Sandler-1990"><DESCRIPTION><P>Not specified</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Sezai-2011"><DESCRIPTION><P>See above</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Sezai-2012"><DESCRIPTION><P>See above</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="UNKNOWN" STUDY_ID="STD-Shukla-2010"><DESCRIPTION><P>See above</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="NO" STUDY_ID="STD-Silverman-1982"><DESCRIPTION><P>See above</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="NO" STUDY_ID="STD-Stephenson-1980"><DESCRIPTION><P>See above</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="UNKNOWN" STUDY_ID="STD-Stone-1988"><DESCRIPTION><P>Not specified</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Sun-2011"><DESCRIPTION><P>See above</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="UNKNOWN" STUDY_ID="STD-Suttorp-1991"><DESCRIPTION><P>Not specified</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="UNKNOWN" STUDY_ID="STD-Vecht-1986"><DESCRIPTION><P>Not specified</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Wallace-1998"><DESCRIPTION><P>See above</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="UNKNOWN" STUDY_ID="STD-Wenke-1999"><DESCRIPTION><P>Not specified</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="UNKNOWN" STUDY_ID="STD-White-1984"><DESCRIPTION><P>Not specified</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Whitehead-1980"><DESCRIPTION><P>Application of equal looking ampoules</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="NO" STUDY_ID="STD-Williams-1982"><DESCRIPTION><P>See above</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Yang-2006"><DESCRIPTION><P>See above</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="UNKNOWN" STUDY_ID="STD-Yang-2008"><DESCRIPTION><P>Not specified</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="UNKNOWN" STUDY_ID="STD-Zaugg-1999"><DESCRIPTION><P>Not specified</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY></QUALITY_ITEM_DATA></QUALITY_ITEM><QUALITY_ITEM CORE_ITEM="YES" ID="QIT-03" LEVEL="GROUP" MODIFIED="2011-04-25 07:22:52 +0100" MODIFIED_BY="Hermann Blessberger" NO="3"><NAME>Blinding (performance bias and detection bias)</NAME><DESCRIPTION><P>Performance bias or detection bias due to knowledge of the allocated interventions after assignment</P></DESCRIPTION><QUALITY_ITEM_DATA/></QUALITY_ITEM><QUALITY_ITEM CORE_ITEM="NO" ID="QIT-07" LEVEL="GROUP" MODIFIED="2017-10-28 00:46:08 +0100" MODIFIED_BY="Hermann Blessberger" NO="7"><NAME>Blinding of participants (performance bias)</NAME><DESCRIPTION><P>Was knowledge of the allocated interventions adequately prevented during the study?</P></DESCRIPTION><QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-07.01" NO="1"><NAME>All outcomes</NAME></QUALITY_ITEM_DATA_ENTRY_GROUP><QUALITY_ITEM_DATA><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2014-08-26 13:46:20 +0100" MODIFIED_BY="Jane Cracknell" RESULT="NO" STUDY_ID="STD-Abel-1983"><DESCRIPTION><P>Open-label trial</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="NO" STUDY_ID="STD-Ali-1997"><DESCRIPTION><P>Open-label trial</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Apipan-2010"><DESCRIPTION><P>'The anaesthesiologist and patients were kept unaware of which group the patient was in'</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Auer-2004"><DESCRIPTION><P>Randomized, placebo-controlled, double-blind trial</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="NO" STUDY_ID="STD-Babin_x002d_Ebell-1996"><DESCRIPTION><P>Open-label trial</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Bayliff-1999"><DESCRIPTION><P>Randomized, placebo-controlled, double-blind trial</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="NO" STUDY_ID="STD-Bert-2001"><DESCRIPTION><P>Open-label trial</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="UNKNOWN" STUDY_ID="STD-Booth-2004"><DESCRIPTION><P>Not specified</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Burns-1988"><DESCRIPTION><P>Randomized, placebo-controlled, double-blind trial</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="UNKNOWN" STUDY_ID="STD-But-2006"><DESCRIPTION><P>Not specified</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Coleman-1980"><DESCRIPTION><P>Randomized, placebo-controlled, double-blind trial</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Connolly-2003"><DESCRIPTION><P>Randomized, placebo-controlled, double-blind trial</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Cork-1995"><DESCRIPTION><P>Randomized, placebo-controlled, double-blind trial</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Cucchiara-1986"><DESCRIPTION><P>Randomized, placebo-controlled, double-blind trial</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-DIPOM-_x002d_-Juul-2006"><DESCRIPTION><P>"The DIPOM trial is an investigator initiated and controlled, randomised placebo controlled, multicentre trial with central randomisation and blinding of all parties in all phases. The code was broken when analyses were completed and a conclusion formulated'</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="NO" STUDY_ID="STD-Daudon-1986"><DESCRIPTION><P>Open-label trial</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="NO" STUDY_ID="STD-De-Azevedo-L_x00fa_cio-2003"><DESCRIPTION><P>Open-label trial</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Dy-1998"><DESCRIPTION><P>Randomized, placebo-controlled, double-blind trial</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="NO" STUDY_ID="STD-Evrard-2000"><DESCRIPTION><P>Open-label trial</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="NO" STUDY_ID="STD-Forlani-2002"><DESCRIPTION><P>Open-label trial</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Gibson-1988"><DESCRIPTION><P>Randomized, placebo-controlled, double-blind trial</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Gomes-1999"><DESCRIPTION><P>Randomized, placebo-controlled, double-blind trial</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="UNKNOWN" STUDY_ID="STD-Graham-1996"><DESCRIPTION><P>Not specified</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Gupta-2011"><DESCRIPTION><P>'An independent anaesthesia registrar, blinded to study group allocation and not involved in anaesthesia management, observed changes in heart rate, mean arterial pressure, ... , and sedation'</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Hammon-1984"><DESCRIPTION><P>Randomized, placebo-controlled, double-blind trial</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Harrison-1987"><DESCRIPTION><P>Randomized, placebo-controlled, double-blind trial</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Inada-1989"><DESCRIPTION><P>Randomized, placebo-controlled, double-blind trial</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Ivey-1983"><DESCRIPTION><P>Randomized, placebo-controlled, double-blind trial</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="NO" STUDY_ID="STD-Jacquet-1994"><DESCRIPTION><P>Open-label trial</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Jakobsen-1992"><DESCRIPTION><P>Randomized, double-blind, placebo-controlled trial</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Jakobsen-1997"><DESCRIPTION><P>Randomized, placebo-controlled, double-blind trial</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="NO" STUDY_ID="STD-Janssen-1986"><DESCRIPTION><P>Open-label trial</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="NO" STUDY_ID="STD-Kawaguchi-2010"><DESCRIPTION><P>Open-label trial</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Khuri-1987"><DESCRIPTION><P>Randomized, placebo-controlled, double-blind trial</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="NO" STUDY_ID="STD-Kurian-2001"><DESCRIPTION><P>Open-label trial</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="NO" STUDY_ID="STD-Lai-2006"><DESCRIPTION><P>Open-label trial</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="NO" STUDY_ID="STD-Lamb-1988"><DESCRIPTION><P>Open-label trial</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="UNKNOWN" STUDY_ID="STD-Lee-2010"><DESCRIPTION><P>Not specified</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Liu-1986"><DESCRIPTION><P>Randomized, placebo-controlled, double-blind trial</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="NO" STUDY_ID="STD-Liu-2006"><DESCRIPTION><P>Open-label trial</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Magnusson-1986"><DESCRIPTION><P>Randomized, double-blind, placebo-controlled trial</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Mangano-1996"><DESCRIPTION><P>Randomized, placebo-controlled, triple-blind trial</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Martinussen-1988"><DESCRIPTION><P>Randomized, placebo-controlled, double-blind trial</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="NO" STUDY_ID="STD-Marwick-2009"><DESCRIPTION><P>Open-label trial</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="NO" STUDY_ID="STD-Matangi-1985"><DESCRIPTION><P>Open-label trial</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Matangi-1989"><DESCRIPTION><P>Randomized, placebo-controlled, double-blind trial</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="NO" STUDY_ID="STD-Materne-1985"><DESCRIPTION><P>Open-label trial</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="NO" STUDY_ID="STD-Matsuura-2001"><DESCRIPTION><P>Open-label trial</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Miller-1990"><DESCRIPTION><P>Randomized, placebo-controlled, double-blind trial</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Miller-1991"><DESCRIPTION><P>Randomized, placebo-controlled, double-blind trial</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="NO" STUDY_ID="STD-Mohr-1981"><DESCRIPTION><P>Open-label trial</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Moon-2011"><DESCRIPTION><P>See above</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="NO" STUDY_ID="STD-Myhre-1984"><DESCRIPTION><P>Open-label trial</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Neary-2006"><DESCRIPTION><P>Randomized, triple-blind, placebo-controlled trial</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2011-08-19 21:15:23 +0100" MODIFIED_BY="Hermann Blessberger" RESULT="YES" STUDY_ID="STD-Neustein-1994"><DESCRIPTION><P>Randomized, triple-blind, placebo-controlled trial</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="NO" STUDY_ID="STD-Nystr_x00f6_m-1993"><DESCRIPTION><P>Open-label trial</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="NO" STUDY_ID="STD-Ogawa-2013"><DESCRIPTION><P>Open-label trial</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="NO" STUDY_ID="STD-Oka-1980"><DESCRIPTION><P>Open-label trial</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="NO" STUDY_ID="STD-Ormerod-1984"><DESCRIPTION><P>Open-label trial</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="NO" STUDY_ID="STD-Osada-2012"><DESCRIPTION><P>Open-label trial</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Oxorn-1990"><DESCRIPTION><P>Randomized, triple-blind, placebo-controlled trial</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-POBBLE-2005"><DESCRIPTION><P>Randomized, placebo-controlled, double-blind trial</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-POISE-2008"><DESCRIPTION><P>Randomized, placebo-controlled, triple-blind multi-centre trial</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Paull-1997"><DESCRIPTION><P>Single-blind trial</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Pfisterer-1997"><DESCRIPTION><P>Randomized, placebo-controlled, double-blind trial</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Raby-1999"><DESCRIPTION><P>Randomized, placebo-controlled triple-blinded trial</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Reves-1990"><DESCRIPTION><P>Randomized, double-blind, placebo-controlled trial</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="NO" STUDY_ID="STD-Rubin-1987"><DESCRIPTION><P>Open-label trial</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="NO" STUDY_ID="STD-Sakaguchi-2012"><DESCRIPTION><P>Open-label trial</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="NO" STUDY_ID="STD-Salazar-1979"><DESCRIPTION><P>Open-label trial</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Sandler-1990"><DESCRIPTION><P>Randomized, placebo-controlled, double-blind trial</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Sezai-2011"><DESCRIPTION><P>Double-blind trial</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="NO" STUDY_ID="STD-Sezai-2012"><DESCRIPTION><P>Participants were blinded for IV treatment but not for oral treatment</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Shukla-2010"><DESCRIPTION><P>'Randomized, double-blind study'</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="NO" STUDY_ID="STD-Silverman-1982"><DESCRIPTION><P>Open-label trial</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="NO" STUDY_ID="STD-Stephenson-1980"><DESCRIPTION><P>Open-label trial</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="NO" STUDY_ID="STD-Stone-1988"><DESCRIPTION><P>Open-label trial</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="UNKNOWN" STUDY_ID="STD-Sun-2011"><DESCRIPTION><P>Not specified</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Suttorp-1991"><DESCRIPTION><P>Randomized, double-blind, placebo-controlled trial</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Vecht-1986"><DESCRIPTION><P>Randomized, double-blind, placebo-controlled trial</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2011-08-19 21:27:11 +0100" MODIFIED_BY="Hermann Blessberger" RESULT="YES" STUDY_ID="STD-Wallace-1998"><DESCRIPTION><P>Randomized, placebo-controlled, triple-blind trial</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="NO" STUDY_ID="STD-Wenke-1999"><DESCRIPTION><P>Open-label trial</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-White-1984"><DESCRIPTION><P>Randomized, placebo-controlled, double-blind trial</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Whitehead-1980"><DESCRIPTION><P>Randomized, placebo-controlled, double-blind trial</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="NO" STUDY_ID="STD-Williams-1982"><DESCRIPTION><P>Open-label trial</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Yang-2006"><DESCRIPTION><P>Randomized, placebo-controlled, double-blind trial</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="NO" STUDY_ID="STD-Yang-2008"><DESCRIPTION><P>Open-label trial</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="NO" STUDY_ID="STD-Zaugg-1999"><DESCRIPTION><P>Open-label trial</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY></QUALITY_ITEM_DATA></QUALITY_ITEM><QUALITY_ITEM CORE_ITEM="NO" ID="QIT-08" LEVEL="GROUP" MODIFIED="2017-10-28 00:46:08 +0100" MODIFIED_BY="Hermann Blessberger" NO="8"><NAME>Blinding of doctors/personnel (performance bias)</NAME><DESCRIPTION><P>Was knowledge of the allocated interventions adequately prevented during the study?</P></DESCRIPTION><QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-08.01" NO="1"><NAME>All outcomes</NAME></QUALITY_ITEM_DATA_ENTRY_GROUP><QUALITY_ITEM_DATA><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2014-08-26 13:46:20 +0100" MODIFIED_BY="Jane Cracknell" RESULT="NO" STUDY_ID="STD-Abel-1983"><DESCRIPTION><P>Open-label trial</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="NO" STUDY_ID="STD-Ali-1997"><DESCRIPTION><P>Open-label trial</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Apipan-2010"><DESCRIPTION><P>See above</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Auer-2004"><DESCRIPTION><P>Randomized, placebo-controlled, double-blind trial</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="NO" STUDY_ID="STD-Babin_x002d_Ebell-1996"><DESCRIPTION><P>Open-label trial</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Bayliff-1999"><DESCRIPTION><P>Randomized, placebo-controlled, double-blind trial</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="NO" STUDY_ID="STD-Bert-2001"><DESCRIPTION><P>Open-label trial</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="UNKNOWN" STUDY_ID="STD-Booth-2004"><DESCRIPTION><P>Not specified</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Burns-1988"><DESCRIPTION><P>Randomized, placebo-controlled, double-blind trial</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="UNKNOWN" STUDY_ID="STD-But-2006"><DESCRIPTION><P>Not specified</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Coleman-1980"><DESCRIPTION><P>Randomized, placebo-controlled, double-blind trial</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Connolly-2003"><DESCRIPTION><P>Randomized, placebo-controlled, double-blind trial</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Cork-1995"><DESCRIPTION><P>Randomized, placebo-controlled, double-blind trial</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Cucchiara-1986"><DESCRIPTION><P>Randomized, placebo-controlled, double-blind trial</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-DIPOM-_x002d_-Juul-2006"><DESCRIPTION><P>See above</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="NO" STUDY_ID="STD-Daudon-1986"><DESCRIPTION><P>Open-label trial</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="NO" STUDY_ID="STD-De-Azevedo-L_x00fa_cio-2003"><DESCRIPTION><P>Open-label trial</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Dy-1998"><DESCRIPTION><P>Randomized, placebo-controlled, double-blind trial</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="NO" STUDY_ID="STD-Evrard-2000"><DESCRIPTION><P>Open-label trial</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="NO" STUDY_ID="STD-Forlani-2002"><DESCRIPTION><P>Open-label trial</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Gibson-1988"><DESCRIPTION><P>Randomized, placebo-controlled, double-blind trial</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Gomes-1999"><DESCRIPTION><P>Randomized, placebo-controlled, double-blind trial</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="UNKNOWN" STUDY_ID="STD-Graham-1996"><DESCRIPTION><P>Not specified</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Gupta-2011"><DESCRIPTION><P>See above</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Hammon-1984"><DESCRIPTION><P>Randomized, placebo-controlled, double-blind trial</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Harrison-1987"><DESCRIPTION><P>Randomized, placebo-controlled, double-blind trial</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Inada-1989"><DESCRIPTION><P>Randomized, placebo-controlled, double-blind trial</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Ivey-1983"><DESCRIPTION><P>Randomized, placebo-controlled, double-blind trial</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="NO" STUDY_ID="STD-Jacquet-1994"><DESCRIPTION><P>Open-label trial</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Jakobsen-1992"><DESCRIPTION><P>Randomized, double-blind, placebo-controlled trial</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Jakobsen-1997"><DESCRIPTION><P>Randomized, placebo-controlled, double-blind trial</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="NO" STUDY_ID="STD-Janssen-1986"><DESCRIPTION><P>Open-label trial</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="NO" STUDY_ID="STD-Kawaguchi-2010"><DESCRIPTION><P>Open-label trial</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Khuri-1987"><DESCRIPTION><P>Randomized, placebo-controlled, double-blind trial</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="NO" STUDY_ID="STD-Kurian-2001"><DESCRIPTION><P>Open-label trial</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="NO" STUDY_ID="STD-Lai-2006"><DESCRIPTION><P>Open-label trial</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="NO" STUDY_ID="STD-Lamb-1988"><DESCRIPTION><P>Open-label trial</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="UNKNOWN" STUDY_ID="STD-Lee-2010"><DESCRIPTION><P>Not specified</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Liu-1986"><DESCRIPTION><P>Randomized, placebo-controlled, double-blind trial</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="NO" STUDY_ID="STD-Liu-2006"><DESCRIPTION><P>Open-label trial</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Magnusson-1986"><DESCRIPTION><P>Randomized, double-blind, placebo-controlled trial</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Mangano-1996"><DESCRIPTION><P>Randomized, placebo-controlled, triple-blind trial</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Martinussen-1988"><DESCRIPTION><P>Randomized, placebo-controlled, double-blind trial</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="NO" STUDY_ID="STD-Marwick-2009"><DESCRIPTION><P>Open-label trial</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="NO" STUDY_ID="STD-Matangi-1985"><DESCRIPTION><P>Open-label trial</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Matangi-1989"><DESCRIPTION><P>Randomized, placebo-controlled, double-blind trial</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="NO" STUDY_ID="STD-Materne-1985"><DESCRIPTION><P>Open-label trial</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="NO" STUDY_ID="STD-Matsuura-2001"><DESCRIPTION><P>Open-label trial</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Miller-1990"><DESCRIPTION><P>Randomized, placebo-controlled, double-blind trial</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Miller-1991"><DESCRIPTION><P>Randomized, placebo-controlled, double-blind trial</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="NO" STUDY_ID="STD-Mohr-1981"><DESCRIPTION><P>Open-label trial</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Moon-2011"><DESCRIPTION><P>See above</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="NO" STUDY_ID="STD-Myhre-1984"><DESCRIPTION><P>Open-label trial</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Neary-2006"><DESCRIPTION><P>Randomized, triple-blind, placebo-controlled trial</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2011-08-19 21:15:24 +0100" MODIFIED_BY="Hermann Blessberger" RESULT="YES" STUDY_ID="STD-Neustein-1994"><DESCRIPTION><P>Randomized, triple-blind, placebo-controlled trial</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="NO" STUDY_ID="STD-Nystr_x00f6_m-1993"><DESCRIPTION><P>Open-label trial</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="NO" STUDY_ID="STD-Ogawa-2013"><DESCRIPTION><P>Open-label trial</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="NO" STUDY_ID="STD-Oka-1980"><DESCRIPTION><P>Open-label trial</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="NO" STUDY_ID="STD-Ormerod-1984"><DESCRIPTION><P>Open-label trial</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="NO" STUDY_ID="STD-Osada-2012"><DESCRIPTION><P>Open-label trial</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Oxorn-1990"><DESCRIPTION><P>Randomized, triple-blind, placebo-controlled trial</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="NO" STUDY_ID="STD-POBBLE-2005"><DESCRIPTION><P>'Anesthesiologists were unblinded to the drug allocation because those involved in the trial at participating centers would have immediately identified the active treatment and, for safety reasons, refused to collaborate in a blinded fashion'</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-POISE-2008"><DESCRIPTION><P>Randomized, placebo-controlled, triple-blind multi-centre trial</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="NO" STUDY_ID="STD-Paull-1997"><DESCRIPTION><P>Single-blind trial</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Pfisterer-1997"><DESCRIPTION><P>Randomized, placebo-controlled, double-blind trial</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="NO" STUDY_ID="STD-Raby-1999"><DESCRIPTION><P>Despite the double-blind study design, a "significantly higher use of alternative beta-blockers in the placebo group compared with the esmolol group" was noted. The study authors suggested that "managing clinicians recognized patients receiving the active drug or placebo despite blinding"</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Reves-1990"><DESCRIPTION><P>Randomized, double-blind, placebo-controlled trial</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="NO" STUDY_ID="STD-Rubin-1987"><DESCRIPTION><P>Open-label trial</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="NO" STUDY_ID="STD-Sakaguchi-2012"><DESCRIPTION><P>Open-label trial</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="NO" STUDY_ID="STD-Salazar-1979"><DESCRIPTION><P>Open-label trial</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Sandler-1990"><DESCRIPTION><P>Randomized, placebo-controlled, double-blind trial</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Sezai-2011"><DESCRIPTION><P>See above</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Sezai-2012"><DESCRIPTION><P>Medical staff was blinded for IV and oral treatment</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Shukla-2010"><DESCRIPTION><P>See above</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="NO" STUDY_ID="STD-Silverman-1982"><DESCRIPTION><P>Open-label trial</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="NO" STUDY_ID="STD-Stephenson-1980"><DESCRIPTION><P>Open-label trial</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="NO" STUDY_ID="STD-Stone-1988"><DESCRIPTION><P>Open-label trial</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="UNKNOWN" STUDY_ID="STD-Sun-2011"><DESCRIPTION><P>Not specified</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Suttorp-1991"><DESCRIPTION><P>Randomized, double-blind, placebo-controlled trial</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Vecht-1986"><DESCRIPTION><P>Randomized, double-blind, placebo-controlled trial</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2011-08-19 21:27:12 +0100" MODIFIED_BY="Hermann Blessberger" RESULT="YES" STUDY_ID="STD-Wallace-1998"><DESCRIPTION><P>Randomized, placebo-controlled, triple-blind trial</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="NO" STUDY_ID="STD-Wenke-1999"><DESCRIPTION><P>Open-label trial</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-White-1984"><DESCRIPTION><P>Randomized, placebo-controlled, double-blind trial</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Whitehead-1980"><DESCRIPTION><P>Randomized, placebo-controlled, double-blind trial</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="NO" STUDY_ID="STD-Williams-1982"><DESCRIPTION><P>Open-label trial</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Yang-2006"><DESCRIPTION><P>Randomized, placebo-controlled, double-blind trial</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="NO" STUDY_ID="STD-Yang-2008"><DESCRIPTION><P>Open-label trial</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="NO" STUDY_ID="STD-Zaugg-1999"><DESCRIPTION><P>Open-label trial</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY></QUALITY_ITEM_DATA></QUALITY_ITEM><QUALITY_ITEM CORE_ITEM="NO" ID="QIT-09" LEVEL="GROUP" MODIFIED="2017-10-28 00:46:08 +0100" MODIFIED_BY="Hermann Blessberger" NO="9"><NAME>Blinding of outcome assessors (detection bias)</NAME><DESCRIPTION><P>Was knowledge of the allocated interventions adequately prevented during the study?</P></DESCRIPTION><QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-09.01" NO="1"><NAME>All outcomes</NAME></QUALITY_ITEM_DATA_ENTRY_GROUP><QUALITY_ITEM_DATA><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-09.01" MODIFIED="2014-08-26 13:46:20 +0100" MODIFIED_BY="Jane Cracknell" RESULT="NO" STUDY_ID="STD-Abel-1983"><DESCRIPTION><P>Open-label trial</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-09.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="NO" STUDY_ID="STD-Ali-1997"><DESCRIPTION><P>Open-label trial</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-09.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Apipan-2010"><DESCRIPTION><P>See above</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-09.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="UNKNOWN" STUDY_ID="STD-Auer-2004"><DESCRIPTION><P>Not specified</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-09.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="NO" STUDY_ID="STD-Babin_x002d_Ebell-1996"><DESCRIPTION><P>Open-label trial</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-09.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="UNKNOWN" STUDY_ID="STD-Bayliff-1999"><DESCRIPTION><P>Not specified</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-09.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="NO" STUDY_ID="STD-Bert-2001"><DESCRIPTION><P>Open-label trial</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-09.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="UNKNOWN" STUDY_ID="STD-Booth-2004"><DESCRIPTION><P>Not specified</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-09.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Burns-1988"><DESCRIPTION><P>ECG tracings were interpreted by 2 observers blinded to study group allocation</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-09.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="UNKNOWN" STUDY_ID="STD-But-2006"><DESCRIPTION><P>Not specified</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-09.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="UNKNOWN" STUDY_ID="STD-Coleman-1980"><DESCRIPTION><P>Not specified</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-09.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="UNKNOWN" STUDY_ID="STD-Connolly-2003"><DESCRIPTION><P>Not specified</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-09.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="UNKNOWN" STUDY_ID="STD-Cork-1995"><DESCRIPTION><P>Not specified</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-09.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="UNKNOWN" STUDY_ID="STD-Cucchiara-1986"><DESCRIPTION><P>Not specified</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-09.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-DIPOM-_x002d_-Juul-2006"><DESCRIPTION><P>See above</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-09.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="NO" STUDY_ID="STD-Daudon-1986"><DESCRIPTION><P>Open-label trial</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-09.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="NO" STUDY_ID="STD-De-Azevedo-L_x00fa_cio-2003"><DESCRIPTION><P>Open-label trial</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-09.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="UNKNOWN" STUDY_ID="STD-Dy-1998"><DESCRIPTION><P>Not specified</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-09.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="NO" STUDY_ID="STD-Evrard-2000"><DESCRIPTION><P>Open-label trial</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-09.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="NO" STUDY_ID="STD-Forlani-2002"><DESCRIPTION><P>Open-label trial</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-09.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="UNKNOWN" STUDY_ID="STD-Gibson-1988"><DESCRIPTION><P>Not specified</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-09.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="UNKNOWN" STUDY_ID="STD-Gomes-1999"><DESCRIPTION><P>Not specified</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-09.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="UNKNOWN" STUDY_ID="STD-Graham-1996"><DESCRIPTION><P>Not specified</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-09.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Gupta-2011"><DESCRIPTION><P>See above</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-09.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="UNKNOWN" STUDY_ID="STD-Hammon-1984"><DESCRIPTION><P>Not specified</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-09.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Harrison-1987"><DESCRIPTION><P>'The ST trends and ECG strips were evaluated for myocardial ischaemia independently by a cardiologist who had no knowledge of the patient's treatment group'</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-09.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="UNKNOWN" STUDY_ID="STD-Inada-1989"><DESCRIPTION><P>Not specified</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-09.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="UNKNOWN" STUDY_ID="STD-Ivey-1983"><DESCRIPTION><P>Not specified</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-09.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="NO" STUDY_ID="STD-Jacquet-1994"><DESCRIPTION><P>Open-label trial</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-09.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="UNKNOWN" STUDY_ID="STD-Jakobsen-1992"><DESCRIPTION><P>Not specified</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-09.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="UNKNOWN" STUDY_ID="STD-Jakobsen-1997"><DESCRIPTION><P>Not specified</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-09.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="NO" STUDY_ID="STD-Janssen-1986"><DESCRIPTION><P>Open-label trial</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-09.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="NO" STUDY_ID="STD-Kawaguchi-2010"><DESCRIPTION><P>Open-label trial</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-09.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Khuri-1987"><DESCRIPTION><P>Outcome assessor blinded ('analysed by an independent observer')</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-09.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="NO" STUDY_ID="STD-Kurian-2001"><DESCRIPTION><P>Open-label trial</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-09.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="NO" STUDY_ID="STD-Lai-2006"><DESCRIPTION><P>Open-label trial</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-09.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="NO" STUDY_ID="STD-Lamb-1988"><DESCRIPTION><P>Open-label trial</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-09.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="UNKNOWN" STUDY_ID="STD-Lee-2010"><DESCRIPTION><P>Not specified</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-09.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="UNKNOWN" STUDY_ID="STD-Liu-1986"><DESCRIPTION><P>Not specified</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-09.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="NO" STUDY_ID="STD-Liu-2006"><DESCRIPTION><P>Open-label trial</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-09.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="UNKNOWN" STUDY_ID="STD-Magnusson-1986"><DESCRIPTION><P>Not specified</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-09.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Mangano-1996"><DESCRIPTION><P>Randomized, placebo-controlled, triple-blind trial</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-09.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="UNKNOWN" STUDY_ID="STD-Martinussen-1988"><DESCRIPTION><P>Not specified</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-09.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="NO" STUDY_ID="STD-Marwick-2009"><DESCRIPTION><P>Open-label trial</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-09.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="NO" STUDY_ID="STD-Matangi-1985"><DESCRIPTION><P>Open-label trial</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-09.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="UNKNOWN" STUDY_ID="STD-Matangi-1989"><DESCRIPTION><P>Not specified</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-09.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="NO" STUDY_ID="STD-Materne-1985"><DESCRIPTION><P>Open-label trial</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-09.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="NO" STUDY_ID="STD-Matsuura-2001"><DESCRIPTION><P>Open-label trial</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-09.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="UNKNOWN" STUDY_ID="STD-Miller-1990"><DESCRIPTION><P>Not specified</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-09.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="UNKNOWN" STUDY_ID="STD-Miller-1991"><DESCRIPTION><P>Not specified</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-09.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="NO" STUDY_ID="STD-Mohr-1981"><DESCRIPTION><P>Open-label trial</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-09.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Moon-2011"><DESCRIPTION><P>Intraoperative haemodynamic variables were assessed by an anaesthesiologist blinded to study allocation</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-09.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="NO" STUDY_ID="STD-Myhre-1984"><DESCRIPTION><P>Open-label trial</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-09.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Neary-2006"><DESCRIPTION><P>ECGs and lab reports were evaluated by "blinded cardiology staff"</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-09.01" MODIFIED="2011-08-19 21:15:30 +0100" MODIFIED_BY="Hermann Blessberger" RESULT="YES" STUDY_ID="STD-Neustein-1994"><DESCRIPTION><P>Randomized, triple-blind, placebo-controlled trial</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-09.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="NO" STUDY_ID="STD-Nystr_x00f6_m-1993"><DESCRIPTION><P>Open-label trial</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-09.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="NO" STUDY_ID="STD-Ogawa-2013"><DESCRIPTION><P>Open-label trial</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-09.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="NO" STUDY_ID="STD-Oka-1980"><DESCRIPTION><P>Open-label trial</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-09.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="NO" STUDY_ID="STD-Ormerod-1984"><DESCRIPTION><P>Open-label trial</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-09.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="NO" STUDY_ID="STD-Osada-2012"><DESCRIPTION><P>Open-label trial</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-09.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Oxorn-1990"><DESCRIPTION><P>Cardiologist assessing the ECG was blinded to study group allocation</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-09.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-POBBLE-2005"><DESCRIPTION><P>Holter-ECG results were coded centrally</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-09.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-POISE-2008"><DESCRIPTION><P>Outcome adjudicators were masked to treatment allocation</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-09.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="NO" STUDY_ID="STD-Paull-1997"><DESCRIPTION><P>Single-blind trial</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-09.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="UNKNOWN" STUDY_ID="STD-Pfisterer-1997"><DESCRIPTION><P>Randomized, placebo-controlled, double-blind trial</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-09.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Raby-1999"><DESCRIPTION><P>Holter monitoring was interpreted "by a technician blinded to patient characteristics and randomization"</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-09.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="UNKNOWN" STUDY_ID="STD-Reves-1990"><DESCRIPTION><P>Not specified</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-09.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="NO" STUDY_ID="STD-Rubin-1987"><DESCRIPTION><P>Open-label trial</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-09.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="NO" STUDY_ID="STD-Sakaguchi-2012"><DESCRIPTION><P>Open-label trial</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-09.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="NO" STUDY_ID="STD-Salazar-1979"><DESCRIPTION><P>Open-label trial</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-09.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="UNKNOWN" STUDY_ID="STD-Sandler-1990"><DESCRIPTION><P>Not specified</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-09.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="UNKNOWN" STUDY_ID="STD-Sezai-2011"><DESCRIPTION><P>Not specified</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-09.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="UNKNOWN" STUDY_ID="STD-Sezai-2012"><DESCRIPTION><P>Not specified</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-09.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="UNKNOWN" STUDY_ID="STD-Shukla-2010"><DESCRIPTION><P>Not specified</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-09.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="NO" STUDY_ID="STD-Silverman-1982"><DESCRIPTION><P>Open-label trial</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-09.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="NO" STUDY_ID="STD-Stephenson-1980"><DESCRIPTION><P>Open-label trial</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-09.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="NO" STUDY_ID="STD-Stone-1988"><DESCRIPTION><P>Open-label trial</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-09.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="UNKNOWN" STUDY_ID="STD-Sun-2011"><DESCRIPTION><P>Not specified</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-09.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="UNKNOWN" STUDY_ID="STD-Suttorp-1991"><DESCRIPTION><P>Not specified</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-09.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="UNKNOWN" STUDY_ID="STD-Vecht-1986"><DESCRIPTION><P>Not specified</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-09.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Wallace-1998"><DESCRIPTION><P>Outcome assessors were blinded</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-09.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="NO" STUDY_ID="STD-Wenke-1999"><DESCRIPTION><P>Open-label trial</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-09.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="UNKNOWN" STUDY_ID="STD-White-1984"><DESCRIPTION><P>Not specified</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-09.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Whitehead-1980"><DESCRIPTION><P>Anaesthesiologist evaluating ECG and haemodynamic parameters was blinded to study group allocation</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-09.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="NO" STUDY_ID="STD-Williams-1982"><DESCRIPTION><P>Open-label trial</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-09.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="UNKNOWN" STUDY_ID="STD-Yang-2006"><DESCRIPTION><P>Not specified</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-09.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="NO" STUDY_ID="STD-Yang-2008"><DESCRIPTION><P>Open-label trial</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-09.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="NO" STUDY_ID="STD-Zaugg-1999"><DESCRIPTION><P>Open-label trial</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY></QUALITY_ITEM_DATA></QUALITY_ITEM><QUALITY_ITEM CORE_ITEM="NO" ID="QIT-11" LEVEL="GROUP" MODIFIED="2011-04-25 07:26:04 +0100" MODIFIED_BY="Hermann Blessberger" NO="11"><NAME>Blinding of participants and personnel (performance bias)</NAME><DESCRIPTION><P>Performance bias due to knowledge of the allocated interventions by participants and personnel during the study</P></DESCRIPTION><QUALITY_ITEM_DATA/></QUALITY_ITEM><QUALITY_ITEM CORE_ITEM="NO" ID="QIT-12" LEVEL="GROUP" MODIFIED="2011-04-25 07:26:04 +0100" MODIFIED_BY="Hermann Blessberger" NO="12"><NAME>Blinding of outcome assessment (detection bias)</NAME><DESCRIPTION><P>Detection bias due to knowledge of the allocated interventions by outcome assessors</P></DESCRIPTION><QUALITY_ITEM_DATA/></QUALITY_ITEM><QUALITY_ITEM CORE_ITEM="YES" ID="QIT-04" LEVEL="GROUP" MODIFIED="2017-10-28 00:46:08 +0100" MODIFIED_BY="Hermann Blessberger" NO="4"><NAME>Incomplete outcome data (attrition bias)</NAME><DESCRIPTION><P>Attrition bias due to amount, nature or handling of incomplete outcome data</P></DESCRIPTION><QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-04.01" NO="1"><NAME>All outcomes</NAME></QUALITY_ITEM_DATA_ENTRY_GROUP><QUALITY_ITEM_DATA><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="NO" STUDY_ID="STD-Abel-1983"><DESCRIPTION><P>9 withdrawals in beta-blocker group due to bradycardia (2), severe hypotension (3), preoperative myocardial infarction (2), biventricular failure (1), and cardiac arrest (1)</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="UNKNOWN" STUDY_ID="STD-Ali-1997"><DESCRIPTION><P>Not specified</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="UNKNOWN" STUDY_ID="STD-Apipan-2010"><DESCRIPTION><P>Not reported</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2014-09-10 08:13:01 +0100" MODIFIED_BY="Jane Cracknell" RESULT="NO" STUDY_ID="STD-Auer-2004"><DESCRIPTION><P>Three participants were excluded from analysis after randomization (1 participant refused surgery, 1 was refused to be operated on by the surgeon and 1 suffered from a stroke before the time of surgery&#8212;exact group allocation unclear). Participants were not analysed as randomly assigned (256 were randomly assigned)</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="NO" STUDY_ID="STD-Babin_x002d_Ebell-1996"><DESCRIPTION><P>Six participants were excluded from analysis of supraventricular arrhythmias (bradycardia, hypotension, perioperative myocardial infarction)</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Bayliff-1999"><DESCRIPTION><P>See below</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="NO" STUDY_ID="STD-Bert-2001"><DESCRIPTION><P>No participants lost to follow-up. 3 participants who did not undergo surgery were excluded after enrolment</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Booth-2004"><DESCRIPTION><P>See below</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="UNKNOWN" STUDY_ID="STD-Burns-1988"><DESCRIPTION><P>Not specified</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="UNKNOWN" STUDY_ID="STD-But-2006"><DESCRIPTION><P>Not specified</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2014-09-02 09:03:30 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Coleman-1980"><DESCRIPTION><P> 4 participants excluded because of unreadable ECG recordings (1 placebo group, 3 beta-blocker group)</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="UNKNOWN" STUDY_ID="STD-Connolly-2003"><DESCRIPTION><P>Not specified</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="UNKNOWN" STUDY_ID="STD-Cork-1995"><DESCRIPTION><P>Not specified</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="NO" STUDY_ID="STD-Cucchiara-1986"><DESCRIPTION><P>12 participants were excluded from analysis because of protocol violations</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-DIPOM-_x002d_-Juul-2006"><DESCRIPTION><P>See below</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="UNKNOWN" STUDY_ID="STD-Daudon-1986"><DESCRIPTION><P>Not specified</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-De-Azevedo-L_x00fa_cio-2003"><DESCRIPTION><P>See below</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="UNKNOWN" STUDY_ID="STD-Dy-1998"><DESCRIPTION><P>Not specified</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="UNKNOWN" STUDY_ID="STD-Evrard-2000"><DESCRIPTION><P>Not specified</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="NO" STUDY_ID="STD-Forlani-2002"><DESCRIPTION><P>2 participants with an intraoperative myocardial infarction were excluded from analysis</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="UNKNOWN" STUDY_ID="STD-Gibson-1988"><DESCRIPTION><P>Not specified</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Gomes-1999"><DESCRIPTION><P>Study authors reported incomplete outcome data</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="UNKNOWN" STUDY_ID="STD-Graham-1996"><DESCRIPTION><P>Not specified</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Gupta-2011"><DESCRIPTION><P>Not detected</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="UNKNOWN" STUDY_ID="STD-Hammon-1984"><DESCRIPTION><P>Not specified</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="UNKNOWN" STUDY_ID="STD-Harrison-1987"><DESCRIPTION><P>Not specified</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="UNKNOWN" STUDY_ID="STD-Inada-1989"><DESCRIPTION><P>Not specified</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="NO" STUDY_ID="STD-Ivey-1983"><DESCRIPTION><P>Participants were excluded after randomization because of myocardial infarction or dysrhythmias</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="NO" STUDY_ID="STD-Jacquet-1994"><DESCRIPTION><P>6 participants were withdrawn from analysis (3 because of bradycardia, 3 as the result of hypotension)</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="UNKNOWN" STUDY_ID="STD-Jakobsen-1992"><DESCRIPTION><P>Not specified</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Jakobsen-1997"><DESCRIPTION><P>One participant was withdrawn from the placebo group because an epidural catheter could not be accomplished</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="NO" STUDY_ID="STD-Janssen-1986"><DESCRIPTION><P>21 participants excluded from analysis (2 myocardial infarction, 12 inotropic support after CABG, 1 death, 1 bradycardia, 5 inappropriate data)</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="UNKNOWN" STUDY_ID="STD-Kawaguchi-2010"><DESCRIPTION><P>Not specified</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="NO" STUDY_ID="STD-Khuri-1987"><DESCRIPTION><P>7 participants were excluded from analysis because of "insufficient postoperative data"</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="NO" STUDY_ID="STD-Kurian-2001"><DESCRIPTION><P>4 participants were withdrawn (2 because of hypotension in the esmolol group, 1 in the esmolol group and 1 in the control group because of insufficient monitoring)</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="NO" STUDY_ID="STD-Lai-2006"><DESCRIPTION><P>2 participants were withdrawn from the study after randomization. Exact point of time and study group allocation were unclear</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="UNKNOWN" STUDY_ID="STD-Lamb-1988"><DESCRIPTION><P>Not specified</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="UNKNOWN" STUDY_ID="STD-Lee-2010"><DESCRIPTION><P>Not reported</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="UNKNOWN" STUDY_ID="STD-Liu-1986"><DESCRIPTION><P>Not specified</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="UNKNOWN" STUDY_ID="STD-Liu-2006"><DESCRIPTION><P>Not specified</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="NO" STUDY_ID="STD-Magnusson-1986"><DESCRIPTION><P>"Two patients in the treatment group and one patient in the placebo group were subsequently excluded because of complications during treatment"</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Mangano-1996"><DESCRIPTION><P>Study authors reported incomplete outcome data</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="NO" STUDY_ID="STD-Martinussen-1988"><DESCRIPTION><P>33 participants already randomly assigned were excluded from analysis (in 14 participants, a nasogastric tube for drug administration could not be placed, 19 participants developed disorders as specified in the discontinuation criteria); originally 108 participants were randomly assigned</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Marwick-2009"><DESCRIPTION><P>A total of 17 participants in the beta-blocker group and 17 in the control group did not fulfil the protocol. However, they were included in the analysis based on the intention-to-treat principle</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Matangi-1985"><DESCRIPTION><P>In 4 participants, beta-blocker therapy was discontinued because of side effects (low cardiac output, bronchospasm, nightmares), but "all patients were analysed according to the intention-to-treat principle"</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Matangi-1989"><DESCRIPTION><P>4 withdrawals before random assignment (1 participant died during surgery, 2 suffered from an intraoperative myocardial infarction and required high-dose inotropic support, 1 had bronchospasms postoperatively)</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="UNKNOWN" STUDY_ID="STD-Materne-1985"><DESCRIPTION><P>Not specified</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="UNKNOWN" STUDY_ID="STD-Matsuura-2001"><DESCRIPTION><P>3 participants were potentially withdrawn (unclear)</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="UNKNOWN" STUDY_ID="STD-Miller-1990"><DESCRIPTION><P>Not specified</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="UNKNOWN" STUDY_ID="STD-Miller-1991"><DESCRIPTION><P>Not specified</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="NO" STUDY_ID="STD-Mohr-1981"><DESCRIPTION><P>2 participants who died were not included in the analysis</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="UNKNOWN" STUDY_ID="STD-Moon-2011"><DESCRIPTION><P>Not reported</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="NO" STUDY_ID="STD-Myhre-1984"><DESCRIPTION><P>1 participant died and was excluded from the analysis</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Neary-2006"><DESCRIPTION><P>"19 patients were withdrawn because relatives removed consent" before randomization</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="NO" STUDY_ID="STD-Neustein-1994"><DESCRIPTION><P>2 participants were excluded from analysis (1 in the beta-blocker group because of bradycardia and hypotension and 1 in the control group as the result of a wide QRS complex that did not allow interpretation of intraoperative myocardial ischaemia); number of enrolled participants = 40</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="UNKNOWN" STUDY_ID="STD-Nystr_x00f6_m-1993"><DESCRIPTION><P>Not specified</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Ogawa-2013"><DESCRIPTION><P>'None of the patients was withdrawn from the study'</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="UNKNOWN" STUDY_ID="STD-Oka-1980"><DESCRIPTION><P>Not specified</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="NO" STUDY_ID="STD-Ormerod-1984"><DESCRIPTION><P>Randomization was performed 1 week before surgery. 4 participants were excluded after the surgery because oral drug administration was impossible (low cardiac output or assisted ventilation after operation)</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="UNKNOWN" STUDY_ID="STD-Osada-2012"><DESCRIPTION><P>Not reported</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="UNKNOWN" STUDY_ID="STD-Oxorn-1990"><DESCRIPTION><P>Not specified</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-POBBLE-2005"><DESCRIPTION><P>Incomplete outcome data were reported</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2011-08-19 21:33:58 +0100" MODIFIED_BY="Hermann Blessberger" RESULT="YES" STUDY_ID="STD-POISE-2008"><DESCRIPTION><P>See below.</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="UNKNOWN" STUDY_ID="STD-Paull-1997"><DESCRIPTION><P>Not specified</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Pfisterer-1997"><DESCRIPTION><P>Study authors reported incomplete outcome data</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Raby-1999"><DESCRIPTION><P>"No patient in our study had beta-blocker therapy suspended because of unacceptable side effects"</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="UNKNOWN" STUDY_ID="STD-Reves-1990"><DESCRIPTION><P>Not specified</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="NO" STUDY_ID="STD-Rubin-1987"><DESCRIPTION><P>27 participants were excluded from analysis after randomization</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="UNKNOWN" STUDY_ID="STD-Sakaguchi-2012"><DESCRIPTION><P>Not reported</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="UNKNOWN" STUDY_ID="STD-Salazar-1979"><DESCRIPTION><P>Not specified</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="UNKNOWN" STUDY_ID="STD-Sandler-1990"><DESCRIPTION><P>Not specified</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="NO" STUDY_ID="STD-Sezai-2011"><DESCRIPTION><P>2 participants were withdrawn after randomization because of 'lack of sufficient data'</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="NO" STUDY_ID="STD-Sezai-2012"><DESCRIPTION><P>4 participants were excluded after randomization (off-pump CABG, other surgery done concomitantly)</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="UNKNOWN" STUDY_ID="STD-Shukla-2010"><DESCRIPTION><P>Not reported</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="UNKNOWN" STUDY_ID="STD-Silverman-1982"><DESCRIPTION><P>Not specified</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="NO" STUDY_ID="STD-Stephenson-1980"><DESCRIPTION><P>2 participants who received the study drug and developed bradycardia were excluded from the analysis</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="UNKNOWN" STUDY_ID="STD-Stone-1988"><DESCRIPTION><P>Not specified</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="NO" STUDY_ID="STD-Sun-2011"><DESCRIPTION><P>2 control group participants were excluded from the study as the result of pericarditis after randomization</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="NO" STUDY_ID="STD-Suttorp-1991"><DESCRIPTION><P>3 participants were excluded from analysis because of protocol violations (</P><P>per-protocol analysis); 303 participants enrolled</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="UNKNOWN" STUDY_ID="STD-Vecht-1986"><DESCRIPTION><P>Not specified</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="UNKNOWN" STUDY_ID="STD-Wallace-1998"><DESCRIPTION><P>Not specified</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="UNKNOWN" STUDY_ID="STD-Wenke-1999"><DESCRIPTION><P>Not specified</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="UNKNOWN" STUDY_ID="STD-White-1984"><DESCRIPTION><P>Not specified</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="UNKNOWN" STUDY_ID="STD-Whitehead-1980"><DESCRIPTION><P>Not specified</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="NO" STUDY_ID="STD-Williams-1982"><DESCRIPTION><P>5 participants were excluded from analysis because of postoperative heart failure requiring IABP perioperatively (65 participants randomly assigned)</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Yang-2006"><DESCRIPTION><P>See below</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="UNKNOWN" STUDY_ID="STD-Yang-2008"><DESCRIPTION><P>Not specified</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="NO" STUDY_ID="STD-Zaugg-1999"><DESCRIPTION><P>4 dropouts: 1 control participant who received beta-blockers and 3 participants in the treatment group (massive surgical bleeding, false anaesthetic agent, participant with pacemaker)&#8212;63 participants randomly assigned</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY></QUALITY_ITEM_DATA></QUALITY_ITEM><QUALITY_ITEM CORE_ITEM="NO" ID="QIT-10" LEVEL="STUDY" MODIFIED="2017-10-28 00:46:08 +0100" MODIFIED_BY="Hermann Blessberger" NO="10"><NAME>Intention to treat analysis</NAME><DESCRIPTION><P>Was everyone who began the treatment considered to be part of the trial, whether they finished it or not?</P></DESCRIPTION><QUALITY_ITEM_DATA><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-26 13:46:14 +0100" MODIFIED_BY="Jane Cracknell" RESULT="NO" STUDY_ID="STD-Abel-1983"><DESCRIPTION><P>Participants were not analysed as randomly assigned</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="UNKNOWN" STUDY_ID="STD-Ali-1997"><DESCRIPTION><P>Not specified</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="UNKNOWN" STUDY_ID="STD-Apipan-2010"><DESCRIPTION><P>Not reported</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="NO" STUDY_ID="STD-Auer-2004"><DESCRIPTION><P>See above</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="NO" STUDY_ID="STD-Babin_x002d_Ebell-1996"><DESCRIPTION><P>Not analysed as randomly assigned</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Bayliff-1999"><DESCRIPTION><P>No withdrawals, participants analysed as randomly assigned</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="NO" STUDY_ID="STD-Bert-2001"><DESCRIPTION><P>Not analysed as randomly assigned</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Booth-2004"><DESCRIPTION><P>Study authors stated they used the intention-to-treat principle for data analysis</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="UNKNOWN" STUDY_ID="STD-Burns-1988"><DESCRIPTION><P>Not specified</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="UNKNOWN" STUDY_ID="STD-But-2006"><DESCRIPTION><P>Not specified</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="NO" STUDY_ID="STD-Coleman-1980"><DESCRIPTION><P>Participants were not analysed as randomly assigned</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="UNKNOWN" STUDY_ID="STD-Connolly-2003"><DESCRIPTION><P>Not specified</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="UNKNOWN" STUDY_ID="STD-Cork-1995"><DESCRIPTION><P>Not specified</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="NO" STUDY_ID="STD-Cucchiara-1986"><DESCRIPTION><P>Participants were not analysed as randomly assigned</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-DIPOM-_x002d_-Juul-2006"><DESCRIPTION><P>Study authors used intention-to-treat principle in their analysis</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="UNKNOWN" STUDY_ID="STD-Daudon-1986"><DESCRIPTION><P>Not specified</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-De-Azevedo-L_x00fa_cio-2003"><DESCRIPTION><P>"Analysis was carried out based on the principle intention-to-treat"</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="UNKNOWN" STUDY_ID="STD-Dy-1998"><DESCRIPTION><P>Not specified</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="UNKNOWN" STUDY_ID="STD-Evrard-2000"><DESCRIPTION><P>Not specified</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="NO" STUDY_ID="STD-Forlani-2002"><DESCRIPTION><P>Not analysed as randomly assigned</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="UNKNOWN" STUDY_ID="STD-Gibson-1988"><DESCRIPTION><P>Not specified</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="UNKNOWN" STUDY_ID="STD-Gomes-1999"><DESCRIPTION><P>Not specified</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="UNKNOWN" STUDY_ID="STD-Graham-1996"><DESCRIPTION><P>Not specified</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="NO" STUDY_ID="STD-Gupta-2011"><DESCRIPTION><P>2 participants in the atenolol group were excluded from analysis because of bradycardia. Participants were not analysed as randomly assigned by the study authors. However, these 2 participants were included in our analysis (outcome 'bradycardia')</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="UNKNOWN" STUDY_ID="STD-Hammon-1984"><DESCRIPTION><P>Not specified</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="UNKNOWN" STUDY_ID="STD-Harrison-1987"><DESCRIPTION><P>Not specified</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="UNKNOWN" STUDY_ID="STD-Inada-1989"><DESCRIPTION><P>Not specified</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="NO" STUDY_ID="STD-Ivey-1983"><DESCRIPTION><P>Participants were not analysed as randomly assigned</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="NO" STUDY_ID="STD-Jacquet-1994"><DESCRIPTION><P>Participants were not analysed as randomly assigned; 6 participants in the beta-blocker group had to be excluded from the study because of drug-related side effects</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="UNKNOWN" STUDY_ID="STD-Jakobsen-1992"><DESCRIPTION><P>Not specified</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="NO" STUDY_ID="STD-Jakobsen-1997"><DESCRIPTION><P>Not analysed as randomly assigned</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="NO" STUDY_ID="STD-Janssen-1986"><DESCRIPTION><P>Participants were not analysed as randomly assigned</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="UNKNOWN" STUDY_ID="STD-Kawaguchi-2010"><DESCRIPTION><P>Not specified</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="NO" STUDY_ID="STD-Khuri-1987"><DESCRIPTION><P>Participants were not analysed as randomly assigned</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="NO" STUDY_ID="STD-Kurian-2001"><DESCRIPTION><P>Study authors stated they used the intention-to-treat principle for analysis but participant were not analysed as randomly assigned</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="NO" STUDY_ID="STD-Lai-2006"><DESCRIPTION><P>Not analysed as randomly assigned</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="UNKNOWN" STUDY_ID="STD-Lamb-1988"><DESCRIPTION><P>Not specified</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="UNKNOWN" STUDY_ID="STD-Lee-2010"><DESCRIPTION><P>Not specified</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="UNKNOWN" STUDY_ID="STD-Liu-1986"><DESCRIPTION><P>Not specified</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="UNKNOWN" STUDY_ID="STD-Liu-2006"><DESCRIPTION><P>Not specified</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="NO" STUDY_ID="STD-Magnusson-1986"><DESCRIPTION><P>Participants were not analysed as randomly assigned</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="UNKNOWN" STUDY_ID="STD-Mangano-1996"><DESCRIPTION><P>Not specified</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="NO" STUDY_ID="STD-Martinussen-1988"><DESCRIPTION><P>Participants were not analysed as randomly assigned</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Marwick-2009"><DESCRIPTION><P>See above</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Matangi-1985"><DESCRIPTION><P>See above</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Matangi-1989"><DESCRIPTION><P>Study authors stated that they had applied the intention-to-treat principle</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="UNKNOWN" STUDY_ID="STD-Materne-1985"><DESCRIPTION><P>Not specified</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="UNKNOWN" STUDY_ID="STD-Matsuura-2001"><DESCRIPTION><P>Not specified</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="UNKNOWN" STUDY_ID="STD-Miller-1990"><DESCRIPTION><P>Not specified</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="UNKNOWN" STUDY_ID="STD-Miller-1991"><DESCRIPTION><P>Not specified</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="NO" STUDY_ID="STD-Mohr-1981"><DESCRIPTION><P>Not analysed as randomly assigned</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="UNKNOWN" STUDY_ID="STD-Moon-2011"><DESCRIPTION><P>Not specified</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="NO" STUDY_ID="STD-Myhre-1984"><DESCRIPTION><P>Not analysed as randomly assigned</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Neary-2006"><DESCRIPTION><P>Participants were analysed as randomly assigned</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="NO" STUDY_ID="STD-Neustein-1994"><DESCRIPTION><P>Participants were not analysed as randomly assigned</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="UNKNOWN" STUDY_ID="STD-Nystr_x00f6_m-1993"><DESCRIPTION><P>Not specified</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="UNKNOWN" STUDY_ID="STD-Ogawa-2013"><DESCRIPTION><P>Not specified</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="UNKNOWN" STUDY_ID="STD-Oka-1980"><DESCRIPTION><P>Not specified</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="NO" STUDY_ID="STD-Ormerod-1984"><DESCRIPTION><P>Participants were not analysed as randomly assigned</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="UNKNOWN" STUDY_ID="STD-Osada-2012"><DESCRIPTION><P>Not specified</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="UNKNOWN" STUDY_ID="STD-Oxorn-1990"><DESCRIPTION><P>Not specified</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-POBBLE-2005"><DESCRIPTION><P>Study authors stated they used the intention-to-treat principle for data analysis</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-POISE-2008"><DESCRIPTION><P>Study authors stated they used the intention-to-treat principle for data analysis</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Paull-1997"><DESCRIPTION><P>Study authors stated they used the intention-to-treat principle for data analysis</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Pfisterer-1997"><DESCRIPTION><P>Study authors stated they used the intention-to-treat principle for data analysis</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="UNKNOWN" STUDY_ID="STD-Raby-1999"><DESCRIPTION><P>Not specified</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="UNKNOWN" STUDY_ID="STD-Reves-1990"><DESCRIPTION><P>Not specified</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="NO" STUDY_ID="STD-Rubin-1987"><DESCRIPTION><P>Participants were not analysed as randomly assigned</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="UNKNOWN" STUDY_ID="STD-Sakaguchi-2012"><DESCRIPTION><P>Not specified</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="UNKNOWN" STUDY_ID="STD-Salazar-1979"><DESCRIPTION><P>Not specified</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="UNKNOWN" STUDY_ID="STD-Sandler-1990"><DESCRIPTION><P>Not specified</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="NO" STUDY_ID="STD-Sezai-2011"><DESCRIPTION><P>Participants were not analysed as randomly assigned</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="NO" STUDY_ID="STD-Sezai-2012"><DESCRIPTION><P>Participants were not analysed as randomly assigned</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="UNKNOWN" STUDY_ID="STD-Shukla-2010"><DESCRIPTION><P>Not specified</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="UNKNOWN" STUDY_ID="STD-Silverman-1982"><DESCRIPTION><P>Not specified</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="NO" STUDY_ID="STD-Stephenson-1980"><DESCRIPTION><P>Participants were not analysed as randomly assigned</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="UNKNOWN" STUDY_ID="STD-Stone-1988"><DESCRIPTION><P>Not specified</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="NO" STUDY_ID="STD-Sun-2011"><DESCRIPTION><P>Participants were not analysed as randomly assigned</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="NO" STUDY_ID="STD-Suttorp-1991"><DESCRIPTION><P>Participants were not analysed as randomly assigned</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="UNKNOWN" STUDY_ID="STD-Vecht-1986"><DESCRIPTION><P>Not specified</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Wallace-1998"><DESCRIPTION><P>Study authors stated that they used the intention-to-treat principle</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="UNKNOWN" STUDY_ID="STD-Wenke-1999"><DESCRIPTION><P>Not specified</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="UNKNOWN" STUDY_ID="STD-White-1984"><DESCRIPTION><P>Not specified</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="UNKNOWN" STUDY_ID="STD-Whitehead-1980"><DESCRIPTION><P>Not specified</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="NO" STUDY_ID="STD-Williams-1982"><DESCRIPTION><P>Participants were not analysed as randomly assigned</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Yang-2006"><DESCRIPTION><P>Study authors stated that they used the intention-to-treat principle for data analysis</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="UNKNOWN" STUDY_ID="STD-Yang-2008"><DESCRIPTION><P>Not specified</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="NO" STUDY_ID="STD-Zaugg-1999"><DESCRIPTION><P>Participants were not analysed as randomly assigned</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY></QUALITY_ITEM_DATA></QUALITY_ITEM><QUALITY_ITEM CORE_ITEM="YES" ID="QIT-05" LEVEL="STUDY" MODIFIED="2017-10-28 00:46:08 +0100" MODIFIED_BY="Hermann Blessberger" NO="5"><NAME>Selective reporting (reporting bias)</NAME><DESCRIPTION><P>Reporting bias due to selective outcome reporting</P></DESCRIPTION><QUALITY_ITEM_DATA><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Abel-1983"><DESCRIPTION><P>Not detected</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Ali-1997"><DESCRIPTION><P>Not detected</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Apipan-2010"><DESCRIPTION><P>Not detected</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Auer-2004"><DESCRIPTION><P>Not detected</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Babin_x002d_Ebell-1996"><DESCRIPTION><P>Not detected</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Bayliff-1999"><DESCRIPTION><P>Not detected</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Bert-2001"><DESCRIPTION><P>Not detected</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Booth-2004"><DESCRIPTION><P>Not detected</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Burns-1988"><DESCRIPTION><P>Not detected</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-But-2006"><DESCRIPTION><P>Not detected</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Coleman-1980"><DESCRIPTION><P>Not detected</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Connolly-2003"><DESCRIPTION><P>Not detected</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Cork-1995"><DESCRIPTION><P>Not detected</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Cucchiara-1986"><DESCRIPTION><P>Not detected</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-DIPOM-_x002d_-Juul-2006"><DESCRIPTION><P>Not detected</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Daudon-1986"><DESCRIPTION><P>Not detected</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="NO" STUDY_ID="STD-De-Azevedo-L_x00fa_cio-2003"><DESCRIPTION><P>8 study participants suffered from a myocardial infarction, and 5 suffered from a stroke. Study group allocation of these participants was not specified</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="UNKNOWN" STUDY_ID="STD-Dy-1998"><DESCRIPTION><P>Conference abstract</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Evrard-2000"><DESCRIPTION><P>Not detected</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Forlani-2002"><DESCRIPTION><P>Not detected</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Gibson-1988"><DESCRIPTION><P>Not detected</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Gomes-1999"><DESCRIPTION><P>Not detected</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="NO" STUDY_ID="STD-Graham-1996"><DESCRIPTION><P>Conference abstract, thus authors likely reported on only a subset of data</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Gupta-2011"><DESCRIPTION><P>Not detected</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Hammon-1984"><DESCRIPTION><P>Not detected</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Harrison-1987"><DESCRIPTION><P>Not detected</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Inada-1989"><DESCRIPTION><P>Not detected</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Ivey-1983"><DESCRIPTION><P>Not detected</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Jacquet-1994"><DESCRIPTION><P>Not detected</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Jakobsen-1992"><DESCRIPTION><P>Not detected</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Jakobsen-1997"><DESCRIPTION><P>Not detected</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="NO" STUDY_ID="STD-Janssen-1986"><DESCRIPTION><P>Only statistically significant results were reported</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Kawaguchi-2010"><DESCRIPTION><P>Not detected</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Khuri-1987"><DESCRIPTION><P>Not detected</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Kurian-2001"><DESCRIPTION><P>Not detected</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Lai-2006"><DESCRIPTION><P>Not detected</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Lamb-1988"><DESCRIPTION><P>Not detected</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="UNKNOWN" STUDY_ID="STD-Lee-2010"><DESCRIPTION><P>Not detected</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Liu-1986"><DESCRIPTION><P>Not detected</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Liu-2006"><DESCRIPTION><P>Not detected</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Magnusson-1986"><DESCRIPTION><P>Not detected</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Mangano-1996"><DESCRIPTION><P>Not detected</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Martinussen-1988"><DESCRIPTION><P>Not detected</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Marwick-2009"><DESCRIPTION><P>Not detected</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Matangi-1985"><DESCRIPTION><P>Not detected</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Matangi-1989"><DESCRIPTION><P>Not detected</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Materne-1985"><DESCRIPTION><P>Not detected</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Matsuura-2001"><DESCRIPTION><P>Not detected</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Miller-1990"><DESCRIPTION><P>Not detected</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Miller-1991"><DESCRIPTION><P>Not detected</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Mohr-1981"><DESCRIPTION><P>Not detected</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Moon-2011"><DESCRIPTION><P>Not detected</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Myhre-1984"><DESCRIPTION><P>Not detected</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Neary-2006"><DESCRIPTION><P>Not detected</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Neustein-1994"><DESCRIPTION><P>Not detected</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Nystr_x00f6_m-1993"><DESCRIPTION><P>Not detected</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="UNKNOWN" STUDY_ID="STD-Ogawa-2013"><DESCRIPTION><P>Not detected</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Oka-1980"><DESCRIPTION><P>Not detected</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Ormerod-1984"><DESCRIPTION><P>Not detected</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="UNKNOWN" STUDY_ID="STD-Osada-2012"><DESCRIPTION><P>Not detected (in abstract)</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Oxorn-1990"><DESCRIPTION><P>Not detected</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-POBBLE-2005"><DESCRIPTION><P>Not detected</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-POISE-2008"><DESCRIPTION><P>Not detected</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Paull-1997"><DESCRIPTION><P>Not detected</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Pfisterer-1997"><DESCRIPTION><P>Not detected</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Raby-1999"><DESCRIPTION><P>Not detected</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Reves-1990"><DESCRIPTION><P>Not detected</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Rubin-1987"><DESCRIPTION><P>Not detected</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Sakaguchi-2012"><DESCRIPTION><P>Not detected</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Salazar-1979"><DESCRIPTION><P>Not detected</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Sandler-1990"><DESCRIPTION><P>Not detected</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Sezai-2011"><DESCRIPTION><P>Not detected</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Sezai-2012"><DESCRIPTION><P>Not detected</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="UNKNOWN" STUDY_ID="STD-Shukla-2010"><DESCRIPTION><P>Not detected</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Silverman-1982"><DESCRIPTION><P>Not detected</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Stephenson-1980"><DESCRIPTION><P>Not detected</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Stone-1988"><DESCRIPTION><P>Not detected</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Sun-2011"><DESCRIPTION><P>Not detected</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Suttorp-1991"><DESCRIPTION><P>Not detected</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Vecht-1986"><DESCRIPTION><P>Not detected</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Wallace-1998"><DESCRIPTION><P>Not detected</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Wenke-1999"><DESCRIPTION><P>Not detected</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-White-1984"><DESCRIPTION><P>Not detected</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Whitehead-1980"><DESCRIPTION><P>Not detected</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Williams-1982"><DESCRIPTION><P>Not detected</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Yang-2006"><DESCRIPTION><P>Not detected</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Yang-2008"><DESCRIPTION><P>Not detected</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Zaugg-1999"><DESCRIPTION><P>Not detected</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY></QUALITY_ITEM_DATA></QUALITY_ITEM><QUALITY_ITEM CORE_ITEM="YES" ID="QIT-06" LEVEL="STUDY" MODIFIED="2017-10-28 00:46:08 +0100" MODIFIED_BY="Hermann Blessberger" NO="6"><NAME>Other bias</NAME><DESCRIPTION><P>Bias due to problems not covered elsewhere in the table</P></DESCRIPTION><QUALITY_ITEM_DATA><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Abel-1983"><DESCRIPTION><P>Not detected</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Ali-1997"><DESCRIPTION><P>Not detected</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Apipan-2010"><DESCRIPTION><P>Not detected</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Auer-2004"><DESCRIPTION><P>More than 2 treatment groups, but results were presented identically for all groups</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Babin_x002d_Ebell-1996"><DESCRIPTION><P>Not detected</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Bayliff-1999"><DESCRIPTION><P>Not detected</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Bert-2001"><DESCRIPTION><P>More than 2 treatment groups, but outcomes were presented for all treatment groups identically</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Booth-2004"><DESCRIPTION><P>Not detected</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Burns-1988"><DESCRIPTION><P>Not detected</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-But-2006"><DESCRIPTION><P>Not detected</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Coleman-1980"><DESCRIPTION><P>Not detected</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Connolly-2003"><DESCRIPTION><P>Not detected</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Cork-1995"><DESCRIPTION><P>Not detected</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Cucchiara-1986"><DESCRIPTION><P>Not detected</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-DIPOM-_x002d_-Juul-2006"><DESCRIPTION><P>Not detected</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Daudon-1986"><DESCRIPTION><P>Not detected</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-De-Azevedo-L_x00fa_cio-2003"><DESCRIPTION><P>Not detected</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="UNKNOWN" STUDY_ID="STD-Dy-1998"><DESCRIPTION><P>Conference abstract</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="NO" STUDY_ID="STD-Evrard-2000"><DESCRIPTION><P>Blocked randomization in an open-label trial: Study allocation might have been predictable in some cases</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Forlani-2002"><DESCRIPTION><P>More than 2 intervention groups</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Gibson-1988"><DESCRIPTION><P>Not detected</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="NO" STUDY_ID="STD-Gomes-1999"><DESCRIPTION><P>Significantly more participants from the control group than from the treatment group were receiving long-term beta-blocker treatment before they entered the study</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Graham-1996"><DESCRIPTION><P>Not detected</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Gupta-2011"><DESCRIPTION><P>3 intervention groups&#8212;outcomes were presented identically for all groups</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Hammon-1984"><DESCRIPTION><P>Not detected</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Harrison-1987"><DESCRIPTION><P>Not detected</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Inada-1989"><DESCRIPTION><P>More than 2 intervention groups: 3 intervention groups</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Ivey-1983"><DESCRIPTION><P>Not detected</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="NO" STUDY_ID="STD-Jacquet-1994"><DESCRIPTION><P>Early stopping: 'Because of the large number of drop-outs with this treatment it was decided to end the study after 6 months even though there was a trend towards better results with sotalol than without'</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Jakobsen-1992"><DESCRIPTION><P>Not detected</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Jakobsen-1997"><DESCRIPTION><P>Not detected</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Janssen-1986"><DESCRIPTION><P>Not detected</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Kawaguchi-2010"><DESCRIPTION><P>Not detected</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Khuri-1987"><DESCRIPTION><P>Not detected</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="NO" STUDY_ID="STD-Kurian-2001"><DESCRIPTION><P>Early termination of trial due to many adverse events and problems in participant recruitment</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Lai-2006"><DESCRIPTION><P>Not detected</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Lamb-1988"><DESCRIPTION><P>Not detected</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="UNKNOWN" STUDY_ID="STD-Lee-2010"><DESCRIPTION><P>Not detected</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Liu-1986"><DESCRIPTION><P>Not detected</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Liu-2006"><DESCRIPTION><P>Not detected</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Magnusson-1986"><DESCRIPTION><P>Not detected</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Mangano-1996"><DESCRIPTION><P>Not detected</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Martinussen-1988"><DESCRIPTION><P>Not detected</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="NO" STUDY_ID="STD-Marwick-2009"><DESCRIPTION><P>Differential care programmes for treatment groups: heart rate&#8211;directed administration of beta-blocker exclusively in beta-blocker group (fixed-dose administration in standard of care group), dobutamine stress echo for cardiovascular risk stratification exclusively in standard of care group</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Matangi-1985"><DESCRIPTION><P>Not detected</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Matangi-1989"><DESCRIPTION><P>Not detected</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Materne-1985"><DESCRIPTION><P>Not detected</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Matsuura-2001"><DESCRIPTION><P>Not detected</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Miller-1990"><DESCRIPTION><P>Not detected</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Miller-1991"><DESCRIPTION><P>Not detected</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Mohr-1981"><DESCRIPTION><P>Not detected</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Moon-2011"><DESCRIPTION><P>Not detected</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Myhre-1984"><DESCRIPTION><P>Not detected</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="NO" STUDY_ID="STD-Neary-2006"><DESCRIPTION><P>Early stopping: Of 400 patients planned to be included, only 38 were enrolled because of recruiting problems</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Neustein-1994"><DESCRIPTION><P>Not detected</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Nystr_x00f6_m-1993"><DESCRIPTION><P>Not detected</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="UNKNOWN" STUDY_ID="STD-Ogawa-2013"><DESCRIPTION><P>Not detected</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Oka-1980"><DESCRIPTION><P>Not detected</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Ormerod-1984"><DESCRIPTION><P>3 intervention arms; results were presented identically for all groups</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="UNKNOWN" STUDY_ID="STD-Osada-2012"><DESCRIPTION><P>Not detected (in abstract)</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Oxorn-1990"><DESCRIPTION><P>Not detected</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-POBBLE-2005"><DESCRIPTION><P>Not detected</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-POISE-2008"><DESCRIPTION><P>Not detected</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Paull-1997"><DESCRIPTION><P>Not detected</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Pfisterer-1997"><DESCRIPTION><P>Not detected</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Raby-1999"><DESCRIPTION><P>Not detected</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Reves-1990"><DESCRIPTION><P>Not detected</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Rubin-1987"><DESCRIPTION><P>3 intervention arms&#8212;outcomes were reported identically for all intervention groups</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Sakaguchi-2012"><DESCRIPTION><P>Not detected</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Salazar-1979"><DESCRIPTION><P>Not detected</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Sandler-1990"><DESCRIPTION><P>Not detected</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Sezai-2011"><DESCRIPTION><P>Not detected</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="NO" STUDY_ID="STD-Sezai-2012"><DESCRIPTION><P>The trial was stopped early after an interim analysis for ethical reasons (occurrence of atrial fibrillation was statistically significant less in the beta-blocker group than in the control group, but the incidences of adverse events were not different)</P><P>The results for all 3 treatment groups were presented identically</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="UNKNOWN" STUDY_ID="STD-Shukla-2010"><DESCRIPTION><P>Not detected</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Silverman-1982"><DESCRIPTION><P>Not detected</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Stephenson-1980"><DESCRIPTION><P>Not detected</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Stone-1988"><DESCRIPTION><P>More than 2 intervention groups (3 beta-blocker groups: atenolol, labetalol, oxprenolol; control)</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Sun-2011"><DESCRIPTION><P>Not detected</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Suttorp-1991"><DESCRIPTION><P>Not detected</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Vecht-1986"><DESCRIPTION><P>Not detected</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Wallace-1998"><DESCRIPTION><P>Not detected</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Wenke-1999"><DESCRIPTION><P>Not detected</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-White-1984"><DESCRIPTION><P>Not detected</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Whitehead-1980"><DESCRIPTION><P>Not detected</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Williams-1982"><DESCRIPTION><P>Not detected</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Yang-2006"><DESCRIPTION><P>Not detected</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Yang-2008"><DESCRIPTION><P>Not detected</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Zaugg-1999"><DESCRIPTION><P>Not detected</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY></QUALITY_ITEM_DATA></QUALITY_ITEM></QUALITY_ITEMS><SOF_TABLES MODIFIED="2018-02-23 18:15:04 +0000" MODIFIED_BY="[Empty name]"><SOF_TABLE ID="SOF-01" MODIFIED="2018-02-23 18:15:04 +0000" MODIFIED_BY="[Empty name]" NO="1" READONLY="YES"><TITLE MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell">Beta-blocker versus control&#8212;cardiac surgery</TITLE><TABLE COLS="7" ROWS="35"><TR><TD COLSPAN="7"><P><B>Beta-blocker versus control (placebo or standard care) for preventing surgery-related mortality and morbidity</B></P></TD></TR><TR><TD COLSPAN="7"><P><B>Patient or population:</B> patients with coronary heart disease and/or valvular heart disease<BR/><B>Settings:</B> undergoing cardiac surgery<BR/><B>Intervention:</B> beta-blocker versus control (placebo or standard care)<BR/></P></TD></TR><TR><TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP"><P>Outcomes</P></TH><TH ALIGN="LEFT" COLSPAN="2" VALIGN="TOP"><P>Illustrative comparative risks* (95% CI)</P></TH><TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP"><P>Relative effect<BR/>(95% CI)</P></TH><TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP"><P>No. of participants<BR/>(studies)</P></TH><TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP"><P>Quality of the evidence<BR/>(GRADE)</P></TH><TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP"><P>Comments</P></TH></TR><TR><TH ALIGN="LEFT" VALIGN="TOP"><P>Assumed risk</P></TH><TH ALIGN="LEFT" VALIGN="TOP"><P>Corresponding risk</P></TH></TR><TR><TH ALIGN="LEFT" VALIGN="TOP"><P><B>Control</B></P></TH><TH ALIGN="LEFT" VALIGN="TOP"><P><B>Beta-blocker versus control (placebo or standard care)</B></P></TH></TR><TR><TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP"><P><B>All-cause mortality (30 days)</B>&#8212;<B>cardiac surgery</B><BR/>Follow-up: up to 30 days</P></TD><TD COLSPAN="2" ROWSPAN="1"><P><B>Study population</B></P></TD><TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP"><P><B>RR 0.73 </B><BR/>(0.35 to 1.52)</P></TD><TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP"><P>3,783<BR/>(24 studies)</P></TD><TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP"><P>&#8853;&#8853;&#8853;&#8861;<BR/><B>moderate</B><SUP>a</SUP></P></TD><TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP"><P>It was not possible to perform TSA because of the very small sample size.</P></TD></TR><TR><TD ROWSPAN="1" VALIGN="TOP"><P><B>7 per 1000</B></P></TD><TD ROWSPAN="1" VALIGN="TOP"><P><B>5 per 1000</B><BR/>(2 to 11)</P></TD></TR><TR><TD COLSPAN="2" ROWSPAN="1"><P><B>Moderate</B></P></TD></TR><TR><TD ROWSPAN="1" VALIGN="TOP"><P><B>7 per 1000</B></P></TD><TD ROWSPAN="1" VALIGN="TOP"><P><B>5 per 1000</B><BR/>(2 to 11)</P></TD></TR><TR><TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP"><P><B>Acute myocardial infarction</B>&#8212;<B>cardiac surgery</B><BR/>Follow-up: up to 30 days</P><P/></TD><TD COLSPAN="2" ROWSPAN="1"><P><B>Study population</B></P></TD><TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP"><P><B>RR 1.04 </B><BR/>(0.71 to 1.51)</P></TD><TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP"><P>3,553<BR/>(22 studies)</P></TD><TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP"><P>&#8853;&#8853;&#8853;&#8861;<BR/><B>moderate</B><SUP>a,b</SUP></P></TD><TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP"><P>TSA yielded an inconclusive result.</P></TD></TR><TR><TD ROWSPAN="1" VALIGN="TOP"><P><B>28 per 1000</B></P></TD><TD ROWSPAN="1" VALIGN="TOP"><P><B>29 per 1000</B><BR/>(20 to 43)</P></TD></TR><TR><TD COLSPAN="2" ROWSPAN="1"><P><B>Moderate</B></P></TD></TR><TR><TD ROWSPAN="1" VALIGN="TOP"><P><B>38 per 1000</B></P></TD><TD ROWSPAN="1" VALIGN="TOP"><P><B>40 per 1000</B><BR/>(27 to 57)</P></TD></TR><TR><TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP"><P><B>Cerebrovascular events</B>&#8212;<B>cardiac surgery</B><BR/>Follow-up: up to 30 days</P></TD><TD COLSPAN="2" ROWSPAN="1"><P><B>Study population</B></P></TD><TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP"><P><B>RR 1.52 </B><BR/>(0.58 to 4.02)</P></TD><TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP"><P>1,400<BR/>(4 studies)</P></TD><TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP"><P>&#8853;&#8853;&#8861;&#8861;<BR/><B>low</B><SUP>c</SUP></P></TD><TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP"><P>It was not possible to perform TSA because of the very small sample size.</P></TD></TR><TR><TD ROWSPAN="1" VALIGN="TOP"><P><B>7 per 1000</B></P></TD><TD ROWSPAN="1" VALIGN="TOP"><P><B>11 per 1000</B><BR/>(4 to 30)</P></TD></TR><TR><TD COLSPAN="2" ROWSPAN="1"><P><B>Moderate</B></P></TD></TR><TR><TD ROWSPAN="1" VALIGN="TOP"><P><B>10 per 1000</B></P></TD><TD ROWSPAN="1" VALIGN="TOP"><P><B>15 per 1000</B><BR/>(6 to 40)</P></TD></TR><TR><TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP"><P><B>Ventricular arrhythmias</B>&#8212;<B>cardiac surgery</B><BR/>ECG<BR/>Follow-up: up to 30 days</P></TD><TD COLSPAN="2" ROWSPAN="1"><P><B>Study population</B></P></TD><TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP"><P><B>RR 0.37 </B><BR/>(0.24 to 0.58)</P><P/><P>NNTB: 29,</P><P>95% CI: 24 to 44</P></TD><TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP"><P>2,292<BR/>(12 studies)</P></TD><TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP"><P>&#8853;&#8853;&#8853;&#8861;<BR/><B>moderate</B><SUP>d</SUP></P></TD><TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP"><P>TSA yielded an inconclusive result.</P></TD></TR><TR><TD ROWSPAN="1" VALIGN="TOP"><P><B>54 per 1000</B></P></TD><TD ROWSPAN="1" VALIGN="TOP"><P><B>20 per 1000</B><BR/>(13 to 31)</P></TD></TR><TR><TD COLSPAN="2" ROWSPAN="1"><P><B>Moderate</B></P></TD></TR><TR><TD ROWSPAN="1" VALIGN="TOP"><P><B>66 per 1000</B></P></TD><TD ROWSPAN="1" VALIGN="TOP"><P><B>24 per 1000</B><BR/>(16 to 38)</P></TD></TR><TR><TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP"><P><B>All supraventricular arrhythmias</B>&#8212;<B>cardiac surgery</B><BR/>ECG<BR/>Follow-up: up to 30 days</P></TD><TD COLSPAN="2" ROWSPAN="1"><P><B>Study population</B></P></TD><TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP"><P><B>RR 0.44 </B><BR/>(0.36 to 0.53)</P><P/><P>NNTB: 5,</P><P>95% CI: 5 to 6</P></TD><TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP"><P>6,420<BR/>(48 studies)</P></TD><TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP"><P>&#8853;&#8853;&#8853;&#8853;<BR/><B>high</B><SUP>b</SUP></P></TD><TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP"><P>TSA indicated a significant reduction in all supraventricular arrhythmias with the use of beta-blockers.</P><P><BR/>Upon visual assessment of funnel plots and by applying Egger's test, a reporting bias was detected. However, correcting for the reporting bias did not change the effect estimate. In light of this, the quality of evidence was not downgraded for the presence of a reporting bias in this case.</P></TD></TR><TR><TD ROWSPAN="1" VALIGN="TOP"><P><B>345 per 1000</B></P></TD><TD ROWSPAN="1" VALIGN="TOP"><P><B>152 per 1000</B><BR/>(124 to 183)</P></TD></TR><TR><TD COLSPAN="2" ROWSPAN="1"><P><B>Moderate</B></P></TD></TR><TR><TD ROWSPAN="1" VALIGN="TOP"><P><B>367 per 1000</B></P></TD><TD ROWSPAN="1" VALIGN="TOP"><P><B>161 per 1000</B><BR/>(132 to 195)</P></TD></TR><TR><TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP"><P><B>Bradycardia</B>&#8212;<B>cardiac surgery</B><BR/>ECG<BR/>Follow-up: up to 30 days</P></TD><TD COLSPAN="2" ROWSPAN="1"><P><B>Study population</B></P></TD><TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP"><P><B>RR 1.61 </B><BR/>(0.97 to 2.66)</P></TD><TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP"><P>660<BR/>(8 studies)</P></TD><TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP"><P>&#8853;&#8853;&#8861;&#8861;<BR/><B>low</B><SUP>c</SUP></P></TD><TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP"><P>It was not possible to perform TSA because of the very small sample size.</P></TD></TR><TR><TD ROWSPAN="1" VALIGN="TOP"><P><B>66 per 1000</B></P></TD><TD ROWSPAN="1" VALIGN="TOP"><P><B>106 per 1000</B><BR/>(64 to 174)</P></TD></TR><TR><TD COLSPAN="2" ROWSPAN="1"><P><B>Moderate</B></P></TD></TR><TR><TD ROWSPAN="1" VALIGN="TOP"><P><B>14 per 1000</B></P></TD><TD ROWSPAN="1" VALIGN="TOP"><P><B>23 per 1000</B><BR/>(14 to 37)</P></TD></TR><TR><TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP"><P><B>Hypotension</B>&#8212;<B>cardiac surgery</B><BR/>Follow-up: up to 30 days</P></TD><TD COLSPAN="2" ROWSPAN="1"><P><B>Study population</B></P></TD><TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP"><P><B>RR 1.54 </B><BR/>(0.67 to 3.51)</P></TD><TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP"><P>558<BR/>(6 studies)</P></TD><TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP"><P>&#8853;&#8853;&#8861;&#8861;<BR/><B>low</B><SUP>c</SUP></P></TD><TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP"><P>It was not possible to perform TSA because of the very small sample size.</P></TD></TR><TR><TD ROWSPAN="1" VALIGN="TOP"><P><B>27 per 1000</B></P></TD><TD ROWSPAN="1" VALIGN="TOP"><P><B>42 per 1000</B><BR/>(18 to 96)</P></TD></TR><TR><TD COLSPAN="2" ROWSPAN="1"><P><B>Moderate</B></P></TD></TR><TR><TD ROWSPAN="1" VALIGN="TOP"><P><B>29 per 1000</B></P></TD><TD ROWSPAN="1" VALIGN="TOP"><P><B>45 per 1000</B><BR/>(19 to 102)</P></TD></TR><TR><TD COLSPAN="7"><P>*The basis for the <B>assumed risk</B> is the median control group risk across studies. The <B>corresponding risk</B> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <B>relative effect</B> of the intervention (and its 95% CI).<BR/><B>CI:</B> Confidence interval; <B>ECG:</B> electrocardiogram; <B>NNTB:</B> number needed to treat for an additional beneficial outcome; <B>RR:</B> risk ratio; <B>TSA:</B> trial sequential analysis.</P></TD></TR><TR><TD COLSPAN="7"><P>GRADE Working Group grades of evidence.<BR/><B>High quality:</B> Further research is very unlikely to change our confidence in the estimate of effect.<BR/><B>Moderate quality:</B> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<BR/><B>Low quality:</B> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<BR/><B>Very low quality:</B> We are very uncertain about the estimate.<BR/></P></TD></TR></TABLE><FOOTNOTES><P><SUP>a</SUP>Serious imprecision (-1) due to small sample compared with the calculated optimal information size and the wide confidence interval overlapping zones of no effect as well as potential harm and/or benefit.</P><P><SUP>b</SUP>Reporting bias was detected upon visual assessment of the funnel plot and/or by applying Egger's test. Using the trim-and-fill method to adjust for this bias did not change the effect estimate. Thus the quality of evidence was not downgraded, as robustness of the effect estimate was not affected.</P><P><SUP>c</SUP>Very serious imprecision (-2) due to very small sample compared with the calculated optimal information size and the wide confidence interval overlapping zones of no effect as well as potential harm and/or benefit.</P><P><SUP>d</SUP>Serious imprecision (-1) due to small sample size.</P><P><BR/></P></FOOTNOTES></SOF_TABLE><SOF_TABLE ID="SOF-02" MODIFIED="2018-02-23 18:15:04 +0000" MODIFIED_BY="[Empty name]" NO="2" READONLY="YES"><TITLE MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell">Beta-blocker versus control&#8212;non-cardiac surgery</TITLE><TABLE COLS="7" ROWS="35"><TR><TD COLSPAN="7"><P><B>Beta-blocker versus control (placebo or standard care) for conditions requiring non-cardiac surgery</B></P></TD></TR><TR><TD COLSPAN="7"><P><B>Patient or population:</B> patients with conditions requiring non-cardiac surgery<BR/><B>Settings:</B> non-cardiac surgery in general anaesthesia<BR/><B>Intervention:</B> beta-blocker versus control (placebo or standard care)<BR/></P></TD></TR><TR><TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP"><P>Outcomes</P></TH><TH ALIGN="LEFT" COLSPAN="2" VALIGN="TOP"><P>Illustrative comparative risks* (95% CI)</P></TH><TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP"><P>Relative effect<BR/>(95% CI)</P></TH><TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP"><P>No. of participants<BR/>(studies)</P></TH><TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP"><P>Quality of the evidence<BR/>(GRADE)</P></TH><TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP"><P>Comments</P></TH></TR><TR><TH ALIGN="LEFT" VALIGN="TOP"><P>Assumed risk</P></TH><TH ALIGN="LEFT" VALIGN="TOP"><P>Corresponding risk</P></TH></TR><TR><TH ALIGN="LEFT" VALIGN="TOP"><P><B>Control</B></P></TH><TH ALIGN="LEFT" VALIGN="TOP"><P><B>Beta-blocker versus control (placebo or standard care)</B></P></TH></TR><TR><TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP"><P><B>All-cause mortality (30 days)</B>&#8212;<B>non-cardiac surgery</B><BR/>Follow-up: up to 30 days</P></TD><TD COLSPAN="2" ROWSPAN="1"><P><B>Study population</B></P></TD><TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP"><P><B>RR 1.25 </B><BR/>(1.00 to 1.57)</P><P/><P>NNTH: 167,</P><P>95% CI: 73 to infinite</P></TD><TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP"><P>11,413<BR/>(13 studies)</P></TD><TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP"><P>&#8853;&#8853;&#8861;&#8861;<BR/><B>low</B><SUP>a,b</SUP></P></TD><TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP"><P>It was not possible to perform TSA because of the small sample size compared with the optimal information size.</P></TD></TR><TR><TD ROWSPAN="1" VALIGN="TOP"><P><B>24 per 1000</B></P></TD><TD ROWSPAN="1" VALIGN="TOP"><P><B>30 per 1000</B><BR/>(24 to 38)</P></TD></TR><TR><TD COLSPAN="2" ROWSPAN="1"><P><B>Moderate</B></P></TD></TR><TR><TD ROWSPAN="1" VALIGN="TOP"><P><B>20 per 1000</B></P></TD><TD ROWSPAN="1" VALIGN="TOP"><P><B>26 per 1000</B><BR/>(20 to 31)</P></TD></TR><TR><TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP"><P><B>Acute myocardial infarction</B>&#8212;<B>non-cardiac surgery</B><BR/>Follow-up: up to 30 days</P></TD><TD COLSPAN="2" ROWSPAN="1"><P><B>Study population</B></P></TD><TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP"><P><B>RR 0.73 </B><BR/>(0.61 to 0.87)</P><P/><P>NNTB: 76,</P><P>95% CI: 52 to 157</P></TD><TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP"><P>10,958<BR/>(14 studies)</P></TD><TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP"><P>&#8853;&#8853;&#8853;&#8853;<BR/><B>high</B></P></TD><TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP"><P>TSA indicated a significant reduction in the incidence of acute myocardial infarction with the use of beta-blockers.</P><P/><P/></TD></TR><TR><TD ROWSPAN="1" VALIGN="TOP"><P><B>49 per 1000</B></P></TD><TD ROWSPAN="1" VALIGN="TOP"><P><B>36 per 1000</B><BR/>(30 to 43)</P></TD></TR><TR><TD COLSPAN="2" ROWSPAN="1"><P><B>Moderate</B></P></TD></TR><TR><TD ROWSPAN="1" VALIGN="TOP"><P><B>36 per 1000</B></P></TD><TD ROWSPAN="1" VALIGN="TOP"><P><B>26 per 1000</B><BR/>(22 to 31)</P></TD></TR><TR><TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP"><P><B>Cerebrovascular events</B>&#8212;<B>non-cardiac surgery</B><BR/>Follow-up: up to 30 days</P></TD><TD COLSPAN="2" ROWSPAN="1"><P><B>Study population</B></P></TD><TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP"><P><B>RR 1.59 </B><BR/>(0.93 to 2.71)</P></TD><TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP"><P>9,150<BR/>(5 studies)</P></TD><TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP"><P>&#8853;&#8853;&#8861;&#8861;<BR/><B>low</B><SUP>c,d</SUP></P></TD><TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP"><P>It was not possible to perform TSA because of the small sample size.</P><P/><P>Studies of poorer methodological quality were shown to introduce a source of bias. When meta-analysis was restricted to trials with an assumed lower risk of bias (placebo-controlled trials), beta-blockers statistically significantly increased the incidence of cerebrovascular events in non-cardiac surgery (RR 2.09, 95% CI 1.14 to 3.82, P value 0.02, NNH 265, 95% CI: 102 to 2058).</P></TD></TR><TR><TD ROWSPAN="1" VALIGN="TOP"><P><B>5 per 1000</B></P></TD><TD ROWSPAN="1" VALIGN="TOP"><P><B>8 per 1000</B><BR/>(5 to 14)</P></TD></TR><TR><TD COLSPAN="2" ROWSPAN="1"><P><B>Moderate</B></P></TD></TR><TR><TD ROWSPAN="1" VALIGN="TOP"><P><B>10 per 1000</B></P></TD><TD ROWSPAN="1" VALIGN="TOP"><P><B>16 per 1000</B><BR/>(9 to 27)</P></TD></TR><TR><TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP"><P><B>Ventricular arrhythmias</B>&#8212;<B>non-cardiac surgery</B><BR/>ECG<BR/>Follow-up: up to 30 days</P></TD><TD COLSPAN="2" ROWSPAN="1"><P><B>Study population</B></P></TD><TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP"><P><B>RR 0.68 </B><BR/>(0.31 to 1.49)</P></TD><TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP"><P>476<BR/>(5 studies)</P></TD><TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP"><P>&#8853;&#8853;&#8853;&#8861;<BR/><B>moderate</B><SUP>c</SUP></P></TD><TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP"><P>It was not possible to perform TSA because of the very small sample size.</P><P/><P/></TD></TR><TR><TD ROWSPAN="1" VALIGN="TOP"><P><B>106 per 1000</B></P></TD><TD ROWSPAN="1" VALIGN="TOP"><P><B>72 per 1000</B><BR/>(33 to 158)</P></TD></TR><TR><TD COLSPAN="2" ROWSPAN="1"><P><B>Moderate</B></P></TD></TR><TR><TD ROWSPAN="1" VALIGN="TOP"><P><B>159 per 1000</B></P></TD><TD ROWSPAN="1" VALIGN="TOP"><P><B>108 per 1000</B><BR/>(49 to 237)</P></TD></TR><TR><TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP"><P><B>All supraventricular arrhythmias</B>&#8212;<B>non-cardiac surgery</B><BR/>ECG<BR/>Follow-up: up to 30 days</P></TD><TD COLSPAN="2" ROWSPAN="1"><P><B>Study population</B></P></TD><TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP"><P><B>RR 0.73</B></P><P>(0.57 to 0.94)</P><P/><P>NNTB: 112,</P><P>95% CI: 70 to 505</P></TD><TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP"><P>8,744<BR/>(8 studies)</P></TD><TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP"><P>&#8853;&#8853;&#8853;&#8853;<BR/><B>high</B></P></TD><TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP"><P>TSA indicated a significant reduction in all supraventricular arrhythmias with the use of beta-blockers.</P><P/><P/></TD></TR><TR><TD ROWSPAN="1" VALIGN="TOP"><P><B>33 per 1000</B></P></TD><TD ROWSPAN="1" VALIGN="TOP"><P><B>24 per 1000</B><BR/>(19 to 31)</P></TD></TR><TR><TD COLSPAN="2" ROWSPAN="1"><P><B>Moderate</B></P></TD></TR><TR><TD ROWSPAN="1" VALIGN="TOP"><P><B>124 per 1000</B></P></TD><TD ROWSPAN="1" VALIGN="TOP"><P><B>91 per 1000</B><BR/>(71 to 117)</P></TD></TR><TR><TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP"><P><B>Bradycardia</B>&#8212;<B>non-cardiac surgery</B><BR/>ECG<BR/>Follow-up: up to 30 days</P></TD><TD COLSPAN="2" ROWSPAN="1"><P><B>Study population</B></P></TD><TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP"><P><B>RR 2.23 </B><BR/>(1.48 to 3.36)</P><P/><P>NNTH: 21,</P><P>95% CI: 11 to 53</P></TD><TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP"><P>11,033<BR/>(23 studies)</P></TD><TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP"><P>&#8853;&#8853;&#8853;&#8861;<BR/><B>moderate</B><SUP>e</SUP></P></TD><TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP"><P>TSA indicated a significant increase in bradycardia with the use of beta-blockers.</P><P/></TD></TR><TR><TD ROWSPAN="1" VALIGN="TOP"><P><B>39 per 1000</B></P></TD><TD ROWSPAN="1" VALIGN="TOP"><P><B>87 per 1000</B><BR/>(58 to 131)</P></TD></TR><TR><TD COLSPAN="2" ROWSPAN="1"><P><B>Moderate</B></P></TD></TR><TR><TD ROWSPAN="1" VALIGN="TOP"><P><B>40 per 1000</B></P></TD><TD ROWSPAN="1" VALIGN="TOP"><P><B>89 per 1000</B><BR/>(59 to 134)</P></TD></TR><TR><TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP"><P><B>Hypotension</B>&#8212;<B>non-cardiac surgery</B><BR/>Follow-up: up to 30 days</P></TD><TD COLSPAN="2" ROWSPAN="1"><P><B>Study population</B></P></TD><TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP"><P><B>RR 1.50 </B><BR/>(1.38 to 1.64)</P><P/><P>NNTH: 16,</P><P>95% CI: 13 to 21</P></TD><TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP"><P>10,947<BR/>(22 studies)</P></TD><TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP"><P>&#8853;&#8853;&#8853;&#8853;<BR/><B>high</B></P></TD><TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP"><P>TSA indicated a significant increase in hypotensive episodes with the use of beta-blockers.</P><P/><P/></TD></TR><TR><TD ROWSPAN="1" VALIGN="TOP"><P><B>126 per 1000</B></P></TD><TD ROWSPAN="1" VALIGN="TOP"><P><B>189 per 1000</B><BR/>(174 to 207)</P></TD></TR><TR><TD COLSPAN="2" ROWSPAN="1"><P><B>Moderate</B></P></TD></TR><TR><TD ROWSPAN="1" VALIGN="TOP"><P><B>65 per 1000</B></P></TD><TD ROWSPAN="1" VALIGN="TOP"><P><B>98 per 1000</B><BR/>(90 to 107)</P></TD></TR><TR><TD COLSPAN="7"><P>*The basis for the <B>assumed risk</B> was the median control group risk across studies. The <B>corresponding risk</B> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <B>relative effect</B> of the intervention (and its 95% CI).<BR/><B>CI:</B> Confidence interval; <B>NNTB:</B> number needed to treat for an additional beneficial outcome; <B>NNTH:</B> number needed to treat for an additional harmful outcome; <B>RR:</B> risk ratio; <B>TSA:</B> trial sequential analysis.</P></TD></TR><TR><TD COLSPAN="7"><P>GRADE Working Group grades of evidence.<BR/><B>High quality:</B> Further research is very unlikely to change our confidence in the estimate of effect.<BR/><B>Moderate quality:</B> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<BR/><B>Low quality:</B> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<BR/><B>Very low quality:</B> We are very uncertain about the estimate.<BR/></P></TD></TR></TABLE><FOOTNOTES><P><SUP>a</SUP>Serious imprecision (-1) due to small sample compared with the calculated optimal information size.</P><P><SUP>b</SUP>Studies with a poorer methodological quality introduced a significant source of bias (-1).</P><P><SUP>c</SUP>Serious imprecision (-1) due to small sample compared with the calculated optimal information size and the wide confidence interval overlapping zones of no effect as well as potential harm and/or benefit.</P><P><SUP>d</SUP>Studies with a poorer methodological quality introduced a significant source of bias (-1). Restricting the meta-analysis to studies of an assumed lower risk of bias significantly changed the effect estimate.</P><P><SUP>e</SUP>Serious inconsistency due to a high amount of unexplained heterogeneity (-1).</P></FOOTNOTES></SOF_TABLE></SOF_TABLES><ADDITIONAL_TABLES MODIFIED="2013-12-08 19:10:20 +0000" MODIFIED_BY="Hermann Blessberger"/><ANALYSES_AND_DATA CALCULATED_DATA="YES" MODIFIED="2017-12-08 14:29:45 +0000" MODIFIED_BY="Hermann Blessberger"><COMPARISON ID="CMP-001" MODIFIED="2017-12-08 14:29:45 +0000" MODIFIED_BY="Hermann Blessberger" NO="1"><NAME>Beta-blocker versus control (placebo or standard care)</NAME><DICH_OUTCOME CHI2="4.161166564125606" CI_END="1.5197716038104088" CI_START="0.35242047072087324" CI_STUDY="95" CI_TOTAL="95" DF="12" EFFECT_MEASURE="RR" EFFECT_SIZE="0.7318460384555489" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="13" I2="0.0" I2_Q="0.0" ID="CMP-001.01" LOG_CI_END="0.18177832566987695" LOG_CI_START="-0.4529388730667181" LOG_EFFECT_SIZE="-0.1355802736984206" METHOD="MH" MODIFIED="2017-12-08 14:17:40 +0000" MODIFIED_BY="Hermann Blessberger" NO="1" P_CHI2="0.9803493480143448" P_Q="1.0" P_Z="0.4024096278199055" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="YEAR" STUDIES="24" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="1939" TOTAL_2="1844" WEIGHT="100.00000000000003" Z="0.8373255175436499"><NAME>All-cause mortality (30 days)&#8212;cardiac surgery</NAME><GROUP_LABEL_1>Beta-blocker</GROUP_LABEL_1><GROUP_LABEL_2>Control</GROUP_LABEL_2><GRAPH_LABEL_1>Favours beta-blocker</GRAPH_LABEL_1><GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2><DICH_DATA CI_END="14.051950786893713" CI_START="0.025619218673593205" EFFECT_SIZE="0.6" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="1.1477366201252595" LOG_CI_START="-1.591434119357972" LOG_EFFECT_SIZE="-0.2218487496163564" MODIFIED="2013-11-06 18:42:55 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1345" O_E="0.0" SE="1.6090024514862893" STUDY_ID="STD-Oka-1980" TOTAL_1="19" TOTAL_2="35" VAR="2.588888888888889" WEIGHT="6.369427315296147"/><DICH_DATA CI_END="10.258083464353952" CI_START="0.018010104346265817" EFFECT_SIZE="0.4298245614035088" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="1.0110662283582093" LOG_CI_START="-1.7444837709741272" LOG_EFFECT_SIZE="-0.3667087713079589" MODIFIED="2013-11-06 18:35:32 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1326" O_E="0.0" SE="1.6186237098002971" STUDY_ID="STD-Mohr-1981" TOTAL_1="37" TOTAL_2="48" VAR="2.6199427139276765" WEIGHT="7.789736394798966"/><DICH_DATA CI_END="3.0967497955252377" CI_START="0.035879912310534466" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="3" LOG_CI_END="0.4909061175904471" LOG_CI_START="-1.4451486270297722" LOG_EFFECT_SIZE="-0.47712125471966244" MODIFIED="2013-12-01 02:03:29 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1341" O_E="0.0" SE="1.1372481406154653" STUDY_ID="STD-Abel-1983" TOTAL_1="50" TOTAL_2="50" VAR="1.2933333333333332" WEIGHT="17.834396482829213"><FOOTNOTE>Beta-blocker group originally comprised 50 patients of whom one died. During the course of the study nine patients were withdrawn from the beta-blocker group.</FOOTNOTE></DICH_DATA><DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-11-06 18:41:20 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1343" O_E="0.0" SE="0.0" STUDY_ID="STD-Ivey-1983" TOTAL_1="53" TOTAL_2="56" VAR="0.0" WEIGHT="0.0"/><DICH_DATA CI_END="66.4433184667098" CI_START="0.12341968180365896" EFFECT_SIZE="2.8636363636363638" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.8224513148659036" LOG_CI_START="-0.9086155776031525" LOG_EFFECT_SIZE="0.4569178686313755" MODIFIED="2013-11-06 18:43:13 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1346" O_E="0.0" SE="1.6042422116354729" STUDY_ID="STD-White-1984" TOTAL_1="21" TOTAL_2="20" VAR="2.5735930735930737" WEIGHT="3.0415249815677727"/><DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-11-06 18:41:00 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1340" O_E="0.0" SE="0.0" STUDY_ID="STD-Hammon-1984" TOTAL_1="24" TOTAL_2="26" VAR="0.0" WEIGHT="0.0"/><DICH_DATA CI_END="15.718754250133742" CI_START="0.06361827305694352" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.1964181241632585" LOG_CI_START="-1.1964181241632585" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-11-06 18:35:06 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1325" O_E="0.0" SE="1.4055638569974547" STUDY_ID="STD-Matangi-1985" TOTAL_1="82" TOTAL_2="82" VAR="1.975609756097561" WEIGHT="5.944798827609738"/><DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-11-17 15:00:35 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="3383" O_E="0.0" SE="0.0" STUDY_ID="STD-Janssen-1986" TOTAL_1="80" TOTAL_2="50" VAR="0.0" WEIGHT="0.0"/><DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-11-06 18:38:44 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1334" O_E="0.0" SE="0.0" STUDY_ID="STD-Martinussen-1988" TOTAL_1="35" TOTAL_2="40" VAR="0.0" WEIGHT="0.0"/><DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-11-06 18:42:26 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1344" O_E="0.0" SE="0.0" STUDY_ID="STD-Suttorp-1991" TOTAL_1="150" TOTAL_2="150" VAR="0.0" WEIGHT="0.0"/><DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-11-17 19:21:17 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="388" O_E="0.0" SE="0.0" STUDY_ID="STD-Nystr_x00f6_m-1993" TOTAL_1="50" TOTAL_2="51" VAR="0.0" WEIGHT="0.0"/><DICH_DATA CI_END="60.21015642179821" CI_START="0.11637439315284949" EFFECT_SIZE="2.6470588235294117" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.7796697554754684" LOG_CI_START="-0.934142570681329" LOG_EFFECT_SIZE="0.42276359239706973" MODIFIED="2014-06-22 20:20:50 +0100" MODIFIED_BY="Hermann Blessberger" ORDER="1330" O_E="0.0" SE="1.5941067939721714" STUDY_ID="STD-Cork-1995" TOTAL_1="16" TOTAL_2="14" VAR="2.541176470588235" WEIGHT="3.158174377167673"><FOOTNOTE>One patient in the beta-blocker group died and was excluded from further analysis. Thus, the number of patients in the beta-blocker group is 16 for the outcome mortality but 15 for other outcomes.</FOOTNOTE></DICH_DATA><DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-11-06 18:43:29 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1347" O_E="0.0" SE="0.0" STUDY_ID="STD-Paull-1997" TOTAL_1="50" TOTAL_2="50" VAR="0.0" WEIGHT="0.0"/><DICH_DATA CI_END="8.090192218311387" CI_START="0.01373405082509925" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.9079588403218196" LOG_CI_START="-1.8622013497611447" LOG_EFFECT_SIZE="-0.47712125471966244" MODIFIED="2013-11-06 18:42:06 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1342" O_E="0.0" SE="1.6272058081688268" STUDY_ID="STD-Ali-1997" TOTAL_1="105" TOTAL_2="105" VAR="2.6477987421383644" WEIGHT="8.917198241414606"/><DICH_DATA CI_END="8.928614028566257" CI_START="0.015664675078941228" EFFECT_SIZE="0.37398373983739835" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.9507840494304557" LOG_CI_START="-1.8050786089461033" LOG_EFFECT_SIZE="-0.4271472797578239" MODIFIED="2013-11-06 18:40:43 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1339" O_E="0.0" SE="1.618807367270561" STUDY_ID="STD-Gomes-1999" TOTAL_1="40" TOTAL_2="45" VAR="2.6205372923294448" WEIGHT="8.404715583862043"/><DICH_DATA CI_END="15.773312877448294" CI_START="0.06339822254015756" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.1979229180145214" LOG_CI_START="-1.1979229180145214" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-11-06 18:38:24 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1333" O_E="0.0" SE="1.4073317037116178" STUDY_ID="STD-Evrard-2000" TOTAL_1="103" TOTAL_2="103" VAR="1.9805825242718447" WEIGHT="5.944798827609738"/><DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-11-06 18:39:03 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1335" O_E="0.0" SE="0.0" STUDY_ID="STD-Matsuura-2001" TOTAL_1="40" TOTAL_2="40" VAR="0.0" WEIGHT="0.0"/><DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-11-06 18:37:17 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1329" O_E="0.0" SE="0.0" STUDY_ID="STD-Bert-2001" TOTAL_1="71" TOTAL_2="60" VAR="0.0" WEIGHT="0.0"/><DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-11-06 18:40:11 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1338" O_E="0.0" SE="0.0" STUDY_ID="STD-Forlani-2002" TOTAL_1="51" TOTAL_2="50" VAR="0.0" WEIGHT="0.0"/><DICH_DATA CI_END="21.705078767310894" CI_START="0.18428866547235168" EFFECT_SIZE="2.0" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="1" LOG_CI_END="1.3365613662238505" LOG_CI_START="-0.7345013748958881" LOG_EFFECT_SIZE="0.3010299956639812" MODIFIED="2013-11-06 18:38:08 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1332" O_E="0.0" SE="1.2165525060596438" STUDY_ID="STD-De-Azevedo-L_x00fa_cio-2003" TOTAL_1="100" TOTAL_2="100" VAR="1.48" WEIGHT="5.944798827609738"/><DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-11-06 18:37:50 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1331" O_E="0.0" SE="0.0" STUDY_ID="STD-Connolly-2003" TOTAL_1="500" TOTAL_2="500" VAR="0.0" WEIGHT="0.0"/><DICH_DATA CI_END="38.042628832648475" CI_START="0.06491107031443613" EFFECT_SIZE="1.5714285714285714" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.5802705200441767" LOG_CI_START="-1.1876812297562402" LOG_EFFECT_SIZE="0.1962946451439682" MODIFIED="2013-11-17 14:59:41 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="3384" O_E="0.0" SE="1.6259085594149025" STUDY_ID="STD-Auer-2004" TOTAL_1="125" TOTAL_2="65" VAR="2.6435786435786435" WEIGHT="3.90127423061889"/><DICH_DATA CI_END="4.092080860459946" CI_START="0.009774977905862802" EFFECT_SIZE="0.2" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" LOG_CI_END="0.611944206883865" LOG_CI_START="-2.0098842155559025" LOG_EFFECT_SIZE="-0.6989700043360187" MODIFIED="2013-12-01 02:03:27 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1348" O_E="0.0" SE="1.540074993601121" STUDY_ID="STD-Sezai-2011" TOTAL_1="70" TOTAL_2="70" VAR="2.371830985915493" WEIGHT="14.861997069024344"/><DICH_DATA CI_END="7.866237458523328" CI_START="0.03273717321855499" EFFECT_SIZE="0.5074626865671642" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="0.8957670523419452" LOG_CI_START="-1.4849588236590878" LOG_EFFECT_SIZE="-0.2945958856585713" MODIFIED="2013-11-06 18:43:59 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1349" O_E="0.0" SE="1.3984501643461555" STUDY_ID="STD-Sezai-2012" TOTAL_1="67" TOTAL_2="34" VAR="1.9556628621597894" WEIGHT="7.8871588405911375"/></DICH_OUTCOME><DICH_OUTCOME CHI2="6.688662154126657" CI_END="1.5678386330345673" CI_START="1.0041493045683076" CI_STUDY="95" CI_TOTAL="95" DF="9" EFFECT_MEASURE="RR" EFFECT_SIZE="1.2547286850299497" ESTIMABLE="YES" EVENTS_1="168" EVENTS_2="134" I2="0.0" I2_Q="100.0" ID="CMP-001.02" LOG_CI_END="0.1953013616717651" LOG_CI_START="0.0017982918222351802" LOG_EFFECT_SIZE="0.09854982674700014" METHOD="MH" MODIFIED="2017-12-03 03:42:36 +0000" MODIFIED_BY="Hermann Blessberger" NO="2" P_CHI2="0.6694976558571096" P_Q="0.0" P_Z="0.04589113513048396" Q="5.962790546993262E-32" RANDOM="NO" SCALE="100.0" SORT_BY="YEAR" STUDIES="13" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="5805" TOTAL_2="5608" WEIGHT="99.99999999999997" Z="1.9963932485100226"><NAME>All-cause mortality (30 days)&#8212;non-cardiac surgery</NAME><GROUP_LABEL_1>Beta-blocker</GROUP_LABEL_1><GROUP_LABEL_2>Control</GROUP_LABEL_2><GRAPH_LABEL_1>Favours beta-blocker</GRAPH_LABEL_1><GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2><DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-11-06 18:53:26 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1355" O_E="0.0" SE="0.0" STUDY_ID="STD-Miller-1990" TOTAL_1="30" TOTAL_2="15" VAR="0.0" WEIGHT="0.0"/><DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-11-06 18:53:12 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1356" O_E="0.0" SE="0.0" STUDY_ID="STD-Miller-1991" TOTAL_1="368" TOTAL_2="180" VAR="0.0" WEIGHT="0.0"/><DICH_DATA CI_END="10.888852021315463" CI_START="0.38234045608732375" EFFECT_SIZE="2.04040404040404" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="2" LOG_CI_END="1.0369820958174838" LOG_CI_START="-0.4175497461193362" LOG_EFFECT_SIZE="0.3097161748490738" MODIFIED="2013-11-06 18:53:49 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1357" O_E="0.0" SE="0.8543992040024265" STUDY_ID="STD-Mangano-1996" TOTAL_1="99" TOTAL_2="101" VAR="0.72999799979998" WEIGHT="1.4699070622971762"/><DICH_DATA CI_END="21.785667983536555" CI_START="0.1911775797639689" EFFECT_SIZE="2.0408163265306123" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="1" LOG_CI_END="1.3381708806415864" LOG_CI_START="-0.7185630406986138" LOG_EFFECT_SIZE="0.3098039199714864" MODIFIED="2013-11-06 18:52:13 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1352" O_E="0.0" SE="1.2081356863923414" STUDY_ID="STD-Bayliff-1999" TOTAL_1="49" TOTAL_2="50" VAR="1.4595918367346938" WEIGHT="0.7348785435421041"/><DICH_DATA CI_END="23.10618612076079" CI_START="0.2684527492293484" EFFECT_SIZE="2.490566037735849" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="1" LOG_CI_END="1.3637282672706277" LOG_CI_START="-0.571132144060506" LOG_EFFECT_SIZE="0.3962980616050608" MODIFIED="2013-11-06 19:00:03 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1364" O_E="0.0" SE="1.1365465833294115" STUDY_ID="STD-POBBLE-2005" TOTAL_1="53" TOTAL_2="44" VAR="1.2917381360777587" WEIGHT="0.8112576726205386"/><DICH_DATA CI_END="2.5549775876151535" CI_START="0.6868023908740409" EFFECT_SIZE="1.3246753246753247" ESTIMABLE="YES" EVENTS_1="20" EVENTS_2="15" LOG_CI_END="0.4073870948356017" LOG_CI_START="-0.16316820165673035" LOG_EFFECT_SIZE="0.12210944658943569" MODIFIED="2013-12-07 18:57:15 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1359" O_E="0.0" SE="0.3351470054538631" STUDY_ID="STD-DIPOM-_x002d_-Juul-2006" TOTAL_1="462" TOTAL_2="459" VAR="0.11232351526469174" WEIGHT="11.1719320695768"/><DICH_DATA CI_END="2.086100324386569" CI_START="0.006111296108574041" EFFECT_SIZE="0.11291048133153396" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="4" LOG_CI_END="0.3193351906100624" LOG_CI_START="-2.2138666730459673" LOG_EFFECT_SIZE="-0.9472657412179525" MODIFIED="2013-11-06 19:01:16 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1362" O_E="0.0" SE="1.4880153142630121" STUDY_ID="STD-Yang-2006" TOTAL_1="246" TOTAL_2="250" VAR="2.214189575481251" WEIGHT="3.313864954247924"/><DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-11-06 19:01:34 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1354" O_E="0.0" SE="0.0" STUDY_ID="STD-Lai-2006" TOTAL_1="30" TOTAL_2="30" VAR="0.0" WEIGHT="0.0"/><DICH_DATA CI_END="2.4023415437266507" CI_START="0.185004686617123" EFFECT_SIZE="0.6666666666666666" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="5" LOG_CI_END="0.38063475161440946" LOG_CI_START="-0.7328172697257719" LOG_EFFECT_SIZE="-0.17609125905568127" MODIFIED="2013-11-06 18:51:09 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1350" O_E="0.0" SE="0.6540472290116194" STUDY_ID="STD-Neary-2006" TOTAL_1="18" TOTAL_2="20" VAR="0.42777777777777776" WEIGHT="3.5165240724812823"/><DICH_DATA CI_END="7.99511202377449" CI_START="0.013897380146858233" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.90282455325627" LOG_CI_START="-1.8570670626955947" LOG_EFFECT_SIZE="-0.47712125471966244" MODIFIED="2013-11-06 18:59:18 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1363" O_E="0.0" SE="1.6211739968939571" STUDY_ID="STD-Yang-2008" TOTAL_1="51" TOTAL_2="51" VAR="2.628205128205128" WEIGHT="1.1135659562857394"/><DICH_DATA CI_END="1.7258284961101578" CI_START="1.0262717576233682" EFFECT_SIZE="1.3308527507051506" ESTIMABLE="YES" EVENTS_1="129" EVENTS_2="97" LOG_CI_END="0.23699763558907627" LOG_CI_START="0.011262377548303708" LOG_EFFECT_SIZE="0.12413000656868999" MODIFIED="2017-12-03 02:25:46 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1365" O_E="0.0" SE="0.13259800798069846" STUDY_ID="STD-POISE-2008" TOTAL_1="4174" TOTAL_2="4177" VAR="0.017582231720449374" WEIGHT="71.98472953323875"/><DICH_DATA CI_END="3.986212369346937" CI_START="0.38358505944859494" EFFECT_SIZE="1.2365482233502538" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="5" LOG_CI_END="0.6005604324423948" LOG_CI_START="-0.416138316843905" LOG_EFFECT_SIZE="0.09221105779924482" MODIFIED="2013-11-06 18:52:35 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1353" O_E="0.0" SE="0.5972138780707484" STUDY_ID="STD-Marwick-2009" TOTAL_1="197" TOTAL_2="203" VAR="0.35666441616030276" WEIGHT="3.6562082231381776"/><DICH_DATA CI_END="3.0135058276554862" CI_START="0.036871045707436295" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="3" LOG_CI_END="0.4790720356632876" LOG_CI_START="-1.4333145451026126" LOG_EFFECT_SIZE="-0.47712125471966244" MODIFIED="2013-11-06 18:51:49 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1351" O_E="0.0" SE="1.1233453440081378" STUDY_ID="STD-Kawaguchi-2010" TOTAL_1="28" TOTAL_2="28" VAR="1.2619047619047616" WEIGHT="2.227131912571479"/></DICH_OUTCOME><DICH_OUTCOME CHI2="12.222122050802035" CI_END="1.3066287727035844" CI_START="0.7448934735497141" CI_STUDY="95" CI_TOTAL="95" DF="9" EFFECT_MEASURE="RR" EFFECT_SIZE="0.9865592963117691" ESTIMABLE="YES" EVENTS_1="233" EVENTS_2="215" I2="26.363032846579976" I2_Q="0.0" ID="CMP-001.03" LOG_CI_END="0.11615221736888064" LOG_CI_START="-0.12790583081875548" LOG_EFFECT_SIZE="-0.005876806724937393" METHOD="MH" MODIFIED="2017-12-03 02:02:40 +0000" MODIFIED_BY="Hermann Blessberger" NO="3" P_CHI2="0.20107490712238452" P_Q="1.0" P_Z="0.9247992944814877" Q="0.0" RANDOM="YES" SCALE="100.0" SORT_BY="EFFECT_SIZE" STUDIES="13" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.04175360573490305" TOTALS="YES" TOTAL_1="5805" TOTAL_2="5608" WEIGHT="100.00000000000001" Z="0.09439008146229692"><NAME>Long-term mortality&#8212;non-cardiac surgery</NAME><GROUP_LABEL_1>Beta-blocker</GROUP_LABEL_1><GROUP_LABEL_2>Control</GROUP_LABEL_2><GRAPH_LABEL_1>Favours beta-blocker</GRAPH_LABEL_1><GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2><DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-11-07 10:50:22 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1388" O_E="0.0" SE="0.0" STUDY_ID="STD-Miller-1991" TOTAL_1="368" TOTAL_2="180" VAR="0.0" WEIGHT="0.0"/><DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-11-07 10:51:39 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1385" O_E="0.0" SE="0.0" STUDY_ID="STD-Lai-2006" TOTAL_1="30" TOTAL_2="30" VAR="0.0" WEIGHT="0.0"/><DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-11-07 10:50:11 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1387" O_E="0.0" SE="0.0" STUDY_ID="STD-Miller-1990" TOTAL_1="30" TOTAL_2="15" VAR="0.0" WEIGHT="0.0"/><DICH_DATA CI_END="2.086100324386569" CI_START="0.006111296108574041" EFFECT_SIZE="0.11291048133153396" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="4" LOG_CI_END="0.3193351906100624" LOG_CI_START="-2.2138666730459673" LOG_EFFECT_SIZE="-0.9472657412179525" MODIFIED="2013-11-07 10:51:22 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1392" O_E="0.0" SE="1.4880153142630121" STUDY_ID="STD-Yang-2006" TOTAL_1="246" TOTAL_2="250" VAR="2.214189575481251" WEIGHT="0.9110313339931757"/><DICH_DATA CI_END="7.99511202377449" CI_START="0.013897380146858233" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.90282455325627" LOG_CI_START="-1.8570670626955947" LOG_EFFECT_SIZE="-0.47712125471966244" MODIFIED="2013-11-07 10:52:14 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1393" O_E="0.0" SE="1.6211739968939571" STUDY_ID="STD-Yang-2008" TOTAL_1="51" TOTAL_2="51" VAR="2.628205128205128" WEIGHT="0.769762805570883"/><DICH_DATA CI_END="3.0135058276554862" CI_START="0.036871045707436295" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="3" LOG_CI_END="0.4790720356632876" LOG_CI_START="-1.4333145451026126" LOG_EFFECT_SIZE="-0.47712125471966244" MODIFIED="2013-11-07 10:53:51 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1384" O_E="0.0" SE="1.1233453440081378" STUDY_ID="STD-Kawaguchi-2010" TOTAL_1="28" TOTAL_2="28" VAR="1.2619047619047616" WEIGHT="1.576513430828708"/><DICH_DATA CI_END="1.0730307753136772" CI_START="0.3098783343683285" EFFECT_SIZE="0.5766359244620114" ESTIMABLE="YES" EVENTS_1="13" EVENTS_2="23" LOG_CI_END="0.03061217803048055" LOG_CI_START="-0.5088087870818075" LOG_EFFECT_SIZE="-0.23909830452566347" MODIFIED="2013-11-07 10:45:21 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1381" O_E="0.0" SE="0.3168585450837994" STUDY_ID="STD-Wallace-1998" TOTAL_1="99" TOTAL_2="101" VAR="0.10039933759262215" WEIGHT="14.45791327064421"/><DICH_DATA CI_END="1.739330050693594" CI_START="0.2772637005998054" EFFECT_SIZE="0.6944444444444444" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="8" LOG_CI_END="0.2403820004008043" LOG_CI_START="-0.5571069845913037" LOG_EFFECT_SIZE="-0.15836249209524966" MODIFIED="2013-11-07 10:45:32 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1379" O_E="0.0" SE="0.4684489774185066" STUDY_ID="STD-Neary-2006" TOTAL_1="18" TOTAL_2="20" VAR="0.2194444444444445" WEIGHT="7.8684926031605755"/><DICH_DATA CI_END="1.3750776070230888" CI_START="0.7582504153316847" EFFECT_SIZE="1.021103896103896" ESTIMABLE="YES" EVENTS_1="74" EVENTS_2="72" LOG_CI_END="0.13832720969410692" LOG_CI_START="-0.12018734313242" LOG_EFFECT_SIZE="0.009069933280843453" MODIFIED="2013-11-07 10:45:52 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1378" O_E="0.0" SE="0.1518527279979766" STUDY_ID="STD-DIPOM-_x002d_-Juul-2006" TOTAL_1="462" TOTAL_2="459" VAR="0.02305925100042747" WEIGHT="31.71029683491516"/><DICH_DATA CI_END="3.986212369346937" CI_START="0.38358505944859494" EFFECT_SIZE="1.2365482233502538" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="5" LOG_CI_END="0.6005604324423948" LOG_CI_START="-0.416138316843905" LOG_EFFECT_SIZE="0.09221105779924482" MODIFIED="2013-11-07 10:52:49 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1386" O_E="0.0" SE="0.5972138780707484" STUDY_ID="STD-Marwick-2009" TOTAL_1="197" TOTAL_2="203" VAR="0.35666441616030276" WEIGHT="5.15848885554866"/><DICH_DATA CI_END="1.7258284961101578" CI_START="1.0262717576233682" EFFECT_SIZE="1.3308527507051506" ESTIMABLE="YES" EVENTS_1="129" EVENTS_2="97" LOG_CI_END="0.23699763558907627" LOG_CI_START="0.011262377548303708" LOG_EFFECT_SIZE="0.12413000656868999" MODIFIED="2013-11-07 10:52:03 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1390" O_E="0.0" SE="0.13259800798069846" STUDY_ID="STD-POISE-2008" TOTAL_1="4174" TOTAL_2="4177" VAR="0.017582231720449374" WEIGHT="34.63732903985107"/><DICH_DATA CI_END="21.785667983536555" CI_START="0.1911775797639689" EFFECT_SIZE="2.0408163265306123" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="1" LOG_CI_END="1.3381708806415864" LOG_CI_START="-0.7185630406986138" LOG_EFFECT_SIZE="0.3098039199714864" MODIFIED="2013-11-07 10:50:58 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1382" O_E="0.0" SE="1.2081356863923414" STUDY_ID="STD-Bayliff-1999" TOTAL_1="49" TOTAL_2="50" VAR="1.4595918367346938" WEIGHT="1.3689287406204522"/><DICH_DATA CI_END="23.10618612076079" CI_START="0.2684527492293484" EFFECT_SIZE="2.490566037735849" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="1" LOG_CI_END="1.3637282672706277" LOG_CI_START="-0.571132144060506" LOG_EFFECT_SIZE="0.3962980616050608" MODIFIED="2013-11-07 10:51:11 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1389" O_E="0.0" SE="1.1365465833294115" STUDY_ID="STD-POBBLE-2005" TOTAL_1="53" TOTAL_2="44" VAR="1.2917381360777587" WEIGHT="1.5412430848671088"/></DICH_OUTCOME><DICH_OUTCOME CHI2="0.9520673649550807" CI_END="4.399984179226458" CI_START="0.16262684854521636" CI_STUDY="95" CI_TOTAL="95" DF="2" EFFECT_MEASURE="RR" EFFECT_SIZE="0.8459051724137933" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" I2="0.0" I2_Q="0.0" ID="CMP-001.04" LOG_CI_END="0.6434511149209599" LOG_CI_START="-0.7888077538681787" LOG_EFFECT_SIZE="-0.07267831947360943" METHOD="MH" MODIFIED="2017-12-03 01:58:42 +0000" MODIFIED_BY="Hermann Blessberger" NO="4" P_CHI2="0.6212425997920603" P_Q="1.0" P_Z="0.8423314180816447" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="YEAR" STUDIES="4" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="150" TOTAL_2="170" WEIGHT="100.0" Z="0.1989122102565134"><NAME>Death due to cardiac causes&#8212;cardiac surgery</NAME><GROUP_LABEL_1>Beta-blocker</GROUP_LABEL_1><GROUP_LABEL_2>Control</GROUP_LABEL_2><GRAPH_LABEL_1>Favours beta-blocker</GRAPH_LABEL_1><GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2><DICH_DATA CI_END="14.051950786893713" CI_START="0.025619218673593205" EFFECT_SIZE="0.6" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="1.1477366201252595" LOG_CI_START="-1.591434119357972" LOG_EFFECT_SIZE="-0.2218487496163564" MODIFIED="2013-11-07 10:31:52 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1368" O_E="0.0" SE="1.6090024514862893" STUDY_ID="STD-Oka-1980" TOTAL_1="19" TOTAL_2="35" VAR="2.588888888888889" WEIGHT="34.752155172413794"/><DICH_DATA CI_END="66.4433184667098" CI_START="0.12341968180365896" EFFECT_SIZE="2.8636363636363638" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.8224513148659036" LOG_CI_START="-0.9086155776031525" LOG_EFFECT_SIZE="0.4569178686313755" MODIFIED="2013-11-07 10:32:11 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1369" O_E="0.0" SE="1.6042422116354729" STUDY_ID="STD-White-1984" TOTAL_1="21" TOTAL_2="20" VAR="2.5735930735930737" WEIGHT="16.594827586206897"/><DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-11-07 10:31:41 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1367" O_E="0.0" SE="0.0" STUDY_ID="STD-Gomes-1999" TOTAL_1="40" TOTAL_2="45" VAR="0.0" WEIGHT="0.0"/><DICH_DATA CI_END="8.044961518532196" CI_START="0.013811266947039826" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.9055239710790393" LOG_CI_START="-1.8597664805183645" LOG_EFFECT_SIZE="-0.47712125471966244" MODIFIED="2013-11-07 10:32:30 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1370" O_E="0.0" SE="1.6243452996768142" STUDY_ID="STD-Sezai-2011" TOTAL_1="70" TOTAL_2="70" VAR="2.6384976525821595" WEIGHT="48.65301724137931"/></DICH_OUTCOME><DICH_OUTCOME CHI2="1.5282253003044444" CI_END="1.754721448938362" CI_START="0.9052084742356212" CI_STUDY="95" CI_TOTAL="95" DF="3" EFFECT_MEASURE="RR" EFFECT_SIZE="1.2603129474467891" ESTIMABLE="YES" EVENTS_1="77" EVENTS_2="61" I2="0.0" I2_Q="100.0" ID="CMP-001.05" LOG_CI_END="0.2442081847389606" LOG_CI_START="-0.04325138898979941" LOG_EFFECT_SIZE="0.10047839787458057" METHOD="MH" MODIFIED="2017-12-03 02:25:39 +0000" MODIFIED_BY="Hermann Blessberger" NO="5" P_CHI2="0.6757714682629975" P_Q="0.0" P_Z="0.17063427719403024" Q="2.7019152246678645E-32" RANDOM="NO" SCALE="100.0" SORT_BY="YEAR" STUDIES="4" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="4716" TOTAL_2="4731" WEIGHT="100.0" Z="1.3701686014763672"><NAME>Death due to cardiac causes&#8212;non-cardiac surgery</NAME><GROUP_LABEL_1>Beta-blocker</GROUP_LABEL_1><GROUP_LABEL_2>Control</GROUP_LABEL_2><GRAPH_LABEL_1>Favours beta-blocker</GRAPH_LABEL_1><GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2><DICH_DATA CI_END="5.535882382109476" CI_START="0.04700299293694875" EFFECT_SIZE="0.51010101010101" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" LOG_CI_END="0.7431868543274104" LOG_CI_START="-1.3278744872851878" LOG_EFFECT_SIZE="-0.2923438164788886" MODIFIED="2013-11-07 10:37:49 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1372" O_E="0.0" SE="1.216551683982222" STUDY_ID="STD-Mangano-1996" TOTAL_1="99" TOTAL_2="101" VAR="1.47999799979998" WEIGHT="3.196659804739338"/><DICH_DATA CI_END="8.274975487492005" CI_START="0.013865780185584986" EFFECT_SIZE="0.33873144399460187" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.9177667159628347" LOG_CI_START="-1.8580556889594146" LOG_EFFECT_SIZE="-0.47014448649829005" MODIFIED="2013-11-07 10:38:11 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1377" O_E="0.0" SE="1.6305318211938382" STUDY_ID="STD-Yang-2006" TOTAL_1="246" TOTAL_2="250" VAR="2.658634019925695" WEIGHT="2.4022604714939044"/><DICH_DATA CI_END="1.8180790761671433" CI_START="0.9210386011859882" EFFECT_SIZE="1.2940328470168365" ESTIMABLE="YES" EVENTS_1="75" EVENTS_2="58" LOG_CI_END="0.2596127686528247" LOG_CI_START="-0.035722167923927406" LOG_EFFECT_SIZE="0.11194530036444864" MODIFIED="2017-12-03 02:25:39 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1374" O_E="0.0" SE="0.17348120367669792" STUDY_ID="STD-POISE-2008" TOTAL_1="4174" TOTAL_2="4177" VAR="0.03009572802911595" WEIGHT="93.6058907176127"/><DICH_DATA CI_END="75.42168546066148" CI_START="0.12667071744568087" EFFECT_SIZE="3.090909090909091" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.8774962334274081" LOG_CI_START="-0.8973237696593477" LOG_EFFECT_SIZE="0.49008623188403005" MODIFIED="2013-11-07 10:39:02 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1371" O_E="0.0" SE="1.6299430053937" STUDY_ID="STD-Marwick-2009" TOTAL_1="197" TOTAL_2="203" VAR="2.6567142008318476" WEIGHT="0.7951890061540642"/></DICH_OUTCOME><DICH_OUTCOME CHI2="9.818496620370027" CI_END="1.5111088814762033" CI_START="0.7119610516323913" CI_STUDY="95" CI_TOTAL="95" DF="19" EFFECT_MEASURE="RR" EFFECT_SIZE="1.0372322152665931" ESTIMABLE="YES" EVENTS_1="50" EVENTS_2="51" I2="0.0" I2_Q="0.0" ID="CMP-001.06" LOG_CI_END="0.17929575813165266" LOG_CI_START="-0.14754376412128795" LOG_EFFECT_SIZE="0.015875997005182357" METHOD="MH" MODIFIED="2017-12-08 14:26:51 +0000" MODIFIED_BY="Hermann Blessberger" NO="6" P_CHI2="0.957281848961746" P_Q="1.0" P_Z="0.8489896572397033" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="YEAR" STUDIES="22" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="1751" TOTAL_2="1802" WEIGHT="100.00000000000003" Z="0.19040770916769523"><NAME>Acute myocardial infarction&#8212;cardiac surgery</NAME><GROUP_LABEL_1>Beta-blocker</GROUP_LABEL_1><GROUP_LABEL_2>Control</GROUP_LABEL_2><GRAPH_LABEL_1>Favours beta-blocker</GRAPH_LABEL_1><GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2><DICH_DATA CI_END="3.8257633571979164" CI_START="0.22994486153744298" EFFECT_SIZE="0.9379310344827586" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="5" LOG_CI_END="0.5827181032130841" LOG_CI_START="-0.6383762909425988" LOG_EFFECT_SIZE="-0.027829093864757383" MODIFIED="2013-11-07 11:42:12 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1413" O_E="0.0" SE="0.717276891641784" STUDY_ID="STD-Stephenson-1980" TOTAL_1="87" TOTAL_2="136" VAR="0.5144861392832996" WEIGHT="7.592220867708598"/><DICH_DATA CI_END="3.5279536888293985" CI_START="0.011338017312033452" EFFECT_SIZE="0.2" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="4" LOG_CI_END="0.5475228755476929" LOG_CI_START="-1.9454628842197306" LOG_EFFECT_SIZE="-0.6989700043360187" MODIFIED="2013-11-07 11:42:25 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1410" O_E="0.0" SE="1.46439217576592" STUDY_ID="STD-Oka-1980" TOTAL_1="19" TOTAL_2="35" VAR="2.144444444444445" WEIGHT="6.255167192730359"/><DICH_DATA CI_END="5.214575411505864" CI_START="0.012754575404951726" EFFECT_SIZE="0.2578947368421053" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" LOG_CI_END="0.7172189524659107" LOG_CI_START="-1.8943339943145414" LOG_EFFECT_SIZE="-0.5885575209243152" MODIFIED="2013-11-07 11:42:41 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1408" O_E="0.0" SE="1.5340391283344144" STUDY_ID="STD-Mohr-1981" TOTAL_1="37" TOTAL_2="48" VAR="2.35327604726101" WEIGHT="4.249998654575417"/><DICH_DATA CI_END="2.554588535140364" CI_START="0.2718419952535674" EFFECT_SIZE="0.8333333333333334" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="6" LOG_CI_END="0.4073209587531089" LOG_CI_START="-0.5656834508483586" LOG_EFFECT_SIZE="-0.0791812460476248" MODIFIED="2013-11-07 11:42:54 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1412" O_E="0.0" SE="0.5715476066494082" STUDY_ID="STD-Silverman-1982" TOTAL_1="50" TOTAL_2="50" VAR="0.32666666666666666" WEIGHT="11.67631209309667"/><DICH_DATA CI_END="6.823446325509919" CI_START="0.14655350863704047" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="2" LOG_CI_END="0.8340037796584007" LOG_CI_START="-0.8340037796584007" LOG_EFFECT_SIZE="0.0" MODIFIED="2014-06-22 20:22:17 +0100" MODIFIED_BY="Hermann Blessberger" ORDER="1394" O_E="0.0" SE="0.9797958971132712" STUDY_ID="STD-Abel-1983" TOTAL_1="50" TOTAL_2="50" VAR="0.96" WEIGHT="3.8921040310322232"><FOOTNOTE>Beta-blocker group originally comprised 50 patients of whom two suffered an acute myocardial infarction. During the course of the study nine patients were withdrawn from the beta-blocker group.</FOOTNOTE></DICH_DATA><DICH_DATA CI_END="4.283442722425353" CI_START="0.010892173194178404" EFFECT_SIZE="0.216" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" LOG_CI_END="0.6317929639528874" LOG_CI_START="-1.9628854616510256" LOG_EFFECT_SIZE="-0.6655462488490691" MODIFIED="2013-11-07 11:43:23 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1402" O_E="0.0" SE="1.5241269510650886" STUDY_ID="STD-Hammon-1984" TOTAL_1="24" TOTAL_2="26" VAR="2.3229629629629627" WEIGHT="4.67800965268296"/><DICH_DATA CI_END="18.464793725803222" CI_START="0.08462049580421353" EFFECT_SIZE="1.25" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.2663444604166862" LOG_CI_START="-1.0725244344005735" LOG_EFFECT_SIZE="0.09691001300805642" MODIFIED="2013-11-07 11:43:10 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1409" O_E="0.0" SE="1.3738631664034087" STUDY_ID="STD-Myhre-1984" TOTAL_1="16" TOTAL_2="20" VAR="1.8875" WEIGHT="1.729824013792099"/><DICH_DATA CI_END="2.8734486028922372" CI_START="0.22272888380735792" EFFECT_SIZE="0.8" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="5" LOG_CI_END="0.45840343335420675" LOG_CI_START="-0.6522234593703196" LOG_EFFECT_SIZE="-0.09691001300805639" MODIFIED="2013-11-07 11:43:35 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1406" O_E="0.0" SE="0.6523877344781713" STUDY_ID="STD-Matangi-1985" TOTAL_1="82" TOTAL_2="82" VAR="0.42560975609756097" WEIGHT="9.730260077580558"/><DICH_DATA CI_END="15.548273108710726" CI_START="0.06431582420814068" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.1916821605007981" LOG_CI_START="-1.1916821605007981" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-11-07 11:43:47 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1399" O_E="0.0" SE="1.4" STUDY_ID="STD-Daudon-1986" TOTAL_1="50" TOTAL_2="50" VAR="1.96" WEIGHT="1.9460520155161116"/><DICH_DATA CI_END="8.873814181503294" CI_START="0.015231822201475684" EFFECT_SIZE="0.36764705882352944" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.9481103303087892" LOG_CI_START="-1.8172481383771868" LOG_EFFECT_SIZE="-0.4345689040341987" MODIFIED="2013-11-25 12:59:11 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1404" O_E="0.0" SE="1.6243852532513314" STUDY_ID="STD-Khuri-1987" TOTAL_1="67" TOTAL_2="74" VAR="2.638627450980392" WEIGHT="2.776186092064943"/><DICH_DATA CI_END="24.14022199893455" CI_START="0.21642260771872576" EFFECT_SIZE="2.2857142857142856" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="1" LOG_CI_END="1.3827412596498534" LOG_CI_START="-0.6646973743665175" LOG_EFFECT_SIZE="0.3590219426416679" MODIFIED="2013-11-25 12:59:04 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1405" O_E="0.0" SE="1.2026755886059097" STUDY_ID="STD-Martinussen-1988" TOTAL_1="35" TOTAL_2="40" VAR="1.4464285714285716" WEIGHT="1.8163152144817043"/><DICH_DATA CI_END="5.525756215095862" CI_START="0.3217256984521052" EFFECT_SIZE="1.3333333333333333" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="3" LOG_CI_END="0.7423917208312917" LOG_CI_START="-0.4925142476146918" LOG_EFFECT_SIZE="0.12493873660829993" MODIFIED="2013-11-07 11:44:21 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1407" O_E="0.0" SE="0.7253898787483019" STUDY_ID="STD-Matangi-1989" TOTAL_1="35" TOTAL_2="35" VAR="0.5261904761904761" WEIGHT="5.838156046548335"/><DICH_DATA CI_END="15.840228937301898" CI_START="0.06313040070053004" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.199761454115117" LOG_CI_START="-1.199761454115117" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-11-07 11:44:30 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1414" O_E="0.0" SE="1.4094916341243984" STUDY_ID="STD-Suttorp-1991" TOTAL_1="150" TOTAL_2="150" VAR="1.9866666666666668" WEIGHT="1.9460520155161116"/><DICH_DATA CI_END="6.907791933318855" CI_START="0.013028765323097881" EFFECT_SIZE="0.3" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.8393392478918953" LOG_CI_START="-1.8850967384525705" LOG_EFFECT_SIZE="-0.5228787452803376" MODIFIED="2013-11-25 19:25:06 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1403" O_E="0.0" SE="1.600347184554374" STUDY_ID="STD-Jacquet-1994" TOTAL_1="19" TOTAL_2="17" VAR="2.5611111111111113" WEIGHT="3.07271370870965"/><DICH_DATA CI_END="17.222250445333504" CI_START="0.07299374868245567" EFFECT_SIZE="1.121212121212121" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.2360899004353734" LOG_CI_START="-1.1367143320571584" LOG_EFFECT_SIZE="0.04968778418910748" MODIFIED="2013-11-07 11:44:59 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1396" O_E="0.0" SE="1.393796951736494" STUDY_ID="STD-Babin_x002d_Ebell-1996" TOTAL_1="33" TOTAL_2="37" VAR="1.9426699426699428" WEIGHT="1.8348490432009052"/><DICH_DATA CI_END="6.7963699605826395" CI_START="0.40871491603433024" EFFECT_SIZE="1.6666666666666667" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="3" LOG_CI_END="0.8322770116723457" LOG_CI_START="-0.3885795124396329" LOG_EFFECT_SIZE="0.2218487496163564" MODIFIED="2013-11-07 11:45:14 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1395" O_E="0.0" SE="0.7171371656006362" STUDY_ID="STD-Ali-1997" TOTAL_1="105" TOTAL_2="105" VAR="0.5142857142857143" WEIGHT="5.838156046548335"/><DICH_DATA CI_END="6.429716840797003" CI_START="0.6221113773813055" EFFECT_SIZE="2.0" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="4" LOG_CI_END="0.8081918473896704" LOG_CI_START="-0.20613185606170806" LOG_EFFECT_SIZE="0.3010299956639812" MODIFIED="2013-11-07 11:45:28 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1415" O_E="0.0" SE="0.5958187643906492" STUDY_ID="STD-Wenke-1999" TOTAL_1="100" TOTAL_2="100" VAR="0.355" WEIGHT="7.7842080620644465"/><DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-11-07 11:46:03 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1400" O_E="0.0" SE="0.0" STUDY_ID="STD-Evrard-2000" TOTAL_1="103" TOTAL_2="103" VAR="0.0" WEIGHT="0.0"/><DICH_DATA CI_END="2.6378743799535904" CI_START="0.03008078627713564" EFFECT_SIZE="0.28169014084507044" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="3" LOG_CI_END="0.4212541098638801" LOG_CI_START="-1.5217108159740682" LOG_EFFECT_SIZE="-0.5502283530550941" MODIFIED="2013-11-07 11:46:13 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1397" O_E="0.0" SE="1.141307215268708" STUDY_ID="STD-Bert-2001" TOTAL_1="71" TOTAL_2="60" VAR="1.3025821596244131" WEIGHT="6.32838289015163"/><DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-11-07 11:46:27 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1401" O_E="0.0" SE="0.0" STUDY_ID="STD-Forlani-2002" TOTAL_1="51" TOTAL_2="50" VAR="0.0" WEIGHT="0.0"/><DICH_DATA CI_END="5.80943240846048" CI_START="0.6885354228710294" EFFECT_SIZE="2.0" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="5" LOG_CI_END="0.7641337031450597" LOG_CI_START="-0.16207371181709732" LOG_EFFECT_SIZE="0.3010299956639812" MODIFIED="2013-11-07 11:46:39 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1398" O_E="0.0" SE="0.5440588203494178" STUDY_ID="STD-Connolly-2003" TOTAL_1="500" TOTAL_2="500" VAR="0.29600000000000004" WEIGHT="9.730260077580558"/><DICH_DATA CI_END="52.1508617241787" CI_START="0.1269979711600307" EFFECT_SIZE="2.573529411764706" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="0" LOG_CI_END="1.717261488965115" LOG_CI_START="-0.8962032170049987" LOG_EFFECT_SIZE="0.41052913598005814" MODIFIED="2013-11-07 11:45:44 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1411" O_E="0.0" SE="1.5351621051457824" STUDY_ID="STD-Sezai-2012" TOTAL_1="67" TOTAL_2="34" VAR="2.3567226890756303" WEIGHT="1.2847722044184038"/></DICH_OUTCOME><DICH_OUTCOME CHI2="6.269793019097788" CI_END="0.8701203248774039" CI_START="0.6077471038709278" CI_STUDY="95" CI_TOTAL="95" DF="10" EFFECT_MEASURE="RR" EFFECT_SIZE="0.727195370903496" ESTIMABLE="YES" EVENTS_1="194" EVENTS_2="266" I2="0.0" I2_Q="0.0" ID="CMP-001.07" LOG_CI_END="-0.06042068667221281" LOG_CI_START="-0.21627710204591305" LOG_EFFECT_SIZE="-0.13834889435906292" METHOD="MH" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" NO="7" P_CHI2="0.7921099759304913" P_Q="1.0" P_Z="5.021663179354654E-4" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="YEAR" STUDIES="14" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="5522" TOTAL_2="5436" WEIGHT="100.0" Z="3.479598187787608"><NAME>Acute myocardial infarction&#8212;non-cardiac surgery</NAME><GROUP_LABEL_1>Beta-blocker</GROUP_LABEL_1><GROUP_LABEL_2>Control</GROUP_LABEL_2><GRAPH_LABEL_1>Favours beta-blocker</GRAPH_LABEL_1><GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2><DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-11-07 11:50:12 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1427" O_E="0.0" SE="0.0" STUDY_ID="STD-Stone-1988" TOTAL_1="89" TOTAL_2="39" VAR="0.0" WEIGHT="0.0"/><DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-11-07 11:50:23 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1421" O_E="0.0" SE="0.0" STUDY_ID="STD-Miller-1990" TOTAL_1="30" TOTAL_2="15" VAR="0.0" WEIGHT="0.0"/><DICH_DATA CI_END="65.33683949785127" CI_START="0.12362952338910503" EFFECT_SIZE="2.8421052631578947" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.8151581227650624" LOG_CI_START="-0.9078778050247834" LOG_EFFECT_SIZE="0.45364015887013953" MODIFIED="2013-11-07 11:50:32 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1418" O_E="0.0" SE="1.5995247832289885" STUDY_ID="STD-Jakobsen-1997" TOTAL_1="18" TOTAL_2="17" VAR="2.5584795321637426" WEIGHT="0.19107761689848266"/><DICH_DATA CI_END="5.535882382109476" CI_START="0.04700299293694875" EFFECT_SIZE="0.51010101010101" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" LOG_CI_END="0.7431868543274104" LOG_CI_START="-1.3278744872851878" LOG_EFFECT_SIZE="-0.2923438164788886" MODIFIED="2013-11-07 11:50:48 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1428" O_E="0.0" SE="1.216551683982222" STUDY_ID="STD-Wallace-1998" TOTAL_1="99" TOTAL_2="101" VAR="1.47999799979998" WEIGHT="0.7367550638938337"/><DICH_DATA CI_END="1.2850770513332368" CI_START="0.0037789141856547637" EFFECT_SIZE="0.06968641114982578" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="3" LOG_CI_END="0.10892916810749446" LOG_CI_START="-2.4226329702475167" LOG_EFFECT_SIZE="-1.1568519010700111" MODIFIED="2013-11-07 11:51:06 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1431" O_E="0.0" SE="1.4870521315044227" STUDY_ID="STD-Zaugg-1999" TOTAL_1="40" TOTAL_2="19" VAR="2.2113240418118467" WEIGHT="1.750693023162198"/><DICH_DATA CI_END="5.615700904668708" CI_START="0.011129510111202603" EFFECT_SIZE="0.25" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.7494039689737728" LOG_CI_START="-1.9535239516296976" LOG_EFFECT_SIZE="-0.6020599913279624" MODIFIED="2013-11-07 11:51:15 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1426" O_E="0.0" SE="1.5877132402714706" STUDY_ID="STD-Raby-1999" TOTAL_1="15" TOTAL_2="11" VAR="2.520833333333333" WEIGHT="0.6378831722024534"/><DICH_DATA CI_END="1.9689060372965594" CI_START="0.1260175766811152" EFFECT_SIZE="0.4981132075471698" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="5" LOG_CI_END="0.29422499066461516" LOG_CI_START="-0.8995688761265311" LOG_EFFECT_SIZE="-0.302671942730958" MODIFIED="2013-11-07 11:51:39 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1423" O_E="0.0" SE="0.7012404267280651" STUDY_ID="STD-POBBLE-2005" TOTAL_1="53" TOTAL_2="44" VAR="0.49173813607775874" WEIGHT="2.0331156089957925"/><DICH_DATA CI_END="8.877109838397404" CI_START="0.250179859646748" EFFECT_SIZE="1.4902597402597402" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="2" LOG_CI_END="0.9482715935329684" LOG_CI_START="-0.6017476554593345" LOG_EFFECT_SIZE="0.17326196903681695" MODIFIED="2013-11-07 11:52:08 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1417" O_E="0.0" SE="0.9104889795771052" STUDY_ID="STD-DIPOM-_x002d_-Juul-2006" TOTAL_1="462" TOTAL_2="459" VAR="0.8289901819313583" WEIGHT="0.7466211288102549"/><DICH_DATA CI_END="2.6794711630264745" CI_START="0.11518764581889715" EFFECT_SIZE="0.5555555555555556" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="4" LOG_CI_END="0.428049087445737" LOG_CI_START="-0.9385940976523491" LOG_EFFECT_SIZE="-0.25527250510330607" MODIFIED="2013-11-07 11:52:43 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1422" O_E="0.0" SE="0.8027729719194864" STUDY_ID="STD-Neary-2006" TOTAL_1="18" TOTAL_2="20" VAR="0.6444444444444444" WEIGHT="1.4100575385527916"/><DICH_DATA CI_END="1.6671769426996792" CI_START="0.5071036310519903" EFFECT_SIZE="0.9194734804490902" ESTIMABLE="YES" EVENTS_1="19" EVENTS_2="21" LOG_CI_END="0.22198169530492604" LOG_CI_START="-0.29490327972978975" LOG_EFFECT_SIZE="-0.03646079221243184" MODIFIED="2013-11-07 11:52:27 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1429" O_E="0.0" SE="0.3036207929572834" STUDY_ID="STD-Yang-2006" TOTAL_1="246" TOTAL_2="250" VAR="0.09218558591600953" WEIGHT="7.751052175129409"/><DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-11-07 11:51:54 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1419" O_E="0.0" SE="0.0" STUDY_ID="STD-Lai-2006" TOTAL_1="30" TOTAL_2="30" VAR="0.0" WEIGHT="0.0"/><DICH_DATA CI_END="15.556810748046935" CI_START="0.06428052742915473" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.1919205684576701" LOG_CI_START="-1.1919205684576701" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-11-07 11:52:55 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1430" O_E="0.0" SE="1.4002800840280099" STUDY_ID="STD-Yang-2008" TOTAL_1="51" TOTAL_2="51" VAR="1.9607843137254903" WEIGHT="0.3720985171180978"/><DICH_DATA CI_END="0.8669144321966489" CI_START="0.5773751446800002" EFFECT_SIZE="0.7074848731349105" ESTIMABLE="YES" EVENTS_1="152" EVENTS_2="215" LOG_CI_END="-0.06202376695142708" LOG_CI_START="-0.23854191591886673" LOG_EFFECT_SIZE="-0.1502828414351469" MODIFIED="2013-12-07 20:59:52 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1424" O_E="0.0" SE="0.10368763448240352" STUDY_ID="STD-POISE-2008" TOTAL_1="4174" TOTAL_2="4177" VAR="0.010751125544556516" WEIGHT="79.97244168290077"/><DICH_DATA CI_END="2.2384256247346914" CI_START="0.47436971491585606" EFFECT_SIZE="1.0304568527918783" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="12" LOG_CI_END="0.34994266883162384" LOG_CI_START="-0.3238830453283838" LOG_EFFECT_SIZE="0.013029811751620029" MODIFIED="2013-11-07 11:53:32 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1420" O_E="0.0" SE="0.3958085599886677" STUDY_ID="STD-Marwick-2009" TOTAL_1="197" TOTAL_2="203" VAR="0.15666441616030274" WEIGHT="4.398204472335917"/></DICH_OUTCOME><DICH_OUTCOME CHI2="3.671724678751238" CI_END="1.0541696233454452" CI_START="0.2469457452997947" CI_STUDY="95" CI_TOTAL="95" DF="3" EFFECT_MEASURE="RR" EFFECT_SIZE="0.5102182898617461" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="20" I2="18.294527436618512" I2_Q="0.0" ID="CMP-001.08" LOG_CI_END="0.022910497551937605" LOG_CI_START="-0.6073984520241552" LOG_EFFECT_SIZE="-0.29224397723610884" METHOD="MH" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" NO="8" P_CHI2="0.29916361140303693" P_Q="1.0" P_Z="0.0691433007736594" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="YEAR" STUDIES="4" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="78" TOTAL_2="88" WEIGHT="100.0" Z="1.8174822695020865"><NAME>Myocardial ischaemia&#8212;cardiac surgery</NAME><GROUP_LABEL_1>Beta-blocker</GROUP_LABEL_1><GROUP_LABEL_2>Control</GROUP_LABEL_2><GRAPH_LABEL_1>Favours beta-blocker</GRAPH_LABEL_1><GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2><DICH_DATA CI_END="2.8531415452949767" CI_START="0.03894342756823292" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="3" LOG_CI_END="0.45532331768430767" LOG_CI_START="-1.4095658271236327" LOG_EFFECT_SIZE="-0.47712125471966244" MODIFIED="2013-11-07 11:58:40 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1432" O_E="0.0" SE="1.0954451150103321" STUDY_ID="STD-Harrison-1987" TOTAL_1="15" TOTAL_2="15" VAR="1.2" WEIGHT="15.935927375587935"/><DICH_DATA CI_END="3.004555588665069" CI_START="0.1132539464610019" EFFECT_SIZE="0.5833333333333334" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="3" LOG_CI_END="0.4777802435055779" LOG_CI_START="-0.9459466555723139" LOG_EFFECT_SIZE="-0.23408320603336796" MODIFIED="2013-11-07 11:58:48 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1435" O_E="0.0" SE="0.8363042280801657" STUDY_ID="STD-Reves-1990" TOTAL_1="16" TOTAL_2="14" VAR="0.6994047619047619" WEIGHT="16.998322533960465"/><DICH_DATA CI_END="10.94851618230894" CI_START="0.38853723912594074" EFFECT_SIZE="2.0625" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="2" LOG_CI_END="1.0393552646098279" LOG_CI_START="-0.41056735016590234" LOG_EFFECT_SIZE="0.31439395722196267" MODIFIED="2013-11-07 11:58:56 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1434" O_E="0.0" SE="0.8516917211519599" STUDY_ID="STD-Neustein-1994" TOTAL_1="16" TOTAL_2="22" VAR="0.7253787878787878" WEIGHT="8.946485544189718"/><DICH_DATA CI_END="0.9630309301159309" CI_START="0.09245275176220336" EFFECT_SIZE="0.29838709677419356" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="12" LOG_CI_END="-0.016359764211958033" LOG_CI_START="-1.034080157978522" LOG_EFFECT_SIZE="-0.52521996109524" MODIFIED="2013-11-07 11:59:11 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1433" O_E="0.0" SE="0.5978139970956774" STUDY_ID="STD-Kurian-2001" TOTAL_1="31" TOTAL_2="37" VAR="0.3573815751235106" WEIGHT="58.11926454626188"/></DICH_OUTCOME><DICH_OUTCOME CHI2="12.456008542791606" CI_END="0.7685836416244642" CI_START="0.3422559620050429" CI_STUDY="95" CI_TOTAL="95" DF="9" EFFECT_MEASURE="RR" EFFECT_SIZE="0.5128862774977705" ESTIMABLE="YES" EVENTS_1="60" EVENTS_2="97" I2="27.74571429458136" I2_Q="0.0" ID="CMP-001.09" LOG_CI_END="-0.11430886320738608" LOG_CI_START="-0.465648977837248" LOG_EFFECT_SIZE="-0.2899789205223171" METHOD="MH" MODIFIED="2017-12-04 01:03:02 +0000" MODIFIED_BY="Hermann Blessberger" NO="9" P_CHI2="0.1888049672638734" P_Q="1.0" P_Z="0.0012150794633561943" Q="0.0" RANDOM="YES" SCALE="100.0" SORT_BY="YEAR" STUDIES="14" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.09800846043026638" TOTALS="YES" TOTAL_1="552" TOTAL_2="426" WEIGHT="100.0" Z="3.235316531380433"><NAME>Myocardial ischaemia&#8212;non-cardiac surgery</NAME><GROUP_LABEL_1>Beta-blocker</GROUP_LABEL_1><GROUP_LABEL_2>Control</GROUP_LABEL_2><GRAPH_LABEL_1>Favours beta-blocker</GRAPH_LABEL_1><GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2><DICH_DATA CI_END="1.2469987885761085" CI_START="0.0982358612712665" EFFECT_SIZE="0.35" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="5" LOG_CI_END="0.09586603157399819" LOG_CI_START="-1.007729942873447" LOG_EFFECT_SIZE="-0.4559319556497244" MODIFIED="2013-11-25 13:07:02 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="2856" O_E="0.0" SE="0.6482577382786072" STUDY_ID="STD-Coleman-1980" TOTAL_1="24" TOTAL_2="14" VAR="0.4202380952380952" WEIGHT="8.218532122292466"/><DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-11-10 09:19:46 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="2860" O_E="0.0" SE="0.0" STUDY_ID="STD-Liu-1986" TOTAL_1="16" TOTAL_2="14" VAR="0.0" WEIGHT="0.0"/><DICH_DATA CI_END="66.61522199816511" CI_START="0.11922423317225214" EFFECT_SIZE="2.8181818181818183" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.8235734795372827" LOG_CI_START="-0.9236354621851873" LOG_EFFECT_SIZE="0.44996900867604767" MODIFIED="2013-11-10 09:19:37 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="2857" O_E="0.0" SE="1.6137241312713606" STUDY_ID="STD-Cucchiara-1986" TOTAL_1="32" TOTAL_2="30" VAR="2.6041055718475072" WEIGHT="1.5762569285195942"/><DICH_DATA CI_END="0.34268065818180543" CI_START="0.018523976842803526" EFFECT_SIZE="0.07967313585291114" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="11" LOG_CI_END="-0.46511040762723255" LOG_CI_START="-1.7322657705980822" LOG_EFFECT_SIZE="-1.0986880891126574" MODIFIED="2013-11-10 09:19:54 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="2866" O_E="0.0" SE="0.7443333327292857" STUDY_ID="STD-Stone-1988" TOTAL_1="89" TOTAL_2="39" VAR="0.5540321102118855" WEIGHT="6.532148698712456"/><DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-11-10 09:20:04 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="2862" O_E="0.0" SE="0.0" STUDY_ID="STD-Miller-1990" TOTAL_1="30" TOTAL_2="15" VAR="0.0" WEIGHT="0.0"/><DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-11-10 09:20:11 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="2863" O_E="0.0" SE="0.0" STUDY_ID="STD-Oxorn-1990" TOTAL_1="32" TOTAL_2="16" VAR="0.0" WEIGHT="0.0"/><DICH_DATA CI_END="0.963432747451777" CI_START="0.4699791874804524" EFFECT_SIZE="0.6728992048140985" ESTIMABLE="YES" EVENTS_1="31" EVENTS_2="47" LOG_CI_END="-0.016178595933257885" LOG_CI_START="-0.3279213738994463" LOG_EFFECT_SIZE="-0.1720499849163521" MODIFIED="2013-11-10 09:20:20 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="2868" O_E="0.0" SE="0.18311925092897763" STUDY_ID="STD-Wallace-1998" TOTAL_1="99" TOTAL_2="101" VAR="0.03353266006078988" WEIGHT="32.379425909766766"/><DICH_DATA CI_END="3.1588374622614523" CI_START="0.03662503591899996" EFFECT_SIZE="0.3401360544217687" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="3" LOG_CI_END="0.49952727989090295" LOG_CI_START="-1.4362219407152177" LOG_EFFECT_SIZE="-0.4683473304121573" MODIFIED="2013-11-10 09:20:30 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="2855" O_E="0.0" SE="1.1370686742972156" STUDY_ID="STD-Bayliff-1999" TOTAL_1="49" TOTAL_2="50" VAR="1.292925170068027" WEIGHT="3.062134577551351"/><DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-11-10 09:20:38 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="2869" O_E="0.0" SE="0.0" STUDY_ID="STD-Zaugg-1999" TOTAL_1="40" TOTAL_2="19" VAR="0.0" WEIGHT="0.0"/><DICH_DATA CI_END="1.022049427213816" CI_START="0.20553746115499483" EFFECT_SIZE="0.4583333333333333" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="8" LOG_CI_END="0.009471899171640366" LOG_CI_START="-0.6871090122784024" LOG_EFFECT_SIZE="-0.338818556553381" MODIFIED="2013-11-10 09:20:45 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="2865" O_E="0.0" SE="0.40917507551687754" STUDY_ID="STD-Raby-1999" TOTAL_1="15" TOTAL_2="11" VAR="0.16742424242424245" WEIGHT="16.046349674412433"/><DICH_DATA CI_END="1.5031119175990921" CI_START="0.4585242356722858" EFFECT_SIZE="0.8301886792452831" ESTIMABLE="YES" EVENTS_1="15" EVENTS_2="15" LOG_CI_END="0.1769913181691861" LOG_CI_START="-0.33863770439838925" LOG_EFFECT_SIZE="-0.0808231931146016" MODIFIED="2013-11-25 19:29:21 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="2864" O_E="0.0" SE="0.3028830402610201" STUDY_ID="STD-POBBLE-2005" TOTAL_1="53" TOTAL_2="44" VAR="0.09173813607775871" WEIGHT="22.446916273661436"/><DICH_DATA CI_END="3.9981665126016623" CI_START="0.010004585820506876" EFFECT_SIZE="0.2" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" LOG_CI_END="0.6018608773254143" LOG_CI_START="-1.9998008859974516" LOG_EFFECT_SIZE="-0.6989700043360187" MODIFIED="2013-11-10 09:21:28 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="2859" O_E="0.0" SE="1.5282289982092807" STUDY_ID="STD-Lai-2006" TOTAL_1="30" TOTAL_2="30" VAR="2.335483870967742" WEIGHT="1.750252470522885"/><DICH_DATA CI_END="1.7491265621242627" CI_START="0.09147422688823888" EFFECT_SIZE="0.4" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="5" LOG_CI_END="0.24282123500387298" LOG_CI_START="-1.038701252347948" LOG_EFFECT_SIZE="-0.3979400086720376" MODIFIED="2013-11-10 09:21:37 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="2861" O_E="0.0" SE="0.752772652709081" STUDY_ID="STD-Liu-2006" TOTAL_1="15" TOTAL_2="15" VAR="0.5666666666666667" WEIGHT="6.407981570832445"/><DICH_DATA CI_END="7.848616069043482" CI_START="0.014156777466712338" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.8947930852084158" LOG_CI_START="-1.8490355946477406" LOG_EFFECT_SIZE="-0.47712125471966244" MODIFIED="2013-11-10 09:21:53 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="2858" O_E="0.0" SE="1.611738548718522" STUDY_ID="STD-Kawaguchi-2010" TOTAL_1="28" TOTAL_2="28" VAR="2.5977011494252875" WEIGHT="1.580001773728174"/></DICH_OUTCOME><DICH_OUTCOME CHI2="2.426010540963305" CI_END="4.019042421238696" CI_START="0.5761795319350466" CI_STUDY="95" CI_TOTAL="95" DF="3" EFFECT_MEASURE="RR" EFFECT_SIZE="1.5217391304347827" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="5" I2="0.0" I2_Q="0.0" ID="CMP-001.10" LOG_CI_END="0.6041225902210599" LOG_CI_START="-0.23944217355569433" LOG_EFFECT_SIZE="0.18234020833268277" METHOD="MH" MODIFIED="2017-12-08 14:29:45 +0000" MODIFIED_BY="Hermann Blessberger" NO="10" P_CHI2="0.48881134724772024" P_Q="1.0" P_Z="0.3968226120515944" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="YEAR" STUDIES="4" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="730" TOTAL_2="670" WEIGHT="100.0" Z="0.8473095525364256"><NAME>Cerebrovascular events&#8212;cardiac surgery</NAME><GROUP_LABEL_1>Beta-blocker</GROUP_LABEL_1><GROUP_LABEL_2>Control</GROUP_LABEL_2><GRAPH_LABEL_1>Favours beta-blocker</GRAPH_LABEL_1><GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2><DICH_DATA CI_END="71.21510406800243" CI_START="0.12637768515238015" EFFECT_SIZE="3.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.85257211326778" LOG_CI_START="-0.8983296038284552" LOG_EFFECT_SIZE="0.47712125471966244" MODIFIED="2013-11-10 09:30:14 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="2873" O_E="0.0" SE="1.6158932858054431" STUDY_ID="STD-Matangi-1989" TOTAL_1="35" TOTAL_2="35" VAR="2.611111111111111" WEIGHT="7.729468599033816"/><DICH_DATA CI_END="8.972003519367153" CI_START="0.6068259372270592" EFFECT_SIZE="2.3333333333333335" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="3" LOG_CI_END="0.9528894352677552" LOG_CI_START="-0.21693586467856624" LOG_EFFECT_SIZE="0.36797678529459443" MODIFIED="2013-11-10 09:30:23 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="2872" O_E="0.0" SE="0.6871611719170956" STUDY_ID="STD-Connolly-2003" TOTAL_1="500" TOTAL_2="500" VAR="0.47219047619047616" WEIGHT="46.3768115942029"/><DICH_DATA CI_END="4.226958759183164" CI_START="0.007212341146048458" EFFECT_SIZE="0.1746031746031746" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.6260280106048517" LOG_CI_START="-2.141923739195565" LOG_EFFECT_SIZE="-0.7579478642953567" MODIFIED="2013-11-17 15:03:35 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="3385" O_E="0.0" SE="1.6259085594149025" STUDY_ID="STD-Auer-2004" TOTAL_1="125" TOTAL_2="65" VAR="2.6435786435786435" WEIGHT="30.434782608695652"/><DICH_DATA CI_END="15.672973621805108" CI_START="0.06380410151451699" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.1951514026602095" LOG_CI_START="-1.1951514026602095" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-11-10 09:30:57 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="2874" O_E="0.0" SE="1.4040757000349275" STUDY_ID="STD-Sezai-2011" TOTAL_1="70" TOTAL_2="70" VAR="1.9714285714285715" WEIGHT="15.458937198067632"/></DICH_OUTCOME><DICH_OUTCOME CHI2="4.683815300243554" CI_END="2.707506832501573" CI_START="0.9342911560750178" CI_STUDY="95" CI_TOTAL="95" DF="4" EFFECT_MEASURE="RR" EFFECT_SIZE="1.590471530276133" ESTIMABLE="YES" EVENTS_1="34" EVENTS_2="21" I2="14.599535985289512" I2_Q="0.0" ID="CMP-001.11" LOG_CI_END="0.43256956125820256" LOG_CI_START="-0.02951776212954848" LOG_EFFECT_SIZE="0.20152589956432704" METHOD="MH" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" NO="11" P_CHI2="0.32130474413380594" P_Q="1.0" P_Z="0.08734686496500334" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="YEAR" STUDIES="5" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="4574" TOTAL_2="4576" WEIGHT="99.99999999999999" Z="1.7095621762671682"><NAME>Cerebrovascular events&#8212;non-cardiac surgery</NAME><GROUP_LABEL_1>Beta-blocker</GROUP_LABEL_1><GROUP_LABEL_2>Control</GROUP_LABEL_2><GRAPH_LABEL_1>Favours beta-blocker</GRAPH_LABEL_1><GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2><DICH_DATA CI_END="35.873486053427946" CI_START="0.4642145613500314" EFFECT_SIZE="4.08080808080808" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="1" LOG_CI_END="1.5547735818670396" LOG_CI_START="-0.3332812408409298" LOG_EFFECT_SIZE="0.610746170513055" MODIFIED="2013-11-10 09:33:45 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="2878" O_E="0.0" SE="1.1090527488807644" STUDY_ID="STD-Wallace-1998" TOTAL_1="99" TOTAL_2="101" VAR="1.22999799979998" WEIGHT="4.50605753253813"/><DICH_DATA CI_END="59.88076450297431" CI_START="0.10437408493155693" EFFECT_SIZE="2.5" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.7772873363821649" LOG_CI_START="-0.9814073190380896" LOG_EFFECT_SIZE="0.3979400086720376" MODIFIED="2013-11-10 09:33:52 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="2876" O_E="0.0" SE="1.620470896352639" STUDY_ID="STD-POBBLE-2005" TOTAL_1="53" TOTAL_2="44" VAR="2.6259259259259258" WEIGHT="2.482676326467289"/><DICH_DATA CI_END="3.675054697422891" CI_START="1.013518570917549" EFFECT_SIZE="1.9299575604079677" ESTIMABLE="YES" EVENTS_1="27" EVENTS_2="14" LOG_CI_END="0.5652638072602568" LOG_CI_START="0.005831710772613412" LOG_EFFECT_SIZE="0.2855477590164352" MODIFIED="2014-06-26 18:29:31 +0100" MODIFIED_BY="Hermann Blessberger" ORDER="2877" O_E="0.0" SE="0.328613182710381" STUDY_ID="STD-POISE-2008" TOTAL_1="4174" TOTAL_2="4177" VAR="0.10798662385104625" WEIGHT="63.69913431317078"/><DICH_DATA CI_END="4.065339018491121" CI_START="0.00983927781128726" EFFECT_SIZE="0.2" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" LOG_CI_END="0.609096768311561" LOG_CI_START="-2.0070367769835986" LOG_EFFECT_SIZE="-0.6989700043360187" MODIFIED="2013-11-10 09:33:59 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="2879" O_E="0.0" SE="1.536729794576282" STUDY_ID="STD-Yang-2008" TOTAL_1="51" TOTAL_2="51" VAR="2.3615384615384616" WEIGHT="11.378933162975075"/><DICH_DATA CI_END="2.781185502696919" CI_START="0.09544862473539373" EFFECT_SIZE="0.5152284263959391" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="4" LOG_CI_END="0.4442299569011446" LOG_CI_START="-1.020230324725867" LOG_EFFECT_SIZE="-0.28800018391236115" MODIFIED="2013-11-10 09:34:21 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="2875" O_E="0.0" SE="0.8602312186230142" STUDY_ID="STD-Marwick-2009" TOTAL_1="197" TOTAL_2="203" VAR="0.7399977494936361" WEIGHT="17.933198664848717"/></DICH_OUTCOME><DICH_OUTCOME CHI2="7.355265795537193" CI_END="0.5846514263301511" CI_START="0.2392699974281194" CI_STUDY="95" CI_TOTAL="95" DF="9" EFFECT_MEASURE="RR" EFFECT_SIZE="0.37401810821718456" ESTIMABLE="YES" EVENTS_1="22" EVENTS_2="62" I2="0.0" I2_Q="100.0" ID="CMP-001.12" LOG_CI_END="-0.2331029864655546" LOG_CI_START="-0.6211117550777583" LOG_EFFECT_SIZE="-0.42710737077165645" METHOD="MH" MODIFIED="2015-01-11 13:19:17 +0000" MODIFIED_BY="Hermann Blessberger" NO="12" P_CHI2="0.6001835178731718" P_Q="0.0" P_Z="1.5965450433027967E-5" Q="2.3728056889324606E-31" RANDOM="NO" SCALE="100.0" SORT_BY="YEAR" STUDIES="12" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="1143" TOTAL_2="1149" WEIGHT="100.00000000000001" Z="4.3149285890530935"><NAME>Ventricular arrhythmias&#8212;cardiac surgery</NAME><GROUP_LABEL_1>Beta-blocker</GROUP_LABEL_1><GROUP_LABEL_2>Control</GROUP_LABEL_2><GRAPH_LABEL_1>Favours beta-blocker</GRAPH_LABEL_1><GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2><DICH_DATA CI_END="2.100643308756804" CI_START="0.09496223068712434" EFFECT_SIZE="0.4466338259441708" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="7" LOG_CI_END="0.3223523150476611" LOG_CI_START="-1.0224490922450145" LOG_EFFECT_SIZE="-0.35004838859867665" MODIFIED="2013-11-10 10:18:44 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="2890" O_E="0.0" SE="0.7899430035180444" STUDY_ID="STD-Stephenson-1980" TOTAL_1="87" TOTAL_2="136" VAR="0.624009948807109" WEIGHT="8.914152498280892"/><DICH_DATA CI_END="2.2497616637862223" CI_START="0.007105757023518394" EFFECT_SIZE="0.12643678160919541" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="4" LOG_CI_END="0.3521365120735711" LOG_CI_START="-2.148389646994358" LOG_EFFECT_SIZE="-0.8981265674603934" MODIFIED="2013-11-10 10:18:35 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="2892" O_E="0.0" SE="1.4688214436406157" STUDY_ID="STD-Williams-1982" TOTAL_1="28" TOTAL_2="32" VAR="2.1574364332985025" WEIGHT="6.870470070679628"/><DICH_DATA CI_END="3.163518593329961" CI_START="0.11752815339751992" EFFECT_SIZE="0.6097560975609756" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="4" LOG_CI_END="0.5001703913340872" LOG_CI_START="-0.929858087429483" LOG_EFFECT_SIZE="-0.2148438480476979" MODIFIED="2013-11-10 10:19:01 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="2880" O_E="0.0" SE="0.8400058071808557" STUDY_ID="STD-Abel-1983" TOTAL_1="41" TOTAL_2="50" VAR="0.7056097560975609" WEIGHT="5.882610389345328"/><DICH_DATA CI_END="1.2109704352624893" CI_START="0.20023745210140398" EFFECT_SIZE="0.49242424242424243" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="11" LOG_CI_END="0.08313354036923343" LOG_CI_START="-0.6984546894952222" LOG_EFFECT_SIZE="-0.3076605745629943" MODIFIED="2013-11-10 10:18:18 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="2884" O_E="0.0" SE="0.4591087951465162" STUDY_ID="STD-Hammon-1984" TOTAL_1="24" TOTAL_2="26" VAR="0.21078088578088577" WEIGHT="17.234613657760022"/><DICH_DATA CI_END="1.1353041994287865" CI_START="0.017975942725812367" EFFECT_SIZE="0.14285714285714285" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="7" LOG_CI_END="0.05511224428890028" LOG_CI_START="-1.745308324317414" LOG_EFFECT_SIZE="-0.8450980400142568" MODIFIED="2013-11-10 10:16:46 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="2886" O_E="0.0" SE="1.0575759542248981" STUDY_ID="STD-Matangi-1985" TOTAL_1="82" TOTAL_2="82" VAR="1.1184668989547037" WEIGHT="11.424459811015165"/><DICH_DATA CI_END="0.8881346973235159" CI_START="0.14888665577098886" EFFECT_SIZE="0.36363636363636365" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="11" LOG_CI_END="-0.05152116274832839" LOG_CI_START="-0.8271442249121969" LOG_EFFECT_SIZE="-0.43933269383026263" MODIFIED="2013-11-10 10:17:54 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="2885" O_E="0.0" SE="0.45560482611113506" STUDY_ID="STD-Harrison-1987" TOTAL_1="15" TOTAL_2="15" VAR="0.20757575757575764" WEIGHT="17.952722560166688"/><DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-11-10 10:16:41 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="2887" O_E="0.0" SE="0.0" STUDY_ID="STD-Matangi-1989" TOTAL_1="35" TOTAL_2="35" VAR="0.0" WEIGHT="0.0"/><DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-11-10 10:16:16 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="2888" O_E="0.0" SE="0.0" STUDY_ID="STD-Nystr_x00f6_m-1993" TOTAL_1="50" TOTAL_2="51" VAR="0.0" WEIGHT="0.0"/><DICH_DATA CI_END="105.56063520158432" CI_START="0.2481517124265242" EFFECT_SIZE="5.118110236220472" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="0" LOG_CI_END="2.0235019948836785" LOG_CI_START="-0.6052827235098813" LOG_EFFECT_SIZE="0.7091096356868987" MODIFIED="2013-11-10 10:19:13 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="2889" O_E="0.0" SE="1.5441611562785993" STUDY_ID="STD-Pfisterer-1997" TOTAL_1="126" TOTAL_2="129" VAR="2.3844336765596608" WEIGHT="0.8065071684263069"/><DICH_DATA CI_END="1.368626413931854" CI_START="0.059645679953455225" EFFECT_SIZE="0.2857142857142857" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="7" LOG_CI_END="0.13628491744763105" LOG_CI_START="-1.2244210061481822" LOG_EFFECT_SIZE="-0.5440680443502757" MODIFIED="2013-11-25 13:12:36 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="2883" O_E="0.0" SE="0.799285395123133" STUDY_ID="STD-Connolly-2003" TOTAL_1="500" TOTAL_2="500" VAR="0.6388571428571428" WEIGHT="11.424459811015165"/><DICH_DATA CI_END="4.5514705860751805" CI_START="0.13367108245439305" EFFECT_SIZE="0.78" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="2" LOG_CI_END="0.6581517404437857" LOG_CI_START="-0.8739625350628248" LOG_EFFECT_SIZE="-0.10790539730951958" MODIFIED="2013-11-17 15:05:21 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="3386" O_E="0.0" SE="0.8999715095205614" STUDY_ID="STD-Auer-2004" TOTAL_1="125" TOTAL_2="65" VAR="0.8099487179487179" WEIGHT="4.29490970338916"/><DICH_DATA CI_END="0.7668557273673595" CI_START="0.014024095769338475" EFFECT_SIZE="0.1037037037037037" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="9" LOG_CI_END="-0.11528633448889981" LOG_CI_START="-1.8531251311446366" LOG_EFFECT_SIZE="-0.9842057328167682" MODIFIED="2013-11-10 10:17:26 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="2891" O_E="0.0" SE="1.0208151115963615" STUDY_ID="STD-Sun-2011" TOTAL_1="30" TOTAL_2="28" VAR="1.042063492063492" WEIGHT="15.195094329921647"/></DICH_OUTCOME><DICH_OUTCOME CHI2="7.314150194211838" CI_END="1.4854864070834266" CI_START="0.3079724159034136" CI_STUDY="95" CI_TOTAL="95" DF="4" EFFECT_MEASURE="RR" EFFECT_SIZE="0.6763792113756636" ESTIMABLE="YES" EVENTS_1="22" EVENTS_2="24" I2="45.31148672383759" I2_Q="0.0" ID="CMP-001.13" LOG_CI_END="0.17186868215404175" LOG_CI_START="-0.511488180114516" LOG_EFFECT_SIZE="-0.16980974898023712" METHOD="MH" MODIFIED="2017-12-04 01:55:13 +0000" MODIFIED_BY="Hermann Blessberger" NO="13" P_CHI2="0.1201893406969895" P_Q="1.0" P_Z="0.3300184793029065" Q="0.0" RANDOM="YES" SCALE="100.0" SORT_BY="YEAR" STUDIES="5" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.3417712420654909" TOTALS="YES" TOTAL_1="249" TOTAL_2="227" WEIGHT="100.0" Z="0.9740766811653208"><NAME>Ventricular arrhythmias&#8212;non-cardiac surgery</NAME><GROUP_LABEL_1>Beta-blocker</GROUP_LABEL_1><GROUP_LABEL_2>Control</GROUP_LABEL_2><GRAPH_LABEL_1>Favours beta-blocker</GRAPH_LABEL_1><GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2><DICH_DATA CI_END="0.698737197573076" CI_START="0.08944707712296021" EFFECT_SIZE="0.25" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="8" LOG_CI_END="-0.1556861362780481" LOG_CI_START="-1.0484338463778766" LOG_EFFECT_SIZE="-0.6020599913279624" MODIFIED="2014-04-07 21:25:17 +0100" MODIFIED_BY="Hermann Blessberger" ORDER="2896" O_E="0.0" SE="0.5244044240850758" STUDY_ID="STD-Sandler-1990" TOTAL_1="30" TOTAL_2="15" VAR="0.275" WEIGHT="26.124392981803567"/><DICH_DATA CI_END="3.6746104414217298" CI_START="0.37928140736840954" EFFECT_SIZE="1.1805555555555556" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="4" LOG_CI_END="0.5652113047512454" LOG_CI_START="-0.4210384461851969" LOG_EFFECT_SIZE="0.07208642928302428" MODIFIED="2013-12-09 12:39:24 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="2894" O_E="0.0" SE="0.5793279857150695" STUDY_ID="STD-Jakobsen-1997" TOTAL_1="18" TOTAL_2="17" VAR="0.33562091503267977" WEIGHT="23.786478982305145"/><DICH_DATA CI_END="3.9833644750180848" CI_START="0.11612876150877542" EFFECT_SIZE="0.6801346801346801" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="3" LOG_CI_END="0.6002500458638188" LOG_CI_START="-0.9350602056049961" LOG_EFFECT_SIZE="-0.16740507987058859" MODIFIED="2013-12-09 12:28:38 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="2898" O_E="0.0" SE="0.9018488416210964" STUDY_ID="STD-Wallace-1998" TOTAL_1="99" TOTAL_2="101" VAR="0.8133313331333133" WEIGHT="13.949215120415445"/><DICH_DATA CI_END="4.14361531793994" CI_START="0.010043403358372081" EFFECT_SIZE="0.204" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" LOG_CI_END="0.6173794298813183" LOG_CI_START="-1.998119095029521" LOG_EFFECT_SIZE="-0.6903698325741012" MODIFIED="2013-12-09 12:28:30 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="2893" O_E="0.0" SE="1.5363567804591305" STUDY_ID="STD-Bayliff-1999" TOTAL_1="49" TOTAL_2="50" VAR="2.360392156862745" WEIGHT="5.962916348428381"/><DICH_DATA CI_END="3.080458562544285" CI_START="0.5524939578722114" EFFECT_SIZE="1.3045822102425877" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="7" LOG_CI_END="0.4886153711624102" LOG_CI_START="-0.25767246710367697" LOG_EFFECT_SIZE="0.11547145202936662" MODIFIED="2014-04-07 21:25:16 +0100" MODIFIED_BY="Hermann Blessberger" ORDER="2895" O_E="0.0" SE="0.4383731703818781" STUDY_ID="STD-POBBLE-2005" TOTAL_1="53" TOTAL_2="44" VAR="0.19217103651065914" WEIGHT="30.176996567047464"/></DICH_OUTCOME><DICH_OUTCOME CHI2="73.87854420491638" CI_END="0.5656392760817595" CI_START="0.4016037582417624" CI_STUDY="95" CI_TOTAL="95" DF="35" EFFECT_MEASURE="RR" EFFECT_SIZE="0.4766160499643129" ESTIMABLE="YES" EVENTS_1="495" EVENTS_2="862" I2="52.62494628627121" I2_Q="0.0" ID="CMP-001.14" LOG_CI_END="-0.24746044222147956" LOG_CI_START="-0.39620223167971536" LOG_EFFECT_SIZE="-0.3218313369505975" METHOD="MH" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" NO="14" P_CHI2="1.351513206526711E-4" P_Q="1.0" P_Z="2.2228116486013427E-17" Q="0.0" RANDOM="YES" SCALE="100.0" SORT_BY="YEAR" STUDIES="36" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.10950941230710698" TOTALS="YES" TOTAL_1="2759" TOTAL_2="2613" WEIGHT="100.00000000000004" Z="8.481514600799631"><NAME>Atrial fibrillation and flutter&#8212;cardiac surgery</NAME><GROUP_LABEL_1>Beta-blocker</GROUP_LABEL_1><GROUP_LABEL_2>Control</GROUP_LABEL_2><GRAPH_LABEL_1>Favours beta-blocker</GRAPH_LABEL_1><GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2><DICH_DATA CI_END="22.44975451350426" CI_START="0.2155925579092004" EFFECT_SIZE="2.2" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="1" LOG_CI_END="1.3512115963855165" LOG_CI_START="-0.6663662347411039" LOG_EFFECT_SIZE="0.3424226808222063" MODIFIED="2013-11-10 10:42:08 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="2927" O_E="0.0" SE="1.1851352051751118" STUDY_ID="STD-Salazar-1979" TOTAL_1="20" TOTAL_2="22" VAR="1.4045454545454545" WEIGHT="0.5041962305607683"/><DICH_DATA CI_END="1.0124518038855774" CI_START="0.20532344839946126" EFFECT_SIZE="0.4559386973180077" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="24" LOG_CI_END="0.00537435849931325" LOG_CI_START="-0.6875614503908136" LOG_EFFECT_SIZE="-0.3410935459457502" MODIFIED="2013-11-10 10:41:38 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="2935" O_E="0.0" SE="0.4070339242296343" STUDY_ID="STD-Stephenson-1980" TOTAL_1="87" TOTAL_2="136" VAR="0.16567661547377568" WEIGHT="2.774053475335204"/><DICH_DATA CI_END="1.4875364844811094" CI_START="0.02439011043885608" EFFECT_SIZE="0.19047619047619047" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="6" LOG_CI_END="0.17246762637672552" LOG_CI_START="-1.6127862331886396" LOG_EFFECT_SIZE="-0.7201593034059569" MODIFIED="2013-11-10 10:40:30 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="2934" O_E="0.0" SE="1.048666954257824" STUDY_ID="STD-Williams-1982" TOTAL_1="28" TOTAL_2="32" VAR="1.099702380952381" WEIGHT="0.6313044257296881"/><DICH_DATA CI_END="0.6999722648647813" CI_START="0.0656002668274423" EFFECT_SIZE="0.21428571428571427" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="14" LOG_CI_END="-0.15491916777833195" LOG_CI_START="-1.1830943941388192" LOG_EFFECT_SIZE="-0.6690067809585756" MODIFIED="2013-11-10 10:40:46 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="2930" O_E="0.0" SE="0.603955217513604" STUDY_ID="STD-Silverman-1982" TOTAL_1="50" TOTAL_2="50" VAR="0.36476190476190473" WEIGHT="1.6095866000223817"/><DICH_DATA CI_END="0.9290042098937271" CI_START="0.1778738493698285" EFFECT_SIZE="0.4065040650406504" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="18" LOG_CI_END="-0.03198231794449341" LOG_CI_START="-0.7498878962622648" LOG_EFFECT_SIZE="-0.39093510710337914" MODIFIED="2013-11-10 10:42:37 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="2899" O_E="0.0" SE="0.4217012903937848" STUDY_ID="STD-Abel-1983" TOTAL_1="41" TOTAL_2="50" VAR="0.1778319783197832" WEIGHT="2.656703077352644"/><DICH_DATA CI_END="1.5715363292104452" CI_START="0.18776337809660357" EFFECT_SIZE="0.5432098765432098" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="9" LOG_CI_END="0.19632442505659703" LOG_CI_START="-0.7263891098415217" LOG_EFFECT_SIZE="-0.2650323423924623" MODIFIED="2013-11-10 10:40:57 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="2921" O_E="0.0" SE="0.5420064979048165" STUDY_ID="STD-Ormerod-1984" TOTAL_1="27" TOTAL_2="33" VAR="0.2937710437710438" WEIGHT="1.892927726161155"/><DICH_DATA CI_END="1.3632093309631186" CI_START="0.12220958833054184" EFFECT_SIZE="0.40816326530612246" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="7" LOG_CI_END="0.134562550113297" LOG_CI_START="-0.912894718842362" LOG_EFFECT_SIZE="-0.3891660843645325" MODIFIED="2013-11-10 10:44:12 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="2933" O_E="0.0" SE="0.615281584781658" STUDY_ID="STD-White-1984" TOTAL_1="21" TOTAL_2="20" VAR="0.37857142857142856" WEIGHT="1.5640457333977251"/><DICH_DATA CI_END="1.0292435704622704" CI_START="0.21516120532846186" EFFECT_SIZE="0.47058823529411764" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="17" LOG_CI_END="0.012518162702335212" LOG_CI_START="-0.667236031474996" LOG_EFFECT_SIZE="-0.32735893438633035" MODIFIED="2013-11-10 10:35:55 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="2916" O_E="0.0" SE="0.39929097849729295" STUDY_ID="STD-Matangi-1985" TOTAL_1="82" TOTAL_2="82" VAR="0.15943328550932567" WEIGHT="2.838451324119216"/><DICH_DATA CI_END="0.7102222721256239" CI_START="0.04268142296235359" EFFECT_SIZE="0.17410714285714285" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="14" LOG_CI_END="-0.148605712617911" LOG_CI_START="-1.3697611099974163" LOG_EFFECT_SIZE="-0.7591834113076636" MODIFIED="2013-11-10 10:42:25 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="2917" O_E="0.0" SE="0.717312725237428" STUDY_ID="STD-Materne-1985" TOTAL_1="32" TOTAL_2="39" VAR="0.5145375457875457" WEIGHT="1.2232745418069344"/><DICH_DATA CI_END="0.3925291896546882" CI_START="0.0015155153127434649" EFFECT_SIZE="0.024390243902439025" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="20" LOG_CI_END="-0.4061280422700622" LOG_CI_START="-2.819439671169409" LOG_EFFECT_SIZE="-1.6127838567197355" MODIFIED="2013-11-10 10:39:10 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="2905" O_E="0.0" SE="1.4175911969007033" STUDY_ID="STD-Daudon-1986" TOTAL_1="50" TOTAL_2="50" VAR="2.0095648015303684" WEIGHT="0.3602425775106882"/><DICH_DATA CI_END="2.1367282344833174" CI_START="0.23877818123933087" EFFECT_SIZE="0.7142857142857143" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="7" LOG_CI_END="0.3297492887669275" LOG_CI_START="-0.6220053601234036" LOG_EFFECT_SIZE="-0.146128035678238" MODIFIED="2013-11-10 10:43:59 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="2932" O_E="0.0" SE="0.5590653920196748" STUDY_ID="STD-Vecht-1986" TOTAL_1="66" TOTAL_2="66" VAR="0.3125541125541126" WEIGHT="1.80868687238552"/><DICH_DATA CI_END="0.5762909029931246" CI_START="0.1149255280418162" EFFECT_SIZE="0.25735294117647056" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="17" LOG_CI_END="-0.23935823589507993" LOG_CI_START="-0.939583492144804" LOG_EFFECT_SIZE="-0.589470864019942" MODIFIED="2013-11-17 15:06:52 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="3388" O_E="0.0" SE="0.411315781692008" STUDY_ID="STD-Janssen-1986" TOTAL_1="80" TOTAL_2="50" VAR="0.16918067226890757" WEIGHT="2.73917444135344"/><DICH_DATA CI_END="0.9962321240462663" CI_START="0.1877050579938394" EFFECT_SIZE="0.43243243243243246" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="15" LOG_CI_END="-0.0016394583162494887" LOG_CI_START="-0.7265240245058909" LOG_EFFECT_SIZE="-0.3640817414110702" MODIFIED="2013-11-10 10:41:53 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="2925" O_E="0.0" SE="0.42580078241626834" STUDY_ID="STD-Rubin-1987" TOTAL_1="37" TOTAL_2="40" VAR="0.18130630630630631" WEIGHT="2.624963878737324"/><DICH_DATA CI_END="4.126826287091888" CI_START="0.7815504113324163" EFFECT_SIZE="1.7959183673469388" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="7" LOG_CI_END="0.6156161882509973" LOG_CI_START="-0.10704300400768743" LOG_EFFECT_SIZE="0.25428659212165494" MODIFIED="2013-11-10 10:38:32 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="2915" O_E="0.0" SE="0.4244935867534458" STUDY_ID="STD-Martinussen-1988" TOTAL_1="35" TOTAL_2="40" VAR="0.18019480519480519" WEIGHT="2.6350350136832534"/><DICH_DATA CI_END="0.7332835516809254" CI_START="0.013637289391091267" EFFECT_SIZE="0.1" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="10" LOG_CI_END="-0.13472805657581619" LOG_CI_START="-1.8652719434241833" LOG_EFFECT_SIZE="-1.0" MODIFIED="2013-11-10 10:38:21 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="2914" O_E="0.0" SE="1.016530045465127" STUDY_ID="STD-Lamb-1988" TOTAL_1="30" TOTAL_2="30" VAR="1.0333333333333332" WEIGHT="0.6679665768902044"/><DICH_DATA CI_END="0.8286815540491059" CI_START="0.3432493978592757" EFFECT_SIZE="0.5333333333333333" ESTIMABLE="YES" EVENTS_1="24" EVENTS_2="45" LOG_CI_END="-0.08161232818157535" LOG_CI_START="-0.46439021594589996" LOG_EFFECT_SIZE="-0.27300127206373764" MODIFIED="2013-11-10 10:43:36 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="2936" O_E="0.0" SE="0.22484562605386735" STUDY_ID="STD-Suttorp-1991" TOTAL_1="150" TOTAL_2="150" VAR="0.05055555555555555" WEIGHT="4.7691932027515"/><DICH_DATA CI_END="0.8651318953082401" CI_START="0.13362124391311758" EFFECT_SIZE="0.34" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="15" LOG_CI_END="-0.06291767630644172" LOG_CI_START="-0.8741244896090479" LOG_EFFECT_SIZE="-0.46852108295774486" MODIFIED="2013-11-10 10:35:40 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="2919" O_E="0.0" SE="0.4765068976724385" STUDY_ID="STD-Nystr_x00f6_m-1993" TOTAL_1="50" TOTAL_2="51" VAR="0.22705882352941176" WEIGHT="2.2681307249090623"/><DICH_DATA CI_END="63.82881484401465" CI_START="0.12392766917779852" EFFECT_SIZE="2.8125" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.8050167806434498" LOG_CI_START="-0.9068317184046119" LOG_EFFECT_SIZE="0.4490925311194189" MODIFIED="2013-11-10 10:37:05 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="2904" O_E="0.0" SE="1.592953232207399" STUDY_ID="STD-Cork-1995" TOTAL_1="15" TOTAL_2="14" VAR="2.5374999999999996" WEIGHT="0.28839366916489073"/><DICH_DATA CI_END="0.967053167072245" CI_START="0.41868044849390096" EFFECT_SIZE="0.6363067292644757" ESTIMABLE="YES" EVENTS_1="38" EVENTS_2="30" LOG_CI_END="-0.014549648428526057" LOG_CI_START="-0.37811731928423464" LOG_EFFECT_SIZE="-0.19633348385638036" MODIFIED="2013-11-10 10:39:57 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="2911" O_E="0.0" SE="0.213561449549639" STUDY_ID="STD-Graham-1996" TOTAL_1="213" TOTAL_2="107" VAR="0.045608492733743004" WEIGHT="4.921293621959455"/><DICH_DATA CI_END="0.8367549673280018" CI_START="0.38960932218699135" EFFECT_SIZE="0.5709706959706959" ESTIMABLE="YES" EVENTS_1="29" EVENTS_2="52" LOG_CI_END="-0.07740170080856265" LOG_CI_START="-0.40937066029975144" LOG_EFFECT_SIZE="-0.24338618055415703" MODIFIED="2013-11-10 10:43:48 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="2924" O_E="0.0" SE="0.19500021007797613" STUDY_ID="STD-Pfisterer-1997" TOTAL_1="126" TOTAL_2="129" VAR="0.03802508193045483" WEIGHT="5.174252710691796"/><DICH_DATA CI_END="1.8214515190598082" CI_START="0.4677977958792884" EFFECT_SIZE="0.9230769230769231" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="13" LOG_CI_END="0.26041761626692334" LOG_CI_START="-0.32994182878534717" LOG_EFFECT_SIZE="-0.03476210625921192" MODIFIED="2013-11-10 10:44:24 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="2923" O_E="0.0" SE="0.3467800603500874" STUDY_ID="STD-Paull-1997" TOTAL_1="50" TOTAL_2="50" VAR="0.12025641025641025" WEIGHT="3.322429542445182"/><DICH_DATA CI_END="0.7316733754295464" CI_START="0.276762838173683" EFFECT_SIZE="0.45" ESTIMABLE="YES" EVENTS_1="18" EVENTS_2="40" LOG_CI_END="-0.13568274804766128" LOG_CI_START="-0.5578922244016514" LOG_EFFECT_SIZE="-0.3467874862246563" MODIFIED="2013-11-10 10:42:55 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="2900" O_E="0.0" SE="0.2480079363809483" STUDY_ID="STD-Ali-1997" TOTAL_1="105" TOTAL_2="105" VAR="0.061507936507936505" WEIGHT="4.463762080388986"/><DICH_DATA CI_END="0.7899548058160761" CI_START="0.21326202895259727" EFFECT_SIZE="0.41044776119402987" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="24" LOG_CI_END="-0.10239775446416542" LOG_CI_START="-0.6710864632769621" LOG_EFFECT_SIZE="-0.38674210887056376" MODIFIED="2013-11-10 10:37:52 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="2907" O_E="0.0" SE="0.33405056261114596" STUDY_ID="STD-Dy-1998" TOTAL_1="67" TOTAL_2="66" VAR="0.11158977838082317" WEIGHT="3.452661922253343"/><DICH_DATA CI_END="0.815131215366541" CI_START="0.13431350612509407" EFFECT_SIZE="0.33088235294117646" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="17" LOG_CI_END="-0.08877247528121683" LOG_CI_START="-0.8718803139085308" LOG_EFFECT_SIZE="-0.48032639459487386" MODIFIED="2013-11-10 10:40:15 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="2910" O_E="0.0" SE="0.460001420856004" STUDY_ID="STD-Gomes-1999" TOTAL_1="40" TOTAL_2="45" VAR="0.2116013071895425" WEIGHT="2.377313214351328"/><DICH_DATA CI_END="0.559711576637503" CI_START="0.20705225265439542" EFFECT_SIZE="0.3404255319148936" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="47" LOG_CI_END="-0.2520357103921946" LOG_CI_START="-0.6839200401673907" LOG_EFFECT_SIZE="-0.4679778752797927" MODIFIED="2013-11-10 10:38:08 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="2908" O_E="0.0" SE="0.2536909931718616" STUDY_ID="STD-Evrard-2000" TOTAL_1="103" TOTAL_2="103" VAR="0.06435912001652552" WEIGHT="4.390563068125051"/><DICH_DATA CI_END="0.925811812744811" CI_START="0.17282129888323441" EFFECT_SIZE="0.4" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="15" LOG_CI_END="-0.03347728220825417" LOG_CI_START="-0.762402735135821" LOG_EFFECT_SIZE="-0.3979400086720376" MODIFIED="2013-11-10 10:38:50 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="2918" O_E="0.0" SE="0.42817441928883765" STUDY_ID="STD-Matsuura-2001" TOTAL_1="40" TOTAL_2="40" VAR="0.18333333333333335" WEIGHT="2.606794151788706"/><DICH_DATA CI_END="0.7105931245191439" CI_START="0.13488819843100122" EFFECT_SIZE="0.30959752321981426" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="19" LOG_CI_END="-0.14837899892640086" LOG_CI_START="-0.8700260457358048" LOG_EFFECT_SIZE="-0.5092025223311029" MODIFIED="2013-11-10 10:39:46 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="2909" O_E="0.0" SE="0.4238990475063375" STUDY_ID="STD-Forlani-2002" TOTAL_1="51" TOTAL_2="50" VAR="0.17969040247678017" WEIGHT="2.639630863179168"/><DICH_DATA CI_END="0.9484074945855946" CI_START="0.674815418112704" EFFECT_SIZE="0.8" ESTIMABLE="YES" EVENTS_1="156" EVENTS_2="195" LOG_CI_END="-0.023005022761850884" LOG_CI_START="-0.17081500325426194" LOG_EFFECT_SIZE="-0.09691001300805639" MODIFIED="2013-11-10 10:37:23 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="2903" O_E="0.0" SE="0.08682431421244592" STUDY_ID="STD-Connolly-2003" TOTAL_1="500" TOTAL_2="500" VAR="0.007538461538461539" WEIGHT="6.521953211524734"/><DICH_DATA CI_END="0.8846657886054342" CI_START="0.2374562768789701" EFFECT_SIZE="0.4583333333333333" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="24" LOG_CI_END="-0.05322076724324717" LOG_CI_START="-0.6244163458635148" LOG_EFFECT_SIZE="-0.338818556553381" MODIFIED="2013-11-10 10:37:37 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="2906" O_E="0.0" SE="0.3355231103452601" STUDY_ID="STD-De-Azevedo-L_x00fa_cio-2003" TOTAL_1="100" TOTAL_2="100" VAR="0.11257575757575758" WEIGHT="3.437333330865276"/><DICH_DATA CI_END="0.9248471633511364" CI_START="0.48330986222891537" EFFECT_SIZE="0.6685714285714286" ESTIMABLE="YES" EVENTS_1="45" EVENTS_2="35" LOG_CI_END="-0.0339300311501147" LOG_CI_START="-0.3157743427301508" LOG_EFFECT_SIZE="-0.17485218694013277" MODIFIED="2013-11-17 15:08:32 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="3387" O_E="0.0" SE="0.16555674377395627" STUDY_ID="STD-Auer-2004" TOTAL_1="125" TOTAL_2="65" VAR="0.027409035409035408" WEIGHT="5.575441216744429"/><DICH_DATA CI_END="0.6324601313324618" CI_START="0.13450562372243266" EFFECT_SIZE="0.2916666666666667" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="24" LOG_CI_END="-0.1989668461016144" LOG_CI_START="-0.871259557293084" LOG_EFFECT_SIZE="-0.5351132016973492" MODIFIED="2013-11-10 10:44:52 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="2928" O_E="0.0" SE="0.39490806645646137" STUDY_ID="STD-Sezai-2011" TOTAL_1="70" TOTAL_2="70" VAR="0.15595238095238093" WEIGHT="2.8756709105142133"/><DICH_DATA CI_END="1.6818496358282289" CI_START="0.42805642238869207" EFFECT_SIZE="0.8484848484848485" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="11" LOG_CI_END="0.22578716551115877" LOG_CI_START="-0.3684989825824953" LOG_EFFECT_SIZE="-0.07135590853566824" MODIFIED="2013-11-10 10:45:13 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="2931" O_E="0.0" SE="0.3490866251540896" STUDY_ID="STD-Sun-2011" TOTAL_1="30" TOTAL_2="28" VAR="0.12186147186147188" WEIGHT="3.2993812487358674"/><DICH_DATA CI_END="0.7482025935275345" CI_START="0.1529700826342874" EFFECT_SIZE="0.3383084577114428" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="12" LOG_CI_END="-0.12598079072115415" LOG_CI_START="-0.8153934987073509" LOG_EFFECT_SIZE="-0.47068714471425255" MODIFIED="2013-11-10 10:45:04 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="2929" O_E="0.0" SE="0.404964437319035" STUDY_ID="STD-Sezai-2012" TOTAL_1="67" TOTAL_2="34" VAR="0.1639961954931226" WEIGHT="2.791097275368577"/><DICH_DATA CI_END="0.8263453347887832" CI_START="0.17017703625802433" EFFECT_SIZE="0.375" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="16" LOG_CI_END="-0.0828384204148983" LOG_CI_START="-0.7690990441296639" LOG_EFFECT_SIZE="-0.42596873227228116" MODIFIED="2013-11-10 10:44:40 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="2926" O_E="0.0" SE="0.4031128874149275" STUDY_ID="STD-Sakaguchi-2012" TOTAL_1="30" TOTAL_2="30" VAR="0.1625" WEIGHT="2.8064497851543724"/><DICH_DATA CI_END="0.5360855287701065" CI_START="0.05040605255789461" EFFECT_SIZE="0.1643835616438356" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="17" LOG_CI_END="-0.27076591607279954" LOG_CI_START="-1.2975173120728625" LOG_EFFECT_SIZE="-0.7841416140728311" MODIFIED="2013-11-10 10:45:23 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="2922" O_E="0.0" SE="0.6031188525118167" STUDY_ID="STD-Osada-2012" TOTAL_1="73" TOTAL_2="68" VAR="0.36375235025517055" WEIGHT="1.6130201447001382"/><DICH_DATA CI_END="0.9285567066549609" CI_START="0.2912046168662018" EFFECT_SIZE="0.52" ESTIMABLE="YES" EVENTS_1="13" EVENTS_2="25" LOG_CI_END="-0.032191568892075674" LOG_CI_START="-0.5358017438383259" LOG_EFFECT_SIZE="-0.28399665636520083" MODIFIED="2013-11-10 10:45:33 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="2920" O_E="0.0" SE="0.29582310967399855" STUDY_ID="STD-Ogawa-2013" TOTAL_1="68" TOTAL_2="68" VAR="0.08751131221719458" WEIGHT="3.874621609337794"/></DICH_OUTCOME><DICH_OUTCOME CHI2="1.783444442082041" CI_END="0.9492519881687377" CI_START="0.5625349250530547" CI_STUDY="95" CI_TOTAL="95" DF="2" EFFECT_MEASURE="RR" EFFECT_SIZE="0.7307444122406711" ESTIMABLE="YES" EVENTS_1="94" EVENTS_2="129" I2="0.0" I2_Q="0.0" ID="CMP-001.15" LOG_CI_END="-0.022618484575515598" LOG_CI_START="-0.24985050915088258" LOG_EFFECT_SIZE="-0.13623449686319916" METHOD="MH" MODIFIED="2017-06-17 15:33:56 +0100" MODIFIED_BY="Hermann Blessberger" NO="15" P_CHI2="0.4099491604941542" P_Q="1.0" P_Z="0.018765830949606287" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="YEAR" STUDIES="3" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="4253" TOTAL_2="4257" WEIGHT="100.0" Z="2.350150317084759"><NAME>Atrial fibrillation and flutter&#8212;non-cardiac surgery</NAME><GROUP_LABEL_1>Beta-blocker</GROUP_LABEL_1><GROUP_LABEL_2>Control</GROUP_LABEL_2><GRAPH_LABEL_1>Favours beta-blocker</GRAPH_LABEL_1><GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2><DICH_DATA CI_END="2.4240530226292014" CI_START="0.15463515508026482" EFFECT_SIZE="0.6122448979591837" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="5" LOG_CI_END="0.38454211515738" LOG_CI_START="-0.8106917657750824" LOG_EFFECT_SIZE="-0.21307482530885122" MODIFIED="2013-11-10 10:48:42 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="2937" O_E="0.0" SE="0.7020862981628592" STUDY_ID="STD-Bayliff-1999" TOTAL_1="49" TOTAL_2="50" VAR="0.49292517006802716" WEIGHT="3.824768691477397"/><DICH_DATA CI_END="1.9774190029426781" CI_START="0.006243329812231785" EFFECT_SIZE="0.1111111111111111" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="4" LOG_CI_END="0.29609870339830113" LOG_CI_START="-2.204583722276951" LOG_EFFECT_SIZE="-0.9542425094393249" MODIFIED="2013-11-10 10:48:49 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="2938" O_E="0.0" SE="1.4689132354192893" STUDY_ID="STD-Lai-2006" TOTAL_1="30" TOTAL_2="30" VAR="2.1577060931899643" WEIGHT="3.4774172490881226"/><DICH_DATA CI_END="0.9931562131790224" CI_START="0.5798648580922154" EFFECT_SIZE="0.7588783740616515" ESTIMABLE="YES" EVENTS_1="91" EVENTS_2="120" LOG_CI_END="-0.002982436110955725" LOG_CI_START="-0.23667321027073493" LOG_EFFECT_SIZE="-0.11982782319084534" MODIFIED="2013-11-10 10:49:15 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="2939" O_E="0.0" SE="0.13727111752944285" STUDY_ID="STD-POISE-2008" TOTAL_1="4174" TOTAL_2="4177" VAR="0.01884335970778211" WEIGHT="92.69781405943448"/></DICH_OUTCOME><DICH_OUTCOME CHI2="201.4098315239206" CI_END="0.5322393932735517" CI_START="0.36078792794371006" CI_STUDY="95" CI_TOTAL="95" DF="47" EFFECT_MEASURE="RR" EFFECT_SIZE="0.43820719741827857" ESTIMABLE="YES" EVENTS_1="572" EVENTS_2="1089" I2="76.664495648308" I2_Q="0.0" ID="CMP-001.16" LOG_CI_END="-0.2738929846358436" LOG_CI_START="-0.44274800249136015" LOG_EFFECT_SIZE="-0.35832049356360185" METHOD="MH" MODIFIED="2015-01-11 13:21:12 +0000" MODIFIED_BY="Hermann Blessberger" NO="16" P_CHI2="-2.220446049250313E-16" P_Q="1.0" P_Z="8.921684780059E-17" Q="0.0" RANDOM="YES" SCALE="255.91" SORT_BY="YEAR" STUDIES="48" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.27296219376516123" TOTALS="YES" TOTAL_1="3260" TOTAL_2="3160" WEIGHT="99.99999999999999" Z="8.318322679734708"><NAME>All supraventricular arrhythmias&#8212;cardiac surgery</NAME><GROUP_LABEL_1>Beta-blocker</GROUP_LABEL_1><GROUP_LABEL_2>Control</GROUP_LABEL_2><GRAPH_LABEL_1>Favours beta-blockers</GRAPH_LABEL_1><GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2><DICH_DATA CI_END="2.4143738176207648" CI_START="0.18041945154510514" EFFECT_SIZE="0.66" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="5" LOG_CI_END="0.38280451280407934" LOG_CI_START="-0.7437166417203419" LOG_EFFECT_SIZE="-0.1804560644581313" MODIFIED="2013-11-10 11:46:36 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="2980" O_E="0.0" SE="0.6617241025372945" STUDY_ID="STD-Salazar-1979" TOTAL_1="20" TOTAL_2="22" VAR="0.43787878787878787" WEIGHT="1.383982785455696"/><DICH_DATA CI_END="0.8969131509065325" CI_START="0.05911511257256819" EFFECT_SIZE="0.23026315789473684" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="16" LOG_CI_END="-0.047249608135544637" LOG_CI_START="-1.2283014790534492" LOG_EFFECT_SIZE="-0.637775543594497" MODIFIED="2013-11-10 11:46:45 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="2973" O_E="0.0" SE="0.6937557152782261" STUDY_ID="STD-Oka-1980" TOTAL_1="19" TOTAL_2="35" VAR="0.48129699248120306" WEIGHT="1.3043151475391077"/><DICH_DATA CI_END="1.0124518038855774" CI_START="0.20532344839946126" EFFECT_SIZE="0.4559386973180077" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="24" LOG_CI_END="0.00537435849931325" LOG_CI_START="-0.6875614503908136" LOG_EFFECT_SIZE="-0.3410935459457502" MODIFIED="2013-11-10 11:47:00 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="2984" O_E="0.0" SE="0.4070339242296343" STUDY_ID="STD-Stephenson-1980" TOTAL_1="87" TOTAL_2="136" VAR="0.16567661547377568" WEIGHT="2.242828635018839"/><DICH_DATA CI_END="0.5496310050546848" CI_START="0.03392818225948094" EFFECT_SIZE="0.13655761024182078" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="19" LOG_CI_END="-0.25992877641364504" LOG_CI_START="-1.469439407546866" LOG_EFFECT_SIZE="-0.8646840919802555" MODIFIED="2013-11-10 11:47:12 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="2969" O_E="0.0" SE="0.7104725319018379" STUDY_ID="STD-Mohr-1981" TOTAL_1="37" TOTAL_2="48" VAR="0.504771218587008" WEIGHT="1.2649471736289226"/><DICH_DATA CI_END="0.6999722648647813" CI_START="0.0656002668274423" EFFECT_SIZE="0.21428571428571427" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="14" LOG_CI_END="-0.15491916777833195" LOG_CI_START="-1.1830943941388192" LOG_EFFECT_SIZE="-0.6690067809585756" MODIFIED="2013-11-10 11:47:25 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="2983" O_E="0.0" SE="0.603955217513604" STUDY_ID="STD-Silverman-1982" TOTAL_1="50" TOTAL_2="50" VAR="0.36476190476190473" WEIGHT="1.5426603511830443"/><DICH_DATA CI_END="1.4875364844811094" CI_START="0.02439011043885608" EFFECT_SIZE="0.19047619047619047" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="6" LOG_CI_END="0.17246762637672552" LOG_CI_START="-1.6127862331886396" LOG_EFFECT_SIZE="-0.7201593034059569" MODIFIED="2013-11-10 11:47:30 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="2990" O_E="0.0" SE="1.048666954257824" STUDY_ID="STD-Williams-1982" TOTAL_1="28" TOTAL_2="32" VAR="1.099702380952381" WEIGHT="0.7167021717553191"/><DICH_DATA CI_END="0.9625082004987383" CI_START="0.2097281543575606" EFFECT_SIZE="0.4492939666238768" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="19" LOG_CI_END="-0.016595561646807904" LOG_CI_START="-0.6783432649977698" LOG_EFFECT_SIZE="-0.3474694133222888" MODIFIED="2013-12-01 13:09:03 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="2941" O_E="0.0" SE="0.38871387665231644" STUDY_ID="STD-Abel-1983" TOTAL_1="41" TOTAL_2="50" VAR="0.15109847790207226" WEIGHT="2.319931433216352"/><DICH_DATA CI_END="2.0488361448048726" CI_START="0.32963107650375956" EFFECT_SIZE="0.8218029350104822" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="9" LOG_CI_END="0.3115072271896002" LOG_CI_START="-0.4819718512289136" LOG_EFFECT_SIZE="-0.08523231201965667" MODIFIED="2013-11-10 11:47:38 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="2958" O_E="0.0" SE="0.46609353844781976" STUDY_ID="STD-Ivey-1983" TOTAL_1="53" TOTAL_2="56" VAR="0.21724318658280922" WEIGHT="2.006896948159388"/><DICH_DATA CI_END="1.5715363292104452" CI_START="0.18776337809660357" EFFECT_SIZE="0.5432098765432098" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="9" LOG_CI_END="0.19632442505659703" LOG_CI_START="-0.7263891098415217" LOG_EFFECT_SIZE="-0.2650323423924623" MODIFIED="2013-11-10 11:47:51 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="2974" O_E="0.0" SE="0.5420064979048165" STUDY_ID="STD-Ormerod-1984" TOTAL_1="27" TOTAL_2="33" VAR="0.2937710437710438" WEIGHT="1.7358990379116517"/><DICH_DATA CI_END="1.1085399331216403" CI_START="0.06960551579759253" EFFECT_SIZE="0.2777777777777778" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="9" LOG_CI_END="0.04475134239592844" LOG_CI_START="-1.157356343930503" LOG_EFFECT_SIZE="-0.5563025007672873" MODIFIED="2013-11-10 11:48:07 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="2970" O_E="0.0" SE="0.706124005477162" STUDY_ID="STD-Myhre-1984" TOTAL_1="16" TOTAL_2="20" VAR="0.49861111111111117" WEIGHT="1.27504629252228"/><DICH_DATA CI_END="1.1517322070933487" CI_START="0.8726150111164188" EFFECT_SIZE="1.0025062656641603" ESTIMABLE="YES" EVENTS_1="20" EVENTS_2="19" LOG_CI_END="0.06135151163809717" LOG_CI_START="-0.059177320355668896" LOG_EFFECT_SIZE="0.0010870956412141369" MODIFIED="2013-11-10 11:48:13 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="2989" O_E="0.0" SE="0.07079923254047887" STUDY_ID="STD-White-1984" TOTAL_1="21" TOTAL_2="20" VAR="0.005012531328320802" WEIGHT="3.5391407670636528"/><DICH_DATA CI_END="1.0920886040087217" CI_START="0.18657087736694164" EFFECT_SIZE="0.4513888888888889" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="12" LOG_CI_END="0.03825787524694105" LOG_CI_START="-0.7291561461517292" LOG_EFFECT_SIZE="-0.3454491354523941" MODIFIED="2013-11-10 11:48:23 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="2957" O_E="0.0" SE="0.4507827949302504" STUDY_ID="STD-Hammon-1984" TOTAL_1="24" TOTAL_2="26" VAR="0.2032051282051282" WEIGHT="2.066062991725077"/><DICH_DATA CI_END="0.8109759442010569" CI_START="0.1413241180444068" EFFECT_SIZE="0.3385416666666667" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="18" LOG_CI_END="-0.09099202797834484" LOG_CI_START="-0.8497837161430433" LOG_EFFECT_SIZE="-0.470387872060694" MODIFIED="2013-11-10 11:49:11 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="2967" O_E="0.0" SE="0.4457179937073776" STUDY_ID="STD-Materne-1985" TOTAL_1="32" TOTAL_2="39" VAR="0.1986645299145299" WEIGHT="2.085954065783184"/><DICH_DATA CI_END="0.906876568196414" CI_START="0.1954900201161221" EFFECT_SIZE="0.42105263157894735" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="19" LOG_CI_END="-0.042451819223332604" LOG_CI_START="-0.7088754086984382" LOG_EFFECT_SIZE="-0.3756636139608854" MODIFIED="2013-11-10 11:48:34 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="2965" O_E="0.0" SE="0.3914605153076481" STUDY_ID="STD-Matangi-1985" TOTAL_1="82" TOTAL_2="82" VAR="0.15324133504492937" WEIGHT="2.308267330724086"/><DICH_DATA CI_END="1.0179832018909118" CI_START="0.14531575158417248" EFFECT_SIZE="0.38461538461538464" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="13" LOG_CI_END="0.007740611609507653" LOG_CI_START="-0.8376873075511435" LOG_EFFECT_SIZE="-0.4149733479708179" MODIFIED="2013-11-10 11:49:37 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="2987" O_E="0.0" SE="0.4966085446506601" STUDY_ID="STD-Vecht-1986" TOTAL_1="66" TOTAL_2="66" VAR="0.24662004662004666" WEIGHT="1.8934282300763212"/><DICH_DATA CI_END="0.5400329023288767" CI_START="0.10939334035325655" EFFECT_SIZE="0.24305555555555555" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="18" LOG_CI_END="-0.2675797793167253" LOG_CI_START="-0.9610091161732227" LOG_EFFECT_SIZE="-0.614294447744974" MODIFIED="2013-11-17 15:17:00 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="3390" O_E="0.0" SE="0.4073238250000832" STUDY_ID="STD-Janssen-1986" TOTAL_1="80" TOTAL_2="50" VAR="0.1659126984126984" WEIGHT="2.2416221554842557"/><DICH_DATA CI_END="0.3925291896546882" CI_START="0.0015155153127434649" EFFECT_SIZE="0.024390243902439025" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="20" LOG_CI_END="-0.4061280422700622" LOG_CI_START="-2.819439671169409" LOG_EFFECT_SIZE="-1.6127838567197355" MODIFIED="2013-11-10 11:49:45 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="2950" O_E="0.0" SE="1.4175911969007033" STUDY_ID="STD-Daudon-1986" TOTAL_1="50" TOTAL_2="50" VAR="2.0095648015303684" WEIGHT="0.43100987800772"/><DICH_DATA CI_END="0.421579851024765" CI_START="0.08503552553709799" EFFECT_SIZE="0.18933901918976545" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="35" LOG_CI_END="-0.3751201539574404" LOG_CI_START="-1.070399599915524" LOG_EFFECT_SIZE="-0.7227598769364822" MODIFIED="2013-11-10 11:49:55 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="2962" O_E="0.0" SE="0.4084105882445427" STUDY_ID="STD-Khuri-1987" TOTAL_1="67" TOTAL_2="74" VAR="0.16679920859025338" WEIGHT="2.2371032940188664"/><DICH_DATA CI_END="0.9962321240462663" CI_START="0.1877050579938394" EFFECT_SIZE="0.43243243243243246" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="15" LOG_CI_END="-0.0016394583162494887" LOG_CI_START="-0.7265240245058909" LOG_EFFECT_SIZE="-0.3640817414110702" MODIFIED="2013-11-10 11:50:05 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="2978" O_E="0.0" SE="0.42580078241626834" STUDY_ID="STD-Rubin-1987" TOTAL_1="37" TOTAL_2="40" VAR="0.18130630630630631" WEIGHT="2.1656612369928343"/><DICH_DATA CI_END="0.6607918354063609" CI_START="0.012506908177573097" EFFECT_SIZE="0.09090909090909091" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="11" LOG_CI_END="-0.17993533169837356" LOG_CI_START="-1.9028500386180767" LOG_EFFECT_SIZE="-1.041392685158225" MODIFIED="2013-11-10 11:50:19 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="2963" O_E="0.0" SE="1.0120486274099798" STUDY_ID="STD-Lamb-1988" TOTAL_1="30" TOTAL_2="30" VAR="1.024242424242424" WEIGHT="0.7583936012367029"/><DICH_DATA CI_END="4.126826287091888" CI_START="0.7815504113324163" EFFECT_SIZE="1.7959183673469388" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="7" LOG_CI_END="0.6156161882509973" LOG_CI_START="-0.10704300400768743" LOG_EFFECT_SIZE="0.25428659212165494" MODIFIED="2013-11-10 11:50:13 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="2964" O_E="0.0" SE="0.4244935867534458" STUDY_ID="STD-Martinussen-1988" TOTAL_1="35" TOTAL_2="40" VAR="0.18019480519480519" WEIGHT="2.170973159522062"/><DICH_DATA CI_END="0.9337223063907559" CI_START="0.11899802580555667" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="12" LOG_CI_END="-0.02978226588341088" LOG_CI_START="-0.9244602435559142" LOG_EFFECT_SIZE="-0.47712125471966244" MODIFIED="2013-11-10 11:50:28 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="2966" O_E="0.0" SE="0.5255382728122435" STUDY_ID="STD-Matangi-1989" TOTAL_1="35" TOTAL_2="35" VAR="0.27619047619047615" WEIGHT="1.7914720907596213"/><DICH_DATA CI_END="0.8089575542744424" CI_START="0.33649691357538647" EFFECT_SIZE="0.5217391304347826" ESTIMABLE="YES" EVENTS_1="24" EVENTS_2="46" LOG_CI_END="-0.09207426507251505" LOG_CI_START="-0.47301891486742115" LOG_EFFECT_SIZE="-0.28254658996996806" MODIFIED="2013-11-10 11:50:37 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="2986" O_E="0.0" SE="0.22376877299595657" STUDY_ID="STD-Suttorp-1991" TOTAL_1="150" TOTAL_2="150" VAR="0.05007246376811594" WEIGHT="3.045467905221004"/><DICH_DATA CI_END="0.8651318953082401" CI_START="0.13362124391311758" EFFECT_SIZE="0.34" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="15" LOG_CI_END="-0.06291767630644172" LOG_CI_START="-0.8741244896090479" LOG_EFFECT_SIZE="-0.46852108295774486" MODIFIED="2013-11-10 11:50:44 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="2971" O_E="0.0" SE="0.4765068976724385" STUDY_ID="STD-Nystr_x00f6_m-1993" TOTAL_1="50" TOTAL_2="51" VAR="0.22705882352941176" WEIGHT="1.9675006605013996"/><DICH_DATA CI_END="1.9174334705591203" CI_START="0.15030479565965907" EFFECT_SIZE="0.5368421052631579" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="5" LOG_CI_END="0.2827203041097743" LOG_CI_START="-0.8230271624915971" LOG_EFFECT_SIZE="-0.2701534291909114" MODIFIED="2013-11-10 11:50:53 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="2959" O_E="0.0" SE="0.6495215354198813" STUDY_ID="STD-Jacquet-1994" TOTAL_1="19" TOTAL_2="17" VAR="0.4218782249742002" WEIGHT="1.4158526983455173"/><DICH_DATA CI_END="63.82881484401465" CI_START="0.12392766917779852" EFFECT_SIZE="2.8125" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.8050167806434498" LOG_CI_START="-0.9068317184046119" LOG_EFFECT_SIZE="0.4490925311194189" MODIFIED="2013-11-25 13:20:19 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="2949" O_E="0.0" SE="1.592953232207399" STUDY_ID="STD-Cork-1995" TOTAL_1="15" TOTAL_2="14" VAR="2.5374999999999996" WEIGHT="0.35004622512771594"/><DICH_DATA CI_END="0.967053167072245" CI_START="0.41868044849390096" EFFECT_SIZE="0.6363067292644757" ESTIMABLE="YES" EVENTS_1="38" EVENTS_2="30" LOG_CI_END="-0.014549648428526057" LOG_CI_START="-0.37811731928423464" LOG_EFFECT_SIZE="-0.19633348385638036" MODIFIED="2013-11-10 11:51:30 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="2956" O_E="0.0" SE="0.213561449549639" STUDY_ID="STD-Graham-1996" TOTAL_1="213" TOTAL_2="107" VAR="0.045608492733743004" WEIGHT="3.08814251745362"/><DICH_DATA CI_END="0.7907637030184065" CI_START="0.0484655463980742" EFFECT_SIZE="0.19576719576719576" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="14" LOG_CI_END="-0.10195327352704722" LOG_CI_START="-1.3145668866854512" LOG_EFFECT_SIZE="-0.7082600801062492" MODIFIED="2013-11-10 11:51:21 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="2945" O_E="0.0" SE="0.7122952389034392" STUDY_ID="STD-Babin_x002d_Ebell-1996" TOTAL_1="27" TOTAL_2="37" VAR="0.5073645073645074" WEIGHT="1.2607433275927016"/><DICH_DATA CI_END="0.7316733754295464" CI_START="0.276762838173683" EFFECT_SIZE="0.45" ESTIMABLE="YES" EVENTS_1="18" EVENTS_2="40" LOG_CI_END="-0.13568274804766128" LOG_CI_START="-0.5578922244016514" LOG_EFFECT_SIZE="-0.3467874862246563" MODIFIED="2013-11-10 11:51:43 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="2942" O_E="0.0" SE="0.2480079363809483" STUDY_ID="STD-Ali-1997" TOTAL_1="105" TOTAL_2="105" VAR="0.061507936507936505" WEIGHT="2.9413439130973504"/><DICH_DATA CI_END="1.8214515190598082" CI_START="0.4677977958792884" EFFECT_SIZE="0.9230769230769231" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="13" LOG_CI_END="0.26041761626692334" LOG_CI_START="-0.32994182878534717" LOG_EFFECT_SIZE="-0.03476210625921192" MODIFIED="2013-11-10 11:51:54 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="2976" O_E="0.0" SE="0.3467800603500874" STUDY_ID="STD-Paull-1997" TOTAL_1="50" TOTAL_2="50" VAR="0.12025641025641025" WEIGHT="2.5018950571771126"/><DICH_DATA CI_END="0.8367549673280018" CI_START="0.38960932218699135" EFFECT_SIZE="0.5709706959706959" ESTIMABLE="YES" EVENTS_1="29" EVENTS_2="52" LOG_CI_END="-0.07740170080856265" LOG_CI_START="-0.40937066029975144" LOG_EFFECT_SIZE="-0.24338618055415703" MODIFIED="2013-11-10 11:52:06 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="2977" O_E="0.0" SE="0.19500021007797613" STUDY_ID="STD-Pfisterer-1997" TOTAL_1="126" TOTAL_2="129" VAR="0.03802508193045483" WEIGHT="3.1634467345685113"/><DICH_DATA CI_END="0.7899548058160761" CI_START="0.21326202895259727" EFFECT_SIZE="0.41044776119402987" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="24" LOG_CI_END="-0.10239775446416542" LOG_CI_START="-0.6710864632769621" LOG_EFFECT_SIZE="-0.38674210887056376" MODIFIED="2013-11-10 11:52:16 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="2952" O_E="0.0" SE="0.33405056261114596" STUDY_ID="STD-Dy-1998" TOTAL_1="67" TOTAL_2="66" VAR="0.11158977838082317" WEIGHT="2.5582801625008567"/><DICH_DATA CI_END="0.29201086050273417" CI_START="0.0400237272634076" EFFECT_SIZE="0.10810810810810811" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="37" LOG_CI_END="-0.5346009959190617" LOG_CI_START="-1.3976824695590033" LOG_EFFECT_SIZE="-0.9661417327390326" MODIFIED="2013-11-10 11:52:35 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="2988" O_E="0.0" SE="0.5069783299382993" STUDY_ID="STD-Wenke-1999" TOTAL_1="100" TOTAL_2="100" VAR="0.257027027027027" WEIGHT="1.8562484729805557"/><DICH_DATA CI_END="0.815131215366541" CI_START="0.13431350612509407" EFFECT_SIZE="0.33088235294117646" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="17" LOG_CI_END="-0.08877247528121683" LOG_CI_START="-0.8718803139085308" LOG_EFFECT_SIZE="-0.48032639459487386" MODIFIED="2013-11-10 11:52:25 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="2955" O_E="0.0" SE="0.460001420856004" STUDY_ID="STD-Gomes-1999" TOTAL_1="40" TOTAL_2="45" VAR="0.2116013071895425" WEIGHT="2.0302636906274483"/><DICH_DATA CI_END="0.559711576637503" CI_START="0.20705225265439542" EFFECT_SIZE="0.3404255319148936" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="47" LOG_CI_END="-0.2520357103921946" LOG_CI_START="-0.6839200401673907" LOG_EFFECT_SIZE="-0.4679778752797927" MODIFIED="2013-11-10 11:52:48 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="2953" O_E="0.0" SE="0.2536909931718616" STUDY_ID="STD-Evrard-2000" TOTAL_1="103" TOTAL_2="103" VAR="0.06435912001652552" WEIGHT="2.9164824207591007"/><DICH_DATA CI_END="0.8589583309812318" CI_START="0.26561019438408295" EFFECT_SIZE="0.47764849969381507" ESTIMABLE="YES" EVENTS_1="13" EVENTS_2="23" LOG_CI_END="-0.0660279037634654" LOG_CI_START="-0.5757552603289101" LOG_EFFECT_SIZE="-0.3208915820461878" MODIFIED="2013-11-25 13:21:44 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="2946" O_E="0.0" SE="0.29941637243765074" STUDY_ID="STD-Bert-2001" TOTAL_1="71" TOTAL_2="60" VAR="0.08965016408372196" WEIGHT="2.7130671652443907"/><DICH_DATA CI_END="0.925811812744811" CI_START="0.17282129888323441" EFFECT_SIZE="0.4" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="15" LOG_CI_END="-0.03347728220825417" LOG_CI_START="-0.762402735135821" LOG_EFFECT_SIZE="-0.3979400086720376" MODIFIED="2013-11-10 11:52:58 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="2968" O_E="0.0" SE="0.42817441928883765" STUDY_ID="STD-Matsuura-2001" TOTAL_1="40" TOTAL_2="40" VAR="0.18333333333333335" WEIGHT="2.156040599493529"/><DICH_DATA CI_END="0.7105931245191439" CI_START="0.13488819843100122" EFFECT_SIZE="0.30959752321981426" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="19" LOG_CI_END="-0.14837899892640086" LOG_CI_START="-0.8700260457358048" LOG_EFFECT_SIZE="-0.5092025223311029" MODIFIED="2013-11-10 11:53:25 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="2954" O_E="0.0" SE="0.4238990475063375" STUDY_ID="STD-Forlani-2002" TOTAL_1="51" TOTAL_2="50" VAR="0.17969040247678017" WEIGHT="2.173392332131506"/><DICH_DATA CI_END="0.8846657886054342" CI_START="0.2374562768789701" EFFECT_SIZE="0.4583333333333333" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="24" LOG_CI_END="-0.05322076724324717" LOG_CI_START="-0.6244163458635148" LOG_EFFECT_SIZE="-0.338818556553381" MODIFIED="2013-11-10 11:53:32 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="2951" O_E="0.0" SE="0.3355231103452601" STUDY_ID="STD-De-Azevedo-L_x00fa_cio-2003" TOTAL_1="100" TOTAL_2="100" VAR="0.11257575757575758" WEIGHT="2.55173758736327"/><DICH_DATA CI_END="0.9484074945855946" CI_START="0.674815418112704" EFFECT_SIZE="0.8" ESTIMABLE="YES" EVENTS_1="156" EVENTS_2="195" LOG_CI_END="-0.023005022761850884" LOG_CI_START="-0.17081500325426194" LOG_EFFECT_SIZE="-0.09691001300805639" MODIFIED="2013-11-10 11:53:45 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="2948" O_E="0.0" SE="0.08682431421244592" STUDY_ID="STD-Connolly-2003" TOTAL_1="500" TOTAL_2="500" VAR="0.007538461538461539" WEIGHT="3.507270529285455"/><DICH_DATA CI_END="5.055834822644325" CI_START="0.4316467581119249" EFFECT_SIZE="1.4772727272727273" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="4" LOG_CI_END="0.703792876827747" LOG_CI_START="-0.36487151651441074" LOG_EFFECT_SIZE="0.16946068015666815" MODIFIED="2013-11-10 11:54:19 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="2947" O_E="0.0" SE="0.6277387546232461" STUDY_ID="STD-Booth-2004" TOTAL_1="33" TOTAL_2="39" VAR="0.394055944055944" WEIGHT="1.474909940238398"/><DICH_DATA CI_END="0.9248471633511364" CI_START="0.48330986222891537" EFFECT_SIZE="0.6685714285714286" ESTIMABLE="YES" EVENTS_1="45" EVENTS_2="35" LOG_CI_END="-0.0339300311501147" LOG_CI_START="-0.3157743427301508" LOG_EFFECT_SIZE="-0.17485218694013277" MODIFIED="2013-11-17 15:10:44 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="3389" O_E="0.0" SE="0.16555674377395627" STUDY_ID="STD-Auer-2004" TOTAL_1="125" TOTAL_2="65" VAR="0.027409035409035408" WEIGHT="3.275252708111788"/><DICH_DATA CI_END="1.6818496358282289" CI_START="0.42805642238869207" EFFECT_SIZE="0.8484848484848485" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="11" LOG_CI_END="0.22578716551115877" LOG_CI_START="-0.3684989825824953" LOG_EFFECT_SIZE="-0.07135590853566824" MODIFIED="2013-11-10 11:54:39 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="2985" O_E="0.0" SE="0.3490866251540896" STUDY_ID="STD-Sun-2011" TOTAL_1="30" TOTAL_2="28" VAR="0.12186147186147188" WEIGHT="2.4917241985235536"/><DICH_DATA CI_END="0.6324601313324618" CI_START="0.13450562372243266" EFFECT_SIZE="0.2916666666666667" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="24" LOG_CI_END="-0.1989668461016144" LOG_CI_START="-0.871259557293084" LOG_EFFECT_SIZE="-0.5351132016973492" MODIFIED="2013-11-10 11:54:46 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="2981" O_E="0.0" SE="0.39490806645646137" STUDY_ID="STD-Sezai-2011" TOTAL_1="70" TOTAL_2="70" VAR="0.15595238095238093" WEIGHT="2.2936774355115377"/><DICH_DATA CI_END="0.8263453347887832" CI_START="0.17017703625802433" EFFECT_SIZE="0.375" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="16" LOG_CI_END="-0.0828384204148983" LOG_CI_START="-0.7690990441296639" LOG_EFFECT_SIZE="-0.42596873227228116" MODIFIED="2013-11-10 11:55:03 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="2979" O_E="0.0" SE="0.4031128874149275" STUDY_ID="STD-Sakaguchi-2012" TOTAL_1="30" TOTAL_2="30" VAR="0.1625" WEIGHT="2.2591896515411376"/><DICH_DATA CI_END="0.7482025935275345" CI_START="0.1529700826342874" EFFECT_SIZE="0.3383084577114428" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="12" LOG_CI_END="-0.12598079072115415" LOG_CI_START="-0.8153934987073509" LOG_EFFECT_SIZE="-0.47068714471425255" MODIFIED="2013-11-10 11:54:55 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="2982" O_E="0.0" SE="0.404964437319035" STUDY_ID="STD-Sezai-2012" TOTAL_1="67" TOTAL_2="34" VAR="0.1639961954931226" WEIGHT="2.2514539278250125"/><DICH_DATA CI_END="0.5360855287701065" CI_START="0.05040605255789461" EFFECT_SIZE="0.1643835616438356" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="17" LOG_CI_END="-0.27076591607279954" LOG_CI_START="-1.2975173120728625" LOG_EFFECT_SIZE="-0.7841416140728311" MODIFIED="2013-11-25 13:24:07 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="2975" O_E="0.0" SE="0.6031188525118167" STUDY_ID="STD-Osada-2012" TOTAL_1="73" TOTAL_2="68" VAR="0.36375235025517055" WEIGHT="1.5451063447990583"/><DICH_DATA CI_END="0.9285567066549609" CI_START="0.2912046168662018" EFFECT_SIZE="0.52" ESTIMABLE="YES" EVENTS_1="13" EVENTS_2="25" LOG_CI_END="-0.032191568892075674" LOG_CI_START="-0.5358017438383259" LOG_EFFECT_SIZE="-0.28399665636520083" MODIFIED="2013-11-10 11:55:21 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="2972" O_E="0.0" SE="0.29582310967399855" STUDY_ID="STD-Ogawa-2013" TOTAL_1="68" TOTAL_2="68" VAR="0.08751131221719458" WEIGHT="2.7291650161934724"/></DICH_OUTCOME><DICH_OUTCOME CHI2="6.069811265865222" CI_END="0.9359710466383021" CI_START="0.5725807491224082" CI_STUDY="95" CI_TOTAL="95" DF="7" EFFECT_MEASURE="RR" EFFECT_SIZE="0.7320648899114364" ESTIMABLE="YES" EVENTS_1="108" EVENTS_2="144" I2="0.0" I2_Q="0.0" ID="CMP-001.17" LOG_CI_END="-0.028737585535081343" LOG_CI_START="-0.2421632575901002" LOG_EFFECT_SIZE="-0.1354504215625908" METHOD="MH" MODIFIED="2017-12-08 02:15:26 +0000" MODIFIED_BY="Hermann Blessberger" NO="17" P_CHI2="0.5316220044239742" P_Q="1.0" P_Z="0.012854359918644859" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="YEAR" STUDIES="8" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="4380" TOTAL_2="4364" WEIGHT="99.99999999999999" Z="2.4877789573974787"><NAME>All supraventricular arrhythmias&#8212;non-cardiac surgery</NAME><GROUP_LABEL_1>Beta-blocker</GROUP_LABEL_1><GROUP_LABEL_2>Control</GROUP_LABEL_2><GRAPH_LABEL_1>Favours beta-blocker</GRAPH_LABEL_1><GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2><DICH_DATA CI_END="3.694376342661255" CI_START="0.09210696101758215" EFFECT_SIZE="0.5833333333333334" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="2" LOG_CI_END="0.5675411345302878" LOG_CI_START="-1.0357075465970236" LOG_EFFECT_SIZE="-0.23408320603336796" MODIFIED="2013-11-10 11:57:42 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="2993" O_E="0.0" SE="0.9417562115031479" STUDY_ID="STD-Coleman-1980" TOTAL_1="24" TOTAL_2="14" VAR="0.886904761904762" WEIGHT="1.7378294936414638"/><DICH_DATA CI_END="60.21015642179821" CI_START="0.11637439315284949" EFFECT_SIZE="2.6470588235294117" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.7796697554754684" LOG_CI_START="-0.934142570681329" LOG_EFFECT_SIZE="0.42276359239706973" MODIFIED="2013-11-10 11:57:51 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="2996" O_E="0.0" SE="1.5941067939721714" STUDY_ID="STD-Liu-1986" TOTAL_1="16" TOTAL_2="14" VAR="2.541176470588235" WEIGHT="0.36544200940507343"/><DICH_DATA CI_END="1.5981153088603466" CI_START="0.025243867342839378" EFFECT_SIZE="0.20085470085470086" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="6" LOG_CI_END="0.20360811177088864" LOG_CI_START="-1.5978441107197394" LOG_EFFECT_SIZE="-0.6971179994744253" MODIFIED="2013-11-10 11:57:57 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="2992" O_E="0.0" SE="1.0581819528233132" STUDY_ID="STD-Burns-1988" TOTAL_1="39" TOTAL_2="47" VAR="1.1197490452809604" WEIGHT="3.743405973221874"/><DICH_DATA CI_END="22.711113534056025" CI_START="0.3962817581138951" EFFECT_SIZE="3.0" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="1" LOG_CI_END="1.3562384283562463" LOG_CI_START="-0.40199591891692144" LOG_EFFECT_SIZE="0.47712125471966244" MODIFIED="2013-11-10 11:58:03 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="2998" O_E="0.0" SE="1.0327955589886444" STUDY_ID="STD-Sandler-1990" TOTAL_1="30" TOTAL_2="15" VAR="1.0666666666666667" WEIGHT="0.9171877883107725"/><DICH_DATA CI_END="2.3517506825099073" CI_START="0.24274010071578214" EFFECT_SIZE="0.7555555555555555" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="5" LOG_CI_END="0.3713912787351326" LOG_CI_START="-0.6148584722013096" LOG_EFFECT_SIZE="-0.12173359673308856" MODIFIED="2013-11-10 11:58:09 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="2994" O_E="0.0" SE="0.5793279857150695" STUDY_ID="STD-Jakobsen-1997" TOTAL_1="18" TOTAL_2="17" VAR="0.33562091503267977" WEIGHT="3.5377243263415514"/><DICH_DATA CI_END="1.9266406466126647" CI_START="0.1351098895231352" EFFECT_SIZE="0.5102040816326531" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="6" LOG_CI_END="0.28480071841945853" LOG_CI_START="-0.8693128611324107" LOG_EFFECT_SIZE="-0.292256071356476" MODIFIED="2013-11-10 11:58:16 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="2991" O_E="0.0" SE="0.677932029583124" STUDY_ID="STD-Bayliff-1999" TOTAL_1="49" TOTAL_2="50" VAR="0.45959183673469384" WEIGHT="4.085654693384351"/><DICH_DATA CI_END="1.9774190029426781" CI_START="0.006243329812231785" EFFECT_SIZE="0.1111111111111111" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="4" LOG_CI_END="0.29609870339830113" LOG_CI_START="-2.204583722276951" LOG_EFFECT_SIZE="-0.9542425094393249" MODIFIED="2013-11-10 11:58:22 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="2995" O_E="0.0" SE="1.4689132354192893" STUDY_ID="STD-Lai-2006" TOTAL_1="30" TOTAL_2="30" VAR="2.1577060931899643" WEIGHT="3.0955087855488572"/><DICH_DATA CI_END="0.9931562131790224" CI_START="0.5798648580922154" EFFECT_SIZE="0.7588783740616515" ESTIMABLE="YES" EVENTS_1="91" EVENTS_2="120" LOG_CI_END="-0.002982436110955725" LOG_CI_START="-0.23667321027073493" LOG_EFFECT_SIZE="-0.11982782319084534" MODIFIED="2017-12-08 02:15:26 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="2997" O_E="0.0" SE="0.13727111752944285" STUDY_ID="STD-POISE-2008" TOTAL_1="4174" TOTAL_2="4177" VAR="0.01884335970778211" WEIGHT="82.51724693014604"/></DICH_OUTCOME><DICH_OUTCOME CHI2="4.012670954791197" CI_END="1.0833277873645892" CI_START="0.30941258170230584" CI_STUDY="95" CI_TOTAL="95" DF="4" EFFECT_MEASURE="RR" EFFECT_SIZE="0.578960488736774" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="24" I2="0.3157735815857974" I2_Q="0.0" ID="CMP-001.18" LOG_CI_END="0.03475988294556186" LOG_CI_START="-0.5094620304789664" LOG_EFFECT_SIZE="-0.23735107376670225" METHOD="MH" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" NO="18" P_CHI2="0.4042939533035771" P_Q="1.0" P_Z="0.08734077372203604" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="YEAR" STUDIES="5" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="228" TOTAL_2="234" WEIGHT="100.00000000000001" Z="1.7095950927347552"><NAME>Ventricular extrasystoles&#8212;cardiac surgery</NAME><GROUP_LABEL_1>Beta-blocker</GROUP_LABEL_1><GROUP_LABEL_2>Control</GROUP_LABEL_2><GRAPH_LABEL_1>Favours beta-blocker</GRAPH_LABEL_1><GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2><DICH_DATA CI_END="33.26691095999438" CI_START="0.4041386487796315" EFFECT_SIZE="3.6666666666666665" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="1" LOG_CI_END="1.5220124757917959" LOG_CI_START="-0.39346961491467086" LOG_EFFECT_SIZE="0.5642714304385625" MODIFIED="2013-11-10 12:09:11 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="3004" O_E="0.0" SE="1.125163661870248" STUDY_ID="STD-Ormerod-1984" TOTAL_1="27" TOTAL_2="33" VAR="1.265993265993266" WEIGHT="3.924788672002009"/><DICH_DATA CI_END="9.4761340232665" CI_START="0.017892335903448454" EFFECT_SIZE="0.4117647058823529" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.9766311944265694" LOG_CI_START="-1.7473329571546035" LOG_EFFECT_SIZE="-0.38535088136401713" MODIFIED="2013-11-10 12:08:15 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="3003" O_E="0.0" SE="1.600070026478796" STUDY_ID="STD-Myhre-1984" TOTAL_1="16" TOTAL_2="20" VAR="2.5602240896358546" WEIGHT="5.852755037195978"/><DICH_DATA CI_END="1.1105091403706633" CI_START="0.2140065681230463" EFFECT_SIZE="0.4875" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="15" LOG_CI_END="0.04552213748710874" LOG_CI_START="-0.6695728974179976" LOG_EFFECT_SIZE="-0.3120253799654444" MODIFIED="2013-11-10 12:08:47 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="3002" O_E="0.0" SE="0.420050363280771" STUDY_ID="STD-Materne-1985" TOTAL_1="32" TOTAL_2="39" VAR="0.1764423076923077" WEIGHT="58.96396126951375"/><DICH_DATA CI_END="1.674749508363392" CI_START="0.023884168826590092" EFFECT_SIZE="0.2" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="5" LOG_CI_END="0.22394985897240968" LOG_CI_START="-1.621889867644447" LOG_EFFECT_SIZE="-0.6989700043360187" MODIFIED="2013-11-10 12:08:33 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="3001" O_E="0.0" SE="1.084255392468749" STUDY_ID="STD-Matangi-1985" TOTAL_1="82" TOTAL_2="82" VAR="1.175609756097561" WEIGHT="21.804381511122273"/><DICH_DATA CI_END="5.819752673480798" CI_START="0.12271037260707346" EFFECT_SIZE="0.8450704225352113" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="2" LOG_CI_END="0.7649045284944104" LOG_CI_START="-0.9111187251652737" LOG_EFFECT_SIZE="-0.07310709833543166" MODIFIED="2013-11-10 12:09:00 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="3000" O_E="0.0" SE="0.9845043556486075" STUDY_ID="STD-Bert-2001" TOTAL_1="71" TOTAL_2="60" VAR="0.9692488262910798" WEIGHT="9.454113510165993"/></DICH_OUTCOME><DICH_OUTCOME CHI2="4.640203931433375" CI_END="0.3668597252052659" CI_START="0.1325003152602333" CI_STUDY="95" CI_TOTAL="95" DF="8" EFFECT_MEASURE="RR" EFFECT_SIZE="0.22047455464515694" ESTIMABLE="YES" EVENTS_1="18" EVENTS_2="61" I2="0.0" I2_Q="0.0" ID="CMP-001.19" LOG_CI_END="-0.4354999635811673" LOG_CI_START="-0.8777830884017636" LOG_EFFECT_SIZE="-0.6566415259914654" METHOD="MH" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" NO="19" P_CHI2="0.795247811678171" P_Q="1.0" P_Z="5.8927526599319055E-9" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="YEAR" STUDIES="9" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="293" TOTAL_2="199" WEIGHT="100.0" Z="5.8197732152622335"><NAME>Ventricular extrasystoles&#8212;non-cardiac surgery</NAME><GROUP_LABEL_1>Beta-blocker</GROUP_LABEL_1><GROUP_LABEL_2>Control</GROUP_LABEL_2><GRAPH_LABEL_1>Favours beta-blocker</GRAPH_LABEL_1><GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2><DICH_DATA CI_END="0.9171435836951519" CI_START="0.12114909059653102" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="12" LOG_CI_END="-0.03756266790137051" LOG_CI_START="-0.9166798415379545" LOG_EFFECT_SIZE="-0.47712125471966244" MODIFIED="2013-11-10 12:10:28 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="3013" O_E="0.0" SE="0.5163977794943222" STUDY_ID="STD-Whitehead-1980" TOTAL_1="30" TOTAL_2="30" VAR="0.26666666666666666" WEIGHT="18.07729947539542"/><DICH_DATA CI_END="8.613245613073193" CI_START="0.039506336294567505" EFFECT_SIZE="0.5833333333333334" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="0.935166831621311" LOG_CI_START="-1.4033332436880468" LOG_EFFECT_SIZE="-0.23408320603336796" MODIFIED="2013-11-10 12:10:19 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="3006" O_E="0.0" SE="1.373646519998781" STUDY_ID="STD-Coleman-1980" TOTAL_1="24" TOTAL_2="14" VAR="1.8869047619047619" WEIGHT="1.9028736289889914"/><DICH_DATA CI_END="1.7345779408820627" CI_START="0.027586862124896305" EFFECT_SIZE="0.21875" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="4" LOG_CI_END="0.2391938190437444" LOG_CI_START="-1.5592976956550426" LOG_EFFECT_SIZE="-0.6600519383056491" MODIFIED="2013-11-10 12:10:38 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="3008" O_E="0.0" SE="1.0564428184106458" STUDY_ID="STD-Liu-1986" TOTAL_1="16" TOTAL_2="14" VAR="1.1160714285714286" WEIGHT="6.427484257918371"/><DICH_DATA CI_END="2.10640095810011" CI_START="0.03441187529935919" EFFECT_SIZE="0.2692307692307692" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="4" LOG_CI_END="0.32354104363765107" LOG_CI_START="-1.4632916595507734" LOG_EFFECT_SIZE="-0.5698753079565612" MODIFIED="2013-11-10 12:11:00 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="3009" O_E="0.0" SE="1.049594374817411" STUDY_ID="STD-Magnusson-1986" TOTAL_1="13" TOTAL_2="14" VAR="1.1016483516483517" WEIGHT="5.802589955065196"/><DICH_DATA CI_END="0.388319499409608" CI_START="0.007727374155017464" EFFECT_SIZE="0.054778554778554776" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="22" LOG_CI_END="-0.41081080086943617" LOG_CI_START="-2.11196805895654" LOG_EFFECT_SIZE="-1.261389429912988" MODIFIED="2013-11-10 12:11:10 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="3005" O_E="0.0" SE="0.9992681942646023" STUDY_ID="STD-Burns-1988" TOTAL_1="39" TOTAL_2="47" VAR="0.998536924068839" WEIGHT="30.05876540676215"/><DICH_DATA CI_END="0.6884626717910228" CI_START="0.05122892377407" EFFECT_SIZE="0.18780096308186195" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="7" LOG_CI_END="-0.16211960206596732" LOG_CI_START="-1.2904847677600486" LOG_EFFECT_SIZE="-0.726302184913008" MODIFIED="2013-11-10 12:11:18 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="3012" O_E="0.0" SE="0.6628072838263553" STUDY_ID="STD-Stone-1988" TOTAL_1="89" TOTAL_2="39" VAR="0.4393134954932707" WEIGHT="14.66426767340019"/><DICH_DATA CI_END="2.437512373700911" CI_START="0.025640895477837246" EFFECT_SIZE="0.25" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" LOG_CI_END="0.38694682901319455" LOG_CI_START="-1.5910668116691191" LOG_EFFECT_SIZE="-0.6020599913279624" MODIFIED="2013-11-10 12:11:28 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="3007" O_E="0.0" SE="1.161895003862225" STUDY_ID="STD-Inada-1989" TOTAL_1="20" TOTAL_2="10" VAR="1.3499999999999999" WEIGHT="4.017177661198982"/><DICH_DATA CI_END="0.8968345474639214" CI_START="0.15680149744193167" EFFECT_SIZE="0.375" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="8" LOG_CI_END="-0.047287670390829956" LOG_CI_START="-0.8046497941537323" LOG_EFFECT_SIZE="-0.42596873227228116" MODIFIED="2013-11-10 12:11:45 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="3011" O_E="0.0" SE="0.4448782605013046" STUDY_ID="STD-Oxorn-1990" TOTAL_1="32" TOTAL_2="16" VAR="0.19791666666666663" WEIGHT="16.068710644795928"/><DICH_DATA CI_END="3.987709581650965" CI_START="0.007422505812621207" EFFECT_SIZE="0.17204301075268819" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.6007235218364254" LOG_CI_START="-2.1294494536324464" LOG_EFFECT_SIZE="-0.7643629658980103" MODIFIED="2013-11-10 12:11:36 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="3010" O_E="0.0" SE="1.603717120364604" STUDY_ID="STD-Miller-1990" TOTAL_1="30" TOTAL_2="15" VAR="2.5719086021505375" WEIGHT="2.9808312964747765"/></DICH_OUTCOME><DICH_OUTCOME CHI2="5.333465520840571" CI_END="2.657318890589438" CI_START="0.9740784253242729" CI_STUDY="95" CI_TOTAL="95" DF="6" EFFECT_MEASURE="RR" EFFECT_SIZE="1.608862020351591" ESTIMABLE="YES" EVENTS_1="39" EVENTS_2="20" I2="0.0" I2_Q="0.0" ID="CMP-001.20" LOG_CI_END="0.42444367488943624" LOG_CI_START="-0.011406075652776602" LOG_EFFECT_SIZE="0.20651879961832983" METHOD="MH" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" NO="20" P_CHI2="0.5018087530675711" P_Q="1.0" P_Z="0.06325704165847698" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="YEAR" STUDIES="8" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="355" TOTAL_2="305" WEIGHT="100.0" Z="1.8573804797585545"><NAME>Bradycardia&#8212;cardiac surgery</NAME><GROUP_LABEL_1>Beta-blocker</GROUP_LABEL_1><GROUP_LABEL_2>Control</GROUP_LABEL_2><GRAPH_LABEL_1>Favours beta blocker</GRAPH_LABEL_1><GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2><DICH_DATA CI_END="2.4299040831536463" CI_START="0.4829865998611526" EFFECT_SIZE="1.0833333333333333" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="8" LOG_CI_END="0.38558913080850166" LOG_CI_START="-0.3160649182900778" LOG_EFFECT_SIZE="0.03476210625921191" MODIFIED="2013-11-10 12:28:58 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="3020" O_E="0.0" SE="0.41215506168406435" STUDY_ID="STD-Hammon-1984" TOTAL_1="24" TOTAL_2="26" VAR="0.16987179487179488" WEIGHT="34.508997455394194"/><DICH_DATA CI_END="7.9127893408891605" CI_START="0.014041965016931132" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.8983296038284552" LOG_CI_START="-1.85257211326778" LOG_EFFECT_SIZE="-0.47712125471966244" MODIFIED="2013-11-26 12:24:06 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="3021" O_E="0.0" SE="1.6158932858054431" STUDY_ID="STD-Matangi-1989" TOTAL_1="35" TOTAL_2="35" VAR="2.611111111111111" WEIGHT="6.740038565506678"/><DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-11-10 12:29:21 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="3018" O_E="0.0" SE="0.0" STUDY_ID="STD-Cork-1995" TOTAL_1="15" TOTAL_2="14" VAR="0.0" WEIGHT="0.0"/><DICH_DATA CI_END="79.58504943420188" CI_START="0.14126038260699514" EFFECT_SIZE="3.3529411764705883" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.9008314903751011" LOG_CI_START="-0.8499796217866659" LOG_EFFECT_SIZE="0.5254259342942175" MODIFIED="2013-11-10 12:29:31 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="3016" O_E="0.0" SE="1.615840064018435" STUDY_ID="STD-Babin_x002d_Ebell-1996" TOTAL_1="33" TOTAL_2="37" VAR="2.6109391124871" WEIGHT="2.121863992844695"/><DICH_DATA CI_END="80.35752625709628" CI_START="0.14098207571047106" EFFECT_SIZE="3.3658536585365852" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.9050265588697803" LOG_CI_START="-0.8508360995067785" LOG_EFFECT_SIZE="0.527095229681501" MODIFIED="2013-11-10 12:29:40 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="3019" O_E="0.0" SE="1.618807367270561" STUDY_ID="STD-Gomes-1999" TOTAL_1="40" TOTAL_2="45" VAR="2.6205372923294448" WEIGHT="2.1175600090863895"/><DICH_DATA CI_END="19.55229681746766" CI_START="1.1201957603483597" EFFECT_SIZE="4.68" ESTIMABLE="YES" EVENTS_1="18" EVENTS_2="2" LOG_CI_END="1.2911977815048645" LOG_CI_START="0.04929392464338349" LOG_EFFECT_SIZE="0.670245853074124" MODIFIED="2013-11-17 22:06:46 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="603" O_E="0.0" SE="0.7295004730436714" STUDY_ID="STD-Auer-2004" TOTAL_1="125" TOTAL_2="65" VAR="0.5321709401709402" WEIGHT="11.82462906229242"/><DICH_DATA CI_END="68.25874292736694" CI_START="0.13185124152633113" EFFECT_SIZE="3.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.8341582859242351" LOG_CI_START="-0.87991577648491" LOG_EFFECT_SIZE="0.47712125471966244" MODIFIED="2013-11-10 12:30:06 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="3017" O_E="0.0" SE="1.5942605391424158" STUDY_ID="STD-But-2006" TOTAL_1="15" TOTAL_2="15" VAR="2.5416666666666665" WEIGHT="2.2466795218355595"/><DICH_DATA CI_END="2.5620784080305095" CI_START="0.4818618732998068" EFFECT_SIZE="1.1111111111111112" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="9" LOG_CI_END="0.40859241645235506" LOG_CI_START="-0.31707743533100474" LOG_EFFECT_SIZE="0.04575749056067514" MODIFIED="2013-11-10 12:30:21 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="3022" O_E="0.0" SE="0.4262620630612449" STUDY_ID="STD-Ogawa-2013" TOTAL_1="68" TOTAL_2="68" VAR="0.18169934640522875" WEIGHT="40.44023139304007"/></DICH_OUTCOME><DICH_OUTCOME CHI2="79.61367252344694" CI_END="3.35571487992304" CI_START="1.478562609998888" CI_STUDY="95" CI_TOTAL="95" DF="19" EFFECT_MEASURE="RR" EFFECT_SIZE="2.2274726824971647" ESTIMABLE="YES" EVENTS_1="539" EVENTS_2="212" I2="76.13475248939895" I2_Q="0.0" ID="CMP-001.21" LOG_CI_END="0.5257850536654742" LOG_CI_START="0.16983971952924046" LOG_EFFECT_SIZE="0.3478123865973573" METHOD="MH" MODIFIED="2017-12-04 12:50:11 +0000" MODIFIED_BY="Hermann Blessberger" NO="21" P_CHI2="2.1675823358435764E-9" P_Q="1.0" P_Z="1.279548486681103E-4" Q="0.0" RANDOM="YES" SCALE="833.81" SORT_BY="YEAR" STUDIES="23" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.4033793954831132" TOTALS="YES" TOTAL_1="5636" TOTAL_2="5397" WEIGHT="99.99999999999997" Z="3.830362056926584"><NAME>Bradycardia&#8212;non-cardiac surgery</NAME><GROUP_LABEL_1>Beta-blocker</GROUP_LABEL_1><GROUP_LABEL_2>Control</GROUP_LABEL_2><GRAPH_LABEL_1>Favours beta-blocker</GRAPH_LABEL_1><GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2><DICH_DATA CI_END="4.316762529506007" CI_START="0.7786184873819648" EFFECT_SIZE="1.8333333333333333" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="6" LOG_CI_END="0.6351581582319411" LOG_CI_START="-0.10867528868277829" LOG_EFFECT_SIZE="0.2632414347745814" MODIFIED="2013-11-26 14:03:41 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="3045" O_E="0.0" SE="0.4369314487526515" STUDY_ID="STD-Whitehead-1980" TOTAL_1="30" TOTAL_2="30" VAR="0.19090909090909092" WEIGHT="7.35604701748607"/><DICH_DATA CI_END="163.3214889303036" CI_START="0.5693353304979463" EFFECT_SIZE="9.642857142857142" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="0" LOG_CI_END="2.213043330541109" LOG_CI_START="-0.24463186490757274" LOG_EFFECT_SIZE="0.984205732816768" MODIFIED="2013-11-26 14:03:39 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="3035" O_E="0.0" SE="1.4436505754949789" STUDY_ID="STD-Magnusson-1986" TOTAL_1="13" TOTAL_2="14" VAR="2.084126984126984" WEIGHT="1.7574282758369892"/><DICH_DATA CI_END="6.690017380199802" CI_START="0.012930488128094391" EFFECT_SIZE="0.29411764705882354" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.8254272460361436" LOG_CI_START="-1.8883850801206539" LOG_EFFECT_SIZE="-0.5314789170422551" MODIFIED="2013-11-26 14:03:40 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="3033" O_E="0.0" SE="1.5941067939721714" STUDY_ID="STD-Liu-1986" TOTAL_1="16" TOTAL_2="14" VAR="2.541176470588235" WEIGHT="1.4846429297618757"/><DICH_DATA CI_END="7.401691333129458" CI_START="0.01324713701913913" EFFECT_SIZE="0.31313131313131315" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.8693309700979578" LOG_CI_START="-1.8778779716245122" LOG_EFFECT_SIZE="-0.5042735007632773" MODIFIED="2013-11-26 14:03:40 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="3026" O_E="0.0" SE="1.6137241312713606" STUDY_ID="STD-Cucchiara-1986" TOTAL_1="32" TOTAL_2="30" VAR="2.6041055718475072" WEIGHT="1.45357802128329"/><DICH_DATA CI_END="13.482091688489398" CI_START="0.060717144136267914" EFFECT_SIZE="0.9047619047619048" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.1297572763459856" LOG_CI_START="-1.2166886639081658" LOG_EFFECT_SIZE="-0.0434656937810903" MODIFIED="2013-11-26 14:03:38 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="3027" O_E="0.0" SE="1.3783139604000185" STUDY_ID="STD-Gibson-1988" TOTAL_1="21" TOTAL_2="19" VAR="1.899749373433584" WEIGHT="1.8981196826037314"/><DICH_DATA CI_END="1.2063517837162632" CI_START="0.7282887347158697" EFFECT_SIZE="0.9373219373219374" ESTIMABLE="YES" EVENTS_1="28" EVENTS_2="36" LOG_CI_END="0.08147397069709093" LOG_CI_START="-0.13769640772879047" LOG_EFFECT_SIZE="-0.02811121851584977" MODIFIED="2013-11-26 14:03:38 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="3025" O_E="0.0" SE="0.12874176519823316" STUDY_ID="STD-Burns-1988" TOTAL_1="39" TOTAL_2="47" VAR="0.016574442106356998" WEIGHT="10.409749016569759"/><DICH_DATA CI_END="307.7461518428873" CI_START="1.1868046625898883" EFFECT_SIZE="19.11111111111111" ESTIMABLE="YES" EVENTS_1="21" EVENTS_2="0" LOG_CI_END="2.48819263107907" LOG_CI_START="0.07437924385737768" LOG_EFFECT_SIZE="1.281285937468224" MODIFIED="2013-11-26 14:03:37 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="3043" O_E="0.0" SE="1.417885932222993" STUDY_ID="STD-Stone-1988" TOTAL_1="89" TOTAL_2="39" VAR="2.010400516795866" WEIGHT="1.8111071459386736"/><DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-11-26 14:03:37 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="3029" O_E="0.0" SE="0.0" STUDY_ID="STD-Inada-1989" TOTAL_1="20" TOTAL_2="10" VAR="0.0" WEIGHT="0.0"/><DICH_DATA CI_END="2.1277244659381767" CI_START="0.22038907230653051" EFFECT_SIZE="0.6847826086956522" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="5" LOG_CI_END="0.327915387405769" LOG_CI_START="-0.656809943189716" LOG_EFFECT_SIZE="-0.16444727789197353" MODIFIED="2013-11-26 14:03:14 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="3038" O_E="0.0" SE="0.5784325336607887" STUDY_ID="STD-Miller-1991" TOTAL_1="368" TOTAL_2="180" VAR="0.3345841959972395" WEIGHT="5.923888520139916"/><DICH_DATA CI_END="16.55061376388459" CI_START="0.9667315199460398" EFFECT_SIZE="4.0" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="2" LOG_CI_END="1.2188141038111788" LOG_CI_START="-0.014694121155254026" LOG_EFFECT_SIZE="0.6020599913279624" MODIFIED="2013-11-10 12:46:30 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="3047" O_E="0.0" SE="0.7245688373094719" STUDY_ID="STD-Jakobsen-1992" TOTAL_1="20" TOTAL_2="20" VAR="0.5249999999999999" WEIGHT="4.708865867899588"/><DICH_DATA CI_END="3.881860085359043" CI_START="0.38609570678958227" EFFECT_SIZE="1.2242424242424241" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="5" LOG_CI_END="0.5890398779736322" LOG_CI_START="-0.41330502750819725" LOG_EFFECT_SIZE="0.08786742523271744" MODIFIED="2014-06-22 20:43:17 +0100" MODIFIED_BY="Hermann Blessberger" ORDER="3036" O_E="0.0" SE="0.5887823591673299" STUDY_ID="STD-Mangano-1996" TOTAL_1="99" TOTAL_2="101" VAR="0.3466646664666467" WEIGHT="5.828476311761677"/><DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-11-10 12:54:01 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="3031" O_E="0.0" SE="0.0" STUDY_ID="STD-Jakobsen-1997" TOTAL_1="18" TOTAL_2="17" VAR="0.0" WEIGHT="0.0"/><DICH_DATA CI_END="25.948956020600956" CI_START="1.4445429510900611" EFFECT_SIZE="6.122448979591836" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="2" LOG_CI_END="1.4141198899836058" LOG_CI_START="0.15973045939869154" LOG_EFFECT_SIZE="0.7869251746911488" MODIFIED="2013-11-10 12:54:07 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="3024" O_E="0.0" SE="0.7368345608534029" STUDY_ID="STD-Bayliff-1999" TOTAL_1="49" TOTAL_2="50" VAR="0.5429251700680272" WEIGHT="4.619669192133293"/><DICH_DATA CI_END="9.055780428661802" CI_START="1.9026886986063845" EFFECT_SIZE="4.150943396226415" ESTIMABLE="YES" EVENTS_1="30" EVENTS_2="6" LOG_CI_END="0.9569258838335278" LOG_CI_START="0.27936773860930664" LOG_EFFECT_SIZE="0.6181468112214172" MODIFIED="2013-11-10 12:54:21 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="3040" O_E="0.0" SE="0.3980010084716185" STUDY_ID="STD-POBBLE-2005" TOTAL_1="53" TOTAL_2="44" VAR="0.15840480274442537" WEIGHT="7.781660754511033"/><DICH_DATA CI_END="4.968546281602201" CI_START="2.221629425589266" EFFECT_SIZE="3.3223889931207005" ESTIMABLE="YES" EVENTS_1="85" EVENTS_2="26" LOG_CI_END="0.6962293395925384" LOG_CI_START="0.34667161903172805" LOG_EFFECT_SIZE="0.5214504793121333" MODIFIED="2013-11-25 13:38:19 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1505" O_E="0.0" SE="0.2053319353960433" STUDY_ID="STD-Yang-2006" TOTAL_1="246" TOTAL_2="250" VAR="0.0421612036934849" WEIGHT="9.81193196743652"/><DICH_DATA CI_END="7.731389706964666" CI_START="0.29102141856503916" EFFECT_SIZE="1.5" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="2" LOG_CI_END="0.8882575647876686" LOG_CI_START="-0.5360750466763062" LOG_EFFECT_SIZE="0.17609125905568124" MODIFIED="2013-11-10 12:54:33 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="3034" O_E="0.0" SE="0.8366600265340756" STUDY_ID="STD-Liu-2006" TOTAL_1="15" TOTAL_2="15" VAR="0.7" WEIGHT="3.962022551578986"/><DICH_DATA CI_END="3.4327496636168187" CI_START="2.194313719081089" EFFECT_SIZE="2.74454544160693" ESTIMABLE="YES" EVENTS_1="277" EVENTS_2="101" LOG_CI_END="0.5356421332614679" LOG_CI_START="0.3412987183735157" LOG_EFFECT_SIZE="0.43847042581749185" MODIFIED="2013-11-10 12:55:26 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="3041" O_E="0.0" SE="0.11415828392060205" STUDY_ID="STD-POISE-2008" TOTAL_1="4174" TOTAL_2="4177" VAR="0.01303211378769679" WEIGHT="10.498302641795231"/><DICH_DATA CI_END="3.6290326949803244" CI_START="0.9972510940069231" EFFECT_SIZE="1.9023818820773135" ESTIMABLE="YES" EVENTS_1="24" EVENTS_2="13" LOG_CI_END="0.5597908808998064" LOG_CI_START="-0.0011954785870280453" LOG_EFFECT_SIZE="0.27929770115638924" MODIFIED="2013-11-10 12:55:50 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="3037" O_E="0.0" SE="0.32952616448983174" STUDY_ID="STD-Marwick-2009" TOTAL_1="197" TOTAL_2="203" VAR="0.10858749308337966" WEIGHT="8.538860901907547"/><DICH_DATA CI_END="99.95416281504153" CI_START="0.25011464551267176" EFFECT_SIZE="5.0" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="0" LOG_CI_END="1.9998008859974516" LOG_CI_START="-0.6018608773254143" LOG_EFFECT_SIZE="0.6989700043360189" MODIFIED="2013-11-10 12:56:02 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="3023" O_E="0.0" SE="1.5282289982092807" STUDY_ID="STD-Apipan-2010" TOTAL_1="30" TOTAL_2="30" VAR="2.335483870967742" WEIGHT="1.5961417648704392"/><DICH_DATA CI_END="99.95416281504153" CI_START="0.25011464551267176" EFFECT_SIZE="5.0" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="0" LOG_CI_END="1.9998008859974516" LOG_CI_START="-0.6018608773254143" LOG_EFFECT_SIZE="0.6989700043360189" MODIFIED="2013-11-10 12:56:23 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="3042" O_E="0.0" SE="1.5282289982092807" STUDY_ID="STD-Shukla-2010" TOTAL_1="30" TOTAL_2="30" VAR="2.335483870967742" WEIGHT="1.5961417648704392"/><DICH_DATA CI_END="7.53745610550098" CI_START="1.3585485416660203" EFFECT_SIZE="3.2" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="5" LOG_CI_END="0.8772247960345471" LOG_CI_START="0.1330751606052648" LOG_EFFECT_SIZE="0.505149978319906" MODIFIED="2013-11-10 12:56:15 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="3032" O_E="0.0" SE="0.4371171794512641" STUDY_ID="STD-Kawaguchi-2010" TOTAL_1="28" TOTAL_2="28" VAR="0.19107142857142861" WEIGHT="7.354038165906522"/><DICH_DATA CI_END="98.52270194459342" CI_START="0.25374862348029537" EFFECT_SIZE="5.0" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="0" LOG_CI_END="1.9935363136779938" LOG_CI_START="-0.5955963050059561" LOG_EFFECT_SIZE="0.6989700043360189" MODIFIED="2013-11-10 12:56:31 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="3028" O_E="0.0" SE="1.5208693166281149" STUDY_ID="STD-Gupta-2011" TOTAL_1="22" TOTAL_2="22" VAR="2.313043478260869" WEIGHT="1.6093275057084135"/><DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-11-10 12:56:37 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="3039" O_E="0.0" SE="0.0" STUDY_ID="STD-Moon-2011" TOTAL_1="27" TOTAL_2="27" VAR="0.0" WEIGHT="0.0"/></DICH_OUTCOME><DICH_OUTCOME CHI2="3.6475355346541005" CI_END="3.514310916780185" CI_START="0.6720037696434165" CI_STUDY="95" CI_TOTAL="95" DF="5" EFFECT_MEASURE="RR" EFFECT_SIZE="1.5367596376061206" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="7" I2="0.0" I2_Q="100.00000000000001" ID="CMP-001.22" LOG_CI_END="0.5458401815954322" LOG_CI_START="-0.1726282907397124" LOG_EFFECT_SIZE="0.1866059454278599" METHOD="MH" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" NO="22" P_CHI2="0.6011906676485825" P_Q="0.0" P_Z="0.30862442227650333" Q="1.7300945326521053E-32" RANDOM="NO" SCALE="100.0" SORT_BY="YEAR" STUDIES="6" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="302" TOTAL_2="256" WEIGHT="100.0" Z="1.0181126839175894"><NAME>Hypotension&#8212;cardiac surgery</NAME><GROUP_LABEL_1>Beta-blocker</GROUP_LABEL_1><GROUP_LABEL_2>Control</GROUP_LABEL_2><GRAPH_LABEL_1>Favours beta-blocker</GRAPH_LABEL_1><GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2><DICH_DATA CI_END="107.61816341755203" CI_START="0.27865799953456794" EFFECT_SIZE="5.476190476190476" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="0" LOG_CI_END="2.031885576221638" LOG_CI_START="-0.5549284849822533" LOG_EFFECT_SIZE="0.7384785456196924" MODIFIED="2013-11-10 13:36:55 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="3054" O_E="0.0" SE="1.5195073844872842" STUDY_ID="STD-Salazar-1979" TOTAL_1="20" TOTAL_2="22" VAR="2.308902691511387" WEIGHT="5.627668446294865"/><DICH_DATA CI_END="9.614160867147643" CI_START="0.2854860998584822" EFFECT_SIZE="1.6567164179104477" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="2" LOG_CI_END="0.9829113846045738" LOG_CI_START="-0.5444150324329121" LOG_EFFECT_SIZE="0.21924817608583097" MODIFIED="2013-11-10 13:37:04 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="3052" O_E="0.0" SE="0.8971590977555159" STUDY_ID="STD-Khuri-1987" TOTAL_1="67" TOTAL_2="74" VAR="0.8048944466854914" WEIGHT="22.411842728371848"/><DICH_DATA CI_END="6.706930006003608" CI_START="0.1490995133548233" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="2" LOG_CI_END="0.8265237740363401" LOG_CI_START="-0.82652377403634" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-11-10 13:37:10 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="3053" O_E="0.0" SE="0.9710083124552245" STUDY_ID="STD-Matangi-1989" TOTAL_1="35" TOTAL_2="35" VAR="0.9428571428571428" WEIGHT="23.582610632092766"/><DICH_DATA CI_END="80.35752625709628" CI_START="0.14098207571047106" EFFECT_SIZE="3.3658536585365852" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.9050265588697803" LOG_CI_START="-0.8508360995067785" LOG_EFFECT_SIZE="0.527095229681501" MODIFIED="2013-11-10 13:37:17 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="3051" O_E="0.0" SE="1.618807367270561" STUDY_ID="STD-Gomes-1999" TOTAL_1="40" TOTAL_2="45" VAR="2.6205372923294448" WEIGHT="5.5568220454931225"/><DICH_DATA CI_END="2.813973227965783" CI_START="0.024022971977195374" EFFECT_SIZE="0.26" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" LOG_CI_END="0.44931996125720636" LOG_CI_START="-1.6193732653155704" LOG_EFFECT_SIZE="-0.585026652029182" MODIFIED="2013-11-26 12:31:00 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="3393" O_E="0.0" SE="1.2151606414854723" STUDY_ID="STD-Auer-2004" TOTAL_1="125" TOTAL_2="65" VAR="1.4766153846153847" WEIGHT="31.029750831701012"/><DICH_DATA CI_END="25.6782739076548" CI_START="0.3504908481140964" EFFECT_SIZE="3.0" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="1" LOG_CI_END="1.4095658271236327" LOG_CI_START="-0.45532331768430767" LOG_EFFECT_SIZE="0.47712125471966244" MODIFIED="2013-11-10 13:37:43 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="3050" O_E="0.0" SE="1.0954451150103321" STUDY_ID="STD-But-2006" TOTAL_1="15" TOTAL_2="15" VAR="1.2" WEIGHT="11.791305316046383"/></DICH_OUTCOME><DICH_OUTCOME CHI2="18.832773006123087" CI_END="1.637851533872014" CI_START="1.3797136069781395" CI_STUDY="95" CI_TOTAL="95" DF="18" EFFECT_MEASURE="RR" EFFECT_SIZE="1.5032518243771518" ESTIMABLE="YES" EVENTS_1="1056" EVENTS_2="659" I2="4.421935133250575" I2_Q="0.0" ID="CMP-001.23" LOG_CI_END="0.21427453176969202" LOG_CI_START="0.13978894740334802" LOG_EFFECT_SIZE="0.17703173958652005" METHOD="MH" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" NO="23" P_CHI2="0.4021886162523848" P_Q="1.0" P_Z="1.2013915982071046E-20" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="YEAR" STUDIES="22" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="5611" TOTAL_2="5336" WEIGHT="100.0" Z="9.316590227808769"><NAME>Hypotension&#8212;non-cardiac surgery</NAME><GROUP_LABEL_1>Beta-blocker</GROUP_LABEL_1><GROUP_LABEL_2>Control</GROUP_LABEL_2><GRAPH_LABEL_1>Favours beta-blocker</GRAPH_LABEL_1><GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2><DICH_DATA CI_END="15.259760455310136" CI_START="0.0655318281652329" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.1835477162038213" LOG_CI_START="-1.1835477162038213" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-11-10 13:45:32 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="3075" O_E="0.0" SE="1.390443574307614" STUDY_ID="STD-Whitehead-1980" TOTAL_1="30" TOTAL_2="30" VAR="1.9333333333333331" WEIGHT="0.1482941454300571"/><DICH_DATA CI_END="2.917064814565508" CI_START="0.30129815615047" EFFECT_SIZE="0.9375" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="5" LOG_CI_END="0.4649460788630512" LOG_CI_START="-0.5210035260635382" LOG_EFFECT_SIZE="-0.028028723600243537" MODIFIED="2013-11-10 13:45:40 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="3056" O_E="0.0" SE="0.5791516784631352" STUDY_ID="STD-Cucchiara-1986" TOTAL_1="32" TOTAL_2="30" VAR="0.3354166666666667" WEIGHT="0.7653891377035205"/><DICH_DATA CI_END="21.029313937505744" CI_START="0.2205993627858741" EFFECT_SIZE="2.1538461538461537" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="1" LOG_CI_END="1.3228251044497223" LOG_CI_START="-0.6563957463789576" LOG_EFFECT_SIZE="0.33321467903538243" MODIFIED="2013-11-10 13:45:48 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="3064" O_E="0.0" SE="1.162604125077987" STUDY_ID="STD-Magnusson-1986" TOTAL_1="13" TOTAL_2="14" VAR="1.3516483516483517" WEIGHT="0.1428017696733883"/><DICH_DATA CI_END="89.07654204661276" CI_START="0.23194835082374035" EFFECT_SIZE="4.545454545454546" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="0" LOG_CI_END="1.9497633493675715" LOG_CI_START="-0.6346087110119837" LOG_EFFECT_SIZE="0.6575773191777938" MODIFIED="2013-11-10 13:46:17 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="3057" O_E="0.0" SE="1.5180729411149698" STUDY_ID="STD-Gibson-1988" TOTAL_1="21" TOTAL_2="19" VAR="2.3045454545454547" WEIGHT="0.07767788570145848"/><DICH_DATA CI_END="11.195845482255095" CI_START="0.6174400630049328" EFFECT_SIZE="2.6292134831460676" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="2" LOG_CI_END="1.049056895986779" LOG_CI_START="-0.20940519445631867" LOG_EFFECT_SIZE="0.4198258507652301" MODIFIED="2013-11-10 13:46:06 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="3074" O_E="0.0" SE="0.7392268614140911" STUDY_ID="STD-Stone-1988" TOTAL_1="89" TOTAL_2="39" VAR="0.5464563526361279" WEIGHT="0.4124430919773463"/><DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-11-10 13:46:29 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="3059" O_E="0.0" SE="0.0" STUDY_ID="STD-Inada-1989" TOTAL_1="20" TOTAL_2="10" VAR="0.0" WEIGHT="0.0"/><DICH_DATA CI_END="35.88938623485869" CI_START="0.0668025523135909" EFFECT_SIZE="1.5483870967741935" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.5549660312757505" LOG_CI_START="-1.1752069441931212" LOG_EFFECT_SIZE="0.18987954354131453" MODIFIED="2013-11-10 13:46:46 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="3067" O_E="0.0" SE="1.603717120364604" STUDY_ID="STD-Miller-1990" TOTAL_1="30" TOTAL_2="15" VAR="2.5719086021505375" WEIGHT="0.09781103209216531"/><DICH_DATA CI_END="81.01190363542146" CI_START="0.2663500355480702" EFFECT_SIZE="4.645161290322581" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="0" LOG_CI_END="1.9085488374385386" LOG_CI_START="-0.5745472409165846" LOG_EFFECT_SIZE="0.667000798260977" MODIFIED="2013-11-10 13:46:38 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="3072" O_E="0.0" SE="1.4585829279496223" STUDY_ID="STD-Sandler-1990" TOTAL_1="30" TOTAL_2="15" VAR="2.1274641577060933" WEIGHT="0.09781103209216531"/><DICH_DATA CI_END="2.6979150176212503" CI_START="1.2709157890073948" EFFECT_SIZE="1.8517080745341614" ESTIMABLE="YES" EVENTS_1="106" EVENTS_2="28" LOG_CI_END="0.4310282655881383" LOG_CI_START="0.10411677511654042" LOG_EFFECT_SIZE="0.2675725203523394" MODIFIED="2013-11-10 13:47:01 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="3068" O_E="0.0" SE="0.19202942774099305" STUDY_ID="STD-Miller-1991" TOTAL_1="368" TOTAL_2="180" VAR="0.03687530111853327" WEIGHT="5.576725819384337"/><DICH_DATA CI_END="69.5152908317231" CI_START="0.12946791838627933" EFFECT_SIZE="3.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.84208034406391" LOG_CI_START="-0.8878378346245852" LOG_EFFECT_SIZE="0.47712125471966244" MODIFIED="2013-11-10 13:47:15 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="3060" O_E="0.0" SE="1.6035674514745464" STUDY_ID="STD-Jakobsen-1992" TOTAL_1="20" TOTAL_2="20" VAR="2.5714285714285716" WEIGHT="0.07414707271502854"/><DICH_DATA CI_END="2.4440278509874847" CI_START="0.5796419209128254" EFFECT_SIZE="1.1902356902356903" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="12" LOG_CI_END="0.38810615061358633" LOG_CI_START="-0.23684021298217456" LOG_EFFECT_SIZE="0.07563296881570589" MODIFIED="2014-06-22 20:49:19 +0100" MODIFIED_BY="Hermann Blessberger" ORDER="3065" O_E="0.0" SE="0.36709658751054164" STUDY_ID="STD-Mangano-1996" TOTAL_1="99" TOTAL_2="101" VAR="0.13475990456188475" WEIGHT="1.7617344477090784"/><DICH_DATA CI_END="7.259648833094586" CI_START="0.013736613709900562" EFFECT_SIZE="0.3157894736842105" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.8609156133257376" LOG_CI_START="-1.8621203144641083" LOG_EFFECT_SIZE="-0.5006023505691853" MODIFIED="2013-11-10 13:47:35 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="3061" O_E="0.0" SE="1.5995247832289885" STUDY_ID="STD-Jakobsen-1997" TOTAL_1="18" TOTAL_2="17" VAR="2.5584795321637426" WEIGHT="0.2284531429598177"/><DICH_DATA CI_END="3.258712269150733" CI_START="1.0890244032150478" EFFECT_SIZE="1.8838304552590266" ESTIMABLE="YES" EVENTS_1="24" EVENTS_2="13" LOG_CI_END="0.5130460157469269" LOG_CI_START="0.03703761167762189" LOG_EFFECT_SIZE="0.2750418137122744" MODIFIED="2013-11-10 13:47:44 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="3055" O_E="0.0" SE="0.2796096928299115" STUDY_ID="STD-Bayliff-1999" TOTAL_1="49" TOTAL_2="50" VAR="0.07818158032443746" WEIGHT="1.9083509219989165"/><DICH_DATA CI_END="1.4291890961291949" CI_START="1.0016090630908658" EFFECT_SIZE="1.1964483906770256" ESTIMABLE="YES" EVENTS_1="49" EVENTS_2="34" LOG_CI_END="0.15508969413200707" LOG_CI_START="6.982456113067668E-4" LOG_EFFECT_SIZE="0.07789396987165693" MODIFIED="2013-11-10 13:47:54 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="3070" O_E="0.0" SE="0.09069030111105522" STUDY_ID="STD-POBBLE-2005" TOTAL_1="53" TOTAL_2="44" VAR="0.008224730715613863" WEIGHT="5.509815465256967"/><DICH_DATA CI_END="1.6001337406240679" CI_START="1.0973785289749167" EFFECT_SIZE="1.3251235453531005" ESTIMABLE="YES" EVENTS_1="133" EVENTS_2="102" LOG_CI_END="0.20415628289821494" LOG_CI_START="0.04035645864943841" LOG_EFFECT_SIZE="0.12225637077382669" MODIFIED="2013-11-10 13:48:06 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="3076" O_E="0.0" SE="0.09621682758593815" STUDY_ID="STD-Yang-2006" TOTAL_1="246" TOTAL_2="250" VAR="0.009257677910702148" WEIGHT="15.004018940044324"/><DICH_DATA CI_END="6.20048286508611" CI_START="0.16127776203218527" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="2" LOG_CI_END="0.7924255116719207" LOG_CI_START="-0.7924255116719207" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-11-10 13:48:16 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="3063" O_E="0.0" SE="0.9309493362512627" STUDY_ID="STD-Liu-2006" TOTAL_1="15" TOTAL_2="15" VAR="0.8666666666666667" WEIGHT="0.2965882908601142"/><DICH_DATA CI_END="1.7412304767530802" CI_START="1.3764647865839486" EFFECT_SIZE="1.5481416074046312" ESTIMABLE="YES" EVENTS_1="625" EVENTS_2="404" LOG_CI_END="0.24085626000721605" LOG_CI_START="0.13876510553109628" LOG_EFFECT_SIZE="0.18981068276915616" MODIFIED="2013-12-08 11:41:15 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="3071" O_E="0.0" SE="0.05996884949863775" STUDY_ID="STD-POISE-2008" TOTAL_1="4174" TOTAL_2="4177" VAR="0.003596262910190265" WEIGHT="59.889312480451096"/><DICH_DATA CI_END="2.3140090156976254" CI_START="1.0534324826660835" EFFECT_SIZE="1.561298261805876" ESTIMABLE="YES" EVENTS_1="50" EVENTS_2="33" LOG_CI_END="0.36436504669010483" LOG_CI_START="0.022606705729397786" LOG_EFFECT_SIZE="0.1934858762097513" MODIFIED="2013-11-10 13:48:48 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="3066" O_E="0.0" SE="0.20075054121139094" STUDY_ID="STD-Marwick-2009" TOTAL_1="197" TOTAL_2="203" VAR="0.040300779796666374" WEIGHT="4.820301197204006"/><DICH_DATA CI_END="70.82882080128432" CI_START="0.12706691849706483" EFFECT_SIZE="3.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.850210011475669" LOG_CI_START="-0.8959675020363438" LOG_EFFECT_SIZE="0.47712125471966244" MODIFIED="2013-11-10 13:49:02 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="3073" O_E="0.0" SE="1.613118265234886" STUDY_ID="STD-Shukla-2010" TOTAL_1="30" TOTAL_2="30" VAR="2.6021505376344085" WEIGHT="0.07414707271502854"/><DICH_DATA CI_END="1.48504132021836" CI_START="0.8795192640077785" EFFECT_SIZE="1.1428571428571428" ESTIMABLE="YES" EVENTS_1="24" EVENTS_2="21" LOG_CI_END="0.171738537756374" LOG_CI_START="-0.05575464380100051" LOG_EFFECT_SIZE="0.05799194697768673" MODIFIED="2013-11-10 13:49:30 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="3062" O_E="0.0" SE="0.13363062095621217" STUDY_ID="STD-Kawaguchi-2010" TOTAL_1="28" TOTAL_2="28" VAR="0.01785714285714285" WEIGHT="3.114177054031199"/><DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-11-10 13:49:16 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="3069" O_E="0.0" SE="0.0" STUDY_ID="STD-Moon-2011" TOTAL_1="27" TOTAL_2="27" VAR="0.0" WEIGHT="0.0"/><DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-11-10 13:49:45 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="3058" O_E="0.0" SE="0.0" STUDY_ID="STD-Gupta-2011" TOTAL_1="22" TOTAL_2="22" VAR="0.0" WEIGHT="0.0"/></DICH_OUTCOME><DICH_OUTCOME CHI2="0.09303220818048605" CI_END="1.3427512845324863" CI_START="0.03737671869422976" CI_STUDY="95" CI_TOTAL="95" DF="2" EFFECT_MEASURE="RR" EFFECT_SIZE="0.22402597402597405" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="4" I2="0.0" I2_Q="0.0" ID="CMP-001.24" LOG_CI_END="0.12799557651214638" LOG_CI_START="-1.4273988280385241" LOG_EFFECT_SIZE="-0.6497016257631889" METHOD="MH" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" NO="24" P_CHI2="0.9545491900457851" P_Q="1.0" P_Z="0.10154949900018825" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="YEAR" STUDIES="3" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="172" TOTAL_2="139" WEIGHT="100.0" Z="1.6373876406747574"><NAME>Congestive heart failure&#8212;cardiac surgery</NAME><GROUP_LABEL_1>Beta-blocker</GROUP_LABEL_1><GROUP_LABEL_2>Control</GROUP_LABEL_2><GRAPH_LABEL_1>Favours beta-blocker</GRAPH_LABEL_1><GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2><DICH_DATA CI_END="7.9127893408891605" CI_START="0.014041965016931132" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.8983296038284552" LOG_CI_START="-1.85257211326778" LOG_EFFECT_SIZE="-0.47712125471966244" MODIFIED="2013-11-10 13:54:25 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="3077" O_E="0.0" SE="1.6158932858054431" STUDY_ID="STD-Matangi-1989" TOTAL_1="35" TOTAL_2="35" VAR="2.611111111111111" WEIGHT="25.08116883116883"/><DICH_DATA CI_END="4.092080860459946" CI_START="0.009774977905862802" EFFECT_SIZE="0.2" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" LOG_CI_END="0.611944206883865" LOG_CI_START="-2.0098842155559025" LOG_EFFECT_SIZE="-0.6989700043360187" MODIFIED="2013-11-10 13:54:32 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="3078" O_E="0.0" SE="1.540074993601121" STUDY_ID="STD-Sezai-2011" TOTAL_1="70" TOTAL_2="70" VAR="2.371830985915493" WEIGHT="41.80194805194805"/><DICH_DATA CI_END="4.103163647782676" CI_START="0.0071739263778377955" EFFECT_SIZE="0.1715686274509804" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.6131188384174836" LOG_CI_START="-2.14424308456873" LOG_EFFECT_SIZE="-0.7655621230756231" MODIFIED="2013-11-10 13:54:39 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="3079" O_E="0.0" SE="1.6196880427237514" STUDY_ID="STD-Sezai-2012" TOTAL_1="67" TOTAL_2="34" VAR="2.623389355742297" WEIGHT="33.116883116883116"/></DICH_OUTCOME><DICH_OUTCOME CHI2="1.8390964020271596" CI_END="1.4815572346084287" CI_START="0.9383036072485224" CI_STUDY="95" CI_TOTAL="95" DF="4" EFFECT_MEASURE="RR" EFFECT_SIZE="1.1790464357175394" ESTIMABLE="YES" EVENTS_1="154" EVENTS_2="131" I2="0.0" I2_Q="0.0" ID="CMP-001.25" LOG_CI_END="0.17071843353762536" LOG_CI_START="-0.027656614053537077" LOG_EFFECT_SIZE="0.07153090974204411" METHOD="MH" MODIFIED="2017-12-05 09:54:24 +0000" MODIFIED_BY="Hermann Blessberger" NO="25" P_CHI2="0.7653222538708768" P_Q="1.0" P_Z="0.15751930148012072" Q="0.0" RANDOM="NO" SCALE="125.90459003303094" SORT_BY="YEAR" STUDIES="5" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="4581" TOTAL_2="4592" WEIGHT="100.0" Z="1.413464128459648"><NAME>Congestive heart failure&#8212;non-cardiac surgery</NAME><GROUP_LABEL_1>Beta-blocker</GROUP_LABEL_1><GROUP_LABEL_2>Control</GROUP_LABEL_2><GRAPH_LABEL_1>Favours beta-blocker</GRAPH_LABEL_1><GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2><DICH_DATA CI_END="8.060808530068375" CI_START="0.015823601309021718" EFFECT_SIZE="0.35714285714285715" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.9063786053951907" LOG_CI_START="-1.8006946680796287" LOG_EFFECT_SIZE="-0.4471580313422192" MODIFIED="2013-11-10 14:04:36 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="3082" O_E="0.0" SE="1.5901482410679288" STUDY_ID="STD-Magnusson-1986" TOTAL_1="13" TOTAL_2="14" VAR="2.528571428571428" WEIGHT="1.103263292296873"/><DICH_DATA CI_END="3.384989540859917" CI_START="0.5082811058206856" EFFECT_SIZE="1.3116883116883118" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="7" LOG_CI_END="0.529557331114563" LOG_CI_START="-0.2938960338942417" LOG_EFFECT_SIZE="0.11783064861016074" MODIFIED="2014-06-26 20:25:50 +0100" MODIFIED_BY="Hermann Blessberger" ORDER="3087" O_E="0.0" SE="0.48370058276606814" STUDY_ID="STD-Wallace-1998" TOTAL_1="99" TOTAL_2="101" VAR="0.23396625376823393" WEIGHT="5.279114853640538"><FOOTNOTE>Mangano et al. reported 5 and 2 patients in the control and drug group with CHF between day 1 and 7 after surgery, respectively. Wallace et al. reported 7 and 9 patients with CHF in the control and drug group, respectively, until hospital discharge in the same set of patients. Data from Wallace 1998 was chosen to be presented due to longer follow-up until hospital discharge.</FOOTNOTE></DICH_DATA><DICH_DATA CI_END="6.341211041538326" CI_START="0.6568037637213733" EFFECT_SIZE="2.0408163265306123" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="4" LOG_CI_END="0.8021722071611551" LOG_CI_START="-0.18256436721818248" LOG_EFFECT_SIZE="0.3098039199714864" MODIFIED="2013-11-10 14:05:06 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="3080" O_E="0.0" SE="0.5784391383150814" STUDY_ID="STD-Bayliff-1999" TOTAL_1="49" TOTAL_2="50" VAR="0.33459183673469384" WEIGHT="3.0163292705220908"/><DICH_DATA CI_END="7.010763785170189" CI_START="0.4092059762747028" EFFECT_SIZE="1.6937669376693767" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="3" LOG_CI_END="0.8457653346022119" LOG_CI_START="-0.38805803223218227" LOG_EFFECT_SIZE="0.22885365118501486" MODIFIED="2013-11-10 14:05:16 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="3086" O_E="0.0" SE="0.7247539532026899" STUDY_ID="STD-Yang-2006" TOTAL_1="246" TOTAL_2="250" VAR="0.5252682926829269" WEIGHT="2.2669010159118352"/><DICH_DATA CI_END="1.4559367832756067" CI_START="0.8906630317937844" EFFECT_SIZE="1.138748905374816" ESTIMABLE="YES" EVENTS_1="132" EVENTS_2="116" LOG_CI_END="0.16314251833512286" LOG_CI_START="-0.05028657330588837" LOG_EFFECT_SIZE="0.05642797251461725" MODIFIED="2017-12-05 09:54:24 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="3084" O_E="0.0" SE="0.12536930492097248" STUDY_ID="STD-POISE-2008" TOTAL_1="4174" TOTAL_2="4177" VAR="0.015717462616367778" WEIGHT="88.33439156762866"/></DICH_OUTCOME><DICH_OUTCOME CHI2="1.4612849942823773" CI_END="7.140937434672779" CI_START="0.31009540371843614" CI_STUDY="95" CI_TOTAL="95" DF="2" EFFECT_MEASURE="RR" EFFECT_SIZE="1.4880765695127884" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="1" I2="0.0" I2_Q="0.0" ID="CMP-001.26" LOG_CI_END="0.8537552280200981" LOG_CI_START="-0.508504670894289" LOG_EFFECT_SIZE="0.17262527856290452" METHOD="MH" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" NO="26" P_CHI2="0.48159954930100957" P_Q="1.0" P_Z="0.6193777582615365" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="YEAR" STUDIES="3" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="93" TOTAL_2="103" WEIGHT="100.0" Z="0.49673242099267073"><NAME>Bronchospasm&#8212;cardiac surgery</NAME><GROUP_LABEL_1>Beta-blocker</GROUP_LABEL_1><GROUP_LABEL_2>Control</GROUP_LABEL_2><GRAPH_LABEL_1>Favours beta-blocker</GRAPH_LABEL_1><GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2><DICH_DATA CI_END="92.32275117918559" CI_START="0.16209093911639244" EFFECT_SIZE="3.8684210526315788" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.9653087377975342" LOG_CI_START="-0.7902412615348021" LOG_EFFECT_SIZE="0.5875337381313659" MODIFIED="2013-11-10 14:14:39 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="3089" O_E="0.0" SE="1.6186237098002971" STUDY_ID="STD-Mohr-1981" TOTAL_1="37" TOTAL_2="48" VAR="2.6199427139276765" WEIGHT="17.671551397826203"/><DICH_DATA CI_END="7.382590940745529" CI_START="0.013713297978184326" EFFECT_SIZE="0.3181818181818182" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.8682088054265785" LOG_CI_START="-1.8628580870424774" LOG_EFFECT_SIZE="-0.4973246408079494" MODIFIED="2013-11-10 14:13:51 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="3090" O_E="0.0" SE="1.6042422116354729" STUDY_ID="STD-White-1984" TOTAL_1="21" TOTAL_2="20" VAR="2.5735930735930737" WEIGHT="62.09917265992538"/><DICH_DATA CI_END="71.21510406800243" CI_START="0.12637768515238015" EFFECT_SIZE="3.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.85257211326778" LOG_CI_START="-0.8983296038284552" LOG_EFFECT_SIZE="0.47712125471966244" MODIFIED="2013-11-10 14:13:58 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="3088" O_E="0.0" SE="1.6158932858054431" STUDY_ID="STD-Matangi-1989" TOTAL_1="35" TOTAL_2="35" VAR="2.611111111111111" WEIGHT="20.229275942248417"/></DICH_OUTCOME><DICH_OUTCOME CHI2="3.3042805869012395" CI_END="1.5862677008295947" CI_START="0.5538393876131482" CI_STUDY="95" CI_TOTAL="95" DF="6" EFFECT_MEASURE="RR" EFFECT_SIZE="0.9373033297806956" ESTIMABLE="YES" EVENTS_1="22" EVENTS_2="21" I2="0.0" I2_Q="0.0" ID="CMP-001.27" LOG_CI_END="0.2003764813311155" LOG_CI_START="-0.25661616160097084" LOG_EFFECT_SIZE="-0.028119840134927614" METHOD="MH" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" NO="27" P_CHI2="0.7698005605463883" P_Q="1.0" P_Z="0.809398207717784" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="YEAR" STUDIES="8" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="646" TOTAL_2="434" WEIGHT="100.0" Z="0.2412024559602048"><NAME>Bronchospasm&#8212;non-cardiac surgery</NAME><GROUP_LABEL_1>Beta-blocker</GROUP_LABEL_1><GROUP_LABEL_2>Control</GROUP_LABEL_2><GRAPH_LABEL_1>Favours beta-blocker</GRAPH_LABEL_1><GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2><DICH_DATA CI_END="66.61522199816511" CI_START="0.11922423317225214" EFFECT_SIZE="2.8181818181818183" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.8235734795372827" LOG_CI_START="-0.9236354621851873" LOG_EFFECT_SIZE="0.44996900867604767" MODIFIED="2013-11-10 14:16:00 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="3092" O_E="0.0" SE="1.6137241312713606" STUDY_ID="STD-Cucchiara-1986" TOTAL_1="32" TOTAL_2="30" VAR="2.6041055718475072" WEIGHT="2.206493746302396"/><DICH_DATA CI_END="7.190006335094644" CI_START="0.03477048396741213" EFFECT_SIZE="0.5" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="0.8567292730387149" LOG_CI_START="-1.4587892643666773" LOG_EFFECT_SIZE="-0.3010299956639812" MODIFIED="2013-11-10 14:16:06 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="3093" O_E="0.0" SE="1.3601470508735443" STUDY_ID="STD-Inada-1989" TOTAL_1="20" TOTAL_2="10" VAR="1.8499999999999999" WEIGHT="5.705680798519326"/><DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-11-10 14:16:14 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="3097" O_E="0.0" SE="0.0" STUDY_ID="STD-Miller-1990" TOTAL_1="30" TOTAL_2="15" VAR="0.0" WEIGHT="0.0"/><DICH_DATA CI_END="5.291026045497317" CI_START="0.18087121868109135" EFFECT_SIZE="0.9782608695652174" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="2" LOG_CI_END="0.723539899386512" LOG_CI_START="-0.7426305351989728" LOG_EFFECT_SIZE="-0.009545317906230389" MODIFIED="2013-11-10 14:16:23 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="3098" O_E="0.0" SE="0.8612357709362151" STUDY_ID="STD-Miller-1991" TOTAL_1="368" TOTAL_2="180" VAR="0.7417270531400967" WEIGHT="11.494656207236016"/><DICH_DATA CI_END="14.903914722906746" CI_START="0.06709646549862758" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.1733003569528007" LOG_CI_START="-1.1733003569528007" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-11-10 14:16:29 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="3094" O_E="0.0" SE="1.378404875209022" STUDY_ID="STD-Jakobsen-1992" TOTAL_1="20" TOTAL_2="20" VAR="1.9" WEIGHT="4.279260598889495"/><DICH_DATA CI_END="136.46047637797233" CI_START="0.373585094769823" EFFECT_SIZE="7.14" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="0" LOG_CI_END="2.1350068830509046" LOG_CI_START="-0.4276104594985559" LOG_EFFECT_SIZE="0.8536982117761743" MODIFIED="2013-11-10 14:16:38 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="3096" O_E="0.0" SE="1.5052941121739825" STUDY_ID="STD-Mangano-1996" TOTAL_1="99" TOTAL_2="101" VAR="2.2659103641456584" WEIGHT="2.1184458410344034"/><DICH_DATA CI_END="1.446151791426689" CI_START="0.4050013729748808" EFFECT_SIZE="0.7653061224489796" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="16" LOG_CI_END="0.16021387990126323" LOG_CI_START="-0.39254350450285286" LOG_EFFECT_SIZE="-0.11616481230079483" MODIFIED="2013-12-08 13:52:14 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="3091" O_E="0.0" SE="0.32469242379215935" STUDY_ID="STD-Bayliff-1999" TOTAL_1="49" TOTAL_2="50" VAR="0.1054251700680272" WEIGHT="67.77657190968412"/><DICH_DATA CI_END="7.848616069043482" CI_START="0.014156777466712338" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.8947930852084158" LOG_CI_START="-1.8490355946477406" LOG_EFFECT_SIZE="-0.47712125471966244" MODIFIED="2013-11-10 14:16:53 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="3095" O_E="0.0" SE="1.611738548718522" STUDY_ID="STD-Kawaguchi-2010" TOTAL_1="28" TOTAL_2="28" VAR="2.5977011494252875" WEIGHT="6.418890898334243"/></DICH_OUTCOME><CONT_OUTCOME CHI2="30.82187376265084" CI_END="-0.19057109548480994" CI_START="-0.898270250548719" CI_STUDY="95" CI_TOTAL="95" DF="13" EFFECT_MEASURE="MD" EFFECT_SIZE="-0.5444206730167644" ESTIMABLE="YES" I2="57.822161948657815" I2_Q="0.0" ID="CMP-001.28" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" NO="28" P_CHI2="0.0035797176246025186" P_Q="1.0" P_Z="0.0025652842057218707" Q="0.0" RANDOM="YES" SCALE="4.3" SORT_BY="YEAR" STUDIES="14" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.16580847981899574" TOTALS="YES" TOTAL_1="1272" TOTAL_2="1178" UNITS="" WEIGHT="100.0" Z="3.015532529371342"><NAME>Length of stay&#8212;cardiac surgery</NAME><GROUP_LABEL_1>Beta-blocker</GROUP_LABEL_1><GROUP_LABEL_2>Control</GROUP_LABEL_2><GRAPH_LABEL_1>Favours beta-blocker</GRAPH_LABEL_1><GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2><CONT_DATA CI_END="0.8525956472955156" CI_START="-1.2525956472955142" EFFECT_SIZE="-0.1999999999999993" ESTIMABLE="YES" MEAN_1="10.0" MEAN_2="10.2" MODIFIED="2013-11-10 14:44:56 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="3108" SD_1="1.5" SD_2="1.7" SE="0.5370484639504883" STUDY_ID="STD-Jacquet-1994" TOTAL_1="19" TOTAL_2="17" WEIGHT="7.175725447273321"/><CONT_DATA CI_END="1.5979397562798727" CI_START="-3.197939756279874" EFFECT_SIZE="-0.8000000000000007" ESTIMABLE="YES" MEAN_1="7.6" MEAN_2="8.4" MODIFIED="2013-11-10 14:45:14 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="3104" SD_1="3.9" SD_2="2.6" SE="1.2234611325486162" STUDY_ID="STD-Cork-1995" TOTAL_1="15" TOTAL_2="14" WEIGHT="1.9603619455741499"/><CONT_DATA CI_END="0.49035874809146784" CI_START="-1.2903587480914687" EFFECT_SIZE="-0.40000000000000036" ESTIMABLE="YES" MEAN_1="10.0" MEAN_2="10.4" MODIFIED="2013-11-10 14:45:26 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="3109" SD_1="4.0" SD_2="3.2" SE="0.45427301476685505" STUDY_ID="STD-Pfisterer-1997" TOTAL_1="126" TOTAL_2="129" WEIGHT="8.757839005699221"/><CONT_DATA CI_END="0.3228748645299382" CI_START="-2.322874864529938" EFFECT_SIZE="-1.0" ESTIMABLE="YES" MEAN_1="7.0" MEAN_2="8.0" MODIFIED="2013-11-10 14:45:44 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="3107" SD_1="2.0" SD_2="4.0" SE="0.674948557710553" STUDY_ID="STD-Gomes-1999" TOTAL_1="40" TOTAL_2="45" WEIGHT="5.245598762316369"/><CONT_DATA CI_END="-0.6213610519607327" CI_START="-2.1986389480392674" EFFECT_SIZE="-1.4100000000000001" ESTIMABLE="YES" MEAN_1="8.42" MEAN_2="9.83" MODIFIED="2013-11-28 18:56:12 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="3112" SD_1="2.81" SD_2="2.88" SE="0.40237420394453716" STUDY_ID="STD-Wenke-1999" TOTAL_1="100" TOTAL_2="100" WEIGHT="9.945963823974873"/><CONT_DATA CI_END="2.627257429639835" CI_START="-4.627257429639835" EFFECT_SIZE="-1.0" ESTIMABLE="YES" MEAN_1="21.0" MEAN_2="22.0" MODIFIED="2013-11-10 14:47:38 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="3113" SD_1="4.0" SD_2="11.0" SE="1.8506755523321747" STUDY_ID="STD-Matsuura-2001" TOTAL_1="40" TOTAL_2="40" WEIGHT="0.907713801286598"/><CONT_DATA CI_END="0.9081080402146975" CI_START="-0.9081080402146975" EFFECT_SIZE="0.0" ESTIMABLE="YES" MEAN_1="8.0" MEAN_2="8.0" MODIFIED="2013-11-10 14:44:31 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="3100" SD_1="2.3" SD_2="2.9" SE="0.4633289424590134" STUDY_ID="STD-Bert-2001" TOTAL_1="71" TOTAL_2="60" WEIGHT="8.566567664335407"/><CONT_DATA CI_END="0.30800399250821786" CI_START="-0.9080039925082193" EFFECT_SIZE="-0.3000000000000007" ESTIMABLE="YES" MEAN_1="5.6" MEAN_2="5.9" MODIFIED="2013-11-10 14:48:00 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="3106" SD_1="1.4" SD_2="1.7" SE="0.3102118188416096" STUDY_ID="STD-Forlani-2002" TOTAL_1="51" TOTAL_2="50" WEIGHT="12.438666811378871"/><CONT_DATA CI_END="0.5986973363346225" CI_START="-0.19869733633462217" EFFECT_SIZE="0.20000000000000018" ESTIMABLE="YES" MEAN_1="6.5" MEAN_2="6.3" MODIFIED="2013-11-10 14:48:20 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="3103" SD_1="3.8" SD_2="2.5" SE="0.20342074623793907" STUDY_ID="STD-Connolly-2003" TOTAL_1="500" TOTAL_2="500" WEIGHT="15.731697137582914"/><CONT_DATA CI_END="0.6873907364900345" CI_START="-4.287390736490032" EFFECT_SIZE="-1.799999999999999" ESTIMABLE="YES" MEAN_1="11.3" MEAN_2="13.1" MODIFIED="2013-11-25 13:46:47 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="3394" SD_1="7.0" SD_2="8.9" SE="1.2691002263869409" STUDY_ID="STD-Auer-2004" TOTAL_1="125" TOTAL_2="65" WEIGHT="1.8348247173241303"/><CONT_DATA CI_END="-0.5799305882439878" CI_START="-0.8200694117560126" EFFECT_SIZE="-0.7000000000000002" ESTIMABLE="YES" MEAN_1="5.1" MEAN_2="5.8" MODIFIED="2013-12-07 15:21:18 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="3101" SD_1="0.3" SD_2="0.2" SE="0.061261029642944734" STUDY_ID="STD-Booth-2004" TOTAL_1="33" TOTAL_2="39" WEIGHT="19.222691830061876"/><CONT_DATA CI_END="0.8331433922667311" CI_START="-2.03314339226673" EFFECT_SIZE="-0.5999999999999996" ESTIMABLE="YES" MEAN_1="7.5" MEAN_2="8.1" MODIFIED="2013-11-10 14:48:45 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="3102" SD_1="2.1" SD_2="1.9" SE="0.731209044437134" STUDY_ID="STD-But-2006" TOTAL_1="15" TOTAL_2="15" WEIGHT="4.653164971321886"/><CONT_DATA CI_END="-0.6816580345935019" CI_START="-4.9183419654064995" EFFECT_SIZE="-2.8000000000000007" ESTIMABLE="YES" MEAN_1="11.2" MEAN_2="14.0" MODIFIED="2013-11-10 14:49:07 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="3110" SD_1="4.9" SD_2="7.6" SE="1.0808065771186153" STUDY_ID="STD-Sezai-2011" TOTAL_1="70" TOTAL_2="70" WEIGHT="2.443437271356669"/><CONT_DATA CI_END="2.5534736631582517" CI_START="-3.9534736631582503" EFFECT_SIZE="-0.6999999999999993" ESTIMABLE="YES" MEAN_1="11.5" MEAN_2="12.2" MODIFIED="2013-11-10 14:49:36 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="3111" SD_1="5.0" SD_2="9.0" SE="1.6599660446932882" STUDY_ID="STD-Sezai-2012" TOTAL_1="67" TOTAL_2="34" WEIGHT="1.11574681051372"/></CONT_OUTCOME><CONT_OUTCOME CHI2="3.109542519456295" CI_END="0.8396604843024991" CI_START="-1.7484787202947654" CI_STUDY="95" CI_TOTAL="95" DF="2" EFFECT_MEASURE="MD" EFFECT_SIZE="-0.45440911799613315" ESTIMABLE="YES" I2="35.68185713859604" I2_Q="0.0" ID="CMP-001.29" MODIFIED="2017-12-05 10:11:47 +0000" MODIFIED_BY="Hermann Blessberger" NO="29" P_CHI2="0.21123779549911226" P_Q="1.0" P_Z="0.49130407532430953" Q="0.0" RANDOM="YES" SCALE="2.49" SORT_BY="YEAR" STUDIES="3" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.5891179693527354" TOTALS="YES" TOTAL_1="276" TOTAL_2="275" UNITS="" WEIGHT="100.0" Z="0.6882361690105625"><NAME>Length of stay&#8212;non-cardiac surgery</NAME><GROUP_LABEL_1>Beta-blocker</GROUP_LABEL_1><GROUP_LABEL_2>Control</GROUP_LABEL_2><GRAPH_LABEL_1>Favours beta-blocker</GRAPH_LABEL_1><GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2><CONT_DATA CI_END="1.0653205264171248" CI_START="-26.665320526417123" EFFECT_SIZE="-12.799999999999999" ESTIMABLE="YES" MEAN_1="15.9" MEAN_2="28.7" MODIFIED="2013-12-09 16:37:35 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="3116" SD_1="21.5" SD_2="41.3" SE="7.074273117151643" STUDY_ID="STD-POBBLE-2005" TOTAL_1="49" TOTAL_2="42" WEIGHT="0.8609400733405568"/><CONT_DATA CI_END="1.833472026316095" CI_START="-2.2334720263160954" EFFECT_SIZE="-0.20000000000000018" ESTIMABLE="YES" MEAN_1="7.8" MEAN_2="8.0" MODIFIED="2013-11-10 18:01:42 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="3115" SD_1="8.9" SD_2="11.7" SE="1.0375047921063159" STUDY_ID="STD-Marwick-2009" TOTAL_1="197" TOTAL_2="203" WEIGHT="26.173725549047948"/><CONT_DATA CI_END="-0.22108058562828417" CI_START="-0.5789194143717157" EFFECT_SIZE="-0.3999999999999999" ESTIMABLE="YES" MEAN_1="1.3" MEAN_2="1.7" MODIFIED="2014-01-06 21:39:56 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="3114" SD_1="0.3" SD_2="0.4" SE="0.09128709291752769" STUDY_ID="STD-Lee-2010" TOTAL_1="30" TOTAL_2="30" WEIGHT="72.9653343776115"/></CONT_OUTCOME><CONT_OUTCOME CHI2="0.15991655336218094" CI_END="7028.427118268213" CI_START="908.0779304684393" CI_STUDY="95" CI_TOTAL="95" DF="1" EFFECT_MEASURE="MD" EFFECT_SIZE="3968.2525243683262" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-001.30" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" NO="30" P_CHI2="0.6892335625115216" P_Q="1.0" P_Z="0.01103574875922892" Q="0.0" RANDOM="YES" SCALE="1000.0" SORT_BY="YEAR" STUDIES="3" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="586" TOTAL_2="584" UNITS="" WEIGHT="100.00000000000001" Z="2.541564799873153"><NAME>Cost of care&#8212;cardiac surgery</NAME><GROUP_LABEL_1>Beta-blocker</GROUP_LABEL_1><GROUP_LABEL_2>Control</GROUP_LABEL_2><GRAPH_LABEL_1>Favours beta-blocker</GRAPH_LABEL_1><GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2><CONT_DATA CI_END="9292.28359267728" CI_START="-3692.2835926772805" EFFECT_SIZE="2800.0" ESTIMABLE="YES" MEAN_1="34351.0" MEAN_2="31551.0" MODIFIED="2013-12-01 19:08:07 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="3120" SD_1="11128.0" SD_2="6727.5" SE="3312.4504551550867" STUDY_ID="STD-Cork-1995" TOTAL_1="16" TOTAL_2="14" WEIGHT="22.217615475326824"><FOOTNOTE>Standard error of the mean was converted to standard deviation.</FOOTNOTE></CONT_DATA><CONT_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" MEAN_1="4585.57" MEAN_2="4414.13" MODIFIED="2013-12-01 19:43:31 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="3119" SD_1="0.0" SD_2="0.0" SE="0.0" STUDY_ID="STD-Connolly-2003" TOTAL_1="500" TOTAL_2="500" WEIGHT="0.0"><FOOTNOTE>Canadian $ were converted into US$. No standard deviation was provided.</FOOTNOTE></CONT_DATA><CONT_DATA CI_END="7771.759076913364" CI_START="832.1409230866302" EFFECT_SIZE="4301.949999999997" ESTIMABLE="YES" MEAN_1="39981.43" MEAN_2="35679.48" MODIFIED="2013-11-10 18:29:01 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="3121" SD_1="13417.62" SD_2="6273.4" SE="1770.3432840005112" STUDY_ID="STD-Sezai-2011" TOTAL_1="70" TOTAL_2="70" WEIGHT="77.78238452467319"/></CONT_OUTCOME></COMPARISON><COMPARISON ID="CMP-002" MODIFIED="2017-12-08 02:36:48 +0000" MODIFIED_BY="Hermann Blessberger" NO="2"><NAME>Stratification placebo versus standard care</NAME><DICH_OUTCOME CHI2="4.1611665641256055" CI_END="1.5197716038104085" CI_START="0.35242047072087324" CI_STUDY="95" CI_TOTAL="95" DF="12" EFFECT_MEASURE="RR" EFFECT_SIZE="0.7318460384555489" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="13" I2="0.0" I2_Q="0.0" ID="CMP-002.01" LOG_CI_END="0.1817783256698769" LOG_CI_START="-0.4529388730667181" LOG_EFFECT_SIZE="-0.1355802736984206" METHOD="MH" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" NO="1" P_CHI2="0.9803493480143448" P_Q="0.8169010057197079" P_Z="0.4024096278199055" Q="0.053607379495379304" RANDOM="NO" SCALE="100.0" SORT_BY="YEAR" STUDIES="24" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="1939" TOTAL_2="1844" WEIGHT="100.00000000000001" Z="0.83732551754365"><NAME>All-cause mortality (30 days)&#8212;cardiac</NAME><GROUP_LABEL_1>Beta-blocker</GROUP_LABEL_1><GROUP_LABEL_2>Control</GROUP_LABEL_2><GRAPH_LABEL_1>Favours beta-blocker</GRAPH_LABEL_1><GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2><DICH_SUBGROUP CHI2="2.502670251954749" CI_END="2.4301742775652366" CI_START="0.2683979600798311" DF="5" EFFECT_SIZE="0.8076223243181101" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="4" I2="0.0" ID="CMP-002.01.01" LOG_CI_END="0.38563741971802384" LOG_CI_START="-0.5712207892833717" LOG_EFFECT_SIZE="-0.092791684782674" MODIFIED="2014-06-22 16:25:32 +0100" MODIFIED_BY="Hermann Blessberger" NO="1" P_CHI2="0.7760929028609833" P_Z="0.7038441014321415" STUDIES="12" TAU2="0.0" TOTAL_1="1151" TOTAL_2="1070" WEIGHT="41.254845082831864" Z="0.38013648945675543"><NAME>Placebo</NAME><DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-11-17 19:21:59 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="369" O_E="0.0" SE="0.0" STUDY_ID="STD-Ivey-1983" TOTAL_1="53" TOTAL_2="56" VAR="0.0" WEIGHT="0.0"/><DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-11-17 19:22:05 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="368" O_E="0.0" SE="0.0" STUDY_ID="STD-Hammon-1984" TOTAL_1="24" TOTAL_2="26" VAR="0.0" WEIGHT="0.0"/><DICH_DATA CI_END="66.4433184667098" CI_START="0.12341968180365896" EFFECT_SIZE="2.8636363636363638" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.8224513148659036" LOG_CI_START="-0.9086155776031525" LOG_EFFECT_SIZE="0.4569178686313755" MODIFIED="2013-11-17 19:22:12 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="375" O_E="0.0" SE="1.6042422116354729" STUDY_ID="STD-White-1984" TOTAL_1="21" TOTAL_2="20" VAR="2.5735930735930737" WEIGHT="3.0415249815677727"/><DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-11-17 19:22:20 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="370" O_E="0.0" SE="0.0" STUDY_ID="STD-Martinussen-1988" TOTAL_1="35" TOTAL_2="40" VAR="0.0" WEIGHT="0.0"/><DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-11-17 19:22:34 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="374" O_E="0.0" SE="0.0" STUDY_ID="STD-Suttorp-1991" TOTAL_1="150" TOTAL_2="150" VAR="0.0" WEIGHT="0.0"/><DICH_DATA CI_END="60.21015642179821" CI_START="0.11637439315284949" EFFECT_SIZE="2.6470588235294117" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.7796697554754684" LOG_CI_START="-0.934142570681329" LOG_EFFECT_SIZE="0.42276359239706973" MODIFIED="2014-06-22 16:25:32 +0100" MODIFIED_BY="Hermann Blessberger" ORDER="366" O_E="0.0" SE="1.5941067939721714" STUDY_ID="STD-Cork-1995" TOTAL_1="16" TOTAL_2="14" VAR="2.541176470588235" WEIGHT="3.158174377167673"/><DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-11-17 19:22:47 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="371" O_E="0.0" SE="0.0" STUDY_ID="STD-Paull-1997" TOTAL_1="50" TOTAL_2="50" VAR="0.0" WEIGHT="0.0"/><DICH_DATA CI_END="8.928614028566257" CI_START="0.015664675078941228" EFFECT_SIZE="0.37398373983739835" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.9507840494304557" LOG_CI_START="-1.8050786089461033" LOG_EFFECT_SIZE="-0.4271472797578239" MODIFIED="2013-11-17 19:22:54 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="367" O_E="0.0" SE="1.618807367270561" STUDY_ID="STD-Gomes-1999" TOTAL_1="40" TOTAL_2="45" VAR="2.6205372923294448" WEIGHT="8.404715583862043"/><DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-11-17 19:23:00 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="365" O_E="0.0" SE="0.0" STUDY_ID="STD-Connolly-2003" TOTAL_1="500" TOTAL_2="500" VAR="0.0" WEIGHT="0.0"/><DICH_DATA CI_END="38.042628832648475" CI_START="0.06491107031443613" EFFECT_SIZE="1.5714285714285714" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.5802705200441767" LOG_CI_START="-1.1876812297562402" LOG_EFFECT_SIZE="0.1962946451439682" MODIFIED="2013-11-17 19:23:08 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="364" O_E="0.0" SE="1.6259085594149025" STUDY_ID="STD-Auer-2004" TOTAL_1="125" TOTAL_2="65" VAR="2.6435786435786435" WEIGHT="3.90127423061889"/><DICH_DATA CI_END="4.092080860459946" CI_START="0.009774977905862802" EFFECT_SIZE="0.2" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" LOG_CI_END="0.611944206883865" LOG_CI_START="-2.0098842155559025" LOG_EFFECT_SIZE="-0.6989700043360187" MODIFIED="2013-11-17 19:23:19 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="372" O_E="0.0" SE="1.540074993601121" STUDY_ID="STD-Sezai-2011" TOTAL_1="70" TOTAL_2="70" VAR="2.371830985915493" WEIGHT="14.861997069024344"/><DICH_DATA CI_END="7.866237458523328" CI_START="0.03273717321855499" EFFECT_SIZE="0.5074626865671642" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="0.8957670523419452" LOG_CI_START="-1.4849588236590878" LOG_EFFECT_SIZE="-0.2945958856585713" MODIFIED="2013-11-17 19:23:24 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="373" O_E="0.0" SE="1.3984501643461555" STUDY_ID="STD-Sezai-2012" TOTAL_1="67" TOTAL_2="34" VAR="1.9556628621597894" WEIGHT="7.8871588405911375"/></DICH_SUBGROUP><DICH_SUBGROUP CHI2="1.6084204456217888" CI_END="1.804500506580718" CI_START="0.2552172893311637" DF="6" EFFECT_SIZE="0.6786307743436357" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="9" I2="0.0" ID="CMP-002.01.02" LOG_CI_END="0.25635700831582503" LOG_CI_START="-0.5930899082942033" LOG_EFFECT_SIZE="-0.16836644998918915" MODIFIED="2014-06-22 16:24:37 +0100" MODIFIED_BY="Hermann Blessberger" NO="2" P_CHI2="0.9519701409767426" P_Z="0.43718371035250925" STUDIES="12" TAU2="0.0" TOTAL_1="788" TOTAL_2="774" WEIGHT="58.74515491716815" Z="0.7769577397504891"><NAME>Standard care</NAME><DICH_DATA CI_END="14.051950786893713" CI_START="0.025619218673593205" EFFECT_SIZE="0.6" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="1.1477366201252595" LOG_CI_START="-1.591434119357972" LOG_EFFECT_SIZE="-0.2218487496163564" MODIFIED="2013-11-17 19:23:48 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="387" O_E="0.0" SE="1.6090024514862893" STUDY_ID="STD-Oka-1980" TOTAL_1="19" TOTAL_2="35" VAR="2.588888888888889" WEIGHT="6.369427315296147"/><DICH_DATA CI_END="10.258083464353952" CI_START="0.018010104346265817" EFFECT_SIZE="0.4298245614035088" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="1.0110662283582093" LOG_CI_START="-1.7444837709741272" LOG_EFFECT_SIZE="-0.3667087713079589" MODIFIED="2013-11-17 19:23:55 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="385" O_E="0.0" SE="1.6186237098002971" STUDY_ID="STD-Mohr-1981" TOTAL_1="37" TOTAL_2="48" VAR="2.6199427139276765" WEIGHT="7.789736394798966"/><DICH_DATA CI_END="3.0967497955252377" CI_START="0.035879912310534466" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="3" LOG_CI_END="0.4909061175904471" LOG_CI_START="-1.4451486270297722" LOG_EFFECT_SIZE="-0.47712125471966244" MODIFIED="2014-06-22 16:24:37 +0100" MODIFIED_BY="Hermann Blessberger" ORDER="376" O_E="0.0" SE="1.1372481406154653" STUDY_ID="STD-Abel-1983" TOTAL_1="50" TOTAL_2="50" VAR="1.2933333333333332" WEIGHT="17.834396482829213"/><DICH_DATA CI_END="15.718754250133742" CI_START="0.06361827305694352" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.1964181241632585" LOG_CI_START="-1.1964181241632585" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-11-17 19:24:10 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="383" O_E="0.0" SE="1.4055638569974547" STUDY_ID="STD-Matangi-1985" TOTAL_1="82" TOTAL_2="82" VAR="1.975609756097561" WEIGHT="5.944798827609738"/><DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-11-17 19:24:20 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="382" O_E="0.0" SE="0.0" STUDY_ID="STD-Janssen-1986" TOTAL_1="80" TOTAL_2="50" VAR="0.0" WEIGHT="0.0"/><DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-11-17 19:24:30 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="386" O_E="0.0" SE="0.0" STUDY_ID="STD-Nystr_x00f6_m-1993" TOTAL_1="50" TOTAL_2="51" VAR="0.0" WEIGHT="0.0"/><DICH_DATA CI_END="8.090192218311387" CI_START="0.01373405082509925" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.9079588403218196" LOG_CI_START="-1.8622013497611447" LOG_EFFECT_SIZE="-0.47712125471966244" MODIFIED="2013-11-17 19:24:37 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="377" O_E="0.0" SE="1.6272058081688268" STUDY_ID="STD-Ali-1997" TOTAL_1="105" TOTAL_2="105" VAR="2.6477987421383644" WEIGHT="8.917198241414606"/><DICH_DATA CI_END="15.773312877448294" CI_START="0.06339822254015756" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.1979229180145214" LOG_CI_START="-1.1979229180145214" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-11-17 19:24:44 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="380" O_E="0.0" SE="1.4073317037116178" STUDY_ID="STD-Evrard-2000" TOTAL_1="103" TOTAL_2="103" VAR="1.9805825242718447" WEIGHT="5.944798827609738"/><DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-11-17 19:25:05 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="378" O_E="0.0" SE="0.0" STUDY_ID="STD-Bert-2001" TOTAL_1="71" TOTAL_2="60" VAR="0.0" WEIGHT="0.0"/><DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-11-17 19:24:56 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="384" O_E="0.0" SE="0.0" STUDY_ID="STD-Matsuura-2001" TOTAL_1="40" TOTAL_2="40" VAR="0.0" WEIGHT="0.0"/><DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-11-17 19:25:15 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="381" O_E="0.0" SE="0.0" STUDY_ID="STD-Forlani-2002" TOTAL_1="51" TOTAL_2="50" VAR="0.0" WEIGHT="0.0"/><DICH_DATA CI_END="21.705078767310894" CI_START="0.18428866547235168" EFFECT_SIZE="2.0" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="1" LOG_CI_END="1.3365613662238505" LOG_CI_START="-0.7345013748958881" LOG_EFFECT_SIZE="0.3010299956639812" MODIFIED="2013-11-17 19:25:21 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="379" O_E="0.0" SE="1.2165525060596438" STUDY_ID="STD-De-Azevedo-L_x00fa_cio-2003" TOTAL_1="100" TOTAL_2="100" VAR="1.48" WEIGHT="5.944798827609738"/></DICH_SUBGROUP></DICH_OUTCOME><DICH_OUTCOME CHI2="6.688662154126654" CI_END="1.5678386330345675" CI_START="1.0041493045683079" CI_STUDY="95" CI_TOTAL="95" DF="9" EFFECT_MEASURE="RR" EFFECT_SIZE="1.25472868502995" ESTIMABLE="YES" EVENTS_1="168" EVENTS_2="134" I2="0.0" I2_Q="0.0" ID="CMP-002.02" LOG_CI_END="0.19530136167176518" LOG_CI_START="0.0017982918222352762" LOG_EFFECT_SIZE="0.09854982674700022" METHOD="MH" MODIFIED="2017-12-03 02:25:07 +0000" MODIFIED_BY="Hermann Blessberger" NO="2" P_CHI2="0.66949765585711" P_Q="0.3410620417486865" P_Z="0.04589113513048386" Q="0.9064356593941164" RANDOM="NO" SCALE="100.0" SORT_BY="YEAR" STUDIES="13" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="5805" TOTAL_2="5608" WEIGHT="100.00000000000001" Z="1.9963932485100235"><NAME>All-cause mortality (30 days)&#8212;non-cardiac</NAME><GROUP_LABEL_1>Beta-blocker</GROUP_LABEL_1><GROUP_LABEL_2>Control</GROUP_LABEL_2><GRAPH_LABEL_1>Favours beta-blocker</GRAPH_LABEL_1><GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2><DICH_SUBGROUP CHI2="4.5288925707229275" CI_END="1.621219359625678" CI_START="1.0241278112019092" DF="6" EFFECT_SIZE="1.2885401950469402" ESTIMABLE="YES" EVENTS_1="161" EVENTS_2="125" I2="0.0" ID="CMP-002.02.01" LOG_CI_END="0.20984178118389377" LOG_CI_START="0.01035415999517196" LOG_EFFECT_SIZE="0.11009797058953286" MODIFIED="2017-12-03 02:25:07 +0000" MODIFIED_BY="Hermann Blessberger" NO="1" P_CHI2="0.6054883915922284" P_Z="0.030508657701826192" STUDIES="9" TAU2="0.0" TOTAL_1="5499" TOTAL_2="5296" WEIGHT="93.00309390800462" Z="2.163423031871156"><NAME>Placebo</NAME><DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-11-17 19:31:33 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="392" O_E="0.0" SE="0.0" STUDY_ID="STD-Miller-1990" TOTAL_1="30" TOTAL_2="15" VAR="0.0" WEIGHT="0.0"/><DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-11-17 19:31:40 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="393" O_E="0.0" SE="0.0" STUDY_ID="STD-Miller-1991" TOTAL_1="368" TOTAL_2="180" VAR="0.0" WEIGHT="0.0"/><DICH_DATA CI_END="10.888852021315463" CI_START="0.38234045608732375" EFFECT_SIZE="2.04040404040404" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="2" LOG_CI_END="1.0369820958174838" LOG_CI_START="-0.4175497461193362" LOG_EFFECT_SIZE="0.3097161748490738" MODIFIED="2013-11-17 19:31:48 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="391" O_E="0.0" SE="0.8543992040024265" STUDY_ID="STD-Mangano-1996" TOTAL_1="99" TOTAL_2="101" VAR="0.72999799979998" WEIGHT="1.4699070622971766"/><DICH_DATA CI_END="21.785667983536555" CI_START="0.1911775797639689" EFFECT_SIZE="2.0408163265306123" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="1" LOG_CI_END="1.3381708806415864" LOG_CI_START="-0.7185630406986138" LOG_EFFECT_SIZE="0.3098039199714864" MODIFIED="2013-11-17 19:31:54 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="389" O_E="0.0" SE="1.2081356863923414" STUDY_ID="STD-Bayliff-1999" TOTAL_1="49" TOTAL_2="50" VAR="1.4595918367346938" WEIGHT="0.7348785435421044"/><DICH_DATA CI_END="23.10618612076079" CI_START="0.2684527492293484" EFFECT_SIZE="2.490566037735849" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="1" LOG_CI_END="1.3637282672706277" LOG_CI_START="-0.571132144060506" LOG_EFFECT_SIZE="0.3962980616050608" MODIFIED="2014-06-22 16:50:51 +0100" MODIFIED_BY="Hermann Blessberger" ORDER="395" O_E="0.0" SE="1.1365465833294115" STUDY_ID="STD-POBBLE-2005" TOTAL_1="53" TOTAL_2="44" VAR="1.2917381360777587" WEIGHT="0.8112576726205388"/><DICH_DATA CI_END="2.086100324386569" CI_START="0.006111296108574041" EFFECT_SIZE="0.11291048133153396" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="4" LOG_CI_END="0.3193351906100624" LOG_CI_START="-2.2138666730459673" LOG_EFFECT_SIZE="-0.9472657412179525" MODIFIED="2013-11-17 19:32:46 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="398" O_E="0.0" SE="1.4880153142630121" STUDY_ID="STD-Yang-2006" TOTAL_1="246" TOTAL_2="250" VAR="2.214189575481251" WEIGHT="3.313864954247925"/><DICH_DATA CI_END="2.4023415437266507" CI_START="0.185004686617123" EFFECT_SIZE="0.6666666666666666" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="5" LOG_CI_END="0.38063475161440946" LOG_CI_START="-0.7328172697257719" LOG_EFFECT_SIZE="-0.17609125905568127" MODIFIED="2013-11-17 19:32:21 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="394" O_E="0.0" SE="0.6540472290116194" STUDY_ID="STD-Neary-2006" TOTAL_1="18" TOTAL_2="20" VAR="0.42777777777777776" WEIGHT="3.516524072481283"/><DICH_DATA CI_END="2.5549775876151535" CI_START="0.6868023908740409" EFFECT_SIZE="1.3246753246753247" ESTIMABLE="YES" EVENTS_1="20" EVENTS_2="15" LOG_CI_END="0.4073870948356017" LOG_CI_START="-0.16316820165673035" LOG_EFFECT_SIZE="0.12210944658943569" MODIFIED="2013-11-17 19:32:56 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="390" O_E="0.0" SE="0.3351470054538631" STUDY_ID="STD-DIPOM-_x002d_-Juul-2006" TOTAL_1="462" TOTAL_2="459" VAR="0.11232351526469174" WEIGHT="11.171932069576803"/><DICH_DATA CI_END="1.7258284961101578" CI_START="1.0262717576233682" EFFECT_SIZE="1.3308527507051506" ESTIMABLE="YES" EVENTS_1="129" EVENTS_2="97" LOG_CI_END="0.23699763558907627" LOG_CI_START="0.011262377548303708" LOG_EFFECT_SIZE="0.12413000656868999" MODIFIED="2017-12-03 02:25:07 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="396" O_E="0.0" SE="0.13259800798069846" STUDY_ID="STD-POISE-2008" TOTAL_1="4174" TOTAL_2="4177" VAR="0.017582231720449374" WEIGHT="71.98472953323878"/></DICH_SUBGROUP><DICH_SUBGROUP CHI2="1.4282847638021556" CI_END="2.061564174111357" CI_START="0.3145748336392061" DF="2" EFFECT_SIZE="0.8053050397877983" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="9" I2="0.0" ID="CMP-002.02.02" LOG_CI_END="0.3141968584333517" LOG_CI_START="-0.502276024398052" LOG_EFFECT_SIZE="-0.09403958298235016" MODIFIED="2013-11-26 21:58:54 +0000" MODIFIED_BY="Hermann Blessberger" NO="2" P_CHI2="0.48961190192135773" P_Z="0.6516372708219734" STUDIES="4" TAU2="0.0" TOTAL_1="306" TOTAL_2="312" WEIGHT="6.996906091995399" Z="0.4514888360465776"><NAME>Standard care</NAME><DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-11-17 19:34:08 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="401" O_E="0.0" SE="0.0" STUDY_ID="STD-Lai-2006" TOTAL_1="30" TOTAL_2="30" VAR="0.0" WEIGHT="0.0"/><DICH_DATA CI_END="7.99511202377449" CI_START="0.013897380146858233" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.90282455325627" LOG_CI_START="-1.8570670626955947" LOG_EFFECT_SIZE="-0.47712125471966244" MODIFIED="2013-11-17 19:34:14 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="404" O_E="0.0" SE="1.6211739968939571" STUDY_ID="STD-Yang-2008" TOTAL_1="51" TOTAL_2="51" VAR="2.628205128205128" WEIGHT="1.1135659562857398"/><DICH_DATA CI_END="3.986212369346937" CI_START="0.38358505944859494" EFFECT_SIZE="1.2365482233502538" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="5" LOG_CI_END="0.6005604324423948" LOG_CI_START="-0.416138316843905" LOG_EFFECT_SIZE="0.09221105779924482" MODIFIED="2013-11-17 19:34:22 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="402" O_E="0.0" SE="0.5972138780707484" STUDY_ID="STD-Marwick-2009" TOTAL_1="197" TOTAL_2="203" VAR="0.35666441616030276" WEIGHT="3.656208223138179"/><DICH_DATA CI_END="3.0135058276554862" CI_START="0.036871045707436295" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="3" LOG_CI_END="0.4790720356632876" LOG_CI_START="-1.4333145451026126" LOG_EFFECT_SIZE="-0.47712125471966244" MODIFIED="2013-11-17 19:34:39 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="400" O_E="0.0" SE="1.1233453440081378" STUDY_ID="STD-Kawaguchi-2010" TOTAL_1="28" TOTAL_2="28" VAR="1.2619047619047616" WEIGHT="2.2271319125714797"/></DICH_SUBGROUP></DICH_OUTCOME><DICH_OUTCOME CHI2="0.9520673649550806" CI_END="4.399984179226458" CI_START="0.16262684854521636" CI_STUDY="95" CI_TOTAL="95" DF="2" EFFECT_MEASURE="RR" EFFECT_SIZE="0.8459051724137933" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" I2="0.0" I2_Q="0.0" ID="CMP-002.03" LOG_CI_END="0.6434511149209599" LOG_CI_START="-0.7888077538681787" LOG_EFFECT_SIZE="-0.07267831947360943" METHOD="MH" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" NO="3" P_CHI2="0.6212425997920604" P_Q="0.7966333964172533" P_Z="0.8423314180816447" Q="0.06641266481105002" RANDOM="NO" SCALE="100.0" SORT_BY="YEAR" STUDIES="4" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="150" TOTAL_2="170" WEIGHT="100.0" Z="0.1989122102565134"><NAME>Death due to cardiac causes&#8212;cardiac surgery</NAME><GROUP_LABEL_1>Beta-blocker</GROUP_LABEL_1><GROUP_LABEL_2>Control</GROUP_LABEL_2><GRAPH_LABEL_1>Favours beta-blocker</GRAPH_LABEL_1><GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2><DICH_SUBGROUP CHI2="0.8876019341187397" CI_END="6.857678102289517" CI_START="0.1391566955679687" DF="1" EFFECT_SIZE="0.9768786127167631" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" I2="0.0" ID="CMP-002.03.01" LOG_CI_END="0.8361770955820167" LOG_CI_START="-0.8564958926122603" LOG_EFFECT_SIZE="-0.010159398515121822" MODIFIED="2013-11-17 19:39:24 +0000" MODIFIED_BY="Hermann Blessberger" NO="1" P_CHI2="0.346128098275048" P_Z="0.981229622109427" STUDIES="3" TAU2="0.0" TOTAL_1="131" TOTAL_2="135" WEIGHT="65.2478448275862" Z="0.023527350330639366"><NAME>Placebo</NAME><DICH_DATA CI_END="66.4433184667098" CI_START="0.12341968180365896" EFFECT_SIZE="2.8636363636363638" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.8224513148659036" LOG_CI_START="-0.9086155776031525" LOG_EFFECT_SIZE="0.4569178686313755" MODIFIED="2013-11-17 19:39:12 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="407" O_E="0.0" SE="1.6042422116354729" STUDY_ID="STD-White-1984" TOTAL_1="21" TOTAL_2="20" VAR="2.5735930735930737" WEIGHT="16.594827586206897"/><DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-11-17 19:39:17 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="405" O_E="0.0" SE="0.0" STUDY_ID="STD-Gomes-1999" TOTAL_1="40" TOTAL_2="45" VAR="0.0" WEIGHT="0.0"/><DICH_DATA CI_END="8.044961518532196" CI_START="0.013811266947039826" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.9055239710790393" LOG_CI_START="-1.8597664805183645" LOG_EFFECT_SIZE="-0.47712125471966244" MODIFIED="2013-11-17 19:39:24 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="406" O_E="0.0" SE="1.6243452996768142" STUDY_ID="STD-Sezai-2011" TOTAL_1="70" TOTAL_2="70" VAR="2.6384976525821595" WEIGHT="48.65301724137931"/></DICH_SUBGROUP><DICH_SUBGROUP CHI2="0.0" CI_END="14.051950786893713" CI_START="0.025619218673593205" DF="0" EFFECT_SIZE="0.6" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" I2="0.0" ID="CMP-002.03.02" LOG_CI_END="1.1477366201252595" LOG_CI_START="-1.591434119357972" LOG_EFFECT_SIZE="-0.2218487496163564" MODIFIED="2013-11-17 19:39:31 +0000" MODIFIED_BY="Hermann Blessberger" NO="2" P_CHI2="1.0" P_Z="0.7508796370655153" STUDIES="1" TAU2="0.0" TOTAL_1="19" TOTAL_2="35" WEIGHT="34.752155172413794" Z="0.31747970507697115"><NAME>Standard care</NAME><DICH_DATA CI_END="14.051950786893713" CI_START="0.025619218673593205" EFFECT_SIZE="0.6" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="1.1477366201252595" LOG_CI_START="-1.591434119357972" LOG_EFFECT_SIZE="-0.2218487496163564" MODIFIED="2013-11-17 19:39:31 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="408" O_E="0.0" SE="1.6090024514862893" STUDY_ID="STD-Oka-1980" TOTAL_1="19" TOTAL_2="35" VAR="2.588888888888889" WEIGHT="34.752155172413794"/></DICH_SUBGROUP></DICH_OUTCOME><DICH_OUTCOME CHI2="1.5282253003044441" CI_END="1.7547214489383618" CI_START="0.9052084742356212" CI_STUDY="95" CI_TOTAL="95" DF="3" EFFECT_MEASURE="RR" EFFECT_SIZE="1.2603129474467891" ESTIMABLE="YES" EVENTS_1="77" EVENTS_2="61" I2="0.0" I2_Q="0.0" ID="CMP-002.04" LOG_CI_END="0.24420818473896055" LOG_CI_START="-0.04325138898979941" LOG_EFFECT_SIZE="0.10047839787458057" METHOD="MH" MODIFIED="2017-06-17 15:36:10 +0100" MODIFIED_BY="Hermann Blessberger" NO="4" P_CHI2="0.6757714682629976" P_Q="0.5791899973436061" P_Z="0.17063427719403018" Q="0.3075461326273533" RANDOM="NO" SCALE="100.0" SORT_BY="YEAR" STUDIES="4" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="4716" TOTAL_2="4731" WEIGHT="100.0" Z="1.3701686014763674"><NAME>Death due to cardiac causes&#8212;non-cardiac surgery</NAME><GROUP_LABEL_1>Beta-blocker</GROUP_LABEL_1><GROUP_LABEL_2>Control</GROUP_LABEL_2><GRAPH_LABEL_1>Favours beta-blocker</GRAPH_LABEL_1><GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2><DICH_SUBGROUP CHI2="1.2246556910135689" CI_END="1.7380744090176699" CI_START="0.8927223845959722" DF="2" EFFECT_SIZE="1.2456395670592233" ESTIMABLE="YES" EVENTS_1="76" EVENTS_2="61" I2="0.0" ID="CMP-002.04.01" LOG_CI_END="0.24006836517020647" LOG_CI_START="-0.04928357535873857" LOG_EFFECT_SIZE="0.09539239490573394" MODIFIED="2017-06-17 15:36:10 +0100" MODIFIED_BY="Hermann Blessberger" NO="1" P_CHI2="0.5420877881944786" P_Z="0.1962511136114979" STUDIES="3" TAU2="0.0" TOTAL_1="4519" TOTAL_2="4528" WEIGHT="99.20481099384594" Z="1.2923062349088186"><NAME>Placebo</NAME><DICH_DATA CI_END="5.535882382109476" CI_START="0.04700299293694875" EFFECT_SIZE="0.51010101010101" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" LOG_CI_END="0.7431868543274104" LOG_CI_START="-1.3278744872851878" LOG_EFFECT_SIZE="-0.2923438164788886" MODIFIED="2013-11-17 19:41:48 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="409" O_E="0.0" SE="1.216551683982222" STUDY_ID="STD-Mangano-1996" TOTAL_1="99" TOTAL_2="101" VAR="1.47999799979998" WEIGHT="3.196659804739338"/><DICH_DATA CI_END="8.274975487492005" CI_START="0.013865780185584986" EFFECT_SIZE="0.33873144399460187" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.9177667159628347" LOG_CI_START="-1.8580556889594146" LOG_EFFECT_SIZE="-0.47014448649829005" MODIFIED="2013-11-17 19:41:55 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="412" O_E="0.0" SE="1.6305318211938382" STUDY_ID="STD-Yang-2006" TOTAL_1="246" TOTAL_2="250" VAR="2.658634019925695" WEIGHT="2.4022604714939044"/><DICH_DATA CI_END="1.8180790761671433" CI_START="0.9210386011859882" EFFECT_SIZE="1.2940328470168365" ESTIMABLE="YES" EVENTS_1="75" EVENTS_2="58" LOG_CI_END="0.2596127686528247" LOG_CI_START="-0.035722167923927406" LOG_EFFECT_SIZE="0.11194530036444864" MODIFIED="2013-11-17 19:42:09 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="410" O_E="0.0" SE="0.17348120367669792" STUDY_ID="STD-POISE-2008" TOTAL_1="4174" TOTAL_2="4177" VAR="0.03009572802911595" WEIGHT="93.6058907176127"/></DICH_SUBGROUP><DICH_SUBGROUP CHI2="0.0" CI_END="75.42168546066148" CI_START="0.1266707174456808" DF="0" EFFECT_SIZE="3.090909090909091" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" I2="0.0" ID="CMP-002.04.02" LOG_CI_END="1.8774962334274081" LOG_CI_START="-0.8973237696593478" LOG_EFFECT_SIZE="0.49008623188403005" MODIFIED="2013-11-26 21:58:54 +0000" MODIFIED_BY="Hermann Blessberger" NO="2" P_CHI2="1.0" P_Z="0.48872749560042816" STUDIES="1" TAU2="0.0" TOTAL_1="197" TOTAL_2="203" WEIGHT="0.7951890061540642" Z="0.6923341786084224"><NAME>Standard care</NAME><DICH_DATA CI_END="75.42168546066148" CI_START="0.12667071744568087" EFFECT_SIZE="3.090909090909091" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.8774962334274081" LOG_CI_START="-0.8973237696593477" LOG_EFFECT_SIZE="0.49008623188403005" MODIFIED="2013-11-17 19:42:29 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="414" O_E="0.0" SE="1.6299430053937" STUDY_ID="STD-Marwick-2009" TOTAL_1="197" TOTAL_2="203" VAR="2.6567142008318476" WEIGHT="0.7951890061540642"/></DICH_SUBGROUP></DICH_OUTCOME><DICH_OUTCOME CHI2="9.818496620370027" CI_END="1.5111088814762033" CI_START="0.7119610516323913" CI_STUDY="95" CI_TOTAL="95" DF="19" EFFECT_MEASURE="RR" EFFECT_SIZE="1.0372322152665931" ESTIMABLE="YES" EVENTS_1="50" EVENTS_2="51" I2="0.0" I2_Q="3.3942426400841144" ID="CMP-002.05" LOG_CI_END="0.17929575813165266" LOG_CI_START="-0.14754376412128795" LOG_EFFECT_SIZE="0.015875997005182357" METHOD="MH" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" NO="5" P_CHI2="0.957281848961746" P_Q="0.3089559728912876" P_Z="0.8489896572397033" Q="1.0351349933258995" RANDOM="NO" SCALE="100.0" SORT_BY="YEAR" STUDIES="22" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="1751" TOTAL_2="1802" WEIGHT="100.0" Z="0.19040770916769525"><NAME>Acute myocardial infarction&#8212;cardiac surgery</NAME><GROUP_LABEL_1>Beta-blocker</GROUP_LABEL_1><GROUP_LABEL_2>Control</GROUP_LABEL_2><GRAPH_LABEL_1>Favours beta-blocker</GRAPH_LABEL_1><GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2><DICH_SUBGROUP CHI2="3.0051289233529506" CI_END="2.692821944142287" CI_START="0.7051558314169336" DF="6" EFFECT_SIZE="1.3779909640049959" ESTIMABLE="YES" EVENTS_1="19" EVENTS_2="13" I2="0.0" ID="CMP-002.05.01" LOG_CI_END="0.4302076377661343" LOG_CI_START="-0.15171489826244894" LOG_EFFECT_SIZE="0.13924636975184268" MODIFIED="2013-11-17 19:48:42 +0000" MODIFIED_BY="Hermann Blessberger" NO="1" P_CHI2="0.8082028906024131" P_Z="0.3482511325765417" STUDIES="7" TAU2="0.0" TOTAL_1="878" TOTAL_2="859" WEIGHT="28.06975130329301" Z="0.9379869408534263"><NAME>Placebo</NAME><DICH_DATA CI_END="4.283442722425353" CI_START="0.010892173194178404" EFFECT_SIZE="0.216" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" LOG_CI_END="0.6317929639528874" LOG_CI_START="-1.9628854616510256" LOG_EFFECT_SIZE="-0.6655462488490691" MODIFIED="2013-11-17 19:47:58 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="417" O_E="0.0" SE="1.5241269510650886" STUDY_ID="STD-Hammon-1984" TOTAL_1="24" TOTAL_2="26" VAR="2.3229629629629627" WEIGHT="4.6780096526829595"/><DICH_DATA CI_END="8.873814181503294" CI_START="0.015231822201475684" EFFECT_SIZE="0.36764705882352944" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.9481103303087892" LOG_CI_START="-1.8172481383771868" LOG_EFFECT_SIZE="-0.4345689040341987" MODIFIED="2013-11-17 19:48:06 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="418" O_E="0.0" SE="1.6243852532513314" STUDY_ID="STD-Khuri-1987" TOTAL_1="67" TOTAL_2="74" VAR="2.638627450980392" WEIGHT="2.7761860920649424"/><DICH_DATA CI_END="24.14022199893455" CI_START="0.21642260771872576" EFFECT_SIZE="2.2857142857142856" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="1" LOG_CI_END="1.3827412596498534" LOG_CI_START="-0.6646973743665175" LOG_EFFECT_SIZE="0.3590219426416679" MODIFIED="2013-11-17 19:48:12 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="419" O_E="0.0" SE="1.2026755886059097" STUDY_ID="STD-Martinussen-1988" TOTAL_1="35" TOTAL_2="40" VAR="1.4464285714285716" WEIGHT="1.816315214481704"/><DICH_DATA CI_END="5.525756215095862" CI_START="0.3217256984521052" EFFECT_SIZE="1.3333333333333333" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="3" LOG_CI_END="0.7423917208312917" LOG_CI_START="-0.4925142476146918" LOG_EFFECT_SIZE="0.12493873660829993" MODIFIED="2013-11-17 19:48:20 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="420" O_E="0.0" SE="0.7253898787483019" STUDY_ID="STD-Matangi-1989" TOTAL_1="35" TOTAL_2="35" VAR="0.5261904761904761" WEIGHT="5.838156046548335"/><DICH_DATA CI_END="15.840228937301898" CI_START="0.06313040070053004" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.199761454115117" LOG_CI_START="-1.199761454115117" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-11-17 19:48:27 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="422" O_E="0.0" SE="1.4094916341243984" STUDY_ID="STD-Suttorp-1991" TOTAL_1="150" TOTAL_2="150" VAR="1.9866666666666668" WEIGHT="1.9460520155161114"/><DICH_DATA CI_END="5.80943240846048" CI_START="0.6885354228710294" EFFECT_SIZE="2.0" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="5" LOG_CI_END="0.7641337031450597" LOG_CI_START="-0.16207371181709732" LOG_EFFECT_SIZE="0.3010299956639812" MODIFIED="2013-11-17 19:48:36 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="416" O_E="0.0" SE="0.5440588203494178" STUDY_ID="STD-Connolly-2003" TOTAL_1="500" TOTAL_2="500" VAR="0.29600000000000004" WEIGHT="9.730260077580557"/><DICH_DATA CI_END="52.1508617241787" CI_START="0.1269979711600307" EFFECT_SIZE="2.573529411764706" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="0" LOG_CI_END="1.717261488965115" LOG_CI_START="-0.8962032170049987" LOG_EFFECT_SIZE="0.41052913598005814" MODIFIED="2013-11-17 19:48:42 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="421" O_E="0.0" SE="1.5351621051457824" STUDY_ID="STD-Sezai-2012" TOTAL_1="67" TOTAL_2="34" VAR="2.3567226890756303" WEIGHT="1.2847722044184038"/></DICH_SUBGROUP><DICH_SUBGROUP CHI2="5.905286346880028" CI_END="1.4295173754800654" CI_START="0.5719964653729107" DF="12" EFFECT_SIZE="0.9042559847541831" ESTIMABLE="YES" EVENTS_1="31" EVENTS_2="38" I2="0.0" ID="CMP-002.05.02" LOG_CI_END="0.15518943848327116" LOG_CI_START="-0.24260665490240133" LOG_EFFECT_SIZE="-0.043708608209565084" MODIFIED="2014-06-22 17:23:40 +0100" MODIFIED_BY="Hermann Blessberger" NO="2" P_CHI2="0.9207809777067314" P_Z="0.6666795396708761" STUDIES="15" TAU2="0.0" TOTAL_1="873" TOTAL_2="943" WEIGHT="71.93024869670698" Z="0.4307095988600516"><NAME>Standard care</NAME><DICH_DATA CI_END="3.5279536888293985" CI_START="0.011338017312033452" EFFECT_SIZE="0.2" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="4" LOG_CI_END="0.5475228755476929" LOG_CI_START="-1.9454628842197306" LOG_EFFECT_SIZE="-0.6989700043360187" MODIFIED="2013-11-17 19:49:01 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="434" O_E="0.0" SE="1.46439217576592" STUDY_ID="STD-Oka-1980" TOTAL_1="19" TOTAL_2="35" VAR="2.144444444444445" WEIGHT="6.255167192730358"/><DICH_DATA CI_END="3.8257633571979164" CI_START="0.22994486153744298" EFFECT_SIZE="0.9379310344827586" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="5" LOG_CI_END="0.5827181032130841" LOG_CI_START="-0.6383762909425988" LOG_EFFECT_SIZE="-0.027829093864757383" MODIFIED="2013-11-17 19:48:54 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="436" O_E="0.0" SE="0.717276891641784" STUDY_ID="STD-Stephenson-1980" TOTAL_1="87" TOTAL_2="136" VAR="0.5144861392832996" WEIGHT="7.592220867708597"/><DICH_DATA CI_END="5.214575411505864" CI_START="0.012754575404951726" EFFECT_SIZE="0.2578947368421053" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" LOG_CI_END="0.7172189524659107" LOG_CI_START="-1.8943339943145414" LOG_EFFECT_SIZE="-0.5885575209243152" MODIFIED="2013-11-17 19:49:07 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="432" O_E="0.0" SE="1.5340391283344144" STUDY_ID="STD-Mohr-1981" TOTAL_1="37" TOTAL_2="48" VAR="2.35327604726101" WEIGHT="4.249998654575416"/><DICH_DATA CI_END="2.554588535140364" CI_START="0.2718419952535674" EFFECT_SIZE="0.8333333333333334" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="6" LOG_CI_END="0.4073209587531089" LOG_CI_START="-0.5656834508483586" LOG_EFFECT_SIZE="-0.0791812460476248" MODIFIED="2013-11-17 19:49:15 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="435" O_E="0.0" SE="0.5715476066494082" STUDY_ID="STD-Silverman-1982" TOTAL_1="50" TOTAL_2="50" VAR="0.32666666666666666" WEIGHT="11.67631209309667"/><DICH_DATA CI_END="6.823446325509919" CI_START="0.14655350863704047" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="2" LOG_CI_END="0.8340037796584007" LOG_CI_START="-0.8340037796584007" LOG_EFFECT_SIZE="0.0" MODIFIED="2014-06-22 17:23:40 +0100" MODIFIED_BY="Hermann Blessberger" ORDER="423" O_E="0.0" SE="0.9797958971132712" STUDY_ID="STD-Abel-1983" TOTAL_1="50" TOTAL_2="50" VAR="0.96" WEIGHT="3.892104031032223"/><DICH_DATA CI_END="18.464793725803222" CI_START="0.08462049580421353" EFFECT_SIZE="1.25" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.2663444604166862" LOG_CI_START="-1.0725244344005735" LOG_EFFECT_SIZE="0.09691001300805642" MODIFIED="2013-11-17 19:49:28 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="433" O_E="0.0" SE="1.3738631664034087" STUDY_ID="STD-Myhre-1984" TOTAL_1="16" TOTAL_2="20" VAR="1.8875" WEIGHT="1.7298240137920988"/><DICH_DATA CI_END="2.8734486028922372" CI_START="0.22272888380735792" EFFECT_SIZE="0.8" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="5" LOG_CI_END="0.45840343335420675" LOG_CI_START="-0.6522234593703196" LOG_EFFECT_SIZE="-0.09691001300805639" MODIFIED="2013-11-17 19:49:38 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="431" O_E="0.0" SE="0.6523877344781713" STUDY_ID="STD-Matangi-1985" TOTAL_1="82" TOTAL_2="82" VAR="0.42560975609756097" WEIGHT="9.730260077580557"/><DICH_DATA CI_END="15.548273108710726" CI_START="0.06431582420814068" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.1916821605007981" LOG_CI_START="-1.1916821605007981" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-11-17 19:49:47 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="427" O_E="0.0" SE="1.4" STUDY_ID="STD-Daudon-1986" TOTAL_1="50" TOTAL_2="50" VAR="1.96" WEIGHT="1.9460520155161114"/><DICH_DATA CI_END="6.907791933318855" CI_START="0.013028765323097881" EFFECT_SIZE="0.3" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.8393392478918953" LOG_CI_START="-1.8850967384525705" LOG_EFFECT_SIZE="-0.5228787452803376" MODIFIED="2013-11-17 19:49:54 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="430" O_E="0.0" SE="1.600347184554374" STUDY_ID="STD-Jacquet-1994" TOTAL_1="19" TOTAL_2="17" VAR="2.5611111111111113" WEIGHT="3.0727137087096494"/><DICH_DATA CI_END="17.222250445333504" CI_START="0.07299374868245567" EFFECT_SIZE="1.121212121212121" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.2360899004353734" LOG_CI_START="-1.1367143320571584" LOG_EFFECT_SIZE="0.04968778418910748" MODIFIED="2013-11-17 19:50:00 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="425" O_E="0.0" SE="1.393796951736494" STUDY_ID="STD-Babin_x002d_Ebell-1996" TOTAL_1="33" TOTAL_2="37" VAR="1.9426699426699428" WEIGHT="1.834849043200905"/><DICH_DATA CI_END="6.7963699605826395" CI_START="0.40871491603433024" EFFECT_SIZE="1.6666666666666667" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="3" LOG_CI_END="0.8322770116723457" LOG_CI_START="-0.3885795124396329" LOG_EFFECT_SIZE="0.2218487496163564" MODIFIED="2013-11-17 19:50:10 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="424" O_E="0.0" SE="0.7171371656006362" STUDY_ID="STD-Ali-1997" TOTAL_1="105" TOTAL_2="105" VAR="0.5142857142857143" WEIGHT="5.838156046548335"/><DICH_DATA CI_END="6.429716840797003" CI_START="0.6221113773813055" EFFECT_SIZE="2.0" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="4" LOG_CI_END="0.8081918473896704" LOG_CI_START="-0.20613185606170806" LOG_EFFECT_SIZE="0.3010299956639812" MODIFIED="2013-11-17 19:50:18 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="437" O_E="0.0" SE="0.5958187643906492" STUDY_ID="STD-Wenke-1999" TOTAL_1="100" TOTAL_2="100" VAR="0.355" WEIGHT="7.784208062064446"/><DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-11-17 19:50:24 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="428" O_E="0.0" SE="0.0" STUDY_ID="STD-Evrard-2000" TOTAL_1="103" TOTAL_2="103" VAR="0.0" WEIGHT="0.0"/><DICH_DATA CI_END="2.6378743799535904" CI_START="0.03008078627713564" EFFECT_SIZE="0.28169014084507044" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="3" LOG_CI_END="0.4212541098638801" LOG_CI_START="-1.5217108159740682" LOG_EFFECT_SIZE="-0.5502283530550941" MODIFIED="2014-06-22 17:17:59 +0100" MODIFIED_BY="Hermann Blessberger" ORDER="426" O_E="0.0" SE="1.141307215268708" STUDY_ID="STD-Bert-2001" TOTAL_1="71" TOTAL_2="60" VAR="1.3025821596244131" WEIGHT="6.328382890151629"/><DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-11-17 19:50:39 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="429" O_E="0.0" SE="0.0" STUDY_ID="STD-Forlani-2002" TOTAL_1="51" TOTAL_2="50" VAR="0.0" WEIGHT="0.0"/></DICH_SUBGROUP></DICH_OUTCOME><DICH_OUTCOME CHI2="6.269793019097788" CI_END="0.8777760704007815" CI_START="0.6113724854812779" CI_STUDY="95" CI_TOTAL="95" DF="10" EFFECT_MEASURE="RR" EFFECT_SIZE="0.7325627194014961" ESTIMABLE="YES" EVENTS_1="194" EVENTS_2="266" I2="0.0" I2_Q="0.0" ID="CMP-002.06" LOG_CI_END="-0.05661626290156223" LOG_CI_START="-0.21369411038019123" LOG_EFFECT_SIZE="-0.13515518664087667" METHOD="MH" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" NO="6" P_CHI2="0.7921099759304913" P_Q="0.8485418136068008" P_Z="7.439691406071839E-4" Q="0.036473125537573994" RANDOM="YES" SCALE="100.0" SORT_BY="YEAR" STUDIES="14" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="5522" TOTAL_2="5436" WEIGHT="99.99999999999999" Z="3.372840949783806"><NAME>Acute myocardial infarction&#8212;non-cardiac surgery</NAME><GROUP_LABEL_1>Beta-blocker</GROUP_LABEL_1><GROUP_LABEL_2>Control</GROUP_LABEL_2><GRAPH_LABEL_1>Favours beta-blocker</GRAPH_LABEL_1><GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2><DICH_SUBGROUP CHI2="2.953415763514872" CI_END="0.8728527606339845" CI_START="0.6007707407778906" DF="7" EFFECT_SIZE="0.7241439080708376" ESTIMABLE="YES" EVENTS_1="181" EVENTS_2="250" I2="0.0" ID="CMP-002.06.01" LOG_CI_END="-0.05905901017445144" LOG_CI_START="-0.22129122684965707" LOG_EFFECT_SIZE="-0.14017511851205428" MODIFIED="2013-11-17 19:54:55 +0000" MODIFIED_BY="Hermann Blessberger" NO="1" P_CHI2="0.8892779576998733" P_Z="7.066797701795612E-4" STUDIES="9" TAU2="0.0" TOTAL_1="5115" TOTAL_2="5094" WEIGHT="93.74663288485227" Z="3.386974417816103"><NAME>Placebo</NAME><DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-11-17 19:53:41 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="440" O_E="0.0" SE="0.0" STUDY_ID="STD-Miller-1990" TOTAL_1="30" TOTAL_2="15" VAR="0.0" WEIGHT="0.0"/><DICH_DATA CI_END="65.33683949785127" CI_START="0.12362952338910503" EFFECT_SIZE="2.8421052631578947" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.8151581227650624" LOG_CI_START="-0.9078778050247834" LOG_EFFECT_SIZE="0.45364015887013953" MODIFIED="2013-11-17 19:53:56 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="439" O_E="0.0" SE="1.5995247832289885" STUDY_ID="STD-Jakobsen-1997" TOTAL_1="18" TOTAL_2="17" VAR="2.5584795321637426" WEIGHT="0.33275388876432793"/><DICH_DATA CI_END="5.535882382109476" CI_START="0.04700299293694875" EFFECT_SIZE="0.51010101010101" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" LOG_CI_END="0.7431868543274104" LOG_CI_START="-1.3278744872851878" LOG_EFFECT_SIZE="-0.2923438164788886" MODIFIED="2013-11-17 19:54:02 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="445" O_E="0.0" SE="1.216551683982222" STUDY_ID="STD-Wallace-1998" TOTAL_1="99" TOTAL_2="101" VAR="1.47999799979998" WEIGHT="0.5752332190762974"/><DICH_DATA CI_END="5.615700904668708" CI_START="0.011129510111202603" EFFECT_SIZE="0.25" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.7494039689737728" LOG_CI_START="-1.9535239516296976" LOG_EFFECT_SIZE="-0.6020599913279624" MODIFIED="2013-11-17 19:54:09 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="444" O_E="0.0" SE="1.5877132402714706" STUDY_ID="STD-Raby-1999" TOTAL_1="15" TOTAL_2="11" VAR="2.520833333333333" WEIGHT="0.3377232450848624"/><DICH_DATA CI_END="1.9689060372965594" CI_START="0.1260175766811152" EFFECT_SIZE="0.4981132075471698" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="5" LOG_CI_END="0.29422499066461516" LOG_CI_START="-0.8995688761265311" LOG_EFFECT_SIZE="-0.302671942730958" MODIFIED="2013-11-17 19:54:16 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="442" O_E="0.0" SE="0.7012404267280651" STUDY_ID="STD-POBBLE-2005" TOTAL_1="53" TOTAL_2="44" VAR="0.49173813607775874" WEIGHT="1.731295482676984"/><DICH_DATA CI_END="2.6794711630264745" CI_START="0.11518764581889715" EFFECT_SIZE="0.5555555555555556" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="4" LOG_CI_END="0.428049087445737" LOG_CI_START="-0.9385940976523491" LOG_EFFECT_SIZE="-0.25527250510330607" MODIFIED="2013-11-17 19:54:28 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="441" O_E="0.0" SE="0.8027729719194864" STUDY_ID="STD-Neary-2006" TOTAL_1="18" TOTAL_2="20" VAR="0.6444444444444444" WEIGHT="1.3210510556660027"/><DICH_DATA CI_END="1.6671769426996792" CI_START="0.5071036310519903" EFFECT_SIZE="0.9194734804490902" ESTIMABLE="YES" EVENTS_1="19" EVENTS_2="21" LOG_CI_END="0.22198169530492604" LOG_CI_START="-0.29490327972978975" LOG_EFFECT_SIZE="-0.03646079221243184" MODIFIED="2013-11-17 19:54:46 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="446" O_E="0.0" SE="0.3036207929572834" STUDY_ID="STD-Yang-2006" TOTAL_1="246" TOTAL_2="250" VAR="0.09218558591600953" WEIGHT="9.235109862262902"/><DICH_DATA CI_END="8.877109838397404" CI_START="0.250179859646748" EFFECT_SIZE="1.4902597402597402" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="2" LOG_CI_END="0.9482715935329684" LOG_CI_START="-0.6017476554593345" LOG_EFFECT_SIZE="0.17326196903681695" MODIFIED="2013-11-17 19:54:38 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="438" O_E="0.0" SE="0.9104889795771052" STUDY_ID="STD-DIPOM-_x002d_-Juul-2006" TOTAL_1="462" TOTAL_2="459" VAR="0.8289901819313583" WEIGHT="1.026965134457909"/><DICH_DATA CI_END="0.8669144321966489" CI_START="0.5773751446800002" EFFECT_SIZE="0.7074848731349105" ESTIMABLE="YES" EVENTS_1="152" EVENTS_2="215" LOG_CI_END="-0.06202376695142708" LOG_CI_START="-0.23854191591886673" LOG_EFFECT_SIZE="-0.1502828414351469" MODIFIED="2013-11-17 19:54:55 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="443" O_E="0.0" SE="0.10368763448240352" STUDY_ID="STD-POISE-2008" TOTAL_1="4174" TOTAL_2="4177" VAR="0.010751125544556516" WEIGHT="79.18650099686299"/></DICH_SUBGROUP><DICH_SUBGROUP CHI2="3.184852021504" CI_END="2.5970612724718256" CI_START="0.15284675320650953" DF="2" EFFECT_SIZE="0.6300415727360256" ESTIMABLE="YES" EVENTS_1="13" EVENTS_2="16" I2="37.20273386342361" ID="CMP-002.06.02" LOG_CI_END="0.41448219606076037" LOG_CI_START="-0.8157437821879616" LOG_EFFECT_SIZE="-0.20063079306360068" MODIFIED="2013-11-26 21:58:54 +0000" MODIFIED_BY="Hermann Blessberger" NO="2" P_CHI2="0.2034316141446092" P_Z="0.5226411211621051" STUDIES="5" TAU2="0.6828585381516818" TOTAL_1="407" TOTAL_2="342" WEIGHT="6.253367115147715" Z="0.639279507256291"><NAME>Standard care</NAME><DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-11-17 19:55:06 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="451" O_E="0.0" SE="0.0" STUDY_ID="STD-Stone-1988" TOTAL_1="89" TOTAL_2="39" VAR="0.0" WEIGHT="0.0"/><DICH_DATA CI_END="1.2850770513332368" CI_START="0.0037789141856547637" EFFECT_SIZE="0.06968641114982578" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="3" LOG_CI_END="0.10892916810749446" LOG_CI_START="-2.4226329702475167" LOG_EFFECT_SIZE="-1.1568519010700111" MODIFIED="2013-11-17 19:55:13 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="453" O_E="0.0" SE="1.4870521315044227" STUDY_ID="STD-Zaugg-1999" TOTAL_1="40" TOTAL_2="19" VAR="2.2113240418118467" WEIGHT="0.38499288098630524"/><DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-11-17 19:55:42 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="448" O_E="0.0" SE="0.0" STUDY_ID="STD-Lai-2006" TOTAL_1="30" TOTAL_2="30" VAR="0.0" WEIGHT="0.0"/><DICH_DATA CI_END="15.556810748046935" CI_START="0.06428052742915473" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.1919205684576701" LOG_CI_START="-1.1919205684576701" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-11-17 19:55:48 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="452" O_E="0.0" SE="1.4002800840280099" STUDY_ID="STD-Yang-2008" TOTAL_1="51" TOTAL_2="51" VAR="1.9607843137254903" WEIGHT="0.4341854469622261"/><DICH_DATA CI_END="2.2384256247346914" CI_START="0.47436971491585606" EFFECT_SIZE="1.0304568527918783" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="12" LOG_CI_END="0.34994266883162384" LOG_CI_START="-0.3238830453283838" LOG_EFFECT_SIZE="0.013029811751620029" MODIFIED="2013-11-17 19:55:55 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="449" O_E="0.0" SE="0.3958085599886677" STUDY_ID="STD-Marwick-2009" TOTAL_1="197" TOTAL_2="203" VAR="0.15666441616030274" WEIGHT="5.434188787199184"/></DICH_SUBGROUP></DICH_OUTCOME><DICH_OUTCOME CHI2="3.671724678751238" CI_END="1.0541696233454452" CI_START="0.2469457452997947" CI_STUDY="95" CI_TOTAL="95" DF="3" EFFECT_MEASURE="RR" EFFECT_SIZE="0.5102182898617461" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="20" I2="18.294527436618512" I2_Q="39.17592521520564" ID="CMP-002.07" LOG_CI_END="0.022910497551937605" LOG_CI_START="-0.6073984520241552" LOG_EFFECT_SIZE="-0.29224397723610884" METHOD="MH" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" NO="7" P_CHI2="0.29916361140303693" P_Q="0.19976586071046465" P_Z="0.0691433007736594" Q="1.6440858386061201" RANDOM="NO" SCALE="100.0" SORT_BY="YEAR" STUDIES="4" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="78" TOTAL_2="88" WEIGHT="100.0" Z="1.8174822695020865"><NAME>Myocardial ischaemia&#8212;cardiac surgery</NAME><GROUP_LABEL_1>Beta-blocker</GROUP_LABEL_1><GROUP_LABEL_2>Control</GROUP_LABEL_2><GRAPH_LABEL_1>Favours beta-blocker</GRAPH_LABEL_1><GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2><DICH_SUBGROUP CHI2="2.0166403742455454" CI_END="2.102705659091385" CI_START="0.307561292092478" DF="2" EFFECT_SIZE="0.8041833555852247" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="8" I2="0.8251532825613906" ID="CMP-002.07.01" LOG_CI_END="0.3227784835379686" LOG_CI_START="-0.5120683232543628" LOG_EFFECT_SIZE="-0.09464491985819709" MODIFIED="2013-11-17 19:59:39 +0000" MODIFIED_BY="Hermann Blessberger" NO="1" P_CHI2="0.36483143360915427" P_Z="0.6567574431538399" STUDIES="3" TAU2="0.0" TOTAL_1="47" TOTAL_2="51" WEIGHT="41.88073545373812" Z="0.4443944271751631"><NAME>Placebo</NAME><DICH_DATA CI_END="2.8531415452949767" CI_START="0.03894342756823292" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="3" LOG_CI_END="0.45532331768430767" LOG_CI_START="-1.4095658271236327" LOG_EFFECT_SIZE="-0.47712125471966244" MODIFIED="2013-11-17 19:59:30 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="454" O_E="0.0" SE="1.0954451150103321" STUDY_ID="STD-Harrison-1987" TOTAL_1="15" TOTAL_2="15" VAR="1.2" WEIGHT="15.935927375587935"/><DICH_DATA CI_END="3.004555588665069" CI_START="0.1132539464610019" EFFECT_SIZE="0.5833333333333334" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="3" LOG_CI_END="0.4777802435055779" LOG_CI_START="-0.9459466555723139" LOG_EFFECT_SIZE="-0.23408320603336796" MODIFIED="2013-11-17 19:59:35 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="456" O_E="0.0" SE="0.8363042280801657" STUDY_ID="STD-Reves-1990" TOTAL_1="16" TOTAL_2="14" VAR="0.6994047619047619" WEIGHT="16.998322533960465"/><DICH_DATA CI_END="10.94851618230894" CI_START="0.38853723912594074" EFFECT_SIZE="2.0625" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="2" LOG_CI_END="1.0393552646098279" LOG_CI_START="-0.41056735016590234" LOG_EFFECT_SIZE="0.31439395722196267" MODIFIED="2013-11-17 19:59:39 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="455" O_E="0.0" SE="0.8516917211519599" STUDY_ID="STD-Neustein-1994" TOTAL_1="16" TOTAL_2="22" VAR="0.7253787878787878" WEIGHT="8.946485544189718"/></DICH_SUBGROUP><DICH_SUBGROUP CHI2="0.0" CI_END="0.9630309301159309" CI_START="0.09245275176220336" DF="0" EFFECT_SIZE="0.29838709677419356" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="12" I2="0.0" ID="CMP-002.07.02" LOG_CI_END="-0.016359764211958033" LOG_CI_START="-1.034080157978522" LOG_EFFECT_SIZE="-0.52521996109524" MODIFIED="2013-11-17 19:59:45 +0000" MODIFIED_BY="Hermann Blessberger" NO="2" P_CHI2="1.0" P_Z="0.04307557293396961" STUDIES="1" TAU2="0.0" TOTAL_1="31" TOTAL_2="37" WEIGHT="58.11926454626188" Z="2.022976475686733"><NAME>Standard care</NAME><DICH_DATA CI_END="0.9630309301159309" CI_START="0.09245275176220336" EFFECT_SIZE="0.29838709677419356" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="12" LOG_CI_END="-0.016359764211958033" LOG_CI_START="-1.034080157978522" LOG_EFFECT_SIZE="-0.52521996109524" MODIFIED="2013-11-17 19:59:45 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="457" O_E="0.0" SE="0.5978139970956774" STUDY_ID="STD-Kurian-2001" TOTAL_1="31" TOTAL_2="37" VAR="0.3573815751235106" WEIGHT="58.11926454626188"/></DICH_SUBGROUP></DICH_OUTCOME><DICH_OUTCOME CHI2="12.456008542791606" CI_END="0.7685836416244641" CI_START="0.3422559620050428" CI_STUDY="95" CI_TOTAL="95" DF="9" EFFECT_MEASURE="RR" EFFECT_SIZE="0.5128862774977705" ESTIMABLE="YES" EVENTS_1="60" EVENTS_2="97" I2="27.74571429458136" I2_Q="83.8078016545955" ID="CMP-002.08" LOG_CI_END="-0.11430886320738615" LOG_CI_START="-0.46564897783724807" LOG_EFFECT_SIZE="-0.2899789205223171" METHOD="MH" MODIFIED="2017-06-17 15:36:35 +0100" MODIFIED_BY="Hermann Blessberger" NO="8" P_CHI2="0.1888049672638734" P_Q="0.012950911153106426" P_Z="0.0012150794633561935" Q="6.175813676861297" RANDOM="YES" SCALE="100.0" SORT_BY="YEAR" STUDIES="14" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.09800846043026636" TOTALS="YES" TOTAL_1="552" TOTAL_2="426" WEIGHT="100.0" Z="3.2353165313804335"><NAME>Myocardial ischaemia&#8212;non-cardiac surgery</NAME><GROUP_LABEL_1>Beta-blocker</GROUP_LABEL_1><GROUP_LABEL_2>Control</GROUP_LABEL_2><GRAPH_LABEL_1>Favours beta-blocker</GRAPH_LABEL_1><GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2><DICH_SUBGROUP CHI2="3.481161616540669" CI_END="0.8605209600793369" CI_START="0.49495112769789273" DF="5" EFFECT_SIZE="0.6526222640999472" ESTIMABLE="YES" EVENTS_1="56" EVENTS_2="78" I2="0.0" ID="CMP-002.08.01" LOG_CI_END="-0.06523854691000097" LOG_CI_START="-0.30543768191286197" LOG_EFFECT_SIZE="-0.18533811441143141" MODIFIED="2017-06-17 15:36:35 +0100" MODIFIED_BY="Hermann Blessberger" NO="1" P_CHI2="0.6262401332997443" P_Z="0.00248942434849491" STUDIES="9" TAU2="0.0" TOTAL_1="350" TOTAL_2="295" WEIGHT="83.72961548620404" Z="3.024623957989215"><NAME>Placebo</NAME><DICH_DATA CI_END="1.2469987885761085" CI_START="0.0982358612712665" EFFECT_SIZE="0.35" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="5" LOG_CI_END="0.09586603157399819" LOG_CI_START="-1.007729942873447" LOG_EFFECT_SIZE="-0.4559319556497244" MODIFIED="2013-11-17 20:02:33 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="459" O_E="0.0" SE="0.6482577382786072" STUDY_ID="STD-Coleman-1980" TOTAL_1="24" TOTAL_2="14" VAR="0.4202380952380952" WEIGHT="8.218532122292464"/><DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-11-17 20:02:40 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="461" O_E="0.0" SE="0.0" STUDY_ID="STD-Liu-1986" TOTAL_1="16" TOTAL_2="14" VAR="0.0" WEIGHT="0.0"/><DICH_DATA CI_END="66.61522199816511" CI_START="0.11922423317225214" EFFECT_SIZE="2.8181818181818183" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.8235734795372827" LOG_CI_START="-0.9236354621851873" LOG_EFFECT_SIZE="0.44996900867604767" MODIFIED="2013-11-17 20:02:47 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="460" O_E="0.0" SE="1.6137241312713606" STUDY_ID="STD-Cucchiara-1986" TOTAL_1="32" TOTAL_2="30" VAR="2.6041055718475072" WEIGHT="1.5762569285195938"/><DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-11-17 20:03:03 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="462" O_E="0.0" SE="0.0" STUDY_ID="STD-Miller-1990" TOTAL_1="30" TOTAL_2="15" VAR="0.0" WEIGHT="0.0"/><DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-11-17 20:02:56 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="463" O_E="0.0" SE="0.0" STUDY_ID="STD-Oxorn-1990" TOTAL_1="32" TOTAL_2="16" VAR="0.0" WEIGHT="0.0"/><DICH_DATA CI_END="0.963432747451777" CI_START="0.4699791874804524" EFFECT_SIZE="0.6728992048140985" ESTIMABLE="YES" EVENTS_1="31" EVENTS_2="47" LOG_CI_END="-0.016178595933257885" LOG_CI_START="-0.3279213738994463" LOG_EFFECT_SIZE="-0.1720499849163521" MODIFIED="2013-11-17 20:03:18 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="467" O_E="0.0" SE="0.18311925092897763" STUDY_ID="STD-Wallace-1998" TOTAL_1="99" TOTAL_2="101" VAR="0.03353266006078988" WEIGHT="32.379425909766766"/><DICH_DATA CI_END="1.022049427213816" CI_START="0.20553746115499483" EFFECT_SIZE="0.4583333333333333" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="8" LOG_CI_END="0.009471899171640366" LOG_CI_START="-0.6871090122784024" LOG_EFFECT_SIZE="-0.338818556553381" MODIFIED="2013-11-17 20:03:28 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="465" O_E="0.0" SE="0.40917507551687754" STUDY_ID="STD-Raby-1999" TOTAL_1="15" TOTAL_2="11" VAR="0.16742424242424245" WEIGHT="16.04634967441243"/><DICH_DATA CI_END="3.1588374622614523" CI_START="0.03662503591899996" EFFECT_SIZE="0.3401360544217687" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="3" LOG_CI_END="0.49952727989090295" LOG_CI_START="-1.4362219407152177" LOG_EFFECT_SIZE="-0.4683473304121573" MODIFIED="2013-11-17 20:03:42 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="458" O_E="0.0" SE="1.1370686742972156" STUDY_ID="STD-Bayliff-1999" TOTAL_1="49" TOTAL_2="50" VAR="1.292925170068027" WEIGHT="3.06213457755135"/><DICH_DATA CI_END="1.5031119175990921" CI_START="0.4585242356722858" EFFECT_SIZE="0.8301886792452831" ESTIMABLE="YES" EVENTS_1="15" EVENTS_2="15" LOG_CI_END="0.1769913181691861" LOG_CI_START="-0.33863770439838925" LOG_EFFECT_SIZE="-0.0808231931146016" MODIFIED="2013-11-17 20:03:50 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="464" O_E="0.0" SE="0.3028830402610201" STUDY_ID="STD-POBBLE-2005" TOTAL_1="53" TOTAL_2="44" VAR="0.09173813607775871" WEIGHT="22.44691627366144"/></DICH_SUBGROUP><DICH_SUBGROUP CHI2="2.496636347368813" CI_END="0.48272488198992725" CI_START="0.07421963053517884" DF="3" EFFECT_SIZE="0.18928196530950908" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="19" I2="0.0" ID="CMP-002.08.02" LOG_CI_END="-0.31630031495296823" LOG_CI_START="-1.129481211896862" LOG_EFFECT_SIZE="-0.7228907634249152" MODIFIED="2013-11-17 20:04:58 +0000" MODIFIED_BY="Hermann Blessberger" NO="2" P_CHI2="0.47589955484744784" P_Z="4.927157046438002E-4" STUDIES="5" TAU2="0.0" TOTAL_1="202" TOTAL_2="131" WEIGHT="16.270384513795957" Z="3.484685551257495"><NAME>Standard care</NAME><DICH_DATA CI_END="0.34268065818180543" CI_START="0.018523976842803526" EFFECT_SIZE="0.07967313585291114" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="11" LOG_CI_END="-0.46511040762723255" LOG_CI_START="-1.7322657705980822" LOG_EFFECT_SIZE="-1.0986880891126574" MODIFIED="2013-11-17 20:04:03 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="471" O_E="0.0" SE="0.7443333327292857" STUDY_ID="STD-Stone-1988" TOTAL_1="89" TOTAL_2="39" VAR="0.5540321102118855" WEIGHT="6.532148698712454"/><DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-11-17 20:04:09 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="472" O_E="0.0" SE="0.0" STUDY_ID="STD-Zaugg-1999" TOTAL_1="40" TOTAL_2="19" VAR="0.0" WEIGHT="0.0"/><DICH_DATA CI_END="1.7491265621242627" CI_START="0.09147422688823888" EFFECT_SIZE="0.4" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="5" LOG_CI_END="0.24282123500387298" LOG_CI_START="-1.038701252347948" LOG_EFFECT_SIZE="-0.3979400086720376" MODIFIED="2013-11-17 20:04:27 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="470" O_E="0.0" SE="0.752772652709081" STUDY_ID="STD-Liu-2006" TOTAL_1="15" TOTAL_2="15" VAR="0.5666666666666667" WEIGHT="6.407981570832443"/><DICH_DATA CI_END="3.9981665126016623" CI_START="0.010004585820506876" EFFECT_SIZE="0.2" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" LOG_CI_END="0.6018608773254143" LOG_CI_START="-1.9998008859974516" LOG_EFFECT_SIZE="-0.6989700043360187" MODIFIED="2013-11-17 20:04:58 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="469" O_E="0.0" SE="1.5282289982092807" STUDY_ID="STD-Lai-2006" TOTAL_1="30" TOTAL_2="30" VAR="2.335483870967742" WEIGHT="1.7502524705228846"/><DICH_DATA CI_END="7.848616069043482" CI_START="0.014156777466712338" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.8947930852084158" LOG_CI_START="-1.8490355946477406" LOG_EFFECT_SIZE="-0.47712125471966244" MODIFIED="2013-11-17 20:04:32 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="468" O_E="0.0" SE="1.611738548718522" STUDY_ID="STD-Kawaguchi-2010" TOTAL_1="28" TOTAL_2="28" VAR="2.5977011494252875" WEIGHT="1.5800017737281735"/></DICH_SUBGROUP></DICH_OUTCOME><DICH_OUTCOME CHI2="4.683815300243554" CI_END="2.707506832501573" CI_START="0.9342911560750178" CI_STUDY="95" CI_TOTAL="95" DF="4" EFFECT_MEASURE="RR" EFFECT_SIZE="1.590471530276133" ESTIMABLE="YES" EVENTS_1="34" EVENTS_2="21" I2="14.599535985289512" I2_Q="77.08363276154752" ID="CMP-002.09" LOG_CI_END="0.43256956125820256" LOG_CI_START="-0.02951776212954848" LOG_EFFECT_SIZE="0.20152589956432704" METHOD="MH" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" NO="9" P_CHI2="0.32130474413380594" P_Q="0.03671284304676736" P_Z="0.08734686496500334" Q="4.363693379472691" RANDOM="NO" SCALE="100.0" SORT_BY="YEAR" STUDIES="5" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="4574" TOTAL_2="4576" WEIGHT="99.99999999999999" Z="1.7095621762671682"><NAME>Cerebrovascular events&#8212;non-cardiac surgery</NAME><GROUP_LABEL_1>Beta-blocker</GROUP_LABEL_1><GROUP_LABEL_2>Control</GROUP_LABEL_2><GRAPH_LABEL_1>Favours beta-blocker</GRAPH_LABEL_1><GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2><DICH_SUBGROUP CHI2="0.43467582252525144" CI_END="3.8153950091289834" CI_START="1.1416717553651972" DF="2" EFFECT_SIZE="2.0870861787391286" ESTIMABLE="YES" EVENTS_1="32" EVENTS_2="15" I2="0.0" ID="CMP-002.09.01" LOG_CI_END="0.5815395072723889" LOG_CI_START="0.05754125686536585" LOG_EFFECT_SIZE="0.31954038206887736" MODIFIED="2013-12-08 07:38:36 +0000" MODIFIED_BY="Hermann Blessberger" NO="1" P_CHI2="0.8046581418969698" P_Z="0.016829169035311738" STUDIES="3" TAU2="0.0" TOTAL_1="4326" TOTAL_2="4322" WEIGHT="70.6878681721762" Z="2.3904188228670242"><NAME>Placebo</NAME><DICH_DATA CI_END="35.873486053427946" CI_START="0.4642145613500314" EFFECT_SIZE="4.08080808080808" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="1" LOG_CI_END="1.5547735818670396" LOG_CI_START="-0.3332812408409298" LOG_EFFECT_SIZE="0.610746170513055" MODIFIED="2013-11-17 20:09:38 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="475" O_E="0.0" SE="1.1090527488807644" STUDY_ID="STD-Wallace-1998" TOTAL_1="99" TOTAL_2="101" VAR="1.22999799979998" WEIGHT="4.50605753253813"/><DICH_DATA CI_END="59.88076450297431" CI_START="0.10437408493155693" EFFECT_SIZE="2.5" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.7772873363821649" LOG_CI_START="-0.9814073190380896" LOG_EFFECT_SIZE="0.3979400086720376" MODIFIED="2013-11-17 20:09:44 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="473" O_E="0.0" SE="1.620470896352639" STUDY_ID="STD-POBBLE-2005" TOTAL_1="53" TOTAL_2="44" VAR="2.6259259259259258" WEIGHT="2.482676326467289"/><DICH_DATA CI_END="3.675054697422891" CI_START="1.013518570917549" EFFECT_SIZE="1.9299575604079677" ESTIMABLE="YES" EVENTS_1="27" EVENTS_2="14" LOG_CI_END="0.5652638072602568" LOG_CI_START="0.005831710772613412" LOG_EFFECT_SIZE="0.2855477590164352" MODIFIED="2013-12-08 07:38:36 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="474" O_E="0.0" SE="0.328613182710381" STUDY_ID="STD-POISE-2008" TOTAL_1="4174" TOTAL_2="4177" VAR="0.10798662385104625" WEIGHT="63.69913431317078"/></DICH_SUBGROUP><DICH_SUBGROUP CHI2="0.2923745104391888" CI_END="1.668400500739096" CI_START="0.09250580698429836" DF="1" EFFECT_SIZE="0.3928571428571429" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="6" I2="0.0" ID="CMP-002.09.02" LOG_CI_END="0.2223003115191508" LOG_CI_START="-1.0338310038871392" LOG_EFFECT_SIZE="-0.4057653461839941" MODIFIED="2013-11-17 20:10:22 +0000" MODIFIED_BY="Hermann Blessberger" NO="2" P_CHI2="0.5887029693519956" P_Z="0.20542514078186536" STUDIES="2" TAU2="0.0" TOTAL_1="248" TOTAL_2="254" WEIGHT="29.31213182782379" Z="1.266245741891761"><NAME>Standard care</NAME><DICH_DATA CI_END="4.065339018491121" CI_START="0.00983927781128726" EFFECT_SIZE="0.2" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" LOG_CI_END="0.609096768311561" LOG_CI_START="-2.0070367769835986" LOG_EFFECT_SIZE="-0.6989700043360187" MODIFIED="2013-11-17 20:10:15 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="477" O_E="0.0" SE="1.536729794576282" STUDY_ID="STD-Yang-2008" TOTAL_1="51" TOTAL_2="51" VAR="2.3615384615384616" WEIGHT="11.378933162975075"/><DICH_DATA CI_END="2.781185502696919" CI_START="0.09544862473539373" EFFECT_SIZE="0.5152284263959391" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="4" LOG_CI_END="0.4442299569011446" LOG_CI_START="-1.020230324725867" LOG_EFFECT_SIZE="-0.28800018391236115" MODIFIED="2013-11-17 20:10:22 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="476" O_E="0.0" SE="0.8602312186230142" STUDY_ID="STD-Marwick-2009" TOTAL_1="197" TOTAL_2="203" VAR="0.7399977494936361" WEIGHT="17.933198664848717"/></DICH_SUBGROUP></DICH_OUTCOME><DICH_OUTCOME CHI2="7.355265795537193" CI_END="0.5846514263301511" CI_START="0.2392699974281194" CI_STUDY="95" CI_TOTAL="95" DF="9" EFFECT_MEASURE="RR" EFFECT_SIZE="0.37401810821718456" ESTIMABLE="YES" EVENTS_1="22" EVENTS_2="62" I2="0.0" I2_Q="0.0" ID="CMP-002.10" LOG_CI_END="-0.2331029864655546" LOG_CI_START="-0.6211117550777583" LOG_EFFECT_SIZE="-0.42710737077165645" METHOD="MH" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" NO="10" P_CHI2="0.6001835178731718" P_Q="0.5776831486894998" P_Z="1.5965450433027967E-5" Q="0.3099953457891715" RANDOM="NO" SCALE="100.0" SORT_BY="YEAR" STUDIES="12" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="1143" TOTAL_2="1149" WEIGHT="100.0" Z="4.3149285890530935"><NAME>Ventricular arrhythmias&#8212;cardiac surgery</NAME><GROUP_LABEL_1>Beta-blocker</GROUP_LABEL_1><GROUP_LABEL_2>Control</GROUP_LABEL_2><GRAPH_LABEL_1>Favours beta-blocker</GRAPH_LABEL_1><GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2><DICH_SUBGROUP CHI2="5.431352960104544" CI_END="0.6798681865253238" CI_START="0.24546055300709083" DF="5" EFFECT_SIZE="0.4085104907299615" ESTIMABLE="YES" EVENTS_1="17" EVENTS_2="40" I2="7.941906248277428" ID="CMP-002.10.01" LOG_CI_END="-0.16757528054931434" LOG_CI_START="-0.610018291678899" LOG_EFFECT_SIZE="-0.3887967861141067" MODIFIED="2013-11-17 20:17:25 +0000" MODIFIED_BY="Hermann Blessberger" NO="1" P_CHI2="0.36553208676244897" P_Z="5.718275841910123E-4" STUDIES="7" TAU2="0.0" TOTAL_1="855" TOTAL_2="798" WEIGHT="66.90830723067899" Z="3.4446366149758703"><NAME>Placebo</NAME><DICH_DATA CI_END="1.2109704352624893" CI_START="0.20023745210140398" EFFECT_SIZE="0.49242424242424243" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="11" LOG_CI_END="0.08313354036923343" LOG_CI_START="-0.6984546894952222" LOG_EFFECT_SIZE="-0.3076605745629943" MODIFIED="2013-11-17 20:16:27 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="480" O_E="0.0" SE="0.4591087951465162" STUDY_ID="STD-Hammon-1984" TOTAL_1="24" TOTAL_2="26" VAR="0.21078088578088577" WEIGHT="17.234613657760022"/><DICH_DATA CI_END="0.8881346973235159" CI_START="0.14888665577098886" EFFECT_SIZE="0.36363636363636365" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="11" LOG_CI_END="-0.05152116274832839" LOG_CI_START="-0.8271442249121969" LOG_EFFECT_SIZE="-0.43933269383026263" MODIFIED="2013-11-17 20:16:33 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="481" O_E="0.0" SE="0.45560482611113506" STUDY_ID="STD-Harrison-1987" TOTAL_1="15" TOTAL_2="15" VAR="0.20757575757575764" WEIGHT="17.952722560166688"/><DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-11-17 20:16:44 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="482" O_E="0.0" SE="0.0" STUDY_ID="STD-Matangi-1989" TOTAL_1="35" TOTAL_2="35" VAR="0.0" WEIGHT="0.0"/><DICH_DATA CI_END="105.56063520158432" CI_START="0.2481517124265242" EFFECT_SIZE="5.118110236220472" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="0" LOG_CI_END="2.0235019948836785" LOG_CI_START="-0.6052827235098813" LOG_EFFECT_SIZE="0.7091096356868987" MODIFIED="2013-11-17 20:16:50 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="483" O_E="0.0" SE="1.5441611562785993" STUDY_ID="STD-Pfisterer-1997" TOTAL_1="126" TOTAL_2="129" VAR="2.3844336765596608" WEIGHT="0.8065071684263069"/><DICH_DATA CI_END="1.368626413931854" CI_START="0.059645679953455225" EFFECT_SIZE="0.2857142857142857" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="7" LOG_CI_END="0.13628491744763105" LOG_CI_START="-1.2244210061481822" LOG_EFFECT_SIZE="-0.5440680443502757" MODIFIED="2013-11-17 20:16:58 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="479" O_E="0.0" SE="0.799285395123133" STUDY_ID="STD-Connolly-2003" TOTAL_1="500" TOTAL_2="500" VAR="0.6388571428571428" WEIGHT="11.424459811015165"/><DICH_DATA CI_END="4.5514705860751805" CI_START="0.13367108245439305" EFFECT_SIZE="0.78" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="2" LOG_CI_END="0.6581517404437857" LOG_CI_START="-0.8739625350628248" LOG_EFFECT_SIZE="-0.10790539730951958" MODIFIED="2013-11-17 20:17:16 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="478" O_E="0.0" SE="0.8999715095205614" STUDY_ID="STD-Auer-2004" TOTAL_1="125" TOTAL_2="65" VAR="0.8099487179487179" WEIGHT="4.29490970338916"/><DICH_DATA CI_END="0.7668557273673595" CI_START="0.014024095769338475" EFFECT_SIZE="0.1037037037037037" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="9" LOG_CI_END="-0.11528633448889981" LOG_CI_START="-1.8531251311446366" LOG_EFFECT_SIZE="-0.9842057328167682" MODIFIED="2013-11-17 20:17:25 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="484" O_E="0.0" SE="1.0208151115963615" STUDY_ID="STD-Sun-2011" TOTAL_1="30" TOTAL_2="28" VAR="1.042063492063492" WEIGHT="15.195094329921647"/></DICH_SUBGROUP><DICH_SUBGROUP CHI2="1.78944344287472" CI_END="0.7508346898477122" CI_START="0.12330935517503266" DF="3" EFFECT_SIZE="0.3042777373521879" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="22" I2="0.0" ID="CMP-002.10.02" LOG_CI_END="-0.12445567043880314" LOG_CI_START="-0.9090039733088189" LOG_EFFECT_SIZE="-0.516729821873811" MODIFIED="2013-11-17 20:16:16 +0000" MODIFIED_BY="Hermann Blessberger" NO="2" P_CHI2="0.6172349880140058" P_Z="0.009828766054273333" STUDIES="5" TAU2="0.0" TOTAL_1="288" TOTAL_2="351" WEIGHT="33.091692769321014" Z="2.5817960141028142"><NAME>Standard care</NAME><DICH_DATA CI_END="2.100643308756804" CI_START="0.09496223068712434" EFFECT_SIZE="0.4466338259441708" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="7" LOG_CI_END="0.3223523150476611" LOG_CI_START="-1.0224490922450145" LOG_EFFECT_SIZE="-0.35004838859867665" MODIFIED="2013-11-17 20:15:50 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="494" O_E="0.0" SE="0.7899430035180444" STUDY_ID="STD-Stephenson-1980" TOTAL_1="87" TOTAL_2="136" VAR="0.624009948807109" WEIGHT="8.914152498280892"/><DICH_DATA CI_END="2.2497616637862223" CI_START="0.007105757023518394" EFFECT_SIZE="0.12643678160919541" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="4" LOG_CI_END="0.3521365120735711" LOG_CI_START="-2.148389646994358" LOG_EFFECT_SIZE="-0.8981265674603934" MODIFIED="2013-11-17 20:15:58 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="495" O_E="0.0" SE="1.4688214436406157" STUDY_ID="STD-Williams-1982" TOTAL_1="28" TOTAL_2="32" VAR="2.1574364332985025" WEIGHT="6.870470070679628"/><DICH_DATA CI_END="3.163518593329961" CI_START="0.11752815339751992" EFFECT_SIZE="0.6097560975609756" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="4" LOG_CI_END="0.5001703913340872" LOG_CI_START="-0.929858087429483" LOG_EFFECT_SIZE="-0.2148438480476979" MODIFIED="2013-11-17 20:16:04 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="491" O_E="0.0" SE="0.8400058071808557" STUDY_ID="STD-Abel-1983" TOTAL_1="41" TOTAL_2="50" VAR="0.7056097560975609" WEIGHT="5.882610389345328"/><DICH_DATA CI_END="1.1353041994287865" CI_START="0.017975942725812367" EFFECT_SIZE="0.14285714285714285" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="7" LOG_CI_END="0.05511224428890028" LOG_CI_START="-1.745308324317414" LOG_EFFECT_SIZE="-0.8450980400142568" MODIFIED="2013-11-17 20:16:10 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="492" O_E="0.0" SE="1.0575759542248981" STUDY_ID="STD-Matangi-1985" TOTAL_1="82" TOTAL_2="82" VAR="1.1184668989547037" WEIGHT="11.424459811015165"/><DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-11-17 20:16:16 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="493" O_E="0.0" SE="0.0" STUDY_ID="STD-Nystr_x00f6_m-1993" TOTAL_1="50" TOTAL_2="51" VAR="0.0" WEIGHT="0.0"/></DICH_SUBGROUP></DICH_OUTCOME><DICH_OUTCOME CHI2="73.87854420491638" CI_END="0.5656392760817593" CI_START="0.40160375824176237" CI_STUDY="95" CI_TOTAL="95" DF="35" EFFECT_MEASURE="RR" EFFECT_SIZE="0.47661604996431284" ESTIMABLE="YES" EVENTS_1="495" EVENTS_2="862" I2="52.62494628627121" I2_Q="92.37002633190707" ID="CMP-002.11" LOG_CI_END="-0.24746044222147964" LOG_CI_START="-0.3962022316797154" LOG_EFFECT_SIZE="-0.3218313369505975" METHOD="MH" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" NO="11" P_CHI2="1.351513206526711E-4" P_Q="2.9432314720034825E-4" P_Z="2.22281164860131E-17" Q="13.106205125999423" RANDOM="YES" SCALE="100.0" SORT_BY="YEAR" STUDIES="36" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.10950941230710698" TOTALS="YES" TOTAL_1="2759" TOTAL_2="2613" WEIGHT="100.0" Z="8.481514600799633"><NAME>Atrial fibrillation&#8212;cardiac surgery</NAME><GROUP_LABEL_1>Beta-blocker</GROUP_LABEL_1><GROUP_LABEL_2>Control</GROUP_LABEL_2><GRAPH_LABEL_1>Favours beta-blocker</GRAPH_LABEL_1><GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2><DICH_SUBGROUP CHI2="25.942165408385367" CI_END="0.7577702099057592" CI_START="0.511072667297569" DF="14" EFFECT_SIZE="0.6223147454264402" ESTIMABLE="YES" EVENTS_1="364" EVENTS_2="479" I2="46.03380334829437" ID="CMP-002.11.01" LOG_CI_END="-0.1204624720721752" LOG_CI_START="-0.2915173449482213" LOG_EFFECT_SIZE="-0.20598990851019824" MODIFIED="2014-06-22 18:13:14 +0100" MODIFIED_BY="Hermann Blessberger" NO="1" P_CHI2="0.0263285655682145" P_Z="2.352583305345158E-6" STUDIES="15" TAU2="0.05425058886742418" TOTAL_1="1575" TOTAL_2="1384" WEIGHT="51.37684936597181" Z="4.720506292168034"><NAME>Placebo</NAME><DICH_DATA CI_END="1.3632093309631186" CI_START="0.12220958833054184" EFFECT_SIZE="0.40816326530612246" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="7" LOG_CI_END="0.134562550113297" LOG_CI_START="-0.912894718842362" LOG_EFFECT_SIZE="-0.3891660843645325" MODIFIED="2014-06-22 18:10:40 +0100" MODIFIED_BY="Hermann Blessberger" ORDER="510" O_E="0.0" SE="0.615281584781658" STUDY_ID="STD-White-1984" TOTAL_1="21" TOTAL_2="20" VAR="0.37857142857142856" WEIGHT="1.564045733397725"/><DICH_DATA CI_END="2.1367282344833174" CI_START="0.23877818123933087" EFFECT_SIZE="0.7142857142857143" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="7" LOG_CI_END="0.3297492887669275" LOG_CI_START="-0.6220053601234036" LOG_EFFECT_SIZE="-0.146128035678238" MODIFIED="2013-11-17 21:15:56 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="509" O_E="0.0" SE="0.5590653920196748" STUDY_ID="STD-Vecht-1986" TOTAL_1="66" TOTAL_2="66" VAR="0.3125541125541126" WEIGHT="1.8086868723855198"/><DICH_DATA CI_END="4.126826287091888" CI_START="0.7815504113324163" EFFECT_SIZE="1.7959183673469388" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="7" LOG_CI_END="0.6156161882509973" LOG_CI_START="-0.10704300400768743" LOG_EFFECT_SIZE="0.25428659212165494" MODIFIED="2013-11-17 21:16:16 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="502" O_E="0.0" SE="0.4244935867534458" STUDY_ID="STD-Martinussen-1988" TOTAL_1="35" TOTAL_2="40" VAR="0.18019480519480519" WEIGHT="2.6350350136832534"/><DICH_DATA CI_END="0.8286815540491059" CI_START="0.3432493978592757" EFFECT_SIZE="0.5333333333333333" ESTIMABLE="YES" EVENTS_1="24" EVENTS_2="45" LOG_CI_END="-0.08161232818157535" LOG_CI_START="-0.46439021594589996" LOG_EFFECT_SIZE="-0.27300127206373764" MODIFIED="2014-06-22 18:13:14 +0100" MODIFIED_BY="Hermann Blessberger" ORDER="508" O_E="0.0" SE="0.22484562605386735" STUDY_ID="STD-Suttorp-1991" TOTAL_1="150" TOTAL_2="150" VAR="0.05055555555555555" WEIGHT="4.769193202751499"/><DICH_DATA CI_END="63.82881484401465" CI_START="0.12392766917779852" EFFECT_SIZE="2.8125" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.8050167806434498" LOG_CI_START="-0.9068317184046119" LOG_EFFECT_SIZE="0.4490925311194189" MODIFIED="2013-11-17 21:16:34 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="498" O_E="0.0" SE="1.592953232207399" STUDY_ID="STD-Cork-1995" TOTAL_1="15" TOTAL_2="14" VAR="2.5374999999999996" WEIGHT="0.2883936691648907"/><DICH_DATA CI_END="0.967053167072245" CI_START="0.41868044849390096" EFFECT_SIZE="0.6363067292644757" ESTIMABLE="YES" EVENTS_1="38" EVENTS_2="30" LOG_CI_END="-0.014549648428526057" LOG_CI_START="-0.37811731928423464" LOG_EFFECT_SIZE="-0.19633348385638036" MODIFIED="2013-11-17 21:16:44 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="501" O_E="0.0" SE="0.213561449549639" STUDY_ID="STD-Graham-1996" TOTAL_1="213" TOTAL_2="107" VAR="0.045608492733743004" WEIGHT="4.921293621959454"/><DICH_DATA CI_END="0.8367549673280018" CI_START="0.38960932218699135" EFFECT_SIZE="0.5709706959706959" ESTIMABLE="YES" EVENTS_1="29" EVENTS_2="52" LOG_CI_END="-0.07740170080856265" LOG_CI_START="-0.40937066029975144" LOG_EFFECT_SIZE="-0.24338618055415703" MODIFIED="2013-11-17 21:17:03 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="504" O_E="0.0" SE="0.19500021007797613" STUDY_ID="STD-Pfisterer-1997" TOTAL_1="126" TOTAL_2="129" VAR="0.03802508193045483" WEIGHT="5.174252710691795"/><DICH_DATA CI_END="1.8214515190598082" CI_START="0.4677977958792884" EFFECT_SIZE="0.9230769230769231" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="13" LOG_CI_END="0.26041761626692334" LOG_CI_START="-0.32994182878534717" LOG_EFFECT_SIZE="-0.03476210625921192" MODIFIED="2013-11-17 21:16:53 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="503" O_E="0.0" SE="0.3467800603500874" STUDY_ID="STD-Paull-1997" TOTAL_1="50" TOTAL_2="50" VAR="0.12025641025641025" WEIGHT="3.3224295424451817"/><DICH_DATA CI_END="0.7899548058160761" CI_START="0.21326202895259727" EFFECT_SIZE="0.41044776119402987" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="24" LOG_CI_END="-0.10239775446416542" LOG_CI_START="-0.6710864632769621" LOG_EFFECT_SIZE="-0.38674210887056376" MODIFIED="2013-11-17 21:17:13 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="499" O_E="0.0" SE="0.33405056261114596" STUDY_ID="STD-Dy-1998" TOTAL_1="67" TOTAL_2="66" VAR="0.11158977838082317" WEIGHT="3.4526619222533426"/><DICH_DATA CI_END="0.815131215366541" CI_START="0.13431350612509407" EFFECT_SIZE="0.33088235294117646" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="17" LOG_CI_END="-0.08877247528121683" LOG_CI_START="-0.8718803139085308" LOG_EFFECT_SIZE="-0.48032639459487386" MODIFIED="2013-11-17 21:17:22 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="500" O_E="0.0" SE="0.460001420856004" STUDY_ID="STD-Gomes-1999" TOTAL_1="40" TOTAL_2="45" VAR="0.2116013071895425" WEIGHT="2.377313214351328"/><DICH_DATA CI_END="0.9484074945855946" CI_START="0.674815418112704" EFFECT_SIZE="0.8" ESTIMABLE="YES" EVENTS_1="156" EVENTS_2="195" LOG_CI_END="-0.023005022761850884" LOG_CI_START="-0.17081500325426194" LOG_EFFECT_SIZE="-0.09691001300805639" MODIFIED="2013-11-17 21:17:31 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="497" O_E="0.0" SE="0.08682431421244592" STUDY_ID="STD-Connolly-2003" TOTAL_1="500" TOTAL_2="500" VAR="0.007538461538461539" WEIGHT="6.521953211524732"/><DICH_DATA CI_END="0.9248471633511364" CI_START="0.48330986222891537" EFFECT_SIZE="0.6685714285714286" ESTIMABLE="YES" EVENTS_1="45" EVENTS_2="35" LOG_CI_END="-0.0339300311501147" LOG_CI_START="-0.3157743427301508" LOG_EFFECT_SIZE="-0.17485218694013277" MODIFIED="2013-11-17 21:17:42 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="496" O_E="0.0" SE="0.16555674377395627" STUDY_ID="STD-Auer-2004" TOTAL_1="125" TOTAL_2="65" VAR="0.027409035409035408" WEIGHT="5.575441216744428"/><DICH_DATA CI_END="0.6324601313324618" CI_START="0.13450562372243266" EFFECT_SIZE="0.2916666666666667" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="24" LOG_CI_END="-0.1989668461016144" LOG_CI_START="-0.871259557293084" LOG_EFFECT_SIZE="-0.5351132016973492" MODIFIED="2013-11-17 21:18:00 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="505" O_E="0.0" SE="0.39490806645646137" STUDY_ID="STD-Sezai-2011" TOTAL_1="70" TOTAL_2="70" VAR="0.15595238095238093" WEIGHT="2.875670910514213"/><DICH_DATA CI_END="1.6818496358282289" CI_START="0.42805642238869207" EFFECT_SIZE="0.8484848484848485" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="11" LOG_CI_END="0.22578716551115877" LOG_CI_START="-0.3684989825824953" LOG_EFFECT_SIZE="-0.07135590853566824" MODIFIED="2013-11-17 21:17:51 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="507" O_E="0.0" SE="0.3490866251540896" STUDY_ID="STD-Sun-2011" TOTAL_1="30" TOTAL_2="28" VAR="0.12186147186147188" WEIGHT="3.299381248735867"/><DICH_DATA CI_END="0.7482025935275345" CI_START="0.1529700826342874" EFFECT_SIZE="0.3383084577114428" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="12" LOG_CI_END="-0.12598079072115415" LOG_CI_START="-0.8153934987073509" LOG_EFFECT_SIZE="-0.47068714471425255" MODIFIED="2013-11-17 21:18:08 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="506" O_E="0.0" SE="0.404964437319035" STUDY_ID="STD-Sezai-2012" TOTAL_1="67" TOTAL_2="34" VAR="0.1639961954931226" WEIGHT="2.7910972753685765"/></DICH_SUBGROUP><DICH_SUBGROUP CHI2="17.12381230038356" CI_END="0.45501594033331494" CI_START="0.31667703725684476" DF="20" EFFECT_SIZE="0.37959596927442657" ESTIMABLE="YES" EVENTS_1="131" EVENTS_2="383" I2="0.0" ID="CMP-002.11.02" LOG_CI_END="-0.34197338866698523" LOG_CI_START="-0.4993834268528971" LOG_EFFECT_SIZE="-0.4206784077599412" MODIFIED="2014-06-22 18:17:37 +0100" MODIFIED_BY="Hermann Blessberger" NO="2" P_CHI2="0.6449200896450231" P_Z="1.1134323514082935E-25" STUDIES="21" TAU2="0.0" TOTAL_1="1184" TOTAL_2="1229" WEIGHT="48.6231506340282" Z="10.4760095072124"><NAME>Standard care</NAME><DICH_DATA CI_END="22.44975451350426" CI_START="0.2155925579092004" EFFECT_SIZE="2.2" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="1" LOG_CI_END="1.3512115963855165" LOG_CI_START="-0.6663662347411039" LOG_EFFECT_SIZE="0.3424226808222063" MODIFIED="2013-11-17 21:18:18 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="528" O_E="0.0" SE="1.1851352051751118" STUDY_ID="STD-Salazar-1979" TOTAL_1="20" TOTAL_2="22" VAR="1.4045454545454545" WEIGHT="0.5041962305607682"/><DICH_DATA CI_END="1.0124518038855774" CI_START="0.20532344839946126" EFFECT_SIZE="0.4559386973180077" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="24" LOG_CI_END="0.00537435849931325" LOG_CI_START="-0.6875614503908136" LOG_EFFECT_SIZE="-0.3410935459457502" MODIFIED="2013-11-17 21:18:26 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="530" O_E="0.0" SE="0.4070339242296343" STUDY_ID="STD-Stephenson-1980" TOTAL_1="87" TOTAL_2="136" VAR="0.16567661547377568" WEIGHT="2.7740534753352035"/><DICH_DATA CI_END="1.4875364844811094" CI_START="0.02439011043885608" EFFECT_SIZE="0.19047619047619047" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="6" LOG_CI_END="0.17246762637672552" LOG_CI_START="-1.6127862331886396" LOG_EFFECT_SIZE="-0.7201593034059569" MODIFIED="2013-11-17 21:18:34 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="531" O_E="0.0" SE="1.048666954257824" STUDY_ID="STD-Williams-1982" TOTAL_1="28" TOTAL_2="32" VAR="1.099702380952381" WEIGHT="0.6313044257296881"/><DICH_DATA CI_END="0.6999722648647813" CI_START="0.0656002668274423" EFFECT_SIZE="0.21428571428571427" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="14" LOG_CI_END="-0.15491916777833195" LOG_CI_START="-1.1830943941388192" LOG_EFFECT_SIZE="-0.6690067809585756" MODIFIED="2013-11-17 21:18:41 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="529" O_E="0.0" SE="0.603955217513604" STUDY_ID="STD-Silverman-1982" TOTAL_1="50" TOTAL_2="50" VAR="0.36476190476190473" WEIGHT="1.6095866000223813"/><DICH_DATA CI_END="0.9290042098937271" CI_START="0.1778738493698285" EFFECT_SIZE="0.4065040650406504" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="18" LOG_CI_END="-0.03198231794449341" LOG_CI_START="-0.7498878962622648" LOG_EFFECT_SIZE="-0.39093510710337914" MODIFIED="2013-11-17 21:18:49 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="511" O_E="0.0" SE="0.4217012903937848" STUDY_ID="STD-Abel-1983" TOTAL_1="41" TOTAL_2="50" VAR="0.1778319783197832" WEIGHT="2.656703077352644"/><DICH_DATA CI_END="1.5715363292104452" CI_START="0.18776337809660357" EFFECT_SIZE="0.5432098765432098" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="9" LOG_CI_END="0.19632442505659703" LOG_CI_START="-0.7263891098415217" LOG_EFFECT_SIZE="-0.2650323423924623" MODIFIED="2013-11-17 21:19:21 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="524" O_E="0.0" SE="0.5420064979048165" STUDY_ID="STD-Ormerod-1984" TOTAL_1="27" TOTAL_2="33" VAR="0.2937710437710438" WEIGHT="1.8929277261611548"/><DICH_DATA CI_END="1.0292435704622704" CI_START="0.21516120532846186" EFFECT_SIZE="0.47058823529411764" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="17" LOG_CI_END="0.012518162702335212" LOG_CI_START="-0.667236031474996" LOG_EFFECT_SIZE="-0.32735893438633035" MODIFIED="2013-11-17 21:20:10 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="519" O_E="0.0" SE="0.39929097849729295" STUDY_ID="STD-Matangi-1985" TOTAL_1="82" TOTAL_2="82" VAR="0.15943328550932567" WEIGHT="2.8384513241192155"/><DICH_DATA CI_END="0.7102222721256239" CI_START="0.04268142296235359" EFFECT_SIZE="0.17410714285714285" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="14" LOG_CI_END="-0.148605712617911" LOG_CI_START="-1.3697611099974163" LOG_EFFECT_SIZE="-0.7591834113076636" MODIFIED="2013-11-17 21:19:34 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="520" O_E="0.0" SE="0.717312725237428" STUDY_ID="STD-Materne-1985" TOTAL_1="32" TOTAL_2="39" VAR="0.5145375457875457" WEIGHT="1.2232745418069342"/><DICH_DATA CI_END="0.5762909029931246" CI_START="0.1149255280418162" EFFECT_SIZE="0.25735294117647056" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="17" LOG_CI_END="-0.23935823589507993" LOG_CI_START="-0.939583492144804" LOG_EFFECT_SIZE="-0.589470864019942" MODIFIED="2013-11-17 21:20:18 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="517" O_E="0.0" SE="0.411315781692008" STUDY_ID="STD-Janssen-1986" TOTAL_1="80" TOTAL_2="50" VAR="0.16918067226890757" WEIGHT="2.7391744413534393"/><DICH_DATA CI_END="0.3925291896546882" CI_START="0.0015155153127434649" EFFECT_SIZE="0.024390243902439025" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="20" LOG_CI_END="-0.4061280422700622" LOG_CI_START="-2.819439671169409" LOG_EFFECT_SIZE="-1.6127838567197355" MODIFIED="2013-11-17 21:20:29 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="513" O_E="0.0" SE="1.4175911969007033" STUDY_ID="STD-Daudon-1986" TOTAL_1="50" TOTAL_2="50" VAR="2.0095648015303684" WEIGHT="0.36024257751068817"/><DICH_DATA CI_END="0.9962321240462663" CI_START="0.1877050579938394" EFFECT_SIZE="0.43243243243243246" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="15" LOG_CI_END="-0.0016394583162494887" LOG_CI_START="-0.7265240245058909" LOG_EFFECT_SIZE="-0.3640817414110702" MODIFIED="2013-11-17 21:20:37 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="526" O_E="0.0" SE="0.42580078241626834" STUDY_ID="STD-Rubin-1987" TOTAL_1="37" TOTAL_2="40" VAR="0.18130630630630631" WEIGHT="2.6249638787373235"/><DICH_DATA CI_END="0.7332835516809254" CI_START="0.013637289391091267" EFFECT_SIZE="0.1" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="10" LOG_CI_END="-0.13472805657581619" LOG_CI_START="-1.8652719434241833" LOG_EFFECT_SIZE="-1.0" MODIFIED="2013-11-17 21:20:48 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="518" O_E="0.0" SE="1.016530045465127" STUDY_ID="STD-Lamb-1988" TOTAL_1="30" TOTAL_2="30" VAR="1.0333333333333332" WEIGHT="0.6679665768902043"/><DICH_DATA CI_END="0.8651318953082401" CI_START="0.13362124391311758" EFFECT_SIZE="0.34" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="15" LOG_CI_END="-0.06291767630644172" LOG_CI_START="-0.8741244896090479" LOG_EFFECT_SIZE="-0.46852108295774486" MODIFIED="2013-11-17 21:20:56 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="522" O_E="0.0" SE="0.4765068976724385" STUDY_ID="STD-Nystr_x00f6_m-1993" TOTAL_1="50" TOTAL_2="51" VAR="0.22705882352941176" WEIGHT="2.268130724909062"/><DICH_DATA CI_END="0.7316733754295464" CI_START="0.276762838173683" EFFECT_SIZE="0.45" ESTIMABLE="YES" EVENTS_1="18" EVENTS_2="40" LOG_CI_END="-0.13568274804766128" LOG_CI_START="-0.5578922244016514" LOG_EFFECT_SIZE="-0.3467874862246563" MODIFIED="2013-11-17 21:21:05 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="512" O_E="0.0" SE="0.2480079363809483" STUDY_ID="STD-Ali-1997" TOTAL_1="105" TOTAL_2="105" VAR="0.061507936507936505" WEIGHT="4.463762080388985"/><DICH_DATA CI_END="0.559711576637503" CI_START="0.20705225265439542" EFFECT_SIZE="0.3404255319148936" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="47" LOG_CI_END="-0.2520357103921946" LOG_CI_START="-0.6839200401673907" LOG_EFFECT_SIZE="-0.4679778752797927" MODIFIED="2013-11-17 21:21:14 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="515" O_E="0.0" SE="0.2536909931718616" STUDY_ID="STD-Evrard-2000" TOTAL_1="103" TOTAL_2="103" VAR="0.06435912001652552" WEIGHT="4.39056306812505"/><DICH_DATA CI_END="0.925811812744811" CI_START="0.17282129888323441" EFFECT_SIZE="0.4" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="15" LOG_CI_END="-0.03347728220825417" LOG_CI_START="-0.762402735135821" LOG_EFFECT_SIZE="-0.3979400086720376" MODIFIED="2013-11-17 21:21:20 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="521" O_E="0.0" SE="0.42817441928883765" STUDY_ID="STD-Matsuura-2001" TOTAL_1="40" TOTAL_2="40" VAR="0.18333333333333335" WEIGHT="2.6067941517887054"/><DICH_DATA CI_END="0.7105931245191439" CI_START="0.13488819843100122" EFFECT_SIZE="0.30959752321981426" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="19" LOG_CI_END="-0.14837899892640086" LOG_CI_START="-0.8700260457358048" LOG_EFFECT_SIZE="-0.5092025223311029" MODIFIED="2013-11-17 21:21:28 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="516" O_E="0.0" SE="0.4238990475063375" STUDY_ID="STD-Forlani-2002" TOTAL_1="51" TOTAL_2="50" VAR="0.17969040247678017" WEIGHT="2.6396308631791676"/><DICH_DATA CI_END="0.8846657886054342" CI_START="0.2374562768789701" EFFECT_SIZE="0.4583333333333333" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="24" LOG_CI_END="-0.05322076724324717" LOG_CI_START="-0.6244163458635148" LOG_EFFECT_SIZE="-0.338818556553381" MODIFIED="2013-11-17 21:21:39 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="514" O_E="0.0" SE="0.3355231103452601" STUDY_ID="STD-De-Azevedo-L_x00fa_cio-2003" TOTAL_1="100" TOTAL_2="100" VAR="0.11257575757575758" WEIGHT="3.4373333308652754"/><DICH_DATA CI_END="0.8263453347887832" CI_START="0.17017703625802433" EFFECT_SIZE="0.375" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="16" LOG_CI_END="-0.0828384204148983" LOG_CI_START="-0.7690990441296639" LOG_EFFECT_SIZE="-0.42596873227228116" MODIFIED="2013-11-17 21:21:57 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="527" O_E="0.0" SE="0.4031128874149275" STUDY_ID="STD-Sakaguchi-2012" TOTAL_1="30" TOTAL_2="30" VAR="0.1625" WEIGHT="2.806449785154372"/><DICH_DATA CI_END="0.5360855287701065" CI_START="0.05040605255789461" EFFECT_SIZE="0.1643835616438356" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="17" LOG_CI_END="-0.27076591607279954" LOG_CI_START="-1.2975173120728625" LOG_EFFECT_SIZE="-0.7841416140728311" MODIFIED="2013-11-17 21:22:07 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="525" O_E="0.0" SE="0.6031188525118167" STUDY_ID="STD-Osada-2012" TOTAL_1="73" TOTAL_2="68" VAR="0.36375235025517055" WEIGHT="1.613020144700138"/><DICH_DATA CI_END="0.9285567066549609" CI_START="0.2912046168662018" EFFECT_SIZE="0.52" ESTIMABLE="YES" EVENTS_1="13" EVENTS_2="25" LOG_CI_END="-0.032191568892075674" LOG_CI_START="-0.5358017438383259" LOG_EFFECT_SIZE="-0.28399665636520083" MODIFIED="2014-06-22 18:17:37 +0100" MODIFIED_BY="Hermann Blessberger" ORDER="523" O_E="0.0" SE="0.29582310967399855" STUDY_ID="STD-Ogawa-2013" TOTAL_1="68" TOTAL_2="68" VAR="0.08751131221719458" WEIGHT="3.8746216093377934"/></DICH_SUBGROUP></DICH_OUTCOME><DICH_OUTCOME CHI2="1.7834444420820406" CI_END="0.9492519881687379" CI_START="0.5625349250530548" CI_STUDY="95" CI_TOTAL="95" DF="2" EFFECT_MEASURE="RR" EFFECT_SIZE="0.7307444122406713" ESTIMABLE="YES" EVENTS_1="94" EVENTS_2="129" I2="0.0" I2_Q="40.582386134244864" ID="CMP-002.12" LOG_CI_END="-0.022618484575515498" LOG_CI_START="-0.2498505091508825" LOG_EFFECT_SIZE="-0.13623449686319902" METHOD="MH" MODIFIED="2017-06-17 15:37:09 +0100" MODIFIED_BY="Hermann Blessberger" NO="12" P_CHI2="0.4099491604941542" P_Q="0.19452603205143915" P_Z="0.018765830949606422" Q="1.6830026231940995" RANDOM="NO" SCALE="100.0" SORT_BY="YEAR" STUDIES="3" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="4253" TOTAL_2="4257" WEIGHT="100.00000000000001" Z="2.3501503170847564"><NAME>Atrial fibrillation&#8212;non-cardiac surgery</NAME><GROUP_LABEL_1>Beta-blocker</GROUP_LABEL_1><GROUP_LABEL_2>Control</GROUP_LABEL_2><GRAPH_LABEL_1>Favours beta-blocker</GRAPH_LABEL_1><GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2><DICH_SUBGROUP CHI2="0.09008248514022482" CI_END="0.9805897521358004" CI_START="0.5783369701867597" DF="1" EFFECT_SIZE="0.7530679293705212" ESTIMABLE="YES" EVENTS_1="94" EVENTS_2="125" I2="0.0" ID="CMP-002.12.01" LOG_CI_END="-0.008512649754055367" LOG_CI_START="-0.23781904453730882" LOG_EFFECT_SIZE="-0.12316584714568211" MODIFIED="2017-06-17 15:37:09 +0100" MODIFIED_BY="Hermann Blessberger" NO="1" P_CHI2="0.7640723351254473" P_Z="0.03524908344683768" STUDIES="2" TAU2="0.0" TOTAL_1="4223" TOTAL_2="4227" WEIGHT="96.5225827509119" Z="2.105485324638074"><NAME>Placebo</NAME><DICH_DATA CI_END="2.4240530226292014" CI_START="0.15463515508026482" EFFECT_SIZE="0.6122448979591837" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="5" LOG_CI_END="0.38454211515738" LOG_CI_START="-0.8106917657750824" LOG_EFFECT_SIZE="-0.21307482530885122" MODIFIED="2013-11-17 21:23:58 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="532" O_E="0.0" SE="0.7020862981628592" STUDY_ID="STD-Bayliff-1999" TOTAL_1="49" TOTAL_2="50" VAR="0.49292517006802716" WEIGHT="3.8247686914773973"/><DICH_DATA CI_END="0.9931562131790224" CI_START="0.5798648580922154" EFFECT_SIZE="0.7588783740616515" ESTIMABLE="YES" EVENTS_1="91" EVENTS_2="120" LOG_CI_END="-0.002982436110955725" LOG_CI_START="-0.23667321027073493" LOG_EFFECT_SIZE="-0.11982782319084534" MODIFIED="2013-11-17 21:24:10 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="533" O_E="0.0" SE="0.13727111752944285" STUDY_ID="STD-POISE-2008" TOTAL_1="4174" TOTAL_2="4177" VAR="0.01884335970778211" WEIGHT="92.69781405943449"/></DICH_SUBGROUP><DICH_SUBGROUP CHI2="0.0" CI_END="1.9774190029426773" CI_START="0.006243329812231785" DF="0" EFFECT_SIZE="0.1111111111111111" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="4" I2="0.0" ID="CMP-002.12.02" LOG_CI_END="0.2960987033983009" LOG_CI_START="-2.204583722276951" LOG_EFFECT_SIZE="-0.9542425094393249" MODIFIED="2013-11-17 21:24:22 +0000" MODIFIED_BY="Hermann Blessberger" NO="2" P_CHI2="1.0" P_Z="0.13470149407860718" STUDIES="1" TAU2="0.0" TOTAL_1="30" TOTAL_2="30" WEIGHT="3.4774172490881234" Z="1.4958164473948934"><NAME>Standard care</NAME><DICH_DATA CI_END="1.9774190029426781" CI_START="0.006243329812231785" EFFECT_SIZE="0.1111111111111111" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="4" LOG_CI_END="0.29609870339830113" LOG_CI_START="-2.204583722276951" LOG_EFFECT_SIZE="-0.9542425094393249" MODIFIED="2013-11-17 21:24:22 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="535" O_E="0.0" SE="1.4689132354192893" STUDY_ID="STD-Lai-2006" TOTAL_1="30" TOTAL_2="30" VAR="2.1577060931899643" WEIGHT="3.4774172490881234"/></DICH_SUBGROUP></DICH_OUTCOME><DICH_OUTCOME CHI2="201.40983152392073" CI_END="0.5322393932735516" CI_START="0.36078792794371" CI_STUDY="95" CI_TOTAL="95" DF="47" EFFECT_MEASURE="RR" EFFECT_SIZE="0.43820719741827846" ESTIMABLE="YES" EVENTS_1="572" EVENTS_2="1089" I2="76.66449564830802" I2_Q="91.6714640634323" ID="CMP-002.13" LOG_CI_END="-0.27389298463584366" LOG_CI_START="-0.4427480024913602" LOG_EFFECT_SIZE="-0.35832049356360196" METHOD="MH" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" NO="13" P_CHI2="-4.440892098500626E-16" P_Q="5.300388548156176E-4" P_Z="8.921684780058808E-17" Q="12.00691223062805" RANDOM="YES" SCALE="100.0" SORT_BY="YEAR" STUDIES="48" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.2729621937651614" TOTALS="YES" TOTAL_1="3260" TOTAL_2="3160" WEIGHT="100.0" Z="8.31832267973471"><NAME>All supraventricular arrhythmias&#8212;cardiac surgery</NAME><GROUP_LABEL_1>Beta-blocker</GROUP_LABEL_1><GROUP_LABEL_2>Control</GROUP_LABEL_2><GRAPH_LABEL_1>Favours beta-blocker</GRAPH_LABEL_1><GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2><DICH_SUBGROUP CHI2="79.95564580691871" CI_END="0.7571401438079652" CI_START="0.47620876824987113" DF="19" EFFECT_SIZE="0.6004638001372951" ESTIMABLE="YES" EVENTS_1="408" EVENTS_2="570" I2="76.23682504437242" ID="CMP-002.13.01" LOG_CI_END="-0.12082372677561458" LOG_CI_START="-0.3222026123593684" LOG_EFFECT_SIZE="-0.2215131695674915" MODIFIED="2013-11-17 21:46:36 +0000" MODIFIED_BY="Hermann Blessberger" NO="1" P_CHI2="1.8926535894081553E-9" P_Z="1.6189381280901105E-5" STUDIES="20" TAU2="0.1553537908118527" TOTAL_1="1787" TOTAL_2="1614" WEIGHT="47.73690851349699" Z="4.311850601368337"><NAME>Placebo</NAME><DICH_DATA CI_END="2.0488361448048726" CI_START="0.32963107650375956" EFFECT_SIZE="0.8218029350104822" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="9" LOG_CI_END="0.3115072271896002" LOG_CI_START="-0.4819718512289136" LOG_EFFECT_SIZE="-0.08523231201965667" MODIFIED="2013-11-17 21:42:37 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="544" O_E="0.0" SE="0.46609353844781976" STUDY_ID="STD-Ivey-1983" TOTAL_1="53" TOTAL_2="56" VAR="0.21724318658280922" WEIGHT="2.006896948159388"/><DICH_DATA CI_END="1.0920886040087217" CI_START="0.18657087736694164" EFFECT_SIZE="0.4513888888888889" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="12" LOG_CI_END="0.03825787524694105" LOG_CI_START="-0.7291561461517292" LOG_EFFECT_SIZE="-0.3454491354523941" MODIFIED="2013-11-17 21:42:44 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="543" O_E="0.0" SE="0.4507827949302504" STUDY_ID="STD-Hammon-1984" TOTAL_1="24" TOTAL_2="26" VAR="0.2032051282051282" WEIGHT="2.0660629917250763"/><DICH_DATA CI_END="1.1517322070933487" CI_START="0.8726150111164188" EFFECT_SIZE="1.0025062656641603" ESTIMABLE="YES" EVENTS_1="20" EVENTS_2="19" LOG_CI_END="0.06135151163809717" LOG_CI_START="-0.059177320355668896" LOG_EFFECT_SIZE="0.0010870956412141369" MODIFIED="2013-11-17 21:42:50 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="555" O_E="0.0" SE="0.07079923254047887" STUDY_ID="STD-White-1984" TOTAL_1="21" TOTAL_2="20" VAR="0.005012531328320802" WEIGHT="3.5391407670636514"/><DICH_DATA CI_END="1.0179832018909118" CI_START="0.14531575158417248" EFFECT_SIZE="0.38461538461538464" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="13" LOG_CI_END="0.007740611609507653" LOG_CI_START="-0.8376873075511435" LOG_EFFECT_SIZE="-0.4149733479708179" MODIFIED="2013-11-17 21:42:56 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="554" O_E="0.0" SE="0.4966085446506601" STUDY_ID="STD-Vecht-1986" TOTAL_1="66" TOTAL_2="66" VAR="0.24662004662004666" WEIGHT="1.8934282300763214"/><DICH_DATA CI_END="0.421579851024765" CI_START="0.08503552553709799" EFFECT_SIZE="0.18933901918976545" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="35" LOG_CI_END="-0.3751201539574404" LOG_CI_START="-1.070399599915524" LOG_EFFECT_SIZE="-0.7227598769364822" MODIFIED="2013-11-17 21:43:04 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="545" O_E="0.0" SE="0.4084105882445427" STUDY_ID="STD-Khuri-1987" TOTAL_1="67" TOTAL_2="74" VAR="0.16679920859025338" WEIGHT="2.2371032940188664"/><DICH_DATA CI_END="4.126826287091888" CI_START="0.7815504113324163" EFFECT_SIZE="1.7959183673469388" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="7" LOG_CI_END="0.6156161882509973" LOG_CI_START="-0.10704300400768743" LOG_EFFECT_SIZE="0.25428659212165494" MODIFIED="2013-11-17 21:43:55 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="584" O_E="0.0" SE="0.4244935867534458" STUDY_ID="STD-Martinussen-1988" TOTAL_1="35" TOTAL_2="40" VAR="0.18019480519480519" WEIGHT="2.170973159522062"/><DICH_DATA CI_END="0.9337223063907559" CI_START="0.11899802580555667" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="12" LOG_CI_END="-0.02978226588341088" LOG_CI_START="-0.9244602435559142" LOG_EFFECT_SIZE="-0.47712125471966244" MODIFIED="2013-11-17 21:44:02 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="547" O_E="0.0" SE="0.5255382728122435" STUDY_ID="STD-Matangi-1989" TOTAL_1="35" TOTAL_2="35" VAR="0.27619047619047615" WEIGHT="1.7914720907596215"/><DICH_DATA CI_END="0.8089575542744424" CI_START="0.33649691357538647" EFFECT_SIZE="0.5217391304347826" ESTIMABLE="YES" EVENTS_1="24" EVENTS_2="46" LOG_CI_END="-0.09207426507251505" LOG_CI_START="-0.47301891486742115" LOG_EFFECT_SIZE="-0.28254658996996806" MODIFIED="2013-11-17 21:44:11 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="553" O_E="0.0" SE="0.22376877299595657" STUDY_ID="STD-Suttorp-1991" TOTAL_1="150" TOTAL_2="150" VAR="0.05007246376811594" WEIGHT="3.0454679052210034"/><DICH_DATA CI_END="63.82881484401465" CI_START="0.12392766917779852" EFFECT_SIZE="2.8125" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.8050167806434498" LOG_CI_START="-0.9068317184046119" LOG_EFFECT_SIZE="0.4490925311194189" MODIFIED="2013-11-17 21:44:16 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="539" O_E="0.0" SE="1.592953232207399" STUDY_ID="STD-Cork-1995" TOTAL_1="15" TOTAL_2="14" VAR="2.5374999999999996" WEIGHT="0.35004622512771605"/><DICH_DATA CI_END="0.967053167072245" CI_START="0.41868044849390096" EFFECT_SIZE="0.6363067292644757" ESTIMABLE="YES" EVENTS_1="38" EVENTS_2="30" LOG_CI_END="-0.014549648428526057" LOG_CI_START="-0.37811731928423464" LOG_EFFECT_SIZE="-0.19633348385638036" MODIFIED="2013-11-17 21:44:27 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="542" O_E="0.0" SE="0.213561449549639" STUDY_ID="STD-Graham-1996" TOTAL_1="213" TOTAL_2="107" VAR="0.045608492733743004" WEIGHT="3.088142517453619"/><DICH_DATA CI_END="1.8214515190598082" CI_START="0.4677977958792884" EFFECT_SIZE="0.9230769230769231" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="13" LOG_CI_END="0.26041761626692334" LOG_CI_START="-0.32994182878534717" LOG_EFFECT_SIZE="-0.03476210625921192" MODIFIED="2013-11-17 21:44:33 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="548" O_E="0.0" SE="0.3467800603500874" STUDY_ID="STD-Paull-1997" TOTAL_1="50" TOTAL_2="50" VAR="0.12025641025641025" WEIGHT="2.501895057177112"/><DICH_DATA CI_END="0.8367549673280018" CI_START="0.38960932218699135" EFFECT_SIZE="0.5709706959706959" ESTIMABLE="YES" EVENTS_1="29" EVENTS_2="52" LOG_CI_END="-0.07740170080856265" LOG_CI_START="-0.40937066029975144" LOG_EFFECT_SIZE="-0.24338618055415703" MODIFIED="2013-11-17 21:44:41 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="549" O_E="0.0" SE="0.19500021007797613" STUDY_ID="STD-Pfisterer-1997" TOTAL_1="126" TOTAL_2="129" VAR="0.03802508193045483" WEIGHT="3.1634467345685104"/><DICH_DATA CI_END="0.7899548058160761" CI_START="0.21326202895259727" EFFECT_SIZE="0.41044776119402987" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="24" LOG_CI_END="-0.10239775446416542" LOG_CI_START="-0.6710864632769621" LOG_EFFECT_SIZE="-0.38674210887056376" MODIFIED="2013-11-17 21:44:46 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="540" O_E="0.0" SE="0.33405056261114596" STUDY_ID="STD-Dy-1998" TOTAL_1="67" TOTAL_2="66" VAR="0.11158977838082317" WEIGHT="2.5582801625008567"/><DICH_DATA CI_END="0.815131215366541" CI_START="0.13431350612509407" EFFECT_SIZE="0.33088235294117646" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="17" LOG_CI_END="-0.08877247528121683" LOG_CI_START="-0.8718803139085308" LOG_EFFECT_SIZE="-0.48032639459487386" MODIFIED="2013-11-17 21:44:53 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="541" O_E="0.0" SE="0.460001420856004" STUDY_ID="STD-Gomes-1999" TOTAL_1="40" TOTAL_2="45" VAR="0.2116013071895425" WEIGHT="2.0302636906274487"/><DICH_DATA CI_END="0.9484074945855946" CI_START="0.674815418112704" EFFECT_SIZE="0.8" ESTIMABLE="YES" EVENTS_1="156" EVENTS_2="195" LOG_CI_END="-0.023005022761850884" LOG_CI_START="-0.17081500325426194" LOG_EFFECT_SIZE="-0.09691001300805639" MODIFIED="2013-11-17 21:45:02 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="538" O_E="0.0" SE="0.08682431421244592" STUDY_ID="STD-Connolly-2003" TOTAL_1="500" TOTAL_2="500" VAR="0.007538461538461539" WEIGHT="3.507270529285454"/><DICH_DATA CI_END="5.055834822644325" CI_START="0.4316467581119249" EFFECT_SIZE="1.4772727272727273" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="4" LOG_CI_END="0.703792876827747" LOG_CI_START="-0.36487151651441074" LOG_EFFECT_SIZE="0.16946068015666815" MODIFIED="2013-11-17 21:45:16 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="537" O_E="0.0" SE="0.6277387546232461" STUDY_ID="STD-Booth-2004" TOTAL_1="33" TOTAL_2="39" VAR="0.394055944055944" WEIGHT="1.4749099402383985"/><DICH_DATA CI_END="0.9248471633511364" CI_START="0.48330986222891537" EFFECT_SIZE="0.6685714285714286" ESTIMABLE="YES" EVENTS_1="45" EVENTS_2="35" LOG_CI_END="-0.0339300311501147" LOG_CI_START="-0.3157743427301508" LOG_EFFECT_SIZE="-0.17485218694013277" MODIFIED="2013-11-17 21:45:10 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="536" O_E="0.0" SE="0.16555674377395627" STUDY_ID="STD-Auer-2004" TOTAL_1="125" TOTAL_2="65" VAR="0.027409035409035408" WEIGHT="3.2752527081117875"/><DICH_DATA CI_END="1.6818496358282289" CI_START="0.42805642238869207" EFFECT_SIZE="0.8484848484848485" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="11" LOG_CI_END="0.22578716551115877" LOG_CI_START="-0.3684989825824953" LOG_EFFECT_SIZE="-0.07135590853566824" MODIFIED="2013-11-17 21:46:22 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="552" O_E="0.0" SE="0.3490866251540896" STUDY_ID="STD-Sun-2011" TOTAL_1="30" TOTAL_2="28" VAR="0.12186147186147188" WEIGHT="2.4917241985235536"/><DICH_DATA CI_END="0.6324601313324618" CI_START="0.13450562372243266" EFFECT_SIZE="0.2916666666666667" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="24" LOG_CI_END="-0.1989668461016144" LOG_CI_START="-0.871259557293084" LOG_EFFECT_SIZE="-0.5351132016973492" MODIFIED="2013-11-17 21:46:30 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="550" O_E="0.0" SE="0.39490806645646137" STUDY_ID="STD-Sezai-2011" TOTAL_1="70" TOTAL_2="70" VAR="0.15595238095238093" WEIGHT="2.2936774355115377"/><DICH_DATA CI_END="0.7482025935275345" CI_START="0.1529700826342874" EFFECT_SIZE="0.3383084577114428" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="12" LOG_CI_END="-0.12598079072115415" LOG_CI_START="-0.8153934987073509" LOG_EFFECT_SIZE="-0.47068714471425255" MODIFIED="2013-11-17 21:46:36 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="551" O_E="0.0" SE="0.404964437319035" STUDY_ID="STD-Sezai-2012" TOTAL_1="67" TOTAL_2="34" VAR="0.1639961954931226" WEIGHT="2.2514539278250125"/></DICH_SUBGROUP><DICH_SUBGROUP CHI2="26.288743060567445" CI_END="0.4282365344963954" CI_START="0.3104275906089435" DF="27" EFFECT_SIZE="0.3646044920382081" ESTIMABLE="YES" EVENTS_1="164" EVENTS_2="519" I2="0.0" ID="CMP-002.13.02" LOG_CI_END="-0.3683162841379404" LOG_CI_START="-0.5080396858780745" LOG_EFFECT_SIZE="-0.4381779850080074" MODIFIED="2013-12-01 13:09:15 +0000" MODIFIED_BY="Hermann Blessberger" NO="2" P_CHI2="0.502623538710071" P_Z="9.871558919116937E-35" STUDIES="28" TAU2="0.0" TOTAL_1="1473" TOTAL_2="1546" WEIGHT="52.263091486503" Z="12.293045527638933"><NAME>Standard care</NAME><DICH_DATA CI_END="2.4143738176207648" CI_START="0.18041945154510514" EFFECT_SIZE="0.66" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="5" LOG_CI_END="0.38280451280407934" LOG_CI_START="-0.7437166417203419" LOG_EFFECT_SIZE="-0.1804560644581313" MODIFIED="2013-11-17 21:46:56 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="579" O_E="0.0" SE="0.6617241025372945" STUDY_ID="STD-Salazar-1979" TOTAL_1="20" TOTAL_2="22" VAR="0.43787878787878787" WEIGHT="1.3839827854556963"/><DICH_DATA CI_END="1.0124518038855774" CI_START="0.20532344839946126" EFFECT_SIZE="0.4559386973180077" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="24" LOG_CI_END="0.00537435849931325" LOG_CI_START="-0.6875614503908136" LOG_EFFECT_SIZE="-0.3410935459457502" MODIFIED="2013-11-17 21:47:11 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="581" O_E="0.0" SE="0.4070339242296343" STUDY_ID="STD-Stephenson-1980" TOTAL_1="87" TOTAL_2="136" VAR="0.16567661547377568" WEIGHT="2.2428286350188396"/><DICH_DATA CI_END="0.8969131509065325" CI_START="0.05911511257256819" EFFECT_SIZE="0.23026315789473684" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="16" LOG_CI_END="-0.047249608135544637" LOG_CI_START="-1.2283014790534492" LOG_EFFECT_SIZE="-0.637775543594497" MODIFIED="2013-11-17 21:47:18 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="574" O_E="0.0" SE="0.6937557152782261" STUDY_ID="STD-Oka-1980" TOTAL_1="19" TOTAL_2="35" VAR="0.48129699248120306" WEIGHT="1.304315147539108"/><DICH_DATA CI_END="0.5496310050546848" CI_START="0.03392818225948094" EFFECT_SIZE="0.13655761024182078" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="19" LOG_CI_END="-0.25992877641364504" LOG_CI_START="-1.469439407546866" LOG_EFFECT_SIZE="-0.8646840919802555" MODIFIED="2013-11-17 21:47:26 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="570" O_E="0.0" SE="0.7104725319018379" STUDY_ID="STD-Mohr-1981" TOTAL_1="37" TOTAL_2="48" VAR="0.504771218587008" WEIGHT="1.2649471736289228"/><DICH_DATA CI_END="0.6999722648647813" CI_START="0.0656002668274423" EFFECT_SIZE="0.21428571428571427" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="14" LOG_CI_END="-0.15491916777833195" LOG_CI_START="-1.1830943941388192" LOG_EFFECT_SIZE="-0.6690067809585756" MODIFIED="2013-11-17 21:47:42 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="580" O_E="0.0" SE="0.603955217513604" STUDY_ID="STD-Silverman-1982" TOTAL_1="50" TOTAL_2="50" VAR="0.36476190476190473" WEIGHT="1.5426603511830446"/><DICH_DATA CI_END="1.4875364844811094" CI_START="0.02439011043885608" EFFECT_SIZE="0.19047619047619047" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="6" LOG_CI_END="0.17246762637672552" LOG_CI_START="-1.6127862331886396" LOG_EFFECT_SIZE="-0.7201593034059569" MODIFIED="2013-11-17 21:47:32 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="583" O_E="0.0" SE="1.048666954257824" STUDY_ID="STD-Williams-1982" TOTAL_1="28" TOTAL_2="32" VAR="1.099702380952381" WEIGHT="0.7167021717553193"/><DICH_DATA CI_END="0.9625082004987383" CI_START="0.2097281543575606" EFFECT_SIZE="0.4492939666238768" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="19" LOG_CI_END="-0.016595561646807904" LOG_CI_START="-0.6783432649977698" LOG_EFFECT_SIZE="-0.3474694133222888" MODIFIED="2013-12-01 13:09:15 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="556" O_E="0.0" SE="0.38871387665231644" STUDY_ID="STD-Abel-1983" TOTAL_1="41" TOTAL_2="50" VAR="0.15109847790207226" WEIGHT="2.319931433216352"/><DICH_DATA CI_END="1.1085399331216403" CI_START="0.06960551579759253" EFFECT_SIZE="0.2777777777777778" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="9" LOG_CI_END="0.04475134239592844" LOG_CI_START="-1.157356343930503" LOG_EFFECT_SIZE="-0.5563025007672873" MODIFIED="2013-11-17 21:48:15 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="571" O_E="0.0" SE="0.706124005477162" STUDY_ID="STD-Myhre-1984" TOTAL_1="16" TOTAL_2="20" VAR="0.49861111111111117" WEIGHT="1.2750462925222803"/><DICH_DATA CI_END="1.5715363292104452" CI_START="0.18776337809660357" EFFECT_SIZE="0.5432098765432098" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="9" LOG_CI_END="0.19632442505659703" LOG_CI_START="-0.7263891098415217" LOG_EFFECT_SIZE="-0.2650323423924623" MODIFIED="2013-11-17 21:48:09 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="575" O_E="0.0" SE="0.5420064979048165" STUDY_ID="STD-Ormerod-1984" TOTAL_1="27" TOTAL_2="33" VAR="0.2937710437710438" WEIGHT="1.7358990379116521"/><DICH_DATA CI_END="0.8109759442010569" CI_START="0.1413241180444068" EFFECT_SIZE="0.3385416666666667" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="18" LOG_CI_END="-0.09099202797834484" LOG_CI_START="-0.8497837161430433" LOG_EFFECT_SIZE="-0.470387872060694" MODIFIED="2013-11-17 21:48:39 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="568" O_E="0.0" SE="0.4457179937073776" STUDY_ID="STD-Materne-1985" TOTAL_1="32" TOTAL_2="39" VAR="0.1986645299145299" WEIGHT="2.085954065783184"/><DICH_DATA CI_END="0.906876568196414" CI_START="0.1954900201161221" EFFECT_SIZE="0.42105263157894735" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="19" LOG_CI_END="-0.042451819223332604" LOG_CI_START="-0.7088754086984382" LOG_EFFECT_SIZE="-0.3756636139608854" MODIFIED="2013-11-17 21:48:33 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="567" O_E="0.0" SE="0.3914605153076481" STUDY_ID="STD-Matangi-1985" TOTAL_1="82" TOTAL_2="82" VAR="0.15324133504492937" WEIGHT="2.308267330724086"/><DICH_DATA CI_END="0.5400329023288767" CI_START="0.10939334035325655" EFFECT_SIZE="0.24305555555555555" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="18" LOG_CI_END="-0.2675797793167253" LOG_CI_START="-0.9610091161732227" LOG_EFFECT_SIZE="-0.614294447744974" MODIFIED="2013-11-17 21:48:54 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="565" O_E="0.0" SE="0.4073238250000832" STUDY_ID="STD-Janssen-1986" TOTAL_1="80" TOTAL_2="50" VAR="0.1659126984126984" WEIGHT="2.2416221554842557"/><DICH_DATA CI_END="0.3925291896546882" CI_START="0.0015155153127434649" EFFECT_SIZE="0.024390243902439025" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="20" LOG_CI_END="-0.4061280422700622" LOG_CI_START="-2.819439671169409" LOG_EFFECT_SIZE="-1.6127838567197355" MODIFIED="2013-11-17 21:48:46 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="560" O_E="0.0" SE="1.4175911969007033" STUDY_ID="STD-Daudon-1986" TOTAL_1="50" TOTAL_2="50" VAR="2.0095648015303684" WEIGHT="0.4310098780077201"/><DICH_DATA CI_END="0.9962321240462663" CI_START="0.1877050579938394" EFFECT_SIZE="0.43243243243243246" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="15" LOG_CI_END="-0.0016394583162494887" LOG_CI_START="-0.7265240245058909" LOG_EFFECT_SIZE="-0.3640817414110702" MODIFIED="2013-11-17 21:49:01 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="577" O_E="0.0" SE="0.42580078241626834" STUDY_ID="STD-Rubin-1987" TOTAL_1="37" TOTAL_2="40" VAR="0.18130630630630631" WEIGHT="2.1656612369928347"/><DICH_DATA CI_END="0.6607918354063609" CI_START="0.012506908177573097" EFFECT_SIZE="0.09090909090909091" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="11" LOG_CI_END="-0.17993533169837356" LOG_CI_START="-1.9028500386180767" LOG_EFFECT_SIZE="-1.041392685158225" MODIFIED="2013-11-17 21:49:06 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="566" O_E="0.0" SE="1.0120486274099798" STUDY_ID="STD-Lamb-1988" TOTAL_1="30" TOTAL_2="30" VAR="1.024242424242424" WEIGHT="0.7583936012367031"/><DICH_DATA CI_END="0.8651318953082401" CI_START="0.13362124391311758" EFFECT_SIZE="0.34" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="15" LOG_CI_END="-0.06291767630644172" LOG_CI_START="-0.8741244896090479" LOG_EFFECT_SIZE="-0.46852108295774486" MODIFIED="2013-11-17 21:49:18 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="572" O_E="0.0" SE="0.4765068976724385" STUDY_ID="STD-Nystr_x00f6_m-1993" TOTAL_1="50" TOTAL_2="51" VAR="0.22705882352941176" WEIGHT="1.9675006605013994"/><DICH_DATA CI_END="1.9174334705591203" CI_START="0.15030479565965907" EFFECT_SIZE="0.5368421052631579" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="5" LOG_CI_END="0.2827203041097743" LOG_CI_START="-0.8230271624915971" LOG_EFFECT_SIZE="-0.2701534291909114" MODIFIED="2013-11-17 21:49:24 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="564" O_E="0.0" SE="0.6495215354198813" STUDY_ID="STD-Jacquet-1994" TOTAL_1="19" TOTAL_2="17" VAR="0.4218782249742002" WEIGHT="1.4158526983455175"/><DICH_DATA CI_END="0.7907637030184065" CI_START="0.0484655463980742" EFFECT_SIZE="0.19576719576719576" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="14" LOG_CI_END="-0.10195327352704722" LOG_CI_START="-1.3145668866854512" LOG_EFFECT_SIZE="-0.7082600801062492" MODIFIED="2013-11-17 21:49:29 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="558" O_E="0.0" SE="0.7122952389034392" STUDY_ID="STD-Babin_x002d_Ebell-1996" TOTAL_1="27" TOTAL_2="37" VAR="0.5073645073645074" WEIGHT="1.2607433275927016"/><DICH_DATA CI_END="0.7316733754295464" CI_START="0.276762838173683" EFFECT_SIZE="0.45" ESTIMABLE="YES" EVENTS_1="18" EVENTS_2="40" LOG_CI_END="-0.13568274804766128" LOG_CI_START="-0.5578922244016514" LOG_EFFECT_SIZE="-0.3467874862246563" MODIFIED="2013-11-17 21:49:38 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="557" O_E="0.0" SE="0.2480079363809483" STUDY_ID="STD-Ali-1997" TOTAL_1="105" TOTAL_2="105" VAR="0.061507936507936505" WEIGHT="2.9413439130973504"/><DICH_DATA CI_END="0.29201086050273417" CI_START="0.0400237272634076" EFFECT_SIZE="0.10810810810810811" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="37" LOG_CI_END="-0.5346009959190617" LOG_CI_START="-1.3976824695590033" LOG_EFFECT_SIZE="-0.9661417327390326" MODIFIED="2013-11-17 21:49:44 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="582" O_E="0.0" SE="0.5069783299382993" STUDY_ID="STD-Wenke-1999" TOTAL_1="100" TOTAL_2="100" VAR="0.257027027027027" WEIGHT="1.856248472980556"/><DICH_DATA CI_END="0.559711576637503" CI_START="0.20705225265439542" EFFECT_SIZE="0.3404255319148936" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="47" LOG_CI_END="-0.2520357103921946" LOG_CI_START="-0.6839200401673907" LOG_EFFECT_SIZE="-0.4679778752797927" MODIFIED="2013-11-17 21:49:52 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="562" O_E="0.0" SE="0.2536909931718616" STUDY_ID="STD-Evrard-2000" TOTAL_1="103" TOTAL_2="103" VAR="0.06435912001652552" WEIGHT="2.9164824207591002"/><DICH_DATA CI_END="0.8589583309812318" CI_START="0.26561019438408295" EFFECT_SIZE="0.47764849969381507" ESTIMABLE="YES" EVENTS_1="13" EVENTS_2="23" LOG_CI_END="-0.0660279037634654" LOG_CI_START="-0.5757552603289101" LOG_EFFECT_SIZE="-0.3208915820461878" MODIFIED="2013-11-17 21:49:59 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="559" O_E="0.0" SE="0.29941637243765074" STUDY_ID="STD-Bert-2001" TOTAL_1="71" TOTAL_2="60" VAR="0.08965016408372196" WEIGHT="2.7130671652443903"/><DICH_DATA CI_END="0.925811812744811" CI_START="0.17282129888323441" EFFECT_SIZE="0.4" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="15" LOG_CI_END="-0.03347728220825417" LOG_CI_START="-0.762402735135821" LOG_EFFECT_SIZE="-0.3979400086720376" MODIFIED="2013-11-17 21:50:05 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="569" O_E="0.0" SE="0.42817441928883765" STUDY_ID="STD-Matsuura-2001" TOTAL_1="40" TOTAL_2="40" VAR="0.18333333333333335" WEIGHT="2.1560405994935286"/><DICH_DATA CI_END="0.7105931245191439" CI_START="0.13488819843100122" EFFECT_SIZE="0.30959752321981426" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="19" LOG_CI_END="-0.14837899892640086" LOG_CI_START="-0.8700260457358048" LOG_EFFECT_SIZE="-0.5092025223311029" MODIFIED="2013-11-17 21:50:11 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="563" O_E="0.0" SE="0.4238990475063375" STUDY_ID="STD-Forlani-2002" TOTAL_1="51" TOTAL_2="50" VAR="0.17969040247678017" WEIGHT="2.173392332131506"/><DICH_DATA CI_END="0.8846657886054342" CI_START="0.2374562768789701" EFFECT_SIZE="0.4583333333333333" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="24" LOG_CI_END="-0.05322076724324717" LOG_CI_START="-0.6244163458635148" LOG_EFFECT_SIZE="-0.338818556553381" MODIFIED="2013-11-17 21:50:17 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="561" O_E="0.0" SE="0.3355231103452601" STUDY_ID="STD-De-Azevedo-L_x00fa_cio-2003" TOTAL_1="100" TOTAL_2="100" VAR="0.11257575757575758" WEIGHT="2.55173758736327"/><DICH_DATA CI_END="0.8263453347887832" CI_START="0.17017703625802433" EFFECT_SIZE="0.375" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="16" LOG_CI_END="-0.0828384204148983" LOG_CI_START="-0.7690990441296639" LOG_EFFECT_SIZE="-0.42596873227228116" MODIFIED="2013-11-17 21:50:30 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="578" O_E="0.0" SE="0.4031128874149275" STUDY_ID="STD-Sakaguchi-2012" TOTAL_1="30" TOTAL_2="30" VAR="0.1625" WEIGHT="2.259189651541138"/><DICH_DATA CI_END="0.5360855287701065" CI_START="0.05040605255789461" EFFECT_SIZE="0.1643835616438356" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="17" LOG_CI_END="-0.27076591607279954" LOG_CI_START="-1.2975173120728625" LOG_EFFECT_SIZE="-0.7841416140728311" MODIFIED="2013-11-17 21:50:23 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="576" O_E="0.0" SE="0.6031188525118167" STUDY_ID="STD-Osada-2012" TOTAL_1="73" TOTAL_2="68" VAR="0.36375235025517055" WEIGHT="1.5451063447990585"/><DICH_DATA CI_END="0.9285567066549609" CI_START="0.2912046168662018" EFFECT_SIZE="0.52" ESTIMABLE="YES" EVENTS_1="13" EVENTS_2="25" LOG_CI_END="-0.032191568892075674" LOG_CI_START="-0.5358017438383259" LOG_EFFECT_SIZE="-0.28399665636520083" MODIFIED="2013-11-17 21:50:41 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="573" O_E="0.0" SE="0.29582310967399855" STUDY_ID="STD-Ogawa-2013" TOTAL_1="68" TOTAL_2="68" VAR="0.08751131221719458" WEIGHT="2.729165016193473"/></DICH_SUBGROUP></DICH_OUTCOME><DICH_OUTCOME CHI2="6.069811265865222" CI_END="0.9359710466383022" CI_START="0.5725807491224083" CI_STUDY="95" CI_TOTAL="95" DF="7" EFFECT_MEASURE="RR" EFFECT_SIZE="0.7320648899114365" ESTIMABLE="YES" EVENTS_1="108" EVENTS_2="144" I2="0.0" I2_Q="40.54536080377478" ID="CMP-002.14" LOG_CI_END="-0.02873758553508129" LOG_CI_START="-0.24216325759010013" LOG_EFFECT_SIZE="-0.1354504215625907" METHOD="MH" MODIFIED="2017-06-17 15:37:29 +0100" MODIFIED_BY="Hermann Blessberger" NO="14" P_CHI2="0.5316220044239742" P_Q="0.19466502294781918" P_Z="0.012854359918644902" Q="1.6819545346151727" RANDOM="NO" SCALE="100.0" SORT_BY="YEAR" STUDIES="8" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="4380" TOTAL_2="4364" WEIGHT="100.0" Z="2.4877789573974773"><NAME>All supraventricular arrhythmias&#8212;non-cardiac surgery</NAME><GROUP_LABEL_1>Beta-blocker</GROUP_LABEL_1><GROUP_LABEL_2>Control</GROUP_LABEL_2><GRAPH_LABEL_1>Favours beta-blocker</GRAPH_LABEL_1><GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2><DICH_SUBGROUP CHI2="4.379068657931078" CI_END="0.9632291172726208" CI_START="0.5869366681422833" DF="6" EFFECT_SIZE="0.7519005843524958" ESTIMABLE="YES" EVENTS_1="108" EVENTS_2="140" I2="0.0" ID="CMP-002.14.01" LOG_CI_END="-0.016270397681250052" LOG_CI_START="-0.2314087576283507" LOG_EFFECT_SIZE="-0.12383957765480039" MODIFIED="2017-06-17 15:37:29 +0100" MODIFIED_BY="Hermann Blessberger" NO="1" P_CHI2="0.6255214547118372" P_Z="0.024044419958190632" STUDIES="7" TAU2="0.0" TOTAL_1="4350" TOTAL_2="4334" WEIGHT="96.90449121445114" Z="2.2564187262907605"><NAME>Placebo</NAME><DICH_DATA CI_END="3.694376342661255" CI_START="0.09210696101758215" EFFECT_SIZE="0.5833333333333334" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="2" LOG_CI_END="0.5675411345302878" LOG_CI_START="-1.0357075465970236" LOG_EFFECT_SIZE="-0.23408320603336796" MODIFIED="2013-11-17 21:53:03 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="587" O_E="0.0" SE="0.9417562115031479" STUDY_ID="STD-Coleman-1980" TOTAL_1="24" TOTAL_2="14" VAR="0.886904761904762" WEIGHT="1.737829493641464"/><DICH_DATA CI_END="60.21015642179821" CI_START="0.11637439315284949" EFFECT_SIZE="2.6470588235294117" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.7796697554754684" LOG_CI_START="-0.934142570681329" LOG_EFFECT_SIZE="0.42276359239706973" MODIFIED="2013-11-17 21:53:09 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="589" O_E="0.0" SE="1.5941067939721714" STUDY_ID="STD-Liu-1986" TOTAL_1="16" TOTAL_2="14" VAR="2.541176470588235" WEIGHT="0.3654420094050735"/><DICH_DATA CI_END="1.5981153088603466" CI_START="0.025243867342839378" EFFECT_SIZE="0.20085470085470086" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="6" LOG_CI_END="0.20360811177088864" LOG_CI_START="-1.5978441107197394" LOG_EFFECT_SIZE="-0.6971179994744253" MODIFIED="2013-11-17 21:53:18 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="586" O_E="0.0" SE="1.0581819528233132" STUDY_ID="STD-Burns-1988" TOTAL_1="39" TOTAL_2="47" VAR="1.1197490452809604" WEIGHT="3.7434059732218747"/><DICH_DATA CI_END="22.711113534056025" CI_START="0.3962817581138951" EFFECT_SIZE="3.0" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="1" LOG_CI_END="1.3562384283562463" LOG_CI_START="-0.40199591891692144" LOG_EFFECT_SIZE="0.47712125471966244" MODIFIED="2013-11-17 21:53:24 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="591" O_E="0.0" SE="1.0327955589886444" STUDY_ID="STD-Sandler-1990" TOTAL_1="30" TOTAL_2="15" VAR="1.0666666666666667" WEIGHT="0.9171877883107726"/><DICH_DATA CI_END="2.3517506825099073" CI_START="0.24274010071578214" EFFECT_SIZE="0.7555555555555555" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="5" LOG_CI_END="0.3713912787351326" LOG_CI_START="-0.6148584722013096" LOG_EFFECT_SIZE="-0.12173359673308856" MODIFIED="2013-11-17 21:53:29 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="588" O_E="0.0" SE="0.5793279857150695" STUDY_ID="STD-Jakobsen-1997" TOTAL_1="18" TOTAL_2="17" VAR="0.33562091503267977" WEIGHT="3.5377243263415523"/><DICH_DATA CI_END="1.9266406466126647" CI_START="0.1351098895231352" EFFECT_SIZE="0.5102040816326531" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="6" LOG_CI_END="0.28480071841945853" LOG_CI_START="-0.8693128611324107" LOG_EFFECT_SIZE="-0.292256071356476" MODIFIED="2013-11-17 21:53:38 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="585" O_E="0.0" SE="0.677932029583124" STUDY_ID="STD-Bayliff-1999" TOTAL_1="49" TOTAL_2="50" VAR="0.45959183673469384" WEIGHT="4.085654693384352"/><DICH_DATA CI_END="0.9931562131790224" CI_START="0.5798648580922154" EFFECT_SIZE="0.7588783740616515" ESTIMABLE="YES" EVENTS_1="91" EVENTS_2="120" LOG_CI_END="-0.002982436110955725" LOG_CI_START="-0.23667321027073493" LOG_EFFECT_SIZE="-0.11982782319084534" MODIFIED="2013-12-08 09:37:08 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="590" O_E="0.0" SE="0.13727111752944285" STUDY_ID="STD-POISE-2008" TOTAL_1="4174" TOTAL_2="4177" VAR="0.01884335970778211" WEIGHT="82.51724693014606"/></DICH_SUBGROUP><DICH_SUBGROUP CHI2="0.0" CI_END="1.9774190029426773" CI_START="0.006243329812231785" DF="0" EFFECT_SIZE="0.1111111111111111" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="4" I2="0.0" ID="CMP-002.14.02" LOG_CI_END="0.2960987033983009" LOG_CI_START="-2.204583722276951" LOG_EFFECT_SIZE="-0.9542425094393249" MODIFIED="2013-11-17 21:54:03 +0000" MODIFIED_BY="Hermann Blessberger" NO="2" P_CHI2="1.0" P_Z="0.13470149407860718" STUDIES="1" TAU2="0.0" TOTAL_1="30" TOTAL_2="30" WEIGHT="3.0955087855488577" Z="1.4958164473948934"><NAME>Standard care</NAME><DICH_DATA CI_END="1.9774190029426781" CI_START="0.006243329812231785" EFFECT_SIZE="0.1111111111111111" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="4" LOG_CI_END="0.29609870339830113" LOG_CI_START="-2.204583722276951" LOG_EFFECT_SIZE="-0.9542425094393249" MODIFIED="2013-11-17 21:54:03 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="593" O_E="0.0" SE="1.4689132354192893" STUDY_ID="STD-Lai-2006" TOTAL_1="30" TOTAL_2="30" VAR="2.1577060931899643" WEIGHT="3.0955087855488577"/></DICH_SUBGROUP></DICH_OUTCOME><DICH_OUTCOME CHI2="4.640203931433373" CI_END="0.3668597252052659" CI_START="0.13250031526023334" CI_STUDY="95" CI_TOTAL="95" DF="8" EFFECT_MEASURE="RR" EFFECT_SIZE="0.22047455464515697" ESTIMABLE="YES" EVENTS_1="18" EVENTS_2="61" I2="0.0" I2_Q="0.0" ID="CMP-002.15" LOG_CI_END="-0.4354999635811673" LOG_CI_START="-0.8777830884017633" LOG_EFFECT_SIZE="-0.6566415259914653" METHOD="MH" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" NO="15" P_CHI2="0.7952478116781713" P_Q="0.7967351230412303" P_Z="5.892752659931927E-9" Q="0.06634475180045951" RANDOM="NO" SCALE="100.0" SORT_BY="YEAR" STUDIES="9" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="293" TOTAL_2="199" WEIGHT="100.0" Z="5.819773215262233"><NAME>Ventricular extrasystoles&#8212;non-cardiac surgery</NAME><GROUP_LABEL_1>Beta-blocker</GROUP_LABEL_1><GROUP_LABEL_2>Control</GROUP_LABEL_2><GRAPH_LABEL_1>Favours beta-blocker</GRAPH_LABEL_1><GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2><DICH_SUBGROUP CHI2="4.412696047203041" CI_END="0.39304843565874875" CI_START="0.13005101951035364" DF="7" EFFECT_SIZE="0.22608925178869055" ESTIMABLE="YES" EVENTS_1="15" EVENTS_2="54" I2="0.0" ID="CMP-002.15.01" LOG_CI_END="-0.40555392788623174" LOG_CI_START="-0.8858862388853685" LOG_EFFECT_SIZE="-0.6457200833858001" MODIFIED="2013-11-17 21:59:34 +0000" MODIFIED_BY="Hermann Blessberger" NO="1" P_CHI2="0.7312030711918625" P_Z="1.3669490494212144E-7" STUDIES="8" TAU2="0.0" TOTAL_1="204" TOTAL_2="160" WEIGHT="85.33573232659981" Z="5.269635535855689"><NAME>Placebo</NAME><DICH_DATA CI_END="0.9171435836951519" CI_START="0.12114909059653102" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="12" LOG_CI_END="-0.03756266790137051" LOG_CI_START="-0.9166798415379545" LOG_EFFECT_SIZE="-0.47712125471966244" MODIFIED="2013-11-17 21:58:50 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="601" O_E="0.0" SE="0.5163977794943222" STUDY_ID="STD-Whitehead-1980" TOTAL_1="30" TOTAL_2="30" VAR="0.26666666666666666" WEIGHT="18.07729947539542"/><DICH_DATA CI_END="8.613245613073193" CI_START="0.039506336294567505" EFFECT_SIZE="0.5833333333333334" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="0.935166831621311" LOG_CI_START="-1.4033332436880468" LOG_EFFECT_SIZE="-0.23408320603336796" MODIFIED="2013-11-17 21:58:46 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="595" O_E="0.0" SE="1.373646519998781" STUDY_ID="STD-Coleman-1980" TOTAL_1="24" TOTAL_2="14" VAR="1.8869047619047619" WEIGHT="1.9028736289889914"/><DICH_DATA CI_END="2.10640095810011" CI_START="0.03441187529935919" EFFECT_SIZE="0.2692307692307692" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="4" LOG_CI_END="0.32354104363765107" LOG_CI_START="-1.4632916595507734" LOG_EFFECT_SIZE="-0.5698753079565612" MODIFIED="2013-11-17 21:59:07 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="598" O_E="0.0" SE="1.049594374817411" STUDY_ID="STD-Magnusson-1986" TOTAL_1="13" TOTAL_2="14" VAR="1.1016483516483517" WEIGHT="5.802589955065196"/><DICH_DATA CI_END="1.7345779408820627" CI_START="0.027586862124896305" EFFECT_SIZE="0.21875" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="4" LOG_CI_END="0.2391938190437444" LOG_CI_START="-1.5592976956550426" LOG_EFFECT_SIZE="-0.6600519383056491" MODIFIED="2013-11-17 21:58:59 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="597" O_E="0.0" SE="1.0564428184106458" STUDY_ID="STD-Liu-1986" TOTAL_1="16" TOTAL_2="14" VAR="1.1160714285714286" WEIGHT="6.427484257918371"/><DICH_DATA CI_END="0.388319499409608" CI_START="0.007727374155017464" EFFECT_SIZE="0.054778554778554776" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="22" LOG_CI_END="-0.41081080086943617" LOG_CI_START="-2.11196805895654" LOG_EFFECT_SIZE="-1.261389429912988" MODIFIED="2013-11-17 21:59:14 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="594" O_E="0.0" SE="0.9992681942646023" STUDY_ID="STD-Burns-1988" TOTAL_1="39" TOTAL_2="47" VAR="0.998536924068839" WEIGHT="30.05876540676215"/><DICH_DATA CI_END="2.437512373700911" CI_START="0.025640895477837246" EFFECT_SIZE="0.25" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" LOG_CI_END="0.38694682901319455" LOG_CI_START="-1.5910668116691191" LOG_EFFECT_SIZE="-0.6020599913279624" MODIFIED="2013-11-17 21:59:21 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="596" O_E="0.0" SE="1.161895003862225" STUDY_ID="STD-Inada-1989" TOTAL_1="20" TOTAL_2="10" VAR="1.3499999999999999" WEIGHT="4.017177661198982"/><DICH_DATA CI_END="3.987709581650965" CI_START="0.007422505812621207" EFFECT_SIZE="0.17204301075268819" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.6007235218364254" LOG_CI_START="-2.1294494536324464" LOG_EFFECT_SIZE="-0.7643629658980103" MODIFIED="2013-11-17 21:59:28 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="599" O_E="0.0" SE="1.603717120364604" STUDY_ID="STD-Miller-1990" TOTAL_1="30" TOTAL_2="15" VAR="2.5719086021505375" WEIGHT="2.9808312964747765"/><DICH_DATA CI_END="0.8968345474639214" CI_START="0.15680149744193167" EFFECT_SIZE="0.375" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="8" LOG_CI_END="-0.047287670390829956" LOG_CI_START="-0.8046497941537323" LOG_EFFECT_SIZE="-0.42596873227228116" MODIFIED="2013-11-17 21:59:34 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="600" O_E="0.0" SE="0.4448782605013046" STUDY_ID="STD-Oxorn-1990" TOTAL_1="32" TOTAL_2="16" VAR="0.19791666666666663" WEIGHT="16.068710644795928"/></DICH_SUBGROUP><DICH_SUBGROUP CHI2="0.0" CI_END="0.6884626717910228" CI_START="0.05122892377407" DF="0" EFFECT_SIZE="0.18780096308186195" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="7" I2="0.0" ID="CMP-002.15.02" LOG_CI_END="-0.16211960206596732" LOG_CI_START="-1.2904847677600486" LOG_EFFECT_SIZE="-0.726302184913008" MODIFIED="2013-11-17 21:59:40 +0000" MODIFIED_BY="Hermann Blessberger" NO="2" P_CHI2="1.0" P_Z="0.011630359419586648" STUDIES="1" TAU2="0.0" TOTAL_1="89" TOTAL_2="39" WEIGHT="14.66426767340019" Z="2.523165669416257"><NAME>Standard care</NAME><DICH_DATA CI_END="0.6884626717910228" CI_START="0.05122892377407" EFFECT_SIZE="0.18780096308186195" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="7" LOG_CI_END="-0.16211960206596732" LOG_CI_START="-1.2904847677600486" LOG_EFFECT_SIZE="-0.726302184913008" MODIFIED="2013-11-17 21:59:40 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="602" O_E="0.0" SE="0.6628072838263553" STUDY_ID="STD-Stone-1988" TOTAL_1="89" TOTAL_2="39" VAR="0.4393134954932707" WEIGHT="14.66426767340019"/></DICH_SUBGROUP></DICH_OUTCOME><DICH_OUTCOME CHI2="5.333465520840571" CI_END="2.657318890589438" CI_START="0.9740784253242729" CI_STUDY="95" CI_TOTAL="95" DF="6" EFFECT_MEASURE="RR" EFFECT_SIZE="1.608862020351591" ESTIMABLE="YES" EVENTS_1="39" EVENTS_2="20" I2="0.0" I2_Q="0.0" ID="CMP-002.16" LOG_CI_END="0.42444367488943624" LOG_CI_START="-0.011406075652776602" LOG_EFFECT_SIZE="0.20651879961832983" METHOD="MH" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" NO="16" P_CHI2="0.5018087530675711" P_Q="0.4048336109912921" P_Z="0.06325704165847698" Q="0.6939230460922401" RANDOM="NO" SCALE="100.0" SORT_BY="YEAR" STUDIES="8" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="355" TOTAL_2="305" WEIGHT="99.99999999999999" Z="1.8573804797585545"><NAME>Bradycardia&#8212;cardiac surgery</NAME><GROUP_LABEL_1>Beta-blocker</GROUP_LABEL_1><GROUP_LABEL_2>Control</GROUP_LABEL_2><GRAPH_LABEL_1>Favours beta-blocker</GRAPH_LABEL_1><GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2><DICH_SUBGROUP CHI2="4.741919374373767" CI_END="3.625275437825136" CI_START="0.9904303261283599" DF="4" EFFECT_SIZE="1.8948833035810628" ESTIMABLE="YES" EVENTS_1="28" EVENTS_2="11" I2="15.645971932446596" ID="CMP-002.16.01" LOG_CI_END="0.5593410085851414" LOG_CI_START="-0.004176070395274003" LOG_EFFECT_SIZE="0.27758246909493367" MODIFIED="2013-11-17 22:08:54 +0000" MODIFIED_BY="Hermann Blessberger" NO="1" P_CHI2="0.3148177137214657" P_Z="0.05349362990040877" STUDIES="6" TAU2="0.0" TOTAL_1="254" TOTAL_2="200" WEIGHT="57.437904614115226" Z="1.9309144743230786"><NAME>Placebo</NAME><DICH_DATA CI_END="2.4299040831536463" CI_START="0.4829865998611526" EFFECT_SIZE="1.0833333333333333" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="8" LOG_CI_END="0.38558913080850166" LOG_CI_START="-0.3160649182900778" LOG_EFFECT_SIZE="0.03476210625921191" MODIFIED="2013-11-17 22:08:16 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="608" O_E="0.0" SE="0.41215506168406435" STUDY_ID="STD-Hammon-1984" TOTAL_1="24" TOTAL_2="26" VAR="0.16987179487179488" WEIGHT="34.50899745539419"/><DICH_DATA CI_END="7.9127893408891605" CI_START="0.014041965016931132" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.8983296038284552" LOG_CI_START="-1.85257211326778" LOG_EFFECT_SIZE="-0.47712125471966244" MODIFIED="2013-11-17 22:08:26 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="609" O_E="0.0" SE="1.6158932858054431" STUDY_ID="STD-Matangi-1989" TOTAL_1="35" TOTAL_2="35" VAR="2.611111111111111" WEIGHT="6.740038565506677"/><DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-11-17 22:08:32 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="606" O_E="0.0" SE="0.0" STUDY_ID="STD-Cork-1995" TOTAL_1="15" TOTAL_2="14" VAR="0.0" WEIGHT="0.0"/><DICH_DATA CI_END="80.35752625709628" CI_START="0.14098207571047106" EFFECT_SIZE="3.3658536585365852" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.9050265588697803" LOG_CI_START="-0.8508360995067785" LOG_EFFECT_SIZE="0.527095229681501" MODIFIED="2013-11-17 22:08:40 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="607" O_E="0.0" SE="1.618807367270561" STUDY_ID="STD-Gomes-1999" TOTAL_1="40" TOTAL_2="45" VAR="2.6205372923294448" WEIGHT="2.117560009086389"/><DICH_DATA CI_END="19.55229681746766" CI_START="1.1201957603483597" EFFECT_SIZE="4.68" ESTIMABLE="YES" EVENTS_1="18" EVENTS_2="2" LOG_CI_END="1.2911977815048645" LOG_CI_START="0.04929392464338349" LOG_EFFECT_SIZE="0.670245853074124" MODIFIED="2013-11-17 22:08:47 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="604" O_E="0.0" SE="0.7295004730436714" STUDY_ID="STD-Auer-2004" TOTAL_1="125" TOTAL_2="65" VAR="0.5321709401709402" WEIGHT="11.824629062292416"/><DICH_DATA CI_END="68.25874292736694" CI_START="0.13185124152633113" EFFECT_SIZE="3.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.8341582859242351" LOG_CI_START="-0.87991577648491" LOG_EFFECT_SIZE="0.47712125471966244" MODIFIED="2013-11-17 22:08:54 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="605" O_E="0.0" SE="1.5942605391424158" STUDY_ID="STD-But-2006" TOTAL_1="15" TOTAL_2="15" VAR="2.5416666666666665" WEIGHT="2.246679521835559"/></DICH_SUBGROUP><DICH_SUBGROUP CHI2="0.4402019824624263" CI_END="2.723068169446341" CI_START="0.549167513614795" DF="1" EFFECT_SIZE="1.2228739002932554" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="9" I2="0.0" ID="CMP-002.16.02" LOG_CI_END="0.4350585136292789" LOG_CI_START="-0.2602951616667592" LOG_EFFECT_SIZE="0.08738167598125988" MODIFIED="2013-11-26 12:23:45 +0000" MODIFIED_BY="Hermann Blessberger" NO="2" P_CHI2="0.507025006705076" P_Z="0.6222966166073567" STUDIES="2" TAU2="0.0" TOTAL_1="101" TOTAL_2="105" WEIGHT="42.56209538588476" Z="0.4925980660391395"><NAME>Standard care</NAME><DICH_DATA CI_END="79.58504943420188" CI_START="0.14126038260699514" EFFECT_SIZE="3.3529411764705883" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.9008314903751011" LOG_CI_START="-0.8499796217866659" LOG_EFFECT_SIZE="0.5254259342942175" MODIFIED="2013-11-17 22:09:05 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="610" O_E="0.0" SE="1.615840064018435" STUDY_ID="STD-Babin_x002d_Ebell-1996" TOTAL_1="33" TOTAL_2="37" VAR="2.6109391124871" WEIGHT="2.1218639928446947"/><DICH_DATA CI_END="2.5620784080305095" CI_START="0.4818618732998068" EFFECT_SIZE="1.1111111111111112" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="9" LOG_CI_END="0.40859241645235506" LOG_CI_START="-0.31707743533100474" LOG_EFFECT_SIZE="0.04575749056067514" MODIFIED="2013-11-17 22:09:14 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="611" O_E="0.0" SE="0.4262620630612449" STUDY_ID="STD-Ogawa-2013" TOTAL_1="68" TOTAL_2="68" VAR="0.18169934640522875" WEIGHT="40.440231393040065"/></DICH_SUBGROUP></DICH_OUTCOME><DICH_OUTCOME CHI2="79.61367252344694" CI_END="3.35571487992304" CI_START="1.478562609998888" CI_STUDY="95" CI_TOTAL="95" DF="19" EFFECT_MEASURE="RR" EFFECT_SIZE="2.2274726824971647" ESTIMABLE="YES" EVENTS_1="539" EVENTS_2="212" I2="76.13475248939895" I2_Q="0.0" ID="CMP-002.17" LOG_CI_END="0.5257850536654742" LOG_CI_START="0.16983971952924046" LOG_EFFECT_SIZE="0.3478123865973573" METHOD="MH" MODIFIED="2017-06-17 15:37:51 +0100" MODIFIED_BY="Hermann Blessberger" NO="17" P_CHI2="2.1675823358435764E-9" P_Q="0.7193928344962586" P_Z="1.2795484866811056E-4" Q="0.12907527882223732" RANDOM="YES" SCALE="100.0" SORT_BY="YEAR" STUDIES="23" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.40337939548311313" TOTALS="YES" TOTAL_1="5636" TOTAL_2="5397" WEIGHT="100.00000000000001" Z="3.8303620569265835"><NAME>Bradycardia&#8212;non-cardiac surgery</NAME><GROUP_LABEL_1>Beta-blocker</GROUP_LABEL_1><GROUP_LABEL_2>Control</GROUP_LABEL_2><GRAPH_LABEL_1>Favours beta-blocker</GRAPH_LABEL_1><GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2><DICH_SUBGROUP CHI2="75.11690958776992" CI_END="3.4556964774794854" CI_START="1.3111733317975105" DF="15" EFFECT_SIZE="2.1286185811595506" ESTIMABLE="YES" EVENTS_1="475" EVENTS_2="192" I2="80.03112736890043" ID="CMP-002.17.01" LOG_CI_END="0.538535590304372" LOG_CI_START="0.11766010745462889" LOG_EFFECT_SIZE="0.3280978488795005" MODIFIED="2017-06-17 15:37:51 +0100" MODIFIED_BY="Hermann Blessberger" NO="1" P_CHI2="5.393261393038529E-10" P_Z="0.002244455700356347" STUDIES="19" TAU2="0.4624695589199588" TOTAL_1="5307" TOTAL_2="5112" WEIGHT="78.33397123466828" Z="3.0558205142040333"><NAME>Placebo</NAME><DICH_DATA CI_END="4.316762529506007" CI_START="0.7786184873819648" EFFECT_SIZE="1.8333333333333333" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="6" LOG_CI_END="0.6351581582319411" LOG_CI_START="-0.10867528868277829" LOG_EFFECT_SIZE="0.2632414347745814" MODIFIED="2013-11-17 22:12:55 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="630" O_E="0.0" SE="0.4369314487526515" STUDY_ID="STD-Whitehead-1980" TOTAL_1="30" TOTAL_2="30" VAR="0.19090909090909092" WEIGHT="7.356047017486071"/><DICH_DATA CI_END="7.401691333129458" CI_START="0.01324713701913913" EFFECT_SIZE="0.31313131313131315" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.8693309700979578" LOG_CI_START="-1.8778779716245122" LOG_EFFECT_SIZE="-0.5042735007632773" MODIFIED="2013-11-17 22:13:00 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="615" O_E="0.0" SE="1.6137241312713606" STUDY_ID="STD-Cucchiara-1986" TOTAL_1="32" TOTAL_2="30" VAR="2.6041055718475072" WEIGHT="1.45357802128329"/><DICH_DATA CI_END="163.3214889303036" CI_START="0.5693353304979463" EFFECT_SIZE="9.642857142857142" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="0" LOG_CI_END="2.213043330541109" LOG_CI_START="-0.24463186490757274" LOG_EFFECT_SIZE="0.984205732816768" MODIFIED="2013-11-17 22:20:29 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="622" O_E="0.0" SE="1.4436505754949789" STUDY_ID="STD-Magnusson-1986" TOTAL_1="13" TOTAL_2="14" VAR="2.084126984126984" WEIGHT="1.7574282758369892"/><DICH_DATA CI_END="6.690017380199802" CI_START="0.012930488128094391" EFFECT_SIZE="0.29411764705882354" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.8254272460361436" LOG_CI_START="-1.8883850801206539" LOG_EFFECT_SIZE="-0.5314789170422551" MODIFIED="2013-11-17 22:13:18 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="621" O_E="0.0" SE="1.5941067939721714" STUDY_ID="STD-Liu-1986" TOTAL_1="16" TOTAL_2="14" VAR="2.541176470588235" WEIGHT="1.4846429297618757"/><DICH_DATA CI_END="1.2063517837162632" CI_START="0.7282887347158697" EFFECT_SIZE="0.9373219373219374" ESTIMABLE="YES" EVENTS_1="28" EVENTS_2="36" LOG_CI_END="0.08147397069709093" LOG_CI_START="-0.13769640772879047" LOG_EFFECT_SIZE="-0.02811121851584977" MODIFIED="2013-11-17 22:13:27 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="614" O_E="0.0" SE="0.12874176519823316" STUDY_ID="STD-Burns-1988" TOTAL_1="39" TOTAL_2="47" VAR="0.016574442106356998" WEIGHT="10.40974901656976"/><DICH_DATA CI_END="13.482091688489398" CI_START="0.060717144136267914" EFFECT_SIZE="0.9047619047619048" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.1297572763459856" LOG_CI_START="-1.2166886639081658" LOG_EFFECT_SIZE="-0.0434656937810903" MODIFIED="2013-11-17 22:13:32 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="616" O_E="0.0" SE="1.3783139604000185" STUDY_ID="STD-Gibson-1988" TOTAL_1="21" TOTAL_2="19" VAR="1.899749373433584" WEIGHT="1.8981196826037314"/><DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-11-17 22:13:37 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="618" O_E="0.0" SE="0.0" STUDY_ID="STD-Inada-1989" TOTAL_1="20" TOTAL_2="10" VAR="0.0" WEIGHT="0.0"/><DICH_DATA CI_END="2.1277244659381767" CI_START="0.22038907230653051" EFFECT_SIZE="0.6847826086956522" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="5" LOG_CI_END="0.327915387405769" LOG_CI_START="-0.656809943189716" LOG_EFFECT_SIZE="-0.16444727789197353" MODIFIED="2013-11-17 22:13:45 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="624" O_E="0.0" SE="0.5784325336607887" STUDY_ID="STD-Miller-1991" TOTAL_1="368" TOTAL_2="180" VAR="0.3345841959972395" WEIGHT="5.923888520139916"/><DICH_DATA CI_END="16.55061376388459" CI_START="0.9667315199460398" EFFECT_SIZE="4.0" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="2" LOG_CI_END="1.2188141038111788" LOG_CI_START="-0.014694121155254026" LOG_EFFECT_SIZE="0.6020599913279624" MODIFIED="2013-11-17 22:13:54 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="619" O_E="0.0" SE="0.7245688373094719" STUDY_ID="STD-Jakobsen-1992" TOTAL_1="20" TOTAL_2="20" VAR="0.5249999999999999" WEIGHT="4.708865867899588"/><DICH_DATA CI_END="3.881860085359043" CI_START="0.38609570678958227" EFFECT_SIZE="1.2242424242424241" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="5" LOG_CI_END="0.5890398779736322" LOG_CI_START="-0.41330502750819725" LOG_EFFECT_SIZE="0.08786742523271744" MODIFIED="2014-06-22 20:43:45 +0100" MODIFIED_BY="Hermann Blessberger" ORDER="623" O_E="0.0" SE="0.5887823591673299" STUDY_ID="STD-Mangano-1996" TOTAL_1="99" TOTAL_2="101" VAR="0.3466646664666467" WEIGHT="5.828476311761678"/><DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-11-17 22:14:14 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="620" O_E="0.0" SE="0.0" STUDY_ID="STD-Jakobsen-1997" TOTAL_1="18" TOTAL_2="17" VAR="0.0" WEIGHT="0.0"/><DICH_DATA CI_END="25.948956020600956" CI_START="1.4445429510900611" EFFECT_SIZE="6.122448979591836" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="2" LOG_CI_END="1.4141198899836058" LOG_CI_START="0.15973045939869154" LOG_EFFECT_SIZE="0.7869251746911488" MODIFIED="2013-11-17 22:14:20 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="613" O_E="0.0" SE="0.7368345608534029" STUDY_ID="STD-Bayliff-1999" TOTAL_1="49" TOTAL_2="50" VAR="0.5429251700680272" WEIGHT="4.619669192133293"/><DICH_DATA CI_END="9.055780428661802" CI_START="1.9026886986063845" EFFECT_SIZE="4.150943396226415" ESTIMABLE="YES" EVENTS_1="30" EVENTS_2="6" LOG_CI_END="0.9569258838335278" LOG_CI_START="0.27936773860930664" LOG_EFFECT_SIZE="0.6181468112214172" MODIFIED="2013-11-17 22:14:27 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="626" O_E="0.0" SE="0.3980010084716185" STUDY_ID="STD-POBBLE-2005" TOTAL_1="53" TOTAL_2="44" VAR="0.15840480274442537" WEIGHT="7.7816607545110354"/><DICH_DATA CI_END="4.968546281602201" CI_START="2.221629425589266" EFFECT_SIZE="3.3223889931207005" ESTIMABLE="YES" EVENTS_1="85" EVENTS_2="26" LOG_CI_END="0.6962293395925384" LOG_CI_START="0.34667161903172805" LOG_EFFECT_SIZE="0.5214504793121333" MODIFIED="2013-11-17 22:14:40 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="631" O_E="0.0" SE="0.2053319353960433" STUDY_ID="STD-Yang-2006" TOTAL_1="246" TOTAL_2="250" VAR="0.0421612036934849" WEIGHT="9.81193196743652"/><DICH_DATA CI_END="3.4327496636168187" CI_START="2.194313719081089" EFFECT_SIZE="2.74454544160693" ESTIMABLE="YES" EVENTS_1="277" EVENTS_2="101" LOG_CI_END="0.5356421332614679" LOG_CI_START="0.3412987183735157" LOG_EFFECT_SIZE="0.43847042581749185" MODIFIED="2013-11-17 22:14:53 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="627" O_E="0.0" SE="0.11415828392060205" STUDY_ID="STD-POISE-2008" TOTAL_1="4174" TOTAL_2="4177" VAR="0.01303211378769679" WEIGHT="10.498302641795231"/><DICH_DATA CI_END="99.95416281504153" CI_START="0.25011464551267176" EFFECT_SIZE="5.0" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="0" LOG_CI_END="1.9998008859974516" LOG_CI_START="-0.6018608773254143" LOG_EFFECT_SIZE="0.6989700043360189" MODIFIED="2013-11-17 22:15:05 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="612" O_E="0.0" SE="1.5282289982092807" STUDY_ID="STD-Apipan-2010" TOTAL_1="30" TOTAL_2="30" VAR="2.335483870967742" WEIGHT="1.5961417648704392"/><DICH_DATA CI_END="99.95416281504153" CI_START="0.25011464551267176" EFFECT_SIZE="5.0" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="0" LOG_CI_END="1.9998008859974516" LOG_CI_START="-0.6018608773254143" LOG_EFFECT_SIZE="0.6989700043360189" MODIFIED="2013-11-17 22:15:10 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="628" O_E="0.0" SE="1.5282289982092807" STUDY_ID="STD-Shukla-2010" TOTAL_1="30" TOTAL_2="30" VAR="2.335483870967742" WEIGHT="1.5961417648704392"/><DICH_DATA CI_END="98.52270194459342" CI_START="0.25374862348029537" EFFECT_SIZE="5.0" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="0" LOG_CI_END="1.9935363136779938" LOG_CI_START="-0.5955963050059561" LOG_EFFECT_SIZE="0.6989700043360189" MODIFIED="2013-11-17 22:15:32 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="617" O_E="0.0" SE="1.5208693166281149" STUDY_ID="STD-Gupta-2011" TOTAL_1="22" TOTAL_2="22" VAR="2.313043478260869" WEIGHT="1.6093275057084135"/><DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-11-17 22:15:26 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="625" O_E="0.0" SE="0.0" STUDY_ID="STD-Moon-2011" TOTAL_1="27" TOTAL_2="27" VAR="0.0" WEIGHT="0.0"/></DICH_SUBGROUP><DICH_SUBGROUP CHI2="3.785079707800868" CI_END="4.479006295181559" CI_START="1.3430228265730486" DF="3" EFFECT_SIZE="2.4526328087981732" ESTIMABLE="YES" EVENTS_1="64" EVENTS_2="20" I2="20.74143131471859" ID="CMP-002.17.02" LOG_CI_END="0.6511816728400199" LOG_CI_START="0.1280833941806057" LOG_EFFECT_SIZE="0.38963253351031285" MODIFIED="2013-11-17 22:16:10 +0000" MODIFIED_BY="Hermann Blessberger" NO="2" P_CHI2="0.2856266845076101" P_Z="0.0035027948432007332" STUDIES="4" TAU2="0.08374620882799357" TOTAL_1="329" TOTAL_2="285" WEIGHT="21.66602876533173" Z="2.9197791850602766"><NAME>Standard care</NAME><DICH_DATA CI_END="307.7461518428873" CI_START="1.1868046625898883" EFFECT_SIZE="19.11111111111111" ESTIMABLE="YES" EVENTS_1="21" EVENTS_2="0" LOG_CI_END="2.48819263107907" LOG_CI_START="0.07437924385737768" LOG_EFFECT_SIZE="1.281285937468224" MODIFIED="2013-11-17 22:15:50 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="635" O_E="0.0" SE="1.417885932222993" STUDY_ID="STD-Stone-1988" TOTAL_1="89" TOTAL_2="39" VAR="2.010400516795866" WEIGHT="1.8111071459386736"/><DICH_DATA CI_END="7.731389706964666" CI_START="0.29102141856503916" EFFECT_SIZE="1.5" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="2" LOG_CI_END="0.8882575647876686" LOG_CI_START="-0.5360750466763062" LOG_EFFECT_SIZE="0.17609125905568124" MODIFIED="2013-11-17 22:15:55 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="633" O_E="0.0" SE="0.8366600265340756" STUDY_ID="STD-Liu-2006" TOTAL_1="15" TOTAL_2="15" VAR="0.7" WEIGHT="3.962022551578987"/><DICH_DATA CI_END="3.6290326949803244" CI_START="0.9972510940069231" EFFECT_SIZE="1.9023818820773135" ESTIMABLE="YES" EVENTS_1="24" EVENTS_2="13" LOG_CI_END="0.5597908808998064" LOG_CI_START="-0.0011954785870280453" LOG_EFFECT_SIZE="0.27929770115638924" MODIFIED="2013-11-17 22:16:04 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="634" O_E="0.0" SE="0.32952616448983174" STUDY_ID="STD-Marwick-2009" TOTAL_1="197" TOTAL_2="203" VAR="0.10858749308337966" WEIGHT="8.538860901907547"/><DICH_DATA CI_END="7.53745610550098" CI_START="1.3585485416660203" EFFECT_SIZE="3.2" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="5" LOG_CI_END="0.8772247960345471" LOG_CI_START="0.1330751606052648" LOG_EFFECT_SIZE="0.505149978319906" MODIFIED="2013-11-17 22:16:10 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="632" O_E="0.0" SE="0.4371171794512641" STUDY_ID="STD-Kawaguchi-2010" TOTAL_1="28" TOTAL_2="28" VAR="0.19107142857142861" WEIGHT="7.354038165906523"/></DICH_SUBGROUP></DICH_OUTCOME><DICH_OUTCOME CHI2="3.6475355346541005" CI_END="3.5143109167801865" CI_START="0.6720037696434166" CI_STUDY="95" CI_TOTAL="95" DF="5" EFFECT_MEASURE="RR" EFFECT_SIZE="1.536759637606121" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="7" I2="0.0" I2_Q="0.0" ID="CMP-002.18" LOG_CI_END="0.5458401815954325" LOG_CI_START="-0.17262829073971234" LOG_EFFECT_SIZE="0.18660594542786005" METHOD="MH" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" NO="18" P_CHI2="0.6011906676485825" P_Q="0.3645583561547804" P_Z="0.3086244222765031" Q="0.8221294721248686" RANDOM="NO" SCALE="100.0" SORT_BY="YEAR" STUDIES="6" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="302" TOTAL_2="256" WEIGHT="100.00000000000001" Z="1.01811268391759"><NAME>Hypotension&#8212;cardiac surgery</NAME><GROUP_LABEL_1>Beta-blocker</GROUP_LABEL_1><GROUP_LABEL_2>Control</GROUP_LABEL_2><GRAPH_LABEL_1>Favours beta-blocker</GRAPH_LABEL_1><GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2><DICH_SUBGROUP CHI2="2.8283976859906175" CI_END="3.1382436484045924" CI_START="0.5400441857045682" DF="4" EFFECT_SIZE="1.3018410946214563" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="7" I2="0.0" ID="CMP-002.18.01" LOG_CI_END="0.4966866585147387" LOG_CI_START="-0.26757070532033267" LOG_EFFECT_SIZE="0.114557976597203" MODIFIED="2013-11-17 22:22:16 +0000" MODIFIED_BY="Hermann Blessberger" NO="1" P_CHI2="0.5869408147299752" P_Z="0.5568171627914142" STUDIES="5" TAU2="0.0" TOTAL_1="282" TOTAL_2="234" WEIGHT="94.37233155370515" Z="0.5875756489819163"><NAME>Placebo</NAME><DICH_DATA CI_END="9.614160867147643" CI_START="0.2854860998584822" EFFECT_SIZE="1.6567164179104477" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="2" LOG_CI_END="0.9829113846045738" LOG_CI_START="-0.5444150324329121" LOG_EFFECT_SIZE="0.21924817608583097" MODIFIED="2013-11-17 22:21:51 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="639" O_E="0.0" SE="0.8971590977555159" STUDY_ID="STD-Khuri-1987" TOTAL_1="67" TOTAL_2="74" VAR="0.8048944466854914" WEIGHT="22.41184272837185"/><DICH_DATA CI_END="6.706930006003608" CI_START="0.1490995133548233" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="2" LOG_CI_END="0.8265237740363401" LOG_CI_START="-0.82652377403634" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-11-17 22:22:00 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="640" O_E="0.0" SE="0.9710083124552245" STUDY_ID="STD-Matangi-1989" TOTAL_1="35" TOTAL_2="35" VAR="0.9428571428571428" WEIGHT="23.58261063209277"/><DICH_DATA CI_END="80.35752625709628" CI_START="0.14098207571047106" EFFECT_SIZE="3.3658536585365852" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.9050265588697803" LOG_CI_START="-0.8508360995067785" LOG_EFFECT_SIZE="0.527095229681501" MODIFIED="2013-11-17 22:22:05 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="638" O_E="0.0" SE="1.618807367270561" STUDY_ID="STD-Gomes-1999" TOTAL_1="40" TOTAL_2="45" VAR="2.6205372923294448" WEIGHT="5.556822045493123"/><DICH_DATA CI_END="2.813973227965783" CI_START="0.024022971977195374" EFFECT_SIZE="0.26" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" LOG_CI_END="0.44931996125720636" LOG_CI_START="-1.6193732653155704" LOG_EFFECT_SIZE="-0.585026652029182" MODIFIED="2013-11-17 22:22:10 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="636" O_E="0.0" SE="1.2151606414854723" STUDY_ID="STD-Auer-2004" TOTAL_1="125" TOTAL_2="65" VAR="1.4766153846153847" WEIGHT="31.029750831701016"/><DICH_DATA CI_END="25.6782739076548" CI_START="0.3504908481140964" EFFECT_SIZE="3.0" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="1" LOG_CI_END="1.4095658271236327" LOG_CI_START="-0.45532331768430767" LOG_EFFECT_SIZE="0.47712125471966244" MODIFIED="2013-11-17 22:22:16 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="637" O_E="0.0" SE="1.0954451150103321" STUDY_ID="STD-But-2006" TOTAL_1="15" TOTAL_2="15" VAR="1.2" WEIGHT="11.791305316046385"/></DICH_SUBGROUP><DICH_SUBGROUP CHI2="0.0" CI_END="107.61816341755203" CI_START="0.27865799953456794" DF="0" EFFECT_SIZE="5.476190476190476" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="0" I2="0.0" ID="CMP-002.18.02" LOG_CI_END="2.031885576221638" LOG_CI_START="-0.5549284849822533" LOG_EFFECT_SIZE="0.7384785456196924" MODIFIED="2013-11-17 22:22:21 +0000" MODIFIED_BY="Hermann Blessberger" NO="2" P_CHI2="1.0" P_Z="0.2631174367492456" STUDIES="1" TAU2="0.0" TOTAL_1="20" TOTAL_2="22" WEIGHT="5.627668446294866" Z="1.119053258970231"><NAME>Standard care</NAME><DICH_DATA CI_END="107.61816341755203" CI_START="0.27865799953456794" EFFECT_SIZE="5.476190476190476" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="0" LOG_CI_END="2.031885576221638" LOG_CI_START="-0.5549284849822533" LOG_EFFECT_SIZE="0.7384785456196924" MODIFIED="2013-11-17 22:22:21 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="641" O_E="0.0" SE="1.5195073844872842" STUDY_ID="STD-Salazar-1979" TOTAL_1="20" TOTAL_2="22" VAR="2.308902691511387" WEIGHT="5.627668446294866"/></DICH_SUBGROUP></DICH_OUTCOME><DICH_OUTCOME CHI2="18.832773006123087" CI_END="1.637851533872014" CI_START="1.3797136069781395" CI_STUDY="95" CI_TOTAL="95" DF="18" EFFECT_MEASURE="RR" EFFECT_SIZE="1.5032518243771518" ESTIMABLE="YES" EVENTS_1="1056" EVENTS_2="659" I2="4.421935133250575" I2_Q="0.0" ID="CMP-002.19" LOG_CI_END="0.21427453176969202" LOG_CI_START="0.13978894740334802" LOG_EFFECT_SIZE="0.17703173958652005" METHOD="MH" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" NO="19" P_CHI2="0.4021886162523848" P_Q="0.7519219904632775" P_Z="1.2013915982071046E-20" Q="0.0999230763799987" RANDOM="NO" SCALE="100.0" SORT_BY="YEAR" STUDIES="22" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="5611" TOTAL_2="5336" WEIGHT="100.0" Z="9.316590227808769"><NAME>Hypotension&#8212;non-cardiac surgery</NAME><GROUP_LABEL_1>Beta-blocker</GROUP_LABEL_1><GROUP_LABEL_2>Control</GROUP_LABEL_2><GRAPH_LABEL_1>Favours beta-blocker</GRAPH_LABEL_1><GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2><DICH_SUBGROUP CHI2="14.039842615416473" CI_END="1.6518082808716614" CI_START="1.3785835493037335" DF="14" EFFECT_SIZE="1.5090247587807675" ESTIMABLE="YES" EVENTS_1="968" EVENTS_2="601" I2="0.2837824932077532" ID="CMP-002.19.01" LOG_CI_END="0.21795963899446588" LOG_CI_START="0.13943309173452126" LOG_EFFECT_SIZE="0.1786963653644936" MODIFIED="2014-06-22 20:49:37 +0100" MODIFIED_BY="Hermann Blessberger" NO="1" P_CHI2="0.4467470824872347" P_Z="4.652128694274978E-19" STUDIES="18" TAU2="0.0" TOTAL_1="5282" TOTAL_2="5051" WEIGHT="91.35649036592733" Z="8.920255697050626"><NAME>Placebo</NAME><DICH_DATA CI_END="15.259760455310136" CI_START="0.0655318281652329" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.1835477162038213" LOG_CI_START="-1.1835477162038213" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-11-17 22:25:11 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="658" O_E="0.0" SE="1.390443574307614" STUDY_ID="STD-Whitehead-1980" TOTAL_1="30" TOTAL_2="30" VAR="1.9333333333333331" WEIGHT="0.1482941454300571"/><DICH_DATA CI_END="2.917064814565508" CI_START="0.30129815615047" EFFECT_SIZE="0.9375" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="5" LOG_CI_END="0.4649460788630512" LOG_CI_START="-0.5210035260635382" LOG_EFFECT_SIZE="-0.028028723600243537" MODIFIED="2013-11-17 22:25:18 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="643" O_E="0.0" SE="0.5791516784631352" STUDY_ID="STD-Cucchiara-1986" TOTAL_1="32" TOTAL_2="30" VAR="0.3354166666666667" WEIGHT="0.7653891377035205"/><DICH_DATA CI_END="21.029313937505744" CI_START="0.2205993627858741" EFFECT_SIZE="2.1538461538461537" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="1" LOG_CI_END="1.3228251044497223" LOG_CI_START="-0.6563957463789576" LOG_EFFECT_SIZE="0.33321467903538243" MODIFIED="2013-11-17 22:25:24 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="649" O_E="0.0" SE="1.162604125077987" STUDY_ID="STD-Magnusson-1986" TOTAL_1="13" TOTAL_2="14" VAR="1.3516483516483517" WEIGHT="0.1428017696733883"/><DICH_DATA CI_END="89.07654204661276" CI_START="0.23194835082374035" EFFECT_SIZE="4.545454545454546" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="0" LOG_CI_END="1.9497633493675715" LOG_CI_START="-0.6346087110119837" LOG_EFFECT_SIZE="0.6575773191777938" MODIFIED="2013-11-17 22:25:38 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="644" O_E="0.0" SE="1.5180729411149698" STUDY_ID="STD-Gibson-1988" TOTAL_1="21" TOTAL_2="19" VAR="2.3045454545454547" WEIGHT="0.07767788570145848"/><DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-11-17 22:25:44 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="646" O_E="0.0" SE="0.0" STUDY_ID="STD-Inada-1989" TOTAL_1="20" TOTAL_2="10" VAR="0.0" WEIGHT="0.0"/><DICH_DATA CI_END="81.01190363542146" CI_START="0.2663500355480702" EFFECT_SIZE="4.645161290322581" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="0" LOG_CI_END="1.9085488374385386" LOG_CI_START="-0.5745472409165846" LOG_EFFECT_SIZE="0.667000798260977" MODIFIED="2013-11-17 22:25:57 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="656" O_E="0.0" SE="1.4585829279496223" STUDY_ID="STD-Sandler-1990" TOTAL_1="30" TOTAL_2="15" VAR="2.1274641577060933" WEIGHT="0.09781103209216531"/><DICH_DATA CI_END="35.88938623485869" CI_START="0.0668025523135909" EFFECT_SIZE="1.5483870967741935" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.5549660312757505" LOG_CI_START="-1.1752069441931212" LOG_EFFECT_SIZE="0.18987954354131453" MODIFIED="2013-11-17 22:25:51 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="651" O_E="0.0" SE="1.603717120364604" STUDY_ID="STD-Miller-1990" TOTAL_1="30" TOTAL_2="15" VAR="2.5719086021505375" WEIGHT="0.09781103209216531"/><DICH_DATA CI_END="2.6979150176212503" CI_START="1.2709157890073948" EFFECT_SIZE="1.8517080745341614" ESTIMABLE="YES" EVENTS_1="106" EVENTS_2="28" LOG_CI_END="0.4310282655881383" LOG_CI_START="0.10411677511654042" LOG_EFFECT_SIZE="0.2675725203523394" MODIFIED="2013-11-17 22:26:07 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="652" O_E="0.0" SE="0.19202942774099305" STUDY_ID="STD-Miller-1991" TOTAL_1="368" TOTAL_2="180" VAR="0.03687530111853327" WEIGHT="5.576725819384337"/><DICH_DATA CI_END="69.5152908317231" CI_START="0.12946791838627933" EFFECT_SIZE="3.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.84208034406391" LOG_CI_START="-0.8878378346245852" LOG_EFFECT_SIZE="0.47712125471966244" MODIFIED="2013-11-17 22:26:15 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="647" O_E="0.0" SE="1.6035674514745464" STUDY_ID="STD-Jakobsen-1992" TOTAL_1="20" TOTAL_2="20" VAR="2.5714285714285716" WEIGHT="0.07414707271502854"/><DICH_DATA CI_END="2.4440278509874847" CI_START="0.5796419209128254" EFFECT_SIZE="1.1902356902356903" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="12" LOG_CI_END="0.38810615061358633" LOG_CI_START="-0.23684021298217456" LOG_EFFECT_SIZE="0.07563296881570589" MODIFIED="2014-06-22 20:49:37 +0100" MODIFIED_BY="Hermann Blessberger" ORDER="650" O_E="0.0" SE="0.36709658751054164" STUDY_ID="STD-Mangano-1996" TOTAL_1="99" TOTAL_2="101" VAR="0.13475990456188475" WEIGHT="1.7617344477090784"/><DICH_DATA CI_END="7.259648833094586" CI_START="0.013736613709900562" EFFECT_SIZE="0.3157894736842105" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.8609156133257376" LOG_CI_START="-1.8621203144641083" LOG_EFFECT_SIZE="-0.5006023505691853" MODIFIED="2013-11-17 22:26:32 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="648" O_E="0.0" SE="1.5995247832289885" STUDY_ID="STD-Jakobsen-1997" TOTAL_1="18" TOTAL_2="17" VAR="2.5584795321637426" WEIGHT="0.2284531429598177"/><DICH_DATA CI_END="3.258712269150733" CI_START="1.0890244032150478" EFFECT_SIZE="1.8838304552590266" ESTIMABLE="YES" EVENTS_1="24" EVENTS_2="13" LOG_CI_END="0.5130460157469269" LOG_CI_START="0.03703761167762189" LOG_EFFECT_SIZE="0.2750418137122744" MODIFIED="2013-11-17 22:26:41 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="642" O_E="0.0" SE="0.2796096928299115" STUDY_ID="STD-Bayliff-1999" TOTAL_1="49" TOTAL_2="50" VAR="0.07818158032443746" WEIGHT="1.9083509219989165"/><DICH_DATA CI_END="1.4291890961291949" CI_START="1.0016090630908658" EFFECT_SIZE="1.1964483906770256" ESTIMABLE="YES" EVENTS_1="49" EVENTS_2="34" LOG_CI_END="0.15508969413200707" LOG_CI_START="6.982456113067668E-4" LOG_EFFECT_SIZE="0.07789396987165693" MODIFIED="2013-11-17 22:26:48 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="654" O_E="0.0" SE="0.09069030111105522" STUDY_ID="STD-POBBLE-2005" TOTAL_1="53" TOTAL_2="44" VAR="0.008224730715613863" WEIGHT="5.509815465256967"/><DICH_DATA CI_END="1.6001337406240679" CI_START="1.0973785289749167" EFFECT_SIZE="1.3251235453531005" ESTIMABLE="YES" EVENTS_1="133" EVENTS_2="102" LOG_CI_END="0.20415628289821494" LOG_CI_START="0.04035645864943841" LOG_EFFECT_SIZE="0.12225637077382669" MODIFIED="2013-11-17 22:27:05 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="659" O_E="0.0" SE="0.09621682758593815" STUDY_ID="STD-Yang-2006" TOTAL_1="246" TOTAL_2="250" VAR="0.009257677910702148" WEIGHT="15.004018940044324"/><DICH_DATA CI_END="1.7412304767530802" CI_START="1.3764647865839486" EFFECT_SIZE="1.5481416074046312" ESTIMABLE="YES" EVENTS_1="625" EVENTS_2="404" LOG_CI_END="0.24085626000721605" LOG_CI_START="0.13876510553109628" LOG_EFFECT_SIZE="0.18981068276915616" MODIFIED="2013-11-17 22:27:29 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="655" O_E="0.0" SE="0.05996884949863775" STUDY_ID="STD-POISE-2008" TOTAL_1="4174" TOTAL_2="4177" VAR="0.003596262910190265" WEIGHT="59.889312480451096"/><DICH_DATA CI_END="70.82882080128432" CI_START="0.12706691849706483" EFFECT_SIZE="3.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.850210011475669" LOG_CI_START="-0.8959675020363438" LOG_EFFECT_SIZE="0.47712125471966244" MODIFIED="2013-11-17 22:27:36 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="657" O_E="0.0" SE="1.613118265234886" STUDY_ID="STD-Shukla-2010" TOTAL_1="30" TOTAL_2="30" VAR="2.6021505376344085" WEIGHT="0.07414707271502854"/><DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-11-17 22:27:52 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="653" O_E="0.0" SE="0.0" STUDY_ID="STD-Moon-2011" TOTAL_1="27" TOTAL_2="27" VAR="0.0" WEIGHT="0.0"/><DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-11-17 22:27:46 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="645" O_E="0.0" SE="0.0" STUDY_ID="STD-Gupta-2011" TOTAL_1="22" TOTAL_2="22" VAR="0.0" WEIGHT="0.0"/></DICH_SUBGROUP><DICH_SUBGROUP CHI2="4.002121942986838" CI_END="1.8812197773684158" CI_START="1.1056886156167849" DF="3" EFFECT_SIZE="1.4422355186686395" ESTIMABLE="YES" EVENTS_1="88" EVENTS_2="58" I2="25.03976533605922" ID="CMP-002.19.02" LOG_CI_END="0.2744395358601465" LOG_CI_START="0.04363283803585246" LOG_EFFECT_SIZE="0.15903618694799945" MODIFIED="2013-11-17 22:28:28 +0000" MODIFIED_BY="Hermann Blessberger" NO="2" P_CHI2="0.2612351687110088" P_Z="0.006912998182749318" STUDIES="4" TAU2="0.0" TOTAL_1="329" TOTAL_2="285" WEIGHT="8.643509634072664" Z="2.7010065270631745"><NAME>Standard care</NAME><DICH_DATA CI_END="11.195845482255095" CI_START="0.6174400630049328" EFFECT_SIZE="2.6292134831460676" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="2" LOG_CI_END="1.049056895986779" LOG_CI_START="-0.20940519445631867" LOG_EFFECT_SIZE="0.4198258507652301" MODIFIED="2013-11-17 22:28:03 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="663" O_E="0.0" SE="0.7392268614140911" STUDY_ID="STD-Stone-1988" TOTAL_1="89" TOTAL_2="39" VAR="0.5464563526361279" WEIGHT="0.4124430919773463"/><DICH_DATA CI_END="6.20048286508611" CI_START="0.16127776203218527" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="2" LOG_CI_END="0.7924255116719207" LOG_CI_START="-0.7924255116719207" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-11-17 22:28:13 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="661" O_E="0.0" SE="0.9309493362512627" STUDY_ID="STD-Liu-2006" TOTAL_1="15" TOTAL_2="15" VAR="0.8666666666666667" WEIGHT="0.2965882908601142"/><DICH_DATA CI_END="2.3140090156976254" CI_START="1.0534324826660835" EFFECT_SIZE="1.561298261805876" ESTIMABLE="YES" EVENTS_1="50" EVENTS_2="33" LOG_CI_END="0.36436504669010483" LOG_CI_START="0.022606705729397786" LOG_EFFECT_SIZE="0.1934858762097513" MODIFIED="2013-11-17 22:28:21 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="662" O_E="0.0" SE="0.20075054121139094" STUDY_ID="STD-Marwick-2009" TOTAL_1="197" TOTAL_2="203" VAR="0.040300779796666374" WEIGHT="4.820301197204006"/><DICH_DATA CI_END="1.48504132021836" CI_START="0.8795192640077785" EFFECT_SIZE="1.1428571428571428" ESTIMABLE="YES" EVENTS_1="24" EVENTS_2="21" LOG_CI_END="0.171738537756374" LOG_CI_START="-0.05575464380100051" LOG_EFFECT_SIZE="0.05799194697768673" MODIFIED="2013-11-17 22:28:28 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="660" O_E="0.0" SE="0.13363062095621217" STUDY_ID="STD-Kawaguchi-2010" TOTAL_1="28" TOTAL_2="28" VAR="0.01785714285714285" WEIGHT="3.114177054031199"/></DICH_SUBGROUP></DICH_OUTCOME><DICH_OUTCOME CHI2="1.4612849942823773" CI_END="7.140937434672779" CI_START="0.31009540371843614" CI_STUDY="95" CI_TOTAL="95" DF="2" EFFECT_MEASURE="RR" EFFECT_SIZE="1.4880765695127884" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="1" I2="0.0" I2_Q="0.0" ID="CMP-002.20" LOG_CI_END="0.8537552280200981" LOG_CI_START="-0.508504670894289" LOG_EFFECT_SIZE="0.17262527856290452" METHOD="MH" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" NO="20" P_CHI2="0.48159954930100957" P_Q="0.4671359416086801" P_Z="0.6193777582615365" Q="0.5287428606034996" RANDOM="NO" SCALE="100.0" SORT_BY="YEAR" STUDIES="3" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="93" TOTAL_2="103" WEIGHT="100.0" Z="0.49673242099267073"><NAME>Bronchospasm&#8212;cardiac surgery</NAME><GROUP_LABEL_1>Beta-blocker</GROUP_LABEL_1><GROUP_LABEL_2>Control</GROUP_LABEL_2><GRAPH_LABEL_1>Favours beta-blocker</GRAPH_LABEL_1><GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2><DICH_SUBGROUP CHI2="0.9710606942013055" CI_END="6.672794080099164" CI_START="0.14308970901903162" DF="1" EFFECT_SIZE="0.9771428571428571" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" I2="0.0" ID="CMP-002.20.01" LOG_CI_END="0.8243077228941522" LOG_CI_START="-0.8443915994824334" LOG_EFFECT_SIZE="-0.010041938294140627" MODIFIED="2013-11-17 22:37:13 +0000" MODIFIED_BY="Hermann Blessberger" NO="1" P_CHI2="0.32441599327959225" P_Z="0.9811800991758833" STUDIES="2" TAU2="0.0" TOTAL_1="56" TOTAL_2="55" WEIGHT="82.3284486021738" Z="0.023589435349512893"><NAME>Placebo</NAME><DICH_DATA CI_END="7.382590940745529" CI_START="0.013713297978184326" EFFECT_SIZE="0.3181818181818182" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.8682088054265785" LOG_CI_START="-1.8628580870424774" LOG_EFFECT_SIZE="-0.4973246408079494" MODIFIED="2013-11-17 22:37:08 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="672" O_E="0.0" SE="1.6042422116354729" STUDY_ID="STD-White-1984" TOTAL_1="21" TOTAL_2="20" VAR="2.5735930735930737" WEIGHT="62.09917265992538"/><DICH_DATA CI_END="71.21510406800243" CI_START="0.12637768515238015" EFFECT_SIZE="3.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.85257211326778" LOG_CI_START="-0.8983296038284552" LOG_EFFECT_SIZE="0.47712125471966244" MODIFIED="2013-11-17 22:37:13 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="671" O_E="0.0" SE="1.6158932858054431" STUDY_ID="STD-Matangi-1989" TOTAL_1="35" TOTAL_2="35" VAR="2.611111111111111" WEIGHT="20.229275942248417"/></DICH_SUBGROUP><DICH_SUBGROUP CHI2="0.0" CI_END="92.3227511791855" CI_START="0.1620909391163925" DF="0" EFFECT_SIZE="3.8684210526315788" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" I2="0.0" ID="CMP-002.20.02" LOG_CI_END="1.9653087377975338" LOG_CI_START="-0.790241261534802" LOG_EFFECT_SIZE="0.5875337381313659" MODIFIED="2013-11-17 22:37:18 +0000" MODIFIED_BY="Hermann Blessberger" NO="2" P_CHI2="1.0" P_Z="0.40326718076139" STUDIES="1" TAU2="0.0" TOTAL_1="37" TOTAL_2="48" WEIGHT="17.671551397826203" Z="0.8358004512483402"><NAME>Standard care</NAME><DICH_DATA CI_END="92.32275117918559" CI_START="0.16209093911639244" EFFECT_SIZE="3.8684210526315788" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.9653087377975342" LOG_CI_START="-0.7902412615348021" LOG_EFFECT_SIZE="0.5875337381313659" MODIFIED="2013-11-17 22:37:18 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="673" O_E="0.0" SE="1.6186237098002971" STUDY_ID="STD-Mohr-1981" TOTAL_1="37" TOTAL_2="48" VAR="2.6199427139276765" WEIGHT="17.671551397826203"/></DICH_SUBGROUP></DICH_OUTCOME><DICH_OUTCOME CHI2="3.3042805869012404" CI_END="1.5862677008295947" CI_START="0.5538393876131482" CI_STUDY="95" CI_TOTAL="95" DF="6" EFFECT_MEASURE="RR" EFFECT_SIZE="0.9373033297806956" ESTIMABLE="YES" EVENTS_1="22" EVENTS_2="21" I2="0.0" I2_Q="0.0" ID="CMP-002.21" LOG_CI_END="0.2003764813311155" LOG_CI_START="-0.25661616160097084" LOG_EFFECT_SIZE="-0.028119840134927614" METHOD="MH" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" NO="21" P_CHI2="0.7698005605463882" P_Q="0.5099638068573588" P_Z="0.809398207717784" Q="0.4341414135729806" RANDOM="NO" SCALE="100.0" SORT_BY="YEAR" STUDIES="8" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="646" TOTAL_2="434" WEIGHT="100.0" Z="0.2412024559602048"><NAME>Bronchospasm&#8212;non-cardiac surgery</NAME><GROUP_LABEL_1>Beta-blocker</GROUP_LABEL_1><GROUP_LABEL_2>Control</GROUP_LABEL_2><GRAPH_LABEL_1>Favours beta-blocker</GRAPH_LABEL_1><GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2><DICH_SUBGROUP CHI2="2.990320661642226" CI_END="1.6719090812917514" CI_START="0.5729460755141952" DF="5" EFFECT_SIZE="0.9787306814147866" ESTIMABLE="YES" EVENTS_1="22" EVENTS_2="20" I2="0.0" ID="CMP-002.21.01" LOG_CI_END="0.2232126567352412" LOG_CI_START="-0.24188625099712763" LOG_EFFECT_SIZE="-0.00933679713094322" MODIFIED="2013-11-17 22:40:08 +0000" MODIFIED_BY="Hermann Blessberger" NO="1" P_CHI2="0.701478385283415" P_Z="0.9372775934878514" STUDIES="7" TAU2="0.0" TOTAL_1="618" TOTAL_2="406" WEIGHT="93.58110910166576" Z="0.07869201928178185"><NAME>Placebo</NAME><DICH_DATA CI_END="66.61522199816511" CI_START="0.11922423317225214" EFFECT_SIZE="2.8181818181818183" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.8235734795372827" LOG_CI_START="-0.9236354621851873" LOG_EFFECT_SIZE="0.44996900867604767" MODIFIED="2013-11-17 22:39:34 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="675" O_E="0.0" SE="1.6137241312713606" STUDY_ID="STD-Cucchiara-1986" TOTAL_1="32" TOTAL_2="30" VAR="2.6041055718475072" WEIGHT="2.206493746302396"/><DICH_DATA CI_END="7.190006335094644" CI_START="0.03477048396741213" EFFECT_SIZE="0.5" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="0.8567292730387149" LOG_CI_START="-1.4587892643666773" LOG_EFFECT_SIZE="-0.3010299956639812" MODIFIED="2013-11-17 22:39:39 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="676" O_E="0.0" SE="1.3601470508735443" STUDY_ID="STD-Inada-1989" TOTAL_1="20" TOTAL_2="10" VAR="1.8499999999999999" WEIGHT="5.705680798519326"/><DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-11-17 22:39:45 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="679" O_E="0.0" SE="0.0" STUDY_ID="STD-Miller-1990" TOTAL_1="30" TOTAL_2="15" VAR="0.0" WEIGHT="0.0"/><DICH_DATA CI_END="5.291026045497317" CI_START="0.18087121868109135" EFFECT_SIZE="0.9782608695652174" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="2" LOG_CI_END="0.723539899386512" LOG_CI_START="-0.7426305351989728" LOG_EFFECT_SIZE="-0.009545317906230389" MODIFIED="2013-11-17 22:39:52 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="680" O_E="0.0" SE="0.8612357709362151" STUDY_ID="STD-Miller-1991" TOTAL_1="368" TOTAL_2="180" VAR="0.7417270531400967" WEIGHT="11.494656207236016"/><DICH_DATA CI_END="14.903914722906746" CI_START="0.06709646549862758" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.1733003569528007" LOG_CI_START="-1.1733003569528007" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-11-17 22:39:56 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="677" O_E="0.0" SE="1.378404875209022" STUDY_ID="STD-Jakobsen-1992" TOTAL_1="20" TOTAL_2="20" VAR="1.9" WEIGHT="4.279260598889495"/><DICH_DATA CI_END="136.46047637797233" CI_START="0.373585094769823" EFFECT_SIZE="7.14" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="0" LOG_CI_END="2.1350068830509046" LOG_CI_START="-0.4276104594985559" LOG_EFFECT_SIZE="0.8536982117761743" MODIFIED="2013-11-17 22:40:02 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="678" O_E="0.0" SE="1.5052941121739825" STUDY_ID="STD-Mangano-1996" TOTAL_1="99" TOTAL_2="101" VAR="2.2659103641456584" WEIGHT="2.1184458410344034"/><DICH_DATA CI_END="1.446151791426689" CI_START="0.4050013729748808" EFFECT_SIZE="0.7653061224489796" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="16" LOG_CI_END="0.16021387990126323" LOG_CI_START="-0.39254350450285286" LOG_EFFECT_SIZE="-0.11616481230079483" MODIFIED="2013-11-17 22:40:08 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="674" O_E="0.0" SE="0.32469242379215935" STUDY_ID="STD-Bayliff-1999" TOTAL_1="49" TOTAL_2="50" VAR="0.1054251700680272" WEIGHT="67.77657190968412"/></DICH_SUBGROUP><DICH_SUBGROUP CHI2="0.0" CI_END="7.848616069043482" CI_START="0.014156777466712338" DF="0" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" I2="0.0" ID="CMP-002.21.02" LOG_CI_END="0.8947930852084158" LOG_CI_START="-1.8490355946477406" LOG_EFFECT_SIZE="-0.47712125471966244" MODIFIED="2013-11-17 22:40:13 +0000" MODIFIED_BY="Hermann Blessberger" NO="2" P_CHI2="1.0" P_Z="0.49547179043695244" STUDIES="1" TAU2="0.0" TOTAL_1="28" TOTAL_2="28" WEIGHT="6.418890898334243" Z="0.6816318251751228"><NAME>Standard care</NAME><DICH_DATA CI_END="7.848616069043482" CI_START="0.014156777466712338" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.8947930852084158" LOG_CI_START="-1.8490355946477406" LOG_EFFECT_SIZE="-0.47712125471966244" MODIFIED="2013-11-17 22:40:13 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="681" O_E="0.0" SE="1.611738548718522" STUDY_ID="STD-Kawaguchi-2010" TOTAL_1="28" TOTAL_2="28" VAR="2.5977011494252875" WEIGHT="6.418890898334243"/></DICH_SUBGROUP></DICH_OUTCOME><CONT_OUTCOME CHI2="30.821873762650842" CI_END="-0.19057109548480994" CI_START="-0.898270250548719" CI_STUDY="95" CI_TOTAL="95" DF="13" EFFECT_MEASURE="MD" EFFECT_SIZE="-0.5444206730167644" ESTIMABLE="YES" I2="57.822161948657815" I2_Q="0.0" ID="CMP-002.22" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" NO="22" P_CHI2="0.0035797176246029627" P_Q="0.822619228954734" P_Z="0.0025652842057218707" Q="0.05025552994100348" RANDOM="YES" SCALE="2.0" SORT_BY="YEAR" STUDIES="14" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.1658084798189957" TOTALS="YES" TOTAL_1="1272" TOTAL_2="1178" UNITS="" WEIGHT="100.00000000000003" Z="3.015532529371342"><NAME>Length of stay&#8212;cardiac surgery</NAME><GROUP_LABEL_1>Beta-blocker</GROUP_LABEL_1><GROUP_LABEL_2>Control</GROUP_LABEL_2><GRAPH_LABEL_1>Favours experimental</GRAPH_LABEL_1><GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2><CONT_SUBGROUP CHI2="23.41139500436162" CI_END="-0.09440994976562911" CI_START="-1.1102171427320324" DF="8" EFFECT_SIZE="-0.6023135462488308" ESTIMABLE="YES" I2="65.82860611890246" ID="CMP-002.22.01" MODIFIED="2013-11-28 21:12:13 +0000" MODIFIED_BY="Hermann Blessberger" NO="1" P_CHI2="0.002874338972015944" P_Z="0.020110208682535824" STUDIES="9" TAU2="0.23733949588197809" TOTAL_1="991" TOTAL_2="911" WEIGHT="60.96536245175095" Z="2.3242852900084805"><NAME>Placebo</NAME><CONT_DATA CI_END="1.5979397562798727" CI_START="-3.197939756279874" EFFECT_SIZE="-0.8000000000000007" ESTIMABLE="YES" MEAN_1="7.6" MEAN_2="8.4" MODIFIED="2013-11-28 21:10:12 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1738" SD_1="3.9" SD_2="2.6" SE="1.2234611325486162" STUDY_ID="STD-Cork-1995" TOTAL_1="15" TOTAL_2="14" WEIGHT="1.9603619455741499"/><CONT_DATA CI_END="0.49035874809146784" CI_START="-1.2903587480914687" EFFECT_SIZE="-0.40000000000000036" ESTIMABLE="YES" MEAN_1="10.0" MEAN_2="10.4" MODIFIED="2013-11-28 21:10:25 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1740" SD_1="4.0" SD_2="3.2" SE="0.45427301476685505" STUDY_ID="STD-Pfisterer-1997" TOTAL_1="126" TOTAL_2="129" WEIGHT="8.757839005699223"/><CONT_DATA CI_END="0.3228748645299382" CI_START="-2.322874864529938" EFFECT_SIZE="-1.0" ESTIMABLE="YES" MEAN_1="7.0" MEAN_2="8.0" MODIFIED="2013-11-28 21:10:35 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1739" SD_1="2.0" SD_2="4.0" SE="0.674948557710553" STUDY_ID="STD-Gomes-1999" TOTAL_1="40" TOTAL_2="45" WEIGHT="5.245598762316369"/><CONT_DATA CI_END="0.5986973363346225" CI_START="-0.19869733633462217" EFFECT_SIZE="0.20000000000000018" ESTIMABLE="YES" MEAN_1="6.5" MEAN_2="6.3" MODIFIED="2013-11-28 21:10:54 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1737" SD_1="3.8" SD_2="2.5" SE="0.20342074623793907" STUDY_ID="STD-Connolly-2003" TOTAL_1="500" TOTAL_2="500" WEIGHT="15.731697137582918"/><CONT_DATA CI_END="0.6873907364900345" CI_START="-4.287390736490032" EFFECT_SIZE="-1.799999999999999" ESTIMABLE="YES" MEAN_1="11.3" MEAN_2="13.1" MODIFIED="2013-11-28 21:11:12 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1734" SD_1="7.0" SD_2="8.9" SE="1.2691002263869409" STUDY_ID="STD-Auer-2004" TOTAL_1="125" TOTAL_2="65" WEIGHT="1.8348247173241303"/><CONT_DATA CI_END="-0.5799305882439878" CI_START="-0.8200694117560126" EFFECT_SIZE="-0.7000000000000002" ESTIMABLE="YES" MEAN_1="5.1" MEAN_2="5.8" MODIFIED="2013-11-28 21:11:28 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1735" SD_1="0.3" SD_2="0.2" SE="0.061261029642944734" STUDY_ID="STD-Booth-2004" TOTAL_1="33" TOTAL_2="39" WEIGHT="19.22269183006188"/><CONT_DATA CI_END="0.8331433922667311" CI_START="-2.03314339226673" EFFECT_SIZE="-0.5999999999999996" ESTIMABLE="YES" MEAN_1="7.5" MEAN_2="8.1" MODIFIED="2013-11-28 21:11:44 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1736" SD_1="2.1" SD_2="1.9" SE="0.731209044437134" STUDY_ID="STD-But-2006" TOTAL_1="15" TOTAL_2="15" WEIGHT="4.653164971321886"/><CONT_DATA CI_END="-0.6816580345935019" CI_START="-4.9183419654064995" EFFECT_SIZE="-2.8000000000000007" ESTIMABLE="YES" MEAN_1="11.2" MEAN_2="14.0" MODIFIED="2013-11-28 21:12:04 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1741" SD_1="4.9" SD_2="7.6" SE="1.0808065771186153" STUDY_ID="STD-Sezai-2011" TOTAL_1="70" TOTAL_2="70" WEIGHT="2.443437271356669"/><CONT_DATA CI_END="2.5534736631582517" CI_START="-3.9534736631582503" EFFECT_SIZE="-0.6999999999999993" ESTIMABLE="YES" MEAN_1="11.5" MEAN_2="12.2" MODIFIED="2013-11-28 21:12:13 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1742" SD_1="5.0" SD_2="9.0" SE="1.6599660446932882" STUDY_ID="STD-Sezai-2012" TOTAL_1="67" TOTAL_2="34" WEIGHT="1.11574681051372"/></CONT_SUBGROUP><CONT_SUBGROUP CHI2="7.075914923636436" CI_END="0.05757406653225994" CI_START="-1.087151425591395" DF="4" EFFECT_SIZE="-0.5147886795295675" ESTIMABLE="YES" I2="43.4702078364683" ID="CMP-002.22.02" MODIFIED="2013-11-28 21:13:59 +0000" MODIFIED_BY="Hermann Blessberger" NO="2" P_CHI2="0.13193065832292228" P_Z="0.077932393126266" STUDIES="5" TAU2="0.17296313289994453" TOTAL_1="281" TOTAL_2="267" WEIGHT="39.03463754824907" Z="1.7628108720721913"><NAME>Standard care</NAME><CONT_DATA CI_END="0.8525956472955156" CI_START="-1.2525956472955142" EFFECT_SIZE="-0.1999999999999993" ESTIMABLE="YES" MEAN_1="10.0" MEAN_2="10.2" MODIFIED="2013-11-28 21:13:04 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1747" SD_1="1.5" SD_2="1.7" SE="0.5370484639504883" STUDY_ID="STD-Jacquet-1994" TOTAL_1="19" TOTAL_2="17" WEIGHT="7.175725447273321"/><CONT_DATA CI_END="-0.6213610519607327" CI_START="-2.1986389480392674" EFFECT_SIZE="-1.4100000000000001" ESTIMABLE="YES" MEAN_1="8.42" MEAN_2="9.83" MODIFIED="2013-11-28 21:13:19 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1746" SD_1="2.81" SD_2="2.88" SE="0.40237420394453716" STUDY_ID="STD-Wenke-1999" TOTAL_1="100" TOTAL_2="100" WEIGHT="9.945963823974875"/><CONT_DATA CI_END="0.9081080402146975" CI_START="-0.9081080402146975" EFFECT_SIZE="0.0" ESTIMABLE="YES" MEAN_1="8.0" MEAN_2="8.0" MODIFIED="2013-11-28 21:13:33 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1743" SD_1="2.3" SD_2="2.9" SE="0.4633289424590134" STUDY_ID="STD-Bert-2001" TOTAL_1="71" TOTAL_2="60" WEIGHT="8.566567664335407"/><CONT_DATA CI_END="2.627257429639835" CI_START="-4.627257429639835" EFFECT_SIZE="-1.0" ESTIMABLE="YES" MEAN_1="21.0" MEAN_2="22.0" MODIFIED="2013-11-28 21:13:45 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1745" SD_1="4.0" SD_2="11.0" SE="1.8506755523321747" STUDY_ID="STD-Matsuura-2001" TOTAL_1="40" TOTAL_2="40" WEIGHT="0.907713801286598"/><CONT_DATA CI_END="0.30800399250821786" CI_START="-0.9080039925082193" EFFECT_SIZE="-0.3000000000000007" ESTIMABLE="YES" MEAN_1="5.6" MEAN_2="5.9" MODIFIED="2013-11-28 21:13:59 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1744" SD_1="1.4" SD_2="1.7" SE="0.3102118188416096" STUDY_ID="STD-Forlani-2002" TOTAL_1="51" TOTAL_2="50" WEIGHT="12.438666811378871"/></CONT_SUBGROUP></CONT_OUTCOME><CONT_OUTCOME CHI2="3.109542519456295" CI_END="0.839660484302499" CI_START="-1.7484787202947651" CI_STUDY="95" CI_TOTAL="95" DF="2" EFFECT_MEASURE="MD" EFFECT_SIZE="-0.45440911799613304" ESTIMABLE="YES" I2="35.68185713859604" I2_Q="0.0" ID="CMP-002.23" MODIFIED="2017-12-08 02:36:48 +0000" MODIFIED_BY="Hermann Blessberger" NO="23" P_CHI2="0.21123779549911226" P_Q="0.46167838829207986" P_Z="0.49130407532430953" Q="0.5418227467746232" RANDOM="YES" SCALE="2.0" SORT_BY="YEAR" STUDIES="3" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.5891179693527354" TOTALS="YES" TOTAL_1="276" TOTAL_2="275" UNITS="" WEIGHT="100.0" Z="0.6882361690105624"><NAME>Length of stay&#8212;non-cardiac surgery</NAME><GROUP_LABEL_1>Beta-blocker</GROUP_LABEL_1><GROUP_LABEL_2>Control</GROUP_LABEL_2><GRAPH_LABEL_1>Favours beta-blocker</GRAPH_LABEL_1><GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2><CONT_SUBGROUP CHI2="3.071902406804124" CI_END="6.9079599610554805" CI_START="-16.072717476964336" DF="1" EFFECT_SIZE="-4.582378757954428" ESTIMABLE="YES" I2="67.44688249909744" ID="CMP-002.23.01" MODIFIED="2017-12-08 02:36:48 +0000" MODIFIED_BY="Hermann Blessberger" NO="1" P_CHI2="0.07965645378299924" P_Z="0.4344267431806905" STUDIES="2" TAU2="51.85316326529215" TOTAL_1="79" TOTAL_2="72" WEIGHT="73.82627445095206" Z="0.7816390403055029"><NAME>Placebo</NAME><CONT_DATA CI_END="1.0653205264171248" CI_START="-26.665320526417123" EFFECT_SIZE="-12.799999999999999" ESTIMABLE="YES" MEAN_1="15.9" MEAN_2="28.7" MODIFIED="2017-08-31 17:38:25 +0100" MODIFIED_BY="[Empty name]" ORDER="1749" SD_1="21.5" SD_2="41.3" SE="7.074273117151643" STUDY_ID="STD-POBBLE-2005" TOTAL_1="49" TOTAL_2="42" WEIGHT="0.8609400733405568"/><CONT_DATA CI_END="-0.22108058562828417" CI_START="-0.5789194143717157" EFFECT_SIZE="-0.3999999999999999" ESTIMABLE="YES" MEAN_1="1.3" MEAN_2="1.7" MODIFIED="2017-12-08 02:36:48 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1748" SD_1="0.3" SD_2="0.4" SE="0.09128709291752769" STUDY_ID="STD-Lee-2010" TOTAL_1="30" TOTAL_2="30" WEIGHT="72.9653343776115"/></CONT_SUBGROUP><CONT_SUBGROUP CHI2="0.0" CI_END="1.833472026316095" CI_START="-2.2334720263160954" DF="0" EFFECT_SIZE="-0.20000000000000018" ESTIMABLE="YES" I2="0.0" ID="CMP-002.23.02" MODIFIED="2013-11-28 21:17:00 +0000" MODIFIED_BY="Hermann Blessberger" NO="2" P_CHI2="1.0" P_Z="0.8471389475203157" STUDIES="1" TAU2="0.0" TOTAL_1="197" TOTAL_2="203" WEIGHT="26.173725549047948" Z="0.192770193951553"><NAME>Standard care</NAME><CONT_DATA CI_END="1.833472026316095" CI_START="-2.2334720263160954" EFFECT_SIZE="-0.20000000000000018" ESTIMABLE="YES" MEAN_1="7.8" MEAN_2="8.0" MODIFIED="2013-11-28 21:17:00 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1751" SD_1="8.9" SD_2="11.7" SE="1.0375047921063159" STUDY_ID="STD-Marwick-2009" TOTAL_1="197" TOTAL_2="203" WEIGHT="26.173725549047948"/></CONT_SUBGROUP></CONT_OUTCOME></COMPARISON><COMPARISON ID="CMP-003" MODIFIED="2017-12-08 02:36:42 +0000" MODIFIED_BY="Hermann Blessberger" NO="3"><NAME>Stratification for start of beta-blocker therapy</NAME><DICH_OUTCOME CHI2="4.1611665641256055" CI_END="1.5197716038104088" CI_START="0.35242047072087324" CI_STUDY="95" CI_TOTAL="95" DF="12" EFFECT_MEASURE="RR" EFFECT_SIZE="0.7318460384555489" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="13" I2="0.0" I2_Q="0.0" ID="CMP-003.01" LOG_CI_END="0.18177832566987695" LOG_CI_START="-0.4529388730667181" LOG_EFFECT_SIZE="-0.1355802736984206" METHOD="MH" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" NO="1" P_CHI2="0.9803493480143448" P_Q="0.5295703354210428" P_Z="0.4024096278199055" Q="1.2713786779399816" RANDOM="NO" SCALE="100.0" SORT_BY="YEAR" STUDIES="24" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="1939" TOTAL_2="1844" WEIGHT="100.0" Z="0.8373255175436499"><NAME>All-cause mortality (30 days)&#8212;cardiac surgery</NAME><GROUP_LABEL_1>Beta-blocker</GROUP_LABEL_1><GROUP_LABEL_2>Control</GROUP_LABEL_2><GRAPH_LABEL_1>Favours beta-blocker</GRAPH_LABEL_1><GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2><DICH_SUBGROUP CHI2="0.7278949724339896" CI_END="1.6810437985736695" CI_START="0.1396810528729181" DF="4" EFFECT_SIZE="0.484571942760061" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="6" I2="0.0" ID="CMP-003.01.01" LOG_CI_END="0.22557902886544434" LOG_CI_START="-0.8548625000476182" LOG_EFFECT_SIZE="-0.3146417355910869" MODIFIED="2014-06-22 16:24:45 +0100" MODIFIED_BY="Hermann Blessberger" NO="1" P_CHI2="0.9478448774050842" P_Z="0.2536430949180366" STUDIES="7" TAU2="0.0" TOTAL_1="413" TOTAL_2="377" WEIGHT="45.4270118540209" Z="1.1415452910480017"><NAME>Before surgery</NAME><DICH_DATA CI_END="14.051950786893713" CI_START="0.025619218673593205" EFFECT_SIZE="0.6" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="1.1477366201252595" LOG_CI_START="-1.591434119357972" LOG_EFFECT_SIZE="-0.2218487496163564" MODIFIED="2013-11-17 23:04:27 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="688" O_E="0.0" SE="1.6090024514862893" STUDY_ID="STD-Oka-1980" TOTAL_1="19" TOTAL_2="35" VAR="2.588888888888889" WEIGHT="6.369427315296147"/><DICH_DATA CI_END="3.0967497955252377" CI_START="0.035879912310534466" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="3" LOG_CI_END="0.4909061175904471" LOG_CI_START="-1.4451486270297722" LOG_EFFECT_SIZE="-0.47712125471966244" MODIFIED="2014-06-22 16:24:44 +0100" MODIFIED_BY="Hermann Blessberger" ORDER="682" O_E="0.0" SE="1.1372481406154653" STUDY_ID="STD-Abel-1983" TOTAL_1="50" TOTAL_2="50" VAR="1.2933333333333332" WEIGHT="17.834396482829213"/><DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-11-17 23:04:47 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="686" O_E="0.0" SE="0.0" STUDY_ID="STD-Hammon-1984" TOTAL_1="24" TOTAL_2="26" VAR="0.0" WEIGHT="0.0"/><DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-11-17 23:04:55 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="687" O_E="0.0" SE="0.0" STUDY_ID="STD-Nystr_x00f6_m-1993" TOTAL_1="50" TOTAL_2="51" VAR="0.0" WEIGHT="0.0"/><DICH_DATA CI_END="8.090192218311387" CI_START="0.01373405082509925" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.9079588403218196" LOG_CI_START="-1.8622013497611447" LOG_EFFECT_SIZE="-0.47712125471966244" MODIFIED="2013-11-17 23:05:07 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="683" O_E="0.0" SE="1.6272058081688268" STUDY_ID="STD-Ali-1997" TOTAL_1="105" TOTAL_2="105" VAR="2.6477987421383644" WEIGHT="8.917198241414606"/><DICH_DATA CI_END="8.928614028566257" CI_START="0.015664675078941228" EFFECT_SIZE="0.37398373983739835" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.9507840494304557" LOG_CI_START="-1.8050786089461033" LOG_EFFECT_SIZE="-0.4271472797578239" MODIFIED="2013-11-17 23:05:18 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="685" O_E="0.0" SE="1.618807367270561" STUDY_ID="STD-Gomes-1999" TOTAL_1="40" TOTAL_2="45" VAR="2.6205372923294448" WEIGHT="8.404715583862043"/><DICH_DATA CI_END="38.042628832648475" CI_START="0.06491107031443613" EFFECT_SIZE="1.5714285714285714" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.5802705200441767" LOG_CI_START="-1.1876812297562402" LOG_EFFECT_SIZE="0.1962946451439682" MODIFIED="2013-11-17 23:05:27 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="684" O_E="0.0" SE="1.6259085594149025" STUDY_ID="STD-Auer-2004" TOTAL_1="125" TOTAL_2="65" VAR="2.6435786435786435" WEIGHT="3.90127423061889"/></DICH_SUBGROUP><DICH_SUBGROUP CHI2="1.3913668110868085" CI_END="2.6605407060280557" CI_START="0.13168490427251897" DF="2" EFFECT_SIZE="0.5919062832800852" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="3" I2="0.0" ID="CMP-003.01.02" LOG_CI_END="0.4249699079771949" LOG_CI_START="-0.8804640076267105" LOG_EFFECT_SIZE="-0.22774704982475782" MODIFIED="2014-06-22 16:25:48 +0100" MODIFIED_BY="Hermann Blessberger" NO="2" P_CHI2="0.4987335506110827" P_Z="0.49405487486315713" STUDIES="3" TAU2="0.0" TOTAL_1="153" TOTAL_2="118" WEIGHT="25.907330286783154" Z="0.6838737831248656"><NAME>During surgery</NAME><DICH_DATA CI_END="60.21015642179821" CI_START="0.11637439315284949" EFFECT_SIZE="2.6470588235294117" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.7796697554754684" LOG_CI_START="-0.934142570681329" LOG_EFFECT_SIZE="0.42276359239706973" MODIFIED="2014-06-22 16:25:48 +0100" MODIFIED_BY="Hermann Blessberger" ORDER="689" O_E="0.0" SE="1.5941067939721714" STUDY_ID="STD-Cork-1995" TOTAL_1="16" TOTAL_2="14" VAR="2.541176470588235" WEIGHT="3.158174377167673"/><DICH_DATA CI_END="4.092080860459946" CI_START="0.009774977905862802" EFFECT_SIZE="0.2" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" LOG_CI_END="0.611944206883865" LOG_CI_START="-2.0098842155559025" LOG_EFFECT_SIZE="-0.6989700043360187" MODIFIED="2013-11-17 23:05:45 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="690" O_E="0.0" SE="1.540074993601121" STUDY_ID="STD-Sezai-2011" TOTAL_1="70" TOTAL_2="70" VAR="2.371830985915493" WEIGHT="14.861997069024344"/><DICH_DATA CI_END="7.866237458523328" CI_START="0.03273717321855499" EFFECT_SIZE="0.5074626865671642" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="0.8957670523419452" LOG_CI_START="-1.4849588236590878" LOG_EFFECT_SIZE="-0.2945958856585713" MODIFIED="2013-11-17 23:05:51 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="691" O_E="0.0" SE="1.3984501643461555" STUDY_ID="STD-Sezai-2012" TOTAL_1="67" TOTAL_2="34" VAR="1.9556628621597894" WEIGHT="7.8871588405911375"/></DICH_SUBGROUP><DICH_SUBGROUP CHI2="0.9015766108544534" CI_END="4.12387002968061" CI_START="0.37900089823505323" DF="4" EFFECT_SIZE="1.2501801651976274" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="4" I2="0.0" ID="CMP-003.01.03" LOG_CI_END="0.6153049693462035" LOG_CI_START="-0.42135976074943476" LOG_EFFECT_SIZE="0.09697260429838436" MODIFIED="2013-11-17 23:08:15 +0000" MODIFIED_BY="Hermann Blessberger" NO="3" P_CHI2="0.924334548745606" P_Z="0.7138567195244323" STUDIES="14" TAU2="0.0" TOTAL_1="1373" TOTAL_2="1349" WEIGHT="28.66565785919595" Z="0.3666813510561954"><NAME>After surgery</NAME><DICH_DATA CI_END="10.258083464353952" CI_START="0.018010104346265817" EFFECT_SIZE="0.4298245614035088" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="1.0110662283582093" LOG_CI_START="-1.7444837709741272" LOG_EFFECT_SIZE="-0.3667087713079589" MODIFIED="2013-11-17 23:06:06 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="702" O_E="0.0" SE="1.6186237098002971" STUDY_ID="STD-Mohr-1981" TOTAL_1="37" TOTAL_2="48" VAR="2.6199427139276765" WEIGHT="7.789736394798966"/><DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-11-17 23:06:16 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="697" O_E="0.0" SE="0.0" STUDY_ID="STD-Ivey-1983" TOTAL_1="53" TOTAL_2="56" VAR="0.0" WEIGHT="0.0"/><DICH_DATA CI_END="66.4433184667098" CI_START="0.12341968180365896" EFFECT_SIZE="2.8636363636363638" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.8224513148659036" LOG_CI_START="-0.9086155776031525" LOG_EFFECT_SIZE="0.4569178686313755" MODIFIED="2013-11-17 23:06:24 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="705" O_E="0.0" SE="1.6042422116354729" STUDY_ID="STD-White-1984" TOTAL_1="21" TOTAL_2="20" VAR="2.5735930735930737" WEIGHT="3.0415249815677727"/><DICH_DATA CI_END="15.718754250133742" CI_START="0.06361827305694352" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.1964181241632585" LOG_CI_START="-1.1964181241632585" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-11-17 23:06:32 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="700" O_E="0.0" SE="1.4055638569974547" STUDY_ID="STD-Matangi-1985" TOTAL_1="82" TOTAL_2="82" VAR="1.975609756097561" WEIGHT="5.944798827609738"/><DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-11-17 23:06:41 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="698" O_E="0.0" SE="0.0" STUDY_ID="STD-Janssen-1986" TOTAL_1="80" TOTAL_2="50" VAR="0.0" WEIGHT="0.0"/><DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-11-17 23:06:51 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="699" O_E="0.0" SE="0.0" STUDY_ID="STD-Martinussen-1988" TOTAL_1="35" TOTAL_2="40" VAR="0.0" WEIGHT="0.0"/><DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-11-17 23:07:00 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="704" O_E="0.0" SE="0.0" STUDY_ID="STD-Suttorp-1991" TOTAL_1="150" TOTAL_2="150" VAR="0.0" WEIGHT="0.0"/><DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-11-17 23:07:12 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="703" O_E="0.0" SE="0.0" STUDY_ID="STD-Paull-1997" TOTAL_1="50" TOTAL_2="50" VAR="0.0" WEIGHT="0.0"/><DICH_DATA CI_END="15.773312877448294" CI_START="0.06339822254015756" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.1979229180145214" LOG_CI_START="-1.1979229180145214" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-11-17 23:07:21 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="695" O_E="0.0" SE="1.4073317037116178" STUDY_ID="STD-Evrard-2000" TOTAL_1="103" TOTAL_2="103" VAR="1.9805825242718447" WEIGHT="5.944798827609738"/><DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-11-17 23:07:29 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="701" O_E="0.0" SE="0.0" STUDY_ID="STD-Matsuura-2001" TOTAL_1="71" TOTAL_2="60" VAR="0.0" WEIGHT="0.0"/><DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-11-17 23:07:37 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="692" O_E="0.0" SE="0.0" STUDY_ID="STD-Bert-2001" TOTAL_1="40" TOTAL_2="40" VAR="0.0" WEIGHT="0.0"/><DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-11-17 23:07:53 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="696" O_E="0.0" SE="0.0" STUDY_ID="STD-Forlani-2002" TOTAL_1="51" TOTAL_2="50" VAR="0.0" WEIGHT="0.0"/><DICH_DATA CI_END="21.705078767310894" CI_START="0.18428866547235168" EFFECT_SIZE="2.0" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="1" LOG_CI_END="1.3365613662238505" LOG_CI_START="-0.7345013748958881" LOG_EFFECT_SIZE="0.3010299956639812" MODIFIED="2013-11-17 23:08:07 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="694" O_E="0.0" SE="1.2165525060596438" STUDY_ID="STD-De-Azevedo-L_x00fa_cio-2003" TOTAL_1="100" TOTAL_2="100" VAR="1.48" WEIGHT="5.944798827609738"/><DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-11-17 23:08:15 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="693" O_E="0.0" SE="0.0" STUDY_ID="STD-Connolly-2003" TOTAL_1="500" TOTAL_2="500" VAR="0.0" WEIGHT="0.0"/></DICH_SUBGROUP></DICH_OUTCOME><DICH_OUTCOME CHI2="6.688662154126654" CI_END="1.5678386330345675" CI_START="1.0041493045683079" CI_STUDY="95" CI_TOTAL="95" DF="9" EFFECT_MEASURE="RR" EFFECT_SIZE="1.25472868502995" ESTIMABLE="YES" EVENTS_1="168" EVENTS_2="134" I2="0.0" I2_Q="57.57263638549821" ID="CMP-003.02" LOG_CI_END="0.19530136167176518" LOG_CI_START="0.0017982918222352762" LOG_EFFECT_SIZE="0.09854982674700022" METHOD="MH" MODIFIED="2017-12-03 02:24:07 +0000" MODIFIED_BY="Hermann Blessberger" NO="2" P_CHI2="0.66949765585711" P_Q="0.12472444030356433" P_Z="0.04589113513048386" Q="2.3569694527477005" RANDOM="NO" SCALE="100.0" SORT_BY="YEAR" STUDIES="13" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="5805" TOTAL_2="5608" WEIGHT="100.00000000000003" Z="1.9963932485100235"><NAME>All-cause mortality (30 days)&#8212;non-cardiac surgery</NAME><GROUP_LABEL_1>Beta-blocker</GROUP_LABEL_1><GROUP_LABEL_2>Control</GROUP_LABEL_2><GRAPH_LABEL_1>Favours beta-blocker</GRAPH_LABEL_1><GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2><DICH_SUBGROUP CHI2="4.190683218645403" CI_END="1.6314134212181428" CI_START="1.0334257441501484" DF="7" EFFECT_SIZE="1.2984393050269616" ESTIMABLE="YES" EVENTS_1="164" EVENTS_2="126" I2="0.0" ID="CMP-003.02.01" LOG_CI_END="0.2125640308147161" LOG_CI_START="0.014279276256563509" LOG_EFFECT_SIZE="0.11342165353563984" MODIFIED="2017-12-03 02:24:07 +0000" MODIFIED_BY="Hermann Blessberger" NO="1" P_CHI2="0.7575713338091763" P_Z="0.024944984378399183" STUDIES="8" TAU2="0.0" TOTAL_1="5331" TOTAL_2="5335" WEIGHT="94.25634401494726" Z="2.242253636616705"><NAME>Before surgery</NAME><DICH_DATA CI_END="10.888852021315463" CI_START="0.38234045608732375" EFFECT_SIZE="2.04040404040404" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="2" LOG_CI_END="1.0369820958174838" LOG_CI_START="-0.4175497461193362" LOG_EFFECT_SIZE="0.3097161748490738" MODIFIED="2013-11-18 20:49:07 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="702" O_E="0.0" SE="0.8543992040024265" STUDY_ID="STD-Mangano-1996" TOTAL_1="99" TOTAL_2="101" VAR="0.72999799979998" WEIGHT="1.4699070622971766"/><DICH_DATA CI_END="21.785667983536555" CI_START="0.1911775797639689" EFFECT_SIZE="2.0408163265306123" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="1" LOG_CI_END="1.3381708806415864" LOG_CI_START="-0.7185630406986138" LOG_EFFECT_SIZE="0.3098039199714864" MODIFIED="2013-11-18 20:49:22 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="699" O_E="0.0" SE="1.2081356863923414" STUDY_ID="STD-Bayliff-1999" TOTAL_1="49" TOTAL_2="50" VAR="1.4595918367346938" WEIGHT="0.7348785435421044"/><DICH_DATA CI_END="23.10618612076079" CI_START="0.2684527492293484" EFFECT_SIZE="2.490566037735849" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="1" LOG_CI_END="1.3637282672706277" LOG_CI_START="-0.571132144060506" LOG_EFFECT_SIZE="0.3962980616050608" MODIFIED="2013-11-18 20:49:29 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="704" O_E="0.0" SE="1.1365465833294115" STUDY_ID="STD-POBBLE-2005" TOTAL_1="53" TOTAL_2="44" VAR="1.2917381360777587" WEIGHT="0.8112576726205388"/><DICH_DATA CI_END="2.086100324386569" CI_START="0.006111296108574041" EFFECT_SIZE="0.11291048133153396" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="4" LOG_CI_END="0.3193351906100624" LOG_CI_START="-2.2138666730459673" LOG_EFFECT_SIZE="-0.9472657412179525" MODIFIED="2013-11-18 20:49:38 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="707" O_E="0.0" SE="1.4880153142630121" STUDY_ID="STD-Yang-2006" TOTAL_1="246" TOTAL_2="250" VAR="2.214189575481251" WEIGHT="3.313864954247925"/><DICH_DATA CI_END="2.5549775876151535" CI_START="0.6868023908740409" EFFECT_SIZE="1.3246753246753247" ESTIMABLE="YES" EVENTS_1="20" EVENTS_2="15" LOG_CI_END="0.4073870948356017" LOG_CI_START="-0.16316820165673035" LOG_EFFECT_SIZE="0.12210944658943569" MODIFIED="2013-12-07 18:55:37 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="701" O_E="0.0" SE="0.3351470054538631" STUDY_ID="STD-DIPOM-_x002d_-Juul-2006" TOTAL_1="462" TOTAL_2="459" VAR="0.11232351526469174" WEIGHT="11.171932069576803"/><DICH_DATA CI_END="7.99511202377449" CI_START="0.013897380146858233" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.90282455325627" LOG_CI_START="-1.8570670626955947" LOG_EFFECT_SIZE="-0.47712125471966244" MODIFIED="2013-11-18 20:50:05 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="708" O_E="0.0" SE="1.6211739968939571" STUDY_ID="STD-Yang-2008" TOTAL_1="51" TOTAL_2="51" VAR="2.628205128205128" WEIGHT="1.1135659562857398"/><DICH_DATA CI_END="1.7258284961101578" CI_START="1.0262717576233682" EFFECT_SIZE="1.3308527507051506" ESTIMABLE="YES" EVENTS_1="129" EVENTS_2="97" LOG_CI_END="0.23699763558907627" LOG_CI_START="0.011262377548303708" LOG_EFFECT_SIZE="0.12413000656868999" MODIFIED="2017-12-03 02:24:07 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="705" O_E="0.0" SE="0.13259800798069846" STUDY_ID="STD-POISE-2008" TOTAL_1="4174" TOTAL_2="4177" VAR="0.017582231720449374" WEIGHT="71.98472953323878"/><DICH_DATA CI_END="3.986212369346937" CI_START="0.38358505944859494" EFFECT_SIZE="1.2365482233502538" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="5" LOG_CI_END="0.6005604324423948" LOG_CI_START="-0.416138316843905" LOG_EFFECT_SIZE="0.09221105779924482" MODIFIED="2013-11-18 20:50:30 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="703" O_E="0.0" SE="0.5972138780707484" STUDY_ID="STD-Marwick-2009" TOTAL_1="197" TOTAL_2="203" VAR="0.35666441616030276" WEIGHT="3.656208223138179"/></DICH_SUBGROUP><DICH_SUBGROUP CHI2="0.28936214149510464" CI_END="1.6190305821990345" CI_START="0.1783875170991997" DF="1" EFFECT_SIZE="0.5374149659863945" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="8" I2="0.0" ID="CMP-003.02.02" LOG_CI_END="0.20925505230794086" LOG_CI_START="-0.7486355392234104" LOG_EFFECT_SIZE="-0.26969024345773474" MODIFIED="2017-06-17 15:39:25 +0100" MODIFIED_BY="Hermann Blessberger" NO="2" P_CHI2="0.5906296493083439" P_Z="0.269749369876111" STUDIES="5" TAU2="0.0" TOTAL_1="474" TOTAL_2="273" WEIGHT="5.743655985052763" Z="1.1036399539408126"><NAME>During surgery</NAME><DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-11-18 20:50:58 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="711" O_E="0.0" SE="0.0" STUDY_ID="STD-Miller-1990" TOTAL_1="30" TOTAL_2="15" VAR="0.0" WEIGHT="0.0"/><DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-11-18 20:51:41 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="712" O_E="0.0" SE="0.0" STUDY_ID="STD-Miller-1991" TOTAL_1="368" TOTAL_2="180" VAR="0.0" WEIGHT="0.0"/><DICH_DATA CI_END="2.4023415437266507" CI_START="0.185004686617123" EFFECT_SIZE="0.6666666666666666" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="5" LOG_CI_END="0.38063475161440946" LOG_CI_START="-0.7328172697257719" LOG_EFFECT_SIZE="-0.17609125905568127" MODIFIED="2013-11-18 20:51:50 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="713" O_E="0.0" SE="0.6540472290116194" STUDY_ID="STD-Neary-2006" TOTAL_1="18" TOTAL_2="20" VAR="0.42777777777777776" WEIGHT="3.516524072481283"/><DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-11-18 20:51:56 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="710" O_E="0.0" SE="0.0" STUDY_ID="STD-Lai-2006" TOTAL_1="30" TOTAL_2="30" VAR="0.0" WEIGHT="0.0"/><DICH_DATA CI_END="3.0135058276554862" CI_START="0.036871045707436295" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="3" LOG_CI_END="0.4790720356632876" LOG_CI_START="-1.4333145451026126" LOG_EFFECT_SIZE="-0.47712125471966244" MODIFIED="2013-11-18 20:52:11 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="709" O_E="0.0" SE="1.1233453440081378" STUDY_ID="STD-Kawaguchi-2010" TOTAL_1="28" TOTAL_2="28" VAR="1.2619047619047616" WEIGHT="2.2271319125714797"/></DICH_SUBGROUP><DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-003.02.03" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2013-11-18 20:45:16 +0000" MODIFIED_BY="Hermann Blessberger" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0"><NAME>After surgery</NAME></DICH_SUBGROUP></DICH_OUTCOME><DICH_OUTCOME CHI2="0.9520673649550806" CI_END="4.399984179226458" CI_START="0.16262684854521636" CI_STUDY="95" CI_TOTAL="95" DF="2" EFFECT_MEASURE="RR" EFFECT_SIZE="0.8459051724137933" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" I2="0.0" I2_Q="0.0" ID="CMP-003.03" LOG_CI_END="0.6434511149209599" LOG_CI_START="-0.7888077538681787" LOG_EFFECT_SIZE="-0.07267831947360943" METHOD="MH" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" NO="3" P_CHI2="0.6212425997920604" P_Q="0.621280074643648" P_Z="0.8423314180816447" Q="0.9519467236303771" RANDOM="NO" SCALE="100.0" SORT_BY="YEAR" STUDIES="4" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="150" TOTAL_2="170" WEIGHT="100.0" Z="0.1989122102565134"><NAME>Death due to cardiac causes&#8212;cardiac surgery</NAME><GROUP_LABEL_1>Beta-blocker</GROUP_LABEL_1><GROUP_LABEL_2>Control</GROUP_LABEL_2><GRAPH_LABEL_1>Favours beta-blocker</GRAPH_LABEL_1><GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2><DICH_SUBGROUP CHI2="0.0" CI_END="14.051950786893713" CI_START="0.025619218673593205" DF="0" EFFECT_SIZE="0.6" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" I2="0.0" ID="CMP-003.03.01" LOG_CI_END="1.1477366201252595" LOG_CI_START="-1.591434119357972" LOG_EFFECT_SIZE="-0.2218487496163564" MODIFIED="2013-11-18 20:56:06 +0000" MODIFIED_BY="Hermann Blessberger" NO="1" P_CHI2="1.0" P_Z="0.7508796370655153" STUDIES="2" TAU2="0.0" TOTAL_1="59" TOTAL_2="80" WEIGHT="34.752155172413794" Z="0.31747970507697115"><NAME>Before surgery</NAME><DICH_DATA CI_END="14.051950786893713" CI_START="0.025619218673593205" EFFECT_SIZE="0.6" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="1.1477366201252595" LOG_CI_START="-1.591434119357972" LOG_EFFECT_SIZE="-0.2218487496163564" MODIFIED="2013-11-18 20:56:00 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="717" O_E="0.0" SE="1.6090024514862893" STUDY_ID="STD-Oka-1980" TOTAL_1="19" TOTAL_2="35" VAR="2.588888888888889" WEIGHT="34.752155172413794"/><DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-11-18 20:56:06 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="716" O_E="0.0" SE="0.0" STUDY_ID="STD-Gomes-1999" TOTAL_1="40" TOTAL_2="45" VAR="0.0" WEIGHT="0.0"/></DICH_SUBGROUP><DICH_SUBGROUP CHI2="0.0" CI_END="8.044961518532196" CI_START="0.013811266947039826" DF="0" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" I2="0.0" ID="CMP-003.03.02" LOG_CI_END="0.9055239710790393" LOG_CI_START="-1.8597664805183645" LOG_EFFECT_SIZE="-0.47712125471966244" MODIFIED="2013-11-18 20:56:13 +0000" MODIFIED_BY="Hermann Blessberger" NO="2" P_CHI2="1.0" P_Z="0.49882379491619766" STUDIES="1" TAU2="0.0" TOTAL_1="70" TOTAL_2="70" WEIGHT="48.65301724137931" Z="0.6763415936788156"><NAME>During surgery</NAME><DICH_DATA CI_END="8.044961518532196" CI_START="0.013811266947039826" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.9055239710790393" LOG_CI_START="-1.8597664805183645" LOG_EFFECT_SIZE="-0.47712125471966244" MODIFIED="2013-11-18 20:56:13 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="718" O_E="0.0" SE="1.6243452996768142" STUDY_ID="STD-Sezai-2011" TOTAL_1="70" TOTAL_2="70" VAR="2.6384976525821595" WEIGHT="48.65301724137931"/></DICH_SUBGROUP><DICH_SUBGROUP CHI2="0.0" CI_END="66.4433184667098" CI_START="0.12341968180365896" DF="0" EFFECT_SIZE="2.8636363636363638" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" I2="0.0" ID="CMP-003.03.03" LOG_CI_END="1.8224513148659036" LOG_CI_START="-0.9086155776031525" LOG_EFFECT_SIZE="0.4569178686313755" MODIFIED="2013-11-18 20:56:18 +0000" MODIFIED_BY="Hermann Blessberger" NO="3" P_CHI2="1.0" P_Z="0.5119406943006533" STUDIES="1" TAU2="0.0" TOTAL_1="21" TOTAL_2="20" WEIGHT="16.594827586206897" Z="0.6558188441885238"><NAME>After surgery</NAME><DICH_DATA CI_END="66.4433184667098" CI_START="0.12341968180365896" EFFECT_SIZE="2.8636363636363638" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.8224513148659036" LOG_CI_START="-0.9086155776031525" LOG_EFFECT_SIZE="0.4569178686313755" MODIFIED="2013-11-18 20:56:18 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="719" O_E="0.0" SE="1.6042422116354729" STUDY_ID="STD-White-1984" TOTAL_1="21" TOTAL_2="20" VAR="2.5735930735930737" WEIGHT="16.594827586206897"/></DICH_SUBGROUP></DICH_OUTCOME><DICH_OUTCOME CHI2="1.5282253003044441" CI_END="1.754721448938362" CI_START="0.9052084742356215" CI_STUDY="95" CI_TOTAL="95" DF="3" EFFECT_MEASURE="RR" EFFECT_SIZE="1.2603129474467893" ESTIMABLE="YES" EVENTS_1="77" EVENTS_2="61" I2="0.0" I2_Q="0.0" ID="CMP-003.04" LOG_CI_END="0.2442081847389606" LOG_CI_START="-0.0432513889897993" LOG_EFFECT_SIZE="0.10047839787458064" METHOD="MH" MODIFIED="2017-12-03 02:24:13 +0000" MODIFIED_BY="Hermann Blessberger" NO="4" P_CHI2="0.6757714682629976" P_Q="1.0" P_Z="0.17063427719402982" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="YEAR" STUDIES="4" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="4716" TOTAL_2="4731" WEIGHT="100.0" Z="1.3701686014763685"><NAME>Death due to cardiac causes&#8212;non-cardiac surgery</NAME><GROUP_LABEL_1>Beta-blocker</GROUP_LABEL_1><GROUP_LABEL_2>Control</GROUP_LABEL_2><GRAPH_LABEL_1>Favours beta-blocker</GRAPH_LABEL_1><GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2><DICH_SUBGROUP CHI2="1.5282253003044441" CI_END="1.754721448938362" CI_START="0.9052084742356215" DF="3" EFFECT_SIZE="1.2603129474467893" ESTIMABLE="YES" EVENTS_1="77" EVENTS_2="61" I2="0.0" ID="CMP-003.04.01" LOG_CI_END="0.2442081847389606" LOG_CI_START="-0.0432513889897993" LOG_EFFECT_SIZE="0.10047839787458064" MODIFIED="2017-12-03 02:24:13 +0000" MODIFIED_BY="Hermann Blessberger" NO="1" P_CHI2="0.6757714682629976" P_Z="0.17063427719402982" STUDIES="4" TAU2="0.0" TOTAL_1="4716" TOTAL_2="4731" WEIGHT="100.0" Z="1.3701686014763685"><NAME>Before surgery</NAME><DICH_DATA CI_END="5.535882382109476" CI_START="0.04700299293694875" EFFECT_SIZE="0.51010101010101" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" LOG_CI_END="0.7431868543274104" LOG_CI_START="-1.3278744872851878" LOG_EFFECT_SIZE="-0.2923438164788886" MODIFIED="2013-11-18 20:58:28 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="720" O_E="0.0" SE="1.216551683982222" STUDY_ID="STD-Mangano-1996" TOTAL_1="99" TOTAL_2="101" VAR="1.47999799979998" WEIGHT="3.196659804739338"/><DICH_DATA CI_END="8.274975487492005" CI_START="0.013865780185584986" EFFECT_SIZE="0.33873144399460187" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.9177667159628347" LOG_CI_START="-1.8580556889594146" LOG_EFFECT_SIZE="-0.47014448649829005" MODIFIED="2013-11-18 20:58:42 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="724" O_E="0.0" SE="1.6305318211938382" STUDY_ID="STD-Yang-2006" TOTAL_1="246" TOTAL_2="250" VAR="2.658634019925695" WEIGHT="2.4022604714939044"/><DICH_DATA CI_END="1.8180790761671433" CI_START="0.9210386011859882" EFFECT_SIZE="1.2940328470168365" ESTIMABLE="YES" EVENTS_1="75" EVENTS_2="58" LOG_CI_END="0.2596127686528247" LOG_CI_START="-0.035722167923927406" LOG_EFFECT_SIZE="0.11194530036444864" MODIFIED="2017-12-03 02:24:13 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="722" O_E="0.0" SE="0.17348120367669792" STUDY_ID="STD-POISE-2008" TOTAL_1="4174" TOTAL_2="4177" VAR="0.03009572802911595" WEIGHT="93.6058907176127"/><DICH_DATA CI_END="75.42168546066148" CI_START="0.12667071744568087" EFFECT_SIZE="3.090909090909091" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.8774962334274081" LOG_CI_START="-0.8973237696593477" LOG_EFFECT_SIZE="0.49008623188403005" MODIFIED="2013-11-18 20:59:14 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="721" O_E="0.0" SE="1.6299430053937" STUDY_ID="STD-Marwick-2009" TOTAL_1="197" TOTAL_2="203" VAR="2.6567142008318476" WEIGHT="0.7951890061540642"/></DICH_SUBGROUP><DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-003.04.02" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2017-06-17 15:39:46 +0100" MODIFIED_BY="Hermann Blessberger" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0"><NAME>During surgery</NAME></DICH_SUBGROUP><DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-003.04.03" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2013-11-18 20:57:11 +0000" MODIFIED_BY="Hermann Blessberger" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0"><NAME>After surgery</NAME></DICH_SUBGROUP></DICH_OUTCOME><DICH_OUTCOME CHI2="12.222122050802039" CI_END="1.3066287727035846" CI_START="0.7448934735497141" CI_STUDY="95" CI_TOTAL="95" DF="9" EFFECT_MEASURE="RR" EFFECT_SIZE="0.986559296311769" ESTIMABLE="YES" EVENTS_1="233" EVENTS_2="215" I2="26.36303284658" I2_Q="17.883127101475868" ID="CMP-003.05" LOG_CI_END="0.1161522173688807" LOG_CI_START="-0.12790583081875548" LOG_EFFECT_SIZE="-0.005876806724937442" METHOD="MH" MODIFIED="2017-06-17 15:40:03 +0100" MODIFIED_BY="Hermann Blessberger" NO="5" P_CHI2="0.2010749071223844" P_Q="0.2697975237229935" P_Z="0.9247992944814873" Q="1.2177765235114948" RANDOM="YES" SCALE="100.0" SORT_BY="YEAR" STUDIES="13" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.04175360573490309" TOTALS="YES" TOTAL_1="5805" TOTAL_2="5608" WEIGHT="100.0" Z="0.0943900814622974"><NAME>Long-term mortality&#8212;non-cardiac surgery</NAME><GROUP_LABEL_1>Beta-blocker</GROUP_LABEL_1><GROUP_LABEL_2>Control</GROUP_LABEL_2><GRAPH_LABEL_1>Favours beta-blocker</GRAPH_LABEL_1><GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2><DICH_SUBGROUP CHI2="10.149146358432638" CI_END="1.3972397016373495" CI_START="0.7645907636298446" DF="7" EFFECT_SIZE="1.0335940065851954" ESTIMABLE="YES" EVENTS_1="227" EVENTS_2="204" I2="31.02868209025384" ID="CMP-003.05.01" LOG_CI_END="0.14527091732995084" LOG_CI_START="-0.11657095262724415" LOG_EFFECT_SIZE="0.014349982351353286" MODIFIED="2013-11-26 21:58:54 +0000" MODIFIED_BY="Hermann Blessberger" NO="1" P_CHI2="0.18027791427687756" P_Z="0.8299016245073764" STUDIES="8" TAU2="0.044994963574122415" TOTAL_1="5331" TOTAL_2="5335" WEIGHT="90.55499396601071" Z="0.21482774005575023"><NAME>Before surgery</NAME><DICH_DATA CI_END="1.0730307753136772" CI_START="0.3098783343683285" EFFECT_SIZE="0.5766359244620114" ESTIMABLE="YES" EVENTS_1="13" EVENTS_2="23" LOG_CI_END="0.03061217803048055" LOG_CI_START="-0.5088087870818075" LOG_EFFECT_SIZE="-0.23909830452566347" MODIFIED="2013-11-18 21:02:53 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="728" O_E="0.0" SE="0.3168585450837994" STUDY_ID="STD-Wallace-1998" TOTAL_1="99" TOTAL_2="101" VAR="0.10039933759262215" WEIGHT="14.457913270644218"/><DICH_DATA CI_END="21.785667983536555" CI_START="0.1911775797639689" EFFECT_SIZE="2.0408163265306123" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="1" LOG_CI_END="1.3381708806415864" LOG_CI_START="-0.7185630406986138" LOG_EFFECT_SIZE="0.3098039199714864" MODIFIED="2013-11-18 21:05:30 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="731" O_E="0.0" SE="1.2081356863923414" STUDY_ID="STD-Bayliff-1999" TOTAL_1="49" TOTAL_2="50" VAR="1.4595918367346938" WEIGHT="1.368928740620453"/><DICH_DATA CI_END="23.10618612076079" CI_START="0.2684527492293484" EFFECT_SIZE="2.490566037735849" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="1" LOG_CI_END="1.3637282672706277" LOG_CI_START="-0.571132144060506" LOG_EFFECT_SIZE="0.3962980616050608" MODIFIED="2013-11-18 21:05:36 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="734" O_E="0.0" SE="1.1365465833294115" STUDY_ID="STD-POBBLE-2005" TOTAL_1="53" TOTAL_2="44" VAR="1.2917381360777587" WEIGHT="1.54124308486711"/><DICH_DATA CI_END="1.3750776070230888" CI_START="0.7582504153316847" EFFECT_SIZE="1.021103896103896" ESTIMABLE="YES" EVENTS_1="74" EVENTS_2="72" LOG_CI_END="0.13832720969410692" LOG_CI_START="-0.12018734313242" LOG_EFFECT_SIZE="0.009069933280843453" MODIFIED="2013-11-18 21:03:05 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="727" O_E="0.0" SE="0.1518527279979766" STUDY_ID="STD-DIPOM-_x002d_-Juul-2006" TOTAL_1="462" TOTAL_2="459" VAR="0.02305925100042747" WEIGHT="31.710296834915162"/><DICH_DATA CI_END="2.086100324386569" CI_START="0.006111296108574041" EFFECT_SIZE="0.11291048133153396" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="4" LOG_CI_END="0.3193351906100624" LOG_CI_START="-2.2138666730459673" LOG_EFFECT_SIZE="-0.9472657412179525" MODIFIED="2013-11-18 21:05:45 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="737" O_E="0.0" SE="1.4880153142630121" STUDY_ID="STD-Yang-2006" TOTAL_1="246" TOTAL_2="250" VAR="2.214189575481251" WEIGHT="0.9110313339931763"/><DICH_DATA CI_END="1.7258284961101578" CI_START="1.0262717576233682" EFFECT_SIZE="1.3308527507051506" ESTIMABLE="YES" EVENTS_1="129" EVENTS_2="97" LOG_CI_END="0.23699763558907627" LOG_CI_START="0.011262377548303708" LOG_EFFECT_SIZE="0.12413000656868999" MODIFIED="2013-11-18 21:06:06 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="735" O_E="0.0" SE="0.13259800798069846" STUDY_ID="STD-POISE-2008" TOTAL_1="4174" TOTAL_2="4177" VAR="0.017582231720449374" WEIGHT="34.63732903985106"/><DICH_DATA CI_END="7.99511202377449" CI_START="0.013897380146858233" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.90282455325627" LOG_CI_START="-1.8570670626955947" LOG_EFFECT_SIZE="-0.47712125471966244" MODIFIED="2013-11-18 21:05:53 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="738" O_E="0.0" SE="1.6211739968939571" STUDY_ID="STD-Yang-2008" TOTAL_1="51" TOTAL_2="51" VAR="2.628205128205128" WEIGHT="0.7697628055708834"/><DICH_DATA CI_END="3.986212369346937" CI_START="0.38358505944859494" EFFECT_SIZE="1.2365482233502538" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="5" LOG_CI_END="0.6005604324423948" LOG_CI_START="-0.416138316843905" LOG_EFFECT_SIZE="0.09221105779924482" MODIFIED="2013-11-18 21:06:23 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="733" O_E="0.0" SE="0.5972138780707484" STUDY_ID="STD-Marwick-2009" TOTAL_1="197" TOTAL_2="203" VAR="0.35666441616030276" WEIGHT="5.158488855548663"/></DICH_SUBGROUP><DICH_SUBGROUP CHI2="0.3774722544908355" CI_END="1.4535962540479068" CI_START="0.26692577052590066" DF="1" EFFECT_SIZE="0.6228983064235287" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="11" I2="0.0" ID="CMP-003.05.02" LOG_CI_END="0.16244379511421858" LOG_CI_START="-0.5736094949389532" LOG_EFFECT_SIZE="-0.20558284991236733" MODIFIED="2017-06-17 15:40:03 +0100" MODIFIED_BY="Hermann Blessberger" NO="2" P_CHI2="0.5389594653126322" P_Z="0.273581172527105" STUDIES="5" TAU2="0.0" TOTAL_1="474" TOTAL_2="273" WEIGHT="9.445006033989287" Z="1.0948527426274688"><NAME>During surgery</NAME><DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-11-18 21:06:33 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="741" O_E="0.0" SE="0.0" STUDY_ID="STD-Miller-1990" TOTAL_1="30" TOTAL_2="15" VAR="0.0" WEIGHT="0.0"/><DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-11-18 21:06:40 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="742" O_E="0.0" SE="0.0" STUDY_ID="STD-Miller-1991" TOTAL_1="368" TOTAL_2="180" VAR="0.0" WEIGHT="0.0"/><DICH_DATA CI_END="1.739330050693594" CI_START="0.2772637005998054" EFFECT_SIZE="0.6944444444444444" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="8" LOG_CI_END="0.2403820004008043" LOG_CI_START="-0.5571069845913037" LOG_EFFECT_SIZE="-0.15836249209524966" MODIFIED="2013-11-18 21:03:12 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="729" O_E="0.0" SE="0.4684489774185066" STUDY_ID="STD-Neary-2006" TOTAL_1="18" TOTAL_2="20" VAR="0.2194444444444445" WEIGHT="7.868492603160579"/><DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-11-18 21:06:46 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="740" O_E="0.0" SE="0.0" STUDY_ID="STD-Lai-2006" TOTAL_1="30" TOTAL_2="30" VAR="0.0" WEIGHT="0.0"/><DICH_DATA CI_END="3.0135058276554862" CI_START="0.036871045707436295" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="3" LOG_CI_END="0.4790720356632876" LOG_CI_START="-1.4333145451026126" LOG_EFFECT_SIZE="-0.47712125471966244" MODIFIED="2013-11-18 21:06:55 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="739" O_E="0.0" SE="1.1233453440081378" STUDY_ID="STD-Kawaguchi-2010" TOTAL_1="28" TOTAL_2="28" VAR="1.2619047619047616" WEIGHT="1.576513430828709"/></DICH_SUBGROUP><DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-003.05.03" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2013-11-18 21:00:28 +0000" MODIFIED_BY="Hermann Blessberger" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0"><NAME>After surgery</NAME></DICH_SUBGROUP></DICH_OUTCOME><DICH_OUTCOME CHI2="9.818496620370027" CI_END="1.5111088814762033" CI_START="0.7119610516323913" CI_STUDY="95" CI_TOTAL="95" DF="19" EFFECT_MEASURE="RR" EFFECT_SIZE="1.0372322152665931" ESTIMABLE="YES" EVENTS_1="50" EVENTS_2="51" I2="0.0" I2_Q="0.0" ID="CMP-003.06" LOG_CI_END="0.17929575813165266" LOG_CI_START="-0.14754376412128795" LOG_EFFECT_SIZE="0.015875997005182357" METHOD="MH" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" NO="6" P_CHI2="0.957281848961746" P_Q="0.7388376820094325" P_Z="0.8489896572397033" Q="0.6053541511966751" RANDOM="NO" SCALE="100.0" SORT_BY="YEAR" STUDIES="22" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="1751" TOTAL_2="1802" WEIGHT="100.00000000000001" Z="0.19040770916769525"><NAME>Acute myocardial infarction&#8212;cardiac surgery</NAME><GROUP_LABEL_1>Beta-blocker</GROUP_LABEL_1><GROUP_LABEL_2>Control</GROUP_LABEL_2><GRAPH_LABEL_1>Favours beta-blocker</GRAPH_LABEL_1><GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2><DICH_SUBGROUP CHI2="2.82926871066224" CI_END="1.9125613115942552" CI_START="0.339561155063884" DF="4" EFFECT_SIZE="0.805873146404223" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="12" I2="0.0" ID="CMP-003.06.01" LOG_CI_END="0.28161536636696627" LOG_CI_START="-0.469081997775314" LOG_EFFECT_SIZE="-0.09373331570417386" MODIFIED="2014-06-22 17:24:53 +0100" MODIFIED_BY="Hermann Blessberger" NO="1" P_CHI2="0.5867910863481312" P_Z="0.6245240697158466" STUDIES="5" TAU2="0.0" TOTAL_1="214" TOTAL_2="236" WEIGHT="22.393260936785975" Z="0.4894486958579063"><NAME>Before surgery</NAME><DICH_DATA CI_END="3.5279536888293985" CI_START="0.011338017312033452" EFFECT_SIZE="0.2" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="4" LOG_CI_END="0.5475228755476929" LOG_CI_START="-1.9454628842197306" LOG_EFFECT_SIZE="-0.6989700043360187" MODIFIED="2013-11-18 21:11:13 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="747" O_E="0.0" SE="1.46439217576592" STUDY_ID="STD-Oka-1980" TOTAL_1="19" TOTAL_2="35" VAR="2.144444444444445" WEIGHT="6.255167192730358"/><DICH_DATA CI_END="6.823446325509919" CI_START="0.14655350863704047" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="2" LOG_CI_END="0.8340037796584007" LOG_CI_START="-0.8340037796584007" LOG_EFFECT_SIZE="0.0" MODIFIED="2014-06-22 17:24:53 +0100" MODIFIED_BY="Hermann Blessberger" ORDER="743" O_E="0.0" SE="0.9797958971132712" STUDY_ID="STD-Abel-1983" TOTAL_1="50" TOTAL_2="50" VAR="0.96" WEIGHT="3.892104031032223"/><DICH_DATA CI_END="18.464793725803222" CI_START="0.08462049580421353" EFFECT_SIZE="1.25" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.2663444604166862" LOG_CI_START="-1.0725244344005735" LOG_EFFECT_SIZE="0.09691001300805642" MODIFIED="2013-11-18 21:11:30 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="746" O_E="0.0" SE="1.3738631664034087" STUDY_ID="STD-Myhre-1984" TOTAL_1="16" TOTAL_2="20" VAR="1.8875" WEIGHT="1.7298240137920988"/><DICH_DATA CI_END="4.283442722425353" CI_START="0.010892173194178404" EFFECT_SIZE="0.216" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" LOG_CI_END="0.6317929639528874" LOG_CI_START="-1.9628854616510256" LOG_EFFECT_SIZE="-0.6655462488490691" MODIFIED="2013-11-18 21:11:24 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="745" O_E="0.0" SE="1.5241269510650886" STUDY_ID="STD-Hammon-1984" TOTAL_1="24" TOTAL_2="26" VAR="2.3229629629629627" WEIGHT="4.6780096526829595"/><DICH_DATA CI_END="6.7963699605826395" CI_START="0.40871491603433024" EFFECT_SIZE="1.6666666666666667" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="3" LOG_CI_END="0.8322770116723457" LOG_CI_START="-0.3885795124396329" LOG_EFFECT_SIZE="0.2218487496163564" MODIFIED="2013-11-18 21:11:38 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="744" O_E="0.0" SE="0.7171371656006362" STUDY_ID="STD-Ali-1997" TOTAL_1="105" TOTAL_2="105" VAR="0.5142857142857143" WEIGHT="5.838156046548335"/></DICH_SUBGROUP><DICH_SUBGROUP CHI2="0.16311603905786654" CI_END="12.646854698467722" CI_START="0.23374118842321007" DF="1" EFFECT_SIZE="1.7193286035646307" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="1" I2="0.0" ID="CMP-003.06.02" LOG_CI_END="1.1019825289152074" LOG_CI_START="-0.6312647521829635" LOG_EFFECT_SIZE="0.23535888836612193" MODIFIED="2013-11-18 21:11:53 +0000" MODIFIED_BY="Hermann Blessberger" NO="2" P_CHI2="0.6863039351892237" P_Z="0.5945252816270621" STUDIES="2" TAU2="0.0" TOTAL_1="100" TOTAL_2="71" WEIGHT="3.1196212476193086" Z="0.532289823465593"><NAME>During surgery</NAME><DICH_DATA CI_END="17.222250445333504" CI_START="0.07299374868245567" EFFECT_SIZE="1.121212121212121" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.2360899004353734" LOG_CI_START="-1.1367143320571584" LOG_EFFECT_SIZE="0.04968778418910748" MODIFIED="2013-11-18 21:11:46 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="748" O_E="0.0" SE="1.393796951736494" STUDY_ID="STD-Babin_x002d_Ebell-1996" TOTAL_1="33" TOTAL_2="37" VAR="1.9426699426699428" WEIGHT="1.834849043200905"/><DICH_DATA CI_END="52.1508617241787" CI_START="0.1269979711600307" EFFECT_SIZE="2.573529411764706" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="0" LOG_CI_END="1.717261488965115" LOG_CI_START="-0.8962032170049987" LOG_EFFECT_SIZE="0.41052913598005814" MODIFIED="2013-11-18 21:11:53 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="749" O_E="0.0" SE="1.5351621051457824" STUDY_ID="STD-Sezai-2012" TOTAL_1="67" TOTAL_2="34" VAR="2.3567226890756303" WEIGHT="1.2847722044184038"/></DICH_SUBGROUP><DICH_SUBGROUP CHI2="6.627350587662624" CI_END="1.655575061550545" CI_START="0.7022071355194612" DF="12" EFFECT_SIZE="1.0782191899650386" ESTIMABLE="YES" EVENTS_1="39" EVENTS_2="38" I2="0.0" ID="CMP-003.06.03" LOG_CI_END="0.21894887586320064" LOG_CI_START="-0.153534761739106" LOG_EFFECT_SIZE="0.03270705706204736" MODIFIED="2013-11-18 21:13:48 +0000" MODIFIED_BY="Hermann Blessberger" NO="3" P_CHI2="0.8812260926096496" P_Z="0.7306949952287496" STUDIES="15" TAU2="0.0" TOTAL_1="1437" TOTAL_2="1495" WEIGHT="74.48711781559473" Z="0.34420118045750253"><NAME>After surgery</NAME><DICH_DATA CI_END="3.8257633571979164" CI_START="0.22994486153744298" EFFECT_SIZE="0.9379310344827586" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="5" LOG_CI_END="0.5827181032130841" LOG_CI_START="-0.6383762909425988" LOG_EFFECT_SIZE="-0.027829093864757383" MODIFIED="2013-11-18 21:12:00 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="762" O_E="0.0" SE="0.717276891641784" STUDY_ID="STD-Stephenson-1980" TOTAL_1="87" TOTAL_2="136" VAR="0.5144861392832996" WEIGHT="7.592220867708597"/><DICH_DATA CI_END="5.214575411505864" CI_START="0.012754575404951726" EFFECT_SIZE="0.2578947368421053" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" LOG_CI_END="0.7172189524659107" LOG_CI_START="-1.8943339943145414" LOG_EFFECT_SIZE="-0.5885575209243152" MODIFIED="2013-11-18 21:12:06 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="760" O_E="0.0" SE="1.5340391283344144" STUDY_ID="STD-Mohr-1981" TOTAL_1="37" TOTAL_2="48" VAR="2.35327604726101" WEIGHT="4.249998654575416"/><DICH_DATA CI_END="2.554588535140364" CI_START="0.2718419952535674" EFFECT_SIZE="0.8333333333333334" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="6" LOG_CI_END="0.4073209587531089" LOG_CI_START="-0.5656834508483586" LOG_EFFECT_SIZE="-0.0791812460476248" MODIFIED="2013-11-18 21:12:12 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="761" O_E="0.0" SE="0.5715476066494082" STUDY_ID="STD-Silverman-1982" TOTAL_1="50" TOTAL_2="50" VAR="0.32666666666666666" WEIGHT="11.67631209309667"/><DICH_DATA CI_END="2.8734486028922372" CI_START="0.22272888380735792" EFFECT_SIZE="0.8" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="5" LOG_CI_END="0.45840343335420675" LOG_CI_START="-0.6522234593703196" LOG_EFFECT_SIZE="-0.09691001300805639" MODIFIED="2013-11-18 21:12:20 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="758" O_E="0.0" SE="0.6523877344781713" STUDY_ID="STD-Matangi-1985" TOTAL_1="82" TOTAL_2="82" VAR="0.42560975609756097" WEIGHT="9.730260077580557"/><DICH_DATA CI_END="15.548273108710726" CI_START="0.06431582420814068" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.1916821605007981" LOG_CI_START="-1.1916821605007981" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-11-18 21:12:28 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="752" O_E="0.0" SE="1.4" STUDY_ID="STD-Daudon-1986" TOTAL_1="50" TOTAL_2="50" VAR="1.96" WEIGHT="1.9460520155161114"/><DICH_DATA CI_END="8.873814181503294" CI_START="0.015231822201475684" EFFECT_SIZE="0.36764705882352944" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.9481103303087892" LOG_CI_START="-1.8172481383771868" LOG_EFFECT_SIZE="-0.4345689040341987" MODIFIED="2013-11-18 21:12:34 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="756" O_E="0.0" SE="1.6243852532513314" STUDY_ID="STD-Khuri-1987" TOTAL_1="67" TOTAL_2="74" VAR="2.638627450980392" WEIGHT="2.7761860920649424"/><DICH_DATA CI_END="24.14022199893455" CI_START="0.21642260771872576" EFFECT_SIZE="2.2857142857142856" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="1" LOG_CI_END="1.3827412596498534" LOG_CI_START="-0.6646973743665175" LOG_EFFECT_SIZE="0.3590219426416679" MODIFIED="2013-11-18 21:12:40 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="757" O_E="0.0" SE="1.2026755886059097" STUDY_ID="STD-Martinussen-1988" TOTAL_1="35" TOTAL_2="40" VAR="1.4464285714285716" WEIGHT="1.816315214481704"/><DICH_DATA CI_END="5.525756215095862" CI_START="0.3217256984521052" EFFECT_SIZE="1.3333333333333333" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="3" LOG_CI_END="0.7423917208312917" LOG_CI_START="-0.4925142476146918" LOG_EFFECT_SIZE="0.12493873660829993" MODIFIED="2013-11-18 21:12:47 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="759" O_E="0.0" SE="0.7253898787483019" STUDY_ID="STD-Matangi-1989" TOTAL_1="35" TOTAL_2="35" VAR="0.5261904761904761" WEIGHT="5.838156046548335"/><DICH_DATA CI_END="15.840228937301898" CI_START="0.06313040070053004" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.199761454115117" LOG_CI_START="-1.199761454115117" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-11-18 21:12:53 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="763" O_E="0.0" SE="1.4094916341243984" STUDY_ID="STD-Suttorp-1991" TOTAL_1="150" TOTAL_2="150" VAR="1.9866666666666668" WEIGHT="1.9460520155161114"/><DICH_DATA CI_END="6.907791933318855" CI_START="0.013028765323097881" EFFECT_SIZE="0.3" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.8393392478918953" LOG_CI_START="-1.8850967384525705" LOG_EFFECT_SIZE="-0.5228787452803376" MODIFIED="2013-11-18 21:12:59 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="755" O_E="0.0" SE="1.600347184554374" STUDY_ID="STD-Jacquet-1994" TOTAL_1="19" TOTAL_2="17" VAR="2.5611111111111113" WEIGHT="3.0727137087096494"/><DICH_DATA CI_END="6.429716840797003" CI_START="0.6221113773813055" EFFECT_SIZE="2.0" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="4" LOG_CI_END="0.8081918473896704" LOG_CI_START="-0.20613185606170806" LOG_EFFECT_SIZE="0.3010299956639812" MODIFIED="2013-11-18 21:13:07 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="764" O_E="0.0" SE="0.5958187643906492" STUDY_ID="STD-Wenke-1999" TOTAL_1="100" TOTAL_2="100" VAR="0.355" WEIGHT="7.784208062064446"/><DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-11-18 21:13:18 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="753" O_E="0.0" SE="0.0" STUDY_ID="STD-Evrard-2000" TOTAL_1="103" TOTAL_2="103" VAR="0.0" WEIGHT="0.0"/><DICH_DATA CI_END="2.6378743799535904" CI_START="0.03008078627713564" EFFECT_SIZE="0.28169014084507044" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="3" LOG_CI_END="0.4212541098638801" LOG_CI_START="-1.5217108159740682" LOG_EFFECT_SIZE="-0.5502283530550941" MODIFIED="2013-11-18 21:13:27 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="750" O_E="0.0" SE="1.141307215268708" STUDY_ID="STD-Bert-2001" TOTAL_1="71" TOTAL_2="60" VAR="1.3025821596244131" WEIGHT="6.328382890151629"/><DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-11-18 21:13:33 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="754" O_E="0.0" SE="0.0" STUDY_ID="STD-Forlani-2002" TOTAL_1="51" TOTAL_2="50" VAR="0.0" WEIGHT="0.0"/><DICH_DATA CI_END="5.80943240846048" CI_START="0.6885354228710294" EFFECT_SIZE="2.0" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="5" LOG_CI_END="0.7641337031450597" LOG_CI_START="-0.16207371181709732" LOG_EFFECT_SIZE="0.3010299956639812" MODIFIED="2013-11-18 21:13:48 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="751" O_E="0.0" SE="0.5440588203494178" STUDY_ID="STD-Connolly-2003" TOTAL_1="500" TOTAL_2="500" VAR="0.29600000000000004" WEIGHT="9.730260077580557"/></DICH_SUBGROUP></DICH_OUTCOME><DICH_OUTCOME CHI2="6.269793019097788" CI_END="0.8777760704007815" CI_START="0.6113724854812779" CI_STUDY="95" CI_TOTAL="95" DF="10" EFFECT_MEASURE="RR" EFFECT_SIZE="0.732562719401496" ESTIMABLE="YES" EVENTS_1="194" EVENTS_2="266" I2="0.0" I2_Q="0.0" ID="CMP-003.07" LOG_CI_END="-0.05661626290156223" LOG_CI_START="-0.21369411038019123" LOG_EFFECT_SIZE="-0.13515518664087675" METHOD="MH" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" NO="7" P_CHI2="0.7921099759304913" P_Q="0.49549368957408957" P_Z="7.439691406071839E-4" Q="1.404401567462783" RANDOM="YES" SCALE="100.0" SORT_BY="YEAR" STUDIES="14" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="5522" TOTAL_2="5436" WEIGHT="100.00000000000003" Z="3.372840949783806"><NAME>Acute myocardial infarction&#8212;non-cardiac surgery</NAME><GROUP_LABEL_1>Beta-blocker</GROUP_LABEL_1><GROUP_LABEL_2>Control</GROUP_LABEL_2><GRAPH_LABEL_1>Favours beta-blocker</GRAPH_LABEL_1><GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2><DICH_SUBGROUP CHI2="3.151430270673578" CI_END="0.8942192618863581" CI_START="0.6204917184303804" DF="7" EFFECT_SIZE="0.7448863312354528" ESTIMABLE="YES" EVENTS_1="192" EVENTS_2="258" I2="0.0" ID="CMP-003.07.01" LOG_CI_END="-0.048555979468144425" LOG_CI_START="-0.20726401056168806" LOG_EFFECT_SIZE="-0.12790999501491626" MODIFIED="2013-12-07 20:56:23 +0000" MODIFIED_BY="Hermann Blessberger" NO="1" P_CHI2="0.8706492059880855" P_Z="0.0015817704228790785" STUDIES="9" TAU2="0.0" TOTAL_1="5389" TOTAL_2="5341" WEIGHT="97.95623281826286" Z="3.159247604101017"><NAME>Before surgery</NAME><DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-11-20 23:59:36 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="776" O_E="0.0" SE="0.0" STUDY_ID="STD-Stone-1988" TOTAL_1="89" TOTAL_2="39" VAR="0.0" WEIGHT="0.0"/><DICH_DATA CI_END="65.33683949785127" CI_START="0.12362952338910503" EFFECT_SIZE="2.8421052631578947" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.8151581227650624" LOG_CI_START="-0.9078778050247834" LOG_EFFECT_SIZE="0.45364015887013953" MODIFIED="2013-11-20 23:59:45 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="777" O_E="0.0" SE="1.5995247832289885" STUDY_ID="STD-Jakobsen-1997" TOTAL_1="18" TOTAL_2="17" VAR="2.5584795321637426" WEIGHT="0.332753888764328"/><DICH_DATA CI_END="5.535882382109476" CI_START="0.04700299293694875" EFFECT_SIZE="0.51010101010101" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" LOG_CI_END="0.7431868543274104" LOG_CI_START="-1.3278744872851878" LOG_EFFECT_SIZE="-0.2923438164788886" MODIFIED="2013-11-20 23:59:55 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="778" O_E="0.0" SE="1.216551683982222" STUDY_ID="STD-Wallace-1998" TOTAL_1="99" TOTAL_2="101" VAR="1.47999799979998" WEIGHT="0.5752332190762975"/><DICH_DATA CI_END="1.9689060372965594" CI_START="0.1260175766811152" EFFECT_SIZE="0.4981132075471698" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="5" LOG_CI_END="0.29422499066461516" LOG_CI_START="-0.8995688761265311" LOG_EFFECT_SIZE="-0.302671942730958" MODIFIED="2013-11-21 00:00:10 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="780" O_E="0.0" SE="0.7012404267280651" STUDY_ID="STD-POBBLE-2005" TOTAL_1="53" TOTAL_2="44" VAR="0.49173813607775874" WEIGHT="1.7312954826769844"/><DICH_DATA CI_END="8.877109838397404" CI_START="0.250179859646748" EFFECT_SIZE="1.4902597402597402" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="2" LOG_CI_END="0.9482715935329684" LOG_CI_START="-0.6017476554593345" LOG_EFFECT_SIZE="0.17326196903681695" MODIFIED="2013-11-21 00:00:18 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="782" O_E="0.0" SE="0.9104889795771052" STUDY_ID="STD-DIPOM-_x002d_-Juul-2006" TOTAL_1="462" TOTAL_2="459" VAR="0.8289901819313583" WEIGHT="1.0269651344579092"/><DICH_DATA CI_END="1.6671769426996792" CI_START="0.5071036310519903" EFFECT_SIZE="0.9194734804490902" ESTIMABLE="YES" EVENTS_1="19" EVENTS_2="21" LOG_CI_END="0.22198169530492604" LOG_CI_START="-0.29490327972978975" LOG_EFFECT_SIZE="-0.03646079221243184" MODIFIED="2013-11-21 00:00:26 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="781" O_E="0.0" SE="0.3036207929572834" STUDY_ID="STD-Yang-2006" TOTAL_1="246" TOTAL_2="250" VAR="0.09218558591600953" WEIGHT="9.235109862262904"/><DICH_DATA CI_END="15.556810748046935" CI_START="0.06428052742915473" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.1919205684576701" LOG_CI_START="-1.1919205684576701" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-11-21 00:00:37 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="783" O_E="0.0" SE="1.4002800840280099" STUDY_ID="STD-Yang-2008" TOTAL_1="51" TOTAL_2="51" VAR="1.9607843137254903" WEIGHT="0.4341854469622262"/><DICH_DATA CI_END="0.8669144321966489" CI_START="0.5773751446800002" EFFECT_SIZE="0.7074848731349105" ESTIMABLE="YES" EVENTS_1="152" EVENTS_2="215" LOG_CI_END="-0.06202376695142708" LOG_CI_START="-0.23854191591886673" LOG_EFFECT_SIZE="-0.1502828414351469" MODIFIED="2013-12-07 20:56:23 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="784" O_E="0.0" SE="0.10368763448240352" STUDY_ID="STD-POISE-2008" TOTAL_1="4174" TOTAL_2="4177" VAR="0.010751125544556516" WEIGHT="79.18650099686302"/><DICH_DATA CI_END="2.2384256247346914" CI_START="0.47436971491585606" EFFECT_SIZE="1.0304568527918783" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="12" LOG_CI_END="0.34994266883162384" LOG_CI_START="-0.3238830453283838" LOG_EFFECT_SIZE="0.013029811751620029" MODIFIED="2013-11-21 00:00:57 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="785" O_E="0.0" SE="0.3958085599886677" STUDY_ID="STD-Marwick-2009" TOTAL_1="197" TOTAL_2="203" VAR="0.15666441616030274" WEIGHT="5.434188787199185"/></DICH_SUBGROUP><DICH_SUBGROUP CHI2="1.5844910037206845" CI_END="1.992318813386939" CI_START="0.03987607412459969" DF="1" EFFECT_SIZE="0.28186140686949696" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="7" I2="36.88825006567971" ID="CMP-003.07.02" LOG_CI_END="0.29935883600330715" LOG_CI_START="-1.3992876053741683" LOG_EFFECT_SIZE="-0.5499643846854305" MODIFIED="2013-11-21 00:01:53 +0000" MODIFIED_BY="Hermann Blessberger" NO="2" P_CHI2="0.20811503209747018" P_Z="0.20439102928503916" STUDIES="4" TAU2="0.8345854944629196" TOTAL_1="118" TOTAL_2="84" WEIGHT="1.7060439366523084" Z="1.269140370245701"><NAME>During surgery</NAME><DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-11-21 00:01:30 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="788" O_E="0.0" SE="0.0" STUDY_ID="STD-Miller-1990" TOTAL_1="30" TOTAL_2="15" VAR="0.0" WEIGHT="0.0"/><DICH_DATA CI_END="1.2850770513332368" CI_START="0.0037789141856547637" EFFECT_SIZE="0.06968641114982578" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="3" LOG_CI_END="0.10892916810749446" LOG_CI_START="-2.4226329702475167" LOG_EFFECT_SIZE="-1.1568519010700111" MODIFIED="2013-11-21 00:01:36 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="790" O_E="0.0" SE="1.4870521315044227" STUDY_ID="STD-Zaugg-1999" TOTAL_1="40" TOTAL_2="19" VAR="2.2113240418118467" WEIGHT="0.38499288098630535"/><DICH_DATA CI_END="2.6794711630264745" CI_START="0.11518764581889715" EFFECT_SIZE="0.5555555555555556" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="4" LOG_CI_END="0.428049087445737" LOG_CI_START="-0.9385940976523491" LOG_EFFECT_SIZE="-0.25527250510330607" MODIFIED="2013-11-21 00:01:53 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="789" O_E="0.0" SE="0.8027729719194864" STUDY_ID="STD-Neary-2006" TOTAL_1="18" TOTAL_2="20" VAR="0.6444444444444444" WEIGHT="1.321051055666003"/><DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-11-21 00:01:43 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="787" O_E="0.0" SE="0.0" STUDY_ID="STD-Lai-2006" TOTAL_1="30" TOTAL_2="30" VAR="0.0" WEIGHT="0.0"/></DICH_SUBGROUP><DICH_SUBGROUP CHI2="0.0" CI_END="5.615700904668708" CI_START="0.011129510111202603" DF="0" EFFECT_SIZE="0.25" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" I2="0.0" ID="CMP-003.07.03" LOG_CI_END="0.7494039689737728" LOG_CI_START="-1.9535239516296976" LOG_EFFECT_SIZE="-0.6020599913279624" MODIFIED="2013-11-21 00:02:09 +0000" MODIFIED_BY="Hermann Blessberger" NO="3" P_CHI2="1.0" P_Z="0.3825873244207372" STUDIES="1" TAU2="0.0" TOTAL_1="15" TOTAL_2="11" WEIGHT="0.33772324508486246" Z="0.8731390064385046"><NAME>After surgery</NAME><DICH_DATA CI_END="5.615700904668708" CI_START="0.011129510111202603" EFFECT_SIZE="0.25" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.7494039689737728" LOG_CI_START="-1.9535239516296976" LOG_EFFECT_SIZE="-0.6020599913279624" MODIFIED="2013-11-21 00:02:09 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="791" O_E="0.0" SE="1.5877132402714706" STUDY_ID="STD-Raby-1999" TOTAL_1="15" TOTAL_2="11" VAR="2.520833333333333" WEIGHT="0.33772324508486246"/></DICH_SUBGROUP></DICH_OUTCOME><DICH_OUTCOME CHI2="3.6717246787512376" CI_END="1.0541696233454452" CI_START="0.2469457452997947" CI_STUDY="95" CI_TOTAL="95" DF="3" EFFECT_MEASURE="RR" EFFECT_SIZE="0.5102182898617461" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="20" I2="18.294527436618502" I2_Q="39.17592521520564" ID="CMP-003.08" LOG_CI_END="0.022910497551937605" LOG_CI_START="-0.6073984520241552" LOG_EFFECT_SIZE="-0.29224397723610884" METHOD="MH" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" NO="8" P_CHI2="0.29916361140303704" P_Q="0.19976586071046465" P_Z="0.0691433007736594" Q="1.6440858386061201" RANDOM="NO" SCALE="100.0" SORT_BY="YEAR" STUDIES="4" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="78" TOTAL_2="88" WEIGHT="100.0" Z="1.8174822695020865"><NAME>Myocardial ischaemia&#8212;cardiac surgery</NAME><GROUP_LABEL_1>Beta-blocker</GROUP_LABEL_1><GROUP_LABEL_2>Control</GROUP_LABEL_2><GRAPH_LABEL_1>Favours beta-blocker</GRAPH_LABEL_1><GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2><DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-003.08.01" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2013-11-21 00:10:55 +0000" MODIFIED_BY="Hermann Blessberger" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0"><NAME>Before surgery</NAME></DICH_SUBGROUP><DICH_SUBGROUP CHI2="2.0166403742455454" CI_END="2.102705659091385" CI_START="0.307561292092478" DF="2" EFFECT_SIZE="0.8041833555852247" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="8" I2="0.8251532825613906" ID="CMP-003.08.02" LOG_CI_END="0.3227784835379686" LOG_CI_START="-0.5120683232543628" LOG_EFFECT_SIZE="-0.09464491985819709" MODIFIED="2013-11-21 00:13:45 +0000" MODIFIED_BY="Hermann Blessberger" NO="2" P_CHI2="0.36483143360915427" P_Z="0.6567574431538399" STUDIES="3" TAU2="0.0" TOTAL_1="47" TOTAL_2="51" WEIGHT="41.88073545373812" Z="0.4443944271751631"><NAME>During surgery</NAME><DICH_DATA CI_END="2.8531415452949767" CI_START="0.03894342756823292" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="3" LOG_CI_END="0.45532331768430767" LOG_CI_START="-1.4095658271236327" LOG_EFFECT_SIZE="-0.47712125471966244" MODIFIED="2013-11-21 00:13:35 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="792" O_E="0.0" SE="1.0954451150103321" STUDY_ID="STD-Harrison-1987" TOTAL_1="15" TOTAL_2="15" VAR="1.2" WEIGHT="15.935927375587935"/><DICH_DATA CI_END="3.004555588665069" CI_START="0.1132539464610019" EFFECT_SIZE="0.5833333333333334" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="3" LOG_CI_END="0.4777802435055779" LOG_CI_START="-0.9459466555723139" LOG_EFFECT_SIZE="-0.23408320603336796" MODIFIED="2013-11-21 00:13:41 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="794" O_E="0.0" SE="0.8363042280801657" STUDY_ID="STD-Reves-1990" TOTAL_1="16" TOTAL_2="14" VAR="0.6994047619047619" WEIGHT="16.998322533960465"/><DICH_DATA CI_END="10.94851618230894" CI_START="0.38853723912594074" EFFECT_SIZE="2.0625" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="2" LOG_CI_END="1.0393552646098279" LOG_CI_START="-0.41056735016590234" LOG_EFFECT_SIZE="0.31439395722196267" MODIFIED="2013-11-21 00:13:45 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="793" O_E="0.0" SE="0.8516917211519599" STUDY_ID="STD-Neustein-1994" TOTAL_1="16" TOTAL_2="22" VAR="0.7253787878787878" WEIGHT="8.946485544189718"/></DICH_SUBGROUP><DICH_SUBGROUP CHI2="0.0" CI_END="0.9630309301159309" CI_START="0.09245275176220336" DF="0" EFFECT_SIZE="0.29838709677419356" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="12" I2="0.0" ID="CMP-003.08.03" LOG_CI_END="-0.016359764211958033" LOG_CI_START="-1.034080157978522" LOG_EFFECT_SIZE="-0.52521996109524" MODIFIED="2013-11-21 00:13:55 +0000" MODIFIED_BY="Hermann Blessberger" NO="3" P_CHI2="1.0" P_Z="0.04307557293396961" STUDIES="1" TAU2="0.0" TOTAL_1="31" TOTAL_2="37" WEIGHT="58.11926454626188" Z="2.022976475686733"><NAME>After surgery</NAME><DICH_DATA CI_END="0.9630309301159309" CI_START="0.09245275176220336" EFFECT_SIZE="0.29838709677419356" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="12" LOG_CI_END="-0.016359764211958033" LOG_CI_START="-1.034080157978522" LOG_EFFECT_SIZE="-0.52521996109524" MODIFIED="2013-11-21 00:13:55 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="795" O_E="0.0" SE="0.5978139970956774" STUDY_ID="STD-Kurian-2001" TOTAL_1="31" TOTAL_2="37" VAR="0.3573815751235106" WEIGHT="58.11926454626188"/></DICH_SUBGROUP></DICH_OUTCOME><DICH_OUTCOME CHI2="12.456008542791606" CI_END="0.7685836416244642" CI_START="0.3422559620050429" CI_STUDY="95" CI_TOTAL="95" DF="9" EFFECT_MEASURE="RR" EFFECT_SIZE="0.5128862774977706" ESTIMABLE="YES" EVENTS_1="60" EVENTS_2="97" I2="27.74571429458136" I2_Q="0.0" ID="CMP-003.09" LOG_CI_END="-0.11430886320738608" LOG_CI_START="-0.465648977837248" LOG_EFFECT_SIZE="-0.28997892052231705" METHOD="MH" MODIFIED="2017-06-17 15:40:21 +0100" MODIFIED_BY="Hermann Blessberger" NO="9" P_CHI2="0.1888049672638734" P_Q="0.9545434863153655" P_Z="0.0012150794633561967" Q="0.09304415884503722" RANDOM="YES" SCALE="100.0" SORT_BY="YEAR" STUDIES="14" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0980084604302664" TOTALS="YES" TOTAL_1="552" TOTAL_2="426" WEIGHT="100.0" Z="3.2353165313804326"><NAME>Myocardial ischaemia&#8212;non-cardiac surgery</NAME><GROUP_LABEL_1>Beta-blocker</GROUP_LABEL_1><GROUP_LABEL_2>Control</GROUP_LABEL_2><GRAPH_LABEL_1>Favours beta-blocker</GRAPH_LABEL_1><GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2><DICH_SUBGROUP CHI2="9.382453634128012" CI_END="1.0083701725880907" CI_START="0.22959848936773591" DF="3" EFFECT_SIZE="0.4811655311321757" ESTIMABLE="YES" EVENTS_1="49" EVENTS_2="76" I2="68.02542152632962" ID="CMP-003.09.01" LOG_CI_END="0.0036199908402011196" LOG_CI_START="-0.639030973684407" LOG_EFFECT_SIZE="-0.31770549142210297" MODIFIED="2013-11-21 00:17:42 +0000" MODIFIED_BY="Hermann Blessberger" NO="1" P_CHI2="0.02461536422165056" P_Z="0.05263744858357842" STUDIES="4" TAU2="0.3202607920229953" TOTAL_1="290" TOTAL_2="234" WEIGHT="64.420625459692" Z="1.9378834087288674"><NAME>Before surgery</NAME><DICH_DATA CI_END="0.34268065818180543" CI_START="0.018523976842803526" EFFECT_SIZE="0.07967313585291114" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="11" LOG_CI_END="-0.46511040762723255" LOG_CI_START="-1.7322657705980822" LOG_EFFECT_SIZE="-1.0986880891126574" MODIFIED="2013-11-21 00:17:14 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="798" O_E="0.0" SE="0.7443333327292857" STUDY_ID="STD-Stone-1988" TOTAL_1="89" TOTAL_2="39" VAR="0.5540321102118855" WEIGHT="6.532148698712455"/><DICH_DATA CI_END="0.963432747451777" CI_START="0.4699791874804524" EFFECT_SIZE="0.6728992048140985" ESTIMABLE="YES" EVENTS_1="31" EVENTS_2="47" LOG_CI_END="-0.016178595933257885" LOG_CI_START="-0.3279213738994463" LOG_EFFECT_SIZE="-0.1720499849163521" MODIFIED="2013-11-21 00:17:22 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="799" O_E="0.0" SE="0.18311925092897763" STUDY_ID="STD-Wallace-1998" TOTAL_1="99" TOTAL_2="101" VAR="0.03353266006078988" WEIGHT="32.379425909766766"/><DICH_DATA CI_END="3.1588374622614523" CI_START="0.03662503591899996" EFFECT_SIZE="0.3401360544217687" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="3" LOG_CI_END="0.49952727989090295" LOG_CI_START="-1.4362219407152177" LOG_EFFECT_SIZE="-0.4683473304121573" MODIFIED="2013-11-21 00:17:31 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="796" O_E="0.0" SE="1.1370686742972156" STUDY_ID="STD-Bayliff-1999" TOTAL_1="49" TOTAL_2="50" VAR="1.292925170068027" WEIGHT="3.062134577551351"/><DICH_DATA CI_END="1.5031119175990921" CI_START="0.4585242356722858" EFFECT_SIZE="0.8301886792452831" ESTIMABLE="YES" EVENTS_1="15" EVENTS_2="15" LOG_CI_END="0.1769913181691861" LOG_CI_START="-0.33863770439838925" LOG_EFFECT_SIZE="-0.0808231931146016" MODIFIED="2013-11-21 00:17:42 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="797" O_E="0.0" SE="0.3028830402610201" STUDY_ID="STD-POBBLE-2005" TOTAL_1="53" TOTAL_2="44" VAR="0.09173813607775871" WEIGHT="22.446916273661436"/></DICH_SUBGROUP><DICH_SUBGROUP CHI2="1.731956668980784" CI_END="0.9454667556448907" CI_START="0.17339814830743439" DF="4" EFFECT_SIZE="0.40489774599898876" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="13" I2="0.0" ID="CMP-003.09.02" LOG_CI_END="-0.024353737145547484" LOG_CI_START="-0.7609555446000466" LOG_EFFECT_SIZE="-0.39265464087279695" MODIFIED="2017-06-17 15:40:21 +0100" MODIFIED_BY="Hermann Blessberger" NO="2" P_CHI2="0.7849048295394727" P_Z="0.03665682580432222" STUDIES="9" TAU2="0.0" TOTAL_1="247" TOTAL_2="181" WEIGHT="19.533024865895563" Z="2.0895657509521652"><NAME>During surgery</NAME><DICH_DATA CI_END="1.2469987885761085" CI_START="0.0982358612712665" EFFECT_SIZE="0.35" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="5" LOG_CI_END="0.09586603157399819" LOG_CI_START="-1.007729942873447" LOG_EFFECT_SIZE="-0.4559319556497244" MODIFIED="2013-11-21 00:17:50 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="800" O_E="0.0" SE="0.6482577382786072" STUDY_ID="STD-Coleman-1980" TOTAL_1="24" TOTAL_2="14" VAR="0.4202380952380952" WEIGHT="8.218532122292466"/><DICH_DATA CI_END="66.61522199816511" CI_START="0.11922423317225214" EFFECT_SIZE="2.8181818181818183" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.8235734795372827" LOG_CI_START="-0.9236354621851873" LOG_EFFECT_SIZE="0.44996900867604767" MODIFIED="2013-11-21 00:18:04 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="801" O_E="0.0" SE="1.6137241312713606" STUDY_ID="STD-Cucchiara-1986" TOTAL_1="32" TOTAL_2="30" VAR="2.6041055718475072" WEIGHT="1.5762569285195942"/><DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-11-21 00:17:57 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="804" O_E="0.0" SE="0.0" STUDY_ID="STD-Liu-1986" TOTAL_1="16" TOTAL_2="14" VAR="0.0" WEIGHT="0.0"/><DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-11-21 00:18:31 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="807" O_E="0.0" SE="0.0" STUDY_ID="STD-Oxorn-1990" TOTAL_1="32" TOTAL_2="16" VAR="0.0" WEIGHT="0.0"/><DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-11-21 00:18:11 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="806" O_E="0.0" SE="0.0" STUDY_ID="STD-Miller-1990" TOTAL_1="30" TOTAL_2="15" VAR="0.0" WEIGHT="0.0"/><DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-11-21 00:18:37 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="809" O_E="0.0" SE="0.0" STUDY_ID="STD-Zaugg-1999" TOTAL_1="40" TOTAL_2="19" VAR="0.0" WEIGHT="0.0"/><DICH_DATA CI_END="3.9981665126016623" CI_START="0.010004585820506876" EFFECT_SIZE="0.2" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" LOG_CI_END="0.6018608773254143" LOG_CI_START="-1.9998008859974516" LOG_EFFECT_SIZE="-0.6989700043360187" MODIFIED="2013-11-21 00:18:54 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="803" O_E="0.0" SE="1.5282289982092807" STUDY_ID="STD-Lai-2006" TOTAL_1="30" TOTAL_2="30" VAR="2.335483870967742" WEIGHT="1.750252470522885"/><DICH_DATA CI_END="1.7491265621242627" CI_START="0.09147422688823888" EFFECT_SIZE="0.4" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="5" LOG_CI_END="0.24282123500387298" LOG_CI_START="-1.038701252347948" LOG_EFFECT_SIZE="-0.3979400086720376" MODIFIED="2013-11-21 00:18:48 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="805" O_E="0.0" SE="0.752772652709081" STUDY_ID="STD-Liu-2006" TOTAL_1="15" TOTAL_2="15" VAR="0.5666666666666667" WEIGHT="6.407981570832444"/><DICH_DATA CI_END="7.848616069043482" CI_START="0.014156777466712338" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.8947930852084158" LOG_CI_START="-1.8490355946477406" LOG_EFFECT_SIZE="-0.47712125471966244" MODIFIED="2013-11-21 00:19:07 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="802" O_E="0.0" SE="1.611738548718522" STUDY_ID="STD-Kawaguchi-2010" TOTAL_1="28" TOTAL_2="28" VAR="2.5977011494252875" WEIGHT="1.580001773728174"/></DICH_SUBGROUP><DICH_SUBGROUP CHI2="7.362106864336365E-32" CI_END="1.0220494272138163" CI_START="0.20553746115499485" DF="0" EFFECT_SIZE="0.45833333333333337" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="8" I2="100.0" ID="CMP-003.09.03" LOG_CI_END="0.00947189917164046" LOG_CI_START="-0.6871090122784023" LOG_EFFECT_SIZE="-0.33881855655338095" MODIFIED="2013-11-21 00:19:15 +0000" MODIFIED_BY="Hermann Blessberger" NO="3" P_CHI2="0.0" P_Z="0.056564374045462974" STUDIES="1" TAU2="0.0" TOTAL_1="15" TOTAL_2="11" WEIGHT="16.046349674412433" Z="1.9066619748626288"><NAME>After surgery</NAME><DICH_DATA CI_END="1.022049427213816" CI_START="0.20553746115499483" EFFECT_SIZE="0.4583333333333333" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="8" LOG_CI_END="0.009471899171640366" LOG_CI_START="-0.6871090122784024" LOG_EFFECT_SIZE="-0.338818556553381" MODIFIED="2013-11-21 00:19:15 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="810" O_E="0.0" SE="0.40917507551687754" STUDY_ID="STD-Raby-1999" TOTAL_1="15" TOTAL_2="11" VAR="0.16742424242424245" WEIGHT="16.046349674412433"/></DICH_SUBGROUP></DICH_OUTCOME><DICH_OUTCOME CHI2="2.426010540963305" CI_END="4.019042421238696" CI_START="0.5761795319350466" CI_STUDY="95" CI_TOTAL="95" DF="3" EFFECT_MEASURE="RR" EFFECT_SIZE="1.5217391304347827" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="5" I2="0.0" I2_Q="16.81812121458156" ID="CMP-003.10" LOG_CI_END="0.6041225902210599" LOG_CI_START="-0.23944217355569433" LOG_EFFECT_SIZE="0.18234020833268277" METHOD="MH" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" NO="10" P_CHI2="0.48881134724772024" P_Q="0.30053690949027423" P_Z="0.3968226120515944" Q="2.404369832952841" RANDOM="NO" SCALE="100.0" SORT_BY="YEAR" STUDIES="4" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="730" TOTAL_2="670" WEIGHT="100.0" Z="0.8473095525364256"><NAME>Cerebrovascular events&#8212;cardiac surgery</NAME><GROUP_LABEL_1>Beta-blocker</GROUP_LABEL_1><GROUP_LABEL_2>Control</GROUP_LABEL_2><GRAPH_LABEL_1>Favours beta-blocker</GRAPH_LABEL_1><GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2><DICH_SUBGROUP CHI2="0.0" CI_END="4.226958759183164" CI_START="0.007212341146048458" DF="0" EFFECT_SIZE="0.1746031746031746" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" I2="0.0" ID="CMP-003.10.01" LOG_CI_END="0.6260280106048517" LOG_CI_START="-2.141923739195565" LOG_EFFECT_SIZE="-0.7579478642953567" MODIFIED="2013-11-21 00:23:04 +0000" MODIFIED_BY="Hermann Blessberger" NO="1" P_CHI2="1.0" P_Z="0.28309467815903855" STUDIES="1" TAU2="0.0" TOTAL_1="125" TOTAL_2="65" WEIGHT="30.434782608695652" Z="1.0733933611993542"><NAME>Before surgery</NAME><DICH_DATA CI_END="4.226958759183164" CI_START="0.007212341146048458" EFFECT_SIZE="0.1746031746031746" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.6260280106048517" LOG_CI_START="-2.141923739195565" LOG_EFFECT_SIZE="-0.7579478642953567" MODIFIED="2013-11-21 00:23:04 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="811" O_E="0.0" SE="1.6259085594149025" STUDY_ID="STD-Auer-2004" TOTAL_1="125" TOTAL_2="65" VAR="2.6435786435786435" WEIGHT="30.434782608695652"/></DICH_SUBGROUP><DICH_SUBGROUP CHI2="0.0" CI_END="15.672973621805108" CI_START="0.06380410151451699" DF="0" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" I2="0.0" ID="CMP-003.10.02" LOG_CI_END="1.1951514026602095" LOG_CI_START="-1.1951514026602095" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-11-21 00:23:11 +0000" MODIFIED_BY="Hermann Blessberger" NO="2" P_CHI2="1.0" P_Z="1.0" STUDIES="1" TAU2="0.0" TOTAL_1="70" TOTAL_2="70" WEIGHT="15.458937198067632" Z="0.0"><NAME>During surgery</NAME><DICH_DATA CI_END="15.672973621805108" CI_START="0.06380410151451699" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.1951514026602095" LOG_CI_START="-1.1951514026602095" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-11-21 00:23:11 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="812" O_E="0.0" SE="1.4040757000349275" STUDY_ID="STD-Sezai-2011" TOTAL_1="70" TOTAL_2="70" VAR="1.9714285714285715" WEIGHT="15.458937198067632"/></DICH_SUBGROUP><DICH_SUBGROUP CHI2="0.020489954089139218" CI_END="8.377551811287054" CI_START="0.7040194219661124" DF="1" EFFECT_SIZE="2.4285714285714284" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="3" I2="0.0" ID="CMP-003.10.03" LOG_CI_END="0.9231171224263168" LOG_CI_START="-0.1524153596982826" LOG_EFFECT_SIZE="0.3853508813640171" MODIFIED="2013-11-21 00:23:24 +0000" MODIFIED_BY="Hermann Blessberger" NO="3" P_CHI2="0.8861771564677654" P_Z="0.16018043515943572" STUDIES="2" TAU2="0.0" TOTAL_1="535" TOTAL_2="535" WEIGHT="54.106280193236714" Z="1.404464972349841"><NAME>After surgery</NAME><DICH_DATA CI_END="71.21510406800243" CI_START="0.12637768515238015" EFFECT_SIZE="3.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.85257211326778" LOG_CI_START="-0.8983296038284552" LOG_EFFECT_SIZE="0.47712125471966244" MODIFIED="2013-11-21 00:23:17 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="814" O_E="0.0" SE="1.6158932858054431" STUDY_ID="STD-Matangi-1989" TOTAL_1="35" TOTAL_2="35" VAR="2.611111111111111" WEIGHT="7.729468599033816"/><DICH_DATA CI_END="8.972003519367153" CI_START="0.6068259372270592" EFFECT_SIZE="2.3333333333333335" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="3" LOG_CI_END="0.9528894352677552" LOG_CI_START="-0.21693586467856624" LOG_EFFECT_SIZE="0.36797678529459443" MODIFIED="2013-11-21 00:23:24 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="813" O_E="0.0" SE="0.6871611719170956" STUDY_ID="STD-Connolly-2003" TOTAL_1="500" TOTAL_2="500" VAR="0.47219047619047616" WEIGHT="46.3768115942029"/></DICH_SUBGROUP></DICH_OUTCOME><DICH_OUTCOME CHI2="7.355265795537194" CI_END="0.6310702168459981" CI_START="0.25126224628297683" CI_STUDY="95" CI_TOTAL="95" DF="9" EFFECT_MEASURE="RR" EFFECT_SIZE="0.39820110528100094" ESTIMABLE="YES" EVENTS_1="22" EVENTS_2="62" I2="0.0" I2_Q="28.003096022697083" ID="CMP-003.11" LOG_CI_END="-0.19992231572865557" LOG_CI_START="-0.5998727619554969" LOG_EFFECT_SIZE="-0.3998975388420762" METHOD="MH" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" NO="11" P_CHI2="0.6001835178731716" P_Q="0.24933757845391813" P_Z="8.87662131043575E-5" Q="2.7778972282342886" RANDOM="YES" SCALE="100.0" SORT_BY="YEAR" STUDIES="12" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="1143" TOTAL_2="1149" WEIGHT="100.0" Z="3.919409421996919"><NAME>Ventricular arrhythmias&#8212;cardiac surgery</NAME><GROUP_LABEL_1>Beta-blocker</GROUP_LABEL_1><GROUP_LABEL_2>Control</GROUP_LABEL_2><GRAPH_LABEL_1>Favours beta-blocker</GRAPH_LABEL_1><GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2><DICH_SUBGROUP CHI2="2.2707699489570485" CI_END="1.258240070337322" CI_START="0.3096068537890347" DF="3" EFFECT_SIZE="0.6241472178007621" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="17" I2="0.0" ID="CMP-003.11.01" LOG_CI_END="0.09976351175765369" LOG_CI_START="-0.5091894338747669" LOG_EFFECT_SIZE="-0.20471296105855663" MODIFIED="2013-12-09 11:50:43 +0000" MODIFIED_BY="Hermann Blessberger" NO="1" P_CHI2="0.518143838483725" P_Z="0.18758057729716995" STUDIES="5" TAU2="0.0" TOTAL_1="366" TOTAL_2="321" WEIGHT="43.13649956923309" Z="1.3177702274734184"><NAME>Before surgery</NAME><DICH_DATA CI_END="3.163518593329961" CI_START="0.11752815339751992" EFFECT_SIZE="0.6097560975609756" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="4" LOG_CI_END="0.5001703913340872" LOG_CI_START="-0.929858087429483" LOG_EFFECT_SIZE="-0.2148438480476979" MODIFIED="2013-11-21 00:28:06 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="815" O_E="0.0" SE="0.8400058071808557" STUDY_ID="STD-Abel-1983" TOTAL_1="41" TOTAL_2="50" VAR="0.7056097560975609" WEIGHT="7.82209341953662"/><DICH_DATA CI_END="1.2109704352624893" CI_START="0.20023745210140398" EFFECT_SIZE="0.49242424242424243" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="11" LOG_CI_END="0.08313354036923343" LOG_CI_START="-0.6984546894952222" LOG_EFFECT_SIZE="-0.3076605745629943" MODIFIED="2013-11-21 00:28:12 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="817" O_E="0.0" SE="0.4591087951465162" STUDY_ID="STD-Hammon-1984" TOTAL_1="24" TOTAL_2="26" VAR="0.21078088578088577" WEIGHT="26.185227419857828"/><DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-12-09 11:50:41 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="818" O_E="0.0" SE="0.0" STUDY_ID="STD-Nystr_x00f6_m-1993" TOTAL_1="50" TOTAL_2="51" VAR="0.0" WEIGHT="0.0"/><DICH_DATA CI_END="105.56063520158432" CI_START="0.2481517124265242" EFFECT_SIZE="5.118110236220472" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="0" LOG_CI_END="2.0235019948836785" LOG_CI_START="-0.6052827235098813" LOG_EFFECT_SIZE="0.7091096356868987" MODIFIED="2013-12-09 11:50:42 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="819" O_E="0.0" SE="1.5441611562785993" STUDY_ID="STD-Pfisterer-1997" TOTAL_1="126" TOTAL_2="129" VAR="2.3844336765596608" WEIGHT="2.314740596138142"/><DICH_DATA CI_END="4.5514705860751805" CI_START="0.13367108245439305" EFFECT_SIZE="0.78" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="2" LOG_CI_END="0.6581517404437857" LOG_CI_START="-0.8739625350628248" LOG_EFFECT_SIZE="-0.10790539730951958" MODIFIED="2013-12-09 11:50:43 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="816" O_E="0.0" SE="0.8999715095205614" STUDY_ID="STD-Auer-2004" TOTAL_1="125" TOTAL_2="65" VAR="0.8099487179487179" WEIGHT="6.814438133700496"/></DICH_SUBGROUP><DICH_SUBGROUP CHI2="1.4651273207354365" CI_END="0.8413733265808485" CI_START="0.07939949447711488" DF="1" EFFECT_SIZE="0.2584658909741242" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="20" I2="31.746546129653826" ID="CMP-003.11.02" LOG_CI_END="-0.07501126020869478" LOG_CI_START="-1.100182262642153" LOG_EFFECT_SIZE="-0.5875967614254238" MODIFIED="2013-11-21 00:28:44 +0000" MODIFIED_BY="Hermann Blessberger" NO="2" P_CHI2="0.2261163788652647" P_Z="0.024653886304426883" STUDIES="2" TAU2="0.2906206780352726" TOTAL_1="45" TOTAL_2="43" WEIGHT="31.886101204601307" Z="2.246783194398747"><NAME>During surgery</NAME><DICH_DATA CI_END="0.8881346973235159" CI_START="0.14888665577098886" EFFECT_SIZE="0.36363636363636365" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="11" LOG_CI_END="-0.05152116274832839" LOG_CI_START="-0.8271442249121969" LOG_EFFECT_SIZE="-0.43933269383026263" MODIFIED="2013-11-21 00:28:39 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="820" O_E="0.0" SE="0.45560482611113506" STUDY_ID="STD-Harrison-1987" TOTAL_1="15" TOTAL_2="15" VAR="0.20757575757575764" WEIGHT="26.589547326677636"/><DICH_DATA CI_END="0.7668557273673595" CI_START="0.014024095769338475" EFFECT_SIZE="0.1037037037037037" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="9" LOG_CI_END="-0.11528633448889981" LOG_CI_START="-1.8531251311446366" LOG_EFFECT_SIZE="-0.9842057328167682" MODIFIED="2013-11-21 00:28:44 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="821" O_E="0.0" SE="1.0208151115963615" STUDY_ID="STD-Sun-2011" TOTAL_1="30" TOTAL_2="28" VAR="1.042063492063492" WEIGHT="5.296553877923671"/></DICH_SUBGROUP><DICH_SUBGROUP CHI2="1.057462336445748" CI_END="0.6745764462878774" CI_START="0.10684850937845428" DF="3" EFFECT_SIZE="0.2684725083647758" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="25" I2="0.0" ID="CMP-003.11.03" LOG_CI_END="-0.17096882683757458" LOG_CI_START="-0.9712315322105112" LOG_EFFECT_SIZE="-0.5711001795240429" MODIFIED="2013-11-21 00:29:28 +0000" MODIFIED_BY="Hermann Blessberger" NO="3" P_CHI2="0.7873514956647176" P_Z="0.0051512388866969796" STUDIES="5" TAU2="0.0" TOTAL_1="732" TOTAL_2="785" WEIGHT="24.977399226165595" Z="2.797420836723494"><NAME>After surgery</NAME><DICH_DATA CI_END="2.100643308756804" CI_START="0.09496223068712434" EFFECT_SIZE="0.4466338259441708" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="7" LOG_CI_END="0.3223523150476611" LOG_CI_START="-1.0224490922450145" LOG_EFFECT_SIZE="-0.35004838859867665" MODIFIED="2013-11-21 00:28:58 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="829" O_E="0.0" SE="0.7899430035180444" STUDY_ID="STD-Stephenson-1980" TOTAL_1="87" TOTAL_2="136" VAR="0.624009948807109" WEIGHT="8.844963835084117"/><DICH_DATA CI_END="2.2497616637862223" CI_START="0.007105757023518394" EFFECT_SIZE="0.12643678160919541" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="4" LOG_CI_END="0.3521365120735711" LOG_CI_START="-2.148389646994358" LOG_EFFECT_SIZE="-0.8981265674603934" MODIFIED="2013-11-21 00:29:06 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="830" O_E="0.0" SE="1.4688214436406157" STUDY_ID="STD-Williams-1982" TOTAL_1="28" TOTAL_2="32" VAR="2.1574364332985025" WEIGHT="2.5582887841997963"/><DICH_DATA CI_END="1.1353041994287865" CI_START="0.017975942725812367" EFFECT_SIZE="0.14285714285714285" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="7" LOG_CI_END="0.05511224428890028" LOG_CI_START="-1.745308324317414" LOG_EFFECT_SIZE="-0.8450980400142568" MODIFIED="2013-11-21 00:29:13 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="827" O_E="0.0" SE="1.0575759542248981" STUDY_ID="STD-Matangi-1985" TOTAL_1="82" TOTAL_2="82" VAR="1.1184668989547037" WEIGHT="4.934741864144427"/><DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-11-21 00:29:21 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="828" O_E="0.0" SE="0.0" STUDY_ID="STD-Matangi-1989" TOTAL_1="35" TOTAL_2="35" VAR="0.0" WEIGHT="0.0"/><DICH_DATA CI_END="1.368626413931854" CI_START="0.059645679953455225" EFFECT_SIZE="0.2857142857142857" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="7" LOG_CI_END="0.13628491744763105" LOG_CI_START="-1.2244210061481822" LOG_EFFECT_SIZE="-0.5440680443502757" MODIFIED="2013-11-21 00:29:28 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="826" O_E="0.0" SE="0.799285395123133" STUDY_ID="STD-Connolly-2003" TOTAL_1="500" TOTAL_2="500" VAR="0.6388571428571428" WEIGHT="8.639404742737254"/></DICH_SUBGROUP></DICH_OUTCOME><DICH_OUTCOME CHI2="7.314150194211837" CI_END="1.1902250305243167" CI_START="0.4337117040075984" CI_STUDY="95" CI_TOTAL="95" DF="4" EFFECT_MEASURE="RR" EFFECT_SIZE="0.7184807068677608" ESTIMABLE="YES" EVENTS_1="22" EVENTS_2="24" I2="45.31148672383758" I2_Q="80.84849453395758" ID="CMP-003.12" LOG_CI_END="0.0756290792713098" LOG_CI_START="-0.36279885795884337" LOG_EFFECT_SIZE="-0.1435848893437668" METHOD="MH" MODIFIED="2017-06-17 15:40:45 +0100" MODIFIED_BY="Hermann Blessberger" NO="12" P_CHI2="0.1201893406969895" P_Q="0.022309070561343236" P_Z="0.19922101385497493" Q="5.221521628015626" RANDOM="NO" SCALE="100.0" SORT_BY="YEAR" STUDIES="5" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="249" TOTAL_2="227" WEIGHT="100.0" Z="1.2837740843609589"><NAME>Ventricular arrhythmias&#8212;non-cardiac surgery</NAME><GROUP_LABEL_1>Beta-blocker</GROUP_LABEL_1><GROUP_LABEL_2>Control</GROUP_LABEL_2><GRAPH_LABEL_1>Favours beta-blocker</GRAPH_LABEL_1><GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2><DICH_SUBGROUP CHI2="1.6910770050118047" CI_END="1.8619347632218166" CI_START="0.5466339505525487" DF="3" EFFECT_SIZE="1.0088591355045886" ESTIMABLE="YES" EVENTS_1="18" EVENTS_2="16" I2="0.0" ID="CMP-003.12.01" LOG_CI_END="0.26996446049649925" LOG_CI_START="-0.2623033984762519" LOG_EFFECT_SIZE="0.0038305310101236618" MODIFIED="2013-12-09 12:35:52 +0000" MODIFIED_BY="Hermann Blessberger" NO="1" P_CHI2="0.6389194842325072" P_Z="0.9774944677414845" STUDIES="4" TAU2="0.0" TOTAL_1="219" TOTAL_2="212" WEIGHT="61.73487080131855" Z="0.02821024300056622"><NAME>Before surgery</NAME><DICH_DATA CI_END="3.6746104414217298" CI_START="0.37928140736840954" EFFECT_SIZE="1.1805555555555556" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="4" LOG_CI_END="0.5652113047512454" LOG_CI_START="-0.4210384461851969" LOG_EFFECT_SIZE="0.07208642928302428" MODIFIED="2013-12-09 12:35:51 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="832" O_E="0.0" SE="0.5793279857150695" STUDY_ID="STD-Jakobsen-1997" TOTAL_1="18" TOTAL_2="17" VAR="0.33562091503267977" WEIGHT="14.759406976634274"/><DICH_DATA CI_END="3.9833644750180848" CI_START="0.11612876150877542" EFFECT_SIZE="0.6801346801346801" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="3" LOG_CI_END="0.6002500458638188" LOG_CI_START="-0.9350602056049961" LOG_EFFECT_SIZE="-0.16740507987058859" MODIFIED="2013-11-21 00:32:01 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="834" O_E="0.0" SE="0.9018488416210964" STUDY_ID="STD-Wallace-1998" TOTAL_1="99" TOTAL_2="101" VAR="0.8133313331333133" WEIGHT="10.654446911257867"/><DICH_DATA CI_END="4.14361531793994" CI_START="0.010043403358372081" EFFECT_SIZE="0.204" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" LOG_CI_END="0.6173794298813183" LOG_CI_START="-1.998119095029521" LOG_EFFECT_SIZE="-0.6903698325741012" MODIFIED="2013-11-21 00:32:08 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="831" O_E="0.0" SE="1.5363567804591305" STUDY_ID="STD-Bayliff-1999" TOTAL_1="49" TOTAL_2="50" VAR="2.360392156862745" WEIGHT="8.879593718753432"/><DICH_DATA CI_END="3.080458562544285" CI_START="0.5524939578722114" EFFECT_SIZE="1.3045822102425877" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="7" LOG_CI_END="0.4886153711624102" LOG_CI_START="-0.25767246710367697" LOG_EFFECT_SIZE="0.11547145202936662" MODIFIED="2013-12-09 12:35:52 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="833" O_E="0.0" SE="0.4383731703818781" STUDY_ID="STD-POBBLE-2005" TOTAL_1="53" TOTAL_2="44" VAR="0.19217103651065914" WEIGHT="27.44142319467298"/></DICH_SUBGROUP><DICH_SUBGROUP CHI2="0.0" CI_END="0.698737197573076" CI_START="0.08944707712296021" DF="0" EFFECT_SIZE="0.25" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="8" I2="0.0" ID="CMP-003.12.02" LOG_CI_END="-0.1556861362780481" LOG_CI_START="-1.0484338463778766" LOG_EFFECT_SIZE="-0.6020599913279624" MODIFIED="2017-06-17 15:40:45 +0100" MODIFIED_BY="Hermann Blessberger" NO="2" P_CHI2="1.0" P_Z="0.008203931563833216" STUDIES="1" TAU2="0.0" TOTAL_1="30" TOTAL_2="15" WEIGHT="38.26512919868145" Z="2.64355962201987"><NAME>During surgery</NAME><DICH_DATA CI_END="0.698737197573076" CI_START="0.08944707712296021" EFFECT_SIZE="0.25" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="8" LOG_CI_END="-0.1556861362780481" LOG_CI_START="-1.0484338463778766" LOG_EFFECT_SIZE="-0.6020599913279624" MODIFIED="2013-12-08 08:37:29 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="835" O_E="0.0" SE="0.5244044240850758" STUDY_ID="STD-Sandler-1990" TOTAL_1="30" TOTAL_2="15" VAR="0.275" WEIGHT="38.26512919868145"/></DICH_SUBGROUP><DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-003.12.03" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2013-11-21 00:30:51 +0000" MODIFIED_BY="Hermann Blessberger" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0"><NAME>After surgery</NAME></DICH_SUBGROUP></DICH_OUTCOME><DICH_OUTCOME CHI2="73.87854420491638" CI_END="0.5656392760817595" CI_START="0.4016037582417625" CI_STUDY="95" CI_TOTAL="95" DF="35" EFFECT_MEASURE="RR" EFFECT_SIZE="0.47661604996431295" ESTIMABLE="YES" EVENTS_1="495" EVENTS_2="862" I2="52.62494628627121" I2_Q="0.0" ID="CMP-003.13" LOG_CI_END="-0.24746044222147956" LOG_CI_START="-0.3962022316797153" LOG_EFFECT_SIZE="-0.32183133695059746" METHOD="MH" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" NO="13" P_CHI2="1.351513206526711E-4" P_Q="0.9313852348522049" P_Z="2.2228116486013427E-17" Q="0.1421646330038634" RANDOM="YES" SCALE="100.0" SORT_BY="YEAR" STUDIES="36" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.10950941230710698" TOTALS="YES" TOTAL_1="2759" TOTAL_2="2613" WEIGHT="99.99999999999999" Z="8.481514600799631"><NAME>Atrial fibrillation&#8212;cardiac surgery</NAME><GROUP_LABEL_1>Beta-blocker</GROUP_LABEL_1><GROUP_LABEL_2>Control</GROUP_LABEL_2><GRAPH_LABEL_1>Favours beta-blocker</GRAPH_LABEL_1><GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2><DICH_SUBGROUP CHI2="8.093716275386384" CI_END="0.650080888114241" CI_START="0.38651830141711985" DF="6" EFFECT_SIZE="0.501266556492301" ESTIMABLE="YES" EVENTS_1="109" EVENTS_2="187" I2="25.868416981128153" ID="CMP-003.13.01" LOG_CI_END="-0.187032601701686" LOG_CI_START="-0.41282993766728177" LOG_EFFECT_SIZE="-0.29993126968448386" MODIFIED="2013-11-21 00:39:57 +0000" MODIFIED_BY="Hermann Blessberger" NO="1" P_CHI2="0.23131758638477473" P_Z="1.919994069148194E-7" STUDIES="7" TAU2="0.029977326417048006" TOTAL_1="517" TOTAL_2="475" WEIGHT="23.183569601328443" Z="5.206921365170833"><NAME>Before surgery</NAME><DICH_DATA CI_END="0.9290042098937271" CI_START="0.1778738493698285" EFFECT_SIZE="0.4065040650406504" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="18" LOG_CI_END="-0.03198231794449341" LOG_CI_START="-0.7498878962622648" LOG_EFFECT_SIZE="-0.39093510710337914" MODIFIED="2013-11-21 00:39:09 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="837" O_E="0.0" SE="0.4217012903937848" STUDY_ID="STD-Abel-1983" TOTAL_1="41" TOTAL_2="50" VAR="0.1778319783197832" WEIGHT="2.656703077352643"/><DICH_DATA CI_END="0.7332835516809254" CI_START="0.013637289391091267" EFFECT_SIZE="0.1" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="10" LOG_CI_END="-0.13472805657581619" LOG_CI_START="-1.8652719434241833" LOG_EFFECT_SIZE="-1.0" MODIFIED="2013-11-21 00:39:15 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="841" O_E="0.0" SE="1.016530045465127" STUDY_ID="STD-Lamb-1988" TOTAL_1="30" TOTAL_2="30" VAR="1.0333333333333332" WEIGHT="0.6679665768902041"/><DICH_DATA CI_END="0.8651318953082401" CI_START="0.13362124391311758" EFFECT_SIZE="0.34" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="15" LOG_CI_END="-0.06291767630644172" LOG_CI_START="-0.8741244896090479" LOG_EFFECT_SIZE="-0.46852108295774486" MODIFIED="2013-11-21 00:39:24 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="842" O_E="0.0" SE="0.4765068976724385" STUDY_ID="STD-Nystr_x00f6_m-1993" TOTAL_1="50" TOTAL_2="51" VAR="0.22705882352941176" WEIGHT="2.268130724909061"/><DICH_DATA CI_END="0.8367549673280018" CI_START="0.38960932218699135" EFFECT_SIZE="0.5709706959706959" ESTIMABLE="YES" EVENTS_1="29" EVENTS_2="52" LOG_CI_END="-0.07740170080856265" LOG_CI_START="-0.40937066029975144" LOG_EFFECT_SIZE="-0.24338618055415703" MODIFIED="2013-11-21 00:39:40 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="843" O_E="0.0" SE="0.19500021007797613" STUDY_ID="STD-Pfisterer-1997" TOTAL_1="126" TOTAL_2="129" VAR="0.03802508193045483" WEIGHT="5.1742527106917935"/><DICH_DATA CI_END="0.7316733754295464" CI_START="0.276762838173683" EFFECT_SIZE="0.45" ESTIMABLE="YES" EVENTS_1="18" EVENTS_2="40" LOG_CI_END="-0.13568274804766128" LOG_CI_START="-0.5578922244016514" LOG_EFFECT_SIZE="-0.3467874862246563" MODIFIED="2013-11-21 00:39:32 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="838" O_E="0.0" SE="0.2480079363809483" STUDY_ID="STD-Ali-1997" TOTAL_1="105" TOTAL_2="105" VAR="0.061507936507936505" WEIGHT="4.463762080388984"/><DICH_DATA CI_END="0.815131215366541" CI_START="0.13431350612509407" EFFECT_SIZE="0.33088235294117646" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="17" LOG_CI_END="-0.08877247528121683" LOG_CI_START="-0.8718803139085308" LOG_EFFECT_SIZE="-0.48032639459487386" MODIFIED="2013-11-21 00:39:48 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="840" O_E="0.0" SE="0.460001420856004" STUDY_ID="STD-Gomes-1999" TOTAL_1="40" TOTAL_2="45" VAR="0.2116013071895425" WEIGHT="2.377313214351327"/><DICH_DATA CI_END="0.9248471633511364" CI_START="0.48330986222891537" EFFECT_SIZE="0.6685714285714286" ESTIMABLE="YES" EVENTS_1="45" EVENTS_2="35" LOG_CI_END="-0.0339300311501147" LOG_CI_START="-0.3157743427301508" LOG_EFFECT_SIZE="-0.17485218694013277" MODIFIED="2013-11-21 00:39:57 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="839" O_E="0.0" SE="0.16555674377395627" STUDY_ID="STD-Auer-2004" TOTAL_1="125" TOTAL_2="65" VAR="0.027409035409035408" WEIGHT="5.5754412167444265"/></DICH_SUBGROUP><DICH_SUBGROUP CHI2="6.32901889273569" CI_END="0.7771151517923238" CI_START="0.3097694639483699" DF="4" EFFECT_SIZE="0.4906389140670196" ESTIMABLE="YES" EVENTS_1="39" EVENTS_2="72" I2="36.79905104105294" ID="CMP-003.13.02" LOG_CI_END="-0.10951462330640147" LOG_CI_START="-0.5089613957838653" LOG_EFFECT_SIZE="-0.3092380095451334" MODIFIED="2013-11-21 00:40:33 +0000" MODIFIED_BY="Hermann Blessberger" NO="2" P_CHI2="0.17588770358001482" P_Z="0.0024079583510723318" STUDIES="5" TAU2="0.09686844903858365" TOTAL_1="250" TOTAL_2="214" WEIGHT="13.129164713121337" Z="3.0346739697014824"><NAME>During surgery</NAME><DICH_DATA CI_END="63.82881484401465" CI_START="0.12392766917779852" EFFECT_SIZE="2.8125" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.8050167806434498" LOG_CI_START="-0.9068317184046119" LOG_EFFECT_SIZE="0.4490925311194189" MODIFIED="2013-11-21 00:40:04 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="844" O_E="0.0" SE="1.592953232207399" STUDY_ID="STD-Cork-1995" TOTAL_1="15" TOTAL_2="14" VAR="2.5374999999999996" WEIGHT="0.2883936691648906"/><DICH_DATA CI_END="0.6324601313324618" CI_START="0.13450562372243266" EFFECT_SIZE="0.2916666666666667" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="24" LOG_CI_END="-0.1989668461016144" LOG_CI_START="-0.871259557293084" LOG_EFFECT_SIZE="-0.5351132016973492" MODIFIED="2013-11-21 00:40:19 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="846" O_E="0.0" SE="0.39490806645646137" STUDY_ID="STD-Sezai-2011" TOTAL_1="70" TOTAL_2="70" VAR="0.15595238095238093" WEIGHT="2.875670910514212"/><DICH_DATA CI_END="1.6818496358282289" CI_START="0.42805642238869207" EFFECT_SIZE="0.8484848484848485" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="11" LOG_CI_END="0.22578716551115877" LOG_CI_START="-0.3684989825824953" LOG_EFFECT_SIZE="-0.07135590853566824" MODIFIED="2013-11-21 00:40:10 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="848" O_E="0.0" SE="0.3490866251540896" STUDY_ID="STD-Sun-2011" TOTAL_1="30" TOTAL_2="28" VAR="0.12186147186147188" WEIGHT="3.299381248735866"/><DICH_DATA CI_END="0.7482025935275345" CI_START="0.1529700826342874" EFFECT_SIZE="0.3383084577114428" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="12" LOG_CI_END="-0.12598079072115415" LOG_CI_START="-0.8153934987073509" LOG_EFFECT_SIZE="-0.47068714471425255" MODIFIED="2013-11-21 00:40:26 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="847" O_E="0.0" SE="0.404964437319035" STUDY_ID="STD-Sezai-2012" TOTAL_1="67" TOTAL_2="34" VAR="0.1639961954931226" WEIGHT="2.791097275368576"/><DICH_DATA CI_END="0.9285567066549609" CI_START="0.2912046168662018" EFFECT_SIZE="0.52" ESTIMABLE="YES" EVENTS_1="13" EVENTS_2="25" LOG_CI_END="-0.032191568892075674" LOG_CI_START="-0.5358017438383259" LOG_EFFECT_SIZE="-0.28399665636520083" MODIFIED="2013-11-21 00:40:33 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="845" O_E="0.0" SE="0.29582310967399855" STUDY_ID="STD-Ogawa-2013" TOTAL_1="68" TOTAL_2="68" VAR="0.08751131221719458" WEIGHT="3.874621609337792"/></DICH_SUBGROUP><DICH_SUBGROUP CHI2="57.66359692471617" CI_END="0.5948656342533494" CI_START="0.3694438811808799" DF="23" EFFECT_SIZE="0.4687957643789918" ESTIMABLE="YES" EVENTS_1="347" EVENTS_2="603" I2="60.113483676663286" ID="CMP-003.13.03" LOG_CI_END="-0.22558111980463225" LOG_CI_START="-0.4324515219361413" LOG_EFFECT_SIZE="-0.32901632087038674" MODIFIED="2013-11-21 00:45:00 +0000" MODIFIED_BY="Hermann Blessberger" NO="3" P_CHI2="8.25460763288488E-5" P_Z="4.5340870052218324E-10" STUDIES="24" TAU2="0.16285214132696038" TOTAL_1="1992" TOTAL_2="1924" WEIGHT="63.6872656855502" Z="6.23443598105339"><NAME>After surgery</NAME><DICH_DATA CI_END="22.44975451350426" CI_START="0.2155925579092004" EFFECT_SIZE="2.2" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="1" LOG_CI_END="1.3512115963855165" LOG_CI_START="-0.6663662347411039" LOG_EFFECT_SIZE="0.3424226808222063" MODIFIED="2013-11-21 00:40:44 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="866" O_E="0.0" SE="1.1851352051751118" STUDY_ID="STD-Salazar-1979" TOTAL_1="20" TOTAL_2="22" VAR="1.4045454545454545" WEIGHT="0.5041962305607681"/><DICH_DATA CI_END="1.0124518038855774" CI_START="0.20532344839946126" EFFECT_SIZE="0.4559386973180077" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="24" LOG_CI_END="0.00537435849931325" LOG_CI_START="-0.6875614503908136" LOG_EFFECT_SIZE="-0.3410935459457502" MODIFIED="2013-11-21 00:40:51 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="868" O_E="0.0" SE="0.4070339242296343" STUDY_ID="STD-Stephenson-1980" TOTAL_1="87" TOTAL_2="136" VAR="0.16567661547377568" WEIGHT="2.7740534753352026"/><DICH_DATA CI_END="1.4875364844811094" CI_START="0.02439011043885608" EFFECT_SIZE="0.19047619047619047" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="6" LOG_CI_END="0.17246762637672552" LOG_CI_START="-1.6127862331886396" LOG_EFFECT_SIZE="-0.7201593034059569" MODIFIED="2013-11-21 00:41:07 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="872" O_E="0.0" SE="1.048666954257824" STUDY_ID="STD-Williams-1982" TOTAL_1="28" TOTAL_2="32" VAR="1.099702380952381" WEIGHT="0.6313044257296879"/><DICH_DATA CI_END="0.6999722648647813" CI_START="0.0656002668274423" EFFECT_SIZE="0.21428571428571427" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="14" LOG_CI_END="-0.15491916777833195" LOG_CI_START="-1.1830943941388192" LOG_EFFECT_SIZE="-0.6690067809585756" MODIFIED="2013-11-21 00:41:00 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="867" O_E="0.0" SE="0.603955217513604" STUDY_ID="STD-Silverman-1982" TOTAL_1="50" TOTAL_2="50" VAR="0.36476190476190473" WEIGHT="1.6095866000223809"/><DICH_DATA CI_END="1.3632093309631186" CI_START="0.12220958833054184" EFFECT_SIZE="0.40816326530612246" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="7" LOG_CI_END="0.134562550113297" LOG_CI_START="-0.912894718842362" LOG_EFFECT_SIZE="-0.3891660843645325" MODIFIED="2013-11-21 00:41:21 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="871" O_E="0.0" SE="0.615281584781658" STUDY_ID="STD-White-1984" TOTAL_1="21" TOTAL_2="20" VAR="0.37857142857142856" WEIGHT="1.5640457333977245"/><DICH_DATA CI_END="1.5715363292104452" CI_START="0.18776337809660357" EFFECT_SIZE="0.5432098765432098" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="9" LOG_CI_END="0.19632442505659703" LOG_CI_START="-0.7263891098415217" LOG_EFFECT_SIZE="-0.2650323423924623" MODIFIED="2013-11-21 00:41:14 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="861" O_E="0.0" SE="0.5420064979048165" STUDY_ID="STD-Ormerod-1984" TOTAL_1="27" TOTAL_2="33" VAR="0.2937710437710438" WEIGHT="1.8929277261611541"/><DICH_DATA CI_END="0.7102222721256239" CI_START="0.04268142296235359" EFFECT_SIZE="0.17410714285714285" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="14" LOG_CI_END="-0.148605712617911" LOG_CI_START="-1.3697611099974163" LOG_EFFECT_SIZE="-0.7591834113076636" MODIFIED="2013-11-21 00:41:40 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="859" O_E="0.0" SE="0.717312725237428" STUDY_ID="STD-Materne-1985" TOTAL_1="32" TOTAL_2="39" VAR="0.5145375457875457" WEIGHT="1.2232745418069337"/><DICH_DATA CI_END="1.0292435704622704" CI_START="0.21516120532846186" EFFECT_SIZE="0.47058823529411764" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="17" LOG_CI_END="0.012518162702335212" LOG_CI_START="-0.667236031474996" LOG_EFFECT_SIZE="-0.32735893438633035" MODIFIED="2013-11-21 00:41:48 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="858" O_E="0.0" SE="0.39929097849729295" STUDY_ID="STD-Matangi-1985" TOTAL_1="82" TOTAL_2="82" VAR="0.15943328550932567" WEIGHT="2.8384513241192146"/><DICH_DATA CI_END="0.5762909029931246" CI_START="0.1149255280418162" EFFECT_SIZE="0.25735294117647056" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="17" LOG_CI_END="-0.23935823589507993" LOG_CI_START="-0.939583492144804" LOG_EFFECT_SIZE="-0.589470864019942" MODIFIED="2013-11-21 00:42:04 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="856" O_E="0.0" SE="0.411315781692008" STUDY_ID="STD-Janssen-1986" TOTAL_1="80" TOTAL_2="50" VAR="0.16918067226890757" WEIGHT="2.7391744413534385"/><DICH_DATA CI_END="2.1367282344833174" CI_START="0.23877818123933087" EFFECT_SIZE="0.7142857142857143" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="7" LOG_CI_END="0.3297492887669275" LOG_CI_START="-0.6220053601234036" LOG_EFFECT_SIZE="-0.146128035678238" MODIFIED="2013-11-21 00:41:55 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="870" O_E="0.0" SE="0.5590653920196748" STUDY_ID="STD-Vecht-1986" TOTAL_1="66" TOTAL_2="66" VAR="0.3125541125541126" WEIGHT="1.8086868723855192"/><DICH_DATA CI_END="0.3925291896546882" CI_START="0.0015155153127434649" EFFECT_SIZE="0.024390243902439025" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="20" LOG_CI_END="-0.4061280422700622" LOG_CI_START="-2.819439671169409" LOG_EFFECT_SIZE="-1.6127838567197355" MODIFIED="2013-11-21 00:42:13 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="850" O_E="0.0" SE="1.4175911969007033" STUDY_ID="STD-Daudon-1986" TOTAL_1="50" TOTAL_2="50" VAR="2.0095648015303684" WEIGHT="0.36024257751068806"/><DICH_DATA CI_END="0.9962321240462663" CI_START="0.1877050579938394" EFFECT_SIZE="0.43243243243243246" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="15" LOG_CI_END="-0.0016394583162494887" LOG_CI_START="-0.7265240245058909" LOG_EFFECT_SIZE="-0.3640817414110702" MODIFIED="2013-11-21 00:42:23 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="864" O_E="0.0" SE="0.42580078241626834" STUDY_ID="STD-Rubin-1987" TOTAL_1="37" TOTAL_2="40" VAR="0.18130630630630631" WEIGHT="2.6249638787373226"/><DICH_DATA CI_END="4.126826287091888" CI_START="0.7815504113324163" EFFECT_SIZE="1.7959183673469388" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="7" LOG_CI_END="0.6156161882509973" LOG_CI_START="-0.10704300400768743" LOG_EFFECT_SIZE="0.25428659212165494" MODIFIED="2013-11-21 00:42:32 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="857" O_E="0.0" SE="0.4244935867534458" STUDY_ID="STD-Martinussen-1988" TOTAL_1="35" TOTAL_2="40" VAR="0.18019480519480519" WEIGHT="2.6350350136832525"/><DICH_DATA CI_END="0.8286815540491059" CI_START="0.3432493978592757" EFFECT_SIZE="0.5333333333333333" ESTIMABLE="YES" EVENTS_1="24" EVENTS_2="45" LOG_CI_END="-0.08161232818157535" LOG_CI_START="-0.46439021594589996" LOG_EFFECT_SIZE="-0.27300127206373764" MODIFIED="2013-11-21 00:42:43 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="869" O_E="0.0" SE="0.22484562605386735" STUDY_ID="STD-Suttorp-1991" TOTAL_1="150" TOTAL_2="150" VAR="0.05055555555555555" WEIGHT="4.769193202751498"/><DICH_DATA CI_END="0.967053167072245" CI_START="0.41868044849390096" EFFECT_SIZE="0.6363067292644757" ESTIMABLE="YES" EVENTS_1="38" EVENTS_2="30" LOG_CI_END="-0.014549648428526057" LOG_CI_START="-0.37811731928423464" LOG_EFFECT_SIZE="-0.19633348385638036" MODIFIED="2013-11-21 00:42:54 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="855" O_E="0.0" SE="0.213561449549639" STUDY_ID="STD-Graham-1996" TOTAL_1="213" TOTAL_2="107" VAR="0.045608492733743004" WEIGHT="4.921293621959453"/><DICH_DATA CI_END="1.8214515190598082" CI_START="0.4677977958792884" EFFECT_SIZE="0.9230769230769231" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="13" LOG_CI_END="0.26041761626692334" LOG_CI_START="-0.32994182878534717" LOG_EFFECT_SIZE="-0.03476210625921192" MODIFIED="2013-11-21 00:43:02 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="863" O_E="0.0" SE="0.3467800603500874" STUDY_ID="STD-Paull-1997" TOTAL_1="50" TOTAL_2="50" VAR="0.12025641025641025" WEIGHT="3.3224295424451804"/><DICH_DATA CI_END="0.7899548058160761" CI_START="0.21326202895259727" EFFECT_SIZE="0.41044776119402987" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="24" LOG_CI_END="-0.10239775446416542" LOG_CI_START="-0.6710864632769621" LOG_EFFECT_SIZE="-0.38674210887056376" MODIFIED="2013-11-21 00:43:14 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="852" O_E="0.0" SE="0.33405056261114596" STUDY_ID="STD-Dy-1998" TOTAL_1="67" TOTAL_2="66" VAR="0.11158977838082317" WEIGHT="3.4526619222533417"/><DICH_DATA CI_END="0.559711576637503" CI_START="0.20705225265439542" EFFECT_SIZE="0.3404255319148936" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="47" LOG_CI_END="-0.2520357103921946" LOG_CI_START="-0.6839200401673907" LOG_EFFECT_SIZE="-0.4679778752797927" MODIFIED="2013-11-21 00:43:25 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="853" O_E="0.0" SE="0.2536909931718616" STUDY_ID="STD-Evrard-2000" TOTAL_1="103" TOTAL_2="103" VAR="0.06435912001652552" WEIGHT="4.390563068125049"/><DICH_DATA CI_END="0.925811812744811" CI_START="0.17282129888323441" EFFECT_SIZE="0.4" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="15" LOG_CI_END="-0.03347728220825417" LOG_CI_START="-0.762402735135821" LOG_EFFECT_SIZE="-0.3979400086720376" MODIFIED="2013-11-21 00:44:15 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="860" O_E="0.0" SE="0.42817441928883765" STUDY_ID="STD-Matsuura-2001" TOTAL_1="40" TOTAL_2="40" VAR="0.18333333333333335" WEIGHT="2.6067941517887045"/><DICH_DATA CI_END="0.7105931245191439" CI_START="0.13488819843100122" EFFECT_SIZE="0.30959752321981426" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="19" LOG_CI_END="-0.14837899892640086" LOG_CI_START="-0.8700260457358048" LOG_EFFECT_SIZE="-0.5092025223311029" MODIFIED="2013-11-21 00:43:57 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="854" O_E="0.0" SE="0.4238990475063375" STUDY_ID="STD-Forlani-2002" TOTAL_1="51" TOTAL_2="50" VAR="0.17969040247678017" WEIGHT="2.6396308631791667"/><DICH_DATA CI_END="0.8846657886054342" CI_START="0.2374562768789701" EFFECT_SIZE="0.4583333333333333" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="24" LOG_CI_END="-0.05322076724324717" LOG_CI_START="-0.6244163458635148" LOG_EFFECT_SIZE="-0.338818556553381" MODIFIED="2013-11-21 00:44:29 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="851" O_E="0.0" SE="0.3355231103452601" STUDY_ID="STD-De-Azevedo-L_x00fa_cio-2003" TOTAL_1="100" TOTAL_2="100" VAR="0.11257575757575758" WEIGHT="3.4373333308652745"/><DICH_DATA CI_END="0.9484074945855946" CI_START="0.674815418112704" EFFECT_SIZE="0.8" ESTIMABLE="YES" EVENTS_1="156" EVENTS_2="195" LOG_CI_END="-0.023005022761850884" LOG_CI_START="-0.17081500325426194" LOG_EFFECT_SIZE="-0.09691001300805639" MODIFIED="2013-11-21 00:44:44 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="849" O_E="0.0" SE="0.08682431421244592" STUDY_ID="STD-Connolly-2003" TOTAL_1="500" TOTAL_2="500" VAR="0.007538461538461539" WEIGHT="6.52195321152473"/><DICH_DATA CI_END="0.5360855287701065" CI_START="0.05040605255789461" EFFECT_SIZE="0.1643835616438356" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="17" LOG_CI_END="-0.27076591607279954" LOG_CI_START="-1.2975173120728625" LOG_EFFECT_SIZE="-0.7841416140728311" MODIFIED="2013-11-21 00:44:53 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="862" O_E="0.0" SE="0.6031188525118167" STUDY_ID="STD-Osada-2012" TOTAL_1="73" TOTAL_2="68" VAR="0.36375235025517055" WEIGHT="1.6130201447001375"/><DICH_DATA CI_END="0.8263453347887832" CI_START="0.17017703625802433" EFFECT_SIZE="0.375" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="16" LOG_CI_END="-0.0828384204148983" LOG_CI_START="-0.7690990441296639" LOG_EFFECT_SIZE="-0.42596873227228116" MODIFIED="2013-11-21 00:45:00 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="865" O_E="0.0" SE="0.4031128874149275" STUDY_ID="STD-Sakaguchi-2012" TOTAL_1="30" TOTAL_2="30" VAR="0.1625" WEIGHT="2.806449785154371"/></DICH_SUBGROUP></DICH_OUTCOME><DICH_OUTCOME CHI2="1.7834444420820406" CI_END="0.9492519881687379" CI_START="0.5625349250530548" CI_STUDY="95" CI_TOTAL="95" DF="2" EFFECT_MEASURE="RR" EFFECT_SIZE="0.7307444122406713" ESTIMABLE="YES" EVENTS_1="94" EVENTS_2="129" I2="0.0" I2_Q="40.582386134244864" ID="CMP-003.14" LOG_CI_END="-0.022618484575515498" LOG_CI_START="-0.2498505091508825" LOG_EFFECT_SIZE="-0.13623449686319902" METHOD="MH" MODIFIED="2017-06-17 15:41:09 +0100" MODIFIED_BY="Hermann Blessberger" NO="14" P_CHI2="0.4099491604941542" P_Q="0.19452603205143915" P_Z="0.018765830949606422" Q="1.6830026231940995" RANDOM="NO" SCALE="100.0" SORT_BY="YEAR" STUDIES="3" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="4253" TOTAL_2="4257" WEIGHT="100.00000000000001" Z="2.3501503170847564"><NAME>Atrial fibrillation and flutter&#8212;non-cardiac surgery</NAME><GROUP_LABEL_1>Beta-blocker</GROUP_LABEL_1><GROUP_LABEL_2>Control</GROUP_LABEL_2><GRAPH_LABEL_1>Favours beta-blocker</GRAPH_LABEL_1><GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2><DICH_SUBGROUP CHI2="0.09008248514022482" CI_END="0.9805897521358004" CI_START="0.5783369701867597" DF="1" EFFECT_SIZE="0.7530679293705212" ESTIMABLE="YES" EVENTS_1="94" EVENTS_2="125" I2="0.0" ID="CMP-003.14.01" LOG_CI_END="-0.008512649754055367" LOG_CI_START="-0.23781904453730882" LOG_EFFECT_SIZE="-0.12316584714568211" MODIFIED="2014-06-22 18:36:17 +0100" MODIFIED_BY="Hermann Blessberger" NO="1" P_CHI2="0.7640723351254473" P_Z="0.03524908344683768" STUDIES="2" TAU2="0.0" TOTAL_1="4223" TOTAL_2="4227" WEIGHT="96.5225827509119" Z="2.105485324638074"><NAME>Before surgery</NAME><DICH_DATA CI_END="2.4240530226292014" CI_START="0.15463515508026482" EFFECT_SIZE="0.6122448979591837" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="5" LOG_CI_END="0.38454211515738" LOG_CI_START="-0.8106917657750824" LOG_EFFECT_SIZE="-0.21307482530885122" MODIFIED="2014-06-22 18:36:17 +0100" MODIFIED_BY="Hermann Blessberger" ORDER="873" O_E="0.0" SE="0.7020862981628592" STUDY_ID="STD-Bayliff-1999" TOTAL_1="49" TOTAL_2="50" VAR="0.49292517006802716" WEIGHT="3.8247686914773973"/><DICH_DATA CI_END="0.9931562131790224" CI_START="0.5798648580922154" EFFECT_SIZE="0.7588783740616515" ESTIMABLE="YES" EVENTS_1="91" EVENTS_2="120" LOG_CI_END="-0.002982436110955725" LOG_CI_START="-0.23667321027073493" LOG_EFFECT_SIZE="-0.11982782319084534" MODIFIED="2013-11-21 00:46:56 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="874" O_E="0.0" SE="0.13727111752944285" STUDY_ID="STD-POISE-2008" TOTAL_1="4174" TOTAL_2="4177" VAR="0.01884335970778211" WEIGHT="92.69781405943449"/></DICH_SUBGROUP><DICH_SUBGROUP CHI2="0.0" CI_END="1.9774190029426773" CI_START="0.006243329812231785" DF="0" EFFECT_SIZE="0.1111111111111111" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="4" I2="0.0" ID="CMP-003.14.02" LOG_CI_END="0.2960987033983009" LOG_CI_START="-2.204583722276951" LOG_EFFECT_SIZE="-0.9542425094393249" MODIFIED="2017-06-17 15:41:09 +0100" MODIFIED_BY="Hermann Blessberger" NO="2" P_CHI2="1.0" P_Z="0.13470149407860718" STUDIES="1" TAU2="0.0" TOTAL_1="30" TOTAL_2="30" WEIGHT="3.4774172490881234" Z="1.4958164473948934"><NAME>During surgery</NAME><DICH_DATA CI_END="1.9774190029426781" CI_START="0.006243329812231785" EFFECT_SIZE="0.1111111111111111" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="4" LOG_CI_END="0.29609870339830113" LOG_CI_START="-2.204583722276951" LOG_EFFECT_SIZE="-0.9542425094393249" MODIFIED="2013-11-21 00:47:06 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="875" O_E="0.0" SE="1.4689132354192893" STUDY_ID="STD-Lai-2006" TOTAL_1="30" TOTAL_2="30" VAR="2.1577060931899643" WEIGHT="3.4774172490881234"/></DICH_SUBGROUP><DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-003.14.03" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2013-11-21 00:45:54 +0000" MODIFIED_BY="Hermann Blessberger" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0"><NAME>After surgery</NAME></DICH_SUBGROUP></DICH_OUTCOME><DICH_OUTCOME CHI2="201.40983152392056" CI_END="0.5322393932735516" CI_START="0.36078792794371006" CI_STUDY="95" CI_TOTAL="95" DF="47" EFFECT_MEASURE="RR" EFFECT_SIZE="0.4382071974182785" ESTIMABLE="YES" EVENTS_1="572" EVENTS_2="1089" I2="76.664495648308" I2_Q="0.0" ID="CMP-003.15" LOG_CI_END="-0.27389298463584366" LOG_CI_START="-0.44274800249136015" LOG_EFFECT_SIZE="-0.3583204935636019" METHOD="MH" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" NO="15" P_CHI2="-1.1102230246251565E-15" P_Q="0.698236239091034" P_Z="8.921684780058808E-17" Q="0.7183958845899632" RANDOM="YES" SCALE="100.0" SORT_BY="YEAR" STUDIES="48" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.27296219376516123" TOTALS="YES" TOTAL_1="3260" TOTAL_2="3160" WEIGHT="100.0" Z="8.31832267973471"><NAME>All supraventricular arrhythmias&#8212;cardiac surgery</NAME><GROUP_LABEL_1>Beta-blocker</GROUP_LABEL_1><GROUP_LABEL_2>Control</GROUP_LABEL_2><GRAPH_LABEL_1>Favours beta-blocker</GRAPH_LABEL_1><GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2><DICH_SUBGROUP CHI2="10.800661698397578" CI_END="0.6136863539616696" CI_START="0.3869453127058325" DF="9" EFFECT_SIZE="0.4873018142147641" ESTIMABLE="YES" EVENTS_1="119" EVENTS_2="226" I2="16.67177205138024" ID="CMP-003.15.01" LOG_CI_END="-0.21205353365762994" LOG_CI_START="-0.41235040983467786" LOG_EFFECT_SIZE="-0.3122019717461539" MODIFIED="2013-12-01 13:09:24 +0000" MODIFIED_BY="Hermann Blessberger" NO="1" P_CHI2="0.2896206236045049" P_Z="9.96457038474224E-10" STUDIES="10" TAU2="0.02201179521210527" TOTAL_1="576" TOTAL_2="556" WEIGHT="21.101557173146027" Z="6.109976672666365"><NAME>Before surgery</NAME><DICH_DATA CI_END="0.8969131509065325" CI_START="0.05911511257256819" EFFECT_SIZE="0.23026315789473684" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="16" LOG_CI_END="-0.047249608135544637" LOG_CI_START="-1.2283014790534492" LOG_EFFECT_SIZE="-0.637775543594497" MODIFIED="2013-11-21 01:17:07 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="885" O_E="0.0" SE="0.6937557152782261" STUDY_ID="STD-Oka-1980" TOTAL_1="19" TOTAL_2="35" VAR="0.48129699248120306" WEIGHT="1.3043151475391082"/><DICH_DATA CI_END="0.9625082004987383" CI_START="0.2097281543575606" EFFECT_SIZE="0.4492939666238768" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="19" LOG_CI_END="-0.016595561646807904" LOG_CI_START="-0.6783432649977698" LOG_EFFECT_SIZE="-0.3474694133222888" MODIFIED="2013-12-01 13:09:24 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="877" O_E="0.0" SE="0.38871387665231644" STUDY_ID="STD-Abel-1983" TOTAL_1="41" TOTAL_2="50" VAR="0.15109847790207226" WEIGHT="2.319931433216353"/><DICH_DATA CI_END="1.1085399331216403" CI_START="0.06960551579759253" EFFECT_SIZE="0.2777777777777778" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="9" LOG_CI_END="0.04475134239592844" LOG_CI_START="-1.157356343930503" LOG_EFFECT_SIZE="-0.5563025007672873" MODIFIED="2013-11-21 01:17:20 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="883" O_E="0.0" SE="0.706124005477162" STUDY_ID="STD-Myhre-1984" TOTAL_1="16" TOTAL_2="20" VAR="0.49861111111111117" WEIGHT="1.2750462925222805"/><DICH_DATA CI_END="1.0920886040087217" CI_START="0.18657087736694164" EFFECT_SIZE="0.4513888888888889" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="12" LOG_CI_END="0.03825787524694105" LOG_CI_START="-0.7291561461517292" LOG_EFFECT_SIZE="-0.3454491354523941" MODIFIED="2013-11-21 01:17:26 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="881" O_E="0.0" SE="0.4507827949302504" STUDY_ID="STD-Hammon-1984" TOTAL_1="24" TOTAL_2="26" VAR="0.2032051282051282" WEIGHT="2.0660629917250772"/><DICH_DATA CI_END="0.6607918354063609" CI_START="0.012506908177573097" EFFECT_SIZE="0.09090909090909091" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="11" LOG_CI_END="-0.17993533169837356" LOG_CI_START="-1.9028500386180767" LOG_EFFECT_SIZE="-1.041392685158225" MODIFIED="2013-11-21 01:17:35 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="882" O_E="0.0" SE="1.0120486274099798" STUDY_ID="STD-Lamb-1988" TOTAL_1="30" TOTAL_2="30" VAR="1.024242424242424" WEIGHT="0.7583936012367032"/><DICH_DATA CI_END="0.8651318953082401" CI_START="0.13362124391311758" EFFECT_SIZE="0.34" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="15" LOG_CI_END="-0.06291767630644172" LOG_CI_START="-0.8741244896090479" LOG_EFFECT_SIZE="-0.46852108295774486" MODIFIED="2013-11-21 01:17:42 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="884" O_E="0.0" SE="0.4765068976724385" STUDY_ID="STD-Nystr_x00f6_m-1993" TOTAL_1="50" TOTAL_2="51" VAR="0.22705882352941176" WEIGHT="1.9675006605014003"/><DICH_DATA CI_END="0.7316733754295464" CI_START="0.276762838173683" EFFECT_SIZE="0.45" ESTIMABLE="YES" EVENTS_1="18" EVENTS_2="40" LOG_CI_END="-0.13568274804766128" LOG_CI_START="-0.5578922244016514" LOG_EFFECT_SIZE="-0.3467874862246563" MODIFIED="2013-11-21 01:17:55 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="878" O_E="0.0" SE="0.2480079363809483" STUDY_ID="STD-Ali-1997" TOTAL_1="105" TOTAL_2="105" VAR="0.061507936507936505" WEIGHT="2.9413439130973518"/><DICH_DATA CI_END="0.8367549673280018" CI_START="0.38960932218699135" EFFECT_SIZE="0.5709706959706959" ESTIMABLE="YES" EVENTS_1="29" EVENTS_2="52" LOG_CI_END="-0.07740170080856265" LOG_CI_START="-0.40937066029975144" LOG_EFFECT_SIZE="-0.24338618055415703" MODIFIED="2013-11-21 01:18:02 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="886" O_E="0.0" SE="0.19500021007797613" STUDY_ID="STD-Pfisterer-1997" TOTAL_1="126" TOTAL_2="129" VAR="0.03802508193045483" WEIGHT="3.163446734568512"/><DICH_DATA CI_END="0.815131215366541" CI_START="0.13431350612509407" EFFECT_SIZE="0.33088235294117646" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="17" LOG_CI_END="-0.08877247528121683" LOG_CI_START="-0.8718803139085308" LOG_EFFECT_SIZE="-0.48032639459487386" MODIFIED="2013-11-21 01:18:10 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="880" O_E="0.0" SE="0.460001420856004" STUDY_ID="STD-Gomes-1999" TOTAL_1="40" TOTAL_2="45" VAR="0.2116013071895425" WEIGHT="2.030263690627449"/><DICH_DATA CI_END="0.9248471633511364" CI_START="0.48330986222891537" EFFECT_SIZE="0.6685714285714286" ESTIMABLE="YES" EVENTS_1="45" EVENTS_2="35" LOG_CI_END="-0.0339300311501147" LOG_CI_START="-0.3157743427301508" LOG_EFFECT_SIZE="-0.17485218694013277" MODIFIED="2013-11-21 01:18:18 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="879" O_E="0.0" SE="0.16555674377395627" STUDY_ID="STD-Auer-2004" TOTAL_1="125" TOTAL_2="65" VAR="0.027409035409035408" WEIGHT="3.2752527081117893"/></DICH_SUBGROUP><DICH_SUBGROUP CHI2="11.105626090589817" CI_END="0.8221459702714607" CI_START="0.3157566163631969" DF="6" EFFECT_SIZE="0.509507634613608" ESTIMABLE="YES" EVENTS_1="46" EVENTS_2="90" I2="45.97332963439128" ID="CMP-003.15.02" LOG_CI_END="-0.0850510675507747" LOG_CI_START="-0.5006475404720098" LOG_EFFECT_SIZE="-0.29284930401139225" MODIFIED="2013-11-21 01:19:15 +0000" MODIFIED_BY="Hermann Blessberger" NO="2" P_CHI2="0.08516638390817477" P_Z="0.005741854440638381" STUDIES="7" TAU2="0.17421265794322793" TOTAL_1="310" TOTAL_2="290" WEIGHT="12.851720071012396" Z="2.7621701634062283"><NAME>During surgery</NAME><DICH_DATA CI_END="63.82881484401465" CI_START="0.12392766917779852" EFFECT_SIZE="2.8125" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.8050167806434498" LOG_CI_START="-0.9068317184046119" LOG_EFFECT_SIZE="0.4490925311194189" MODIFIED="2013-11-21 01:18:26 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="889" O_E="0.0" SE="1.592953232207399" STUDY_ID="STD-Cork-1995" TOTAL_1="15" TOTAL_2="14" VAR="2.5374999999999996" WEIGHT="0.35004622512771605"/><DICH_DATA CI_END="0.7907637030184065" CI_START="0.0484655463980742" EFFECT_SIZE="0.19576719576719576" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="14" LOG_CI_END="-0.10195327352704722" LOG_CI_START="-1.3145668866854512" LOG_EFFECT_SIZE="-0.7082600801062492" MODIFIED="2013-11-21 01:18:32 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="887" O_E="0.0" SE="0.7122952389034392" STUDY_ID="STD-Babin_x002d_Ebell-1996" TOTAL_1="27" TOTAL_2="37" VAR="0.5073645073645074" WEIGHT="1.260743327592702"/><DICH_DATA CI_END="5.055834822644325" CI_START="0.4316467581119249" EFFECT_SIZE="1.4772727272727273" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="4" LOG_CI_END="0.703792876827747" LOG_CI_START="-0.36487151651441074" LOG_EFFECT_SIZE="0.16946068015666815" MODIFIED="2013-11-21 01:18:38 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="888" O_E="0.0" SE="0.6277387546232461" STUDY_ID="STD-Booth-2004" TOTAL_1="33" TOTAL_2="39" VAR="0.394055944055944" WEIGHT="1.4749099402383987"/><DICH_DATA CI_END="1.6818496358282289" CI_START="0.42805642238869207" EFFECT_SIZE="0.8484848484848485" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="11" LOG_CI_END="0.22578716551115877" LOG_CI_START="-0.3684989825824953" LOG_EFFECT_SIZE="-0.07135590853566824" MODIFIED="2013-11-21 01:18:53 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="893" O_E="0.0" SE="0.3490866251540896" STUDY_ID="STD-Sun-2011" TOTAL_1="30" TOTAL_2="28" VAR="0.12186147186147188" WEIGHT="2.4917241985235545"/><DICH_DATA CI_END="0.6324601313324618" CI_START="0.13450562372243266" EFFECT_SIZE="0.2916666666666667" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="24" LOG_CI_END="-0.1989668461016144" LOG_CI_START="-0.871259557293084" LOG_EFFECT_SIZE="-0.5351132016973492" MODIFIED="2013-11-21 01:19:03 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="891" O_E="0.0" SE="0.39490806645646137" STUDY_ID="STD-Sezai-2011" TOTAL_1="70" TOTAL_2="70" VAR="0.15595238095238093" WEIGHT="2.2936774355115386"/><DICH_DATA CI_END="0.7482025935275345" CI_START="0.1529700826342874" EFFECT_SIZE="0.3383084577114428" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="12" LOG_CI_END="-0.12598079072115415" LOG_CI_START="-0.8153934987073509" LOG_EFFECT_SIZE="-0.47068714471425255" MODIFIED="2013-11-21 01:19:08 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="892" O_E="0.0" SE="0.404964437319035" STUDY_ID="STD-Sezai-2012" TOTAL_1="67" TOTAL_2="34" VAR="0.1639961954931226" WEIGHT="2.2514539278250134"/><DICH_DATA CI_END="0.9285567066549609" CI_START="0.2912046168662018" EFFECT_SIZE="0.52" ESTIMABLE="YES" EVENTS_1="13" EVENTS_2="25" LOG_CI_END="-0.032191568892075674" LOG_CI_START="-0.5358017438383259" LOG_EFFECT_SIZE="-0.28399665636520083" MODIFIED="2013-11-21 01:19:15 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="890" O_E="0.0" SE="0.29582310967399855" STUDY_ID="STD-Ogawa-2013" TOTAL_1="68" TOTAL_2="68" VAR="0.08751131221719458" WEIGHT="2.7291650161934737"/></DICH_SUBGROUP><DICH_SUBGROUP CHI2="173.3594725739682" CI_END="0.5539736600068722" CI_START="0.3283481596547783" DF="30" EFFECT_SIZE="0.4264929445611948" ESTIMABLE="YES" EVENTS_1="407" EVENTS_2="773" I2="82.69491735607367" ID="CMP-003.15.03" LOG_CI_END="-0.25651088434308494" LOG_CI_START="-0.48366541352901204" LOG_EFFECT_SIZE="-0.37008814893604847" MODIFIED="2013-12-01 13:24:20 +0000" MODIFIED_BY="Hermann Blessberger" NO="3" P_CHI2="-2.220446049250313E-16" P_Z="1.6974259892821704E-10" STUDIES="31" TAU2="0.35544381973844674" TOTAL_1="2374" TOTAL_2="2314" WEIGHT="66.04672275584159" Z="6.386484527685031"><NAME>After surgery</NAME><DICH_DATA CI_END="2.4143738176207648" CI_START="0.18041945154510514" EFFECT_SIZE="0.66" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="5" LOG_CI_END="0.38280451280407934" LOG_CI_START="-0.7437166417203419" LOG_EFFECT_SIZE="-0.1804560644581313" MODIFIED="2013-11-21 01:19:23 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="917" O_E="0.0" SE="0.6617241025372945" STUDY_ID="STD-Salazar-1979" TOTAL_1="20" TOTAL_2="22" VAR="0.43787878787878787" WEIGHT="1.3839827854556965"/><DICH_DATA CI_END="1.0124518038855774" CI_START="0.20532344839946126" EFFECT_SIZE="0.4559386973180077" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="24" LOG_CI_END="0.00537435849931325" LOG_CI_START="-0.6875614503908136" LOG_EFFECT_SIZE="-0.3410935459457502" MODIFIED="2013-11-21 01:19:30 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="919" O_E="0.0" SE="0.4070339242296343" STUDY_ID="STD-Stephenson-1980" TOTAL_1="87" TOTAL_2="136" VAR="0.16567661547377568" WEIGHT="2.24282863501884"/><DICH_DATA CI_END="0.5496310050546848" CI_START="0.03392818225948094" EFFECT_SIZE="0.13655761024182078" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="19" LOG_CI_END="-0.25992877641364504" LOG_CI_START="-1.469439407546866" LOG_EFFECT_SIZE="-0.8646840919802555" MODIFIED="2013-11-21 01:19:37 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="911" O_E="0.0" SE="0.7104725319018379" STUDY_ID="STD-Mohr-1981" TOTAL_1="37" TOTAL_2="48" VAR="0.504771218587008" WEIGHT="1.264947173628923"/><DICH_DATA CI_END="1.4875364844811094" CI_START="0.02439011043885608" EFFECT_SIZE="0.19047619047619047" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="6" LOG_CI_END="0.17246762637672552" LOG_CI_START="-1.6127862331886396" LOG_EFFECT_SIZE="-0.7201593034059569" MODIFIED="2013-11-21 01:19:43 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="924" O_E="0.0" SE="1.048666954257824" STUDY_ID="STD-Williams-1982" TOTAL_1="28" TOTAL_2="32" VAR="1.099702380952381" WEIGHT="0.7167021717553194"/><DICH_DATA CI_END="0.6999722648647813" CI_START="0.0656002668274423" EFFECT_SIZE="0.21428571428571427" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="14" LOG_CI_END="-0.15491916777833195" LOG_CI_START="-1.1830943941388192" LOG_EFFECT_SIZE="-0.6690067809585756" MODIFIED="2013-11-21 01:19:51 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="918" O_E="0.0" SE="0.603955217513604" STUDY_ID="STD-Silverman-1982" TOTAL_1="50" TOTAL_2="50" VAR="0.36476190476190473" WEIGHT="1.5426603511830448"/><DICH_DATA CI_END="2.0488361448048726" CI_START="0.32963107650375956" EFFECT_SIZE="0.8218029350104822" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="9" LOG_CI_END="0.3115072271896002" LOG_CI_START="-0.4819718512289136" LOG_EFFECT_SIZE="-0.08523231201965667" MODIFIED="2013-11-21 01:20:02 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="902" O_E="0.0" SE="0.46609353844781976" STUDY_ID="STD-Ivey-1983" TOTAL_1="53" TOTAL_2="56" VAR="0.21724318658280922" WEIGHT="2.006896948159389"/><DICH_DATA CI_END="1.5715363292104452" CI_START="0.18776337809660357" EFFECT_SIZE="0.5432098765432098" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="9" LOG_CI_END="0.19632442505659703" LOG_CI_START="-0.7263891098415217" LOG_EFFECT_SIZE="-0.2650323423924623" MODIFIED="2013-11-21 01:20:11 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="912" O_E="0.0" SE="0.5420064979048165" STUDY_ID="STD-Ormerod-1984" TOTAL_1="27" TOTAL_2="33" VAR="0.2937710437710438" WEIGHT="1.7358990379116523"/><DICH_DATA CI_END="1.1517322070933487" CI_START="0.8726150111164188" EFFECT_SIZE="1.0025062656641603" ESTIMABLE="YES" EVENTS_1="20" EVENTS_2="19" LOG_CI_END="0.06135151163809717" LOG_CI_START="-0.059177320355668896" LOG_EFFECT_SIZE="0.0010870956412141369" MODIFIED="2013-11-21 01:20:17 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="923" O_E="0.0" SE="0.07079923254047887" STUDY_ID="STD-White-1984" TOTAL_1="21" TOTAL_2="20" VAR="0.005012531328320802" WEIGHT="3.5391407670636537"/><DICH_DATA CI_END="0.8109759442010569" CI_START="0.1413241180444068" EFFECT_SIZE="0.3385416666666667" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="18" LOG_CI_END="-0.09099202797834484" LOG_CI_START="-0.8497837161430433" LOG_EFFECT_SIZE="-0.470387872060694" MODIFIED="2013-11-21 01:20:35 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="909" O_E="0.0" SE="0.4457179937073776" STUDY_ID="STD-Materne-1985" TOTAL_1="32" TOTAL_2="39" VAR="0.1986645299145299" WEIGHT="2.0859540657831843"/><DICH_DATA CI_END="0.906876568196414" CI_START="0.1954900201161221" EFFECT_SIZE="0.42105263157894735" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="19" LOG_CI_END="-0.042451819223332604" LOG_CI_START="-0.7088754086984382" LOG_EFFECT_SIZE="-0.3756636139608854" MODIFIED="2013-11-21 01:20:27 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="907" O_E="0.0" SE="0.3914605153076481" STUDY_ID="STD-Matangi-1985" TOTAL_1="82" TOTAL_2="82" VAR="0.15324133504492937" WEIGHT="2.308267330724087"/><DICH_DATA CI_END="0.3925291896546882" CI_START="0.0015155153127434649" EFFECT_SIZE="0.024390243902439025" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="20" LOG_CI_END="-0.4061280422700622" LOG_CI_START="-2.819439671169409" LOG_EFFECT_SIZE="-1.6127838567197355" MODIFIED="2013-11-21 01:20:41 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="896" O_E="0.0" SE="1.4175911969007033" STUDY_ID="STD-Daudon-1986" TOTAL_1="50" TOTAL_2="50" VAR="2.0095648015303684" WEIGHT="0.4310098780077201"/><DICH_DATA CI_END="1.0179832018909118" CI_START="0.14531575158417248" EFFECT_SIZE="0.38461538461538464" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="13" LOG_CI_END="0.007740611609507653" LOG_CI_START="-0.8376873075511435" LOG_EFFECT_SIZE="-0.4149733479708179" MODIFIED="2013-11-21 01:20:57 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="921" O_E="0.0" SE="0.4966085446506601" STUDY_ID="STD-Vecht-1986" TOTAL_1="66" TOTAL_2="66" VAR="0.24662004662004666" WEIGHT="1.8934282300763219"/><DICH_DATA CI_END="0.5400329023288767" CI_START="0.10939334035325655" EFFECT_SIZE="0.24305555555555555" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="18" LOG_CI_END="-0.2675797793167253" LOG_CI_START="-0.9610091161732227" LOG_EFFECT_SIZE="-0.614294447744974" MODIFIED="2013-11-21 01:20:47 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="904" O_E="0.0" SE="0.4073238250000832" STUDY_ID="STD-Janssen-1986" TOTAL_1="80" TOTAL_2="50" VAR="0.1659126984126984" WEIGHT="2.2416221554842566"/><DICH_DATA CI_END="0.421579851024765" CI_START="0.08503552553709799" EFFECT_SIZE="0.18933901918976545" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="35" LOG_CI_END="-0.3751201539574404" LOG_CI_START="-1.070399599915524" LOG_EFFECT_SIZE="-0.7227598769364822" MODIFIED="2013-11-21 01:21:07 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="905" O_E="0.0" SE="0.4084105882445427" STUDY_ID="STD-Khuri-1987" TOTAL_1="67" TOTAL_2="74" VAR="0.16679920859025338" WEIGHT="2.2371032940188673"/><DICH_DATA CI_END="0.9962321240462663" CI_START="0.1877050579938394" EFFECT_SIZE="0.43243243243243246" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="15" LOG_CI_END="-0.0016394583162494887" LOG_CI_START="-0.7265240245058909" LOG_EFFECT_SIZE="-0.3640817414110702" MODIFIED="2013-11-21 01:21:14 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="915" O_E="0.0" SE="0.42580078241626834" STUDY_ID="STD-Rubin-1987" TOTAL_1="37" TOTAL_2="40" VAR="0.18130630630630631" WEIGHT="2.165661236992835"/><DICH_DATA CI_END="4.126826287091888" CI_START="0.7815504113324163" EFFECT_SIZE="1.7959183673469388" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="7" LOG_CI_END="0.6156161882509973" LOG_CI_START="-0.10704300400768743" LOG_EFFECT_SIZE="0.25428659212165494" MODIFIED="2013-12-01 13:24:20 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="906" O_E="0.0" SE="0.4244935867534458" STUDY_ID="STD-Martinussen-1988" TOTAL_1="35" TOTAL_2="40" VAR="0.18019480519480519" WEIGHT="2.1709731595220623"/><DICH_DATA CI_END="0.9337223063907559" CI_START="0.11899802580555667" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="12" LOG_CI_END="-0.02978226588341088" LOG_CI_START="-0.9244602435559142" LOG_EFFECT_SIZE="-0.47712125471966244" MODIFIED="2013-11-21 01:21:27 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="908" O_E="0.0" SE="0.5255382728122435" STUDY_ID="STD-Matangi-1989" TOTAL_1="35" TOTAL_2="35" VAR="0.27619047619047615" WEIGHT="1.7914720907596218"/><DICH_DATA CI_END="0.8089575542744424" CI_START="0.33649691357538647" EFFECT_SIZE="0.5217391304347826" ESTIMABLE="YES" EVENTS_1="24" EVENTS_2="46" LOG_CI_END="-0.09207426507251505" LOG_CI_START="-0.47301891486742115" LOG_EFFECT_SIZE="-0.28254658996996806" MODIFIED="2013-11-21 01:21:37 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="920" O_E="0.0" SE="0.22376877299595657" STUDY_ID="STD-Suttorp-1991" TOTAL_1="150" TOTAL_2="150" VAR="0.05007246376811594" WEIGHT="3.0454679052210047"/><DICH_DATA CI_END="1.9174334705591203" CI_START="0.15030479565965907" EFFECT_SIZE="0.5368421052631579" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="5" LOG_CI_END="0.2827203041097743" LOG_CI_START="-0.8230271624915971" LOG_EFFECT_SIZE="-0.2701534291909114" MODIFIED="2013-11-21 01:21:43 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="903" O_E="0.0" SE="0.6495215354198813" STUDY_ID="STD-Jacquet-1994" TOTAL_1="19" TOTAL_2="17" VAR="0.4218782249742002" WEIGHT="1.4158526983455177"/><DICH_DATA CI_END="0.967053167072245" CI_START="0.41868044849390096" EFFECT_SIZE="0.6363067292644757" ESTIMABLE="YES" EVENTS_1="38" EVENTS_2="30" LOG_CI_END="-0.014549648428526057" LOG_CI_START="-0.37811731928423464" LOG_EFFECT_SIZE="-0.19633348385638036" MODIFIED="2013-11-21 01:21:55 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="901" O_E="0.0" SE="0.213561449549639" STUDY_ID="STD-Graham-1996" TOTAL_1="213" TOTAL_2="107" VAR="0.045608492733743004" WEIGHT="3.088142517453621"/><DICH_DATA CI_END="1.8214515190598082" CI_START="0.4677977958792884" EFFECT_SIZE="0.9230769230769231" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="13" LOG_CI_END="0.26041761626692334" LOG_CI_START="-0.32994182878534717" LOG_EFFECT_SIZE="-0.03476210625921192" MODIFIED="2013-11-21 01:22:02 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="914" O_E="0.0" SE="0.3467800603500874" STUDY_ID="STD-Paull-1997" TOTAL_1="50" TOTAL_2="50" VAR="0.12025641025641025" WEIGHT="2.5018950571771135"/><DICH_DATA CI_END="0.7899548058160761" CI_START="0.21326202895259727" EFFECT_SIZE="0.41044776119402987" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="24" LOG_CI_END="-0.10239775446416542" LOG_CI_START="-0.6710864632769621" LOG_EFFECT_SIZE="-0.38674210887056376" MODIFIED="2013-11-21 01:22:14 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="898" O_E="0.0" SE="0.33405056261114596" STUDY_ID="STD-Dy-1998" TOTAL_1="67" TOTAL_2="66" VAR="0.11158977838082317" WEIGHT="2.5582801625008575"/><DICH_DATA CI_END="0.29201086050273417" CI_START="0.0400237272634076" EFFECT_SIZE="0.10810810810810811" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="37" LOG_CI_END="-0.5346009959190617" LOG_CI_START="-1.3976824695590033" LOG_EFFECT_SIZE="-0.9661417327390326" MODIFIED="2013-11-21 01:22:21 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="922" O_E="0.0" SE="0.5069783299382993" STUDY_ID="STD-Wenke-1999" TOTAL_1="100" TOTAL_2="100" VAR="0.257027027027027" WEIGHT="1.8562484729805564"/><DICH_DATA CI_END="0.559711576637503" CI_START="0.20705225265439542" EFFECT_SIZE="0.3404255319148936" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="47" LOG_CI_END="-0.2520357103921946" LOG_CI_START="-0.6839200401673907" LOG_EFFECT_SIZE="-0.4679778752797927" MODIFIED="2013-11-21 01:22:30 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="899" O_E="0.0" SE="0.2536909931718616" STUDY_ID="STD-Evrard-2000" TOTAL_1="103" TOTAL_2="103" VAR="0.06435912001652552" WEIGHT="2.916482420759102"/><DICH_DATA CI_END="0.8589583309812318" CI_START="0.26561019438408295" EFFECT_SIZE="0.47764849969381507" ESTIMABLE="YES" EVENTS_1="13" EVENTS_2="23" LOG_CI_END="-0.0660279037634654" LOG_CI_START="-0.5757552603289101" LOG_EFFECT_SIZE="-0.3208915820461878" MODIFIED="2013-11-21 01:22:36 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="894" O_E="0.0" SE="0.29941637243765074" STUDY_ID="STD-Bert-2001" TOTAL_1="71" TOTAL_2="60" VAR="0.08965016408372196" WEIGHT="2.7130671652443916"/><DICH_DATA CI_END="0.925811812744811" CI_START="0.17282129888323441" EFFECT_SIZE="0.4" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="15" LOG_CI_END="-0.03347728220825417" LOG_CI_START="-0.762402735135821" LOG_EFFECT_SIZE="-0.3979400086720376" MODIFIED="2013-11-21 01:22:43 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="910" O_E="0.0" SE="0.42817441928883765" STUDY_ID="STD-Matsuura-2001" TOTAL_1="40" TOTAL_2="40" VAR="0.18333333333333335" WEIGHT="2.1560405994935294"/><DICH_DATA CI_END="0.7105931245191439" CI_START="0.13488819843100122" EFFECT_SIZE="0.30959752321981426" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="19" LOG_CI_END="-0.14837899892640086" LOG_CI_START="-0.8700260457358048" LOG_EFFECT_SIZE="-0.5092025223311029" MODIFIED="2013-11-21 01:22:51 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="900" O_E="0.0" SE="0.4238990475063375" STUDY_ID="STD-Forlani-2002" TOTAL_1="51" TOTAL_2="50" VAR="0.17969040247678017" WEIGHT="2.1733923321315065"/><DICH_DATA CI_END="0.8846657886054342" CI_START="0.2374562768789701" EFFECT_SIZE="0.4583333333333333" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="24" LOG_CI_END="-0.05322076724324717" LOG_CI_START="-0.6244163458635148" LOG_EFFECT_SIZE="-0.338818556553381" MODIFIED="2013-11-21 01:23:14 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="897" O_E="0.0" SE="0.3355231103452601" STUDY_ID="STD-De-Azevedo-L_x00fa_cio-2003" TOTAL_1="100" TOTAL_2="100" VAR="0.11257575757575758" WEIGHT="2.551737587363271"/><DICH_DATA CI_END="0.9484074945855946" CI_START="0.674815418112704" EFFECT_SIZE="0.8" ESTIMABLE="YES" EVENTS_1="156" EVENTS_2="195" LOG_CI_END="-0.023005022761850884" LOG_CI_START="-0.17081500325426194" LOG_EFFECT_SIZE="-0.09691001300805639" MODIFIED="2013-11-21 01:23:04 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="895" O_E="0.0" SE="0.08682431421244592" STUDY_ID="STD-Connolly-2003" TOTAL_1="500" TOTAL_2="500" VAR="0.007538461538461539" WEIGHT="3.507270529285456"/><DICH_DATA CI_END="0.5360855287701065" CI_START="0.05040605255789461" EFFECT_SIZE="0.1643835616438356" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="17" LOG_CI_END="-0.27076591607279954" LOG_CI_START="-1.2975173120728625" LOG_EFFECT_SIZE="-0.7841416140728311" MODIFIED="2013-11-21 01:23:22 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="913" O_E="0.0" SE="0.6031188525118167" STUDY_ID="STD-Osada-2012" TOTAL_1="73" TOTAL_2="68" VAR="0.36375235025517055" WEIGHT="1.5451063447990587"/><DICH_DATA CI_END="0.8263453347887832" CI_START="0.17017703625802433" EFFECT_SIZE="0.375" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="16" LOG_CI_END="-0.0828384204148983" LOG_CI_START="-0.7690990441296639" LOG_EFFECT_SIZE="-0.42596873227228116" MODIFIED="2013-11-21 01:23:33 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="916" O_E="0.0" SE="0.4031128874149275" STUDY_ID="STD-Sakaguchi-2012" TOTAL_1="30" TOTAL_2="30" VAR="0.1625" WEIGHT="2.259189651541138"/></DICH_SUBGROUP></DICH_OUTCOME><DICH_OUTCOME CHI2="6.069811265865222" CI_END="0.9359710466383024" CI_START="0.5725807491224083" CI_STUDY="95" CI_TOTAL="95" DF="7" EFFECT_MEASURE="RR" EFFECT_SIZE="0.7320648899114366" ESTIMABLE="YES" EVENTS_1="108" EVENTS_2="144" I2="0.0" I2_Q="0.0" ID="CMP-003.16" LOG_CI_END="-0.028737585535081187" LOG_CI_START="-0.24216325759010013" LOG_EFFECT_SIZE="-0.13545042156259066" METHOD="MH" MODIFIED="2017-06-17 15:41:23 +0100" MODIFIED_BY="Hermann Blessberger" NO="16" P_CHI2="0.5316220044239742" P_Q="0.7908607247553396" P_Z="0.012854359918644953" Q="0.07032737384374924" RANDOM="NO" SCALE="100.0" SORT_BY="YEAR" STUDIES="8" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="4380" TOTAL_2="4364" WEIGHT="100.0" Z="2.487778957397476"><NAME>All supraventricular arrhythmias&#8212;non-cardiac surgery</NAME><GROUP_LABEL_1>Beta-blocker</GROUP_LABEL_1><GROUP_LABEL_2>Control</GROUP_LABEL_2><GRAPH_LABEL_1>Favours beta-blockers</GRAPH_LABEL_1><GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2><DICH_SUBGROUP CHI2="1.8546446785574604" CI_END="0.9357320176086417" CI_START="0.5627824505454572" DF="3" EFFECT_SIZE="0.7256814438330611" ESTIMABLE="YES" EVENTS_1="99" EVENTS_2="137" I2="0.0" ID="CMP-003.16.01" LOG_CI_END="-0.028848510169595765" LOG_CI_START="-0.24965945379255347" LOG_EFFECT_SIZE="-0.13925398198107464" MODIFIED="2013-12-08 09:36:57 +0000" MODIFIED_BY="Hermann Blessberger" NO="1" P_CHI2="0.6031166270587693" P_Z="0.013432390256466422" STUDIES="4" TAU2="0.0" TOTAL_1="4280" TOTAL_2="4291" WEIGHT="93.88403192309383" Z="2.472094769476082"><NAME>Before surgery</NAME><DICH_DATA CI_END="1.5981153088603466" CI_START="0.025243867342839378" EFFECT_SIZE="0.20085470085470086" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="6" LOG_CI_END="0.20360811177088864" LOG_CI_START="-1.5978441107197394" LOG_EFFECT_SIZE="-0.6971179994744253" MODIFIED="2013-11-21 01:27:02 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="926" O_E="0.0" SE="1.0581819528233132" STUDY_ID="STD-Burns-1988" TOTAL_1="39" TOTAL_2="47" VAR="1.1197490452809604" WEIGHT="3.7434059732218747"/><DICH_DATA CI_END="2.3517506825099073" CI_START="0.24274010071578214" EFFECT_SIZE="0.7555555555555555" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="5" LOG_CI_END="0.3713912787351326" LOG_CI_START="-0.6148584722013096" LOG_EFFECT_SIZE="-0.12173359673308856" MODIFIED="2013-11-21 01:27:09 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="927" O_E="0.0" SE="0.5793279857150695" STUDY_ID="STD-Jakobsen-1997" TOTAL_1="18" TOTAL_2="17" VAR="0.33562091503267977" WEIGHT="3.5377243263415523"/><DICH_DATA CI_END="1.9266406466126647" CI_START="0.1351098895231352" EFFECT_SIZE="0.5102040816326531" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="6" LOG_CI_END="0.28480071841945853" LOG_CI_START="-0.8693128611324107" LOG_EFFECT_SIZE="-0.292256071356476" MODIFIED="2013-11-21 01:27:14 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="925" O_E="0.0" SE="0.677932029583124" STUDY_ID="STD-Bayliff-1999" TOTAL_1="49" TOTAL_2="50" VAR="0.45959183673469384" WEIGHT="4.085654693384352"/><DICH_DATA CI_END="0.9931562131790224" CI_START="0.5798648580922154" EFFECT_SIZE="0.7588783740616515" ESTIMABLE="YES" EVENTS_1="91" EVENTS_2="120" LOG_CI_END="-0.002982436110955725" LOG_CI_START="-0.23667321027073493" LOG_EFFECT_SIZE="-0.11982782319084534" MODIFIED="2013-12-08 09:36:57 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="928" O_E="0.0" SE="0.13727111752944285" STUDY_ID="STD-POISE-2008" TOTAL_1="4174" TOTAL_2="4177" VAR="0.01884335970778211" WEIGHT="82.51724693014606"/></DICH_SUBGROUP><DICH_SUBGROUP CHI2="4.091462791284586" CI_END="2.168027518364566" CI_START="0.3177962913781175" DF="3" EFFECT_SIZE="0.8300548806807672" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="7" I2="26.676590915346008" ID="CMP-003.16.02" LOG_CI_END="0.33606479031931763" LOG_CI_START="-0.4978511752325313" LOG_EFFECT_SIZE="-0.08089319245660684" MODIFIED="2017-06-17 15:41:23 +0100" MODIFIED_BY="Hermann Blessberger" NO="2" P_CHI2="0.25175576985196724" P_Z="0.7037607898021951" STUDIES="4" TAU2="0.0" TOTAL_1="100" TOTAL_2="73" WEIGHT="6.115968076906168" Z="0.38024873094855943"><NAME>During surgery</NAME><DICH_DATA CI_END="3.694376342661255" CI_START="0.09210696101758215" EFFECT_SIZE="0.5833333333333334" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="2" LOG_CI_END="0.5675411345302878" LOG_CI_START="-1.0357075465970236" LOG_EFFECT_SIZE="-0.23408320603336796" MODIFIED="2013-11-21 01:27:29 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="934" O_E="0.0" SE="0.9417562115031479" STUDY_ID="STD-Coleman-1980" TOTAL_1="24" TOTAL_2="14" VAR="0.886904761904762" WEIGHT="1.737829493641464"/><DICH_DATA CI_END="60.21015642179821" CI_START="0.11637439315284949" EFFECT_SIZE="2.6470588235294117" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.7796697554754684" LOG_CI_START="-0.934142570681329" LOG_EFFECT_SIZE="0.42276359239706973" MODIFIED="2013-11-21 01:27:34 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="935" O_E="0.0" SE="1.5941067939721714" STUDY_ID="STD-Liu-1986" TOTAL_1="16" TOTAL_2="14" VAR="2.541176470588235" WEIGHT="0.3654420094050735"/><DICH_DATA CI_END="22.711113534056025" CI_START="0.3962817581138951" EFFECT_SIZE="3.0" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="1" LOG_CI_END="1.3562384283562463" LOG_CI_START="-0.40199591891692144" LOG_EFFECT_SIZE="0.47712125471966244" MODIFIED="2013-11-21 01:27:41 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="936" O_E="0.0" SE="1.0327955589886444" STUDY_ID="STD-Sandler-1990" TOTAL_1="30" TOTAL_2="15" VAR="1.0666666666666667" WEIGHT="0.9171877883107726"/><DICH_DATA CI_END="1.9774190029426781" CI_START="0.006243329812231785" EFFECT_SIZE="0.1111111111111111" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="4" LOG_CI_END="0.29609870339830113" LOG_CI_START="-2.204583722276951" LOG_EFFECT_SIZE="-0.9542425094393249" MODIFIED="2013-11-21 01:27:46 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="937" O_E="0.0" SE="1.4689132354192893" STUDY_ID="STD-Lai-2006" TOTAL_1="30" TOTAL_2="30" VAR="2.1577060931899643" WEIGHT="3.0955087855488577"/></DICH_SUBGROUP><DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-003.16.03" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2013-11-21 01:26:51 +0000" MODIFIED_BY="Hermann Blessberger" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0"><NAME>After surgery</NAME></DICH_SUBGROUP></DICH_OUTCOME><DICH_OUTCOME CHI2="4.012670954791197" CI_END="1.0833277873645892" CI_START="0.30941258170230584" CI_STUDY="95" CI_TOTAL="95" DF="4" EFFECT_MEASURE="RR" EFFECT_SIZE="0.578960488736774" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="24" I2="0.3157735815857974" I2_Q="0.0" ID="CMP-003.17" LOG_CI_END="0.03475988294556186" LOG_CI_START="-0.5094620304789664" LOG_EFFECT_SIZE="-0.23735107376670225" METHOD="MH" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" NO="17" P_CHI2="0.4042939533035771" P_Q="0.8261938742431384" P_Z="0.08734077372203604" Q="0.04821785488771626" RANDOM="NO" SCALE="100.0" SORT_BY="YEAR" STUDIES="5" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="228" TOTAL_2="234" WEIGHT="100.0" Z="1.7095950927347552"><NAME>Ventricular extrasystoles&#8212;cardiac surgery</NAME><GROUP_LABEL_1>Beta-blocker</GROUP_LABEL_1><GROUP_LABEL_2>Control</GROUP_LABEL_2><GRAPH_LABEL_1>Favours beta-blocker</GRAPH_LABEL_1><GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2><DICH_SUBGROUP CHI2="0.0" CI_END="9.476134023266496" CI_START="0.017892335903448454" DF="0" EFFECT_SIZE="0.4117647058823529" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" I2="0.0" ID="CMP-003.17.01" LOG_CI_END="0.9766311944265692" LOG_CI_START="-1.7473329571546035" LOG_EFFECT_SIZE="-0.38535088136401713" MODIFIED="2013-11-23 14:03:45 +0000" MODIFIED_BY="Hermann Blessberger" NO="1" P_CHI2="1.0" P_Z="0.5792091860689961" STUDIES="1" TAU2="0.0" TOTAL_1="16" TOTAL_2="20" WEIGHT="5.852755037195978" Z="0.5545402265634287"><NAME>Before surgery</NAME><DICH_DATA CI_END="9.4761340232665" CI_START="0.017892335903448454" EFFECT_SIZE="0.4117647058823529" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.9766311944265694" LOG_CI_START="-1.7473329571546035" LOG_EFFECT_SIZE="-0.38535088136401713" MODIFIED="2013-11-23 14:03:45 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="918" O_E="0.0" SE="1.600070026478796" STUDY_ID="STD-Myhre-1984" TOTAL_1="16" TOTAL_2="20" VAR="2.5602240896358546" WEIGHT="5.852755037195978"/></DICH_SUBGROUP><DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-003.17.02" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2013-11-23 14:00:16 +0000" MODIFIED_BY="Hermann Blessberger" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0"><NAME>During surgery</NAME></DICH_SUBGROUP><DICH_SUBGROUP CHI2="3.9710355495881804" CI_END="1.1167701386381899" CI_START="0.3110206566870053" DF="3" EFFECT_SIZE="0.5893543771685146" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="23" I2="24.452955342816875" ID="CMP-003.17.03" LOG_CI_END="0.0479637928166584" LOG_CI_START="-0.5072107659980394" LOG_EFFECT_SIZE="-0.2296234865906905" MODIFIED="2013-11-23 14:04:16 +0000" MODIFIED_BY="Hermann Blessberger" NO="3" P_CHI2="0.2646088730560523" P_Z="0.10495215082090184" STUDIES="4" TAU2="0.0" TOTAL_1="212" TOTAL_2="214" WEIGHT="94.14724496280402" Z="1.6213054311535384"><NAME>After surgery</NAME><DICH_DATA CI_END="33.26691095999438" CI_START="0.4041386487796315" EFFECT_SIZE="3.6666666666666665" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="1" LOG_CI_END="1.5220124757917959" LOG_CI_START="-0.39346961491467086" LOG_EFFECT_SIZE="0.5642714304385625" MODIFIED="2013-11-23 14:03:56 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="922" O_E="0.0" SE="1.125163661870248" STUDY_ID="STD-Ormerod-1984" TOTAL_1="27" TOTAL_2="33" VAR="1.265993265993266" WEIGHT="3.924788672002009"/><DICH_DATA CI_END="1.674749508363392" CI_START="0.023884168826590092" EFFECT_SIZE="0.2" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="5" LOG_CI_END="0.22394985897240968" LOG_CI_START="-1.621889867644447" LOG_EFFECT_SIZE="-0.6989700043360187" MODIFIED="2013-11-23 14:04:03 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="920" O_E="0.0" SE="1.084255392468749" STUDY_ID="STD-Matangi-1985" TOTAL_1="82" TOTAL_2="82" VAR="1.175609756097561" WEIGHT="21.804381511122273"/><DICH_DATA CI_END="1.1105091403706633" CI_START="0.2140065681230463" EFFECT_SIZE="0.4875" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="15" LOG_CI_END="0.04552213748710874" LOG_CI_START="-0.6695728974179976" LOG_EFFECT_SIZE="-0.3120253799654444" MODIFIED="2013-11-23 14:04:10 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="921" O_E="0.0" SE="0.420050363280771" STUDY_ID="STD-Materne-1985" TOTAL_1="32" TOTAL_2="39" VAR="0.1764423076923077" WEIGHT="58.96396126951375"/><DICH_DATA CI_END="5.819752673480798" CI_START="0.12271037260707346" EFFECT_SIZE="0.8450704225352113" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="2" LOG_CI_END="0.7649045284944104" LOG_CI_START="-0.9111187251652737" LOG_EFFECT_SIZE="-0.07310709833543166" MODIFIED="2013-11-23 14:04:16 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="919" O_E="0.0" SE="0.9845043556486075" STUDY_ID="STD-Bert-2001" TOTAL_1="71" TOTAL_2="60" VAR="0.9692488262910798" WEIGHT="9.454113510165993"/></DICH_SUBGROUP></DICH_OUTCOME><DICH_OUTCOME CHI2="4.640203931433374" CI_END="0.3668597252052659" CI_START="0.13250031526023334" CI_STUDY="95" CI_TOTAL="95" DF="8" EFFECT_MEASURE="RR" EFFECT_SIZE="0.22047455464515697" ESTIMABLE="YES" EVENTS_1="18" EVENTS_2="61" I2="0.0" I2_Q="66.29339993233039" ID="CMP-003.18" LOG_CI_END="-0.4354999635811673" LOG_CI_START="-0.8777830884017633" LOG_EFFECT_SIZE="-0.6566415259914653" METHOD="MH" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" NO="18" P_CHI2="0.7952478116781712" P_Q="0.08499114988567547" P_Z="5.892752659931927E-9" Q="2.966778013778882" RANDOM="NO" SCALE="100.0" SORT_BY="YEAR" STUDIES="9" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="293" TOTAL_2="199" WEIGHT="100.0" Z="5.819773215262233"><NAME>Ventricular extrasystoles&#8212;non-cardiac surgery</NAME><GROUP_LABEL_1>Beta-blocker</GROUP_LABEL_1><GROUP_LABEL_2>Control</GROUP_LABEL_2><GRAPH_LABEL_1>Favours experimental</GRAPH_LABEL_1><GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2><DICH_SUBGROUP CHI2="1.6986825348515149" CI_END="0.3181859190113193" CI_START="0.04377161225869873" DF="2" EFFECT_SIZE="0.11801487479610857" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="33" I2="0.0" ID="CMP-003.18.01" LOG_CI_END="-0.49731904351720224" LOG_CI_START="-1.3588074565360564" LOG_EFFECT_SIZE="-0.9280632500266294" MODIFIED="2013-11-23 14:07:09 +0000" MODIFIED_BY="Hermann Blessberger" NO="1" P_CHI2="0.42769687286795655" P_Z="2.4122647645421498E-5" STUDIES="3" TAU2="0.0" TOTAL_1="141" TOTAL_2="100" WEIGHT="50.52562303522753" Z="4.222855508998182"><NAME>Before surgery</NAME><DICH_DATA CI_END="2.10640095810011" CI_START="0.03441187529935919" EFFECT_SIZE="0.2692307692307692" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="4" LOG_CI_END="0.32354104363765107" LOG_CI_START="-1.4632916595507734" LOG_EFFECT_SIZE="-0.5698753079565612" MODIFIED="2013-11-23 14:06:54 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="924" O_E="0.0" SE="1.049594374817411" STUDY_ID="STD-Magnusson-1986" TOTAL_1="13" TOTAL_2="14" VAR="1.1016483516483517" WEIGHT="5.802589955065196"/><DICH_DATA CI_END="0.388319499409608" CI_START="0.007727374155017464" EFFECT_SIZE="0.054778554778554776" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="22" LOG_CI_END="-0.41081080086943617" LOG_CI_START="-2.11196805895654" LOG_EFFECT_SIZE="-1.261389429912988" MODIFIED="2013-11-23 14:07:01 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="923" O_E="0.0" SE="0.9992681942646023" STUDY_ID="STD-Burns-1988" TOTAL_1="39" TOTAL_2="47" VAR="0.998536924068839" WEIGHT="30.05876540676215"/><DICH_DATA CI_END="0.6884626717910228" CI_START="0.05122892377407" EFFECT_SIZE="0.18780096308186195" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="7" LOG_CI_END="-0.16211960206596732" LOG_CI_START="-1.2904847677600486" LOG_EFFECT_SIZE="-0.726302184913008" MODIFIED="2013-11-23 14:07:09 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="925" O_E="0.0" SE="0.6628072838263553" STUDY_ID="STD-Stone-1988" TOTAL_1="89" TOTAL_2="39" VAR="0.4393134954932707" WEIGHT="14.66426767340019"/></DICH_SUBGROUP><DICH_SUBGROUP CHI2="0.6357087770886942" CI_END="0.5854172795438795" CI_START="0.18055048795000195" DF="5" EFFECT_SIZE="0.3251113278186568" ESTIMABLE="YES" EVENTS_1="13" EVENTS_2="28" I2="0.0" ID="CMP-003.18.02" LOG_CI_END="-0.23253446280451057" LOG_CI_START="-0.743401333525125" LOG_EFFECT_SIZE="-0.4879678981648178" MODIFIED="2013-11-23 14:07:54 +0000" MODIFIED_BY="Hermann Blessberger" NO="2" P_CHI2="0.9863099964375404" P_Z="1.8095355655306E-4" STUDIES="6" TAU2="0.0" TOTAL_1="152" TOTAL_2="99" WEIGHT="49.47437696477247" Z="3.744222069697655"><NAME>During surgery</NAME><DICH_DATA CI_END="8.613245613073193" CI_START="0.039506336294567505" EFFECT_SIZE="0.5833333333333334" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="0.935166831621311" LOG_CI_START="-1.4033332436880468" LOG_EFFECT_SIZE="-0.23408320603336796" MODIFIED="2013-11-23 14:07:29 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="926" O_E="0.0" SE="1.373646519998781" STUDY_ID="STD-Coleman-1980" TOTAL_1="24" TOTAL_2="14" VAR="1.8869047619047619" WEIGHT="1.9028736289889914"/><DICH_DATA CI_END="0.9171435836951519" CI_START="0.12114909059653102" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="12" LOG_CI_END="-0.03756266790137051" LOG_CI_START="-0.9166798415379545" LOG_EFFECT_SIZE="-0.47712125471966244" MODIFIED="2013-11-23 14:07:23 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="931" O_E="0.0" SE="0.5163977794943222" STUDY_ID="STD-Whitehead-1980" TOTAL_1="30" TOTAL_2="30" VAR="0.26666666666666666" WEIGHT="18.07729947539542"/><DICH_DATA CI_END="1.7345779408820627" CI_START="0.027586862124896305" EFFECT_SIZE="0.21875" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="4" LOG_CI_END="0.2391938190437444" LOG_CI_START="-1.5592976956550426" LOG_EFFECT_SIZE="-0.6600519383056491" MODIFIED="2013-11-23 14:07:38 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="928" O_E="0.0" SE="1.0564428184106458" STUDY_ID="STD-Liu-1986" TOTAL_1="16" TOTAL_2="14" VAR="1.1160714285714286" WEIGHT="6.427484257918371"/><DICH_DATA CI_END="2.437512373700911" CI_START="0.025640895477837246" EFFECT_SIZE="0.25" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" LOG_CI_END="0.38694682901319455" LOG_CI_START="-1.5910668116691191" LOG_EFFECT_SIZE="-0.6020599913279624" MODIFIED="2013-11-23 14:07:43 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="927" O_E="0.0" SE="1.161895003862225" STUDY_ID="STD-Inada-1989" TOTAL_1="20" TOTAL_2="10" VAR="1.3499999999999999" WEIGHT="4.017177661198982"/><DICH_DATA CI_END="0.8968345474639214" CI_START="0.15680149744193167" EFFECT_SIZE="0.375" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="8" LOG_CI_END="-0.047287670390829956" LOG_CI_START="-0.8046497941537323" LOG_EFFECT_SIZE="-0.42596873227228116" MODIFIED="2013-11-23 14:07:50 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="930" O_E="0.0" SE="0.4448782605013046" STUDY_ID="STD-Oxorn-1990" TOTAL_1="32" TOTAL_2="16" VAR="0.19791666666666663" WEIGHT="16.068710644795928"/><DICH_DATA CI_END="3.987709581650965" CI_START="0.007422505812621207" EFFECT_SIZE="0.17204301075268819" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.6007235218364254" LOG_CI_START="-2.1294494536324464" LOG_EFFECT_SIZE="-0.7643629658980103" MODIFIED="2013-11-23 14:07:54 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="929" O_E="0.0" SE="1.603717120364604" STUDY_ID="STD-Miller-1990" TOTAL_1="30" TOTAL_2="15" VAR="2.5719086021505375" WEIGHT="2.9808312964747765"/></DICH_SUBGROUP><DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-003.18.03" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2013-11-23 14:05:06 +0000" MODIFIED_BY="Hermann Blessberger" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0"><NAME>After surgery</NAME></DICH_SUBGROUP></DICH_OUTCOME><DICH_OUTCOME CHI2="5.333465520840571" CI_END="2.3149678352315277" CI_START="0.8359559876109597" CI_STUDY="95" CI_TOTAL="95" DF="6" EFFECT_MEASURE="RR" EFFECT_SIZE="1.391118694787967" ESTIMABLE="YES" EVENTS_1="39" EVENTS_2="20" I2="0.0" I2_Q="0.0" ID="CMP-003.19" LOG_CI_END="0.36454496119479135" LOG_CI_START="-0.07781658720316514" LOG_EFFECT_SIZE="0.14336418699581308" METHOD="MH" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" NO="19" P_CHI2="0.5018087530675711" P_Q="0.5324001370897993" P_Z="0.2039412626726994" Q="1.2607211989130325" RANDOM="YES" SCALE="100.0" SORT_BY="YEAR" STUDIES="8" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="355" TOTAL_2="305" WEIGHT="100.0" Z="1.2704026568415787"><NAME>Bradycardia&#8212;cardiac surgery</NAME><GROUP_LABEL_1>Beta-blocker</GROUP_LABEL_1><GROUP_LABEL_2>Control</GROUP_LABEL_2><GRAPH_LABEL_1>Favours Beta-blocker</GRAPH_LABEL_1><GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2><DICH_SUBGROUP CHI2="3.7903850107582895" CI_END="6.774779423716115" CI_START="0.6285452649692137" DF="2" EFFECT_SIZE="2.0635541010566265" ESTIMABLE="YES" EVENTS_1="27" EVENTS_2="10" I2="47.23491164292337" ID="CMP-003.19.01" LOG_CI_END="0.8308951598235825" LOG_CI_START="-0.20166344093986205" LOG_EFFECT_SIZE="0.3146158594418602" MODIFIED="2013-11-23 14:10:57 +0000" MODIFIED_BY="Hermann Blessberger" NO="1" P_CHI2="0.15028951414791614" P_Z="0.23232780091164895" STUDIES="3" TAU2="0.5200289825575027" TOTAL_1="189" TOTAL_2="136" WEIGHT="55.01153060106124" Z="1.1943840340204208"><NAME>Before surgery</NAME><DICH_DATA CI_END="2.4299040831536463" CI_START="0.4829865998611526" EFFECT_SIZE="1.0833333333333333" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="8" LOG_CI_END="0.38558913080850166" LOG_CI_START="-0.3160649182900778" LOG_EFFECT_SIZE="0.03476210625921191" MODIFIED="2013-11-23 14:10:48 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="934" O_E="0.0" SE="0.41215506168406435" STUDY_ID="STD-Hammon-1984" TOTAL_1="24" TOTAL_2="26" VAR="0.16987179487179488" WEIGHT="39.747394707597"/><DICH_DATA CI_END="80.35752625709628" CI_START="0.14098207571047106" EFFECT_SIZE="3.3658536585365852" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.9050265588697803" LOG_CI_START="-0.8508360995067785" LOG_EFFECT_SIZE="0.527095229681501" MODIFIED="2013-11-23 14:10:52 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="933" O_E="0.0" SE="1.618807367270561" STUDY_ID="STD-Gomes-1999" TOTAL_1="40" TOTAL_2="45" VAR="2.6205372923294448" WEIGHT="2.5765560750540737"/><DICH_DATA CI_END="19.55229681746766" CI_START="1.1201957603483597" EFFECT_SIZE="4.68" ESTIMABLE="YES" EVENTS_1="18" EVENTS_2="2" LOG_CI_END="1.2911977815048645" LOG_CI_START="0.04929392464338349" LOG_EFFECT_SIZE="0.670245853074124" MODIFIED="2013-11-23 14:10:57 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="932" O_E="0.0" SE="0.7295004730436714" STUDY_ID="STD-Auer-2004" TOTAL_1="125" TOTAL_2="65" VAR="0.5321709401709402" WEIGHT="12.687579818410164"/></DICH_SUBGROUP><DICH_SUBGROUP CHI2="0.7583149690081046" CI_END="2.7650389933002066" CI_START="0.5785898837184239" DF="2" EFFECT_SIZE="1.2648413298159078" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="9" I2="0.0" ID="CMP-003.19.02" LOG_CI_END="0.44170126021782463" LOG_CI_START="-0.23762916398854397" LOG_EFFECT_SIZE="0.10203604811464029" MODIFIED="2013-11-23 14:11:24 +0000" MODIFIED_BY="Hermann Blessberger" NO="2" P_CHI2="0.684437976378544" P_Z="0.5560110478772323" STUDIES="4" TAU2="0.0" TOTAL_1="131" TOTAL_2="134" WEIGHT="42.402611887274304" Z="0.5887767492914128"><NAME>During surgery</NAME><DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-11-23 14:11:03 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="937" O_E="0.0" SE="0.0" STUDY_ID="STD-Cork-1995" TOTAL_1="15" TOTAL_2="14" VAR="0.0" WEIGHT="0.0"/><DICH_DATA CI_END="79.58504943420188" CI_START="0.14126038260699514" EFFECT_SIZE="3.3529411764705883" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.9008314903751011" LOG_CI_START="-0.8499796217866659" LOG_EFFECT_SIZE="0.5254259342942175" MODIFIED="2013-11-23 14:11:10 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="935" O_E="0.0" SE="1.615840064018435" STUDY_ID="STD-Babin_x002d_Ebell-1996" TOTAL_1="33" TOTAL_2="37" VAR="2.6109391124871" WEIGHT="2.5860278580090954"/><DICH_DATA CI_END="68.25874292736694" CI_START="0.13185124152633113" EFFECT_SIZE="3.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.8341582859242351" LOG_CI_START="-0.87991577648491" LOG_EFFECT_SIZE="0.47712125471966244" MODIFIED="2013-11-23 14:11:16 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="936" O_E="0.0" SE="1.5942605391424158" STUDY_ID="STD-But-2006" TOTAL_1="15" TOTAL_2="15" VAR="2.5416666666666665" WEIGHT="2.65650935624545"/><DICH_DATA CI_END="2.5620784080305095" CI_START="0.4818618732998068" EFFECT_SIZE="1.1111111111111112" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="9" LOG_CI_END="0.40859241645235506" LOG_CI_START="-0.31707743533100474" LOG_EFFECT_SIZE="0.04575749056067514" MODIFIED="2013-11-23 14:11:24 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="938" O_E="0.0" SE="0.4262620630612449" STUDY_ID="STD-Ogawa-2013" TOTAL_1="68" TOTAL_2="68" VAR="0.18169934640522875" WEIGHT="37.16007467301976"/></DICH_SUBGROUP><DICH_SUBGROUP CHI2="0.0" CI_END="7.9127893408891605" CI_START="0.014041965016931132" DF="0" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" I2="0.0" ID="CMP-003.19.03" LOG_CI_END="0.8983296038284552" LOG_CI_START="-1.85257211326778" LOG_EFFECT_SIZE="-0.47712125471966244" MODIFIED="2013-11-23 14:11:30 +0000" MODIFIED_BY="Hermann Blessberger" NO="3" P_CHI2="1.0" P_Z="0.4965809361801813" STUDIES="1" TAU2="0.0" TOTAL_1="35" TOTAL_2="35" WEIGHT="2.5858575116644533" Z="0.6798792335599723"><NAME>After surgery</NAME><DICH_DATA CI_END="7.9127893408891605" CI_START="0.014041965016931132" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.8983296038284552" LOG_CI_START="-1.85257211326778" LOG_EFFECT_SIZE="-0.47712125471966244" MODIFIED="2013-11-23 14:11:30 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="939" O_E="0.0" SE="1.6158932858054431" STUDY_ID="STD-Matangi-1989" TOTAL_1="35" TOTAL_2="35" VAR="2.611111111111111" WEIGHT="2.5858575116644533"/></DICH_SUBGROUP></DICH_OUTCOME><DICH_OUTCOME CHI2="79.61367252344694" CI_END="2.883414751746119" CI_START="2.1461013638761277" CI_STUDY="95" CI_TOTAL="95" DF="19" EFFECT_MEASURE="RR" EFFECT_SIZE="2.4875892609799735" ESTIMABLE="YES" EVENTS_1="539" EVENTS_2="212" I2="76.13475248939895" I2_Q="74.73790199321604" ID="CMP-003.20" LOG_CI_END="0.45990711600578976" LOG_CI_START="0.33165023055278414" LOG_EFFECT_SIZE="0.3957786732792869" METHOD="MH" MODIFIED="2017-06-17 15:41:41 +0100" MODIFIED_BY="Hermann Blessberger" NO="20" P_CHI2="2.1675823358435764E-9" P_Q="0.046635328273908705" P_Z="1.1058301697382526E-33" Q="3.958499407814257" RANDOM="NO" SCALE="100.0" SORT_BY="YEAR" STUDIES="23" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="5636" TOTAL_2="5397" WEIGHT="100.0" Z="12.096223025167331"><NAME>Bradycardia&#8212;non-cardiac surgery</NAME><GROUP_LABEL_1>Beta-blocker</GROUP_LABEL_1><GROUP_LABEL_2>Control</GROUP_LABEL_2><GRAPH_LABEL_1>Favours beta-blocker</GRAPH_LABEL_1><GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2><DICH_SUBGROUP CHI2="73.31710492723074" CI_END="3.0423848054660065" CI_START="2.2252433059663246" DF="11" EFFECT_SIZE="2.6019312870513875" ESTIMABLE="YES" EVENTS_1="499" EVENTS_2="191" I2="84.99667981855285" ID="CMP-003.20.01" LOG_CI_END="0.4832141434189261" LOG_CI_START="0.3473775032547683" LOG_EFFECT_SIZE="0.4152958233368472" MODIFIED="2014-06-22 20:44:03 +0100" MODIFIED_BY="Hermann Blessberger" NO="1" P_CHI2="2.8473667867956465E-11" P_Z="4.285927822411827E-33" STUDIES="13" TAU2="0.0" TOTAL_1="5049" TOTAL_2="5014" WEIGHT="88.61013018811514" Z="11.984466866766688"><NAME>Before surgery</NAME><DICH_DATA CI_END="163.3214889303036" CI_START="0.5693353304979463" EFFECT_SIZE="9.642857142857142" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="0" LOG_CI_END="2.213043330541109" LOG_CI_START="-0.24463186490757274" LOG_EFFECT_SIZE="0.984205732816768" MODIFIED="2013-11-23 14:16:18 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="946" O_E="0.0" SE="1.4436505754949789" STUDY_ID="STD-Magnusson-1986" TOTAL_1="13" TOTAL_2="14" VAR="2.084126984126984" WEIGHT="0.22529576021770703"/><DICH_DATA CI_END="1.2063517837162632" CI_START="0.7282887347158697" EFFECT_SIZE="0.9373219373219374" ESTIMABLE="YES" EVENTS_1="28" EVENTS_2="36" LOG_CI_END="0.08147397069709093" LOG_CI_START="-0.13769640772879047" LOG_EFFECT_SIZE="-0.02811121851584977" MODIFIED="2013-11-23 14:16:30 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="942" O_E="0.0" SE="0.12874176519823316" STUDY_ID="STD-Burns-1988" TOTAL_1="39" TOTAL_2="47" VAR="0.016574442106356998" WEIGHT="15.23777769605342"/><DICH_DATA CI_END="307.7461518428873" CI_START="1.1868046625898883" EFFECT_SIZE="19.11111111111111" ESTIMABLE="YES" EVENTS_1="21" EVENTS_2="0" LOG_CI_END="2.48819263107907" LOG_CI_START="0.07437924385737768" LOG_EFFECT_SIZE="1.281285937468224" MODIFIED="2013-11-23 14:16:50 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="951" O_E="0.0" SE="1.417885932222993" STUDY_ID="STD-Stone-1988" TOTAL_1="89" TOTAL_2="39" VAR="2.010400516795866" WEIGHT="0.3230889748177007"/><DICH_DATA CI_END="16.55061376388459" CI_START="0.9667315199460398" EFFECT_SIZE="4.0" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="2" LOG_CI_END="1.2188141038111788" LOG_CI_START="-0.014694121155254026" LOG_EFFECT_SIZE="0.6020599913279624" MODIFIED="2013-11-23 14:16:57 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="944" O_E="0.0" SE="0.7245688373094719" STUDY_ID="STD-Jakobsen-1992" TOTAL_1="20" TOTAL_2="20" VAR="0.5249999999999999" WEIGHT="0.9333681494733577"/><DICH_DATA CI_END="3.881860085359043" CI_START="0.38609570678958227" EFFECT_SIZE="1.2242424242424241" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="5" LOG_CI_END="0.5890398779736322" LOG_CI_START="-0.41330502750819725" LOG_EFFECT_SIZE="0.08786742523271744" MODIFIED="2014-06-22 20:44:03 +0100" MODIFIED_BY="Hermann Blessberger" ORDER="947" O_E="0.0" SE="0.5887823591673299" STUDY_ID="STD-Mangano-1996" TOTAL_1="99" TOTAL_2="101" VAR="0.3466646664666467" WEIGHT="2.3100861699465605"/><DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-11-23 14:18:49 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="945" O_E="0.0" SE="0.0" STUDY_ID="STD-Jakobsen-1997" TOTAL_1="18" TOTAL_2="17" VAR="0.0" WEIGHT="0.0"/><DICH_DATA CI_END="25.948956020600956" CI_START="1.4445429510900611" EFFECT_SIZE="6.122448979591836" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="2" LOG_CI_END="1.4141198899836058" LOG_CI_START="0.15973045939869154" LOG_EFFECT_SIZE="0.7869251746911488" MODIFIED="2013-11-23 14:19:02 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="941" O_E="0.0" SE="0.7368345608534029" STUDY_ID="STD-Bayliff-1999" TOTAL_1="49" TOTAL_2="50" VAR="0.5429251700680272" WEIGHT="0.9239401883675662"/><DICH_DATA CI_END="9.055780428661802" CI_START="1.9026886986063845" EFFECT_SIZE="4.150943396226415" ESTIMABLE="YES" EVENTS_1="30" EVENTS_2="6" LOG_CI_END="0.9569258838335278" LOG_CI_START="0.27936773860930664" LOG_EFFECT_SIZE="0.6181468112214172" MODIFIED="2013-11-23 14:19:09 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="949" O_E="0.0" SE="0.3980010084716185" STUDY_ID="STD-POBBLE-2005" TOTAL_1="53" TOTAL_2="44" VAR="0.15840480274442537" WEIGHT="3.059907953943585"/><DICH_DATA CI_END="4.968546281602201" CI_START="2.221629425589266" EFFECT_SIZE="3.3223889931207005" ESTIMABLE="YES" EVENTS_1="85" EVENTS_2="26" LOG_CI_END="0.6962293395925384" LOG_CI_START="0.34667161903172805" LOG_EFFECT_SIZE="0.5214504793121333" MODIFIED="2013-11-23 14:19:20 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="952" O_E="0.0" SE="0.2053319353960433" STUDY_ID="STD-Yang-2006" TOTAL_1="246" TOTAL_2="250" VAR="0.0421612036934849" WEIGHT="12.035932830708862"/><DICH_DATA CI_END="3.4327496636168187" CI_START="2.194313719081089" EFFECT_SIZE="2.74454544160693" ESTIMABLE="YES" EVENTS_1="277" EVENTS_2="101" LOG_CI_END="0.5356421332614679" LOG_CI_START="0.3412987183735157" LOG_EFFECT_SIZE="0.43847042581749185" MODIFIED="2013-11-23 14:19:30 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="950" O_E="0.0" SE="0.11415828392060205" STUDY_ID="STD-POISE-2008" TOTAL_1="4174" TOTAL_2="4177" VAR="0.01303211378769679" WEIGHT="47.118158812846524"/><DICH_DATA CI_END="3.6290326949803244" CI_START="0.9972510940069231" EFFECT_SIZE="1.9023818820773135" ESTIMABLE="YES" EVENTS_1="24" EVENTS_2="13" LOG_CI_END="0.5597908808998064" LOG_CI_START="-0.0011954785870280453" LOG_EFFECT_SIZE="0.27929770115638924" MODIFIED="2013-11-23 14:19:40 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="948" O_E="0.0" SE="0.32952616448983174" STUDY_ID="STD-Marwick-2009" TOTAL_1="197" TOTAL_2="203" VAR="0.10858749308337966" WEIGHT="5.975889577003172"/><DICH_DATA CI_END="99.95416281504153" CI_START="0.25011464551267176" EFFECT_SIZE="5.0" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="0" LOG_CI_END="1.9998008859974516" LOG_CI_START="-0.6018608773254143" LOG_EFFECT_SIZE="0.6989700043360189" MODIFIED="2013-11-23 14:19:48 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="940" O_E="0.0" SE="1.5282289982092807" STUDY_ID="STD-Apipan-2010" TOTAL_1="30" TOTAL_2="30" VAR="2.335483870967742" WEIGHT="0.23334203736833942"/><DICH_DATA CI_END="98.52270194459342" CI_START="0.25374862348029537" EFFECT_SIZE="5.0" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="0" LOG_CI_END="1.9935363136779938" LOG_CI_START="-0.5955963050059561" LOG_EFFECT_SIZE="0.6989700043360189" MODIFIED="2013-11-23 14:19:53 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="943" O_E="0.0" SE="1.5208693166281149" STUDY_ID="STD-Gupta-2011" TOTAL_1="22" TOTAL_2="22" VAR="2.313043478260869" WEIGHT="0.23334203736833942"/></DICH_SUBGROUP><DICH_SUBGROUP CHI2="7.6492757155459845" CI_END="2.5163641895036886" CI_START="1.01484857135895" DF="7" EFFECT_SIZE="1.5980389866134805" ESTIMABLE="YES" EVENTS_1="40" EVENTS_2="21" I2="8.48806788630237" ID="CMP-003.20.02" LOG_CI_END="0.40077349609188917" LOG_CI_START="0.00640124468328508" LOG_EFFECT_SIZE="0.2035873703875871" MODIFIED="2017-06-17 15:41:41 +0100" MODIFIED_BY="Hermann Blessberger" NO="2" P_CHI2="0.3645334763467808" P_Z="0.043012333107965615" STUDIES="10" TAU2="0.0" TOTAL_1="587" TOTAL_2="383" WEIGHT="11.389869811884868" Z="2.023590210729423"><NAME>During surgery</NAME><DICH_DATA CI_END="4.316762529506007" CI_START="0.7786184873819648" EFFECT_SIZE="1.8333333333333333" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="6" LOG_CI_END="0.6351581582319411" LOG_CI_START="-0.10867528868277829" LOG_EFFECT_SIZE="0.2632414347745814" MODIFIED="2013-11-23 14:20:21 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="963" O_E="0.0" SE="0.4369314487526515" STUDY_ID="STD-Whitehead-1980" TOTAL_1="30" TOTAL_2="30" VAR="0.19090909090909092" WEIGHT="2.800104448420073"/><DICH_DATA CI_END="6.690017380199802" CI_START="0.012930488128094391" EFFECT_SIZE="0.29411764705882354" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.8254272460361436" LOG_CI_START="-1.8883850801206539" LOG_EFFECT_SIZE="-0.5314789170422551" MODIFIED="2013-11-23 14:20:34 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="957" O_E="0.0" SE="1.5941067939721714" STUDY_ID="STD-Liu-1986" TOTAL_1="16" TOTAL_2="14" VAR="2.541176470588235" WEIGHT="0.7437777441115819"/><DICH_DATA CI_END="7.401691333129458" CI_START="0.01324713701913913" EFFECT_SIZE="0.31313131313131315" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.8693309700979578" LOG_CI_START="-1.8778779716245122" LOG_EFFECT_SIZE="-0.5042735007632773" MODIFIED="2013-11-23 14:20:29 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="953" O_E="0.0" SE="1.6137241312713606" STUDY_ID="STD-Cucchiara-1986" TOTAL_1="32" TOTAL_2="30" VAR="2.6041055718475072" WEIGHT="0.7219019281083001"/><DICH_DATA CI_END="13.482091688489398" CI_START="0.060717144136267914" EFFECT_SIZE="0.9047619047619048" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.1297572763459856" LOG_CI_START="-1.2166886639081658" LOG_EFFECT_SIZE="-0.0434656937810903" MODIFIED="2013-11-23 14:20:41 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="954" O_E="0.0" SE="1.3783139604000185" STUDY_ID="STD-Gibson-1988" TOTAL_1="21" TOTAL_2="19" VAR="1.899749373433584" WEIGHT="0.4900182784735128"/><DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-11-23 14:20:50 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="955" O_E="0.0" SE="0.0" STUDY_ID="STD-Inada-1989" TOTAL_1="20" TOTAL_2="10" VAR="0.0" WEIGHT="0.0"/><DICH_DATA CI_END="2.1277244659381767" CI_START="0.22038907230653051" EFFECT_SIZE="0.6847826086956522" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="5" LOG_CI_END="0.327915387405769" LOG_CI_START="-0.656809943189716" LOG_EFFECT_SIZE="-0.16444727789197353" MODIFIED="2013-11-23 14:21:05 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="959" O_E="0.0" SE="0.5784325336607887" STUDY_ID="STD-Miller-1991" TOTAL_1="368" TOTAL_2="180" VAR="0.3345841959972395" WEIGHT="3.1339368522463102"/><DICH_DATA CI_END="7.731389706964666" CI_START="0.29102141856503916" EFFECT_SIZE="1.5" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="2" LOG_CI_END="0.8882575647876686" LOG_CI_START="-0.5360750466763062" LOG_EFFECT_SIZE="0.17609125905568124" MODIFIED="2013-11-23 14:21:18 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="958" O_E="0.0" SE="0.8366600265340756" STUDY_ID="STD-Liu-2006" TOTAL_1="15" TOTAL_2="15" VAR="0.7" WEIGHT="0.9333681494733577"/><DICH_DATA CI_END="7.53745610550098" CI_START="1.3585485416660203" EFFECT_SIZE="3.2" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="5" LOG_CI_END="0.8772247960345471" LOG_CI_START="0.1330751606052648" LOG_EFFECT_SIZE="0.505149978319906" MODIFIED="2013-11-23 14:21:31 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="956" O_E="0.0" SE="0.4371171794512641" STUDY_ID="STD-Kawaguchi-2010" TOTAL_1="28" TOTAL_2="28" VAR="0.19107142857142861" WEIGHT="2.3334203736833943"/><DICH_DATA CI_END="99.95416281504153" CI_START="0.25011464551267176" EFFECT_SIZE="5.0" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="0" LOG_CI_END="1.9998008859974516" LOG_CI_START="-0.6018608773254143" LOG_EFFECT_SIZE="0.6989700043360189" MODIFIED="2013-11-23 14:21:36 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="961" O_E="0.0" SE="1.5282289982092807" STUDY_ID="STD-Shukla-2010" TOTAL_1="30" TOTAL_2="30" VAR="2.335483870967742" WEIGHT="0.23334203736833942"/><DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-11-23 14:21:40 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="960" O_E="0.0" SE="0.0" STUDY_ID="STD-Moon-2011" TOTAL_1="27" TOTAL_2="27" VAR="0.0" WEIGHT="0.0"/></DICH_SUBGROUP><DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-003.20.03" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2013-11-23 14:12:30 +0000" MODIFIED_BY="Hermann Blessberger" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0"><NAME>After surgery</NAME></DICH_SUBGROUP></DICH_OUTCOME><DICH_OUTCOME CHI2="3.6475355346541005" CI_END="3.693037975048062" CI_START="0.5971206839421426" CI_STUDY="95" CI_TOTAL="95" DF="5" EFFECT_MEASURE="RR" EFFECT_SIZE="1.4849880004515201" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="7" I2="0.0" I2_Q="0.0" ID="CMP-003.21" LOG_CI_END="0.567383773469833" LOG_CI_START="-0.22393788482834756" LOG_EFFECT_SIZE="0.1717229443207427" METHOD="MH" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" NO="21" P_CHI2="0.6011906676485825" P_Q="0.7096062649872168" P_Z="0.39496114333823107" Q="0.6860902699900108" RANDOM="YES" SCALE="100.0" SORT_BY="YEAR" STUDIES="6" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="302" TOTAL_2="256" WEIGHT="99.99999999999999" Z="0.8506548068244796"><NAME>Hypotension&#8212;cardiac surgery</NAME><GROUP_LABEL_1>Beta-blocker</GROUP_LABEL_1><GROUP_LABEL_2>Control</GROUP_LABEL_2><GRAPH_LABEL_1>Favours beta-blocker</GRAPH_LABEL_1><GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2><DICH_SUBGROUP CHI2="1.613733373813878" CI_END="8.96771660132642" CI_START="0.0626575652084336" DF="1" EFFECT_SIZE="0.7495967500719054" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="2" I2="38.031894473582575" ID="CMP-003.21.01" LOG_CI_END="0.9526818751862852" LOG_CI_START="-1.203026485245672" LOG_EFFECT_SIZE="-0.12517230502969348" MODIFIED="2013-11-23 14:28:45 +0000" MODIFIED_BY="Hermann Blessberger" NO="1" P_CHI2="0.20396785337633916" P_Z="0.8199474113354734" STUDIES="2" TAU2="1.2572796677259563" TOTAL_1="165" TOTAL_2="110" WEIGHT="22.877350362794544" Z="0.22761261608773614"><NAME>Before surgery</NAME><DICH_DATA CI_END="80.35752625709628" CI_START="0.14098207571047106" EFFECT_SIZE="3.3658536585365852" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.9050265588697803" LOG_CI_START="-0.8508360995067785" LOG_EFFECT_SIZE="0.527095229681501" MODIFIED="2013-11-23 14:28:39 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="965" O_E="0.0" SE="1.618807367270561" STUDY_ID="STD-Gomes-1999" TOTAL_1="40" TOTAL_2="45" VAR="2.6205372923294448" WEIGHT="8.245005780484771"/><DICH_DATA CI_END="2.813973227965783" CI_START="0.024022971977195374" EFFECT_SIZE="0.26" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" LOG_CI_END="0.44931996125720636" LOG_CI_START="-1.6193732653155704" LOG_EFFECT_SIZE="-0.585026652029182" MODIFIED="2013-11-23 14:28:45 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="964" O_E="0.0" SE="1.2151606414854723" STUDY_ID="STD-Auer-2004" TOTAL_1="125" TOTAL_2="65" VAR="1.4766153846153847" WEIGHT="14.632344582309772"/></DICH_SUBGROUP><DICH_SUBGROUP CHI2="0.0" CI_END="25.6782739076548" CI_START="0.3504908481140964" DF="0" EFFECT_SIZE="3.0" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="1" I2="0.0" ID="CMP-003.21.02" LOG_CI_END="1.4095658271236327" LOG_CI_START="-0.45532331768430767" LOG_EFFECT_SIZE="0.47712125471966244" MODIFIED="2013-11-23 14:28:57 +0000" MODIFIED_BY="Hermann Blessberger" NO="2" P_CHI2="1.0" P_Z="0.3159133624715845" STUDIES="1" TAU2="0.0" TOTAL_1="15" TOTAL_2="15" WEIGHT="18.00528760269349" Z="1.0028912207598348"><NAME>During surgery</NAME><DICH_DATA CI_END="25.6782739076548" CI_START="0.3504908481140964" EFFECT_SIZE="3.0" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="1" LOG_CI_END="1.4095658271236327" LOG_CI_START="-0.45532331768430767" LOG_EFFECT_SIZE="0.47712125471966244" MODIFIED="2013-11-23 14:28:57 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="966" O_E="0.0" SE="1.0954451150103321" STUDY_ID="STD-But-2006" TOTAL_1="15" TOTAL_2="15" VAR="1.2" WEIGHT="18.00528760269349"/></DICH_SUBGROUP><DICH_SUBGROUP CHI2="0.9043890941711882" CI_END="5.383264469148534" CI_START="0.503333439486004" DF="2" EFFECT_SIZE="1.6460792875555323" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="4" I2="0.0" ID="CMP-003.21.03" LOG_CI_END="0.7310457163697348" LOG_CI_START="-0.29814421583408063" LOG_EFFECT_SIZE="0.21645075026782712" MODIFIED="2013-11-23 14:29:20 +0000" MODIFIED_BY="Hermann Blessberger" NO="3" P_CHI2="0.6362304099556226" P_Z="0.4097083656851762" STUDIES="3" TAU2="0.0" TOTAL_1="122" TOTAL_2="131" WEIGHT="59.117362034511956" Z="0.8244069664443652"><NAME>After surgery</NAME><DICH_DATA CI_END="107.61816341755203" CI_START="0.27865799953456794" EFFECT_SIZE="5.476190476190476" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="0" LOG_CI_END="2.031885576221638" LOG_CI_START="-0.5549284849822533" LOG_EFFECT_SIZE="0.7384785456196924" MODIFIED="2013-11-23 14:29:04 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="969" O_E="0.0" SE="1.5195073844872842" STUDY_ID="STD-Salazar-1979" TOTAL_1="20" TOTAL_2="22" VAR="2.308902691511387" WEIGHT="9.35784136883173"/><DICH_DATA CI_END="9.614160867147643" CI_START="0.2854860998584822" EFFECT_SIZE="1.6567164179104477" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="2" LOG_CI_END="0.9829113846045738" LOG_CI_START="-0.5444150324329121" LOG_EFFECT_SIZE="0.21924817608583097" MODIFIED="2013-11-23 14:29:12 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="967" O_E="0.0" SE="0.8971590977555159" STUDY_ID="STD-Khuri-1987" TOTAL_1="67" TOTAL_2="74" VAR="0.8048944466854914" WEIGHT="26.843700080433976"/><DICH_DATA CI_END="6.706930006003608" CI_START="0.1490995133548233" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="2" LOG_CI_END="0.8265237740363401" LOG_CI_START="-0.82652377403634" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-11-23 14:29:20 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="968" O_E="0.0" SE="0.9710083124552245" STUDY_ID="STD-Matangi-1989" TOTAL_1="35" TOTAL_2="35" VAR="0.9428571428571428" WEIGHT="22.915820585246255"/></DICH_SUBGROUP></DICH_OUTCOME><DICH_OUTCOME CHI2="18.83277300612309" CI_END="1.529877271721423" CI_START="1.2857944410426518" CI_STUDY="95" CI_TOTAL="95" DF="18" EFFECT_MEASURE="RR" EFFECT_SIZE="1.4025361640460128" ESTIMABLE="YES" EVENTS_1="1056" EVENTS_2="659" I2="4.421935133250593" I2_Q="0.0" ID="CMP-003.22" LOG_CI_END="0.18465659267903645" LOG_CI_START="0.1091715438164194" LOG_EFFECT_SIZE="0.1469140682477279" METHOD="MH" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" NO="22" P_CHI2="0.40218861625238467" P_Q="0.897138713240864" P_Z="2.361656615797949E-14" Q="0.016712464748166143" RANDOM="YES" SCALE="100.0" SORT_BY="YEAR" STUDIES="22" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.001744342295593023" TOTALS="YES" TOTAL_1="5611" TOTAL_2="5336" WEIGHT="100.0" Z="7.629226897948201"><NAME>Hypotension&#8212;non-cardiac surgery</NAME><GROUP_LABEL_1>Beta-blocker</GROUP_LABEL_1><GROUP_LABEL_2>Control</GROUP_LABEL_2><GRAPH_LABEL_1>Favours beta-blocker</GRAPH_LABEL_1><GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2><DICH_SUBGROUP CHI2="10.842896888513852" CI_END="1.575867924047356" CI_START="1.259706754225083" DF="9" EFFECT_SIZE="1.408946935725088" ESTIMABLE="YES" EVENTS_1="910" EVENTS_2="602" I2="16.99635168961238" ID="CMP-003.22.01" LOG_CI_END="0.1975198157797625" LOG_CI_START="0.1002694579396607" LOG_EFFECT_SIZE="0.14889463685971163" MODIFIED="2014-06-22 20:49:57 +0100" MODIFIED_BY="Hermann Blessberger" NO="1" P_CHI2="0.2866316659115652" P_Z="1.9540106709292525E-9" STUDIES="11" TAU2="0.005009090248282201" TOTAL_1="4980" TOTAL_2="4937" WEIGHT="83.63839847722612" Z="6.001584615575934"><NAME>Before surgery</NAME><DICH_DATA CI_END="21.029313937505744" CI_START="0.2205993627858741" EFFECT_SIZE="2.1538461538461537" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="1" LOG_CI_END="1.3228251044497223" LOG_CI_START="-0.6563957463789576" LOG_EFFECT_SIZE="0.33321467903538243" MODIFIED="2013-11-23 14:32:41 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="974" O_E="0.0" SE="1.162604125077987" STUDY_ID="STD-Magnusson-1986" TOTAL_1="13" TOTAL_2="14" VAR="1.3516483516483517" WEIGHT="0.1452691038300591"/><DICH_DATA CI_END="11.195845482255095" CI_START="0.6174400630049328" EFFECT_SIZE="2.6292134831460676" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="2" LOG_CI_END="1.049056895986779" LOG_CI_START="-0.20940519445631867" LOG_EFFECT_SIZE="0.4198258507652301" MODIFIED="2013-11-23 14:32:48 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="979" O_E="0.0" SE="0.7392268614140911" STUDY_ID="STD-Stone-1988" TOTAL_1="89" TOTAL_2="39" VAR="0.5464563526361279" WEIGHT="0.3586389904227936"/><DICH_DATA CI_END="69.5152908317231" CI_START="0.12946791838627933" EFFECT_SIZE="3.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.84208034406391" LOG_CI_START="-0.8878378346245852" LOG_EFFECT_SIZE="0.47712125471966244" MODIFIED="2013-11-23 14:32:58 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="972" O_E="0.0" SE="1.6035674514745464" STUDY_ID="STD-Jakobsen-1992" TOTAL_1="20" TOTAL_2="20" VAR="2.5714285714285716" WEIGHT="0.07640611430766124"/><DICH_DATA CI_END="2.4440278509874847" CI_START="0.5796419209128254" EFFECT_SIZE="1.1902356902356903" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="12" LOG_CI_END="0.38810615061358633" LOG_CI_START="-0.23684021298217456" LOG_EFFECT_SIZE="0.07563296881570589" MODIFIED="2014-06-22 20:49:57 +0100" MODIFIED_BY="Hermann Blessberger" ORDER="975" O_E="0.0" SE="0.36709658751054164" STUDY_ID="STD-Mangano-1996" TOTAL_1="99" TOTAL_2="101" VAR="0.13475990456188475" WEIGHT="1.4402932385294949"/><DICH_DATA CI_END="7.259648833094586" CI_START="0.013736613709900562" EFFECT_SIZE="0.3157894736842105" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.8609156133257376" LOG_CI_START="-1.8621203144641083" LOG_EFFECT_SIZE="-0.5006023505691853" MODIFIED="2013-11-23 14:33:13 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="973" O_E="0.0" SE="1.5995247832289885" STUDY_ID="STD-Jakobsen-1997" TOTAL_1="18" TOTAL_2="17" VAR="2.5584795321637426" WEIGHT="0.07679255933073638"/><DICH_DATA CI_END="3.258712269150733" CI_START="1.0890244032150478" EFFECT_SIZE="1.8838304552590266" ESTIMABLE="YES" EVENTS_1="24" EVENTS_2="13" LOG_CI_END="0.5130460157469269" LOG_CI_START="0.03703761167762189" LOG_EFFECT_SIZE="0.2750418137122744" MODIFIED="2013-11-23 14:33:27 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="970" O_E="0.0" SE="0.2796096928299115" STUDY_ID="STD-Bayliff-1999" TOTAL_1="49" TOTAL_2="50" VAR="0.07818158032443746" WEIGHT="2.459854541987035"/><DICH_DATA CI_END="1.4291890961291949" CI_START="1.0016090630908658" EFFECT_SIZE="1.1964483906770256" ESTIMABLE="YES" EVENTS_1="49" EVENTS_2="34" LOG_CI_END="0.15508969413200707" LOG_CI_START="6.982456113067668E-4" LOG_EFFECT_SIZE="0.07789396987165693" MODIFIED="2013-11-23 14:33:37 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="977" O_E="0.0" SE="0.09069030111105522" STUDY_ID="STD-POBBLE-2005" TOTAL_1="53" TOTAL_2="44" VAR="0.008224730715613863" WEIGHT="19.721607370952995"/><DICH_DATA CI_END="1.6001337406240679" CI_START="1.0973785289749167" EFFECT_SIZE="1.3251235453531005" ESTIMABLE="YES" EVENTS_1="133" EVENTS_2="102" LOG_CI_END="0.20415628289821494" LOG_CI_START="0.04035645864943841" LOG_EFFECT_SIZE="0.12225637077382669" MODIFIED="2013-11-23 14:33:52 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="980" O_E="0.0" SE="0.09621682758593815" STUDY_ID="STD-Yang-2006" TOTAL_1="246" TOTAL_2="250" VAR="0.009257677910702148" WEIGHT="17.870003880459297"/><DICH_DATA CI_END="1.7412304767530802" CI_START="1.3764647865839486" EFFECT_SIZE="1.5481416074046312" ESTIMABLE="YES" EVENTS_1="625" EVENTS_2="404" LOG_CI_END="0.24085626000721605" LOG_CI_START="0.13876510553109628" LOG_EFFECT_SIZE="0.18981068276915616" MODIFIED="2013-11-23 14:34:03 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="978" O_E="0.0" SE="0.05996884949863775" STUDY_ID="STD-POISE-2008" TOTAL_1="4174" TOTAL_2="4177" VAR="0.003596262910190265" WEIGHT="36.81345768949247"/><DICH_DATA CI_END="2.3140090156976254" CI_START="1.0534324826660835" EFFECT_SIZE="1.561298261805876" ESTIMABLE="YES" EVENTS_1="50" EVENTS_2="33" LOG_CI_END="0.36436504669010483" LOG_CI_START="0.022606705729397786" LOG_EFFECT_SIZE="0.1934858762097513" MODIFIED="2013-11-23 14:34:14 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="976" O_E="0.0" SE="0.20075054121139094" STUDY_ID="STD-Marwick-2009" TOTAL_1="197" TOTAL_2="203" VAR="0.040300779796666374" WEIGHT="4.676074987913567"/><DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-11-23 14:34:23 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="971" O_E="0.0" SE="0.0" STUDY_ID="STD-Gupta-2011" TOTAL_1="22" TOTAL_2="22" VAR="0.0" WEIGHT="0.0"/></DICH_SUBGROUP><DICH_SUBGROUP CHI2="8.976585514723634" CI_END="1.8279082501803752" CI_START="1.0436286328764608" DF="8" EFFECT_SIZE="1.381179708857377" ESTIMABLE="YES" EVENTS_1="146" EVENTS_2="57" I2="10.879253733190787" ID="CMP-003.22.02" LOG_CI_END="0.2619543930168576" LOG_CI_START="0.01854598584564424" LOG_EFFECT_SIZE="0.1402501894312509" MODIFIED="2013-11-23 14:35:50 +0000" MODIFIED_BY="Hermann Blessberger" NO="2" P_CHI2="0.3442750938835003" P_Z="0.023906126289652486" STUDIES="11" TAU2="0.021210908000170035" TOTAL_1="631" TOTAL_2="399" WEIGHT="16.361601522773878" Z="2.258634558311026"><NAME>During surgery</NAME><DICH_DATA CI_END="15.259760455310136" CI_START="0.0655318281652329" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.1835477162038213" LOG_CI_START="-1.1835477162038213" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-11-23 14:34:33 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="991" O_E="0.0" SE="1.390443574307614" STUDY_ID="STD-Whitehead-1980" TOTAL_1="30" TOTAL_2="30" VAR="1.9333333333333331" WEIGHT="0.10160116374423402"/><DICH_DATA CI_END="2.917064814565508" CI_START="0.30129815615047" EFFECT_SIZE="0.9375" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="5" LOG_CI_END="0.4649460788630512" LOG_CI_START="-0.5210035260635382" LOG_EFFECT_SIZE="-0.028028723600243537" MODIFIED="2013-11-23 14:34:39 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="981" O_E="0.0" SE="0.5791516784631352" STUDY_ID="STD-Cucchiara-1986" TOTAL_1="32" TOTAL_2="30" VAR="0.3354166666666667" WEIGHT="0.5831224209006727"/><DICH_DATA CI_END="89.07654204661276" CI_START="0.23194835082374035" EFFECT_SIZE="4.545454545454546" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="0" LOG_CI_END="1.9497633493675715" LOG_CI_START="-0.6346087110119837" LOG_EFFECT_SIZE="0.6575773191777938" MODIFIED="2013-11-23 14:34:47 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="982" O_E="0.0" SE="1.5180729411149698" STUDY_ID="STD-Gibson-1988" TOTAL_1="21" TOTAL_2="19" VAR="2.3045454545454547" WEIGHT="0.08524780539231454"/><DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-11-23 14:34:53 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="983" O_E="0.0" SE="0.0" STUDY_ID="STD-Inada-1989" TOTAL_1="20" TOTAL_2="10" VAR="0.0" WEIGHT="0.0"/><DICH_DATA CI_END="35.88938623485869" CI_START="0.0668025523135909" EFFECT_SIZE="1.5483870967741935" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.5549660312757505" LOG_CI_START="-1.1752069441931212" LOG_EFFECT_SIZE="0.18987954354131453" MODIFIED="2013-11-23 14:35:07 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="986" O_E="0.0" SE="1.603717120364604" STUDY_ID="STD-Miller-1990" TOTAL_1="30" TOTAL_2="15" VAR="2.5719086021505375" WEIGHT="0.07639186324778433"/><DICH_DATA CI_END="81.01190363542146" CI_START="0.2663500355480702" EFFECT_SIZE="4.645161290322581" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="0" LOG_CI_END="1.9085488374385386" LOG_CI_START="-0.5745472409165846" LOG_EFFECT_SIZE="0.667000798260977" MODIFIED="2013-11-23 14:34:59 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="989" O_E="0.0" SE="1.4585829279496223" STUDY_ID="STD-Sandler-1990" TOTAL_1="30" TOTAL_2="15" VAR="2.1274641577060933" WEIGHT="0.09233766621692079"/><DICH_DATA CI_END="2.6979150176212503" CI_START="1.2709157890073948" EFFECT_SIZE="1.8517080745341614" ESTIMABLE="YES" EVENTS_1="106" EVENTS_2="28" LOG_CI_END="0.4310282655881383" LOG_CI_START="0.10411677511654042" LOG_EFFECT_SIZE="0.2675725203523394" MODIFIED="2013-11-23 14:35:16 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="987" O_E="0.0" SE="0.19202942774099305" STUDY_ID="STD-Miller-1991" TOTAL_1="368" TOTAL_2="180" VAR="0.03687530111853327" WEIGHT="5.090832705810838"/><DICH_DATA CI_END="6.20048286508611" CI_START="0.16127776203218527" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="2" LOG_CI_END="0.7924255116719207" LOG_CI_START="-0.7924255116719207" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-11-23 14:35:23 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="985" O_E="0.0" SE="0.9309493362512627" STUDY_ID="STD-Liu-2006" TOTAL_1="15" TOTAL_2="15" VAR="0.8666666666666667" WEIGHT="0.2263975718298737"/><DICH_DATA CI_END="70.82882080128432" CI_START="0.12706691849706483" EFFECT_SIZE="3.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.850210011475669" LOG_CI_START="-0.8959675020363438" LOG_EFFECT_SIZE="0.47712125471966244" MODIFIED="2013-11-23 14:35:34 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="990" O_E="0.0" SE="1.613118265234886" STUDY_ID="STD-Shukla-2010" TOTAL_1="30" TOTAL_2="30" VAR="2.6021505376344085" WEIGHT="0.07550463933654322"/><DICH_DATA CI_END="1.48504132021836" CI_START="0.8795192640077785" EFFECT_SIZE="1.1428571428571428" ESTIMABLE="YES" EVENTS_1="24" EVENTS_2="21" LOG_CI_END="0.171738537756374" LOG_CI_START="-0.05575464380100051" LOG_EFFECT_SIZE="0.05799194697768673" MODIFIED="2013-11-23 14:35:41 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="984" O_E="0.0" SE="0.13363062095621217" STUDY_ID="STD-Kawaguchi-2010" TOTAL_1="28" TOTAL_2="28" VAR="0.01785714285714285" WEIGHT="10.030165686294696"/><DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-11-23 14:35:50 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="988" O_E="0.0" SE="0.0" STUDY_ID="STD-Moon-2011" TOTAL_1="27" TOTAL_2="27" VAR="0.0" WEIGHT="0.0"/></DICH_SUBGROUP><DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-003.22.03" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2013-11-23 14:30:19 +0000" MODIFIED_BY="Hermann Blessberger" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0"><NAME>After surgery</NAME></DICH_SUBGROUP></DICH_OUTCOME><DICH_OUTCOME CHI2="0.09303220818048605" CI_END="1.3427512845324863" CI_START="0.03737671869422976" CI_STUDY="95" CI_TOTAL="95" DF="2" EFFECT_MEASURE="RR" EFFECT_SIZE="0.22402597402597405" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="4" I2="0.0" I2_Q="0.0" ID="CMP-003.23" LOG_CI_END="0.12799557651214638" LOG_CI_START="-1.4273988280385241" LOG_EFFECT_SIZE="-0.6497016257631889" METHOD="MH" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" NO="23" P_CHI2="0.9545491900457851" P_Q="0.7697330985147935" P_Z="0.10154949900018825" Q="0.08568736931360918" RANDOM="NO" SCALE="100.0" SORT_BY="YEAR" STUDIES="3" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="172" TOTAL_2="139" WEIGHT="100.0" Z="1.6373876406747574"><NAME>Congestive heart failure&#8212;cardiac surgery</NAME><GROUP_LABEL_1>Beta-blocker</GROUP_LABEL_1><GROUP_LABEL_2>Control</GROUP_LABEL_2><GRAPH_LABEL_1>Favours beta-blocker</GRAPH_LABEL_1><GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2><DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-003.23.01" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2013-11-23 14:39:14 +0000" MODIFIED_BY="Hermann Blessberger" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0"><NAME>Before surgery</NAME></DICH_SUBGROUP><DICH_SUBGROUP CHI2="0.0047569470437718525" CI_END="1.6874394145128593" CI_START="0.020819035955885037" DF="1" EFFECT_SIZE="0.18743228602383533" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="3" I2="0.0" ID="CMP-003.23.02" LOG_CI_END="0.2272281889607856" LOG_CI_START="-1.6815393847550189" LOG_EFFECT_SIZE="-0.7271555978971166" MODIFIED="2013-11-23 14:40:19 +0000" MODIFIED_BY="Hermann Blessberger" NO="2" P_CHI2="0.9450130021112558" P_Z="0.13535388509894164" STUDIES="2" TAU2="0.0" TOTAL_1="137" TOTAL_2="104" WEIGHT="74.91883116883116" Z="1.4933183093220708"><NAME>During surgery</NAME><DICH_DATA CI_END="4.092080860459946" CI_START="0.009774977905862802" EFFECT_SIZE="0.2" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" LOG_CI_END="0.611944206883865" LOG_CI_START="-2.0098842155559025" LOG_EFFECT_SIZE="-0.6989700043360187" MODIFIED="2013-11-23 14:40:13 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="992" O_E="0.0" SE="1.540074993601121" STUDY_ID="STD-Sezai-2011" TOTAL_1="70" TOTAL_2="70" VAR="2.371830985915493" WEIGHT="41.80194805194805"/><DICH_DATA CI_END="4.103163647782676" CI_START="0.0071739263778377955" EFFECT_SIZE="0.1715686274509804" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.6131188384174836" LOG_CI_START="-2.14424308456873" LOG_EFFECT_SIZE="-0.7655621230756231" MODIFIED="2013-11-23 14:40:19 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="993" O_E="0.0" SE="1.6196880427237514" STUDY_ID="STD-Sezai-2012" TOTAL_1="67" TOTAL_2="34" VAR="2.623389355742297" WEIGHT="33.116883116883116"/></DICH_SUBGROUP><DICH_SUBGROUP CHI2="0.0" CI_END="7.9127893408891605" CI_START="0.014041965016931132" DF="0" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" I2="0.0" ID="CMP-003.23.03" LOG_CI_END="0.8983296038284552" LOG_CI_START="-1.85257211326778" LOG_EFFECT_SIZE="-0.47712125471966244" MODIFIED="2013-11-23 14:40:26 +0000" MODIFIED_BY="Hermann Blessberger" NO="3" P_CHI2="1.0" P_Z="0.4965809361801813" STUDIES="1" TAU2="0.0" TOTAL_1="35" TOTAL_2="35" WEIGHT="25.08116883116883" Z="0.6798792335599723"><NAME>After surgery</NAME><DICH_DATA CI_END="7.9127893408891605" CI_START="0.014041965016931132" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.8983296038284552" LOG_CI_START="-1.85257211326778" LOG_EFFECT_SIZE="-0.47712125471966244" MODIFIED="2013-11-23 14:40:26 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="994" O_E="0.0" SE="1.6158932858054431" STUDY_ID="STD-Matangi-1989" TOTAL_1="35" TOTAL_2="35" VAR="2.611111111111111" WEIGHT="25.08116883116883"/></DICH_SUBGROUP></DICH_OUTCOME><DICH_OUTCOME CHI2="1.8390964020271596" CI_END="1.4815572346084287" CI_START="0.9383036072485224" CI_STUDY="95" CI_TOTAL="95" DF="4" EFFECT_MEASURE="RR" EFFECT_SIZE="1.1790464357175394" ESTIMABLE="YES" EVENTS_1="154" EVENTS_2="131" I2="0.0" I2_Q="0.0" ID="CMP-003.24" LOG_CI_END="0.17071843353762536" LOG_CI_START="-0.027656614053537077" LOG_EFFECT_SIZE="0.07153090974204411" METHOD="MH" MODIFIED="2017-06-17 15:41:56 +0100" MODIFIED_BY="Hermann Blessberger" NO="24" P_CHI2="0.7653222538708768" P_Q="1.0" P_Z="0.15751930148012083" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="YEAR" STUDIES="5" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="4581" TOTAL_2="4592" WEIGHT="100.0" Z="1.4134641284596479"><NAME>Congestive heart failure&#8212;non-cardiac surgery</NAME><GROUP_LABEL_1>Beta-blocker</GROUP_LABEL_1><GROUP_LABEL_2>Control</GROUP_LABEL_2><GRAPH_LABEL_1>Favours beta-blocker</GRAPH_LABEL_1><GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2><DICH_SUBGROUP CHI2="1.8390964020271596" CI_END="1.4815572346084287" CI_START="0.9383036072485224" DF="4" EFFECT_SIZE="1.1790464357175394" ESTIMABLE="YES" EVENTS_1="154" EVENTS_2="131" I2="0.0" ID="CMP-003.24.01" LOG_CI_END="0.17071843353762536" LOG_CI_START="-0.027656614053537077" LOG_EFFECT_SIZE="0.07153090974204411" MODIFIED="2013-11-26 21:58:54 +0000" MODIFIED_BY="Hermann Blessberger" NO="1" P_CHI2="0.7653222538708768" P_Z="0.15751930148012083" STUDIES="5" TAU2="0.0" TOTAL_1="4581" TOTAL_2="4592" WEIGHT="100.0" Z="1.4134641284596479"><NAME>Before surgery</NAME><DICH_DATA CI_END="8.060808530068375" CI_START="0.015823601309021718" EFFECT_SIZE="0.35714285714285715" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.9063786053951907" LOG_CI_START="-1.8006946680796287" LOG_EFFECT_SIZE="-0.4471580313422192" MODIFIED="2013-11-23 14:42:27 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="997" O_E="0.0" SE="1.5901482410679288" STUDY_ID="STD-Magnusson-1986" TOTAL_1="13" TOTAL_2="14" VAR="2.528571428571428" WEIGHT="1.103263292296873"/><DICH_DATA CI_END="3.384989540859917" CI_START="0.5082811058206856" EFFECT_SIZE="1.3116883116883118" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="7" LOG_CI_END="0.529557331114563" LOG_CI_START="-0.2938960338942417" LOG_EFFECT_SIZE="0.11783064861016074" MODIFIED="2013-11-23 14:44:13 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1002" O_E="0.0" SE="0.48370058276606814" STUDY_ID="STD-Wallace-1998" TOTAL_1="99" TOTAL_2="101" VAR="0.23396625376823393" WEIGHT="5.279114853640538"/><DICH_DATA CI_END="6.341211041538326" CI_START="0.6568037637213733" EFFECT_SIZE="2.0408163265306123" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="4" LOG_CI_END="0.8021722071611551" LOG_CI_START="-0.18256436721818248" LOG_EFFECT_SIZE="0.3098039199714864" MODIFIED="2013-11-23 14:44:20 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="995" O_E="0.0" SE="0.5784391383150814" STUDY_ID="STD-Bayliff-1999" TOTAL_1="49" TOTAL_2="50" VAR="0.33459183673469384" WEIGHT="3.0163292705220908"/><DICH_DATA CI_END="7.010763785170189" CI_START="0.4092059762747028" EFFECT_SIZE="1.6937669376693767" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="3" LOG_CI_END="0.8457653346022119" LOG_CI_START="-0.38805803223218227" LOG_EFFECT_SIZE="0.22885365118501486" MODIFIED="2013-11-23 14:44:27 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1000" O_E="0.0" SE="0.7247539532026899" STUDY_ID="STD-Yang-2006" TOTAL_1="246" TOTAL_2="250" VAR="0.5252682926829269" WEIGHT="2.2669010159118352"/><DICH_DATA CI_END="1.4559367832756067" CI_START="0.8906630317937844" EFFECT_SIZE="1.138748905374816" ESTIMABLE="YES" EVENTS_1="132" EVENTS_2="116" LOG_CI_END="0.16314251833512286" LOG_CI_START="-0.05028657330588837" LOG_EFFECT_SIZE="0.05642797251461725" MODIFIED="2013-11-23 14:44:39 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="999" O_E="0.0" SE="0.12536930492097248" STUDY_ID="STD-POISE-2008" TOTAL_1="4174" TOTAL_2="4177" VAR="0.015717462616367778" WEIGHT="88.33439156762866"/></DICH_SUBGROUP><DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-003.24.02" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2017-06-17 15:41:56 +0100" MODIFIED_BY="Hermann Blessberger" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0"><NAME>During surgery</NAME></DICH_SUBGROUP><DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-003.24.03" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2013-11-23 14:41:25 +0000" MODIFIED_BY="Hermann Blessberger" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0"><NAME>After surgery</NAME></DICH_SUBGROUP></DICH_OUTCOME><DICH_OUTCOME CHI2="3.3042805869012404" CI_END="1.5862677008295942" CI_START="0.5538393876131482" CI_STUDY="95" CI_TOTAL="95" DF="6" EFFECT_MEASURE="RR" EFFECT_SIZE="0.9373033297806954" ESTIMABLE="YES" EVENTS_1="22" EVENTS_2="21" I2="0.0" I2_Q="0.0" ID="CMP-003.25" LOG_CI_END="0.20037648133111538" LOG_CI_START="-0.25661616160097084" LOG_EFFECT_SIZE="-0.02811984013492772" METHOD="MH" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" NO="25" P_CHI2="0.7698005605463882" P_Q="0.8789539170573193" P_Z="0.8093982077177833" Q="0.023193908218558136" RANDOM="NO" SCALE="100.0" SORT_BY="YEAR" STUDIES="8" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="646" TOTAL_2="434" WEIGHT="99.99999999999997" Z="0.2412024559602057"><NAME>Bronchospasm&#8212;non-cardiac surgery</NAME><GROUP_LABEL_1>Beta-blocker</GROUP_LABEL_1><GROUP_LABEL_2>Control</GROUP_LABEL_2><GRAPH_LABEL_1>Favours beta-blocker</GRAPH_LABEL_1><GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2><DICH_SUBGROUP CHI2="2.2673895126499177" CI_END="1.73235964108401" CI_START="0.5329999496807195" DF="2" EFFECT_SIZE="0.9609097780367764" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="17" I2="11.792835379988032" ID="CMP-003.25.01" LOG_CI_END="0.23863805738366478" LOG_CI_START="-0.2732728319741536" LOG_EFFECT_SIZE="-0.017317387295244374" MODIFIED="2013-11-23 14:50:04 +0000" MODIFIED_BY="Hermann Blessberger" NO="1" P_CHI2="0.321842275873894" P_Z="0.8945042834305968" STUDIES="3" TAU2="0.0" TOTAL_1="168" TOTAL_2="171" WEIGHT="74.174278349608" Z="0.13260688963889528"><NAME>Before surgery</NAME><DICH_DATA CI_END="14.903914722906746" CI_START="0.06709646549862758" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.1733003569528007" LOG_CI_START="-1.1733003569528007" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-11-23 14:49:50 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1003" O_E="0.0" SE="1.378404875209022" STUDY_ID="STD-Jakobsen-1992" TOTAL_1="20" TOTAL_2="20" VAR="1.9" WEIGHT="4.279260598889494"/><DICH_DATA CI_END="136.46047637797233" CI_START="0.373585094769823" EFFECT_SIZE="7.14" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="0" LOG_CI_END="2.1350068830509046" LOG_CI_START="-0.4276104594985559" LOG_EFFECT_SIZE="0.8536982117761743" MODIFIED="2013-11-23 14:49:57 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1012" O_E="0.0" SE="1.5052941121739825" STUDY_ID="STD-Mangano-1996" TOTAL_1="99" TOTAL_2="101" VAR="2.2659103641456584" WEIGHT="2.118445841034403"/><DICH_DATA CI_END="1.446151791426689" CI_START="0.4050013729748808" EFFECT_SIZE="0.7653061224489796" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="16" LOG_CI_END="0.16021387990126323" LOG_CI_START="-0.39254350450285286" LOG_EFFECT_SIZE="-0.11616481230079483" MODIFIED="2013-11-23 14:50:04 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1011" O_E="0.0" SE="0.32469242379215935" STUDY_ID="STD-Bayliff-1999" TOTAL_1="49" TOTAL_2="50" VAR="0.1054251700680272" WEIGHT="67.77657190968411"/></DICH_SUBGROUP><DICH_SUBGROUP CHI2="1.069096995537293" CI_END="2.728184924819643" CI_START="0.2771203446108941" DF="3" EFFECT_SIZE="0.8695030457268483" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="4" I2="0.0" ID="CMP-003.25.02" LOG_CI_END="0.4358738048065763" LOG_CI_START="-0.5573315895988161" LOG_EFFECT_SIZE="-0.060728892396119866" MODIFIED="2013-11-23 14:50:35 +0000" MODIFIED_BY="Hermann Blessberger" NO="2" P_CHI2="0.7845389613724827" P_Z="0.8105772364980162" STUDIES="5" TAU2="0.0" TOTAL_1="478" TOTAL_2="263" WEIGHT="25.825721650391976" Z="0.23968142458320316"><NAME>During surgery</NAME><DICH_DATA CI_END="66.61522199816511" CI_START="0.11922423317225214" EFFECT_SIZE="2.8181818181818183" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.8235734795372827" LOG_CI_START="-0.9236354621851873" LOG_EFFECT_SIZE="0.44996900867604767" MODIFIED="2013-11-23 14:50:10 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1006" O_E="0.0" SE="1.6137241312713606" STUDY_ID="STD-Cucchiara-1986" TOTAL_1="32" TOTAL_2="30" VAR="2.6041055718475072" WEIGHT="2.2064937463023955"/><DICH_DATA CI_END="7.190006335094644" CI_START="0.03477048396741213" EFFECT_SIZE="0.5" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="0.8567292730387149" LOG_CI_START="-1.4587892643666773" LOG_EFFECT_SIZE="-0.3010299956639812" MODIFIED="2013-11-23 14:50:16 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1007" O_E="0.0" SE="1.3601470508735443" STUDY_ID="STD-Inada-1989" TOTAL_1="20" TOTAL_2="10" VAR="1.8499999999999999" WEIGHT="5.705680798519325"/><DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-11-23 14:50:22 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1009" O_E="0.0" SE="0.0" STUDY_ID="STD-Miller-1990" TOTAL_1="30" TOTAL_2="15" VAR="0.0" WEIGHT="0.0"/><DICH_DATA CI_END="5.291026045497317" CI_START="0.18087121868109135" EFFECT_SIZE="0.9782608695652174" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="2" LOG_CI_END="0.723539899386512" LOG_CI_START="-0.7426305351989728" LOG_EFFECT_SIZE="-0.009545317906230389" MODIFIED="2013-11-23 14:50:29 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1010" O_E="0.0" SE="0.8612357709362151" STUDY_ID="STD-Miller-1991" TOTAL_1="368" TOTAL_2="180" VAR="0.7417270531400967" WEIGHT="11.494656207236012"/><DICH_DATA CI_END="7.848616069043482" CI_START="0.014156777466712338" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.8947930852084158" LOG_CI_START="-1.8490355946477406" LOG_EFFECT_SIZE="-0.47712125471966244" MODIFIED="2013-11-23 14:50:35 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1008" O_E="0.0" SE="1.611738548718522" STUDY_ID="STD-Kawaguchi-2010" TOTAL_1="28" TOTAL_2="28" VAR="2.5977011494252875" WEIGHT="6.418890898334242"/></DICH_SUBGROUP><DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-003.25.03" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2013-11-23 14:46:31 +0000" MODIFIED_BY="Hermann Blessberger" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0"><NAME>After surgery</NAME></DICH_SUBGROUP></DICH_OUTCOME><CONT_OUTCOME CHI2="30.821873762650842" CI_END="-0.19057109548480983" CI_START="-0.8982702505487188" CI_STUDY="95" CI_TOTAL="95" DF="13" EFFECT_MEASURE="MD" EFFECT_SIZE="-0.5444206730167643" ESTIMABLE="YES" I2="57.822161948657815" I2_Q="0.0" ID="CMP-003.26" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" NO="26" P_CHI2="0.0035797176246029627" P_Q="0.4040157378160829" P_Z="0.0025652842057218754" Q="1.8126031179943587" RANDOM="YES" SCALE="2.0" SORT_BY="YEAR" STUDIES="14" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.1658084798189957" TOTALS="YES" TOTAL_1="1272" TOTAL_2="1178" UNITS="" WEIGHT="100.00000000000003" Z="3.0155325293713418"><NAME>Length of stay&#8212;cardiac surgery</NAME><GROUP_LABEL_1>Beta-blocker</GROUP_LABEL_1><GROUP_LABEL_2>Control</GROUP_LABEL_2><GRAPH_LABEL_1>Favours beta-blocker</GRAPH_LABEL_1><GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2><CONT_SUBGROUP CHI2="1.383305114961729" CI_END="0.0227289930090272" CI_START="-1.3934312728053904" DF="2" EFFECT_SIZE="-0.6853511398981816" ESTIMABLE="YES" I2="0.0" ID="CMP-003.26.01" MODIFIED="2013-11-28 21:20:11 +0000" MODIFIED_BY="Hermann Blessberger" NO="1" P_CHI2="0.5007479239662769" P_Z="0.057821314218862566" STUDIES="3" TAU2="0.0" TOTAL_1="291" TOTAL_2="239" WEIGHT="15.838262485339722" Z="1.8970501904195323"><NAME>Before surgery</NAME><CONT_DATA CI_END="0.49035874809146784" CI_START="-1.2903587480914687" EFFECT_SIZE="-0.40000000000000036" ESTIMABLE="YES" MEAN_1="10.0" MEAN_2="10.4" MODIFIED="2013-11-28 21:19:51 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1754" SD_1="4.0" SD_2="3.2" SE="0.45427301476685505" STUDY_ID="STD-Pfisterer-1997" TOTAL_1="126" TOTAL_2="129" WEIGHT="8.757839005699223"/><CONT_DATA CI_END="0.3228748645299382" CI_START="-2.322874864529938" EFFECT_SIZE="-1.0" ESTIMABLE="YES" MEAN_1="7.0" MEAN_2="8.0" MODIFIED="2013-11-28 21:20:00 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1753" SD_1="2.0" SD_2="4.0" SE="0.674948557710553" STUDY_ID="STD-Gomes-1999" TOTAL_1="40" TOTAL_2="45" WEIGHT="5.245598762316369"/><CONT_DATA CI_END="0.6873907364900345" CI_START="-4.287390736490032" EFFECT_SIZE="-1.799999999999999" ESTIMABLE="YES" MEAN_1="11.3" MEAN_2="13.1" MODIFIED="2013-11-28 21:20:11 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1752" SD_1="7.0" SD_2="8.9" SE="1.2691002263869409" STUDY_ID="STD-Auer-2004" TOTAL_1="125" TOTAL_2="65" WEIGHT="1.8348247173241303"/></CONT_SUBGROUP><CONT_SUBGROUP CHI2="3.79019322261951" CI_END="-0.5869762641985374" CI_START="-0.8254396801257029" DF="4" EFFECT_SIZE="-0.7062079721621202" ESTIMABLE="YES" I2="0.0" ID="CMP-003.26.02" MODIFIED="2013-12-07 15:22:23 +0000" MODIFIED_BY="Hermann Blessberger" NO="2" P_CHI2="0.4351441738820301" P_Z="3.716092847615046E-31" STUDIES="5" TAU2="0.0" TOTAL_1="200" TOTAL_2="172" WEIGHT="29.395402828828306" Z="11.608843106194389"><NAME>During surgery</NAME><CONT_DATA CI_END="1.5979397562798727" CI_START="-3.197939756279874" EFFECT_SIZE="-0.8000000000000007" ESTIMABLE="YES" MEAN_1="7.6" MEAN_2="8.4" MODIFIED="2013-11-28 21:20:24 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1757" SD_1="3.9" SD_2="2.6" SE="1.2234611325486162" STUDY_ID="STD-Cork-1995" TOTAL_1="15" TOTAL_2="14" WEIGHT="1.9603619455741499"/><CONT_DATA CI_END="-0.5799305882439878" CI_START="-0.8200694117560126" EFFECT_SIZE="-0.7000000000000002" ESTIMABLE="YES" MEAN_1="5.1" MEAN_2="5.8" MODIFIED="2013-12-07 15:22:23 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1755" SD_1="0.3" SD_2="0.2" SE="0.061261029642944734" STUDY_ID="STD-Booth-2004" TOTAL_1="33" TOTAL_2="39" WEIGHT="19.22269183006188"/><CONT_DATA CI_END="0.8331433922667311" CI_START="-2.03314339226673" EFFECT_SIZE="-0.5999999999999996" ESTIMABLE="YES" MEAN_1="7.5" MEAN_2="8.1" MODIFIED="2013-11-28 21:20:49 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1756" SD_1="2.1" SD_2="1.9" SE="0.731209044437134" STUDY_ID="STD-But-2006" TOTAL_1="15" TOTAL_2="15" WEIGHT="4.653164971321886"/><CONT_DATA CI_END="-0.6816580345935019" CI_START="-4.9183419654064995" EFFECT_SIZE="-2.8000000000000007" ESTIMABLE="YES" MEAN_1="11.2" MEAN_2="14.0" MODIFIED="2013-11-28 21:21:04 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1758" SD_1="4.9" SD_2="7.6" SE="1.0808065771186153" STUDY_ID="STD-Sezai-2011" TOTAL_1="70" TOTAL_2="70" WEIGHT="2.443437271356669"/><CONT_DATA CI_END="2.5534736631582517" CI_START="-3.9534736631582503" EFFECT_SIZE="-0.6999999999999993" ESTIMABLE="YES" MEAN_1="11.5" MEAN_2="12.2" MODIFIED="2013-11-28 21:21:15 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1759" SD_1="5.0" SD_2="9.0" SE="1.6599660446932882" STUDY_ID="STD-Sezai-2012" TOTAL_1="67" TOTAL_2="34" WEIGHT="1.11574681051372"/></CONT_SUBGROUP><CONT_SUBGROUP CHI2="13.3168922637238" CI_END="0.2156089756530919" CI_START="-0.8667329569385724" DF="5" EFFECT_SIZE="-0.3255619906427403" ESTIMABLE="YES" I2="62.45370240307215" ID="CMP-003.26.03" MODIFIED="2013-11-28 21:22:39 +0000" MODIFIED_BY="Hermann Blessberger" NO="3" P_CHI2="0.02058340186327756" P_Z="0.23836199182294138" STUDIES="6" TAU2="0.2474599677788688" TOTAL_1="781" TOTAL_2="767" WEIGHT="54.76633468583199" Z="1.1790909271472707"><NAME>After surgery</NAME><CONT_DATA CI_END="0.8525956472955156" CI_START="-1.2525956472955142" EFFECT_SIZE="-0.1999999999999993" ESTIMABLE="YES" MEAN_1="10.0" MEAN_2="10.2" MODIFIED="2013-11-28 21:21:30 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1763" SD_1="1.5" SD_2="1.7" SE="0.5370484639504883" STUDY_ID="STD-Jacquet-1994" TOTAL_1="19" TOTAL_2="17" WEIGHT="7.175725447273321"/><CONT_DATA CI_END="-0.6213610519607327" CI_START="-2.1986389480392674" EFFECT_SIZE="-1.4100000000000001" ESTIMABLE="YES" MEAN_1="8.42" MEAN_2="9.83" MODIFIED="2013-11-28 21:21:45 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1765" SD_1="2.81" SD_2="2.88" SE="0.40237420394453716" STUDY_ID="STD-Wenke-1999" TOTAL_1="100" TOTAL_2="100" WEIGHT="9.945963823974875"/><CONT_DATA CI_END="2.627257429639835" CI_START="-4.627257429639835" EFFECT_SIZE="-1.0" ESTIMABLE="YES" MEAN_1="21.0" MEAN_2="22.0" MODIFIED="2013-11-28 21:21:54 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1764" SD_1="4.0" SD_2="11.0" SE="1.8506755523321747" STUDY_ID="STD-Matsuura-2001" TOTAL_1="40" TOTAL_2="40" WEIGHT="0.907713801286598"/><CONT_DATA CI_END="0.9081080402146975" CI_START="-0.9081080402146975" EFFECT_SIZE="0.0" ESTIMABLE="YES" MEAN_1="8.0" MEAN_2="8.0" MODIFIED="2013-11-28 21:22:09 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1760" SD_1="2.3" SD_2="2.9" SE="0.4633289424590134" STUDY_ID="STD-Bert-2001" TOTAL_1="71" TOTAL_2="60" WEIGHT="8.566567664335407"/><CONT_DATA CI_END="0.30800399250821786" CI_START="-0.9080039925082193" EFFECT_SIZE="-0.3000000000000007" ESTIMABLE="YES" MEAN_1="5.6" MEAN_2="5.9" MODIFIED="2013-11-28 21:22:24 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1762" SD_1="1.4" SD_2="1.7" SE="0.3102118188416096" STUDY_ID="STD-Forlani-2002" TOTAL_1="51" TOTAL_2="50" WEIGHT="12.438666811378871"/><CONT_DATA CI_END="0.5986973363346225" CI_START="-0.19869733633462217" EFFECT_SIZE="0.20000000000000018" ESTIMABLE="YES" MEAN_1="6.5" MEAN_2="6.3" MODIFIED="2013-11-28 21:22:39 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1761" SD_1="3.8" SD_2="2.5" SE="0.20342074623793907" STUDY_ID="STD-Connolly-2003" TOTAL_1="500" TOTAL_2="500" WEIGHT="15.731697137582918"/></CONT_SUBGROUP></CONT_OUTCOME><CONT_OUTCOME CHI2="3.109542519456295" CI_END="0.8396604843024991" CI_START="-1.7484787202947654" CI_STUDY="95" CI_TOTAL="95" DF="2" EFFECT_MEASURE="MD" EFFECT_SIZE="-0.45440911799613315" ESTIMABLE="YES" I2="35.68185713859604" I2_Q="0.0" ID="CMP-003.27" MODIFIED="2017-12-08 02:36:42 +0000" MODIFIED_BY="Hermann Blessberger" NO="27" P_CHI2="0.21123779549911226" P_Q="0.4879661732532484" P_Z="0.49130407532430953" Q="0.481007903662397" RANDOM="YES" SCALE="2.0" SORT_BY="YEAR" STUDIES="3" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.5891179693527354" TOTALS="YES" TOTAL_1="276" TOTAL_2="275" UNITS="" WEIGHT="100.0" Z="0.6882361690105625"><NAME>Length of stay&#8212;non-cardiac surgery</NAME><GROUP_LABEL_1>Beta-blocker</GROUP_LABEL_1><GROUP_LABEL_2>Control</GROUP_LABEL_2><GRAPH_LABEL_1>Favours beta-blocker</GRAPH_LABEL_1><GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2><CONT_SUBGROUP CHI2="3.105527106230739" CI_END="7.188928915604478" CI_START="-16.3025063804925" DF="1" EFFECT_SIZE="-4.55678873244401" ESTIMABLE="YES" I2="67.79934723501007" ID="CMP-003.27.01" MODIFIED="2013-11-28 21:25:37 +0000" MODIFIED_BY="Hermann Blessberger" NO="1" P_CHI2="0.07802724774760617" P_Z="0.4470308887881661" STUDIES="2" TAU2="53.819121835150874" TOTAL_1="246" TOTAL_2="245" WEIGHT="27.034665622388506" Z="0.7603742971151759"><NAME>Before surgery</NAME><CONT_DATA CI_END="1.0653205264171248" CI_START="-26.665320526417123" EFFECT_SIZE="-12.799999999999999" ESTIMABLE="YES" MEAN_1="15.9" MEAN_2="28.7" MODIFIED="2013-11-28 21:25:22 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1767" SD_1="21.5" SD_2="41.3" SE="7.074273117151643" STUDY_ID="STD-POBBLE-2005" TOTAL_1="49" TOTAL_2="42" WEIGHT="0.8609400733405568"/><CONT_DATA CI_END="1.833472026316095" CI_START="-2.2334720263160954" EFFECT_SIZE="-0.20000000000000018" ESTIMABLE="YES" MEAN_1="7.8" MEAN_2="8.0" MODIFIED="2013-11-28 21:25:37 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1766" SD_1="8.9" SD_2="11.7" SE="1.0375047921063159" STUDY_ID="STD-Marwick-2009" TOTAL_1="197" TOTAL_2="203" WEIGHT="26.173725549047948"/></CONT_SUBGROUP><CONT_SUBGROUP CHI2="0.0" CI_END="-0.22108058562828417" CI_START="-0.5789194143717157" DF="0" EFFECT_SIZE="-0.3999999999999999" ESTIMABLE="YES" I2="0.0" ID="CMP-003.27.02" MODIFIED="2017-12-08 02:36:42 +0000" MODIFIED_BY="Hermann Blessberger" NO="2" P_CHI2="1.0" P_Z="1.1771339097414749E-5" STUDIES="1" TAU2="0.0" TOTAL_1="30" TOTAL_2="30" WEIGHT="72.9653343776115" Z="4.381780460041328"><NAME>During surgery</NAME><CONT_DATA CI_END="-0.22108058562828417" CI_START="-0.5789194143717157" EFFECT_SIZE="-0.3999999999999999" ESTIMABLE="YES" MEAN_1="1.3" MEAN_2="1.7" MODIFIED="2017-12-08 02:36:42 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1768" SD_1="0.3" SD_2="0.4" SE="0.09128709291752769" STUDY_ID="STD-Lee-2010" TOTAL_1="30" TOTAL_2="30" WEIGHT="72.9653343776115"/></CONT_SUBGROUP><CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-003.27.03" MODIFIED="2013-11-28 21:23:46 +0000" MODIFIED_BY="Hermann Blessberger" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0"><NAME>After surgery</NAME></CONT_SUBGROUP></CONT_OUTCOME></COMPARISON><COMPARISON ID="CMP-004" MODIFIED="2017-12-08 02:36:36 +0000" MODIFIED_BY="Hermann Blessberger" NO="4"><NAME>Stratification for risk status of non-cardiac surgery</NAME><DICH_OUTCOME CHI2="6.688662154126656" CI_END="1.5678386330345675" CI_START="1.0041493045683079" CI_STUDY="95" CI_TOTAL="95" DF="9" EFFECT_MEASURE="RR" EFFECT_SIZE="1.25472868502995" ESTIMABLE="YES" EVENTS_1="168" EVENTS_2="134" I2="0.0" I2_Q="34.04506365978817" ID="CMP-004.01" LOG_CI_END="0.19530136167176518" LOG_CI_START="0.0017982918222352762" LOG_EFFECT_SIZE="0.09854982674700022" METHOD="MH" MODIFIED="2017-12-03 02:24:23 +0000" MODIFIED_BY="Hermann Blessberger" NO="1" P_CHI2="0.6694976558571097" P_Q="0.21819787138862468" P_Z="0.04589113513048386" Q="1.5161867412649044" RANDOM="NO" SCALE="100.0" SORT_BY="YEAR" STUDIES="13" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="5805" TOTAL_2="5608" WEIGHT="100.0" Z="1.9963932485100235"><NAME>All-cause mortality (30 days)&#8212;non-cardiac</NAME><GROUP_LABEL_1>Experimental</GROUP_LABEL_1><GROUP_LABEL_2>Control</GROUP_LABEL_2><GRAPH_LABEL_1>Favours beta-blocker</GRAPH_LABEL_1><GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2><DICH_SUBGROUP CHI2="0.7361538407914828" CI_END="1.662566079125949" CI_START="1.0377431989401755" DF="3" EFFECT_SIZE="1.3135130914465936" ESTIMABLE="YES" EVENTS_1="155" EVENTS_2="118" I2="0.0" ID="CMP-004.01.01" LOG_CI_END="0.22077891546654685" LOG_CI_START="0.016089895823207922" LOG_EFFECT_SIZE="0.1184344056448774" MODIFIED="2017-12-03 02:24:23 +0000" MODIFIED_BY="Hermann Blessberger" NO="1" P_CHI2="0.8646690559669714" P_Z="0.023323358359797115" STUDIES="6" TAU2="0.0" TOTAL_1="5282" TOTAL_2="5085" WEIGHT="87.9264357822395" Z="2.268095963318772"><NAME>Low and medium risk</NAME><DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-11-23 15:42:18 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1016" O_E="0.0" SE="0.0" STUDY_ID="STD-Miller-1990" TOTAL_1="30" TOTAL_2="15" VAR="0.0" WEIGHT="0.0"/><DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-11-23 15:42:26 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1017" O_E="0.0" SE="0.0" STUDY_ID="STD-Miller-1991" TOTAL_1="368" TOTAL_2="180" VAR="0.0" WEIGHT="0.0"/><DICH_DATA CI_END="2.5549775876151535" CI_START="0.6868023908740409" EFFECT_SIZE="1.3246753246753247" ESTIMABLE="YES" EVENTS_1="20" EVENTS_2="15" LOG_CI_END="0.4073870948356017" LOG_CI_START="-0.16316820165673035" LOG_EFFECT_SIZE="0.12210944658943569" MODIFIED="2013-11-23 15:42:34 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1014" O_E="0.0" SE="0.3351470054538631" STUDY_ID="STD-DIPOM-_x002d_-Juul-2006" TOTAL_1="462" TOTAL_2="459" VAR="0.11232351526469174" WEIGHT="11.171932069576803"/><DICH_DATA CI_END="7.99511202377449" CI_START="0.013897380146858233" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.90282455325627" LOG_CI_START="-1.8570670626955947" LOG_EFFECT_SIZE="-0.47712125471966244" MODIFIED="2013-11-23 15:43:04 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1019" O_E="0.0" SE="1.6211739968939571" STUDY_ID="STD-Yang-2008" TOTAL_1="51" TOTAL_2="51" VAR="2.628205128205128" WEIGHT="1.1135659562857398"/><DICH_DATA CI_END="1.7258284961101578" CI_START="1.0262717576233682" EFFECT_SIZE="1.3308527507051506" ESTIMABLE="YES" EVENTS_1="129" EVENTS_2="97" LOG_CI_END="0.23699763558907627" LOG_CI_START="0.011262377548303708" LOG_EFFECT_SIZE="0.12413000656868999" MODIFIED="2017-12-03 02:24:23 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1018" O_E="0.0" SE="0.13259800798069846" STUDY_ID="STD-POISE-2008" TOTAL_1="4174" TOTAL_2="4177" VAR="0.017582231720449374" WEIGHT="71.98472953323878"/><DICH_DATA CI_END="3.986212369346937" CI_START="0.38358505944859494" EFFECT_SIZE="1.2365482233502538" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="5" LOG_CI_END="0.6005604324423948" LOG_CI_START="-0.416138316843905" LOG_EFFECT_SIZE="0.09221105779924482" MODIFIED="2013-11-23 15:43:25 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1015" O_E="0.0" SE="0.5972138780707484" STUDY_ID="STD-Marwick-2009" TOTAL_1="197" TOTAL_2="203" VAR="0.35666441616030276" WEIGHT="3.656208223138179"/></DICH_SUBGROUP><DICH_SUBGROUP CHI2="5.171281600512156" CI_END="1.662062819020338" CI_START="0.41112377830011726" DF="5" EFFECT_SIZE="0.8266278158444618" ESTIMABLE="YES" EVENTS_1="13" EVENTS_2="16" I2="3.3121692791820223" ID="CMP-004.01.02" LOG_CI_END="0.22064743427258857" LOG_CI_START="-0.3860274040615685" LOG_EFFECT_SIZE="-0.08268998489448995" MODIFIED="2017-06-17 15:42:38 +0100" MODIFIED_BY="Hermann Blessberger" NO="2" P_CHI2="0.39533683834571365" P_Z="0.5931426392668122" STUDIES="7" TAU2="0.0" TOTAL_1="523" TOTAL_2="523" WEIGHT="12.073564217760506" Z="0.5342875030729177"><NAME>High risk</NAME><DICH_DATA CI_END="10.888852021315463" CI_START="0.38234045608732375" EFFECT_SIZE="2.04040404040404" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="2" LOG_CI_END="1.0369820958174838" LOG_CI_START="-0.4175497461193362" LOG_EFFECT_SIZE="0.3097161748490738" MODIFIED="2013-11-23 15:44:11 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1023" O_E="0.0" SE="0.8543992040024265" STUDY_ID="STD-Mangano-1996" TOTAL_1="99" TOTAL_2="101" VAR="0.72999799979998" WEIGHT="1.4699070622971766"/><DICH_DATA CI_END="21.785667983536555" CI_START="0.1911775797639689" EFFECT_SIZE="2.0408163265306123" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="1" LOG_CI_END="1.3381708806415864" LOG_CI_START="-0.7185630406986138" LOG_EFFECT_SIZE="0.3098039199714864" MODIFIED="2013-11-23 15:44:17 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1020" O_E="0.0" SE="1.2081356863923414" STUDY_ID="STD-Bayliff-1999" TOTAL_1="49" TOTAL_2="50" VAR="1.4595918367346938" WEIGHT="0.7348785435421044"/><DICH_DATA CI_END="23.10618612076079" CI_START="0.2684527492293484" EFFECT_SIZE="2.490566037735849" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="1" LOG_CI_END="1.3637282672706277" LOG_CI_START="-0.571132144060506" LOG_EFFECT_SIZE="0.3962980616050608" MODIFIED="2013-11-23 15:44:33 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1025" O_E="0.0" SE="1.1365465833294115" STUDY_ID="STD-POBBLE-2005" TOTAL_1="53" TOTAL_2="44" VAR="1.2917381360777587" WEIGHT="0.8112576726205388"/><DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-11-23 15:44:40 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1022" O_E="0.0" SE="0.0" STUDY_ID="STD-Lai-2006" TOTAL_1="30" TOTAL_2="30" VAR="0.0" WEIGHT="0.0"/><DICH_DATA CI_END="2.4023415437266507" CI_START="0.185004686617123" EFFECT_SIZE="0.6666666666666666" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="5" LOG_CI_END="0.38063475161440946" LOG_CI_START="-0.7328172697257719" LOG_EFFECT_SIZE="-0.17609125905568127" MODIFIED="2013-11-23 15:44:46 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1024" O_E="0.0" SE="0.6540472290116194" STUDY_ID="STD-Neary-2006" TOTAL_1="18" TOTAL_2="20" VAR="0.42777777777777776" WEIGHT="3.516524072481283"/><DICH_DATA CI_END="2.086100324386569" CI_START="0.006111296108574041" EFFECT_SIZE="0.11291048133153396" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="4" LOG_CI_END="0.3193351906100624" LOG_CI_START="-2.2138666730459673" LOG_EFFECT_SIZE="-0.9472657412179525" MODIFIED="2013-11-23 15:44:59 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1028" O_E="0.0" SE="1.4880153142630121" STUDY_ID="STD-Yang-2006" TOTAL_1="246" TOTAL_2="250" VAR="2.214189575481251" WEIGHT="3.313864954247925"/><DICH_DATA CI_END="3.0135058276554862" CI_START="0.036871045707436295" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="3" LOG_CI_END="0.4790720356632876" LOG_CI_START="-1.4333145451026126" LOG_EFFECT_SIZE="-0.47712125471966244" MODIFIED="2013-11-23 15:45:11 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1021" O_E="0.0" SE="1.1233453440081378" STUDY_ID="STD-Kawaguchi-2010" TOTAL_1="28" TOTAL_2="28" VAR="1.2619047619047616" WEIGHT="2.2271319125714797"/></DICH_SUBGROUP></DICH_OUTCOME><DICH_OUTCOME CHI2="12.222122050802037" CI_END="1.2957439418677086" CI_START="0.9100475827192767" CI_STUDY="95" CI_TOTAL="95" DF="9" EFFECT_MEASURE="RR" EFFECT_SIZE="1.085904527166111" ESTIMABLE="YES" EVENTS_1="233" EVENTS_2="215" I2="26.36303284657999" I2_Q="85.00018447814168" ID="CMP-004.02" LOG_CI_END="0.11251918701218595" LOG_CI_START="-0.04093589957762738" LOG_EFFECT_SIZE="0.03579164371727927" METHOD="MH" MODIFIED="2017-12-03 02:24:33 +0000" MODIFIED_BY="Hermann Blessberger" NO="2" P_CHI2="0.2010749071223843" P_Q="0.009822863545138172" P_Z="0.36057060767868687" Q="6.666748657960231" RANDOM="NO" SCALE="100.0" SORT_BY="YEAR" STUDIES="13" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="5805" TOTAL_2="5608" WEIGHT="99.99999999999997" Z="0.9142783623832438"><NAME>Long-term mortality&#8212;non-cardiac surgery</NAME><GROUP_LABEL_1>Experimental</GROUP_LABEL_1><GROUP_LABEL_2>Control</GROUP_LABEL_2><GRAPH_LABEL_1>Favours beta-blocker</GRAPH_LABEL_1><GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2><DICH_SUBGROUP CHI2="2.351019126083831" CI_END="1.4456920202789219" CI_START="0.9833021143477539" DF="3" EFFECT_SIZE="1.1922885641638687" ESTIMABLE="YES" EVENTS_1="209" EVENTS_2="175" I2="0.0" ID="CMP-004.02.01" LOG_CI_END="0.16007578387181115" LOG_CI_START="-0.0073130269941060685" LOG_EFFECT_SIZE="0.07638137843885254" MODIFIED="2017-12-03 02:24:33 +0000" MODIFIED_BY="Hermann Blessberger" NO="1" P_CHI2="0.5028176714196702" P_Z="0.0736620497448936" STUDIES="6" TAU2="0.0" TOTAL_1="5282" TOTAL_2="5085" WEIGHT="81.48874610252906" Z="1.7887067845842173"><NAME>Low and medium risk</NAME><DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-11-23 15:54:30 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1042" O_E="0.0" SE="0.0" STUDY_ID="STD-Miller-1990" TOTAL_1="30" TOTAL_2="15" VAR="0.0" WEIGHT="0.0"/><DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-11-23 15:54:37 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1043" O_E="0.0" SE="0.0" STUDY_ID="STD-Miller-1991" TOTAL_1="368" TOTAL_2="180" VAR="0.0" WEIGHT="0.0"/><DICH_DATA CI_END="1.3750776070230888" CI_START="0.7582504153316847" EFFECT_SIZE="1.021103896103896" ESTIMABLE="YES" EVENTS_1="74" EVENTS_2="72" LOG_CI_END="0.13832720969410692" LOG_CI_START="-0.12018734313242" LOG_EFFECT_SIZE="0.009069933280843453" MODIFIED="2013-11-23 15:52:56 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1036" O_E="0.0" SE="0.1518527279979766" STUDY_ID="STD-DIPOM-_x002d_-Juul-2006" TOTAL_1="462" TOTAL_2="459" VAR="0.02305925100042747" WEIGHT="33.516365890171826"/><DICH_DATA CI_END="1.7258284961101578" CI_START="1.0262717576233682" EFFECT_SIZE="1.3308527507051506" ESTIMABLE="YES" EVENTS_1="129" EVENTS_2="97" LOG_CI_END="0.23699763558907627" LOG_CI_START="0.011262377548303708" LOG_EFFECT_SIZE="0.12413000656868999" MODIFIED="2017-12-03 02:24:33 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1044" O_E="0.0" SE="0.13259800798069846" STUDY_ID="STD-POISE-2008" TOTAL_1="4174" TOTAL_2="4177" VAR="0.017582231720449374" WEIGHT="44.99122067911335"/><DICH_DATA CI_END="7.99511202377449" CI_START="0.013897380146858233" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.90282455325627" LOG_CI_START="-1.8570670626955947" LOG_EFFECT_SIZE="-0.47712125471966244" MODIFIED="2013-11-23 15:54:54 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1045" O_E="0.0" SE="1.6211739968939571" STUDY_ID="STD-Yang-2008" TOTAL_1="51" TOTAL_2="51" VAR="2.628205128205128" WEIGHT="0.6959905525083029"/><DICH_DATA CI_END="3.986212369346937" CI_START="0.38358505944859494" EFFECT_SIZE="1.2365482233502538" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="5" LOG_CI_END="0.6005604324423948" LOG_CI_START="-0.416138316843905" LOG_EFFECT_SIZE="0.09221105779924482" MODIFIED="2013-11-23 15:55:09 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1041" O_E="0.0" SE="0.5972138780707484" STUDY_ID="STD-Marwick-2009" TOTAL_1="197" TOTAL_2="203" VAR="0.35666441616030276" WEIGHT="2.2851689807355946"/></DICH_SUBGROUP><DICH_SUBGROUP CHI2="4.1991217626399315" CI_END="0.9789380610182828" CI_START="0.3896227741775754" DF="5" EFFECT_SIZE="0.617589315874198" ESTIMABLE="YES" EVENTS_1="24" EVENTS_2="40" I2="0.0" ID="CMP-004.02.02" LOG_CI_END="-0.009244785836241073" LOG_CI_START="-0.4093556657293042" LOG_EFFECT_SIZE="-0.2093002257827727" MODIFIED="2017-06-17 15:43:03 +0100" MODIFIED_BY="Hermann Blessberger" NO="2" P_CHI2="0.5211181988689877" P_Z="0.04031214334691077" STUDIES="7" TAU2="0.0" TOTAL_1="523" TOTAL_2="523" WEIGHT="18.511253897470915" Z="2.0505361143889664"><NAME>High risk</NAME><DICH_DATA CI_END="1.0730307753136772" CI_START="0.3098783343683285" EFFECT_SIZE="0.5766359244620114" ESTIMABLE="YES" EVENTS_1="13" EVENTS_2="23" LOG_CI_END="0.03061217803048055" LOG_CI_START="-0.5088087870818075" LOG_EFFECT_SIZE="-0.23909830452566347" MODIFIED="2013-11-23 15:53:06 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1039" O_E="0.0" SE="0.3168585450837994" STUDY_ID="STD-Wallace-1998" TOTAL_1="99" TOTAL_2="101" VAR="0.10039933759262215" WEIGHT="10.565136587076038"/><DICH_DATA CI_END="21.785667983536555" CI_START="0.1911775797639689" EFFECT_SIZE="2.0408163265306123" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="1" LOG_CI_END="1.3381708806415864" LOG_CI_START="-0.7185630406986138" LOG_EFFECT_SIZE="0.3098039199714864" MODIFIED="2013-11-23 15:56:14 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1046" O_E="0.0" SE="1.2081356863923414" STUDY_ID="STD-Bayliff-1999" TOTAL_1="49" TOTAL_2="50" VAR="1.4595918367346938" WEIGHT="0.459306896604806"/><DICH_DATA CI_END="23.10618612076079" CI_START="0.2684527492293484" EFFECT_SIZE="2.490566037735849" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="1" LOG_CI_END="1.3637282672706277" LOG_CI_START="-0.571132144060506" LOG_EFFECT_SIZE="0.3962980616050608" MODIFIED="2013-11-23 15:56:28 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1049" O_E="0.0" SE="1.1365465833294115" STUDY_ID="STD-POBBLE-2005" TOTAL_1="53" TOTAL_2="44" VAR="1.2917381360777587" WEIGHT="0.5070446636830247"/><DICH_DATA CI_END="2.086100324386569" CI_START="0.006111296108574041" EFFECT_SIZE="0.11291048133153396" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="4" LOG_CI_END="0.3193351906100624" LOG_CI_START="-2.2138666730459673" LOG_EFFECT_SIZE="-0.9472657412179525" MODIFIED="2013-11-23 15:56:48 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1051" O_E="0.0" SE="1.4880153142630121" STUDY_ID="STD-Yang-2006" TOTAL_1="246" TOTAL_2="250" VAR="2.214189575481251" WEIGHT="2.071200800837962"/><DICH_DATA CI_END="1.739330050693594" CI_START="0.2772637005998054" EFFECT_SIZE="0.6944444444444444" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="8" LOG_CI_END="0.2403820004008043" LOG_CI_START="-0.5571069845913037" LOG_EFFECT_SIZE="-0.15836249209524966" MODIFIED="2013-11-23 15:53:13 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1037" O_E="0.0" SE="0.4684489774185066" STUDY_ID="STD-Neary-2006" TOTAL_1="18" TOTAL_2="20" VAR="0.2194444444444445" WEIGHT="3.5165838442524775"/><DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-11-23 15:56:35 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1048" O_E="0.0" SE="0.0" STUDY_ID="STD-Lai-2006" TOTAL_1="30" TOTAL_2="30" VAR="0.0" WEIGHT="0.0"/><DICH_DATA CI_END="3.0135058276554862" CI_START="0.036871045707436295" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="3" LOG_CI_END="0.4790720356632876" LOG_CI_START="-1.4333145451026126" LOG_EFFECT_SIZE="-0.47712125471966244" MODIFIED="2013-11-23 15:56:56 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1047" O_E="0.0" SE="1.1233453440081378" STUDY_ID="STD-Kawaguchi-2010" TOTAL_1="28" TOTAL_2="28" VAR="1.2619047619047616" WEIGHT="1.3919811050166058"/></DICH_SUBGROUP></DICH_OUTCOME><DICH_OUTCOME CHI2="1.5282253003044441" CI_END="1.754721448938362" CI_START="0.9052084742356215" CI_STUDY="95" CI_TOTAL="95" DF="3" EFFECT_MEASURE="RR" EFFECT_SIZE="1.2603129474467893" ESTIMABLE="YES" EVENTS_1="77" EVENTS_2="61" I2="0.0" I2_Q="19.3108035917991" ID="CMP-004.03" LOG_CI_END="0.2442081847389606" LOG_CI_START="-0.0432513889897993" LOG_EFFECT_SIZE="0.10047839787458064" METHOD="MH" MODIFIED="2017-06-17 15:43:17 +0100" MODIFIED_BY="Hermann Blessberger" NO="3" P_CHI2="0.6757714682629976" P_Q="0.26560159560771945" P_Z="0.17063427719402982" Q="1.2393232855375969" RANDOM="NO" SCALE="100.0" SORT_BY="YEAR" STUDIES="4" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="4716" TOTAL_2="4731" WEIGHT="100.0" Z="1.3701686014763685"><NAME>Death due to cardiac causes&#8212;non-cardiac surgery</NAME><GROUP_LABEL_1>Experimental</GROUP_LABEL_1><GROUP_LABEL_2>Control</GROUP_LABEL_2><GRAPH_LABEL_1>Favours beta-blocker</GRAPH_LABEL_1><GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2><DICH_SUBGROUP CHI2="0.28228238993524307" CI_END="1.8351591886842773" CI_START="0.9339370240720035" DF="1" EFFECT_SIZE="1.3091688628202958" ESTIMABLE="YES" EVENTS_1="76" EVENTS_2="58" I2="0.0" ID="CMP-004.03.01" LOG_CI_END="0.2636737425764297" LOG_CI_START="-0.029682407517355847" LOG_EFFECT_SIZE="0.11699566752953695" MODIFIED="2013-11-26 21:58:54 +0000" MODIFIED_BY="Hermann Blessberger" NO="1" P_CHI2="0.5952092098238282" P_Z="0.11797329714360032" STUDIES="2" TAU2="0.0" TOTAL_1="4371" TOTAL_2="4380" WEIGHT="94.40107972376676" Z="1.5633372242702628"><NAME>Low and medium risk</NAME><DICH_DATA CI_END="1.8180790761671433" CI_START="0.9210386011859882" EFFECT_SIZE="1.2940328470168365" ESTIMABLE="YES" EVENTS_1="75" EVENTS_2="58" LOG_CI_END="0.2596127686528247" LOG_CI_START="-0.035722167923927406" LOG_EFFECT_SIZE="0.11194530036444864" MODIFIED="2013-11-23 15:48:15 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1031" O_E="0.0" SE="0.17348120367669792" STUDY_ID="STD-POISE-2008" TOTAL_1="4174" TOTAL_2="4177" VAR="0.03009572802911595" WEIGHT="93.6058907176127"/><DICH_DATA CI_END="75.42168546066148" CI_START="0.12667071744568087" EFFECT_SIZE="3.090909090909091" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.8774962334274081" LOG_CI_START="-0.8973237696593477" LOG_EFFECT_SIZE="0.49008623188403005" MODIFIED="2013-11-23 15:48:23 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1030" O_E="0.0" SE="1.6299430053937" STUDY_ID="STD-Marwick-2009" TOTAL_1="197" TOTAL_2="203" VAR="2.6567142008318476" WEIGHT="0.7951890061540642"/></DICH_SUBGROUP><DICH_SUBGROUP CHI2="0.04058867625487403" CI_END="2.929781039414311" CI_START="0.0650548522875461" DF="1" EFFECT_SIZE="0.4365735593848433" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="3" I2="0.0" ID="CMP-004.03.02" LOG_CI_END="0.46683516406486464" LOG_CI_START="-1.1867203048961865" LOG_EFFECT_SIZE="-0.3599425704156609" MODIFIED="2017-06-17 15:43:17 +0100" MODIFIED_BY="Hermann Blessberger" NO="2" P_CHI2="0.8403340665615788" P_Z="0.39350300471711575" STUDIES="2" TAU2="0.0" TOTAL_1="345" TOTAL_2="351" WEIGHT="5.598920276233242" Z="0.853281898019092"><NAME>High risk</NAME><DICH_DATA CI_END="5.535882382109476" CI_START="0.04700299293694875" EFFECT_SIZE="0.51010101010101" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" LOG_CI_END="0.7431868543274104" LOG_CI_START="-1.3278744872851878" LOG_EFFECT_SIZE="-0.2923438164788886" MODIFIED="2014-06-22 16:56:09 +0100" MODIFIED_BY="Hermann Blessberger" ORDER="1032" O_E="0.0" SE="1.216551683982222" STUDY_ID="STD-Mangano-1996" TOTAL_1="99" TOTAL_2="101" VAR="1.47999799979998" WEIGHT="3.196659804739338"/><DICH_DATA CI_END="8.274975487492005" CI_START="0.013865780185584986" EFFECT_SIZE="0.33873144399460187" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.9177667159628347" LOG_CI_START="-1.8580556889594146" LOG_EFFECT_SIZE="-0.47014448649829005" MODIFIED="2013-11-23 15:48:56 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1035" O_E="0.0" SE="1.6305318211938382" STUDY_ID="STD-Yang-2006" TOTAL_1="246" TOTAL_2="250" VAR="2.658634019925695" WEIGHT="2.4022604714939044"/></DICH_SUBGROUP></DICH_OUTCOME><DICH_OUTCOME CHI2="6.269793019097788" CI_END="0.8701203248774039" CI_START="0.6077471038709278" CI_STUDY="95" CI_TOTAL="95" DF="10" EFFECT_MEASURE="RR" EFFECT_SIZE="0.727195370903496" ESTIMABLE="YES" EVENTS_1="194" EVENTS_2="266" I2="0.0" I2_Q="0.0" ID="CMP-004.04" LOG_CI_END="-0.06042068667221281" LOG_CI_START="-0.21627710204591305" LOG_EFFECT_SIZE="-0.13834889435906292" METHOD="MH" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" NO="4" P_CHI2="0.7921099759304913" P_Q="0.6839856896805147" P_Z="5.021663179354654E-4" Q="0.16567398255157603" RANDOM="NO" SCALE="100.0" SORT_BY="YEAR" STUDIES="14" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="5522" TOTAL_2="5436" WEIGHT="100.0" Z="3.479598187787608"><NAME>Acute myocardial infarction&#8212;non-cardiac surgery</NAME><GROUP_LABEL_1>Experimental</GROUP_LABEL_1><GROUP_LABEL_2>Control</GROUP_LABEL_2><GRAPH_LABEL_1>Favours beta-blocker</GRAPH_LABEL_1><GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2><DICH_SUBGROUP CHI2="4.093605293033801" CI_END="0.8695077203184697" CI_START="0.5915161804567318" DF="5" EFFECT_SIZE="0.7171665675423119" ESTIMABLE="YES" EVENTS_1="169" EVENTS_2="235" I2="0.0" ID="CMP-004.04.01" LOG_CI_END="-0.06072655756371291" LOG_CI_START="-0.22803337109190497" LOG_EFFECT_SIZE="-0.14437996432780895" MODIFIED="2013-12-07 20:55:44 +0000" MODIFIED_BY="Hermann Blessberger" NO="1" P_CHI2="0.5360194923514461" P_Z="7.176090260767628E-4" STUDIES="8" TAU2="0.0" TOTAL_1="5142" TOTAL_2="5064" WEIGHT="87.97681388822107" Z="3.3827615768200605"><NAME>Low and medium risk</NAME><DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-11-23 16:04:05 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1057" O_E="0.0" SE="0.0" STUDY_ID="STD-Stone-1988" TOTAL_1="89" TOTAL_2="39" VAR="0.0" WEIGHT="0.0"/><DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-11-23 16:04:14 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1055" O_E="0.0" SE="0.0" STUDY_ID="STD-Miller-1990" TOTAL_1="30" TOTAL_2="15" VAR="0.0" WEIGHT="0.0"/><DICH_DATA CI_END="5.535882382109476" CI_START="0.04700299293694875" EFFECT_SIZE="0.51010101010101" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" LOG_CI_END="0.7431868543274104" LOG_CI_START="-1.3278744872851878" LOG_EFFECT_SIZE="-0.2923438164788886" MODIFIED="2013-11-23 16:04:20 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1058" O_E="0.0" SE="1.216551683982222" STUDY_ID="STD-Wallace-1998" TOTAL_1="99" TOTAL_2="101" VAR="1.47999799979998" WEIGHT="0.7367550638938337"/><DICH_DATA CI_END="1.2850770513332368" CI_START="0.0037789141856547637" EFFECT_SIZE="0.06968641114982578" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="3" LOG_CI_END="0.10892916810749446" LOG_CI_START="-2.4226329702475167" LOG_EFFECT_SIZE="-1.1568519010700111" MODIFIED="2013-11-23 16:04:26 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1060" O_E="0.0" SE="1.4870521315044227" STUDY_ID="STD-Zaugg-1999" TOTAL_1="40" TOTAL_2="19" VAR="2.2113240418118467" WEIGHT="1.750693023162198"/><DICH_DATA CI_END="8.877109838397404" CI_START="0.250179859646748" EFFECT_SIZE="1.4902597402597402" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="2" LOG_CI_END="0.9482715935329684" LOG_CI_START="-0.6017476554593345" LOG_EFFECT_SIZE="0.17326196903681695" MODIFIED="2013-11-23 16:04:34 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1053" O_E="0.0" SE="0.9104889795771052" STUDY_ID="STD-DIPOM-_x002d_-Juul-2006" TOTAL_1="462" TOTAL_2="459" VAR="0.8289901819313583" WEIGHT="0.7466211288102549"/><DICH_DATA CI_END="15.556810748046935" CI_START="0.06428052742915473" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.1919205684576701" LOG_CI_START="-1.1919205684576701" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-11-23 16:05:02 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1059" O_E="0.0" SE="1.4002800840280099" STUDY_ID="STD-Yang-2008" TOTAL_1="51" TOTAL_2="51" VAR="1.9607843137254903" WEIGHT="0.3720985171180978"/><DICH_DATA CI_END="0.8669144321966489" CI_START="0.5773751446800002" EFFECT_SIZE="0.7074848731349105" ESTIMABLE="YES" EVENTS_1="152" EVENTS_2="215" LOG_CI_END="-0.06202376695142708" LOG_CI_START="-0.23854191591886673" LOG_EFFECT_SIZE="-0.1502828414351469" MODIFIED="2013-12-07 20:55:44 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1056" O_E="0.0" SE="0.10368763448240352" STUDY_ID="STD-POISE-2008" TOTAL_1="4174" TOTAL_2="4177" VAR="0.010751125544556516" WEIGHT="79.97244168290077"/><DICH_DATA CI_END="2.2384256247346914" CI_START="0.47436971491585606" EFFECT_SIZE="1.0304568527918783" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="12" LOG_CI_END="0.34994266883162384" LOG_CI_START="-0.3238830453283838" LOG_EFFECT_SIZE="0.013029811751620029" MODIFIED="2013-11-23 16:05:21 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1054" O_E="0.0" SE="0.3958085599886677" STUDY_ID="STD-Marwick-2009" TOTAL_1="197" TOTAL_2="203" VAR="0.15666441616030274" WEIGHT="4.398204472335917"/></DICH_SUBGROUP><DICH_SUBGROUP CHI2="2.0377734515559585" CI_END="1.3114503039692962" CI_START="0.48871570045833035" DF="4" EFFECT_SIZE="0.8005787618471057" ESTIMABLE="YES" EVENTS_1="25" EVENTS_2="31" I2="0.0" ID="CMP-004.04.02" LOG_CI_END="0.11775183810530558" LOG_CI_START="-0.3109437086229686" LOG_EFFECT_SIZE="-0.0965959352588315" MODIFIED="2013-11-26 21:58:26 +0000" MODIFIED_BY="Hermann Blessberger" NO="2" P_CHI2="0.7288113854931869" P_Z="0.3770964754544881" STUDIES="6" TAU2="0.0" TOTAL_1="380" TOTAL_2="372" WEIGHT="12.02318611177893" Z="0.8832587863585838"><NAME>High risk</NAME><DICH_DATA CI_END="65.33683949785127" CI_START="0.12362952338910503" EFFECT_SIZE="2.8421052631578947" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.8151581227650624" LOG_CI_START="-0.9078778050247834" LOG_EFFECT_SIZE="0.45364015887013953" MODIFIED="2013-11-23 16:05:45 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1061" O_E="0.0" SE="1.5995247832289885" STUDY_ID="STD-Jakobsen-1997" TOTAL_1="18" TOTAL_2="17" VAR="2.5584795321637426" WEIGHT="0.19107761689848266"/><DICH_DATA CI_END="5.615700904668708" CI_START="0.011129510111202603" EFFECT_SIZE="0.25" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.7494039689737728" LOG_CI_START="-1.9535239516296976" LOG_EFFECT_SIZE="-0.6020599913279624" MODIFIED="2013-11-23 16:06:10 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1066" O_E="0.0" SE="1.5877132402714706" STUDY_ID="STD-Raby-1999" TOTAL_1="15" TOTAL_2="11" VAR="2.520833333333333" WEIGHT="0.6378831722024534"/><DICH_DATA CI_END="1.9689060372965594" CI_START="0.1260175766811152" EFFECT_SIZE="0.4981132075471698" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="5" LOG_CI_END="0.29422499066461516" LOG_CI_START="-0.8995688761265311" LOG_EFFECT_SIZE="-0.302671942730958" MODIFIED="2013-11-23 16:06:16 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1064" O_E="0.0" SE="0.7012404267280651" STUDY_ID="STD-POBBLE-2005" TOTAL_1="53" TOTAL_2="44" VAR="0.49173813607775874" WEIGHT="2.0331156089957925"/><DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-11-23 16:06:35 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1062" O_E="0.0" SE="0.0" STUDY_ID="STD-Lai-2006" TOTAL_1="30" TOTAL_2="30" VAR="0.0" WEIGHT="0.0"/><DICH_DATA CI_END="2.6794711630264745" CI_START="0.11518764581889715" EFFECT_SIZE="0.5555555555555556" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="4" LOG_CI_END="0.428049087445737" LOG_CI_START="-0.9385940976523491" LOG_EFFECT_SIZE="-0.25527250510330607" MODIFIED="2013-11-23 16:06:48 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1063" O_E="0.0" SE="0.8027729719194864" STUDY_ID="STD-Neary-2006" TOTAL_1="18" TOTAL_2="20" VAR="0.6444444444444444" WEIGHT="1.4100575385527916"/><DICH_DATA CI_END="1.6671769426996792" CI_START="0.5071036310519903" EFFECT_SIZE="0.9194734804490902" ESTIMABLE="YES" EVENTS_1="19" EVENTS_2="21" LOG_CI_END="0.22198169530492604" LOG_CI_START="-0.29490327972978975" LOG_EFFECT_SIZE="-0.03646079221243184" MODIFIED="2013-11-23 16:06:28 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1067" O_E="0.0" SE="0.3036207929572834" STUDY_ID="STD-Yang-2006" TOTAL_1="246" TOTAL_2="250" VAR="0.09218558591600953" WEIGHT="7.751052175129409"/></DICH_SUBGROUP></DICH_OUTCOME><DICH_OUTCOME CHI2="12.456008542791608" CI_END="0.7685836416244641" CI_START="0.3422559620050428" CI_STUDY="95" CI_TOTAL="95" DF="9" EFFECT_MEASURE="RR" EFFECT_SIZE="0.5128862774977705" ESTIMABLE="YES" EVENTS_1="60" EVENTS_2="97" I2="27.745714294581372" I2_Q="0.0" ID="CMP-004.05" LOG_CI_END="-0.11430886320738615" LOG_CI_START="-0.46564897783724807" LOG_EFFECT_SIZE="-0.2899789205223171" METHOD="MH" MODIFIED="2017-06-17 15:43:38 +0100" MODIFIED_BY="Hermann Blessberger" NO="5" P_CHI2="0.1888049672638732" P_Q="0.47203101217995047" P_Z="0.0012150794633561943" Q="0.5172177091585813" RANDOM="YES" SCALE="100.0" SORT_BY="YEAR" STUDIES="14" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.09800846043026643" TOTALS="YES" TOTAL_1="552" TOTAL_2="426" WEIGHT="100.00000000000003" Z="3.235316531380433"><NAME>Myocardial ischaemia&#8212;non-cardiac surgery</NAME><GROUP_LABEL_1>Beta-blocker</GROUP_LABEL_1><GROUP_LABEL_2>Control</GROUP_LABEL_2><GRAPH_LABEL_1>Favours beta-blocker</GRAPH_LABEL_1><GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2><DICH_SUBGROUP CHI2="9.69991424661956" CI_END="1.193527663439732" CI_START="0.12522909291231196" DF="3" EFFECT_SIZE="0.3866062423943886" ESTIMABLE="YES" EVENTS_1="37" EVENTS_2="63" I2="69.07189152681936" ID="CMP-004.05.01" LOG_CI_END="0.07683248948436915" LOG_CI_START="-0.90229476518699" LOG_EFFECT_SIZE="-0.4127311378513105" MODIFIED="2013-11-24 06:24:55 +0000" MODIFIED_BY="Hermann Blessberger" NO="1" P_CHI2="0.021297034765352163" P_Z="0.09846001516418915" STUDIES="8" TAU2="0.8104858948578428" TOTAL_1="362" TOTAL_2="248" WEIGHT="48.706363659291284" Z="1.6523657402598244"><NAME>Low and medium risk</NAME><DICH_DATA CI_END="1.2469987885761085" CI_START="0.0982358612712665" EFFECT_SIZE="0.35" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="5" LOG_CI_END="0.09586603157399819" LOG_CI_START="-1.007729942873447" LOG_EFFECT_SIZE="-0.4559319556497244" MODIFIED="2013-11-23 16:10:28 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1068" O_E="0.0" SE="0.6482577382786072" STUDY_ID="STD-Coleman-1980" TOTAL_1="24" TOTAL_2="14" VAR="0.4202380952380952" WEIGHT="8.218532122292467"/><DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-11-23 16:10:40 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1070" O_E="0.0" SE="0.0" STUDY_ID="STD-Liu-1986" TOTAL_1="16" TOTAL_2="14" VAR="0.0" WEIGHT="0.0"/><DICH_DATA CI_END="66.61522199816511" CI_START="0.11922423317225214" EFFECT_SIZE="2.8181818181818183" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.8235734795372827" LOG_CI_START="-0.9236354621851873" LOG_EFFECT_SIZE="0.44996900867604767" MODIFIED="2013-11-23 16:10:33 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1069" O_E="0.0" SE="1.6137241312713606" STUDY_ID="STD-Cucchiara-1986" TOTAL_1="32" TOTAL_2="30" VAR="2.6041055718475072" WEIGHT="1.5762569285195949"/><DICH_DATA CI_END="0.34268065818180543" CI_START="0.018523976842803526" EFFECT_SIZE="0.07967313585291114" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="11" LOG_CI_END="-0.46511040762723255" LOG_CI_START="-1.7322657705980822" LOG_EFFECT_SIZE="-1.0986880891126574" MODIFIED="2013-11-23 16:10:45 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1074" O_E="0.0" SE="0.7443333327292857" STUDY_ID="STD-Stone-1988" TOTAL_1="89" TOTAL_2="39" VAR="0.5540321102118855" WEIGHT="6.532148698712458"/><DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-11-23 16:11:21 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1073" O_E="0.0" SE="0.0" STUDY_ID="STD-Oxorn-1990" TOTAL_1="32" TOTAL_2="16" VAR="0.0" WEIGHT="0.0"/><DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-11-23 16:10:55 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1072" O_E="0.0" SE="0.0" STUDY_ID="STD-Miller-1990" TOTAL_1="30" TOTAL_2="15" VAR="0.0" WEIGHT="0.0"/><DICH_DATA CI_END="0.963432747451777" CI_START="0.4699791874804524" EFFECT_SIZE="0.6728992048140985" ESTIMABLE="YES" EVENTS_1="31" EVENTS_2="47" LOG_CI_END="-0.016178595933257885" LOG_CI_START="-0.3279213738994463" LOG_EFFECT_SIZE="-0.1720499849163521" MODIFIED="2013-11-23 16:11:33 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1075" O_E="0.0" SE="0.18311925092897763" STUDY_ID="STD-Wallace-1998" TOTAL_1="99" TOTAL_2="101" VAR="0.03353266006078988" WEIGHT="32.379425909766766"/><DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-11-23 16:11:38 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1076" O_E="0.0" SE="0.0" STUDY_ID="STD-Zaugg-1999" TOTAL_1="40" TOTAL_2="19" VAR="0.0" WEIGHT="0.0"/></DICH_SUBGROUP><DICH_SUBGROUP CHI2="2.797303856218327" CI_END="0.931405749088283" CI_START="0.3895747185072281" DF="5" EFFECT_SIZE="0.6023720880959557" ESTIMABLE="YES" EVENTS_1="23" EVENTS_2="34" I2="0.0" ID="CMP-004.05.02" LOG_CI_END="-0.030861085718714217" LOG_CI_START="-0.4094092344655447" LOG_EFFECT_SIZE="-0.22013516009212947" MODIFIED="2017-06-17 15:43:38 +0100" MODIFIED_BY="Hermann Blessberger" NO="2" P_CHI2="0.7312008071089524" P_Z="0.02263524786605941" STUDIES="6" TAU2="0.0" TOTAL_1="190" TOTAL_2="178" WEIGHT="51.29363634070874" Z="2.279535572633785"><NAME>High risk</NAME><DICH_DATA CI_END="3.1588374622614523" CI_START="0.03662503591899996" EFFECT_SIZE="0.3401360544217687" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="3" LOG_CI_END="0.49952727989090295" LOG_CI_START="-1.4362219407152177" LOG_EFFECT_SIZE="-0.4683473304121573" MODIFIED="2013-11-23 16:11:49 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1077" O_E="0.0" SE="1.1370686742972156" STUDY_ID="STD-Bayliff-1999" TOTAL_1="49" TOTAL_2="50" VAR="1.292925170068027" WEIGHT="3.0621345775513524"/><DICH_DATA CI_END="1.022049427213816" CI_START="0.20553746115499483" EFFECT_SIZE="0.4583333333333333" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="8" LOG_CI_END="0.009471899171640366" LOG_CI_START="-0.6871090122784024" LOG_EFFECT_SIZE="-0.338818556553381" MODIFIED="2013-11-23 16:11:55 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1081" O_E="0.0" SE="0.40917507551687754" STUDY_ID="STD-Raby-1999" TOTAL_1="15" TOTAL_2="11" VAR="0.16742424242424245" WEIGHT="16.046349674412433"/><DICH_DATA CI_END="1.5031119175990921" CI_START="0.4585242356722858" EFFECT_SIZE="0.8301886792452831" ESTIMABLE="YES" EVENTS_1="15" EVENTS_2="15" LOG_CI_END="0.1769913181691861" LOG_CI_START="-0.33863770439838925" LOG_EFFECT_SIZE="-0.0808231931146016" MODIFIED="2013-11-23 16:12:05 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1080" O_E="0.0" SE="0.3028830402610201" STUDY_ID="STD-POBBLE-2005" TOTAL_1="53" TOTAL_2="44" VAR="0.09173813607775871" WEIGHT="22.44691627366144"/><DICH_DATA CI_END="3.9981665126016623" CI_START="0.010004585820506876" EFFECT_SIZE="0.2" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" LOG_CI_END="0.6018608773254143" LOG_CI_START="-1.9998008859974516" LOG_EFFECT_SIZE="-0.6989700043360187" MODIFIED="2013-11-23 16:12:11 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1079" O_E="0.0" SE="1.5282289982092807" STUDY_ID="STD-Lai-2006" TOTAL_1="30" TOTAL_2="30" VAR="2.335483870967742" WEIGHT="1.7502524705228857"/><DICH_DATA CI_END="1.7491265621242627" CI_START="0.09147422688823888" EFFECT_SIZE="0.4" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="5" LOG_CI_END="0.24282123500387298" LOG_CI_START="-1.038701252347948" LOG_EFFECT_SIZE="-0.3979400086720376" MODIFIED="2013-11-24 06:24:55 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1507" O_E="0.0" SE="0.752772652709081" STUDY_ID="STD-Liu-2006" TOTAL_1="15" TOTAL_2="15" VAR="0.5666666666666667" WEIGHT="6.407981570832447"/><DICH_DATA CI_END="7.848616069043482" CI_START="0.014156777466712338" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.8947930852084158" LOG_CI_START="-1.8490355946477406" LOG_EFFECT_SIZE="-0.47712125471966244" MODIFIED="2013-11-23 16:12:22 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1078" O_E="0.0" SE="1.611738548718522" STUDY_ID="STD-Kawaguchi-2010" TOTAL_1="28" TOTAL_2="28" VAR="2.5977011494252875" WEIGHT="1.5800017737281746"/></DICH_SUBGROUP></DICH_OUTCOME><DICH_OUTCOME CHI2="4.683815300243553" CI_END="2.707506832501573" CI_START="0.9342911560750178" CI_STUDY="95" CI_TOTAL="95" DF="4" EFFECT_MEASURE="RR" EFFECT_SIZE="1.590471530276133" ESTIMABLE="YES" EVENTS_1="34" EVENTS_2="21" I2="14.599535985289496" I2_Q="0.0" ID="CMP-004.06" LOG_CI_END="0.43256956125820256" LOG_CI_START="-0.02951776212954848" LOG_EFFECT_SIZE="0.20152589956432704" METHOD="MH" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" NO="6" P_CHI2="0.32130474413380605" P_Q="0.776359872975551" P_Z="0.08734686496500334" Q="0.0806934471586491" RANDOM="NO" SCALE="100.0" SORT_BY="YEAR" STUDIES="5" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="4574" TOTAL_2="4576" WEIGHT="99.99999999999999" Z="1.7095621762671682"><NAME>Cerebrovascular events&#8212;non-cardiac surgery</NAME><GROUP_LABEL_1>Beta-blocker</GROUP_LABEL_1><GROUP_LABEL_2>Control</GROUP_LABEL_2><GRAPH_LABEL_1>Favours beta-blocker</GRAPH_LABEL_1><GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2><DICH_SUBGROUP CHI2="4.613059759762377" CI_END="2.68948478848566" CI_START="0.9133643260428465" DF="3" EFFECT_SIZE="1.5673160055450504" ESTIMABLE="YES" EVENTS_1="33" EVENTS_2="21" I2="34.96724178239277" ID="CMP-004.06.01" LOG_CI_END="0.42966909228939354" LOG_CI_START="-0.039355954963851164" LOG_EFFECT_SIZE="0.1951565686627712" MODIFIED="2013-12-08 06:59:11 +0000" MODIFIED_BY="Hermann Blessberger" NO="1" P_CHI2="0.2024246717956637" P_Z="0.10288139427923212" STUDIES="4" TAU2="0.0" TOTAL_1="4521" TOTAL_2="4532" WEIGHT="97.5173236735327" Z="1.631042300045538"><NAME>Low and medium risk</NAME><DICH_DATA CI_END="35.873486053427946" CI_START="0.4642145613500314" EFFECT_SIZE="4.08080808080808" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="1" LOG_CI_END="1.5547735818670396" LOG_CI_START="-0.3332812408409298" LOG_EFFECT_SIZE="0.610746170513055" MODIFIED="2013-11-23 16:14:47 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1085" O_E="0.0" SE="1.1090527488807644" STUDY_ID="STD-Wallace-1998" TOTAL_1="99" TOTAL_2="101" VAR="1.22999799979998" WEIGHT="4.50605753253813"/><DICH_DATA CI_END="4.065339018491121" CI_START="0.00983927781128726" EFFECT_SIZE="0.2" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" LOG_CI_END="0.609096768311561" LOG_CI_START="-2.0070367769835986" LOG_EFFECT_SIZE="-0.6989700043360187" MODIFIED="2013-11-23 16:15:02 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1086" O_E="0.0" SE="1.536729794576282" STUDY_ID="STD-Yang-2008" TOTAL_1="51" TOTAL_2="51" VAR="2.3615384615384616" WEIGHT="11.378933162975075"/><DICH_DATA CI_END="3.675054697422891" CI_START="1.013518570917549" EFFECT_SIZE="1.9299575604079677" ESTIMABLE="YES" EVENTS_1="27" EVENTS_2="14" LOG_CI_END="0.5652638072602568" LOG_CI_START="0.005831710772613412" LOG_EFFECT_SIZE="0.2855477590164352" MODIFIED="2013-12-08 06:59:11 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1084" O_E="0.0" SE="0.328613182710381" STUDY_ID="STD-POISE-2008" TOTAL_1="4174" TOTAL_2="4177" VAR="0.10798662385104625" WEIGHT="63.69913431317078"/><DICH_DATA CI_END="2.781185502696919" CI_START="0.09544862473539373" EFFECT_SIZE="0.5152284263959391" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="4" LOG_CI_END="0.4442299569011446" LOG_CI_START="-1.020230324725867" LOG_EFFECT_SIZE="-0.28800018391236115" MODIFIED="2013-11-23 16:15:09 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1083" O_E="0.0" SE="0.8602312186230142" STUDY_ID="STD-Marwick-2009" TOTAL_1="197" TOTAL_2="203" VAR="0.7399977494936361" WEIGHT="17.933198664848717"/></DICH_SUBGROUP><DICH_SUBGROUP CHI2="0.0" CI_END="59.880764502974365" CI_START="0.10437408493155684" DF="0" EFFECT_SIZE="2.5" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" I2="0.0" ID="CMP-004.06.02" LOG_CI_END="1.7772873363821653" LOG_CI_START="-0.9814073190380901" LOG_EFFECT_SIZE="0.3979400086720376" MODIFIED="2013-11-23 16:15:17 +0000" MODIFIED_BY="Hermann Blessberger" NO="2" P_CHI2="1.0" P_Z="0.5717696302647202" STUDIES="1" TAU2="0.0" TOTAL_1="53" TOTAL_2="44" WEIGHT="2.482676326467289" Z="0.565447200524579"><NAME>High risk</NAME><DICH_DATA CI_END="59.88076450297431" CI_START="0.10437408493155693" EFFECT_SIZE="2.5" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.7772873363821649" LOG_CI_START="-0.9814073190380896" LOG_EFFECT_SIZE="0.3979400086720376" MODIFIED="2013-11-23 16:15:17 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1087" O_E="0.0" SE="1.620470896352639" STUDY_ID="STD-POBBLE-2005" TOTAL_1="53" TOTAL_2="44" VAR="2.6259259259259258" WEIGHT="2.482676326467289"/></DICH_SUBGROUP></DICH_OUTCOME><DICH_OUTCOME CHI2="7.314150194211837" CI_END="1.1902250305243167" CI_START="0.4337117040075984" CI_STUDY="95" CI_TOTAL="95" DF="4" EFFECT_MEASURE="RR" EFFECT_SIZE="0.7184807068677608" ESTIMABLE="YES" EVENTS_1="22" EVENTS_2="24" I2="45.31148672383758" I2_Q="76.24750109738079" ID="CMP-004.07" LOG_CI_END="0.0756290792713098" LOG_CI_START="-0.36279885795884337" LOG_EFFECT_SIZE="-0.1435848893437668" METHOD="MH" MODIFIED="2017-06-17 15:43:53 +0100" MODIFIED_BY="Hermann Blessberger" NO="7" P_CHI2="0.1201893406969895" P_Q="0.04018450511936311" P_Z="0.199221013854975" Q="4.210083343650757" RANDOM="NO" SCALE="100.0" SORT_BY="YEAR" STUDIES="5" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="249" TOTAL_2="227" WEIGHT="100.0" Z="1.2837740843609586"><NAME>Ventricular arrhythmias&#8212;non-cardiac surgery</NAME><GROUP_LABEL_1>Beta-blocker</GROUP_LABEL_1><GROUP_LABEL_2>Control</GROUP_LABEL_2><GRAPH_LABEL_1>Favours beta-blocker</GRAPH_LABEL_1><GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2><DICH_SUBGROUP CHI2="0.9411525555203557" CI_END="0.8234285895994724" CI_START="0.1434451076190226" DF="1" EFFECT_SIZE="0.3436812515277438" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="11" I2="0.0" ID="CMP-004.07.01" LOG_CI_END="-0.08437405828856927" LOG_CI_START="-0.843314259340568" LOG_EFFECT_SIZE="-0.46384415881456864" MODIFIED="2013-12-08 08:37:23 +0000" MODIFIED_BY="Hermann Blessberger" NO="1" P_CHI2="0.33198177514063465" P_Z="0.016586118396150575" STUDIES="2" TAU2="0.0" TOTAL_1="129" TOTAL_2="116" WEIGHT="48.919576109939314" Z="2.395756199119945"><NAME>Low and medium risk</NAME><DICH_DATA CI_END="0.698737197573076" CI_START="0.08944707712296021" EFFECT_SIZE="0.25" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="8" LOG_CI_END="-0.1556861362780481" LOG_CI_START="-1.0484338463778766" LOG_EFFECT_SIZE="-0.6020599913279624" MODIFIED="2013-12-08 08:37:23 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1088" O_E="0.0" SE="0.5244044240850758" STUDY_ID="STD-Sandler-1990" TOTAL_1="30" TOTAL_2="15" VAR="0.275" WEIGHT="38.26512919868145"/><DICH_DATA CI_END="3.9833644750180848" CI_START="0.11612876150877542" EFFECT_SIZE="0.6801346801346801" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="3" LOG_CI_END="0.6002500458638188" LOG_CI_START="-0.9350602056049961" LOG_EFFECT_SIZE="-0.16740507987058859" MODIFIED="2013-11-23 16:19:19 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1089" O_E="0.0" SE="0.9018488416210964" STUDY_ID="STD-Wallace-1998" TOTAL_1="99" TOTAL_2="101" VAR="0.8133313331333133" WEIGHT="10.654446911257867"/></DICH_SUBGROUP><DICH_SUBGROUP CHI2="1.388708828016705" CI_END="2.072249641808901" CI_START="0.5601857850523677" DF="2" EFFECT_SIZE="1.0774250750846701" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="13" I2="0.0" ID="CMP-004.07.02" LOG_CI_END="0.3164420732398407" LOG_CI_START="-0.2516679157760061" LOG_EFFECT_SIZE="0.03238707873191728" MODIFIED="2017-06-17 15:43:53 +0100" MODIFIED_BY="Hermann Blessberger" NO="2" P_CHI2="0.4993968029388959" P_Z="0.8231704465542543" STUDIES="3" TAU2="0.0" TOTAL_1="120" TOTAL_2="111" WEIGHT="51.080423890060686" Z="0.22346907854581097"><NAME>High risk</NAME><DICH_DATA CI_END="3.6746104414217298" CI_START="0.37928140736840954" EFFECT_SIZE="1.1805555555555556" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="4" LOG_CI_END="0.5652113047512454" LOG_CI_START="-0.4210384461851969" LOG_EFFECT_SIZE="0.07208642928302428" MODIFIED="2013-12-09 12:36:13 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1091" O_E="0.0" SE="0.5793279857150695" STUDY_ID="STD-Jakobsen-1997" TOTAL_1="18" TOTAL_2="17" VAR="0.33562091503267977" WEIGHT="14.759406976634274"/><DICH_DATA CI_END="4.14361531793994" CI_START="0.010043403358372081" EFFECT_SIZE="0.204" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" LOG_CI_END="0.6173794298813183" LOG_CI_START="-1.998119095029521" LOG_EFFECT_SIZE="-0.6903698325741012" MODIFIED="2013-12-09 12:36:14 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1090" O_E="0.0" SE="1.5363567804591305" STUDY_ID="STD-Bayliff-1999" TOTAL_1="49" TOTAL_2="50" VAR="2.360392156862745" WEIGHT="8.879593718753432"/><DICH_DATA CI_END="3.080458562544285" CI_START="0.5524939578722114" EFFECT_SIZE="1.3045822102425877" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="7" LOG_CI_END="0.4886153711624102" LOG_CI_START="-0.25767246710367697" LOG_EFFECT_SIZE="0.11547145202936662" MODIFIED="2013-12-09 12:36:15 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1092" O_E="0.0" SE="0.4383731703818781" STUDY_ID="STD-POBBLE-2005" TOTAL_1="53" TOTAL_2="44" VAR="0.19217103651065914" WEIGHT="27.44142319467298"/></DICH_SUBGROUP></DICH_OUTCOME><DICH_OUTCOME CHI2="1.783444442082041" CI_END="0.9492519881687377" CI_START="0.5625349250530547" CI_STUDY="95" CI_TOTAL="95" DF="2" EFFECT_MEASURE="RR" EFFECT_SIZE="0.7307444122406711" ESTIMABLE="YES" EVENTS_1="94" EVENTS_2="129" I2="0.0" I2_Q="23.140238910024447" ID="CMP-004.08" LOG_CI_END="-0.022618484575515598" LOG_CI_START="-0.24985050915088258" LOG_EFFECT_SIZE="-0.13623449686319916" METHOD="MH" MODIFIED="2017-06-17 15:44:10 +0100" MODIFIED_BY="Hermann Blessberger" NO="8" P_CHI2="0.4099491604941542" P_Q="0.2540178219700242" P_Z="0.018765830949606287" Q="1.3010709190591345" RANDOM="NO" SCALE="100.0" SORT_BY="YEAR" STUDIES="3" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="4253" TOTAL_2="4257" WEIGHT="100.0" Z="2.350150317084759"><NAME>Atrial fibrillation&#8212;non-cardiac surgery</NAME><GROUP_LABEL_1>Beta-blocker</GROUP_LABEL_1><GROUP_LABEL_2>Control</GROUP_LABEL_2><GRAPH_LABEL_1>Favours beta-blocker</GRAPH_LABEL_1><GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2><DICH_SUBGROUP CHI2="0.0" CI_END="0.9931562131790224" CI_START="0.5798648580922154" DF="0" EFFECT_SIZE="0.7588783740616515" ESTIMABLE="YES" EVENTS_1="91" EVENTS_2="120" I2="0.0" ID="CMP-004.08.01" LOG_CI_END="-0.002982436110955725" LOG_CI_START="-0.23667321027073493" LOG_EFFECT_SIZE="-0.11982782319084534" MODIFIED="2013-11-23 16:24:55 +0000" MODIFIED_BY="Hermann Blessberger" NO="1" P_CHI2="1.0" P_Z="0.04443210393456549" STUDIES="1" TAU2="0.0" TOTAL_1="4174" TOTAL_2="4177" WEIGHT="92.69781405943448" Z="2.0099913541243435"><NAME>Low and medium risk</NAME><DICH_DATA CI_END="0.9931562131790224" CI_START="0.5798648580922154" EFFECT_SIZE="0.7588783740616515" ESTIMABLE="YES" EVENTS_1="91" EVENTS_2="120" LOG_CI_END="-0.002982436110955725" LOG_CI_START="-0.23667321027073493" LOG_EFFECT_SIZE="-0.11982782319084534" MODIFIED="2013-11-23 16:24:55 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1094" O_E="0.0" SE="0.13727111752944285" STUDY_ID="STD-POISE-2008" TOTAL_1="4174" TOTAL_2="4177" VAR="0.01884335970778211" WEIGHT="92.69781405943448"/></DICH_SUBGROUP><DICH_SUBGROUP CHI2="1.176503012558152" CI_END="1.2250983330554344" CI_START="0.11392940455034073" DF="1" EFFECT_SIZE="0.3735970069481561" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="9" I2="15.002342592763041" ID="CMP-004.08.02" LOG_CI_END="0.08817094893682065" LOG_CI_START="-0.9433641724454774" LOG_EFFECT_SIZE="-0.42759661175432845" MODIFIED="2017-06-17 15:44:10 +0100" MODIFIED_BY="Hermann Blessberger" NO="2" P_CHI2="0.278069118751437" P_Z="0.10418252551623768" STUDIES="2" TAU2="0.0" TOTAL_1="79" TOTAL_2="80" WEIGHT="7.302185940565519" Z="1.6249063004792077"><NAME>High risk</NAME><DICH_DATA CI_END="2.4240530226292014" CI_START="0.15463515508026482" EFFECT_SIZE="0.6122448979591837" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="5" LOG_CI_END="0.38454211515738" LOG_CI_START="-0.8106917657750824" LOG_EFFECT_SIZE="-0.21307482530885122" MODIFIED="2014-06-22 18:37:05 +0100" MODIFIED_BY="Hermann Blessberger" ORDER="1095" O_E="0.0" SE="0.7020862981628592" STUDY_ID="STD-Bayliff-1999" TOTAL_1="49" TOTAL_2="50" VAR="0.49292517006802716" WEIGHT="3.824768691477397"/><DICH_DATA CI_END="1.9774190029426781" CI_START="0.006243329812231785" EFFECT_SIZE="0.1111111111111111" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="4" LOG_CI_END="0.29609870339830113" LOG_CI_START="-2.204583722276951" LOG_EFFECT_SIZE="-0.9542425094393249" MODIFIED="2013-11-23 16:25:06 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1096" O_E="0.0" SE="1.4689132354192893" STUDY_ID="STD-Lai-2006" TOTAL_1="30" TOTAL_2="30" VAR="2.1577060931899643" WEIGHT="3.4774172490881226"/></DICH_SUBGROUP></DICH_OUTCOME><DICH_OUTCOME CHI2="6.069811265865222" CI_END="0.9359710466383023" CI_START="0.5725807491224082" CI_STUDY="95" CI_TOTAL="95" DF="7" EFFECT_MEASURE="RR" EFFECT_SIZE="0.7320648899114365" ESTIMABLE="YES" EVENTS_1="108" EVENTS_2="144" I2="0.0" I2_Q="15.069983899017181" ID="CMP-004.09" LOG_CI_END="-0.02873758553508124" LOG_CI_START="-0.2421632575901002" LOG_EFFECT_SIZE="-0.1354504215625907" METHOD="MH" MODIFIED="2017-06-17 15:44:22 +0100" MODIFIED_BY="Hermann Blessberger" NO="9" P_CHI2="0.5316220044239742" P_Q="0.2778778279771297" P_Z="0.012854359918644918" Q="1.1774400216891374" RANDOM="NO" SCALE="100.0" SORT_BY="YEAR" STUDIES="8" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="4380" TOTAL_2="4364" WEIGHT="100.00000000000001" Z="2.487778957397477"><NAME>All supraventricular arrhythmias&#8212;non-cardiac surgery</NAME><GROUP_LABEL_1>Beta-blocker</GROUP_LABEL_1><GROUP_LABEL_2>Control</GROUP_LABEL_2><GRAPH_LABEL_1>Favours beta-blocker</GRAPH_LABEL_1><GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2><DICH_SUBGROUP CHI2="4.03993646470782" CI_END="0.9877191114946121" CI_START="0.5891235128506578" DF="4" EFFECT_SIZE="0.7628161984865269" ESTIMABLE="YES" EVENTS_1="101" EVENTS_2="129" I2="0.9885419005149646" ID="CMP-004.09.01" LOG_CI_END="-0.005366542934491985" LOG_CI_START="-0.2297936435388103" LOG_EFFECT_SIZE="-0.11758009323665113" MODIFIED="2013-12-08 09:36:41 +0000" MODIFIED_BY="Hermann Blessberger" NO="1" P_CHI2="0.4006282488405962" P_Z="0.04000492661768767" STUDIES="5" TAU2="0.0" TOTAL_1="4283" TOTAL_2="4267" WEIGHT="89.28111219472525" Z="2.0536980375556624"><NAME>Low and medium risk</NAME><DICH_DATA CI_END="3.694376342661255" CI_START="0.09210696101758215" EFFECT_SIZE="0.5833333333333334" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="2" LOG_CI_END="0.5675411345302878" LOG_CI_START="-1.0357075465970236" LOG_EFFECT_SIZE="-0.23408320603336796" MODIFIED="2013-11-23 16:27:23 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1099" O_E="0.0" SE="0.9417562115031479" STUDY_ID="STD-Coleman-1980" TOTAL_1="24" TOTAL_2="14" VAR="0.886904761904762" WEIGHT="1.737829493641464"/><DICH_DATA CI_END="60.21015642179821" CI_START="0.11637439315284949" EFFECT_SIZE="2.6470588235294117" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.7796697554754684" LOG_CI_START="-0.934142570681329" LOG_EFFECT_SIZE="0.42276359239706973" MODIFIED="2013-11-23 16:27:29 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1100" O_E="0.0" SE="1.5941067939721714" STUDY_ID="STD-Liu-1986" TOTAL_1="16" TOTAL_2="14" VAR="2.541176470588235" WEIGHT="0.3654420094050735"/><DICH_DATA CI_END="1.5981153088603466" CI_START="0.025243867342839378" EFFECT_SIZE="0.20085470085470086" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="6" LOG_CI_END="0.20360811177088864" LOG_CI_START="-1.5978441107197394" LOG_EFFECT_SIZE="-0.6971179994744253" MODIFIED="2013-11-23 16:27:34 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1098" O_E="0.0" SE="1.0581819528233132" STUDY_ID="STD-Burns-1988" TOTAL_1="39" TOTAL_2="47" VAR="1.1197490452809604" WEIGHT="3.7434059732218747"/><DICH_DATA CI_END="22.711113534056025" CI_START="0.3962817581138951" EFFECT_SIZE="3.0" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="1" LOG_CI_END="1.3562384283562463" LOG_CI_START="-0.40199591891692144" LOG_EFFECT_SIZE="0.47712125471966244" MODIFIED="2013-11-23 16:27:40 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1102" O_E="0.0" SE="1.0327955589886444" STUDY_ID="STD-Sandler-1990" TOTAL_1="30" TOTAL_2="15" VAR="1.0666666666666667" WEIGHT="0.9171877883107726"/><DICH_DATA CI_END="0.9931562131790224" CI_START="0.5798648580922154" EFFECT_SIZE="0.7588783740616515" ESTIMABLE="YES" EVENTS_1="91" EVENTS_2="120" LOG_CI_END="-0.002982436110955725" LOG_CI_START="-0.23667321027073493" LOG_EFFECT_SIZE="-0.11982782319084534" MODIFIED="2013-12-08 09:36:41 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1101" O_E="0.0" SE="0.13727111752944285" STUDY_ID="STD-POISE-2008" TOTAL_1="4174" TOTAL_2="4177" VAR="0.01884335970778211" WEIGHT="82.51724693014606"/></DICH_SUBGROUP><DICH_SUBGROUP CHI2="1.6277977537384911" CI_END="1.0719668150124966" CI_START="0.2113001149450838" DF="2" EFFECT_SIZE="0.4759272121127935" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="15" I2="0.0" ID="CMP-004.09.02" LOG_CI_END="0.030181341065678238" LOG_CI_START="-0.6751002666959023" LOG_EFFECT_SIZE="-0.322459462815112" MODIFIED="2017-06-17 15:44:22 +0100" MODIFIED_BY="Hermann Blessberger" NO="2" P_CHI2="0.44312720439928854" P_Z="0.07309817167799122" STUDIES="3" TAU2="0.0" TOTAL_1="97" TOTAL_2="97" WEIGHT="10.718887805274761" Z="1.7922172551688094"><NAME>High risk</NAME><DICH_DATA CI_END="2.3517506825099073" CI_START="0.24274010071578214" EFFECT_SIZE="0.7555555555555555" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="5" LOG_CI_END="0.3713912787351326" LOG_CI_START="-0.6148584722013096" LOG_EFFECT_SIZE="-0.12173359673308856" MODIFIED="2013-11-23 16:28:25 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1104" O_E="0.0" SE="0.5793279857150695" STUDY_ID="STD-Jakobsen-1997" TOTAL_1="18" TOTAL_2="17" VAR="0.33562091503267977" WEIGHT="3.5377243263415523"/><DICH_DATA CI_END="1.9266406466126647" CI_START="0.1351098895231352" EFFECT_SIZE="0.5102040816326531" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="6" LOG_CI_END="0.28480071841945853" LOG_CI_START="-0.8693128611324107" LOG_EFFECT_SIZE="-0.292256071356476" MODIFIED="2013-11-23 16:28:33 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1103" O_E="0.0" SE="0.677932029583124" STUDY_ID="STD-Bayliff-1999" TOTAL_1="49" TOTAL_2="50" VAR="0.45959183673469384" WEIGHT="4.085654693384352"/><DICH_DATA CI_END="1.9774190029426781" CI_START="0.006243329812231785" EFFECT_SIZE="0.1111111111111111" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="4" LOG_CI_END="0.29609870339830113" LOG_CI_START="-2.204583722276951" LOG_EFFECT_SIZE="-0.9542425094393249" MODIFIED="2013-11-23 16:28:38 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1105" O_E="0.0" SE="1.4689132354192893" STUDY_ID="STD-Lai-2006" TOTAL_1="30" TOTAL_2="30" VAR="2.1577060931899643" WEIGHT="3.0955087855488577"/></DICH_SUBGROUP></DICH_OUTCOME><DICH_OUTCOME CHI2="79.61367252344698" CI_END="3.355714879923041" CI_START="1.4785626099988882" CI_STUDY="95" CI_TOTAL="95" DF="19" EFFECT_MEASURE="RR" EFFECT_SIZE="2.227472682497165" ESTIMABLE="YES" EVENTS_1="539" EVENTS_2="212" I2="76.13475248939895" I2_Q="57.06292323957957" ID="CMP-004.10" LOG_CI_END="0.5257850536654743" LOG_CI_START="0.1698397195292405" LOG_EFFECT_SIZE="0.3478123865973574" METHOD="MH" MODIFIED="2017-06-17 15:44:36 +0100" MODIFIED_BY="Hermann Blessberger" NO="10" P_CHI2="2.1675828909550887E-9" P_Q="0.1269844318028337" P_Z="1.279548486681103E-4" Q="2.3289894782073377" RANDOM="YES" SCALE="100.0" SORT_BY="YEAR" STUDIES="23" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.4033793954831133" TOTALS="YES" TOTAL_1="5636" TOTAL_2="5397" WEIGHT="100.0" Z="3.830362056926584"><NAME>Bradycardia&#8212;non-cardiac surgery</NAME><GROUP_LABEL_1>Beta-blocker</GROUP_LABEL_1><GROUP_LABEL_2>Control</GROUP_LABEL_2><GRAPH_LABEL_1>Favours beta-blocker</GRAPH_LABEL_1><GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2><DICH_SUBGROUP CHI2="62.72533982596247" CI_END="3.4020630945263406" CI_START="1.037883209169121" DF="11" EFFECT_SIZE="1.8790806694612208" ESTIMABLE="YES" EVENTS_1="384" EVENTS_2="165" I2="82.46322773137528" ID="CMP-004.10.01" LOG_CI_END="0.5317423637593638" LOG_CI_START="0.016148486010435933" LOG_EFFECT_SIZE="0.2739454248848999" MODIFIED="2013-11-24 06:25:21 +0000" MODIFIED_BY="Hermann Blessberger" NO="1" P_CHI2="2.8783171401869367E-9" P_Z="0.037275222903000595" STUDIES="14" TAU2="0.5261523954681528" TOTAL_1="5085" TOTAL_2="4851" WEIGHT="57.134753868359816" Z="2.082736780537899"><NAME>Low and medium risk</NAME><DICH_DATA CI_END="4.316762529506007" CI_START="0.7786184873819648" EFFECT_SIZE="1.8333333333333333" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="6" LOG_CI_END="0.6351581582319411" LOG_CI_START="-0.10867528868277829" LOG_EFFECT_SIZE="0.2632414347745814" MODIFIED="2013-11-23 16:42:27 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1121" O_E="0.0" SE="0.4369314487526515" STUDY_ID="STD-Whitehead-1980" TOTAL_1="30" TOTAL_2="30" VAR="0.19090909090909092" WEIGHT="7.35604701748607"/><DICH_DATA CI_END="6.690017380199802" CI_START="0.012930488128094391" EFFECT_SIZE="0.29411764705882354" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.8254272460361436" LOG_CI_START="-1.8883850801206539" LOG_EFFECT_SIZE="-0.5314789170422551" MODIFIED="2013-11-23 16:42:35 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1112" O_E="0.0" SE="1.5941067939721714" STUDY_ID="STD-Liu-1986" TOTAL_1="16" TOTAL_2="14" VAR="2.541176470588235" WEIGHT="1.484642929761876"/><DICH_DATA CI_END="7.401691333129458" CI_START="0.01324713701913913" EFFECT_SIZE="0.31313131313131315" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.8693309700979578" LOG_CI_START="-1.8778779716245122" LOG_EFFECT_SIZE="-0.5042735007632773" MODIFIED="2013-11-23 16:42:41 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1109" O_E="0.0" SE="1.6137241312713606" STUDY_ID="STD-Cucchiara-1986" TOTAL_1="32" TOTAL_2="30" VAR="2.6041055718475072" WEIGHT="1.45357802128329"/><DICH_DATA CI_END="163.3214889303036" CI_START="0.5693353304979463" EFFECT_SIZE="9.642857142857142" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="0" LOG_CI_END="2.213043330541109" LOG_CI_START="-0.24463186490757274" LOG_EFFECT_SIZE="0.984205732816768" MODIFIED="2013-11-23 16:42:47 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1114" O_E="0.0" SE="1.4436505754949789" STUDY_ID="STD-Magnusson-1986" TOTAL_1="13" TOTAL_2="14" VAR="2.084126984126984" WEIGHT="1.7574282758369895"/><DICH_DATA CI_END="307.7461518428873" CI_START="1.1868046625898883" EFFECT_SIZE="19.11111111111111" ESTIMABLE="YES" EVENTS_1="21" EVENTS_2="0" LOG_CI_END="2.48819263107907" LOG_CI_START="0.07437924385737768" LOG_EFFECT_SIZE="1.281285937468224" MODIFIED="2013-11-23 16:43:02 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1120" O_E="0.0" SE="1.417885932222993" STUDY_ID="STD-Stone-1988" TOTAL_1="89" TOTAL_2="39" VAR="2.010400516795866" WEIGHT="1.8111071459386738"/><DICH_DATA CI_END="1.2063517837162632" CI_START="0.7282887347158697" EFFECT_SIZE="0.9373219373219374" ESTIMABLE="YES" EVENTS_1="28" EVENTS_2="36" LOG_CI_END="0.08147397069709093" LOG_CI_START="-0.13769640772879047" LOG_EFFECT_SIZE="-0.02811121851584977" MODIFIED="2013-11-23 16:42:55 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1108" O_E="0.0" SE="0.12874176519823316" STUDY_ID="STD-Burns-1988" TOTAL_1="39" TOTAL_2="47" VAR="0.016574442106356998" WEIGHT="10.409749016569757"/><DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-11-23 16:43:10 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1110" O_E="0.0" SE="0.0" STUDY_ID="STD-Inada-1989" TOTAL_1="20" TOTAL_2="10" VAR="0.0" WEIGHT="0.0"/><DICH_DATA CI_END="2.1277244659381767" CI_START="0.22038907230653051" EFFECT_SIZE="0.6847826086956522" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="5" LOG_CI_END="0.327915387405769" LOG_CI_START="-0.656809943189716" LOG_EFFECT_SIZE="-0.16444727789197353" MODIFIED="2013-11-23 16:43:20 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1116" O_E="0.0" SE="0.5784325336607887" STUDY_ID="STD-Miller-1991" TOTAL_1="368" TOTAL_2="180" VAR="0.3345841959972395" WEIGHT="5.923888520139916"/><DICH_DATA CI_END="16.55061376388459" CI_START="0.9667315199460398" EFFECT_SIZE="4.0" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="2" LOG_CI_END="1.2188141038111788" LOG_CI_START="-0.014694121155254026" LOG_EFFECT_SIZE="0.6020599913279624" MODIFIED="2013-11-23 16:43:35 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1111" O_E="0.0" SE="0.7245688373094719" STUDY_ID="STD-Jakobsen-1992" TOTAL_1="20" TOTAL_2="20" VAR="0.5249999999999999" WEIGHT="4.708865867899588"/><DICH_DATA CI_END="3.4327496636168187" CI_START="2.194313719081089" EFFECT_SIZE="2.74454544160693" ESTIMABLE="YES" EVENTS_1="277" EVENTS_2="101" LOG_CI_END="0.5356421332614679" LOG_CI_START="0.3412987183735157" LOG_EFFECT_SIZE="0.43847042581749185" MODIFIED="2013-11-23 16:43:59 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1118" O_E="0.0" SE="0.11415828392060205" STUDY_ID="STD-POISE-2008" TOTAL_1="4174" TOTAL_2="4177" VAR="0.01303211378769679" WEIGHT="10.49830264179523"/><DICH_DATA CI_END="3.6290326949803244" CI_START="0.9972510940069231" EFFECT_SIZE="1.9023818820773135" ESTIMABLE="YES" EVENTS_1="24" EVENTS_2="13" LOG_CI_END="0.5597908808998064" LOG_CI_START="-0.0011954785870280453" LOG_EFFECT_SIZE="0.27929770115638924" MODIFIED="2013-11-23 16:44:13 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1115" O_E="0.0" SE="0.32952616448983174" STUDY_ID="STD-Marwick-2009" TOTAL_1="197" TOTAL_2="203" VAR="0.10858749308337966" WEIGHT="8.538860901907547"/><DICH_DATA CI_END="99.95416281504153" CI_START="0.25011464551267176" EFFECT_SIZE="5.0" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="0" LOG_CI_END="1.9998008859974516" LOG_CI_START="-0.6018608773254143" LOG_EFFECT_SIZE="0.6989700043360189" MODIFIED="2013-11-23 16:44:26 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1119" O_E="0.0" SE="1.5282289982092807" STUDY_ID="STD-Shukla-2010" TOTAL_1="30" TOTAL_2="30" VAR="2.335483870967742" WEIGHT="1.5961417648704392"/><DICH_DATA CI_END="99.95416281504153" CI_START="0.25011464551267176" EFFECT_SIZE="5.0" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="0" LOG_CI_END="1.9998008859974516" LOG_CI_START="-0.6018608773254143" LOG_EFFECT_SIZE="0.6989700043360189" MODIFIED="2013-11-23 16:44:21 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1107" O_E="0.0" SE="1.5282289982092807" STUDY_ID="STD-Apipan-2010" TOTAL_1="30" TOTAL_2="30" VAR="2.335483870967742" WEIGHT="1.5961417648704392"/><DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-11-23 16:44:32 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1117" O_E="0.0" SE="0.0" STUDY_ID="STD-Moon-2011" TOTAL_1="27" TOTAL_2="27" VAR="0.0" WEIGHT="0.0"/></DICH_SUBGROUP><DICH_SUBGROUP CHI2="5.6496423575307135" CI_END="4.263575285483368" CI_START="2.3348784687396056" DF="7" EFFECT_SIZE="3.1551434411014396" ESTIMABLE="YES" EVENTS_1="155" EVENTS_2="47" I2="0.0" ID="CMP-004.10.02" LOG_CI_END="0.6297739360847281" LOG_CI_START="0.36826428030711494" LOG_EFFECT_SIZE="0.49901910819592155" MODIFIED="2017-06-17 15:44:36 +0100" MODIFIED_BY="Hermann Blessberger" NO="2" P_CHI2="0.5812010052590799" P_Z="7.426481805640746E-14" STUDIES="9" TAU2="0.0" TOTAL_1="551" TOTAL_2="546" WEIGHT="42.86524613164018" Z="7.480102229900381"><NAME>High risk</NAME><DICH_DATA CI_END="13.482091688489398" CI_START="0.060717144136267914" EFFECT_SIZE="0.9047619047619048" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.1297572763459856" LOG_CI_START="-1.2166886639081658" LOG_EFFECT_SIZE="-0.0434656937810903" MODIFIED="2013-11-23 16:44:40 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1123" O_E="0.0" SE="1.3783139604000185" STUDY_ID="STD-Gibson-1988" TOTAL_1="21" TOTAL_2="19" VAR="1.899749373433584" WEIGHT="1.8981196826037312"/><DICH_DATA CI_END="3.881860085359043" CI_START="0.38609570678958227" EFFECT_SIZE="1.2242424242424241" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="5" LOG_CI_END="0.5890398779736322" LOG_CI_START="-0.41330502750819725" LOG_EFFECT_SIZE="0.08786742523271744" MODIFIED="2013-11-23 16:44:48 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1127" O_E="0.0" SE="0.5887823591673299" STUDY_ID="STD-Mangano-1996" TOTAL_1="99" TOTAL_2="101" VAR="0.3466646664666467" WEIGHT="5.828476311761678"/><DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-11-23 16:44:54 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1125" O_E="0.0" SE="0.0" STUDY_ID="STD-Jakobsen-1997" TOTAL_1="18" TOTAL_2="17" VAR="0.0" WEIGHT="0.0"/><DICH_DATA CI_END="25.948956020600956" CI_START="1.4445429510900611" EFFECT_SIZE="6.122448979591836" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="2" LOG_CI_END="1.4141198899836058" LOG_CI_START="0.15973045939869154" LOG_EFFECT_SIZE="0.7869251746911488" MODIFIED="2013-11-23 16:45:00 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1122" O_E="0.0" SE="0.7368345608534029" STUDY_ID="STD-Bayliff-1999" TOTAL_1="49" TOTAL_2="50" VAR="0.5429251700680272" WEIGHT="4.619669192133293"/><DICH_DATA CI_END="9.055780428661802" CI_START="1.9026886986063845" EFFECT_SIZE="4.150943396226415" ESTIMABLE="YES" EVENTS_1="30" EVENTS_2="6" LOG_CI_END="0.9569258838335278" LOG_CI_START="0.27936773860930664" LOG_EFFECT_SIZE="0.6181468112214172" MODIFIED="2013-11-23 16:45:08 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1128" O_E="0.0" SE="0.3980010084716185" STUDY_ID="STD-POBBLE-2005" TOTAL_1="53" TOTAL_2="44" VAR="0.15840480274442537" WEIGHT="7.781660754511034"/><DICH_DATA CI_END="7.731389706964666" CI_START="0.29102141856503916" EFFECT_SIZE="1.5" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="2" LOG_CI_END="0.8882575647876686" LOG_CI_START="-0.5360750466763062" LOG_EFFECT_SIZE="0.17609125905568124" MODIFIED="2013-11-24 06:25:21 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1508" O_E="0.0" SE="0.8366600265340756" STUDY_ID="STD-Liu-2006" TOTAL_1="15" TOTAL_2="15" VAR="0.7" WEIGHT="3.962022551578987"/><DICH_DATA CI_END="4.968546281602201" CI_START="2.221629425589266" EFFECT_SIZE="3.3223889931207005" ESTIMABLE="YES" EVENTS_1="85" EVENTS_2="26" LOG_CI_END="0.6962293395925384" LOG_CI_START="0.34667161903172805" LOG_EFFECT_SIZE="0.5214504793121333" MODIFIED="2013-11-23 16:45:22 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1130" O_E="0.0" SE="0.2053319353960433" STUDY_ID="STD-Yang-2006" TOTAL_1="246" TOTAL_2="250" VAR="0.0421612036934849" WEIGHT="9.811931967436518"/><DICH_DATA CI_END="7.53745610550098" CI_START="1.3585485416660203" EFFECT_SIZE="3.2" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="5" LOG_CI_END="0.8772247960345471" LOG_CI_START="0.1330751606052648" LOG_EFFECT_SIZE="0.505149978319906" MODIFIED="2013-11-23 16:45:34 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1126" O_E="0.0" SE="0.4371171794512641" STUDY_ID="STD-Kawaguchi-2010" TOTAL_1="28" TOTAL_2="28" VAR="0.19107142857142861" WEIGHT="7.354038165906523"/><DICH_DATA CI_END="98.52270194459342" CI_START="0.25374862348029537" EFFECT_SIZE="5.0" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="0" LOG_CI_END="1.9935363136779938" LOG_CI_START="-0.5955963050059561" LOG_EFFECT_SIZE="0.6989700043360189" MODIFIED="2013-11-23 16:45:39 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1124" O_E="0.0" SE="1.5208693166281149" STUDY_ID="STD-Gupta-2011" TOTAL_1="22" TOTAL_2="22" VAR="2.313043478260869" WEIGHT="1.6093275057084138"/></DICH_SUBGROUP></DICH_OUTCOME><DICH_OUTCOME CHI2="18.832773006123084" CI_END="1.637851533872014" CI_START="1.3797136069781395" CI_STUDY="95" CI_TOTAL="95" DF="18" EFFECT_MEASURE="RR" EFFECT_SIZE="1.5032518243771518" ESTIMABLE="YES" EVENTS_1="1056" EVENTS_2="659" I2="4.421935133250558" I2_Q="79.58659069607106" ID="CMP-004.11" LOG_CI_END="0.21427453176969202" LOG_CI_START="0.13978894740334802" LOG_EFFECT_SIZE="0.17703173958652005" METHOD="MH" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" NO="11" P_CHI2="0.4021886162523849" P_Q="0.026876420805391765" P_Z="1.2013915982071046E-20" Q="4.898740749824339" RANDOM="NO" SCALE="100.0" SORT_BY="YEAR" STUDIES="22" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="5611" TOTAL_2="5336" WEIGHT="100.0" Z="9.316590227808769"><NAME>Hypotension&#8212;non-cardiac surgery</NAME><GROUP_LABEL_1>Beta-blocker</GROUP_LABEL_1><GROUP_LABEL_2>Control</GROUP_LABEL_2><GRAPH_LABEL_1>Favours beta-blocker</GRAPH_LABEL_1><GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2><DICH_SUBGROUP CHI2="3.131681132889057" CI_END="1.7571955875260794" CI_START="1.4197082679742523" DF="10" EFFECT_SIZE="1.579463549455526" ESTIMABLE="YES" EVENTS_1="808" EVENTS_2="474" I2="0.0" ID="CMP-004.11.01" LOG_CI_END="0.2448201040427016" LOG_CI_START="0.15219911154822532" LOG_EFFECT_SIZE="0.19850960779546348" MODIFIED="2013-11-24 06:25:39 +0000" MODIFIED_BY="Hermann Blessberger" NO="1" P_CHI2="0.9781529946869294" P_Z="4.412940157967932E-17" STUDIES="13" TAU2="0.0" TOTAL_1="5060" TOTAL_2="4790" WEIGHT="72.09918385143813" Z="8.40137146851419"><NAME>Low and medium risk</NAME><DICH_DATA CI_END="15.259760455310136" CI_START="0.0655318281652329" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.1835477162038213" LOG_CI_START="-1.1835477162038213" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-11-23 16:51:07 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1144" O_E="0.0" SE="1.390443574307614" STUDY_ID="STD-Whitehead-1980" TOTAL_1="30" TOTAL_2="30" VAR="1.9333333333333331" WEIGHT="0.1482941454300571"/><DICH_DATA CI_END="2.917064814565508" CI_START="0.30129815615047" EFFECT_SIZE="0.9375" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="5" LOG_CI_END="0.4649460788630512" LOG_CI_START="-0.5210035260635382" LOG_EFFECT_SIZE="-0.028028723600243537" MODIFIED="2013-11-23 16:51:21 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1131" O_E="0.0" SE="0.5791516784631352" STUDY_ID="STD-Cucchiara-1986" TOTAL_1="32" TOTAL_2="30" VAR="0.3354166666666667" WEIGHT="0.7653891377035205"/><DICH_DATA CI_END="21.029313937505744" CI_START="0.2205993627858741" EFFECT_SIZE="2.1538461538461537" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="1" LOG_CI_END="1.3228251044497223" LOG_CI_START="-0.6563957463789576" LOG_EFFECT_SIZE="0.33321467903538243" MODIFIED="2013-11-23 16:51:15 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1135" O_E="0.0" SE="1.162604125077987" STUDY_ID="STD-Magnusson-1986" TOTAL_1="13" TOTAL_2="14" VAR="1.3516483516483517" WEIGHT="0.1428017696733883"/><DICH_DATA CI_END="11.195845482255095" CI_START="0.6174400630049328" EFFECT_SIZE="2.6292134831460676" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="2" LOG_CI_END="1.049056895986779" LOG_CI_START="-0.20940519445631867" LOG_EFFECT_SIZE="0.4198258507652301" MODIFIED="2013-11-23 16:51:27 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1143" O_E="0.0" SE="0.7392268614140911" STUDY_ID="STD-Stone-1988" TOTAL_1="89" TOTAL_2="39" VAR="0.5464563526361279" WEIGHT="0.4124430919773463"/><DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-11-23 16:51:32 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1132" O_E="0.0" SE="0.0" STUDY_ID="STD-Inada-1989" TOTAL_1="20" TOTAL_2="10" VAR="0.0" WEIGHT="0.0"/><DICH_DATA CI_END="81.01190363542146" CI_START="0.2663500355480702" EFFECT_SIZE="4.645161290322581" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="0" LOG_CI_END="1.9085488374385386" LOG_CI_START="-0.5745472409165846" LOG_EFFECT_SIZE="0.667000798260977" MODIFIED="2013-11-23 16:51:40 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1141" O_E="0.0" SE="1.4585829279496223" STUDY_ID="STD-Sandler-1990" TOTAL_1="30" TOTAL_2="15" VAR="2.1274641577060933" WEIGHT="0.09781103209216531"/><DICH_DATA CI_END="35.88938623485869" CI_START="0.0668025523135909" EFFECT_SIZE="1.5483870967741935" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.5549660312757505" LOG_CI_START="-1.1752069441931212" LOG_EFFECT_SIZE="0.18987954354131453" MODIFIED="2013-11-23 16:51:46 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1137" O_E="0.0" SE="1.603717120364604" STUDY_ID="STD-Miller-1990" TOTAL_1="30" TOTAL_2="15" VAR="2.5719086021505375" WEIGHT="0.09781103209216531"/><DICH_DATA CI_END="2.6979150176212503" CI_START="1.2709157890073948" EFFECT_SIZE="1.8517080745341614" ESTIMABLE="YES" EVENTS_1="106" EVENTS_2="28" LOG_CI_END="0.4310282655881383" LOG_CI_START="0.10411677511654042" LOG_EFFECT_SIZE="0.2675725203523394" MODIFIED="2013-11-23 16:51:55 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1138" O_E="0.0" SE="0.19202942774099305" STUDY_ID="STD-Miller-1991" TOTAL_1="368" TOTAL_2="180" VAR="0.03687530111853327" WEIGHT="5.576725819384337"/><DICH_DATA CI_END="69.5152908317231" CI_START="0.12946791838627933" EFFECT_SIZE="3.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.84208034406391" LOG_CI_START="-0.8878378346245852" LOG_EFFECT_SIZE="0.47712125471966244" MODIFIED="2013-11-23 16:52:07 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1133" O_E="0.0" SE="1.6035674514745464" STUDY_ID="STD-Jakobsen-1992" TOTAL_1="20" TOTAL_2="20" VAR="2.5714285714285716" WEIGHT="0.07414707271502854"/><DICH_DATA CI_END="1.7412304767530802" CI_START="1.3764647865839486" EFFECT_SIZE="1.5481416074046312" ESTIMABLE="YES" EVENTS_1="625" EVENTS_2="404" LOG_CI_END="0.24085626000721605" LOG_CI_START="0.13876510553109628" LOG_EFFECT_SIZE="0.18981068276915616" MODIFIED="2013-11-23 16:52:25 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1140" O_E="0.0" SE="0.05996884949863775" STUDY_ID="STD-POISE-2008" TOTAL_1="4174" TOTAL_2="4177" VAR="0.003596262910190265" WEIGHT="59.889312480451096"/><DICH_DATA CI_END="2.3140090156976254" CI_START="1.0534324826660835" EFFECT_SIZE="1.561298261805876" ESTIMABLE="YES" EVENTS_1="50" EVENTS_2="33" LOG_CI_END="0.36436504669010483" LOG_CI_START="0.022606705729397786" LOG_EFFECT_SIZE="0.1934858762097513" MODIFIED="2013-11-23 16:52:35 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1136" O_E="0.0" SE="0.20075054121139094" STUDY_ID="STD-Marwick-2009" TOTAL_1="197" TOTAL_2="203" VAR="0.040300779796666374" WEIGHT="4.820301197204006"/><DICH_DATA CI_END="70.82882080128432" CI_START="0.12706691849706483" EFFECT_SIZE="3.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.850210011475669" LOG_CI_START="-0.8959675020363438" LOG_EFFECT_SIZE="0.47712125471966244" MODIFIED="2013-11-23 16:52:40 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1142" O_E="0.0" SE="1.613118265234886" STUDY_ID="STD-Shukla-2010" TOTAL_1="30" TOTAL_2="30" VAR="2.6021505376344085" WEIGHT="0.07414707271502854"/><DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-11-23 16:52:45 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1139" O_E="0.0" SE="0.0" STUDY_ID="STD-Moon-2011" TOTAL_1="27" TOTAL_2="27" VAR="0.0" WEIGHT="0.0"/></DICH_SUBGROUP><DICH_SUBGROUP CHI2="5.284744882479823" CI_END="1.4876728806648414" CI_START="1.147059319767397" DF="7" EFFECT_SIZE="1.3063112349405164" ESTIMABLE="YES" EVENTS_1="248" EVENTS_2="185" I2="0.0" ID="CMP-004.11.02" LOG_CI_END="0.1725074461693646" LOG_CI_START="0.05958587786769669" LOG_EFFECT_SIZE="0.11604666201853063" MODIFIED="2014-06-22 20:50:15 +0100" MODIFIED_BY="Hermann Blessberger" NO="2" P_CHI2="0.625258200493839" P_Z="5.615496674796137E-5" STUDIES="9" TAU2="0.0" TOTAL_1="551" TOTAL_2="546" WEIGHT="27.900816148561873" Z="4.0284116046775225"><NAME>High risk</NAME><DICH_DATA CI_END="89.07654204661276" CI_START="0.23194835082374035" EFFECT_SIZE="4.545454545454546" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="0" LOG_CI_END="1.9497633493675715" LOG_CI_START="-0.6346087110119837" LOG_EFFECT_SIZE="0.6575773191777938" MODIFIED="2013-11-23 16:52:52 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1146" O_E="0.0" SE="1.5180729411149698" STUDY_ID="STD-Gibson-1988" TOTAL_1="21" TOTAL_2="19" VAR="2.3045454545454547" WEIGHT="0.07767788570145848"/><DICH_DATA CI_END="2.4440278509874847" CI_START="0.5796419209128254" EFFECT_SIZE="1.1902356902356903" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="12" LOG_CI_END="0.38810615061358633" LOG_CI_START="-0.23684021298217456" LOG_EFFECT_SIZE="0.07563296881570589" MODIFIED="2014-06-22 20:50:15 +0100" MODIFIED_BY="Hermann Blessberger" ORDER="1150" O_E="0.0" SE="0.36709658751054164" STUDY_ID="STD-Mangano-1996" TOTAL_1="99" TOTAL_2="101" VAR="0.13475990456188475" WEIGHT="1.7617344477090784"/><DICH_DATA CI_END="7.259648833094586" CI_START="0.013736613709900562" EFFECT_SIZE="0.3157894736842105" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.8609156133257376" LOG_CI_START="-1.8621203144641083" LOG_EFFECT_SIZE="-0.5006023505691853" MODIFIED="2013-11-23 16:53:06 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1148" O_E="0.0" SE="1.5995247832289885" STUDY_ID="STD-Jakobsen-1997" TOTAL_1="18" TOTAL_2="17" VAR="2.5584795321637426" WEIGHT="0.2284531429598177"/><DICH_DATA CI_END="3.258712269150733" CI_START="1.0890244032150478" EFFECT_SIZE="1.8838304552590266" ESTIMABLE="YES" EVENTS_1="24" EVENTS_2="13" LOG_CI_END="0.5130460157469269" LOG_CI_START="0.03703761167762189" LOG_EFFECT_SIZE="0.2750418137122744" MODIFIED="2013-11-23 16:53:13 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1145" O_E="0.0" SE="0.2796096928299115" STUDY_ID="STD-Bayliff-1999" TOTAL_1="49" TOTAL_2="50" VAR="0.07818158032443746" WEIGHT="1.9083509219989165"/><DICH_DATA CI_END="1.4291890961291949" CI_START="1.0016090630908658" EFFECT_SIZE="1.1964483906770256" ESTIMABLE="YES" EVENTS_1="49" EVENTS_2="34" LOG_CI_END="0.15508969413200707" LOG_CI_START="6.982456113067668E-4" LOG_EFFECT_SIZE="0.07789396987165693" MODIFIED="2013-11-23 16:53:25 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1151" O_E="0.0" SE="0.09069030111105522" STUDY_ID="STD-POBBLE-2005" TOTAL_1="53" TOTAL_2="44" VAR="0.008224730715613863" WEIGHT="5.509815465256967"/><DICH_DATA CI_END="6.20048286508611" CI_START="0.16127776203218527" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="2" LOG_CI_END="0.7924255116719207" LOG_CI_START="-0.7924255116719207" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-11-24 06:25:39 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1509" O_E="0.0" SE="0.9309493362512627" STUDY_ID="STD-Liu-2006" TOTAL_1="15" TOTAL_2="15" VAR="0.8666666666666667" WEIGHT="0.2965882908601142"/><DICH_DATA CI_END="1.6001337406240679" CI_START="1.0973785289749167" EFFECT_SIZE="1.3251235453531005" ESTIMABLE="YES" EVENTS_1="133" EVENTS_2="102" LOG_CI_END="0.20415628289821494" LOG_CI_START="0.04035645864943841" LOG_EFFECT_SIZE="0.12225637077382669" MODIFIED="2013-11-23 16:53:35 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1153" O_E="0.0" SE="0.09621682758593815" STUDY_ID="STD-Yang-2006" TOTAL_1="246" TOTAL_2="250" VAR="0.009257677910702148" WEIGHT="15.004018940044324"/><DICH_DATA CI_END="1.48504132021836" CI_START="0.8795192640077785" EFFECT_SIZE="1.1428571428571428" ESTIMABLE="YES" EVENTS_1="24" EVENTS_2="21" LOG_CI_END="0.171738537756374" LOG_CI_START="-0.05575464380100051" LOG_EFFECT_SIZE="0.05799194697768673" MODIFIED="2013-11-23 16:53:41 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1149" O_E="0.0" SE="0.13363062095621217" STUDY_ID="STD-Kawaguchi-2010" TOTAL_1="28" TOTAL_2="28" VAR="0.01785714285714285" WEIGHT="3.114177054031199"/><DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-11-23 16:53:46 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1147" O_E="0.0" SE="0.0" STUDY_ID="STD-Gupta-2011" TOTAL_1="22" TOTAL_2="22" VAR="0.0" WEIGHT="0.0"/></DICH_SUBGROUP></DICH_OUTCOME><DICH_OUTCOME CHI2="1.8390964020271596" CI_END="1.4815572346084287" CI_START="0.9383036072485224" CI_STUDY="95" CI_TOTAL="95" DF="4" EFFECT_MEASURE="RR" EFFECT_SIZE="1.1790464357175394" ESTIMABLE="YES" EVENTS_1="154" EVENTS_2="131" I2="0.0" I2_Q="0.0" ID="CMP-004.12" LOG_CI_END="0.17071843353762536" LOG_CI_START="-0.027656614053537077" LOG_EFFECT_SIZE="0.07153090974204411" METHOD="MH" MODIFIED="2017-08-31 17:21:47 +0100" MODIFIED_BY="[Empty name]" NO="12" P_CHI2="0.7653222538708768" P_Q="0.320159136987776" P_Z="0.15751930148012083" Q="0.9882972262964999" RANDOM="NO" SCALE="100.0" SORT_BY="YEAR" STUDIES="5" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="4581" TOTAL_2="4592" WEIGHT="100.0" Z="1.4134641284596479"><NAME>Congestive heart failure&#8212;non-cardiac surgery</NAME><GROUP_LABEL_1>Beta-blocker</GROUP_LABEL_1><GROUP_LABEL_2>Control</GROUP_LABEL_2><GRAPH_LABEL_1>Favours beta-blocer</GRAPH_LABEL_1><GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2><DICH_SUBGROUP CHI2="0.5285750624546547" CI_END="1.4421092678144114" CI_START="0.8840407987684491" DF="1" EFFECT_SIZE="1.1291073593906098" ESTIMABLE="YES" EVENTS_1="132" EVENTS_2="117" I2="0.0" ID="CMP-004.12.01" LOG_CI_END="0.1589981678806405" LOG_CI_START="-0.05352769169378415" LOG_EFFECT_SIZE="0.0527352380934282" MODIFIED="2013-11-26 21:58:54 +0000" MODIFIED_BY="Hermann Blessberger" NO="1" P_CHI2="0.46720662407370583" P_Z="0.330715464745464" STUDIES="2" TAU2="0.0" TOTAL_1="4187" TOTAL_2="4191" WEIGHT="89.43765485992553" Z="0.97267379683806"><NAME>Low and medium risk</NAME><DICH_DATA CI_END="8.060808530068375" CI_START="0.015823601309021718" EFFECT_SIZE="0.35714285714285715" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.9063786053951907" LOG_CI_START="-1.8006946680796287" LOG_EFFECT_SIZE="-0.4471580313422192" MODIFIED="2013-11-23 16:56:12 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1155" O_E="0.0" SE="1.5901482410679288" STUDY_ID="STD-Magnusson-1986" TOTAL_1="13" TOTAL_2="14" VAR="2.528571428571428" WEIGHT="1.103263292296873"/><DICH_DATA CI_END="1.4559367832756067" CI_START="0.8906630317937844" EFFECT_SIZE="1.138748905374816" ESTIMABLE="YES" EVENTS_1="132" EVENTS_2="116" LOG_CI_END="0.16314251833512286" LOG_CI_START="-0.05028657330588837" LOG_EFFECT_SIZE="0.05642797251461725" MODIFIED="2013-11-23 16:56:27 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1156" O_E="0.0" SE="0.12536930492097248" STUDY_ID="STD-POISE-2008" TOTAL_1="4174" TOTAL_2="4177" VAR="0.015717462616367778" WEIGHT="88.33439156762866"/></DICH_SUBGROUP><DICH_SUBGROUP CHI2="0.3519341684159029" CI_END="3.052346616320408" CI_START="0.840702865149738" DF="2" EFFECT_SIZE="1.6019102801875875" ESTIMABLE="YES" EVENTS_1="22" EVENTS_2="14" I2="0.0" ID="CMP-004.12.02" LOG_CI_END="0.484633849403378" LOG_CI_START="-0.0753574724869638" LOG_EFFECT_SIZE="0.2046381884582071" MODIFIED="2017-06-17 15:44:49 +0100" MODIFIED_BY="Hermann Blessberger" NO="2" P_CHI2="0.8386456230360899" P_Z="0.15201130384994663" STUDIES="3" TAU2="0.0" TOTAL_1="394" TOTAL_2="401" WEIGHT="10.562345140074463" Z="1.4324631956284024"><NAME>High risk</NAME><DICH_DATA CI_END="3.384989540859917" CI_START="0.5082811058206856" EFFECT_SIZE="1.3116883116883118" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="7" LOG_CI_END="0.529557331114563" LOG_CI_START="-0.2938960338942417" LOG_EFFECT_SIZE="0.11783064861016074" MODIFIED="2013-11-23 16:56:47 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1159" O_E="0.0" SE="0.48370058276606814" STUDY_ID="STD-Wallace-1998" TOTAL_1="99" TOTAL_2="101" VAR="0.23396625376823393" WEIGHT="5.279114853640538"/><DICH_DATA CI_END="6.341211041538326" CI_START="0.6568037637213733" EFFECT_SIZE="2.0408163265306123" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="4" LOG_CI_END="0.8021722071611551" LOG_CI_START="-0.18256436721818248" LOG_EFFECT_SIZE="0.3098039199714864" MODIFIED="2013-11-23 16:56:54 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1157" O_E="0.0" SE="0.5784391383150814" STUDY_ID="STD-Bayliff-1999" TOTAL_1="49" TOTAL_2="50" VAR="0.33459183673469384" WEIGHT="3.0163292705220908"/><DICH_DATA CI_END="7.010763785170189" CI_START="0.4092059762747028" EFFECT_SIZE="1.6937669376693767" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="3" LOG_CI_END="0.8457653346022119" LOG_CI_START="-0.38805803223218227" LOG_EFFECT_SIZE="0.22885365118501486" MODIFIED="2013-11-23 16:57:02 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1160" O_E="0.0" SE="0.7247539532026899" STUDY_ID="STD-Yang-2006" TOTAL_1="246" TOTAL_2="250" VAR="0.5252682926829269" WEIGHT="2.2669010159118352"/></DICH_SUBGROUP></DICH_OUTCOME><DICH_OUTCOME CHI2="3.30428058690124" CI_END="1.5862677008295942" CI_START="0.5538393876131482" CI_STUDY="95" CI_TOTAL="95" DF="6" EFFECT_MEASURE="RR" EFFECT_SIZE="0.9373033297806954" ESTIMABLE="YES" EVENTS_1="22" EVENTS_2="21" I2="0.0" I2_Q="0.0" ID="CMP-004.13" LOG_CI_END="0.20037648133111538" LOG_CI_START="-0.25661616160097084" LOG_EFFECT_SIZE="-0.02811984013492772" METHOD="MH" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" NO="13" P_CHI2="0.7698005605463883" P_Q="0.8347960719942216" P_Z="0.8093982077177833" Q="0.04349502722492958" RANDOM="NO" SCALE="100.0" SORT_BY="YEAR" STUDIES="8" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="646" TOTAL_2="434" WEIGHT="99.99999999999997" Z="0.2412024559602057"><NAME>Bronchospasm&#8212;non-cardiac surgery</NAME><GROUP_LABEL_1>Beta-blocker</GROUP_LABEL_1><GROUP_LABEL_2>Control</GROUP_LABEL_2><GRAPH_LABEL_1>Favours beta-blocker</GRAPH_LABEL_1><GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2><DICH_SUBGROUP CHI2="0.6770393262880383" CI_END="3.2413427454401815" CI_START="0.3326503923053219" DF="3" EFFECT_SIZE="1.0383804388886981" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="4" I2="0.0" ID="CMP-004.13.01" LOG_CI_END="0.5107249565438197" LOG_CI_START="-0.47801196004015933" LOG_EFFECT_SIZE="0.01635649825183015" MODIFIED="2013-11-23 16:59:17 +0000" MODIFIED_BY="Hermann Blessberger" NO="1" P_CHI2="0.8785907932137205" P_Z="0.9482960835999678" STUDIES="5" TAU2="0.0" TOTAL_1="470" TOTAL_2="255" WEIGHT="23.686091350947226" Z="0.06484666840910168"><NAME>Low and medium risk</NAME><DICH_DATA CI_END="66.61522199816511" CI_START="0.11922423317225214" EFFECT_SIZE="2.8181818181818183" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.8235734795372827" LOG_CI_START="-0.9236354621851873" LOG_EFFECT_SIZE="0.44996900867604767" MODIFIED="2013-11-23 16:58:55 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1161" O_E="0.0" SE="1.6137241312713606" STUDY_ID="STD-Cucchiara-1986" TOTAL_1="32" TOTAL_2="30" VAR="2.6041055718475072" WEIGHT="2.2064937463023955"/><DICH_DATA CI_END="7.190006335094644" CI_START="0.03477048396741213" EFFECT_SIZE="0.5" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="0.8567292730387149" LOG_CI_START="-1.4587892643666773" LOG_EFFECT_SIZE="-0.3010299956639812" MODIFIED="2013-11-23 16:58:59 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1162" O_E="0.0" SE="1.3601470508735443" STUDY_ID="STD-Inada-1989" TOTAL_1="20" TOTAL_2="10" VAR="1.8499999999999999" WEIGHT="5.705680798519325"/><DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-11-23 16:59:03 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1164" O_E="0.0" SE="0.0" STUDY_ID="STD-Miller-1990" TOTAL_1="30" TOTAL_2="15" VAR="0.0" WEIGHT="0.0"/><DICH_DATA CI_END="5.291026045497317" CI_START="0.18087121868109135" EFFECT_SIZE="0.9782608695652174" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="2" LOG_CI_END="0.723539899386512" LOG_CI_START="-0.7426305351989728" LOG_EFFECT_SIZE="-0.009545317906230389" MODIFIED="2013-11-23 16:59:11 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1165" O_E="0.0" SE="0.8612357709362151" STUDY_ID="STD-Miller-1991" TOTAL_1="368" TOTAL_2="180" VAR="0.7417270531400967" WEIGHT="11.494656207236012"/><DICH_DATA CI_END="14.903914722906746" CI_START="0.06709646549862758" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.1733003569528007" LOG_CI_START="-1.1733003569528007" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-11-23 16:59:17 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1163" O_E="0.0" SE="1.378404875209022" STUDY_ID="STD-Jakobsen-1992" TOTAL_1="20" TOTAL_2="20" VAR="1.9" WEIGHT="4.279260598889494"/></DICH_SUBGROUP><DICH_SUBGROUP CHI2="2.535730113084142" CI_END="1.6351173132706078" CI_START="0.5019282269905182" DF="2" EFFECT_SIZE="0.9059313075346364" ESTIMABLE="YES" EVENTS_1="15" EVENTS_2="17" I2="21.12725286968918" ID="CMP-004.13.02" LOG_CI_END="0.21354891704422982" LOG_CI_START="-0.2993583801666861" LOG_EFFECT_SIZE="-0.04290473156122813" MODIFIED="2013-11-23 16:59:34 +0000" MODIFIED_BY="Hermann Blessberger" NO="2" P_CHI2="0.28143192904888137" P_Z="0.7429855723225609" STUDIES="3" TAU2="0.0" TOTAL_1="176" TOTAL_2="179" WEIGHT="76.31390864905275" Z="0.3279022508887652"><NAME>High risk</NAME><DICH_DATA CI_END="136.46047637797233" CI_START="0.373585094769823" EFFECT_SIZE="7.14" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="0" LOG_CI_END="2.1350068830509046" LOG_CI_START="-0.4276104594985559" LOG_EFFECT_SIZE="0.8536982117761743" MODIFIED="2013-11-23 16:59:22 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1168" O_E="0.0" SE="1.5052941121739825" STUDY_ID="STD-Mangano-1996" TOTAL_1="99" TOTAL_2="101" VAR="2.2659103641456584" WEIGHT="2.118445841034403"/><DICH_DATA CI_END="1.446151791426689" CI_START="0.4050013729748808" EFFECT_SIZE="0.7653061224489796" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="16" LOG_CI_END="0.16021387990126323" LOG_CI_START="-0.39254350450285286" LOG_EFFECT_SIZE="-0.11616481230079483" MODIFIED="2013-11-23 16:59:28 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1166" O_E="0.0" SE="0.32469242379215935" STUDY_ID="STD-Bayliff-1999" TOTAL_1="49" TOTAL_2="50" VAR="0.1054251700680272" WEIGHT="67.77657190968411"/><DICH_DATA CI_END="7.848616069043482" CI_START="0.014156777466712338" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.8947930852084158" LOG_CI_START="-1.8490355946477406" LOG_EFFECT_SIZE="-0.47712125471966244" MODIFIED="2013-11-23 16:59:34 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1167" O_E="0.0" SE="1.611738548718522" STUDY_ID="STD-Kawaguchi-2010" TOTAL_1="28" TOTAL_2="28" VAR="2.5977011494252875" WEIGHT="6.418890898334242"/></DICH_SUBGROUP></DICH_OUTCOME><CONT_OUTCOME CHI2="3.109542519456295" CI_END="0.8396604843024991" CI_START="-1.7484787202947654" CI_STUDY="95" CI_TOTAL="95" DF="2" EFFECT_MEASURE="MD" EFFECT_SIZE="-0.45440911799613315" ESTIMABLE="YES" I2="35.68185713859604" I2_Q="67.4549897760648" ID="CMP-004.14" MODIFIED="2017-12-08 02:36:36 +0000" MODIFIED_BY="Hermann Blessberger" NO="14" P_CHI2="0.21123779549911226" P_Q="0.07961897099877135" P_Z="0.49130407532430953" Q="3.0726676474188075" RANDOM="YES" SCALE="2.0" SORT_BY="YEAR" STUDIES="3" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.5891179693527354" TOTALS="YES" TOTAL_1="276" TOTAL_2="275" UNITS="" WEIGHT="99.99999999999999" Z="0.6882361690105625"><NAME>Length of stay&#8212;non-cardiac surgery</NAME><GROUP_LABEL_1>Beta-blocker</GROUP_LABEL_1><GROUP_LABEL_2>Control</GROUP_LABEL_2><GRAPH_LABEL_1>Favours beta-blocker</GRAPH_LABEL_1><GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2><CONT_SUBGROUP CHI2="0.03687487203748888" CI_END="-0.22023271081454954" CI_START="-0.5766943831823262" DF="1" EFFECT_SIZE="-0.3984635469984379" ESTIMABLE="YES" I2="0.0" ID="CMP-004.14.01" MODIFIED="2017-12-08 02:36:36 +0000" MODIFIED_BY="Hermann Blessberger" NO="1" P_CHI2="0.8477201016284426" P_Z="1.1769578869640556E-5" STUDIES="2" TAU2="0.0" TOTAL_1="227" TOTAL_2="233" WEIGHT="99.13905992665943" Z="4.381813035221678"><NAME>Low and medium risk</NAME><CONT_DATA CI_END="1.833472026316095" CI_START="-2.2334720263160954" EFFECT_SIZE="-0.20000000000000018" ESTIMABLE="YES" MEAN_1="7.8" MEAN_2="8.0" MODIFIED="2013-11-28 21:28:07 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1771" SD_1="8.9" SD_2="11.7" SE="1.0375047921063159" STUDY_ID="STD-Marwick-2009" TOTAL_1="197" TOTAL_2="203" WEIGHT="26.173725549047944"/><CONT_DATA CI_END="-0.22108058562828417" CI_START="-0.5789194143717157" EFFECT_SIZE="-0.3999999999999999" ESTIMABLE="YES" MEAN_1="1.3" MEAN_2="1.7" MODIFIED="2017-12-08 02:36:36 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1770" SD_1="0.3" SD_2="0.4" SE="0.09128709291752769" STUDY_ID="STD-Lee-2010" TOTAL_1="30" TOTAL_2="30" WEIGHT="72.96533437761148"/></CONT_SUBGROUP><CONT_SUBGROUP CHI2="6.305169696730175E-32" CI_END="1.065320526417123" CI_START="-26.665320526417126" DF="0" EFFECT_SIZE="-12.8" ESTIMABLE="YES" I2="100.0" ID="CMP-004.14.02" MODIFIED="2017-06-17 15:45:03 +0100" MODIFIED_BY="Hermann Blessberger" NO="2" P_CHI2="0.0" P_Z="0.07039304794146149" STUDIES="1" TAU2="0.0" TOTAL_1="49" TOTAL_2="42" WEIGHT="0.8609400733405566" Z="1.8093731734736505"><NAME>High risk</NAME><CONT_DATA CI_END="1.0653205264171248" CI_START="-26.665320526417123" EFFECT_SIZE="-12.799999999999999" ESTIMABLE="YES" MEAN_1="15.9" MEAN_2="28.7" MODIFIED="2013-11-28 21:28:31 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1772" SD_1="21.5" SD_2="41.3" SE="7.074273117151643" STUDY_ID="STD-POBBLE-2005" TOTAL_1="49" TOTAL_2="42" WEIGHT="0.8609400733405566"/></CONT_SUBGROUP></CONT_OUTCOME></COMPARISON><COMPARISON ID="CMP-005" MODIFIED="2017-12-03 02:24:40 +0000" MODIFIED_BY="Hermann Blessberger" NO="5"><NAME>Stratification for type of beta-blocker</NAME><DICH_OUTCOME CHI2="4.305444983328667" CI_END="1.7984083067586423" CI_START="0.40418755754238034" CI_STUDY="95" CI_TOTAL="95" DF="11" EFFECT_MEASURE="RR" EFFECT_SIZE="0.8525809410095346" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="12" I2="0.0" I2_Q="0.0" ID="CMP-005.01" LOG_CI_END="0.2548882998782404" LOG_CI_START="-0.3934170598802347" LOG_EFFECT_SIZE="-0.06926438000099712" METHOD="MH" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" NO="1" P_CHI2="0.9601155724963938" P_Q="0.6418989577429729" P_Z="0.6753610706108862" Q="3.378156313834778" RANDOM="NO" SCALE="100.0" SORT_BY="YEAR" STUDIES="23" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="1801" TOTAL_2="1854" WEIGHT="99.99999999999999" Z="0.4188016901912589"><NAME>All-cause mortality (30 days)&#8212;cardiac</NAME><GROUP_LABEL_1>Beta-blocker</GROUP_LABEL_1><GROUP_LABEL_2>Control</GROUP_LABEL_2><GRAPH_LABEL_1>Favours Beta-blocker</GRAPH_LABEL_1><GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2><DICH_SUBGROUP CHI2="0.04972913323037842" CI_END="15.85290422296029" CI_START="0.3558101986026317" DF="1" EFFECT_SIZE="2.375" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="1" I2="0.0" ID="CMP-005.01.01" LOG_CI_END="1.2001088357945269" LOG_CI_START="-0.4487816078727561" LOG_EFFECT_SIZE="0.3756636139608854" MODIFIED="2013-11-24 05:39:32 +0000" MODIFIED_BY="Hermann Blessberger" NO="1" P_CHI2="0.8235352751387377" P_Z="0.37181978853159603" STUDIES="5" TAU2="0.0" TOTAL_1="751" TOTAL_2="765" WEIGHT="10.038379397060758" Z="0.8930698294641379"><NAME>Metoprolol</NAME><DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-11-24 05:39:32 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1496" O_E="0.0" SE="0.0" STUDY_ID="STD-Janssen-1986" TOTAL_1="39" TOTAL_2="50" VAR="0.0" WEIGHT="0.0"><FOOTNOTE>Only patients in the metoprolol subgroup considered.</FOOTNOTE></DICH_DATA><DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-11-23 18:08:50 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1167" O_E="0.0" SE="0.0" STUDY_ID="STD-Paull-1997" TOTAL_1="50" TOTAL_2="50" VAR="0.0" WEIGHT="0.0"/><DICH_DATA CI_END="21.705078767310894" CI_START="0.18428866547235168" EFFECT_SIZE="2.0" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="1" LOG_CI_END="1.3365613662238505" LOG_CI_START="-0.7345013748958881" LOG_EFFECT_SIZE="0.3010299956639812" MODIFIED="2013-11-23 18:09:00 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1166" O_E="0.0" SE="1.2165525060596438" STUDY_ID="STD-De-Azevedo-L_x00fa_cio-2003" TOTAL_1="100" TOTAL_2="100" VAR="1.48" WEIGHT="6.744536157400197"/><DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-11-23 18:09:05 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1165" O_E="0.0" SE="0.0" STUDY_ID="STD-Connolly-2003" TOTAL_1="500" TOTAL_2="500" VAR="0.0" WEIGHT="0.0"/><DICH_DATA CI_END="75.72189594697373" CI_START="0.13044510965923498" EFFECT_SIZE="3.142857142857143" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.8792214794201312" LOG_CI_START="-0.8845721978042321" LOG_EFFECT_SIZE="0.4973246408079494" MODIFIED="2013-11-24 05:26:17 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1480" O_E="0.0" SE="1.6234660870009374" STUDY_ID="STD-Auer-2004" TOTAL_1="62" TOTAL_2="65" VAR="2.6356421356421356" WEIGHT="3.293843239660561"><FOOTNOTE>Only patiens in the metoprolol subgroup considered.</FOOTNOTE></DICH_DATA></DICH_SUBGROUP><DICH_SUBGROUP CHI2="0.3914474315767948" CI_END="1.9197619123709246" CI_START="0.13146718683289163" DF="3" EFFECT_SIZE="0.5023800334491187" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="6" I2="0.0" ID="CMP-005.01.02" LOG_CI_END="0.2832473711227885" LOG_CI_START="-0.8811826301071247" LOG_EFFECT_SIZE="-0.2989676294921681" MODIFIED="2014-06-22 16:24:56 +0100" MODIFIED_BY="Hermann Blessberger" NO="2" P_CHI2="0.9420035447376778" P_Z="0.3142028828342802" STUDIES="8" TAU2="0.0" TOTAL_1="371" TOTAL_2="397" WEIGHT="43.04210143798993" Z="1.0064422691429216"><NAME>Propranolol</NAME><DICH_DATA CI_END="14.051950786893713" CI_START="0.025619218673593205" EFFECT_SIZE="0.6" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="1.1477366201252595" LOG_CI_START="-1.591434119357972" LOG_EFFECT_SIZE="-0.2218487496163564" MODIFIED="2013-11-23 18:09:11 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1175" O_E="0.0" SE="1.6090024514862893" STUDY_ID="STD-Oka-1980" TOTAL_1="19" TOTAL_2="35" VAR="2.588888888888889" WEIGHT="7.22628874007164"/><DICH_DATA CI_END="10.258083464353952" CI_START="0.018010104346265817" EFFECT_SIZE="0.4298245614035088" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="1.0110662283582093" LOG_CI_START="-1.7444837709741272" LOG_EFFECT_SIZE="-0.3667087713079589" MODIFIED="2013-11-23 18:09:17 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1174" O_E="0.0" SE="1.6186237098002971" STUDY_ID="STD-Mohr-1981" TOTAL_1="37" TOTAL_2="48" VAR="2.6199427139276765" WEIGHT="8.8376680683175"/><DICH_DATA CI_END="3.0967497955252377" CI_START="0.035879912310534466" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="3" LOG_CI_END="0.4909061175904471" LOG_CI_START="-1.4451486270297722" LOG_EFFECT_SIZE="-0.47712125471966244" MODIFIED="2014-06-22 16:24:56 +0100" MODIFIED_BY="Hermann Blessberger" ORDER="1168" O_E="0.0" SE="1.1372481406154653" STUDY_ID="STD-Abel-1983" TOTAL_1="50" TOTAL_2="50" VAR="1.2933333333333332" WEIGHT="20.23360847220059"/><DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-11-23 18:09:24 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1171" O_E="0.0" SE="0.0" STUDY_ID="STD-Ivey-1983" TOTAL_1="53" TOTAL_2="56" VAR="0.0" WEIGHT="0.0"/><DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-11-23 18:09:40 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1170" O_E="0.0" SE="0.0" STUDY_ID="STD-Hammon-1984" TOTAL_1="24" TOTAL_2="26" VAR="0.0" WEIGHT="0.0"/><DICH_DATA CI_END="15.718754250133742" CI_START="0.06361827305694352" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.1964181241632585" LOG_CI_START="-1.1964181241632585" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-11-23 18:09:46 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1173" O_E="0.0" SE="1.4055638569974547" STUDY_ID="STD-Matangi-1985" TOTAL_1="82" TOTAL_2="82" VAR="1.975609756097561" WEIGHT="6.744536157400197"/><DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-11-23 18:09:52 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1172" O_E="0.0" SE="0.0" STUDY_ID="STD-Martinussen-1988" TOTAL_1="35" TOTAL_2="40" VAR="0.0" WEIGHT="0.0"/><DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-11-23 18:09:57 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1169" O_E="0.0" SE="0.0" STUDY_ID="STD-Bert-2001" TOTAL_1="71" TOTAL_2="60" VAR="0.0" WEIGHT="0.0"/></DICH_SUBGROUP><DICH_SUBGROUP CHI2="0.21123187230882123" CI_END="4.798809127586461" CI_START="0.08358555225822202" DF="1" EFFECT_SIZE="0.6333333333333333" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" I2="0.0" ID="CMP-005.01.03" LOG_CI_END="0.6811334762327975" LOG_CI_START="-1.0778687837664647" LOG_EFFECT_SIZE="-0.1983676537668335" MODIFIED="2013-11-24 05:39:07 +0000" MODIFIED_BY="Hermann Blessberger" NO="3" P_CHI2="0.6458035974023886" P_Z="0.6584448128679861" STUDIES="8" TAU2="0.0" TOTAL_1="538" TOTAL_2="554" WEIGHT="16.27991486269013" Z="0.4420613502575807"><NAME>Sotalol</NAME><DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-11-24 05:39:07 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1497" O_E="0.0" SE="0.0" STUDY_ID="STD-Janssen-1986" TOTAL_1="41" TOTAL_2="50" VAR="0.0" WEIGHT="0.0"><FOOTNOTE>Only patients in the sotalol subgroup considered.</FOOTNOTE></DICH_DATA><DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-11-23 18:10:08 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1181" O_E="0.0" SE="0.0" STUDY_ID="STD-Suttorp-1991" TOTAL_1="150" TOTAL_2="150" VAR="0.0" WEIGHT="0.0"/><DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-11-23 18:10:14 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1180" O_E="0.0" SE="0.0" STUDY_ID="STD-Nystr_x00f6_m-1993" TOTAL_1="50" TOTAL_2="51" VAR="0.0" WEIGHT="0.0"/><DICH_DATA CI_END="8.928614028566257" CI_START="0.015664675078941228" EFFECT_SIZE="0.37398373983739835" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.9507840494304557" LOG_CI_START="-1.8050786089461033" LOG_EFFECT_SIZE="-0.4271472797578239" MODIFIED="2013-11-23 18:10:21 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1178" O_E="0.0" SE="1.618807367270561" STUDY_ID="STD-Gomes-1999" TOTAL_1="40" TOTAL_2="45" VAR="2.6205372923294448" WEIGHT="9.535378705289933"/><DICH_DATA CI_END="15.773312877448294" CI_START="0.06339822254015756" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.1979229180145214" LOG_CI_START="-1.1979229180145214" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-11-23 18:10:31 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1176" O_E="0.0" SE="1.4073317037116178" STUDY_ID="STD-Evrard-2000" TOTAL_1="103" TOTAL_2="103" VAR="1.9805825242718447" WEIGHT="6.744536157400197"/><DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-11-23 18:10:36 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1179" O_E="0.0" SE="0.0" STUDY_ID="STD-Matsuura-2001" TOTAL_1="40" TOTAL_2="40" VAR="0.0" WEIGHT="0.0"/><DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-11-23 18:10:42 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1177" O_E="0.0" SE="0.0" STUDY_ID="STD-Forlani-2002" TOTAL_1="51" TOTAL_2="50" VAR="0.0" WEIGHT="0.0"/><DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-11-24 05:26:32 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1481" O_E="0.0" SE="0.0" STUDY_ID="STD-Auer-2004" TOTAL_1="63" TOTAL_2="65" VAR="0.0" WEIGHT="0.0"><FOOTNOTE>Only patients in the sotalol subgroup considered.</FOOTNOTE></DICH_DATA></DICH_SUBGROUP><DICH_SUBGROUP CHI2="0.0" CI_END="60.21015642179821" CI_START="0.11637439315284949" DF="0" EFFECT_SIZE="2.6470588235294117" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" I2="0.0" ID="CMP-005.01.04" LOG_CI_END="1.7796697554754684" LOG_CI_START="-0.934142570681329" LOG_EFFECT_SIZE="0.42276359239706973" MODIFIED="2014-06-22 16:26:09 +0100" MODIFIED_BY="Hermann Blessberger" NO="4" P_CHI2="1.0" P_Z="0.54142806391921" STUDIES="1" TAU2="0.0" TOTAL_1="16" TOTAL_2="14" WEIGHT="3.5830348336188544" Z="0.6106549130804955"><NAME>Esmolol</NAME><DICH_DATA CI_END="60.21015642179821" CI_START="0.11637439315284949" EFFECT_SIZE="2.6470588235294117" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.7796697554754684" LOG_CI_START="-0.934142570681329" LOG_EFFECT_SIZE="0.42276359239706973" MODIFIED="2014-06-22 16:26:09 +0100" MODIFIED_BY="Hermann Blessberger" ORDER="1182" O_E="0.0" SE="1.5941067939721714" STUDY_ID="STD-Cork-1995" TOTAL_1="16" TOTAL_2="14" VAR="2.541176470588235" WEIGHT="3.5830348336188544"/></DICH_SUBGROUP><DICH_SUBGROUP CHI2="0.0" CI_END="66.4433184667098" CI_START="0.12341968180365896" DF="0" EFFECT_SIZE="2.8636363636363638" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" I2="0.0" ID="CMP-005.01.05" LOG_CI_END="1.8224513148659036" LOG_CI_START="-0.9086155776031525" LOG_EFFECT_SIZE="0.4569178686313755" MODIFIED="2013-11-23 18:10:54 +0000" MODIFIED_BY="Hermann Blessberger" NO="5" P_CHI2="1.0" P_Z="0.5119406943006533" STUDIES="1" TAU2="0.0" TOTAL_1="21" TOTAL_2="20" WEIGHT="3.450692917739636" Z="0.6558188441885238"><NAME>Timolol</NAME><DICH_DATA CI_END="66.4433184667098" CI_START="0.12341968180365896" EFFECT_SIZE="2.8636363636363638" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.8224513148659036" LOG_CI_START="-0.9086155776031525" LOG_EFFECT_SIZE="0.4569178686313755" MODIFIED="2013-11-23 18:10:54 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1183" O_E="0.0" SE="1.6042422116354729" STUDY_ID="STD-White-1984" TOTAL_1="21" TOTAL_2="20" VAR="2.5735930735930737" WEIGHT="3.450692917739636"/></DICH_SUBGROUP><DICH_SUBGROUP CHI2="0.614732646692963" CI_END="2.8501153158957484" CI_START="0.0644442238401253" DF="1" EFFECT_SIZE="0.42857142857142855" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="3" I2="0.0" ID="CMP-005.01.06" LOG_CI_END="0.4548624319537887" LOG_CI_START="-1.1908160025429777" LOG_EFFECT_SIZE="-0.36797678529459443" MODIFIED="2013-11-24 05:48:59 +0000" MODIFIED_BY="Hermann Blessberger" NO="6" P_CHI2="0.43301162080489164" P_Z="0.38075652087943856" STUDIES="2" TAU2="0.0" TOTAL_1="104" TOTAL_2="104" WEIGHT="23.60587655090069" Z="0.8765032477864076"><NAME>Landiolol</NAME><DICH_DATA CI_END="4.092080860459946" CI_START="0.009774977905862802" EFFECT_SIZE="0.2" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" LOG_CI_END="0.611944206883865" LOG_CI_START="-2.0098842155559025" LOG_EFFECT_SIZE="-0.6989700043360187" MODIFIED="2013-11-23 18:11:13 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1184" O_E="0.0" SE="1.540074993601121" STUDY_ID="STD-Sezai-2011" TOTAL_1="70" TOTAL_2="70" VAR="2.371830985915493" WEIGHT="16.86134039350049"/><DICH_DATA CI_END="15.344261514858012" CI_START="0.06517094348474765" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.1859459916443629" LOG_CI_START="-1.1859459916443629" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-11-24 05:48:59 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1502" O_E="0.0" SE="1.393261092038472" STUDY_ID="STD-Sezai-2012" TOTAL_1="34" TOTAL_2="34" VAR="1.9411764705882355" WEIGHT="6.744536157400197"><FOOTNOTE>Only patients in the landiolol subgroup considered.</FOOTNOTE></DICH_DATA></DICH_SUBGROUP></DICH_OUTCOME><DICH_OUTCOME CHI2="6.688662154126654" CI_END="1.5678386330345677" CI_START="1.004149304568308" CI_STUDY="95" CI_TOTAL="95" DF="9" EFFECT_MEASURE="RR" EFFECT_SIZE="1.2547286850299502" ESTIMABLE="YES" EVENTS_1="168" EVENTS_2="134" I2="0.0" I2_Q="0.0" ID="CMP-005.02" LOG_CI_END="0.19530136167176523" LOG_CI_START="0.0017982918222353723" LOG_EFFECT_SIZE="0.09854982674700029" METHOD="MH" MODIFIED="2017-12-03 02:24:40 +0000" MODIFIED_BY="Hermann Blessberger" NO="2" P_CHI2="0.66949765585711" P_Q="0.7932400134954245" P_Z="0.04589113513048364" Q="1.6861055760502788" RANDOM="NO" SCALE="100.0" SORT_BY="YEAR" STUDIES="13" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="5805" TOTAL_2="5608" WEIGHT="100.0" Z="1.9963932485100255"><NAME>All-cause mortality (30 days)&#8212;non-cardiac</NAME><GROUP_LABEL_1>Beta-blocker</GROUP_LABEL_1><GROUP_LABEL_2>Control</GROUP_LABEL_2><GRAPH_LABEL_1>Favours beta-blocker</GRAPH_LABEL_1><GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2><DICH_SUBGROUP CHI2="3.7858275212089842" CI_END="1.6244872020046441" CI_START="1.0124913821683805" DF="4" EFFECT_SIZE="1.282489490199638" ESTIMABLE="YES" EVENTS_1="152" EVENTS_2="118" I2="0.0" ID="CMP-005.02.01" LOG_CI_END="0.21071629424631017" LOG_CI_START="0.005391335400142035" LOG_EFFECT_SIZE="0.1080538148232261" MODIFIED="2017-12-03 02:24:40 +0000" MODIFIED_BY="Hermann Blessberger" NO="1" P_CHI2="0.4357662566500383" P_Z="0.03912291079224788" STUDIES="6" TAU2="0.0" TOTAL_1="5016" TOTAL_2="5011" WEIGHT="88.39535018596978" Z="2.0628917851565496"><NAME>Metoprolol</NAME><DICH_DATA CI_END="23.10618612076079" CI_START="0.2684527492293484" EFFECT_SIZE="2.490566037735849" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="1" LOG_CI_END="1.3637282672706277" LOG_CI_START="-0.571132144060506" LOG_EFFECT_SIZE="0.3962980616050608" MODIFIED="2013-11-23 18:16:13 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1187" O_E="0.0" SE="1.1365465833294115" STUDY_ID="STD-POBBLE-2005" TOTAL_1="53" TOTAL_2="44" VAR="1.2917381360777587" WEIGHT="0.8112576726205388"/><DICH_DATA CI_END="2.5549775876151535" CI_START="0.6868023908740409" EFFECT_SIZE="1.3246753246753247" ESTIMABLE="YES" EVENTS_1="20" EVENTS_2="15" LOG_CI_END="0.4073870948356017" LOG_CI_START="-0.16316820165673035" LOG_EFFECT_SIZE="0.12210944658943569" MODIFIED="2013-11-23 18:16:19 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1185" O_E="0.0" SE="0.3351470054538631" STUDY_ID="STD-DIPOM-_x002d_-Juul-2006" TOTAL_1="462" TOTAL_2="459" VAR="0.11232351526469174" WEIGHT="11.171932069576803"/><DICH_DATA CI_END="2.086100324386569" CI_START="0.006111296108574041" EFFECT_SIZE="0.11291048133153396" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="4" LOG_CI_END="0.3193351906100624" LOG_CI_START="-2.2138666730459673" LOG_EFFECT_SIZE="-0.9472657412179525" MODIFIED="2013-11-23 18:16:34 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1189" O_E="0.0" SE="1.4880153142630121" STUDY_ID="STD-Yang-2006" TOTAL_1="246" TOTAL_2="250" VAR="2.214189575481251" WEIGHT="3.313864954247925"/><DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-11-23 18:16:25 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1186" O_E="0.0" SE="0.0" STUDY_ID="STD-Lai-2006" TOTAL_1="30" TOTAL_2="30" VAR="0.0" WEIGHT="0.0"/><DICH_DATA CI_END="1.7258284961101578" CI_START="1.0262717576233682" EFFECT_SIZE="1.3308527507051506" ESTIMABLE="YES" EVENTS_1="129" EVENTS_2="97" LOG_CI_END="0.23699763558907627" LOG_CI_START="0.011262377548303708" LOG_EFFECT_SIZE="0.12413000656868999" MODIFIED="2017-12-03 02:24:40 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1188" O_E="0.0" SE="0.13259800798069846" STUDY_ID="STD-POISE-2008" TOTAL_1="4174" TOTAL_2="4177" VAR="0.017582231720449374" WEIGHT="71.98472953323878"/><DICH_DATA CI_END="7.99511202377449" CI_START="0.013897380146858233" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.90282455325627" LOG_CI_START="-1.8570670626955947" LOG_EFFECT_SIZE="-0.47712125471966244" MODIFIED="2013-11-23 18:16:52 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1190" O_E="0.0" SE="1.6211739968939571" STUDY_ID="STD-Yang-2008" TOTAL_1="51" TOTAL_2="51" VAR="2.628205128205128" WEIGHT="1.1135659562857398"/></DICH_SUBGROUP><DICH_SUBGROUP CHI2="0.0" CI_END="21.785667983536555" CI_START="0.1911775797639689" DF="0" EFFECT_SIZE="2.0408163265306123" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="1" I2="0.0" ID="CMP-005.02.02" LOG_CI_END="1.3381708806415864" LOG_CI_START="-0.7185630406986138" LOG_EFFECT_SIZE="0.3098039199714864" MODIFIED="2013-11-23 18:17:31 +0000" MODIFIED_BY="Hermann Blessberger" NO="2" P_CHI2="1.0" P_Z="0.5548855766979995" STUDIES="1" TAU2="0.0" TOTAL_1="49" TOTAL_2="50" WEIGHT="0.7348785435421044" Z="0.590455108571145"><NAME>Propranolol</NAME><DICH_DATA CI_END="21.785667983536555" CI_START="0.1911775797639689" EFFECT_SIZE="2.0408163265306123" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="1" LOG_CI_END="1.3381708806415864" LOG_CI_START="-0.7185630406986138" LOG_EFFECT_SIZE="0.3098039199714864" MODIFIED="2013-11-23 18:17:31 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1191" O_E="0.0" SE="1.2081356863923414" STUDY_ID="STD-Bayliff-1999" TOTAL_1="49" TOTAL_2="50" VAR="1.4595918367346938" WEIGHT="0.7348785435421044"/></DICH_SUBGROUP><DICH_SUBGROUP CHI2="1.094719222097602" CI_END="2.8727665246555225" CI_START="0.39974254416551114" DF="1" EFFECT_SIZE="1.0716188685159067" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="7" I2="8.652375895630083" ID="CMP-005.02.03" LOG_CI_END="0.45830033146566007" LOG_CI_START="-0.39821962778929115" LOG_EFFECT_SIZE="0.03004035183818446" MODIFIED="2013-11-23 18:17:44 +0000" MODIFIED_BY="Hermann Blessberger" NO="3" P_CHI2="0.2954284217580396" P_Z="0.8906498764963104" STUDIES="2" TAU2="0.0" TOTAL_1="117" TOTAL_2="121" WEIGHT="4.98643113477846" Z="0.13748192800309877"><NAME>Atenolol</NAME><DICH_DATA CI_END="10.888852021315463" CI_START="0.38234045608732375" EFFECT_SIZE="2.04040404040404" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="2" LOG_CI_END="1.0369820958174838" LOG_CI_START="-0.4175497461193362" LOG_EFFECT_SIZE="0.3097161748490738" MODIFIED="2013-11-23 18:17:39 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1192" O_E="0.0" SE="0.8543992040024265" STUDY_ID="STD-Mangano-1996" TOTAL_1="99" TOTAL_2="101" VAR="0.72999799979998" WEIGHT="1.4699070622971766"/><DICH_DATA CI_END="2.4023415437266507" CI_START="0.185004686617123" EFFECT_SIZE="0.6666666666666666" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="5" LOG_CI_END="0.38063475161440946" LOG_CI_START="-0.7328172697257719" LOG_EFFECT_SIZE="-0.17609125905568127" MODIFIED="2013-11-23 18:17:44 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1193" O_E="0.0" SE="0.6540472290116194" STUDY_ID="STD-Neary-2006" TOTAL_1="18" TOTAL_2="20" VAR="0.42777777777777776" WEIGHT="3.516524072481283"/></DICH_SUBGROUP><DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-005.02.04" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2017-06-17 15:46:17 +0100" MODIFIED_BY="Hermann Blessberger" NO="4" P_CHI2="0.0" P_Z="0.0" STUDIES="2" TAU2="0.0" TOTAL_1="398" TOTAL_2="195" WEIGHT="0.0" Z="0.0"><NAME>Esmolol</NAME><DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-11-23 18:17:49 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1194" O_E="0.0" SE="0.0" STUDY_ID="STD-Miller-1990" TOTAL_1="30" TOTAL_2="15" VAR="0.0" WEIGHT="0.0"/><DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-11-23 18:17:55 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1195" O_E="0.0" SE="0.0" STUDY_ID="STD-Miller-1991" TOTAL_1="368" TOTAL_2="180" VAR="0.0" WEIGHT="0.0"/></DICH_SUBGROUP><DICH_SUBGROUP CHI2="0.0" CI_END="3.986212369346937" CI_START="0.38358505944859494" DF="0" EFFECT_SIZE="1.2365482233502538" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="5" I2="0.0" ID="CMP-005.02.05" LOG_CI_END="0.6005604324423948" LOG_CI_START="-0.416138316843905" LOG_EFFECT_SIZE="0.09221105779924482" MODIFIED="2013-11-26 21:58:54 +0000" MODIFIED_BY="Hermann Blessberger" NO="5" P_CHI2="1.0" P_Z="0.7221971439197759" STUDIES="1" TAU2="0.0" TOTAL_1="197" TOTAL_2="203" WEIGHT="3.656208223138179" Z="0.35552390005344237"><NAME>Bisoprolol</NAME><DICH_DATA CI_END="3.986212369346937" CI_START="0.38358505944859494" EFFECT_SIZE="1.2365482233502538" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="5" LOG_CI_END="0.6005604324423948" LOG_CI_START="-0.416138316843905" LOG_EFFECT_SIZE="0.09221105779924482" MODIFIED="2013-11-23 18:18:32 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1198" O_E="0.0" SE="0.5972138780707484" STUDY_ID="STD-Marwick-2009" TOTAL_1="197" TOTAL_2="203" VAR="0.35666441616030276" WEIGHT="3.656208223138179"/></DICH_SUBGROUP><DICH_SUBGROUP CHI2="0.0" CI_END="3.0135058276554876" CI_START="0.036871045707436295" DF="0" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="3" I2="0.0" ID="CMP-005.02.06" LOG_CI_END="0.47907203566328777" LOG_CI_START="-1.4333145451026126" LOG_EFFECT_SIZE="-0.47712125471966244" MODIFIED="2013-11-23 18:18:41 +0000" MODIFIED_BY="Hermann Blessberger" NO="6" P_CHI2="1.0" P_Z="0.32808290363237314" STUDIES="1" TAU2="0.0" TOTAL_1="28" TOTAL_2="28" WEIGHT="2.2271319125714797" Z="0.9779826787265795"><NAME>Landiolol</NAME><DICH_DATA CI_END="3.0135058276554862" CI_START="0.036871045707436295" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="3" LOG_CI_END="0.4790720356632876" LOG_CI_START="-1.4333145451026126" LOG_EFFECT_SIZE="-0.47712125471966244" MODIFIED="2013-11-23 18:18:41 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1200" O_E="0.0" SE="1.1233453440081378" STUDY_ID="STD-Kawaguchi-2010" TOTAL_1="28" TOTAL_2="28" VAR="1.2619047619047616" WEIGHT="2.2271319125714797"/></DICH_SUBGROUP></DICH_OUTCOME><DICH_OUTCOME CHI2="12.222122050802039" CI_END="1.2957439418677084" CI_START="0.9100475827192767" CI_STUDY="95" CI_TOTAL="95" DF="9" EFFECT_MEASURE="RR" EFFECT_SIZE="1.085904527166111" ESTIMABLE="YES" EVENTS_1="233" EVENTS_2="215" I2="26.36303284658" I2_Q="42.14996175336558" ID="CMP-005.03" LOG_CI_END="0.11251918701218587" LOG_CI_START="-0.04093589957762738" LOG_EFFECT_SIZE="0.03579164371727927" METHOD="MH" MODIFIED="2017-06-17 15:46:27 +0100" MODIFIED_BY="Hermann Blessberger" NO="3" P_CHI2="0.2010749071223844" P_Q="0.14048009404981254" P_Z="0.36057060767868687" Q="6.914429309357822" RANDOM="NO" SCALE="100.0" SORT_BY="YEAR" STUDIES="13" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="5805" TOTAL_2="5608" WEIGHT="99.99999999999999" Z="0.9142783623832439"><NAME>Long-term mortality&#8212;non-cardiac surgery</NAME><GROUP_LABEL_1>Beta-blocker</GROUP_LABEL_1><GROUP_LABEL_2>Control</GROUP_LABEL_2><GRAPH_LABEL_1>Favours beta-blocker</GRAPH_LABEL_1><GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2><DICH_SUBGROUP CHI2="5.256911793702" CI_END="1.4214779038007113" CI_START="0.9659192826613285" DF="4" EFFECT_SIZE="1.171764872812849" ESTIMABLE="YES" EVENTS_1="206" EVENTS_2="175" I2="23.909699135675677" ID="CMP-005.03.01" LOG_CI_END="0.1527401131773534" LOG_CI_START="-0.015059164018702272" LOG_EFFECT_SIZE="0.06884047457932556" MODIFIED="2013-11-24 05:30:50 +0000" MODIFIED_BY="Hermann Blessberger" NO="1" P_CHI2="0.2619377981835218" P_Z="0.10779803239387828" STUDIES="6" TAU2="0.0" TOTAL_1="5016" TOTAL_2="5011" WEIGHT="81.78182258631446" Z="1.6081696311060723"><NAME>Metorpolol</NAME><DICH_DATA CI_END="23.10618612076079" CI_START="0.2684527492293484" EFFECT_SIZE="2.490566037735849" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="1" LOG_CI_END="1.3637282672706277" LOG_CI_START="-0.571132144060506" LOG_EFFECT_SIZE="0.3962980616050608" MODIFIED="2013-11-23 18:24:40 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1206" O_E="0.0" SE="1.1365465833294115" STUDY_ID="STD-POBBLE-2005" TOTAL_1="53" TOTAL_2="44" VAR="1.2917381360777587" WEIGHT="0.5070446636830247"/><DICH_DATA CI_END="2.086100324386569" CI_START="0.006111296108574041" EFFECT_SIZE="0.11291048133153396" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="4" LOG_CI_END="0.3193351906100624" LOG_CI_START="-2.2138666730459673" LOG_EFFECT_SIZE="-0.9472657412179525" MODIFIED="2013-11-23 18:24:59 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1208" O_E="0.0" SE="1.4880153142630121" STUDY_ID="STD-Yang-2006" TOTAL_1="246" TOTAL_2="250" VAR="2.214189575481251" WEIGHT="2.071200800837962"/><DICH_DATA CI_END="1.3750776070230888" CI_START="0.7582504153316847" EFFECT_SIZE="1.021103896103896" ESTIMABLE="YES" EVENTS_1="74" EVENTS_2="72" LOG_CI_END="0.13832720969410692" LOG_CI_START="-0.12018734313242" LOG_EFFECT_SIZE="0.009069933280843453" MODIFIED="2013-11-23 18:33:35 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1204" O_E="0.0" SE="0.1518527279979766" STUDY_ID="STD-DIPOM-_x002d_-Juul-2006" TOTAL_1="462" TOTAL_2="459" VAR="0.02305925100042747" WEIGHT="33.516365890171826"/><DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-11-23 18:25:04 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1205" O_E="0.0" SE="0.0" STUDY_ID="STD-Lai-2006" TOTAL_1="30" TOTAL_2="30" VAR="0.0" WEIGHT="0.0"/><DICH_DATA CI_END="7.99511202377449" CI_START="0.013897380146858233" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.90282455325627" LOG_CI_START="-1.8570670626955947" LOG_EFFECT_SIZE="-0.47712125471966244" MODIFIED="2013-11-23 18:25:10 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1209" O_E="0.0" SE="1.6211739968939571" STUDY_ID="STD-Yang-2008" TOTAL_1="51" TOTAL_2="51" VAR="2.628205128205128" WEIGHT="0.6959905525083029"/><DICH_DATA CI_END="1.7258284961101578" CI_START="1.0262717576233682" EFFECT_SIZE="1.3308527507051506" ESTIMABLE="YES" EVENTS_1="129" EVENTS_2="97" LOG_CI_END="0.23699763558907627" LOG_CI_START="0.011262377548303708" LOG_EFFECT_SIZE="0.12413000656868999" MODIFIED="2013-11-23 18:25:25 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1207" O_E="0.0" SE="0.13259800798069846" STUDY_ID="STD-POISE-2008" TOTAL_1="4174" TOTAL_2="4177" VAR="0.017582231720449374" WEIGHT="44.99122067911335"/></DICH_SUBGROUP><DICH_SUBGROUP CHI2="0.0" CI_END="21.785667983536555" CI_START="0.1911775797639689" DF="0" EFFECT_SIZE="2.0408163265306123" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="1" I2="0.0" ID="CMP-005.03.02" LOG_CI_END="1.3381708806415864" LOG_CI_START="-0.7185630406986138" LOG_EFFECT_SIZE="0.3098039199714864" MODIFIED="2013-11-23 18:25:36 +0000" MODIFIED_BY="Hermann Blessberger" NO="2" P_CHI2="1.0" P_Z="0.5548855766979995" STUDIES="1" TAU2="0.0" TOTAL_1="49" TOTAL_2="50" WEIGHT="0.459306896604806" Z="0.590455108571145"><NAME>Propranolol</NAME><DICH_DATA CI_END="21.785667983536555" CI_START="0.1911775797639689" EFFECT_SIZE="2.0408163265306123" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="1" LOG_CI_END="1.3381708806415864" LOG_CI_START="-0.7185630406986138" LOG_EFFECT_SIZE="0.3098039199714864" MODIFIED="2013-11-23 18:25:36 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1210" O_E="0.0" SE="1.2081356863923414" STUDY_ID="STD-Bayliff-1999" TOTAL_1="49" TOTAL_2="50" VAR="1.4595918367346938" WEIGHT="0.459306896604806"/></DICH_SUBGROUP><DICH_SUBGROUP CHI2="0.10912234238225307" CI_END="1.0158711886171268" CI_START="0.3615652549424463" DF="1" EFFECT_SIZE="0.6060558763852038" ESTIMABLE="YES" EVENTS_1="18" EVENTS_2="31" I2="0.0" ID="CMP-005.03.03" LOG_CI_END="0.006838643361939973" LOG_CI_START="-0.4418133102535658" LOG_EFFECT_SIZE="-0.21748733344581292" MODIFIED="2013-11-23 18:22:16 +0000" MODIFIED_BY="Hermann Blessberger" NO="3" P_CHI2="0.7411455950811126" P_Z="0.057405054081294184" STUDIES="2" TAU2="0.0" TOTAL_1="117" TOTAL_2="121" WEIGHT="14.081720431328517" Z="1.900213906179745"><NAME>Atenolol</NAME><DICH_DATA CI_END="1.0730307753136772" CI_START="0.3098783343683285" EFFECT_SIZE="0.5766359244620114" ESTIMABLE="YES" EVENTS_1="13" EVENTS_2="23" LOG_CI_END="0.03061217803048055" LOG_CI_START="-0.5088087870818075" LOG_EFFECT_SIZE="-0.23909830452566347" MODIFIED="2013-11-23 18:22:10 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1202" O_E="0.0" SE="0.3168585450837994" STUDY_ID="STD-Wallace-1998" TOTAL_1="99" TOTAL_2="101" VAR="0.10039933759262215" WEIGHT="10.565136587076038"/><DICH_DATA CI_END="1.739330050693594" CI_START="0.2772637005998054" EFFECT_SIZE="0.6944444444444444" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="8" LOG_CI_END="0.2403820004008043" LOG_CI_START="-0.5571069845913037" LOG_EFFECT_SIZE="-0.15836249209524966" MODIFIED="2013-11-23 18:22:16 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1201" O_E="0.0" SE="0.4684489774185066" STUDY_ID="STD-Neary-2006" TOTAL_1="18" TOTAL_2="20" VAR="0.2194444444444445" WEIGHT="3.5165838442524775"/></DICH_SUBGROUP><DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-005.03.04" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2017-06-17 15:46:27 +0100" MODIFIED_BY="Hermann Blessberger" NO="4" P_CHI2="0.0" P_Z="0.0" STUDIES="2" TAU2="0.0" TOTAL_1="398" TOTAL_2="195" WEIGHT="0.0" Z="0.0"><NAME>Esmolol</NAME><DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-11-23 18:25:53 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1211" O_E="0.0" SE="0.0" STUDY_ID="STD-Miller-1990" TOTAL_1="30" TOTAL_2="15" VAR="0.0" WEIGHT="0.0"/><DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-11-23 18:26:01 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1212" O_E="0.0" SE="0.0" STUDY_ID="STD-Miller-1991" TOTAL_1="368" TOTAL_2="180" VAR="0.0" WEIGHT="0.0"/></DICH_SUBGROUP><DICH_SUBGROUP CHI2="0.0" CI_END="3.986212369346937" CI_START="0.38358505944859494" DF="0" EFFECT_SIZE="1.2365482233502538" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="5" I2="0.0" ID="CMP-005.03.05" LOG_CI_END="0.6005604324423948" LOG_CI_START="-0.416138316843905" LOG_EFFECT_SIZE="0.09221105779924482" MODIFIED="2013-11-26 21:58:54 +0000" MODIFIED_BY="Hermann Blessberger" NO="5" P_CHI2="1.0" P_Z="0.7221971439197759" STUDIES="1" TAU2="0.0" TOTAL_1="197" TOTAL_2="203" WEIGHT="2.2851689807355946" Z="0.35552390005344237"><NAME>Bisoprolol</NAME><DICH_DATA CI_END="3.986212369346937" CI_START="0.38358505944859494" EFFECT_SIZE="1.2365482233502538" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="5" LOG_CI_END="0.6005604324423948" LOG_CI_START="-0.416138316843905" LOG_EFFECT_SIZE="0.09221105779924482" MODIFIED="2013-11-23 18:26:49 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1214" O_E="0.0" SE="0.5972138780707484" STUDY_ID="STD-Marwick-2009" TOTAL_1="197" TOTAL_2="203" VAR="0.35666441616030276" WEIGHT="2.2851689807355946"/></DICH_SUBGROUP><DICH_SUBGROUP CHI2="0.0" CI_END="3.0135058276554876" CI_START="0.036871045707436295" DF="0" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="3" I2="0.0" ID="CMP-005.03.06" LOG_CI_END="0.47907203566328777" LOG_CI_START="-1.4333145451026126" LOG_EFFECT_SIZE="-0.47712125471966244" MODIFIED="2013-11-23 18:26:58 +0000" MODIFIED_BY="Hermann Blessberger" NO="6" P_CHI2="1.0" P_Z="0.32808290363237314" STUDIES="1" TAU2="0.0" TOTAL_1="28" TOTAL_2="28" WEIGHT="1.3919811050166058" Z="0.9779826787265795"><NAME>Landiolol</NAME><DICH_DATA CI_END="3.0135058276554862" CI_START="0.036871045707436295" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="3" LOG_CI_END="0.4790720356632876" LOG_CI_START="-1.4333145451026126" LOG_EFFECT_SIZE="-0.47712125471966244" MODIFIED="2013-11-23 18:26:58 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1216" O_E="0.0" SE="1.1233453440081378" STUDY_ID="STD-Kawaguchi-2010" TOTAL_1="28" TOTAL_2="28" VAR="1.2619047619047616" WEIGHT="1.3919811050166058"/></DICH_SUBGROUP></DICH_OUTCOME><DICH_OUTCOME CHI2="0.9520673649550806" CI_END="4.399984179226458" CI_START="0.16262684854521636" CI_STUDY="95" CI_TOTAL="95" DF="2" EFFECT_MEASURE="RR" EFFECT_SIZE="0.8459051724137933" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" I2="0.0" I2_Q="0.0" ID="CMP-005.04" LOG_CI_END="0.6434511149209599" LOG_CI_START="-0.7888077538681787" LOG_EFFECT_SIZE="-0.07267831947360943" METHOD="MH" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" NO="4" P_CHI2="0.6212425997920604" P_Q="0.621280074643648" P_Z="0.8423314180816447" Q="0.9519467236303771" RANDOM="NO" SCALE="100.0" SORT_BY="YEAR" STUDIES="4" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="150" TOTAL_2="170" WEIGHT="100.0" Z="0.1989122102565134"><NAME>Death due to cardiac causes&#8212;cardiac surgery</NAME><GROUP_LABEL_1>Beta-blocker</GROUP_LABEL_1><GROUP_LABEL_2>Control</GROUP_LABEL_2><GRAPH_LABEL_1>Favours beta-blocker</GRAPH_LABEL_1><GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2><DICH_SUBGROUP CHI2="0.0" CI_END="14.051950786893713" CI_START="0.025619218673593205" DF="0" EFFECT_SIZE="0.6" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" I2="0.0" ID="CMP-005.04.01" LOG_CI_END="1.1477366201252595" LOG_CI_START="-1.591434119357972" LOG_EFFECT_SIZE="-0.2218487496163564" MODIFIED="2013-11-23 18:30:53 +0000" MODIFIED_BY="Hermann Blessberger" NO="1" P_CHI2="1.0" P_Z="0.7508796370655153" STUDIES="1" TAU2="0.0" TOTAL_1="19" TOTAL_2="35" WEIGHT="34.752155172413794" Z="0.31747970507697115"><NAME>Propranolol</NAME><DICH_DATA CI_END="14.051950786893713" CI_START="0.025619218673593205" EFFECT_SIZE="0.6" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="1.1477366201252595" LOG_CI_START="-1.591434119357972" LOG_EFFECT_SIZE="-0.2218487496163564" MODIFIED="2013-11-23 18:30:53 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1217" O_E="0.0" SE="1.6090024514862893" STUDY_ID="STD-Oka-1980" TOTAL_1="19" TOTAL_2="35" VAR="2.588888888888889" WEIGHT="34.752155172413794"/></DICH_SUBGROUP><DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-005.04.02" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2013-11-23 18:31:04 +0000" MODIFIED_BY="Hermann Blessberger" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="40" TOTAL_2="45" WEIGHT="0.0" Z="0.0"><NAME>Sotalol</NAME><DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-11-23 18:31:04 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1218" O_E="0.0" SE="0.0" STUDY_ID="STD-Gomes-1999" TOTAL_1="40" TOTAL_2="45" VAR="0.0" WEIGHT="0.0"/></DICH_SUBGROUP><DICH_SUBGROUP CHI2="0.0" CI_END="66.4433184667098" CI_START="0.12341968180365896" DF="0" EFFECT_SIZE="2.8636363636363638" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" I2="0.0" ID="CMP-005.04.03" LOG_CI_END="1.8224513148659036" LOG_CI_START="-0.9086155776031525" LOG_EFFECT_SIZE="0.4569178686313755" MODIFIED="2013-11-23 18:31:12 +0000" MODIFIED_BY="Hermann Blessberger" NO="3" P_CHI2="1.0" P_Z="0.5119406943006533" STUDIES="1" TAU2="0.0" TOTAL_1="21" TOTAL_2="20" WEIGHT="16.594827586206897" Z="0.6558188441885238"><NAME>Timolol</NAME><DICH_DATA CI_END="66.4433184667098" CI_START="0.12341968180365896" EFFECT_SIZE="2.8636363636363638" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.8224513148659036" LOG_CI_START="-0.9086155776031525" LOG_EFFECT_SIZE="0.4569178686313755" MODIFIED="2013-11-23 18:31:12 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1219" O_E="0.0" SE="1.6042422116354729" STUDY_ID="STD-White-1984" TOTAL_1="21" TOTAL_2="20" VAR="2.5735930735930737" WEIGHT="16.594827586206897"/></DICH_SUBGROUP><DICH_SUBGROUP CHI2="0.0" CI_END="8.044961518532196" CI_START="0.013811266947039826" DF="0" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" I2="0.0" ID="CMP-005.04.04" LOG_CI_END="0.9055239710790393" LOG_CI_START="-1.8597664805183645" LOG_EFFECT_SIZE="-0.47712125471966244" MODIFIED="2013-11-23 18:31:25 +0000" MODIFIED_BY="Hermann Blessberger" NO="4" P_CHI2="1.0" P_Z="0.49882379491619766" STUDIES="1" TAU2="0.0" TOTAL_1="70" TOTAL_2="70" WEIGHT="48.65301724137931" Z="0.6763415936788156"><NAME>Landiolol</NAME><DICH_DATA CI_END="8.044961518532196" CI_START="0.013811266947039826" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.9055239710790393" LOG_CI_START="-1.8597664805183645" LOG_EFFECT_SIZE="-0.47712125471966244" MODIFIED="2013-11-23 18:31:25 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1220" O_E="0.0" SE="1.6243452996768142" STUDY_ID="STD-Sezai-2011" TOTAL_1="70" TOTAL_2="70" VAR="2.6384976525821595" WEIGHT="48.65301724137931"/></DICH_SUBGROUP></DICH_OUTCOME><DICH_OUTCOME CHI2="1.528225300304444" CI_END="1.7547214489383616" CI_START="0.9052084742356211" CI_STUDY="95" CI_TOTAL="95" DF="3" EFFECT_MEASURE="RR" EFFECT_SIZE="1.260312947446789" ESTIMABLE="YES" EVENTS_1="77" EVENTS_2="61" I2="0.0" I2_Q="0.0" ID="CMP-005.05" LOG_CI_END="0.2442081847389605" LOG_CI_START="-0.04325138898979946" LOG_EFFECT_SIZE="0.10047839787458049" METHOD="MH" MODIFIED="2017-06-17 15:46:57 +0100" MODIFIED_BY="Hermann Blessberger" NO="5" P_CHI2="0.6757714682629976" P_Q="0.6512402567305096" P_Z="0.17063427719403051" Q="0.8577533534046997" RANDOM="NO" SCALE="100.0" SORT_BY="YEAR" STUDIES="4" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="4716" TOTAL_2="4731" WEIGHT="99.99999999999999" Z="1.3701686014763663"><NAME>Death due to cardiac causes&#8212;non-cardiac surgery</NAME><GROUP_LABEL_1>Beta-blocker</GROUP_LABEL_1><GROUP_LABEL_2>Control</GROUP_LABEL_2><GRAPH_LABEL_1>Favours beta-blocker</GRAPH_LABEL_1><GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2><DICH_SUBGROUP CHI2="0.6685806500905314" CI_END="1.7793918318630264" CI_START="0.9066186549966629" DF="1" EFFECT_SIZE="1.2701298474233669" ESTIMABLE="YES" EVENTS_1="75" EVENTS_2="59" I2="0.0" ID="CMP-005.05.01" LOG_CI_END="0.2502715926473541" LOG_CI_START="-0.042575348945147785" LOG_EFFECT_SIZE="0.10384812185110316" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" NO="1" P_CHI2="0.4135472180328764" P_Z="0.16450823455702748" STUDIES="2" TAU2="0.0" TOTAL_1="4420" TOTAL_2="4427" WEIGHT="96.00815118910658" Z="1.3900679828407718"><NAME>Metoprolol</NAME><DICH_DATA CI_END="8.274975487492005" CI_START="0.013865780185584986" EFFECT_SIZE="0.33873144399460187" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.9177667159628347" LOG_CI_START="-1.8580556889594146" LOG_EFFECT_SIZE="-0.47014448649829005" MODIFIED="2013-11-23 18:35:32 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1222" O_E="0.0" SE="1.6305318211938382" STUDY_ID="STD-Yang-2006" TOTAL_1="246" TOTAL_2="250" VAR="2.658634019925695" WEIGHT="2.402260471493904"/><DICH_DATA CI_END="1.8180790761671433" CI_START="0.9210386011859882" EFFECT_SIZE="1.2940328470168365" ESTIMABLE="YES" EVENTS_1="75" EVENTS_2="58" LOG_CI_END="0.2596127686528247" LOG_CI_START="-0.035722167923927406" LOG_EFFECT_SIZE="0.11194530036444864" MODIFIED="2013-11-23 18:35:43 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1221" O_E="0.0" SE="0.17348120367669792" STUDY_ID="STD-POISE-2008" TOTAL_1="4174" TOTAL_2="4177" VAR="0.03009572802911595" WEIGHT="93.60589071761268"/></DICH_SUBGROUP><DICH_SUBGROUP CHI2="0.0" CI_END="5.535882382109476" CI_START="0.04700299293694875" DF="0" EFFECT_SIZE="0.51010101010101" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" I2="0.0" ID="CMP-005.05.02" LOG_CI_END="0.7431868543274104" LOG_CI_START="-1.3278744872851878" LOG_EFFECT_SIZE="-0.2923438164788886" MODIFIED="2013-11-23 18:36:04 +0000" MODIFIED_BY="Hermann Blessberger" NO="2" P_CHI2="1.0" P_Z="0.5800419831958323" STUDIES="1" TAU2="0.0" TOTAL_1="99" TOTAL_2="101" WEIGHT="3.1966598047393378" Z="0.5533233998327299"><NAME>Atenolol</NAME><DICH_DATA CI_END="5.535882382109476" CI_START="0.04700299293694875" EFFECT_SIZE="0.51010101010101" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" LOG_CI_END="0.7431868543274104" LOG_CI_START="-1.3278744872851878" LOG_EFFECT_SIZE="-0.2923438164788886" MODIFIED="2013-11-23 18:36:04 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1223" O_E="0.0" SE="1.216551683982222" STUDY_ID="STD-Mangano-1996" TOTAL_1="99" TOTAL_2="101" VAR="1.47999799979998" WEIGHT="3.1966598047393378"/></DICH_SUBGROUP><DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-005.05.03" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2017-06-17 15:46:57 +0100" MODIFIED_BY="Hermann Blessberger" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0"><NAME>Esmolol</NAME></DICH_SUBGROUP><DICH_SUBGROUP CHI2="0.0" CI_END="75.42168546066148" CI_START="0.1266707174456808" DF="0" EFFECT_SIZE="3.090909090909091" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" I2="0.0" ID="CMP-005.05.04" LOG_CI_END="1.8774962334274081" LOG_CI_START="-0.8973237696593478" LOG_EFFECT_SIZE="0.49008623188403005" MODIFIED="2013-11-26 21:58:54 +0000" MODIFIED_BY="Hermann Blessberger" NO="4" P_CHI2="1.0" P_Z="0.48872749560042816" STUDIES="1" TAU2="0.0" TOTAL_1="197" TOTAL_2="203" WEIGHT="0.7951890061540641" Z="0.6923341786084224"><NAME>Bisoprolol</NAME><DICH_DATA CI_END="75.42168546066148" CI_START="0.12667071744568087" EFFECT_SIZE="3.090909090909091" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.8774962334274081" LOG_CI_START="-0.8973237696593477" LOG_EFFECT_SIZE="0.49008623188403005" MODIFIED="2013-11-23 18:36:34 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1226" O_E="0.0" SE="1.6299430053937" STUDY_ID="STD-Marwick-2009" TOTAL_1="197" TOTAL_2="203" VAR="2.6567142008318476" WEIGHT="0.7951890061540641"/></DICH_SUBGROUP></DICH_OUTCOME><DICH_OUTCOME CHI2="9.51107551792549" CI_END="1.4753341512844493" CI_START="0.6742860634465437" CI_STUDY="95" CI_TOTAL="95" DF="18" EFFECT_MEASURE="RR" EFFECT_SIZE="0.9973952361716186" ESTIMABLE="YES" EVENTS_1="44" EVENTS_2="48" I2="0.0" I2_Q="0.0" ID="CMP-005.06" LOG_CI_END="0.1688903956521174" LOG_CI_START="-0.1711558164924411" LOG_EFFECT_SIZE="-0.0011327104201618837" METHOD="MH" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" NO="6" P_CHI2="0.946702673441157" P_Q="0.4331245913353776" P_Z="0.989581942224507" Q="5.911959147148043" RANDOM="NO" SCALE="100.0" SORT_BY="YEAR" STUDIES="21" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="1613" TOTAL_2="1697" WEIGHT="100.0" Z="0.013057470126952863"><NAME>Acute myocardial infarction&#8212;cardiac surgery</NAME><GROUP_LABEL_1>Beta-blocker</GROUP_LABEL_1><GROUP_LABEL_2>Control</GROUP_LABEL_2><GRAPH_LABEL_1>Favours beta-blocker</GRAPH_LABEL_1><GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2><DICH_SUBGROUP CHI2="0.0" CI_END="4.396259097660198" CI_START="0.9098644804918122" DF="1" EFFECT_SIZE="2.0" ESTIMABLE="YES" EVENTS_1="18" EVENTS_2="9" I2="0.0" ID="CMP-005.06.01" LOG_CI_END="0.6430832800590414" LOG_CI_START="-0.04102328873107911" LOG_EFFECT_SIZE="0.3010299956639812" MODIFIED="2013-11-23 18:42:04 +0000" MODIFIED_BY="Hermann Blessberger" NO="1" P_CHI2="1.0" P_Z="0.08454536937195127" STUDIES="2" TAU2="0.0" TOTAL_1="600" TOTAL_2="600" WEIGHT="18.662173570701043" Z="1.7249007002260268"><NAME>Metoprolol</NAME><DICH_DATA CI_END="6.429716840797003" CI_START="0.6221113773813055" EFFECT_SIZE="2.0" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="4" LOG_CI_END="0.8081918473896704" LOG_CI_START="-0.20613185606170806" LOG_EFFECT_SIZE="0.3010299956639812" MODIFIED="2013-11-23 18:41:55 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1229" O_E="0.0" SE="0.5958187643906492" STUDY_ID="STD-Wenke-1999" TOTAL_1="100" TOTAL_2="100" VAR="0.355" WEIGHT="8.29429936475602"/><DICH_DATA CI_END="5.80943240846048" CI_START="0.6885354228710294" EFFECT_SIZE="2.0" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="5" LOG_CI_END="0.7641337031450597" LOG_CI_START="-0.16207371181709732" LOG_EFFECT_SIZE="0.3010299956639812" MODIFIED="2013-11-23 18:42:04 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1228" O_E="0.0" SE="0.5440588203494178" STUDY_ID="STD-Connolly-2003" TOTAL_1="500" TOTAL_2="500" VAR="0.29600000000000004" WEIGHT="10.367874205945025"/></DICH_SUBGROUP><DICH_SUBGROUP CHI2="4.072856793991864" CI_END="1.2060745523819876" CI_START="0.4099826745007661" DF="10" EFFECT_SIZE="0.7031853743024534" ESTIMABLE="YES" EVENTS_1="19" EVENTS_2="32" I2="0.0" ID="CMP-005.06.02" LOG_CI_END="0.08137415414525268" LOG_CI_START="-0.3872344957868445" LOG_EFFECT_SIZE="-0.15293017082079594" MODIFIED="2014-06-22 17:25:35 +0100" MODIFIED_BY="Hermann Blessberger" NO="2" P_CHI2="0.9440004628749024" P_Z="0.20080332125254585" STUDIES="11" TAU2="0.0" TOTAL_1="504" TOTAL_2="584" WEIGHT="63.7009924975885" Z="1.279266300362792"><NAME>Propranolol</NAME><DICH_DATA CI_END="3.8257633571979164" CI_START="0.22994486153744298" EFFECT_SIZE="0.9379310344827586" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="5" LOG_CI_END="0.5827181032130841" LOG_CI_START="-0.6383762909425988" LOG_EFFECT_SIZE="-0.027829093864757383" MODIFIED="2013-11-23 18:42:20 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1240" O_E="0.0" SE="0.717276891641784" STUDY_ID="STD-Stephenson-1980" TOTAL_1="87" TOTAL_2="136" VAR="0.5144861392832996" WEIGHT="8.08973144320374"/><DICH_DATA CI_END="3.5279536888293985" CI_START="0.011338017312033452" EFFECT_SIZE="0.2" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="4" LOG_CI_END="0.5475228755476929" LOG_CI_START="-1.9454628842197306" LOG_EFFECT_SIZE="-0.6989700043360187" MODIFIED="2013-11-23 18:42:27 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1238" O_E="0.0" SE="1.46439217576592" STUDY_ID="STD-Oka-1980" TOTAL_1="19" TOTAL_2="35" VAR="2.144444444444445" WEIGHT="6.665061989536087"/><DICH_DATA CI_END="5.214575411505864" CI_START="0.012754575404951726" EFFECT_SIZE="0.2578947368421053" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" LOG_CI_END="0.7172189524659107" LOG_CI_START="-1.8943339943145414" LOG_EFFECT_SIZE="-0.5885575209243152" MODIFIED="2013-11-23 18:42:35 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1236" O_E="0.0" SE="1.5340391283344144" STUDY_ID="STD-Mohr-1981" TOTAL_1="37" TOTAL_2="48" VAR="2.35327604726101" WEIGHT="4.528496779608172"/><DICH_DATA CI_END="2.554588535140364" CI_START="0.2718419952535674" EFFECT_SIZE="0.8333333333333334" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="6" LOG_CI_END="0.4073209587531089" LOG_CI_START="-0.5656834508483586" LOG_EFFECT_SIZE="-0.0791812460476248" MODIFIED="2013-11-23 18:42:43 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1239" O_E="0.0" SE="0.5715476066494082" STUDY_ID="STD-Silverman-1982" TOTAL_1="50" TOTAL_2="50" VAR="0.32666666666666666" WEIGHT="12.441449047134029"/><DICH_DATA CI_END="6.823446325509919" CI_START="0.14655350863704047" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="2" LOG_CI_END="0.8340037796584007" LOG_CI_START="-0.8340037796584007" LOG_EFFECT_SIZE="0.0" MODIFIED="2014-06-22 17:25:35 +0100" MODIFIED_BY="Hermann Blessberger" ORDER="1230" O_E="0.0" SE="0.9797958971132712" STUDY_ID="STD-Abel-1983" TOTAL_1="50" TOTAL_2="50" VAR="0.96" WEIGHT="4.14714968237801"/><DICH_DATA CI_END="18.464793725803222" CI_START="0.08462049580421353" EFFECT_SIZE="1.25" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.2663444604166862" LOG_CI_START="-1.0725244344005735" LOG_EFFECT_SIZE="0.09691001300805642" MODIFIED="2013-11-23 18:42:59 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1237" O_E="0.0" SE="1.3738631664034087" STUDY_ID="STD-Myhre-1984" TOTAL_1="16" TOTAL_2="20" VAR="1.8875" WEIGHT="1.8431776366124488"/><DICH_DATA CI_END="4.283442722425353" CI_START="0.010892173194178404" EFFECT_SIZE="0.216" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" LOG_CI_END="0.6317929639528874" LOG_CI_START="-1.9628854616510256" LOG_EFFECT_SIZE="-0.6655462488490691" MODIFIED="2013-11-23 18:43:06 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1233" O_E="0.0" SE="1.5241269510650886" STUDY_ID="STD-Hammon-1984" TOTAL_1="24" TOTAL_2="26" VAR="2.3229629629629627" WEIGHT="4.984554906704338"/><DICH_DATA CI_END="2.8734486028922372" CI_START="0.22272888380735792" EFFECT_SIZE="0.8" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="5" LOG_CI_END="0.45840343335420675" LOG_CI_START="-0.6522234593703196" LOG_EFFECT_SIZE="-0.09691001300805639" MODIFIED="2013-11-23 18:43:15 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1235" O_E="0.0" SE="0.6523877344781713" STUDY_ID="STD-Matangi-1985" TOTAL_1="82" TOTAL_2="82" VAR="0.42560975609756097" WEIGHT="10.367874205945025"/><DICH_DATA CI_END="24.14022199893455" CI_START="0.21642260771872576" EFFECT_SIZE="2.2857142857142856" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="1" LOG_CI_END="1.3827412596498534" LOG_CI_START="-0.6646973743665175" LOG_EFFECT_SIZE="0.3590219426416679" MODIFIED="2013-11-23 18:43:36 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1234" O_E="0.0" SE="1.2026755886059097" STUDY_ID="STD-Martinussen-1988" TOTAL_1="35" TOTAL_2="40" VAR="1.4464285714285716" WEIGHT="1.9353365184430713"/><DICH_DATA CI_END="17.222250445333504" CI_START="0.07299374868245567" EFFECT_SIZE="1.121212121212121" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.2360899004353734" LOG_CI_START="-1.1367143320571584" LOG_EFFECT_SIZE="0.04968778418910748" MODIFIED="2013-11-23 18:43:52 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1231" O_E="0.0" SE="1.393796951736494" STUDY_ID="STD-Babin_x002d_Ebell-1996" TOTAL_1="33" TOTAL_2="37" VAR="1.9426699426699428" WEIGHT="1.9550848502639189"/><DICH_DATA CI_END="2.6378743799535904" CI_START="0.03008078627713564" EFFECT_SIZE="0.28169014084507044" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="3" LOG_CI_END="0.4212541098638801" LOG_CI_START="-1.5217108159740682" LOG_EFFECT_SIZE="-0.5502283530550941" MODIFIED="2013-11-23 18:43:58 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1232" O_E="0.0" SE="1.141307215268708" STUDY_ID="STD-Bert-2001" TOTAL_1="71" TOTAL_2="60" VAR="1.3025821596244131" WEIGHT="6.743075437759664"/></DICH_SUBGROUP><DICH_SUBGROUP CHI2="0.31975138152757665" CI_END="4.163598014976206" CI_START="0.0784251051783547" DF="1" EFFECT_SIZE="0.5714285714285714" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" I2="0.0" ID="CMP-005.06.03" LOG_CI_END="0.619468792811362" LOG_CI_START="-1.105544890183951" LOG_EFFECT_SIZE="-0.24303804868629447" MODIFIED="2013-11-23 18:44:34 +0000" MODIFIED_BY="Hermann Blessberger" NO="3" P_CHI2="0.5717572205997631" P_Z="0.5807561015875977" STUDIES="4" TAU2="0.0" TOTAL_1="323" TOTAL_2="320" WEIGHT="5.347640379908487" Z="0.5522806305755241"><NAME>Sotalol</NAME><DICH_DATA CI_END="15.840228937301898" CI_START="0.06313040070053004" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.199761454115117" LOG_CI_START="-1.199761454115117" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-11-23 18:44:11 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1244" O_E="0.0" SE="1.4094916341243984" STUDY_ID="STD-Suttorp-1991" TOTAL_1="150" TOTAL_2="150" VAR="1.9866666666666668" WEIGHT="2.073574841189005"/><DICH_DATA CI_END="6.907791933318855" CI_START="0.013028765323097881" EFFECT_SIZE="0.3" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.8393392478918953" LOG_CI_START="-1.8850967384525705" LOG_EFFECT_SIZE="-0.5228787452803376" MODIFIED="2013-11-23 18:44:16 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1243" O_E="0.0" SE="1.600347184554374" STUDY_ID="STD-Jacquet-1994" TOTAL_1="19" TOTAL_2="17" VAR="2.5611111111111113" WEIGHT="3.2740655387194817"/><DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-11-23 18:44:23 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1241" O_E="0.0" SE="0.0" STUDY_ID="STD-Evrard-2000" TOTAL_1="103" TOTAL_2="103" VAR="0.0" WEIGHT="0.0"/><DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-11-23 18:44:34 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1242" O_E="0.0" SE="0.0" STUDY_ID="STD-Forlani-2002" TOTAL_1="51" TOTAL_2="50" VAR="0.0" WEIGHT="0.0"/></DICH_SUBGROUP><DICH_SUBGROUP CHI2="0.0" CI_END="5.525756215095863" CI_START="0.3217256984521051" DF="0" EFFECT_SIZE="1.3333333333333333" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="3" I2="0.0" ID="CMP-005.06.04" LOG_CI_END="0.7423917208312917" LOG_CI_START="-0.4925142476146919" LOG_EFFECT_SIZE="0.12493873660829993" MODIFIED="2013-11-23 18:44:43 +0000" MODIFIED_BY="Hermann Blessberger" NO="4" P_CHI2="1.0" P_Z="0.6916701334814933" STUDIES="1" TAU2="0.0" TOTAL_1="35" TOTAL_2="35" WEIGHT="6.220724523567014" Z="0.39658958703448033"><NAME>Atenolol</NAME><DICH_DATA CI_END="5.525756215095862" CI_START="0.3217256984521052" EFFECT_SIZE="1.3333333333333333" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="3" LOG_CI_END="0.7423917208312917" LOG_CI_START="-0.4925142476146918" LOG_EFFECT_SIZE="0.12493873660829993" MODIFIED="2013-11-23 18:44:43 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1245" O_E="0.0" SE="0.7253898787483019" STUDY_ID="STD-Matangi-1989" TOTAL_1="35" TOTAL_2="35" VAR="0.5261904761904761" WEIGHT="6.220724523567014"/></DICH_SUBGROUP><DICH_SUBGROUP CHI2="0.0" CI_END="15.548273108710726" CI_START="0.06431582420814068" DF="0" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" I2="0.0" ID="CMP-005.06.05" LOG_CI_END="1.1916821605007981" LOG_CI_START="-1.1916821605007981" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-11-23 18:44:50 +0000" MODIFIED_BY="Hermann Blessberger" NO="5" P_CHI2="1.0" P_Z="1.0" STUDIES="1" TAU2="0.0" TOTAL_1="50" TOTAL_2="50" WEIGHT="2.073574841189005" Z="0.0"><NAME>Acebutolol</NAME><DICH_DATA CI_END="15.548273108710726" CI_START="0.06431582420814068" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.1916821605007981" LOG_CI_START="-1.1916821605007981" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-11-23 18:44:50 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1246" O_E="0.0" SE="1.4" STUDY_ID="STD-Daudon-1986" TOTAL_1="50" TOTAL_2="50" VAR="1.96" WEIGHT="2.073574841189005"/></DICH_SUBGROUP><DICH_SUBGROUP CHI2="1.868539894026882E-32" CI_END="8.87381418150329" CI_START="0.015231822201475696" DF="0" EFFECT_SIZE="0.3676470588235295" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" I2="99.99999999999999" ID="CMP-005.06.06" LOG_CI_END="0.9481103303087891" LOG_CI_START="-1.8172481383771866" LOG_EFFECT_SIZE="-0.4345689040341986" MODIFIED="2013-11-23 18:45:35 +0000" MODIFIED_BY="Hermann Blessberger" NO="6" P_CHI2="0.0" P_Z="0.5378902308770543" STUDIES="1" TAU2="0.0" TOTAL_1="67" TOTAL_2="74" WEIGHT="2.958106766451448" Z="0.6160065035711599"><NAME>Nadolol</NAME><DICH_DATA CI_END="8.873814181503294" CI_START="0.015231822201475684" EFFECT_SIZE="0.36764705882352944" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.9481103303087892" LOG_CI_START="-1.8172481383771868" LOG_EFFECT_SIZE="-0.4345689040341987" MODIFIED="2013-11-23 18:45:35 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1247" O_E="0.0" SE="1.6243852532513314" STUDY_ID="STD-Khuri-1987" TOTAL_1="67" TOTAL_2="74" VAR="2.638627450980392" WEIGHT="2.958106766451448"/></DICH_SUBGROUP><DICH_SUBGROUP CHI2="0.0" CI_END="71.14657198220529" CI_START="0.1264994187246438" DF="0" EFFECT_SIZE="3.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" I2="0.0" ID="CMP-005.06.07" LOG_CI_END="1.8521539795421889" LOG_CI_START="-0.8979114701028642" LOG_EFFECT_SIZE="0.47712125471966244" MODIFIED="2013-11-24 05:51:14 +0000" MODIFIED_BY="Hermann Blessberger" NO="7" P_CHI2="1.0" P_Z="0.49645002695858653" STUDIES="1" TAU2="0.0" TOTAL_1="34" TOTAL_2="34" WEIGHT="1.0367874205945025" Z="0.6800859780481203"><NAME>Landiolol</NAME><DICH_DATA CI_END="71.14657198220529" CI_START="0.1264994187246438" EFFECT_SIZE="3.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.8521539795421889" LOG_CI_START="-0.8979114701028642" LOG_EFFECT_SIZE="0.47712125471966244" MODIFIED="2013-11-24 05:51:14 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1503" O_E="0.0" SE="1.6154020581650284" STUDY_ID="STD-Sezai-2012" TOTAL_1="34" TOTAL_2="34" VAR="2.6095238095238096" WEIGHT="1.0367874205945025"><FOOTNOTE>Only patients in the landiolol subgroup considered.</FOOTNOTE></DICH_DATA></DICH_SUBGROUP></DICH_OUTCOME><DICH_OUTCOME CHI2="6.269793019097788" CI_END="0.870120324877404" CI_START="0.6077471038709279" CI_STUDY="95" CI_TOTAL="95" DF="10" EFFECT_MEASURE="RR" EFFECT_SIZE="0.7271953709034961" ESTIMABLE="YES" EVENTS_1="194" EVENTS_2="266" I2="0.0" I2_Q="6.519407981354492" ID="CMP-005.07" LOG_CI_END="-0.06042068667221275" LOG_CI_START="-0.21627710204591297" LOG_EFFECT_SIZE="-0.13834889435906284" METHOD="MH" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" NO="7" P_CHI2="0.7921099759304913" P_Q="0.3604784022297025" P_Z="5.021663179354677E-4" Q="3.2092222944005577" RANDOM="NO" SCALE="100.0" SORT_BY="YEAR" STUDIES="13" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="5433" TOTAL_2="5397" WEIGHT="100.0" Z="3.4795981877876065"><NAME>Acute myocardial infarction&#8212;non-cardiac surgery</NAME><GROUP_LABEL_1>Beta-blocker</GROUP_LABEL_1><GROUP_LABEL_2>Control</GROUP_LABEL_2><GRAPH_LABEL_1>Favours beta-blocker</GRAPH_LABEL_1><GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2><DICH_SUBGROUP CHI2="2.3518444011595685" CI_END="0.8846203755357788" CI_START="0.6072765970321845" DF="5" EFFECT_SIZE="0.7329455991550129" ESTIMABLE="YES" EVENTS_1="179" EVENTS_2="244" I2="0.0" ID="CMP-005.07.01" LOG_CI_END="-0.05324306170975203" LOG_CI_START="-0.21661345521141254" LOG_EFFECT_SIZE="-0.1349282584605823" MODIFIED="2014-06-22 17:32:39 +0100" MODIFIED_BY="Hermann Blessberger" NO="1" P_CHI2="0.7986231900929411" P_Z="0.0012058865195856627" STUDIES="7" TAU2="0.0" TOTAL_1="5034" TOTAL_2="5028" WEIGHT="91.0664067298528" Z="3.23748411705656"><NAME>Metoprolol</NAME><DICH_DATA CI_END="65.33683949785127" CI_START="0.12362952338910503" EFFECT_SIZE="2.8421052631578947" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.8151581227650624" LOG_CI_START="-0.9078778050247834" LOG_EFFECT_SIZE="0.45364015887013953" MODIFIED="2013-11-23 18:50:01 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1249" O_E="0.0" SE="1.5995247832289885" STUDY_ID="STD-Jakobsen-1997" TOTAL_1="18" TOTAL_2="17" VAR="2.5584795321637426" WEIGHT="0.19107761689848266"/><DICH_DATA CI_END="1.9689060372965594" CI_START="0.1260175766811152" EFFECT_SIZE="0.4981132075471698" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="5" LOG_CI_END="0.29422499066461516" LOG_CI_START="-0.8995688761265311" LOG_EFFECT_SIZE="-0.302671942730958" MODIFIED="2013-11-23 18:50:08 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1250" O_E="0.0" SE="0.7012404267280651" STUDY_ID="STD-POBBLE-2005" TOTAL_1="53" TOTAL_2="44" VAR="0.49173813607775874" WEIGHT="2.0331156089957925"/><DICH_DATA CI_END="1.6671769426996792" CI_START="0.5071036310519903" EFFECT_SIZE="0.9194734804490902" ESTIMABLE="YES" EVENTS_1="19" EVENTS_2="21" LOG_CI_END="0.22198169530492604" LOG_CI_START="-0.29490327972978975" LOG_EFFECT_SIZE="-0.03646079221243184" MODIFIED="2013-11-23 18:50:24 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1252" O_E="0.0" SE="0.3036207929572834" STUDY_ID="STD-Yang-2006" TOTAL_1="246" TOTAL_2="250" VAR="0.09218558591600953" WEIGHT="7.751052175129409"/><DICH_DATA CI_END="8.877109838397404" CI_START="0.250179859646748" EFFECT_SIZE="1.4902597402597402" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="2" LOG_CI_END="0.9482715935329684" LOG_CI_START="-0.6017476554593345" LOG_EFFECT_SIZE="0.17326196903681695" MODIFIED="2013-11-23 18:50:35 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1248" O_E="0.0" SE="0.9104889795771052" STUDY_ID="STD-DIPOM-_x002d_-Juul-2006" TOTAL_1="462" TOTAL_2="459" VAR="0.8289901819313583" WEIGHT="0.7466211288102549"/><DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-11-23 18:50:15 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1254" O_E="0.0" SE="0.0" STUDY_ID="STD-Lai-2006" TOTAL_1="30" TOTAL_2="30" VAR="0.0" WEIGHT="0.0"/><DICH_DATA CI_END="15.556810748046935" CI_START="0.06428052742915473" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.1919205684576701" LOG_CI_START="-1.1919205684576701" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-11-23 18:53:00 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1253" O_E="0.0" SE="1.4002800840280099" STUDY_ID="STD-Yang-2008" TOTAL_1="51" TOTAL_2="51" VAR="1.9607843137254903" WEIGHT="0.3720985171180978"/><DICH_DATA CI_END="0.8669144321966489" CI_START="0.5773751446800002" EFFECT_SIZE="0.7074848731349105" ESTIMABLE="YES" EVENTS_1="152" EVENTS_2="215" LOG_CI_END="-0.06202376695142708" LOG_CI_START="-0.23854191591886673" LOG_EFFECT_SIZE="-0.1502828414351469" MODIFIED="2014-06-22 17:32:39 +0100" MODIFIED_BY="Hermann Blessberger" ORDER="1251" O_E="0.0" SE="0.10368763448240352" STUDY_ID="STD-POISE-2008" TOTAL_1="4174" TOTAL_2="4177" VAR="0.010751125544556516" WEIGHT="79.97244168290077"/></DICH_SUBGROUP><DICH_SUBGROUP CHI2="1.6459025101813385" CI_END="0.9948122314190563" CI_START="0.10861970242842528" DF="2" EFFECT_SIZE="0.3287190419627309" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="9" I2="0.0" ID="CMP-005.07.02" LOG_CI_END="-0.002258883630141867" LOG_CI_START="-0.964091391323081" LOG_EFFECT_SIZE="-0.48317513747661145" MODIFIED="2014-06-22 17:33:03 +0100" MODIFIED_BY="Hermann Blessberger" NO="2" P_CHI2="0.4391339726512209" P_Z="0.048933570720566026" STUDIES="3" TAU2="0.0" TOTAL_1="157" TOTAL_2="140" WEIGHT="3.897505625608823" Z="1.9691700168272446"><NAME>Atenolol</NAME><DICH_DATA CI_END="5.535882382109476" CI_START="0.04700299293694875" EFFECT_SIZE="0.51010101010101" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" LOG_CI_END="0.7431868543274104" LOG_CI_START="-1.3278744872851878" LOG_EFFECT_SIZE="-0.2923438164788886" MODIFIED="2013-11-23 18:53:35 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1256" O_E="0.0" SE="1.216551683982222" STUDY_ID="STD-Wallace-1998" TOTAL_1="99" TOTAL_2="101" VAR="1.47999799979998" WEIGHT="0.7367550638938337"/><DICH_DATA CI_END="1.2850770513332368" CI_START="0.0037789141856547637" EFFECT_SIZE="0.06968641114982578" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="3" LOG_CI_END="0.10892916810749446" LOG_CI_START="-2.4226329702475167" LOG_EFFECT_SIZE="-1.1568519010700111" MODIFIED="2014-06-22 17:33:03 +0100" MODIFIED_BY="Hermann Blessberger" ORDER="1257" O_E="0.0" SE="1.4870521315044227" STUDY_ID="STD-Zaugg-1999" TOTAL_1="40" TOTAL_2="19" VAR="2.2113240418118467" WEIGHT="1.750693023162198"/><DICH_DATA CI_END="2.6794711630264745" CI_START="0.11518764581889715" EFFECT_SIZE="0.5555555555555556" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="4" LOG_CI_END="0.428049087445737" LOG_CI_START="-0.9385940976523491" LOG_EFFECT_SIZE="-0.25527250510330607" MODIFIED="2013-11-23 18:53:46 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1255" O_E="0.0" SE="0.8027729719194864" STUDY_ID="STD-Neary-2006" TOTAL_1="18" TOTAL_2="20" VAR="0.6444444444444444" WEIGHT="1.4100575385527916"/></DICH_SUBGROUP><DICH_SUBGROUP CHI2="0.0" CI_END="5.61570090466871" CI_START="0.011129510111202603" DF="0" EFFECT_SIZE="0.25" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" I2="0.0" ID="CMP-005.07.03" LOG_CI_END="0.7494039689737729" LOG_CI_START="-1.9535239516296976" LOG_EFFECT_SIZE="-0.6020599913279624" MODIFIED="2013-11-23 18:53:57 +0000" MODIFIED_BY="Hermann Blessberger" NO="3" P_CHI2="1.0" P_Z="0.3825873244207373" STUDIES="2" TAU2="0.0" TOTAL_1="45" TOTAL_2="26" WEIGHT="0.6378831722024534" Z="0.8731390064385045"><NAME>Esmolol</NAME><DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-11-23 18:53:52 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1258" O_E="0.0" SE="0.0" STUDY_ID="STD-Miller-1990" TOTAL_1="30" TOTAL_2="15" VAR="0.0" WEIGHT="0.0"/><DICH_DATA CI_END="5.615700904668708" CI_START="0.011129510111202603" EFFECT_SIZE="0.25" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.7494039689737728" LOG_CI_START="-1.9535239516296976" LOG_EFFECT_SIZE="-0.6020599913279624" MODIFIED="2013-11-23 18:53:57 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1259" O_E="0.0" SE="1.5877132402714706" STUDY_ID="STD-Raby-1999" TOTAL_1="15" TOTAL_2="11" VAR="2.520833333333333" WEIGHT="0.6378831722024534"/></DICH_SUBGROUP><DICH_SUBGROUP CHI2="0.0" CI_END="2.2384256247346914" CI_START="0.47436971491585606" DF="0" EFFECT_SIZE="1.0304568527918783" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="12" I2="0.0" ID="CMP-005.07.04" LOG_CI_END="0.34994266883162384" LOG_CI_START="-0.3238830453283838" LOG_EFFECT_SIZE="0.013029811751620029" MODIFIED="2013-11-26 21:58:54 +0000" MODIFIED_BY="Hermann Blessberger" NO="4" P_CHI2="1.0" P_Z="0.9395782936016867" STUDIES="1" TAU2="0.0" TOTAL_1="197" TOTAL_2="203" WEIGHT="4.398204472335917" Z="0.0757999026212518"><NAME>Bisoprolol</NAME><DICH_DATA CI_END="2.2384256247346914" CI_START="0.47436971491585606" EFFECT_SIZE="1.0304568527918783" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="12" LOG_CI_END="0.34994266883162384" LOG_CI_START="-0.3238830453283838" LOG_EFFECT_SIZE="0.013029811751620029" MODIFIED="2013-11-23 18:54:15 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1261" O_E="0.0" SE="0.3958085599886677" STUDY_ID="STD-Marwick-2009" TOTAL_1="197" TOTAL_2="203" VAR="0.15666441616030274" WEIGHT="4.398204472335917"/></DICH_SUBGROUP></DICH_OUTCOME><DICH_OUTCOME CHI2="4.633163091469021" CI_END="0.8287009045637324" CI_START="0.48320842177028106" CI_STUDY="95" CI_TOTAL="95" DF="8" EFFECT_MEASURE="RR" EFFECT_SIZE="0.6327995387275858" ESTIMABLE="YES" EVENTS_1="58" EVENTS_2="86" I2="0.0" I2_Q="0.0" ID="CMP-005.08" LOG_CI_END="-0.08160218710438348" LOG_CI_START="-0.3158655050647237" LOG_EFFECT_SIZE="-0.19873384608455363" METHOD="MH" MODIFIED="2017-06-17 15:47:14 +0100" MODIFIED_BY="Hermann Blessberger" NO="8" P_CHI2="0.7959674796096601" P_Q="0.9694950083778792" P_Z="8.828754255352955E-4" Q="0.5399705574174728" RANDOM="YES" SCALE="100.0" SORT_BY="YEAR" STUDIES="13" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="463" TOTAL_2="387" WEIGHT="100.0" Z="3.3254133359521028"><NAME>Myocardial ischaemia&#8212;non-cardiac surgery</NAME><GROUP_LABEL_1>Beta-blocker</GROUP_LABEL_1><GROUP_LABEL_2>Control</GROUP_LABEL_2><GRAPH_LABEL_1>Favours beta-blocker</GRAPH_LABEL_1><GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2><DICH_SUBGROUP CHI2="2.626560658965087" CI_END="1.058301686869646" CI_START="0.39068132907895226" DF="3" EFFECT_SIZE="0.6430075501833011" ESTIMABLE="YES" EVENTS_1="20" EVENTS_2="27" I2="0.0" ID="CMP-005.08.01" LOG_CI_END="0.024609488366560774" LOG_CI_START="-0.4081773435019613" LOG_EFFECT_SIZE="-0.1917839275677002" MODIFIED="2013-11-23 19:01:45 +0000" MODIFIED_BY="Hermann Blessberger" NO="1" P_CHI2="0.45285218635480495" P_Z="0.08237556638455884" STUDIES="4" TAU2="0.0" TOTAL_1="122" TOTAL_2="103" WEIGHT="29.299519863506777" Z="1.7370657476959641"><NAME>Metoprolol</NAME><DICH_DATA CI_END="1.2469987885761085" CI_START="0.0982358612712665" EFFECT_SIZE="0.35" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="5" LOG_CI_END="0.09586603157399819" LOG_CI_START="-1.007729942873447" LOG_EFFECT_SIZE="-0.4559319556497244" MODIFIED="2013-11-23 19:01:18 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1263" O_E="0.0" SE="0.6482577382786072" STUDY_ID="STD-Coleman-1980" TOTAL_1="24" TOTAL_2="14" VAR="0.4202380952380952" WEIGHT="4.505970714968512"/><DICH_DATA CI_END="1.5031119175990921" CI_START="0.4585242356722858" EFFECT_SIZE="0.8301886792452831" ESTIMABLE="YES" EVENTS_1="15" EVENTS_2="15" LOG_CI_END="0.1769913181691861" LOG_CI_START="-0.33863770439838925" LOG_EFFECT_SIZE="-0.0808231931146016" MODIFIED="2013-11-23 19:01:31 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1266" O_E="0.0" SE="0.3028830402610201" STUDY_ID="STD-POBBLE-2005" TOTAL_1="53" TOTAL_2="44" VAR="0.09173813607775871" WEIGHT="20.641149160170166"/><DICH_DATA CI_END="3.9981665126016623" CI_START="0.010004585820506876" EFFECT_SIZE="0.2" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" LOG_CI_END="0.6018608773254143" LOG_CI_START="-1.9998008859974516" LOG_EFFECT_SIZE="-0.6989700043360187" MODIFIED="2013-11-23 19:01:40 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1264" O_E="0.0" SE="1.5282289982092807" STUDY_ID="STD-Lai-2006" TOTAL_1="30" TOTAL_2="30" VAR="2.335483870967742" WEIGHT="0.8107872522675024"/><DICH_DATA CI_END="1.7491265621242627" CI_START="0.09147422688823888" EFFECT_SIZE="0.4" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="5" LOG_CI_END="0.24282123500387298" LOG_CI_START="-1.038701252347948" LOG_EFFECT_SIZE="-0.3979400086720376" MODIFIED="2013-11-23 19:01:45 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1265" O_E="0.0" SE="0.752772652709081" STUDY_ID="STD-Liu-2006" TOTAL_1="15" TOTAL_2="15" VAR="0.5666666666666667" WEIGHT="3.341612736100598"/></DICH_SUBGROUP><DICH_SUBGROUP CHI2="3.81335344981482E-32" CI_END="3.1588374622614523" CI_START="0.03662503591899996" DF="0" EFFECT_SIZE="0.3401360544217687" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="3" I2="100.0" ID="CMP-005.08.02" LOG_CI_END="0.49952727989090295" LOG_CI_START="-1.4362219407152177" LOG_EFFECT_SIZE="-0.4683473304121573" MODIFIED="2014-06-22 17:39:48 +0100" MODIFIED_BY="Hermann Blessberger" NO="2" P_CHI2="0.0" P_Z="0.34291976177070893" STUDIES="1" TAU2="0.0" TOTAL_1="49" TOTAL_2="50" WEIGHT="1.4645708771818364" Z="0.9484120051210798"><NAME>Propranolol</NAME><DICH_DATA CI_END="3.1588374622614523" CI_START="0.03662503591899996" EFFECT_SIZE="0.3401360544217687" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="3" LOG_CI_END="0.49952727989090295" LOG_CI_START="-1.4362219407152177" LOG_EFFECT_SIZE="-0.4683473304121573" MODIFIED="2014-06-22 17:39:48 +0100" MODIFIED_BY="Hermann Blessberger" ORDER="1267" O_E="0.0" SE="1.1370686742972156" STUDY_ID="STD-Bayliff-1999" TOTAL_1="49" TOTAL_2="50" VAR="1.292925170068027" WEIGHT="1.4645708771818364"/></DICH_SUBGROUP><DICH_SUBGROUP CHI2="0.0" CI_END="0.963432747451777" CI_START="0.4699791874804524" DF="0" EFFECT_SIZE="0.6728992048140985" ESTIMABLE="YES" EVENTS_1="31" EVENTS_2="47" I2="0.0" ID="CMP-005.08.03" LOG_CI_END="-0.016178595933257885" LOG_CI_START="-0.3279213738994463" LOG_EFFECT_SIZE="-0.1720499849163521" MODIFIED="2013-11-23 19:02:17 +0000" MODIFIED_BY="Hermann Blessberger" NO="3" P_CHI2="1.0" P_Z="0.03051061934198282" STUDIES="2" TAU2="0.0" TOTAL_1="139" TOTAL_2="120" WEIGHT="56.46973866744293" Z="2.1633975046779343"><NAME>Atenolol</NAME><DICH_DATA CI_END="0.963432747451777" CI_START="0.4699791874804524" EFFECT_SIZE="0.6728992048140985" ESTIMABLE="YES" EVENTS_1="31" EVENTS_2="47" LOG_CI_END="-0.016178595933257885" LOG_CI_START="-0.3279213738994463" LOG_EFFECT_SIZE="-0.1720499849163521" MODIFIED="2013-11-23 19:02:07 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1268" O_E="0.0" SE="0.18311925092897763" STUDY_ID="STD-Wallace-1998" TOTAL_1="99" TOTAL_2="101" VAR="0.03353266006078988" WEIGHT="56.46973866744293"/><DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-11-23 19:02:17 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1269" O_E="0.0" SE="0.0" STUDY_ID="STD-Zaugg-1999" TOTAL_1="40" TOTAL_2="19" VAR="0.0" WEIGHT="0.0"/></DICH_SUBGROUP><DICH_SUBGROUP CHI2="1.2996239383344874" CI_END="2.418980875275719" CI_START="0.15628273308308646" DF="1" EFFECT_SIZE="0.6148535943326721" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="8" I2="23.054664468435828" ID="CMP-005.08.04" LOG_CI_END="0.3836324347963335" LOG_CI_START="-0.806089002409346" LOG_EFFECT_SIZE="-0.21122828380650624" MODIFIED="2017-06-17 15:47:14 +0100" MODIFIED_BY="Hermann Blessberger" NO="4" P_CHI2="0.25428204735725435" P_Z="0.4864532923160765" STUDIES="5" TAU2="0.4152083390817762" TOTAL_1="125" TOTAL_2="86" WEIGHT="12.03722586669252" Z="0.6959609465377482"><NAME>Esmolol</NAME><DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-11-23 19:02:34 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1271" O_E="0.0" SE="0.0" STUDY_ID="STD-Liu-1986" TOTAL_1="16" TOTAL_2="14" VAR="0.0" WEIGHT="0.0"/><DICH_DATA CI_END="66.61522199816511" CI_START="0.11922423317225214" EFFECT_SIZE="2.8181818181818183" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.8235734795372827" LOG_CI_START="-0.9236354621851873" LOG_EFFECT_SIZE="0.44996900867604767" MODIFIED="2013-11-23 19:02:27 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1270" O_E="0.0" SE="1.6137241312713606" STUDY_ID="STD-Cucchiara-1986" TOTAL_1="32" TOTAL_2="30" VAR="2.6041055718475072" WEIGHT="0.7271519906597286"/><DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-11-23 19:02:51 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1273" O_E="0.0" SE="0.0" STUDY_ID="STD-Oxorn-1990" TOTAL_1="32" TOTAL_2="16" VAR="0.0" WEIGHT="0.0"/><DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-11-23 19:02:42 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1272" O_E="0.0" SE="0.0" STUDY_ID="STD-Miller-1990" TOTAL_1="30" TOTAL_2="15" VAR="0.0" WEIGHT="0.0"/><DICH_DATA CI_END="1.022049427213816" CI_START="0.20553746115499483" EFFECT_SIZE="0.4583333333333333" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="8" LOG_CI_END="0.009471899171640366" LOG_CI_START="-0.6871090122784024" LOG_EFFECT_SIZE="-0.338818556553381" MODIFIED="2013-11-23 19:02:59 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1274" O_E="0.0" SE="0.40917507551687754" STUDY_ID="STD-Raby-1999" TOTAL_1="15" TOTAL_2="11" VAR="0.16742424242424245" WEIGHT="11.310073876032792"/></DICH_SUBGROUP><DICH_SUBGROUP CHI2="0.0" CI_END="7.848616069043482" CI_START="0.014156777466712338" DF="0" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" I2="0.0" ID="CMP-005.08.05" LOG_CI_END="0.8947930852084158" LOG_CI_START="-1.8490355946477406" LOG_EFFECT_SIZE="-0.47712125471966244" MODIFIED="2013-11-23 19:03:15 +0000" MODIFIED_BY="Hermann Blessberger" NO="5" P_CHI2="1.0" P_Z="0.49547179043695244" STUDIES="1" TAU2="0.0" TOTAL_1="28" TOTAL_2="28" WEIGHT="0.7289447251759269" Z="0.6816318251751228"><NAME>Landiolol</NAME><DICH_DATA CI_END="7.848616069043482" CI_START="0.014156777466712338" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.8947930852084158" LOG_CI_START="-1.8490355946477406" LOG_EFFECT_SIZE="-0.47712125471966244" MODIFIED="2013-11-23 19:03:15 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1276" O_E="0.0" SE="1.611738548718522" STUDY_ID="STD-Kawaguchi-2010" TOTAL_1="28" TOTAL_2="28" VAR="2.5977011494252875" WEIGHT="0.7289447251759269"/></DICH_SUBGROUP></DICH_OUTCOME><DICH_OUTCOME CHI2="2.30982242065736" CI_END="3.598786518746552" CI_START="0.5551819543055817" CI_STUDY="95" CI_TOTAL="95" DF="4" EFFECT_MEASURE="RR" EFFECT_SIZE="1.4134996754885698" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="6" I2="0.0" I2_Q="0.0" ID="CMP-005.09" LOG_CI_END="0.5561560849190371" LOG_CI_START="-0.25556465867869915" LOG_EFFECT_SIZE="0.150295713120169" METHOD="MH" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" NO="9" P_CHI2="0.6789813445709066" P_Q="0.7721416214579454" P_Z="0.46796029429569663" Q="1.1204426273323844" RANDOM="NO" SCALE="100.0" SORT_BY="YEAR" STUDIES="4" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="730" TOTAL_2="735" WEIGHT="100.00000000000001" Z="0.7258017909969224"><NAME>Cerebrovascular events&#8212;cardiac surgery</NAME><GROUP_LABEL_1>Beta-blocker</GROUP_LABEL_1><GROUP_LABEL_2>Control</GROUP_LABEL_2><GRAPH_LABEL_1>Favours beta-blocker</GRAPH_LABEL_1><GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2><DICH_SUBGROUP CHI2="1.1645478812145371" CI_END="5.404314062260209" CI_START="0.5236752007992105" DF="1" EFFECT_SIZE="1.6822916666666667" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="4" I2="14.129765196337472" ID="CMP-005.09.01" LOG_CI_END="0.7327405793476452" LOG_CI_START="-0.28093799209253856" LOG_EFFECT_SIZE="0.2259012936275533" MODIFIED="2013-11-24 05:32:28 +0000" MODIFIED_BY="Hermann Blessberger" NO="1" P_CHI2="0.2805243931110022" P_Z="0.38235376371226093" STUDIES="2" TAU2="0.0" TOTAL_1="562" TOTAL_2="565" WEIGHT="59.99855772697772" Z="0.8735676417465611"><NAME>Metoprolol</NAME><DICH_DATA CI_END="8.972003519367153" CI_START="0.6068259372270592" EFFECT_SIZE="2.3333333333333335" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="3" LOG_CI_END="0.9528894352677552" LOG_CI_START="-0.21693586467856624" LOG_EFFECT_SIZE="0.36797678529459443" MODIFIED="2013-11-23 19:06:09 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1277" O_E="0.0" SE="0.6871611719170956" STUDY_ID="STD-Connolly-2003" TOTAL_1="500" TOTAL_2="500" VAR="0.47219047619047616" WEIGHT="40.31153097281316"/><DICH_DATA CI_END="8.413543994108187" CI_START="0.014493901073248328" EFFECT_SIZE="0.3492063492063492" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.924978969980806" LOG_CI_START="-1.838814707243557" LOG_EFFECT_SIZE="-0.4569178686313755" MODIFIED="2013-11-24 05:32:28 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1488" O_E="0.0" SE="1.6234660870009374" STUDY_ID="STD-Auer-2004" TOTAL_1="62" TOTAL_2="65" VAR="2.6356421356421356" WEIGHT="19.687026754164563"><FOOTNOTE>Only patients in the metoprolol subgroup considered.</FOOTNOTE></DICH_DATA></DICH_SUBGROUP><DICH_SUBGROUP CHI2="0.0" CI_END="71.21510406800243" CI_START="0.12637768515238015" DF="0" EFFECT_SIZE="3.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" I2="0.0" ID="CMP-005.09.02" LOG_CI_END="1.85257211326778" LOG_CI_START="-0.8983296038284552" LOG_EFFECT_SIZE="0.47712125471966244" MODIFIED="2013-11-23 19:06:17 +0000" MODIFIED_BY="Hermann Blessberger" NO="2" P_CHI2="1.0" P_Z="0.4965809361801813" STUDIES="1" TAU2="0.0" TOTAL_1="35" TOTAL_2="35" WEIGHT="6.718588495468859" Z="0.6798792335599723"><NAME>Atenolol</NAME><DICH_DATA CI_END="71.21510406800243" CI_START="0.12637768515238015" EFFECT_SIZE="3.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.85257211326778" LOG_CI_START="-0.8983296038284552" LOG_EFFECT_SIZE="0.47712125471966244" MODIFIED="2013-11-23 19:06:17 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1278" O_E="0.0" SE="1.6158932858054431" STUDY_ID="STD-Matangi-1989" TOTAL_1="35" TOTAL_2="35" VAR="2.611111111111111" WEIGHT="6.718588495468859"/></DICH_SUBGROUP><DICH_SUBGROUP CHI2="0.0" CI_END="15.672973621805108" CI_START="0.06380410151451699" DF="0" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" I2="0.0" ID="CMP-005.09.03" LOG_CI_END="1.1951514026602095" LOG_CI_START="-1.1951514026602095" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-11-23 19:06:29 +0000" MODIFIED_BY="Hermann Blessberger" NO="3" P_CHI2="1.0" P_Z="1.0" STUDIES="1" TAU2="0.0" TOTAL_1="70" TOTAL_2="70" WEIGHT="13.437176990937719" Z="0.0"><NAME>Landiolol</NAME><DICH_DATA CI_END="15.672973621805108" CI_START="0.06380410151451699" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.1951514026602095" LOG_CI_START="-1.1951514026602095" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-11-23 19:06:29 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1279" O_E="0.0" SE="1.4040757000349275" STUDY_ID="STD-Sezai-2011" TOTAL_1="70" TOTAL_2="70" VAR="1.9714285714285715" WEIGHT="13.437176990937719"/></DICH_SUBGROUP><DICH_SUBGROUP CHI2="0.0" CI_END="8.283322353507462" CI_START="0.014265298084163663" DF="0" EFFECT_SIZE="0.34374999999999994" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" I2="0.0" ID="CMP-005.09.04" LOG_CI_END="0.9182045626779441" LOG_CI_START="-1.8457191490013058" LOG_EFFECT_SIZE="-0.463757293161681" MODIFIED="2013-11-24 05:32:42 +0000" MODIFIED_BY="Hermann Blessberger" NO="4" P_CHI2="1.0" P_Z="0.5107163795927263" STUDIES="1" TAU2="0.0" TOTAL_1="63" TOTAL_2="65" WEIGHT="19.84567678661571" Z="0.6577226341840224"><NAME>Sotalol</NAME><DICH_DATA CI_END="8.283322353507454" CI_START="0.014265298084163663" EFFECT_SIZE="0.34375" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.9182045626779438" LOG_CI_START="-1.8457191490013058" LOG_EFFECT_SIZE="-0.46375729316168096" MODIFIED="2013-11-24 05:32:42 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1489" O_E="0.0" SE="1.6235424698834187" STUDY_ID="STD-Auer-2004" TOTAL_1="63" TOTAL_2="65" VAR="2.6358901515151514" WEIGHT="19.84567678661571"><FOOTNOTE>Only patients in the sotalol subgroup considered.</FOOTNOTE></DICH_DATA></DICH_SUBGROUP></DICH_OUTCOME><DICH_OUTCOME CHI2="4.683815300243554" CI_END="2.707506832501573" CI_START="0.9342911560750178" CI_STUDY="95" CI_TOTAL="95" DF="4" EFFECT_MEASURE="RR" EFFECT_SIZE="1.590471530276133" ESTIMABLE="YES" EVENTS_1="34" EVENTS_2="21" I2="14.599535985289512" I2_Q="19.40161485775443" ID="CMP-005.10" LOG_CI_END="0.43256956125820256" LOG_CI_START="-0.02951776212954848" LOG_EFFECT_SIZE="0.20152589956432704" METHOD="MH" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" NO="10" P_CHI2="0.32130474413380594" P_Q="0.2891761248105489" P_Z="0.08734686496500334" Q="2.4814392949316075" RANDOM="NO" SCALE="100.0" SORT_BY="YEAR" STUDIES="5" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="4574" TOTAL_2="4576" WEIGHT="100.0" Z="1.7095621762671682"><NAME>Cerebrovascular events&#8212;non-cardiac surgery</NAME><GROUP_LABEL_1>Beta-blocker</GROUP_LABEL_1><GROUP_LABEL_2>Control</GROUP_LABEL_2><GRAPH_LABEL_1>Favours beta-blocker</GRAPH_LABEL_1><GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2><DICH_SUBGROUP CHI2="2.1479106947969955" CI_END="3.0796668935079703" CI_START="0.9322434148138542" DF="2" EFFECT_SIZE="1.6944023079815032" ESTIMABLE="YES" EVENTS_1="28" EVENTS_2="16" I2="6.886259058874647" ID="CMP-005.10.01" LOG_CI_END="0.4885037443787316" LOG_CI_START="-0.030470675727563023" LOG_EFFECT_SIZE="0.2290165343255843" MODIFIED="2013-12-08 06:59:25 +0000" MODIFIED_BY="Hermann Blessberger" NO="1" P_CHI2="0.3416546919444472" P_Z="0.08366382199349215" STUDIES="3" TAU2="0.0" TOTAL_1="4278" TOTAL_2="4272" WEIGHT="77.56074380261315" Z="1.7298122672419634"><NAME>Metoprolol</NAME><DICH_DATA CI_END="59.88076450297431" CI_START="0.10437408493155693" EFFECT_SIZE="2.5" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.7772873363821649" LOG_CI_START="-0.9814073190380896" LOG_EFFECT_SIZE="0.3979400086720376" MODIFIED="2013-11-23 19:08:57 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1280" O_E="0.0" SE="1.620470896352639" STUDY_ID="STD-POBBLE-2005" TOTAL_1="53" TOTAL_2="44" VAR="2.6259259259259258" WEIGHT="2.482676326467289"/><DICH_DATA CI_END="3.675054697422891" CI_START="1.013518570917549" EFFECT_SIZE="1.9299575604079677" ESTIMABLE="YES" EVENTS_1="27" EVENTS_2="14" LOG_CI_END="0.5652638072602568" LOG_CI_START="0.005831710772613412" LOG_EFFECT_SIZE="0.2855477590164352" MODIFIED="2013-12-08 06:59:25 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1281" O_E="0.0" SE="0.328613182710381" STUDY_ID="STD-POISE-2008" TOTAL_1="4174" TOTAL_2="4177" VAR="0.10798662385104625" WEIGHT="63.69913431317078"/><DICH_DATA CI_END="4.065339018491121" CI_START="0.00983927781128726" EFFECT_SIZE="0.2" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" LOG_CI_END="0.609096768311561" LOG_CI_START="-2.0070367769835986" LOG_EFFECT_SIZE="-0.6989700043360187" MODIFIED="2013-11-23 19:09:15 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1282" O_E="0.0" SE="1.536729794576282" STUDY_ID="STD-Yang-2008" TOTAL_1="51" TOTAL_2="51" VAR="2.3615384615384616" WEIGHT="11.378933162975075"/></DICH_SUBGROUP><DICH_SUBGROUP CHI2="0.0" CI_END="35.873486053427946" CI_START="0.4642145613500314" DF="0" EFFECT_SIZE="4.08080808080808" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="1" I2="0.0" ID="CMP-005.10.02" LOG_CI_END="1.5547735818670396" LOG_CI_START="-0.3332812408409298" LOG_EFFECT_SIZE="0.610746170513055" MODIFIED="2013-11-23 19:09:32 +0000" MODIFIED_BY="Hermann Blessberger" NO="2" P_CHI2="1.0" P_Z="0.20479277802759255" STUDIES="1" TAU2="0.0" TOTAL_1="99" TOTAL_2="101" WEIGHT="4.50605753253813" Z="1.2680145549846633"><NAME>Atenolol</NAME><DICH_DATA CI_END="35.873486053427946" CI_START="0.4642145613500314" EFFECT_SIZE="4.08080808080808" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="1" LOG_CI_END="1.5547735818670396" LOG_CI_START="-0.3332812408409298" LOG_EFFECT_SIZE="0.610746170513055" MODIFIED="2013-11-23 19:09:32 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1283" O_E="0.0" SE="1.1090527488807644" STUDY_ID="STD-Wallace-1998" TOTAL_1="99" TOTAL_2="101" VAR="1.22999799979998" WEIGHT="4.50605753253813"/></DICH_SUBGROUP><DICH_SUBGROUP CHI2="0.0" CI_END="2.781185502696919" CI_START="0.09544862473539373" DF="0" EFFECT_SIZE="0.5152284263959391" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="4" I2="0.0" ID="CMP-005.10.03" LOG_CI_END="0.4442299569011446" LOG_CI_START="-1.020230324725867" LOG_EFFECT_SIZE="-0.28800018391236115" MODIFIED="2013-11-23 19:09:52 +0000" MODIFIED_BY="Hermann Blessberger" NO="3" P_CHI2="1.0" P_Z="0.4407712551741897" STUDIES="1" TAU2="0.0" TOTAL_1="197" TOTAL_2="203" WEIGHT="17.933198664848717" Z="0.7708914951001814"><NAME>Bisoprolol</NAME><DICH_DATA CI_END="2.781185502696919" CI_START="0.09544862473539373" EFFECT_SIZE="0.5152284263959391" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="4" LOG_CI_END="0.4442299569011446" LOG_CI_START="-1.020230324725867" LOG_EFFECT_SIZE="-0.28800018391236115" MODIFIED="2013-11-23 19:09:52 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1284" O_E="0.0" SE="0.8602312186230142" STUDY_ID="STD-Marwick-2009" TOTAL_1="197" TOTAL_2="203" VAR="0.7399977494936361" WEIGHT="17.933198664848717"/></DICH_SUBGROUP></DICH_OUTCOME><DICH_OUTCOME CHI2="9.244536482671833" CI_END="0.6479873437907646" CI_START="0.2608101462528935" CI_STUDY="95" CI_TOTAL="95" DF="10" EFFECT_MEASURE="RR" EFFECT_SIZE="0.41109813172050946" ESTIMABLE="YES" EVENTS_1="22" EVENTS_2="64" I2="0.0" I2_Q="43.86570612095212" ID="CMP-005.11" LOG_CI_END="-0.18843347649902123" LOG_CI_START="-0.5836755173268865" LOG_EFFECT_SIZE="-0.3860544969129538" METHOD="MH" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" NO="11" P_CHI2="0.5090643143082745" P_Q="0.14825189293866237" P_Z="1.2876550114981376E-4" Q="5.3443266008904935" RANDOM="YES" SCALE="100.0" SORT_BY="YEAR" STUDIES="12" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="1143" TOTAL_2="1214" WEIGHT="100.0" Z="3.8288078284093996"><NAME>Ventricular arrhythmias&#8212;cardiac surgery</NAME><GROUP_LABEL_1>Beta-blocker</GROUP_LABEL_1><GROUP_LABEL_2>Control</GROUP_LABEL_2><GRAPH_LABEL_1>Favours beta-blocker</GRAPH_LABEL_1><GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2><DICH_SUBGROUP CHI2="0.032043800931260004" CI_END="1.0742733234484647" CI_START="0.06660851451466605" DF="1" EFFECT_SIZE="0.2674990659004917" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="9" I2="0.0" ID="CMP-005.11.01" LOG_CI_END="0.03111479138550453" LOG_CI_START="-1.1764702517549002" LOG_EFFECT_SIZE="-0.5726777301846978" MODIFIED="2013-11-24 05:34:02 +0000" MODIFIED_BY="Hermann Blessberger" NO="1" P_CHI2="0.8579316027322416" P_Z="0.06303243741630153" STUDIES="2" TAU2="0.0" TOTAL_1="562" TOTAL_2="565" WEIGHT="10.71249952249088" Z="1.85896261681282"><NAME>Metoprolol</NAME><DICH_DATA CI_END="1.368626413931854" CI_START="0.059645679953455225" EFFECT_SIZE="0.2857142857142857" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="7" LOG_CI_END="0.13628491744763105" LOG_CI_START="-1.2244210061481822" LOG_EFFECT_SIZE="-0.5440680443502757" MODIFIED="2013-11-23 19:13:59 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1285" O_E="0.0" SE="0.799285395123133" STUDY_ID="STD-Connolly-2003" TOTAL_1="500" TOTAL_2="500" VAR="0.6388571428571428" WEIGHT="8.437187787763971"/><DICH_DATA CI_END="4.279157103047954" CI_START="0.010259082735265884" EFFECT_SIZE="0.20952380952380953" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" LOG_CI_END="0.6313582312687743" LOG_CI_START="-1.9888914677642378" LOG_EFFECT_SIZE="-0.6787666182477319" MODIFIED="2013-11-24 05:34:02 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1490" O_E="0.0" SE="1.5391476436571863" STUDY_ID="STD-Auer-2004" TOTAL_1="62" TOTAL_2="65" VAR="2.368975468975469" WEIGHT="2.2753117347269094"><FOOTNOTE>Only patients in the metoprolol subgroup considered.</FOOTNOTE></DICH_DATA></DICH_SUBGROUP><DICH_SUBGROUP CHI2="2.149434906303785" CI_END="0.7915284217477607" CI_START="0.21616942435072645" DF="4" EFFECT_SIZE="0.41364748674016194" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="33" I2="0.0" ID="CMP-005.11.02" LOG_CI_END="-0.10153348612492803" LOG_CI_START="-0.665205733947995" LOG_EFFECT_SIZE="-0.38336961003646153" MODIFIED="2013-11-23 19:14:40 +0000" MODIFIED_BY="Hermann Blessberger" NO="2" P_CHI2="0.7082967224497279" P_Z="0.0076747118900674476" STUDIES="5" TAU2="0.0" TOTAL_1="262" TOTAL_2="326" WEIGHT="49.16691511298085" Z="2.666055074879211"><NAME>Propranolol</NAME><DICH_DATA CI_END="2.100643308756804" CI_START="0.09496223068712434" EFFECT_SIZE="0.4466338259441708" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="7" LOG_CI_END="0.3223523150476611" LOG_CI_START="-1.0224490922450145" LOG_EFFECT_SIZE="-0.35004838859867665" MODIFIED="2013-11-23 19:14:07 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1289" O_E="0.0" SE="0.7899430035180444" STUDY_ID="STD-Stephenson-1980" TOTAL_1="87" TOTAL_2="136" VAR="0.624009948807109" WEIGHT="8.637935491484043"/><DICH_DATA CI_END="2.2497616637862223" CI_START="0.007105757023518394" EFFECT_SIZE="0.12643678160919541" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="4" LOG_CI_END="0.3521365120735711" LOG_CI_START="-2.148389646994358" LOG_EFFECT_SIZE="-0.8981265674603934" MODIFIED="2013-11-23 19:14:14 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1290" O_E="0.0" SE="1.4688214436406157" STUDY_ID="STD-Williams-1982" TOTAL_1="28" TOTAL_2="32" VAR="2.1574364332985025" WEIGHT="2.4984085744760787"/><DICH_DATA CI_END="3.163518593329961" CI_START="0.11752815339751992" EFFECT_SIZE="0.6097560975609756" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="4" LOG_CI_END="0.5001703913340872" LOG_CI_START="-0.929858087429483" LOG_EFFECT_SIZE="-0.2148438480476979" MODIFIED="2013-11-23 19:14:23 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1286" O_E="0.0" SE="0.8400058071808557" STUDY_ID="STD-Abel-1983" TOTAL_1="41" TOTAL_2="50" VAR="0.7056097560975609" WEIGHT="7.6390067417021355"/><DICH_DATA CI_END="1.2109704352624893" CI_START="0.20023745210140398" EFFECT_SIZE="0.49242424242424243" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="11" LOG_CI_END="0.08313354036923343" LOG_CI_START="-0.6984546894952222" LOG_EFFECT_SIZE="-0.3076605745629943" MODIFIED="2013-11-23 19:14:31 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1287" O_E="0.0" SE="0.4591087951465162" STUDY_ID="STD-Hammon-1984" TOTAL_1="24" TOTAL_2="26" VAR="0.21078088578088577" WEIGHT="25.572326749984953"/><DICH_DATA CI_END="1.1353041994287865" CI_START="0.017975942725812367" EFFECT_SIZE="0.14285714285714285" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="7" LOG_CI_END="0.05511224428890028" LOG_CI_START="-1.745308324317414" LOG_EFFECT_SIZE="-0.8450980400142568" MODIFIED="2013-11-23 19:14:40 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1288" O_E="0.0" SE="1.0575759542248981" STUDY_ID="STD-Matangi-1985" TOTAL_1="82" TOTAL_2="82" VAR="1.1184668989547037" WEIGHT="4.819237555333643"/></DICH_SUBGROUP><DICH_SUBGROUP CHI2="0.4594410065162467" CI_END="9.546701453386897" CI_START="0.45811434658868105" DF="1" EFFECT_SIZE="2.0912869000678866" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="2" I2="0.0" ID="CMP-005.11.03" LOG_CI_END="0.9798533414217192" LOG_CI_START="-0.339026107379699" LOG_EFFECT_SIZE="0.3204136170210101" MODIFIED="2013-11-24 05:34:15 +0000" MODIFIED_BY="Hermann Blessberger" NO="3" P_CHI2="0.497885366284747" P_Z="0.34093356765644667" STUDIES="3" TAU2="0.0" TOTAL_1="239" TOTAL_2="245" WEIGHT="8.980821492598508" Z="0.9523222916061175"><NAME>Sotalol</NAME><DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-11-23 19:14:51 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1291" O_E="0.0" SE="0.0" STUDY_ID="STD-Nystr_x00f6_m-1993" TOTAL_1="50" TOTAL_2="51" VAR="0.0" WEIGHT="0.0"/><DICH_DATA CI_END="105.56063520158432" CI_START="0.2481517124265242" EFFECT_SIZE="5.118110236220472" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="0" LOG_CI_END="2.0235019948836785" LOG_CI_START="-0.6052827235098813" LOG_EFFECT_SIZE="0.7091096356868987" MODIFIED="2013-11-23 19:14:59 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1292" O_E="0.0" SE="1.5441611562785993" STUDY_ID="STD-Pfisterer-1997" TOTAL_1="126" TOTAL_2="129" VAR="2.3844336765596608" WEIGHT="2.260560961216235"/><DICH_DATA CI_END="8.953419344951097" CI_START="0.26750949824593184" EFFECT_SIZE="1.5476190476190477" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="2" LOG_CI_END="0.951988925711867" LOG_CI_START="-0.5726607932219568" LOG_EFFECT_SIZE="0.18966406624495513" MODIFIED="2013-11-24 05:34:15 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1491" O_E="0.0" SE="0.8955867920395555" STUDY_ID="STD-Auer-2004" TOTAL_1="63" TOTAL_2="65" VAR="0.8020757020757021" WEIGHT="6.720260531382274"><FOOTNOTE>Only patients in the sotalol subgroup considered.</FOOTNOTE></DICH_DATA></DICH_SUBGROUP><DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-005.11.04" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2013-11-23 19:15:37 +0000" MODIFIED_BY="Hermann Blessberger" NO="4" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="35" TOTAL_2="35" WEIGHT="0.0" Z="0.0"><NAME>Atenolol</NAME><DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-11-23 19:15:37 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1293" O_E="0.0" SE="0.0" STUDY_ID="STD-Matangi-1989" TOTAL_1="35" TOTAL_2="35" VAR="0.0" WEIGHT="0.0"/></DICH_SUBGROUP><DICH_SUBGROUP CHI2="1.4651273207354365" CI_END="0.8413733265808485" CI_START="0.07939949447711488" DF="1" EFFECT_SIZE="0.2584658909741242" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="20" I2="31.746546129653826" ID="CMP-005.11.05" LOG_CI_END="-0.07501126020869478" LOG_CI_START="-1.100182262642153" LOG_EFFECT_SIZE="-0.5875967614254238" MODIFIED="2013-11-23 19:15:56 +0000" MODIFIED_BY="Hermann Blessberger" NO="5" P_CHI2="0.2261163788652647" P_Z="0.024653886304426883" STUDIES="2" TAU2="0.2906206780352726" TOTAL_1="45" TOTAL_2="43" WEIGHT="31.13976387192976" Z="2.246783194398747"><NAME>Esmolol</NAME><DICH_DATA CI_END="0.8881346973235159" CI_START="0.14888665577098886" EFFECT_SIZE="0.36363636363636365" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="11" LOG_CI_END="-0.05152116274832839" LOG_CI_START="-0.8271442249121969" LOG_EFFECT_SIZE="-0.43933269383026263" MODIFIED="2013-11-23 19:15:49 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1294" O_E="0.0" SE="0.45560482611113506" STUDY_ID="STD-Harrison-1987" TOTAL_1="15" TOTAL_2="15" VAR="0.20757575757575764" WEIGHT="25.967183002441196"/><DICH_DATA CI_END="0.7668557273673595" CI_START="0.014024095769338475" EFFECT_SIZE="0.1037037037037037" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="9" LOG_CI_END="-0.11528633448889981" LOG_CI_START="-1.8531251311446366" LOG_EFFECT_SIZE="-0.9842057328167682" MODIFIED="2013-11-23 19:15:56 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1295" O_E="0.0" SE="1.0208151115963615" STUDY_ID="STD-Sun-2011" TOTAL_1="30" TOTAL_2="28" VAR="1.042063492063492" WEIGHT="5.172580869488565"/></DICH_SUBGROUP></DICH_OUTCOME><DICH_OUTCOME CHI2="7.314150194211838" CI_END="1.1902250305243163" CI_START="0.43371170400759823" CI_STUDY="95" CI_TOTAL="95" DF="4" EFFECT_MEASURE="RR" EFFECT_SIZE="0.7184807068677606" ESTIMABLE="YES" EVENTS_1="22" EVENTS_2="24" I2="45.31148672383759" I2_Q="58.96639926663919" ID="CMP-005.12" LOG_CI_END="0.07562907927130964" LOG_CI_START="-0.36279885795884353" LOG_EFFECT_SIZE="-0.14358488934376692" METHOD="MH" MODIFIED="2017-06-17 15:47:33 +0100" MODIFIED_BY="Hermann Blessberger" NO="12" P_CHI2="0.1201893406969895" P_Q="0.06261667682956584" P_Z="0.19922101385497454" Q="7.31108151949474" RANDOM="NO" SCALE="100.0" SORT_BY="YEAR" STUDIES="5" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="249" TOTAL_2="227" WEIGHT="99.99999999999999" Z="1.28377408436096"><NAME>Ventricular arrhythmias&#8212;non-cardiac surgery</NAME><GROUP_LABEL_1>Beta-blocker</GROUP_LABEL_1><GROUP_LABEL_2>Control</GROUP_LABEL_2><GRAPH_LABEL_1>Favours beta-blocker</GRAPH_LABEL_1><GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2><DICH_SUBGROUP CHI2="0.018961654062545567" CI_END="2.5042686273858483" CI_START="0.6351705645807104" DF="1" EFFECT_SIZE="1.2612048675446943" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="11" I2="0.0" ID="CMP-005.12.01" LOG_CI_END="0.3986809128507026" LOG_CI_START="-0.1971096364253849" LOG_EFFECT_SIZE="0.10078563821265885" MODIFIED="2013-12-09 12:28:53 +0000" MODIFIED_BY="Hermann Blessberger" NO="1" P_CHI2="0.8904764816828411" P_Z="0.5072625067294442" STUDIES="2" TAU2="0.0" TOTAL_1="71" TOTAL_2="61" WEIGHT="42.200830171307246" Z="0.6631062587203191"><NAME>Metoprolol</NAME><DICH_DATA CI_END="3.6746104414217298" CI_START="0.37928140736840954" EFFECT_SIZE="1.1805555555555556" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="4" LOG_CI_END="0.5652113047512454" LOG_CI_START="-0.4210384461851969" LOG_EFFECT_SIZE="0.07208642928302428" MODIFIED="2013-12-09 12:28:52 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1296" O_E="0.0" SE="0.5793279857150695" STUDY_ID="STD-Jakobsen-1997" TOTAL_1="18" TOTAL_2="17" VAR="0.33562091503267977" WEIGHT="14.759406976634272"/><DICH_DATA CI_END="3.080458562544285" CI_START="0.5524939578722114" EFFECT_SIZE="1.3045822102425877" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="7" LOG_CI_END="0.4886153711624102" LOG_CI_START="-0.25767246710367697" LOG_EFFECT_SIZE="0.11547145202936662" MODIFIED="2013-12-09 12:28:53 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1297" O_E="0.0" SE="0.4383731703818781" STUDY_ID="STD-POBBLE-2005" TOTAL_1="53" TOTAL_2="44" VAR="0.19217103651065914" WEIGHT="27.441423194672975"/></DICH_SUBGROUP><DICH_SUBGROUP CHI2="2.088797254852945E-32" CI_END="4.143615317939941" CI_START="0.010043403358372081" DF="0" EFFECT_SIZE="0.20400000000000001" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" I2="100.0" ID="CMP-005.12.02" LOG_CI_END="0.6173794298813183" LOG_CI_START="-1.998119095029521" LOG_EFFECT_SIZE="-0.6903698325741012" MODIFIED="2013-11-23 19:19:03 +0000" MODIFIED_BY="Hermann Blessberger" NO="2" P_CHI2="0.0" P_Z="0.3008191080627727" STUDIES="1" TAU2="0.0" TOTAL_1="49" TOTAL_2="50" WEIGHT="8.87959371875343" Z="1.0346784714048438"><NAME>Propranolol</NAME><DICH_DATA CI_END="4.14361531793994" CI_START="0.010043403358372081" EFFECT_SIZE="0.204" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" LOG_CI_END="0.6173794298813183" LOG_CI_START="-1.998119095029521" LOG_EFFECT_SIZE="-0.6903698325741012" MODIFIED="2013-11-23 19:19:03 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1298" O_E="0.0" SE="1.5363567804591305" STUDY_ID="STD-Bayliff-1999" TOTAL_1="49" TOTAL_2="50" VAR="2.360392156862745" WEIGHT="8.87959371875343"/></DICH_SUBGROUP><DICH_SUBGROUP CHI2="0.0" CI_END="3.9833644750180848" CI_START="0.11612876150877542" DF="0" EFFECT_SIZE="0.6801346801346801" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="3" I2="0.0" ID="CMP-005.12.03" LOG_CI_END="0.6002500458638188" LOG_CI_START="-0.9350602056049961" LOG_EFFECT_SIZE="-0.16740507987058859" MODIFIED="2013-11-23 19:19:09 +0000" MODIFIED_BY="Hermann Blessberger" NO="3" P_CHI2="1.0" P_Z="0.6690765046634826" STUDIES="1" TAU2="0.0" TOTAL_1="99" TOTAL_2="101" WEIGHT="10.654446911257867" Z="0.4274157969850165"><NAME>Atenolol</NAME><DICH_DATA CI_END="3.9833644750180848" CI_START="0.11612876150877542" EFFECT_SIZE="0.6801346801346801" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="3" LOG_CI_END="0.6002500458638188" LOG_CI_START="-0.9350602056049961" LOG_EFFECT_SIZE="-0.16740507987058859" MODIFIED="2013-11-23 19:19:09 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1299" O_E="0.0" SE="0.9018488416210964" STUDY_ID="STD-Wallace-1998" TOTAL_1="99" TOTAL_2="101" VAR="0.8133313331333133" WEIGHT="10.654446911257867"/></DICH_SUBGROUP><DICH_SUBGROUP CHI2="0.0" CI_END="0.698737197573076" CI_START="0.08944707712296021" DF="0" EFFECT_SIZE="0.25" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="8" I2="0.0" ID="CMP-005.12.04" LOG_CI_END="-0.1556861362780481" LOG_CI_START="-1.0484338463778766" LOG_EFFECT_SIZE="-0.6020599913279624" MODIFIED="2017-06-17 15:47:33 +0100" MODIFIED_BY="Hermann Blessberger" NO="4" P_CHI2="1.0" P_Z="0.008203931563833216" STUDIES="1" TAU2="0.0" TOTAL_1="30" TOTAL_2="15" WEIGHT="38.26512919868145" Z="2.64355962201987"><NAME>Esmolol</NAME><DICH_DATA CI_END="0.698737197573076" CI_START="0.08944707712296021" EFFECT_SIZE="0.25" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="8" LOG_CI_END="-0.1556861362780481" LOG_CI_START="-1.0484338463778766" LOG_EFFECT_SIZE="-0.6020599913279624" MODIFIED="2013-11-23 19:19:17 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1300" O_E="0.0" SE="0.5244044240850758" STUDY_ID="STD-Sandler-1990" TOTAL_1="30" TOTAL_2="15" VAR="0.275" WEIGHT="38.26512919868145"/></DICH_SUBGROUP></DICH_OUTCOME><DICH_OUTCOME CHI2="73.92783089047393" CI_END="0.5809317288879827" CI_START="0.4128877446634954" CI_STUDY="95" CI_TOTAL="95" DF="36" EFFECT_MEASURE="RR" EFFECT_SIZE="0.48975462360658156" ESTIMABLE="YES" EVENTS_1="474" EVENTS_2="874" I2="51.30386003975286" I2_Q="64.70994255735508" ID="CMP-005.13" LOG_CI_END="-0.2358749029097983" LOG_CI_START="-0.38416800766539755" LOG_EFFECT_SIZE="-0.3100214552875979" METHOD="MH" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" NO="13" P_CHI2="1.9944367504698413E-4" P_Q="0.005935923326892967" P_Z="2.5059625257855536E-16" Q="19.83561520515157" RANDOM="YES" SCALE="100.0" SORT_BY="YEAR" STUDIES="35" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.10844587649610804" TOTALS="YES" TOTAL_1="2621" TOTAL_2="2623" WEIGHT="100.0" Z="8.194998517292069"><NAME>Atrial fibrillation&#8212;cardiac surgery</NAME><GROUP_LABEL_1>Beta-blocker</GROUP_LABEL_1><GROUP_LABEL_2>Control</GROUP_LABEL_2><GRAPH_LABEL_1>Favours beta-blocker</GRAPH_LABEL_1><GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2><DICH_SUBGROUP CHI2="8.258228472236858" CI_END="0.8292145977210732" CI_START="0.5605088135971393" DF="6" EFFECT_SIZE="0.6817492870447815" ESTIMABLE="YES" EVENTS_1="258" EVENTS_2="338" I2="27.345192492902598" ID="CMP-005.13.01" LOG_CI_END="-0.08133306107177646" LOG_CI_START="-0.25141755404758204" LOG_EFFECT_SIZE="-0.16637530755967922" MODIFIED="2013-11-24 05:40:44 +0000" MODIFIED_BY="Hermann Blessberger" NO="1" P_CHI2="0.21978880074434415" P_Z="1.258493675756381E-4" STUDIES="7" TAU2="0.018226857738513073" TOTAL_1="1031" TOTAL_2="938" WEIGHT="29.513648670896284" Z="3.8344425764920502"><NAME>Metoprolol</NAME><DICH_DATA CI_END="1.038940365019772" CI_START="0.19707195856954568" EFFECT_SIZE="0.45248868778280543" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="17" LOG_CI_END="0.016590619851566072" LOG_CI_START="-0.7053751672217875" LOG_EFFECT_SIZE="-0.3443922736851107" MODIFIED="2013-11-24 05:40:44 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1498" O_E="0.0" SE="0.42408627711517116" STUDY_ID="STD-Janssen-1986" TOTAL_1="39" TOTAL_2="50" VAR="0.17984917043740573" WEIGHT="2.6319639645803905"><FOOTNOTE>Only patients in the metoprolol subgroup considered.</FOOTNOTE></DICH_DATA><DICH_DATA CI_END="0.967053167072245" CI_START="0.41868044849390096" EFFECT_SIZE="0.6363067292644757" ESTIMABLE="YES" EVENTS_1="38" EVENTS_2="30" LOG_CI_END="-0.014549648428526057" LOG_CI_START="-0.37811731928423464" LOG_EFFECT_SIZE="-0.19633348385638036" MODIFIED="2013-11-23 19:26:02 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1305" O_E="0.0" SE="0.213561449549639" STUDY_ID="STD-Graham-1996" TOTAL_1="213" TOTAL_2="107" VAR="0.045608492733743004" WEIGHT="4.925418074731188"/><DICH_DATA CI_END="1.8214515190598082" CI_START="0.4677977958792884" EFFECT_SIZE="0.9230769230769231" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="13" LOG_CI_END="0.26041761626692334" LOG_CI_START="-0.32994182878534717" LOG_EFFECT_SIZE="-0.03476210625921192" MODIFIED="2013-11-23 19:26:08 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1306" O_E="0.0" SE="0.3467800603500874" STUDY_ID="STD-Paull-1997" TOTAL_1="50" TOTAL_2="50" VAR="0.12025641025641025" WEIGHT="3.3177725744260202"/><DICH_DATA CI_END="0.7899548058160761" CI_START="0.21326202895259727" EFFECT_SIZE="0.41044776119402987" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="24" LOG_CI_END="-0.10239775446416542" LOG_CI_START="-0.6710864632769621" LOG_EFFECT_SIZE="-0.38674210887056376" MODIFIED="2013-11-23 19:26:16 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1304" O_E="0.0" SE="0.33405056261114596" STUDY_ID="STD-Dy-1998" TOTAL_1="67" TOTAL_2="66" VAR="0.11158977838082317" WEIGHT="3.4484510027268866"/><DICH_DATA CI_END="0.9484074945855946" CI_START="0.674815418112704" EFFECT_SIZE="0.8" ESTIMABLE="YES" EVENTS_1="156" EVENTS_2="195" LOG_CI_END="-0.023005022761850884" LOG_CI_START="-0.17081500325426194" LOG_EFFECT_SIZE="-0.09691001300805639" MODIFIED="2013-11-23 19:26:37 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1302" O_E="0.0" SE="0.08682431421244592" STUDY_ID="STD-Connolly-2003" TOTAL_1="500" TOTAL_2="500" VAR="0.007538461538461539" WEIGHT="6.542108939483387"/><DICH_DATA CI_END="0.8846657886054342" CI_START="0.2374562768789701" EFFECT_SIZE="0.4583333333333333" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="24" LOG_CI_END="-0.05322076724324717" LOG_CI_START="-0.6244163458635148" LOG_EFFECT_SIZE="-0.338818556553381" MODIFIED="2013-11-23 19:26:26 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1303" O_E="0.0" SE="0.3355231103452601" STUDY_ID="STD-De-Azevedo-L_x00fa_cio-2003" TOTAL_1="100" TOTAL_2="100" VAR="0.11257575757575758" WEIGHT="3.4330674365085057"/><DICH_DATA CI_END="1.0920771323502998" CI_START="0.5134923166717597" EFFECT_SIZE="0.7488479262672811" ESTIMABLE="YES" EVENTS_1="25" EVENTS_2="35" LOG_CI_END="0.03825331325068957" LOG_CI_START="-0.2894660503179622" LOG_EFFECT_SIZE="-0.1256063685336363" MODIFIED="2013-11-24 05:29:53 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1484" O_E="0.0" SE="0.1925039763972388" STUDY_ID="STD-Auer-2004" TOTAL_1="62" TOTAL_2="65" VAR="0.037057780928748674" WEIGHT="5.214866678439907"><FOOTNOTE>Only patients in the metoprolol subgroup considered.</FOOTNOTE></DICH_DATA></DICH_SUBGROUP><DICH_SUBGROUP CHI2="13.836768055175222" CI_END="0.818661884006485" CI_START="0.3355341483930647" DF="8" EFFECT_SIZE="0.5241078305768555" ESTIMABLE="YES" EVENTS_1="48" EVENTS_2="111" I2="42.18303025605865" ID="CMP-005.13.02" LOG_CI_END="-0.08689542941135434" LOG_CI_START="-0.47426327369476123" LOG_EFFECT_SIZE="-0.2805793515530578" MODIFIED="2013-11-23 19:27:49 +0000" MODIFIED_BY="Hermann Blessberger" NO="2" P_CHI2="0.08612055356055448" P_Z="0.004521360542410131" STUDIES="9" TAU2="0.18458556828937997" TOTAL_1="407" TOTAL_2="485" WEIGHT="18.118195620625453" Z="2.8392931006800772"><NAME>Propranolol</NAME><DICH_DATA CI_END="22.44975451350426" CI_START="0.2155925579092004" EFFECT_SIZE="2.2" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="1" LOG_CI_END="1.3512115963855165" LOG_CI_START="-0.6663662347411039" LOG_EFFECT_SIZE="0.3424226808222063" MODIFIED="2013-11-23 19:26:49 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1312" O_E="0.0" SE="1.1851352051751118" STUDY_ID="STD-Salazar-1979" TOTAL_1="20" TOTAL_2="22" VAR="1.4045454545454545" WEIGHT="0.5015112506782609"/><DICH_DATA CI_END="1.0124518038855774" CI_START="0.20532344839946126" EFFECT_SIZE="0.4559386973180077" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="24" LOG_CI_END="0.00537435849931325" LOG_CI_START="-0.6875614503908136" LOG_EFFECT_SIZE="-0.3410935459457502" MODIFIED="2013-11-23 19:26:56 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1314" O_E="0.0" SE="0.4070339242296343" STUDY_ID="STD-Stephenson-1980" TOTAL_1="87" TOTAL_2="136" VAR="0.16567661547377568" WEIGHT="2.7680405545831084"/><DICH_DATA CI_END="1.4875364844811094" CI_START="0.02439011043885608" EFFECT_SIZE="0.19047619047619047" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="6" LOG_CI_END="0.17246762637672552" LOG_CI_START="-1.6127862331886396" LOG_EFFECT_SIZE="-0.7201593034059569" MODIFIED="2013-11-23 19:27:03 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1315" O_E="0.0" SE="1.048666954257824" STUDY_ID="STD-Williams-1982" TOTAL_1="28" TOTAL_2="32" VAR="1.099702380952381" WEIGHT="0.628053858471399"/><DICH_DATA CI_END="0.6999722648647813" CI_START="0.0656002668274423" EFFECT_SIZE="0.21428571428571427" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="14" LOG_CI_END="-0.15491916777833195" LOG_CI_START="-1.1830943941388192" LOG_EFFECT_SIZE="-0.6690067809585756" MODIFIED="2013-11-23 19:27:11 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1313" O_E="0.0" SE="0.603955217513604" STUDY_ID="STD-Silverman-1982" TOTAL_1="50" TOTAL_2="50" VAR="0.36476190476190473" WEIGHT="1.6034862585708425"/><DICH_DATA CI_END="0.9290042098937271" CI_START="0.1778738493698285" EFFECT_SIZE="0.4065040650406504" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="18" LOG_CI_END="-0.03198231794449341" LOG_CI_START="-0.7498878962622648" LOG_EFFECT_SIZE="-0.39093510710337914" MODIFIED="2013-11-23 19:27:18 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1307" O_E="0.0" SE="0.4217012903937848" STUDY_ID="STD-Abel-1983" TOTAL_1="41" TOTAL_2="50" VAR="0.1778319783197832" WEIGHT="2.6505095030281076"/><DICH_DATA CI_END="1.5715363292104452" CI_START="0.18776337809660357" EFFECT_SIZE="0.5432098765432098" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="9" LOG_CI_END="0.19632442505659703" LOG_CI_START="-0.7263891098415217" LOG_EFFECT_SIZE="-0.2650323423924623" MODIFIED="2013-11-23 19:27:24 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1310" O_E="0.0" SE="0.5420064979048165" STUDY_ID="STD-Ormerod-1984" TOTAL_1="27" TOTAL_2="33" VAR="0.2937710437710438" WEIGHT="1.886499887155515"/><DICH_DATA CI_END="1.0292435704622704" CI_START="0.21516120532846186" EFFECT_SIZE="0.47058823529411764" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="17" LOG_CI_END="0.012518162702335212" LOG_CI_START="-0.667236031474996" LOG_EFFECT_SIZE="-0.32735893438633035" MODIFIED="2013-11-23 19:27:31 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1309" O_E="0.0" SE="0.39929097849729295" STUDY_ID="STD-Matangi-1985" TOTAL_1="82" TOTAL_2="82" VAR="0.15943328550932567" WEIGHT="2.832553935944556"/><DICH_DATA CI_END="0.9962321240462663" CI_START="0.1877050579938394" EFFECT_SIZE="0.43243243243243246" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="15" LOG_CI_END="-0.0016394583162494887" LOG_CI_START="-0.7265240245058909" LOG_EFFECT_SIZE="-0.3640817414110702" MODIFIED="2013-11-23 19:27:40 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1311" O_E="0.0" SE="0.42580078241626834" STUDY_ID="STD-Rubin-1987" TOTAL_1="37" TOTAL_2="40" VAR="0.18130630630630631" WEIGHT="2.6187280708544094"/><DICH_DATA CI_END="4.126826287091888" CI_START="0.7815504113324163" EFFECT_SIZE="1.7959183673469388" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="7" LOG_CI_END="0.6156161882509973" LOG_CI_START="-0.10704300400768743" LOG_EFFECT_SIZE="0.25428659212165494" MODIFIED="2013-11-23 19:27:49 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1308" O_E="0.0" SE="0.4244935867534458" STUDY_ID="STD-Martinussen-1988" TOTAL_1="35" TOTAL_2="40" VAR="0.18019480519480519" WEIGHT="2.6288123013392535"/></DICH_SUBGROUP><DICH_SUBGROUP CHI2="10.071108845713695" CI_END="0.566512634155774" CI_START="0.35883578569909524" DF="8" EFFECT_SIZE="0.45087138541467814" ESTIMABLE="YES" EVENTS_1="112" EVENTS_2="262" I2="20.564854153027724" ID="CMP-005.13.03" LOG_CI_END="-0.24679040021726215" LOG_CI_START="-0.4451042524822783" LOG_EFFECT_SIZE="-0.34594732634977027" MODIFIED="2013-11-24 05:40:56 +0000" MODIFIED_BY="Hermann Blessberger" NO="3" P_CHI2="0.2600705400063442" P_Z="8.025419453363472E-12" STUDIES="9" TAU2="0.024126259941658637" TOTAL_1="664" TOTAL_2="683" WEIGHT="29.757221557263602" Z="6.838093178557908"><NAME>Sotalol</NAME><DICH_DATA CI_END="0.5164872204769708" CI_START="0.009963567613512778" EFFECT_SIZE="0.07173601147776183" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="17" LOG_CI_END="-0.2869404198268302" LOG_CI_START="-2.0015851276971506" LOG_EFFECT_SIZE="-1.1442627737619906" MODIFIED="2013-11-24 05:40:56 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1499" O_E="0.0" SE="1.007190789031217" STUDY_ID="STD-Janssen-1986" TOTAL_1="41" TOTAL_2="50" VAR="1.0144332855093257" WEIGHT="0.6757469551228067"><FOOTNOTE>Only patients in the sotalol subgroup considered.</FOOTNOTE></DICH_DATA><DICH_DATA CI_END="0.8286815540491059" CI_START="0.3432493978592757" EFFECT_SIZE="0.5333333333333333" ESTIMABLE="YES" EVENTS_1="24" EVENTS_2="45" LOG_CI_END="-0.08161232818157535" LOG_CI_START="-0.46439021594589996" LOG_EFFECT_SIZE="-0.27300127206373764" MODIFIED="2013-11-23 19:28:12 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1322" O_E="0.0" SE="0.22484562605386735" STUDY_ID="STD-Suttorp-1991" TOTAL_1="150" TOTAL_2="150" VAR="0.05055555555555555" WEIGHT="4.772171954083238"/><DICH_DATA CI_END="0.8651318953082401" CI_START="0.13362124391311758" EFFECT_SIZE="0.34" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="15" LOG_CI_END="-0.06291767630644172" LOG_CI_START="-0.8741244896090479" LOG_EFFECT_SIZE="-0.46852108295774486" MODIFIED="2013-11-23 19:28:19 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1320" O_E="0.0" SE="0.4765068976724385" STUDY_ID="STD-Nystr_x00f6_m-1993" TOTAL_1="50" TOTAL_2="51" VAR="0.22705882352941176" WEIGHT="2.261614143224535"/><DICH_DATA CI_END="0.8367549673280018" CI_START="0.38960932218699135" EFFECT_SIZE="0.5709706959706959" ESTIMABLE="YES" EVENTS_1="29" EVENTS_2="52" LOG_CI_END="-0.07740170080856265" LOG_CI_START="-0.40937066029975144" LOG_EFFECT_SIZE="-0.24338618055415703" MODIFIED="2013-11-23 19:28:30 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1321" O_E="0.0" SE="0.19500021007797613" STUDY_ID="STD-Pfisterer-1997" TOTAL_1="126" TOTAL_2="129" VAR="0.03802508193045483" WEIGHT="5.180427457067923"/><DICH_DATA CI_END="0.815131215366541" CI_START="0.13431350612509407" EFFECT_SIZE="0.33088235294117646" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="17" LOG_CI_END="-0.08877247528121683" LOG_CI_START="-0.8718803139085308" LOG_EFFECT_SIZE="-0.48032639459487386" MODIFIED="2013-11-23 19:28:38 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1318" O_E="0.0" SE="0.460001420856004" STUDY_ID="STD-Gomes-1999" TOTAL_1="40" TOTAL_2="45" VAR="0.2116013071895425" WEIGHT="2.3708447172004936"/><DICH_DATA CI_END="0.559711576637503" CI_START="0.20705225265439542" EFFECT_SIZE="0.3404255319148936" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="47" LOG_CI_END="-0.2520357103921946" LOG_CI_START="-0.6839200401673907" LOG_EFFECT_SIZE="-0.4679778752797927" MODIFIED="2013-11-23 19:28:47 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1316" O_E="0.0" SE="0.2536909931718616" STUDY_ID="STD-Evrard-2000" TOTAL_1="103" TOTAL_2="103" VAR="0.06435912001652552" WEIGHT="4.390973582992127"/><DICH_DATA CI_END="0.925811812744811" CI_START="0.17282129888323441" EFFECT_SIZE="0.4" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="15" LOG_CI_END="-0.03347728220825417" LOG_CI_START="-0.762402735135821" LOG_EFFECT_SIZE="-0.3979400086720376" MODIFIED="2013-11-23 19:28:55 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1319" O_E="0.0" SE="0.42817441928883765" STUDY_ID="STD-Matsuura-2001" TOTAL_1="40" TOTAL_2="40" VAR="0.18333333333333335" WEIGHT="2.6005354361592943"/><DICH_DATA CI_END="0.7105931245191439" CI_START="0.13488819843100122" EFFECT_SIZE="0.30959752321981426" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="19" LOG_CI_END="-0.14837899892640086" LOG_CI_START="-0.8700260457358048" LOG_EFFECT_SIZE="-0.5092025223311029" MODIFIED="2013-11-23 19:29:03 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1317" O_E="0.0" SE="0.4238990475063375" STUDY_ID="STD-Forlani-2002" TOTAL_1="51" TOTAL_2="50" VAR="0.17969040247678017" WEIGHT="2.6334142212179303"/><DICH_DATA CI_END="0.9029960738346579" CI_START="0.38493167985048793" EFFECT_SIZE="0.5895691609977324" ESTIMABLE="YES" EVENTS_1="20" EVENTS_2="35" LOG_CI_END="-0.04431413796517636" LOG_CI_START="-0.41461634502886485" LOG_EFFECT_SIZE="-0.2294652414970206" MODIFIED="2013-11-24 05:30:05 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1485" O_E="0.0" SE="0.21751734945469825" STUDY_ID="STD-Auer-2004" TOTAL_1="63" TOTAL_2="65" VAR="0.04731379731379731" WEIGHT="4.871493090195254"><FOOTNOTE>Only patients in the sotalol subgroup considered.</FOOTNOTE></DICH_DATA></DICH_SUBGROUP><DICH_SUBGROUP CHI2="0.0" CI_END="0.7332835516809254" CI_START="0.013637289391091267" DF="0" EFFECT_SIZE="0.10000000000000002" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="10" I2="0.0" ID="CMP-005.13.04" LOG_CI_END="-0.13472805657581619" LOG_CI_START="-1.8652719434241833" LOG_EFFECT_SIZE="-0.9999999999999999" MODIFIED="2013-11-23 19:29:10 +0000" MODIFIED_BY="Hermann Blessberger" NO="4" P_CHI2="1.0" P_Z="0.02350395535196713" STUDIES="1" TAU2="0.0" TOTAL_1="30" TOTAL_2="30" WEIGHT="0.664561211277763" Z="2.265142189614737"><NAME>Atenolol</NAME><DICH_DATA CI_END="0.7332835516809254" CI_START="0.013637289391091267" EFFECT_SIZE="0.1" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="10" LOG_CI_END="-0.13472805657581619" LOG_CI_START="-1.8652719434241833" LOG_EFFECT_SIZE="-1.0" MODIFIED="2013-11-23 19:29:10 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1323" O_E="0.0" SE="1.016530045465127" STUDY_ID="STD-Lamb-1988" TOTAL_1="30" TOTAL_2="30" VAR="1.0333333333333332" WEIGHT="0.664561211277763"/></DICH_SUBGROUP><DICH_SUBGROUP CHI2="0.554328763675223" CI_END="1.748831894789372" CI_START="0.4594494569215089" DF="1" EFFECT_SIZE="0.8963815394730027" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="11" I2="0.0" ID="CMP-005.13.05" LOG_CI_END="0.24274806523961237" LOG_CI_START="-0.3377622574822478" LOG_EFFECT_SIZE="-0.047507096121317725" MODIFIED="2013-11-23 19:29:25 +0000" MODIFIED_BY="Hermann Blessberger" NO="5" P_CHI2="0.45655443848626687" P_Z="0.7483662899326129" STUDIES="2" TAU2="0.0" TOTAL_1="45" TOTAL_2="42" WEIGHT="3.581421917406804" Z="0.3207942865556176"><NAME>Esmolol</NAME><DICH_DATA CI_END="63.82881484401465" CI_START="0.12392766917779852" EFFECT_SIZE="2.8125" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.8050167806434498" LOG_CI_START="-0.9068317184046119" LOG_EFFECT_SIZE="0.4490925311194189" MODIFIED="2013-11-23 19:29:18 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1324" O_E="0.0" SE="1.592953232207399" STUDY_ID="STD-Cork-1995" TOTAL_1="15" TOTAL_2="14" VAR="2.5374999999999996" WEIGHT="0.2867716159413047"/><DICH_DATA CI_END="1.6818496358282289" CI_START="0.42805642238869207" EFFECT_SIZE="0.8484848484848485" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="11" LOG_CI_END="0.22578716551115877" LOG_CI_START="-0.3684989825824953" LOG_EFFECT_SIZE="-0.07135590853566824" MODIFIED="2013-11-23 19:29:25 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1325" O_E="0.0" SE="0.3490866251540896" STUDY_ID="STD-Sun-2011" TOTAL_1="30" TOTAL_2="28" VAR="0.12186147186147188" WEIGHT="3.2946503014654995"/></DICH_SUBGROUP><DICH_SUBGROUP CHI2="1.845416524659985" CI_END="0.6621471564201726" CI_START="0.01205168619351053" DF="1" EFFECT_SIZE="0.08933078832687669" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="34" I2="45.81169147251196" ID="CMP-005.13.06" LOG_CI_END="-0.1790454816794867" LOG_CI_START="-1.9189521851799831" LOG_EFFECT_SIZE="-1.048998833429735" MODIFIED="2013-11-23 19:29:46 +0000" MODIFIED_BY="Hermann Blessberger" NO="6" P_CHI2="0.17431760099094196" P_Z="0.01811079923859257" STUDIES="2" TAU2="1.06695891717781" TOTAL_1="82" TOTAL_2="89" WEIGHT="1.5762336154656549" Z="2.3633450336278052"><NAME>Acebutolol</NAME><DICH_DATA CI_END="0.7102222721256239" CI_START="0.04268142296235359" EFFECT_SIZE="0.17410714285714285" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="14" LOG_CI_END="-0.148605712617911" LOG_CI_START="-1.3697611099974163" LOG_EFFECT_SIZE="-0.7591834113076636" MODIFIED="2013-11-23 19:29:40 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1327" O_E="0.0" SE="0.717312725237428" STUDY_ID="STD-Materne-1985" TOTAL_1="32" TOTAL_2="39" VAR="0.5145375457875457" WEIGHT="1.2179813259148582"/><DICH_DATA CI_END="0.3925291896546882" CI_START="0.0015155153127434649" EFFECT_SIZE="0.024390243902439025" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="20" LOG_CI_END="-0.4061280422700622" LOG_CI_START="-2.819439671169409" LOG_EFFECT_SIZE="-1.6127838567197355" MODIFIED="2013-11-23 19:29:46 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1326" O_E="0.0" SE="1.4175911969007033" STUDY_ID="STD-Daudon-1986" TOTAL_1="50" TOTAL_2="50" VAR="2.0095648015303684" WEIGHT="0.3582522895507967"/></DICH_SUBGROUP><DICH_SUBGROUP CHI2="3.6401812368023347" CI_END="0.5382315341500716" CI_START="0.26679189758089533" DF="4" EFFECT_SIZE="0.3789403809753905" ESTIMABLE="YES" EVENTS_1="34" EVENTS_2="94" I2="0.0" ID="CMP-005.13.07" LOG_CI_END="-0.2690308611873289" LOG_CI_START="-0.573827363995893" LOG_EFFECT_SIZE="-0.42142911259161087" MODIFIED="2013-11-24 05:52:06 +0000" MODIFIED_BY="Hermann Blessberger" NO="7" P_CHI2="0.4568859678376116" P_Z="5.962669190213446E-8" STUDIES="5" TAU2="0.0" TOTAL_1="275" TOTAL_2="270" WEIGHT="13.428365485649755" Z="5.419917060104958"><NAME>Landiolol</NAME><DICH_DATA CI_END="0.6324601313324618" CI_START="0.13450562372243266" EFFECT_SIZE="0.2916666666666667" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="24" LOG_CI_END="-0.1989668461016144" LOG_CI_START="-0.871259557293084" LOG_EFFECT_SIZE="-0.5351132016973492" MODIFIED="2013-11-23 19:29:59 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1331" O_E="0.0" SE="0.39490806645646137" STUDY_ID="STD-Sezai-2011" TOTAL_1="70" TOTAL_2="70" VAR="0.15595238095238093" WEIGHT="2.8698455958767024"/><DICH_DATA CI_END="0.5360855287701065" CI_START="0.05040605255789461" EFFECT_SIZE="0.1643835616438356" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="17" LOG_CI_END="-0.27076591607279954" LOG_CI_START="-1.2975173120728625" LOG_EFFECT_SIZE="-0.7841416140728311" MODIFIED="2013-11-23 19:30:05 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1329" O_E="0.0" SE="0.6031188525118167" STUDY_ID="STD-Osada-2012" TOTAL_1="73" TOTAL_2="68" VAR="0.36375235025517055" WEIGHT="1.606914494186982"/><DICH_DATA CI_END="1.054651649041015" CI_START="0.16461464908244738" EFFECT_SIZE="0.4166666666666667" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="12" LOG_CI_END="0.02310903604935179" LOG_CI_START="-0.7835315194725638" LOG_EFFECT_SIZE="-0.38021124171160603" MODIFIED="2013-11-24 05:52:06 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1505" O_E="0.0" SE="0.47382465524872025" STUDY_ID="STD-Sezai-2012" TOTAL_1="34" TOTAL_2="34" VAR="0.2245098039215686" WEIGHT="2.278928456016024"><FOOTNOTE>Only patients in the landiolol subgroup considered.</FOOTNOTE></DICH_DATA><DICH_DATA CI_END="0.8263453347887832" CI_START="0.17017703625802433" EFFECT_SIZE="0.375" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="16" LOG_CI_END="-0.0828384204148983" LOG_CI_START="-0.7690990441296639" LOG_EFFECT_SIZE="-0.42596873227228116" MODIFIED="2013-11-23 19:30:13 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1330" O_E="0.0" SE="0.4031128874149275" STUDY_ID="STD-Sakaguchi-2012" TOTAL_1="30" TOTAL_2="30" VAR="0.1625" WEIGHT="2.8004935321719873"/><DICH_DATA CI_END="0.9285567066549609" CI_START="0.2912046168662018" EFFECT_SIZE="0.52" ESTIMABLE="YES" EVENTS_1="13" EVENTS_2="25" LOG_CI_END="-0.032191568892075674" LOG_CI_START="-0.5358017438383259" LOG_EFFECT_SIZE="-0.28399665636520083" MODIFIED="2013-11-23 19:30:20 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1328" O_E="0.0" SE="0.29582310967399855" STUDY_ID="STD-Ogawa-2013" TOTAL_1="68" TOTAL_2="68" VAR="0.08751131221719458" WEIGHT="3.872183407398059"/></DICH_SUBGROUP><DICH_SUBGROUP CHI2="0.4535648681755665" CI_END="1.2478474903102539" CI_START="0.24646753276499625" DF="1" EFFECT_SIZE="0.5545754161552429" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="14" I2="0.0" ID="CMP-005.13.08" LOG_CI_END="0.09616150989445302" LOG_CI_START="-0.6082402823489617" LOG_EFFECT_SIZE="-0.25603938622725436" MODIFIED="2013-11-23 19:31:40 +0000" MODIFIED_BY="Hermann Blessberger" NO="8" P_CHI2="0.5006469273256156" P_Z="0.15420505692728143" STUDIES="2" TAU2="0.0" TOTAL_1="87" TOTAL_2="86" WEIGHT="3.360351921414691" Z="1.4248344656560628"><NAME>Timolol</NAME><DICH_DATA CI_END="1.3632093309631186" CI_START="0.12220958833054184" EFFECT_SIZE="0.40816326530612246" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="7" LOG_CI_END="0.134562550113297" LOG_CI_START="-0.912894718842362" LOG_EFFECT_SIZE="-0.3891660843645325" MODIFIED="2013-11-23 19:31:34 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1333" O_E="0.0" SE="0.615281584781658" STUDY_ID="STD-White-1984" TOTAL_1="21" TOTAL_2="20" VAR="0.37857142857142856" WEIGHT="1.5580189180152384"/><DICH_DATA CI_END="2.1367282344833174" CI_START="0.23877818123933087" EFFECT_SIZE="0.7142857142857143" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="7" LOG_CI_END="0.3297492887669275" LOG_CI_START="-0.6220053601234036" LOG_EFFECT_SIZE="-0.146128035678238" MODIFIED="2013-11-23 19:31:40 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1332" O_E="0.0" SE="0.5590653920196748" STUDY_ID="STD-Vecht-1986" TOTAL_1="66" TOTAL_2="66" VAR="0.3125541125541126" WEIGHT="1.8023330033994522"/></DICH_SUBGROUP></DICH_OUTCOME><DICH_OUTCOME CHI2="1.783444442082041" CI_END="0.9638337600569815" CI_START="0.5696557741199099" CI_STUDY="95" CI_TOTAL="95" DF="2" EFFECT_MEASURE="RR" EFFECT_SIZE="0.7409814212975675" ESTIMABLE="YES" EVENTS_1="94" EVENTS_2="129" I2="0.0" I2_Q="0.0" ID="CMP-005.14" LOG_CI_END="-0.015997865802319794" LOG_CI_START="-0.2443874961853107" LOG_EFFECT_SIZE="-0.13019268099381526" METHOD="MH" MODIFIED="2017-06-17 15:47:47 +0100" MODIFIED_BY="Hermann Blessberger" NO="14" P_CHI2="0.4099491604941542" P_Q="0.8548519062761701" P_Z="0.025447515659458415" Q="0.033463892490119364" RANDOM="YES" SCALE="100.0" SORT_BY="YEAR" STUDIES="3" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="4253" TOTAL_2="4257" WEIGHT="100.00000000000001" Z="2.234540730861431"><NAME>Atrial fibrillation and flutter&#8212;non-cardiac surgery</NAME><GROUP_LABEL_1>Beta-blocker</GROUP_LABEL_1><GROUP_LABEL_2>Control</GROUP_LABEL_2><GRAPH_LABEL_1>Favours beta-blocker</GRAPH_LABEL_1><GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2><DICH_SUBGROUP CHI2="1.7075961442381382" CI_END="2.366347281907985" CI_START="0.10765619231590712" DF="1" EFFECT_SIZE="0.5047295692420944" ESTIMABLE="YES" EVENTS_1="91" EVENTS_2="124" I2="41.43814371013584" ID="CMP-005.14.01" LOG_CI_END="0.3740784814366708" LOG_CI_START="-0.9679609847788675" LOG_EFFECT_SIZE="-0.2969412516710983" MODIFIED="2013-11-23 19:34:39 +0000" MODIFIED_BY="Hermann Blessberger" NO="1" P_CHI2="0.1912976468114711" P_Z="0.38576236445719947" STUDIES="2" TAU2="0.7700590003070359" TOTAL_1="4204" TOTAL_2="4207" WEIGHT="96.34870457975276" Z="0.8673279340149087"><NAME>Metoprolol</NAME><DICH_DATA CI_END="1.9774190029426781" CI_START="0.006243329812231785" EFFECT_SIZE="0.1111111111111111" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="4" LOG_CI_END="0.29609870339830113" LOG_CI_START="-2.204583722276951" LOG_EFFECT_SIZE="-0.9542425094393249" MODIFIED="2013-11-23 19:34:29 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1334" O_E="0.0" SE="1.4689132354192893" STUDY_ID="STD-Lai-2006" TOTAL_1="30" TOTAL_2="30" VAR="2.1577060931899643" WEIGHT="0.8341337226948862"/><DICH_DATA CI_END="0.9931562131790224" CI_START="0.5798648580922154" EFFECT_SIZE="0.7588783740616515" ESTIMABLE="YES" EVENTS_1="91" EVENTS_2="120" LOG_CI_END="-0.002982436110955725" LOG_CI_START="-0.23667321027073493" LOG_EFFECT_SIZE="-0.11982782319084534" MODIFIED="2013-11-23 19:34:39 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1335" O_E="0.0" SE="0.13727111752944285" STUDY_ID="STD-POISE-2008" TOTAL_1="4174" TOTAL_2="4177" VAR="0.01884335970778211" WEIGHT="95.51457085705788"/></DICH_SUBGROUP><DICH_SUBGROUP CHI2="0.0" CI_END="2.4240530226292014" CI_START="0.15463515508026482" DF="0" EFFECT_SIZE="0.6122448979591837" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="5" I2="0.0" ID="CMP-005.14.02" LOG_CI_END="0.38454211515738" LOG_CI_START="-0.8106917657750824" LOG_EFFECT_SIZE="-0.21307482530885122" MODIFIED="2013-11-23 19:34:50 +0000" MODIFIED_BY="Hermann Blessberger" NO="2" P_CHI2="1.0" P_Z="0.48467257216380144" STUDIES="1" TAU2="0.0" TOTAL_1="49" TOTAL_2="50" WEIGHT="3.6512954202472487" Z="0.6988071377155178"><NAME>Propranolol</NAME><DICH_DATA CI_END="2.4240530226292014" CI_START="0.15463515508026482" EFFECT_SIZE="0.6122448979591837" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="5" LOG_CI_END="0.38454211515738" LOG_CI_START="-0.8106917657750824" LOG_EFFECT_SIZE="-0.21307482530885122" MODIFIED="2013-11-23 19:34:50 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1336" O_E="0.0" SE="0.7020862981628592" STUDY_ID="STD-Bayliff-1999" TOTAL_1="49" TOTAL_2="50" VAR="0.49292517006802716" WEIGHT="3.6512954202472487"/></DICH_SUBGROUP><DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-005.14.03" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2017-06-17 15:47:47 +0100" MODIFIED_BY="Hermann Blessberger" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0"><NAME>Esmolol</NAME></DICH_SUBGROUP></DICH_OUTCOME><DICH_OUTCOME CHI2="199.98065204226307" CI_END="0.5398279948578245" CI_START="0.36651974625590855" CI_STUDY="95" CI_TOTAL="95" DF="48" EFFECT_MEASURE="RR" EFFECT_SIZE="0.4448118924861674" ESTIMABLE="YES" EVENTS_1="551" EVENTS_2="1102" I2="75.99767802044376" I2_Q="43.78544451749286" ID="CMP-005.15" LOG_CI_END="-0.267744597184061" LOG_CI_START="-0.43590262277191877" LOG_EFFECT_SIZE="-0.35182360997798984" METHOD="MH" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" NO="15" P_CHI2="-2.220446049250313E-16" P_Q="0.07593506562768815" P_Z="2.3769781949179154E-16" Q="14.231189647118072" RANDOM="YES" SCALE="100.0" SORT_BY="YEAR" STUDIES="47" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.271439977868782" TOTALS="YES" TOTAL_1="3122" TOTAL_2="3170" WEIGHT="100.0" Z="8.201352294154411"><NAME>All supraventricular arrhythmias&#8212;cardiac surgery</NAME><GROUP_LABEL_1>Beta-blocker</GROUP_LABEL_1><GROUP_LABEL_2>Control</GROUP_LABEL_2><GRAPH_LABEL_1>Favours beta-blocker</GRAPH_LABEL_1><GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2><DICH_SUBGROUP CHI2="24.8556197460021" CI_END="0.7989745020312498" CI_START="0.42854370314339874" DF="8" EFFECT_SIZE="0.5851457013578967" ESTIMABLE="YES" EVENTS_1="267" EVENTS_2="380" I2="67.81411977753336" ID="CMP-005.15.01" LOG_CI_END="-0.09746708026526327" LOG_CI_START="-0.36800488187102953" LOG_EFFECT_SIZE="-0.23273598106814633" MODIFIED="2013-11-24 05:42:21 +0000" MODIFIED_BY="Hermann Blessberger" NO="1" P_CHI2="0.0016445816124198709" P_Z="7.456956861578674E-4" STUDIES="9" TAU2="0.12675357760590739" TOTAL_1="1164" TOTAL_2="1077" WEIGHT="22.806556299745345" Z="3.372202613406912"><NAME>Metoprolol</NAME><DICH_DATA CI_END="0.9738057991036437" CI_START="0.1875408710080555" EFFECT_SIZE="0.42735042735042733" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="18" LOG_CI_END="-0.011527643518597037" LOG_CI_START="-0.7269040713016887" LOG_EFFECT_SIZE="-0.36921585741014284" MODIFIED="2013-11-24 05:42:21 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1500" O_E="0.0" SE="0.42021565485021684" STUDY_ID="STD-Janssen-1986" TOTAL_1="39" TOTAL_2="50" VAR="0.1765811965811966" WEIGHT="2.177769257643564"><FOOTNOTE>Only patients in the metoprolol subgroup considered.</FOOTNOTE></DICH_DATA><DICH_DATA CI_END="0.967053167072245" CI_START="0.41868044849390096" EFFECT_SIZE="0.6363067292644757" ESTIMABLE="YES" EVENTS_1="38" EVENTS_2="30" LOG_CI_END="-0.014549648428526057" LOG_CI_START="-0.37811731928423464" LOG_EFFECT_SIZE="-0.19633348385638036" MODIFIED="2013-11-23 19:45:08 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1342" O_E="0.0" SE="0.213561449549639" STUDY_ID="STD-Graham-1996" TOTAL_1="213" TOTAL_2="107" VAR="0.045608492733743004" WEIGHT="3.07740560500517"/><DICH_DATA CI_END="1.8214515190598082" CI_START="0.4677977958792884" EFFECT_SIZE="0.9230769230769231" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="13" LOG_CI_END="0.26041761626692334" LOG_CI_START="-0.32994182878534717" LOG_EFFECT_SIZE="-0.03476210625921192" MODIFIED="2013-11-23 19:45:14 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1343" O_E="0.0" SE="0.3467800603500874" STUDY_ID="STD-Paull-1997" TOTAL_1="50" TOTAL_2="50" VAR="0.12025641025641025" WEIGHT="2.4909260592382148"/><DICH_DATA CI_END="0.7899548058160761" CI_START="0.21326202895259727" EFFECT_SIZE="0.41044776119402987" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="24" LOG_CI_END="-0.10239775446416542" LOG_CI_START="-0.6710864632769621" LOG_EFFECT_SIZE="-0.38674210887056376" MODIFIED="2013-11-23 19:45:22 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1341" O_E="0.0" SE="0.33405056261114596" STUDY_ID="STD-Dy-1998" TOTAL_1="67" TOTAL_2="66" VAR="0.11158977838082317" WEIGHT="2.5472870568695747"/><DICH_DATA CI_END="0.29201086050273417" CI_START="0.0400237272634076" EFFECT_SIZE="0.10810810810810811" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="37" LOG_CI_END="-0.5346009959190617" LOG_CI_START="-1.3976824695590033" LOG_EFFECT_SIZE="-0.9661417327390326" MODIFIED="2013-11-23 19:45:31 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1344" O_E="0.0" SE="0.5069783299382993" STUDY_ID="STD-Wenke-1999" TOTAL_1="100" TOTAL_2="100" VAR="0.257027027027027" WEIGHT="1.8462585770759536"/><DICH_DATA CI_END="0.8846657886054342" CI_START="0.2374562768789701" EFFECT_SIZE="0.4583333333333333" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="24" LOG_CI_END="-0.05322076724324717" LOG_CI_START="-0.6244163458635148" LOG_EFFECT_SIZE="-0.338818556553381" MODIFIED="2013-11-23 19:45:40 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1340" O_E="0.0" SE="0.3355231103452601" STUDY_ID="STD-De-Azevedo-L_x00fa_cio-2003" TOTAL_1="100" TOTAL_2="100" VAR="0.11257575757575758" WEIGHT="2.5407467726838453"/><DICH_DATA CI_END="0.9484074945855946" CI_START="0.674815418112704" EFFECT_SIZE="0.8" ESTIMABLE="YES" EVENTS_1="156" EVENTS_2="195" LOG_CI_END="-0.023005022761850884" LOG_CI_START="-0.17081500325426194" LOG_EFFECT_SIZE="-0.09691001300805639" MODIFIED="2013-11-23 19:45:51 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1339" O_E="0.0" SE="0.08682431421244592" STUDY_ID="STD-Connolly-2003" TOTAL_1="500" TOTAL_2="500" VAR="0.007538461538461539" WEIGHT="3.497355360376979"/><DICH_DATA CI_END="5.055834822644325" CI_START="0.4316467581119249" EFFECT_SIZE="1.4772727272727273" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="4" LOG_CI_END="0.703792876827747" LOG_CI_START="-0.36487151651441074" LOG_EFFECT_SIZE="0.16946068015666815" MODIFIED="2013-11-23 19:46:00 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1338" O_E="0.0" SE="0.6277387546232461" STUDY_ID="STD-Booth-2004" TOTAL_1="33" TOTAL_2="39" VAR="0.394055944055944" WEIGHT="1.466104762398359"/><DICH_DATA CI_END="1.0920771323502998" CI_START="0.5134923166717597" EFFECT_SIZE="0.7488479262672811" ESTIMABLE="YES" EVENTS_1="25" EVENTS_2="35" LOG_CI_END="0.03825331325068957" LOG_CI_START="-0.2894660503179622" LOG_EFFECT_SIZE="-0.1256063685336363" MODIFIED="2013-11-24 05:29:19 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1486" O_E="0.0" SE="0.1925039763972388" STUDY_ID="STD-Auer-2004" TOTAL_1="62" TOTAL_2="65" VAR="0.037057780928748674" WEIGHT="3.1627028484536828"><FOOTNOTE>Only patients in the metoprolol subgroup considered.</FOOTNOTE></DICH_DATA></DICH_SUBGROUP><DICH_SUBGROUP CHI2="20.868220957183855" CI_END="0.6078286662966134" CI_START="0.34000786076417383" DF="15" EFFECT_SIZE="0.4546059002461939" ESTIMABLE="YES" EVENTS_1="83" EVENTS_2="220" I2="28.12037005561669" ID="CMP-005.15.02" LOG_CI_END="-0.21621882166170603" LOG_CI_START="-0.4685110422311552" LOG_EFFECT_SIZE="-0.3423649319464306" MODIFIED="2013-12-01 13:09:36 +0000" MODIFIED_BY="Hermann Blessberger" NO="2" P_CHI2="0.14109292144543217" P_Z="1.041040428397024E-7" STUDIES="16" TAU2="0.09387403346710173" TOTAL_1="654" TOTAL_2="767" WEIGHT="28.328254701181237" Z="5.319410441352046"><NAME>Propranolol</NAME><DICH_DATA CI_END="2.4143738176207648" CI_START="0.18041945154510514" EFFECT_SIZE="0.66" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="5" LOG_CI_END="0.38280451280407934" LOG_CI_START="-0.7437166417203419" LOG_EFFECT_SIZE="-0.1804560644581313" MODIFIED="2013-11-23 19:46:21 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1357" O_E="0.0" SE="0.6617241025372945" STUDY_ID="STD-Salazar-1979" TOTAL_1="20" TOTAL_2="22" VAR="0.43787878787878787" WEIGHT="1.3755264735766932"/><DICH_DATA CI_END="0.8969131509065325" CI_START="0.05911511257256819" EFFECT_SIZE="0.23026315789473684" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="16" LOG_CI_END="-0.047249608135544637" LOG_CI_START="-1.2283014790534492" LOG_EFFECT_SIZE="-0.637775543594497" MODIFIED="2013-11-23 19:46:28 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1354" O_E="0.0" SE="0.6937557152782261" STUDY_ID="STD-Oka-1980" TOTAL_1="19" TOTAL_2="35" VAR="0.48129699248120306" WEIGHT="1.296185492306671"/><DICH_DATA CI_END="1.0124518038855774" CI_START="0.20532344839946126" EFFECT_SIZE="0.4559386973180077" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="24" LOG_CI_END="0.00537435849931325" LOG_CI_START="-0.6875614503908136" LOG_EFFECT_SIZE="-0.3410935459457502" MODIFIED="2013-11-23 19:46:37 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1359" O_E="0.0" SE="0.4070339242296343" STUDY_ID="STD-Stephenson-1980" TOTAL_1="87" TOTAL_2="136" VAR="0.16567661547377568" WEIGHT="2.2320972375576353"/><DICH_DATA CI_END="0.5496310050546848" CI_START="0.03392818225948094" EFFECT_SIZE="0.13655761024182078" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="19" LOG_CI_END="-0.25992877641364504" LOG_CI_START="-1.469439407546866" LOG_EFFECT_SIZE="-0.8646840919802555" MODIFIED="2013-11-23 19:46:43 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1352" O_E="0.0" SE="0.7104725319018379" STUDY_ID="STD-Mohr-1981" TOTAL_1="37" TOTAL_2="48" VAR="0.504771218587008" WEIGHT="1.2569861719923008"/><DICH_DATA CI_END="0.6999722648647813" CI_START="0.0656002668274423" EFFECT_SIZE="0.21428571428571427" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="14" LOG_CI_END="-0.15491916777833195" LOG_CI_START="-1.1830943941388192" LOG_EFFECT_SIZE="-0.6690067809585756" MODIFIED="2013-11-23 19:46:50 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1358" O_E="0.0" SE="0.603955217513604" STUDY_ID="STD-Silverman-1982" TOTAL_1="50" TOTAL_2="50" VAR="0.36476190476190473" WEIGHT="1.5336118410339734"/><DICH_DATA CI_END="1.4875364844811094" CI_START="0.02439011043885608" EFFECT_SIZE="0.19047619047619047" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="6" LOG_CI_END="0.17246762637672552" LOG_CI_START="-1.6127862331886396" LOG_EFFECT_SIZE="-0.7201593034059569" MODIFIED="2013-11-23 19:46:56 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1360" O_E="0.0" SE="1.048666954257824" STUDY_ID="STD-Williams-1982" TOTAL_1="28" TOTAL_2="32" VAR="1.099702380952381" WEIGHT="0.7115867540766316"/><DICH_DATA CI_END="2.0488361448048726" CI_START="0.32963107650375956" EFFECT_SIZE="0.8218029350104822" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="9" LOG_CI_END="0.3115072271896002" LOG_CI_START="-0.4819718512289136" LOG_EFFECT_SIZE="-0.08523231201965667" MODIFIED="2013-11-23 19:47:09 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1349" O_E="0.0" SE="0.46609353844781976" STUDY_ID="STD-Ivey-1983" TOTAL_1="53" TOTAL_2="56" VAR="0.21724318658280922" WEIGHT="1.9965630319707457"/><DICH_DATA CI_END="0.9625082004987383" CI_START="0.2097281543575606" EFFECT_SIZE="0.4492939666238768" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="19" LOG_CI_END="-0.016595561646807904" LOG_CI_START="-0.6783432649977698" LOG_EFFECT_SIZE="-0.3474694133222888" MODIFIED="2013-12-01 13:09:36 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1345" O_E="0.0" SE="0.38871387665231644" STUDY_ID="STD-Abel-1983" TOTAL_1="41" TOTAL_2="50" VAR="0.15109847790207226" WEIGHT="2.309107554981101"/><DICH_DATA CI_END="1.0920886040087217" CI_START="0.18657087736694164" EFFECT_SIZE="0.4513888888888889" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="12" LOG_CI_END="0.03825787524694105" LOG_CI_START="-0.7291561461517292" LOG_EFFECT_SIZE="-0.3454491354523941" MODIFIED="2013-11-23 19:47:16 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1348" O_E="0.0" SE="0.4507827949302504" STUDY_ID="STD-Hammon-1984" TOTAL_1="24" TOTAL_2="26" VAR="0.2032051282051282" WEIGHT="2.0556131897388545"/><DICH_DATA CI_END="1.5715363292104452" CI_START="0.18776337809660357" EFFECT_SIZE="0.5432098765432098" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="9" LOG_CI_END="0.19632442505659703" LOG_CI_START="-0.7263891098415217" LOG_EFFECT_SIZE="-0.2650323423924623" MODIFIED="2013-11-23 19:47:27 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1355" O_E="0.0" SE="0.5420064979048165" STUDY_ID="STD-Ormerod-1984" TOTAL_1="27" TOTAL_2="33" VAR="0.2937710437710438" WEIGHT="1.7262344560440517"/><DICH_DATA CI_END="1.1085399331216403" CI_START="0.06960551579759253" EFFECT_SIZE="0.2777777777777778" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="9" LOG_CI_END="0.04475134239592844" LOG_CI_START="-1.157356343930503" LOG_EFFECT_SIZE="-0.5563025007672873" MODIFIED="2013-11-23 19:47:22 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1353" O_E="0.0" SE="0.706124005477162" STUDY_ID="STD-Myhre-1984" TOTAL_1="16" TOTAL_2="20" VAR="0.49861111111111117" WEIGHT="1.267041569648379"/><DICH_DATA CI_END="0.906876568196414" CI_START="0.1954900201161221" EFFECT_SIZE="0.42105263157894735" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="19" LOG_CI_END="-0.042451819223332604" LOG_CI_START="-0.7088754086984382" LOG_EFFECT_SIZE="-0.3756636139608854" MODIFIED="2013-11-23 19:47:35 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1351" O_E="0.0" SE="0.3914605153076481" STUDY_ID="STD-Matangi-1985" TOTAL_1="82" TOTAL_2="82" VAR="0.15324133504492937" WEIGHT="2.297456259133238"/><DICH_DATA CI_END="0.9962321240462663" CI_START="0.1877050579938394" EFFECT_SIZE="0.43243243243243246" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="15" LOG_CI_END="-0.0016394583162494887" LOG_CI_START="-0.7265240245058909" LOG_EFFECT_SIZE="-0.3640817414110702" MODIFIED="2013-11-23 19:47:42 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1356" O_E="0.0" SE="0.42580078241626834" STUDY_ID="STD-Rubin-1987" TOTAL_1="37" TOTAL_2="40" VAR="0.18130630630630631" WEIGHT="2.155040857526298"/><DICH_DATA CI_END="4.126826287091888" CI_START="0.7815504113324163" EFFECT_SIZE="1.7959183673469388" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="7" LOG_CI_END="0.6156161882509973" LOG_CI_START="-0.10704300400768743" LOG_EFFECT_SIZE="0.25428659212165494" MODIFIED="2013-11-23 19:47:48 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1350" O_E="0.0" SE="0.4244935867534458" STUDY_ID="STD-Martinussen-1988" TOTAL_1="35" TOTAL_2="40" VAR="0.18019480519480519" WEIGHT="2.1603445462551036"/><DICH_DATA CI_END="0.7907637030184065" CI_START="0.0484655463980742" EFFECT_SIZE="0.19576719576719576" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="14" LOG_CI_END="-0.10195327352704722" LOG_CI_START="-1.3145668866854512" LOG_EFFECT_SIZE="-0.7082600801062492" MODIFIED="2013-11-23 19:47:54 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1346" O_E="0.0" SE="0.7122952389034392" STUDY_ID="STD-Babin_x002d_Ebell-1996" TOTAL_1="27" TOTAL_2="37" VAR="0.5073645073645074" WEIGHT="1.252800618114394"/><DICH_DATA CI_END="0.8589583309812318" CI_START="0.26561019438408295" EFFECT_SIZE="0.47764849969381507" ESTIMABLE="YES" EVENTS_1="13" EVENTS_2="23" LOG_CI_END="-0.0660279037634654" LOG_CI_START="-0.5757552603289101" LOG_EFFECT_SIZE="-0.3208915820461878" MODIFIED="2013-11-23 19:48:01 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1347" O_E="0.0" SE="0.29941637243765074" STUDY_ID="STD-Bert-2001" TOTAL_1="71" TOTAL_2="60" VAR="0.08965016408372196" WEIGHT="2.70205864722517"/></DICH_SUBGROUP><DICH_SUBGROUP CHI2="10.26789227271504" CI_END="0.5639760854028764" CI_START="0.36924361141956213" DF="9" EFFECT_SIZE="0.456338215064688" ESTIMABLE="YES" EVENTS_1="115" EVENTS_2="269" I2="12.348125974054295" ID="CMP-005.15.03" LOG_CI_END="-0.24873931126092344" LOG_CI_START="-0.43268701002883175" LOG_EFFECT_SIZE="-0.3407131606448776" MODIFIED="2013-11-24 05:42:27 +0000" MODIFIED_BY="Hermann Blessberger" NO="3" P_CHI2="0.3292364746805181" P_Z="3.853710324889177E-13" STUDIES="10" TAU2="0.014291020704305846" TOTAL_1="683" TOTAL_2="700" WEIGHT="22.607309920130668" Z="7.260602099353604"><NAME>Sotalol</NAME><DICH_DATA CI_END="0.4862436695219137" CI_START="0.009440028920356301" EFFECT_SIZE="0.06775067750677506" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="18" LOG_CI_END="-0.31314603977337685" LOG_CI_START="-2.0250266752006687" LOG_EFFECT_SIZE="-1.1690863574870227" MODIFIED="2013-11-24 05:42:27 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1501" O_E="0.0" SE="1.0055671591958026" STUDY_ID="STD-Janssen-1986" TOTAL_1="41" TOTAL_2="50" VAR="1.0111653116531165" WEIGHT="0.7607069364685238"><FOOTNOTE>Only patients in the sotalol subgroup considered.</FOOTNOTE></DICH_DATA><DICH_DATA CI_END="0.8089575542744424" CI_START="0.33649691357538647" EFFECT_SIZE="0.5217391304347826" ESTIMABLE="YES" EVENTS_1="24" EVENTS_2="46" LOG_CI_END="-0.09207426507251505" LOG_CI_START="-0.47301891486742115" LOG_EFFECT_SIZE="-0.28254658996996806" MODIFIED="2013-11-23 19:48:25 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1368" O_E="0.0" SE="0.22376877299595657" STUDY_ID="STD-Suttorp-1991" TOTAL_1="150" TOTAL_2="150" VAR="0.05007246376811594" WEIGHT="3.034678022172545"/><DICH_DATA CI_END="0.8651318953082401" CI_START="0.13362124391311758" EFFECT_SIZE="0.34" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="15" LOG_CI_END="-0.06291767630644172" LOG_CI_START="-0.8741244896090479" LOG_EFFECT_SIZE="-0.46852108295774486" MODIFIED="2013-11-23 19:48:31 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1366" O_E="0.0" SE="0.4765068976724385" STUDY_ID="STD-Nystr_x00f6_m-1993" TOTAL_1="50" TOTAL_2="51" VAR="0.22705882352941176" WEIGHT="1.957249922675667"/><DICH_DATA CI_END="1.9174334705591203" CI_START="0.15030479565965907" EFFECT_SIZE="0.5368421052631579" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="5" LOG_CI_END="0.2827203041097743" LOG_CI_START="-0.8230271624915971" LOG_EFFECT_SIZE="-0.2701534291909114" MODIFIED="2013-11-23 19:48:36 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1364" O_E="0.0" SE="0.6495215354198813" STUDY_ID="STD-Jacquet-1994" TOTAL_1="19" TOTAL_2="17" VAR="0.4218782249742002" WEIGHT="1.4072712017219229"/><DICH_DATA CI_END="0.8367549673280018" CI_START="0.38960932218699135" EFFECT_SIZE="0.5709706959706959" ESTIMABLE="YES" EVENTS_1="29" EVENTS_2="52" LOG_CI_END="-0.07740170080856265" LOG_CI_START="-0.40937066029975144" LOG_EFFECT_SIZE="-0.24338618055415703" MODIFIED="2013-11-23 19:48:46 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1367" O_E="0.0" SE="0.19500021007797613" STUDY_ID="STD-Pfisterer-1997" TOTAL_1="126" TOTAL_2="129" VAR="0.03802508193045483" WEIGHT="3.152817126183799"/><DICH_DATA CI_END="0.815131215366541" CI_START="0.13431350612509407" EFFECT_SIZE="0.33088235294117646" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="17" LOG_CI_END="-0.08877247528121683" LOG_CI_START="-0.8718803139085308" LOG_EFFECT_SIZE="-0.48032639459487386" MODIFIED="2013-11-23 19:48:52 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1363" O_E="0.0" SE="0.460001420856004" STUDY_ID="STD-Gomes-1999" TOTAL_1="40" TOTAL_2="45" VAR="0.2116013071895425" WEIGHT="2.019882711211152"/><DICH_DATA CI_END="0.559711576637503" CI_START="0.20705225265439542" EFFECT_SIZE="0.3404255319148936" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="47" LOG_CI_END="-0.2520357103921946" LOG_CI_START="-0.6839200401673907" LOG_EFFECT_SIZE="-0.4679778752797927" MODIFIED="2013-11-23 19:49:02 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1361" O_E="0.0" SE="0.2536909931718616" STUDY_ID="STD-Evrard-2000" TOTAL_1="103" TOTAL_2="103" VAR="0.06435912001652552" WEIGHT="2.9055668899496987"/><DICH_DATA CI_END="0.925811812744811" CI_START="0.17282129888323441" EFFECT_SIZE="0.4" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="15" LOG_CI_END="-0.03347728220825417" LOG_CI_START="-0.762402735135821" LOG_EFFECT_SIZE="-0.3979400086720376" MODIFIED="2013-11-23 19:49:22 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1365" O_E="0.0" SE="0.42817441928883765" STUDY_ID="STD-Matsuura-2001" TOTAL_1="40" TOTAL_2="40" VAR="0.18333333333333335" WEIGHT="2.1454353552794614"/><DICH_DATA CI_END="0.7105931245191439" CI_START="0.13488819843100122" EFFECT_SIZE="0.30959752321981426" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="19" LOG_CI_END="-0.14837899892640086" LOG_CI_START="-0.8700260457358048" LOG_EFFECT_SIZE="-0.5092025223311029" MODIFIED="2013-11-23 19:49:32 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1362" O_E="0.0" SE="0.4238990475063375" STUDY_ID="STD-Forlani-2002" TOTAL_1="51" TOTAL_2="50" VAR="0.17969040247678017" WEIGHT="2.1627599979925076"/><DICH_DATA CI_END="0.9029960738346579" CI_START="0.38493167985048793" EFFECT_SIZE="0.5895691609977324" ESTIMABLE="YES" EVENTS_1="20" EVENTS_2="35" LOG_CI_END="-0.04431413796517636" LOG_CI_START="-0.41461634502886485" LOG_EFFECT_SIZE="-0.2294652414970206" MODIFIED="2013-11-24 05:29:43 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1487" O_E="0.0" SE="0.21751734945469825" STUDY_ID="STD-Auer-2004" TOTAL_1="63" TOTAL_2="65" VAR="0.04731379731379731" WEIGHT="3.060941756475395"><FOOTNOTE>Only patients in the sotalol subgroup considered.</FOOTNOTE></DICH_DATA></DICH_SUBGROUP><DICH_SUBGROUP CHI2="1.403642942806996" CI_END="0.760101740374637" CI_START="0.06789860687777179" DF="1" EFFECT_SIZE="0.2271780122652886" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="23" I2="28.756810617363527" ID="CMP-005.15.04" LOG_CI_END="-0.11912827307968551" LOG_CI_START="-1.1681391363454652" LOG_EFFECT_SIZE="-0.6436337047125753" MODIFIED="2013-11-23 19:49:56 +0000" MODIFIED_BY="Hermann Blessberger" NO="4" P_CHI2="0.23611479546236314" P_Z="0.016167124261984203" STUDIES="2" TAU2="0.26245528142688657" TOTAL_1="65" TOTAL_2="65" WEIGHT="2.5346809647571575" Z="2.4051207182839627"><NAME>Atenolol</NAME><DICH_DATA CI_END="0.6607918354063609" CI_START="0.012506908177573097" EFFECT_SIZE="0.09090909090909091" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="11" LOG_CI_END="-0.17993533169837356" LOG_CI_START="-1.9028500386180767" LOG_EFFECT_SIZE="-1.041392685158225" MODIFIED="2013-11-23 19:49:49 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1369" O_E="0.0" SE="1.0120486274099798" STUDY_ID="STD-Lamb-1988" TOTAL_1="30" TOTAL_2="30" VAR="1.024242424242424" WEIGHT="0.7530292445901308"/><DICH_DATA CI_END="0.9337223063907559" CI_START="0.11899802580555667" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="12" LOG_CI_END="-0.02978226588341088" LOG_CI_START="-0.9244602435559142" LOG_EFFECT_SIZE="-0.47712125471966244" MODIFIED="2013-11-23 19:49:56 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1370" O_E="0.0" SE="0.5255382728122435" STUDY_ID="STD-Matangi-1989" TOTAL_1="35" TOTAL_2="35" VAR="0.27619047619047615" WEIGHT="1.781651720167027"/></DICH_SUBGROUP><DICH_SUBGROUP CHI2="17.873286638924778" CI_END="5.075909773710479" CI_START="0.07997436177985237" DF="1" EFFECT_SIZE="0.637136284168945" ESTIMABLE="YES" EVENTS_1="25" EVENTS_2="32" I2="94.40505811716699" ID="CMP-005.15.05" LOG_CI_END="0.7055138937363153" LOG_CI_START="-1.097049217034344" LOG_EFFECT_SIZE="-0.1957676616490142" MODIFIED="2013-11-23 19:50:16 +0000" MODIFIED_BY="Hermann Blessberger" NO="5" P_CHI2="2.3611478559892873E-5" P_Z="0.6703086678510732" STUDIES="2" TAU2="2.1229343077071907" TOTAL_1="87" TOTAL_2="86" WEIGHT="5.412657388012253" Z="0.42572441860928456"><NAME>Timolol</NAME><DICH_DATA CI_END="1.1517322070933487" CI_START="0.8726150111164188" EFFECT_SIZE="1.0025062656641603" ESTIMABLE="YES" EVENTS_1="20" EVENTS_2="19" LOG_CI_END="0.06135151163809717" LOG_CI_START="-0.059177320355668896" LOG_EFFECT_SIZE="0.0010870956412141369" MODIFIED="2013-11-23 19:50:09 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1372" O_E="0.0" SE="0.07079923254047887" STUDY_ID="STD-White-1984" TOTAL_1="21" TOTAL_2="20" VAR="0.005012531328320802" WEIGHT="3.529310489256187"/><DICH_DATA CI_END="1.0179832018909118" CI_START="0.14531575158417248" EFFECT_SIZE="0.38461538461538464" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="13" LOG_CI_END="0.007740611609507653" LOG_CI_START="-0.8376873075511435" LOG_EFFECT_SIZE="-0.4149733479708179" MODIFIED="2013-11-23 19:50:16 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1371" O_E="0.0" SE="0.4966085446506601" STUDY_ID="STD-Vecht-1986" TOTAL_1="66" TOTAL_2="66" VAR="0.24662004662004666" WEIGHT="1.8833468987560664"/></DICH_SUBGROUP><DICH_SUBGROUP CHI2="0.554328763675223" CI_END="1.748831894789372" CI_START="0.4594494569215089" DF="1" EFFECT_SIZE="0.8963815394730027" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="11" I2="0.0" ID="CMP-005.15.06" LOG_CI_END="0.24274806523961237" LOG_CI_START="-0.3377622574822478" LOG_EFFECT_SIZE="-0.047507096121317725" MODIFIED="2013-11-23 19:50:32 +0000" MODIFIED_BY="Hermann Blessberger" NO="6" P_CHI2="0.45655443848626687" P_Z="0.7483662899326129" STUDIES="2" TAU2="0.0" TOTAL_1="45" TOTAL_2="42" WEIGHT="2.828111112551551" Z="0.3207942865556176"><NAME>Esmolol</NAME><DICH_DATA CI_END="63.82881484401465" CI_START="0.12392766917779852" EFFECT_SIZE="2.8125" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.8050167806434498" LOG_CI_START="-0.9068317184046119" LOG_EFFECT_SIZE="0.4490925311194189" MODIFIED="2013-11-23 19:50:26 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1373" O_E="0.0" SE="1.592953232207399" STUDY_ID="STD-Cork-1995" TOTAL_1="15" TOTAL_2="14" VAR="2.5374999999999996" WEIGHT="0.3473505123561975"/><DICH_DATA CI_END="1.6818496358282289" CI_START="0.42805642238869207" EFFECT_SIZE="0.8484848484848485" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="11" LOG_CI_END="0.22578716551115877" LOG_CI_START="-0.3684989825824953" LOG_EFFECT_SIZE="-0.07135590853566824" MODIFIED="2013-11-23 19:50:32 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1374" O_E="0.0" SE="0.3490866251540896" STUDY_ID="STD-Sun-2011" TOTAL_1="30" TOTAL_2="28" VAR="0.12186147186147188" WEIGHT="2.4807606001953535"/></DICH_SUBGROUP><DICH_SUBGROUP CHI2="0.0" CI_END="0.421579851024765" CI_START="0.08503552553709799" DF="0" EFFECT_SIZE="0.18933901918976545" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="35" I2="0.0" ID="CMP-005.15.07" LOG_CI_END="-0.3751201539574404" LOG_CI_START="-1.070399599915524" LOG_EFFECT_SIZE="-0.7227598769364822" MODIFIED="2013-11-23 19:50:56 +0000" MODIFIED_BY="Hermann Blessberger" NO="7" P_CHI2="1.0" P_Z="4.604196517397977E-5" STUDIES="1" TAU2="0.0" TOTAL_1="67" TOTAL_2="74" WEIGHT="2.2263794992274843" Z="4.074860364422476"><NAME>Nadolol</NAME><DICH_DATA CI_END="0.421579851024765" CI_START="0.08503552553709799" EFFECT_SIZE="0.18933901918976545" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="35" LOG_CI_END="-0.3751201539574404" LOG_CI_START="-1.070399599915524" LOG_EFFECT_SIZE="-0.7227598769364822" MODIFIED="2013-11-23 19:50:56 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1375" O_E="0.0" SE="0.4084105882445427" STUDY_ID="STD-Khuri-1987" TOTAL_1="67" TOTAL_2="74" VAR="0.16679920859025338" WEIGHT="2.2263794992274843"/></DICH_SUBGROUP><DICH_SUBGROUP CHI2="3.6401812368023347" CI_END="0.5382315341500716" CI_START="0.26679189758089533" DF="4" EFFECT_SIZE="0.3789403809753905" ESTIMABLE="YES" EVENTS_1="34" EVENTS_2="94" I2="0.0" ID="CMP-005.15.08" LOG_CI_END="-0.2690308611873289" LOG_CI_START="-0.573827363995893" LOG_EFFECT_SIZE="-0.42142911259161087" MODIFIED="2013-11-24 05:52:52 +0000" MODIFIED_BY="Hermann Blessberger" NO="8" P_CHI2="0.4568859678376116" P_Z="5.962669190213446E-8" STUDIES="5" TAU2="0.0" TOTAL_1="275" TOTAL_2="270" WEIGHT="10.752838096930466" Z="5.419917060104958"><NAME>Landiolol</NAME><DICH_DATA CI_END="0.6324601313324618" CI_START="0.13450562372243266" EFFECT_SIZE="0.2916666666666667" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="24" LOG_CI_END="-0.1989668461016144" LOG_CI_START="-0.871259557293084" LOG_EFFECT_SIZE="-0.5351132016973492" MODIFIED="2013-11-23 19:51:06 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1379" O_E="0.0" SE="0.39490806645646137" STUDY_ID="STD-Sezai-2011" TOTAL_1="70" TOTAL_2="70" VAR="0.15595238095238093" WEIGHT="2.2828829770884873"/><DICH_DATA CI_END="1.054651649041015" CI_START="0.16461464908244738" EFFECT_SIZE="0.4166666666666667" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="12" LOG_CI_END="0.02310903604935179" LOG_CI_START="-0.7835315194725638" LOG_EFFECT_SIZE="-0.38021124171160603" MODIFIED="2013-11-24 05:52:52 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1506" O_E="0.0" SE="0.47382465524872025" STUDY_ID="STD-Sezai-2012" TOTAL_1="34" TOTAL_2="34" VAR="0.2245098039215686" WEIGHT="1.9673095468826574"><FOOTNOTE>Only patients in the landiolol subgroup considered.</FOOTNOTE></DICH_DATA><DICH_DATA CI_END="0.8263453347887832" CI_START="0.17017703625802433" EFFECT_SIZE="0.375" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="16" LOG_CI_END="-0.0828384204148983" LOG_CI_START="-0.7690990441296639" LOG_EFFECT_SIZE="-0.42596873227228116" MODIFIED="2013-11-23 19:51:12 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1378" O_E="0.0" SE="0.4031128874149275" STUDY_ID="STD-Sakaguchi-2012" TOTAL_1="30" TOTAL_2="30" VAR="0.1625" WEIGHT="2.2484370886555256"/><DICH_DATA CI_END="0.5360855287701065" CI_START="0.05040605255789461" EFFECT_SIZE="0.1643835616438356" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="17" LOG_CI_END="-0.27076591607279954" LOG_CI_START="-1.2975173120728625" LOG_EFFECT_SIZE="-0.7841416140728311" MODIFIED="2013-11-23 19:51:19 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1377" O_E="0.0" SE="0.6031188525118167" STUDY_ID="STD-Osada-2012" TOTAL_1="73" TOTAL_2="68" VAR="0.36375235025517055" WEIGHT="1.5360493149724097"/><DICH_DATA CI_END="0.9285567066549609" CI_START="0.2912046168662018" EFFECT_SIZE="0.52" ESTIMABLE="YES" EVENTS_1="13" EVENTS_2="25" LOG_CI_END="-0.032191568892075674" LOG_CI_START="-0.5358017438383259" LOG_EFFECT_SIZE="-0.28399665636520083" MODIFIED="2013-11-23 19:51:30 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1376" O_E="0.0" SE="0.29582310967399855" STUDY_ID="STD-Ogawa-2013" TOTAL_1="68" TOTAL_2="68" VAR="0.08751131221719458" WEIGHT="2.7181591693313853"/></DICH_SUBGROUP><DICH_SUBGROUP CHI2="4.478465296485382" CI_END="2.392147495717213" CI_START="0.005587645194028636" DF="1" EFFECT_SIZE="0.11561345707940716" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="38" I2="77.67092220665901" ID="CMP-005.15.09" LOG_CI_END="0.3787879539958214" LOG_CI_START="-2.25277117864369" LOG_EFFECT_SIZE="-0.9369916123239342" MODIFIED="2013-11-23 19:51:52 +0000" MODIFIED_BY="Hermann Blessberger" NO="9" P_CHI2="0.03432457446388304" P_Z="0.1627965493751358" STUDIES="2" TAU2="3.8406245480560965" TOTAL_1="82" TOTAL_2="89" WEIGHT="2.50321201746383" Z="1.3957275678840693"><NAME>Acebutolol</NAME><DICH_DATA CI_END="0.8109759442010569" CI_START="0.1413241180444068" EFFECT_SIZE="0.3385416666666667" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="18" LOG_CI_END="-0.09099202797834484" LOG_CI_START="-0.8497837161430433" LOG_EFFECT_SIZE="-0.470387872060694" MODIFIED="2013-11-23 19:51:45 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1381" O_E="0.0" SE="0.4457179937073776" STUDY_ID="STD-Materne-1985" TOTAL_1="32" TOTAL_2="39" VAR="0.1986645299145299" WEIGHT="2.0754677403354247"/><DICH_DATA CI_END="0.3925291896546882" CI_START="0.0015155153127434649" EFFECT_SIZE="0.024390243902439025" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="20" LOG_CI_END="-0.4061280422700622" LOG_CI_START="-2.819439671169409" LOG_EFFECT_SIZE="-1.6127838567197355" MODIFIED="2013-11-23 19:51:52 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1380" O_E="0.0" SE="1.4175911969007033" STUDY_ID="STD-Daudon-1986" TOTAL_1="50" TOTAL_2="50" VAR="2.0095648015303684" WEIGHT="0.4277442771284054"/></DICH_SUBGROUP></DICH_OUTCOME><DICH_OUTCOME CHI2="6.069811265865222" CI_END="0.9504821619982233" CI_START="0.5778398169621463" CI_STUDY="95" CI_TOTAL="95" DF="7" EFFECT_MEASURE="RR" EFFECT_SIZE="0.7410981301520322" ESTIMABLE="YES" EVENTS_1="108" EVENTS_2="144" I2="0.0" I2_Q="30.106046112339573" ID="CMP-005.16" LOG_CI_END="-0.022056029265065183" LOG_CI_START="-0.23819253571585014" LOG_EFFECT_SIZE="-0.13012428249045765" METHOD="MH" MODIFIED="2017-06-17 15:48:03 +0100" MODIFIED_BY="Hermann Blessberger" NO="16" P_CHI2="0.5316220044239742" P_Q="0.23159006539794325" P_Z="0.018275924461020932" Q="4.292216755718038" RANDOM="YES" SCALE="100.0" SORT_BY="YEAR" STUDIES="8" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="4380" TOTAL_2="4364" WEIGHT="100.0" Z="2.359979916243222"><NAME>All supraventricular arrhythmias&#8212;non-cardiac surgery</NAME><GROUP_LABEL_1>Beta-blocker</GROUP_LABEL_1><GROUP_LABEL_2>Control</GROUP_LABEL_2><GRAPH_LABEL_1>Favours beta-blocker</GRAPH_LABEL_1><GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2><DICH_SUBGROUP CHI2="1.7743072312487849" CI_END="0.9621584345430375" CI_START="0.5741328398387575" DF="3" EFFECT_SIZE="0.7432407109402763" ESTIMABLE="YES" EVENTS_1="97" EVENTS_2="131" I2="0.0" ID="CMP-005.16.01" LOG_CI_END="-0.016753408645789482" LOG_CI_START="-0.24098761120090473" LOG_EFFECT_SIZE="-0.12887050992334712" MODIFIED="2013-12-08 09:36:27 +0000" MODIFIED_BY="Hermann Blessberger" NO="1" P_CHI2="0.6205419931383748" P_Z="0.024269426060902426" STUDIES="4" TAU2="0.0" TOTAL_1="4246" TOTAL_2="4238" WEIGHT="92.90787819707116" Z="2.252837035928889"><NAME>Metoprolol</NAME><DICH_DATA CI_END="3.694376342661255" CI_START="0.09210696101758215" EFFECT_SIZE="0.5833333333333334" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="2" LOG_CI_END="0.5675411345302878" LOG_CI_START="-1.0357075465970236" LOG_EFFECT_SIZE="-0.23408320603336796" MODIFIED="2013-11-23 19:54:51 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1382" O_E="0.0" SE="0.9417562115031479" STUDY_ID="STD-Coleman-1980" TOTAL_1="24" TOTAL_2="14" VAR="0.886904761904762" WEIGHT="1.8174165232653283"/><DICH_DATA CI_END="2.3517506825099073" CI_START="0.24274010071578214" EFFECT_SIZE="0.7555555555555555" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="5" LOG_CI_END="0.3713912787351326" LOG_CI_START="-0.6148584722013096" LOG_EFFECT_SIZE="-0.12173359673308856" MODIFIED="2013-11-23 19:54:58 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1383" O_E="0.0" SE="0.5793279857150695" STUDY_ID="STD-Jakobsen-1997" TOTAL_1="18" TOTAL_2="17" VAR="0.33562091503267977" WEIGHT="4.802666629674929"/><DICH_DATA CI_END="1.9774190029426781" CI_START="0.006243329812231785" EFFECT_SIZE="0.1111111111111111" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="4" LOG_CI_END="0.29609870339830113" LOG_CI_START="-2.204583722276951" LOG_EFFECT_SIZE="-0.9542425094393249" MODIFIED="2013-11-23 19:55:05 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1384" O_E="0.0" SE="1.4689132354192893" STUDY_ID="STD-Lai-2006" TOTAL_1="30" TOTAL_2="30" VAR="2.1577060931899643" WEIGHT="0.7470319400476879"/><DICH_DATA CI_END="0.9931562131790224" CI_START="0.5798648580922154" EFFECT_SIZE="0.7588783740616515" ESTIMABLE="YES" EVENTS_1="91" EVENTS_2="120" LOG_CI_END="-0.002982436110955725" LOG_CI_START="-0.23667321027073493" LOG_EFFECT_SIZE="-0.11982782319084534" MODIFIED="2013-12-08 09:36:27 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1385" O_E="0.0" SE="0.13727111752944285" STUDY_ID="STD-POISE-2008" TOTAL_1="4174" TOTAL_2="4177" VAR="0.01884335970778211" WEIGHT="85.54076310408321"/></DICH_SUBGROUP><DICH_SUBGROUP CHI2="0.0" CI_END="1.926640646612665" CI_START="0.1351098895231352" DF="0" EFFECT_SIZE="0.5102040816326531" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="6" I2="0.0" ID="CMP-005.16.02" LOG_CI_END="0.28480071841945864" LOG_CI_START="-0.8693128611324107" LOG_EFFECT_SIZE="-0.292256071356476" MODIFIED="2013-11-23 19:55:22 +0000" MODIFIED_BY="Hermann Blessberger" NO="2" P_CHI2="1.0" P_Z="0.3208839823687424" STUDIES="1" TAU2="0.0" TOTAL_1="49" TOTAL_2="50" WEIGHT="3.507188857618668" Z="0.9926429846606225"><NAME>Propranolol</NAME><DICH_DATA CI_END="1.9266406466126647" CI_START="0.1351098895231352" EFFECT_SIZE="0.5102040816326531" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="6" LOG_CI_END="0.28480071841945853" LOG_CI_START="-0.8693128611324107" LOG_EFFECT_SIZE="-0.292256071356476" MODIFIED="2013-11-23 19:55:22 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1386" O_E="0.0" SE="0.677932029583124" STUDY_ID="STD-Bayliff-1999" TOTAL_1="49" TOTAL_2="50" VAR="0.45959183673469384" WEIGHT="3.507188857618668"/></DICH_SUBGROUP><DICH_SUBGROUP CHI2="0.004353429923349453" CI_END="15.807135858549856" CI_START="0.5287463731304423" DF="1" EFFECT_SIZE="2.891014658348932" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="1" I2="0.0" ID="CMP-005.16.03" LOG_CI_END="1.1988531859656313" LOG_CI_START="-0.2767525985953177" LOG_EFFECT_SIZE="0.46105029368515665" MODIFIED="2017-06-17 15:48:03 +0100" MODIFIED_BY="Hermann Blessberger" NO="3" P_CHI2="0.9473933290300054" P_Z="0.22066031934164543" STUDIES="2" TAU2="0.0" TOTAL_1="46" TOTAL_2="29" WEIGHT="2.1454359654811097" Z="1.2247742318974322"><NAME>Esmolol</NAME><DICH_DATA CI_END="60.21015642179821" CI_START="0.11637439315284949" EFFECT_SIZE="2.6470588235294117" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.7796697554754684" LOG_CI_START="-0.934142570681329" LOG_EFFECT_SIZE="0.42276359239706973" MODIFIED="2013-11-23 19:55:29 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1387" O_E="0.0" SE="1.5941067939721714" STUDY_ID="STD-Liu-1986" TOTAL_1="16" TOTAL_2="14" VAR="2.541176470588235" WEIGHT="0.6343028071857194"/><DICH_DATA CI_END="22.711113534056025" CI_START="0.3962817581138951" EFFECT_SIZE="3.0" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="1" LOG_CI_END="1.3562384283562463" LOG_CI_START="-0.40199591891692144" LOG_EFFECT_SIZE="0.47712125471966244" MODIFIED="2013-11-23 19:55:35 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1388" O_E="0.0" SE="1.0327955589886444" STUDY_ID="STD-Sandler-1990" TOTAL_1="30" TOTAL_2="15" VAR="1.0666666666666667" WEIGHT="1.5111331582953902"/></DICH_SUBGROUP><DICH_SUBGROUP CHI2="4.403112178045415E-32" CI_END="1.5981153088603466" CI_START="0.025243867342839378" DF="0" EFFECT_SIZE="0.20085470085470086" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="6" I2="100.0" ID="CMP-005.16.04" LOG_CI_END="0.20360811177088864" LOG_CI_START="-1.5978441107197394" LOG_EFFECT_SIZE="-0.6971179994744253" MODIFIED="2013-11-23 19:55:55 +0000" MODIFIED_BY="Hermann Blessberger" NO="4" P_CHI2="0.0" P_Z="0.12928780311218052" STUDIES="1" TAU2="0.0" TOTAL_1="39" TOTAL_2="47" WEIGHT="1.4394969798290602" Z="1.5169163576877425"><NAME>Nadolol</NAME><DICH_DATA CI_END="1.5981153088603466" CI_START="0.025243867342839378" EFFECT_SIZE="0.20085470085470086" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="6" LOG_CI_END="0.20360811177088864" LOG_CI_START="-1.5978441107197394" LOG_EFFECT_SIZE="-0.6971179994744253" MODIFIED="2013-11-23 19:55:55 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1390" O_E="0.0" SE="1.0581819528233132" STUDY_ID="STD-Burns-1988" TOTAL_1="39" TOTAL_2="47" VAR="1.1197490452809604" WEIGHT="1.4394969798290602"/></DICH_SUBGROUP></DICH_OUTCOME><DICH_OUTCOME CHI2="4.012670954791197" CI_END="1.0833277873645892" CI_START="0.30941258170230584" CI_STUDY="95" CI_TOTAL="95" DF="4" EFFECT_MEASURE="RR" EFFECT_SIZE="0.578960488736774" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="24" I2="0.3157735815857974" I2_Q="0.0" ID="CMP-005.17" LOG_CI_END="0.03475988294556186" LOG_CI_START="-0.5094620304789664" LOG_EFFECT_SIZE="-0.23735107376670225" METHOD="MH" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" NO="17" P_CHI2="0.4042939533035771" P_Q="0.561753512055982" P_Z="0.08734077372203604" Q="0.3366774899255436" RANDOM="NO" SCALE="100.0" SORT_BY="YEAR" STUDIES="5" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="228" TOTAL_2="234" WEIGHT="100.0" Z="1.7095950927347552"><NAME>Ventricular extrasystoles&#8212;cardiac surgery</NAME><GROUP_LABEL_1>Beta-blocker</GROUP_LABEL_1><GROUP_LABEL_2>Control</GROUP_LABEL_2><GRAPH_LABEL_1>Favours beta.blocker</GRAPH_LABEL_1><GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2><DICH_SUBGROUP CHI2="3.641506990430946" CI_END="1.8727306589616317" CI_START="0.26946616460908224" DF="3" EFFECT_SIZE="0.7103784540765788" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="9" I2="17.616525029793454" ID="CMP-005.17.01" LOG_CI_END="0.27247532049428935" LOG_CI_START="-0.5694957590341458" LOG_EFFECT_SIZE="-0.14851021926992825" MODIFIED="2013-11-23 20:12:15 +0000" MODIFIED_BY="Hermann Blessberger" NO="1" P_CHI2="0.3028677424856022" P_Z="0.48930633093565346" STUDIES="4" TAU2="0.0" TOTAL_1="196" TOTAL_2="195" WEIGHT="41.036038730486254" Z="0.6914125394146047"><NAME>Propranolol</NAME><DICH_DATA CI_END="9.4761340232665" CI_START="0.017892335903448454" EFFECT_SIZE="0.4117647058823529" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.9766311944265694" LOG_CI_START="-1.7473329571546035" LOG_EFFECT_SIZE="-0.38535088136401713" MODIFIED="2013-11-23 20:11:56 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1393" O_E="0.0" SE="1.600070026478796" STUDY_ID="STD-Myhre-1984" TOTAL_1="16" TOTAL_2="20" VAR="2.5602240896358546" WEIGHT="5.852755037195978"/><DICH_DATA CI_END="33.26691095999438" CI_START="0.4041386487796315" EFFECT_SIZE="3.6666666666666665" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="1" LOG_CI_END="1.5220124757917959" LOG_CI_START="-0.39346961491467086" LOG_EFFECT_SIZE="0.5642714304385625" MODIFIED="2013-11-23 20:12:02 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1394" O_E="0.0" SE="1.125163661870248" STUDY_ID="STD-Ormerod-1984" TOTAL_1="27" TOTAL_2="33" VAR="1.265993265993266" WEIGHT="3.924788672002009"/><DICH_DATA CI_END="1.674749508363392" CI_START="0.023884168826590092" EFFECT_SIZE="0.2" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="5" LOG_CI_END="0.22394985897240968" LOG_CI_START="-1.621889867644447" LOG_EFFECT_SIZE="-0.6989700043360187" MODIFIED="2013-11-23 20:12:08 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1392" O_E="0.0" SE="1.084255392468749" STUDY_ID="STD-Matangi-1985" TOTAL_1="82" TOTAL_2="82" VAR="1.175609756097561" WEIGHT="21.804381511122273"/><DICH_DATA CI_END="5.819752673480798" CI_START="0.12271037260707346" EFFECT_SIZE="0.8450704225352113" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="2" LOG_CI_END="0.7649045284944104" LOG_CI_START="-0.9111187251652737" LOG_EFFECT_SIZE="-0.07310709833543166" MODIFIED="2013-11-23 20:12:15 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1391" O_E="0.0" SE="0.9845043556486075" STUDY_ID="STD-Bert-2001" TOTAL_1="71" TOTAL_2="60" VAR="0.9692488262910798" WEIGHT="9.454113510165993"/></DICH_SUBGROUP><DICH_SUBGROUP CHI2="0.0" CI_END="1.1105091403706633" CI_START="0.2140065681230463" DF="0" EFFECT_SIZE="0.4875" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="15" I2="0.0" ID="CMP-005.17.02" LOG_CI_END="0.04552213748710874" LOG_CI_START="-0.6695728974179976" LOG_EFFECT_SIZE="-0.3120253799654444" MODIFIED="2013-11-23 20:12:23 +0000" MODIFIED_BY="Hermann Blessberger" NO="2" P_CHI2="1.0" P_Z="0.08718715915943334" STUDIES="1" TAU2="0.0" TOTAL_1="32" TOTAL_2="39" WEIGHT="58.96396126951375" Z="1.7104258235434433"><NAME>Acebutolol</NAME><DICH_DATA CI_END="1.1105091403706633" CI_START="0.2140065681230463" EFFECT_SIZE="0.4875" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="15" LOG_CI_END="0.04552213748710874" LOG_CI_START="-0.6695728974179976" LOG_EFFECT_SIZE="-0.3120253799654444" MODIFIED="2013-11-23 20:12:23 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1395" O_E="0.0" SE="0.420050363280771" STUDY_ID="STD-Materne-1985" TOTAL_1="32" TOTAL_2="39" VAR="0.1764423076923077" WEIGHT="58.96396126951375"/></DICH_SUBGROUP></DICH_OUTCOME><DICH_OUTCOME CHI2="4.412696047203043" CI_END="0.3930484356587487" CI_START="0.13005101951035364" CI_STUDY="95" CI_TOTAL="95" DF="7" EFFECT_MEASURE="RR" EFFECT_SIZE="0.22608925178869052" ESTIMABLE="YES" EVENTS_1="15" EVENTS_2="54" I2="0.0" I2_Q="0.0" ID="CMP-005.18" LOG_CI_END="-0.4055539278862318" LOG_CI_START="-0.8858862388853685" LOG_EFFECT_SIZE="-0.6457200833858002" METHOD="MH" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" NO="18" P_CHI2="0.7312030711918622" P_Q="0.40312423611546333" P_Z="1.3669490494212094E-7" Q="2.9263273439208075" RANDOM="NO" SCALE="100.0" SORT_BY="YEAR" STUDIES="8" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="204" TOTAL_2="160" WEIGHT="99.99999999999999" Z="5.26963553585569"><NAME>Ventricular extrasystoles&#8212;non-cardiac surgery</NAME><GROUP_LABEL_1>Beta-blocker</GROUP_LABEL_1><GROUP_LABEL_2>Control</GROUP_LABEL_2><GRAPH_LABEL_1>Favours beta-blocker</GRAPH_LABEL_1><GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2><DICH_SUBGROUP CHI2="0.2056571811251071" CI_END="0.7959844778038845" CI_START="0.14298039013788452" DF="2" EFFECT_SIZE="0.33735763097949883" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="17" I2="0.0" ID="CMP-005.18.01" LOG_CI_END="-0.09909540119430132" LOG_CI_START="-0.8447235222475247" LOG_EFFECT_SIZE="-0.4719094617209129" MODIFIED="2013-11-23 21:19:05 +0000" MODIFIED_BY="Hermann Blessberger" NO="1" P_CHI2="0.9022817077586929" P_Z="0.013104014175742007" STUDIES="3" TAU2="0.0" TOTAL_1="67" TOTAL_2="58" WEIGHT="30.21332606694337" Z="2.480929897413703"><NAME>Metoprolol</NAME><DICH_DATA CI_END="0.9171435836951519" CI_START="0.12114909059653102" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="12" LOG_CI_END="-0.03756266790137051" LOG_CI_START="-0.9166798415379545" LOG_EFFECT_SIZE="-0.47712125471966244" MODIFIED="2013-11-23 21:18:53 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1398" O_E="0.0" SE="0.5163977794943222" STUDY_ID="STD-Whitehead-1980" TOTAL_1="30" TOTAL_2="30" VAR="0.26666666666666666" WEIGHT="21.183739779966217"/><DICH_DATA CI_END="8.613245613073193" CI_START="0.039506336294567505" EFFECT_SIZE="0.5833333333333334" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="0.935166831621311" LOG_CI_START="-1.4033332436880468" LOG_EFFECT_SIZE="-0.23408320603336796" MODIFIED="2013-11-23 21:18:58 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1396" O_E="0.0" SE="1.373646519998781" STUDY_ID="STD-Coleman-1980" TOTAL_1="24" TOTAL_2="14" VAR="1.8869047619047619" WEIGHT="2.229867345259602"/><DICH_DATA CI_END="2.10640095810011" CI_START="0.03441187529935919" EFFECT_SIZE="0.2692307692307692" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="4" LOG_CI_END="0.32354104363765107" LOG_CI_START="-1.4632916595507734" LOG_EFFECT_SIZE="-0.5698753079565612" MODIFIED="2013-11-23 21:19:05 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1397" O_E="0.0" SE="1.049594374817411" STUDY_ID="STD-Magnusson-1986" TOTAL_1="13" TOTAL_2="14" VAR="1.1016483516483517" WEIGHT="6.799718941717551"/></DICH_SUBGROUP><DICH_SUBGROUP CHI2="0.42205940723011587" CI_END="0.6895495516151375" CI_START="0.14102048454004892" DF="2" EFFECT_SIZE="0.3118342698985155" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="13" I2="0.0" ID="CMP-005.18.02" LOG_CI_END="-0.16143451959722116" LOG_CI_START="-0.8507177974400855" LOG_EFFECT_SIZE="-0.5060761585186533" MODIFIED="2013-11-23 21:19:34 +0000" MODIFIED_BY="Hermann Blessberger" NO="2" P_CHI2="0.8097501164266325" P_Z="0.004001594700836641" STUDIES="3" TAU2="0.0" TOTAL_1="78" TOTAL_2="45" WEIGHT="29.85505075609187" Z="2.878036000626915"><NAME>Esmolol</NAME><DICH_DATA CI_END="1.7345779408820627" CI_START="0.027586862124896305" EFFECT_SIZE="0.21875" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="4" LOG_CI_END="0.2391938190437444" LOG_CI_START="-1.5592976956550426" LOG_EFFECT_SIZE="-0.6600519383056491" MODIFIED="2013-11-23 21:19:15 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1399" O_E="0.0" SE="1.0564428184106458" STUDY_ID="STD-Liu-1986" TOTAL_1="16" TOTAL_2="14" VAR="1.1160714285714286" WEIGHT="7.531996366210211"/><DICH_DATA CI_END="3.987709581650965" CI_START="0.007422505812621207" EFFECT_SIZE="0.17204301075268819" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.6007235218364254" LOG_CI_START="-2.1294494536324464" LOG_EFFECT_SIZE="-0.7643629658980103" MODIFIED="2013-11-23 21:19:34 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1400" O_E="0.0" SE="1.603717120364604" STUDY_ID="STD-Miller-1990" TOTAL_1="30" TOTAL_2="15" VAR="2.5719086021505375" WEIGHT="3.493063474356132"/><DICH_DATA CI_END="0.8968345474639214" CI_START="0.15680149744193167" EFFECT_SIZE="0.375" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="8" LOG_CI_END="-0.047287670390829956" LOG_CI_START="-0.8046497941537323" LOG_EFFECT_SIZE="-0.42596873227228116" MODIFIED="2013-11-23 21:19:30 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1401" O_E="0.0" SE="0.4448782605013046" STUDY_ID="STD-Oxorn-1990" TOTAL_1="32" TOTAL_2="16" VAR="0.19791666666666663" WEIGHT="18.829990915525528"/></DICH_SUBGROUP><DICH_SUBGROUP CHI2="0.0" CI_END="2.437512373700911" CI_START="0.025640895477837246" DF="0" EFFECT_SIZE="0.25" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" I2="0.0" ID="CMP-005.18.03" LOG_CI_END="0.38694682901319455" LOG_CI_START="-1.5910668116691191" LOG_EFFECT_SIZE="-0.6020599913279624" MODIFIED="2013-11-23 21:19:43 +0000" MODIFIED_BY="Hermann Blessberger" NO="3" P_CHI2="1.0" P_Z="0.23281761761037922" STUDIES="1" TAU2="0.0" TOTAL_1="20" TOTAL_2="10" WEIGHT="4.707497728881382" Z="1.1931322163463527"><NAME>Labetalol</NAME><DICH_DATA CI_END="2.437512373700911" CI_START="0.025640895477837246" EFFECT_SIZE="0.25" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" LOG_CI_END="0.38694682901319455" LOG_CI_START="-1.5910668116691191" LOG_EFFECT_SIZE="-0.6020599913279624" MODIFIED="2013-11-23 21:19:43 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1402" O_E="0.0" SE="1.161895003862225" STUDY_ID="STD-Inada-1989" TOTAL_1="20" TOTAL_2="10" VAR="1.3499999999999999" WEIGHT="4.707497728881382"/></DICH_SUBGROUP><DICH_SUBGROUP CHI2="0.0" CI_END="0.388319499409608" CI_START="0.007727374155017464" DF="0" EFFECT_SIZE="0.054778554778554776" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="22" I2="0.0" ID="CMP-005.18.04" LOG_CI_END="-0.41081080086943617" LOG_CI_START="-2.11196805895654" LOG_EFFECT_SIZE="-1.261389429912988" MODIFIED="2013-11-23 21:19:51 +0000" MODIFIED_BY="Hermann Blessberger" NO="4" P_CHI2="1.0" P_Z="0.003653993007485849" STUDIES="1" TAU2="0.0" TOTAL_1="39" TOTAL_2="47" WEIGHT="35.22412544808336" Z="2.9065835522918837"><NAME>Nadolol</NAME><DICH_DATA CI_END="0.388319499409608" CI_START="0.007727374155017464" EFFECT_SIZE="0.054778554778554776" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="22" LOG_CI_END="-0.41081080086943617" LOG_CI_START="-2.11196805895654" LOG_EFFECT_SIZE="-1.261389429912988" MODIFIED="2013-11-23 21:19:51 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1403" O_E="0.0" SE="0.9992681942646023" STUDY_ID="STD-Burns-1988" TOTAL_1="39" TOTAL_2="47" VAR="0.998536924068839" WEIGHT="35.22412544808336"/></DICH_SUBGROUP></DICH_OUTCOME><DICH_OUTCOME CHI2="7.401288452926611" CI_END="2.8342759649380156" CI_START="1.1147242939716173" CI_STUDY="95" CI_TOTAL="95" DF="7" EFFECT_MEASURE="RR" EFFECT_SIZE="1.7774803160474812" ESTIMABLE="YES" EVENTS_1="39" EVENTS_2="22" I2="5.421872900628996" I2_Q="23.095587270763765" ID="CMP-005.19" LOG_CI_END="0.45244213391951144" LOG_CI_START="0.04716746611695732" LOG_EFFECT_SIZE="0.24980480001823438" METHOD="MH" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" NO="19" P_CHI2="0.3883262637099204" P_Q="0.2604238451406351" P_Z="0.015684276419584444" Q="6.501577507137225" RANDOM="NO" SCALE="100.0" SORT_BY="YEAR" STUDIES="8" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="355" TOTAL_2="370" WEIGHT="99.99999999999999" Z="2.4161806799111485"><NAME>Bradycardia&#8212;cardiac surgery</NAME><GROUP_LABEL_1>Beta-blocker</GROUP_LABEL_1><GROUP_LABEL_2>Control</GROUP_LABEL_2><GRAPH_LABEL_1>Favours beta-blocker</GRAPH_LABEL_1><GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2><DICH_SUBGROUP CHI2="0.4720088921392414" CI_END="2.6516805137056605" CI_START="0.5565312783930286" DF="1" EFFECT_SIZE="1.214801690064059" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="8" I2="0.0" ID="CMP-005.19.01" LOG_CI_END="0.42352119714864145" LOG_CI_START="-0.2545104222515364" LOG_EFFECT_SIZE="0.08450538744855253" MODIFIED="2013-11-23 21:23:09 +0000" MODIFIED_BY="Hermann Blessberger" NO="1" P_CHI2="0.49206446966456996" P_Z="0.6251575174094324" STUDIES="2" TAU2="0.0" TOTAL_1="57" TOTAL_2="63" WEIGHT="34.62401707608506" Z="0.488553958723308"><NAME>Propranolol</NAME><DICH_DATA CI_END="2.4299040831536463" CI_START="0.4829865998611526" EFFECT_SIZE="1.0833333333333333" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="8" LOG_CI_END="0.38558913080850166" LOG_CI_START="-0.3160649182900778" LOG_EFFECT_SIZE="0.03476210625921191" MODIFIED="2013-11-23 21:23:00 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1405" O_E="0.0" SE="0.41215506168406435" STUDY_ID="STD-Hammon-1984" TOTAL_1="24" TOTAL_2="26" VAR="0.16987179487179488" WEIGHT="32.61840071281177"/><DICH_DATA CI_END="79.58504943420188" CI_START="0.14126038260699514" EFFECT_SIZE="3.3529411764705883" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.9008314903751011" LOG_CI_START="-0.8499796217866659" LOG_EFFECT_SIZE="0.5254259342942175" MODIFIED="2013-11-23 21:23:09 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1404" O_E="0.0" SE="1.615840064018435" STUDY_ID="STD-Babin_x002d_Ebell-1996" TOTAL_1="33" TOTAL_2="37" VAR="2.6109391124871" WEIGHT="2.005616363273293"/></DICH_SUBGROUP><DICH_SUBGROUP CHI2="0.0129341089323377" CI_END="15.550667563320573" CI_START="1.0186209617494475" DF="1" EFFECT_SIZE="3.9799793905490946" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="2" I2="0.0" ID="CMP-005.19.02" LOG_CI_END="1.1917490372756212" LOG_CI_START="0.00801260908583604" LOG_EFFECT_SIZE="0.5998808231807287" MODIFIED="2013-11-24 05:35:47 +0000" MODIFIED_BY="Hermann Blessberger" NO="2" P_CHI2="0.9094532400244992" P_Z="0.04697809500696322" STUDIES="2" TAU2="0.0" TOTAL_1="103" TOTAL_2="110" WEIGHT="10.363198749276481" Z="1.9864976365532019"><NAME>Sotalol</NAME><DICH_DATA CI_END="80.35752625709628" CI_START="0.14098207571047106" EFFECT_SIZE="3.3658536585365852" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.9050265588697803" LOG_CI_START="-0.8508360995067785" LOG_EFFECT_SIZE="0.527095229681501" MODIFIED="2013-11-23 21:23:17 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1406" O_E="0.0" SE="1.618807367270561" STUDY_ID="STD-Gomes-1999" TOTAL_1="40" TOTAL_2="45" VAR="2.6205372923294448" WEIGHT="2.0015481759238543"/><DICH_DATA CI_END="18.686304543115966" CI_START="0.9114695709405812" EFFECT_SIZE="4.126984126984127" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="2" LOG_CI_END="1.271523422554925" LOG_CI_START="-0.04025782552045233" LOG_EFFECT_SIZE="0.6156327985172363" MODIFIED="2013-11-24 05:35:47 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1493" O_E="0.0" SE="0.7705467985413792" STUDY_ID="STD-Auer-2004" TOTAL_1="63" TOTAL_2="65" VAR="0.5937423687423689" WEIGHT="8.361650573352627"><FOOTNOTE>Only patients in the sotalol subgroup considered.</FOOTNOTE></DICH_DATA></DICH_SUBGROUP><DICH_SUBGROUP CHI2="0.0" CI_END="7.9127893408891605" CI_START="0.014041965016931132" DF="0" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" I2="0.0" ID="CMP-005.19.03" LOG_CI_END="0.8983296038284552" LOG_CI_START="-1.85257211326778" LOG_EFFECT_SIZE="-0.47712125471966244" MODIFIED="2013-11-23 21:23:27 +0000" MODIFIED_BY="Hermann Blessberger" NO="3" P_CHI2="1.0" P_Z="0.4965809361801813" STUDIES="1" TAU2="0.0" TOTAL_1="35" TOTAL_2="35" WEIGHT="6.370781389221049" Z="0.6798792335599723"><NAME>Atenolol</NAME><DICH_DATA CI_END="7.9127893408891605" CI_START="0.014041965016931132" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.8983296038284552" LOG_CI_START="-1.85257211326778" LOG_EFFECT_SIZE="-0.47712125471966244" MODIFIED="2013-11-23 21:23:27 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1407" O_E="0.0" SE="1.6158932858054431" STUDY_ID="STD-Matangi-1989" TOTAL_1="35" TOTAL_2="35" VAR="2.611111111111111" WEIGHT="6.370781389221049"/></DICH_SUBGROUP><DICH_SUBGROUP CHI2="0.0" CI_END="68.25874292736694" CI_START="0.13185124152633113" DF="0" EFFECT_SIZE="3.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" I2="0.0" ID="CMP-005.19.04" LOG_CI_END="1.8341582859242351" LOG_CI_START="-0.87991577648491" LOG_EFFECT_SIZE="0.47712125471966244" MODIFIED="2013-11-23 21:23:41 +0000" MODIFIED_BY="Hermann Blessberger" NO="4" P_CHI2="1.0" P_Z="0.4907574432545426" STUDIES="2" TAU2="0.0" TOTAL_1="30" TOTAL_2="29" WEIGHT="2.1235937964070164" Z="0.6891046110061"><NAME>Esmolol</NAME><DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-11-23 21:23:35 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1409" O_E="0.0" SE="0.0" STUDY_ID="STD-Cork-1995" TOTAL_1="15" TOTAL_2="14" VAR="0.0" WEIGHT="0.0"/><DICH_DATA CI_END="68.25874292736694" CI_START="0.13185124152633113" EFFECT_SIZE="3.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.8341582859242351" LOG_CI_START="-0.87991577648491" LOG_EFFECT_SIZE="0.47712125471966244" MODIFIED="2013-11-23 21:23:41 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1408" O_E="0.0" SE="1.5942605391424158" STUDY_ID="STD-But-2006" TOTAL_1="15" TOTAL_2="15" VAR="2.5416666666666665" WEIGHT="2.1235937964070164"/></DICH_SUBGROUP><DICH_SUBGROUP CHI2="0.0" CI_END="2.5620784080305095" CI_START="0.4818618732998068" DF="0" EFFECT_SIZE="1.1111111111111112" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="9" I2="0.0" ID="CMP-005.19.05" LOG_CI_END="0.40859241645235506" LOG_CI_START="-0.31707743533100474" LOG_EFFECT_SIZE="0.04575749056067514" MODIFIED="2013-11-23 21:24:08 +0000" MODIFIED_BY="Hermann Blessberger" NO="5" P_CHI2="1.0" P_Z="0.8047742626152457" STUDIES="1" TAU2="0.0" TOTAL_1="68" TOTAL_2="68" WEIGHT="38.22468833532629" Z="0.24717310027819261"><NAME>Landiolol</NAME><DICH_DATA CI_END="2.5620784080305095" CI_START="0.4818618732998068" EFFECT_SIZE="1.1111111111111112" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="9" LOG_CI_END="0.40859241645235506" LOG_CI_START="-0.31707743533100474" LOG_EFFECT_SIZE="0.04575749056067514" MODIFIED="2013-11-23 21:24:08 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1410" O_E="0.0" SE="0.4262620630612449" STUDY_ID="STD-Ogawa-2013" TOTAL_1="68" TOTAL_2="68" VAR="0.18169934640522875" WEIGHT="38.22468833532629"/></DICH_SUBGROUP><DICH_SUBGROUP CHI2="0.0" CI_END="22.976342687213744" CI_START="1.1959208648274957" DF="0" EFFECT_SIZE="5.241935483870968" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="2" I2="0.0" ID="CMP-005.19.06" LOG_CI_END="1.3612809000193824" LOG_CI_START="0.07770244294185868" LOG_EFFECT_SIZE="0.7194916714806205" MODIFIED="2014-06-22 19:01:37 +0100" MODIFIED_BY="Hermann Blessberger" NO="6" P_CHI2="1.0" P_Z="0.02800188677198679" STUDIES="1" TAU2="0.0" TOTAL_1="62" TOTAL_2="65" WEIGHT="8.293720653684096" Z="2.197259942316671"><NAME>Metoprolol</NAME><DICH_DATA CI_END="22.976342687213744" CI_START="1.1959208648274957" EFFECT_SIZE="5.241935483870968" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="2" LOG_CI_END="1.3612809000193824" LOG_CI_START="0.07770244294185868" LOG_EFFECT_SIZE="0.7194916714806205" MODIFIED="2014-06-22 19:01:37 +0100" MODIFIED_BY="Hermann Blessberger" ORDER="1492" O_E="0.0" SE="0.753980339503173" STUDY_ID="STD-Auer-2004" TOTAL_1="62" TOTAL_2="65" VAR="0.56848635235732" WEIGHT="8.293720653684096"><FOOTNOTE>Only patients in the metoprolol subgroup considered.</FOOTNOTE></DICH_DATA></DICH_SUBGROUP></DICH_OUTCOME><DICH_OUTCOME CHI2="75.51010952022501" CI_END="3.2157537483082423" CI_START="1.424797842161155" CI_STUDY="95" CI_TOTAL="95" DF="18" EFFECT_MEASURE="RR" EFFECT_SIZE="2.1405137237381195" ESTIMABLE="YES" EVENTS_1="518" EVENTS_2="212" I2="76.16213231000707" I2_Q="89.77549124344269" ID="CMP-005.20" LOG_CI_END="0.5072827845274213" LOG_CI_START="0.15375324872202253" LOG_EFFECT_SIZE="0.33051801662472197" METHOD="MH" MODIFIED="2017-06-17 15:48:24 +0100" MODIFIED_BY="Hermann Blessberger" NO="20" P_CHI2="5.167372196801523E-9" P_Q="8.332268208732785E-11" P_Z="2.475544416479015E-4" Q="58.682525907682376" RANDOM="YES" SCALE="100.0" SORT_BY="YEAR" STUDIES="22" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.3843182568090522" TOTALS="YES" TOTAL_1="5547" TOTAL_2="5358" WEIGHT="100.0" Z="3.6647767341433735"><NAME>Bradycardia&#8212;non-cardiac surgery</NAME><GROUP_LABEL_1>Beta-blocker</GROUP_LABEL_1><GROUP_LABEL_2>Control</GROUP_LABEL_2><GRAPH_LABEL_1>Favours beta-blocker</GRAPH_LABEL_1><GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2><DICH_SUBGROUP CHI2="4.09401414924634" CI_END="3.4525715049432217" CI_START="2.3985741394802287" DF="6" EFFECT_SIZE="2.8777158870297024" ESTIMABLE="YES" EVENTS_1="418" EVENTS_2="143" I2="0.0" ID="CMP-005.20.01" LOG_CI_END="0.5381426818576759" LOG_CI_START="0.37995314697099103" LOG_EFFECT_SIZE="0.45904791441433346" MODIFIED="2013-11-23 22:11:38 +0000" MODIFIED_BY="Hermann Blessberger" NO="1" P_CHI2="0.6639553388587918" P_Z="5.558674502794189E-30" STUDIES="8" TAU2="0.0" TOTAL_1="4569" TOTAL_2="4567" WEIGHT="46.87457677936199" Z="11.375182057078668"><NAME>Metoprolol</NAME><DICH_DATA CI_END="4.316762529506007" CI_START="0.7786184873819648" EFFECT_SIZE="1.8333333333333333" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="6" LOG_CI_END="0.6351581582319411" LOG_CI_START="-0.10867528868277829" LOG_EFFECT_SIZE="0.2632414347745814" MODIFIED="2013-11-23 22:10:34 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1417" O_E="0.0" SE="0.4369314487526515" STUDY_ID="STD-Whitehead-1980" TOTAL_1="30" TOTAL_2="30" VAR="0.19090909090909092" WEIGHT="7.496992644461293"/><DICH_DATA CI_END="163.3214889303036" CI_START="0.5693353304979463" EFFECT_SIZE="9.642857142857142" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="0" LOG_CI_END="2.213043330541109" LOG_CI_START="-0.24463186490757274" LOG_EFFECT_SIZE="0.984205732816768" MODIFIED="2013-11-23 22:10:39 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1414" O_E="0.0" SE="1.4436505754949789" STUDY_ID="STD-Magnusson-1986" TOTAL_1="13" TOTAL_2="14" VAR="2.084126984126984" WEIGHT="1.7470410618064205"/><DICH_DATA CI_END="16.55061376388459" CI_START="0.9667315199460398" EFFECT_SIZE="4.0" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="2" LOG_CI_END="1.2188141038111788" LOG_CI_START="-0.014694121155254026" LOG_EFFECT_SIZE="0.6020599913279624" MODIFIED="2013-11-23 22:10:47 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1411" O_E="0.0" SE="0.7245688373094719" STUDY_ID="STD-Jakobsen-1992" TOTAL_1="20" TOTAL_2="20" VAR="0.5249999999999999" WEIGHT="4.742536688825632"/><DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-11-23 22:10:54 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1412" O_E="0.0" SE="0.0" STUDY_ID="STD-Jakobsen-1997" TOTAL_1="18" TOTAL_2="17" VAR="0.0" WEIGHT="0.0"/><DICH_DATA CI_END="9.055780428661802" CI_START="1.9026886986063845" EFFECT_SIZE="4.150943396226415" ESTIMABLE="YES" EVENTS_1="30" EVENTS_2="6" LOG_CI_END="0.9569258838335278" LOG_CI_START="0.27936773860930664" LOG_EFFECT_SIZE="0.6181468112214172" MODIFIED="2013-11-23 22:11:01 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1415" O_E="0.0" SE="0.3980010084716185" STUDY_ID="STD-POBBLE-2005" TOTAL_1="53" TOTAL_2="44" VAR="0.15840480274442537" WEIGHT="7.945995879157896"/><DICH_DATA CI_END="4.968546281602201" CI_START="2.221629425589266" EFFECT_SIZE="3.3223889931207005" ESTIMABLE="YES" EVENTS_1="85" EVENTS_2="26" LOG_CI_END="0.6962293395925384" LOG_CI_START="0.34667161903172805" LOG_EFFECT_SIZE="0.5214504793121333" MODIFIED="2013-11-23 22:11:25 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1418" O_E="0.0" SE="0.2053319353960433" STUDY_ID="STD-Yang-2006" TOTAL_1="246" TOTAL_2="250" VAR="0.0421612036934849" WEIGHT="10.111800436190626"/><DICH_DATA CI_END="7.731389706964666" CI_START="0.29102141856503916" EFFECT_SIZE="1.5" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="2" LOG_CI_END="0.8882575647876686" LOG_CI_START="-0.5360750466763062" LOG_EFFECT_SIZE="0.17609125905568124" MODIFIED="2013-11-23 22:11:14 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1413" O_E="0.0" SE="0.8366600265340756" STUDY_ID="STD-Liu-2006" TOTAL_1="15" TOTAL_2="15" VAR="0.7" WEIGHT="3.977130485127783"/><DICH_DATA CI_END="3.4327496636168187" CI_START="2.194313719081089" EFFECT_SIZE="2.74454544160693" ESTIMABLE="YES" EVENTS_1="277" EVENTS_2="101" LOG_CI_END="0.5356421332614679" LOG_CI_START="0.3412987183735157" LOG_EFFECT_SIZE="0.43847042581749185" MODIFIED="2013-11-23 22:11:38 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1416" O_E="0.0" SE="0.11415828392060205" STUDY_ID="STD-POISE-2008" TOTAL_1="4174" TOTAL_2="4177" VAR="0.01303211378769679" WEIGHT="10.853079583792342"/></DICH_SUBGROUP><DICH_SUBGROUP CHI2="0.014250213062454085" CI_END="21.641681979746537" CI_START="1.6046456791324544" DF="1" EFFECT_SIZE="5.8929815440029145" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="2" I2="0.0" ID="CMP-005.20.02" LOG_CI_END="1.3352910108770373" LOG_CI_START="0.20537915101791293" LOG_EFFECT_SIZE="0.770335080947475" MODIFIED="2013-11-23 22:11:56 +0000" MODIFIED_BY="Hermann Blessberger" NO="2" P_CHI2="0.9049788585580157" P_Z="0.007529461388823598" STUDIES="2" TAU2="0.0" TOTAL_1="79" TOTAL_2="80" WEIGHT="6.236439671550592" Z="2.6724721959694127"><NAME>Propranolol</NAME><DICH_DATA CI_END="25.948956020600956" CI_START="1.4445429510900611" EFFECT_SIZE="6.122448979591836" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="2" LOG_CI_END="1.4141198899836058" LOG_CI_START="0.15973045939869154" LOG_EFFECT_SIZE="0.7869251746911488" MODIFIED="2013-11-23 22:11:50 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1420" O_E="0.0" SE="0.7368345608534029" STUDY_ID="STD-Bayliff-1999" TOTAL_1="49" TOTAL_2="50" VAR="0.5429251700680272" WEIGHT="4.650855503241636"/><DICH_DATA CI_END="99.95416281504153" CI_START="0.25011464551267176" EFFECT_SIZE="5.0" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="0" LOG_CI_END="1.9998008859974516" LOG_CI_START="-0.6018608773254143" LOG_EFFECT_SIZE="0.6989700043360189" MODIFIED="2013-11-23 22:11:56 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1419" O_E="0.0" SE="1.5282289982092807" STUDY_ID="STD-Apipan-2010" TOTAL_1="30" TOTAL_2="30" VAR="2.335483870967742" WEIGHT="1.5855841683089562"/></DICH_SUBGROUP><DICH_SUBGROUP CHI2="0.7587767286897873" CI_END="4.314093059148964" CI_START="0.5013566545413213" DF="1" EFFECT_SIZE="1.470679864387508" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="5" I2="0.0" ID="CMP-005.20.03" LOG_CI_END="0.6348895090184934" LOG_CI_START="-0.299853216263828" LOG_EFFECT_SIZE="0.16751814637733273" MODIFIED="2014-07-11 15:58:12 +0100" MODIFIED_BY="Hermann Blessberger" NO="3" P_CHI2="0.38371164912329303" P_Z="0.4823658708798587" STUDIES="2" TAU2="0.0" TOTAL_1="121" TOTAL_2="123" WEIGHT="7.498331943846649" Z="0.7025024635678558"><NAME>Atenolol</NAME><DICH_DATA CI_END="3.881860085359043" CI_START="0.38609570678958227" EFFECT_SIZE="1.2242424242424241" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="5" LOG_CI_END="0.5890398779736322" LOG_CI_START="-0.41330502750819725" LOG_EFFECT_SIZE="0.08786742523271744" MODIFIED="2014-07-11 15:58:12 +0100" MODIFIED_BY="Hermann Blessberger" ORDER="1422" O_E="0.0" SE="0.5887823591673299" STUDY_ID="STD-Mangano-1996" TOTAL_1="99" TOTAL_2="101" VAR="0.3466646664666467" WEIGHT="5.899556689246209"/><DICH_DATA CI_END="98.52270194459342" CI_START="0.25374862348029537" EFFECT_SIZE="5.0" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="0" LOG_CI_END="1.9935363136779938" LOG_CI_START="-0.5955963050059561" LOG_EFFECT_SIZE="0.6989700043360189" MODIFIED="2013-11-23 22:12:25 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1421" O_E="0.0" SE="1.5208693166281149" STUDY_ID="STD-Gupta-2011" TOTAL_1="22" TOTAL_2="22" VAR="2.313043478260869" WEIGHT="1.5987752546004401"/></DICH_SUBGROUP><DICH_SUBGROUP CHI2="2.2409352342175923" CI_END="1.8233793052301723" CI_START="0.30016151874444624" DF="4" EFFECT_SIZE="0.7398028801681443" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="8" I2="0.0" ID="CMP-005.20.04" LOG_CI_END="0.26087702138859276" LOG_CI_START="-0.5226449858707798" LOG_EFFECT_SIZE="-0.13088398224109354" MODIFIED="2017-06-17 15:48:24 +0100" MODIFIED_BY="Hermann Blessberger" NO="4" P_CHI2="0.6915423174572699" P_Z="0.5125919551899166" STUDIES="6" TAU2="0.0" TOTAL_1="494" TOTAL_2="300" WEIGHT="12.38950663843609" Z="0.654807111910014"><NAME>Esmolol</NAME><DICH_DATA CI_END="6.690017380199802" CI_START="0.012930488128094391" EFFECT_SIZE="0.29411764705882354" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.8254272460361436" LOG_CI_START="-1.8883850801206539" LOG_EFFECT_SIZE="-0.5314789170422551" MODIFIED="2013-11-23 22:12:44 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1425" O_E="0.0" SE="1.5941067939721714" STUDY_ID="STD-Liu-1986" TOTAL_1="16" TOTAL_2="14" VAR="2.541176470588235" WEIGHT="1.4741011680347684"/><DICH_DATA CI_END="7.401691333129458" CI_START="0.01324713701913913" EFFECT_SIZE="0.31313131313131315" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.8693309700979578" LOG_CI_START="-1.8778779716245122" LOG_EFFECT_SIZE="-0.5042735007632773" MODIFIED="2013-11-23 22:12:49 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1423" O_E="0.0" SE="1.6137241312713606" STUDY_ID="STD-Cucchiara-1986" TOTAL_1="32" TOTAL_2="30" VAR="2.6041055718475072" WEIGHT="1.4430601019115028"/><DICH_DATA CI_END="13.482091688489398" CI_START="0.060717144136267914" EFFECT_SIZE="0.9047619047619048" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.1297572763459856" LOG_CI_START="-1.2166886639081658" LOG_EFFECT_SIZE="-0.0434656937810903" MODIFIED="2013-11-23 22:12:58 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1424" O_E="0.0" SE="1.3783139604000185" STUDY_ID="STD-Gibson-1988" TOTAL_1="21" TOTAL_2="19" VAR="1.899749373433584" WEIGHT="1.8880680841651716"/><DICH_DATA CI_END="2.1277244659381767" CI_START="0.22038907230653051" EFFECT_SIZE="0.6847826086956522" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="5" LOG_CI_END="0.327915387405769" LOG_CI_START="-0.656809943189716" LOG_EFFECT_SIZE="-0.16444727789197353" MODIFIED="2013-11-23 22:13:05 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1426" O_E="0.0" SE="0.5784325336607887" STUDY_ID="STD-Miller-1991" TOTAL_1="368" TOTAL_2="180" VAR="0.3345841959972395" WEIGHT="5.998693116015691"/><DICH_DATA CI_END="99.95416281504153" CI_START="0.25011464551267176" EFFECT_SIZE="5.0" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="0" LOG_CI_END="1.9998008859974516" LOG_CI_START="-0.6018608773254143" LOG_EFFECT_SIZE="0.6989700043360189" MODIFIED="2014-06-22 19:51:33 +0100" MODIFIED_BY="Hermann Blessberger" ORDER="1428" O_E="0.0" SE="1.5282289982092807" STUDY_ID="STD-Shukla-2010" TOTAL_1="30" TOTAL_2="30" VAR="2.335483870967742" WEIGHT="1.5855841683089562"/><DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-11-23 22:13:22 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1427" O_E="0.0" SE="0.0" STUDY_ID="STD-Moon-2011" TOTAL_1="27" TOTAL_2="27" VAR="0.0" WEIGHT="0.0"/></DICH_SUBGROUP><DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-005.20.05" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2013-11-23 22:13:35 +0000" MODIFIED_BY="Hermann Blessberger" NO="5" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="20" TOTAL_2="10" WEIGHT="0.0" Z="0.0"><NAME>Labetalol</NAME><DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-11-23 22:13:35 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1430" O_E="0.0" SE="0.0" STUDY_ID="STD-Inada-1989" TOTAL_1="20" TOTAL_2="10" VAR="0.0" WEIGHT="0.0"/></DICH_SUBGROUP><DICH_SUBGROUP CHI2="0.0" CI_END="7.53745610550098" CI_START="1.3585485416660203" DF="0" EFFECT_SIZE="3.2" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="5" I2="0.0" ID="CMP-005.20.06" LOG_CI_END="0.8772247960345471" LOG_CI_START="0.1330751606052648" LOG_EFFECT_SIZE="0.505149978319906" MODIFIED="2013-11-23 22:13:46 +0000" MODIFIED_BY="Hermann Blessberger" NO="6" P_CHI2="1.0" P_Z="0.007791848836826527" STUDIES="1" TAU2="0.0" TOTAL_1="28" TOTAL_2="28" WEIGHT="7.494877479223913" Z="2.660958810325974"><NAME>Landiolol</NAME><DICH_DATA CI_END="7.53745610550098" CI_START="1.3585485416660203" EFFECT_SIZE="3.2" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="5" LOG_CI_END="0.8772247960345471" LOG_CI_START="0.1330751606052648" LOG_EFFECT_SIZE="0.505149978319906" MODIFIED="2013-11-23 22:13:46 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1431" O_E="0.0" SE="0.4371171794512641" STUDY_ID="STD-Kawaguchi-2010" TOTAL_1="28" TOTAL_2="28" VAR="0.19107142857142861" WEIGHT="7.494877479223913"/></DICH_SUBGROUP><DICH_SUBGROUP CHI2="0.0" CI_END="3.6290326949803244" CI_START="0.997251094006923" DF="0" EFFECT_SIZE="1.9023818820773135" ESTIMABLE="YES" EVENTS_1="24" EVENTS_2="13" I2="0.0" ID="CMP-005.20.07" LOG_CI_END="0.5597908808998064" LOG_CI_START="-0.0011954785870280935" LOG_EFFECT_SIZE="0.27929770115638924" MODIFIED="2013-11-23 22:13:54 +0000" MODIFIED_BY="Hermann Blessberger" NO="7" P_CHI2="1.0" P_Z="0.050984465481431256" STUDIES="1" TAU2="0.0" TOTAL_1="197" TOTAL_2="203" WEIGHT="8.74908680955136" Z="1.951610501660338"><NAME>Bisoprolol</NAME><DICH_DATA CI_END="3.6290326949803244" CI_START="0.9972510940069231" EFFECT_SIZE="1.9023818820773135" ESTIMABLE="YES" EVENTS_1="24" EVENTS_2="13" LOG_CI_END="0.5597908808998064" LOG_CI_START="-0.0011954785870280453" LOG_EFFECT_SIZE="0.27929770115638924" MODIFIED="2013-11-23 22:13:54 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1432" O_E="0.0" SE="0.32952616448983174" STUDY_ID="STD-Marwick-2009" TOTAL_1="197" TOTAL_2="203" VAR="0.10858749308337966" WEIGHT="8.74908680955136"/></DICH_SUBGROUP><DICH_SUBGROUP CHI2="0.0" CI_END="1.2063517837162632" CI_START="0.7282887347158697" DF="0" EFFECT_SIZE="0.9373219373219374" ESTIMABLE="YES" EVENTS_1="28" EVENTS_2="36" I2="0.0" ID="CMP-005.20.08" LOG_CI_END="0.08147397069709093" LOG_CI_START="-0.13769640772879047" LOG_EFFECT_SIZE="-0.02811121851584977" MODIFIED="2013-11-23 22:14:07 +0000" MODIFIED_BY="Hermann Blessberger" NO="8" P_CHI2="1.0" P_Z="0.6151206625555028" STUDIES="1" TAU2="0.0" TOTAL_1="39" TOTAL_2="47" WEIGHT="10.7571806780294" Z="0.5027775764984013"><NAME>Nadolol</NAME><DICH_DATA CI_END="1.2063517837162632" CI_START="0.7282887347158697" EFFECT_SIZE="0.9373219373219374" ESTIMABLE="YES" EVENTS_1="28" EVENTS_2="36" LOG_CI_END="0.08147397069709093" LOG_CI_START="-0.13769640772879047" LOG_EFFECT_SIZE="-0.02811121851584977" MODIFIED="2013-11-23 22:14:07 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1433" O_E="0.0" SE="0.12874176519823316" STUDY_ID="STD-Burns-1988" TOTAL_1="39" TOTAL_2="47" VAR="0.016574442106356998" WEIGHT="10.7571806780294"/></DICH_SUBGROUP></DICH_OUTCOME><DICH_OUTCOME CHI2="3.941511219478616" CI_END="2.9695619135550615" CI_START="0.6159644179789664" CI_STUDY="95" CI_TOTAL="95" DF="6" EFFECT_MEASURE="RR" EFFECT_SIZE="1.3524586780140269" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="9" I2="0.0" I2_Q="0.0" ID="CMP-005.21" LOG_CI_END="0.4726923844825503" LOG_CI_START="-0.21044437472147587" LOG_EFFECT_SIZE="0.13112400488053724" METHOD="MH" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" NO="21" P_CHI2="0.6845916194704936" P_Q="0.6902800050117195" P_Z="0.45180654273238463" Q="3.062958211393892" RANDOM="NO" SCALE="100.0" SORT_BY="YEAR" STUDIES="6" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="302" TOTAL_2="321" WEIGHT="99.99999999999999" Z="0.7524066700025197"><NAME>Hypotension&#8212;cardiac surgery</NAME><GROUP_LABEL_1>Beta-blocker</GROUP_LABEL_1><GROUP_LABEL_2>Control</GROUP_LABEL_2><GRAPH_LABEL_1>Favours beta-blocker</GRAPH_LABEL_1><GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2><DICH_SUBGROUP CHI2="0.0" CI_END="107.61816341755203" CI_START="0.27865799953456794" DF="0" EFFECT_SIZE="5.476190476190476" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="0" I2="0.0" ID="CMP-005.21.01" LOG_CI_END="2.031885576221638" LOG_CI_START="-0.5549284849822533" LOG_EFFECT_SIZE="0.7384785456196924" MODIFIED="2013-11-23 22:28:27 +0000" MODIFIED_BY="Hermann Blessberger" NO="1" P_CHI2="1.0" P_Z="0.2631174367492456" STUDIES="1" TAU2="0.0" TOTAL_1="20" TOTAL_2="22" WEIGHT="4.651845902957963" Z="1.119053258970231"><NAME>Propranolol</NAME><DICH_DATA CI_END="107.61816341755203" CI_START="0.27865799953456794" EFFECT_SIZE="5.476190476190476" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="0" LOG_CI_END="2.031885576221638" LOG_CI_START="-0.5549284849822533" LOG_EFFECT_SIZE="0.7384785456196924" MODIFIED="2013-11-23 22:28:27 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1434" O_E="0.0" SE="1.5195073844872842" STUDY_ID="STD-Salazar-1979" TOTAL_1="20" TOTAL_2="22" VAR="2.308902691511387" WEIGHT="4.651845902957963"/></DICH_SUBGROUP><DICH_SUBGROUP CHI2="0.8631696309759103" CI_END="5.961737374477148" CI_START="0.19072202932948024" DF="1" EFFECT_SIZE="1.066318268806124" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="2" I2="0.0" ID="CMP-005.21.02" LOG_CI_END="0.7753728406453622" LOG_CI_START="-0.7195991409147608" LOG_EFFECT_SIZE="0.027886849865300656" MODIFIED="2013-11-24 05:37:37 +0000" MODIFIED_BY="Hermann Blessberger" NO="2" P_CHI2="0.3528532997355537" P_Z="0.9417095132999321" STUDIES="2" TAU2="0.0" TOTAL_1="103" TOTAL_2="110" WEIGHT="23.782148426842355" Z="0.07312139899936554"><NAME>Sotalol</NAME><DICH_DATA CI_END="80.35752625709628" CI_START="0.14098207571047106" EFFECT_SIZE="3.3658536585365852" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.9050265588697803" LOG_CI_START="-0.8508360995067785" LOG_EFFECT_SIZE="0.527095229681501" MODIFIED="2013-11-23 22:28:38 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1435" O_E="0.0" SE="1.618807367270561" STUDY_ID="STD-Gomes-1999" TOTAL_1="40" TOTAL_2="45" VAR="2.6205372923294448" WEIGHT="4.593284077140758"/><DICH_DATA CI_END="5.547895543126586" CI_START="0.047968633590376314" EFFECT_SIZE="0.5158730158730159" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" LOG_CI_END="0.744128275495914" LOG_CI_START="-1.3190426524453285" LOG_EFFECT_SIZE="-0.2874571884747073" MODIFIED="2013-11-24 05:37:37 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1495" O_E="0.0" SE="1.21191681593349" STUDY_ID="STD-Auer-2004" TOTAL_1="63" TOTAL_2="65" VAR="1.4687423687423689" WEIGHT="19.188864349701596"><FOOTNOTE>Only patients in the sotalol subgroup considered.</FOOTNOTE></DICH_DATA></DICH_SUBGROUP><DICH_SUBGROUP CHI2="0.0" CI_END="25.6782739076548" CI_START="0.3504908481140964" DF="0" EFFECT_SIZE="3.0" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="1" I2="0.0" ID="CMP-005.21.03" LOG_CI_END="1.4095658271236327" LOG_CI_START="-0.45532331768430767" LOG_EFFECT_SIZE="0.47712125471966244" MODIFIED="2013-11-23 22:28:45 +0000" MODIFIED_BY="Hermann Blessberger" NO="3" P_CHI2="1.0" P_Z="0.3159133624715845" STUDIES="1" TAU2="0.0" TOTAL_1="15" TOTAL_2="15" WEIGHT="9.74672474905478" Z="1.0028912207598348"><NAME>Esmolol</NAME><DICH_DATA CI_END="25.6782739076548" CI_START="0.3504908481140964" EFFECT_SIZE="3.0" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="1" LOG_CI_END="1.4095658271236327" LOG_CI_START="-0.45532331768430767" LOG_EFFECT_SIZE="0.47712125471966244" MODIFIED="2013-11-23 22:28:45 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1436" O_E="0.0" SE="1.0954451150103321" STUDY_ID="STD-But-2006" TOTAL_1="15" TOTAL_2="15" VAR="1.2" WEIGHT="9.74672474905478"/></DICH_SUBGROUP><DICH_SUBGROUP CHI2="0.0" CI_END="9.614160867147643" CI_START="0.2854860998584822" DF="0" EFFECT_SIZE="1.6567164179104477" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="2" I2="0.0" ID="CMP-005.21.04" LOG_CI_END="0.9829113846045738" LOG_CI_START="-0.5444150324329121" LOG_EFFECT_SIZE="0.21924817608583097" MODIFIED="2013-11-23 22:28:55 +0000" MODIFIED_BY="Hermann Blessberger" NO="4" P_CHI2="1.0" P_Z="0.5736345124779296" STUDIES="1" TAU2="0.0" TOTAL_1="67" TOTAL_2="74" WEIGHT="18.52568959394809" Z="0.5627068634586156"><NAME>Nadolol</NAME><DICH_DATA CI_END="9.614160867147643" CI_START="0.2854860998584822" EFFECT_SIZE="1.6567164179104477" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="2" LOG_CI_END="0.9829113846045738" LOG_CI_START="-0.5444150324329121" LOG_EFFECT_SIZE="0.21924817608583097" MODIFIED="2013-11-23 22:28:55 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1437" O_E="0.0" SE="0.8971590977555159" STUDY_ID="STD-Khuri-1987" TOTAL_1="67" TOTAL_2="74" VAR="0.8048944466854914" WEIGHT="18.52568959394809"/></DICH_SUBGROUP><DICH_SUBGROUP CHI2="0.0" CI_END="6.706930006003608" CI_START="0.1490995133548233" DF="0" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="2" I2="0.0" ID="CMP-005.21.05" LOG_CI_END="0.8265237740363401" LOG_CI_START="-0.82652377403634" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-11-23 22:29:02 +0000" MODIFIED_BY="Hermann Blessberger" NO="5" P_CHI2="1.0" P_Z="1.0" STUDIES="1" TAU2="0.0" TOTAL_1="35" TOTAL_2="35" WEIGHT="19.49344949810956" Z="0.0"><NAME>Atenolol</NAME><DICH_DATA CI_END="6.706930006003608" CI_START="0.1490995133548233" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="2" LOG_CI_END="0.8265237740363401" LOG_CI_START="-0.82652377403634" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-11-23 22:29:02 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1438" O_E="0.0" SE="0.9710083124552245" STUDY_ID="STD-Matangi-1989" TOTAL_1="35" TOTAL_2="35" VAR="0.9428571428571428" WEIGHT="19.49344949810956"/></DICH_SUBGROUP><DICH_SUBGROUP CHI2="0.0" CI_END="4.279157103047954" CI_START="0.010259082735265884" DF="0" EFFECT_SIZE="0.20952380952380953" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" I2="0.0" ID="CMP-005.21.06" LOG_CI_END="0.6313582312687743" LOG_CI_START="-1.9888914677642378" LOG_EFFECT_SIZE="-0.6787666182477319" MODIFIED="2014-06-22 20:00:08 +0100" MODIFIED_BY="Hermann Blessberger" NO="6" P_CHI2="1.0" P_Z="0.3098943481714851" STUDIES="1" TAU2="0.0" TOTAL_1="62" TOTAL_2="65" WEIGHT="23.800141829087252" Z="1.0154437771061005"><NAME>Metoprolol</NAME><DICH_DATA CI_END="4.279157103047954" CI_START="0.010259082735265884" EFFECT_SIZE="0.20952380952380953" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" LOG_CI_END="0.6313582312687743" LOG_CI_START="-1.9888914677642378" LOG_EFFECT_SIZE="-0.6787666182477319" MODIFIED="2014-06-22 20:00:08 +0100" MODIFIED_BY="Hermann Blessberger" ORDER="1494" O_E="0.0" SE="1.5391476436571863" STUDY_ID="STD-Auer-2004" TOTAL_1="62" TOTAL_2="65" VAR="2.368975468975469" WEIGHT="23.800141829087252"><FOOTNOTE>Only patients in the metoprolol subgroup considered.</FOOTNOTE></DICH_DATA></DICH_SUBGROUP></DICH_OUTCOME><DICH_OUTCOME CHI2="18.008087062566087" CI_END="1.6329700435772967" CI_START="1.3752658364550214" CI_STUDY="95" CI_TOTAL="95" DF="17" EFFECT_MEASURE="RR" EFFECT_SIZE="1.4985886403167226" ESTIMABLE="YES" EVENTS_1="1044" EVENTS_2="657" I2="5.597968618563744" I2_Q="20.51697108989993" ID="CMP-005.22" LOG_CI_END="0.21297821778724463" LOG_CI_START="0.138386654636477" LOG_EFFECT_SIZE="0.17568243621186078" METHOD="MH" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" NO="22" P_CHI2="0.38833102779949946" P_Q="0.2789558115945764" P_Z="2.6452384280863576E-20" Q="6.2906510591780425" RANDOM="NO" SCALE="100.0" SORT_BY="YEAR" STUDIES="21" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="5522" TOTAL_2="5297" WEIGHT="99.99999999999999" Z="9.23244488107926"><NAME>Hypotension&#8212;non-cardiac surgery</NAME><GROUP_LABEL_1>Beta-blocker</GROUP_LABEL_1><GROUP_LABEL_2>Control</GROUP_LABEL_2><GRAPH_LABEL_1>Favours beta-blocker</GRAPH_LABEL_1><GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2><DICH_SUBGROUP CHI2="8.838339709059644" CI_END="1.6275714587387367" CI_START="1.344115510722767" DF="7" EFFECT_SIZE="1.4790686402261444" ESTIMABLE="YES" EVENTS_1="813" EVENTS_2="545" I2="20.799604558934007" ID="CMP-005.22.01" LOG_CI_END="0.21154006541511633" LOG_CI_START="0.1284365927608612" LOG_EFFECT_SIZE="0.16998832908798875" MODIFIED="2013-11-23 22:34:48 +0000" MODIFIED_BY="Hermann Blessberger" NO="1" P_CHI2="0.2644720899929557" P_Z="1.0728768991673715E-15" STUDIES="8" TAU2="0.0" TOTAL_1="4569" TOTAL_2="4567" WEIGHT="81.63010905315409" Z="8.018220951866352"><NAME>Metoprolol</NAME><DICH_DATA CI_END="15.259760455310136" CI_START="0.0655318281652329" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.1835477162038213" LOG_CI_START="-1.1835477162038213" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-11-23 22:33:52 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1445" O_E="0.0" SE="1.390443574307614" STUDY_ID="STD-Whitehead-1980" TOTAL_1="30" TOTAL_2="30" VAR="1.9333333333333331" WEIGHT="0.1489083074575461"/><DICH_DATA CI_END="21.029313937505744" CI_START="0.2205993627858741" EFFECT_SIZE="2.1538461538461537" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="1" LOG_CI_END="1.3228251044497223" LOG_CI_START="-0.6563957463789576" LOG_EFFECT_SIZE="0.33321467903538243" MODIFIED="2013-11-23 22:33:57 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1442" O_E="0.0" SE="1.162604125077987" STUDY_ID="STD-Magnusson-1986" TOTAL_1="13" TOTAL_2="14" VAR="1.3516483516483517" WEIGHT="0.14339318495911846"/><DICH_DATA CI_END="69.5152908317231" CI_START="0.12946791838627933" EFFECT_SIZE="3.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.84208034406391" LOG_CI_START="-0.8878378346245852" LOG_EFFECT_SIZE="0.47712125471966244" MODIFIED="2013-11-23 22:34:04 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1439" O_E="0.0" SE="1.6035674514745464" STUDY_ID="STD-Jakobsen-1992" TOTAL_1="20" TOTAL_2="20" VAR="2.5714285714285716" WEIGHT="0.07445415372877305"/><DICH_DATA CI_END="7.259648833094586" CI_START="0.013736613709900562" EFFECT_SIZE="0.3157894736842105" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.8609156133257376" LOG_CI_START="-1.8621203144641083" LOG_EFFECT_SIZE="-0.5006023505691853" MODIFIED="2013-11-23 22:34:09 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1440" O_E="0.0" SE="1.5995247832289885" STUDY_ID="STD-Jakobsen-1997" TOTAL_1="18" TOTAL_2="17" VAR="2.5584795321637426" WEIGHT="0.22939928446162508"/><DICH_DATA CI_END="1.4291890961291949" CI_START="1.0016090630908658" EFFECT_SIZE="1.1964483906770256" ESTIMABLE="YES" EVENTS_1="49" EVENTS_2="34" LOG_CI_END="0.15508969413200707" LOG_CI_START="6.982456113067668E-4" LOG_EFFECT_SIZE="0.07789396987165693" MODIFIED="2013-11-23 22:34:18 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1443" O_E="0.0" SE="0.09069030111105522" STUDY_ID="STD-POBBLE-2005" TOTAL_1="53" TOTAL_2="44" VAR="0.008224730715613863" WEIGHT="5.532634433783466"/><DICH_DATA CI_END="1.6001337406240679" CI_START="1.0973785289749167" EFFECT_SIZE="1.3251235453531005" ESTIMABLE="YES" EVENTS_1="133" EVENTS_2="102" LOG_CI_END="0.20415628289821494" LOG_CI_START="0.04035645864943841" LOG_EFFECT_SIZE="0.12225637077382669" MODIFIED="2013-11-23 22:34:37 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1446" O_E="0.0" SE="0.09621682758593815" STUDY_ID="STD-Yang-2006" TOTAL_1="246" TOTAL_2="250" VAR="0.009257677910702148" WEIGHT="15.066158269051398"/><DICH_DATA CI_END="6.20048286508611" CI_START="0.16127776203218527" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="2" LOG_CI_END="0.7924255116719207" LOG_CI_START="-0.7924255116719207" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-11-23 22:34:26 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1441" O_E="0.0" SE="0.9309493362512627" STUDY_ID="STD-Liu-2006" TOTAL_1="15" TOTAL_2="15" VAR="0.8666666666666667" WEIGHT="0.2978166149150922"/><DICH_DATA CI_END="1.7412304767530802" CI_START="1.3764647865839486" EFFECT_SIZE="1.5481416074046312" ESTIMABLE="YES" EVENTS_1="625" EVENTS_2="404" LOG_CI_END="0.24085626000721605" LOG_CI_START="0.13876510553109628" LOG_EFFECT_SIZE="0.18981068276915616" MODIFIED="2013-11-23 22:34:48 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1444" O_E="0.0" SE="0.05996884949863775" STUDY_ID="STD-POISE-2008" TOTAL_1="4174" TOTAL_2="4177" VAR="0.003596262910190265" WEIGHT="60.137344804797074"/></DICH_SUBGROUP><DICH_SUBGROUP CHI2="0.0" CI_END="3.2587122691507338" CI_START="1.0890244032150478" DF="0" EFFECT_SIZE="1.8838304552590266" ESTIMABLE="YES" EVENTS_1="24" EVENTS_2="13" I2="0.0" ID="CMP-005.22.02" LOG_CI_END="0.513046015746927" LOG_CI_START="0.03703761167762189" LOG_EFFECT_SIZE="0.2750418137122744" MODIFIED="2013-11-23 22:35:06 +0000" MODIFIED_BY="Hermann Blessberger" NO="2" P_CHI2="1.0" P_Z="0.02351460521924916" STUDIES="1" TAU2="0.0" TOTAL_1="49" TOTAL_2="50" WEIGHT="1.9162543808173105" Z="2.2649686203445505"><NAME>Propranolol</NAME><DICH_DATA CI_END="3.258712269150733" CI_START="1.0890244032150478" EFFECT_SIZE="1.8838304552590266" ESTIMABLE="YES" EVENTS_1="24" EVENTS_2="13" LOG_CI_END="0.5130460157469269" LOG_CI_START="0.03703761167762189" LOG_EFFECT_SIZE="0.2750418137122744" MODIFIED="2013-11-23 22:35:06 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1447" O_E="0.0" SE="0.2796096928299115" STUDY_ID="STD-Bayliff-1999" TOTAL_1="49" TOTAL_2="50" VAR="0.07818158032443746" WEIGHT="1.9162543808173105"/></DICH_SUBGROUP><DICH_SUBGROUP CHI2="0.0" CI_END="2.4440278509874847" CI_START="0.5796419209128254" DF="0" EFFECT_SIZE="1.1902356902356903" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="12" I2="0.0" ID="CMP-005.22.03" LOG_CI_END="0.38810615061358633" LOG_CI_START="-0.23684021298217456" LOG_EFFECT_SIZE="0.07563296881570589" MODIFIED="2014-06-22 20:51:06 +0100" MODIFIED_BY="Hermann Blessberger" NO="3" P_CHI2="1.0" P_Z="0.635213285762206" STUDIES="2" TAU2="0.0" TOTAL_1="121" TOTAL_2="123" WEIGHT="1.7690306925956478" Z="0.47440197609825757"><NAME>Atenolol</NAME><DICH_DATA CI_END="2.4440278509874847" CI_START="0.5796419209128254" EFFECT_SIZE="1.1902356902356903" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="12" LOG_CI_END="0.38810615061358633" LOG_CI_START="-0.23684021298217456" LOG_EFFECT_SIZE="0.07563296881570589" MODIFIED="2014-06-22 20:51:06 +0100" MODIFIED_BY="Hermann Blessberger" ORDER="1448" O_E="0.0" SE="0.36709658751054164" STUDY_ID="STD-Mangano-1996" TOTAL_1="99" TOTAL_2="101" VAR="0.13475990456188475" WEIGHT="1.7690306925956478"/><DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-11-23 22:35:23 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1449" O_E="0.0" SE="0.0" STUDY_ID="STD-Gupta-2011" TOTAL_1="22" TOTAL_2="22" VAR="0.0" WEIGHT="0.0"/></DICH_SUBGROUP><DICH_SUBGROUP CHI2="2.207450651356372" CI_END="2.582655753513408" CI_START="1.2931831476416198" DF="5" EFFECT_SIZE="1.827524800543951" ESTIMABLE="YES" EVENTS_1="119" EVENTS_2="33" I2="0.0" ID="CMP-005.22.04" LOG_CI_END="0.41206652219618184" LOG_CI_START="0.11166003638651809" LOG_EFFECT_SIZE="0.26186327929134995" MODIFIED="2013-11-23 22:36:13 +0000" MODIFIED_BY="Hermann Blessberger" NO="4" P_CHI2="0.8197591294559532" P_Z="6.331819791648225E-4" STUDIES="7" TAU2="0.0" TOTAL_1="538" TOTAL_2="316" WEIGHT="6.717266882916946" Z="3.4169874521936108"><NAME>Esmolol</NAME><DICH_DATA CI_END="2.917064814565508" CI_START="0.30129815615047" EFFECT_SIZE="0.9375" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="5" LOG_CI_END="0.4649460788630512" LOG_CI_START="-0.5210035260635382" LOG_EFFECT_SIZE="-0.028028723600243537" MODIFIED="2013-11-23 22:35:31 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1450" O_E="0.0" SE="0.5791516784631352" STUDY_ID="STD-Cucchiara-1986" TOTAL_1="32" TOTAL_2="30" VAR="0.3354166666666667" WEIGHT="0.768559006232496"/><DICH_DATA CI_END="89.07654204661276" CI_START="0.23194835082374035" EFFECT_SIZE="4.545454545454546" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="0" LOG_CI_END="1.9497633493675715" LOG_CI_START="-0.6346087110119837" LOG_EFFECT_SIZE="0.6575773191777938" MODIFIED="2013-11-23 22:35:36 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1451" O_E="0.0" SE="1.5180729411149698" STUDY_ID="STD-Gibson-1988" TOTAL_1="21" TOTAL_2="19" VAR="2.3045454545454547" WEIGHT="0.0779995896206194"/><DICH_DATA CI_END="81.01190363542146" CI_START="0.2663500355480702" EFFECT_SIZE="4.645161290322581" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="0" LOG_CI_END="1.9085488374385386" LOG_CI_START="-0.5745472409165846" LOG_EFFECT_SIZE="0.667000798260977" MODIFIED="2013-11-23 22:35:44 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1455" O_E="0.0" SE="1.4585829279496223" STUDY_ID="STD-Sandler-1990" TOTAL_1="30" TOTAL_2="15" VAR="2.1274641577060933" WEIGHT="0.09821611768476445"/><DICH_DATA CI_END="35.88938623485869" CI_START="0.0668025523135909" EFFECT_SIZE="1.5483870967741935" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.5549660312757505" LOG_CI_START="-1.1752069441931212" LOG_EFFECT_SIZE="0.18987954354131453" MODIFIED="2013-11-23 22:35:52 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1452" O_E="0.0" SE="1.603717120364604" STUDY_ID="STD-Miller-1990" TOTAL_1="30" TOTAL_2="15" VAR="2.5719086021505375" WEIGHT="0.09821611768476445"/><DICH_DATA CI_END="2.6979150176212503" CI_START="1.2709157890073948" EFFECT_SIZE="1.8517080745341614" ESTIMABLE="YES" EVENTS_1="106" EVENTS_2="28" LOG_CI_END="0.4310282655881383" LOG_CI_START="0.10411677511654042" LOG_EFFECT_SIZE="0.2675725203523394" MODIFIED="2013-11-23 22:36:01 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1453" O_E="0.0" SE="0.19202942774099305" STUDY_ID="STD-Miller-1991" TOTAL_1="368" TOTAL_2="180" VAR="0.03687530111853327" WEIGHT="5.599821897965529"/><DICH_DATA CI_END="70.82882080128432" CI_START="0.12706691849706483" EFFECT_SIZE="3.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.850210011475669" LOG_CI_START="-0.8959675020363438" LOG_EFFECT_SIZE="0.47712125471966244" MODIFIED="2013-11-23 22:36:06 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1456" O_E="0.0" SE="1.613118265234886" STUDY_ID="STD-Shukla-2010" TOTAL_1="30" TOTAL_2="30" VAR="2.6021505376344085" WEIGHT="0.07445415372877305"/><DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-11-23 22:36:13 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1454" O_E="0.0" SE="0.0" STUDY_ID="STD-Moon-2011" TOTAL_1="27" TOTAL_2="27" VAR="0.0" WEIGHT="0.0"/></DICH_SUBGROUP><DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-005.22.05" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2013-11-23 22:36:19 +0000" MODIFIED_BY="Hermann Blessberger" NO="5" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="20" TOTAL_2="10" WEIGHT="0.0" Z="0.0"><NAME>Labetalol</NAME><DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-11-23 22:36:19 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1457" O_E="0.0" SE="0.0" STUDY_ID="STD-Inada-1989" TOTAL_1="20" TOTAL_2="10" VAR="0.0" WEIGHT="0.0"/></DICH_SUBGROUP><DICH_SUBGROUP CHI2="0.0" CI_END="2.3140090156976254" CI_START="1.0534324826660835" DF="0" EFFECT_SIZE="1.561298261805876" ESTIMABLE="YES" EVENTS_1="50" EVENTS_2="33" I2="0.0" ID="CMP-005.22.06" LOG_CI_END="0.36436504669010483" LOG_CI_START="0.022606705729397786" LOG_EFFECT_SIZE="0.1934858762097513" MODIFIED="2013-11-23 22:36:33 +0000" MODIFIED_BY="Hermann Blessberger" NO="6" P_CHI2="1.0" P_Z="0.026469024905786585" STUDIES="1" TAU2="0.0" TOTAL_1="197" TOTAL_2="203" WEIGHT="4.840264533907536" Z="2.219260239982781"><NAME>Bisoprolol</NAME><DICH_DATA CI_END="2.3140090156976254" CI_START="1.0534324826660835" EFFECT_SIZE="1.561298261805876" ESTIMABLE="YES" EVENTS_1="50" EVENTS_2="33" LOG_CI_END="0.36436504669010483" LOG_CI_START="0.022606705729397786" LOG_EFFECT_SIZE="0.1934858762097513" MODIFIED="2013-11-23 22:36:33 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1458" O_E="0.0" SE="0.20075054121139094" STUDY_ID="STD-Marwick-2009" TOTAL_1="197" TOTAL_2="203" VAR="0.040300779796666374" WEIGHT="4.840264533907536"/></DICH_SUBGROUP><DICH_SUBGROUP CHI2="0.0" CI_END="1.48504132021836" CI_START="0.8795192640077784" DF="0" EFFECT_SIZE="1.1428571428571428" ESTIMABLE="YES" EVENTS_1="24" EVENTS_2="21" I2="0.0" ID="CMP-005.22.07" LOG_CI_END="0.171738537756374" LOG_CI_START="-0.05575464380100056" LOG_EFFECT_SIZE="0.05799194697768673" MODIFIED="2013-11-23 22:36:41 +0000" MODIFIED_BY="Hermann Blessberger" NO="7" P_CHI2="1.0" P_Z="0.31767000868797524" STUDIES="1" TAU2="0.0" TOTAL_1="28" TOTAL_2="28" WEIGHT="3.1270744566084683" Z="0.9992574431595125"><NAME>Landiolol</NAME><DICH_DATA CI_END="1.48504132021836" CI_START="0.8795192640077785" EFFECT_SIZE="1.1428571428571428" ESTIMABLE="YES" EVENTS_1="24" EVENTS_2="21" LOG_CI_END="0.171738537756374" LOG_CI_START="-0.05575464380100051" LOG_EFFECT_SIZE="0.05799194697768673" MODIFIED="2013-11-23 22:36:41 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1459" O_E="0.0" SE="0.13363062095621217" STUDY_ID="STD-Kawaguchi-2010" TOTAL_1="28" TOTAL_2="28" VAR="0.01785714285714285" WEIGHT="3.1270744566084683"/></DICH_SUBGROUP></DICH_OUTCOME><DICH_OUTCOME CHI2="0.09303220818048605" CI_END="1.3427512845324863" CI_START="0.03737671869422976" CI_STUDY="95" CI_TOTAL="95" DF="2" EFFECT_MEASURE="RR" EFFECT_SIZE="0.22402597402597405" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="4" I2="0.0" I2_Q="0.0" ID="CMP-005.23" LOG_CI_END="0.12799557651214638" LOG_CI_START="-1.4273988280385241" LOG_EFFECT_SIZE="-0.6497016257631889" METHOD="MH" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" NO="23" P_CHI2="0.9545491900457851" P_Q="0.7697330985147935" P_Z="0.10154949900018825" Q="0.08568736931360918" RANDOM="NO" SCALE="100.0" SORT_BY="YEAR" STUDIES="3" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="172" TOTAL_2="139" WEIGHT="100.0" Z="1.6373876406747574"><NAME>Congestive heart failure&#8212;cardiac surgery</NAME><GROUP_LABEL_1>Beta-blocker</GROUP_LABEL_1><GROUP_LABEL_2>Control</GROUP_LABEL_2><GRAPH_LABEL_1>Favours beta-blocker</GRAPH_LABEL_1><GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2><DICH_SUBGROUP CHI2="0.0" CI_END="7.9127893408891605" CI_START="0.014041965016931132" DF="0" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" I2="0.0" ID="CMP-005.23.01" LOG_CI_END="0.8983296038284552" LOG_CI_START="-1.85257211326778" LOG_EFFECT_SIZE="-0.47712125471966244" MODIFIED="2013-11-23 22:38:25 +0000" MODIFIED_BY="Hermann Blessberger" NO="1" P_CHI2="1.0" P_Z="0.4965809361801813" STUDIES="1" TAU2="0.0" TOTAL_1="35" TOTAL_2="35" WEIGHT="25.08116883116883" Z="0.6798792335599723"><NAME>Atenolol</NAME><DICH_DATA CI_END="7.9127893408891605" CI_START="0.014041965016931132" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.8983296038284552" LOG_CI_START="-1.85257211326778" LOG_EFFECT_SIZE="-0.47712125471966244" MODIFIED="2013-11-23 22:38:25 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1460" O_E="0.0" SE="1.6158932858054431" STUDY_ID="STD-Matangi-1989" TOTAL_1="35" TOTAL_2="35" VAR="2.611111111111111" WEIGHT="25.08116883116883"/></DICH_SUBGROUP><DICH_SUBGROUP CHI2="0.0047569470437718525" CI_END="1.6874394145128593" CI_START="0.020819035955885037" DF="1" EFFECT_SIZE="0.18743228602383533" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="3" I2="0.0" ID="CMP-005.23.02" LOG_CI_END="0.2272281889607856" LOG_CI_START="-1.6815393847550189" LOG_EFFECT_SIZE="-0.7271555978971166" MODIFIED="2014-06-22 20:11:15 +0100" MODIFIED_BY="Hermann Blessberger" NO="2" P_CHI2="0.9450130021112558" P_Z="0.13535388509894164" STUDIES="2" TAU2="0.0" TOTAL_1="137" TOTAL_2="104" WEIGHT="74.91883116883116" Z="1.4933183093220708"><NAME>Landiolol</NAME><DICH_DATA CI_END="4.092080860459946" CI_START="0.009774977905862802" EFFECT_SIZE="0.2" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" LOG_CI_END="0.611944206883865" LOG_CI_START="-2.0098842155559025" LOG_EFFECT_SIZE="-0.6989700043360187" MODIFIED="2013-11-23 22:38:32 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1461" O_E="0.0" SE="1.540074993601121" STUDY_ID="STD-Sezai-2011" TOTAL_1="70" TOTAL_2="70" VAR="2.371830985915493" WEIGHT="41.80194805194805"/><DICH_DATA CI_END="4.103163647782676" CI_START="0.0071739263778377955" EFFECT_SIZE="0.1715686274509804" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.6131188384174836" LOG_CI_START="-2.14424308456873" LOG_EFFECT_SIZE="-0.7655621230756231" MODIFIED="2014-06-22 20:11:15 +0100" MODIFIED_BY="Hermann Blessberger" ORDER="1504" O_E="0.0" SE="1.6196880427237514" STUDY_ID="STD-Sezai-2012" TOTAL_1="67" TOTAL_2="34" VAR="2.623389355742297" WEIGHT="33.116883116883116"><FOOTNOTE>Only patients in the landiolol subgroup considered.</FOOTNOTE></DICH_DATA></DICH_SUBGROUP></DICH_OUTCOME><DICH_OUTCOME CHI2="1.8390964020271594" CI_END="1.4815572346084287" CI_START="0.9383036072485224" CI_STUDY="95" CI_TOTAL="95" DF="4" EFFECT_MEASURE="RR" EFFECT_SIZE="1.1790464357175394" ESTIMABLE="YES" EVENTS_1="154" EVENTS_2="131" I2="0.0" I2_Q="0.0" ID="CMP-005.24" LOG_CI_END="0.17071843353762536" LOG_CI_START="-0.027656614053537077" LOG_EFFECT_SIZE="0.07153090974204411" METHOD="MH" MODIFIED="2017-06-17 15:48:40 +0100" MODIFIED_BY="Hermann Blessberger" NO="24" P_CHI2="0.7653222538708769" P_Q="0.6029878187896034" P_Z="0.15751930148012083" Q="1.011716792217769" RANDOM="NO" SCALE="100.0" SORT_BY="YEAR" STUDIES="5" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="4581" TOTAL_2="4592" WEIGHT="100.0" Z="1.4134641284596479"><NAME>Congestive heart failure&#8212;non-cardiac surgery</NAME><GROUP_LABEL_1>Beta-blocker</GROUP_LABEL_1><GROUP_LABEL_2>Control</GROUP_LABEL_2><GRAPH_LABEL_1>Favours beta-blocker</GRAPH_LABEL_1><GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2><DICH_SUBGROUP CHI2="0.8305310285012293" CI_END="1.4545611600264965" CI_START="0.898276971908164" DF="2" EFFECT_SIZE="1.143065524930145" ESTIMABLE="YES" EVENTS_1="137" EVENTS_2="120" I2="0.0" ID="CMP-005.24.01" LOG_CI_END="0.16273198677496312" LOG_CI_START="-0.046589733683546526" LOG_EFFECT_SIZE="0.058071126545708306" MODIFIED="2013-11-23 22:41:53 +0000" MODIFIED_BY="Hermann Blessberger" NO="1" P_CHI2="0.6601649894003236" P_Z="0.2768216927325665" STUDIES="3" TAU2="0.0" TOTAL_1="4433" TOTAL_2="4441" WEIGHT="91.70455587583737" Z="1.0874869203439046"><NAME>Metoprolol</NAME><DICH_DATA CI_END="8.060808530068375" CI_START="0.015823601309021718" EFFECT_SIZE="0.35714285714285715" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.9063786053951907" LOG_CI_START="-1.8006946680796287" LOG_EFFECT_SIZE="-0.4471580313422192" MODIFIED="2013-11-23 22:41:38 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1462" O_E="0.0" SE="1.5901482410679288" STUDY_ID="STD-Magnusson-1986" TOTAL_1="13" TOTAL_2="14" VAR="2.528571428571428" WEIGHT="1.103263292296873"/><DICH_DATA CI_END="7.010763785170189" CI_START="0.4092059762747028" EFFECT_SIZE="1.6937669376693767" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="3" LOG_CI_END="0.8457653346022119" LOG_CI_START="-0.38805803223218227" LOG_EFFECT_SIZE="0.22885365118501486" MODIFIED="2013-11-23 22:41:46 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1464" O_E="0.0" SE="0.7247539532026899" STUDY_ID="STD-Yang-2006" TOTAL_1="246" TOTAL_2="250" VAR="0.5252682926829269" WEIGHT="2.2669010159118352"/><DICH_DATA CI_END="1.4559367832756067" CI_START="0.8906630317937844" EFFECT_SIZE="1.138748905374816" ESTIMABLE="YES" EVENTS_1="132" EVENTS_2="116" LOG_CI_END="0.16314251833512286" LOG_CI_START="-0.05028657330588837" LOG_EFFECT_SIZE="0.05642797251461725" MODIFIED="2013-11-23 22:41:53 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1463" O_E="0.0" SE="0.12536930492097248" STUDY_ID="STD-POISE-2008" TOTAL_1="4174" TOTAL_2="4177" VAR="0.015717462616367778" WEIGHT="88.33439156762866"/></DICH_SUBGROUP><DICH_SUBGROUP CHI2="0.0" CI_END="6.341211041538326" CI_START="0.6568037637213733" DF="0" EFFECT_SIZE="2.0408163265306123" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="4" I2="0.0" ID="CMP-005.24.02" LOG_CI_END="0.8021722071611551" LOG_CI_START="-0.18256436721818248" LOG_EFFECT_SIZE="0.3098039199714864" MODIFIED="2013-11-23 22:42:10 +0000" MODIFIED_BY="Hermann Blessberger" NO="2" P_CHI2="1.0" P_Z="0.21748909324041443" STUDIES="1" TAU2="0.0" TOTAL_1="49" TOTAL_2="50" WEIGHT="3.0163292705220908" Z="1.2332324018657537"><NAME>Propranolol</NAME><DICH_DATA CI_END="6.341211041538326" CI_START="0.6568037637213733" EFFECT_SIZE="2.0408163265306123" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="4" LOG_CI_END="0.8021722071611551" LOG_CI_START="-0.18256436721818248" LOG_EFFECT_SIZE="0.3098039199714864" MODIFIED="2013-11-23 22:42:10 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1465" O_E="0.0" SE="0.5784391383150814" STUDY_ID="STD-Bayliff-1999" TOTAL_1="49" TOTAL_2="50" VAR="0.33459183673469384" WEIGHT="3.0163292705220908"/></DICH_SUBGROUP><DICH_SUBGROUP CHI2="0.0" CI_END="3.3849895408599173" CI_START="0.5082811058206856" DF="0" EFFECT_SIZE="1.3116883116883118" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="7" I2="0.0" ID="CMP-005.24.03" LOG_CI_END="0.5295573311145632" LOG_CI_START="-0.2938960338942417" LOG_EFFECT_SIZE="0.11783064861016074" MODIFIED="2013-11-23 22:42:18 +0000" MODIFIED_BY="Hermann Blessberger" NO="3" P_CHI2="1.0" P_Z="0.5748552290967489" STUDIES="1" TAU2="0.0" TOTAL_1="99" TOTAL_2="101" WEIGHT="5.279114853640538" Z="0.5609153775173176"><NAME>Atenolol</NAME><DICH_DATA CI_END="3.384989540859917" CI_START="0.5082811058206856" EFFECT_SIZE="1.3116883116883118" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="7" LOG_CI_END="0.529557331114563" LOG_CI_START="-0.2938960338942417" LOG_EFFECT_SIZE="0.11783064861016074" MODIFIED="2013-11-23 22:42:18 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1466" O_E="0.0" SE="0.48370058276606814" STUDY_ID="STD-Wallace-1998" TOTAL_1="99" TOTAL_2="101" VAR="0.23396625376823393" WEIGHT="5.279114853640538"/></DICH_SUBGROUP><DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-005.24.04" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2017-06-17 15:48:40 +0100" MODIFIED_BY="Hermann Blessberger" NO="4" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0"><NAME>Esmolol</NAME></DICH_SUBGROUP><DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-005.24.05" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2013-12-10 03:51:05 +0000" MODIFIED_BY="Hermann Blessberger" NO="5" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0"><NAME>Bisoprolol</NAME></DICH_SUBGROUP></DICH_OUTCOME><DICH_OUTCOME CHI2="1.4612849942823773" CI_END="7.140937434672779" CI_START="0.31009540371843614" CI_STUDY="95" CI_TOTAL="95" DF="2" EFFECT_MEASURE="RR" EFFECT_SIZE="1.4880765695127884" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="1" I2="0.0" I2_Q="0.0" ID="CMP-005.25" LOG_CI_END="0.8537552280200981" LOG_CI_START="-0.508504670894289" LOG_EFFECT_SIZE="0.17262527856290452" METHOD="MH" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" NO="25" P_CHI2="0.48159954930100957" P_Q="0.4818376622584154" P_Z="0.6193777582615365" Q="1.4602963943836726" RANDOM="NO" SCALE="100.0" SORT_BY="YEAR" STUDIES="3" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="93" TOTAL_2="103" WEIGHT="100.0" Z="0.49673242099267073"><NAME>Bronchospasm&#8212;cardiac surgery</NAME><GROUP_LABEL_1>Beta-blocker</GROUP_LABEL_1><GROUP_LABEL_2>Control</GROUP_LABEL_2><GRAPH_LABEL_1>Favours beta-blocker</GRAPH_LABEL_1><GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2><DICH_SUBGROUP CHI2="0.0" CI_END="92.3227511791855" CI_START="0.1620909391163925" DF="0" EFFECT_SIZE="3.8684210526315788" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" I2="0.0" ID="CMP-005.25.01" LOG_CI_END="1.9653087377975338" LOG_CI_START="-0.790241261534802" LOG_EFFECT_SIZE="0.5875337381313659" MODIFIED="2013-11-23 22:44:59 +0000" MODIFIED_BY="Hermann Blessberger" NO="1" P_CHI2="1.0" P_Z="0.40326718076139" STUDIES="1" TAU2="0.0" TOTAL_1="37" TOTAL_2="48" WEIGHT="17.671551397826203" Z="0.8358004512483402"><NAME>Propranolol</NAME><DICH_DATA CI_END="92.32275117918559" CI_START="0.16209093911639244" EFFECT_SIZE="3.8684210526315788" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.9653087377975342" LOG_CI_START="-0.7902412615348021" LOG_EFFECT_SIZE="0.5875337381313659" MODIFIED="2013-11-23 22:44:59 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1469" O_E="0.0" SE="1.6186237098002971" STUDY_ID="STD-Mohr-1981" TOTAL_1="37" TOTAL_2="48" VAR="2.6199427139276765" WEIGHT="17.671551397826203"/></DICH_SUBGROUP><DICH_SUBGROUP CHI2="0.0" CI_END="71.21510406800243" CI_START="0.12637768515238015" DF="0" EFFECT_SIZE="3.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" I2="0.0" ID="CMP-005.25.02" LOG_CI_END="1.85257211326778" LOG_CI_START="-0.8983296038284552" LOG_EFFECT_SIZE="0.47712125471966244" MODIFIED="2013-11-23 22:45:07 +0000" MODIFIED_BY="Hermann Blessberger" NO="2" P_CHI2="1.0" P_Z="0.4965809361801813" STUDIES="1" TAU2="0.0" TOTAL_1="35" TOTAL_2="35" WEIGHT="20.229275942248417" Z="0.6798792335599723"><NAME>Atenolol</NAME><DICH_DATA CI_END="71.21510406800243" CI_START="0.12637768515238015" EFFECT_SIZE="3.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.85257211326778" LOG_CI_START="-0.8983296038284552" LOG_EFFECT_SIZE="0.47712125471966244" MODIFIED="2013-11-23 22:45:07 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1470" O_E="0.0" SE="1.6158932858054431" STUDY_ID="STD-Matangi-1989" TOTAL_1="35" TOTAL_2="35" VAR="2.611111111111111" WEIGHT="20.229275942248417"/></DICH_SUBGROUP><DICH_SUBGROUP CHI2="0.0" CI_END="7.382590940745529" CI_START="0.013713297978184326" DF="0" EFFECT_SIZE="0.3181818181818182" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" I2="0.0" ID="CMP-005.25.03" LOG_CI_END="0.8682088054265785" LOG_CI_START="-1.8628580870424774" LOG_EFFECT_SIZE="-0.4973246408079494" MODIFIED="2013-11-23 22:45:12 +0000" MODIFIED_BY="Hermann Blessberger" NO="3" P_CHI2="1.0" P_Z="0.47534153044019734" STUDIES="1" TAU2="0.0" TOTAL_1="21" TOTAL_2="20" WEIGHT="62.09917265992538" Z="0.7138150935048501"><NAME>Timolol</NAME><DICH_DATA CI_END="7.382590940745529" CI_START="0.013713297978184326" EFFECT_SIZE="0.3181818181818182" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.8682088054265785" LOG_CI_START="-1.8628580870424774" LOG_EFFECT_SIZE="-0.4973246408079494" MODIFIED="2013-11-23 22:45:12 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1471" O_E="0.0" SE="1.6042422116354729" STUDY_ID="STD-White-1984" TOTAL_1="21" TOTAL_2="20" VAR="2.5735930735930737" WEIGHT="62.09917265992538"/></DICH_SUBGROUP></DICH_OUTCOME><DICH_OUTCOME CHI2="3.30428058690124" CI_END="1.5862677008295942" CI_START="0.5538393876131481" CI_STUDY="95" CI_TOTAL="95" DF="6" EFFECT_MEASURE="RR" EFFECT_SIZE="0.9373033297806954" ESTIMABLE="YES" EVENTS_1="22" EVENTS_2="21" I2="0.0" I2_Q="0.0" ID="CMP-005.26" LOG_CI_END="0.20037648133111538" LOG_CI_START="-0.2566161616009709" LOG_EFFECT_SIZE="-0.02811984013492772" METHOD="MH" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" NO="26" P_CHI2="0.7698005605463883" P_Q="0.7147562453370608" P_Z="0.8093982077177834" Q="2.9041765104889947" RANDOM="NO" SCALE="100.0" SORT_BY="YEAR" STUDIES="8" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="646" TOTAL_2="434" WEIGHT="100.0" Z="0.24120245596020565"><NAME>Bronchospasm&#8212;non-cardiac surgery</NAME><GROUP_LABEL_1>Beta-blocker</GROUP_LABEL_1><GROUP_LABEL_2>Control</GROUP_LABEL_2><GRAPH_LABEL_1>Favours beta-blocker</GRAPH_LABEL_1><GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2><DICH_SUBGROUP CHI2="0.0" CI_END="14.903914722906746" CI_START="0.06709646549862758" DF="0" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" I2="0.0" ID="CMP-005.26.01" LOG_CI_END="1.1733003569528007" LOG_CI_START="-1.1733003569528007" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-11-23 22:48:19 +0000" MODIFIED_BY="Hermann Blessberger" NO="1" P_CHI2="1.0" P_Z="1.0" STUDIES="1" TAU2="0.0" TOTAL_1="20" TOTAL_2="20" WEIGHT="4.279260598889495" Z="0.0"><NAME>Metoprolol</NAME><DICH_DATA CI_END="14.903914722906746" CI_START="0.06709646549862758" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.1733003569528007" LOG_CI_START="-1.1733003569528007" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-11-23 22:48:19 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1472" O_E="0.0" SE="1.378404875209022" STUDY_ID="STD-Jakobsen-1992" TOTAL_1="20" TOTAL_2="20" VAR="1.9" WEIGHT="4.279260598889495"/></DICH_SUBGROUP><DICH_SUBGROUP CHI2="0.0" CI_END="1.446151791426689" CI_START="0.4050013729748808" DF="0" EFFECT_SIZE="0.7653061224489796" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="16" I2="0.0" ID="CMP-005.26.02" LOG_CI_END="0.16021387990126323" LOG_CI_START="-0.39254350450285286" LOG_EFFECT_SIZE="-0.11616481230079483" MODIFIED="2013-11-23 22:48:51 +0000" MODIFIED_BY="Hermann Blessberger" NO="2" P_CHI2="1.0" P_Z="0.4100571598039501" STUDIES="1" TAU2="0.0" TOTAL_1="49" TOTAL_2="50" WEIGHT="67.77657190968412" Z="0.8237930593215171"><NAME>Propranolol</NAME><DICH_DATA CI_END="1.446151791426689" CI_START="0.4050013729748808" EFFECT_SIZE="0.7653061224489796" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="16" LOG_CI_END="0.16021387990126323" LOG_CI_START="-0.39254350450285286" LOG_EFFECT_SIZE="-0.11616481230079483" MODIFIED="2013-11-23 22:48:51 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1473" O_E="0.0" SE="0.32469242379215935" STUDY_ID="STD-Bayliff-1999" TOTAL_1="49" TOTAL_2="50" VAR="0.1054251700680272" WEIGHT="67.77657190968412"/></DICH_SUBGROUP><DICH_SUBGROUP CHI2="0.0" CI_END="136.46047637797233" CI_START="0.373585094769823" DF="0" EFFECT_SIZE="7.140000000000001" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="0" I2="0.0" ID="CMP-005.26.03" LOG_CI_END="2.1350068830509046" LOG_CI_START="-0.4276104594985559" LOG_EFFECT_SIZE="0.8536982117761744" MODIFIED="2013-11-23 22:48:41 +0000" MODIFIED_BY="Hermann Blessberger" NO="3" P_CHI2="1.0" P_Z="0.19159804589629867" STUDIES="1" TAU2="0.0" TOTAL_1="99" TOTAL_2="101" WEIGHT="2.1184458410344034" Z="1.3058662492956694"><NAME>Atenolol</NAME><DICH_DATA CI_END="136.46047637797233" CI_START="0.373585094769823" EFFECT_SIZE="7.14" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="0" LOG_CI_END="2.1350068830509046" LOG_CI_START="-0.4276104594985559" LOG_EFFECT_SIZE="0.8536982117761743" MODIFIED="2013-11-23 22:48:41 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1474" O_E="0.0" SE="1.5052941121739825" STUDY_ID="STD-Mangano-1996" TOTAL_1="99" TOTAL_2="101" VAR="2.2659103641456584" WEIGHT="2.1184458410344034"/></DICH_SUBGROUP><DICH_SUBGROUP CHI2="0.336161323300631" CI_END="5.453146171202521" CI_START="0.29790662235988186" DF="1" EFFECT_SIZE="1.2745698714066895" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="2" I2="0.0" ID="CMP-005.26.04" LOG_CI_END="0.7366471390761214" LOG_CI_START="-0.5259198424634163" LOG_EFFECT_SIZE="0.10536364830635259" MODIFIED="2013-11-23 22:49:11 +0000" MODIFIED_BY="Hermann Blessberger" NO="4" P_CHI2="0.5620535698964998" P_Z="0.7435729322016852" STUDIES="3" TAU2="0.0" TOTAL_1="430" TOTAL_2="225" WEIGHT="13.701149953538412" Z="0.3271255449883295"><NAME>Esmolol</NAME><DICH_DATA CI_END="66.61522199816511" CI_START="0.11922423317225214" EFFECT_SIZE="2.8181818181818183" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.8235734795372827" LOG_CI_START="-0.9236354621851873" LOG_EFFECT_SIZE="0.44996900867604767" MODIFIED="2013-11-23 22:48:59 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1475" O_E="0.0" SE="1.6137241312713606" STUDY_ID="STD-Cucchiara-1986" TOTAL_1="32" TOTAL_2="30" VAR="2.6041055718475072" WEIGHT="2.206493746302396"/><DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-11-23 22:49:04 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1476" O_E="0.0" SE="0.0" STUDY_ID="STD-Miller-1990" TOTAL_1="30" TOTAL_2="15" VAR="0.0" WEIGHT="0.0"/><DICH_DATA CI_END="5.291026045497317" CI_START="0.18087121868109135" EFFECT_SIZE="0.9782608695652174" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="2" LOG_CI_END="0.723539899386512" LOG_CI_START="-0.7426305351989728" LOG_EFFECT_SIZE="-0.009545317906230389" MODIFIED="2013-11-23 22:49:11 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1477" O_E="0.0" SE="0.8612357709362151" STUDY_ID="STD-Miller-1991" TOTAL_1="368" TOTAL_2="180" VAR="0.7417270531400967" WEIGHT="11.494656207236016"/></DICH_SUBGROUP><DICH_SUBGROUP CHI2="0.0" CI_END="7.190006335094644" CI_START="0.03477048396741213" DF="0" EFFECT_SIZE="0.5" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" I2="0.0" ID="CMP-005.26.05" LOG_CI_END="0.8567292730387149" LOG_CI_START="-1.4587892643666773" LOG_EFFECT_SIZE="-0.3010299956639812" MODIFIED="2013-11-23 22:49:19 +0000" MODIFIED_BY="Hermann Blessberger" NO="5" P_CHI2="1.0" P_Z="0.6103233575072315" STUDIES="1" TAU2="0.0" TOTAL_1="20" TOTAL_2="10" WEIGHT="5.705680798519326" Z="0.5096119424107686"><NAME>Labetalol</NAME><DICH_DATA CI_END="7.190006335094644" CI_START="0.03477048396741213" EFFECT_SIZE="0.5" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="0.8567292730387149" LOG_CI_START="-1.4587892643666773" LOG_EFFECT_SIZE="-0.3010299956639812" MODIFIED="2013-11-23 22:49:19 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1478" O_E="0.0" SE="1.3601470508735443" STUDY_ID="STD-Inada-1989" TOTAL_1="20" TOTAL_2="10" VAR="1.8499999999999999" WEIGHT="5.705680798519326"/></DICH_SUBGROUP><DICH_SUBGROUP CHI2="0.0" CI_END="7.848616069043482" CI_START="0.014156777466712338" DF="0" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" I2="0.0" ID="CMP-005.26.06" LOG_CI_END="0.8947930852084158" LOG_CI_START="-1.8490355946477406" LOG_EFFECT_SIZE="-0.47712125471966244" MODIFIED="2013-11-23 22:49:26 +0000" MODIFIED_BY="Hermann Blessberger" NO="6" P_CHI2="1.0" P_Z="0.49547179043695244" STUDIES="1" TAU2="0.0" TOTAL_1="28" TOTAL_2="28" WEIGHT="6.418890898334243" Z="0.6816318251751228"><NAME>Landiolol</NAME><DICH_DATA CI_END="7.848616069043482" CI_START="0.014156777466712338" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.8947930852084158" LOG_CI_START="-1.8490355946477406" LOG_EFFECT_SIZE="-0.47712125471966244" MODIFIED="2013-11-23 22:49:26 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1479" O_E="0.0" SE="1.611738548718522" STUDY_ID="STD-Kawaguchi-2010" TOTAL_1="28" TOTAL_2="28" VAR="2.5977011494252875" WEIGHT="6.418890898334243"/></DICH_SUBGROUP></DICH_OUTCOME><CONT_OUTCOME CHI2="29.959315536020032" CI_END="-0.15504809961291566" CI_START="-0.8901991390280536" CI_STUDY="95" CI_TOTAL="95" DF="11" EFFECT_MEASURE="MD" EFFECT_SIZE="-0.5226236193204846" ESTIMABLE="YES" I2="63.28354035066416" I2_Q="33.00049261300344" ID="CMP-005.27" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" NO="27" P_CHI2="0.001608076285988136" P_Q="0.20138546900517218" P_Z="0.005324740428646023" Q="5.970193149175795" RANDOM="YES" SCALE="5.51" SORT_BY="YEAR" STUDIES="12" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.1791317807783595" TOTALS="YES" TOTAL_1="1080" TOTAL_2="1079" UNITS="" WEIGHT="100.0" Z="2.7867020963557088"><NAME>Length of stay&#8212;cardiac surgery</NAME><GROUP_LABEL_1>Beta-blocker</GROUP_LABEL_1><GROUP_LABEL_2>Control</GROUP_LABEL_2><GRAPH_LABEL_1>Favours beta-blocker</GRAPH_LABEL_1><GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2><CONT_SUBGROUP CHI2="0.0" CI_END="0.9081080402146975" CI_START="-0.9081080402146975" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="YES" I2="0.0" ID="CMP-005.27.01" MODIFIED="2013-11-28 21:32:58 +0000" MODIFIED_BY="Hermann Blessberger" NO="1" P_CHI2="1.0" P_Z="1.0" STUDIES="1" TAU2="0.0" TOTAL_1="71" TOTAL_2="60" WEIGHT="8.931310990747232" Z="0.0"><NAME>Propranolol</NAME><CONT_DATA CI_END="0.9081080402146975" CI_START="-0.9081080402146975" EFFECT_SIZE="0.0" ESTIMABLE="YES" MEAN_1="8.0" MEAN_2="8.0" MODIFIED="2013-11-28 21:32:58 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1774" SD_1="2.3" SD_2="2.9" SE="0.4633289424590134" STUDY_ID="STD-Bert-2001" TOTAL_1="71" TOTAL_2="60" WEIGHT="8.931310990747232"/></CONT_SUBGROUP><CONT_SUBGROUP CHI2="21.67233091415189" CI_END="0.15162049315439174" CI_START="-1.3038902193793631" DF="2" EFFECT_SIZE="-0.5761348631124856" ESTIMABLE="YES" I2="90.77164330905444" ID="CMP-005.27.02" MODIFIED="2014-01-06 20:15:08 +0000" MODIFIED_BY="Hermann Blessberger" NO="2" P_CHI2="1.9675037106647864E-5" P_Z="0.1207519193816426" STUDIES="3" TAU2="0.3545378552490836" TOTAL_1="633" TOTAL_2="639" WEIGHT="45.49520603597496" Z="1.5516252435856925"><NAME>Metoprolol</NAME><CONT_DATA CI_END="-0.6213610519607327" CI_START="-2.1986389480392674" EFFECT_SIZE="-1.4100000000000001" ESTIMABLE="YES" MEAN_1="8.42" MEAN_2="9.83" MODIFIED="2013-11-28 21:33:19 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1777" SD_1="2.81" SD_2="2.88" SE="0.40237420394453716" STUDY_ID="STD-Wenke-1999" TOTAL_1="100" TOTAL_2="100" WEIGHT="10.313255040508565"/><CONT_DATA CI_END="0.5986973363346225" CI_START="-0.19869733633462217" EFFECT_SIZE="0.20000000000000018" ESTIMABLE="YES" MEAN_1="6.5" MEAN_2="6.3" MODIFIED="2013-12-07 16:53:17 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1776" SD_1="3.8" SD_2="2.5" SE="0.20342074623793907" STUDY_ID="STD-Connolly-2003" TOTAL_1="500" TOTAL_2="500" WEIGHT="15.95016504762815"/><CONT_DATA CI_END="-0.5799305882439878" CI_START="-0.8200694117560126" EFFECT_SIZE="-0.7000000000000002" ESTIMABLE="YES" MEAN_1="5.1" MEAN_2="5.8" MODIFIED="2013-12-07 16:53:17 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1775" SD_1="0.3" SD_2="0.2" SE="0.061261029642944734" STUDY_ID="STD-Booth-2004" TOTAL_1="33" TOTAL_2="39" WEIGHT="19.231785947838247"/></CONT_SUBGROUP><CONT_SUBGROUP CHI2="1.1352300473064285" CI_END="0.03710169533427954" CI_START="-0.8144194714314852" DF="4" EFFECT_SIZE="-0.3886588880486028" ESTIMABLE="YES" I2="0.0" ID="CMP-005.27.03" MODIFIED="2013-11-28 21:35:07 +0000" MODIFIED_BY="Hermann Blessberger" NO="3" P_CHI2="0.8886430513812136" P_Z="0.07358768359254265" STUDIES="5" TAU2="0.0" TOTAL_1="276" TOTAL_2="281" WEIGHT="35.936858051947056" Z="1.7891684965153418"><NAME>Sotalol</NAME><CONT_DATA CI_END="0.8525956472955156" CI_START="-1.2525956472955142" EFFECT_SIZE="-0.1999999999999993" ESTIMABLE="YES" MEAN_1="10.0" MEAN_2="10.2" MODIFIED="2013-11-28 21:34:24 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1780" SD_1="1.5" SD_2="1.7" SE="0.5370484639504883" STUDY_ID="STD-Jacquet-1994" TOTAL_1="19" TOTAL_2="17" WEIGHT="7.522570813462358"/><CONT_DATA CI_END="0.49035874809146784" CI_START="-1.2903587480914687" EFFECT_SIZE="-0.40000000000000036" ESTIMABLE="YES" MEAN_1="10.0" MEAN_2="10.4" MODIFIED="2013-11-28 21:34:34 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1782" SD_1="4.0" SD_2="3.2" SE="0.45427301476685505" STUDY_ID="STD-Pfisterer-1997" TOTAL_1="126" TOTAL_2="129" WEIGHT="9.123834111038576"/><CONT_DATA CI_END="0.3228748645299382" CI_START="-2.322874864529938" EFFECT_SIZE="-1.0" ESTIMABLE="YES" MEAN_1="7.0" MEAN_2="8.0" MODIFIED="2013-11-28 21:34:46 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1779" SD_1="2.0" SD_2="4.0" SE="0.674948557710553" STUDY_ID="STD-Gomes-1999" TOTAL_1="40" TOTAL_2="45" WEIGHT="5.541625138886966"/><CONT_DATA CI_END="2.627257429639835" CI_START="-4.627257429639835" EFFECT_SIZE="-1.0" ESTIMABLE="YES" MEAN_1="21.0" MEAN_2="22.0" MODIFIED="2013-11-28 21:34:55 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1781" SD_1="4.0" SD_2="11.0" SE="1.8506755523321747" STUDY_ID="STD-Matsuura-2001" TOTAL_1="40" TOTAL_2="40" WEIGHT="0.9758797714110348"/><CONT_DATA CI_END="0.30800399250821786" CI_START="-0.9080039925082193" EFFECT_SIZE="-0.3000000000000007" ESTIMABLE="YES" MEAN_1="5.6" MEAN_2="5.9" MODIFIED="2013-11-28 21:35:07 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1778" SD_1="1.4" SD_2="1.7" SE="0.3102118188416096" STUDY_ID="STD-Forlani-2002" TOTAL_1="51" TOTAL_2="50" WEIGHT="12.77294821714812"/></CONT_SUBGROUP><CONT_SUBGROUP CHI2="0.019689653555857882" CI_END="0.5775435658187731" CI_START="-1.882817580164092" DF="1" EFFECT_SIZE="-0.6526370071726595" ESTIMABLE="YES" I2="0.0" ID="CMP-005.27.04" MODIFIED="2013-11-28 21:35:42 +0000" MODIFIED_BY="Hermann Blessberger" NO="4" P_CHI2="0.8884073085268271" P_Z="0.2984316090963238" STUDIES="2" TAU2="0.0" TOTAL_1="30" TOTAL_2="29" WEIGHT="7.026021856919096" Z="1.0398026575284978"><NAME>Esmolol</NAME><CONT_DATA CI_END="1.5979397562798727" CI_START="-3.197939756279874" EFFECT_SIZE="-0.8000000000000007" ESTIMABLE="YES" MEAN_1="7.6" MEAN_2="8.4" MODIFIED="2013-11-28 21:35:27 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1784" SD_1="3.9" SD_2="2.6" SE="1.2234611325486162" STUDY_ID="STD-Cork-1995" TOTAL_1="15" TOTAL_2="14" WEIGHT="2.098581469579067"/><CONT_DATA CI_END="0.8331433922667311" CI_START="-2.03314339226673" EFFECT_SIZE="-0.5999999999999996" ESTIMABLE="YES" MEAN_1="7.5" MEAN_2="8.1" MODIFIED="2013-11-28 21:35:42 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1783" SD_1="2.1" SD_2="1.9" SE="0.731209044437134" STUDY_ID="STD-But-2006" TOTAL_1="15" TOTAL_2="15" WEIGHT="4.927440387340029"/></CONT_SUBGROUP><CONT_SUBGROUP CHI2="1.6882800344096498E-31" CI_END="-0.6816580345935024" CI_START="-4.9183419654064995" DF="0" EFFECT_SIZE="-2.800000000000001" ESTIMABLE="YES" I2="100.0" ID="CMP-005.27.05" MODIFIED="2013-11-28 21:35:59 +0000" MODIFIED_BY="Hermann Blessberger" NO="5" P_CHI2="0.0" P_Z="0.00957926898982183" STUDIES="1" TAU2="0.0" TOTAL_1="70" TOTAL_2="70" WEIGHT="2.610603064411655" Z="2.590657809896645"><NAME>Landiolol</NAME><CONT_DATA CI_END="-0.6816580345935019" CI_START="-4.9183419654064995" EFFECT_SIZE="-2.8000000000000007" ESTIMABLE="YES" MEAN_1="11.2" MEAN_2="14.0" MODIFIED="2013-11-28 21:35:59 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1785" SD_1="4.9" SD_2="7.6" SE="1.0808065771186153" STUDY_ID="STD-Sezai-2011" TOTAL_1="70" TOTAL_2="70" WEIGHT="2.610603064411655"/></CONT_SUBGROUP></CONT_OUTCOME><CONT_OUTCOME CHI2="3.109542519456295" CI_END="0.8396604843025024" CI_START="-1.7484787202947696" CI_STUDY="95" CI_TOTAL="95" DF="2" EFFECT_MEASURE="MD" EFFECT_SIZE="-0.45440911799613354" ESTIMABLE="YES" I2="35.68185713859604" I2_Q="35.681857138596065" ID="CMP-005.28" MODIFIED="2017-06-17 15:48:54 +0100" MODIFIED_BY="Hermann Blessberger" NO="28" P_CHI2="0.21123779549911226" P_Q="0.21123779549911237" P_Z="0.49130407532431053" Q="3.1095425194562964" RANDOM="YES" SCALE="2.0" SORT_BY="YEAR" STUDIES="3" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.5891179693527399" TOTALS="YES" TOTAL_1="276" TOTAL_2="275" UNITS="" WEIGHT="100.0" Z="0.688236169010561"><NAME>Length of stay&#8212;non-cardiac surgery</NAME><GROUP_LABEL_1>Beta-blocker</GROUP_LABEL_1><GROUP_LABEL_2>Control</GROUP_LABEL_2><GRAPH_LABEL_1>Favours beta-blocker</GRAPH_LABEL_1><GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2><CONT_SUBGROUP CHI2="0.0" CI_END="1.833472026316095" CI_START="-2.2334720263160954" DF="0" EFFECT_SIZE="-0.20000000000000018" ESTIMABLE="YES" I2="0.0" ID="CMP-005.28.01" MODIFIED="2013-11-28 21:39:11 +0000" MODIFIED_BY="Hermann Blessberger" NO="1" P_CHI2="1.0" P_Z="0.8471389475203157" STUDIES="1" TAU2="0.0" TOTAL_1="197" TOTAL_2="203" WEIGHT="26.173725549048036" Z="0.192770193951553"><NAME>Bisoprolol</NAME><CONT_DATA CI_END="1.833472026316095" CI_START="-2.2334720263160954" EFFECT_SIZE="-0.20000000000000018" ESTIMABLE="YES" MEAN_1="7.8" MEAN_2="8.0" MODIFIED="2013-11-28 21:39:11 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1789" SD_1="8.9" SD_2="11.7" SE="1.0375047921063159" STUDY_ID="STD-Marwick-2009" TOTAL_1="197" TOTAL_2="203" WEIGHT="26.173725549048036"/></CONT_SUBGROUP><CONT_SUBGROUP CHI2="6.305169696730175E-32" CI_END="1.065320526417123" CI_START="-26.665320526417126" DF="0" EFFECT_SIZE="-12.8" ESTIMABLE="YES" I2="100.0" ID="CMP-005.28.02" MODIFIED="2013-11-28 21:39:30 +0000" MODIFIED_BY="Hermann Blessberger" NO="2" P_CHI2="0.0" P_Z="0.07039304794146149" STUDIES="1" TAU2="0.0" TOTAL_1="49" TOTAL_2="42" WEIGHT="0.8609400733405618" Z="1.8093731734736505"><NAME>Metoprolol</NAME><CONT_DATA CI_END="1.0653205264171248" CI_START="-26.665320526417123" EFFECT_SIZE="-12.799999999999999" ESTIMABLE="YES" MEAN_1="15.9" MEAN_2="28.7" MODIFIED="2013-11-28 21:39:30 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1786" SD_1="21.5" SD_2="41.3" SE="7.074273117151643" STUDY_ID="STD-POBBLE-2005" TOTAL_1="49" TOTAL_2="42" WEIGHT="0.8609400733405618"/></CONT_SUBGROUP><CONT_SUBGROUP CHI2="0.0" CI_END="-0.22108058562828417" CI_START="-0.5789194143717157" DF="0" EFFECT_SIZE="-0.3999999999999999" ESTIMABLE="YES" I2="0.0" ID="CMP-005.28.03" MODIFIED="2017-06-17 15:48:54 +0100" MODIFIED_BY="Hermann Blessberger" NO="3" P_CHI2="1.0" P_Z="1.1771339097414749E-5" STUDIES="1" TAU2="0.0" TOTAL_1="30" TOTAL_2="30" WEIGHT="72.9653343776114" Z="4.381780460041328"><NAME>Esmolol</NAME><CONT_DATA CI_END="-0.22108058562828417" CI_START="-0.5789194143717157" EFFECT_SIZE="-0.3999999999999999" ESTIMABLE="YES" MEAN_1="1.3" MEAN_2="1.7" MODIFIED="2014-01-06 21:39:26 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1787" SD_1="0.3" SD_2="0.4" SE="0.09128709291752769" STUDY_ID="STD-Lee-2010" TOTAL_1="30" TOTAL_2="30" WEIGHT="72.9653343776114"/></CONT_SUBGROUP></CONT_OUTCOME></COMPARISON><COMPARISON ID="CMP-006" MODIFIED="2017-12-08 02:32:18 +0000" MODIFIED_BY="Hermann Blessberger" NO="6"><NAME>Stratification according to results of meta-regression analysis</NAME><DICH_OUTCOME CHI2="6.688662154126654" CI_END="1.597780362615781" CI_START="1.017251346362137" CI_STUDY="95" CI_TOTAL="95" DF="9" EFFECT_MEASURE="RR" EFFECT_SIZE="1.2748898874263168" ESTIMABLE="YES" EVENTS_1="168" EVENTS_2="134" I2="0.0" I2_Q="31.87161877776411" ID="CMP-006.01" LOG_CI_END="0.20351707919583936" LOG_CI_START="0.00742827332724947" LOG_EFFECT_SIZE="0.10547267626154441" METHOD="MH" MODIFIED="2017-12-08 02:31:20 +0000" MODIFIED_BY="Hermann Blessberger" NO="1" P_CHI2="0.66949765585711" P_Q="0.22569074326733507" P_Z="0.03499126768020615" Q="1.4678170566507132" RANDOM="YES" SCALE="100.0" SORT_BY="YEAR" STUDIES="13" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="5805" TOTAL_2="5608" WEIGHT="100.0" Z="2.1084594391810025"><NAME>All-cause mortality (30 days)&#8212;non-cardiac surgery: hospital status</NAME><GROUP_LABEL_1>Beta-blocker</GROUP_LABEL_1><GROUP_LABEL_2>Control</GROUP_LABEL_2><GRAPH_LABEL_1>Favours beta-blocker</GRAPH_LABEL_1><GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2><DICH_SUBGROUP CHI2="3.776690213586947" CI_END="2.138116053799677" CI_START="0.15463512563825407" DF="3" EFFECT_SIZE="0.5750024735672717" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="10" I2="20.565367283573895" ID="CMP-006.01.01" LOG_CI_END="0.3300312743792692" LOG_CI_START="-0.8106918484632915" LOG_EFFECT_SIZE="-0.2403302870420111" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" NO="1" P_CHI2="0.28660940693365367" P_Z="0.40888361296862763" STUDIES="7" TAU2="0.3804344505998334" TOTAL_1="852" TOTAL_2="655" WEIGHT="3.9727973328456336" Z="0.8258598384904071"><NAME>University hospital or predominantly university hospitals in multi-centre trials</NAME><DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-11-26 18:11:06 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1535" O_E="0.0" SE="0.0" STUDY_ID="STD-Miller-1990" TOTAL_1="30" TOTAL_2="15" VAR="0.0" WEIGHT="0.0"/><DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-11-26 18:11:12 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1536" O_E="0.0" SE="0.0" STUDY_ID="STD-Miller-1991" TOTAL_1="368" TOTAL_2="180" VAR="0.0" WEIGHT="0.0"/><DICH_DATA CI_END="10.888852021315463" CI_START="0.38234045608732375" EFFECT_SIZE="2.04040404040404" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="2" LOG_CI_END="1.0369820958174838" LOG_CI_START="-0.4175497461193362" LOG_EFFECT_SIZE="0.3097161748490738" MODIFIED="2013-11-26 18:11:17 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1534" O_E="0.0" SE="0.8543992040024265" STUDY_ID="STD-Mangano-1996" TOTAL_1="99" TOTAL_2="101" VAR="0.72999799979998" WEIGHT="1.8174360463970272"/><DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-11-26 18:11:36 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1533" O_E="0.0" SE="0.0" STUDY_ID="STD-Lai-2006" TOTAL_1="30" TOTAL_2="30" VAR="0.0" WEIGHT="0.0"/><DICH_DATA CI_END="2.086100324386569" CI_START="0.006111296108574041" EFFECT_SIZE="0.11291048133153396" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="4" LOG_CI_END="0.3193351906100624" LOG_CI_START="-2.2138666730459673" LOG_EFFECT_SIZE="-0.9472657412179525" MODIFIED="2013-11-26 18:11:31 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1537" O_E="0.0" SE="1.4880153142630121" STUDY_ID="STD-Yang-2006" TOTAL_1="246" TOTAL_2="250" VAR="2.214189575481251" WEIGHT="0.5991919993326913"/><DICH_DATA CI_END="7.99511202377449" CI_START="0.013897380146858233" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.90282455325627" LOG_CI_START="-1.8570670626955947" LOG_EFFECT_SIZE="-0.47712125471966244" MODIFIED="2013-11-26 18:11:42 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1538" O_E="0.0" SE="1.6211739968939571" STUDY_ID="STD-Yang-2008" TOTAL_1="51" TOTAL_2="51" VAR="2.628205128205128" WEIGHT="0.5048025606510667"/><DICH_DATA CI_END="3.0135058276554862" CI_START="0.036871045707436295" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="3" LOG_CI_END="0.4790720356632876" LOG_CI_START="-1.4333145451026126" LOG_EFFECT_SIZE="-0.47712125471966244" MODIFIED="2013-11-26 18:11:47 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1532" O_E="0.0" SE="1.1233453440081378" STUDY_ID="STD-Kawaguchi-2010" TOTAL_1="28" TOTAL_2="28" VAR="1.2619047619047616" WEIGHT="1.0513667264648487"/></DICH_SUBGROUP><DICH_SUBGROUP CHI2="1.5468506807074935" CI_END="1.65070401409663" CI_START="1.041274557034713" DF="5" EFFECT_SIZE="1.3110438936488324" ESTIMABLE="YES" EVENTS_1="163" EVENTS_2="124" I2="0.0" ID="CMP-006.01.02" LOG_CI_END="0.21766920738241777" LOG_CI_START="0.01756525677633958" LOG_EFFECT_SIZE="0.11761723207937866" MODIFIED="2017-12-03 03:25:35 +0000" MODIFIED_BY="Hermann Blessberger" NO="2" P_CHI2="0.9076007948332621" P_Z="0.02121939655549683" STUDIES="6" TAU2="0.0" TOTAL_1="4953" TOTAL_2="4953" WEIGHT="96.02720266715437" Z="2.3040578473203723"><NAME>Other hospital or predominantly non-university hospitals in multi-centre trials</NAME><DICH_DATA CI_END="21.785667983536555" CI_START="0.1911775797639689" EFFECT_SIZE="2.0408163265306123" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="1" LOG_CI_END="1.3381708806415864" LOG_CI_START="-0.7185630406986138" LOG_EFFECT_SIZE="0.3098039199714864" MODIFIED="2013-11-26 18:11:59 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1539" O_E="0.0" SE="1.2081356863923414" STUDY_ID="STD-Bayliff-1999" TOTAL_1="49" TOTAL_2="50" VAR="1.4595918367346938" WEIGHT="0.9089696483931273"/><DICH_DATA CI_END="23.10618612076079" CI_START="0.2684527492293484" EFFECT_SIZE="2.490566037735849" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="1" LOG_CI_END="1.3637282672706277" LOG_CI_START="-0.571132144060506" LOG_EFFECT_SIZE="0.3962980616050608" MODIFIED="2013-11-26 18:12:05 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1543" O_E="0.0" SE="1.1365465833294115" STUDY_ID="STD-POBBLE-2005" TOTAL_1="53" TOTAL_2="44" VAR="1.2917381360777587" WEIGHT="1.0270848568911097"/><DICH_DATA CI_END="2.4023415437266507" CI_START="0.185004686617123" EFFECT_SIZE="0.6666666666666666" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="5" LOG_CI_END="0.38063475161440946" LOG_CI_START="-0.7328172697257719" LOG_EFFECT_SIZE="-0.17609125905568127" MODIFIED="2013-11-26 18:12:10 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1542" O_E="0.0" SE="0.6540472290116194" STUDY_ID="STD-Neary-2006" TOTAL_1="18" TOTAL_2="20" VAR="0.42777777777777776" WEIGHT="3.1014343136903695"/><DICH_DATA CI_END="2.5549775876151535" CI_START="0.6868023908740409" EFFECT_SIZE="1.3246753246753247" ESTIMABLE="YES" EVENTS_1="20" EVENTS_2="15" LOG_CI_END="0.4073870948356017" LOG_CI_START="-0.16316820165673035" LOG_EFFECT_SIZE="0.12210944658943569" MODIFIED="2013-11-26 18:12:20 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1540" O_E="0.0" SE="0.3351470054538631" STUDY_ID="STD-DIPOM-_x002d_-Juul-2006" TOTAL_1="462" TOTAL_2="459" VAR="0.11232351526469174" WEIGHT="11.811637799153369"/><DICH_DATA CI_END="1.7258284961101578" CI_START="1.0262717576233682" EFFECT_SIZE="1.3308527507051506" ESTIMABLE="YES" EVENTS_1="129" EVENTS_2="97" LOG_CI_END="0.23699763558907627" LOG_CI_START="0.011262377548303708" LOG_EFFECT_SIZE="0.12413000656868999" MODIFIED="2017-12-03 03:25:35 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1544" O_E="0.0" SE="0.13259800798069846" STUDY_ID="STD-POISE-2008" TOTAL_1="4174" TOTAL_2="4177" VAR="0.017582231720449374" WEIGHT="75.45826375903916"/><DICH_DATA CI_END="3.986212369346937" CI_START="0.38358505944859494" EFFECT_SIZE="1.2365482233502538" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="5" LOG_CI_END="0.6005604324423948" LOG_CI_START="-0.416138316843905" LOG_EFFECT_SIZE="0.09221105779924482" MODIFIED="2013-11-26 18:12:36 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1541" O_E="0.0" SE="0.5972138780707484" STUDY_ID="STD-Marwick-2009" TOTAL_1="197" TOTAL_2="203" VAR="0.35666441616030276" WEIGHT="3.719812289987228"/></DICH_SUBGROUP></DICH_OUTCOME><DICH_OUTCOME CHI2="12.456008542791608" CI_END="0.7685836416244642" CI_START="0.3422559620050429" CI_STUDY="95" CI_TOTAL="95" DF="9" EFFECT_MEASURE="RR" EFFECT_SIZE="0.5128862774977705" ESTIMABLE="YES" EVENTS_1="60" EVENTS_2="97" I2="27.745714294581372" I2_Q="68.84056175557653" ID="CMP-006.02" LOG_CI_END="-0.11430886320738608" LOG_CI_START="-0.465648977837248" LOG_EFFECT_SIZE="-0.2899789205223171" METHOD="MH" MODIFIED="2017-12-08 02:31:23 +0000" MODIFIED_BY="Hermann Blessberger" NO="2" P_CHI2="0.1888049672638732" P_Q="0.07322083057956963" P_Z="0.0012150794633561967" Q="3.209300476329889" RANDOM="YES" SCALE="100.0" SORT_BY="YEAR" STUDIES="14" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.09800846043026643" TOTALS="YES" TOTAL_1="552" TOTAL_2="426" WEIGHT="100.0" Z="3.2353165313804326"><NAME>Myocardial ischaemia&#8212;non-cardiac surgery: use of intention-to-treat analysis</NAME><GROUP_LABEL_1>Beta-blocker</GROUP_LABEL_1><GROUP_LABEL_2>Control</GROUP_LABEL_2><GRAPH_LABEL_1>Favours beta-blocker</GRAPH_LABEL_1><GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2><DICH_SUBGROUP CHI2="3.2855755747662085" CI_END="0.9069575138507014" CI_START="0.5045705075813707" DF="5" EFFECT_SIZE="0.676479129846876" ESTIMABLE="YES" EVENTS_1="51" EVENTS_2="72" I2="0.0" ID="CMP-006.02.01" LOG_CI_END="-0.04241305685651819" LOG_CI_START="-0.29707813782357734" LOG_EFFECT_SIZE="-0.16974559734004777" MODIFIED="2017-08-08 16:23:43 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.6560508321812389" P_Z="0.008980219610004135" STUDIES="7" TAU2="0.0" TOTAL_1="327" TOTAL_2="288" WEIGHT="69.4335182823145" Z="2.6128062477773755"><NAME>Intention-to-treat analysis definitely used</NAME><DICH_DATA CI_END="1.2469987885761085" CI_START="0.0982358612712665" EFFECT_SIZE="0.35" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="5" LOG_CI_END="0.09586603157399819" LOG_CI_START="-1.007729942873447" LOG_EFFECT_SIZE="-0.4559319556497244" MODIFIED="2013-11-26 18:44:12 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1547" O_E="0.0" SE="0.6482577382786072" STUDY_ID="STD-Coleman-1980" TOTAL_1="24" TOTAL_2="14" VAR="0.4202380952380952" WEIGHT="8.218532122292466"/><DICH_DATA CI_END="66.61522199816511" CI_START="0.11922423317225214" EFFECT_SIZE="2.8181818181818183" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.8235734795372827" LOG_CI_START="-0.9236354621851873" LOG_EFFECT_SIZE="0.44996900867604767" MODIFIED="2013-11-26 18:44:17 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1548" O_E="0.0" SE="1.6137241312713606" STUDY_ID="STD-Cucchiara-1986" TOTAL_1="32" TOTAL_2="30" VAR="2.6041055718475072" WEIGHT="1.5762569285195944"/><DICH_DATA CI_END="0.963432747451777" CI_START="0.4699791874804524" EFFECT_SIZE="0.6728992048140985" ESTIMABLE="YES" EVENTS_1="31" EVENTS_2="47" LOG_CI_END="-0.016178595933257885" LOG_CI_START="-0.3279213738994463" LOG_EFFECT_SIZE="-0.1720499849163521" MODIFIED="2013-11-26 18:44:24 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1552" O_E="0.0" SE="0.18311925092897763" STUDY_ID="STD-Wallace-1998" TOTAL_1="99" TOTAL_2="101" VAR="0.03353266006078988" WEIGHT="32.37942590976676"/><DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-11-26 18:44:31 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1553" O_E="0.0" SE="0.0" STUDY_ID="STD-Zaugg-1999" TOTAL_1="40" TOTAL_2="19" VAR="0.0" WEIGHT="0.0"/><DICH_DATA CI_END="3.1588374622614523" CI_START="0.03662503591899996" EFFECT_SIZE="0.3401360544217687" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="3" LOG_CI_END="0.49952727989090295" LOG_CI_START="-1.4362219407152177" LOG_EFFECT_SIZE="-0.4683473304121573" MODIFIED="2013-11-26 18:44:38 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1546" O_E="0.0" SE="1.1370686742972156" STUDY_ID="STD-Bayliff-1999" TOTAL_1="49" TOTAL_2="50" VAR="1.292925170068027" WEIGHT="3.0621345775513515"/><DICH_DATA CI_END="1.5031119175990921" CI_START="0.4585242356722858" EFFECT_SIZE="0.8301886792452831" ESTIMABLE="YES" EVENTS_1="15" EVENTS_2="15" LOG_CI_END="0.1769913181691861" LOG_CI_START="-0.33863770439838925" LOG_EFFECT_SIZE="-0.0808231931146016" MODIFIED="2013-11-26 18:44:45 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1550" O_E="0.0" SE="0.3028830402610201" STUDY_ID="STD-POBBLE-2005" TOTAL_1="53" TOTAL_2="44" VAR="0.09173813607775871" WEIGHT="22.446916273661436"/><DICH_DATA CI_END="3.9981665126016623" CI_START="0.010004585820506876" EFFECT_SIZE="0.2" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" LOG_CI_END="0.6018608773254143" LOG_CI_START="-1.9998008859974516" LOG_EFFECT_SIZE="-0.6989700043360187" MODIFIED="2013-11-26 18:44:50 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1549" O_E="0.0" SE="1.5282289982092807" STUDY_ID="STD-Lai-2006" TOTAL_1="30" TOTAL_2="30" VAR="2.335483870967742" WEIGHT="1.7502524705228852"/></DICH_SUBGROUP><DICH_SUBGROUP CHI2="4.859880457624334" CI_END="0.7015895957878008" CI_START="0.11312819881342234" DF="3" EFFECT_SIZE="0.2817260500516609" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="25" I2="38.2700865554521" ID="CMP-006.02.02" LOG_CI_END="-0.15391685995765153" LOG_CI_START="-0.9464291275005358" LOG_EFFECT_SIZE="-0.5501729937290937" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" NO="2" P_CHI2="0.18234977667339958" P_Z="0.006503195735644207" STUDIES="7" TAU2="0.32761019922284496" TOTAL_1="225" TOTAL_2="138" WEIGHT="30.5664817176855" Z="2.7212682935971206"><NAME>Intention-to-treat analysis not used or unclear</NAME><DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-11-26 18:45:08 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1555" O_E="0.0" SE="0.0" STUDY_ID="STD-Liu-1986" TOTAL_1="16" TOTAL_2="14" VAR="0.0" WEIGHT="0.0"/><DICH_DATA CI_END="0.34268065818180543" CI_START="0.018523976842803526" EFFECT_SIZE="0.07967313585291114" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="11" LOG_CI_END="-0.46511040762723255" LOG_CI_START="-1.7322657705980822" LOG_EFFECT_SIZE="-1.0986880891126574" MODIFIED="2013-11-26 18:45:15 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1560" O_E="0.0" SE="0.7443333327292857" STUDY_ID="STD-Stone-1988" TOTAL_1="89" TOTAL_2="39" VAR="0.5540321102118855" WEIGHT="6.532148698712456"/><DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-11-26 18:45:20 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1557" O_E="0.0" SE="0.0" STUDY_ID="STD-Miller-1990" TOTAL_1="30" TOTAL_2="15" VAR="0.0" WEIGHT="0.0"/><DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-11-26 18:45:28 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1558" O_E="0.0" SE="0.0" STUDY_ID="STD-Oxorn-1990" TOTAL_1="32" TOTAL_2="16" VAR="0.0" WEIGHT="0.0"/><DICH_DATA CI_END="1.022049427213816" CI_START="0.20553746115499483" EFFECT_SIZE="0.4583333333333333" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="8" LOG_CI_END="0.009471899171640366" LOG_CI_START="-0.6871090122784024" LOG_EFFECT_SIZE="-0.338818556553381" MODIFIED="2013-11-26 18:45:35 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1559" O_E="0.0" SE="0.40917507551687754" STUDY_ID="STD-Raby-1999" TOTAL_1="15" TOTAL_2="11" VAR="0.16742424242424245" WEIGHT="16.04634967441243"/><DICH_DATA CI_END="1.7491265621242627" CI_START="0.09147422688823888" EFFECT_SIZE="0.4" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="5" LOG_CI_END="0.24282123500387298" LOG_CI_START="-1.038701252347948" LOG_EFFECT_SIZE="-0.3979400086720376" MODIFIED="2013-11-26 18:45:58 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1556" O_E="0.0" SE="0.752772652709081" STUDY_ID="STD-Liu-2006" TOTAL_1="15" TOTAL_2="15" VAR="0.5666666666666667" WEIGHT="6.407981570832445"/><DICH_DATA CI_END="7.848616069043482" CI_START="0.014156777466712338" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.8947930852084158" LOG_CI_START="-1.8490355946477406" LOG_EFFECT_SIZE="-0.47712125471966244" MODIFIED="2013-11-26 18:46:03 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1554" O_E="0.0" SE="1.611738548718522" STUDY_ID="STD-Kawaguchi-2010" TOTAL_1="28" TOTAL_2="28" VAR="2.5977011494252875" WEIGHT="1.5800017737281742"/></DICH_SUBGROUP></DICH_OUTCOME><DICH_OUTCOME CHI2="12.456008542791608" CI_END="0.7685836416244641" CI_START="0.3422559620050428" CI_STUDY="95" CI_TOTAL="95" DF="9" EFFECT_MEASURE="RR" EFFECT_SIZE="0.5128862774977705" ESTIMABLE="YES" EVENTS_1="60" EVENTS_2="97" I2="27.745714294581372" I2_Q="83.80780165459551" ID="CMP-006.03" LOG_CI_END="-0.11430886320738615" LOG_CI_START="-0.46564897783724807" LOG_EFFECT_SIZE="-0.2899789205223171" METHOD="MH" MODIFIED="2017-12-08 02:31:26 +0000" MODIFIED_BY="Hermann Blessberger" NO="3" P_CHI2="0.1888049672638732" P_Q="0.012950911153106204" P_Z="0.0012150794633561943" Q="6.175813676861298" RANDOM="YES" SCALE="100.0" SORT_BY="YEAR" STUDIES="14" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.09800846043026643" TOTALS="YES" TOTAL_1="552" TOTAL_2="426" WEIGHT="100.00000000000003" Z="3.235316531380433"><NAME>Myocardial ischaemia&#8212;non-cardiac surgery: blinding status of participants</NAME><GROUP_LABEL_1>Beta-blocker</GROUP_LABEL_1><GROUP_LABEL_2>Control</GROUP_LABEL_2><GRAPH_LABEL_1>Favours beta-blocker</GRAPH_LABEL_1><GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2><DICH_SUBGROUP CHI2="3.4811616165406694" CI_END="0.860520960079337" CI_START="0.4949511276978928" DF="5" EFFECT_SIZE="0.6526222640999473" ESTIMABLE="YES" EVENTS_1="56" EVENTS_2="78" I2="0.0" ID="CMP-006.03.01" LOG_CI_END="-0.06523854691000092" LOG_CI_START="-0.3054376819128619" LOG_EFFECT_SIZE="-0.18533811441143136" MODIFIED="2017-06-17 15:49:57 +0100" MODIFIED_BY="Hermann Blessberger" NO="1" P_CHI2="0.6262401332997443" P_Z="0.002489424348494917" STUDIES="9" TAU2="0.0" TOTAL_1="350" TOTAL_2="295" WEIGHT="83.72961548620407" Z="3.0246239579892142"><NAME>Participants were definitively blinded</NAME><DICH_DATA CI_END="1.2469987885761085" CI_START="0.0982358612712665" EFFECT_SIZE="0.35" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="5" LOG_CI_END="0.09586603157399819" LOG_CI_START="-1.007729942873447" LOG_EFFECT_SIZE="-0.4559319556497244" MODIFIED="2013-11-26 19:28:10 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1562" O_E="0.0" SE="0.6482577382786072" STUDY_ID="STD-Coleman-1980" TOTAL_1="24" TOTAL_2="14" VAR="0.4202380952380952" WEIGHT="8.218532122292467"/><DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-11-26 19:28:22 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1564" O_E="0.0" SE="0.0" STUDY_ID="STD-Liu-1986" TOTAL_1="16" TOTAL_2="14" VAR="0.0" WEIGHT="0.0"/><DICH_DATA CI_END="66.61522199816511" CI_START="0.11922423317225214" EFFECT_SIZE="2.8181818181818183" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.8235734795372827" LOG_CI_START="-0.9236354621851873" LOG_EFFECT_SIZE="0.44996900867604767" MODIFIED="2013-11-26 19:28:14 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1563" O_E="0.0" SE="1.6137241312713606" STUDY_ID="STD-Cucchiara-1986" TOTAL_1="32" TOTAL_2="30" VAR="2.6041055718475072" WEIGHT="1.5762569285195949"/><DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-11-26 19:28:29 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1565" O_E="0.0" SE="0.0" STUDY_ID="STD-Miller-1990" TOTAL_1="30" TOTAL_2="15" VAR="0.0" WEIGHT="0.0"/><DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-11-26 19:28:37 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1566" O_E="0.0" SE="0.0" STUDY_ID="STD-Oxorn-1990" TOTAL_1="32" TOTAL_2="16" VAR="0.0" WEIGHT="0.0"/><DICH_DATA CI_END="0.963432747451777" CI_START="0.4699791874804524" EFFECT_SIZE="0.6728992048140985" ESTIMABLE="YES" EVENTS_1="31" EVENTS_2="47" LOG_CI_END="-0.016178595933257885" LOG_CI_START="-0.3279213738994463" LOG_EFFECT_SIZE="-0.1720499849163521" MODIFIED="2013-11-26 19:28:46 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1570" O_E="0.0" SE="0.18311925092897763" STUDY_ID="STD-Wallace-1998" TOTAL_1="99" TOTAL_2="101" VAR="0.03353266006078988" WEIGHT="32.379425909766766"/><DICH_DATA CI_END="3.1588374622614523" CI_START="0.03662503591899996" EFFECT_SIZE="0.3401360544217687" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="3" LOG_CI_END="0.49952727989090295" LOG_CI_START="-1.4362219407152177" LOG_EFFECT_SIZE="-0.4683473304121573" MODIFIED="2013-11-26 19:28:59 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1561" O_E="0.0" SE="1.1370686742972156" STUDY_ID="STD-Bayliff-1999" TOTAL_1="49" TOTAL_2="50" VAR="1.292925170068027" WEIGHT="3.0621345775513524"/><DICH_DATA CI_END="1.022049427213816" CI_START="0.20553746115499483" EFFECT_SIZE="0.4583333333333333" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="8" LOG_CI_END="0.009471899171640366" LOG_CI_START="-0.6871090122784024" LOG_EFFECT_SIZE="-0.338818556553381" MODIFIED="2013-11-26 19:28:52 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1568" O_E="0.0" SE="0.40917507551687754" STUDY_ID="STD-Raby-1999" TOTAL_1="15" TOTAL_2="11" VAR="0.16742424242424245" WEIGHT="16.046349674412433"/><DICH_DATA CI_END="1.5031119175990921" CI_START="0.4585242356722858" EFFECT_SIZE="0.8301886792452831" ESTIMABLE="YES" EVENTS_1="15" EVENTS_2="15" LOG_CI_END="0.1769913181691861" LOG_CI_START="-0.33863770439838925" LOG_EFFECT_SIZE="-0.0808231931146016" MODIFIED="2013-11-26 19:29:06 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1567" O_E="0.0" SE="0.3028830402610201" STUDY_ID="STD-POBBLE-2005" TOTAL_1="53" TOTAL_2="44" VAR="0.09173813607775871" WEIGHT="22.44691627366144"/></DICH_SUBGROUP><DICH_SUBGROUP CHI2="2.496636347368813" CI_END="0.48272488198992725" CI_START="0.07421963053517884" DF="3" EFFECT_SIZE="0.18928196530950908" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="19" I2="0.0" ID="CMP-006.03.02" LOG_CI_END="-0.31630031495296823" LOG_CI_START="-1.129481211896862" LOG_EFFECT_SIZE="-0.7228907634249152" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" NO="2" P_CHI2="0.47589955484744784" P_Z="4.927157046438002E-4" STUDIES="5" TAU2="0.0" TOTAL_1="202" TOTAL_2="131" WEIGHT="16.270384513795964" Z="3.484685551257495"><NAME>Participants were not blinded or blinding status was unclear</NAME><DICH_DATA CI_END="0.34268065818180543" CI_START="0.018523976842803526" EFFECT_SIZE="0.07967313585291114" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="11" LOG_CI_END="-0.46511040762723255" LOG_CI_START="-1.7322657705980822" LOG_EFFECT_SIZE="-1.0986880891126574" MODIFIED="2013-11-26 19:29:30 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1574" O_E="0.0" SE="0.7443333327292857" STUDY_ID="STD-Stone-1988" TOTAL_1="89" TOTAL_2="39" VAR="0.5540321102118855" WEIGHT="6.532148698712458"/><DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-11-26 19:29:35 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1575" O_E="0.0" SE="0.0" STUDY_ID="STD-Zaugg-1999" TOTAL_1="40" TOTAL_2="19" VAR="0.0" WEIGHT="0.0"/><DICH_DATA CI_END="1.7491265621242627" CI_START="0.09147422688823888" EFFECT_SIZE="0.4" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="5" LOG_CI_END="0.24282123500387298" LOG_CI_START="-1.038701252347948" LOG_EFFECT_SIZE="-0.3979400086720376" MODIFIED="2013-11-26 19:29:40 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1573" O_E="0.0" SE="0.752772652709081" STUDY_ID="STD-Liu-2006" TOTAL_1="15" TOTAL_2="15" VAR="0.5666666666666667" WEIGHT="6.407981570832447"/><DICH_DATA CI_END="3.9981665126016623" CI_START="0.010004585820506876" EFFECT_SIZE="0.2" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" LOG_CI_END="0.6018608773254143" LOG_CI_START="-1.9998008859974516" LOG_EFFECT_SIZE="-0.6989700043360187" MODIFIED="2013-11-26 19:29:51 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1572" O_E="0.0" SE="1.5282289982092807" STUDY_ID="STD-Lai-2006" TOTAL_1="30" TOTAL_2="30" VAR="2.335483870967742" WEIGHT="1.7502524705228857"/><DICH_DATA CI_END="7.848616069043482" CI_START="0.014156777466712338" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.8947930852084158" LOG_CI_START="-1.8490355946477406" LOG_EFFECT_SIZE="-0.47712125471966244" MODIFIED="2013-11-26 19:29:57 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1571" O_E="0.0" SE="1.611738548718522" STUDY_ID="STD-Kawaguchi-2010" TOTAL_1="28" TOTAL_2="28" VAR="2.5977011494252875" WEIGHT="1.5800017737281746"/></DICH_SUBGROUP></DICH_OUTCOME><DICH_OUTCOME CHI2="4.683815300243554" CI_END="2.707506832501573" CI_START="0.9342911560750178" CI_STUDY="95" CI_TOTAL="95" DF="4" EFFECT_MEASURE="RR" EFFECT_SIZE="1.590471530276133" ESTIMABLE="YES" EVENTS_1="34" EVENTS_2="21" I2="14.599535985289512" I2_Q="77.08363276154752" ID="CMP-006.04" LOG_CI_END="0.43256956125820256" LOG_CI_START="-0.02951776212954848" LOG_EFFECT_SIZE="0.20152589956432704" METHOD="MH" MODIFIED="2017-12-08 02:31:28 +0000" MODIFIED_BY="Hermann Blessberger" NO="4" P_CHI2="0.32130474413380594" P_Q="0.03671284304676736" P_Z="0.08734686496500334" Q="4.363693379472691" RANDOM="NO" SCALE="100.0" SORT_BY="YEAR" STUDIES="5" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="4574" TOTAL_2="4576" WEIGHT="100.0" Z="1.7095621762671682"><NAME>Cerebrovascular events&#8212;non-cardiac surgery: blinding status of participants</NAME><GROUP_LABEL_1>Beta-blocker</GROUP_LABEL_1><GROUP_LABEL_2>Control</GROUP_LABEL_2><GRAPH_LABEL_1>Favours beta-blocker</GRAPH_LABEL_1><GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2><DICH_SUBGROUP CHI2="0.43467582252525144" CI_END="3.8153950091289834" CI_START="1.1416717553651972" DF="2" EFFECT_SIZE="2.0870861787391286" ESTIMABLE="YES" EVENTS_1="32" EVENTS_2="15" I2="0.0" ID="CMP-006.04.01" LOG_CI_END="0.5815395072723889" LOG_CI_START="0.05754125686536585" LOG_EFFECT_SIZE="0.31954038206887736" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" NO="1" P_CHI2="0.8046581418969698" P_Z="0.016829169035311738" STUDIES="3" TAU2="0.0" TOTAL_1="4326" TOTAL_2="4322" WEIGHT="70.68786817217621" Z="2.3904188228670242"><NAME>Participants were definitively blinded</NAME><DICH_DATA CI_END="35.873486053427946" CI_START="0.4642145613500314" EFFECT_SIZE="4.08080808080808" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="1" LOG_CI_END="1.5547735818670396" LOG_CI_START="-0.3332812408409298" LOG_EFFECT_SIZE="0.610746170513055" MODIFIED="2013-11-26 19:46:46 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1578" O_E="0.0" SE="1.1090527488807644" STUDY_ID="STD-Wallace-1998" TOTAL_1="99" TOTAL_2="101" VAR="1.22999799979998" WEIGHT="4.50605753253813"/><DICH_DATA CI_END="59.88076450297431" CI_START="0.10437408493155693" EFFECT_SIZE="2.5" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.7772873363821649" LOG_CI_START="-0.9814073190380896" LOG_EFFECT_SIZE="0.3979400086720376" MODIFIED="2013-11-26 19:46:53 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1576" O_E="0.0" SE="1.620470896352639" STUDY_ID="STD-POBBLE-2005" TOTAL_1="53" TOTAL_2="44" VAR="2.6259259259259258" WEIGHT="2.482676326467289"/><DICH_DATA CI_END="3.675054697422891" CI_START="1.013518570917549" EFFECT_SIZE="1.9299575604079677" ESTIMABLE="YES" EVENTS_1="27" EVENTS_2="14" LOG_CI_END="0.5652638072602568" LOG_CI_START="0.005831710772613412" LOG_EFFECT_SIZE="0.2855477590164352" MODIFIED="2013-12-08 07:38:41 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1577" O_E="0.0" SE="0.328613182710381" STUDY_ID="STD-POISE-2008" TOTAL_1="4174" TOTAL_2="4177" VAR="0.10798662385104625" WEIGHT="63.69913431317078"/></DICH_SUBGROUP><DICH_SUBGROUP CHI2="0.2923745104391888" CI_END="1.668400500739096" CI_START="0.09250580698429836" DF="1" EFFECT_SIZE="0.3928571428571429" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="6" I2="0.0" ID="CMP-006.04.02" LOG_CI_END="0.2223003115191508" LOG_CI_START="-1.0338310038871392" LOG_EFFECT_SIZE="-0.4057653461839941" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" NO="2" P_CHI2="0.5887029693519956" P_Z="0.20542514078186536" STUDIES="2" TAU2="0.0" TOTAL_1="248" TOTAL_2="254" WEIGHT="29.31213182782379" Z="1.266245741891761"><NAME>Participants were not blinded or blinding status was unclear</NAME><DICH_DATA CI_END="4.065339018491121" CI_START="0.00983927781128726" EFFECT_SIZE="0.2" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" LOG_CI_END="0.609096768311561" LOG_CI_START="-2.0070367769835986" LOG_EFFECT_SIZE="-0.6989700043360187" MODIFIED="2013-11-26 19:47:12 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1580" O_E="0.0" SE="1.536729794576282" STUDY_ID="STD-Yang-2008" TOTAL_1="51" TOTAL_2="51" VAR="2.3615384615384616" WEIGHT="11.378933162975075"/><DICH_DATA CI_END="2.781185502696919" CI_START="0.09544862473539373" EFFECT_SIZE="0.5152284263959391" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="4" LOG_CI_END="0.4442299569011446" LOG_CI_START="-1.020230324725867" LOG_EFFECT_SIZE="-0.28800018391236115" MODIFIED="2013-11-26 19:47:17 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1579" O_E="0.0" SE="0.8602312186230142" STUDY_ID="STD-Marwick-2009" TOTAL_1="197" TOTAL_2="203" VAR="0.7399977494936361" WEIGHT="17.933198664848717"/></DICH_SUBGROUP></DICH_OUTCOME><DICH_OUTCOME CHI2="7.314150194211838" CI_END="1.1902250305243167" CI_START="0.4337117040075983" CI_STUDY="95" CI_TOTAL="95" DF="4" EFFECT_MEASURE="RR" EFFECT_SIZE="0.7184807068677607" ESTIMABLE="YES" EVENTS_1="22" EVENTS_2="24" I2="45.31148672383759" I2_Q="63.803266860840324" ID="CMP-006.05" LOG_CI_END="0.0756290792713098" LOG_CI_START="-0.3627988579588435" LOG_EFFECT_SIZE="-0.14358488934376687" METHOD="MH" MODIFIED="2017-12-08 02:31:31 +0000" MODIFIED_BY="Hermann Blessberger" NO="5" P_CHI2="0.1201893406969895" P_Q="0.06312239870885006" P_Z="0.19922101385497473" Q="5.525360513367121" RANDOM="NO" SCALE="100.0" SORT_BY="YEAR" STUDIES="5" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="249" TOTAL_2="227" WEIGHT="100.0" Z="1.2837740843609593"><NAME>Ventricular arrhythmias&#8212;non-cardiac surgery: route of application</NAME><GROUP_LABEL_1>Beta-blocker</GROUP_LABEL_1><GROUP_LABEL_2>Control</GROUP_LABEL_2><GRAPH_LABEL_1>Favours beta-blocker</GRAPH_LABEL_1><GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2><DICH_SUBGROUP CHI2="1.388708828016705" CI_END="2.072249641808901" CI_START="0.5601857850523676" DF="2" EFFECT_SIZE="1.07742507508467" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="13" I2="0.0" ID="CMP-006.05.01" LOG_CI_END="0.3164420732398407" LOG_CI_START="-0.2516679157760062" LOG_EFFECT_SIZE="0.03238707873191719" MODIFIED="2013-11-26 20:16:17 +0000" MODIFIED_BY="Hermann Blessberger" NO="1" P_CHI2="0.4993968029388959" P_Z="0.8231704465542549" STUDIES="3" TAU2="0.0" TOTAL_1="120" TOTAL_2="111" WEIGHT="51.080423890060686" Z="0.22346907854581038"><NAME>Oral application only</NAME><DICH_DATA CI_END="3.6746104414217298" CI_START="0.37928140736840954" EFFECT_SIZE="1.1805555555555556" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="4" LOG_CI_END="0.5652113047512454" LOG_CI_START="-0.4210384461851969" LOG_EFFECT_SIZE="0.07208642928302428" MODIFIED="2013-11-26 20:16:06 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1582" O_E="0.0" SE="0.5793279857150695" STUDY_ID="STD-Jakobsen-1997" TOTAL_1="18" TOTAL_2="17" VAR="0.33562091503267977" WEIGHT="14.759406976634274"/><DICH_DATA CI_END="4.14361531793994" CI_START="0.010043403358372081" EFFECT_SIZE="0.204" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" LOG_CI_END="0.6173794298813183" LOG_CI_START="-1.998119095029521" LOG_EFFECT_SIZE="-0.6903698325741012" MODIFIED="2013-11-26 20:16:12 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1581" O_E="0.0" SE="1.5363567804591305" STUDY_ID="STD-Bayliff-1999" TOTAL_1="49" TOTAL_2="50" VAR="2.360392156862745" WEIGHT="8.879593718753432"/><DICH_DATA CI_END="3.080458562544285" CI_START="0.5524939578722114" EFFECT_SIZE="1.3045822102425877" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="7" LOG_CI_END="0.4886153711624102" LOG_CI_START="-0.25767246710367697" LOG_EFFECT_SIZE="0.11547145202936662" MODIFIED="2013-11-26 20:16:17 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1583" O_E="0.0" SE="0.4383731703818781" STUDY_ID="STD-POBBLE-2005" TOTAL_1="53" TOTAL_2="44" VAR="0.19217103651065914" WEIGHT="27.44142319467298"/></DICH_SUBGROUP><DICH_SUBGROUP CHI2="0.0" CI_END="0.698737197573076" CI_START="0.08944707712296021" DF="0" EFFECT_SIZE="0.25" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="8" I2="0.0" ID="CMP-006.05.02" LOG_CI_END="-0.1556861362780481" LOG_CI_START="-1.0484338463778766" LOG_EFFECT_SIZE="-0.6020599913279624" MODIFIED="2017-06-17 15:50:13 +0100" MODIFIED_BY="Hermann Blessberger" NO="2" P_CHI2="1.0" P_Z="0.008203931563833216" STUDIES="1" TAU2="0.0" TOTAL_1="30" TOTAL_2="15" WEIGHT="38.26512919868145" Z="2.64355962201987"><NAME>Parenteral application only</NAME><DICH_DATA CI_END="0.698737197573076" CI_START="0.08944707712296021" EFFECT_SIZE="0.25" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="8" LOG_CI_END="-0.1556861362780481" LOG_CI_START="-1.0484338463778766" LOG_EFFECT_SIZE="-0.6020599913279624" MODIFIED="2013-11-26 20:16:24 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1584" O_E="0.0" SE="0.5244044240850758" STUDY_ID="STD-Sandler-1990" TOTAL_1="30" TOTAL_2="15" VAR="0.275" WEIGHT="38.26512919868145"/></DICH_SUBGROUP><DICH_SUBGROUP CHI2="0.0" CI_END="3.9833644750180848" CI_START="0.11612876150877542" DF="0" EFFECT_SIZE="0.6801346801346801" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="3" I2="0.0" ID="CMP-006.05.03" LOG_CI_END="0.6002500458638188" LOG_CI_START="-0.9350602056049961" LOG_EFFECT_SIZE="-0.16740507987058859" MODIFIED="2013-11-26 20:16:51 +0000" MODIFIED_BY="Hermann Blessberger" NO="3" P_CHI2="1.0" P_Z="0.6690765046634826" STUDIES="1" TAU2="0.0" TOTAL_1="99" TOTAL_2="101" WEIGHT="10.654446911257867" Z="0.4274157969850165"><NAME>Both parenteral and oral application</NAME><DICH_DATA CI_END="3.9833644750180848" CI_START="0.11612876150877542" EFFECT_SIZE="0.6801346801346801" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="3" LOG_CI_END="0.6002500458638188" LOG_CI_START="-0.9350602056049961" LOG_EFFECT_SIZE="-0.16740507987058859" MODIFIED="2013-11-26 20:16:51 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1586" O_E="0.0" SE="0.9018488416210964" STUDY_ID="STD-Wallace-1998" TOTAL_1="99" TOTAL_2="101" VAR="0.8133313331333133" WEIGHT="10.654446911257867"/></DICH_SUBGROUP></DICH_OUTCOME><DICH_OUTCOME CHI2="79.613672523447" CI_END="3.355714879923041" CI_START="1.478562609998888" CI_STUDY="95" CI_TOTAL="95" DF="19" EFFECT_MEASURE="RR" EFFECT_SIZE="2.227472682497165" ESTIMABLE="YES" EVENTS_1="539" EVENTS_2="212" I2="76.13475248939896" I2_Q="89.0485629384392" ID="CMP-006.06" LOG_CI_END="0.5257850536654743" LOG_CI_START="0.16983971952924046" LOG_EFFECT_SIZE="0.3478123865973574" METHOD="MH" MODIFIED="2017-12-08 02:31:34 +0000" MODIFIED_BY="Hermann Blessberger" NO="6" P_CHI2="2.1675825578881813E-9" P_Q="0.0025128468555062344" P_Z="1.2795484866811056E-4" Q="9.131221723493885" RANDOM="YES" SCALE="100.0" SORT_BY="YEAR" STUDIES="23" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.40337939548311347" TOTALS="YES" TOTAL_1="5636" TOTAL_2="5397" WEIGHT="100.0" Z="3.8303620569265835"><NAME>Bradycardia&#8212;non-cardiac surgery: specification of baseline characteristics</NAME><GROUP_LABEL_1>Beta-blocker</GROUP_LABEL_1><GROUP_LABEL_2>Control</GROUP_LABEL_2><GRAPH_LABEL_1>Favours beta-blocker</GRAPH_LABEL_1><GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2><DICH_SUBGROUP CHI2="18.713931643872193" CI_END="3.4401221841131715" CI_START="2.1268168020300715" DF="16" EFFECT_SIZE="2.704904741799289" ESTIMABLE="YES" EVENTS_1="500" EVENTS_2="169" I2="14.502199193192311" ID="CMP-006.06.01" LOG_CI_END="0.536573867845882" LOG_CI_START="0.32773008261831227" LOG_EFFECT_SIZE="0.4321519752320971" MODIFIED="2017-08-08 16:23:56 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.2837765455453436" P_Z="5.006126554565738E-16" STUDIES="20" TAU2="0.031379196430038885" TOTAL_1="5535" TOTAL_2="5290" WEIGHT="80.78062594466088" Z="8.111347975998495"><NAME>Baseline characteristics specified</NAME><DICH_DATA CI_END="163.3214889303036" CI_START="0.5693353304979463" EFFECT_SIZE="9.642857142857142" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="0" LOG_CI_END="2.213043330541109" LOG_CI_START="-0.24463186490757274" LOG_EFFECT_SIZE="0.984205732816768" MODIFIED="2013-11-26 21:07:26 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1597" O_E="0.0" SE="1.4436505754949789" STUDY_ID="STD-Magnusson-1986" TOTAL_1="13" TOTAL_2="14" VAR="2.084126984126984" WEIGHT="1.75742827583699"/><DICH_DATA CI_END="6.690017380199802" CI_START="0.012930488128094391" EFFECT_SIZE="0.29411764705882354" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.8254272460361436" LOG_CI_START="-1.8883850801206539" LOG_EFFECT_SIZE="-0.5314789170422551" MODIFIED="2013-11-26 21:07:19 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1595" O_E="0.0" SE="1.5941067939721714" STUDY_ID="STD-Liu-1986" TOTAL_1="16" TOTAL_2="14" VAR="2.541176470588235" WEIGHT="1.4846429297618764"/><DICH_DATA CI_END="13.482091688489398" CI_START="0.060717144136267914" EFFECT_SIZE="0.9047619047619048" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.1297572763459856" LOG_CI_START="-1.2166886639081658" LOG_EFFECT_SIZE="-0.0434656937810903" MODIFIED="2013-11-26 21:07:31 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1589" O_E="0.0" SE="1.3783139604000185" STUDY_ID="STD-Gibson-1988" TOTAL_1="21" TOTAL_2="19" VAR="1.899749373433584" WEIGHT="1.898119682603732"/><DICH_DATA CI_END="307.7461518428873" CI_START="1.1868046625898883" EFFECT_SIZE="19.11111111111111" ESTIMABLE="YES" EVENTS_1="21" EVENTS_2="0" LOG_CI_END="2.48819263107907" LOG_CI_START="0.07437924385737768" LOG_EFFECT_SIZE="1.281285937468224" MODIFIED="2013-11-26 21:07:37 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1605" O_E="0.0" SE="1.417885932222993" STUDY_ID="STD-Stone-1988" TOTAL_1="89" TOTAL_2="39" VAR="2.010400516795866" WEIGHT="1.8111071459386745"/><DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-11-26 21:07:43 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1591" O_E="0.0" SE="0.0" STUDY_ID="STD-Inada-1989" TOTAL_1="20" TOTAL_2="10" VAR="0.0" WEIGHT="0.0"/><DICH_DATA CI_END="2.1277244659381767" CI_START="0.22038907230653051" EFFECT_SIZE="0.6847826086956522" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="5" LOG_CI_END="0.327915387405769" LOG_CI_START="-0.656809943189716" LOG_EFFECT_SIZE="-0.16444727789197353" MODIFIED="2013-11-26 21:07:53 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1600" O_E="0.0" SE="0.5784325336607887" STUDY_ID="STD-Miller-1991" TOTAL_1="368" TOTAL_2="180" VAR="0.3345841959972395" WEIGHT="5.923888520139918"/><DICH_DATA CI_END="16.55061376388459" CI_START="0.9667315199460398" EFFECT_SIZE="4.0" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="2" LOG_CI_END="1.2188141038111788" LOG_CI_START="-0.014694121155254026" LOG_EFFECT_SIZE="0.6020599913279624" MODIFIED="2013-11-26 21:08:04 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1592" O_E="0.0" SE="0.7245688373094719" STUDY_ID="STD-Jakobsen-1992" TOTAL_1="20" TOTAL_2="20" VAR="0.5249999999999999" WEIGHT="4.708865867899589"/><DICH_DATA CI_END="3.881860085359043" CI_START="0.38609570678958227" EFFECT_SIZE="1.2242424242424241" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="5" LOG_CI_END="0.5890398779736322" LOG_CI_START="-0.41330502750819725" LOG_EFFECT_SIZE="0.08786742523271744" MODIFIED="2014-06-22 20:45:56 +0100" MODIFIED_BY="Hermann Blessberger" ORDER="1598" O_E="0.0" SE="0.5887823591673299" STUDY_ID="STD-Mangano-1996" TOTAL_1="99" TOTAL_2="101" VAR="0.3466646664666467" WEIGHT="5.828476311761679"/><DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-11-26 21:08:32 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1593" O_E="0.0" SE="0.0" STUDY_ID="STD-Jakobsen-1997" TOTAL_1="18" TOTAL_2="17" VAR="0.0" WEIGHT="0.0"/><DICH_DATA CI_END="25.948956020600956" CI_START="1.4445429510900611" EFFECT_SIZE="6.122448979591836" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="2" LOG_CI_END="1.4141198899836058" LOG_CI_START="0.15973045939869154" LOG_EFFECT_SIZE="0.7869251746911488" MODIFIED="2013-11-26 21:08:39 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1588" O_E="0.0" SE="0.7368345608534029" STUDY_ID="STD-Bayliff-1999" TOTAL_1="49" TOTAL_2="50" VAR="0.5429251700680272" WEIGHT="4.619669192133295"/><DICH_DATA CI_END="9.055780428661802" CI_START="1.9026886986063845" EFFECT_SIZE="4.150943396226415" ESTIMABLE="YES" EVENTS_1="30" EVENTS_2="6" LOG_CI_END="0.9569258838335278" LOG_CI_START="0.27936773860930664" LOG_EFFECT_SIZE="0.6181468112214172" MODIFIED="2013-11-26 21:08:47 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1602" O_E="0.0" SE="0.3980010084716185" STUDY_ID="STD-POBBLE-2005" TOTAL_1="53" TOTAL_2="44" VAR="0.15840480274442537" WEIGHT="7.781660754511033"/><DICH_DATA CI_END="7.731389706964666" CI_START="0.29102141856503916" EFFECT_SIZE="1.5" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="2" LOG_CI_END="0.8882575647876686" LOG_CI_START="-0.5360750466763062" LOG_EFFECT_SIZE="0.17609125905568124" MODIFIED="2013-11-26 21:08:54 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1596" O_E="0.0" SE="0.8366600265340756" STUDY_ID="STD-Liu-2006" TOTAL_1="15" TOTAL_2="15" VAR="0.7" WEIGHT="3.9620225515789875"/><DICH_DATA CI_END="4.968546281602201" CI_START="2.221629425589266" EFFECT_SIZE="3.3223889931207005" ESTIMABLE="YES" EVENTS_1="85" EVENTS_2="26" LOG_CI_END="0.6962293395925384" LOG_CI_START="0.34667161903172805" LOG_EFFECT_SIZE="0.5214504793121333" MODIFIED="2013-11-26 21:09:11 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1607" O_E="0.0" SE="0.2053319353960433" STUDY_ID="STD-Yang-2006" TOTAL_1="246" TOTAL_2="250" VAR="0.0421612036934849" WEIGHT="9.81193196743652"/><DICH_DATA CI_END="3.4327496636168187" CI_START="2.194313719081089" EFFECT_SIZE="2.74454544160693" ESTIMABLE="YES" EVENTS_1="277" EVENTS_2="101" LOG_CI_END="0.5356421332614679" LOG_CI_START="0.3412987183735157" LOG_EFFECT_SIZE="0.43847042581749185" MODIFIED="2013-11-26 21:09:24 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1603" O_E="0.0" SE="0.11415828392060205" STUDY_ID="STD-POISE-2008" TOTAL_1="4174" TOTAL_2="4177" VAR="0.01303211378769679" WEIGHT="10.49830264179523"/><DICH_DATA CI_END="3.6290326949803244" CI_START="0.9972510940069231" EFFECT_SIZE="1.9023818820773135" ESTIMABLE="YES" EVENTS_1="24" EVENTS_2="13" LOG_CI_END="0.5597908808998064" LOG_CI_START="-0.0011954785870280453" LOG_EFFECT_SIZE="0.27929770115638924" MODIFIED="2013-11-26 21:09:35 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1599" O_E="0.0" SE="0.32952616448983174" STUDY_ID="STD-Marwick-2009" TOTAL_1="197" TOTAL_2="203" VAR="0.10858749308337966" WEIGHT="8.53886090190755"/><DICH_DATA CI_END="7.53745610550098" CI_START="1.3585485416660203" EFFECT_SIZE="3.2" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="5" LOG_CI_END="0.8772247960345471" LOG_CI_START="0.1330751606052648" LOG_EFFECT_SIZE="0.505149978319906" MODIFIED="2013-11-26 21:10:02 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1594" O_E="0.0" SE="0.4371171794512641" STUDY_ID="STD-Kawaguchi-2010" TOTAL_1="28" TOTAL_2="28" VAR="0.19107142857142861" WEIGHT="7.354038165906523"/><DICH_DATA CI_END="99.95416281504153" CI_START="0.25011464551267176" EFFECT_SIZE="5.0" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="0" LOG_CI_END="1.9998008859974516" LOG_CI_START="-0.6018608773254143" LOG_EFFECT_SIZE="0.6989700043360189" MODIFIED="2013-11-26 21:10:06 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1604" O_E="0.0" SE="1.5282289982092807" STUDY_ID="STD-Shukla-2010" TOTAL_1="30" TOTAL_2="30" VAR="2.335483870967742" WEIGHT="1.59614176487044"/><DICH_DATA CI_END="99.95416281504153" CI_START="0.25011464551267176" EFFECT_SIZE="5.0" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="0" LOG_CI_END="1.9998008859974516" LOG_CI_START="-0.6018608773254143" LOG_EFFECT_SIZE="0.6989700043360189" MODIFIED="2013-11-26 21:09:51 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1587" O_E="0.0" SE="1.5282289982092807" STUDY_ID="STD-Apipan-2010" TOTAL_1="30" TOTAL_2="30" VAR="2.335483870967742" WEIGHT="1.59614176487044"/><DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-11-26 21:10:21 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1601" O_E="0.0" SE="0.0" STUDY_ID="STD-Moon-2011" TOTAL_1="27" TOTAL_2="27" VAR="0.0" WEIGHT="0.0"/><DICH_DATA CI_END="98.52270194459342" CI_START="0.25374862348029537" EFFECT_SIZE="5.0" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="0" LOG_CI_END="1.9935363136779938" LOG_CI_START="-0.5955963050059561" LOG_EFFECT_SIZE="0.6989700043360189" MODIFIED="2013-11-26 21:10:16 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1590" O_E="0.0" SE="1.5208693166281149" STUDY_ID="STD-Gupta-2011" TOTAL_1="22" TOTAL_2="22" VAR="2.313043478260869" WEIGHT="1.6093275057084144"/></DICH_SUBGROUP><DICH_SUBGROUP CHI2="2.9425084774119306" CI_END="1.866338869567361" CI_START="0.6346127298693713" DF="2" EFFECT_SIZE="1.088302533709014" ESTIMABLE="YES" EVENTS_1="39" EVENTS_2="43" I2="32.03078205711439" ID="CMP-006.06.02" LOG_CI_END="0.27099050105125777" LOG_CI_START="-0.19749122051708468" LOG_EFFECT_SIZE="0.036749640267086534" MODIFIED="2013-11-26 21:10:41 +0000" MODIFIED_BY="Hermann Blessberger" NO="2" P_CHI2="0.2296373400610262" P_Z="0.7584663756389098" STUDIES="3" TAU2="0.09109228147058783" TOTAL_1="101" TOTAL_2="107" WEIGHT="19.219374055339117" Z="0.3074953324845357"><NAME>Baseline characteristics not specified</NAME><DICH_DATA CI_END="4.316762529506007" CI_START="0.7786184873819648" EFFECT_SIZE="1.8333333333333333" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="6" LOG_CI_END="0.6351581582319411" LOG_CI_START="-0.10867528868277829" LOG_EFFECT_SIZE="0.2632414347745814" MODIFIED="2013-11-26 21:10:28 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1610" O_E="0.0" SE="0.4369314487526515" STUDY_ID="STD-Whitehead-1980" TOTAL_1="30" TOTAL_2="30" VAR="0.19090909090909092" WEIGHT="7.35604701748607"/><DICH_DATA CI_END="7.401691333129458" CI_START="0.01324713701913913" EFFECT_SIZE="0.31313131313131315" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.8693309700979578" LOG_CI_START="-1.8778779716245122" LOG_EFFECT_SIZE="-0.5042735007632773" MODIFIED="2013-11-26 21:10:34 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1609" O_E="0.0" SE="1.6137241312713606" STUDY_ID="STD-Cucchiara-1986" TOTAL_1="32" TOTAL_2="30" VAR="2.6041055718475072" WEIGHT="1.4535780212832907"/><DICH_DATA CI_END="1.2063517837162632" CI_START="0.7282887347158697" EFFECT_SIZE="0.9373219373219374" ESTIMABLE="YES" EVENTS_1="28" EVENTS_2="36" LOG_CI_END="0.08147397069709093" LOG_CI_START="-0.13769640772879047" LOG_EFFECT_SIZE="-0.02811121851584977" MODIFIED="2013-11-26 21:10:41 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1608" O_E="0.0" SE="0.12874176519823316" STUDY_ID="STD-Burns-1988" TOTAL_1="39" TOTAL_2="47" VAR="0.016574442106356998" WEIGHT="10.409749016569759"/></DICH_SUBGROUP></DICH_OUTCOME><DICH_OUTCOME CHI2="79.61367252344698" CI_END="3.355714879923041" CI_START="1.478562609998888" CI_STUDY="95" CI_TOTAL="95" DF="19" EFFECT_MEASURE="RR" EFFECT_SIZE="2.2274726824971647" ESTIMABLE="YES" EVENTS_1="539" EVENTS_2="212" I2="76.13475248939895" I2_Q="97.25766515109817" ID="CMP-006.07" LOG_CI_END="0.5257850536654743" LOG_CI_START="0.16983971952924046" LOG_EFFECT_SIZE="0.3478123865973573" METHOD="MH" MODIFIED="2017-12-08 02:31:36 +0000" MODIFIED_BY="Hermann Blessberger" NO="7" P_CHI2="2.1675828909550887E-9" P_Q="1.5541579134747963E-9" P_Z="1.2795484866811105E-4" Q="36.465277039397556" RANDOM="YES" SCALE="100.0" SORT_BY="YEAR" STUDIES="23" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.40337939548311363" TOTALS="YES" TOTAL_1="5636" TOTAL_2="5397" WEIGHT="100.0" Z="3.8303620569265826"><NAME>Bradycardia&#8212;non-cardiac surgery: specification of outcome parameters</NAME><GROUP_LABEL_1>Beta-blocker</GROUP_LABEL_1><GROUP_LABEL_2>Control</GROUP_LABEL_2><GRAPH_LABEL_1>Favours beta-blockers</GRAPH_LABEL_1><GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2><DICH_SUBGROUP CHI2="19.57268984396381" CI_END="3.3203465832764842" CI_START="2.107539966785413" DF="17" EFFECT_SIZE="2.6453285481834916" ESTIMABLE="YES" EVENTS_1="511" EVENTS_2="175" I2="13.144283511738298" ID="CMP-006.07.01" LOG_CI_END="0.5211834184475609" LOG_CI_START="0.32377581921126786" LOG_EFFECT_SIZE="0.4224796188294143" MODIFIED="2017-06-17 15:50:31 +0100" MODIFIED_BY="Hermann Blessberger" NO="1" P_CHI2="0.2966666684600885" P_Z="4.8950690295571684E-17" STUDIES="21" TAU2="0.02755841449932906" TOTAL_1="5565" TOTAL_2="5320" WEIGHT="88.13667296214695" Z="8.389189071862516"><NAME>Outcome parameters explicitly defined</NAME><DICH_DATA CI_END="4.316762529506007" CI_START="0.7786184873819648" EFFECT_SIZE="1.8333333333333333" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="6" LOG_CI_END="0.6351581582319411" LOG_CI_START="-0.10867528868277829" LOG_EFFECT_SIZE="0.2632414347745814" MODIFIED="2013-11-26 21:22:51 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1655" O_E="0.0" SE="0.4369314487526515" STUDY_ID="STD-Whitehead-1980" TOTAL_1="30" TOTAL_2="30" VAR="0.19090909090909092" WEIGHT="7.35604701748607"/><DICH_DATA CI_END="163.3214889303036" CI_START="0.5693353304979463" EFFECT_SIZE="9.642857142857142" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="0" LOG_CI_END="2.213043330541109" LOG_CI_START="-0.24463186490757274" LOG_EFFECT_SIZE="0.984205732816768" MODIFIED="2013-11-26 21:22:59 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1645" O_E="0.0" SE="1.4436505754949789" STUDY_ID="STD-Magnusson-1986" TOTAL_1="13" TOTAL_2="14" VAR="2.084126984126984" WEIGHT="1.7574282758369901"/><DICH_DATA CI_END="6.690017380199802" CI_START="0.012930488128094391" EFFECT_SIZE="0.29411764705882354" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.8254272460361436" LOG_CI_START="-1.8883850801206539" LOG_EFFECT_SIZE="-0.5314789170422551" MODIFIED="2013-11-26 21:23:05 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1643" O_E="0.0" SE="1.5941067939721714" STUDY_ID="STD-Liu-1986" TOTAL_1="16" TOTAL_2="14" VAR="2.541176470588235" WEIGHT="1.4846429297618766"/><DICH_DATA CI_END="13.482091688489398" CI_START="0.060717144136267914" EFFECT_SIZE="0.9047619047619048" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.1297572763459856" LOG_CI_START="-1.2166886639081658" LOG_EFFECT_SIZE="-0.0434656937810903" MODIFIED="2013-11-26 21:23:09 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1637" O_E="0.0" SE="1.3783139604000185" STUDY_ID="STD-Gibson-1988" TOTAL_1="21" TOTAL_2="19" VAR="1.899749373433584" WEIGHT="1.8981196826037325"/><DICH_DATA CI_END="307.7461518428873" CI_START="1.1868046625898883" EFFECT_SIZE="19.11111111111111" ESTIMABLE="YES" EVENTS_1="21" EVENTS_2="0" LOG_CI_END="2.48819263107907" LOG_CI_START="0.07437924385737768" LOG_EFFECT_SIZE="1.281285937468224" MODIFIED="2013-11-26 21:23:15 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1653" O_E="0.0" SE="1.417885932222993" STUDY_ID="STD-Stone-1988" TOTAL_1="89" TOTAL_2="39" VAR="2.010400516795866" WEIGHT="1.811107145938675"/><DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-11-26 21:23:21 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1639" O_E="0.0" SE="0.0" STUDY_ID="STD-Inada-1989" TOTAL_1="20" TOTAL_2="10" VAR="0.0" WEIGHT="0.0"/><DICH_DATA CI_END="2.1277244659381767" CI_START="0.22038907230653051" EFFECT_SIZE="0.6847826086956522" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="5" LOG_CI_END="0.327915387405769" LOG_CI_START="-0.656809943189716" LOG_EFFECT_SIZE="-0.16444727789197353" MODIFIED="2013-11-26 21:23:29 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1648" O_E="0.0" SE="0.5784325336607887" STUDY_ID="STD-Miller-1991" TOTAL_1="368" TOTAL_2="180" VAR="0.3345841959972395" WEIGHT="5.923888520139918"/><DICH_DATA CI_END="16.55061376388459" CI_START="0.9667315199460398" EFFECT_SIZE="4.0" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="2" LOG_CI_END="1.2188141038111788" LOG_CI_START="-0.014694121155254026" LOG_EFFECT_SIZE="0.6020599913279624" MODIFIED="2013-11-26 21:23:36 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1640" O_E="0.0" SE="0.7245688373094719" STUDY_ID="STD-Jakobsen-1992" TOTAL_1="20" TOTAL_2="20" VAR="0.5249999999999999" WEIGHT="4.708865867899589"/><DICH_DATA CI_END="3.881860085359043" CI_START="0.38609570678958227" EFFECT_SIZE="1.2242424242424241" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="5" LOG_CI_END="0.5890398779736322" LOG_CI_START="-0.41330502750819725" LOG_EFFECT_SIZE="0.08786742523271744" MODIFIED="2014-06-22 20:46:09 +0100" MODIFIED_BY="Hermann Blessberger" ORDER="1646" O_E="0.0" SE="0.5887823591673299" STUDY_ID="STD-Mangano-1996" TOTAL_1="99" TOTAL_2="101" VAR="0.3466646664666467" WEIGHT="5.828476311761679"/><DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-11-26 21:23:48 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1641" O_E="0.0" SE="0.0" STUDY_ID="STD-Jakobsen-1997" TOTAL_1="18" TOTAL_2="17" VAR="0.0" WEIGHT="0.0"/><DICH_DATA CI_END="25.948956020600956" CI_START="1.4445429510900611" EFFECT_SIZE="6.122448979591836" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="2" LOG_CI_END="1.4141198899836058" LOG_CI_START="0.15973045939869154" LOG_EFFECT_SIZE="0.7869251746911488" MODIFIED="2013-11-26 21:23:55 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1636" O_E="0.0" SE="0.7368345608534029" STUDY_ID="STD-Bayliff-1999" TOTAL_1="49" TOTAL_2="50" VAR="0.5429251700680272" WEIGHT="4.619669192133294"/><DICH_DATA CI_END="9.055780428661802" CI_START="1.9026886986063845" EFFECT_SIZE="4.150943396226415" ESTIMABLE="YES" EVENTS_1="30" EVENTS_2="6" LOG_CI_END="0.9569258838335278" LOG_CI_START="0.27936773860930664" LOG_EFFECT_SIZE="0.6181468112214172" MODIFIED="2013-11-26 21:24:04 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1650" O_E="0.0" SE="0.3980010084716185" STUDY_ID="STD-POBBLE-2005" TOTAL_1="53" TOTAL_2="44" VAR="0.15840480274442537" WEIGHT="7.781660754511034"/><DICH_DATA CI_END="7.731389706964666" CI_START="0.29102141856503916" EFFECT_SIZE="1.5" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="2" LOG_CI_END="0.8882575647876686" LOG_CI_START="-0.5360750466763062" LOG_EFFECT_SIZE="0.17609125905568124" MODIFIED="2013-11-26 21:24:21 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1644" O_E="0.0" SE="0.8366600265340756" STUDY_ID="STD-Liu-2006" TOTAL_1="15" TOTAL_2="15" VAR="0.7" WEIGHT="3.962022551578988"/><DICH_DATA CI_END="4.968546281602201" CI_START="2.221629425589266" EFFECT_SIZE="3.3223889931207005" ESTIMABLE="YES" EVENTS_1="85" EVENTS_2="26" LOG_CI_END="0.6962293395925384" LOG_CI_START="0.34667161903172805" LOG_EFFECT_SIZE="0.5214504793121333" MODIFIED="2013-11-26 21:24:13 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1656" O_E="0.0" SE="0.2053319353960433" STUDY_ID="STD-Yang-2006" TOTAL_1="246" TOTAL_2="250" VAR="0.0421612036934849" WEIGHT="9.811931967436518"/><DICH_DATA CI_END="3.4327496636168187" CI_START="2.194313719081089" EFFECT_SIZE="2.74454544160693" ESTIMABLE="YES" EVENTS_1="277" EVENTS_2="101" LOG_CI_END="0.5356421332614679" LOG_CI_START="0.3412987183735157" LOG_EFFECT_SIZE="0.43847042581749185" MODIFIED="2013-11-26 21:24:40 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1651" O_E="0.0" SE="0.11415828392060205" STUDY_ID="STD-POISE-2008" TOTAL_1="4174" TOTAL_2="4177" VAR="0.01303211378769679" WEIGHT="10.498302641795227"/><DICH_DATA CI_END="3.6290326949803244" CI_START="0.9972510940069231" EFFECT_SIZE="1.9023818820773135" ESTIMABLE="YES" EVENTS_1="24" EVENTS_2="13" LOG_CI_END="0.5597908808998064" LOG_CI_START="-0.0011954785870280453" LOG_EFFECT_SIZE="0.27929770115638924" MODIFIED="2013-11-26 21:24:54 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1647" O_E="0.0" SE="0.32952616448983174" STUDY_ID="STD-Marwick-2009" TOTAL_1="197" TOTAL_2="203" VAR="0.10858749308337966" WEIGHT="8.538860901907546"/><DICH_DATA CI_END="99.95416281504153" CI_START="0.25011464551267176" EFFECT_SIZE="5.0" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="0" LOG_CI_END="1.9998008859974516" LOG_CI_START="-0.6018608773254143" LOG_EFFECT_SIZE="0.6989700043360189" MODIFIED="2013-11-26 21:24:59 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1635" O_E="0.0" SE="1.5282289982092807" STUDY_ID="STD-Apipan-2010" TOTAL_1="30" TOTAL_2="30" VAR="2.335483870967742" WEIGHT="1.5961417648704401"/><DICH_DATA CI_END="7.53745610550098" CI_START="1.3585485416660203" EFFECT_SIZE="3.2" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="5" LOG_CI_END="0.8772247960345471" LOG_CI_START="0.1330751606052648" LOG_EFFECT_SIZE="0.505149978319906" MODIFIED="2013-11-26 21:25:14 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1642" O_E="0.0" SE="0.4371171794512641" STUDY_ID="STD-Kawaguchi-2010" TOTAL_1="28" TOTAL_2="28" VAR="0.19107142857142861" WEIGHT="7.354038165906522"/><DICH_DATA CI_END="99.95416281504153" CI_START="0.25011464551267176" EFFECT_SIZE="5.0" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="0" LOG_CI_END="1.9998008859974516" LOG_CI_START="-0.6018608773254143" LOG_EFFECT_SIZE="0.6989700043360189" MODIFIED="2013-11-26 21:25:08 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1652" O_E="0.0" SE="1.5282289982092807" STUDY_ID="STD-Shukla-2010" TOTAL_1="30" TOTAL_2="30" VAR="2.335483870967742" WEIGHT="1.5961417648704401"/><DICH_DATA CI_END="98.52270194459342" CI_START="0.25374862348029537" EFFECT_SIZE="5.0" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="0" LOG_CI_END="1.9935363136779938" LOG_CI_START="-0.5955963050059561" LOG_EFFECT_SIZE="0.6989700043360189" MODIFIED="2013-11-26 21:25:19 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1638" O_E="0.0" SE="1.5208693166281149" STUDY_ID="STD-Gupta-2011" TOTAL_1="22" TOTAL_2="22" VAR="2.313043478260869" WEIGHT="1.6093275057084147"/><DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-11-26 21:25:24 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1649" O_E="0.0" SE="0.0" STUDY_ID="STD-Moon-2011" TOTAL_1="27" TOTAL_2="27" VAR="0.0" WEIGHT="0.0"/></DICH_SUBGROUP><DICH_SUBGROUP CHI2="0.49266144366362025" CI_END="1.1970585881326647" CI_START="0.7238343636417421" DF="1" EFFECT_SIZE="0.9308448535512723" ESTIMABLE="YES" EVENTS_1="28" EVENTS_2="37" I2="0.0" ID="CMP-006.07.02" LOG_CI_END="0.07811540678071371" LOG_CI_START="-0.1403608028446637" LOG_EFFECT_SIZE="-0.031122698031975" MODIFIED="2013-11-26 21:25:34 +0000" MODIFIED_BY="Hermann Blessberger" NO="2" P_CHI2="0.48274253926996713" P_Z="0.5765662161912429" STUDIES="2" TAU2="0.0" TOTAL_1="71" TOTAL_2="77" WEIGHT="11.863327037853047" Z="0.5584074105732849"><NAME>Outcome parameters vaguely or not defined</NAME><DICH_DATA CI_END="7.401691333129458" CI_START="0.01324713701913913" EFFECT_SIZE="0.31313131313131315" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.8693309700979578" LOG_CI_START="-1.8778779716245122" LOG_EFFECT_SIZE="-0.5042735007632773" MODIFIED="2013-11-26 21:25:29 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1658" O_E="0.0" SE="1.6137241312713606" STUDY_ID="STD-Cucchiara-1986" TOTAL_1="32" TOTAL_2="30" VAR="2.6041055718475072" WEIGHT="1.453578021283291"/><DICH_DATA CI_END="1.2063517837162632" CI_START="0.7282887347158697" EFFECT_SIZE="0.9373219373219374" ESTIMABLE="YES" EVENTS_1="28" EVENTS_2="36" LOG_CI_END="0.08147397069709093" LOG_CI_START="-0.13769640772879047" LOG_EFFECT_SIZE="-0.02811121851584977" MODIFIED="2013-11-26 21:25:34 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1657" O_E="0.0" SE="0.12874176519823316" STUDY_ID="STD-Burns-1988" TOTAL_1="39" TOTAL_2="47" VAR="0.016574442106356998" WEIGHT="10.409749016569757"/></DICH_SUBGROUP></DICH_OUTCOME><DICH_OUTCOME CHI2="54.33757367157329" CI_END="3.2744158064927023" CI_START="0.7138110429411808" CI_STUDY="95" CI_TOTAL="95" DF="4" EFFECT_MEASURE="RR" EFFECT_SIZE="1.528827708362078" ESTIMABLE="YES" EVENTS_1="334" EVENTS_2="152" I2="92.63861131493142" I2_Q="0.934654577013745" ID="CMP-006.08" LOG_CI_END="0.5151338280994627" LOG_CI_START="-0.1464167376197511" LOG_EFFECT_SIZE="0.18435854523985576" METHOD="MH" MODIFIED="2017-12-08 02:31:39 +0000" MODIFIED_BY="Hermann Blessberger" NO="8" P_CHI2="4.472122672183332E-11" P_Q="0.3150385697410091" P_Z="0.27466107251396576" Q="1.0094347278861542" RANDOM="YES" SCALE="100.0" SORT_BY="YEAR" STUDIES="5" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.6023463655111397" TOTALS="YES" TOTAL_1="4708" TOTAL_2="4533" WEIGHT="100.0" Z="1.0923915045541046"><NAME>Bradycardia&#8212;non-cardiac surgery: influence of coronary heart disease</NAME><GROUP_LABEL_1>Beta-blocker</GROUP_LABEL_1><GROUP_LABEL_2>Control</GROUP_LABEL_2><GRAPH_LABEL_1>Favours beta-blocker</GRAPH_LABEL_1><GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2><DICH_SUBGROUP CHI2="8.869046856971469" CI_END="3.083755094815265" CI_START="0.5240411758056458" DF="2" EFFECT_SIZE="1.27122564707594" ESTIMABLE="YES" EVENTS_1="51" EVENTS_2="46" I2="77.44966249188423" ID="CMP-006.08.01" LOG_CI_END="0.48907988001650443" LOG_CI_START="-0.2806345875914295" LOG_EFFECT_SIZE="0.10422264621253748" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" NO="1" P_CHI2="0.011860770324818692" P_Z="0.5955746459860509" STUDIES="3" TAU2="0.4601190941935409" TOTAL_1="435" TOTAL_2="255" WEIGHT="59.54868683860596" Z="0.5307750901054461"><NAME>Percentage of participants diagnosed with coronary heart disease below median (25%)</NAME><DICH_DATA CI_END="1.2063517837162632" CI_START="0.7282887347158697" EFFECT_SIZE="0.9373219373219374" ESTIMABLE="YES" EVENTS_1="28" EVENTS_2="36" LOG_CI_END="0.08147397069709093" LOG_CI_START="-0.13769640772879047" LOG_EFFECT_SIZE="-0.02811121851584977" MODIFIED="2013-11-26 21:36:01 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1679" O_E="0.0" SE="0.12874176519823316" STUDY_ID="STD-Burns-1988" TOTAL_1="39" TOTAL_2="47" VAR="0.016574442106356998" WEIGHT="24.398673241240903"/><DICH_DATA CI_END="2.1277244659381767" CI_START="0.22038907230653051" EFFECT_SIZE="0.6847826086956522" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="5" LOG_CI_END="0.327915387405769" LOG_CI_START="-0.656809943189716" LOG_EFFECT_SIZE="-0.16444727789197353" MODIFIED="2013-11-26 21:36:07 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1681" O_E="0.0" SE="0.5784325336607887" STUDY_ID="STD-Miller-1991" TOTAL_1="368" TOTAL_2="180" VAR="0.3345841959972395" WEIGHT="16.117359351533093"/><DICH_DATA CI_END="7.53745610550098" CI_START="1.3585485416660203" EFFECT_SIZE="3.2" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="5" LOG_CI_END="0.8772247960345471" LOG_CI_START="0.1330751606052648" LOG_EFFECT_SIZE="0.505149978319906" MODIFIED="2013-11-26 21:36:13 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1680" O_E="0.0" SE="0.4371171794512641" STUDY_ID="STD-Kawaguchi-2010" TOTAL_1="28" TOTAL_2="28" VAR="0.19107142857142861" WEIGHT="19.032654245831964"/></DICH_SUBGROUP><DICH_SUBGROUP CHI2="1.8125917265194826" CI_END="4.447591097959188" CI_START="1.1418875892892137" DF="1" EFFECT_SIZE="2.253585826409277" ESTIMABLE="YES" EVENTS_1="283" EVENTS_2="106" I2="44.830378216489585" ID="CMP-006.08.02" LOG_CI_END="0.648124852300832" LOG_CI_START="0.05762335281150929" LOG_EFFECT_SIZE="0.35287410255617063" MODIFIED="2017-08-08 16:24:21 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.1781977935196778" P_Z="0.01915579013525755" STUDIES="2" TAU2="0.1461433138451881" TOTAL_1="4273" TOTAL_2="4278" WEIGHT="40.45131316139404" Z="2.3424852695043614"><NAME>Percentage of participants diagnosed with coronary heart disease above median (25%)</NAME><DICH_DATA CI_END="3.881860085359043" CI_START="0.38609570678958227" EFFECT_SIZE="1.2242424242424241" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="5" LOG_CI_END="0.5890398779736322" LOG_CI_START="-0.41330502750819725" LOG_EFFECT_SIZE="0.08786742523271744" MODIFIED="2014-06-22 20:46:47 +0100" MODIFIED_BY="Hermann Blessberger" ORDER="1682" O_E="0.0" SE="0.5887823591673299" STUDY_ID="STD-Mangano-1996" TOTAL_1="99" TOTAL_2="101" VAR="0.3466646664666467" WEIGHT="15.912192839100413"/><DICH_DATA CI_END="3.4327496636168187" CI_START="2.194313719081089" EFFECT_SIZE="2.74454544160693" ESTIMABLE="YES" EVENTS_1="277" EVENTS_2="101" LOG_CI_END="0.5356421332614679" LOG_CI_START="0.3412987183735157" LOG_EFFECT_SIZE="0.43847042581749185" MODIFIED="2013-11-26 21:36:31 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1683" O_E="0.0" SE="0.11415828392060205" STUDY_ID="STD-POISE-2008" TOTAL_1="4174" TOTAL_2="4177" VAR="0.01303211378769679" WEIGHT="24.539120322293623"/></DICH_SUBGROUP></DICH_OUTCOME><DICH_OUTCOME CHI2="167.82002570057057" CI_END="0.5661935770648678" CI_START="0.35734242849166364" CI_STUDY="95" CI_TOTAL="95" DF="34" EFFECT_MEASURE="RR" EFFECT_SIZE="0.4498054999938771" ESTIMABLE="YES" EVENTS_1="459" EVENTS_2="849" I2="79.74020093366939" I2_Q="58.98072846421679" ID="CMP-006.09" LOG_CI_END="-0.2470350616065698" LOG_CI_START="-0.44691541546326585" LOG_EFFECT_SIZE="-0.34697523853491785" METHOD="MH" MODIFIED="2017-12-08 02:31:41 +0000" MODIFIED_BY="Hermann Blessberger" NO="9" P_CHI2="0.0" P_Q="0.06254550775449041" P_Z="1.012878329556013E-11" Q="7.313635488097215" RANDOM="YES" SCALE="100.0" SORT_BY="YEAR" STUDIES="35" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.28721438533456195" TOTALS="YES" TOTAL_1="2400" TOTAL_2="2358" WEIGHT="100.0" Z="6.8046604674634565"><NAME>All supraventricular arrhythmias&#8212;cardiac surgery: duration of beta-blocker therapy</NAME><GROUP_LABEL_1>Beta-blocker</GROUP_LABEL_1><GROUP_LABEL_2>Control</GROUP_LABEL_2><GRAPH_LABEL_1>Favours beta-blocker</GRAPH_LABEL_1><GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2><DICH_SUBGROUP CHI2="1.0633960536024403" CI_END="1.8070992517228281" CI_START="0.5583084930469053" DF="2" EFFECT_SIZE="1.004449530845409" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="15" I2="0.0" ID="CMP-006.09.01" LOG_CI_END="0.2569820060705077" LOG_CI_START="-0.25312576556646005" LOG_EFFECT_SIZE="0.001928120252023825" MODIFIED="2013-11-26 22:23:32 +0000" MODIFIED_BY="Hermann Blessberger" NO="1" P_CHI2="0.5876064496382355" P_Z="0.9881784497077288" STUDIES="3" TAU2="0.0" TOTAL_1="78" TOTAL_2="81" WEIGHT="5.881347629306018" Z="0.014816658212055158"><NAME>Up to 24 hours</NAME><DICH_DATA CI_END="63.82881484401465" CI_START="0.12392766917779852" EFFECT_SIZE="2.8125" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.8050167806434498" LOG_CI_START="-0.9068317184046119" LOG_EFFECT_SIZE="0.4490925311194189" MODIFIED="2013-11-26 22:23:23 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1734" O_E="0.0" SE="1.592953232207399" STUDY_ID="STD-Cork-1995" TOTAL_1="15" TOTAL_2="14" VAR="2.5374999999999996" WEIGHT="0.4880236644454988"/><DICH_DATA CI_END="5.055834822644325" CI_START="0.4316467581119249" EFFECT_SIZE="1.4772727272727273" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="4" LOG_CI_END="0.703792876827747" LOG_CI_START="-0.36487151651441074" LOG_EFFECT_SIZE="0.16946068015666815" MODIFIED="2013-11-26 22:23:27 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1733" O_E="0.0" SE="0.6277387546232461" STUDY_ID="STD-Booth-2004" TOTAL_1="33" TOTAL_2="39" VAR="0.394055944055944" WEIGHT="2.0234661717561924"/><DICH_DATA CI_END="1.6818496358282289" CI_START="0.42805642238869207" EFFECT_SIZE="0.8484848484848485" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="11" LOG_CI_END="0.22578716551115877" LOG_CI_START="-0.3684989825824953" LOG_EFFECT_SIZE="-0.07135590853566824" MODIFIED="2013-11-26 22:23:32 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1735" O_E="0.0" SE="0.3490866251540896" STUDY_ID="STD-Sun-2011" TOTAL_1="30" TOTAL_2="28" VAR="0.12186147186147188" WEIGHT="3.3698577931043268"/></DICH_SUBGROUP><DICH_SUBGROUP CHI2="161.52875786443337" CI_END="0.6457942310939624" CI_START="0.2569303110947489" DF="18" EFFECT_SIZE="0.40733783607488017" ESTIMABLE="YES" EVENTS_1="150" EVENTS_2="344" I2="88.85647346145824" ID="CMP-006.09.02" LOG_CI_END="-0.189905838871736" LOG_CI_START="-0.5901846572569781" LOG_EFFECT_SIZE="-0.39004524806435703" MODIFIED="2013-12-01 13:09:53 +0000" MODIFIED_BY="Hermann Blessberger" NO="2" P_CHI2="6.661338147750939E-16" P_Z="1.3360829899264543E-4" STUDIES="19" TAU2="0.8151741939950427" TOTAL_1="1016" TOTAL_2="1019" WEIGHT="53.53910953380001" Z="3.8197106788267496"><NAME>2-7 days</NAME><DICH_DATA CI_END="0.8969131509065325" CI_START="0.05911511257256819" EFFECT_SIZE="0.23026315789473684" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="16" LOG_CI_END="-0.047249608135544637" LOG_CI_START="-1.2283014790534492" LOG_EFFECT_SIZE="-0.637775543594497" MODIFIED="2013-11-26 22:23:40 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1748" O_E="0.0" SE="0.6937557152782261" STUDY_ID="STD-Oka-1980" TOTAL_1="19" TOTAL_2="35" VAR="0.48129699248120306" WEIGHT="1.7937632481914423"/><DICH_DATA CI_END="0.9625082004987383" CI_START="0.2097281543575606" EFFECT_SIZE="0.4492939666238768" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="19" LOG_CI_END="-0.016595561646807904" LOG_CI_START="-0.6783432649977698" LOG_EFFECT_SIZE="-0.3474694133222888" MODIFIED="2013-12-01 13:09:53 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1736" O_E="0.0" SE="0.38871387665231644" STUDY_ID="STD-Abel-1983" TOTAL_1="41" TOTAL_2="50" VAR="0.15109847790207226" WEIGHT="3.145076453297367"/><DICH_DATA CI_END="2.0488361448048726" CI_START="0.32963107650375956" EFFECT_SIZE="0.8218029350104822" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="9" LOG_CI_END="0.3115072271896002" LOG_CI_START="-0.4819718512289136" LOG_EFFECT_SIZE="-0.08523231201965667" MODIFIED="2013-11-26 22:23:48 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1742" O_E="0.0" SE="0.46609353844781976" STUDY_ID="STD-Ivey-1983" TOTAL_1="53" TOTAL_2="56" VAR="0.21724318658280922" WEIGHT="2.732692583249968"/><DICH_DATA CI_END="1.1517322070933487" CI_START="0.8726150111164188" EFFECT_SIZE="1.0025062656641603" ESTIMABLE="YES" EVENTS_1="20" EVENTS_2="19" LOG_CI_END="0.06135151163809717" LOG_CI_START="-0.059177320355668896" LOG_EFFECT_SIZE="0.0010870956412141369" MODIFIED="2013-11-26 22:24:12 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1754" O_E="0.0" SE="0.07079923254047887" STUDY_ID="STD-White-1984" TOTAL_1="21" TOTAL_2="20" VAR="0.005012531328320802" WEIGHT="4.7173185861355025"/><DICH_DATA CI_END="1.1085399331216403" CI_START="0.06960551579759253" EFFECT_SIZE="0.2777777777777778" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="9" LOG_CI_END="0.04475134239592844" LOG_CI_START="-1.157356343930503" LOG_EFFECT_SIZE="-0.5563025007672873" MODIFIED="2013-11-26 22:24:02 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1745" O_E="0.0" SE="0.706124005477162" STUDY_ID="STD-Myhre-1984" TOTAL_1="16" TOTAL_2="20" VAR="0.49861111111111117" WEIGHT="1.7542412044124733"/><DICH_DATA CI_END="0.3925291896546882" CI_START="0.0015155153127434649" EFFECT_SIZE="0.024390243902439025" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="20" LOG_CI_END="-0.4061280422700622" LOG_CI_START="-2.819439671169409" LOG_EFFECT_SIZE="-1.6127838567197355" MODIFIED="2013-11-26 22:24:28 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1739" O_E="0.0" SE="1.4175911969007033" STUDY_ID="STD-Daudon-1986" TOTAL_1="50" TOTAL_2="50" VAR="2.0095648015303684" WEIGHT="0.6002002600975137"/><DICH_DATA CI_END="4.126826287091888" CI_START="0.7815504113324163" EFFECT_SIZE="1.7959183673469388" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="7" LOG_CI_END="0.6156161882509973" LOG_CI_START="-0.10704300400768743" LOG_EFFECT_SIZE="0.25428659212165494" MODIFIED="2013-11-26 22:24:33 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1743" O_E="0.0" SE="0.4244935867534458" STUDY_ID="STD-Martinussen-1988" TOTAL_1="35" TOTAL_2="40" VAR="0.18019480519480519" WEIGHT="2.949294736335047"/><DICH_DATA CI_END="0.9337223063907559" CI_START="0.11899802580555667" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="12" LOG_CI_END="-0.02978226588341088" LOG_CI_START="-0.9244602435559142" LOG_EFFECT_SIZE="-0.47712125471966244" MODIFIED="2013-11-26 22:24:41 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1744" O_E="0.0" SE="0.5255382728122435" STUDY_ID="STD-Matangi-1989" TOTAL_1="35" TOTAL_2="35" VAR="0.27619047619047615" WEIGHT="2.4467794999344794"/><DICH_DATA CI_END="0.8089575542744424" CI_START="0.33649691357538647" EFFECT_SIZE="0.5217391304347826" ESTIMABLE="YES" EVENTS_1="24" EVENTS_2="46" LOG_CI_END="-0.09207426507251505" LOG_CI_START="-0.47301891486742115" LOG_EFFECT_SIZE="-0.28254658996996806" MODIFIED="2013-11-26 22:24:50 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1753" O_E="0.0" SE="0.22376877299595657" STUDY_ID="STD-Suttorp-1991" TOTAL_1="150" TOTAL_2="150" VAR="0.05007246376811594" WEIGHT="4.087107069280462"/><DICH_DATA CI_END="0.8651318953082401" CI_START="0.13362124391311758" EFFECT_SIZE="0.34" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="15" LOG_CI_END="-0.06291767630644172" LOG_CI_START="-0.8741244896090479" LOG_EFFECT_SIZE="-0.46852108295774486" MODIFIED="2013-11-26 22:24:57 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1746" O_E="0.0" SE="0.4765068976724385" STUDY_ID="STD-Nystr_x00f6_m-1993" TOTAL_1="50" TOTAL_2="51" VAR="0.22705882352941176" WEIGHT="2.680535251657472"/><DICH_DATA CI_END="0.7907637030184065" CI_START="0.0484655463980742" EFFECT_SIZE="0.19576719576719576" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="14" LOG_CI_END="-0.10195327352704722" LOG_CI_START="-1.3145668866854512" LOG_EFFECT_SIZE="-0.7082600801062492" MODIFIED="2013-11-26 22:25:03 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1737" O_E="0.0" SE="0.7122952389034392" STUDY_ID="STD-Babin_x002d_Ebell-1996" TOTAL_1="27" TOTAL_2="37" VAR="0.5073645073645074" WEIGHT="1.7349157874811263"/><DICH_DATA CI_END="0.815131215366541" CI_START="0.13431350612509407" EFFECT_SIZE="0.33088235294117646" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="17" LOG_CI_END="-0.08877247528121683" LOG_CI_START="-0.8718803139085308" LOG_EFFECT_SIZE="-0.48032639459487386" MODIFIED="2013-11-26 22:25:09 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1741" O_E="0.0" SE="0.460001420856004" STUDY_ID="STD-Gomes-1999" TOTAL_1="40" TOTAL_2="45" VAR="0.2116013071895425" WEIGHT="2.7636008369489544"/><DICH_DATA CI_END="0.8589583309812318" CI_START="0.26561019438408295" EFFECT_SIZE="0.47764849969381507" ESTIMABLE="YES" EVENTS_1="13" EVENTS_2="23" LOG_CI_END="-0.0660279037634654" LOG_CI_START="-0.5757552603289101" LOG_EFFECT_SIZE="-0.3208915820461878" MODIFIED="2013-11-26 22:25:18 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1738" O_E="0.0" SE="0.29941637243765074" STUDY_ID="STD-Bert-2001" TOTAL_1="71" TOTAL_2="60" VAR="0.08965016408372196" WEIGHT="3.6578857509169764"/><DICH_DATA CI_END="0.8846657886054342" CI_START="0.2374562768789701" EFFECT_SIZE="0.4583333333333333" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="24" LOG_CI_END="-0.05322076724324717" LOG_CI_START="-0.6244163458635148" LOG_EFFECT_SIZE="-0.338818556553381" MODIFIED="2013-11-26 22:25:26 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1740" O_E="0.0" SE="0.3355231103452601" STUDY_ID="STD-De-Azevedo-L_x00fa_cio-2003" TOTAL_1="100" TOTAL_2="100" VAR="0.11257575757575758" WEIGHT="3.4481276984663354"/><DICH_DATA CI_END="0.6324601313324618" CI_START="0.13450562372243266" EFFECT_SIZE="0.2916666666666667" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="24" LOG_CI_END="-0.1989668461016144" LOG_CI_START="-0.871259557293084" LOG_EFFECT_SIZE="-0.5351132016973492" MODIFIED="2013-11-26 22:25:35 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1751" O_E="0.0" SE="0.39490806645646137" STUDY_ID="STD-Sezai-2011" TOTAL_1="70" TOTAL_2="70" VAR="0.15595238095238093" WEIGHT="3.1106291586186194"/><DICH_DATA CI_END="0.5360855287701065" CI_START="0.05040605255789461" EFFECT_SIZE="0.1643835616438356" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="17" LOG_CI_END="-0.27076591607279954" LOG_CI_START="-1.2975173120728625" LOG_EFFECT_SIZE="-0.7841416140728311" MODIFIED="2013-11-26 22:25:53 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1749" O_E="0.0" SE="0.6031188525118167" STUDY_ID="STD-Osada-2012" TOTAL_1="73" TOTAL_2="68" VAR="0.36375235025517055" WEIGHT="2.1176619172315054"/><DICH_DATA CI_END="0.8263453347887832" CI_START="0.17017703625802433" EFFECT_SIZE="0.375" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="16" LOG_CI_END="-0.0828384204148983" LOG_CI_START="-0.7690990441296639" LOG_EFFECT_SIZE="-0.42596873227228116" MODIFIED="2013-11-26 22:25:44 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1750" O_E="0.0" SE="0.4031128874149275" STUDY_ID="STD-Sakaguchi-2012" TOTAL_1="30" TOTAL_2="30" VAR="0.1625" WEIGHT="3.065339936407285"/><DICH_DATA CI_END="0.7482025935275345" CI_START="0.1529700826342874" EFFECT_SIZE="0.3383084577114428" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="12" LOG_CI_END="-0.12598079072115415" LOG_CI_START="-0.8153934987073509" LOG_EFFECT_SIZE="-0.47068714471425255" MODIFIED="2013-11-26 22:26:01 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1752" O_E="0.0" SE="0.404964437319035" STUDY_ID="STD-Sezai-2012" TOTAL_1="67" TOTAL_2="34" VAR="0.1639961954931226" WEIGHT="3.05517539684944"/><DICH_DATA CI_END="0.9285567066549609" CI_START="0.2912046168662018" EFFECT_SIZE="0.52" ESTIMABLE="YES" EVENTS_1="13" EVENTS_2="25" LOG_CI_END="-0.032191568892075674" LOG_CI_START="-0.5358017438383259" LOG_EFFECT_SIZE="-0.28399665636520083" MODIFIED="2013-11-26 22:26:08 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1747" O_E="0.0" SE="0.29582310967399855" STUDY_ID="STD-Ogawa-2013" TOTAL_1="68" TOTAL_2="68" VAR="0.08751131221719458" WEIGHT="3.6787641582880424"/></DICH_SUBGROUP><DICH_SUBGROUP CHI2="25.21017879318529" CI_END="0.7043812132199518" CI_START="0.25961872330117186" DF="5" EFFECT_SIZE="0.4276336648271444" ESTIMABLE="YES" EVENTS_1="220" EVENTS_2="312" I2="80.1667412158474" ID="CMP-006.09.03" LOG_CI_END="-0.15219223575943458" LOG_CI_START="-0.5856639900952356" LOG_EFFECT_SIZE="-0.368928112927335" MODIFIED="2013-11-26 22:27:19 +0000" MODIFIED_BY="Hermann Blessberger" NO="3" P_CHI2="1.2689837060930742E-4" P_Z="8.491571575706311E-4" STUDIES="6" TAU2="0.24135150101242311" TOTAL_1="877" TOTAL_2="817" WEIGHT="18.701882880437353" Z="3.33625343284418"><NAME>8-14 days</NAME><DICH_DATA CI_END="0.906876568196414" CI_START="0.1954900201161221" EFFECT_SIZE="0.42105263157894735" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="19" LOG_CI_END="-0.042451819223332604" LOG_CI_START="-0.7088754086984382" LOG_EFFECT_SIZE="-0.3756636139608854" MODIFIED="2013-11-26 22:26:16 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1757" O_E="0.0" SE="0.3914605153076481" STUDY_ID="STD-Matangi-1985" TOTAL_1="82" TOTAL_2="82" VAR="0.15324133504492937" WEIGHT="3.1297753702805013"/><DICH_DATA CI_END="0.6607918354063609" CI_START="0.012506908177573097" EFFECT_SIZE="0.09090909090909091" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="11" LOG_CI_END="-0.17993533169837356" LOG_CI_START="-1.9028500386180767" LOG_EFFECT_SIZE="-1.041392685158225" MODIFIED="2013-11-26 22:26:22 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1756" O_E="0.0" SE="1.0120486274099798" STUDY_ID="STD-Lamb-1988" TOTAL_1="30" TOTAL_2="30" VAR="1.024242424242424" WEIGHT="1.0511421003544412"/><DICH_DATA CI_END="0.29201086050273417" CI_START="0.0400237272634076" EFFECT_SIZE="0.10810810810810811" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="37" LOG_CI_END="-0.5346009959190617" LOG_CI_START="-1.3976824695590033" LOG_EFFECT_SIZE="-0.9661417327390326" MODIFIED="2013-11-26 22:26:46 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1759" O_E="0.0" SE="0.5069783299382993" STUDY_ID="STD-Wenke-1999" TOTAL_1="100" TOTAL_2="100" VAR="0.257027027027027" WEIGHT="2.532933793775705"/><DICH_DATA CI_END="0.925811812744811" CI_START="0.17282129888323441" EFFECT_SIZE="0.4" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="15" LOG_CI_END="-0.03347728220825417" LOG_CI_START="-0.762402735135821" LOG_EFFECT_SIZE="-0.3979400086720376" MODIFIED="2013-11-26 22:26:52 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1758" O_E="0.0" SE="0.42817441928883765" STUDY_ID="STD-Matsuura-2001" TOTAL_1="40" TOTAL_2="40" VAR="0.18333333333333335" WEIGHT="2.929623098047212"/><DICH_DATA CI_END="0.9484074945855946" CI_START="0.674815418112704" EFFECT_SIZE="0.8" ESTIMABLE="YES" EVENTS_1="156" EVENTS_2="195" LOG_CI_END="-0.023005022761850884" LOG_CI_START="-0.17081500325426194" LOG_EFFECT_SIZE="-0.09691001300805639" MODIFIED="2013-11-26 22:27:10 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1755" O_E="0.0" SE="0.08682431421244592" STUDY_ID="STD-Connolly-2003" TOTAL_1="500" TOTAL_2="500" VAR="0.007538461538461539" WEIGHT="4.676892793292486"/><DICH_DATA CI_END="0.9248471633511364" CI_START="0.48330986222891537" EFFECT_SIZE="0.6685714285714286" ESTIMABLE="YES" EVENTS_1="45" EVENTS_2="35" LOG_CI_END="-0.0339300311501147" LOG_CI_START="-0.3157743427301508" LOG_EFFECT_SIZE="-0.17485218694013277" MODIFIED="2013-11-26 22:27:19 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1760" O_E="0.0" SE="0.16555674377395627" STUDY_ID="STD-Auer-2004" TOTAL_1="125" TOTAL_2="65" VAR="0.027409035409035408" WEIGHT="4.381515724687005"/></DICH_SUBGROUP><DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-006.09.04" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2013-11-26 22:19:17 +0000" MODIFIED_BY="Hermann Blessberger" NO="4" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0"><NAME>15-21 days</NAME></DICH_SUBGROUP><DICH_SUBGROUP CHI2="7.021142775065023" CI_END="0.5666631353599499" CI_START="0.32818149794349827" DF="6" EFFECT_SIZE="0.4312404857985712" ESTIMABLE="YES" EVENTS_1="73" EVENTS_2="178" I2="14.543825809831452" ID="CMP-006.09.05" LOG_CI_END="-0.24667503975044658" LOG_CI_START="-0.4838859070353466" LOG_EFFECT_SIZE="-0.3652804733928966" MODIFIED="2013-11-26 22:28:16 +0000" MODIFIED_BY="Hermann Blessberger" NO="5" P_CHI2="0.3188965487789357" P_Z="1.5769956189531547E-9" STUDIES="7" TAU2="0.020125097112443074" TOTAL_1="429" TOTAL_2="441" WEIGHT="21.877659956456625" Z="6.03628813722054"><NAME>More than 21 days</NAME><DICH_DATA CI_END="1.0920886040087217" CI_START="0.18657087736694164" EFFECT_SIZE="0.4513888888888889" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="12" LOG_CI_END="0.03825787524694105" LOG_CI_START="-0.7291561461517292" LOG_EFFECT_SIZE="-0.3454491354523941" MODIFIED="2013-11-26 22:27:32 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1763" O_E="0.0" SE="0.4507827949302504" STUDY_ID="STD-Hammon-1984" TOTAL_1="24" TOTAL_2="26" VAR="0.2032051282051282" WEIGHT="2.8109147929149882"/><DICH_DATA CI_END="0.9962321240462663" CI_START="0.1877050579938394" EFFECT_SIZE="0.43243243243243246" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="15" LOG_CI_END="-0.0016394583162494887" LOG_CI_START="-0.7265240245058909" LOG_EFFECT_SIZE="-0.3640817414110702" MODIFIED="2013-11-26 22:27:46 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1767" O_E="0.0" SE="0.42580078241626834" STUDY_ID="STD-Rubin-1987" TOTAL_1="37" TOTAL_2="40" VAR="0.18130630630630631" WEIGHT="2.9422979388913735"/><DICH_DATA CI_END="0.421579851024765" CI_START="0.08503552553709799" EFFECT_SIZE="0.18933901918976545" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="35" LOG_CI_END="-0.3751201539574404" LOG_CI_START="-1.070399599915524" LOG_EFFECT_SIZE="-0.7227598769364822" MODIFIED="2013-11-26 22:27:39 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1765" O_E="0.0" SE="0.4084105882445427" STUDY_ID="STD-Khuri-1987" TOTAL_1="67" TOTAL_2="74" VAR="0.16679920859025338" WEIGHT="3.0363131936775702"/><DICH_DATA CI_END="1.9174334705591203" CI_START="0.15030479565965907" EFFECT_SIZE="0.5368421052631579" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="5" LOG_CI_END="0.2827203041097743" LOG_CI_START="-0.8230271624915971" LOG_EFFECT_SIZE="-0.2701534291909114" MODIFIED="2013-11-26 22:27:53 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1764" O_E="0.0" SE="0.6495215354198813" STUDY_ID="STD-Jacquet-1994" TOTAL_1="19" TOTAL_2="17" VAR="0.4218782249742002" WEIGHT="1.9440725305861406"/><DICH_DATA CI_END="0.7316733754295464" CI_START="0.276762838173683" EFFECT_SIZE="0.45" ESTIMABLE="YES" EVENTS_1="18" EVENTS_2="40" LOG_CI_END="-0.13568274804766128" LOG_CI_START="-0.5578922244016514" LOG_EFFECT_SIZE="-0.3467874862246563" MODIFIED="2013-11-26 22:28:01 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1761" O_E="0.0" SE="0.2480079363809483" STUDY_ID="STD-Ali-1997" TOTAL_1="105" TOTAL_2="105" VAR="0.061507936507936505" WEIGHT="3.953080657582636"/><DICH_DATA CI_END="0.8367549673280018" CI_START="0.38960932218699135" EFFECT_SIZE="0.5709706959706959" ESTIMABLE="YES" EVENTS_1="29" EVENTS_2="52" LOG_CI_END="-0.07740170080856265" LOG_CI_START="-0.40937066029975144" LOG_EFFECT_SIZE="-0.24338618055415703" MODIFIED="2013-11-26 22:28:11 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1766" O_E="0.0" SE="0.19500021007797613" STUDY_ID="STD-Pfisterer-1997" TOTAL_1="126" TOTAL_2="129" VAR="0.03802508193045483" WEIGHT="4.238499948776554"/><DICH_DATA CI_END="0.7105931245191439" CI_START="0.13488819843100122" EFFECT_SIZE="0.30959752321981426" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="19" LOG_CI_END="-0.14837899892640086" LOG_CI_START="-0.8700260457358048" LOG_EFFECT_SIZE="-0.5092025223311029" MODIFIED="2013-11-26 22:28:16 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1762" O_E="0.0" SE="0.4238990475063375" STUDY_ID="STD-Forlani-2002" TOTAL_1="51" TOTAL_2="50" VAR="0.17969040247678017" WEIGHT="2.9524808940273624"/></DICH_SUBGROUP></DICH_OUTCOME><CONT_OUTCOME CHI2="30.82187376265084" CI_END="-0.19057109548481005" CI_START="-0.8982702505487188" CI_STUDY="95" CI_TOTAL="95" DF="13" EFFECT_MEASURE="MD" EFFECT_SIZE="-0.5444206730167644" ESTIMABLE="YES" I2="57.822161948657815" I2_Q="0.0" ID="CMP-006.10" MODIFIED="2017-12-08 02:31:44 +0000" MODIFIED_BY="Hermann Blessberger" NO="10" P_CHI2="0.0035797176246025186" P_Q="0.8505600770078685" P_Z="0.0025652842057218633" Q="0.03549604339439413" RANDOM="YES" SCALE="2.0" SORT_BY="YEAR" STUDIES="14" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.16580847981899552" TOTALS="YES" TOTAL_1="1272" TOTAL_2="1178" UNITS="" WEIGHT="100.0" Z="3.015532529371343"><NAME>Length of stay&#8212;cardiac surgery: use of intention-to-treat analysis</NAME><GROUP_LABEL_1>Beta-blocker</GROUP_LABEL_1><GROUP_LABEL_2>Control</GROUP_LABEL_2><GRAPH_LABEL_1>Favours beta-blocker</GRAPH_LABEL_1><GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2><CONT_SUBGROUP CHI2="9.559199809852526" CI_END="-0.29522323301053466" CI_START="-0.8513442157997471" DF="8" EFFECT_SIZE="-0.5732837244051409" ESTIMABLE="YES" I2="16.31098670252171" ID="CMP-006.10.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" NO="1" P_CHI2="0.29733643213966376" P_Z="5.324579740276297E-5" STUDIES="9" TAU2="0.031897821309272135" TOTAL_1="577" TOTAL_2="478" WEIGHT="63.51586150351736" Z="4.0409029241140795"><NAME>Intention-to-treat analysis was applied</NAME><CONT_DATA CI_END="0.8525956472955156" CI_START="-1.2525956472955142" EFFECT_SIZE="-0.1999999999999993" ESTIMABLE="YES" MEAN_1="10.0" MEAN_2="10.2" MODIFIED="2013-11-28 21:43:59 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1795" SD_1="1.5" SD_2="1.7" SE="0.5370484639504883" STUDY_ID="STD-Jacquet-1994" TOTAL_1="19" TOTAL_2="17" WEIGHT="7.175725447273318"/><CONT_DATA CI_END="1.5979397562798727" CI_START="-3.197939756279874" EFFECT_SIZE="-0.8000000000000007" ESTIMABLE="YES" MEAN_1="7.6" MEAN_2="8.4" MODIFIED="2013-11-28 21:44:14 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1793" SD_1="3.9" SD_2="2.6" SE="1.2234611325486162" STUDY_ID="STD-Cork-1995" TOTAL_1="15" TOTAL_2="14" WEIGHT="1.9603619455741486"/><CONT_DATA CI_END="0.49035874809146784" CI_START="-1.2903587480914687" EFFECT_SIZE="-0.40000000000000036" ESTIMABLE="YES" MEAN_1="10.0" MEAN_2="10.4" MODIFIED="2013-11-28 21:44:26 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1796" SD_1="4.0" SD_2="3.2" SE="0.45427301476685505" STUDY_ID="STD-Pfisterer-1997" TOTAL_1="126" TOTAL_2="129" WEIGHT="8.757839005699218"/><CONT_DATA CI_END="0.9081080402146975" CI_START="-0.9081080402146975" EFFECT_SIZE="0.0" ESTIMABLE="YES" MEAN_1="8.0" MEAN_2="8.0" MODIFIED="2013-11-28 21:44:40 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1791" SD_1="2.3" SD_2="2.9" SE="0.4633289424590134" STUDY_ID="STD-Bert-2001" TOTAL_1="71" TOTAL_2="60" WEIGHT="8.566567664335405"/><CONT_DATA CI_END="0.30800399250821786" CI_START="-0.9080039925082193" EFFECT_SIZE="-0.3000000000000007" ESTIMABLE="YES" MEAN_1="5.6" MEAN_2="5.9" MODIFIED="2013-11-28 21:44:54 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1794" SD_1="1.4" SD_2="1.7" SE="0.3102118188416096" STUDY_ID="STD-Forlani-2002" TOTAL_1="51" TOTAL_2="50" WEIGHT="12.438666811378871"/><CONT_DATA CI_END="-0.5799305882439878" CI_START="-0.8200694117560126" EFFECT_SIZE="-0.7000000000000002" ESTIMABLE="YES" MEAN_1="5.1" MEAN_2="5.8" MODIFIED="2013-11-28 21:45:08 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1792" SD_1="0.3" SD_2="0.2" SE="0.061261029642944734" STUDY_ID="STD-Booth-2004" TOTAL_1="33" TOTAL_2="39" WEIGHT="19.222691830061887"/><CONT_DATA CI_END="0.6873907364900345" CI_START="-4.287390736490032" EFFECT_SIZE="-1.799999999999999" ESTIMABLE="YES" MEAN_1="11.3" MEAN_2="13.1" MODIFIED="2013-11-28 21:45:20 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1790" SD_1="7.0" SD_2="8.9" SE="1.2691002263869409" STUDY_ID="STD-Auer-2004" TOTAL_1="125" TOTAL_2="65" WEIGHT="1.8348247173241288"/><CONT_DATA CI_END="-0.6816580345935019" CI_START="-4.9183419654064995" EFFECT_SIZE="-2.8000000000000007" ESTIMABLE="YES" MEAN_1="11.2" MEAN_2="14.0" MODIFIED="2013-11-28 21:45:34 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1797" SD_1="4.9" SD_2="7.6" SE="1.0808065771186153" STUDY_ID="STD-Sezai-2011" TOTAL_1="70" TOTAL_2="70" WEIGHT="2.4434372713566677"/><CONT_DATA CI_END="2.5534736631582517" CI_START="-3.9534736631582503" EFFECT_SIZE="-0.6999999999999993" ESTIMABLE="YES" MEAN_1="11.5" MEAN_2="12.2" MODIFIED="2013-11-28 21:45:48 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1798" SD_1="5.0" SD_2="9.0" SE="1.6599660446932882" STUDY_ID="STD-Sezai-2012" TOTAL_1="67" TOTAL_2="34" WEIGHT="1.1157468105137192"/></CONT_SUBGROUP><CONT_SUBGROUP CHI2="14.79199673840307" CI_END="0.2436490742060501" CI_START="-1.5728274447849566" DF="4" EFFECT_SIZE="-0.6645891852894533" ESTIMABLE="YES" I2="72.95834990542436" ID="CMP-006.10.02" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" NO="2" P_CHI2="0.0051526771533986215" P_Z="0.1515228753861667" STUDIES="5" TAU2="0.6529329928657447" TOTAL_1="695" TOTAL_2="700" WEIGHT="36.48413849648264" Z="1.4341730862622775"><NAME>Intention-to-treat analysis was not applied or was unclear</NAME><CONT_DATA CI_END="-0.6213610519607327" CI_START="-2.1986389480392674" EFFECT_SIZE="-1.4100000000000001" ESTIMABLE="YES" MEAN_1="8.42" MEAN_2="9.83" MODIFIED="2013-11-28 21:46:06 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1803" SD_1="2.81" SD_2="2.88" SE="0.40237420394453716" STUDY_ID="STD-Wenke-1999" TOTAL_1="100" TOTAL_2="100" WEIGHT="9.94596382397487"/><CONT_DATA CI_END="0.3228748645299382" CI_START="-2.322874864529938" EFFECT_SIZE="-1.0" ESTIMABLE="YES" MEAN_1="7.0" MEAN_2="8.0" MODIFIED="2013-11-28 21:46:13 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1801" SD_1="2.0" SD_2="4.0" SE="0.674948557710553" STUDY_ID="STD-Gomes-1999" TOTAL_1="40" TOTAL_2="45" WEIGHT="5.245598762316367"/><CONT_DATA CI_END="2.627257429639835" CI_START="-4.627257429639835" EFFECT_SIZE="-1.0" ESTIMABLE="YES" MEAN_1="21.0" MEAN_2="22.0" MODIFIED="2013-11-28 21:46:20 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1802" SD_1="4.0" SD_2="11.0" SE="1.8506755523321747" STUDY_ID="STD-Matsuura-2001" TOTAL_1="40" TOTAL_2="40" WEIGHT="0.9077138012865974"/><CONT_DATA CI_END="0.5986973363346225" CI_START="-0.19869733633462217" EFFECT_SIZE="0.20000000000000018" ESTIMABLE="YES" MEAN_1="6.5" MEAN_2="6.3" MODIFIED="2013-11-28 21:46:32 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1800" SD_1="3.8" SD_2="2.5" SE="0.20342074623793907" STUDY_ID="STD-Connolly-2003" TOTAL_1="500" TOTAL_2="500" WEIGHT="15.73169713758292"/><CONT_DATA CI_END="0.8331433922667311" CI_START="-2.03314339226673" EFFECT_SIZE="-0.5999999999999996" ESTIMABLE="YES" MEAN_1="7.5" MEAN_2="8.1" MODIFIED="2013-11-28 21:46:52 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1799" SD_1="2.1" SD_2="1.9" SE="0.731209044437134" STUDY_ID="STD-But-2006" TOTAL_1="15" TOTAL_2="15" WEIGHT="4.653164971321884"/></CONT_SUBGROUP></CONT_OUTCOME><CONT_OUTCOME CHI2="30.821873762650846" CI_END="-0.19057109548480988" CI_START="-0.898270250548719" CI_STUDY="95" CI_TOTAL="95" DF="13" EFFECT_MEASURE="MD" EFFECT_SIZE="-0.5444206730167644" ESTIMABLE="YES" I2="57.82216194865782" I2_Q="0.0" ID="CMP-006.11" MODIFIED="2017-12-08 02:31:47 +0000" MODIFIED_BY="Hermann Blessberger" NO="11" P_CHI2="0.0035797176246028517" P_Q="0.8588768167293378" P_Z="0.0025652842057218754" Q="0.03161432186860549" RANDOM="YES" SCALE="2.0" SORT_BY="YEAR" STUDIES="14" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.16580847981899588" TOTALS="YES" TOTAL_1="1272" TOTAL_2="1178" UNITS="" WEIGHT="100.0" Z="3.0155325293713418"><NAME>Length of stay&#8212;cardiac surgery: blinding status of participants</NAME><GROUP_LABEL_1>Beta-blocker</GROUP_LABEL_1><GROUP_LABEL_2>Control</GROUP_LABEL_2><GRAPH_LABEL_1>Favours beta-blocker</GRAPH_LABEL_1><GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2><CONT_SUBGROUP CHI2="12.751502134142772" CI_END="0.10026251911862383" CI_START="-1.5344274422162965" DF="5" EFFECT_SIZE="-0.7170824615488363" ESTIMABLE="YES" I2="60.788933355449515" ID="CMP-006.11.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" NO="1" P_CHI2="0.02582218414596027" P_Z="0.08551644445978109" STUDIES="6" TAU2="0.5186194406854022" TOTAL_1="876" TOTAL_2="823" WEIGHT="35.97375883985346" Z="1.7195380553182382"><NAME>Participants were definitively blinded</NAME><CONT_DATA CI_END="1.5979397562798727" CI_START="-3.197939756279874" EFFECT_SIZE="-0.8000000000000007" ESTIMABLE="YES" MEAN_1="7.6" MEAN_2="8.4" MODIFIED="2013-11-28 21:50:59 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1806" SD_1="3.9" SD_2="2.6" SE="1.2234611325486162" STUDY_ID="STD-Cork-1995" TOTAL_1="15" TOTAL_2="14" WEIGHT="1.9603619455741508"/><CONT_DATA CI_END="0.49035874809146784" CI_START="-1.2903587480914687" EFFECT_SIZE="-0.40000000000000036" ESTIMABLE="YES" MEAN_1="10.0" MEAN_2="10.4" MODIFIED="2013-11-28 21:51:11 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1808" SD_1="4.0" SD_2="3.2" SE="0.45427301476685505" STUDY_ID="STD-Pfisterer-1997" TOTAL_1="126" TOTAL_2="129" WEIGHT="8.757839005699221"/><CONT_DATA CI_END="0.3228748645299382" CI_START="-2.322874864529938" EFFECT_SIZE="-1.0" ESTIMABLE="YES" MEAN_1="7.0" MEAN_2="8.0" MODIFIED="2013-11-28 21:51:19 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1807" SD_1="2.0" SD_2="4.0" SE="0.674948557710553" STUDY_ID="STD-Gomes-1999" TOTAL_1="40" TOTAL_2="45" WEIGHT="5.245598762316369"/><CONT_DATA CI_END="0.5986973363346225" CI_START="-0.19869733633462217" EFFECT_SIZE="0.20000000000000018" ESTIMABLE="YES" MEAN_1="6.5" MEAN_2="6.3" MODIFIED="2013-11-28 21:51:42 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1805" SD_1="3.8" SD_2="2.5" SE="0.20342074623793907" STUDY_ID="STD-Connolly-2003" TOTAL_1="500" TOTAL_2="500" WEIGHT="15.731697137582913"/><CONT_DATA CI_END="0.6873907364900345" CI_START="-4.287390736490032" EFFECT_SIZE="-1.799999999999999" ESTIMABLE="YES" MEAN_1="11.3" MEAN_2="13.1" MODIFIED="2013-11-28 21:52:00 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1804" SD_1="7.0" SD_2="8.9" SE="1.2691002263869409" STUDY_ID="STD-Auer-2004" TOTAL_1="125" TOTAL_2="65" WEIGHT="1.834824717324131"/><CONT_DATA CI_END="-0.6816580345935019" CI_START="-4.9183419654064995" EFFECT_SIZE="-2.8000000000000007" ESTIMABLE="YES" MEAN_1="11.2" MEAN_2="14.0" MODIFIED="2013-11-28 21:52:18 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1809" SD_1="4.9" SD_2="7.6" SE="1.0808065771186153" STUDY_ID="STD-Sezai-2011" TOTAL_1="70" TOTAL_2="70" WEIGHT="2.4434372713566703"/></CONT_SUBGROUP><CONT_SUBGROUP CHI2="7.889919401632062" CI_END="-0.40873465586153346" CI_START="-0.8713112673763657" DF="7" EFFECT_SIZE="-0.6400229616189496" ESTIMABLE="YES" I2="11.279195088456524" ID="CMP-006.11.02" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" NO="2" P_CHI2="0.34240089215589276" P_Z="5.8401044701044525E-8" STUDIES="8" TAU2="0.017350874045348134" TOTAL_1="396" TOTAL_2="355" WEIGHT="64.02624116014654" Z="5.4236289636168955"><NAME>Participants were not blinded or blinding status was unclear</NAME><CONT_DATA CI_END="0.8525956472955156" CI_START="-1.2525956472955142" EFFECT_SIZE="-0.1999999999999993" ESTIMABLE="YES" MEAN_1="10.0" MEAN_2="10.2" MODIFIED="2013-11-28 21:52:35 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1814" SD_1="1.5" SD_2="1.7" SE="0.5370484639504883" STUDY_ID="STD-Jacquet-1994" TOTAL_1="19" TOTAL_2="17" WEIGHT="7.175725447273321"/><CONT_DATA CI_END="-0.6213610519607327" CI_START="-2.1986389480392674" EFFECT_SIZE="-1.4100000000000001" ESTIMABLE="YES" MEAN_1="8.42" MEAN_2="9.83" MODIFIED="2013-11-28 21:52:50 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1817" SD_1="2.81" SD_2="2.88" SE="0.40237420394453716" STUDY_ID="STD-Wenke-1999" TOTAL_1="100" TOTAL_2="100" WEIGHT="9.945963823974871"/><CONT_DATA CI_END="0.9081080402146975" CI_START="-0.9081080402146975" EFFECT_SIZE="0.0" ESTIMABLE="YES" MEAN_1="8.0" MEAN_2="8.0" MODIFIED="2013-11-28 21:53:00 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1810" SD_1="2.3" SD_2="2.9" SE="0.4633289424590134" STUDY_ID="STD-Bert-2001" TOTAL_1="71" TOTAL_2="60" WEIGHT="8.566567664335407"/><CONT_DATA CI_END="2.627257429639835" CI_START="-4.627257429639835" EFFECT_SIZE="-1.0" ESTIMABLE="YES" MEAN_1="21.0" MEAN_2="22.0" MODIFIED="2013-11-28 21:53:09 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1815" SD_1="4.0" SD_2="11.0" SE="1.8506755523321747" STUDY_ID="STD-Matsuura-2001" TOTAL_1="40" TOTAL_2="40" WEIGHT="0.9077138012865983"/><CONT_DATA CI_END="0.30800399250821786" CI_START="-0.9080039925082193" EFFECT_SIZE="-0.3000000000000007" ESTIMABLE="YES" MEAN_1="5.6" MEAN_2="5.9" MODIFIED="2013-11-28 21:53:20 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1813" SD_1="1.4" SD_2="1.7" SE="0.3102118188416096" STUDY_ID="STD-Forlani-2002" TOTAL_1="51" TOTAL_2="50" WEIGHT="12.438666811378868"/><CONT_DATA CI_END="-0.5799305882439878" CI_START="-0.8200694117560126" EFFECT_SIZE="-0.7000000000000002" ESTIMABLE="YES" MEAN_1="5.1" MEAN_2="5.8" MODIFIED="2013-11-28 21:53:32 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1811" SD_1="0.3" SD_2="0.2" SE="0.061261029642944734" STUDY_ID="STD-Booth-2004" TOTAL_1="33" TOTAL_2="39" WEIGHT="19.22269183006187"/><CONT_DATA CI_END="0.8331433922667311" CI_START="-2.03314339226673" EFFECT_SIZE="-0.5999999999999996" ESTIMABLE="YES" MEAN_1="7.5" MEAN_2="8.1" MODIFIED="2013-11-28 21:53:43 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1812" SD_1="2.1" SD_2="1.9" SE="0.731209044437134" STUDY_ID="STD-But-2006" TOTAL_1="15" TOTAL_2="15" WEIGHT="4.653164971321887"/><CONT_DATA CI_END="2.5534736631582517" CI_START="-3.9534736631582503" EFFECT_SIZE="-0.6999999999999993" ESTIMABLE="YES" MEAN_1="11.5" MEAN_2="12.2" MODIFIED="2013-11-28 21:53:55 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="1816" SD_1="5.0" SD_2="9.0" SE="1.6599660446932882" STUDY_ID="STD-Sezai-2012" TOTAL_1="67" TOTAL_2="34" WEIGHT="1.1157468105137205"/></CONT_SUBGROUP></CONT_OUTCOME><CONT_OUTCOME CHI2="30.82187376265084" CI_END="-0.19057109548480994" CI_START="-0.898270250548719" CI_STUDY="95" CI_TOTAL="95" DF="13" EFFECT_MEASURE="MD" EFFECT_SIZE="-0.5444206730167644" ESTIMABLE="YES" I2="57.822161948657815" I2_Q="0.0" ID="CMP-006.12" MODIFIED="2017-12-08 02:31:49 +0000" MODIFIED_BY="Hermann Blessberger" NO="12" P_CHI2="0.0035797176246025186" P_Q="0.8671202219839493" P_Z="0.0025652842057218707" Q="0.027995163174139713" RANDOM="YES" SCALE="2.0" SORT_BY="YEAR" STUDIES="14" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.16580847981899574" TOTALS="YES" TOTAL_1="1272" TOTAL_2="1178" UNITS="" WEIGHT="100.0" Z="3.015532529371342"><NAME>Length of stay&#8212;cardiac surgery: blinding status of doctors</NAME><GROUP_LABEL_1>Beta-blocker</GROUP_LABEL_1><GROUP_LABEL_2>Control</GROUP_LABEL_2><GRAPH_LABEL_1>Favours beta-blocker</GRAPH_LABEL_1><GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2><CONT_SUBGROUP CHI2="12.880563739729759" CI_END="0.07427477934009474" CI_START="-1.4462649466108108" DF="6" EFFECT_SIZE="-0.6859950836353581" ESTIMABLE="YES" I2="53.418187889609534" ID="CMP-006.12.01" MODIFIED="2013-11-28 21:55:40 +0000" MODIFIED_BY="Hermann Blessberger" NO="1" P_CHI2="0.04497239097597139" P_Z="0.0769798996597829" STUDIES="7" TAU2="0.44380587552020334" TOTAL_1="943" TOTAL_2="857" WEIGHT="37.08950565036717" Z="1.768484748605977"><NAME>Doctors were definitively blinded</NAME><CONT_DATA CI_END="1.5979397562798727" CI_START="-3.197939756279874" EFFECT_SIZE="-0.8000000000000007" ESTIMABLE="YES" MEAN_1="7.6" MEAN_2="8.4" MODIFIED="2013-11-28 21:55:08 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="2124" SD_1="3.9" SD_2="2.6" SE="1.2234611325486162" STUDY_ID="STD-Cork-1995" TOTAL_1="15" TOTAL_2="14" WEIGHT="1.9603619455741499"/><CONT_DATA CI_END="0.49035874809146784" CI_START="-1.2903587480914687" EFFECT_SIZE="-0.40000000000000036" ESTIMABLE="YES" MEAN_1="10.0" MEAN_2="10.4" MODIFIED="2013-11-28 21:55:08 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="2122" SD_1="4.0" SD_2="3.2" SE="0.45427301476685505" STUDY_ID="STD-Pfisterer-1997" TOTAL_1="126" TOTAL_2="129" WEIGHT="8.757839005699221"/><CONT_DATA CI_END="0.3228748645299382" CI_START="-2.322874864529938" EFFECT_SIZE="-1.0" ESTIMABLE="YES" MEAN_1="7.0" MEAN_2="8.0" MODIFIED="2013-11-28 21:55:08 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="2121" SD_1="2.0" SD_2="4.0" SE="0.674948557710553" STUDY_ID="STD-Gomes-1999" TOTAL_1="40" TOTAL_2="45" WEIGHT="5.245598762316369"/><CONT_DATA CI_END="0.5986973363346225" CI_START="-0.19869733633462217" EFFECT_SIZE="0.20000000000000018" ESTIMABLE="YES" MEAN_1="6.5" MEAN_2="6.3" MODIFIED="2013-11-28 21:55:08 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="2123" SD_1="3.8" SD_2="2.5" SE="0.20342074623793907" STUDY_ID="STD-Connolly-2003" TOTAL_1="500" TOTAL_2="500" WEIGHT="15.731697137582914"/><CONT_DATA CI_END="0.6873907364900345" CI_START="-4.287390736490032" EFFECT_SIZE="-1.799999999999999" ESTIMABLE="YES" MEAN_1="11.3" MEAN_2="13.1" MODIFIED="2013-11-28 21:55:08 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="2120" SD_1="7.0" SD_2="8.9" SE="1.2691002263869409" STUDY_ID="STD-Auer-2004" TOTAL_1="125" TOTAL_2="65" WEIGHT="1.8348247173241303"/><CONT_DATA CI_END="-0.6816580345935019" CI_START="-4.9183419654064995" EFFECT_SIZE="-2.8000000000000007" ESTIMABLE="YES" MEAN_1="11.2" MEAN_2="14.0" MODIFIED="2013-11-28 21:55:08 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="2119" SD_1="4.9" SD_2="7.6" SE="1.0808065771186153" STUDY_ID="STD-Sezai-2011" TOTAL_1="70" TOTAL_2="70" WEIGHT="2.443437271356669"/><CONT_DATA CI_END="2.5534736631582517" CI_START="-3.9534736631582503" EFFECT_SIZE="-0.6999999999999993" ESTIMABLE="YES" MEAN_1="11.5" MEAN_2="12.2" MODIFIED="2013-11-28 21:55:32 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="2133" SD_1="5.0" SD_2="9.0" SE="1.6599660446932882" STUDY_ID="STD-Sezai-2012" TOTAL_1="67" TOTAL_2="34" WEIGHT="1.11574681051372"/></CONT_SUBGROUP><CONT_SUBGROUP CHI2="7.889819680821125" CI_END="-0.3273345194095893" CI_START="-0.9057754167470513" DF="6" EFFECT_SIZE="-0.6165549680783203" ESTIMABLE="YES" I2="23.952634626301673" ID="CMP-006.12.02" MODIFIED="2013-11-28 21:55:49 +0000" MODIFIED_BY="Hermann Blessberger" NO="2" P_CHI2="0.2462872772864939" P_Z="2.9380445025492406E-5" STUDIES="7" TAU2="0.03732812300526562" TOTAL_1="329" TOTAL_2="321" WEIGHT="62.910494349632835" Z="4.178216089094253"><NAME>Doctors were not blinded or blinding status was unclear</NAME><CONT_DATA CI_END="0.8525956472955156" CI_START="-1.2525956472955142" EFFECT_SIZE="-0.1999999999999993" ESTIMABLE="YES" MEAN_1="10.0" MEAN_2="10.2" MODIFIED="2013-11-28 21:55:08 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="2128" SD_1="1.5" SD_2="1.7" SE="0.5370484639504883" STUDY_ID="STD-Jacquet-1994" TOTAL_1="19" TOTAL_2="17" WEIGHT="7.175725447273321"/><CONT_DATA CI_END="-0.6213610519607327" CI_START="-2.1986389480392674" EFFECT_SIZE="-1.4100000000000001" ESTIMABLE="YES" MEAN_1="8.42" MEAN_2="9.83" MODIFIED="2013-11-28 21:55:08 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="2132" SD_1="2.81" SD_2="2.88" SE="0.40237420394453716" STUDY_ID="STD-Wenke-1999" TOTAL_1="100" TOTAL_2="100" WEIGHT="9.945963823974873"/><CONT_DATA CI_END="2.627257429639835" CI_START="-4.627257429639835" EFFECT_SIZE="-1.0" ESTIMABLE="YES" MEAN_1="21.0" MEAN_2="22.0" MODIFIED="2013-11-28 21:55:08 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="2131" SD_1="4.0" SD_2="11.0" SE="1.8506755523321747" STUDY_ID="STD-Matsuura-2001" TOTAL_1="40" TOTAL_2="40" WEIGHT="0.907713801286598"/><CONT_DATA CI_END="0.9081080402146975" CI_START="-0.9081080402146975" EFFECT_SIZE="0.0" ESTIMABLE="YES" MEAN_1="8.0" MEAN_2="8.0" MODIFIED="2013-11-28 21:55:08 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="2125" SD_1="2.3" SD_2="2.9" SE="0.4633289424590134" STUDY_ID="STD-Bert-2001" TOTAL_1="71" TOTAL_2="60" WEIGHT="8.566567664335407"/><CONT_DATA CI_END="0.30800399250821786" CI_START="-0.9080039925082193" EFFECT_SIZE="-0.3000000000000007" ESTIMABLE="YES" MEAN_1="5.6" MEAN_2="5.9" MODIFIED="2013-11-28 21:55:08 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="2129" SD_1="1.4" SD_2="1.7" SE="0.3102118188416096" STUDY_ID="STD-Forlani-2002" TOTAL_1="51" TOTAL_2="50" WEIGHT="12.438666811378871"/><CONT_DATA CI_END="-0.5799305882439878" CI_START="-0.8200694117560126" EFFECT_SIZE="-0.7000000000000002" ESTIMABLE="YES" MEAN_1="5.1" MEAN_2="5.8" MODIFIED="2013-11-28 21:55:08 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="2127" SD_1="0.3" SD_2="0.2" SE="0.061261029642944734" STUDY_ID="STD-Booth-2004" TOTAL_1="33" TOTAL_2="39" WEIGHT="19.222691830061876"/><CONT_DATA CI_END="0.8331433922667311" CI_START="-2.03314339226673" EFFECT_SIZE="-0.5999999999999996" ESTIMABLE="YES" MEAN_1="7.5" MEAN_2="8.1" MODIFIED="2013-11-28 21:55:08 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="2126" SD_1="2.1" SD_2="1.9" SE="0.731209044437134" STUDY_ID="STD-But-2006" TOTAL_1="15" TOTAL_2="15" WEIGHT="4.653164971321886"/></CONT_SUBGROUP></CONT_OUTCOME><CONT_OUTCOME CHI2="30.82187376265084" CI_END="-0.19057109548481" CI_START="-0.8982702505487189" CI_STUDY="95" CI_TOTAL="95" DF="13" EFFECT_MEASURE="MD" EFFECT_SIZE="-0.5444206730167644" ESTIMABLE="YES" I2="57.822161948657815" I2_Q="21.739455835199166" ID="CMP-006.13" MODIFIED="2017-12-08 02:31:52 +0000" MODIFIED_BY="Hermann Blessberger" NO="13" P_CHI2="0.0035797176246025186" P_Q="0.27865448339014864" P_Z="0.0025652842057218676" Q="2.555566181329388" RANDOM="YES" SCALE="2.37" SORT_BY="YEAR" STUDIES="14" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.16580847981899569" TOTALS="YES" TOTAL_1="1272" TOTAL_2="1178" UNITS="" WEIGHT="100.0" Z="3.0155325293713426"><NAME>Length of stay&#8212;cardiac surgery: route of beta-blocker application</NAME><GROUP_LABEL_1>Beta-blocker</GROUP_LABEL_1><GROUP_LABEL_2>Control</GROUP_LABEL_2><GRAPH_LABEL_1>Favours beta-blocker</GRAPH_LABEL_1><GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2><CONT_SUBGROUP CHI2="16.227658778061926" CI_END="0.016379857768509476" CI_START="-1.1404095384925765" DF="6" EFFECT_SIZE="-0.5620148403620335" ESTIMABLE="YES" I2="63.026089702407575" ID="CMP-006.13.01" MODIFIED="2013-11-28 21:59:46 +0000" MODIFIED_BY="Hermann Blessberger" NO="1" P_CHI2="0.012582825553306365" P_Z="0.05685046357737296" STUDIES="7" TAU2="0.3089845055045676" TOTAL_1="982" TOTAL_2="929" WEIGHT="54.86230405956298" Z="1.904458753593208"><NAME>Oral application only</NAME><CONT_DATA CI_END="0.49035874809146784" CI_START="-1.2903587480914687" EFFECT_SIZE="-0.40000000000000036" ESTIMABLE="YES" MEAN_1="10.0" MEAN_2="10.4" MODIFIED="2013-11-28 21:56:23 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="2137" SD_1="4.0" SD_2="3.2" SE="0.45427301476685505" STUDY_ID="STD-Pfisterer-1997" TOTAL_1="126" TOTAL_2="129" WEIGHT="8.757839005699223"/><CONT_DATA CI_END="0.3228748645299382" CI_START="-2.322874864529938" EFFECT_SIZE="-1.0" ESTIMABLE="YES" MEAN_1="7.0" MEAN_2="8.0" MODIFIED="2013-11-28 21:56:23 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="2136" SD_1="2.0" SD_2="4.0" SE="0.674948557710553" STUDY_ID="STD-Gomes-1999" TOTAL_1="40" TOTAL_2="45" WEIGHT="5.2455987623163685"/><CONT_DATA CI_END="-0.6213610519607327" CI_START="-2.1986389480392674" EFFECT_SIZE="-1.4100000000000001" ESTIMABLE="YES" MEAN_1="8.42" MEAN_2="9.83" MODIFIED="2013-11-28 21:59:08 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="2148" SD_1="2.81" SD_2="2.88" SE="0.40237420394453716" STUDY_ID="STD-Wenke-1999" TOTAL_1="100" TOTAL_2="100" WEIGHT="9.945963823974873"/><CONT_DATA CI_END="2.627257429639835" CI_START="-4.627257429639835" EFFECT_SIZE="-1.0" ESTIMABLE="YES" MEAN_1="21.0" MEAN_2="22.0" MODIFIED="2013-11-28 21:59:15 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="2149" SD_1="4.0" SD_2="11.0" SE="1.8506755523321747" STUDY_ID="STD-Matsuura-2001" TOTAL_1="40" TOTAL_2="40" WEIGHT="0.9077138012865978"/><CONT_DATA CI_END="0.30800399250821786" CI_START="-0.9080039925082193" EFFECT_SIZE="-0.3000000000000007" ESTIMABLE="YES" MEAN_1="5.6" MEAN_2="5.9" MODIFIED="2013-11-28 21:59:21 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="2150" SD_1="1.4" SD_2="1.7" SE="0.3102118188416096" STUDY_ID="STD-Forlani-2002" TOTAL_1="51" TOTAL_2="50" WEIGHT="12.43866681137887"/><CONT_DATA CI_END="0.5986973363346225" CI_START="-0.19869733633462217" EFFECT_SIZE="0.20000000000000018" ESTIMABLE="YES" MEAN_1="6.5" MEAN_2="6.3" MODIFIED="2013-11-28 21:56:23 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="2138" SD_1="3.8" SD_2="2.5" SE="0.20342074623793907" STUDY_ID="STD-Connolly-2003" TOTAL_1="500" TOTAL_2="500" WEIGHT="15.731697137582918"/><CONT_DATA CI_END="0.6873907364900345" CI_START="-4.287390736490032" EFFECT_SIZE="-1.799999999999999" ESTIMABLE="YES" MEAN_1="11.3" MEAN_2="13.1" MODIFIED="2013-11-28 21:56:23 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="2135" SD_1="7.0" SD_2="8.9" SE="1.2691002263869409" STUDY_ID="STD-Auer-2004" TOTAL_1="125" TOTAL_2="65" WEIGHT="1.83482471732413"/></CONT_SUBGROUP><CONT_SUBGROUP CHI2="3.790179217565773" CI_END="-0.25179774010374956" CI_START="-1.4240033117664703" DF="3" EFFECT_SIZE="-0.83790052593511" ESTIMABLE="YES" I2="20.848070030663678" ID="CMP-006.13.02" MODIFIED="2013-11-28 22:00:06 +0000" MODIFIED_BY="Hermann Blessberger" NO="2" P_CHI2="0.28503082230809706" P_Z="0.0050788257571973364" STUDIES="4" TAU2="0.11743119461626673" TOTAL_1="133" TOTAL_2="138" WEIGHT="28.279656018314583" Z="2.801991208983115"><NAME>Parenteral application only</NAME><CONT_DATA CI_END="1.5979397562798727" CI_START="-3.197939756279874" EFFECT_SIZE="-0.8000000000000007" ESTIMABLE="YES" MEAN_1="7.6" MEAN_2="8.4" MODIFIED="2013-11-28 21:59:29 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="2151" SD_1="3.9" SD_2="2.6" SE="1.2234611325486162" STUDY_ID="STD-Cork-1995" TOTAL_1="15" TOTAL_2="14" WEIGHT="1.9603619455741499"/><CONT_DATA CI_END="-0.5799305882439878" CI_START="-0.8200694117560126" EFFECT_SIZE="-0.7000000000000002" ESTIMABLE="YES" MEAN_1="5.1" MEAN_2="5.8" MODIFIED="2013-11-28 21:56:23 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="2142" SD_1="0.3" SD_2="0.2" SE="0.061261029642944734" STUDY_ID="STD-Booth-2004" TOTAL_1="33" TOTAL_2="39" WEIGHT="19.22269183006188"/><CONT_DATA CI_END="0.8331433922667311" CI_START="-2.03314339226673" EFFECT_SIZE="-0.5999999999999996" ESTIMABLE="YES" MEAN_1="7.5" MEAN_2="8.1" MODIFIED="2013-11-28 21:56:23 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="2141" SD_1="2.1" SD_2="1.9" SE="0.731209044437134" STUDY_ID="STD-But-2006" TOTAL_1="15" TOTAL_2="15" WEIGHT="4.6531649713218854"/><CONT_DATA CI_END="-0.6816580345935019" CI_START="-4.9183419654064995" EFFECT_SIZE="-2.8000000000000007" ESTIMABLE="YES" MEAN_1="11.2" MEAN_2="14.0" MODIFIED="2013-11-28 21:59:46 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="2152" SD_1="4.9" SD_2="7.6" SE="1.0808065771186153" STUDY_ID="STD-Sezai-2011" TOTAL_1="70" TOTAL_2="70" WEIGHT="2.4434372713566694"/></CONT_SUBGROUP><CONT_SUBGROUP CHI2="0.21075600144320894" CI_END="0.5611047035866202" CI_START="-0.7843459787626762" DF="2" EFFECT_SIZE="-0.111620637588028" ESTIMABLE="YES" I2="0.0" ID="CMP-006.13.03" MODIFIED="2013-11-28 22:00:06 +0000" MODIFIED_BY="Hermann Blessberger" NO="3" P_CHI2="0.8999842653178856" P_Z="0.7450272920532623" STUDIES="3" TAU2="0.0" TOTAL_1="157" TOTAL_2="111" WEIGHT="16.858039922122444" Z="0.3252031939542122"><NAME>Both oral and parenteral</NAME><CONT_DATA CI_END="0.8525956472955156" CI_START="-1.2525956472955142" EFFECT_SIZE="-0.1999999999999993" ESTIMABLE="YES" MEAN_1="10.0" MEAN_2="10.2" MODIFIED="2013-11-28 21:59:54 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="2153" SD_1="1.5" SD_2="1.7" SE="0.5370484639504883" STUDY_ID="STD-Jacquet-1994" TOTAL_1="19" TOTAL_2="17" WEIGHT="7.1757254472733205"/><CONT_DATA CI_END="0.9081080402146975" CI_START="-0.9081080402146975" EFFECT_SIZE="0.0" ESTIMABLE="YES" MEAN_1="8.0" MEAN_2="8.0" MODIFIED="2013-11-28 22:00:02 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="2154" SD_1="2.3" SD_2="2.9" SE="0.4633289424590134" STUDY_ID="STD-Bert-2001" TOTAL_1="71" TOTAL_2="60" WEIGHT="8.566567664335405"/><CONT_DATA CI_END="2.5534736631582517" CI_START="-3.9534736631582503" EFFECT_SIZE="-0.6999999999999993" ESTIMABLE="YES" MEAN_1="11.5" MEAN_2="12.2" MODIFIED="2013-11-28 22:00:06 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="2155" SD_1="5.0" SD_2="9.0" SE="1.6599660446932882" STUDY_ID="STD-Sezai-2012" TOTAL_1="67" TOTAL_2="34" WEIGHT="1.1157468105137198"/></CONT_SUBGROUP></CONT_OUTCOME><CONT_OUTCOME CHI2="30.821873762650846" CI_END="-0.19057109548480983" CI_START="-0.8982702505487188" CI_STUDY="95" CI_TOTAL="95" DF="13" EFFECT_MEASURE="MD" EFFECT_SIZE="-0.5444206730167643" ESTIMABLE="YES" I2="57.82216194865782" I2_Q="0.0" ID="CMP-006.14" MODIFIED="2017-12-08 02:31:56 +0000" MODIFIED_BY="Hermann Blessberger" NO="14" P_CHI2="0.0035797176246028517" P_Q="0.3425358629372044" P_Z="0.0025652842057218754" Q="0.900917772234486" RANDOM="YES" SCALE="2.0" SORT_BY="YEAR" STUDIES="14" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.16580847981899577" TOTALS="YES" TOTAL_1="1272" TOTAL_2="1178" UNITS="" WEIGHT="100.0" Z="3.0155325293713418"><NAME>Length of stay&#8212;cardiac surgery: influence of gender</NAME><GROUP_LABEL_1>Beta-blocker</GROUP_LABEL_1><GROUP_LABEL_2>Control</GROUP_LABEL_2><GRAPH_LABEL_1>Favours beta-blocker</GRAPH_LABEL_1><GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2><CONT_SUBGROUP CHI2="5.993043177897231" CI_END="0.043532989696529134" CI_START="-0.7424395886170025" DF="6" EFFECT_SIZE="-0.3494532994602367" ESTIMABLE="YES" I2="0.0" ID="CMP-006.14.01" MODIFIED="2013-11-28 22:16:00 +0000" MODIFIED_BY="Hermann Blessberger" NO="1" P_CHI2="0.423969964437684" P_Z="0.08135994112028766" STUDIES="7" TAU2="0.0" TOTAL_1="444" TOTAL_2="400" WEIGHT="41.405696811843804" Z="1.7428493057363004"><NAME>Percentage of females below median (20.8%)</NAME><CONT_DATA CI_END="0.8525956472955156" CI_START="-1.2525956472955142" EFFECT_SIZE="-0.1999999999999993" ESTIMABLE="YES" MEAN_1="10.0" MEAN_2="10.2" MODIFIED="2013-11-28 22:02:13 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="2182" SD_1="1.5" SD_2="1.7" SE="0.5370484639504883" STUDY_ID="STD-Jacquet-1994" TOTAL_1="19" TOTAL_2="17" WEIGHT="7.17572544727332"/><CONT_DATA CI_END="0.49035874809146784" CI_START="-1.2903587480914687" EFFECT_SIZE="-0.40000000000000036" ESTIMABLE="YES" MEAN_1="10.0" MEAN_2="10.4" MODIFIED="2013-11-28 22:02:13 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="2181" SD_1="4.0" SD_2="3.2" SE="0.45427301476685505" STUDY_ID="STD-Pfisterer-1997" TOTAL_1="126" TOTAL_2="129" WEIGHT="8.757839005699221"/><CONT_DATA CI_END="2.627257429639835" CI_START="-4.627257429639835" EFFECT_SIZE="-1.0" ESTIMABLE="YES" MEAN_1="21.0" MEAN_2="22.0" MODIFIED="2013-11-28 22:03:39 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="2190" SD_1="4.0" SD_2="11.0" SE="1.8506755523321747" STUDY_ID="STD-Matsuura-2001" TOTAL_1="40" TOTAL_2="40" WEIGHT="0.907713801286598"/><CONT_DATA CI_END="0.9081080402146975" CI_START="-0.9081080402146975" EFFECT_SIZE="0.0" ESTIMABLE="YES" MEAN_1="8.0" MEAN_2="8.0" MODIFIED="2013-11-28 22:15:48 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="2239" SD_1="2.3" SD_2="2.9" SE="0.4633289424590134" STUDY_ID="STD-Bert-2001" TOTAL_1="71" TOTAL_2="60" WEIGHT="8.566567664335407"/><CONT_DATA CI_END="0.30800399250821786" CI_START="-0.9080039925082193" EFFECT_SIZE="-0.3000000000000007" ESTIMABLE="YES" MEAN_1="5.6" MEAN_2="5.9" MODIFIED="2013-11-28 22:02:13 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="2183" SD_1="1.4" SD_2="1.7" SE="0.3102118188416096" STUDY_ID="STD-Forlani-2002" TOTAL_1="51" TOTAL_2="50" WEIGHT="12.438666811378868"/><CONT_DATA CI_END="-0.6816580345935019" CI_START="-4.9183419654064995" EFFECT_SIZE="-2.8000000000000007" ESTIMABLE="YES" MEAN_1="11.2" MEAN_2="14.0" MODIFIED="2013-11-28 22:02:13 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="2176" SD_1="4.9" SD_2="7.6" SE="1.0808065771186153" STUDY_ID="STD-Sezai-2011" TOTAL_1="70" TOTAL_2="70" WEIGHT="2.443437271356669"/><CONT_DATA CI_END="2.5534736631582517" CI_START="-3.9534736631582503" EFFECT_SIZE="-0.6999999999999993" ESTIMABLE="YES" MEAN_1="11.5" MEAN_2="12.2" MODIFIED="2013-11-28 22:02:13 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="2177" SD_1="5.0" SD_2="9.0" SE="1.6599660446932882" STUDY_ID="STD-Sezai-2012" TOTAL_1="67" TOTAL_2="34" WEIGHT="1.11574681051372"/></CONT_SUBGROUP><CONT_SUBGROUP CHI2="22.799976503286413" CI_END="-0.13452266978713479" CI_START="-1.2091374229472724" DF="6" EFFECT_SIZE="-0.6718300463672037" ESTIMABLE="YES" I2="73.68418340635064" ID="CMP-006.14.02" MODIFIED="2013-11-28 22:16:06 +0000" MODIFIED_BY="Hermann Blessberger" NO="2" P_CHI2="8.663166386837506E-4" P_Z="0.014259088789733155" STUDIES="7" TAU2="0.2581132767848583" TOTAL_1="828" TOTAL_2="778" WEIGHT="58.59430318815619" Z="2.4506693040261496"><NAME>Percentage of females above median (20.8%)</NAME><CONT_DATA CI_END="1.5979397562798727" CI_START="-3.197939756279874" EFFECT_SIZE="-0.8000000000000007" ESTIMABLE="YES" MEAN_1="7.6" MEAN_2="8.4" MODIFIED="2013-11-28 22:03:47 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="2191" SD_1="3.9" SD_2="2.6" SE="1.2234611325486162" STUDY_ID="STD-Cork-1995" TOTAL_1="15" TOTAL_2="14" WEIGHT="1.9603619455741499"/><CONT_DATA CI_END="-0.6213610519607327" CI_START="-2.1986389480392674" EFFECT_SIZE="-1.4100000000000001" ESTIMABLE="YES" MEAN_1="8.42" MEAN_2="9.83" MODIFIED="2013-11-28 22:02:13 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="2187" SD_1="2.81" SD_2="2.88" SE="0.40237420394453716" STUDY_ID="STD-Wenke-1999" TOTAL_1="100" TOTAL_2="100" WEIGHT="9.94596382397487"/><CONT_DATA CI_END="0.3228748645299382" CI_START="-2.322874864529938" EFFECT_SIZE="-1.0" ESTIMABLE="YES" MEAN_1="7.0" MEAN_2="8.0" MODIFIED="2013-11-28 22:02:13 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="2188" SD_1="2.0" SD_2="4.0" SE="0.674948557710553" STUDY_ID="STD-Gomes-1999" TOTAL_1="40" TOTAL_2="45" WEIGHT="5.245598762316369"/><CONT_DATA CI_END="0.5986973363346225" CI_START="-0.19869733633462217" EFFECT_SIZE="0.20000000000000018" ESTIMABLE="YES" MEAN_1="6.5" MEAN_2="6.3" MODIFIED="2013-11-28 22:02:13 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="2186" SD_1="3.8" SD_2="2.5" SE="0.20342074623793907" STUDY_ID="STD-Connolly-2003" TOTAL_1="500" TOTAL_2="500" WEIGHT="15.731697137582914"/><CONT_DATA CI_END="-0.5799305882439878" CI_START="-0.8200694117560126" EFFECT_SIZE="-0.7000000000000002" ESTIMABLE="YES" MEAN_1="5.1" MEAN_2="5.8" MODIFIED="2013-11-28 22:04:05 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="2194" SD_1="0.3" SD_2="0.2" SE="0.061261029642944734" STUDY_ID="STD-Booth-2004" TOTAL_1="33" TOTAL_2="39" WEIGHT="19.222691830061873"/><CONT_DATA CI_END="0.6873907364900345" CI_START="-4.287390736490032" EFFECT_SIZE="-1.799999999999999" ESTIMABLE="YES" MEAN_1="11.3" MEAN_2="13.1" MODIFIED="2013-11-28 22:04:00 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="2193" SD_1="7.0" SD_2="8.9" SE="1.2691002263869409" STUDY_ID="STD-Auer-2004" TOTAL_1="125" TOTAL_2="65" WEIGHT="1.8348247173241303"/><CONT_DATA CI_END="0.8331433922667311" CI_START="-2.03314339226673" EFFECT_SIZE="-0.5999999999999996" ESTIMABLE="YES" MEAN_1="7.5" MEAN_2="8.1" MODIFIED="2013-11-28 22:02:13 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="2185" SD_1="2.1" SD_2="1.9" SE="0.731209044437134" STUDY_ID="STD-But-2006" TOTAL_1="15" TOTAL_2="15" WEIGHT="4.6531649713218854"/></CONT_SUBGROUP></CONT_OUTCOME><CONT_OUTCOME CHI2="30.82187376265084" CI_END="-0.19057109548480994" CI_START="-0.898270250548719" CI_STUDY="95" CI_TOTAL="95" DF="13" EFFECT_MEASURE="MD" EFFECT_SIZE="-0.5444206730167644" ESTIMABLE="YES" I2="57.822161948657815" I2_Q="0.0" ID="CMP-006.15" MODIFIED="2017-12-08 02:31:59 +0000" MODIFIED_BY="Hermann Blessberger" NO="15" P_CHI2="0.0035797176246025186" P_Q="0.4754839796652657" P_Z="0.0025652842057218707" Q="0.5092033558267727" RANDOM="YES" SCALE="2.0" SORT_BY="YEAR" STUDIES="14" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.16580847981899574" TOTALS="YES" TOTAL_1="1272" TOTAL_2="1178" UNITS="" WEIGHT="100.00000000000001" Z="3.015532529371342"><NAME>Length of stay&#8212;cardiac surgery: influence of beta-blocker premedication</NAME><GROUP_LABEL_1>Beta-blocker</GROUP_LABEL_1><GROUP_LABEL_2>Control</GROUP_LABEL_2><GRAPH_LABEL_1>Favours beta-blocker</GRAPH_LABEL_1><GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2><CONT_SUBGROUP CHI2="6.335804661932037" CI_END="-0.16380408485970288" CI_START="-1.2128678551767869" DF="6" EFFECT_SIZE="-0.6883359700182449" ESTIMABLE="YES" I2="5.300110717580688" ID="CMP-006.15.01" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" NO="1" P_CHI2="0.3866431082909588" P_Z="0.010110303576919983" STUDIES="7" TAU2="0.03354841346650034" TOTAL_1="383" TOTAL_2="293" WEIGHT="29.691801289785797" Z="2.5720337479416093"><NAME>Percentage of participants with prior beta-blocker therapy below median (43.3%)</NAME><CONT_DATA CI_END="1.5979397562798727" CI_START="-3.197939756279874" EFFECT_SIZE="-0.8000000000000007" ESTIMABLE="YES" MEAN_1="7.6" MEAN_2="8.4" MODIFIED="2013-11-28 22:07:37 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="2209" SD_1="3.9" SD_2="2.6" SE="1.2234611325486162" STUDY_ID="STD-Cork-1995" TOTAL_1="15" TOTAL_2="14" WEIGHT="1.9603619455741499"/><CONT_DATA CI_END="0.3228748645299382" CI_START="-2.322874864529938" EFFECT_SIZE="-1.0" ESTIMABLE="YES" MEAN_1="7.0" MEAN_2="8.0" MODIFIED="2013-11-28 22:07:39 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="2210" SD_1="2.0" SD_2="4.0" SE="0.674948557710553" STUDY_ID="STD-Gomes-1999" TOTAL_1="40" TOTAL_2="45" WEIGHT="5.245598762316369"/><CONT_DATA CI_END="0.30800399250821786" CI_START="-0.9080039925082193" EFFECT_SIZE="-0.3000000000000007" ESTIMABLE="YES" MEAN_1="5.6" MEAN_2="5.9" MODIFIED="2013-11-28 22:04:40 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="2196" SD_1="1.4" SD_2="1.7" SE="0.3102118188416096" STUDY_ID="STD-Forlani-2002" TOTAL_1="51" TOTAL_2="50" WEIGHT="12.438666811378871"/><CONT_DATA CI_END="0.6873907364900345" CI_START="-4.287390736490032" EFFECT_SIZE="-1.799999999999999" ESTIMABLE="YES" MEAN_1="11.3" MEAN_2="13.1" MODIFIED="2013-11-28 22:07:44 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="2211" SD_1="7.0" SD_2="8.9" SE="1.2691002263869409" STUDY_ID="STD-Auer-2004" TOTAL_1="125" TOTAL_2="65" WEIGHT="1.8348247173241303"/><CONT_DATA CI_END="0.8331433922667311" CI_START="-2.03314339226673" EFFECT_SIZE="-0.5999999999999996" ESTIMABLE="YES" MEAN_1="7.5" MEAN_2="8.1" MODIFIED="2013-11-28 22:07:49 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="2212" SD_1="2.1" SD_2="1.9" SE="0.731209044437134" STUDY_ID="STD-But-2006" TOTAL_1="15" TOTAL_2="15" WEIGHT="4.653164971321886"/><CONT_DATA CI_END="-0.6816580345935019" CI_START="-4.9183419654064995" EFFECT_SIZE="-2.8000000000000007" ESTIMABLE="YES" MEAN_1="11.2" MEAN_2="14.0" MODIFIED="2013-11-28 22:04:40 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="2200" SD_1="4.9" SD_2="7.6" SE="1.0808065771186153" STUDY_ID="STD-Sezai-2011" TOTAL_1="70" TOTAL_2="70" WEIGHT="2.443437271356669"/><CONT_DATA CI_END="2.5534736631582517" CI_START="-3.9534736631582503" EFFECT_SIZE="-0.6999999999999993" ESTIMABLE="YES" MEAN_1="11.5" MEAN_2="12.2" MODIFIED="2013-11-28 22:04:40 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="2198" SD_1="5.0" SD_2="9.0" SE="1.6599660446932882" STUDY_ID="STD-Sezai-2012" TOTAL_1="67" TOTAL_2="34" WEIGHT="1.11574681051372"/></CONT_SUBGROUP><CONT_SUBGROUP CHI2="24.48463047609895" CI_END="0.04415705336774317" CI_START="-0.9056081520651955" DF="6" EFFECT_SIZE="-0.43072554934872614" ESTIMABLE="YES" I2="75.4948313152735" ID="CMP-006.15.02" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" NO="2" P_CHI2="4.252050256260409E-4" P_Z="0.07545045411389861" STUDIES="7" TAU2="0.23431487151829297" TOTAL_1="889" TOTAL_2="885" WEIGHT="70.30819871021421" Z="1.777716343188024"><NAME>Percentage of participants with prior beta-blocker therapy above median (43.3%)</NAME><CONT_DATA CI_END="0.8525956472955156" CI_START="-1.2525956472955142" EFFECT_SIZE="-0.1999999999999993" ESTIMABLE="YES" MEAN_1="10.0" MEAN_2="10.2" MODIFIED="2013-11-28 22:07:59 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="2213" SD_1="1.5" SD_2="1.7" SE="0.5370484639504883" STUDY_ID="STD-Jacquet-1994" TOTAL_1="19" TOTAL_2="17" WEIGHT="7.175725447273321"/><CONT_DATA CI_END="0.49035874809146784" CI_START="-1.2903587480914687" EFFECT_SIZE="-0.40000000000000036" ESTIMABLE="YES" MEAN_1="10.0" MEAN_2="10.4" MODIFIED="2013-11-28 22:08:05 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="2214" SD_1="4.0" SD_2="3.2" SE="0.45427301476685505" STUDY_ID="STD-Pfisterer-1997" TOTAL_1="126" TOTAL_2="129" WEIGHT="8.757839005699221"/><CONT_DATA CI_END="-0.6213610519607327" CI_START="-2.1986389480392674" EFFECT_SIZE="-1.4100000000000001" ESTIMABLE="YES" MEAN_1="8.42" MEAN_2="9.83" MODIFIED="2013-11-28 22:04:40 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="2205" SD_1="2.81" SD_2="2.88" SE="0.40237420394453716" STUDY_ID="STD-Wenke-1999" TOTAL_1="100" TOTAL_2="100" WEIGHT="9.945963823974873"/><CONT_DATA CI_END="2.627257429639835" CI_START="-4.627257429639835" EFFECT_SIZE="-1.0" ESTIMABLE="YES" MEAN_1="21.0" MEAN_2="22.0" MODIFIED="2013-11-28 22:08:10 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="2215" SD_1="4.0" SD_2="11.0" SE="1.8506755523321747" STUDY_ID="STD-Matsuura-2001" TOTAL_1="40" TOTAL_2="40" WEIGHT="0.907713801286598"/><CONT_DATA CI_END="0.9081080402146975" CI_START="-0.9081080402146975" EFFECT_SIZE="0.0" ESTIMABLE="YES" MEAN_1="8.0" MEAN_2="8.0" MODIFIED="2013-11-28 22:04:40 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="2208" SD_1="2.3" SD_2="2.9" SE="0.4633289424590134" STUDY_ID="STD-Bert-2001" TOTAL_1="71" TOTAL_2="60" WEIGHT="8.566567664335407"/><CONT_DATA CI_END="0.5986973363346225" CI_START="-0.19869733633462217" EFFECT_SIZE="0.20000000000000018" ESTIMABLE="YES" MEAN_1="6.5" MEAN_2="6.3" MODIFIED="2013-11-28 22:04:40 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="2204" SD_1="3.8" SD_2="2.5" SE="0.20342074623793907" STUDY_ID="STD-Connolly-2003" TOTAL_1="500" TOTAL_2="500" WEIGHT="15.731697137582914"/><CONT_DATA CI_END="-0.5799305882439878" CI_START="-0.8200694117560126" EFFECT_SIZE="-0.7000000000000002" ESTIMABLE="YES" MEAN_1="5.1" MEAN_2="5.8" MODIFIED="2013-11-28 22:04:40 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="2202" SD_1="0.3" SD_2="0.2" SE="0.061261029642944734" STUDY_ID="STD-Booth-2004" TOTAL_1="33" TOTAL_2="39" WEIGHT="19.222691830061876"/></CONT_SUBGROUP></CONT_OUTCOME><CONT_OUTCOME CHI2="30.82187376265084" CI_END="-0.19057109548481016" CI_START="-0.898270250548719" CI_STUDY="95" CI_TOTAL="95" DF="13" EFFECT_MEASURE="MD" EFFECT_SIZE="-0.5444206730167646" ESTIMABLE="YES" I2="57.822161948657815" I2_Q="0.0" ID="CMP-006.16" MODIFIED="2017-12-08 02:32:02 +0000" MODIFIED_BY="Hermann Blessberger" NO="16" P_CHI2="0.0035797176246025186" P_Q="0.468585251765836" P_Z="0.002565284205721855" Q="0.5253103650606934" RANDOM="YES" SCALE="2.0" SORT_BY="YEAR" STUDIES="14" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.16580847981899552" TOTALS="YES" TOTAL_1="1272" TOTAL_2="1178" UNITS="" WEIGHT="100.00000000000001" Z="3.015532529371344"><NAME>Length of stay&#8212;cardiac surgery: specification of co-morbidities</NAME><GROUP_LABEL_1>Beta-blocker</GROUP_LABEL_1><GROUP_LABEL_2>Control</GROUP_LABEL_2><GRAPH_LABEL_1>Favours beta-blocker</GRAPH_LABEL_1><GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2><CONT_SUBGROUP CHI2="14.718613943952864" CI_END="0.20658923361657794" CI_START="-1.095061340227116" DF="5" EFFECT_SIZE="-0.4442360533052691" ESTIMABLE="YES" I2="66.02940997678489" ID="CMP-006.16.01" MODIFIED="2013-11-28 22:11:43 +0000" MODIFIED_BY="Hermann Blessberger" NO="1" P_CHI2="0.011634825646072211" P_Z="0.18095533114526033" STUDIES="6" TAU2="0.3836021740375157" TOTAL_1="745" TOTAL_2="736" WEIGHT="48.625914781057034" Z="1.337819354300992"><NAME>Co-morbidities not specified</NAME><CONT_DATA CI_END="0.8525956472955156" CI_START="-1.2525956472955142" EFFECT_SIZE="-0.1999999999999993" ESTIMABLE="YES" MEAN_1="10.0" MEAN_2="10.2" MODIFIED="2013-11-28 22:09:01 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="2222" SD_1="1.5" SD_2="1.7" SE="0.5370484639504883" STUDY_ID="STD-Jacquet-1994" TOTAL_1="19" TOTAL_2="17" WEIGHT="7.175725447273318"/><CONT_DATA CI_END="1.5979397562798727" CI_START="-3.197939756279874" EFFECT_SIZE="-0.8000000000000007" ESTIMABLE="YES" MEAN_1="7.6" MEAN_2="8.4" MODIFIED="2013-11-28 22:09:01 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="2224" SD_1="3.9" SD_2="2.6" SE="1.2234611325486162" STUDY_ID="STD-Cork-1995" TOTAL_1="15" TOTAL_2="14" WEIGHT="1.9603619455741486"/><CONT_DATA CI_END="-0.6213610519607327" CI_START="-2.1986389480392674" EFFECT_SIZE="-1.4100000000000001" ESTIMABLE="YES" MEAN_1="8.42" MEAN_2="9.83" MODIFIED="2013-11-28 22:11:08 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="2232" SD_1="2.81" SD_2="2.88" SE="0.40237420394453716" STUDY_ID="STD-Wenke-1999" TOTAL_1="100" TOTAL_2="100" WEIGHT="9.94596382397487"/><CONT_DATA CI_END="0.3228748645299382" CI_START="-2.322874864529938" EFFECT_SIZE="-1.0" ESTIMABLE="YES" MEAN_1="7.0" MEAN_2="8.0" MODIFIED="2013-11-28 22:10:59 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="2231" SD_1="2.0" SD_2="4.0" SE="0.674948557710553" STUDY_ID="STD-Gomes-1999" TOTAL_1="40" TOTAL_2="45" WEIGHT="5.245598762316367"/><CONT_DATA CI_END="0.9081080402146975" CI_START="-0.9081080402146975" EFFECT_SIZE="0.0" ESTIMABLE="YES" MEAN_1="8.0" MEAN_2="8.0" MODIFIED="2013-11-28 22:09:01 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="2219" SD_1="2.3" SD_2="2.9" SE="0.4633289424590134" STUDY_ID="STD-Bert-2001" TOTAL_1="71" TOTAL_2="60" WEIGHT="8.566567664335405"/><CONT_DATA CI_END="0.5986973363346225" CI_START="-0.19869733633462217" EFFECT_SIZE="0.20000000000000018" ESTIMABLE="YES" MEAN_1="6.5" MEAN_2="6.3" MODIFIED="2013-11-28 22:11:19 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="2233" SD_1="3.8" SD_2="2.5" SE="0.20342074623793907" STUDY_ID="STD-Connolly-2003" TOTAL_1="500" TOTAL_2="500" WEIGHT="15.73169713758292"/></CONT_SUBGROUP><CONT_SUBGROUP CHI2="6.633753936212488" CI_END="-0.5727413273948015" CI_START="-0.8046535146219252" DF="7" EFFECT_SIZE="-0.6886974210083634" ESTIMABLE="YES" I2="0.0" ID="CMP-006.16.02" MODIFIED="2013-11-28 22:11:43 +0000" MODIFIED_BY="Hermann Blessberger" NO="2" P_CHI2="0.46798232052983035" P_Z="2.555951758643954E-31" STUDIES="8" TAU2="0.0" TOTAL_1="527" TOTAL_2="442" WEIGHT="51.37408521894298" Z="11.640803853917866"><NAME>Co-morbidities specified</NAME><CONT_DATA CI_END="0.49035874809146784" CI_START="-1.2903587480914687" EFFECT_SIZE="-0.40000000000000036" ESTIMABLE="YES" MEAN_1="10.0" MEAN_2="10.4" MODIFIED="2013-11-28 22:10:53 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="2230" SD_1="4.0" SD_2="3.2" SE="0.45427301476685505" STUDY_ID="STD-Pfisterer-1997" TOTAL_1="126" TOTAL_2="129" WEIGHT="8.757839005699218"/><CONT_DATA CI_END="2.627257429639835" CI_START="-4.627257429639835" EFFECT_SIZE="-1.0" ESTIMABLE="YES" MEAN_1="21.0" MEAN_2="22.0" MODIFIED="2013-11-28 22:09:01 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="2229" SD_1="4.0" SD_2="11.0" SE="1.8506755523321747" STUDY_ID="STD-Matsuura-2001" TOTAL_1="40" TOTAL_2="40" WEIGHT="0.9077138012865974"/><CONT_DATA CI_END="0.30800399250821786" CI_START="-0.9080039925082193" EFFECT_SIZE="-0.3000000000000007" ESTIMABLE="YES" MEAN_1="5.6" MEAN_2="5.9" MODIFIED="2013-11-28 22:11:43 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="2238" SD_1="1.4" SD_2="1.7" SE="0.3102118188416096" STUDY_ID="STD-Forlani-2002" TOTAL_1="51" TOTAL_2="50" WEIGHT="12.438666811378871"/><CONT_DATA CI_END="-0.5799305882439878" CI_START="-0.8200694117560126" EFFECT_SIZE="-0.7000000000000002" ESTIMABLE="YES" MEAN_1="5.1" MEAN_2="5.8" MODIFIED="2013-11-28 22:11:30 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="2235" SD_1="0.3" SD_2="0.2" SE="0.061261029642944734" STUDY_ID="STD-Booth-2004" TOTAL_1="33" TOTAL_2="39" WEIGHT="19.222691830061887"/><CONT_DATA CI_END="0.6873907364900345" CI_START="-4.287390736490032" EFFECT_SIZE="-1.799999999999999" ESTIMABLE="YES" MEAN_1="11.3" MEAN_2="13.1" MODIFIED="2013-11-28 22:11:30 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="2234" SD_1="7.0" SD_2="8.9" SE="1.2691002263869409" STUDY_ID="STD-Auer-2004" TOTAL_1="125" TOTAL_2="65" WEIGHT="1.8348247173241288"/><CONT_DATA CI_END="0.8331433922667311" CI_START="-2.03314339226673" EFFECT_SIZE="-0.5999999999999996" ESTIMABLE="YES" MEAN_1="7.5" MEAN_2="8.1" MODIFIED="2013-11-28 22:09:01 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="2225" SD_1="2.1" SD_2="1.9" SE="0.731209044437134" STUDY_ID="STD-But-2006" TOTAL_1="15" TOTAL_2="15" WEIGHT="4.653164971321884"/><CONT_DATA CI_END="-0.6816580345935019" CI_START="-4.9183419654064995" EFFECT_SIZE="-2.8000000000000007" ESTIMABLE="YES" MEAN_1="11.2" MEAN_2="14.0" MODIFIED="2013-11-28 22:11:30 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="2236" SD_1="4.9" SD_2="7.6" SE="1.0808065771186153" STUDY_ID="STD-Sezai-2011" TOTAL_1="70" TOTAL_2="70" WEIGHT="2.4434372713566677"/><CONT_DATA CI_END="2.5534736631582517" CI_START="-3.9534736631582503" EFFECT_SIZE="-0.6999999999999993" ESTIMABLE="YES" MEAN_1="11.5" MEAN_2="12.2" MODIFIED="2013-11-28 22:11:30 +0000" MODIFIED_BY="Hermann Blessberger" ORDER="2237" SD_1="5.0" SD_2="9.0" SE="1.6599660446932882" STUDY_ID="STD-Sezai-2012" TOTAL_1="67" TOTAL_2="34" WEIGHT="1.1157468105137192"/></CONT_SUBGROUP></CONT_OUTCOME></COMPARISON></ANALYSES_AND_DATA><FIGURES MODIFIED="2018-01-31 17:44:23 +0000" MODIFIED_BY="Hermann Blessberger"><FIGURE FILENAME="Figure1_2017_2.jpg" FILE_TYPE="JPG" ID="FIG-01" MODIFIED="2017-12-08 17:32:47 +0000" MODIFIED_BY="Hermann Blessberger" NO="1" SHORT_VERSION_FIGURE="YES" TYPE="OTHER"><CAPTION><P>Flow chart of included trials.</P><P>RCT = randomized controlled trial.</P></CAPTION><FILE>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</FILE></FIGURE><FIGURE FILENAME="Risk of bias graph.png" FILE_TYPE="PNG" ID="FIG-02" MODIFIED="2017-12-08 17:32:57 +0000" MODIFIED_BY="Hermann Blessberger" NO="2" SHORT_VERSION_FIGURE="YES" TYPE="QUALITY_GRAPH_PLOT"><CAPTION><P>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies.</P></CAPTION><FILE>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</FILE></FIGURE><FIGURE FILENAME="Risk of bias summary.png" FILE_TYPE="PNG" ID="FIG-03" MODIFIED="2017-12-08 17:32:59 +0000" MODIFIED_BY="Hermann Blessberger" NO="3" SHORT_VERSION_FIGURE="YES" TYPE="QUALITY_TABLE_PLOT"><CAPTION><P>Risk of bias summary: review authors' judgements about each risk of bias item for each included study.</P></CAPTION><FILE>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</FILE></FIGURE><FIGURE FILENAME="Figure4.png" FILE_TYPE="PNG" ID="FIG-04" MODIFIED="2017-12-08 17:33:01 +0000" MODIFIED_BY="Hermann Blessberger" NO="4" SHORT_VERSION_FIGURE="YES" TYPE="OTHER"><CAPTION><P>TSA acute myocardial infarction&#8212;cardiac surgery.</P></CAPTION><FILE>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</FILE></FIGURE><FIGURE FILENAME="Figure5.png" FILE_TYPE="PNG" ID="FIG-05" MODIFIED="2017-12-08 17:33:04 +0000" MODIFIED_BY="Hermann Blessberger" NO="5" SHORT_VERSION_FIGURE="YES" TYPE="OTHER"><CAPTION><P>TSA ventricular arrhythmias&#8212;cardiac surgery.</P></CAPTION><FILE>iVBORw0KGgoAAAANSUhEUgAAA1MAAALlCAIAAACuPisXAABif0lEQVR42uzdC1gU5eL4cfPSMS8oikqFR/+JZnkjjxZ50KOpx0taamb+KK9xDD2aeEvTlAzxggmmAiIhKZKpmOdIiomBRh68QqZGQoIXVBQEBeS2wPt/h7F1XRDX5Lr7/Tw+PrPDzOzuu2N8m9mdrSEAAABgGmowBAAAAJQfAAAAKD8AAABQfgAAAKD8AAAAQPkBAACA8gMAAADlBwAAAMoPAAAAlB8AAADlBwAAAMoPAAAAlB8AAAAoPwBVV15eXkZGRok/un79eikr3rlzp/jMrKysmzdvyokHbbMKSk5O1mg0ciIhIeGRVnzU5StG8UelfYIPHYGycu3aNf5lAZQfgCokKiqqc+fOXbt27du3r4w/OScmJmb16tV+fn6+vr6hoaGOjo4RERGl5MXIkSP1Zi5evHjFihWenp6jRo2Sm5JzfvzxR2tra1tb2y+KTJw48fz58w99bN9//72ZmdnQoUOTkpLUNl20aNGAAQPkzZ49e8oH5ubmVqtWrWnTps2cObNly5bZ2dl/ehyio6Pr1q2blpYmpwcPHnzjxg3D133U5VVl/hRKf1S6T/ChI1AmtmzZIl90/okBlB+AKmTChAk//fRTbm6uds5LL7106dIlOREUFHTnzp2pU6eWsvq6detatGihm3E3b96sV6+eephQJposG3X+u+++++9//1t7pzL+DHl4Hh4erVq1UpNUbUr1se3atUud8+STTx45ckROHDhwIDMzs5RNFRYWlv4jCwuL9PR0w9d6pHspPv9PPIXHvPcSn6CBC/yJUZWvFOUHUH4AqpAbN2706dPnqaeeat++/c8//yznnDlz5u9//7soOgIUHx+/YsWK2NjYB60uM8Xb23vu3Lkffvih7vxu3bq1adPm+PHjujPfe+89NSLT0tKaNWu2fft2Qx7h7du3GzZsuHXrVvWmo6Oj3gLabNIjH5isRgcHh/3792s0mvnz5+/evdvV1VXeu7+/f48ePdzd3WVTynBZtWqVs7PzZ599JoM1IyPj5MmTPXv2lE9fby29bWrvSLt8Tk7O8uXLZQpPmTJF95EU304pT2H9+vVWVlZXrlzx9PS0tLSMiYnJzs5+44035By1g9esWSMHQf6ttxG9e9c+Kjmt9wTlU5aPZPbs2fb29omJicUX0N2sfJnkQ5LDNWbMGPl/ArpDJ3Ncb1RffvllFxeXtm3byscgH48sP7kbLF26VM6fNGkS/9wAyg9AlZCenj58+PDOnTvL6YKCgkGDBn377bebNm2SXbhgwQJZhE5OTmvXri2+4pdffnn9+vWEhIRGjRrdunVLO//q1at2dna1a9fWDRRZft27d5fZZG5uPnHiRHlHBj482YtqjP7000/aBCy9/M6dO/fxxx/LicjIyFmzZh07duyDDz6QN2WR7Ny5UxZtnTp1zp8/LxeLi4sbP3682qNypnrIrUOHDlFRUXpr6W1T9+7U5ffs2SP7Sd7U7UJJbzull58MJpnFycnJ+fn5LVq0UN8nt2zZMvn32bNn5eiJorPeLVu2vHz5su5Git+7+qiKP8FDhw7t3btXjv+8efPkKiWOgEpGp3zJRNHBSFlvckJ36PSel9wN5P9C3Lx5U8b6Cy+88P3338vya9y4cUpKinxSdevWLcMT2QAoPwCPRcZEgwYN1LeF5ebmXrhwQU7I7JO10aZNGxkiv//+++nTp3VXKSwsfPvttwOLWFtbf/7557o/lWGxePHimjVrauNPe8wvIyOjU6dOY8eO1V0+Ojpa3VTxQ4y//fbbE088ISNGlkrxeiix/FxcXEJCQnTnZGVlbd++/fXXX/fy8pJp0qRJE3W+fNgbNmxQpy0sLNTusbGxUY+W6a5VfJta6vKy0uQWpk+fLtfSW0B3O6WXn1q63t7eMpiee+651atXnzhx4ocffpDzFy5c6OHhoS4zatSoVatW6Q5a8XtXH1XxJzhjxgz5XHyKBAcHlzgCKvkYZMzJMZdVJ/9/QBQdgtUOnd7zkg9ANqs6f3YRWX6yUNU5zz77rHp8EQDlB6BKsLW11f2UrowJd3f3pUuXqol24MABvXeA7du376uvvvqliAyUVq1a5efny/kRERHa43mOjo7qsSLd8pNkasjc0S2kgwcPLi8iC6/4YxswYMC77747f/78h2aTauLEiTKMtDevXLkyfPhw+fidnJz0ym/cuHFLlizRdo86Amoz6a2lt83i5SeKDon16NHDzs5O96d623noUzh+/LjcyNq1a3/88cdXXnll5cqV6nh+9NFH2rPqixYt+uyzz/QGTe/e1UdV/AnKagwNDVXnyJesxBHQknc0evTob775Rj13rzt0es9Lt/xkWa5bt47yAyg/AFVLZmamWhWpqalvv/227o9mzZqVk5OzYMGCjRs3ypvbtm3TW/df//qXtvDkko0bN1aX2bJlS2BgoDr/888/174z75133tGW34QJE2QpGv449+zZU6NGjaNHj+rN12g0tWrVKv7R4927d3fo0CEmJkZ2jHxUrq6u6nnJMWPGyCKR+WJubq4u+fXXX/fs2VNtoIYNG6rnrDt37nzixAm9tfS2qXt36vJBQUFyHPLy8mRy6X6oVm87hjwFeUfqqdu//e1vMuzUmSdPnuzWrZs6LV8s+Uh0Vyl+7+qjKv4E/fz8+vXrl5KSIl++gICAEkdAy8PDQ/cooO7Q6T0vWX5NmzZVfzRo0KCLFy9euHDhmWeeUec8/fTT6kdzAFB+ACqNt7d327Zt3d3dFy9enJycrJ0fGRkpg0BOnD59etKkSbIP9C4O5+/vL9Pt3Llz6k1ZIa1bt37++efj4uIOHz7cpUuXZcuW+fj4yCZQz96Gh4e3bNlSLiDvaPz48X379lUPkhmosLDwzTff1JuZm5sry1IWoexI9QMQWrKB5MNu0KCBbBoZHAcPHmzWrNnMmTPnzJnzyiuvyJaSa6kfMZFZY2dn179//4ULF8pHuGHDhmPHjskV5c2wsDDdtX7//XfdbWrvS7v8pk2bRo0aJdf69NNPdR+M3r3rrvugp7By5crffvtNTqxZs0b39LdcTD54eUdz587VGw35Guneu/ZRyVbTe4Ky8rt27WpmZmZvby83XnwEtNvMysqytLR88cUX5cOWr9r169flT7VDp/e8ZJjWrVtXlqK8qWarzMGaNWvKRyKTXU7I/YF/cQDlB6CSyeAr/ua5pKSkR72aiVZeEdk0uin5+P7E5wN0zyZrrwujnpLWo36gtfhFjIuvVfw9fLp5Khcr8bIspd97cdrFii8vRzUlJeWR7r3EJyj776EjIMs+MDDw4sWLv/zyy549e9avX1/K81LP9srX/TEvTAOA8gMAVIK5c+fOmDHjwoULv/3225dffnn27NlSFpaBaGZm9qf/hwEA5QcAqEyZmZkbN26cPXv2zp07H/rdHps3b37//ff/85//MG4A5QcAAADKDwAAAJQfAAAAKD8AAABQfgAAAKD8AAAAQPkBAACA8gMAAKD8AAAAQPkBAACA8gMAAADlBwAAAMoPAAAAlB8AAAAoPwAAAFB+AAAAMPnyy8/Pv3r1qvxbTt+5c+fxN5iYmJiRkVHKAgkJCexbAACA8qtQsbGxQ4cOHTJkiKen57vvvtu1a9eAgIDH3OaJEyfMzc1PnTpV/Ee5ubnqxODBg2/cuMHuBQAAKL8KIturRYsWe/fu1c45duzY+vXrH3/LnTp1+uWXX9TpwsJCdeLmzZsjR45klwIAAJRfJXBxcWnTpo3ezKysLG9v7+7du8vpwMBACwsLObFnzx45JygoqHfv3qNHjz548OC4ceNefPHFpKSk4gtry0+j0cyfP3/37t2urq5paWlubm5NmzZdsWLFkSNHevbsGR0d/fXXX5uZmUVFRclVZs+eLW/KTJQLy2l7e/vExET2PwAAQPmVDVlXffv2LT4/NjbW2tpaTsh0q1GjhjpRu3btc+fO5eTkPPfcc1u3bpUzx44dK2uv+MLa8jt27NgHH3wgb06ZMmXnzp2//fZb27Zt1QU6dOigBt+rr74aEhIiJ2QRyuw7dOjQ3r17CwoK5s2b5+zszP4HAAAov7IxefLkl19+ufj8uLg4Neby8/O1MffUU0+p79Lr06fPTz/9JCcWLVq0atWqEhfWnu3Nysravn3766+/7uXlJcuvXbt26gI2NjbR0dFywtfXVwZoXl7emjVr5M0ZM2a4uLj4FAkODmb/AwAAlF/Z2LhxY8OGDdPT0x+p/AYMGKAtv5UrV5ZSfleuXBk+fLjcvpOT04PKT/7UwsJiy5Ytv//+u7w5atSo0NBQdRn1s8YAAACUXxnIy8t7/vnn58yZo52TnJwcGRmZlJTUokWLwsJCeVPGnEaj0S2/1157LSIiQlt+JS4sy+/UqVOurq7q2d4xY8asW7fu/PnzrVu3Vu+oc+fOJ06cUKfHjRs3dOhQddrPz69fv34pKSkFBQWP/yljAAAAyu8e2W2DBw9+6623ZJmtWLFC/i2TS84fMmSIra3tF1980aZNm//+978HDhyQVffdd9/FxMRYWlrOnDlTrigTbdiwYbdu3dJb+OjRo/Xq1VuyZElYWFizZs3kwjIuX3nlFVl+Xbt2nTZtWkhISIMGDRYuXKge1Tt06JCPj4/6eFJTU+UyZmZm9vb2sbGx7H8AAIDyK2NZWVnx8fF6M7Ozs4XBp1wftHBeXp46of5IU6T46nozZf+x5wEAAMoPAAAAlB8AAAAoPwAAAFB+jyUrK+vmzZtyIiMjg9EAAACUX7W0YsWK/v37y789PT3XrVvXrFmzESNG6C2zePFidYFRo0atXr2aHQUAAFB+1dJ3332nnV67du3TTz+dnJysu8DNmzfr1at3/fp1UXRdGDc3N3YUAABA+VVvZ8+elYW3b9++4j/q1q1bmzZtjh8/rjvT29vbw8PDwcFh//798qacXrNmjaOjo/rNbP7+/j169HB3d2/VqlVBQYGrq+vs2bPt7e0TExPZzwAAAOVXmXJzc21sbKZNm1biT69evWpnZ1e7dm216qRz5859/PHHciIyMnLWrFmyGmUCiqJL+rVs2fLy5cvx8fF16tQ5f/68XPLQoUN79+6V/Tdv3jxnZ2f2MwAAQPlVpjlz5nTo0EG9RLMUHR0dWET71Rqy2xYvXlyzZk01/lxcXEJCQrSrL1y40MPDQ50eNWrUqlWrbt++3aRJE3XOjBkz5PI+RYKDg9nPAAAA5VdpwsLC6tat+/PPP6s309PT9+3bt7xIVFRURESE+iVvkqOj48svvywnJk6cKPNOu4WPPvroww8/VKcXLVr02Wef6ZafbMHQ0FB12sCvCQEAAKD8yl5qaqqVldXKlSu1cz7//PO0tDTtzS1btgQGBmp/JONPTuzevbtDhw4xMTF37tzZtm3byZMnu3Xrpi7z9ttvy/my/MzNzdU5fn5+/fr1S0lJkQUZEBBQ6U/ZuQi7OwAAlJ/JGT16dIMGDZYsWbJ06VL594ABA5o2baq7wOHDh7t06bJs2TIfH58xY8ao539zcnImTZokV+zZs+elS5fknAkTJixfvnzTpk1z586VNzds2FCjRo3t27ercdm1a1czMzN7e3vt6eNKzL4aRYg/AAAoP+jLK5Kbm6t3tRdRdHln3ZtygZSUlAdtR/ZfpT8XbfYRfwAAgPIzcpQfAACg/Ewx/sg+AAAoP5hE/Mn6YxwAAKD8YCIvNa81AACUHyg/AABA+UHPhQsXKD8AgEHy8kRGRsk/un69tBXv3ClhZlaWuHlTmXjQNqug5GSh0SgTCQllv/Hc3PtuZmYKve9NKD5HKF/PpTwY7UU5cnLEH1/lRflBX1hYWM2aNXW/wI3yAwDoi4oSnTuLrl1F375K/EkxMWL1auHnJ3x9RWiocHQUEREPXF12yciR+jMXLxYrVghPTzFqlLIp6ccfhbW1sLUVX3yh/Jk4UZw///DH9v33wsxMDB0qkpLutumiRWLAAOVmz57KA3NzE7VqiWnTxMyZomXLx6qi6GhRt65QvyVh8GBx40aZjfDFi+Lf/xZ/fI2WkoD/+pf49luxdKnw9y95jlRYKNavF/Pni19+uTeqYWFiyxZlgvKDntDQ0Pbt29eoUcPa2lr7tWyUHwBA34QJ4qef7jsi9dJLouj6/yIoSDmeN3VqaauvWydatLgv427eFPXq3T1MKBNNxpnq3XeVANLeqYw/Q3h4iFat7iapWj/qY9u16+6cJ58UR44oEwcOKIfNSiFbqvQfWViI9PRHWMtwn39+77nL8F2w4O6WX3xR3L5dwhzpk0/EnDn3tiD7r+irWZVl/vY38cdXtlJ+UISHhzdu3DgkJESWn8w+OV0t44/yA4DyduOG6NNHPPWUaN9eqF8Nf+aM+PvflYnoaBEfrxy6K+WLnWRpeXuLuXPvHdBSdesm2rQRx4/fN/O99+5GZFqaaNZMFH2D1MPJDGrYUGzdevdm0deT3kdbfnrkA5PV6OAg9u9XzuHOny927xaursq9+/uLHj2Eu7vSlDKkVq0Szs7is8+UYM3IECdPKgcU5dPXW0tvm1pylZSU+/4UP/Qo70tbfv/3f/cO7I0YoRzXLD5HPgb5vORaH38s4uLuBl+nTkoxr1x5r3opP6jZZ2VlpaZejaJ4UudUv9O+lB8AVIz0dDF8uHLOVxS9sWzQIOXM46ZNShcuWKAUoZOTWLu2hBW//FI5tpeQIBo1Erdu3Zt/9aqwsxO1a4s1a+4rv+7dlWwyN1cO+Bl+1Er2ohqjP/10LwFLL79z55RmkiIjxaxZ4tgx8cEHys0pU8TOnUrR1qmjHKeUi8muGj/+bo/KmepRww4dlJPgemvpbVNr3jylyXT/fPNNaeUnI/u77+5OjxkjliwpYY4cN/kYfvlFHD2qhK96mFP+Ldv01VdLfmMl5WeaIiIi1KN9f7RTDW0OVr8jf5QfAFSYvDzRoMHdN7fl5gr1A4Iy+86eVY7eJSeL338Xp0/ft0phoXj7bREYqPyxtlZOaOqSYbd4sahZ8178aY/5ZWQoeTR27H3LR0ff3VTxQ4y//SaeeEJJMdlYxQ+nlVh+Li5C73hHVpZylPH114WXl3IcsUmTu/Plw96w4e60hcXd8rOxUR6P3lrFt2k43fJ76SWlI1XvvKO8ma/4HFmW06ffGzc1u+WIyUHo1Uv060f54W72WVtb6x7bq6ETT/KnrVu3lglI+QEASmBre9/BJFlgsleWLr2baAcO6L8Hbt8+8dVXynEp+Wf1auXMqfrR1IiIe8fzHB3vvjtNt/wkGVuy2HS/Wf7gQbF8ufJHxk1xAwYobxOcP7+EH5VYfhMnKudwta5cUQ5qysfv5KRffuPGKcfYtOWnjoBafnpr6W1Ta/9+pcx0/+glsl75jRypnDVW/fOfQv5eLj5HbuStt+7OWbRIeYRykOUAiqKP9z77rHIAkvIzcepRPb2wq3F/POkdEaT8AMDUZWberbTUVOUAnq5Zs5TIWLBAbNyo3Ny2TX/df/3rXuHJJRs3vrvMli3KoTvV55/fe2feO+/cK78JE5RSNNyePcovhaNH9edrNMpne4t/9Hj3buVsaUyMUnLyUbm63j1vO2aM8pEUWX7m5neX/Ppr5V19kszWhg3vnrPu3FmcOKG/lt42tf77X2VJ3T8nT+o/HpmM2vKT21HPLxcWKncth674nGvXxAsv3P1wib29cqdnz4r+/e9u4c03lSql/ExcQkJC8ZO5NYrFk1wmoTwuU0T5AUB15O0t2rZVjkgtXqyc0tWKjFSSSDp9WkyaJAIC9C9x5++vpJv2yJNMk9atxfPPK2+bO3xYdOkili0TPj5KM6lnb8PDlauuyAXkHcnK6dv37ulUA8kGkrmjJzdXKUv5y0J2pF4JyXiSD7tBAyWkLl1SDig2a6Zc+WXOHPHKK8qRRbmW+hET2b52dkpULVyoPMING5S398kV5c2wsPvW+v33+7ZpODkmAwYoxz5//fXuc5k7V+lpeV/q8Zric6Rvv1Uew9q1yjlu1ccfKwvs2lXyoUfKDyWWX/V69LyCAFDuZPAVf/NcUtKfv5pJXp7yR2aZbko+vj9xrT7ds8na68IUv1qy+ONy0+plnPWei95autt8HMW3U3yOfDx6Z9hl0RZ/kJSf0UtNTaX8AAAA5WfkwsLC/va3v73wwgvt2rXz1r4b1BjLz1mi/AAA5fqLxtmZcaD8qrQePXp4eXnJiZ9//tnMzCy9+KXGjaL8iqpPwb9JAAC/aCg/02VlZXXgwAGhXNL8du3atS9evGh85af918i/SQAAv2hg0uXn6+vbq1cvPz+/kSNHTp48WS/ySsQ/SAAA+EVD+VVL0dHRXbp0sbW1tbKy2mXA1/ZV+7O9PXqwxwMAyvEXDdlH+VVZhYWFzZs3/67oq/2uXbtWp06dOPVbnI2u/NR/k86zZgkrq7tfkg0AQJn/ouGjhJRfVXbu3LknnngiU/1KQSG6dOny1VdfGWv53eXoKPi/MQBAeTUF5Uf5VWGFhYXPPffcpk2b1Ap88sknExMTjbz8Tp8WlpYc9gMAUH6UnykKCgrq0qWL7L/WrVu7uroasEtX/+F67z2xciX7PQCA8qP8TNT169cN3qWr/3AdP6682+9PfGkPAACUH+VnYru0UQzXwIHC15dXEwBA+VF+MIHyi4xUDvuZ3ndUAwAoP/AimV75Sb17C39/XlAAAOVH+cEEyi8kRHTrxmE/AADlR/nBBMpPsrMTwcG8pgAAyo/ygwmU365dSvxx2A8AQPlRfjD+8pNsbJTTvgAAUH6UH4y//AIClI96AABA+VF+MP7y02hE69bKRV4AAKD8KD8YeflJ3t6iXz9eWQAA5Uf5wQTKLyNDuarz8eO8uAAAyo/yg7GXn+TsLBwceHEBAJQf5QcTKD/1sF9cHK8vAIDyo/xg7OUnOTkJR0deXwAA5Uf5wQTK7/JlYWEh0tJ4iQEAlB/lB2MvP1F02G/2bF5iAADlR/nBBMovIYHDfgAAyo/yg2mUnyg67LdsGa8yAIDyo/xgAuUXEyMsLTnsBwCg/Cg/mED5Se+9Jzw8eKEBAJQf5QcTKL/Tp5Vr+2Vn81oDACg/yo9d2gSGa+RI5ct8AQCg/Cg/ys/4n2R4uPJuPw77AQAoP8qP8jOJ59m7twgI4OUGAFB+lB/lZwJCQ0X79kKj4RUHAFB+lB/lZwJsbMSuXbziAADKj/Kj/EzA1q2iWzcO+wEAKD/Kj/IzDa1bK5/2AACA8qP8jMCpU6dq6ZBV9/3331N+9+zYIQYO5F8IAIDyo/yMTVRUVJMmTXJzcym/ezQa5arOkZHsHgAAyo/yMyrTpk2bPHmyAbu0iQ3XypVi2DB2DwAA5Uf5GY/c3NymTZseOXKE8tOXna0c9ktIYCcBAFB+lJ+R2L59e7t27YpHXolMbnRcXISDAzsJAIDyo/yMxKBBg5YsWWLYLm16w5WRoXzIl8N+AADKj/IzAleuXKldu/bFixcpvwf65BPh6Mg/FQAA5Uf5VXvLli3r06ePwbu0SQ5XWppo3Fhcu8a/FgAA5Uf5VW/t2rXz9/en/B7CyUn5AwAA5Uf5mdIubarDFRenHPZLS2MfAABQfpQf5WcCHBw47AcAoPwoP8rPNMTECAsLDvsBACg/yo/yMw3Dhom1a9kNAACUH+VH+ZmAmBhhaal8sQcAAJQf5Uf5Gb9+/TjsBwCg/Cg/ys80REaKjh2FRsPOAACg/Cg/ys8E2NmJgACGAQBA+VF+lJ8JCA4W3boxDAAAyo/yo/xMQ8eOIjSUYQAAUH6UH+VnAnbtEr17MwwAAMqP8qP8TEP79sqnPQAAoPwoP8rP+O3YoVzhBQAAyo/yo/xMQuvWIjqaYQAAUH6UH+VnAlauFAMHMgwAAMqP8qP8TEB2trCyEsePMxIAAMqP8qP8TICLixg9mmEAAFB+lB/lZwIyMpTDfgkJjAQAgPKj/Cg/EzBvnpg6lWEAAFB+lB/lZwKuXRONG4vkZEYCAPg1yRhQfpSfCfjkE+XIHwCA8gPlR/kZv4QE5bDftWuMBABQfqD8KD8TMHq0cHZmGACA8gPlR/mZgLg4YWkp0tIYCQCg/ED5UX4mYPRosWwZwwAAlB8oP8rPBERHK9f202gYCQCg/ED5UX4mYNgw4e/PMAAA5QfKj/IzAcePi/btOewHAJQfKD/KzzT07s1hPwCg/ED5VV137txJTEwsLCyk/MpAcLDo2JHDfgBA+YHyq3Ju3749bNgwMzOzv/71r6+99hrlVza6deOwHwBQfqD8qhxHR8d33nknLy9PTl+/fp3yKxu7dinxBwCg/ED5VR0y+OrVq3fhwoVH2aXZpw3Tvr2IjGQYAIDyA+VXVVy8eLFRo0Zubm4WFhZWVlabNm2i/MqMv7/yUQ8AAOUHyq+KOHnyZO3atUeOHJmUlLRt2zYzMzP1tK828krEHmOQ7GzRurVykRcAAOUHyq8qOH/+vCy5iIgI9eb/+3//LzQ09GG7NPu0wdauVS7sDACg/ED5VQV37typVatWdHS0erNjx467du2i/MpMdrawsBB/DC8AgPID5VfJBg0aNGPGjIKCgjNnztSrV0+2IOVXlpydxfjxDAMAUH6g/KqEc+fOtW3b9tlnn23Xrp23t7cBuzT79KNISxMNGoi4OEYCACg/UH5VxdWrVw35Ag/K789wdhZOTgwDAFB+oPyq4y7NcD2i5GTl3X6XLzMSAED5gfKj/EyAk5OYPZthAADKD5Qf5WcCLl8WVlbKe/4AAJQfKD/Kz/g5OQkXF4YBACg/UH6UnwlISFDe7cdhPwCg/ED5UX4mYeRIsWwZwwAAlB8oP8rPBJw+rbzbT6NhJACA8gPlR/mZgCFDhAGXywYAUH6g/Ci/6i80VLRvz2E/AKD8QPlRfqahd2/h788wAADlB8qP8jMBwcGiWzeGAQAoP1B+lJ9paN9ehIQwDABA+YHyo/xMwI4dwtaWd/sBAOUHyo/yMw3W1iIigmEAAMoPlB/lZwJ8fcXAgQwDAFB+oPwoPxOg0SiH/aKjGQkAoPxA+VF+JsDXV/k+NwAA5QfKj/IzftnZype5cdgPACg/UH6Un0lYuVK89x7DAACUHyg/ys8EZGSIxo1FQgIjAQCUHyg/ys8EODsLBweGAQAoP1B+lJ8JSE7msB8AUH6g/Cg/kzF1qpg9m2EAAMoPlB/lZwISEoSlpXLwDwBA+YHyo/yM3/jxyhv+AACUHyg/ys/4xcQo7/bLzmYkAIDyA+VH+ZmAYcOEhwfDAACUHyg/ys8EREYq7/bTaBgJAKD8QPlRfiZg4EAREMAwAADlB8qvvLz88ss1a9asVWTMmDGUX2WKiBAdO3LYDwAoP1B+5Vh+e/bseZRdmn26PPXuzWE/AKD8QPlRfqYhNFTY2HDYDwAoP1B+5VV+DRs2/Mtf/tKzZ89ff/1VL/JKxB5TvuzsRHAwwwAAlB8ov7J38ODBGzdunDx58s0333z99dcN2KXZp8vZrl3KYT8AAOUHyq/8/P7773Xq1ElJSaH8KplGI1q3Vk77AgAoP1B+5eTGjRu1atWKioqi/CpfQIDyUQ8AAOUHyq8MpaamnjlzRk5kZGTMnj27RYsW2Q/7AjHKryJoNMLaWrm2MwCA8gPlV1bi4+MbNGjQvHnzevXqtWzZMiwszIBdmn26Qnh4iJEjGQYAoPxA+ZWlvLy8CxcuXL58ubCw0LBdmn26QmRnK1/mFh3NSAAA5QfKrxJ3aYarojg7O9vYyL8YCQCg/ED5UX7GHn5z5qgXUCT+AIDyA+VH+Rl19jk76149m/gDAMoP1a/8NmzYMGvWLMoPj1x+1Xy3AQDKD6ZYfvHx8b6+vtqbO3fupPzw0PhztrUVVlbCyUmkpTEsAED5odqUX1BQUP369c3MzJoUqY4VRflVcPzdPc8rm2/2bOXTvo6OIiGBkQEAyg/VoPwyMzN9fX3T0tJuF/Hz86P88Ahk/82bJxo0EFOniuRk/ToEAFB+qFLlJwUGBi5dulRO7Nq16+zZs5QfHtm1a8rxPwsL4ejoPGMGHwEBAMoPVbT8Tp48OWDAgAULFqg333//fcoPf9Lly869evH5XwCg/FB1y8/T0/PGjRtfffWVnM7KymrevHlqairlhz+HK78AAOWHKl1+8fHx8tfz0qVLt27dOmjQoM6dO1fDXZp9uirGH9kHAJQfqlz5SZcuXXJzcxs+fPi6detSUlIoPzx+/JF9AED5oSqW35kzZ3Rvqqd9KT8AACg/GGH5bdy48ZdfflGn9+3b17BhQ8oPAADKD8ZZfj///PPatWuvX7/u7u7+3HPPBQQEUH4AAFB+MM7ykwoLCydPnjx48OCbN2/++OOPlB/Kz4oVon9/5W9PT7FunWjWTIwYwagAAOVH+ZWp4p/bSE9Pb968eZM/NGrUyNzcXE7Url2b8kP5+e67e9Nr14qnn9Z+8QcAgPKj/B5DaGjo8uXLMzMzp06d2q5du+Kftdy0adOtW7du32/z5s2UH8rqddGl99OzZ0W9emLfvhJW9PYWHh7CwUHs369Md++uzAwMVL4iRPL3Fz16CHd30aqVMtPMTERFKfNnzxZffy0KC4WrqzJtby8SE3kRAIDyM5nykw2Xm5v7/fffP/3002lpaeHh4bICiy+Wnp7u4OCQlJQkp0NCQi5cuED5obzLLzdX2NiIadNKWOvcOfHxx8pEZKSYNUvExgpra+WmRnP3v13x8aJOHXH+vLKk9Oqrcr9VJlasULLv0CGxd68oKFC+TJgLywAA5WdC5RcZGblq1apWrVoFBwdrNJqxY8fm5+cXX2zbtm3e3t7qj+TfU6ZMofxQ3uU3Z47o0EFkZ9+9GR2tHL2Tf2TnubjcLTlVXNzd8pN7qLqN27dFkyb3FvD1VQ7v5eWJNWuUmzNmKFvw8VH+BAfzIgAA5Wcy5Vf0C1UhJ/bv3x8QEFBQUFB8GTk/IyNDnb569WqTJk1yc3MpP5Rf+YWFibp1xc8/372Znq6c812+XPkTFSUmThSrVj1C+cnVLSzEli3i99+Vm6NGidDQuz8q6f90AIDyg5GW34YNG2bNmvXQxZKSkiZMmPDNN9/4+fnZ2tqOHz++OhYGe0x1Kb/UVGFlJVauvLfY55+LtLR7N3fvVg4HxsSIO3fEtm1y/xQtWiincZOTlf92aTRK+Zmb33dH48aJoUPvTvv5iX79REqKcsK3Gl6hCAAoP8rvz4qPj/f19dXe3Llz54OWTE9P37hx49ixY2X/ZWVlUX4oKzt2iGHD7pszerRo0EAsWSKWLlX+HjBANG163wI5OWLSJGWZnj3FpUvKnCFDhK2t+OIL0aaN+O9/5f/SKP8R27793iqHDinndrVl2bWr8rEPe3vl3DEAgPIzlfILCgqqX7++mZmZet2WUvIoJydn27Zt8+bNO3nyZPXcpdmnq6iVK4WT059ZUe9/QNR3BJZy9lajue+m7D8AAOVnWuWXmZnp6+ublpamXq7Fz8+vxMUKCgo6d+7cv3//BQsWvPfee4acIKb8YKCpU5XrswAAKD+Ue/kJww7mhYaGnj59Wntzy5YtydXt0rqUX5U1ZIjYtYthAADKD+VffgYezJOpl629uoYQ7u7uN27coPxQJjp2FDr/WwEAoPxQbuVn4MG8pKSk7t27Ozk5zZ8/387O7t13362GuzT7dBVlaSn+uGQQAIDyQ3mWn+EH827duuXj4zNlypSIiIj8angNNMqP/9oAAPhvsamXX+kH87Kysk6VZOnSpVXh+R87dqxmzZouLi6UX/WVkKAc8wMAUH6oiPIT9x/MK/6jRo0adezYsdP96tevX+lPPj8/v1evXt26daP8qrXwcGFnxzAAAOWHCim/gwcPpqSklLLATz/9VHzmsWPHKv3Jr1692tXV9Y033liyZAnlV335+yvXbQYAUH6oiPILCgpyd3dfuXLlkSNHSl/y6tWrXl5eckk5UenPPDExsXPnzjk5OSWWX40HYI+pgpydxSefMAwAQPmhQspPKywsbOjQobLtNHpfdFAkOTm5UaNGI0eOlJn17rvvent7V+4zf+utt9QvmuOYX3Xn6CjWrmUYAIDyQ4WUX0xMTGxs7Ny5c5955hmZU7L/SlxMpt7MmTO1NxcuXFhQUFBZT/vAgQOdOnX6tUifPn0+/PDDK1euUH7V1MCBIjiYYQAAyg8VUn7u7u7NmzeXJZeYmFjKYrIOPT09tTc3bNiQnp5eWU9727Zt7f/QoEEDCwsLQ75NjvKrmtq35zLOAED5oaLK74cffrh9+7b2pt7Bs4yMjM6dO3coYm5ubmNj81KR3r17V5Eh4GxvdVe3LpdxBgDKDxVVftLhw4d9fHy8vLw8PT3t7Oz0rtLs7u5+ppjU1FTKD4/v2jVhYcEwAADlh4oqv5iYmDFjxsh+cnJycnBw0H0zX3HZ2dn79u2rtrs0+3SVExkpunVjGACA8kNFld+ePXvU/ouKipITn5R6gY3k5OSRI0dSfigrISGi2u5QAED5oRqW36lTp4YOHRobGzt9+vTJkydbWlrm5eVRfo95R1xE0ED+/mL8eIYBACg/VFT5SWfOnMnKysrMzHRzc/vhhx9KWVIuExgYKIp9EITyK6X8qMBSODuLefMYBgCg/FD+5bdo0SJ/f3/Dly/9gyCUn4HlZwotaPhzHD9e+PryDxkAKD+Uf/m99dZbst6OHj0qJz788MObN2+WsvAjfRCE8nuQZcsov0euQwAA5YcyKD/txVBcXFxk2JW+8CN9EITye5DZs428eDIyRGio/nPs3VuMHq18S5sMX39/sXWrCA+n/ACA8kPFlt/KlSvVCR8fn5SUFHU6Li6uxIUf6YMgJl5+QudiJaZwtjch4e4HNayshKWlkJ2n9xxl58na8/aW/8MgHByUD/MWX4Z/zABA+aF8y2/YsGGeRezt7d3c3OTE2rVr+/btW+LCsvN0Pwiyc+fOarhLV9w+LVvnQd9yolc8jo5Co6lmIykf8PHjygG8gQNF69aicWO5L4m1a5UvYVOfC2d7AYDyQ5Urv2bNmnXs2NFGh7xZt27dEhf28fHRPcg3Z84cTXULlorMi61bDbpMXVqasLNT+ik7u6qPnnyowcHKQbshQ5TUs7ZWjt7t2CHi4v5kuVJ+AED5oULLL1j+JjdspoeHh4WFhbW1ddu2bdu1a/fcc8/JTKT8SrFsmZg926Al5SjKlpL9l5xc5Ubs2jXlTXvyiXTrJho0UI5iurgo116+fJl/egBA+aG6ld8jUb+9N6ZIXFxcTk5ONdylK264nJ2VPwaS8efgoLxD7vTpyh+lhATlMivvvXf3TXujRysVGx5eDY5KAgAoP8qvLAUGBi5dulRO7Nq16+zZs5RfKRwdlfe9PZIdO5TSioys6GGR3RkRoXRq796ibl3RsaNSe7pv2gMAUH4wufI7efLkgAEDFixYoN58//33Kb9SyHgKCHjktcLDhYWFKOl8exlLTlZCc+pUpfbkPdrYKNNyThU84wwAoPxQCeXn6el548aNr776Sk5nZWU1b948NTWV8nsQWVShoX9mxdOnlU/LuriU/UOKiVGO5Dk5KW/aa9xY9Oun3EtEhHIFPgAAKD/K7z7x8fHOzs5Lly7dunXroEGDOnfuXA136Yobrvbt//yb9pKTlTgz8AMipZBJJx+D9k17MijHj1cuvBcZyZv2AACUH+X3MJcuXXJzcxs+fPi6deu0V36m/EokMysh4bGirXdv5bowj5pocvnw8Ltv2mvQQClIJyflEsoP+4oWAABNQflRfiXJyckpLCysnrt0xQ1X3bqPexZVo1EO0cmAe+h7765du/umvfbtldO4dnbK9K5dyhX4AACg/Ci/R3P79u0ZM2bMnz//xo0bX375pbm5eYsWLY4cOUL5VcA/H2fnkq94fPq08qa9kSPv1p76pr3ISD6NCwCg/Ci/xzNnzpzBgwf369dP/m1tbe3m5vbhhx/279+f8nuQa9eUD8yW4cPWNXq0snH1TXsBAcppXN60BwCg/Ci/MvPpp5+qEx988EHAH5cqmTx5MuX3IAkJyhvsyqn8QkIe6x2EAABQfpRfaVxdXdUJX1/fX3/9VZ1WL+lM+ZUoMlJ5f145lR87PQCA8qP8ypGdnd3UIn379p04ceK/i3To0IHye5CtW5V34FF+AADKD9Wv/F588cV33nnnPR3/93//16pVK8rvQby9lW9vAwCA8kP1K7/w8PDiMw8ePEj5PYizs/IHAADKD9Wv/Ixol66g4Zo3TyxbxngDACg/UH4mUH7ql6QBAED5gfIz/vIbOFCEhDDeAADKD5SfCZRf796ipPdGAgBA+YHyewypqakpKSlVp/y4AgsAgPID5VcuOnbs2LRp02eeecbW1vbAgQOUHwAAlB/lZ7Ti4uLUCR8fHxsbG8oPAADKj/IzfidOnKhbt252djblBwAA5Uf5Ga2wsLAVK1bY2Ni4uLiUUmAVlmKUHwCA8gPlV17c3d379OnTunXrH374wZAsK+/HExkprK2FRsOeCQCg/ED5lY/Dhw//5S9/ycjIqPTymzqVb+8AAFB+oPzKU0FBgZmZ2UM/3lve5SfLs3FjkZzMCwIAoPxA+ZWp69evnzx5Uk5oNJr169fXqlXr4sWLlVt+vr5i9Gj2SQAA5QfKr6ydO3euefPmTZo0MTc37969++bNmw3Ypct3uGxsRGgo+yQAgPID5VcOCgsLr169ev36dYN36XIcruho0bEjOyQAgPID5VdVdulyHC5HR+HhwRgDACg/UH7GXn7JycLSUly7xhgDACg/UH7GXn6+vuK99xhgAADlB8rPBMrPxkYcP84AAwAoP1B+xl5+kZHKZzv43g4AAOUHys/4y2/0aOHtzegCACg/UH7GXn5pacLKSvkbAADKD5SfkZeft7dwcGBoAQCUHyg/Eyi/jh1FRARDCwCg/ED5GXv58b0dAADKD5SfqZTf+PFi3jzGFQBA+YHyM/byS0sTFhbi8mXGFQBA+YHyM/by8/YWAwcyqAAAyg+UnwmUn42NCA9nUAEAlB8oP+Mtvxr3Y1QBAJQfKD/KDwAAyg+UH+UHAADlB8qP8gMAgPID5Uf5AQBA+YHyq/Dyk7ZuFcOGMZwAAMoPlJ8JlJ+Li/jkE4YTAED5gfIzgfJzdBQeHgwnAIDyA+VnAuXXr58IDWU4AQCUHyg/Eyi/9u1FdDTDCQCg/ED5mUD5WVgIjYbhBABQfqD8jL38EhKErS1jCQCg/ED5mUD5bd0qRo5kLAEAlB8ovwqXnp5+8+bNiiy/ZcvE7NnseAAAyg+UXwXKy8t79dVX69WrZ2lp2atXr0OHDlVM+Tk6irVr2fEAAJQfKL+KLb+tW7fm5+cXFhYuX768W7duFVN+AweK4GB2PAAA5QfKr5KcP39eVt1DT/uWSfm1by9On2bIAQCUHyi/SrJ+/fpOnToZsEuXwXDVrSsyMhhyAADlB8qvMly8eNHCwuJ///ufXuSV6DHv69o15WJ+AABQfqD8KsGtW7c6dOjg5eVl2C79uMMVGSkMeD8hAACUHyi/spaTk9O7d+/58+cbvEs/7nBxMT8AAOUHyq8SFBQUjBw5cuzYsXl5eZoiFVB+XMwPAED5gfKrBImJiXrv4Tt+/Hh5lx8X8wMAUH6g/KrLLl3jcdYtw0+KAABA+YHyo/wAAKD8QPlRfgAAUH68SgxBOZVfjVIxmAAAyg+UH+UHAADlB8qvmpcfowcAoPxA+VF+AABQfqD8KD8AACg/UH7VovyklSvF1KkMGwCA8gPlZwLlJ7OPb+wAAFB+oPxMovyGDBG7djFsAADKD5SfCZRf+/YiOpphAwBQfqD8TKD8atcWGg3DBgCg/ED5GXv5XbsmGjdmzAAAlB8oPxMov/Bw5X1+AABQfqD8jL/8PDyEkxNjBgCg/ED5mUD5TZ2qxB8AAJQfKD/jLz8u6QIAoPxA+ZlK+Vlbi5gYxgwAQPmB8jP28tNoRIMGIi2NMQMAUH6g/Iy9/C5fFlZWDBgAgPID5WcC5RceLmxsGDAAAOUHys8Eym/ZMi7pAgCg/ED5mUb5OTqKtWsZMAAA5QfKzwTKb+BAERzMgAEAKD9QfiZQfu3bc0kXAADlB8rPNMqvbl3lwi4AAFB+oPyMvPwSEoSlJaMFAKD8QPmZQPmFh4vevRktAADlB8rPBMrP359LugAAKD9QflXM1atX58yZY25uPnXq1DIsPy7pAgCg/ED5VTmvvfaabL4RI0Z88MEHZVJ+Ne7H7gUAoPxA+VUVWVlZ8m8Zf46OjpQfAACUH+Vn/Cg/AAAoP8rPpMuvxgNQfgAAUH6Un7GV34PCjvIDAIDyo/woP4VGo1zDOS2NQQUAUH6g/KqYwsLC/Pz8KVOmTJo0SU7Im49Zfrt2CTs7dioAAOUHyq/q8fT01D056+3t/Zjl5+goHrYNAAAoP1B+1WOXLm24NBrRuLG4fJlxAgBQfqD8jL38QkL4ul4AAOUHys80ym/8eLFsGYMEAKD8QPkZe/llZyuf6k1OZpAAAJQfKD9jL7/QUGFjwwgBACg/UH4mUH5OTmLtWkYIAED5gfIzgfKzsBCnTzNCAADKD5SfsZdfRIRo3165qgsAAJQfKD8jLz8nJ+HszPAAACg/UH7GXn4ajbCy4lQvAIBfk0QF5WcC5Xf8uLC2ZmwAAPyaJCooPxMov08+Uc72AgDAr0nGgPIz/vJr3Vo57AcAAL8mGQPKz8jLLzpaKT8+1QsAAOVH+Rl/+XGqFwAAyo/yM5Xy69hRREYyMAAAUH6Un7GX3+nTwtKSU70AAFB+lJ8JlJ+Li5g3j1EBAIDyo/xMoPw6dhTh4YwKAACUH+Vn7OV3+TKf6gUAgPKj/Eyj/JYtEw4ODAkAAJQf5WcC5Wdry6leAAAoP8rPBMovLk5YWHCqFwAAyo/yM4Hy8/AQU6cyHgAAUH6UnwmUn52dCA5mPAAAoPwoP2Mvv4QE5VRvdjbjAQAA5Uf5GXv5rV0rRo9mMAAAoPwoPxMov5EjRUgIgwEAgNGWX0JCQmhoKOXHLl0jOZlTvQAAGHn5hYeHN27cONwYr99G+T1a+e3YIcaPZyQAADDm8pMiIiKsra2N78gf5fdo5TdwoAgIYCQAADDy8lPjr3HjxiHG9R4vyu+Rdum6FhYiI4ORAADA+MtPFJ32tbKyMqYjf5SfgTvzfRgQAABMofzEH+/5M5ojf0QM5QcAAOVXmtDQ0NatWxtH/BExf6b8AACA/mERY3+CNWvWvHDhAuXHMT9UldeIQQAAjvmV0zG/9u3bc8yP8gPlBwAw8vLjfX60BXh1AAAmUX58tpe2AK8OAMAkyo/r+bFLM1y8OgAAkyg/9Ts8jCz7KD/aglcHAED56eN7e0Fb8OoAAEyl/BISEozvG3spP9oCAADKz8ReJYaA8gMAgPKj/ED5AQBA+VF+lB8qSUZGRn5+fulzMjMzc3JySl8GAED5PUhSUlJZbSo1NfXUqVNV6ncQKUP5VRszZswYNmzY888/7+fnV+IcjUbz6aef7tmzZ/r06UuXLn3QWgAA4yu/0NDQli1bTpo0Sb15/fr18ePH//Of/4yLi3uk7Xh5eXXs2LFMHlJERMTnn3++cuXKgIAAyo/yw6M5duxYZmamOtG4cWMZecXnfPvtt9OmTVOXb926tfxnX3wZRhIAjLL8pMmTJz/77LOenp7qzSNHjmzevPlRN3L27NmyKr8xY8b89NNPVe5VYkel/KqXixcv2traljhn1qxZ8p+9OnPEiBHe3t6lrAUAMLLy+/jjjw8fPvzUU0+p1+H7+eefv/nmGzkhfx10795dTgQGBlpYWMiJPXv2yDlBQUG9e/cePXr0wYMHx40b9+KLLyYlJcnye+GFF+bMmdO+ffvPPvussIirq+vs2bPt7e0TExP9/f179Ojh7u7eqlUr+SPtvXt4eKxZs8bR0VH+LW/KjVtbW3/44Ye7d++m/Cg//Hlubm6+vr4lzgkNDX3++edTUlLkdN++fXXLr/haAADjKz/59+rVq5s2bRofH68tv9jYWBlhouhNQeqvcjlRu3btc+fO5eTkPPfcc1u3bpUzx44dK9NQll+TJk1u3ryZnp7+17/+9ejRo4cOHdq7d29BQcG8efOcnZ3lluvUqXP+/Hm5uvau5VoODg5yIi8vr2XLlpcvX5bT//jHP+S6Ve5VYkel/KqRjIyMjz766EFz8vPz5f9p9erVS3aepaWl9hh78bUAAMZaftLbb7/dqVMn+VtALb+4uDi1/OSvCe2v8qeeeio3N1dO9OnTR/19sWjRolWrVsmG69q1q7qMjLlPP/10xowZLi4uPkWCg4Nv374t01DvrhcuXOjh4aFOjxo1Sm6H8qP8UAZWrlwpM670OVJUVJT8d6s9CF/iMgAAYy2/9PT0559/vmPHjoaU34ABA7TlJ39f6Jafq6urn5+fLDnt93nILZRYfh999NGHH36oTsvtfPbZZ5Qf5YfHtXnz5itXrsiJO3fuqP8Ii88RRUfa7ezsfvzxxwetBQAwyvIbMWKEdvrMmTP16tVTyy8pKalFixaFhYXJycnyV7n6aT9t+b322msREREllp9svtTUVBl//fr1S0lJKSgoCAgIkOVnbm6ud9cnT57s1q2bOv3222/HxMTICfnLKCwsjPKj/PBnBAUF1apVq06RJ5544n//+1/xOfJfdWRkpPy/rtjY2AetxUgCgFGW344dOxo2bKj7lu4tW7ao5ScNGTLE1tb2iy++aNOmzX//+98DBw7I3+nfffedTDRLS8uZM2fKOpR5N2zYsIsXL/7jH//w8vKaN2/el19+KYquySdb0MzMzN7eXv5+2bBhg1x3+/bteg9gwoQJy5cv37Rp09y5c+XNo0ePykCcMmWK+u5zyo/yQ9mT/7rUN9UCAEyt/EqUlZWlnc7OzhZFp2sNWTE9Pb2goEB3juy/h66VnJxc1TqP8qP8AAAwlfID5Uf5AQBA+VF+oPwAAKD8KD9QfgAAUH6UH+UHAACMp/wSEhIoP1B+AAAYc/mpF/aTBg8efOPGjUdahfKj/AAAoPyqOu33PN28eXPkyJGPtK7eKtpNUX6UHwAAlF9l8vf3f/nll11cXNq2bTtlypScnByNRjN//vzdu3e7urqmpaW5ubk1bdp0xYoVR44c6dmzZ3R0tCw5+aPZs2fb29snJiYGBgZ26dLFz89PbsfZ2VluU7tKenr68uXL161bJ7dM+VF+AABQfpUsISHhqaeeunnz5u3bt1944YXvv//+2LFjH3zwgfyRzLWdO3f+9ttvMgrVhTt06BAVFXXo0KG9e/cWFBTMmzdPpp5cUQbA5cuXs7OzW7ZsmZ+fr11lz549agvu37+f8qP8AACg/CrZtWvXmjVrpk7PLiKKvttj+/btr7/+upeXl8y4du3aqQvY2NhER0fPmDHDxcXFp0hwcLAMPm0AWFpaJiUlaVeRG7ewsJg+fbrul4VQfpQfAACUX+WXn+y5devWXblyZfjw4enp6U5OTiWW36hRo0JDQ9U5+fn5pZSfFB8f36NHDzs7O8qP8gMAgPKr/PJr2rSpOj1o0KCLFy+6urqqZ3vHjBkjQ/D8+fOtW7dWF+jcufOJEyf8/Pz69euXkpJSUFAQEBCQlZWlDYDmzZvL8tOuEhQUlJOTk5eXJ5PRwA8FU36UHwAAlF85ll/dunU9PDzmzJmjvifv4MGDzZo1mzlzppzzyiuvyIzr2rXrtGnTQkJCGjRosHDhwuTkZDnHzMzM3t4+Njb222+/lQFw4MCBI0eOPPHEE7IFc3Nz1VVkOI4aNSosLOzTTz+tNq8SOyrlBwCAEZef7DzZapmZmdqZeXl56kR+fr78W1NEb8XU1NRSNquuUlhYKLegu2XKr0q7evWq7H1zc/OpU6dSfgAAGF/5Xbx40czMrHpdco/yKy+vvfaabL4RI0ao5/spPwAAjKz8Nm/e/P777//nP//h9aH8hPoZbBl/jo6OlB8AAMZXfqD89JVYfjUegOECAKAqlF9OTs6DfpSQkFBZY5CYmJiRkVHKAsnJyRqNppQHT/mVgbNnz3rdb8eOHaWX3wN2acoPAIDKL7+dO3eeOXNm37599evXf/3112NjY3V/Onjw4Eq5xsqJEyfMzc1PnTr1oAWio6Pr1q2blpb2448/BgYGUn7lJTw8fPz9Fi1aRPkBAFAdy8/Dw+PIkSPqtI2NjZeX1+NszZAPf5S+jO5PO3Xq9Msvv5SymIWFRXp6uij6QuGvvvqK8qsElB8AANWl/FJTU3v06KG9Wbz8Tp482bNnz+jo6MDAwC5duvj5+b388svqlfxke7m6us6ePdve3j4xMVGj0cyfP3/37t1yZlpamkwxuWV3d/dWrVppYy4nJ2f58uXr1q2bMmWKOsfb21ump4ODw/79+/W2oC0/vTuS81etWiUfw2effVavXj3t6eCXXnqp4r/2zaRTRr0Mj3wtJ02aJCceWv2UHwAAlVt+Bw4cePPNN0spP6lDhw5RUVG3b9+Wv7gvX76cnZ3dsmVL+Yv+0KFDe/fuLSgomDdvnuywY8eOqRf3kCWwc+fO+Pj4OnXqnD9//ty5c9pN7dmzR61G2Xnyb/mjjz/+WE5ERkbOmjVLbwva8tO7o7i4uPHjx8ufyjqUd6G9/l/37t3ldii/iuPp6an76Q1Z8ZQfAABVufzWr18/YcKE0stP/frd4t+3O2PGDBcXF58iwcHBougqH9u3b3/99dflRmQpNmnSRG9T165ds7CwmD59unpwTq4eEhKiu4DuFrTlp3dHn3/++YYNG9Tl5da05TdixIjNmzdTflV5l2a4AACozPILCgoaNmzYg8ovIyNDptiDym/UqFGhoaHqnPz8/CtXrgwfPjw9Pd3JyelB5SfFx8f36NHDzs5OTk+cOHHVqlXaH+ltQVt+enc0bty4JUuWaMvvzp072vKTT4fyo/wAAKD8Snb27NlXXnlFe7Njx4665ffxxx/n5uZ27tz5xIkTMgG1v7ibN28uy8/Pz69fv34pKSkFBQUBAQGurq7qudoxY8asW7dOlp+5uXnx0MzJycnLy5M1eePGjd27d3fo0CEmJkbW27Zt2/S2oJbfqVOn9O7o66+/7tmzp1qBDRs2vHXrlrrxv//976dPn6b8KD8AACi/BxoyZEh2dracCA4OfvLJJ+3s7BYvXvzRRx8NKHLs2LEGDRosXLhQRpv8xX3gwIEjR4488cQTssBSU1O7du1qZmZmb28fGxt78ODBZs2azZw5c86cObImly9fLpffvn277n3JtUaNGhUWFvbpp5+Kog98TJo0SW5fltylS5f0tiC7sF69ekuWLElOTta9o8zMTPkg+/fvLx9Vy5Yt1TO/sh179epVCa8SOyrlBwBANSq/yMjIjRs3/unVZf9pp/Py8tSJ/Pz8EhdWPwyqfWeeSvcDuaVsQfeORNGZaPm3RqNRb8qncOjQIcqP8gMAgPJ7iB9//DEqKqr6DlVERMR3331XOa8SOyrlBwBA9So/oXPwrDqqxAdPylB+AABUv/ID5Uf5AQBA+YHyo/wAAKD8QPlRfgAAUH6UHyg/AAAoP8qP8gMAAJQf5Uf5AQBA+YHyo/wAAKD8QPlRfgAAUH6g/Cg/AAAoP1B+lB8AAJQfKD/KDwAAyg+UH+UHAADlB14kyg8AAMqP8gPlBwAA5Uf5UX4AAIDyo/woPwAAKD9QfpQfAACUHyg/yg8AAMoPlB/lBwAA5QfKj/IDAIDyA+VH+QEAQPmB8qP8AACg/Cg/05aenn7z5k3KDwAAyo/yM2Z5eXmvvvpqvXr1LC0te/XqdejQIcoPAADKj/Iz2vLbunVrfn5+YWHh8uXLu3XrRvkBAED5UX5l5tdffw0KCgoMDDxx4kSVGoXz58/LqnvoaV/KDwAAyo/ye7jjx48PGDDghRdeGDRo0KhRo3r16tWzZ09DTrBWjPXr13fq1Ekv8krEHgMAAOVH+ZXmyJEjEydOvHXrlu7M7Oxsf3//7777rgIewNmzZ73ut2PHDu1PL168aGFh8b///c+AXZp9GgAAyo/ye7CCgoLg4OAH/TQiIiIvL6+8H0N4ePj4+y1atEj9kezRDh06yBY0bJdmnwYAgPKj/AwTGBi4dOlSObFr166zZ89W+pPPycnp3bv3/PnzDd6l2acBAKD8KD8DnDx5csCAAQsWLFBvvv/++5X7zAsKCkaOHDl27Ni8vDxNEcoPAADKj/IrG56enjdu3Pjqq6/kdFZWVvPmzVNTUyvxmScmJup9euP48eOUHwAAlB/lVwbi4+OdnZ2XLl26devWQYMGde7cuRru0uzTAABQfpSfYS5duuTm5jZ8+PB169alpKRQfgAAUH4wzvLbsGHDrFmzqvkuzT4NAADlR/kZID4+3tfXV3tz586dlB8AAJQfjLP8goKC6tevb2Zm1qRIdawoyg8AAMqP8jNIZmamr69vWlra7SKrVq2i/AAAoPxgnOUnHT582MfHx8vLy9PT087OLj8/n/IDAIDygxGWX0xMzJgxY9544w0nJycHB4eZM2dWw12afRoAAMqP8jPAnj171P6LioqSE5988gnlBwAA5QfjLL9Tp04NHTo0NjZ2+vTpkydPtrS0zMvLo/wAAKD8YITlJ505cyYrKyszM9PNze2HH36ohrs0+zQAAJQf5WeA9PR0BweHpKQkOR0SEnLhwgXKDwAAyg/GWX7btm3z9vZWP88r/54yZQrlBwAA5QfjLL+AgICMjAx1+urVq02aNMnNzaX8AACg/GCE5ZeUlDRhwoRvvvnGz8/P1tZ2/Pjx1XCXZp8GAIDyo/wMk56evnHjxrFjx8r+y8rKovwAAKD8YLTlV/13aYYLAADKj/Kj/AAAoPxA+VF+AABQfjCV8svPz09NTU1PT8/IyMgscufOHXlz06ZNlB8AAJQfjKr8ZOrVr1+/aRFZTk2aNJETjRo1srKy4tvbAACg/GBU5SdFRkbKv3ft2hUVFaXOKSwsXLJkSTXcpdmnAQCg/Cg/A/j6+qakpKjT+fn5Xbt2rXYXdqH8AACg/Cg/gyQmJr7xxhsrVqxYvXp1//79uZIzAACUH4y2/KSMjIzAwMBx48b5+fndvn2b8gMAgPKDcZbfhg0bZs2aVc13afZpAAAoP8rPAPHx8b6+vtqbO3fupPwAAKD8YJzlFxQUVL9+fTMzsyZFqmNFUX4AAFB+lJ9BMjMzfX1909LSbhdZtWpVVXj+qamp2k8cU34AAFB+lF+ZOXz4sI+Pj5eXl6enp52dXX5+fuU++Y4dOzZt2vSZZ56xtbU9cOAA5QcAAOVH+ZWNmJiYMWPGvPHGG05OTg4ODjNnzqz0Jx8XF6dOyB61sbGh/AAAoPwov7KxZ88etf/Ub/L45JNPqs4onDhxom7dutnZ2ZQfAACUH+VXBk6dOjV06NDY2Njp06dPnjzZ0tKyKnxvb1hY2IoVK2xsbFxcXAzYpdmnAQCg/Cg/w5w5cyYrKyszM9PNze2HH36osPs9e/as1/127Nih/sjd3b1Pnz6tW7fWezw1HoA9BgAAyo/ye6D8/PzU1NT09PSMjIzMInfu3JE3N23aVGFPMjw8fPz9Fi1apLvA4cOH//KXv8hH+LBdmn0aAADKj/J7MJl69evXb1pEllOTJk3kRKNGjaysrKrC2V5VQUGBmZnZQz/eS/kBAED5UX4PERkZKf/etWuX+tkOqbCwcMmSJZX7zK9fv37y5Ek5odFo1q9fX6tWrYsXL1J+AABQfpRfGfD19dVeMzk/P79r165ZWVmV+MzPnTvXvHnzJk2amJubd+/effPmzQbs0uzTAABQfpSfARITE994440VK1asXr26f//+48ePr/QnX1hYePXq1evXrxu8S7NPAwBA+VF+hsnIyAgMDBw3bpyfn9/t27er4S7NPg0AAOVH+RksJSUlqYhMQMoPAADKD8ZZfqdOnerRo0ezZs0sLS1btGjxxBNPUH4AAFB+MM7yW7NmTVBQkPbm0aNHKT8AACg/GGf5JSUlBQQEaG+GhYVRfgAAUH4wzvILDAx88sknq/U3oVF+AABQfpSfQZKTk0NCQrL/sHHjRsoPAADKD8ZZfqLo63F9fHy8vLw8PT3t7Ozy8/MpPwAAKD8YYfnFxMSMGTPmjTfecHJycnBwmDlzZjXcpdmnAQCg/Cg/A+zZs0ftP/Xbez/55BPKDwAAyg/GWX6nTp0aOnRobGzs9OnTJ0+ebGlpmZeXR/kBAED5wQjLT3bemTNnsrKyMjMz3dzcdu7cWQ13afZpAAAoP8rPAD4+ProH+ebMmaPRaCg/AAAoPxhb+Xl4eFhYWFhbW7dt27Zdu3bPPfecjY0N5QcAAOUHIyw/yd3d/cyZMzFF4uLicnJyquEuzT4NAADlR/k9opSUlOq5S7NPAwBA+VF+BiRdaGjo8uXLMzMzp06d2q5dO2dnZ8oPAADKD9Ws/AxMus2bN+fm5n7//fdPP/10WlpaeHi4XIXyAwCA8kN1Kj8Dky4yMnLVqlWtWrUKDg7WaDRjx47l29sAAKD8UM3Kz/Ckiy4iJ/bv3x8QEFBQUED5AQBA+aE6ld//b+/+Y6uq7waOq6AjwApjFZuNLcwgcXlq4clgIaQzZZMJ2VAWu8wMUNz6BxCnVVjGANs/QMhoUpY52pQGgRWmXVlqwgxZqtSsMkRSGIHaSZUfA6G2SIEipbTlPPeW2YFWLM9Aes95vbKYc+tJtn7O9+a+9733noYg6ZQfACg/5dcjq1atmjt3bjSWtDUNAMov2uW3f//+4uLiroeJ+GfZlB8AKD/l1yMbN24cMGBAUlLSkE6flkch2BpUfgCg/KJefmfOnCkuLm5qajrVafXq1d2eFoKtQeUHAMov6uUXc+7cudLS0vnz51dXV3/aOT3cGlR+AKD86L3l19HRkZaWNnHixIULF06fPv3T3tLt4dag8gMA5UfvLb+Kioo9e/Z0PVy/fn1jY2O3Z/Zka1D5AYDyo/eWXyz1Wlpauh7m5+c3NDR88rQebg0qPwBQfvTe8quvrx87dmx2dvaCBQvS09OnTZvW7Wk93xr8PL355pu33HLL4sWLlR8AKD/l1yMnT54sKiqaM2dOVVXVp53Tw63Bz1N7e/u99947ZswY5QcAyk/59chrr712/Pjxzzyth1uDn6ff/va3zz777AMPPLBkyRLlBwDKT/l9to0bN+bn5+fl5b3xxhtXPrMnW4OfmyNHjqSlpZ07d075AYDyU35XbcuWLVOmTCkoKGhra+s9v2FNTU3B5crKymI/f+ihhy7eTbrb8rvpU1gxAKD8Il1+tbW1+/bt+9WvfvWVr3wlllOx/utVv2FlZeXMy+Xk5Lzyyiv33HPPW50mTJjwxBNPvPfeez1Y0tY0ACi/aJdffn7+0KFDn3nmmSNHjiTKr11aWnr3RwYOHJicnNyTu8woPwBQflEvv1dfffXUqVNdD6+wedY77+Tsc34AoPyU31XYunVrUVFRQUHBypUr09PT29vbP3lOr72Ts/IDAOWn/HqqtrZ2xowZsX7Kzs7Oysp6+umnuz2td97J+SqXtDUNAMov2uX38ssvX+y/nTt3xg4WLVrU7Wm98E7Oyg8AlJ/yuzq7d++eMmXKvn37nnzyydmzZ6ekpJw/f/6Tp/XCOzkrPwBQfsrvqu3du/fs2bNnzpxZvnz5q6+++mmn9ao7OSs/AFB+yu8q5OTkrFmzpufnHz16tKCgIC8vL3ag/ABA+ZFI5ffQQw+1t7dv3749dvDEE0988MEHVzi5sbFx0KBBmZmZS5YsmTZtWmFhofIDAOVHwpRf181QFi9eXFtbe+WTY6l36dd+n3nmmY6ODuUHAMqPxCi/vLy8iwdFRUXHjx+/eFxXV9ftyfv27Vu5cmXXw1WrVp0+fVr5AYDyIzHKb+rUqSs7/fSnP12+fHns4Lnnnvve97536TnNzc1paWn/0+lLX/rS6NGj/7dTRkZGAi5paxoAlF9Uy+/2229PTU0dfYnYw379+n3stPz8/L2fcOLECeUHAMqPhCm/TZs29fCHF23YsGHp0qWxg/Ly8pqaGuUHAMqPhCm/q1JdXX3//fcvXLjw4sOf//znyg8AlB/hLL+VK1c2NDSsXbs2dnz27NmhQ4cm3Bu+yg8AlJ/y65H9+/fn5uYuXbr0hRdemDx5clpaWgIuaWsaAJSf8uuZf/3rX8uXL//Rj370+9//vusuMMoPAJQfYSu/06dPZ2Vl1dfXx443b9588OBB5cd/KbeTOQAoP3pd+ZWWlhYWFra3t8eOY/+cM2eO8uO/zL6bOok/AOVHryu/kpKS5ubmi8dHjx4dMmRIa2ur8uO/zD7xB6D86I3lV19f/9hjj7344ourV68eN27czJkzE3BJW9PKDwDlp/x65vTp088///wjjzwS6793331X+fH/dPhwsGhR7sCBsg9A+dF7y2/r1q1FRUUFBQUrV65MT0+/+Jk/5cdVOHYsmDcvSE4OZs2K9Z9veAAoP3pp+dXW1s6YMeOBBx7Izs7Oysp6+umnE3BJW9Ofn49XXVNTMH9+MHhw8Pjj8f4DQPnRm8vv5Zdfvth/O3fujB0sWrRI+XGF7PvPO7mx5uva5ztwwHAAlB8JUH67d++eMmXKvn37nnzyydmzZ6ekpJw/f175cYXs+3f8JSXZ5wNQfiRY+cXs3bv37NmzZ86cWb58eUVFRQIuaWv6RpTf3LlmAqD8SIzyi6Xe7u4sXbpU+fGZ8ecLHADKj0Qqv5MnTw4aNCg1NfWeyw0YMED58akaG3P79ct96imTAFB+JFL5xbz++uuf/OGbb76p/PhUublBAt7rG0D5ofz+o7a2dtmyZUuWLPnnP/+ZmEvamv5ctLQEKSnBrl0mAaD8SNTye+edd4YMGfLoo4/+5je/efDBB3/9618rP7q3YkWQmWkMAMqPBC6//Pz8oqKirocLFy48c+bMjf3lv/3tb99yyy19Os2YMUP59QptbcGIEUFVlUkAKD8SuPzq6urWrVvX9XDlypWtra0XLlx46aWXbmD5Xby/dI+XtDV9/ZWUBBkZxgCg/Ejs8istLe3fv//tnZKTk/v16xc7SEpK+tnPfqb8+Le2tmD48CAB7/UIgPJTfpf54IMP/vjHPx693KFDh/7whz/cwPL74he/+IUvfOE73/nOW2+9pfxuvPLyYPToeP8BoPxIxPLr6Oi4wg1cdu7c2Xb9X+ZramoKLldWVhb7+WuvvdbQ0FBdXf3ggw/+4Ac/+FjkdcuKub7S04NNm4wBQPmRqOUX8/e//33t2rWtra2X/jD2MPbDv/3tb5/D/4DKysqZl8vJybn0hHfeeefWW289fvz4Zy1pa/p6qqiw4Qeg/Ej48ovZsmXLhAkT7r///kcfffTHP/7x+PHjv//972/durWXTKGhoaFPnz47d+5UfjdSRkb86x0AKD8SvfyCzrd9t2/fvnbt2pKSkl27dsUe3tjf/MSJE3v37o0dNDc3z5s374477mhpaVF+N0xVVZCaasMPQPkRkvLrbfbv3z9w4MChQ4f279//a1/72pYtW3qwpK3p62bSJBt+AMoP5XcdnT9//uDBg4cPH75w4ULPlrQ1fX1s2xb/c202/ACUH2Etv/b29gRc0tb09TF1avwvtgGg/Ej08jt79uzu7ixdulT5EVdbGwweHHzWhywBUH4kQPmdPHly0KBBqamp91xuwIAByo+4mTOD3FxjAFB+hKH8Yl5//fVP/vAKt3dWfhFy4ED8E36NjSYBoPwISfl1OXfuXGlp6fz586urqxNzSVvT19rjjwfz5hkDgPIjbOXX0dGRlpY2ceLEhQsXTp8+fe7cucov6hob45/wq6szCQDlR9jKr6KiYs+ePV0P169f35ho7/Epv2ssNzfIyjIGAOVHCMsvlnqX/pGM/Pz8hoYG5Rddzc3xDb8DB0wCQPkRwvKrr68fO3Zsdnb2ggUL0tPTp02bloBL2pq+dvLygunTjQFA+RHO8gs67/BSVFQ0Z86cqqqqxFzS1vQ10tISDBsW7NplEgDKj3CW36pVqxLxWx3K77ooLg4yM40BQPkR2vLbv39/cez1/iN//vOflV9EtbUFI0bY8ANQfoS5/DZu3DhgwICkpKQhnRKxopTftRH7PwCTJhkDgPIjzOXX1NRUXFwc++epTitWrFB+ETViRJCYH/QEQPkpv54qKio6f/5818Nf/vKXbW1tyi9yysqCceOCRLv0ACg/5XcVVqxYkZycPGLEiLvuumvkyJF33nnn6NGjlV8U3X13sHmzMQAoP8JcfkHnrZv37t1b26muru7cuXMJuKSt6f/Opk3BmDHGAKD8CH/5XXT8+PH6Ths2bFB+kZOREaxZYwwAyo/wl9/u3bvHjx9/++23p6Sk3HHHHTfffLPyi5aKivhbvT7hB6D8iEL5/e53v9u4cWPXw+3btyu/aPnhD4PCQmMAUH5Eovzq6+tLSkq6Hm7ZskX5RciePfE/12bDD0D5EZHy27Bhw2233XbTJZRfhGRmBsuWGQOA8iMq5dfY2Lh58+aWj7z00kvKLyoOHAiSk4OmJpMAUH5Epfxizp07V1paOn/+/Orq6sRc0tb0/0t2drB4sTEAKD8iVH4dHR1paWkTJ05cuHDh9OnT586dq/wi4fDh+Cf8bPgBKD8iVX4VFRV79uzperh+/frGxkblF37Z2cG8ecYAoPyIVvnFUq+lpaXrYX5+fkNDg/ILuVjcJyfHt/0AUH5Eqvzq6+vHjh2bnZ29YMGC9PT0adOmJeCStqavUm5ufM8PAOVH1Mov5uTJk0VFRXPmzKmqquo9I/jwww+PHDly4cIF5XeNNTUFgwcHtbUmAaD8iFz5nT59Oisrq76+Pna8efPmgwcP3vBf/tSpU1OnTk1KSvr617/+3e9+V/ldY7m5wcyZxgCg/Ihi+ZWWlhYWFra3t8eOY/+cM2fODf/lZ82a9ZOf/OT8+fOx4/fff1/5XUstLUFKSrBrl0kAKD+iWH4lJSXNzc0Xj48ePTpkyJDW1tYb+JvHgq9///5XtfWo/K7Cc8/F/1AvAMqPaJZffX39Y4899uKLL65evXrcuHEzb/T7gIcOHRo0aNDy5cuTk5OHDRu2bt26j0Vet6yYHmlpCYYPD3bsMAkA5UdEyy/o/Kjf888//8gjj8T67+zZs5/bf29NTU3B5crKyqqrq/v27ZuZmRlL0tLS0qSkpItv+15xSVvTPbNmTZCRYQwAyo9Il9+NUllZOfNyOTk57777bqzkur5l/I1vfKOiokL5XRt33x1s22YMAMoP5ddbfPjhh3369Nn10VcQUlNTy8vLld81EBvjmDHGAKD8UH69y+TJk5966qmOjo69e/f2798/1oLK7xqIZd+aNcYAoPxQfr3L22+/fdddd331q18dOXJkYWFhD5a0Nf1ZNm0KUlODtjaTAFB+KL/e6OjRoz35Ax7Kr0cyMmz4ASg/lF84lrRxXdGOHfHvdtjwA1B+KD/lF35Tp9rwA1B+KD/lFwG7dsXv3mzDD0D5ofyUX/g9/HCwbJkxACg/lJ/yC7u6umDYsKCpySQAlB/KT/mF3cMPB7m5xgCg/FB+yi/sDhwIBg8Ojh0zCQDlh/JTfmG3aFEwf74xAHiZNAPlp/zC7tix+IZfY6NJAHiZNAPlp/zCbv784PHHjQEA5af8lF/YNTfHv9J74IBJAKD8lJ/yC7vFi+Pf6gUA5af8lF/ItbTEN/x27DAJAJSf8lN+YZeXF0yaZAwAKD/lp/wiYPhwG34AKD/lp/wioKwsuO8+YwBA+Sk/5RcBqalBVZUxAKD8lJ/yC7vy8iAjwxgAUH7KT/lFQGpqUFFhDAAoP+Wn/MJu06ZgzJigrc0kAFB+yk/5hV16elBSYgwAKD/lp/zCbtu2+Fu9NvwAUH7KT/mF3333Bc89ZyUAoPyUn/ILu9raICUl/kfbAED5KT/lF3JTp9rwA0D5KT/lFwG1tUFyctDUZBkAoPyUn/ILu6ysYN48awAA5af8lF/Y1dUFgwfb8ANA+Sk/5RcB2dnx/wCA8lN+CWr37t19LhGrur/+9a/KrxtNTfFP+B075tkCgPJTfmGwc+fOIUOGtLa2Kr9uLFoUzJplkQCg/JRfSPziF7+YPXt2D5Z09MbV3BwMHx7/nB8AKD/lFwKtra1f/vKX33jjjY9FXrciN53Fi+Pf6gUA5af8EkVNTU3B5crKyrr+7Z/+9KeRI0f2bElHbE23tATDhgUHDnieAKD8lF/CqKysnHm5nJycrn87efLkJUuWKL9u5OXF/24HACg/5RcO7733Xt++fQ8dOqT8Pq6tLb7ht22bJwkAyk/5hcSyZcsmTJjQ4yUdpXGVlQWTJnmGAKD8lF94jBw5cs2aNcqvG8OHB5WVniEAKD/lF9klHZlxvfBCMGZM/A1fAFB+yk/5hdzo0UF5uSsOgPJTfsov7CoqgrvvtuEHgPJTfsovAjIygpISlxsA5af8lF/YVVYGKSnxezgDgPJTfsov5DIzg8JC1xoA5af8LOmwj2vPnvjdm5ubXWsAlJ/ys6TDPq7p04MVK1xoAJSf8iPs5VdbG/+EX1OTCw2A8lN+hL38srODZctcZQCUn/Ij7OV34ECQnGzDDwDlp/yIQPllZwfz5rnEACg/5UfYy+/wYRt+ACg/5Uc0yi87O5g1y/UFQPkpP8Jefs3N8Xv41dW5vgAoP+VH2MsvNzfIynJxAVB+yo+wl9/FDb9t21xcAJSf8iPs5VdYGNx3nysLgPJTfoS9/NraguHDg6oqVxYA5af8CHv5lZQEGRkuKwDKT/kRgfIbPTrYvNllBUD5KT/CXn7l5UF6evwNXwBQfsqPkJdfLPs2bXJNAVB+yo+wl9/mzcGYMTb8AFB+yo8IlF9GRrBmjQsKgPJTfoS9/LZti9+92YYfAMpP+RH+8ps0KSgudjUBUH7Kj7CX344d8Q2/lhZXEwDlp/wIe/lNnx7k5bmUACg/5RdRJ06ciEr57dkTpKQETU0uOgDKT/lFzpYtW771rW9985vfHDlyZGFhYYjLL7dTMGtW7MiiB+C6vNAoP+XXy40fP76goCB28I9//CMpKen06dOhLL/OJ2NcblKSDT8AruMLjf0F5debDRs27JVXXokdnDp1qm/fvocOHQpf+XU9Gz0nAfBCQ6TLr7i4+N577129enVmZubs2bM/Fnnd8oQEAC80yq9Xq6mpKbhcWVlZ7Oe7du0aNWrUuHHjhg0bVl5e/tnDSvR3ez0bAfBCo/xCr7KycublcnJyLly4MHTo0L/85S+xE44dO3brrbfW1dWF+Dnpg7cAXN8XGtmn/Hqzt99+++abbz5z5szFh6NGjVq7dm2oL7XyAwDlF1UXLly48847161bd7ECb7vttiNHjig/AED5hdPGjRtHjRoV67/hw4c/++yzYb/Uyg8AlF/kvf/++9G41K41ACg/onKpXWsAUH4oPwBA+aH8AADlh/IDAJQfyg8AUH4oPwBA+aH8AADlh/IDAJQfyg8AUH50IzdG+QGA8jOCKGTfTZ1iB6YBAMqP8Gef+AMAlJ/yAwCUH6GLP9kHAMqPSMSf7AMAlB8AgPIDAED5AQCg/AAAUH4AACg/AACUHwAAyg8AAOUHAIDyAwBQfgAAKD8AAJQfAADKDwCA3ur/AKgEaQUyrOcgAAAAAElFTkSuQmCC</FILE></FIGURE><FIGURE FILENAME="Adjusted Boundaries Sketch.png" FILE_TYPE="PNG" ID="FIG-06" MODIFIED="2017-12-08 17:33:07 +0000" MODIFIED_BY="Hermann Blessberger" NO="6" SHORT_VERSION_FIGURE="YES" TYPE="OTHER"><CAPTION><P>TSA supraventricular arrhythmias&#8212;cardiac surgery.</P></CAPTION><FILE>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</FILE></FIGURE><FIGURE FILENAME="Adjusted Boundaries Sketch.png" FILE_TYPE="PNG" ID="FIG-07" MODIFIED="2017-12-08 17:33:09 +0000" MODIFIED_BY="Hermann Blessberger" NO="7" SHORT_VERSION_FIGURE="YES" TYPE="OTHER"><CAPTION><P>TSA ventricular extrasystoles&#8212;cardiac surgery.</P></CAPTION><FILE>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</FILE></FIGURE><FIGURE FILENAME="Adjusted Boundaries Sketch.png" FILE_TYPE="PNG" ID="FIG-08" MODIFIED="2018-01-31 17:38:47 +0000" MODIFIED_BY="Hermann Blessberger" NO="8" SHORT_VERSION_FIGURE="YES" TYPE="OTHER"><CAPTION><P>TSA acute myocardial infarction&#8212;non-cardiac surgery.</P></CAPTION><FILE>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</FILE></FIGURE><FIGURE FILENAME="Adjusted Boundaries Sketch_rm5.png" FILE_TYPE="PNG" ID="FIG-09" MODIFIED="2018-01-31 17:38:51 +0000" MODIFIED_BY="Hermann Blessberger" NO="9" SHORT_VERSION_FIGURE="YES" TYPE="OTHER"><CAPTION><P>TSA supraventricular arrhythmias - non-cardiac surgery.</P></CAPTION><FILE>iVBORw0KGgoAAAANSUhEUgAABHQAAANyCAIAAACMkAtyAACAAElEQVR42uzdB3hUZb74ce7uev1fV5e761qv7koNKdSE3uvSmyICgoBKU4r0miFI7x1BQHoHCb230DuBANI7gVRCevv9f28OjiFA6JAJ38/Dk+fM5GTmzJtB5us55z0ZBAAAAADw1DIwBAAAAABAXAEAAAAAcQUAAAAAxBUAAAAAgLgCAAAAAOIKAAAAAIgrAAAAACCuAAAAAADEFQAAAAAQVwAAAABAXAEAAAAAcQUAAAAAIK4AAI4uMTGRQQAAEFcAgMc2Z86c4OBg+83jx4/Xq1dPv+7bt08X/P39k6/s7e3t6ek5duxYm82m37p582bHjh07d+586tQpa4WVK1e2b99e71+yZEnbtm1HjRqlNwcMGNCvXz9dLTIy8hG3SjdAf3zWrFnWzdDQ0MGDB1tPat2zcOHCnj17jhkzZvTo0X369Ll06ZLeOXLkyIEDBw4fPnzEiBGP8iwzZsyoWrVqmzZtQkJC9GZYWNiUKVNmzpy5aNEi+zrXrl3Tp9CvuhwXF9e9e/evvvrqm2++adKkyZo1a5Kv1rhx44iIiMca/HHjxnXp0kW3tl27dkOHDtWx7du37zP5tepA6fbcvn3bfs/kyZP79+//oPUDAwN1G7Zs2fJMnv3IkSPNmzfXtwF/vwCAuAKAV8X169f/8Y9/aAjZ79E8yJUr165duwICArJnz37x4kX7tw4ePFi0aNGoqCj9yF6/fv3NmzfrnRpO//znPzV+rHXWrVuntaAL2gm6rI//0Ucf6cd6XaF169YXLlx49G1r1apVhgwZ1q9fb93U7NFwspb1ocqWLWsFz+nTpwsUKHD48GENOf0RvefQoUPVq1dP3hX3pZunPbN9+3Z3d/dGjRpZz6i1pgvffvut1XWJiYm62ocffmjV4/79+3v06LFgwQKNzMqVKycft/Dw8I0bN8bHxz/W+GvPaIf4+vr+7//+74YNG3S0dRv0oZ7+N6u/R90ercHkIVetWrVUfqRMmTL2mn1Kly9fTvHmAQAQVwCQzs2dO7dWrVr/+c9/kt9ZpEiRHTt2xMbG5s6dO3kOrV69WjtKY0aXz549qz2jC9owmk+//PKLtc6QIUM0FXTh/Pnz+lVjI3PmzIsXL7ZCTlfWH9yzZ48uP3Tbpk6d+vnnn7/zzjvnzp3Tm1pZVsxohLzxxhsnT560r6kp+Ntvv7Vt21bzICEhQe/R7X/obhNtsJiYGF1YtWqVvuTAwEBXV1erBxYtWqTxZq2m26y1aT2dJqL1IxotGmD6I/ZH03v0pg6absDRo0f37dtnD06LfuvAgQP62qOjo+0/Yg2vVqK+TN0eXb506dLu3bu1uPR59UF0kHU1XUEf094tO3futPbUpeDv76+Pb3WgjnxQUJD1XPqi9ME1PuvUqWOtqc+7bdu2W7duWQGpG6YvsEqVKvPmzUv+gLoNOpL61GFhYfrC9dF0S86cOaO/Yv0pfUzdVI1t6yXcuHHDx8dHN8D6QS1eXU0L3GpgAABxBQDpWXBw8KBBg/Sz74cffqif1+33Fy5c2IorjYrkcaWf8itXrvzaa69NmjQp+eP06tUrT548knRomS4n/5b+iD2u1IoVK/RnNRi0wR66eePGjdPP8bVr186bN6/e1I/p1tF6rVq1ypEjx73rnzhxQhNFv6Wf+B9rHKZNm9a1a1ctAd1U67g+fYRMmTJZy9oJOXPmTN5yVrx9//33ye/ZunVr9uzZQ0JCJk6cqB3o7e2t4Zp8hebNm2u6zJ49u1OnTik2wIqrgwcPWjc9PT1LliypCy1btqxZs6YurF27Vn9TknRY5o8//njs2LFPP/10wYIFyR9Ec6tHjx5arfrjGjz6C9Xt0eDRBOrYsaO2buPGjT/77DNdc8uWLTqSM2bMKF68uL66sWPHTp48WQsqS5Ys9t+UJO2L09eogac/Vb58eX2En376ycXFpVu3bj/88EOHDh103DR3dVm7S+u0UaNGo0eP/ve//z1hwgT9cX3zDBgwoGfPnoUKFdI2468bABBXAJCeLVy4UD9V64J+gm/QoMFD40qS9ofoJ+YMGTLUqFHDfgLVlStX/v73v2td2HcuPSiuNDz0U7h+4rfOcbIkJCRo5mmYWTtS7MaMGXPu3Dl9Fo2EZs2a6eNbD65doZ/X7/uK/P39a9WqpZs3fPjw5Pfrp//AJPee9KUFpXmgG+Dj45M1a1ZrV8/+/fs/+ugj61S0+8ZVv3795s+fn/wefXBdzTr6UTNDyyT5a1TLli3TF65FVKJEidTjSjPJ3d1dN2zVqlVOTk56z6xZs3QodKAKFixo7TDUTNVh0W3TZ7T2mP3222+6sv7i9E5dU+/XX5+2Vv369a0zqaZPn27tudJe1Qdcs2aNDqMOlI6ndTRjtWrVku+50p/Sd4IknZWn61jNqa/RGiLdgKtXr+pXa526desOHTpUF5YvX547d259dvugaRvv3buXv24AQFwBQHrWrl27IUOGaF917dr1n//8p/0MmQfFlbaBddDdkSNH/vrXv2pl2b/1zTffVKxYcdiwYQEBAanEVWJi4vfff/+3v/0t+V6doKCgr7/+WgPPy8sr+c+OHTvWOgTx2LFj7733XqVKlVavXq03dbX333/ffnCdPZ/sTz1+/Pg//elPVoRY9OVoUehTpGg/STr40Doe78SJE5or1j4WDTl97da0gffGlb6ohg0bppjqQ1+FFTO6foUKFf71r39poSVfQdtJhzqVuLI2w/LVV19NmDBh9uzZpUqV0p+aMmWKFbGZMmWyfiMaNs7Ozps2bdI19XWNGzdOkubnyJgxY9u2bSVpco58+fIdP35c28baeA0qDS3dPC00fUar/TSwS5cubT2pdmnyYtRmK1q06MaNG3/++WcdJb1HG0nvsb579OhRTeWlS5dqLevNevXq6e9LF86cOaNlqG8VfV7r0ND8+fM/7r5EAABxBQCOxMfHx/o0bNEP3JpY1rJ+XN61a5d1zlXyOQm0nawzapSmTvLD2/SjdoYMGfr165fiWbRDPvnkE/vkexo8WkGaBC4uLvb9VNowMUn0GZP/7NChQzV4rGVvb299fCvSdJM0z6yZJyyXL18+e/Zsr169rKkgNBu0vjSo7CtoE1pPkWLCCX1Y63hIDTONFn1R1s3Ro0e3bt3aWkdrRMfht99+s/+UrtOyZcsUr1TjSlfTLdHy1JsjRowoV66c/bu6YVpoupGaGVaNJKel9Pbbb9v3XFm/nf/7v/9bsWLF+vXrP/zww3379lmvQvtNc0iX/fz8NNKioqJ0hK3TwHT79dn1tesT6QjrYGre6D2aylqbVkZaO6B0hTlz5livWt8DGmyabXqzcuXK1v1206dP16C1n99ljyt9Un3wo0kKFChgxdXIkSMlac+VlqeOsz6LFVceHh76duJvHAAQVwCQPumH8lq1alnnxlgaN25sTVZx7dq1rFmzzpw5UyPho48+2rBhg32dKVOmlC5deuXKlbNmzapZs6Z+cE/+mPoIKfbVWJGQMWPGLl26WDuaxo0bp92ij+zp6Zn65aS0N8qUKZN8C202m/2gta1bt+pH9h49eixdulSbQbdWH61Ro0baPFu2bNEHb9OmzUMHQX9Ww08TqFixYiVLlrx58+b27du1GDVyunfvbi8KDQMdB80w+w/26dNHnzHFo2k1aQ5p0fXs2VOjaNWqVfpK7d/V/tHI+eKLL3QMc+TIYZ8C0aK99Prrr+vgWDsGJWn2i6+++srf31+rrFmzZtakEZJ08lWdOnW0rLQ89ReR/EG0ezUItTw1MjWWtGN1e3T8NbT0GQcOHPjdd9/pK9Wm1Rf+3nvvaWjpQIWFhbVv317v1w3T6uvWrZv9AfVBNLnr1q2rm/3jjz/qtml6aYlZnVmqVKnatWtPmzbN2dlZfx1NmzbVmzr433777cmTJ/WNpE2oT62jqoOcotkAAMQVAKQf+pH91KlTWkfWp/nIyEj9UH7u3Dn9KBwUFHT+/Hn9YK15owvJp3q7fft2QECAfmq3TuxJ8Zj6MT3FfiENngsXLugjnzlzxjrcTp9XP3mfOHHC2tmSCt0S/YCum2SfTFzzLPm8CPpQmzdvXr16tX7WtzotJCTk+vXrO3fu1C18lAsBWxPf6TjoI9hTSl+4xlXyvWo6SvoqdAX7luhW3Ttbuj61DpfmUHBwsMbP2bNnU2yDbt6xY8f0QfShkp9dpvfoynqnbow9oiTpZDBrA1KcJ6a/F+29FGVrPY5u2NGjR63j/aztsX59+nXv3r36u7P/1vSXogNlfwpfX1/9peiWJ995qLm4aNEiDWYd5759+2rX6XtDn8Ka6VFfgr4cXV9HTN9FX375pfabPoh1tGRgYKA+u3VynS48yuSQAADiCgCA9KlZs2bt27fX8jx+/PjSpUtTn1G9atWqgwcPZtAAgLgCAAApBQQE9O3bt3PnznPmzLlx40Yqa+p3e/ToMWzYMGt+RQAAcQUAAAAAxBUAAAAAEFcAAAAAAOIKAAAAAIgrAAAAACCuAAAAAIC4AgAAAAAQVwAAAABAXAEAAAAAcQUAAAAAxBUAAAAAgLgCAAAAAOIKAAAAAIgrAAAAAABxBQAAAADE1cOFh4dfuHAhJCQkMTExPj7+aR4qISEhNDQ0KirqQSvExsYGBwfzfgIAAACIq/Rm5MiRzZs3nzx58tixYytVqjRz5synebTjx4/nzp1769atD1ph586dn3/+Oe8nAAAAgLhKVzp16lSgQIGIiAjr5tChQ/v27fuUj1m0aNF169aluDM8PHzWrFm6EB8fHxkZyfsJAAAAIK7SjzNnzrz22mtr166133P79u19+/atSKI358+fv2zZMl04ceLE+vXrd+/ePWDAAP2pI0eO9OvXz8/PLyAgYOzYsTdv3rxw4cKYMWOuXr2qKxcvXlxX1gX9umjRok2bNulyt27dcuTIsX379nPnzq1evVqf6KeffpozZ45+6+LFi1OnTo2Li9PH0fV1OSwsjDccAAAAQFw5DG0bjasrV66kuH/UqFEVK1bUhdGjR1eqVEkXJkyY8Mknn2gm/fjjjzlz5tywYYM2VdGiRWNjY3PlyrV582ZdJ2/evNYOK42rnTt3rly5slGjRnqzfPnyZ8+e/fnnn3V9rSYNNldXV71/0KBBJUuW1IVDhw6NHDkyPDy8d+/eGmnNmzevUaMGbzgAAACAuHIYM2fO1LiydjclN3369OrVq+vCrFmzqlSpogu7du0qUqSILpw+fTp//vxxcXHBwcEFCxYMCQnRQLLiqkSJEva40vpKTEw8fvz4/v373d3dd+/e7e3tbQWbr6+v3qPf1dDSMDt37tzChQt1G7T06tWrt3bt2vHjx3fo0EGzjfccAAAAQFw5Bo2fP/3pT2vWrElx/y+//FKtWjUrrqpWraoLO3bsKFq0qC5oCxUuXDg+Pl7jqkCBAkFBQZpSW7ZsseLKOhrQuufy5ctdu3b19/fXptq5c+fSpUutnWBWXGme6XL79u2bN29uTaHRr1+/Vq1aWRsQm4T3HAAAAEBcOQztGRcXl4CAAOumls/Jkyd//fXXQoUK6c3+/ftrMunC9u3brXtOnTqlaaTlo1nl4eEREhJSunRpraOIiAhnZ+dFixbpOkWKFNm9e7eG03fffac3dTXtN29vb+sgwH379uXOnTsmJkaSTuV6++23rTbTfnv//ff1iXRj9AH18XnPAQAAAMSVw0hISNCCql279oABA4YPHz537lzNnrCwsFq1amkajR8/Xuvr1q1ben/lypWvX7++atUqrSk/Pz9tpLJlyx48eHDJkiUaYBMnTmzTps2CBQvOnTtXsWJFraN169Zpj02bNq1Hjx5dunS5ePGi3j9p0qQ5c+boDx46dMjagFGjRtmnrxg2bJibm9uXX36pD84bDgAAACCuHE9ERITGj0aU/Z74+Hhr55JKTEyMjY3Vr3FJrJv2BV1B19RIs1bWe3TZWl8X9Gvyx1TWtx501J8+lHXEIAAAAADiCgAAAABAXAEAAAAAcQUAAAAAxFVacfXq1e3bt+/du3fPnj2HDx8+dOjQvRca9vPzW7FihX69dOkSbw4AAAAAxNV9tGzZsmPHjtpOmzdv7tOnz1/+8pcdO3YkX8Hb27tRo0Z6p6enp3W54echPDz89u3bvPMAAAAA4sohxcXFaTtZs/xFR0fnyZOnW7duKdapVq3aoEGDJGkiwaFDh9qnGYxJYl8t+SyCKSQkSX0zNNsqV66s28CbDwAAACCuHJJ9/vRvv/22YMGC91ZQv379/vznP8+bN0+Xb9++bU2evn379pkzZ2qJzZkzR2/OnTt3/vz5Npvt4MGD+oBDhgwZOXJkkyZNFi1a5O/vrz/bpUuXlStX3ncDYmNj69atmyHJp59+Sl8BAAAAxJUD0zTKmDHjiRMn7vvdXr16aflUqVIlICBAb548ebJly5a6sGPHjjZt2owfP75t27Z6c8uWLdmzZw8JCfn6669r1qx5+PBhba1WrVrpgjbYe++9p6F174O3bt06QzLWIwMAAAAgrhzPpUuX3nnnnUmTJlk3Y2NjR40a1aNHj7Fjx9ov8quBlCVLFnd3d10eMWJEz5497T9epkyZmTNnWst58+Zds2bN4MGDO3bsqDd9fHwqVaqkDbZ+/frFixeHhobe++wHDhz4+OOPrbL6v//7v7179/L+AwAAAIgrh1S+fPm6devab2pHLVu2bO7cuevWrbt+/frq1aut+0+cOPHmm29euHBB06tmzZrWnZGRkaVLlx4yZIh1s2zZshs3bhw4cKAVV9u3b8+fP398fLy1ZlBQ0H034Pjx4x++//57777r6+vLmw8AAAAgrhxSz549M2bMePTo0Zs3b167dm3+/Pnt2rWzfzc2NrZChQpLly7V5SVLlnh4eGgpaV+99957P/zww6xZs7y9vX/99dfChQtHRUWdPXv2s88+0zX1W19//bUu6MoaV/Xq1Vu7du2IESPuneTd7sg33xzq1Yt3HgAAAEBcOaSYmJiBAwcOGTJEM2nq1KmTJ0/u3r27hlDydebNmzdp0qSJEycOGjTo3Llz1p0HDx7UfBo6dGhERITeXLly5c8//7xgwYLLly9HRkaOHTt22LBh1hlWWmItW7Zs3br18ePHU9uU5s2lb1/eeQAAAABx9aqzzzr4hJo1kx9/ZBgBAAAA4gpPh7gCAAAAiCsQVwAAAACIK+IKAAAAAHFFXAEAAAAgrhzUihUrvLy8iCsAAAAAxNWTO3z48LvvvpshQwb7hYOJKwAAgOclISHlPdHRcvu2WYiMlPDwlN+9eVMCAyUx0fygfk26ao5Z03oc/dmYGHPTWg4Lk/j4OwtxcY+xVbqy9cgWfSLdktjYu+7UjbxyxdxjbYzlxg0JCrrrntTdumUeNvkTBQSkfNV6p33aal3QV6R/9PEf8Snu+zjWoOlgJn8QfV5r6JKzns7+q/H3/+MmiKvU+fr6fvTRR2+88cZbb731+uuvjxgxgrgCAAB4jvQD0qFDf9yMipLGjaVTJ5M3FSvKmDF3rTxunHTrJhMnSs2asn27uUdXyJFD5s27s4LWTq1asnq1zJ1r1hk5UipVMpcbHTjQPNr584+6VVoR/ftLwYJy9uyde7y9pXx58fExy5pDutlt2sjkyTJ0qHmKrVvN/frRsWdPmTBBatSQffsenjpDhkiJEpIzp2zZcucefTR9Lbq1e/feWe30aWnU6M6j6Qo6OEWLSrlyUqCAWfnRXb8uLVvKsmX2T73i5SWLF8ugQXfqTpf1hWTPbgY5uXbtZOlSs3D1qnh6yn/+YwbWql8QV6k4evTom2++2axZM09PT3d394ULF2bIkGHYsGHEFQAAwHMRECDvvCMdO951p1ZNkyZmoWlT6dfvj/tPnhQ3N7MPSmnATJtmFvRT/kcfyahRd9bR7/7wg1n4+Wc5csQseHjI4MFmYerUhwdPcseOyWuvSbFiJrRUaKjJDEu9elK9+h/7fL7/XhYulFOnJHdus9/Mqqz58x/y+Bs3mo7ShuzVy7wuNWuW1K1rFg4eNPlkPf65cyZ4Nm0yy7/9JnPmyMWLZo9T+/Zm/UcXGGhaUWvQoo20bp1Z+O47E6s3bpimCg839fX226boLFqwmTPfaVfd4GvXzELp0qbEQFyl4tChQ1pWX3zxRdL/QPnR1dVVF2bPnq19NUiDnrgCAAB45jQVBgww8RAU9Med+tFLs8r6+JQ8rs6elTfeMDujrKayB8CQIeYRrKP+Vq6U6dPvVJZ1CFyBAmKd66GNFBkpu3fL8uWyefPDt+3wYRk+3OxWatzY3IyIMJuqtm6Vv/xFjh//Y01NDs0ejavXXzdRJ0kH+9l3eT3IlSt3dhmdOCF58piFGjXu7KnTrNJ7rF1zqkgR2bDBLOhrtBfdV1+ZR3gstWrJpEl3utHJ6U6magSWKWOWrZv6+Jqj1n4zfUWLFpmXbw2pNcK6Qs+ecvkyb17i6oEOHjyYMWPGOnXqJCS9Xz09PXPkyGF9a8aMGc+mr4grAACA5PTTvPURS+NBM+beuPr227viSk2cKBkymBhIfoBfYKC8+67JAEk6yPDixbt+xB5XVnr16GEWxo696+yj+9LAmDvXNNL/+38yerS5p39/89XLS957787urBRGjDCbV7ny42WPFqa17y5Xrj/2d2nh/PLLneXChe/EVfLwa9Xqrnu0mmrXlgYNzJ/69c2+NU2jFGrWvBNXmpf6WdfqtE2bJEuWP16Olt6nn5rBiYmR8ePN6VVacVZcSdIZZfrdggUlJIT3L3F1f7t27XrzzTc/1TfK77y8vNysnbPJ+upp5w8krgAAAJJbssTsAzlzRlq3FmfnP6ZJSCWuJGmvi7u7ZMxojp2za9tWSpUySWMdAfiguNq3Tz78UKZMuWsOCXX8uDnmbevWu04l0riy8kaD57XXzPFy1k4z3eYPPrhz+N+9dKv0Y+Q779y1a0tf2u7d5il0A1JEnVZK9+53dtzlyycLFvwRV1OnPjCuhg7VT6h33XP1qhw9Kn5+d/7oKN07NYU9rlatElfX+8fVwIF3Dp7Ux7dOMKtb1zStJTzcPHiJEuZXA+Lqvrp3716jRo34ZNOeJN9z9fv/C5hUoECByHvfo8QVAADAk34IMzttvL3NTqd3370za4LcfVigtbPInkDWoWuqWDH57LM/vnXqlKmmFi1kz56Uz1Kw4F0TP2il/OtfZsdOctOnm0kv2rW762g3bQz7vqNevcwRiZpwVpn86U/mBLB7q8+aSzAuTvLmvXPamCUqSmw2s3maLsln59PPn9ow587duVmjhtlZJEkTV2hA7tjxwLj68suUO+h0ZY1GfTT9oy9H/9y8+cC40pHUuLLmJNTBL136zgorVtwJKt2whg3NYYQ6UDpcLi5/zIQhSSdfVa/O+5e4ur+4uLjYu//vhZeXl3XOlV1CQkKU/q14GsQVAACA3ZYtd4XTd9+ZhLA8aEKLn382cWJp3NjMfZfcF1+YpLlXnjx3zpWSpNOlTp82e2ny57/PUXMpbN4sySc2q1JFKlS4s1y+vJl70D63u2bYlStmjg37vBoafp06PXwQdP2FC+XCBbNhGjzamZo0VvxUqvTHrrwCBe6Kq0OH7pwGlpymabdu0ru3+aMh5+kply6lXKdq1T/2QdWuLevXmwXdzrFjzcKvv5rt0Y05cMB8KybGzOGhmacDa80fqENnHQ1oJRyIq0d0756rZ4C4AgAAsOgH9xYt/ggn/QSv1eTsLGvXmpvt25t4uHjRTEHeseMfh/Dt2WOS4KefzBlQbdrcNQeGVWv3fuLfsUOKFzd7paxp7tatM+dcaclMnfqQi0RFRZlKqV//zg+qy5fFfhJ+WJg5lLFePVNfw4ebLFHbtpnzkSZNMvf88IOZ0+Kh8aaNV7asOcquVKk7Z5HpS5s1y8SM/aDH/fvNniUtN/s46MY/QdtoGlWvbl6UtcPq5Enp08ckmbWv7OpVU4y6GfrHw8OcnGanqWbd1J/V0NIf8fF57EtsEVfpT2Ji4qlTpw4ePPjQfVD37rkirgAAAJ6Z+HiTCvrH+oyuX61TmPSr9S39Ghn5x7LFumqwhs316/f5cH/f6/ZaFxfWB7GfIqWfA7XKHtoG+qT6I3Fxd51bleLiucHB5og++5GK1mNqU/n7P3y2DEk6evDe1fSewMC7TpfSDdZHjo7+49mtex6XPoI1zvYdbvo4+lzWQ1lXJX7Yh2lzTtp9Z/Igrl69v8LxjRs3zpkzZ7FixfLnz3/mzJlUVu7du7eLi8uz3YDwFi3C+/blnQcAAJDuhYaGxqcoMRBX6cmSJUs+/PDD4OBgXa5Tp06DBg1SWfmZ77mKi4urXrhw5RIloh80sQwAAADShWPHjn3yySdjrCtWgbhKl+bPn2/fGdWmTZvPP/9cF2JjY/39/W8kc/PmzaioqPbt2zs7Oz+rp9ZnqVevXoYkn376KX0FAACQXp08eTJTpkzWB7+J9tkjQFylPy1atKhUqVKTJk1Klix5MWnySh8fnz//+c//k+SNJG+++aYu618GDw+PZ/W8rVu3zpBMyxQz2wAAACBduH37tqura/IPfmvWrGFYiKt0KDAwsEaNGg0bNuzQoUOhQoU2b94s5qJtIevWrVufZEOSjRs37tq1q0GDBs/wsMD9+/d//PHH1l+wD//2tz0ffGBmDj1wgHchAABAOjNu3Lj/+q//sj746YfP28mvSgziKt3o0aNHuXLlrOUxY8bkyZMnlZWf+YQWR48eff/99995993DR47cuQx5jhzmknajR5tJWgAAAJBeTJgwQcuqZrVq0UysR1ylV99//33VqlWt5V9++cXJySmVlZ/HVOwHDx48kHxvVWSkzJ1rLg+nW1K/vrkwHFPKAAAApAtrSpYMnD+fcSCu0q29e/f+4x//aN++/ZgxY95///3+ya8I/kLi6oEuXJCePUWfLnducyGspJPBAAAA4MAqVhTiirhK3w4fPtyhQ4fmzZsvWbIk9TVtNtsznC3wkcTFmUuGf/GFZMkiVaqY63w/7ErHAAAASKP+8x/iirjCHc/jIsKPyt9fRo40p2PlyCEdOoifH78OAAAA4grElaOy2Ww5tG1eosRE2b1bvv1WsmaVEiVk6lQJDeX3AgAAQFyBuHIwL/Scq9TduiXTpkmZMuZwwaZNZdcu010AAAAgrkBcOYSXv+fqXidOSOfO4uIi+fPL8OHm6EEAAAAQVyCu0rg0tOcqheho8faW6tUlc2b5/HNZudLMhAEAAADiCsRV2uTp6Znm9lylcOmS9O1rZm/Pm1dsNnNhYgAAABBXIK7SmrS75yqFhATZtk2+/FI++UTKl5c5cyQ8nF8fAAAAcQXiKq14mVOxP5mAABkzRooUEScnad1aDh/mlwgAAEBcgbh6+Rxmz9W9Dh6U774TZ2cpVkx++kmCg/ltAgAAEFcgrl4aT09PJycnB34B4eEye7aUK2cuk9WwoWzdag4gBAAAAHEF4uoFc+A9VymcOiXdu0vOnGbeiwED5PJlfrkAAADEFYirF8cBZgt8LLGxsmaNmbo9c2YzjfuyZRITw28ZAACAuAJx9dylnz1XKVy/LkOHiru7uRhx167mwsQAAAAgrkBcPT/pbc9VComJsmOHfP212ZFVqpTMmCG3b/NLBwAAIK5AXD176XbPVQohITJ1qpQpY+a9+PZb2bOHXz0AAABxBeLqWUrne67u5esrbdqIvuRChWT0aLlxg/cAAAAAcQXi6hl4VfZcpRAVJUuWSOXKkiWL1KsnGzZIfDxvBgAAAOIKxNWT6927t4uLy6v7+i9c0L6UXLnMH104e5a3BAAAAHEF4oq4elLx8bJ+vZnAPVMmsztrwQKJjOS9AQAAQFyBuHoMNpvN2dmZcbjj5k0ZM0YKFxYdk7ZtzQlaAAAAIK5AXD0K9lzd3/790rKlZMsmxYvL5MkSGsqQAAAAEFcgroirJxUWZi6NVa6cmcC9YUPx8WFIAAAAiCviCsTVUzh5Ujp3Fjc3KVhQBg2SK1cYEgAAAOKKuMJdOOfqMcTGyooVUqOGfPKJ1K4tK1eaewAAAIgrEFcgrp7Q5csyeLC4u4urq3TvLqdPMyQAAIC4AnH1quOwwCeXkGDOwvrqK3Ml4nLlZO5cCQ9nVAAAAHEF4oq4wpMKDpYJE6RoUTO7YIsWZqZBAAAA4grE1avGy8vL1dWVcXg2Dh+WNm3EycmE1rhxEhDAkAAAAOIKxNWrwtPTM0eOHIzDsxQZKQsXSqVKkjmz1K8vmzebAwgBAACIKxBX6Rt7rp6jc+ekVy8zgbu7u/TtK+fPMyQAAIC4AnGVbrHn6rmLjZV16+SzzyRTJjON+9KlEhXFqAAAAOIKxFV64+Xl5ebmxji8CDduyKhR5jLE2bNLhw7i58eQAAAA4grEVfrBnquXYOdO+eYbM+9F2bIyZYqEhjIkAACAuAJx5fA45+qlCQuTadOkTBlzmaymTWXvXoYEAAAQVyCuHJinp6eTkxPj8DIdPy4dO4qzsxQoIEOHyvXrDAkAACCuQFw5HvZcpRVRUbJkiVSrZua9qFNHVq+WuDhGBQAAEFcgrhxG7969XVxcGIc05NIl6d9f8uWTnDnFZpOzZxkSAABAXIG4cgDsuUqjEhJkyxb58ktzJeJKlcx/s8LDGRUAAEBcgbh6oW7dunX58uWrSfz9/UNCQlJZmdkC07qAABk/XgoXlqxZ5bvv5MgRhgQAABBXIK5ekFGjRmXJkiVPnjzu7u4ffPDBF198kcrK7LlyGAcOSOvWZt6LYsVkwgQJCmJIAAAAcQXi6vkKDw+/ceNGQEDA7du3CxYsOGLEiFRW5pwrBxMRIbNnmwncs2aVRo1k2zZzACEAAABxBeLquTp69Oi//vWva9eu6XJsbKwW181ktL6io6M7d+6cM2dO3iWO58wZ6d5dXF3N1Bf9+smVKwwJAAAgrkBcPS/t27f/7LPPrGUfH58///nP/5PkjSRvvvmmLmfIkMHDw4N3iaOKjTWTtteuba5EXKuWeHtLdDSjAgAAiCsQV89SRERElixZVqxYYd0MCQlZs2bNuiTrk2zYsGHHjh3169d3c3PjXeLwrl+XQYPMXixXV+nSRU6cYEgAAABxBeLq2ViwYEH27NljYmJSX41zrtKVxETZsUOaNpVs2aRsWZkxQ27fZlQAAABxBeLqqVSoUKFLly4PXY24Sp9CQ2XKFClZ0lRW8+aybx9DAgAAiCsQV0/C19c3Y8aMx44de+iaNpvN2dmZd0k6fitIu3ZmAvf8+WX4cLl5kyEBAADEFYirx+Dn5zdjxoxHWZO4eiVERsqCBVK5stmRVa+ebNggcXGMCgAAIK5AXD1LHBb4arl4UX78UdzcJGdODWs5f54hAQAAxBWIK+IKTyouzuy8qldPMmc2u7MWLDDXJgYAACCuQFw9DS8vL1dXV8bhFXXjhowZIwULipOTdOwoj3CSHgAAAHFFXOH+bDZbjhw5GIdX3f790qqVuRJxsWLy888SEsKQAAAA4grE1ePhsED84dYtmTbNXCAra1Zp0sRcMisxkVEBAADEFYirR+Lp6cmeK6R06pR06yZa3fnzy5Ahcu0aQwIAAIgrEFcPwTlXeKCYGFm+XKpXN4cLfvqpWdZ7AAAAiCviCvfFOVd4uCtXpF8/yZNHtMN79ZLTpxkSAABAXBFXSIk9V3hUCQni4yONG5szssqVk9mzJTycUQEAgLgirogr3OHp6enk5MQ44DEEBsr48VK8uJnAvVUrOXCAIQEAgLgCcQX2XOEpHD4sbdqYxCpc2ORWUBBDAgAAcQXi6tXFVOx4WhERMneuVK4s2bJJ/fqyaZPExzMqAAAQVyCuXjnsucIzc+aM9Owpbm5m6os+feTSJYYEAADiCsTVK4TrXOEZi4uTdevk888lc2apVk28vSUqilEBAIC4AnGV/rHnCs+Lv78MHy4eHuLsLJ07i58fQwIAAHEF4io94zpXeL4SE2XXLvnmG7Mjq0QJ+eUXCQlhVAAAIK5AXKVD7LnCCxIaasqqdGlzmSxtLS0u7S4AAEBcgbhKN9hzhRft+HH54QfRd12BAua4QX9/hgQAAOIKxFV6wFTseDmio2XpUqlSxRwu+Nlnsnq1mQkDAAAQVyCuHBd7rvCSXbpk5m3Pk8f88fQ087kDAADiCsSVI+KcK6QJCQmyZYvUq2d2ZOl/o+fNM9cmBgAAxBWIK+IKeEIBATJunBQpYk7Kat1ajhxhSAAAIK5AXDkGzrlCGrV/v7RqJU5OUqyYTJzIBO4AABBXIK7SOpvN5uzszDggjbp9W2bPlvLlJUsWadDAHDrIBO4AABBXIK6IK+DJnTol3bqJm5vkzSsDBsjVqwwJAABpQpUqsnAhw0BcweCwQDiS2FgzaXvt2vLvf0uNGrJ8ucTEMCoAABBXIK7SBPZcwSFduSJDh4qHh5n3oksXOXGCIQEA4OXgsEDiCnbsuYIDS0iQHTukcWPJlEnKlTNnZ92+zagAAEBcgbh6ObiIMNKDkBCZOlVKlpSsWaVZM9m7l3kvAAAgrkBcvWhc5wrpiq+vtG1rjhUsWFBGjZKbNxkSAACIKxBXLwiHBSIdioqSxYvN+bVZski9erJhg8THMyoAABBXIK6eL/ZcIT07f15695acOSVPHrNw9ixDAgAAcQXi6nnx9PTknCukc/Hxsn691Klj5r2oXNlMFxsZyagAAPBsVKsmixYxDMQVDPZc4RVy86aMGSOFC4uzs7RrJ0ePMiQAADwt9lwRV7BjzxVeRfv3S4sWkj27lCghU6aYyQYBAABxBeLqKXl5ebm5uTEOeBXdvi3Tp5sLZGXObC6WtWsXE7gDAEBcgbh6cp6enk5OTowDXmnHj0uXLmbei/z5ZfBguXaNIQEAgLgCcfXYOOcKuCMmRry9pXp1syOrdm1ZtUpiYxkVAACIKxBXEhoaevDgwYsXL6a+GudcASlduSKDBknevOLqKj17ypkzDAkAAMQVXt24Wrx48ccff+zi4qLh5OPjk8qa7LkC7i8hQbZtk0aNzI6sChVk7lxzjhYAAEihYkVZsIBhIK7SrYsXL7777rvz5s3T5YCAgKCgoFRW7t27tzYY7xLggfRv0KRJUqSIZM0qrVrJgQMMCQAAf+A6V8RV+jZy5MhKlSrFxMQcO3YsKirKujM2Nvbm77S4rK/R0dGdO3fOmTMn7xLg4Q4dkjZtxMnJXClr7FgJCGBIAADgsEDiKp1r166du7t7xYoV8+fPnzdv3pMnT+qdPj4+f/nLX/4nyV+TvPXWW7qcIUMGDw8P3iXAo4qMNP+EVKxodmR9+aVs2WIOIAQAgLgCcZUutW7dWjvKaqomTZpUr15dF0JCQlavXr0mydok69at0+KqV68e17kCnsTZs9Krl+TKZaa+6NNHLlxgSAAAxBWIq/SmU6dORYoUsZaXLFni5OSU8OD/s845V8BTiYuTNWvk008lSxapWVN+/VV+PxYXAADiCsSVw5s7d659Z9T48ePd3d1TWZm4Ap6NGzdkxAjx8DAnZXXqZC5MDAAAcQXiytFFRETkzZu3fv36WlYffPDBxIkTU1nZZrM5OzvzLgGejcRE2blTmjWTbNmkVCn55RcJC2NUAADEFYgrB3b16tUuXbo0bdp06dKlqa9JXAHPxa1bMnWqlC5tKuvbb2XPHoYEAJA+Va7Mda6IK9zBYYHA8+XnJ+3bi/4t8/CQ4cPF358hAQCkK1WqyMKFDANxBeIKeFGiomTxYqlaVTJlMrNfrF1rZsIAACAd4LBA4gp2Xl5erq6ujAPwgly4IP36mdnbc+YUT085d44hAQAQVyCu0gmbzZYjRw7GAXihEhJk82Zp0EAyZ5ZKlcy/SRERjAoAgLgCceXYOCwQeJkCAmTcOClY0Mx70bat+PoyJAAA4grEFXEF4CkcPCitW0uOHFKkiPz0kwQGMiQAAOIKxJWD4ZwrIA0JD5dZs6RcOXO44FdfybZt5gBCAACIKxBXDsHT05NzroA058wZ6d5d3NwkTx4ZMECuXmVIAADEFYirtI49V0DaFRsrK1dKrVqSJYv5umyZxMQwKgAA4grEVRrFnivAAVy9KoMGSb584uoqnTvLiRMMCQCAuAJxleZ4eXm5ubkxDoADSEiQHTukaVMztWC5cjJzpoSFMSoAAOIKxFVawZ4rwPGEhMjkyVKypGTPLi1ayP79DAkAgLgCcfXycc4V4MB8faVdOzOBe/78Mnq0uWoWAADEFYirl8XT09PJyYlxABxYZKQsWCBVq5rDBevWlQ0bJD6eUQEAEFcgrl409lwB6ceFC2KzSc6c5o+Xl7kJAABxBeLqhendu7eLiwvjAKQfcXFm59UXX5gJ3KtWNTu1IiMZFQAAcQXi6rljzxWQbt28aU7EKlDAnJTVoYMcO8aQAACIKxBXzxGzBQLp3+7d8u23ZkdW8eJmmsHgYIYEAEBcgbh69jgsEHhVhIXJjBlStqyZwL1JE9m+XRITGRUAAHEF4uqZsdls7LkCXi2//SZduoiLi7i7y9Chcv06QwIAIK5AXD0DnHMFvKJiYsTbW6pVM4cL1qolK1aYewAAIK5AXD0xm83m7OzMOACvritXpH9/sxcrd27p1UtOnWJIAADEFYirJ8E5VwCMhARzFlajRpIpk5QrJ7NnS3g4owIAIK5AXD0G9lwBuEtAgEyYIMWKmXkvWrWSgwcZEgAAcQXi6pFwzhWA+zt0SNq2NYlVqJDJLSZwBwAQVyCuiCsATy4iQubOlQoVJHNmqV9ftmwxBxACAEBcEVe4F4cFAngkp09Lz56SM6fkySP9+smlSwwJAIC4Iq5wFya0APAY4uJk7Vr54gszgXu1arJ0qURHMyoAQFwxDMQVDC4iDOBJ+PvLsGHi4WEuRtyli/j5MSQAQFyBuHrVcc4VgCeXmCi7dsnXX5szskqVkhkz5NYtRgUAiCsQV68o9lwBeAZCQmT6dClTRrJmNa21Zw9DAgDEFYirVw57rgA8S8eOSbt25ljBggVl5Ehz9CAAgLgCcfWK8PT0ZM8VgGcsOlp+/VWqVjWHC376qaxbZ2bCAAAQVyCu0jf2XAF4ji5elB9/lHz5JFcu6dVLzpxhSACAuAJxlW4xFTuA5y4hQTZulLp1zY6sihVl3jyJjGRUAIC4AnGV3rDnCsCLExAg48ZJ0aKSI4e0aSNHjjAkAEBcgbhKPzw9PZ2cnBgHAC/UwYPSqpVkyybFisnPP0twMEMCAMQViCuHx54rAC/N7dsya5aUL28OF/zyS/HxMRfOAgAQVyCu0o7w8PANGzZ4e3svXbp02bJlt/Xjy4MxWyCAl+/kSenWzUx64e4uAwbIlSsMCQAQVyCu0oQDBw68+eabpUuXLleuXMWKFS9fvpzKyuy5ApBWxMbK6tVSo4ZkyiS1asnKlRITw6gAAHEF4upl2r17t5ubW3R09KOsbLPZ2HMFIG25elWGD5cCBczFiDt3lhMnGBIAIK5AXL0ce/fu/fjjj0eNGjV//vyQkBDrzqCgoOXLl69MsirJ6tWrt2zZUq9evVy5cvEuAZDmJCTI9u3y1VeSJYs5L2v2bAkLY1QAgLgCcfVCHTt2rFy5co0aNcqZM6eTk9OVpLMXfHx8Xnvttb8meTPJ3/72N13OkCGDh4cH7xIAaVdIiEyZYiZwz5rVzDG4dy9DAgDEFYirFyQhibVcvHjx1q1b60JcXFzQ74KDg62vemeXLl3c3Nx4lwBwAL6+0r69ZM8uhQvLmDFy8yZDAgDEFYirF6dr164VKlRIZYXevXu7uLjwLgHgMCIjZdEiqVzZTOBer55s2iS//+8kAABxBeLqGQsKCrJms0hISChYsGCnTp2IKwDp0Llz4ulpJnDPk0f/W2ZuAgCIKxBXz9bAgQOzZctWq1YtZ2fnQoUKBQYGprKyzWbT1XiXAHBU8fGybp3UqWPmvaheXZYskagoRgUAiCsQV89GaGjomjVrpk6dun79+qiHfchgzxWAdCIgwJyIVbCgOSmrfXs5dowhAQDiCsTVC0VcAUhXEhNl925p3twkVokSZprB4GBGBQCIKxBXxBUAPKlbt2T6dClb1sx78fXXsmcPQwIAxBWIq+eLc64ApHMnT0q3buLmJu7uMmSIXLvGkAAAcQXiirgCgCcVHS1Ll0q1amZHVu3asnq1xMYyKgBAXIG4epY4LBDAq+XKFRk4UPLlk5w5zUzup08zJABAXIG4Iq4A4EklJsrWrdKwodmRVbGizJ0rt28zKgBAXIG4eipeXl6urq6MA4BXVGCgTJgghQtL1qzy3Xeyfz9DAgDEFYirJ+Tp6ZkjRw7GAcCr7vBhadtWnJykSBEZP15Svfw6AIC4Iq5wH+y5AoA/RETIrFlSoYLZkdWwoTl0MCGBUQEA4grE1SNhzxUA3MfZs9Kjh5n0Ik8e+fFHMw0GAIC4AnGVOi8vLzc3N8YBAO4jLs5M2l6njmTPLjVqmMnco6MZFQAgrogr3B97rgDg4fz9zQWIPTzE2Vk6dpTjxxkSACCuiKvnKDIy8rYDzuTLOVcA8KgSE2XnTvnmG3NGVunSMn26hIUxKgCIK+KKuHr2evToMXz4cPvN+Ph4hxgdT09PJycn3iUA8BhCQmTqVClVylRWs2ayd6/pLgAgrkBcPSsrV64cM2bM5cuXz58/f/r06YULFyY6wr+1nHMFAE/u2DHp0EFy5BB3dxk+3Bw9CADEFYirpzdjxow333zT3d3dw8Mje/bstWvXdojR4ZwrAHhaUVGyeLFUrSqZM8vnn8v69WYmDAAgrkBcPbErV674+flFR0cHBgb6+/sfOHAgwRGujsI5VwDwzFy6JH37St68kiuX2Gxy/jxDAoC4AnH1JCIjI+vUqTNkyBBJ2ot15swZhxgd9lwBwDMWHy+bNkn9+pIli1SqJHPnSng4owKAuAJx9RjGjh1bt27diRMn6rKfn1/z5s0dYnTYcwUAz0tAgIwZIwUKmMtktW8vR44wJACIKxBXj2TWrFknTpxYunSpLm/YsKF48eIOMTq9e/d2cXHhXQIAz9HBg/Ldd2ZqwaJFZdIkCQpiSAAQVyCuUnPx4sUePXo0adKka9euf//738eNG+cQo8OeKwB4QW7flpkzpXx5U1mNG4uPDxO4AyCuQFw90Llz54YNG9axY8dt27ZFRkY6xFTsNpuNc64A4IU6dUp69BA3N/HwkMGD5epVhgQAcQXi6i4aVLdu3bKW/f39e/fu7RCjw2GBAPByxMTI8uVSo4aZ96JmTfH2NvcAAHGF9B1XERERe/bsiYqKOn/+/Pfff79u3br7rjZ69OipU6fqwtmzZ3PmzFm/fn2HGB2bzebs7My7BABemqtXZcAAyZdPXF2lc2ezXwsAiCuk17jatWvXpEmTNK7c3d2bNm06ceLEwMDAe1eLiYnZuXPnmDFj8ufPP3v27NDQUIc4LJA9VwCQJug/Gdu3m3OxsmaVsmVl1ixzjhYAEFdIf3F1/vx5m81WpEgRvenj43Mq2f9WDAsLGzt27MCBA4cNG6Zl5ezsXKNGDb2nb9++DjE67LkCgLQlJMTMKFiihGTLJi1byv79DAkA4grpJ66io6N79+5dokSJ06dPHzp0qFmzZiH6L9/vQkNDK1So0LRp05YtW7ZP0rZtW72pX4krAMCTO3xY2rUz18gqUEBGjTJXzQIA4gqOHlcXLlyYMWOGtRwWFhYVFZX8uwkJCTdv3tSF8PDwBQsWaInFxcX5+fnpnRwWCAB4WhERsnChVKliDhesW1c2bpT4eEYFAHEFR42rrVu3Nm/e3H4zICBAO+re1caNG/fZZ5/FJM31tHLlyp9//tkhRoe4AgDHcP682GySK5fkzi19+siFCwwJAOIKjhdXly5dqly58jfffPPDDz+0bdu2Vq1a/v7+9642a9Ys+1TsBw4cqFChgkOMDhcRBgBHEhcnGzaYXViZM0ulSrJokdx9PAUAEFdI03F17dq1GjVq2Gy23r179+nTp3nz5veNq23btg0fPvz48eM7d+7MkydPy5YtHWJ0uIgwADikGzdk5EhzOpb+N7xDBzl6lCEBQFzBAeIqMTExIiLCfvP06dMxD7jO49KlS+vXr1+sWLF27drd99DBNIjDAgHAse3bJ998Y65EXLKkTJ4syaZcAgDiCmkurnx9fYsUKVK8ePGSJUu6u7uXKVMmLi7uvmvq/evXr1+4cGGI4/zb5unpyZ4rAHB4t27JjBlSpoyZ96JJE9mxgyEBQFwhLcbVvn37xo8fr9W0du3aefPm9e/fP/5+MzUFBwdrgGXOnLlEiRLly5ffvXu3Q4wO51wBQLpy8qR06iQuLuaIweHD5X7HsQMAcYWXFlcJCQnJJ1Vv3bp18osI202ePNk+Q6CG1rRp02JjY9P+6HDOFQCkQzExsmyZ1KhhDhesVUtWrJAHHHMBAMQVXmhc+fr6Fi5cuGTJkqVLl86XL1+hQoXCwsLuXW3RokXJjwbU1rrvamkNe64AID27dEn69pV8+cwE7j16yOnTDAkA4govM64OHz78yy+/7Ny5c9u2bdu3bw8ICLjvarpCixYt5syZM3Xq1AoVKgwePNghRsfT09PJyYl3CQCkZwkJsm2bfPmlZMpkPgbNnSvJJmoCAOIKLy6uVFBQkM1mq1+//pgxYyIe/A/S8uXLK1euXLJkSV0t+ZGEaRl7rgDgFRIYKOPHS9Gikj27fPedHDjAkAAgrvBC4yoyMrJ8+fLVq1cfOHDgDz/8oJWVPJy0tfbv379r167du3cfPXr0yJEjhw8f9vX1nTdv3st92RqEGzZseOihiUzFDgCvokOH5PvvJVs2E1o//aT/ZjAkAIgrvIi42rJli7e3t/3mtm3b/Pz87DevXr3q5OTk7u5eIEnBggULFSqUI0eOOnXqvNyX3bRp0wwZMuzduzf11dhzBQCvrvBw85GoYkX55BNp0ED/wTMHEAIAcYXnF1f79u3btGmTtRwbG9u/f//kswXGxMQcOnTo3p/y9fVNeHn/RC1ZsqRKlSr//ve/d+7cmfqaXOcKACD671rPnuLmZua96N/fTIMBAMQVnkdcaSO1a9euUqVKtWvXzpw5c48ePR605tSpU8uWLVuzZs3Fixe/xBccHBxcqlSpvXv3fvLJJzt+v46k3rlixYpVSVYnWbNmzdatW+vXr58rVy7eJQAAiY2VNWukTh3JnFmqVxdvb4mOZlQAEFd4lnElSbun5syZY7PZ1q1b96B1fvnll/fff3/48OFaVh07dly0aNHLesGtW7f28vJKTEz84IMP7HG1ffv211577Y0kbyb529/+pssZMmTw8PDgXQIA+MP16+YCxPqvg6urdO4sx44xJACIKzybuDp06NCvv/760NU6deq0ZMkS+82ff/45+mX8D79t27YVK1YsNjY2IiLiww8/tMdVXFxc4O+CgoKsr7paly5d3NzceJcAAFJKTJRdu6RxY3Ml4nLlZOZMuXWLUQFAXBFXT8XX13fs2LE//fTT8uXLQ0NDU3xXC8rPz+/EiRNTp04dNGjQ6dOn9ab2mKenp/bMi3+1Xbt2fffddytVqlSiRIn//u//1nDapf80PpjNZuOcKwBAavTfvl9+kdKlzeGCzZrJnj0MCQDiirh6WosXL3ZxcenWrVvymSqCgoLckhQqVChXrlz58+cvWLCgrjZp0qSX8mqvXr26Y8eO7du3r1mz5u233x4zZkx4eHgq6zMVOwDgUfn6Svv24uwsBQvKqFFy4wZDAoC4Iq4ez9mzZydOnFizZs08efJ07Njx4MGDyb8bFxd36NCh+CQJv3sp+6xSuH379ocffvjQ2QLZcwUAeDzR0bJ4sVSrZi6TVbeurF8v8fGMCkBcgbh6JOvXr8+ePbv21a1HONZ8+/bts2fPTgsvW2Pv6NGjqe+2Eq5zBQB4YpcuSd++ki+f5Molnp5y7hxDAhBXIK4ewt/fPyQkRMyZvYlaLN7e3qkUy6JFi2w2mwONDnEFAHgq8fFm59UXX5h5LypVkoULJTKSUQGIKxBX9xcVFdWiRYu8efMWLlw4T548uhAcHPyglZctWzZw4ECrxBxidDjnCgDwbAQGyrhxUqSIODlJ27bmBC0AxBWIqxS2bNmyYsWKX3/9dfXq1UePHp05c+aD1gwNDT1+/PiRI0cOHDgwfvx4hxgdm83m7OzMuwQA8Mzs328mFcyWTUqUkMmTJSiIIQGIKxBXd+zevXvGjBkXL17UXvrtt99q1659/vz5e1fbtm1boUKFXF1dixYt+tFHH7Vr1464AgC8usLCZNYsKVtWPvlEvvpKfHwk2Vy7AIgrvKJxFRcX17x5882bN+/du9fJyalq1aqxsbH3rjZnzpzw8PAVK1YEBARcuHBBFxxidDgsEADwfJ08KT16iJub5M0rAwfK1asMCUBc4VWMq4sXL+7evTv5vOpRUVH3LSu1cOHCoUOHHj58uF+/fqNHj65evbpDjA57rgAAL4L+67l8ueg/jpkzS+3asnKlxMQwKgBxhVcorlq2bDllypQbN25MTXIj1aslBgQE9OrV69atW0uXLnVzc5s+fbpDjA57rgAAL9TVqzJ4sJnA3dVVunSR335jSADiCq9EXI0cOTIsLEwXPD09NUIetJo1MeDatWtv3rxp3RMcHDxt2jSHGB0uIgwAeAn0n04fH2nUSLJmNZ/MZs2SpH9wARBXSLdxNXHixIiICF3YlMS6U++JuedIhkmTJmXOnLlIkSLlypUrX758vnz5PvvsM4cYHa5zBQB4mUJD9R9RKVzYTODeqpXs3cuQAMQV0mdc9e/ff926dUeOHBk9evSYMWMOHz68f//+oUOHXr3nZNzw8PDu3bsvXrx4zZo18+fPX7FihXXd4bSPwwIBAGmCr6+0ayc5cpgrZY0aJQEBDAlAXCFdxVWjRo0yZMjw9ttv/+Mf/7C+/vWvf33nnXeCHnDJjilTpixdulQXVq9effv2bYcYHfZcAQDSkMhIWbhQKlUy817Ury+bNzOBO0BcIZ3E1cKFCy9cuHDjd/7+/ppVixYtunbt2r0rz5s3L1u2bP3799flHTt2pHKOVpri6enJOVcAgDTn7Fnp1Uvy5DF/bDa5cIEhAYgrOHZcxcfH33tnXFxcwv3+L9rkyZP9/PysPVfHjh2rUKGCQ4wOe64AAGmX/kO8dq18/rmZ96JyZVm0SKKiGBWAuIJDxtVjOXDgwKhRowYNGrRp06acOXO2bNnSIUaHPVcAAAdw86Y5Ecvd3cx70aGD+PkxJABxhfQcV2rVqlUNGzasXLly//79oxzkf615eXm5ubnxLgEAOIDERNm9W1q0MPNelColU6aIg0wfBRBXIK4eQ0ISXQgLC9uwYcOVK1ccZXQ8PT2dnJx4lwAAHEloqEybJqVLS5Ys0qyZKa6ka04CIK7g8HF14MABV1dXTZRdu3aVL18+Q4YMr7/+ui47xOhwzhUAwIGdOCFdu5odWe7uMmyYXL/OkADEFRw7rho2bNi3b99x48Zlzpz5u+++Cw4OnjhxYtu2bR1idDjnCgDg8KKi5NdfpWpVyZRJ6tSRNWskNpZRAYgrOF5caUoNHz7cWv7hhx8OHTqkC9HR0YMHD3aI0WHPFQAg/bh8Wfr3l7x5JVcu8fQ087kDIK7gQHF1/fr1cePGRUVFxcTEjB079ujRoxERETdv3hw2bJhDjE7v3r1dXFx4lwAA0o+EBNmyRRo0MGdkVawos2dLeDijAhBXcIC4Cg8Pd3Jyypgx43vvvffWW2+9/fbbuvD6669XrVrVIUaHPVcAgHQrKEjGjpVChSR7dvn+ezl4kCEBiCuk6bgKCAjo06fPpk2bNm7cuGXLlk1JVq5c6SiHBdpsNs65AgCkc4cPS+vW5hpZRYvKhAkmugAQV0iDcRUTExNyv4tsaHQlOsK0sBwWCAB4VUREyNy55oNg1qzSqJE5dDDpMioAiCuklbhydDabzdnZmXEAALxCTp+WHj0kZ07JnVv69JGLFxkSgLgCcfUMsOcKAPCKio2VVavks8/MvBc1aoi3t0RHMyoAcQXi6smx5woA8Kq7fl0GD5Z8+cTFRTp2NBcmBkBcgbgirgAAeEKJibJrl3z7rTkjq0wZmTlTwsIYFYC4AnH1GDgsEACAu4SGytSpUrKkZMsmLVrI3r3iCDNUAcQViCviCgCAtMrPTzp0MNfI8vCQkSPF358hAYgrEFfEFQAATyoyUhYvlqpVJXNmqVtX1q2T+HhGBSCuiCvcBxcRBgDgkVy8KD/+aGZv1z9eXnLuHEMCEFfEFe7CnisAAB5DfLxs3Gh2YWXJIhUryrx55trEAHEF4grEFQAATyggQEaNkgIFzATuP/wgR44wJCCuQFy96ry8vFxdXRkHAACe0MGD0qqVmcC9WDH56ScJCmJIQFyBuHpFeXp6cs4VAABPKyzMXBqrbFlzuGDjxrJtmyQkMCogrkBcvVrYcwUAwLN08qR07SrOzpIvnwwZItevMyQgrkBcvSrYcwUAwLMXEyPLlkmNGmYCd/26fLnExjIqIK5AXKVzXl5ebm5ujAMAAM/F5csyYIDZi+XqavZonTrFkIC4AnHlSCIjIzds2DB27NiZM2cGBgamvjJ7rgAAeO4SE2X7dnMuVpYsUq6czJ4t4eGMCogrEFcOYOPGjbly5friiy9KliyZPXv2s2fPprIy51wBAPDiBAfLpElSvLhkzy4tW8qBAwwJiCsQV2labGxsXFyctVyhQoWOHTumsjJ7rgAAeAmOHJE2bcTJSQoVkvHjzVWzAOIKxFVaFhMT4+HhMXDgQDH/pyx41apVq5OsSbJ27dpt27Y1aNAgV65cvEsAAHgJIiNl0SKpUsXMe1GvnmzaJPHxjAqIKxBXacuVK1fKly+fMWPGWrVqJSYm6j0+Pj5/+ctf3kjy1yRvvfWWLmfIkEEDjHcJAAAv09mz0quX5MoluXNLnz5y4QJDAuIKxFVaERUVtWfPnnnz5uXNm3fRokWSdKxgwO8CAwOtrzExMZ07d2a2QAAA0oS4OFm3TurUMTuyqlSRX3+V6GhGBcQViKu0ol+/fsWLF09lBZvNxjlXAACkLTduyLBhUrCguLlJhw5y9ChDAuIKxNXL+g/yjaioKGu5QYMGNWvWTGXl3r17u7i48C4BACAt2rtXmjY1E7iXKiWTJ0toKEMC4grE1Qv1448/ZsuW7dNPP82fP/+//vUvX1/fVFZmzxUAAGndrVsyfbqUKSPZskmTJrJrlySdUA0QVyCunrvw8PAtW7ZMnTp1yZIlwcHBqa/Mda4AAHAYJ05Ip07i4iIFCsiIEXL9OkMC4grEVRpis9mcnZ0ZBwAAHEZMjJnrokYNM+9FrVqyZg0TuIO4AnGVJnDOFQAAjuriRenXTzw8zATu3bvL6dMMCYgrEFcvE3uuAABwbAkJsmWLuQZx5szmY+68eRIezqiAuAJx9RJwzhUAAOlEYKBMmCBFikj27NKqlRw8yJCAuAJxRVwBAICncOiQiats2aR4cZk0SYKCGBIQVyCuXgQOCwQAIH0KD5cFC6R8eXO4YMOGsnUr816AuAJx9XwxoQUAAOncmTPSs6e4uUnevNK/v1y+zJCAuAJx9VxwEWEAAF4JcXFm0vZPP/3/7N0HWFTX2v99839OeXKSJ29OclJMYq8oIKCCveuxa+w1JpoYE2OLvYRiiz3GnpjYW+y9F+wdewdFFLuCCKK0+103mxBiQTQqM/D9XF5ce2b27BmWw575zVrrXpIjh5ZxX7pUS7oDhCsQrp4j5lwBAJC+XL4sw4ZJwYJiPgB06SLHjtEkIFyBcPV80HMFAEB6FBcn27dLixaSM6eUKydTpkhYGK0CwhUIV38JPVcAAKRroaEyebKUKqXDBVu3lj17aBIQrkC4ekaenp70XAEAADl8WL79VhwcxMNDRo2SK1doEhCuQLh6OvRcAQCAP0RGyrx5Ur26ZM0qDRvKhg0UcAfhCoSrlKIUOwAAeIRz56RfP3FxEScn83FBL9qJ+/d12eTr1+XaNV3ry6TFqCj+OwlXIFy9FPRcAQCAx4qOlrVrpVEjnZFVpYp2at29a+PJqm5dXdZr4kSZOVM+/1wX97p6lf9IwhUIVy+Fp6dnnjx5aAcAAJCca9dk7FgpVkzy5pWOHeXIkVR/RnFxceHh4XfihYWF3Y1PfYGB8uuvCTvcuCGZM8uIEfznEa5AuHpZ6LkCAABPYe9eLSqYM6eULq3dQzdvptYTuXjxQs6cOd95552MGTO+8cYbjRo1MldGRek4QEutWlKz5iPuaALY/PkyZowEBMihQ5oZo6O1Lr255t49OXBAli+X6dNl6lSZPVt+/FGvDAmRceP0Z1iYLFmie164wEuBcEW4wkOoFggAAJ6aCRkzZkjZspItm3z6qUaTuLgX8TixsRIRoROozp/X5Y737RNfX1m0SGbNEh+fc3//+2sZflehQoWkdxw1SjJmfETJw6tXpUMHuX1bfvlF6tfXqWQmJ4aHy5kz2icXGiqDB0vu3Nr9ZR5i1Sq90kQvc5x+/bS0h5eXPo1hw6RAAaZyEa4IV3gIPVcAAODZnTslfXuLu5OUdJNxg+V6gEhcMjHp5k2NSadPi5+fbNwoS5dqH9G4cTJkiPToIe3ba1KrW1dq1NDg5u4uhQtrjDH/3Nz0Z8GC2mFWvrx8/LHUqhX497+/nhiuKlasmPhYBw/K669rF5Pl1i3tjFq8WKOUeSwfH73SRCMTsS5e1IIdJlyZ0OXsrM9w7Vp96ESlSuk15qmaJ7x7t1SrponLPOeOHVOx045wBcKVraLnCgAAPBUrJpnEEhws/hflcJBs8b2/vPWy3/5Z76d/fDmszk6v/tKuj3zWURp9IlWrSrlyUrSoFpYwAcn8y59ftwsVkpIlNSZVrqw9SK1aabLy9tZOoQkT9LO6yTDbtuniWyaJmQhkgtD9+3/qHgsMPPf663/0XJU3x4pndjMx7Jtv/thz717p2VM6dZL16/UhEm8yRzNxy9FRw9WVKxqu7t7VKJUkpslPP0nt2jJpkm4vXKi/jiU6+o/xh4QrwhXhCgnouQIAIN0y6cIkhJAQ7bcxMePQIdmxQ1av1ilJkyfL8OHi6akLC3/+uTRpolOYypbVRGRykYuLBiTzCcLJSTuXihSTMtWlWmP5uIl82jymveOGnhk6Df7/ek3odHrGYlmxVbZs1xF9JiZduKCpzDzoX18969KlS8WKFXNycnJxccmdO3ebNm2s61u31ryUmHyWLNEBjIk2bpR//1uT2/HjetPly5Irl5w4Ibt2SaZMetH8+mXK/LG/CXVZs2prGCZMfvihzsW6eVOPGRjIK4hwRbjCn9FzBQBA2ohJUVE6E8qannT4sOzcqSsAL1yoYWDUKJ0s1LWrfPWVNG0qdepo50zx4tqhZJKSCUjOzvrT3V2vKVFCKlXSsXnNm2snT/fuMmCAVn2YPl3TyKZNOjru2DHtTTIZIzxc+3AeejYRsnedtG8hhfNI3UqyaIZE3Xkxv/WfmGv8/fX5d+mitTbGjNHRhtWra3BKyvwuJhmapjC/gtG3r45CNGHp6681Af78s140v2Aik6xMk1oWLdL7msZZv54XHeGKcIWH0HMFAICtMTHJhJYbN7Q36fhxDTMbN8qyZQkxaeBADTxt2sgnn2g1PBOTypQRDw/tQTIByfwzn/4LFtSkZE1Pql1b9zT7m3BlYtLIkTJtmsakdesSYlJgoEayh8fdPQchITJ+vBZwz51b08z+/S8hZFo/TeQz/x7XP/bAr5mYD607Wj8fxxzzr3e7Ea5AuEqbvL298+XLRzsAAPAixMbqNJ5btyQoSMee+fnJ5s1axWHGDO0/GTxYl7tt21bDT9262l9UrpwmERcXnTVk9SaZmGT+FSmit1avrsPzvvxSqyn4+MgPP2jJu/nzZc0anZ509KiGscuXNSbdu/eCqvc9q4MHtUifg4P+euY3N8ERhCsQrghXAACkTyarmMRiVXE4fVpXQ9q+XWvQzZ6tA8mGDNFxd506abG7Bg00BZUurTnCzU3n/1hhyfwrVEi7mEyCqllTqzi0bKmJ47vvdKHbX3/VQ61cKVu36tyns2fl0iV9OJuLSX9FRITMnaufxbNn15jo60sfEOEKhKs0xcvLy8HBgXYAAKS3mBQSojHJZJjDhzUmrVmjH/snTdJRc1ZM+vxzadhQS35XrKgdR4UL63A7E5CspGR+Fi+uBR6qVtU09dlnGpN69ZJBg7S+3MyZ2j1lYpLJYKdO6dyeGze0CyvtxKS/yN9fM6U1irFv3z+mNIFwBcKVXaPnCgBg10xMCg3VYneBgTo9aedOrfa2YIEWIRg1SqcYWcXumjdPmJ5UokRCQXATkPLn14xktk12KldOx92ZKNWihU4O6tlTx+yZI0yfrpOdfH11utCJE/ooVkyix+U5iI7W/y0TYXPk0AWkFi6kujnhCoQrwhUAAM+BVezORJegIJ0+tGePFmRbvFinJ5mQ07+/LjL75Zcak+rVkwoVdNydh4f2Jpl/Tk6alKwqDiY+Va6sdcPNnm3bau0Hc9/Ro7VXyhxt40atHXfsmPZZXbumdSPM49KhlMpMOP7hB/3Py5tXOnfWlAzCFQhXhCsAACS+nJoJLdb0pBMnNCZt3qz9PzNn6vqwAwdqTGrfPqGKQ5UqunSSVRPc2Vk7lBwdNS8VKaJXliunMalRI41V5lO3p6cO25s8WebN02J327droYTAQI1JtljFAU9r924ta5grlxZA/OUXHbsJwhUIV4QrAECaiUl37+q4uwsXtIqDVexuxQotvTBunAwdKr17S7t20qqVlmeoVk0Lf5tE5OHxp0F3JjWZ+FS2rJZ5aNpUvvgiodidufvEiVrsbtUqnZ5kDu7vL1euJCwyS0xKv0xQnjJF81X27Ppy2bWLVwPhCoQr+0BBCwBIJ8yn0/v39VPrpUty5owcOSI7dmiqmTtXE86wYdKvn2aeli21m6hKFR13ZxKRNTfJyUl7k8x2wYJa18F86K1cOaHY3TffaL4yMWn8eE1cJndt2qRVHExMMnnMxCSTzWJjaX48k5MnpVs3yZNHRwwOH649oSBcgXBly+i5AgB7FB2t05OuXtWJQyYm7dmjY+TmzdOv+3/8UTuFzCfSL76Qxo21QoOJSaVKaW+SyUhWQXBn54SYZK6vVk3q1JFmzXR6krnX999rsTtrkdmNG2XvXi12FxSkjxUeTkxCaoiM1JdjzZqSLZtWZly9WufJ/c7X1/fYsWM0EuEKhCvCFQAgoYrDtWsJi8yamGQizcKFGm/GjdPpSSbwfP21rglkTU8qUUJjkolGJiC5uuq4O/PTXGOur1RJY1KjRjppxdyrXz8ZM0aPM3++bNigMcl8BA0M1JhkHpFid7A/Fy5o/Ufzos+fXyu5X7u2ftOmf/zjHzlz5jxPMXfCFQhXtsDHxye/OUMBAP6y6Gi5c0eL3ZlPgGfOyL59GmmWLtUqDmPH6iKz3btrVYZPP9WYZD6NlCmjk5GsgGSSkhWTrEF3FSpIjRo6PcnEpC5dtNjd8OG6yKwJXevW6Zz/o0cTpidR7A7pTmysjj1t2HD5u+/+3//9X4Z4+fLlO336NG1DuALhKpV5enrmzZuXdgCABz68RUTofKFLl7SKw4EDsmWLLF+unx9++kmXP/ruO63iYE1PqlxZ41CxYtqbZC0ya5KSSU0mJhUtqjGpShUdytS6ta5L6+WlMWnCBJ3ptHatbNsmhw5pEgsOTih2x7g7IIXq1K2bIYkhQ4bQJoQrEK5SGT1XANJ8TIqMTFhk1t9f69Ft3ZpQxWHSJC3D0KePFvhu1UoXMq1RQ5dOMjHJ3T1hbpI1ScnDQ8uCW9OT6tWTzz6TDh2kVy8ZNEh+/lmrOKxcqelr/36NSZcva/loFpkFXrSwsLAKFSpYyapTp040COEKhKvUR88VAHthFbsLC9P0EhCQUOxu7VpZsEBXPRo1Sry9dQTdV19pb1KtWvp2X6KEhiI3N52g4eycUOzOJCUTk8ytDRpoTEpcZHbMGB2/t2SJDjjas0enPwUH6xi/O3d0vB8AG3T79u2SJUt++eWXNAXhCoQrm+Dj4+Po6Eg7AHjJTFwJD9cqDmfPyvHjWmth3TpZtEimTtWYNHiw1mMwn5eaN9eYVLGixqFChf6oCe7qqjHJ/DPxydz68ce6HG2bNtK1qxa7+/HHhGJ369fr9KSTJxMWmSUmAWlPeHj4vXv3aAfCFQhXL8qNGzeGDh3asGHDVq1a7dq1K/md6bkC8BdZ05Nu3EgodufnJ76+GmxmzNCFj0xM6tNHi92ZmFS/vr4FlyunM5GcnTUpubhoWLIWmS1WTG81UapxY41JnTppPfExY7SKw/z52kO1Y4cWuzNh7PJlnZ5ETAIAwhUIVy/ctGnTypQpM2bMmC5durzxxhvbtm1LZmfmXAFIFBenM4Vu3kxYZHb/fp2etHy5zJolv/yixe569dK5Ri1aaEyypid5eCRMT3J11bzk6Ki9SSYmmQRVs6bOYvr8c41Jnp4yYoTGpDlzdIkaE5MOHdKhfeaBQkJ0sB/F7gCAcAXClS26f/9+7O/VpmrUqJH8QGR6roA0HJNMbrl8Wbt6TJLZskVWrNAqDj/9pNXqTNpp316rOFjTkypW1JhUuLBGIyspubhoh1LJklK+vBa7MzHJ7Gzu4u2tKWv8eH0nXbUqodjdqVM6Pck8XGQkxe4AIJ0xbxLz5tEMhKt0oVixYn379jUbAQEBHTp06ByvS7yuXbv27NmzcOHCruZjFAAbjkn37ukoOGt60uHD2u2zZo2udzR5snYH9esn334rX3whzZppb1K5cjo9ycQkKyA5OmpYMheLFdNy4SZE1a6tVRzatZOePbXY3ejROn5v5Uody7dvn47rCwrSEuQmmzHuDgCQvNt37jTNmdP3559pCsJV2jdp0qTcuXPfvHnTbO/fv9/Z2blgvELx3N3dTbJ666233NzceJUAL0dUVMIis+fPa0zatUsrLixapNUXRo3SKUbdu8s332hM+vhj7TIqWVKnJ1kj7sw/J6eEYnfFi+sojDp1dE+zf9eu0revTk+aOlUWL5aNG/XIx4/LxYty/bo+onlcAACer4iIiGrVqmXIkOGdd97ZuXMnDUK4SsvWr1+fMWPG3bt3J78bc66AZ45JVhWHwEDt7dm7V8fdLVsm06fLuHEycKD06KG9Q82bawSqXFl7k0xMKlRIu5KsmuDmX+HCWuyuXDndp3FjXWS2c2cddzdypMak+fO1h2rHDo1hVrG70FDtxWJ6EgAgFURH6zgK84Zk3pa2bo1atKhiyZKJizi/8cYbe/bsoZEIV2nTvn37smbNumHDhifuyZwrwFpk9tYtHQ536pQcOCCbN2tMmjVLxo5NWGS2bVut4lC3rvYXlS+vfUcuLjrcLn9+/VmwoCal4sX1purVpUkTHaTXoYP2RI0YoaUg5s3TKg7btsnRowlVHIhJAADbCk4hIRqcDh7U8Q+zZ+uocW9vLfbaqJFUqqTfEbq66nues7NumPe8atVaJQlXuXLlOnPmDA1JuEqDTpw48d577w0bNiwkJMTf3//atWvJ7EzPFdIYk1jMu4NV7M6anrRihZZeMAln2DAdO9exo3z6qb5TmBRkslCJEgmD7qya4OanNe7O3FSjhtSrJy1bahUHk6+GD5cJEzRxmQOa9GXeffz95cIFTWXEJACA7bp/XwdaBAToWhmrV+s72ahRCV8c1q+vgyuKFdM3v8QlMsxFq5DRV1/Jd9/poHOTtTZs0PpF58/r216SseZt2rQxycrBwSHQBDMQrtKk0aNH//vf//bw8HB2ds6ePXv37t2T2dnb2ztfvny8SmCb7wWhoXL1qpw7pzFp504dIzd3rkyZoqPmvLx0BN3nn+toOmt6UtGiOsrOqnRnfjo66hg8E5NKl9aYZN4+mjf/o4rDTz/p+L2lS3Us3/79usisiUnXr2sVB4rdAQDshnnfMu+UZ89qSSITnMx724gROjDdvEGadFSxor47WpHJel8sWVKDk3nvNO+IAwfqt4YLFuh74dGj2m1l3ndjYp7q8aNiY/u5uh43jwvCVVoVHR0dGRl5J15YWJjZTmZneq7wEljF7szJ//x5nZ5kxaRFi7TY3ahRWuzOxKS2bbU2gzU9qXhxjUlWUjJvB9Y/8+5Qtqy+TZh9WrTQcQq9esn33+sRpk3T0nmbNsmePbrIrHmUGzckPJxidwAAuxUXp1N7r12T06dl925dc9AEmB9+SAhO5r2wfHldZ9DVVVOTk5MGpzJlpFo1fTf99lt9g/z5Z3133LZNv6EMDtbqRi/o60OT1ubO5X+McAXl5eXFnCuknFXs7uZNnZ5kYtK+fTpMYOlSmTlTQ86gQXrO/+orrfRdt64GIXOe9/DQ+Ujm5G9SvPWtmXkvsFZPst4CzP5dukj//vqWMWmSFrtbv14D2NGj+k2ceVsxj8giswCAtMOEnPBwuXJFB06Y8LNihVYxGjxYv2s076C1ammlI6vHyaoVa7bNG2rt2jqu3QpOv/yik4O3btU3Yys4PWWP0/PEIsKEKyRiWGB6PrFHROj0JHNOtmLSli36vdjs2TpGYOBA6d1b5xqZ07hVxaFUKR2DbfUmmfO8iUkmMpmYZE74JibVrKmjD778Us/5np7y448ak+bNk7VrExaZPXdO30Ru39ZeLMbdAQDSLBNyTNS5fFmHUmzfrl8ZTpyo3yB26aLvqeb90sSkxB4n663URClz/eef6z6DBmnQWrVKv2U0b89Xr2oMs/HvFwlXhCsk8vLycnBwoB3s/TQeGanDpM2Z/MwZna1qTuYm1SRWcfDy0tN1q1Y676hGDR1cZ2KSh0fCuknm9G7+FSqkV5oEZXZo0EDP/yZZ9eolQ4boQebM0a/VTPoyB/f31we6dUuzGTEJAJC+3nHDwnSS7uHDWtpo4UL9PnLAAK0P27y5FkoqXVq/hrQqyZo3V2tEe716+h7co4e+JZvgtHKlDvMz76bXrumMqTQwMINwRbhCInqubIo5wd6/r907ly7pWffoUS12t2qVdgH9/LOOmuvXTzp10lN0w4ZStapWRi1RQr/2suapWpXuzMm8SBHtTTI7mDT12We6yGyfPjrcYNw47Zhatkx8fbXg+OnT+gZx86bGpFQcTQAAwDPz9/e/evXqcziQVYvcqqG0ZYtOIjLBqW9f/a6xceM/glPiF5MeHvo2XLeuLr5hgtPIkTJjhk4p3rfvj+CUThCuCFdIRM/Vi2MttWcVuzt+XBeZXbdOS/JMnarTkwYOlG7d9ITctKkOoq5Y8Y+TtslI1hBrk5TMv1KldKZorVr6pdhXX+m9TEwaPVqL5i1ZotOTzJFPnkxYZDY8nN4kAEB6cerUqYwZM5YuXfrOnTvJ7RcTo18lmnfKQ4d0rrBJAuZ91ASntm01OFWurF9VJr77mn/Fimlwssa7e3npznPm6JiQgwf1Td283SapRQ7CFeEKhKunYw2fNudSq4rDnj16Zl60SKs4jBun46itKg7NmmnPv1XsLnGRWfMzf3796e6up25zrjZRqlEjPV137aondnPGnjxZQ5c5pjmyVQr1yhV9RIrdAQDwOMeOHcuRI4e1gm3lqlVv+/npW6m1+m2vXtKmjY7fMJ/7rQlO5i3ZyUm/syxZUod2WLXITXAaO1aD06ZNmrusWuQEJ8IVCFfPLL0NCzRxJTxc63RfvKjTk/bt01XIly3TU/HPP2uPkIlJ7dvrUDpzQraGAJhzsvmXuMKs+Ve4sF5frpxOT2raVHufrCoOw4bJr7/q6WXNGh3OZy0ya1VxoNgdAADPV4369TMk0T9PHp3gVLmyNGmi7+X9+2twWrAgYd338+c1OPG1JeEKhCvC1SPFxupg5pAQnZ5kYpI5bW7ZonNErTHSI0Zo2jGn1pYttVffnGmtoqbWlKT8+fWfm1tCFQdzkzktmN1MTOrQQb/GGjpUD2IOZWLS1q168NOntaqeOS1HRjLuDgCA1BYaeqZ27Ty/J6uaNWtGRETQKoQrEK5S2YteRDgoKKhdu3bffPON+fnFF19Mmzbt4X3i4rQ8d1iYjrvz99cks3u3DmyeP1/LeQ8bpmPnunTRCqXWhNKyZRM6lAoU0H9WIQdz0cNDpydVq6aTS1u10mTVo0dCFYeZM7XYna+vdlUlreLAF1gAANif6dMlc2Zp3Tpg//7M2bNXqlTpbvqpHkG4AuHKlr3oRYT37t2btMveyam5p6eOgjYxqXbthGJ3RYv+UezO2Tmh2F2xYtrdVK+eTmRq21arOPTvL+PHayWexYt1LJ8JYCdO6Og+a5FZYhIAAGnf2bP6+cB8dNmwwbri/PnzN27coGEIVyBc2YQXPSxw//79r7zySmK4ypWree/euiDEyJFaNG/RIi2gt2ePxqRz57SwHvNIAQDAI0RHy/ffS8aMOi4lMpL2IFyBcGWLPD09X2jPlQlXSXuumjdvTpsDAICns22bjm8pUULXNgHhCoQrm/Wi51zt27cvSccV4QoAADyN0FBp3Vo++EArTYFwBcKVjXvRPVcidxo33tKgwWY/vy0bN248efIkbQ4AAFJk9mzJmlUnal+7RmMQrkC4sgMvuufKqFlTF8kFAABIqXPntHBFnjyyejWNQbgC4cpueHp65jFnrhcmMlKr/x06REsDAIAUiInRdVTee0+6d6dwBeEKhCs786J7rk6fFicnXcMKAADgCXbt0sIVxYvzvSzhCoQru/SiS7EvWiTlytHMAAAgWaGhug7mhx/qopYgXIFwZadedM9V797yzTc0MwAAeLz587VwRYMGcvkyjUG4AuHKjr3oaoE1a8qUKTQzAAB4lMBAqVJFcuaUFStoDMIVCFd274X2XMXEiJub7N1LMwMAgD+Li5PhwylcQbgC4SpN8fLyenE9V/7+Ws3i9m2aGQAAJLFrl37/6uEhBw7QGIQrEK7Sjhfac7VokZQtSxsDAIDfhYXpbOwPPpCxY7XzCoQrEK7Skhfac+XjI61b08YAACDe/PmSJYvUqSMXL9IYhCsQrtKgJ5Ziv3LlyooVK9bEMxtnzpxJ+cHr15cJE2hjAADSvcBALXKVIweFKwhXIFylZU/suVqwYEGGJHr37p3CI8fESMGCVLMAACB9Syxc0amThIfTHoQrEK7SsifOuXogXPXp0yeFRw4M1GoWt27RxgAApFd794q7u/6jcAXhCoQrwtVfCVcrVkipUjQwAADpUni4dOwoH34oI0dKbCztQbgC4SpdeOKcqwfCVc+ePVN45L59qWYBAEC6NH++ZMsmH38sly7RGIQrEK7SES8vLwcHh2R2OHHiSL167TNk6FqhQtcuXdqtXr06hUeuX1+LrAIAgHQkOFhq1dLCFUuX0hiEKxCuCFePsGaNZMgg/fs/3ZHd3WXrVhoYAID0ITZWfvhBF7Dq0IHCFYQrEK7SqScOCzTGjdNw1b79Uxw2KEirWVy/TgMDAJAOHDggHh76xeq+fTQG4QqEq/QrJT1XvXpJrlzSvPlTHHbVKilenNYFACCtswpXvPeeFq6Ii6M9CFcgXKVrKem5+uQTadxYqlZ9isMOHqz3AgAAadmyZZI9u06yCgqiMQhXIFzhyYsIGxUqyKBBUqKE3L+f0sOaMPbjj7QuAABpVHCw1K6tJQHnz6cxCFeEK8IVEjxxnavoaClWTBet8vCQGzdSelh3d9myhdYFACDNiY3VcsBW4Yo7d2gPEK4IV/jDE4cFXr0qBQrI6dNSuLCcO5eiY16+LI6O+hMAAKQpBw/qt62urrJzJ40BwhXhCg96Ys/V8eNSqJDcvStFi8quXU842t27dxs2rO/kVOz110sXLVq0adOm0dHRNDIAAHYvPFy6dJGMGbXeemws7QHCFeEqHYmLi1uxYsXgwYNDQkKS39PT0zP5OVfr1kmZMrpRurQsWfKExw0LC/voo48y/C5Hjhz3Uz5PCwAA2CarcEX16hIYSGOAcEW4Sl+uXLlSsmTJzJkz/+tf/zpz5kzyOz+x52ryZD2XGnXqyKRJT3joO3fumMdNDFe5cuWKioriJQgAgL0KDpb69SVrVlmwgMYA4QrpMVwFBARMnTrV/MyYMeOJEyeS3/mJ1QL79pWvvtKNr7+W779/crjKlClTYrjKmTMn4QoAAHs1frwWrmjbVkJDaQwQrpBOw5Xl4sWL77zzTmK4MlmrY8eOXeJ1jdetW7devXq5u7u7uromc5wvv5R+/awYlpCykhEREZ41a95XXvn766+/9re//a1AgQKEKwAA7M+hQ7oGi4vLk+dbA4QrwlU6DFf79+93cnJyi1cwXuHChQsVKvTWW2+Za5I5Tu3aOjLQGDNGGjV6woNevhyXO/fFTZsCL18+HxgYGBwcHMdi7QAA2JF796RnTy1cMWSIUJUKhCsQrh4Zrh7niXOuSpSQjRt1Y9EiqVjxCQ/6ww9SrRovOQAA7NPKlZInj1StmtLVVwDCFeEqnQgODn733XdPnjyZ/G7JVwu8f18KFpRjx3R72zZd2SIZsbG6dvDy5bzkAACwN1euSMOGki2bzJpFY4BwBcLVn9y4cWPnzp1vv/32+vXrzXYyeybfc3Xxoi4HfO2abp84IW5uuuDV4yxcKEWK8HoDAMDejB+v4wBbt5awMBoDhCsQrh70ySef5MyZM0uWLLly5apfv34yE5+8vb3z5cv3uFsPHdK5rNZSVSZiOTnJ5cuPfdBq1WTECF5vAADYj+PHpWRJfbPfuZPGAOEKhKtHi4iICAsLi4yMND/Dw8OT2TP5nqtVq6Rs2YTtyEhxdpbHzeE6eFDMYW7e5PUGAIA9SCxcMWCAxMTQHiBcgXD1HCS/ztXEiVotMFGxYrJly6P3bNNG2rWjOQEAsAerVol596dwBQhXIFw9X8kPC/T2lg4d/vS3M2/eI3a7cUMcHOTwYZoTAADbdvWqrqySKZPMnEljgHAFwtVz5uXl5WCC0WO0aiWDB/9xsUEDXe3qYSNGyMcf05YAANi2X3+VDz+UL76Q0FAaA4QrEK6ev+R7rqpVkxkz/rjYvr306fPgPjExWkVwxQraEgAAW3XihBaucHKSzZtpDBCuQLh6UZLvuSpS5E8n4QEDtC/rAUuXSuHC8vh6hAAAIPVERoqnp7z/vvTvT+EKEK5AuEq1cHX3rhQo8KfygBMnSt26D+5WtaqMHk1DAgBge9at08IVlSrJ6dM0BghXIFy9cMkMC7xwQWuvX7/+xzXLl0u5cn/a5/BhPWlTgR0AANty5Yo0by5ZsvxpfD9AuALhKrXC1YEDuqhgdPQf1+zZIwUL/mkE4Ndf/6mcIAAASH2TJ2vhilatJCSExgDhCoQrmwhXS5f+sYKwJSBAa1eEhSVcvHJFzF1PnaIVAQCwDcePS+nS+vZM4QoQrkC4evmSWUR4zBipU+dP14SE6Cys69dl2bIF33zzZY0aHd9/v0OnTu38/c/QkgAApKb793V5yowZtXDFvXu0BwhXIFylgmR6rr777sEhf9HR4u4u589L167tMiSxceNGWhIAgFSzYYPkySPly1O4AoQrEK5sNFw1by7Dhz94ZcmSsnu39Ojxp3Dl6+tLSwIAkApu3JBPP5VMmWT6dBoDhCsQrlJZv379cufO3aZNmypVqtSoUeO///3v119/HRO/DkblyjJz5oP716ypc7F69SJcAQCQ2qZOlcyZpUUL6vaCcAXClU3w8fHJmjVrjhw5EpNS3rx5o6Pvm5s8PGTbtgf3//RTmTRJvvvuT+Fq06ZNtCQAAC/PmTNSoQKFK0C4AuHKtvTv398kq5w5cyYmJQcHh9jYqIgIPWM/PHK7Wzfp21dWrTqTM+f6zZt9zT+TrEKo9AoAwMsRFZVQuMLLi8IVIFyBcGVbHu65MuHKnLmDgsTJSW7denD/oUPlyy9l0CBp25bGAwDg5dq0Sd+ey5VjIRQQrkC4skUDBgzImTNnnjx5TKx65ZX/MT8dHR1NuNq3TwoVesT+s2ZJtWq6/tX69TQeAAAvy61b0rKlfPCB/PILjQHCFQhXNip+nas8Fy6cd3A48dZbJ/z8jgcGBojELV4slSo9vHvU+vV33nwzvHDh8NDQ8Li4aBoQAIAXbsYMrQfYvLnWBgQIVyBc2SwfHx9n5/xxcTrD6q23JDg44fqRI6Vhwwd3/umnCa+//maGDJlfey3ze+/9Z7FJYAAA4MXx99fCFQ4Osm4djQHCFQhXts7T09PJKc+1a+LiotVc9+xJuL5HD+nc+cGdhwwZkrRI4MyHK7UDAIDnIipK+vfXwhV9+sj9+7QHCFcgXNkBHx+fQoXyHz8uRYpIxYqyYEHC9U2baudV8uFq1qxZNCAAAM/ftm0JhSvMOzRAuALhyl54e3sXKpTP11dXB/7sMxOfEq6vVEnmzn1CuKLnCgCA5+zWLWnVisIVIFyBcGWXfHx8ihTJP326zpL9/nvp2DHh+qJFZffuB3eeNGlS5syZ88fLli3bihUraEAAAJ6b2bO1cEWTJnL1Ko0BwhUIV/bH09PTwyPvsGEaq+bMkbp19cqwMHF2lnPnHtw5Li4uJglzkQYEAOA58PfXQSO5c8uaNTQGCFcgXNkrb2/vokXzdeqk6wJv3y6lS+uVAQFSoICEhtI8AAC8YLGxMniwFq7o3VsiI2kPEK5AuLJjXl5e7u55GzWSSZMkMFDc3PTKXbukcGHaBgCAF2zrVv06s2RJOXqUxgDhCoQru9e3r0/BgvkrV5bly+XOHS1NFBEhS5Y8cgVhAADwnISGypdfauGKiRNpDBCuQLhKI3x8vPLkcShaVPbt04tubtp/NXas1rcAAAAvxJw5WriiQQO5coXGAOEKhKu0o18/70yZ8rm4yNmzerFYMR0T6O2tiwgDAIDnLCBAqlXTwhWrV9MYIFyBcJXWDBjg9a9/ORQqJCEherF+ff3r+PxzGTeOtgEA4PmJidHVJN9/X7p00SH4AOEKhKu0Z/BgnwwZ8rm7i1VWvW1b6ddPateWxYtpGwAAnpOdO8XVVceHULgChCsQrtKwoUO9M2QoXLFi4kX59FMxF/fsoW0AAPjLwsKkTRstXMGYEBCuQLhK8wYP7pMhQxUTqCzz5knBguLuLkFBtA0AAH/N7NmSLRuFK0C4AuEqvRgypHeGDJ90755wcfduee89XeSK0eAAADy78+elenUtXLFqFY0BwhUIV+nF4MEmXPUYOTLh4sWL8o9/SNGiNAwAAM8kJkaGD9dxgF26yN27tAcIVyBcpSNDh3plyDAm8S/CvAu8+67UrEnDAADw9Pbu1SUjixeXQ4doDBCucObMma+++urmzZuEq/Ri0CDvDBl+27RJt0NCbjVv3vx///fjLFnqffxxDS8vL9oHAIAUsQpXvPeejBlDY4BwBcv58+fff//9EiVKhIeHE67ShcGDh2fIsOnYMd0ODg5+/fXXM/yuVKlStA8AAE+2aJEWrqhXT4fXA4QrJBEQEPDhhx+WK1cuIq2UNCBcJad//9EZMhy5fFm3L1269MYbbySGqzJlytA+AAAkJyhIatSQHDlYIBKEKzzOhQsXrHwVGRlJuErjBgyY89ZbQVaQJlwBAJC8HTt2dOvWLSomRi+MGiUZM2rhCmrsgnCFZAUFBWXNmrVEiRJpIF8Rrh6rZctP33478z/+4VKggEuNGtXPnDmTK1euf//73//5z3/+9a9/1a5dmyYCACDRkSNHPvzwwwwZMnzZvLl2WFWqJP7+NAvSu6pVdaVUPMmVK1ccHR3LlStn7/OvCFeP5e7unthP9dprr7Vp06ZOnTpVqlSpUaOG+dmoUaOuXbt2797d/OzRo4fZ6Natm9nuloS1g9kwO3Tp0sVsm58PbJtbrYMk/WndvXs866LZMDtbO1h3TLqd9CGs52Pdy9rHeg6JF5P+TOFzS/obJT63xOdgPeIDd7SuSfkvmHSHh3+ppM/tuTR44qGeY4MnHvCBBn+GF0Pi83n4uT3wiCn/BROf2yMbPJnnZj3cwy+GxPZ/uK0e+WJ45PN55C+YfIMnvTXpiyHxOM/3r++RDZ7Mi+HhBn9ef32PbPBk/vpS2OAp/Ot7jqe7l/nX98wN/sD2U53unvgLPu1fX9L7PtDgT/zrS8nZ4Jn/+pI2uHVNpkyZEt83q2fM6Nm7dxcvr1Q83T38Yki+wZ/qr++5nO4e/gWf++nO3NqnT58HHjTlZ4NUOd097V/fI88GNnG669r12969T2TJMrNWrQ69e//FBn/ih43ncrp74MX5HE93yd/dbPft27dZs2bm7FGkSJGL9jw/k3CVonD1t7/9zdnZuUSJEub/u3jx4uZn0aJFCxQo4ObmZn4WLFjQbLi6urrEc/2d2bauNzsk3TnptrnV2k7c3zqCtZ140Wwkf5Ck1zxwQOs5PHB8a7eUPLcHfqPE55P0sR73fFL+C1p3t65M4XOzDuKaROLFlDR40od7ZIMn3SH5Bre2H2hwq62eocEfaKsHno91qKf6BV9Qgyd9tT9zgyceIflfMJmHeKDBE5/kMzf4I59PSl7tSX/Nhxs88fgpb/Bk/vqe+WyQzIshhQ2e9MXwzKe75F+cqXi6SzwUp7unPd1ZP//3f/838X3zo3fecS9fvkD8++Nf+etL4S+YzF/fMzT44/76nnjHxGtSfrpL+V/fw6e7J/71mZ958+Y1/x25cuUqVKjQM5wNnuqv74HT3XP5sPEiTndJX+3P9teXwl/KuUCB/IUKbXv99e7ZsuX+/f/u4bZK4S/4yL++F3G6e+LZ4NlOd4l3eeQfr/lpPnibV6l5ub766qv79+8nXKXxcPXuu+/euHGDNgEA4HEWLVr0z3/+07xplnV1DXN2lh495N49miV1BQYG/v3vf9++fTtNkWoqV5a5c2mGlGjWrNnbb799+PBhu/4tCFePVaVKlf/5n//529/+9tZbb+XPn//WrVu0CQAAyZg9e/Z///vfm2FhcuWK1K6tFdgXLaJZUlFQUNCrr766c+dOmiLVUNAiBeLi4urUqfPmm28eP37c3n8XwlVyunfvnjdv3tu3b4eEhJj/dRoEAIDkPyFFR0f/cXnJEsmVS2rWlMBAGidVnD9//p///OeOHTtoCsKVzYqNja1Vq9bbb7995MiRNPDrEK6S4+npacIV7QAAwDOKiJCuXeWDD2ToUEmau/BS0HNFuLJxUVFRderUeeutt+x9NCDhKkV8fHzy589POwAA8JeYj00lSoizs2zdSmO8TMy5IlzZsrt371avXv2NN95IG31WhKsn8/LyoucKAIDn4+ef5cMP5fPP5eZNGoNwRbjC3r17c+bM6efnl5Z+KcJVcui5AgDgebp+XZo0kUyZZOpUGuMluH379rBhw4KDg2kKwpUNiouLu3v3bhr7pQhXyfH29s6XLx/tAADA87Rpk+TPL6VKif1XBgMIVyBcEa4AAEhV9+9L//5a6KJXL4mMpD1AuALhKu3z8vJycHCgHQAAeCHOnJGKFSV3blm9msYA4QqEqzSOnisAAF642bMlc2Zp2FAuX6YxnsGhQ4cWLVo0ffr0S5cumYs7duzo06dPv3jTpk1LXKjz8uXLv/35U/6uXbu2bNlCAxKunkpMTMz169fv3buXeE1ISEhoaOitW7dSviqs2TMsLCw8PPyvP5/o6OgjR45cvHiRcEW4AgAA8W7fljZtdJTgmDE0xlPx8/Nr1aqV+ai6adOmpk2bmmu6dOnSs2fPwYMHf/7553Xr1k3cs3379hUqVEi8eOfOHTc3tyFDhtCGhKunEhsb+9NPP2XJkmXz5s3WNdu3by9ZsuTKlStTfhCTxEqVKmXC/19/PuPHj585c+bHH39sIh/hinAFAAB+t2ePFCok7u6ybx+NkUKLFy82H1LNxsmTJ2vXrh0REXH16lXrpkmTJv3666/W9vr163v16mV2sC6aMDZnzpyGDRuaDEYbEq6e1pUrVzJlypQ5c2arv8i8nLp27fq03VB16tSZMGHCX3wm5glUq1YtOjo6LCwsJiaGcEW4AgAAScTGysiR2oX1zTfanYUniYqKqlixYtWqVQcMGHD8z9UXW7Zs6e/vbzbM9b/99tvGjRvNbtZNS5cu3b9/f+/evc29aEPC1dM6e/bsqFGjatSoUbRoURNszDXff/+92TCvt0GDBt2+ffvo0aNm4+bNm0FBQea1t2vXLi8vr02bNpkdzMaSJUvMXZo0aeLp6TlkyJCBAwdaBdnNHZctW/bDDz+cOXPm+vXrM2fOXLNmjXmV3rlzJ/Gh9+3bN3/+/F9//fXq1asm1Jmdc+XKNWfOHBvptiJcPQGLCAMAkAouXpS6dSVrVpk7l8Z4IvMBNEeOHNmyZbOilOXUqVOffvqpaF3G+1OnTo2NjTUfbatVq2Z9Mp43b57Z6N69u/lMTAMSrp6WCT/jx4+PiIjInDnzl19+aa4xAcnkfJOCTNQ5ceLEvXv38uXLd+zYMROr3n///QULFixcuDBr1qzmhbdhwwZzk8lRn3zySbNmzbZs2VKkSBHrIN7e3n5+flOmTDEfv319fT/44IORI0ea+BQaGmo97tq1a82r2ryYZ8+e7eHhYR7FHM3FxcVEOPPohCs7QM8VAACpZtkyyZNHTB4ICKAxHufgwYMtWrQwG56enk5OTollBiZMmDAmfgLbtGnT6tSpM3z48ObNm5sAZj65fv311+3atRs6dGixYsWKFy++bt06mpFw9bThatSoURLfj/Tqq6+OHTvWpCAT46Ojo11dXU24MjcVLFjwyJEjYWFh5pobN27ExMS4u7ubO5qbypYte/z4cfO6/eWXXyS+BIt56W7btq1KlSorVqz47bffevTocfbsWRO6jh49mvRxzSt59OjR1naBAgUWL158+vRpk7JsZEAg4YpwBQCAbYuMlG7d5D//kYEDxZY+P9kO8/HU+tbffK4tUaLEqVOnrOtbtmxpfcY1H2dnzJgxd+7cXr16mY+wa9asMZ9ip0+fvnDhwurVq9euXdt8AqYZCVdPxd/fPzHkzJo165///GeDBg0kfpCqyTyJ4cpEo9DQUBcXFxOuYmNjixYtanWulilT5tixYyZcTZo0yVw8d+5cuXLlVq1aZa63jhkXF3fr1i0TxqxDJTLpa+jQodZ21apVzQvbvLwJV/bEx8cnf/78tAMAAKnp6FEpVUqcneX36mRIFBgYWLdu3QMHDmzevLlz587mI6zET7Jq0qTJA3tu2LAhcc6VpXv37gNNagXh6imZ11uPHj0SL3bp0sVkKmvbRKlly5aZvJQlS5YtW7aEhIQ4Ojpev37d5C5XV1cr/JcoUcJE+ubNm48fP17iO1e9vLzMSzdHjhwmO127dm3OnDkHDx4sXLjwA8l/woQJpUuXNht3797973//e+nSJfNMzEPfv3+fcGUfPD09mXMFAIBNmDJFMmWS5s3FZmau24grV66sX79+x44dVlUAIzg4+NChQw/sdvv27Qf6Ac6fP287qwMRruyFiUmjR4826f306dPWNREREeYaa9bT1KlTK1WqZPKSSVybNm3auXNnzZo1TVI6fPhw9erV16xZExQUVK9evSVLlmzcuLFz586TJ0/++eefrUqDmzdvLlq0aO3atdetW2fuUqNGjZkzZz7w6MOHDzeRbPr06b6+vlYwM4fdvn074co+0HMFAIANMbGqRQv56CMNWgDhKjXExcXFxsaan48bjGd1nybdjo2XuMZH8vYAAExPSURBVJF4X5PHHijgHhdP4pcqtn4+vDDx7du3re8REo/DsEC7Qc8VAAA2Z+NGKVBAypaVY8doDBCuYFMIV8nx8fFxdHSkHQAAsC0xMdK/vxa66NFDfq+PBxCuQLiyafRcAQBguwICpHJlLde+YgWNAcIVCFe2jjlXAADYunnzJHt2XXSY2gwgXNmJ1atXW2teEa7SF09Pzzx58tAOAADYtLAw6dhR3ntPRoyQh6a/A4QrG3H//n2rFoX5jL1hw4Yn7h8XF3f79m3CVdrBnCsAAOzGnj1StKi4u+sGQLhKJSYRJV14yqSp0NBQa7tfv34rV658OHFZZdwTJV7ctGlTnz59rO2wsLB79jDBknCVHOZcAQBgZ0aNkowZpW1bsbcvvEG4sncrVqz45JNPfvrpp3LlynXv3t1cs2vXrmHDhs2aNeuXX345f/78u+++2759+6NHj/bs2XPhwoVmh3379plb27Vrt23btp07d5q7z5w5s1atWj/++KO5tXbt2q6urrt37/b19TUHHz58+B6b/+qEcJUc5lwBAGB/Ll+W+vUlc2aGY4Fw9TJt3br1o48+CggICAoKypw5s0lEJiPNnz8/NDS0cOHCYWFhpUuXXrt2rdmzZs2ao0ePvnnz5qeffurv7z948OB8+fIdPHjQ3Gv//v0HDhywxo4NGTLks88+Mxt16tTZsWPH1atXj9n8AgyEq+TQcwUAgL1avVocHKRqVS0qCBCuXryjR4+6urpaYwJNKPLx8TEb69at++2335ydna9fv162bFkrXLVo0eLnn39evHhxkyZNTJoyMcwEs8DAQCcnpxvxTLiKiooaNmyYFa6mTJnyxhtvDBo0yPYbgXCVHHquAACwY5GR8t138sEH5h1d/jypAyBcvdBwZeLTvHnzvv/++wkTJty7d8/d3d2Eq9KlS5usZW799NNPJ06cuHz58goVKlj3DQsLM3cvUKCAFa5MGIuOjh4yZEjLli3j/5Qj/fz8cufO7enpSbiyY97e3vny5aMdAACw6098Urq0ODmJry+NAcLVi3PixIlMmTIdPnx4//799erVMynLpKkOHTqYQJUtW7YNGzZUqVLlu+++u3nzZu3atc3H7JiYGJOXTHyaM2fO+PHj9+3blzVr1qCgoLNnz3744Ye3bt2aNGlS8eLFDx482KNHD7Pzb7/9Zo5GuLJj9FwBAJBGTJokH30kLVrI9es0BghXL8Lx48fz5s1rIpBJSufOnTPX+Pn59erV68iRIyY+bdy40YSugQMHmrA0ceLEmTNnmrzk7+9v8lK/fv1M4jKpbMiQIceOHTM7mA0T1cLDwwcMGLB169alS5cuXLhw7dq1tl+ZnXCVHC8vL+ZcAQCQRty6Ja1aacSaOJHGAOHquTMhysXFJWkd9nSIcJUchgUCAJDWbNsmBQpIiRLmkyCNAcLVc7RgwYK8efPu2LGDcIVH8/LycnBwoB0AAEhToqNl0CB57z3p2lXu3qU9QLj66+Li4m7cuHHr1q3r6XvkLeEqOfRcAQCQZp09K9WrS65csngxjQHCFQhXLxw9VwAApHHz50v27FKnjgQF0RggXD0sON727ds3btzo5+cXFxeXeNPq1auPvPThtceOHVuwYEF0dPQjbw0NDTXP6urVq9evX79y5QrhinAFAABervBw6dBBRwmOGCGxsbQHCFeJ9u7dO336dLMxcODAf/zjH/v370966+DBg1euXPmSn9LcuXPz5MnzuLIZJlblzp17y5YtUVFRo0aNMrGQcGVDGBYIAEB64ecnRYqIm5vs3k1jgHBlXLt27bPPPgsLCzPbixcv/uCDD+7du5fM/pGRkYn9WrGxseHh4YkXzU03b95M2usV++cvMqKjo2/duhUTE5N4ze3bt80REu9+48YN6+7Hjx93dXW1nolJUHeTTJu8c+eOuaZMmTKbN282Fw8cOPDy18UiXBGuAABAPPPRbdw4+eADadNGQkNpD6TzcDVs2LDevXtb2w+Hq4iIiG7dus2ZM+fMmTMNGzacMmVKkyZNunbtam4yeWzBggUjR440F02IOnjw4IABA8w1w4cPDwkJadeu3dChQ6tXr75x40brUCYgTZ06df369f369bMewjycObLZc/bs2adOnerfv//ChQsHDRok8UsVu7i4mMMGBgb+9ttvffr0GTNmjLl+zZo1ZmPRokXZsmVLrFhYt25d35e7ejjhKjksIgwAQLpz+bI0bixZssjMmTQG0nO4MvlnxowZjwtXRtOmTU3siY6Ozp49+4oVK65du5Y3b94bN26YFDRu3DgTunLmzGlClznI5MmTTRxyd3c/f/68OWznzp0DAgKuXr1qHcfPz69q1apmY//+/eZo27Zt+/bbb83FzZs3m+NPmzZtYvzadIULFzZ39/f3d3NzM9Huiy++2LRp09q1a999992lS5c2atTI6joz0cscwTpyhw4dTPoiXNkKFhEGACCdWr1azGeASpXk9GkaA+kzXJkstHz58mTCVdu2bfv27Ws2XF1drcoW1oaJT4sWLdq1a9fGjRvPnTtnrl+3bp25xtnZOTg42IQiE70eeKx69eply5Zty5YtZrtHjx7Dhw9PeuuGDRuWLFlSoECBU6dOmVTm4eFx4MCB8uXL7969e/v27fv27RsyZEizZs2sncuUKWMdx/ow37JlS8KVrWBYIAAA6Zf5HPndd/L+++LjI1FRtAfSW7gyGem335+8yTYffvhhYri6evWqCTmdOnXq379/0nBVsGDBkydPmnhjFbqwFr8y+wwePNhcLFKkiBWuxo8fn/SBwsPDIyMjJ0yY8N57750/f94EtoYNG1o33b59e8CAAdajFCtWzISrs2fPmuOYR3F0dEzs+/Lx8SlZsmRiuNq6dau13bFjR2ukIuHqxVq9evWwYcNCnzSc2tPTk54rAADStZMnpXx5cXSUDRtoDKSrcDV06FATWqzt0aNHv/baa7t37zapxvysV6/ejh07Pvvss2+//fbu3bvZsmXbuXOnyUgfffTR0aNHJ06cmDFjRhOWRowYsXfv3rp16zZp0sTX1zdXrlxz5sypVauWt7d30gfatm3byJEjzUbz5s3N/kFBQSZltW7d2ly5bt26Bg0a1K9ff8uWLblz5545c6Z53Bw5cty5c8cc08PDY/r06eZRzFPKnz+/yWD79u3LkiWLNQvLaNy48Zo1awhXL9CVK1dKly6dKVOmf/3rX2fOnEl+Z+ZcAQAANXOmfPSRNG0qv39TDqT5cHX58uWvvvoqKirKJJnZs2ePGjXKmkA1duxYE5wuXrw4derUuXPnHjx40IQZk2r8/f1//PFHk47i/2JmtmvXzkQjs20+cps0deDAgdWrV//666+TJk2aNWvW7du3Ex/o2rVrJiOZW81BrGtMQuvWrdvM+HmPZ8+eNXffv3+/2WHx4sUmZZmkd+LECRPqBg8e3L179+PHj5vdTp8+/d1335nnY/Yxd7cet1WrVi+50dJduAoICJg8ebL5vzd52vyvJL8zc64AAECCGzfEfFAzEWvCBBoD6SFcGVu3bjVxxR6feWRk5Lhx406dOkW4ehlM1H7nnXcSw5UJxF26dOker2e8Xr16eXp6enh4FChQgNMCAABIsH27roVVvLiuiwWk9XAlOjD2ZNJeJjv6tB8UFPTyHzcthyvTpjt27Nj9O7OduEjzA+Fq//79+fLlKxDPJZ6bm5urq+ubb75pNjgtAACAP8TEyJAh8t570rmz/L7IKZBWwxUIVwl+/fXX/Pnze/zObE+ePPmR4epx+vbt6+joyKsEAAA86Px5qV5dcuSQpUtpDBCukPbDVTKCg4PffffdkydPJr8bpdgBAEByTLIy+apGDUmNAUggXIFwlfpu3bq1a9eut99+e+PGjWY7mT2pFggAAJ7gzh359lvJmFGGDdMRgwDhinCVrjRv3jxHjhyZM2fOmTNn/fr14+LiHrcn61wBAIAUOXBAq1y4usq2bTQGCFeEq3QkPDz89u3bERER5uedO3eS2ZOeKwAA8BR++klrtbdqpXXbAcIV4QpJsc4VAAB4OlevSuPGkjmzxK9/CsIV4YpwhQT0XAEAgGexaZPkyyelS8uTqmeBcAXCVXpBzxUAAHhG9+6Jj4+8/7707q3bIFyBcJXOUYodAAD8JSdPSoUK2ou1di2NQbgC4Spdo+cKAAA8B7NnS7Zs0rChBAfTGIQrEK7SKeZcAQCA5yM0VFq31lGC48fTGIQrEK4IVwAAAH/Nnj3i5ibu7uLnR2MQrkC4Sl+YcwUAAJ6zmBgZMUK7sDp0kGTX2wThCoSrNMXLy8vBwYF2AAAAz9n581K7tuTIIQsX0hiEKxCuCFcAAAB/zdKlkiuXVK8uZ8/SGIQrEK7SOOZcAQCAFysiQrp21VGCgwZJVBTtQbgC4SrNoucKAAC8DMeOScmS4uQkW7bQGIQrEK7SJgpaAACAl+fXX+WDD6RFC7l5k8YgXIFwldawiDAAAHiprl3TcJUpk0yaRGMQrkC4SlOYcwUAAFLBhg3i6Chly+pwQRCuQLhKGxgWCAAAUkdUlPTtK++9J716SWQk7UG4AuHK7tFzBQAAUtPZs/rpPFcuWb2axiBcgXBl3zw9PZlzBQAAUpn5dJ49u9SvL8HBNAbhCoQre0XPFQAAsAlhYfLNN/LhhzJqlMTG0h6EKxCu7A89VwAAwIbs3SseHlK4sOzeTWMQrkC4sjM+Pj6Ojo60AwAAsBVxcTJihC6H1bGjdmeBcAXClb3w9PTMkycP7QAAAGxLcLA0aKATsebPpzEIVyBc2QfmXAEAANu1cqUWEjQf3wMCaAzCFQhXto45VwAAwKbdvSs9e+pyWP37S3Q07UG4AuHKdtFzBQAA7MDRo1K2rDg7y8aNNAbhCoQrG+Xt7Z0vXz7aAQAA2IFfftFCFy1bys2b1hWRkZFRUVE0DOEKhCubQM8VAACwJyZWffaZZMok06dH3L3738qVv/32W1qFcAXClU3w8vJizhUAALAzW7feLVy4ZsaMGeJ99913NAnhCoSr1MewQAAAYI8aNG6cIYkRFSvqulienjJ2rMydK76+4ucn589LSIjcu0dzEa5AuHoZvLy8HBwcaAcAAGBf5s6b9+qrr1rJKlvu3IdHj5Z+/eTrr6VpU6lSRUqUEDc3cXGRfPmkQAEpXlwqVNCFs9q21QA2apTMmSNr12oACwjQAMbELcIVCFd/HT1XAADATq1YseJvf/tb1qxZT58+/Yibo6M1NZ0/r5UGfX11MeIJE6RvX2nfXho3lpo1pWRJKVRIA5hJX+ZfsWJSsaLUqiVffKHF33/4QaZN0wC2f7+cPSvXrtEDRrgC4eoJ6LkCAAD2a/Xq1QcPHnz2+8fFye3bcuGCBrAtW2TePPnpJxk4UAPYJ59I9epSpoy4uuo/k74KFpSiRbUifJ06WlTDBLBhw2TKFFm+XHbvljNn5OpViYwkXIFwRbgCAADAo8TGSni4XL4sx4/Ljh2yZIlMnKgB7NtvpXlz7QEzAczdXZycNIC5uGgGK1dOPv5YWrWSzp1l6FCZPFkDmLnvyZN6nDt3NNQRrkC4SnsYFggAAPBXmbB0965cuSInTsjOnbJqlQaqIUOkWzddlat6dSlfXooU0UWQHR01g5kwVqqUBjATzzp1kgED5NdfNbZt3apHMMcJC5OYGMIVCFeEKwAAADwmgF29KqdO6TDClStl6lQNYD176iyvunW1v6to0YQhiC4uOh/MBLBq1aRFCy2EOHCgDllcuFA2b9ZBjJcu6YBGWwhghCvCFQhXAAAAtigiQq5f1xqGe/bImjUyfbqW1ujRQ9q0kUaNtOZhsWJaCNHqBCtcWC+aeNO4sbRrJz4+Mn68lu7YskUOH9ZiHmFhL7wQYuXKhCvCFRKwiDAAAICduXdPbtyQc+dk3z5ZvVpmz5aRI+W776R1ay03b7JW0aKau6wqiCaJlS6dEMDattXdRo/Wu2zeLAcPSmCghIZqZcVntbp06euEK8JVmhcbGxuXgrmS9FwBAACkQTExcuuWBAXJoUOyYYOmqbFjNVmZfNWokXY3mcRlLQXm5KRDEE0eq1JF6tfXhGZ2+/FHmTVLk5ufn/j7a5Z7VA/Y+PHjM2TIUKt69Ujq1BOu0qqjR4/WrFnTxcWlYMGCY8aMIVwBAADg0QEsJEQ7r44e1Y6s+fN1VGG/fvLNNxrAqlXTtZgLFtTxhyaDmX/Fium4xDp1dJKYt/fILl0y/P3v1jrOVatWDQ0NpUUJV2nQwoULe/bseeDAgWXLlr355puzZs1KZmcfH5/8+fPzKgEAAMAjxMbqxK2LFzWAbdsmCxboWszffx/RqZPzRx9lSGLdunW0FuEqjatbt26rVq2S2YE5VwAAAHgGAQEBuXPnNrHq//2//zd58mQahHCVxkVHRzs4OPz0009m28/Pr0CBAoXiFY7nEe+tt95yc3PjVQIAAICnderUqTxvvvnzgAE0BeEqLdixY0e/fv2G/M5s79y5M/HWTp06lSlTxiprERAQ0K5du07xvo3XuXPn7t27m2Tl7OzMqwQAAADPIKxy5Zh582gHwlVasHTp0saNG7f8XaNGjZYvX27dNGzYMAcHh+vXryd/hL59+zo6OvIqAQAAwLNgEWHCVZo3derUAgUKXLp06Yl7enp6MucKAAAAhCsQrh5h1apVr7zyio+Pz4oVK2bMmJF0oODDqBYIAADsV0pW9QThCoSrZ/fbb79VrFixVq1alStXLl269ODBg5PZ2dPTM0+ePLxKAACAPWrfvv3YsWNpB8IVCFc2gZ4rAABgpzp16pQhQ4ZXXnllypQptAbhCoSr1Oft7Z0vXz7aAQAA2Je23bolXcGWfEW4AuEq9dFzBQAA7ExIiPz88/f//ndisnr99ddXrlxJwxCuQLhKZVQLBAAAdmPbNvnkE8mWTSpVkjVrfvjhB5OsXnvttfXr19M2hCsQrlIfwwIBAICtu3RJhg4Vd3dxdJRu3eTEicRbfvzxx6VLl9JChCsQrmyCl5cXPVcAAMAWRUfLihVSt652VVWvLosXS1QUrUK4AuHKdjHnCgAA2Bx/f+ndW/LlEzc3GTRILlygSQhXIFzZAS8vLwcHB9oBAACkvogI/ZhuPqznyCHNm8vGjRITQ6sQrkC4shvMuQIAAKnv0CHp2FHy5JESJWT8eLlxgyYhXIFwZX/ouQIAAKkmvqi6lCypsap9e/Hzo0kIVyBc2THmXAEAgJctNla2bJHPPtPhf+XLy8yZEh5OqxCuQLgiXAEAAKRYcLAMGyYFC4qDg/TsKadO0SSEKxCu0g6GBQIAgBcuKkqWLZPatSV7dqlVS7cpqk64AuEq7aGgBQAAeIFOn5ZevcTZWYuqDxxIUXXCFQhXKXLr1q2FCxcOHDhw6NChvr6+0dHRdtE6LCIMAACeP6uoepUq2lXVtKn4+kpcHK1CuALhKkVmz55drVq16tWrN2vWrEGDBpUrV27atOnu3bttv3WYcwUAAJ6nAwfk668lVy4pVUorAd68SZMQrkC4egrz5s2bNGnS7du3k1557ty5H3/88eDBgzbeOvRcAQCA58CEqPHjpXhxLar+zTeyfz9NQrgC4eqp3blz58iRI9Z2eHh4SEhIZGSkSVbm4v379xNvsln0XAEAgGdnFVX/5BMtql6pksyerQMCQbgC4eovCgwMzJ49e69evcz2lClTfH197aJ1PD096bkCAABP7eJFGTxYi6rnz68lK06fpkkIVyBcPTfDhw8fNmzY7NmzzfaZM2caNmxoF61DzxUAAHgK9+7J0qXy8ceSLZv+XLmSouqEK8IV4er5W7hw4eHDhxcvXmy2x48fX6JECbtoHUqxAwCAFDlzRnr3FvOxwdVVBg3SniuAcEW4ekHCw8P79u1bKd7777+/evVqu2gdeq4AAEByIiJk5kwpX14LAH7yic6woqg6CFeEqxdtz549mzZt2rFjx8KFCy9fvmwvrePp6ZknTx5eJQAA4EH792tRdQcHKVlSKwFSVB2EK7y0cOXj4zN27NjEi1evXo2NjbX91qHnCgAA/IkJUT//rEXVc+aUtm3F5teVAeEKaTBcrV69umbNmt7e3iaudOvWrXPnznbROlQLBAAAyiqq3rSpFlWvVk3mzJHwcFoFhCukTrhatGhR2bJlu3btamLVV1991aVLF7toHXquAABI7y5c0AIVbm7i7KwlKyiqDsIVUj1cRUVFRfy+al5ISMgvv/xiF61DzxUAAOnUvXuybJnUqqVF1evVk9WrJTqaVgHhCjYRrg4ePFiuXDlnZ+ciRYpkzpz5yy+/tIvWoecKAIB05+RJ6dlTHB11CeBhw+TSJZoEhCvYVriaPn36qVOnzE9/f/+dO3euXbvWLlrHy8uLnisAANKF8HCZMUMqVtRKFZ9+Kjt2UFQdhCvYaLj67bffFixYcODAgfHjxy9btqxevXp20Tr0XAEAkPb5+WlR9Vy5pEQJrQQYEkKTgHAFmw5XwcHBHTt2DAkJmThxYvbs2X/44Qe7aB1vb+98+fLxKgEAIA26eVNGjxYPD8mbV9q1o6g6CFewm3B18+ZNE6ju3r0bFRW1Zs0as0G4AgAAqSA2VjZtkmbNtKuqcmWKqoNwBfsLVyNHjvzqq6+i48vsbNq0aciQIXbROl5eXg4ODrxKAABIC6yi6gUKSL580qePnD1Lk4BwBbsMVzNmzAgNDbW2d+7cWaFCBcIVAAB4Gayi6jVqSPbsUr++rFkjUVG0CghXsONwtWfPHhNUNm7cOHfu3KxZs/bs2dMuWodhgQAA2LETJ6RbN+2n8vCgqDoIV0g74UriRwM2a9asdOnS33//fbSdLMNHuAIAwP7cuSPTpkmFCtpV1aKF7NxJUXUQrpDWwpU9IlwBAGBP9u6VNm0kd24pVUp++YWi6iBcgXBlQ1hEGAAAO3DjhowZI8WKaVH1jh3lyBGaBIQrEK5entjY2LgUjBCg5woAAFt+OxdfX2nSRHLkkCpV9COsnaz1AsIVCFfP4v79++fPnw8MDLxw4cLFixeDgoKCg4N37969efPm1PqFDx8+XL58eTc3t4IFC44cOZJwBQCA/blwQfr106LqTk7i6SkBATQJCFdI++Hq+vXrzs7OLi4uJqJkyZKlUKFC7u7uGTNmbNu2bWr9wkePHp04caKJWGvXrn3//fenTZuWzM4+Pj758+fnVQIAgE2IjJTFi6V2bcmZU4uqr14tdlIiC4QrEK6eg6ioqF27dkVHR8+ZM+fQoUN34507d27MmDG28MvXrVu3Xbt2yezAnCsAAGzCyZPSo4fkySNubjJ8uFy9SpOAcIV0F64STZs27erv58GAgIAmTZqk4u8cHh6+ePHigQMHFixYcO/eveYaPz8/FxeXwvE84hWJ9/bbb7uZkzgAAEgVYWEyZYqUKaOzqj7/nKLqIFyBcKXOnDnTsmXL7t27d+jQ4f333x86dOhLeNAdO3YMGDBg2O/M9q5du8z1ly9frl+/fpYsWSpXrhwREWGu8ff3/+abbzrE6xTv22+/7datm6urq7OzM68SAABetj17pHVryZVLSpfWouq3btEkIFyBcJXgxIkTixcvHjRoUOvWrRcuXPhyHnTp0qWNGjX67HcNGzZctmxZ0h3q1atnIl8yR+jbt6+joyOvEgAAXpJr12TkSC2q7uAgHTrIsWM0CQhXIFw9yPP/b+9OoKqs94WPd9dZt973PXU73bvOvQ3rljJtQFEEnIecA02PY86mmbMmKqKi7Q2OmaWFommaA5qmmOI84ZA4T4jmgBDihCDIPAhsfu/zh/R00nCIYT+b72ed5dpwn1vyc4d+/e/nt43G395nlZSUVGgBx/ozZ85s1KhRyT9t7rkCAKDMFRRIWJj06CE2NtKmjWzYoHZXAMQViKvH2r17d8+ePefMmTN37tzp06f7+flV1Be8evXqoKCgs2fPbt68+e9///uMGTNKuJhtgQAAlK3r19VSdVdXtVfd319iYxkJiCsQV08QEhJSp06dwYMHDxw4sFevXp988klFfcGhoaFNmjQp3l3x2Wefmc3mEi42Go0Gg4FnCQAApSw3Vy1Vf/99dVTVrZvs2qUOrwDiCsTV030LzU1PTy9+nJaWtmLFior9srWmeprXJQYEBHDPFQAApeniRfH2FkdHqV1b5s6VO3cYCYgrEFfP+o30opeXl7u7e8OGDW1tbQcMGKCL6XDPFQAApSM1VS1Vb9FCvf/vRx+ppeoAcQXi6vmsXLny5MmTixcvjoyM3LVr1549e3QxHe65AgDgzzp5Ui1Vt7GRJk1k6VJVWQBxBeLqz/jhhx/27t175syZ5cuXHzx4sHv37rqYDidXAAA8p+Kl6nXqqFcA+vjIhQuMBMQViKvSERMT07Nnz6SkpKCgoDfeeGPmzJm6mA4nVwAAPJuCAtmzRy1Vd3BQS9XXr2epOogrxkBclY7CIr/7ZGJiYqxOFq36+/s7OzvzLAEA4Mni4mTKFLVU3cVFLVXXPgRAXBFXpeju3butW7du1KhRixYttB+bN2/eqlUrLVe8vb11MR1OrgAAeIKcHPWev23aiL299O4te/eyVB0groirMvp+mzNv3rzw8PCpU6fOnz//p59+OnjwYHBw8Ny5c3UxHZPJxD1XAAA83s8/y9ix6paqunXl66/VTVYAiCviqhz88MMPD9/nKiUlZciQISW/e6+F4GWBAAD8XlqarFihVv/Z26s1gMePMxKAuEK5xtWePXvGjh0bFha2a9euFi1aDNK+F+uByWRycnLiWQIAgHL0qAwYoJrq3XfVm1ZplQWAuEL5x5Vm27ZtHTt29PDwGD16dHZ2ti6mw8kVAAASH//Ppepjx8rFi4wEIK5QwXGlBVVsbGxUVNT169f37dv36BZBC8TJFQCg8ipeqt6tm1StKm3bSkgIS9UB4goWEVehoaG2traurq7u7u42NjadO3fWxXSIKwBAZRQbK0aj2qju6irTp7NUHSCuYFlx5efnt3379ocfXrp0iYUWAABYluxs9Z6/77+v7qrq3p2l6gBxBQuNq8OHDy9evPjKlSvnz5+PjIzcs2ePLqZDXAEAKoXz52X0aDEY1I1VgYEsVQeIK1h0XGll9eqrr7q6utasWdPW1rZbt266mA5vIgwAsGapqfLdd78uVR86VE6cED3cEQ0QV6jscXWjSPHjrKysXbt26WI6vIkwAMAKaQVVvFTd1laaN5eVK1mqDhBX0FNcZWdnBwYG+vr6jh8/vn///h999JEupsPLAgEAVuXOHZk7V732z8lJxo2TS5cYCUBcQX9xFRwc7O3t3bNnz2nTpmlxtX79el1Mx2g0cnIFANC9ggLZsUO6dhUbG7VUPTRUcnOZCkBcQa9xFRISUlBQcPLkyQsXLiQmJppMJl1Mh3uuAAD6FhMj/v5Ss6b635QpLFUHiCtYQ1wdPny4WbNmMTEx3t7eVatW1ctCC06uAAC6lJMjGzZImzZSpYr06MFSdYC4glXF1a1bt27evKk9yMzMXLNmzZEjR3QxHU6uAAA6ExkpI0eKs7M0bizz5rFUHSCuYG1xFRkZOXHixE2bNoWHhx87dmzr1q16WWhhNBoNBgPPEgCApUtJkSVLpGlT9V5VgwfLyZOMBCCuoO+4unPnTk5OzqOfDw0N/Z//+Z+aNWvWq1evbt26tWrVWrBggS6mw8kVAMCiFRbK4cPSv79UrSrNmsmqVZKRwVQA4gp6javo6OhZs2ZpTTVnzpx33nln+vTpf3RZdna27qbDKnYAgIWKj5cvvxR3d/UKwIkTWaoOEFewhrj66aefrl69euHChb///e+XLl06ffq01lGPXpaenh4VFaU9OH78eEBAQPH9V5aPkysAgGXJy5OdO6VLF3VU1b69bNzIUnWAuIL1xNWVK1fmzZunFci0adO0D2fMmBH3uDWvy5cv3759u9ZXb7755ujRo1euXKmL6bAtEABgKWJitN+WxMVFatXSfrsVnfw1JUBcEVfE1bPZsGHDunXrtAenTp3SqikvL+/Ra7Zu3Zqbm+vp6TlixAjtw82bN2dlZVn+dDi5AgBUsOxsWbtWvLzE1lZ69pT9+8VsZioAcQXrjKuwsLCnWf13/vz5f/zjH+3atUtPT//hhx/8/Px0MR2TycTJFQCgYkREyKhRov02VK+eWqqelMRIAOIKVh5X0dHR/v7+t2/fTkhISE5O3rFjh/bgsVdmZGTk5+ebzeb4+HgtsXQxHU6uAADlrXipeqNGYmcnQ4fKiROMBCCuUFni6urVq2+88YbBYHBzc6tRo4aDg8Pdu3etZjqcXAEAyklhoYSHy4cfqqbS/jQWHCw6+YtIAMQVSi2usrOz9+/fn5ubqz3Iz88/fvy4NcUVq9gBAGXu1i354gupU0ctVR8/nqXqAHGFyhtXaWlpe/fu3Vlky5YtQUFBhYWFj172xRdfLFq0SHfT4eQKAFBW8vJk+3a1VL1KFenQQbZulfv3mQpAXKFSx9WhQ4ecnZ2bNm3arFmzGjVqeHp6PnZb4Pfff1+8fl1Lr4KCgqNHj5r1sOyIe64AAKXv6lWZPFm031/c3OSzz+TGDUYCEFcgrpQ7d+6kpqYWP9bCaeHChQ8//K01a9b87W9/q127dr169RwdHTt37qyL6RBXAIBSk5Wllqprf9KytZVevWTfPpaqA8QViKt/kZmZGRYWtmvXrr17927ZsqVRo0ZXr1599LKIiIjg4OC4uLiYmJjIyEittXQxHZPJ5OTkxLMEAPCnRETIyJFqqXrDhrJggdy7x0gA4grE1WMcOnRIy48WLVq0bNmyfv36s2bN+qMrU1NTV61atWDBAq2v9DId4goA8Py0iFq0SC1Vt7eXYcPkzBlGAhBXIK5KkpycnJWVlZ6eHhUVpT34o8tu3brl5uZWq1atDh06eHp6hoWFEVcAAOtkNqul6v36qaXqrVrJqlWSmclUAOIKxNVTmTdv3uuvv25jY9OgQYPt27c/9prFixeHhoYWP87Ly1u9enVOTo7lT4d7rgAAzyA+XmbPFldXtVR94kS5fJmRAMQVcUVcPYOLFy/27Nnz9OnTmZmZcXFxgYGBCQkJj14WEhKSnJxc/LigoGD+/PmZFfrXeFu3bm3WrFlUVFTJl3FyBQB4svv31SL1Dh3UpoouXWTLFpaqAyCuiKvncejQoYiIiIcf7tu37+zZs49epn2yd+/en3/++ZQpUzw8PLS4qsCvOSkpqX79+v/+7/9+7Nixkq/kTYQBACWJipJJk8TFRWrVkpkz5eZNRgKAuCKunl9cXNzkyZOPHz9+6dKlBQsWdO3aNSMj47FX7t+/v1u3bu+//35wcHDFfs0jRoyYOXOmwWA4fPhwyVfyJsIAgMfQfqdbvVo8PaVqVendW91hxVJ1AMQVSuWeq61bt9auXfvtt99u0KDB6dOnLfwL3rlzp5eXV1pa2ltvvfUwrs6cOVOrVq06ReoWqV/kv/7rv9zc3HiWAADkwW8Yau+fvb3aAbh4sTx4xTsAEFeQUjm5un79uvYgJyensLDQcr6w2NjYWbNmffnAzJkzt2zZUlBQ0Lx58+PHj2sPtLg6cuRI8cXR0dHDhg37pMioIt7e3j4+Plpx1axZk2cJAFR2WkQtXKjepcrRUYYOZak6AOIKZRJX4eHhY8aMCQ4Ovnjx4tNcX24Bdv78+V69evV7oHv37suWLQsMDPTw8Dhw4MDatWtfe+21GTNm3CvxnRynTJlSvXp1niUAUElpv2cdPCh9+6ql6i1byvffyx+/6QgAEFf4s3FlLnqVeUZGxsaNG/v377969eo/yqfFixfXLOLn51dRqwKXL1/+3nvvtWvXTvvxpZdecnd3P3HiRAnXG41G7rkCgMro1i2ZNUvc3KR6dfHzkydtlwUA4gqlEFdJSUmXL18ODAx8991369at++233z42rnbu3NmkSZMVK1YcOHBgzpw52mUV+2VrNfjmm28+caEF73MFAJVLbq5s2yadOomNjfpRe8xSdQDEFcotrsLCwv7zP/+za9eu2oMSXvL3/fffJyYmPvwwJCQkNTW1Ar/s7Ozsfv36Xbp0qeTLOLkCgMoiOlqdUGnf893c1JnVrVuMBABxhfKOq/Pnz595cF+vFlfp6emPvWzTpk1afUnRywi3bdvm6+uri+kEBARwzxUAWDPtt61Vq6RVK/X+v336yKFDLFUHQFyhwuJKExERsXz58mXLln333XcffPDBnTt3Hr0mLS2tb9++tWvXdnJy0nLl3LlzupiO0Wg0GAw8SwDACp05I598Ig4O0qCBfPONlLjfCACIK5RHXF2+fLlr165Nmzbt3Lmzl5fXwIED/+jFgVlZWVqAffvttxX7gsBnwj1XAGBtkpNVSmlBZWcnI0ZIZCQjAUBcwVLiKiwsLDY29saNG8XLIebNm5eSkvLoZYmJiVqA2draNmnSZOjQoQkJCbqYDvdcAYCVMJtl/37p1Us1lZeXrF0rFbS3FgBxBeLqD127dq1t27YHDhwIDAzs3Lmzlk+3b99+9DJfX98uXbrcu3evoKBAuzgoKEgX0+HkCgB07+ZNmTlTatUSFxeZOFEtrgAA4gqWGVea06dPa0GVnZ09a9asTZs2PfYaraZ27dr18MMlS5Zk6uGvDP39/Z2dnXmWAID+5OVJaKi0a6c2VXTpIjt2qM8AAHEFy4yrRYsWzZ49W2ukvLy8rKys3NzcR69JTU2dNGmSt7d3//7933333QkTJvj6+g4ZMkT7jC6mw8kVAOhPVJRMmCDOzuLhIV98IY97PQUAEFewrLiaOHFiTExMSkqKFk4DBgxISkp69JqMjIxu3bqNHz/eaDR+/vnnU6dO9fPzmzx5cqRObiA2mUzccwUA+pCeLqtXS4sW6q6q/v0lPJyl6gCIK+gmrhYuXFj80r6NGzeGhoY+9prCwsKsrKzix2eK5Ofnnzp1yqyT3/A4uQIAHThzRoYNUy//a9RIFi1iqToA4go6jqv9RYo/eeXKleTk5Ecv3rt372uvvTZp0iTt8bZt2xYsWKCL6XDPFQBYrsRECQxUS9UNBhk1SnTyDooAiCsQV48xbNiwBg0atG/fvnaRdu3avffeex4eHona73aPCAoKOnnyZPG6i+jo6LZt2xJXAIDnUVCglqr37auOqlq3Vn9qefASCQAgrqDXuBo9enSPHj2GDx/+SRGttYYOHerl5fXY97A6cODA+vXrV65cqaVXx44dO3XqpIvpmEwmJycnniUAYBGuX5dp06RmTalWTSZPll9+YSQAiCtYQ1wVFhZGR0drP/7u8zdv3kxLS3vs/8vq1atbtmyptYpWVnfv3iWuAABP5f592bhRLVW3s5MPPlBL1fPzmQoA4grWE1fPSiux4cOHJyUlpaam7t69Oz09XRfT4WWBAFCRLl2ScePUUvXatdVS9Tt3GAkA4grElcyZM+eLL74oPuk6cuTI+PHjiSsAwONlZEhw8K9L1T/6SPttQx55oQQAEFeovHG1du3aew924+7cubNp06bEFQDg906fVkvV7e2lSRNZskRSUxkJAOIKxNXvXbx4cfTo0YsWLdJy5bXXXgsKCtLFdHgTYQAoD4mJov2+UL++Wqru7S06eaN5ACCuUDFxpblx48asWbO8vb23bNmSqpO/jOTkCgDKkNksBw5I9+5SpYp4esq6dZKdzVQAEFcgrp4gKytr6dKlX3755dy5c318fPr160dcAUDlFRcnU6aIm5u4uMinn0pMDCMBQFyBuHpaq1atGjRoUKdOnfz8/Lp167ZmzRpdTCcgIKBatWo8SwCgdOTmyqZN0qGD2lTRpYvs3s1SdQDEFYirZxYSElJQUHDixInLly8nJiZOnz5dF9MxGo3ccwUApeDyZRk7VrTvqB4eMneuPO7t5gGAuAJx9VTCwsKaN28eHR09atQog8HQsWNHXUyHkysA+FPS02XZMmnWTGXVwIFy+DBL1QEQVyCuSkFCQkJhYWFaWtrWrVu1ytLFdDi5AoDndPKkqil7e2ncWL79VtLSGAkA4grE1Z+SlJQ0bdq0SZMmffrpp1OnTtV+DAgI0B5o0aKL6Wg/2+rVq/MsAYCnlZgoX38tdeqIg4OMGSMXLjASAMQVYyCuSsfdu3e9vLyGDRs2YsSIkSNHjikyYMCATz75RBfT4eQKAJ5KQYGEhUmPHmJjI15eEhLCUnUAIK6Iq1L/3bYgMTHx4YcZGRk5OTnF0WU2my1/OtxzBQBPcO2aTJsmrq5So4aYTBIby0gAgLgirspWfHx8s2bN3n777Zo1aw4cODBBJ3uijEajwWDgWQIAv5ebKxs3Srt2YmsrXbuqpeoFBUwFAIgr4qo8eHt79+zZMzk5OS0tbe3atSaTSRfT4eQKAH7vwgV1M5X2vbFOHZkzh6XqAEBcobzjKigo6OjRow8//O677/Ly8jIzM3/7okEL5O/v7+zszLMEANS6vxUrpGVLtQDwo49E+5bOUnUAIK5QIXEVGhraokWL8UX69++vPZ40aVLnzp33799vydPh5AoA5MQJGTBAvfyvaVNZvpyl6gBAXKGC4+rHH39s3769VlZjx4718fGZOHGir69vjx49Dh48aMnTYVsggMorIUG++kpq1xZnZxk7Vs6fZyQAQFyhIuMqJycnOTm5+EH2I2t5k5KS0tPTLXk6vCwQQKVTUCB796odFVWrSps2sn49S9UBgLiCRcSV2WxetWrV+cf9feeuXbv27dtn4dMxmUxOTk48SwBUCrGxMmWKuLhI9eoydarExTESACCuYEFxpUlPT580aVK/fv1mz54dHBy8fPlyf3///v37/6CH5xn3XAGwfjk58uOP0ratev/f7t3VsVV+PlMBAOIKlhhXmsLCwh07dgwYMKB58+ZeXl5GozEqKkoX0+HkCoA1K16qrn2Xq1tX3V7FUnUAIK5g+XGlX9xzBcAKpafLsmXSrJlaqj5woFoGCAAgrkBclTVOrgBYlSNH1FJ1BwdVVt99x1J1ACCuYA1xVVBQoIvpcM8VAGtw547Mnate++fkpJaq//wzIwEA4gr6i6vs7OwzZ84cP378xG8cPXp07dq1FfUFa1137969xAdKzjziCoCOFS9V79ZNqlSR9u1l0ya1uwIAQFxBp3F169YtBwcHNze32g/UqVPHYDB07dq1or7gCxcuvPPOOy4uLjVq1PDw8Lh27VoJF/OyQAC69MsvYjRKjRri5ibTp6sd6wAA4gp6j6vc3NzTp09L0cLA337+3LlzZrO5Qr7gY8eOab2nVd+9e/fi4+PzS9w4zEILAHqSna3e87dNG7VU/YMPZM8e0clrsAGAuAJx9Wy2bdvm6enZvHnzoKCgCrzn6vjx4waD4fz583fv3n34SS2xkh/Qoqv4R+0nOW7cOE6uAOhAZKRaqm4wqBur5s+X33x/AwAQV7C2uDp06FCtWrUCAgKCg4N9fX2XL19eUV/w6dOnX3/9dQ8PjzfeeOPDDz/My8vTPhkeHv7iiy/+tcgrRV599dWXX375hRdecHd351kCwEKlpsqSJfLuu2oB4ODBcvw4IwEA4grWH1daTV2/fv3hhxs2bEgr+xXA69ate++99zo+0Lp1a+3fazabb968WVBQcPXq1bfeeuvzzz/XrkxOTt68efOWIluLbNu2bd++fR988AELLQBYnMJCOXZMLVW3s5PmzWXlSvXWVQAA4gqVJK5+/PHHyMjI4sdnzpyZNGnS7+7CKgsRERGLFy9e/oD2+Ny5c7+9YNy4cVpxlfBPYFsgAMuSkCBz5kidOuLsLD4+cvEiIwEA4gqVLq5SUlJ69OjRuHFjd3d3GxubgwcPVtQX/Nuo69atW9++fUu42Gg0Ojo68iwBUMHy82XnTunaVWxtf12qnpvLVACAuEIljau4uLjTp09v2LBhxYoVN2/erMAveN68eT179tR+7N2792uvvRYREVHCxZxcAahgv/wi/v7i4qL2qk+bpn0zZSQAQFyhsseVn5/fV1999fDDtLS0cnhZ4GNpNTVq1KhevXr5+PhcunSp5ItZxQ6gYmRny7p14ukpVatKr14SFsZSdQAgrkBc/WrPnj3Dhg1bXWTJkiXTp0/XxXQ4uQJQ3s6dk1GjxNFRGjSQefMkMZGRAICOeXoSV8RV6duwYYODg0Pnzp07derUqlWrjz/+WBfTMRqNBoOBZwmAMpeSIkuXStOm6q6qQYPk5ElGAgDWoF07CQlhDMRVKTt69Oi1a9eKH2dkZKxfv14X0+HkCkDZKiyUQ4ekXz+xsZEWLWTVKu1bJFMBAOvBywKJq1K3Y8eOHj16TJ06dd68efPnz/fz8+vWrZsupsO2QABlJT5eZs8WDw+1VN3Xl6XqAEBcgbh6KidPnqxRo0b79u179uzZvXt3raz27t2ri+lwcgWglBUvVe/cWb38r0MHCQ2V+/eZCgAQVyCunkFaWlq+9keKB7KzsytqW+Az4eQKQKmJidG+p6il6q6uMn26XL/OSACAuAJx9TxycnK++uqroUOHjhgxYsCAAWPGjNHFdDi5AvBnZWbK2rVqW5S9vfTuLfv3i9nMVACAuAJx9fwmTZrUtGnTKVOm+Pv7jxs3zs/PTxfTMZlMnFwBeE6RkTJ6tDg4SL16smCBJCUxEgAgrkBclYLg4OBTp049/DA+Pt6sh7+75eQKwDNLSZElS6RhQ3VUNWSInD7NSACg8vLyUm8KD+KqdG3btq1Ro0ZDhgwZNGhQnz599PKyQH9/f2dnZ54lAJ7MbJafflJL1R0cpFUrCQ6W9HSmAgCV3fvvi07eggh6iquQkJBevXp9+eWXn3/++cQixBUAK3H7tnz5pdSuLY6OMm6cXLnCSAAAv+JlgcRVWTCbzffv3z98+PDOnTtTU1O1x7rYFmgymZycnHiWAHiMvDzZvl06dpQqVdSP27axVB0AQFwRV+UhJSWlSZMmNjY2jRs3btWq1YkTJ3QxHeIKwGNER4ufn1SrJu7uMmOGxMUxEgAAcYXyi6slRYof37t3b/ny5Xl5eZY/HV4WCOCfsrLUUvXWrcXOTnr2lAMHWKoOACCuUAFxFRISojXVb1srXQ+3ehNXAJSICBk5UgwGadBAFi5kqToAgLhCRcbV0aNHhw4dunr16qVLl7Zu3XrWrFm6mA5xBVRq9+7J4sXSuLFaADh8OEvVAQDEFSwirjSbNm1q0aKFu7v7Z599ppfp8CbCQGVkNkt4uPTvL7a2aqn699+zVB0A8JzatmUVO3FV+iIiIrp3756Zmak93rFjx+3bt3UxHU6ugMpF+9Y0a5bUqqWWVUyYIFFRjAQA8Ke0acObCBNXpW/OnDmrVq0qfnzy5MkRI0YQVwAsxf37smWLWqdub69+3LyZpeoAgNLBywKJq7Kwbt26hISE4sfr169v0qSJLqYTEBBQrVo1niWA1bp6VSZPlurVxdVVLVXXyaE6AIC4QqWOq9jY2JEjR06ZMmXQoEF//etfV6xYoYvpGI1G7rkCrFBmprqTqkULdVdVv37y008sVQcAEFfQTVyJupfh9tdff+3n5xceHq6X6XByBVibs2fV3j8HB2nUiKXqAADiCnqNKz3inivASiQnq5Rq2FBl1dChKrEAACCuQFyVJ06uAH0rLJSDB6Vv31+Xqq9dK0U7SwEAIK5AXJU37rkC9Kp4qbqbmzg7y6RJEh3NSAAAFaBdOwkJYQzEFRROrgCdycuTrVulUyd1VNWxo2zfrj4DAEBF4eSKuMJDRqPRYDAwB0AHoqJk/HhxcZHatdWZFUvVAQDEFYgrixIQEFC9enXmAFiujAxZtUrdT+XgoO6tOnRI3WcFAABxBeLK0nDPFWC5zp6VESPE3l7tAFy4UFJSGAkAgLgCcWW5uOcKsDhJSRIUJPXqqazy9pZz5xgJAIC4AnGlA5xcAZbCbJYDB6RXL7WpwstL1qxRLwgEAIC4AnGlF5xcARXvxg2ZMePXpeoTJ0pMDCMBAOiGp6esW8cYiCso/v7+ztqf5wCUv/v3ZfNm6dBBHVV17iw7d0p+PlMBAOjM++/L+vWMgbiCwskVUAGuXJEJE6R6dXF3l9mzJT6ekQAA9IqXBRJXeMhkMnHPFVBOMjNl9Wpp2VLs7KRfPwkPZ6k6AIC4AnFlPXhZIFAeIiJk0CD1RlVNmsiiRSxVBwAQVyCurJDJZHJycmIOQJlITJTAQGnQQKpVk1GjVGIBAEBcgbiyVpxcAaWvoEB++kl695aqVaV1a1m7VrKymAoAgLgCcaVX6enpFy5cuH37dsmXcXIFlKabN2X6dKlZUy2r8PdnqToAgLgCcaV7oaGhVapU0arJ0dExPDycuALKVm6u9l+d/OMfYm8vXbrI9u2Sl8dUAACVQps2vM8VcWXNbty48frrr69cuVJ7HB8ff/fu3RIu5mWBwJ9y+bKMGyeOjuotgGfPljt3GAkAoHJp25b3uSKurFlgYOB7772Xn58fFRWV9+Cvz7UP7z2QkpJS/GNBQcH48eN5nyvgmaWny8qVaqm6vb189JEcOcJSdQBAJcXLAokr6+bt7V2nTh0vLy93d/fatWtHR0drnwwPD3/xxRdfLvJKkVdffVV7/MILL2iX8SwBntapUzJkiBgMaqn6smWSmspIAADEFWMgrqzBunXrPD09Oz2gPd6zZ8+ECRP+8pe/XLhwQbugT58+HTp00B4kJyeHhoZuLrKlyNatW8PCwrp27crJFfBkSUkyb57Uq6deATh6tJw/z0gAACCuiCurcvbs2W+++ea7B7TH165d8/Pza9CgQfEFGzZsMBgMZrP5j/4JAQEBxBXwh7T/dvbtkw8+EFtb8fRUN+yyVB0AAOKKuKo8Vq9e7eLiUvxYyy03N7cSLjYajY6OjjxLgN+Li5Np06RWLdH+azIaWaoOAABxhcoYVxkZGVpc9evXb+nSpW+99VZQUFAJF3NyBfyLnBzZvFktPqpSRS1V37mTpeoAABBXqLxxpbl+/fro0aN79+69/kmbMTm5An51+bL4+KhNFR4e8tVXLFUHAOCptGsnISGMgbiCwskVKrvUVFm+XC1V17Lq449Zqg4AwLPx9OTkirjCr4xGo0H7MyVQCR0/LoMGqTeqatRIli6VtDRGAgDAM+NlgcQVHuLkCpVOYqIEBkrdumqp+pgx8vPPjAQAAOIKxFUp8Pf3d3Z2Zg6wfmazhIVJ9+5qqXrbturV4dnZTAUAAOIKxFWp4eQK1u/6dZk6VWrWFFdX7Rkvv/zCSAAAIK5AXJU+tgXCauXmyo8/ipeX2NiodwHes0cKCpgKAADEFYirssLJFazQhQtqqbqzs9SuzVJ1AADKFtsCiSs8ZDKZOLmClUhLk5UrpXlzdVT18cdqGSBL1QEAKGu8zxVxhYc4uYI10DpqwAC1qaJZM1mxQr11FQAAKB+8LJC4wkOcXEHH7tyROXOkfn2pVk1Gj5bz5xkJAADEFYirCsMqduhPQYHs3i3duknVqmpfxcaNancFAAAgrkBcVSxOrqAnsbHi7y8uLmqv+tSpcu0aIwEAgLgCcWUpuOcKOlC8VL1tW3VXVffusnOn5OczFQAAiCsQV8QV8NR+/lnGjhVHR3Vj1ddfS2IiIwEAgLgCcWWhTCaTk5MTc4BlSU2V5cvV6j97exk0SC0DBAAAlqltW1m/njEQVyCuYGEKC+XIEVVTWlO9+64sW6beugoAAFiyNm1k3TrGQFyBuILFSEhQr/qrU0cMBvHxUa8GBAAAusDLAokrPMQ9V6hIBQVqO0WXLmJjI+3by6ZNLFUHAIC4AnGlV5xcoWL88otaqu7qqv4XEMBSdQAAiCsQV7rHmwijXOXkqJdlt22rjqq6dZOwMDGbmQoAAMQViCtrwJsIo5xcuCDe3uLgoJaqBwWxVB0AAOIKxJW14Z4rlK2UFFmyRJo0UQsABw+WY8cYCQAAxBWIK+vEywJRJgoLVUd99JHY2UmLFrJypaSnMxUAAKxQu3YSEsIYiCsonFyhlMXHy9y50qCBODmJr69cusRIAACwZp6enFwRV/iV0WjkniuUgrw8tVS9a1e1qaJdO9m8We7fZyoAAFg/XhZIXOEhTq7wZ8XGqqXq1atLjRoybZrExTESAACIKxBXlREnV3hOOTmydq36fmprK336yL596h2BAQAAcQXiqtIKCAioXr06c8AziIiQUaOkWjW1VD0wkKXqAAAQV4yBuIJiNBoNBgNzwJOlpMjixdK4sbqrauBAOXWKkQAAAOKKuMI/cc8VnqCwUI4ckX79VFO1bCmrVklaGlMBAADEFXGF3+OeK/yh+Hj58ktxd1evAPT1lYsXGQkAACCuiCv8IU6u8Hu/Xar+j3/Ili0sVQcAAMQViKsn8/f3d3Z2Zg5QoqPFaFQb1V1dZcYMuXGDkQAAAOIKxNXT4uQKkpmplqp7eaml6j17yoEDYjYzFQAAQFyBuHo2JpOJe64qr8hItVTdzk7q1ZOgIElKYiQAAIC4AnH1nDi5qozu3ZOFC6VhQ3FwkCFDWKoOAACIKxBXpYB7rioRs1kOHZL+/cXe/tel6unpTAUAABBXIK6IKzy14qXqbm7i6Cjjx0tUFCMBAADEFYirJ8vKykpMTLxb5N69exkZGSVcbDKZnJyceJZYp7w82b5dOnZUS9W1H7duldxcpgIAAIgrEFdP6+uvv7a1tXV1dXVzc/vf//3fXr16EVeVztWrMnmyVK+uTqtYqg4AAIgrEFfPJy0t7fr167du3UpOTq5bt+7s2bNLuJiXBVqVrCxZs0Y8PdVS9b591R1WLFUHAADEFYirP+/ixYtvv/32jaJTi/z8/JQHUlNTi380m80TJkxgW6A1OHNGRo4Ug0EaNJAFC1iqDgAAiCsQV6Vp3LhxHTt2LH4cHh7+0ksvvVzkP4r87W9/e+WVV1544QV3d3eeJXqlRdQ330jjxmqp+rBhKrEAAACIKxBXz2H9+vVeXl6dH9Aeh4SEFP+fcnJy7OzsQkNDH/whPGnjxo2hRTYX2bJly969e7t06cLJlf4UFmq5rF74V7WqtGqllqpnZjIVAABAXIG4en5nz55duHDh0ge0xxEREcX/pw0bNtjb22uJVfI/gTcR1plbt+Szz9SaCmdnmTBBrlxhJAAAgLgCcVW2vLy8fHx8nngZCy304f592bZNOndWS9U7dJAtW9RnAAAAiCsQV2Xt559/fvXVVyMjI594JSdXli46Wj79VJ1T1aypzqxu3WIkAACAuAJxVX60rFq8eHFhYeETrzQajY6OjjxLLE5mpnz/vbRsKXZ20r8/S9UBAABxBeLK0nFyZXHOnJERI0Qr3oYNZf58SU5mJAAAgLgCcaUDnFxZinv31PtTNWqkskqLq3PnGAkAACCuQFzpSUBAQPXq1ZlDhTGb5aefpE8fsbWV1q1lzRrJymIqAACAuAJxpT+cXFWYGzd+Xaru4iKTJklUFCMBAADEFYgrHeOeq/JWvFS9fXupUkU6dZKtWyUvj6kAAADiCsSV7hmNRoPBwBzKQ1SU+PqqpepubjJ7NkvVAQAAcQXiyqpwclXmMjJk1Srx9FRL1fv0UUvVn2JFPgAAAHEF4kpn/P39nZ2dmUOZOHtWhg9XTdWggSxeLCkpjAQAABBXIK6sFidXpS8pSebNU0Hl5CSjRklEBCMBAADEFYgr68e2wFJjNsvBg9Krlzqqat1avv9esrOZCgAAIK5AXFUWvCywFNy8KTNnqjUV1arJ5MkSE8NIAAAAcQXiqtIxmUxOTk7M4Xncvy+bN6ul6ra20qWL7NjBUnUAAEBcgbiqvLjn6nlcuSITJqil6h4e8sUXcvs2IwEAAMQViKvKjpOrZ5CRoe6kat5cHVX17y/h4SxVBwAAxBVxRVzhV9xz9VROnZLBg8XBQRo2VEvV791jJAAAAMQVcYV/wclVSe7elaAgFVQGg4wcKefOMRIAAADiirjC43HP1WMUFsqBA9Kzp1Stqpaqr1/PUnUAAADiCsQVcfUsrl+XqVPF1VVq1hSTSaKjGQkAAABxBeLqqfCyQOX+fdm0Sdq1U+//27mzbNsm+fk8NwAAAIgrEFfPoLIvtLh0SXx8RMtLd3eZM0fu3OEpAQAAQFyBuHoeJpPJ0dGx0n3Z6emyerW0bKmOqj7+WA4fZqk6AAAAcQXi6k+pdPdcFS9Vt7eXpk1l2TJJSeE5AAAAQFyBuCoFleXk6u5dmT9f6tcX7YsdNUrOn+eXHgAAgLgCcVWarPzkymyWPXukRw+xtRVPT5aqAwAAEFcgrsqK0Wi0zpOra9dk+nS1pqJ6dfn0U/nlF36tAQAAiCsQV2XI2k6ucnMlNFTatpV33pGuXdWxVUEBv8oAAADEFYirMmc9q9gvXpQxY9QtVfXqydy5cvs2v7gAAADEFYir8qP7k6v0dFmxQpo1E4NB+veXI0dYqg4AAEBcgbiqAEaj0aBliR6dOKGWqtvaSpMmaql6Whq/mgAAAMQViKsKo7+Tq8REmTdPvfbP0VF8fFiqDgAAQFyBuLIIutkWWFAge/dKnz5iZ6f2VWzYwFJ1AAAA4grElQXRwclVXJxMnSqurlKjhvbTVTvWAQAAQFyBuLI0lntylZOj3vP3/ffVXVUffCC7drFUHQAAgLgCcWW5LPHk6uefZdw4cXKS2rXVUvWEBH6ZAAAAiCsQV5bOZDJZyslVerp8951a/WdrKx9/rJaqAwAAgLgCcaUXFnFydfy4qik7O2neXJYuldRUfl0AAACIKxBXOuPv7+/s7Fwx/+47dyQwUOrXF63uxoyRyEh+OQAAAIgrEFfE1VMrKJDdu6V7d3nnHbWvYuNGtbsCAAAAxBWIKwuUnp6+bt26b7/9NiYmpuQrTSaTk5NTOf20fvlF7VKvUUNq1lTb1WNjeXYCAADom6cncUVcWbPU1NQ6deq0aNHiww8/fOutt/bv31/OcRVf5J8fZ2er9/xt21aqVlUHVmFhLFUHAACwDtGtWuWsW8cciCurFRwcbG9vX1hYqD0eMWJE+/btS7i41F8WmJyc7OHhUdPVNTE5Wa5elbFjRfvn160rX30ld+/ydAQAALAaYWFh//ff/s13+HBGQVxZrZ07d2pxlZmZqT3u06fPkCFDtAcpKSl79uzZWySsyL59+44dO6ZdUKNGjdL6VyckJDRo0OCFIrXffDPexkYGDZITJ3gWAgAAWBntz5b/8R//UfwHP19fXwZCXOlefn5+zr8qKHrFnZ+fX5UqVWrVqtW0adP09HTtM4cOHfrLX/7yf4r8vyIvv/zySy+9pH3S09OztH4+w4cPf+E3BvXrx/MPAADA+mRkZDg6Ov72D37bt29nLMSVvi1evNje3r7WA3Z2dsHBwXFxcXXq1AkKCtq0aVOTJk2++eYb7cq8vLz4+Pg7v5GQkFD8mZSUlNL6+Wj/tHr16hX/B+bu7n77zh2efwAAAFZp9+7dr7zySvEf/Hx8fBgIcaV7SUlJly5duvKA9rigoMDb27tjx47FF6xatcrR0bE8f0p3796tZTC4ODvfoawAAACs2q5du1588cWxY8cyCuLKak2YMKFhw4bFj2fPnu3i4lLOP4HbgwffCgjgmQcAAGD1rly5kp2dzRyIK6t1/fp1R0fHli1b9u3b97//+7/Xr19f3j+DQYPU21gBAAAAIK70LiUl5Ycffvj222+joqIq4F9PXAEAAADEFYgrAAAAAMQVcQUAAACAuCKuAAAAABBXIK4AAAAA4grEFQAAAADiirgCAAAAQFwRVwAAAACIKxBXAAAAAHEF4goAAAAAcUVcAQAAACCuiCsAAAAAxBWIKwAAAIC4AnEFAAAAgLgirgAAAAAQV5VD8pAhyVOmMAcAAACAuMLzy8jIaOLq2tDDIy09nWkAAAAAxBWeR1paWqtWrV4o0rRp05SUFGYCAAAAEFd4ZiNGjHjhNwYPHsxMAAAAAOIKzyw2NrZGjRrFZeXs7BwTE8NMAAAAAOIKz+PmzZsGg8HOzu7atWtMAwAAACCu8PxiY2M5swIAAACIKwAAAAAAcQUAAAAAxBUAAAAAEFcAAAAAQFwBAAAAAIgrAAAAACCuAAAAAEAH/j8WYcxOO/DWIgAAAABJRU5ErkJggg==</FILE></FIGURE><FIGURE FILENAME="Adjusted Boundaries Sketch_rm5.png" FILE_TYPE="PNG" ID="FIG-10" MODIFIED="2018-01-31 17:39:01 +0000" MODIFIED_BY="Hermann Blessberger" NO="10" SHORT_VERSION_FIGURE="YES" TYPE="OTHER"><CAPTION><P>TSA bradycardia - non-cardiac surgery.</P></CAPTION><FILE>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</FILE></FIGURE><FIGURE FILENAME="Adjusted Boundaries Sketch.png" FILE_TYPE="PNG" ID="FIG-11" MODIFIED="2018-01-31 17:39:04 +0000" MODIFIED_BY="Hermann Blessberger" NO="11" SHORT_VERSION_FIGURE="YES" TYPE="OTHER"><CAPTION><P>TSA hypotension&#8212;non-cardiac surgery.</P></CAPTION><FILE>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</FILE></FIGURE><FIGURE FILENAME="Adjusted Boundaries Sketch.png" FILE_TYPE="PNG" ID="FIG-12" MODIFIED="2018-01-31 17:39:06 +0000" MODIFIED_BY="Hermann Blessberger" NO="12" SHORT_VERSION_FIGURE="YES" TYPE="OTHER"><CAPTION><P>TSA ventricular extrasystoles&#8212;non-cardiac surgery.</P></CAPTION><FILE>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</FILE></FIGURE><FIGURE FILENAME="Adjusted Boundaries Sketch_rm5.png" FILE_TYPE="PNG" ID="FIG-13" MODIFIED="2018-01-31 17:39:09 +0000" MODIFIED_BY="Hermann Blessberger" NO="13" SHORT_VERSION_FIGURE="YES" TYPE="OTHER"><CAPTION><P>TSA congestive heart failure - non-cardiac surgery.</P></CAPTION><FILE>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</FILE></FIGURE></FIGURES><FEEDBACK/><APPENDICES MODIFIED="2018-03-06 09:40:25 +0000" MODIFIED_BY="[Empty name]"><APPENDIX ID="APP-01" MODIFIED="2013-12-08 21:17:49 +0000" MODIFIED_BY="Hermann Blessberger" NO="1"><TITLE MODIFIED="2013-12-08 21:17:44 +0000" MODIFIED_BY="Hermann Blessberger">Search filter for MEDLINE (Ovid SP)</TITLE><APPENDIX_BODY MODIFIED="2013-12-08 21:17:49 +0000" MODIFIED_BY="Hermann Blessberger"><P>1. exp Adrenergic beta-Antagonists/ or exp Bendroflumethiazide/ or (acebutolol* or adimolol* or afurolol* or alpha hydroxymetoprolol* or alprenolol* or amosulalol* or arotinolol* or atenolol* or befunolol* or bendroflumethiazide* or betaxolol* or bevantolol* or bfe 55 or bisoprolol* or bopindolol* or bornaprolol* or brefonalol* or bromoacetylalprenololmenthane* or bucindolol* or bucumolol* or bufetolol* or bufuralol* or bunitrolol* or bunolol* or bupranolol* or butofilolol* or butoxamine* or carazolol* or carteolol* or carvedilol* or celiprolol* or cetamolol* or cloranolol* or cyanoiodopindolol* or cyanopindolol* or deacetylmetipranolol* or diacetolol* or dihydroalprenolol* or dilevalol* or epanolol* or esmolol* or exaprolol* or falintolol* or flestolol* or flusoxolol* or hydroxybenzylpindolol* or indenolol* or iodocyanopindolol* or iodopindolol* or iprocrolol* or isamoltane* or isoxaprolol* or labetalol* or landiolol* or levobunolol* or levomoprolol* or medroxalol* or mepindolol* or mercuderamide* or metipranolol* or metoprolol* or moprolol* or nadolol* or nebivolol* or nifenalol* or nipradilol* or oxprenolol* or pafenolol* or pamatolol* or penbutolol* or pindolol* or practolol* or primidolol* or prizidilol* or pronetalol* or propranolol* or proxodolol* or ridazolol* or salcardolol* or sandoz 204545 or soquinolol* or sotalol* or spirendolol* or talinolol* or tertatolol* or tienoxolol* or tilisolol* or timolol* or tolamolol* or toliprolol* or trasitensin* or trepress* or tribendilol* or viskaldix* or xibenolol* or zolertine or (beta* adj3 (adrenergic* or blocker*))).ti,ab.<BR/>2. exp Premedication/ or Intraoperative Period/ or Intraoperative Complications/ or Perioperative Period/ or Postoperative Complications/ or Postoperative Period/ or Preoperative Period/ or (intraoperat* or perioperat* or peroperat* or postoperat* or preoperat* or premedicat*).ti,ab. <BR/>3. exp Specialties, Surgical/ or General Surgery/ or su.xs. or (surg* or operat*).ti,ab.<BR/>4. 1 and 2 and 3 <BR/>5. ((randomized controlled trial or controlled clinical trial).pt. or randomized.ab. or placebo.ab. or clinical trials as topic.sh. or randomly.ab. or trial.ti.) not (animals not (humans and animals)).sh.<BR/>6. 4 and 5<BR/></P></APPENDIX_BODY></APPENDIX><APPENDIX ID="APP-02" MODIFIED="2018-02-23 18:16:57 +0000" MODIFIED_BY="[Empty name]" NO="2"><TITLE MODIFIED="2018-02-23 18:16:57 +0000" MODIFIED_BY="[Empty name]">Search filter for Embase (Ovid SP)</TITLE><APPENDIX_BODY MODIFIED="2014-05-15 14:18:29 +0100" MODIFIED_BY="Jane Cracknell"><P>1. beta adrenergic receptor blocking agent/ or bendroflumethiazide/ or (acebutolol* or adimolol* or afurolol* or alpha hydroxymetoprolol* or alprenolol* or amosulalol* or arotinolol* or atenolol* or befunolol* or bendroflumethiazide* or betaxolol* or bevantolol* or bfe 55 or bisoprolol* or bopindolol* or bornaprolol* or brefonalol* or bromoacetylalprenololmenthane* or bucindolol* or bucumolol* or bufetolol* or bufuralol* or bunitrolol* or bunolol* or bupranolol* or butofilolol* or butoxamine* or carazolol* or carteolol* or carvedilol* or celiprolol* or cetamolol* or cloranolol* or cyanoiodopindolol* or cyanopindolol* or deacetylmetipranolol* or diacetolol* or dihydroalprenolol* or dilevalol* or epanolol* or esmolol* or exaprolol* or falintolol* or flestolol* or flusoxolol* or hydroxybenzylpindolol* or indenolol* or iodocyanopindolol* or iodopindolol* or iprocrolol* or isamoltane* or isoxaprolol* or labetalol* or landiolol* or levobunolol* or levomoprolol* or medroxalol* or mepindolol* or mercuderamide* or metipranolol* or metoprolol* or moprolol* or nadolol* or nebivolol* or nifenalol* or nipradilol* or oxprenolol* or pafenolol* or pamatolol* or penbutolol* or pindolol* or practolol* or primidolol* or prizidilol* or pronetalol* or propranolol* or proxodolol* or ridazolol* or salcardolol* or sandoz 204545 or soquinolol* or sotalol* or spirendolol* or talinolol* or tertatolol* or tienoxolol* or tilisolol* or timolol* or tolamolol* or toliprolol* or trasitensin* or trepress* or tribendilol* or viskaldix* or xibenolol* or zolertine or (beta* adj3 (adrenergic* or blocker*))).ti,ab.<BR/>2. premedication/ or intraoperative period/ or peroperative complication/ or perioperative period/ or postoperative complication/ or postoperative period/ or preoperative period/ or (intraoperat* or perioperat* or peroperat* or postoperat* or preoperat* or premedicat*).ti,ab.<BR/>3. surgery/ or (surg* or operat*).ti,ab.<BR/>4. 1 and 2 and 3<BR/>5. (placebo.sh. or controlled study.ab. or random*.ti,ab. or trial*.ti,ab. or ((singl* or doubl* or trebl* or tripl*) adj3 (blind* or mask*)).ti,ab.) not (animals not (humans and animals)).sh.<BR/>6. 4 and 5</P></APPENDIX_BODY></APPENDIX><APPENDIX ID="APP-03" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" NO="3"><TITLE MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell">Search filter for CENTRAL (<I>The Cochrane Library</I>)</TITLE><APPENDIX_BODY MODIFIED="2013-12-08 21:16:17 +0000" MODIFIED_BY="Hermann Blessberger"><P>#1 MeSH descriptor Adrenergic beta-Antagonists explode all trees<BR/>#2 MeSH descriptor Bendroflumethiazide explode all trees<BR/>#3 (acebutolol* or adimolol* or afurolol* or alpha hydroxymetoprolol* or alprenolol* or amosulalol* or arotinolol* or atenolol* or befunolol* or bendroflumethiazide* or betaxolol* or bevantolol* or bfe 55 or bisoprolol* or bopindolol* or bornaprolol* or brefonalol* or bromoacetylalprenololmenthane* or bucindolol* or bucumolol* or bufetolol* or bufuralol* or bunitrolol* or bunolol* or bupranolol* or butofilolol* or butoxamine* or carazolol* or carteolol* or carvedilol* or celiprolol* or cetamolol* or cloranolol* or cyanoiodopindolol* or cyanopindolol* or deacetylmetipranolol* or diacetolol* or dihydroalprenolol* or dilevalol* or epanolol* or esmolol* or exaprolol* or falintolol* or flestolol* or flusoxolol* or hydroxybenzylpindolol* or indenolol* or iodocyanopindolol* or iodopindolol* or iprocrolol* or isamoltane* or isoxaprolol* or labetalol* or landiolol* or levobunolol* or levomoprolol* or medroxalol* or mepindolol* or mercuderamide* or metipranolol* or metoprolol* or moprolol* or nadolol* or nebivolol* or nifenalol* or nipradilol* or oxprenolol* or pafenolol* or pamatolol* or penbutolol* or pindolol* or practolol* or primidolol* or prizidilol* or pronetalol* or propranolol* or proxodolol* or ridazolol* or salcardolol* or sandoz 204545 or soquinolol* or sotalol* or spirendolol* or talinolol* or tertatolol* or tienoxolol* or tilisolol* or timolol* or tolamolol* or toliprolol* or trasitensin* or trepress* or tribendilol* or viskaldix* or xibenolol* or zolertine):ti,ab<BR/>#4 (beta* near (adrenergic* or blocker*)):ti,ab<BR/>#5 (#1 OR #2 OR #3 OR #4)<BR/>#6 MeSH descriptor Premedication explode all trees<BR/>#7 MeSH descriptor Intraoperative Period explode all trees<BR/>#8 MeSH descriptor Intraoperative Complications explode all trees<BR/>#9 MeSH descriptor Perioperative Period explode all trees<BR/>#10 MeSH descriptor Postoperative Complications explode all trees<BR/>#11 MeSH descriptor Postoperative Period explode all trees<BR/>#12 MeSH descriptor Preoperative Period explode all trees<BR/>#13 (intraoperat* or perioperat* or peroperat* or postoperat* or preoperat* or premedicat*):ti,ab<BR/>#14 (#6 OR #7 OR #8 OR #9 OR #10 OR #11 OR #12 OR #13)<BR/>#15 MeSH descriptor Specialties, Surgical explode all trees<BR/>#16 (surg* or operat*):ti,ab<BR/>#17 (#15 OR #16)<BR/>#18 (#5 AND #14 AND #17)<BR/></P></APPENDIX_BODY></APPENDIX><APPENDIX ID="APP-04" MODIFIED="2014-05-15 14:18:29 +0100" MODIFIED_BY="Jane Cracknell" NO="4"><TITLE MODIFIED="2013-12-08 21:16:53 +0000" MODIFIED_BY="Hermann Blessberger">Search filter for CINAHL (EBSCO host)</TITLE><APPENDIX_BODY MODIFIED="2014-05-15 14:18:29 +0100" MODIFIED_BY="Jane Cracknell"><P>S1. (MM "Adrenergic Beta-Antagonists") OR AB ( acebutolol* or adimolol* or afurolol* or alpha hydroxymetoprolol* or alprenolol* or amosulalol* or arotinolol* or atenolol* or befunolol* or bendroflumethiazide* or betaxolol* or bevantolol* or bfe 55 or bisoprolol* or bopindolol* or bornaprolol* or brefonalol* or bromoacetylalprenololmenthane* or bucindolol* or bucumolol* or bufetolol* or bufuralol* or bunitrolol* or bunolol* or bupranolol* or butofilolol* or butoxamine* or carazolol* or carteolol* or carvedilol* or celiprolol* or cetamolol* or cloranolol* or cyanoiodopindolol* or cyanopindolol* or deacetylmetipranolol* or diacetolol* or dihydroalprenolol* or dilevalol* or epanolol* or esmolol* or exaprolol* or falintolol* or flestolol* or flusoxolol* or hydroxybenzylpindolol* or indenolol* or iodocyanopindolol* or iodopindolol* or iprocrolol* or isamoltane* or isoxaprolol* or labetalol* or landiolol* or levobunolol* or levomoprolol* or medroxalol* or mepindolol* or mercuderamide* or metipranolol* or metoprolol* or moprolol* or nadolol* or nebivolol* or nifenalol* or nipradilol* or oxprenolol* or pafenolol* or pamatolol* or penbutolol* or pindolol* or practolol* or primidolol* or prizidilol* or pronetalol* or propranolol* or proxodolol* or ridazolol* or salcardolol* or sandoz 204545 or soquinolol* or sotalol* or spirendolol* or talinolol* or tertatolol* or tienoxolol* or tilisolol* or timolol* or tolamolol* or toliprolol* or trasitensin* or trepress* or tribendilol* or viskaldix* or xibenolol* or zolertine ) OR AB ( (beta* and (adrenergic* or blocker*)))<BR/>S2. ((MH "Premedication") OR (MH "Intraoperative Period") OR (MH "Postoperative Period") OR (MH "Intraoperative Complications") OR (MH "Preoperative Period") OR (MH "Postoperative Complications")) OR AB ( intraoperat* or perioperat* or peroperat* or postoperat* or preoperat* or premedicat*)<BR/>S3. (MH "Specialties, Surgical+") OR AB ( surg* or operat* )<BR/>S4. S1 and S2 and S3</P></APPENDIX_BODY></APPENDIX><APPENDIX ID="APP-05" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" NO="5"><TITLE MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell">Search filter for Biosis Previews, CAB Abstracts, Global Health, Life Sciences Collection, Derwent Drug File, Science Citation Index Expanded, International Pharmaceutical Abstracts, PASCAL, Conference Proceedings Citation Index&#8211;Science, System for Information on Grey Literature in Europe, British Library Inside Conferences, Conference Papers Index, Index to Scientific and Technical Proceedings and Books</TITLE><APPENDIX_BODY MODIFIED="2014-08-11 15:37:04 +0100" MODIFIED_BY="[Empty name]"><P>A, B, C, D combined with AND<BR/><BR/>A: beta-blocker (to be combined with OR)<BR/><BR/>Free Text:<BR/>acebutolol*<BR/>adimolol*<BR/>afurolol*<BR/>alpha hydroxymetoprolol*<BR/>alprenolol*<BR/>amosulalol*<BR/>arotinolol*<BR/>atenolol*<BR/>befunolol*<BR/>bendroflumethiazide*<BR/>(beta* adj3 adrenergic*)<BR/>beta blocker*<BR/>betaxolol*<BR/>bevantolol*<BR/>bfe 55<BR/>bisoprolol*<BR/>bopindolol*<BR/>bornaprolol*<BR/>brefonalol*<BR/>bromoacetylalprenololmenthane*<BR/>bucindolol*<BR/>bucumolol*<BR/>bufetolol*<BR/>bufuralol*<BR/>bunitrolol*<BR/>bunolol*<BR/>bupranolol*<BR/>butofilolol*<BR/>butoxamine*<BR/>carazolol*<BR/>carteolol*<BR/>carvedilol*<BR/>celiprolol*<BR/>cetamolol*<BR/>cloranolol*<BR/>cyanoiodopindolol*<BR/>cyanopindolol*<BR/>deacetylmetipranolol*<BR/>diacetolol*<BR/>dihydroalprenolol*<BR/>dilevalol*<BR/>epanolol*<BR/>esmolol*<BR/>exaprolol*<BR/>falintolol*<BR/>flestolol*<BR/>flusoxolol*<BR/>hydroxybenzylpindolol*<BR/>indenolol*<BR/>iodocyanopindolol*<BR/>iodopindolol*<BR/>iprocrolol*<BR/>isamoltane*<BR/>isoxaprolol*<BR/>labetalol*<BR/>landiolol*<BR/>levobunolol*<BR/>levomoprolol*<BR/>medroxalol*<BR/>mepindolol*<BR/>mercuderamide*<BR/>metipranolol*<BR/>metoprolol*<BR/>moprolol*<BR/>nadolol*<BR/>nebivolol*<BR/>nifenalol*<BR/>nipradilol*<BR/>oxprenolol*<BR/>pafenolol*<BR/>pamatolol*<BR/>penbutolol*<BR/>pindolol*<BR/>practolol*<BR/>primidolol*<BR/>prizidilol*<BR/>pronetalol*<BR/>propranolol*<BR/>proxodolol*<BR/>ridazolol*<BR/>salcardolol*<BR/>sandoz 204545<BR/>soquinolol*<BR/>sotalol*<BR/>spirendolol*<BR/>talinolol*<BR/>tertatolol*<BR/>tienoxolol*<BR/>tilisolol*<BR/>timolol*<BR/>tolamolol*<BR/>toliprolol*<BR/>trasitensin*<BR/>trepress*<BR/>tribendilol*<BR/>viskaldix*<BR/>xibenolol*<BR/>zolertine*<BR/><BR/><BR/>B: perioperative (to be combined with OR)<BR/><BR/>Free Text:<BR/>intraoperat*<BR/>perioperat*<BR/>peroperat*<BR/>postoperat*<BR/>preoperat*<BR/>premedicat*<BR/><BR/>C: surgery (to be combined with OR)<BR/><BR/>Free Text:<BR/>surg*<BR/>operat*<BR/><BR/><BR/>D: RCT - Filter (to be combined with OR)<BR/><BR/>Free Text:<BR/>placebo*<BR/>random*<BR/>control*<BR/>prospectiv*<BR/>volunteer*<BR/>(clin* adj3 trial*)<BR/>(compar* adj3 stud*)<BR/>(singl* or doubl* or trebl* or tripl*) adj3 (blind* or mask*)</P></APPENDIX_BODY></APPENDIX><APPENDIX ID="APP-06" MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell" NO="6"><TITLE MODIFIED="2010-09-03 15:58:06 +0100" MODIFIED_BY="Hermann Blessberger">Trial data extraction form</TITLE><APPENDIX_BODY MODIFIED="2014-08-27 12:37:06 +0100" MODIFIED_BY="Jane Cracknell"><P><BR/>1. Study ID<BR/>First author year / ID / Reviewer ID.</P><P><BR/>2. Citation<BR/>Journal.<BR/>Year.<BR/>Volume.<BR/>First page.</P><P><BR/>3. Title</P><P>4. Language</P><P>English, other (specify).</P><P><BR/>5. Study type</P><P>RCT, cross-over RCT, other (specify).</P><P><BR/>6. Centres</P><P>Single-centre, multi-centre, unclear.</P><P><BR/>7. Hospital</P><P>University hospital, other, unclear.</P><P><BR/>8. Allocation<BR/>Allocation was not concealed (e.g. quasi-randomized).<BR/>Allocation concealment was unclear.<BR/>Allocation was concealed (e.g. numbered sealed opaque envelopes).</P><P><BR/>9. Inclusion + exclusion criteria<BR/>Inclusion and exclusion criteria were not clearly defined in the text.<BR/>Inclusion and exclusion criteria were implicitly defined in the text.<BR/>Inclusion and exclusion criteria were explicitly defined in the text.</P><P><BR/>10. Intention-to-treat<BR/>Outcomes of patients who withdrew or were excluded after allocation<BR/>were neither detailed separately nor included in an intention-to-treat.<BR/></P><P>Outcomes of patients who withdrew or were excluded after allocation<BR/>were either detailed separately or included in an intention-to-treat<BR/>or the text stated there were no withdrawals.<BR/></P><P>Unclear.</P><P><BR/>11. Baseline data<BR/>Treatment and control groups were not adequately described at entry.<BR/>Treatment and control groups were adequately described at entry<BR/>(e.g. age, sex, weight, diseases, type of surgery, any scores).<BR/>Unclear.</P><P><BR/>12. Care programme<BR/>The text stated that the care programmes other than the trial options were not identical.<BR/>The text stated that the care programmes other than the trial options were identical.<BR/>Unclear.</P><P><BR/>13. Definition of outcome measures<BR/>Outcome measures were not clearly defined in the text.<BR/>Outcome measures were implicitly defined in the text.<BR/>Outcome measures were explicitly defined in the text.</P><P><BR/>14. Blinding<BR/>Subject was blinded (YES, NO, unclear).<BR/>Physician was blinded (YES, NO, unclear).<BR/>Outcome assessor was blinded (YES, NO, unclear).</P><P><BR/>15. Participants<BR/>Number of eligible participants<BR/>(leave blank if unclear / not stated).<BR/>Number of enrolled participants.</P><P><BR/>16. Withdrawals<BR/>Number of withdrawals (intervention group).<BR/>Number of withdrawals (control group).</P><P><BR/>17. Type of surgery</P><P><BR/>18. Risk of surgery</P><P>High risk:<BR/>any cardiac, high risk vascular (aortic dissection/aortic abdominal aneurysm repair), extensive abdominal (any hepatic/pancreatic/TU surgery), any organ transplantation, brain neurosurgery.</P><P>Intermediate risk:</P><P>lower abdominal, peripheral vascular (including carotid), any orthopaedic surgery on large joints (hip, knee, shoulder, including vertebral), mamma.</P><P>Low risk:</P><P>everything else: dermatologic interventions, ENT (=HNO), peripheral neuro, peripheral orthopaedic surgery.</P><P><BR/>19. Number of treatment groups (including control group)<BR/>Two, three, more (specify), cross-over design.</P><P><BR/>20. Drugs:</P><P>Control group, drug group 1, drug group 2-<BR/>Drug (specify).<BR/>Route.<BR/>Indicate if fixed dose (F) (e.g. 5 &#956;g/kg/min) or goal-directed (D).<BR/>Dose.<BR/>Duration.<BR/>Time treatment was started (before, during, or after surgery).</P><P><BR/>21. Comments on treatment</P><P><BR/>22. Type of patients<BR/>Adult, paediatric, unclear.</P><P><BR/>22. Number of patients in the control group and intervention group<BR/>Overall number of patients, deaths, other outcomes.</P><P><BR/>24. Co-morbidity<BR/>Other diseases specified.<BR/>Other diseases not specified.<BR/>Unclear.<BR/>if other specified - which?</P><P><BR/>23. Data and characteristics of control group, drug group 1 and drug group 2<BR/>Age [mean] [median] or [SD] [SE] [IQR] [range] [individual patient data].<BR/>Sex: M / F [number] [%] [individual patient data].<BR/>Ethnic group (specify).<BR/>Weight [mean] [median] or [SD] [SE] [IQR] [range] [individual patient data].<BR/>ASA-score1 [mean] [median] or [SD] [SE] [IQR] [range] [individual patient data].<BR/>CARE-scale2 [mean] [median] or [SD] [SE] [IQR] [range] [individual patient data].<BR/>Other score (specify) [mean] [median] or [SD] [SE] [IQR] [range] [individual patient data].</P><P><BR/>25. Outcome measures<BR/>Is any of the following outcome-measures stated:<BR/>All-cause mortality (deaths due to any cause occurring 30 days postoperatively or before hospital discharge &#8211; whichever occurs later).<BR/>Long-term all-cause mortality (deaths due to any cause not qualifying as all-cause mortality listed above).<BR/>Deaths due to cardiac causes (until 30 days postoperatively, or until discharge).<BR/>Incidence of myocardial infarction.<BR/>Myocardial ischaemia (criteria of ischaemia met: yes/no).<BR/>Dysrhythmias.<BR/>Cerebrovascular complications.<BR/>Heart failure (occurring 30 days postoperatively, or until discharge)<BR/>Length of stay (in ICU or hospital).<BR/>Quality of life.</P><P><BR/>26. Additional comments on this study</P><P><BR/>27. Contact<BR/>Is it necessary to contact the author(s) (YES, NO, if YES: name and address of corresponding author). </P></APPENDIX_BODY></APPENDIX><APPENDIX ID="APP-07" MODIFIED="2018-03-06 09:40:25 +0000" MODIFIED_BY="[Empty name]" NO="7"><TITLE MODIFIED="2011-07-31 20:55:51 +0100" MODIFIED_BY="Hermann Blessberger">Search results</TITLE><APPENDIX_BODY MODIFIED="2018-03-06 09:40:25 +0000" MODIFIED_BY="[Empty name]"><TABLE COLS="3" ROWS="22"><TR><TH><P>Database</P></TH><TH><P>Period of enquiry/last visit of website</P></TH><TH><P>Number of records</P></TH></TR><TR><TD><P>Biosis Previews</P></TD><TD><P>1970 to 6/2013</P></TD><TD><P>678</P></TD></TR><TR><TD><P>BLIC (British Library Inside Conferences)</P></TD><TD><P>1993 to 6/2003</P></TD><TD><P>35</P></TD></TR><TR><TD><P>CAB Abstracts</P></TD><TD><P>1972 to 6/2013</P></TD><TD><P>5</P></TD></TR><TR><TD><P>CENTRAL</P></TD><TD><P>May 2013</P></TD><TD><P>313</P></TD></TR><TR><TD><P>CINAHL</P></TD><TD><P>1982 to 6/2013</P></TD><TD><P>338</P></TD></TR><TR><TD><P>ClinicalTrials.gov</P></TD><TD><P>6/2013</P></TD><TD><P>95</P></TD></TR><TR><TD><P>CONFSCI</P></TD><TD><P>1973 to 10/2010</P></TD><TD><P>16</P></TD></TR><TR><TD><P>CPCI-Science</P></TD><TD><P>1995 to 6/2013</P></TD><TD><P>75</P></TD></TR><TR><TD><P>Derwent Drug File</P></TD><TD><P>1964 to 6/2013</P></TD><TD><P>557</P></TD></TR><TR><TD><P>Embase</P></TD><TD><P>1974 to 6/2013</P></TD><TD><P>5484</P></TD></TR><TR><TD><P>Global Health</P></TD><TD><P>1972 to 6/2013</P></TD><TD><P>13</P></TD></TR><TR><TD><P>IPA</P></TD><TD><P>1970 to 6/2013</P></TD><TD><P>63</P></TD></TR><TR><TD><P>ISTBP, ISTP/ISSHP</P></TD><TD><P>1978 to 6/2013</P></TD><TD><P>66</P></TD></TR><TR><TD><P>Life Sciences Collection</P></TD><TD><P>1982 to 10/2010</P></TD><TD><P>10</P></TD></TR><TR><TD><P>MEDLINE</P></TD><TD><P>1946 to 6/2013</P></TD><TD><P>964</P></TD></TR><TR><TD><P>mRCT</P></TD><TD><P>6/2013</P></TD><TD><P>214</P></TD></TR><TR><TD><P>National Research Register</P></TD><TD><P>6/2013</P></TD><TD><P>72</P></TD></TR><TR><TD><P>PASCAL</P></TD><TD><P>1977 to 6/2013</P></TD><TD><P>262</P></TD></TR><TR><TD><P>SCI-EXPANDED</P></TD><TD><P>1974 to 6/2013</P></TD><TD><P>914</P></TD></TR><TR><TD><P>SIGLE</P></TD><TD><P>1976 to 2013</P></TD><TD><P>1</P></TD></TR><TR><TH><P>Sum</P></TH><TH><P/></TH><TH><P>10,175</P></TH></TR></TABLE><SUBSECTION><HEADING LEVEL="6">Footnotes</HEADING><P>Records retrieved from each database with respective period of enquiry.</P></SUBSECTION></APPENDIX_BODY></APPENDIX></APPENDICES><EXTENSIONS/></COCHRANE_REVIEW>